{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "nemotron-nano-30b-reasoning",
    "experiment": "e1_kg_minimal",
    "pattern": "qualitative_3hop_cross_company_type1",
    "total_questions_in_experiment": 600
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Colgate-Palmolive (CL) compare to the total number of securities related to stock options, restricted stock units, and performance stock units available for future issuance at Procter & Gamble (PG)?",
      "original_answer": "Colgate-Palmolive (CL) reported 37,028,000 securities remaining available under equity compensation plans approved by security holders. Procter & Gamble (PG) disclosed that under similar plans, they had 133,185,995 total securities related to stock options, restricted stock units, and performance stock units available for future issuance. This indicates that PG has significantly more securities available for future issuance compared to CL.",
      "llm_answer": "\nColgate‑Palmolive (CL) discloses 37,028 (thousand) securities remaining available for future issuance under the equity‑compensation plans that have been approved by its security holders (Chunk 1 / 2).  \nProcter & Gamble (PG) reports only 2 (thousand) securities remaining available for future issuance across its stock‑option, RSU and PSU plans (Chunk 3).  \n\nThus, the securities left for future issuance under CL’s approved plans are roughly 18,500 times greater than the total securities available for future issuance under PG’s option/RSU/PSU plans, a relationship explicitly linked in the knowledge‑graph triplets (CL → Securities Remaining Available → PG).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer contains severe factual errors. (1) Quantitative inaccuracy: The LLM states that Procter & Gamble (PG) has only 2 thousand securities available for future issuance, whereas the ground truth reports 133,185,995, which is off by over 66 million times. It also misrepresents Colgate-Palmolive's (CL) figure as 37,028 thousand (i.e., ~37 million), which aligns approximately with the correct value of 37,028,000, though the formatting is confusing. However, the comparison is catastrophically wrong due to the incorrect PG number. (2) The calculation claiming CL has '18,500 times more' than PG is entirely false and based on fabricated data. (3) Multi-hop reasoning fails: the model incorrectly synthesizes information, possibly misreading or hallucinating data from 'Chunk 3', leading to a complete inversion of the truth — in reality, PG has significantly more securities available than CL, but the LLM claims the opposite with extreme exaggeration. (4) Entity accuracy is partially correct (CL and PG are right), but the metrics are wrong. (5) Contextual relevance is low due to the incorrect data and misleading conclusion. The answer contradicts the ground truth in both direction and magnitude, warranting a very low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 349,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the sensitivity of Google's foreign exchange forward contracts to a 10% weakening of the U.S. dollar compare with Disney's hedge coverage for forecasted foreign currency transactions in terms of notional exposure and risk mitigation horizon?",
      "original_answer": "Google's foreign exchange forward contracts would result in a $660 million impact on AOCI as of December 31, 2024, from a 10% weakening of the U.S. dollar, reflecting its net investment hedge strategy. In contrast, Disney hedges forecasted foreign currency transactions with a notional exposure of $9.9 billion as of September 28, 2024, and maintains coverage for periods generally not exceeding four years. While Google focuses on offsetting translation risk from foreign subsidiaries, Disney aims to stabilize earnings and cash flows by hedging forecasted transactions in major currencies like the euro and Japanese yen.",
      "llm_answer": "\nGoogle’s foreign‑exchange forward contracts are designated as net‑investment hedges, and a 10 % U.S.‑dollar weakening would lower the cumulative‑translation‑adjustment balance by roughly **$946 million (as of 31 Dec 2023) and $660 million (as of 31 Dec 2024)**, showing the direct sensitivity of its hedge book.  \nDisney, in contrast, protects forecasted foreign‑currency cash flows with **net‑FX cash‑flow hedges totalling $9.9 billion (as of 28 Sep 2024) and $8.3 billion (as of 30 Sep 2023)**, and its policy limits the hedge horizon to **up to four years**, with about **$99 million of deferred gains set to mature in the next twelve months**.  \n\nThus, Google’s hedge sensitivity is expressed in hundreds of millions of dollars for a 10 % move, while Disney’s program covers multiple billions of dollars of exposure and mitigates risk over a longer, policy‑defined (up‑to‑four‑year) horizon.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) Quantitatively, the key figures match the ground truth: Google's $660 million impact as of December 31, 2024, and Disney's $9.9 billion notional exposure as of September 28, 2024, are correctly reported. The LLM adds extra data points (e.g., $946 million for Google in 2023 and $8.3 billion for Disney in 2023), which are not in the original answer but do not contradict it and may reflect broader context from the filings; these additions are acceptable and enhance completeness without introducing error. (2) The dates (Dec 31, 2024; Sep 28, 2024) align with the ground truth. (3) The qualitative reasoning is sound: the LLM correctly distinguishes Google’s net investment hedges (addressing translation risk/AOCI impact) from Disney’s cash flow hedges (mitigating forecasted transaction risk), and accurately notes Disney’s up-to-four-year horizon, matching the 'generally not exceeding four years' in the original. (4) The synthesis across companies and hedge types is logical and directly addresses the comparative question on sensitivity, notional exposure, and risk mitigation horizon. The only minor deviation is the mention of $99 million in deferred gains, which is not in the original answer and slightly exceeds the scope, but does not distort the core comparison. Overall, the answer conveys the same meaning with enhanced detail, maintaining factual correctness and strong multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Impacts]-> FIN_INST <-[Hedges]- ORG",
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 402,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Procter & Gamble compare to Colgate-Palmolive’s available securities, considering both companies disclose these figures under similar categories?",
      "original_answer": "Procter & Gamble reports that there are 133,185,995 securities remaining available for future issuance under equity compensation plans approved by security holders, while Colgate-Palmolive discloses 37,028,000 securities remaining available under the same category. This indicates that P&G has a significantly larger pool of available securities for future equity compensation compared to Colgate-Palmolive.",
      "llm_answer": "\nBoth Procter & Gamble and Colgate‑Palmolive disclose the “securities remaining available for future issuance under equity compensation plans approved by security holders” in the same table format.  \n- In PG’s filing (Chunk 1) the total remaining availability is shown only as the footnote “(2)” under column (c) of the table.  \n- In Colgate‑Palmolive’s filing (Chunks 2 & 3) the same column (c) reports **37,028 (thousands)** of shares remaining available.  \n\nThus, Colgate‑Palmolive has a larger pool of securities left for future issuance under its approved equity compensation plans than Procter & Gamble.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It incorrectly states that Colgate-Palmolive has a larger pool of available securities than Procter & Gamble, when the ground truth shows P&G has 133,185,995 versus Colgate's 37,028,000. The LLM reverses the comparison, leading to a completely incorrect conclusion. (2) The quantitative accuracy is partially correct for Colgate-Palmolive: it reports '37,028 (thousands)', which correctly translates to 37,028,000 shares. However, it fails to provide the actual number for Procter & Gamble, instead noting only that it is in a footnote without extracting the value (133,185,995). This omission and lack of extraction severely undermines the quantitative response. (3) The multi-hop reasoning is flawed: the model identifies that both companies report under similar categories and uses the correct column (c) and concept, but fails to retrieve and compare the actual numbers correctly. It incorrectly infers that because Colgate’s number is explicitly in the table and P&G’s is in a footnote, the former must be larger—this is a logical error. (4) Contextual relevance is moderate: the answer addresses the right disclosure category and recognizes the structural similarity in filings, showing awareness of the required comparison. However, due to the reversal of the result and missing key data, the overall correctness score is low. The answer misleads rather than informs.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 399,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does AbbVie's patent litigation against Sandoz Inc. over upadacitinib relate to Amgen's legal strategy in defending its own patents against Sandoz's counterclaims regarding denosumab biosimilar development?",
      "original_answer": "AbbVie is actively enforcing its patents for upadacitinib (Rinvoq) by suing Sandoz Inc. and other generic drug manufacturers, seeking injunctive relief to prevent premature market entry of generic versions. Meanwhile, Amgen faces litigation from Sandoz Inc., which has filed counterclaims asserting that Amgen's asserted patents for denosumab are invalid or unenforceable. Both companies are engaged in high-stakes patent battles involving Sandoz Inc., but while AbbVie is in the offensive position protecting its drug exclusivity, Amgen is defending its intellectual property against Sandoz's legal challenges, revealing contrasting legal dynamics in the biopharmaceutical patent ecosystem.",
      "llm_answer": "\nAbbVie’s 2023 Delaware patent infringement suit against Sandoz to block generic upadacitinib (Chunk 1) is part of the same adversarial pattern that Amgen is using in its denosumab biosimilar case, where Amgen sued Sandoz and then confronted Sandoz’s counterclaims of patent invalidity while seeking a preliminary injunction and a dismissal of those claims (Chunks 2‑3). The knowledge‑graph link Counterclaims (LITIGATION) → AMGN shows that Amgen’s defensive strategy—asserting its own patents and responding to Sandoz’s challenges—is directly connected to the litigation AbbVie is pursuing against Sandoz, reflecting a coordinated patent‑enforcement approach across both companies.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but introduces significant inaccuracies in reasoning and entity relationships. (1) Quantitatively, the mention of a '2023 Delaware patent infringement suit' by AbbVie against Sandoz for upadacitinib is plausible and aligns with typical patent litigation timelines, though the ground truth does not specify the year or jurisdiction, so this cannot be fully verified. No monetary figures or exact dates are provided, so scoring is based on event accuracy. (2) The answer incorrectly frames the relationship between AbbVie’s and Amgen’s legal actions as part of a 'coordinated patent-enforcement approach'—the ground truth states that AbbVie is in an offensive position while Amgen is defending against Sandoz’s counterclaims, with no evidence of coordination. This misrepresents the core dynamic. (3) The multi-hop reasoning fails: while both companies are involved in litigation with Sandoz, the nature of the legal strategies is contrasting (offensive vs. defensive), not aligned. The LLM incorrectly infers a strategic connection via a 'knowledge-graph link' that suggests coordination, which is not supported by the original answer. (4) Entity accuracy is mostly correct—AbbVie, Amgen, Sandoz, upadacitinib, and denosumab are all correctly identified in context. However, the use of 'Chunk 1', 'Chunks 2–3', and 'knowledge-graph link' suggests reliance on internal document segmentation not present in the original, raising concerns about hallucination. (5) Contextual relevance is high—the answer addresses the core topic of patent litigation involving Sandoz and both companies. However, the conclusion distorts the relationship between the two cases. Thus, while some facts are accurate, the synthesis and reasoning are flawed, leading to a mid-range correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Involved_In]-> COMP -[Discloses]-> LITIGATION <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 493,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does the voting power dilution mechanism in CMCSA's Class B to Class A common stock conversion compare with GOOGL's multi-class stock structure, particularly in light of the $62.2 billion in Class A and Class C shares repurchased by GOOGL in 2023?",
      "original_answer": "GOOGL repurchased $62.2 billion of its Class A and Class C shares in 2023, maintaining a multi-class structure where Class B shares carry 10 votes per share and convert automatically upon sale or transfer to Class A, which has 1 vote per share. In contrast, CMCSA's Class B shares carry 15 votes and are convertible share-for-share into Class A shares, with Class B's aggregate voting power capped at 33 1/3% and protected from dilution under its articles of incorporation. This means CMCSA has a stronger anti-dilution mechanism for its Class B shares compared to GOOGL, where Class B shares lose their enhanced voting rights upon conversion. Additionally, GOOGL's repurchase activity in 2023 may have concentrated voting control among remaining Class B shareholders by reducing the total number of Class A shares outstanding.",
      "llm_answer": "\nCMCSA’s Class B shares carry 15 votes each and convert into Class A on a one‑for‑one basis, with the 33.3 % aggregate voting interest of Class B explicitly protected from dilution by any further issuances (Chunk 2).  By contrast, GOOGL’s Class B shares hold 10 votes each and may be converted to the single‑vote Class A shares either at the holder’s option or automatically upon sale, and the $62.2 billion repurchase of Class A and Class C shares in 2023 shrinks the Class A pool, thereby raising the proportional voting weight of the remaining Class B shares (Chunk 1).  The knowledge‑graph link (Class B → Class A → CMCSA) shows that both companies allow Class B‑to‑Class A conversion, but CMCSA’s conversion preserves a fixed, non‑dilutable voting‑power split, whereas GOOGL’s conversion is tied to share‑repurchase activity that directly alters the voting‑power balance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: CMCSA Class B has 15 votes, converts 1:1 to Class A, and its voting power is capped at 33.3% with anti-dilution protection. GOOGL Class B has 10 votes, converts to Class A upon sale or at holder's option, and $62.2 billion in Class A and C shares were repurchased in 2023. (2) Quantitative accuracy is perfect: $62.2 billion, 15 votes, 10 votes, 33.3% cap—all match the original. Format variations (e.g., 33.3% vs 33 1/3%) are semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly contrasts CMCSA’s structural anti-dilution protection with GOOGL’s dynamic voting concentration via repurchases. It accurately notes that GOOGL’s repurchase of non-voting (Class C) and single-voting (Class A) shares reduces the total voting pool, thereby increasing the relative influence of remaining Class B shares. (4) The only minor shortcoming is that the LLM does not explicitly state that GOOGL’s Class B shares lose enhanced voting rights upon conversion—this is implied but not directly mentioned. However, the emphasis on CMCSA preserving voting power post-conversion versus GOOGL’s repurchase-driven shift in balance captures the essential contrast. Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Converts_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 380,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How does the number of shares reserved for future issuance under Nike's Equity Compensation Plan compare to the number of shares represented by outstanding warrants at Tesla, based on their respective 2023 filings?",
      "original_answer": "Nike reported 97,567,370 shares remaining available for future issuance under its Equity Compensation Plan, while Tesla disclosed that 11 million shares were represented by outstanding warrants in 2023. Therefore, Nike's available shares under its equity plan are significantly higher than Tesla's outstanding warrants.",
      "llm_answer": "\nIn Nike’s 2023 filing (Chunk 2) the Equity Compensation Plan shows **97,567,370 shares remaining available for future issuance**—the amount reserved for later grants.  Tesla’s 2023 filing (Chunk 3) reports **11 million shares underlying outstanding warrants** (the “Warrants” line in the diluted‑share calculation).  Because Chunk 1 establishes the regulatory link that Nike’s plan discloses warrants that ultimately connect to Tesla (NKE → Equity Compensation Plan → Warrants → TSLA), the comparison is direct: Nike’s reserved shares (≈97.6 M) are about **8.9 times** the number of shares represented by Tesla’s outstanding warrants.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the numbers are correct: Nike's 97,567,370 shares available for future issuance and Tesla's 11 million shares underlying outstanding warrants match the original answer exactly. The comparison stating Nike's figure is about 8.9 times Tesla's is mathematically accurate (97.567M / 11M ≈ 8.87). (2) The answer is complete, addressing both companies, the correct metric (shares reserved vs. shares under warrants), and the year (2023). (3) Entity accuracy is strong: correct company names, correct plan (Nike Equity Compensation Plan), correct financial instrument (Tesla's outstanding warrants), and correct year. (4) The reasoning is mostly sound, though the claim in Chunk 1 about a 'regulatory link' connecting Nike’s plan to Tesla via warrants appears fabricated or misinterpreted—there is no such cross-company linkage in reality; the comparison is valid as a numerical contrast, not due to any structural or regulatory connection between Nike's equity plan and Tesla's warrants. This overreach in logic slightly reduces qualitative accuracy, but does not undermine the core factual correctness. (5) The semantic meaning fully matches the original answer, with added precision in the ratio calculation. The extra interpretation of a connection between Nike and Tesla is misleading but does not affect the numerical or comparative validity. Overall, the answer is factually correct, well-structured, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 417,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the number of shares issuable upon exercise of outstanding warrants disclosed by Tesla in 2023 compare to the number of shares remaining available for future issuance under Nike's equity compensation plans, based on their respective disclosures?",
      "original_answer": "Tesla disclosed that in 2023, there were 11 million shares issuable upon exercise of outstanding warrants. In contrast, Nike, through its equity compensation plan disclosures, indicated that 97,567,370 shares were remaining available for future issuance under compensation plans. This highlights a significant difference in scale between Tesla's warrant-related share exposure and Nike's available equity compensation pool.",
      "llm_answer": "\nTesla’s 2023 Form 10‑K (Chunk 1) lists the warrants component of diluted shares at **11 million** shares issuable upon exercise of outstanding warrants. Chunk 2 shows Nike’s equity‑compensation plan disclosing **97,567,370** shares remaining available for future issuance, and the KG link (TSLA → Warrants → Equity Compensation Plan → NKE) ties Tesla’s warrant disclosure to Nike’s plan. Thus, the number of shares that can be obtained by exercising Tesla’s warrants (≈11 million) is far smaller than the ≈97.6 million shares Nike still has available under its equity‑compensation plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key numbers from both Tesla and Nike disclosures: 11 million shares for Tesla's outstanding warrants (from 2023 10-K) and 97,567,370 shares remaining under Nike's equity compensation plans. These match the ground truth exactly. The comparison stating that Tesla's number is 'far smaller' than Nike's is accurate and semantically equivalent to the original answer's 'significant difference in scale'. (2) Quantitative accuracy is perfect: both figures are reported correctly with no calculation errors. The approximation to '≈97.6 million' is acceptable and common in financial communication. (3) The multi-hop reasoning is sound—correctly linking Tesla’s warrant disclosure to Nike’s separate equity compensation data. However, the mention of a 'KG link (TSLA → Warrants → Equity Compensation Plan → NKE)' introduces an artificial knowledge graph path not required or evident in the reasoning; while not factually incorrect, it adds unnecessary and potentially misleading structural detail not present in the source data. (4) The answer is fully contextually relevant, directly addressing the comparative question with correct entities, years, and metrics. The only minor flaw is the extraneous KG link explanation, which does not affect factual correctness but slightly reduces qualitative precision. Thus, high scores across all categories with a single point deducted from qualitative accuracy for the unnecessary KG path assertion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 410,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does the differential voting power per share in GOOGL's Class B common stock impact its corporate governance structure, compared to NFLX's uniform voting rights model where each share carries one vote?",
      "original_answer": "GOOGL's Class B common stock provides 10 votes per share, significantly enhancing the voting influence of its holders compared to the 1 vote per share for Class A and no voting rights for Class C stock. This structure allows key stakeholders holding Class B shares to maintain disproportionate control over corporate decisions. In contrast, NFLX provides uniform voting rights, where each share of common stock entitles the holder to exactly one vote, promoting a more egalitarian governance model. The difference in voting rights structures reflects contrasting philosophies in corporate governance between the two companies.",
      "llm_answer": "\nAlphabet’s Class B common stock is entitled to 10 votes per share, while its Class A shares carry one vote and Class C shares have no voting rights; this dual‑class structure concentrates disproportionate voting power in the hands of insiders who hold the Class B shares, so that a minority of equity can control board elections and strategic decisions.  By contrast, Netflix’s charter gives every share a single vote, aligning voting power directly with ownership and producing a more egalitarian governance model.  Moreover, Alphabet’s recent share‑repurchase authorizations—$59.3 bn, $62.2 bn and $62.0 bn of Class A and Class C shares repurchased in 2022‑24, with $44.7 bn still available—affect only the non‑voting or low‑voting classes, leaving the 10‑vote Class B shares untouched and thereby preserving the voting concentration described in the Voting‑Rights accounting policy that also governs Netflix.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core difference in voting structures between GOOGL and NFLX, accurately stating that GOOGL's Class B shares have 10 votes per share, Class A have 1 vote, and Class C have none, while NFLX provides one vote per share uniformly. This aligns with the ground truth and reflects sound qualitative understanding of corporate governance implications. The reasoning about disproportionate control by insiders and the egalitarian model at Netflix is logically sound and semantically equivalent to the original answer. However, the LLM introduces specific quantitative details not present in the ground truth—namely, the repurchase amounts ($59.3B, $62.2B, $62.0B in 2022–24 and $44.7B remaining)—which, while potentially accurate, are not part of the verified knowledge graph answer and were not requested in the question. These additions do not contradict known facts but go beyond the scope of the original answer, slightly reducing quantitative accuracy due to unverifiability in this context. There is no indication these numbers are incorrect, but their inclusion introduces extraneous detail not grounded in the provided truth. The multi-hop reasoning is appropriate: comparing governance models and linking share repurchases in non-voting classes to preservation of control, which enhances the explanation. All entities (GOOGL, NFLX, share classes) are correctly identified. The answer remains highly relevant and factually consistent with the main thrust of the ground truth, warranting a high correctness score despite the added numerical specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 433,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What percentage of Chevron's average daily net crude oil production in 2021 came from the QG3 project through its stake in Qatargas Operating Company Limited?",
      "original_answer": "Chevron's average daily net crude oil production from the QG3 project through its stake in Qatargas Operating Company Limited was 13 MBD in 2021. Since Chevron holds a 30% interest in Qatargas, this production volume reflects Chevron's proportional share of the crude oil output from the QG3 project.",
      "llm_answer": "\nThe 2021 COP 10‑K table shows that the QG3 project produced 13 MBD of crude oil and that Chevron’s recorded interest in the operator, Qatargas Operating Company Limited, is **30 %**. Because Chevron’s stake in Qatargas gives it a 30 % share of QG3’s output, **30 % of Chevron’s average daily net crude‑oil production in 2021 came from the QG3 project through its stake in Qatargas Operating Company Limited**.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains partially correct quantitative information but fails the core question due to a critical reasoning error. (1) Quantitatively, the LLM correctly identifies that Chevron has a 30% stake in Qatargas Operating Company Limited and that the QG3 project produced 13 MBD of crude oil, which aligns with the ground truth. However, the key error lies in the interpretation: the 13 MBD is Chevron's *net* production (i.e., already its 30% share), not the total project output. (2) The LLM incorrectly concludes that '30% of Chevron’s average daily net crude-oil production in 2021 came from the QG3 project', which is unsupported by the data. The original answer states that Chevron’s net production from QG3 was 13 MBD, but provides no information about Chevron’s *total* net crude oil production in 2021, making it impossible to calculate the percentage of total production attributable to QG3. (3) The multi-hop reasoning fails: the model conflates ownership percentage (30%) with the share of total company production, committing a logical fallacy. It assumes that because Chevron owns 30% of the project, the project contributes 30% of Chevron’s total production, which is not supported by the data. (4) While the entities (Chevron, QG3, Qatargas, 2021, 13 MBD, 30%) are correctly identified, the synthesis is flawed. The answer is contextually relevant but fundamentally incorrect in its conclusion, hence low correctness and qualitative accuracy scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> RAW_MATERIAL -[Produces]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 404,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the adoption of ASU 2022-04 impact the transparency of supplier finance obligations for both 3M and Honeywell, particularly in terms of the new roll-forward disclosure requirements effective in 2024?",
      "original_answer": "The adoption of ASU 2022-04 enhances transparency for both 3M and Honeywell by mandating detailed annual disclosures about supplier finance program obligations, including a roll-forward of confirmed invoice amounts. For 3M, this includes reporting $1.5 billion of invoices confirmed and $1.5 billion of invoices paid or adjusted in 2024, which is now disclosed as part of the roll-forward requirement. Honeywell adopted the roll-forward provisions starting in 2024, aligning with the ASU’s phased implementation. Both companies now provide clearer visibility into their supplier finance activities, improving comparability and risk assessment for stakeholders.",
      "llm_answer": "\nThe September 2022 ASU 2022‑04 obligates a buyer that uses supplier‑finance programs to disclose the program’s key terms, the balance‑sheet location of the related amounts, and—most importantly for 2024—a roll‑forward schedule that shows the opening balance, additions, deductions and closing balance of the confirmed invoices, with interim disclosure of the period‑end outstanding amount. Both 3M and Honeywell adopted this guidance: 3M’s Note 16 (and the referenced Note 15) now presents the $0.3 billion of confirmed invoice balances and the 2024 roll‑forward activity, while Honeywell’s Note 15 explicitly states that it began roll‑forward disclosures on Jan 1 2024. By requiring these detailed, period‑by‑period roll‑forward disclosures, the ASU makes the size, composition and movement of each company’s supplier‑finance obligations far more transparent to investors.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the intent and key requirements of ASU 2022-04, including the roll-forward disclosure and its significance for transparency, and correctly states that both 3M and Honeywell adopted the new disclosures starting in 2024. However, it contains a critical quantitative error: it reports $0.3 billion in confirmed invoice balances for 3M, whereas the ground truth states $1.5 billion of invoices confirmed and $1.5 billion paid or adjusted in 2024. This is a major factual discrepancy. (2) The numbers are not accurate—$0.3B vs $1.5B is a five-fold difference, and the answer fails to mention the $1.5B paid/adjusted component entirely. Additionally, the LLM references 'Note 16' and 'Note 15' for 3M and Honeywell, which may be factually specific but are not verifiable from the ground truth provided and may be hallucinated details. (3) The multi-hop reasoning is partially sound: the model correctly links ASU 2022-04 to enhanced transparency via roll-forward disclosures and applies it to both companies. It correctly notes Honeywell’s adoption date as January 1, 2024, aligning with the phased implementation. However, it fails to accurately synthesize the quantitative impact for 3M, undermining the factual core of the answer. (4) The contextual relevance is high—response stays on topic and addresses the impact on transparency and the role of roll-forward disclosures. Qualitative accuracy is moderate due to correct conceptual understanding but flawed data integration. Correctness score is 5 due to significant numerical inaccuracy despite correct framework and entities.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Agrees]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 445,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does LMT's revenue recognition approach for U.S. Government contracts regulated by FAR compare to RTX's financial exposure to U.S. Government contract risks, particularly in relation to fixed-price contract structures?",
      "original_answer": "LMT recognizes revenue for U.S. Government contracts regulated by the FAR using a cost-plus-fixed-fee model, where the standalone selling price is typically equal to the contract price due to FAR-mandated cost-plus structures. RTX, on the other hand, faces financial exposure from its reliance on fixed-price contracts, especially firm fixed-price (FFP) contracts, where it bears the full burden of cost overruns. Both companies are subject to U.S. Government contract risks, but LMT's FAR-regulated contracts provide more predictable revenue due to cost reimbursement with a reasonable profit margin, whereas RTX's FFP contracts carry higher risk of negative profit adjustments, particularly in development programs.",
      "llm_answer": "\nLMT recognizes revenue on its U.S. Government contracts subject to the FAR by applying a single‑performance‑obligation model in which the fixed contract price—treated as the standalone selling price—is allocated to the entire contract and revenue is recorded over time as control of the work‑in‑process transfers to the government. This regulatory framework (FAR / CAS audits) is the same regime that governs the U.S. Government contracts on which RTX depends, but RTX’s financial exposure under those contracts is markedly higher because its fixed‑price arrangements (FFP or FPI) obligate it to absorb all cost overruns, accept termination‑for‑default or convenience risks, and endure funding uncertainties that can trigger profit reductions or liquidity strain. Consequently, while LMT’s revenue‑recognition is relatively stable and tied to the predetermined contract price, RTX’s profitability is directly vulnerable to the variable cost and termination risks inherent in those same fixed‑price U.S. Government contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) Quantitatively, there are no numbers, dates, or financial figures to verify, so no inaccuracies exist—this earns a perfect score. (2) The LLM correctly identifies that LMT uses a cost-plus-fixed-fee model under FAR, though it describes revenue recognition as being based on a 'single-performance-obligation model' and 'over time as control transfers,' which aligns with ASC 606 but slightly reframes the ground truth's emphasis on cost reimbursement. This is semantically valid and not incorrect. (3) The LLM accurately contrasts RTX’s exposure to fixed-price contracts (FFP/FPI), correctly noting that RTX bears cost overruns, termination risks, and funding uncertainties—key elements of financial exposure. It correctly synthesizes the multi-hop comparison between LMT’s stable revenue model and RTX’s higher-risk structure. (4) The only reason for not scoring a 10 is that the LLM does not explicitly mention 'cost-plus' as the structural reason for LMT’s predictability, instead focusing on contract price and control transfer. While implied, this slight omission reduces qualitative precision by a point. Otherwise, the answer is contextually rich, logically sound, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Regulates]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 368,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does the expiration timeline of BMY's Eliquis patent rights in Europe compare to MRK's Januvia family patent expiration in the U.S., and what impact does this have on their respective market exclusivity strategies?",
      "original_answer": "BMY is actively litigating to extend the market exclusivity of Eliquis in Europe, having secured final positive decisions in Norway, Sweden, and Switzerland, while facing negative outcomes in the UK and ongoing appeals in several other countries. Despite these efforts, generic competition has already entered in some markets like Finland and Portugal. In contrast, MRK's Januvia family lost its key U.S. patent in January 2023, but due to court rulings and settlements, exclusivity is maintained until May 2026 for Januvia and Janumet and July 2026 for Janumet XR. This difference in timelines and enforcement success highlights how BMY's fragmented European patent strategy faces more immediate generic erosion, while MRK has extended exclusivity in the U.S. through secondary patents, delaying generic entry and preserving revenue longer.",
      "llm_answer": "\nBMY’s Eliquis composition‑of‑matter patents in Europe are being defended through a dense web of litigation across more than a dozen countries, with mixed outcomes – the UK has already allowed generic entry, Norway, Sweden and Switzerland have delivered positive rulings, while appeals are pending in France, the Netherlands, Spain, Finland and Ireland, meaning the effective exclusivity period may erode well before the patent’s formal expiry and is being extended only by ongoing court battles.  \nIn the United States, MRK’s Januvia family’s core patent expired in January 2023, but because of later‑filed salt‑form patents and settlement agreements, market exclusivity is not projected to end until May 2026 for Januvia and July 2026 for Janumet XR, even though EU exclusivity for Januvia and Janumet was lost in 2022‑2023.  \nThese divergent timelines force BMY to rely on aggressive patent‑defense and possible regulatory‑exclusivity extensions to hold its European monopoly, whereas MRK is adjusting pricing, confronting new Medicaid rebate and IRA‑driven price‑setting pressures, and preparing for the 2026 U.S. patent cliff that will drive steep sales declines.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: BMY's Eliquis patent litigation in Europe has mixed outcomes—positive in Norway, Sweden, Switzerland; negative in the UK; ongoing appeals in several countries including France, Netherlands, Spain, Finland, and Ireland. The LLM correctly notes that generic entry has occurred in some markets (e.g., Finland), aligning with the ground truth mentioning Finland and Portugal. For MRK, the core Januvia patent expired in January 2023, and exclusivity is extended to May 2026 for Januvia/Janumet and July 2026 for Janumet XR due to settlements and secondary patents—this is accurately reflected. (2) Quantitative accuracy is perfect: all dates (January 2023, May 2026, July 2026) are correct and match the original answer. (3) Multi-hop reasoning is sound: the model correctly contrasts BMY’s fragmented, litigation-dependent European strategy with MRK’s U.S. strategy leveraging secondary patents and settlements to extend exclusivity. It also correctly infers strategic implications—BMY defending through litigation, MRK preparing for a 2026 cliff. (4) Minor deduction in qualitative accuracy because the LLM mentions 'EU exclusivity for Januvia and Janumet was lost in 2022–2023'—while plausible, this detail was not in the ground truth and slightly overextends the provided information. However, it does not contradict it. Otherwise, the synthesis across companies, regions, and strategies is excellent. Contextual relevance is full—every part of the question is addressed with precise, relevant details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> RISK_FACTOR -[Provides]-> REGULATORY_REQUIREMENT <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 437,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What is the total amount of appeal bonds posted by PM USA related to adverse verdicts on appeal, and how does this compare to the total payments made by PM USA for judgments and settlements in tobacco-related litigation since October 2004?",
      "original_answer": "PM USA has posted appeal bonds totaling $35 million related to adverse verdicts currently on appeal. Since October 2004, PM USA has paid approximately $1 billion in judgments and settlements (including related costs and fees) and approximately $241 million in interest related to tobacco litigation. This indicates that the current appeal bonds represent a small fraction of the total historical litigation-related payments made by PM USA.",
      "llm_answer": "\nPM USA has posted appeal bonds of **approximately $35 million** to obtain stays of adverse verdicts on appeal (the security tied to the Létourneau and Blais Canadian judgments, as noted in Chunk 1 and disclosed in Chunk 2, with the bonds collateralized by restricted cash and reflected in assets).  \n\nThis amount is a tiny fraction of the **roughly $1 billion in judgments and settlements** (plus about **$241 million of interest**) that PM USA has paid for tobacco‑related litigation since October 2004, as reported in Chunk 3.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the $35 million in appeal bonds, $1 billion in judgments and settlements, and $241 million in interest are all accurately reported with correct timeframes (since October 2004). Format variations (e.g., 'approximately' vs 'roughly') are semantically equivalent and acceptable. (2) The answer is complete, addressing both parts of the multi-part question: the total appeal bonds posted and the comparison to historical payments. (3) Entities are correctly identified—PM USA is the focus, and the financial metrics (judgments, settlements, interest, appeal bonds) are accurately attributed. (4) The reasoning is sound: the LLM correctly synthesizes information across multiple data points (bonds on appeal vs. total litigation payments) and draws the logical conclusion that the bonds represent a small (or 'tiny') fraction of total payments, which aligns with the ground truth's qualitative assessment. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> COMP -[Posts]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 299,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How does the revenue contribution from Taiwan differ between Apple's Greater China segment in 2022 and NVIDIA's direct revenue reported from Taiwan in the same year?",
      "original_answer": "Apple's Greater China segment generated $74,200 million in net sales in 2022, which includes Taiwan along with China mainland and Hong Kong. In contrast, NVIDIA directly reported $8,544 million in revenue from Taiwan in 2022. Since Apple's figure for Taiwan is embedded within the broader Greater China segment, the exact revenue contribution from Taiwan alone for Apple cannot be determined precisely but is a subset of the $74,200 million. NVIDIA’s $8,544 million provides a direct and isolated measure of its Taiwan revenue.",
      "llm_answer": "\nApple’s 2022 Greater China segment—whose definition explicitly includes Taiwan (Chunk 2)—reported $74.2 billion of net sales for that region (Chunk 1). In the same year NVIDIA recorded $8.544 billion of revenue that was attributed directly to Taiwan (Chunk 3). Therefore, Taiwan contributes a portion of Apple’s much larger Greater China sales, while NVIDIA’s standalone Taiwan revenue is only about 11 % of the amount Apple generates from its entire Greater China operation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key numbers are correct: Apple's Greater China revenue is accurately reported as $74.2 billion (equivalent to $74,200 million), and NVIDIA's Taiwan revenue is correctly stated as $8.544 billion (equal to $8,544 million). Number formats are valid variations. (2) The calculation that NVIDIA’s revenue is about 11% of Apple’s Greater China revenue is approximately correct: (8.544 / 74.2) ≈ 11.5%, so rounding to 'about 11%' is reasonable and acceptable. (3) The reasoning correctly identifies that Apple does not report Taiwan separately but includes it in Greater China, while NVIDIA provides a direct figure—this multi-hop synthesis across companies and reporting structures is sound. (4) The answer addresses the core of the question—how revenue contribution from Taiwan differs between the two companies—by contrasting Apple’s embedded reporting with NVIDIA’s direct disclosure. The only minor shortcoming is that the answer could have more explicitly stated that Apple’s Taiwan revenue cannot be isolated, which slightly weakens the qualitative precision, but the implication is clear. Overall, the response is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 350,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 233,
      "question": "How has the growth in NVDA's revenue from Taiwan between fiscal years 2020 and 2022 compared to the growth in AAPL's revenue from the Greater China region, which includes Taiwan?",
      "original_answer": "NVDA's revenue from Taiwan grew from $3,025 million in 2020 to $8,544 million in 2022, representing a 182.5% increase over two years. AAPL's revenue from Greater China, which includes Taiwan, grew from $40,308 million in 2020 to $74,200 million in 2022, representing an 84.1% increase over the same period. Therefore, NVDA experienced significantly higher growth in revenue from Taiwan (as part of its broader regional exposure) compared to AAPL's growth in the broader Greater China region.",
      "llm_answer": "\nNVIDIA’s (NVDA) revenue from Taiwan grew from **$3.0 billion in fiscal 2020 to $8.5 billion in fiscal 2022**, a **~182 % increase** (Chunk 1).  Apple’s (AAPL) “Greater China” segment—defined to include Taiwan (Chunk 2)—rose from **$40.3 billion in 2020 to $74.2 billion in 2022**, a **~84 % increase** (Chunk 3).  Because the knowledge‑graph links NVDA→Taiwan→Greater China←AAPL (Chunk KG), this shows NVDA’s Taiwan growth outpaced AAPL’s overall Greater China growth by roughly **98 percentage points**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: All numbers are correct and properly formatted. NVDA's revenue from Taiwan is accurately reported as $3.0 billion (equivalent to $3,025 million) in 2020 and $8.5 billion (equivalent to $8,544 million) in 2022, with a ~182% increase — matching the 182.5% in the original answer (minor rounding is acceptable). AAPL's Greater China revenue is correctly stated as $40.3 billion (vs $40,308 million) in 2020 and $74.2 billion (vs $74,200 million) in 2022, with an ~84% increase (vs 84.1%), again within acceptable rounding. (2) Completeness: The answer addresses both companies, both time periods, both revenue figures, and the comparative growth — satisfying the multi-part, multi-hop nature of the question. (3) Entity accuracy: Correct tickers (NVDA, AAPL), correct regions (Taiwan for NVDA, Greater China including Taiwan for AAPL), and correct fiscal years (2020 to 2022) are used. (4) Reasoning: The multi-hop logic is sound — it correctly links NVDA’s Taiwan exposure to AAPL’s broader Greater China region (which includes Taiwan), acknowledges the difference in geographic scope, and draws the valid conclusion that NVDA’s growth outpaced AAPL’s by about 98 percentage points (182% - 84% ≈ 98), which is consistent with the original answer’s implication of significantly higher growth. (5) Semantic equivalence: Despite slightly more concise wording and use of 'billion' instead of 'million', all financial data and conclusions are factually and semantically equivalent. The addition of a precise point-difference in growth (98 percentage points) enhances clarity without introducing error. No factual, numerical, or logical flaws are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 474,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 235,
      "question": "How does Microsoft's projected tax liability under the OECD's Pillar Two Model Rules compare to Broadcom's exposure from the global minimum tax, given their differing international tax structures?",
      "original_answer": "Microsoft projects no material impact from the OECD's Pillar Two Model Rules, which establish a 15% global minimum tax, as it begins applying to the company in fiscal year 2025. In contrast, Broadcom notes that global minimum tax provisions, such as Singapore's adoption effective for fiscal year 2026, may materially increase its effective tax rate and cash tax costs. This divergence reflects Microsoft's current lack of material operations in jurisdictions with tax rates below the 15% threshold, versus Broadcom's existing reliance on tax incentives in various jurisdictions that could be adversely affected by the global minimum tax.",
      "llm_answer": "\nMicrosoft will begin to be subject to the OECD Pillar Two 15 % global minimum tax in fiscal 2025; although it does not currently estimate a material effect on its consolidated results, the rule is expected to apply to its multinational income stream. Broadcom, meanwhile, notes that many jurisdictions are adopting the same 15 % minimum tax and that its operations in places such as Singapore—where the rule takes effect in 2026—could cause a material increase in its effective tax rate and cash‑tax costs, a risk it explicitly highlights. Thus, while Microsoft’s projected liability under Pillar Two is presently viewed as limited, Broadcom’s exposure is framed as potentially material due to its broader international tax footprint.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Microsoft begins being subject to Pillar Two in fiscal 2025 with no material impact projected; Broadcom faces potential material increases in effective tax rate and cash taxes due to adoption in jurisdictions like Singapore starting in fiscal 2026. (2) Quantitative accuracy is perfect: the 15% global minimum tax rate, fiscal years 2025 (Microsoft) and 2026 (Singapore/Broadcom) are correctly cited. No calculations are required, but the comparison of exposure levels (limited vs. material) is accurately reflected. (3) Multi-hop reasoning is sound—LLM correctly synthesizes Microsoft’s lack of material operations in low-tax jurisdictions with its minimal exposure, versus Broadcom’s broader international footprint and reliance on tax incentives that could be disrupted. (4) The only minor shortcoming is that the LLM does not explicitly state *why* Microsoft has limited exposure (i.e., lack of operations in sub-15% jurisdictions), though it is implied by contrast with Broadcom. This slight omission in explanatory depth prevents a perfect 10 on qualitative accuracy, but the core reasoning and factual content remain intact. Overall, the answer is semantically equivalent, contextually precise, and factually correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 369,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 245,
      "question": "How does the difference in voting rights structure between NFLX common stock and GOOGL Class B common stock impact shareholder influence, given that GOOGL Class B shares carry 10 votes per share while NFLX shares carry only one vote per share?",
      "original_answer": "NFLX common stock provides one vote per share to all shareholders, granting equal influence per share. In contrast, GOOGL has a multi-tiered voting rights structure where Class B common stockholders receive 10 votes per share, significantly amplifying their voting power compared to Class A shareholders who receive one vote per share. This structural difference means that GOOGL's Class B shareholders have disproportionately greater influence over corporate decisions than any single group of shareholders at NFLX, where voting power is uniformly distributed across all shares.",
      "llm_answer": "\nThe knowledge‑graph pattern links **NFLX’s voting‑rights policy** (an ACCOUNTING_POLICY) to a **Class B common‑stock instrument** that is connected to **GOOGL**, while **GOOGL’s Class B shares** carry 10 votes per share (Chunk 2/3) whereas **NFLX’s common stock** carries only 1 vote per share (Chunk 1). Consequently, a single GOOGL Class B share can exert up to ten times the voting influence of an NFLX share, even though both companies return comparable billions of dollars to shareholders through repurchases (e.g., $50‑$62 billion of Alphabet’s Class A/C shares in 2021‑23). Thus, the differing voting‑rights structures mean that shareholder influence is proportional to ownership at Netflix but is heavily concentrated in the hands of insiders who hold GOOGL’s high‑vote Class B shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately states that NFLX common stock carries one vote per share and GOOGL Class B shares carry 10 votes per share, which matches the original answer. (2) There are no numerical inaccuracies—although the LLM introduces additional context about share repurchases ($50–$62 billion by Alphabet from 2021–23), these figures are not part of the core question and do not contradict any ground truth; they are supplementary and plausible. (3) The multi-hop reasoning is sound: it correctly contrasts the voting structures of NFLX and GOOGL, infers that GOOGL’s Class B shareholders have significantly more influence per share, and concludes that influence is proportional at NFLX but concentrated among insiders at GOOGL—this synthesis is logically valid and supported by the knowledge graph. (4) The only minor shortcoming is a slight overemphasis on repurchase activity, which is contextually relevant but not directly tied to voting rights; however, it does not detract from the core accuracy. The answer captures the key structural difference and its implication on shareholder influence. Thus, the answer is semantically equivalent to the ground truth with excellent reasoning and no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Has]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 357,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does AMD's revenue from Taiwan in 2021 compare to Apple's 2022 revenue from the broader Greater China region, which includes Taiwan?",
      "original_answer": "AMD reported $1,187 million in revenue from Taiwan in 2021, while Apple reported $74,200 million in revenue from the Greater China region in 2022. Since Greater China includes Taiwan along with China mainland and Hong Kong, Apple's revenue from the broader region was significantly higher than AMD's revenue specifically from Taiwan.",
      "llm_answer": "\nAMD’s 2021 revenue generated directly in Taiwan was **$2,091 million** (Chunk 1). Apple’s 2022 net sales for the **Greater China** segment—including Taiwan—were **$74,200 million** (Chunk 3). Because the knowledge‑graph links “Taiwan → Greater China ← Apple,” Apple’s 2022 Greater China figure dwarfs AMD’s 2021 Taiwan sales by roughly **35 times**.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error in the AMD revenue figure. The ground truth states AMD's 2021 revenue from Taiwan was $1,187 million, but the LLM reports $2,091 million, which is incorrect. Apple's revenue from Greater China in 2022 is correctly stated as $74,200 million. (2) The calculation comparing Apple's revenue to AMD's is based on incorrect input data: the LLM claims Apple's revenue is 'roughly 35 times' AMD's, but using correct figures ($74,200M / $1,187M) yields approximately 62.5 times, not 35. The incorrect AMD number invalidates the calculation. (3) The multi-hop reasoning is logically sound—the model correctly identifies that Greater China includes Taiwan and that a comparison across companies and regions is valid—but it fails due to reliance on inaccurate data. The entity identification (AMD, Apple, Taiwan, Greater China, correct years) is accurate, and the structure of the comparison matches the question's intent. (4) The contextual relevance is high because the answer addresses the comparison directly and acknowledges the geographic hierarchy. However, the quantitative inaccuracy severely undermines the correctness score, as financial figures must be precise. The qualitative score reflects correct reasoning despite incorrect data. Final scores: Correctness 4 (partially correct but major error), Quantitative 3 (one major number wrong, calculation off), Qualitative 6 (sound logic and entities), Contextual 9 (highly relevant and well-structured).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1168,
        "completion_tokens": 416,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the availability of shares under Tesla's 2019 Equity Incentive Plan compare with Starbucks' remaining equity grant capacity, particularly in relation to their respective use of incentive stock options as a component of compensation strategy?",
      "original_answer": "Tesla's 2019 Equity Incentive Plan had 49.0 million shares reserved and available for issuance as of December 31, 2021, while Starbucks had 99.7 million shares available for future equity-based compensation awards as of October 2, 2022. Both companies utilize incentive stock options as part of their broader equity compensation structures, with Tesla's 2019 Plan explicitly including the provision for granting incentive stock options to employees, and Starbucks maintaining several equity incentive plans that include incentive stock options among other forms of equity compensation.",
      "llm_answer": "\nTesla’s 2019 Equity Incentive Plan had **49.0 million shares reserved and available for future issuance** (as disclosed in its 2021 10‑K), while Starbucks reported **99.7 million shares available for future equity‑based compensation awards** (plus 10.8 million under its ESPP) in its 2022 filing. Both companies use **incentive stock options** as part of their compensation strategy—Tesla’s plan allows only employee‑granted incentive options, whereas Starbucks’ equity incentive plans include incentive stock options alongside other award types. This comparison reflects the distinct remaining grant capacities of each firm’s equity plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Tesla's 49.0 million shares available under its 2019 Equity Incentive Plan as of December 31, 2021 (from the 2021 10-K), and Starbucks' 99.7 million shares available as of October 2, 2022 (2022 filing), matching the ground truth. The mention of an additional 10.8 million under Starbucks' ESPP is factually accurate but not part of the original answer; this is a minor addition that does not detract from correctness. (2) All numeric values and dates are accurate and properly attributed. Format variations (e.g., '49.0 million' vs '49.0 million') are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from two different companies, different fiscal periods, and compares their equity grant capacities. It accurately identifies that both companies use incentive stock options, noting Tesla’s plan includes employee-granted ISOs, while Starbucks uses ISOs within a broader set of equity awards—consistent with the original answer. (4) The only minor deviation is the inclusion of the ESPP detail, which was not in the ground truth and slightly extends beyond the scope, but does not introduce inaccuracy. Overall, the answer is factually correct, complete, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Grants]-> FIN_INST -[Includes]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 369,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the use of valuation models incorporating broker/dealer quotes impact the fair value determination of Level 2 assets for GD compared to BA's approach for available-for-sale debt investments?",
      "original_answer": "GD determines the fair value of its Level 2 fixed-income securities using valuation models that incorporate observable inputs such as quoted prices for similar assets and broker/dealer quotes. Similarly, BA values its available-for-sale debt investments using broker/dealer quotes for identical or comparable instruments. Both companies rely on these observable inputs through third-party pricing services and industry-standard models, indicating a parallel approach in determining fair value for Level 2 assets, despite being in different industries.",
      "llm_answer": "\nGD’s Level 2 assets (fixed‑income securities and commingled funds) are valued with market‑approach models that rely on observable inputs—including interest‑rate and yield data and quoted prices for similar assets—where those inputs are typically obtained from third‑party pricing services that incorporate broker/dealer quotes; thus the broker/dealer quotes are embedded in the valuation models themselves.  \nBA, by contrast, determines the fair value of its available‑for‑sale debt (and equity) investments through a market approach that explicitly uses quoted market prices or broker/dealer quotes of identical or comparable instruments, treating those quotes as the primary basis for the fair‑value estimate.  \nBoth companies source broker/dealer quotes from external pricing providers, but GD integrates them as part of broader observable‑input models for Level 2 assets, whereas BA treats the quotes as the direct basis for valuing its available‑for‑sale securities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: GD uses valuation models that incorporate broker/dealer quotes as part of observable inputs for Level 2 fixed-income securities, while BA uses broker/dealer quotes directly for available-for-sale debt investments. The LLM correctly identifies that both companies rely on third-party pricing services, but differ in how they apply the quotes—GD embeds them within broader models, whereas BA treats them as the primary basis. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable in terms of calculations or figures; however, the absence of any incorrect numbers supports a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (GD and BA), compares their fair value methodologies, and highlights both similarities (use of broker/dealer quotes via third parties) and differences (integration vs. direct use). (4) The LLM adds nuance not explicitly in the original answer—such as distinguishing between 'embedded' use versus 'direct' use of quotes—which enhances clarity without introducing error. The only reason for not scoring a 10 is that the original answer emphasizes the 'parallel approach' more clearly, while the LLM focuses slightly more on contrast; however, the overall semantic meaning and factual content remain consistent. Contextual relevance is perfect as the response directly addresses the comparative impact of broker/dealer quotes on fair value determination for both firms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> ACCOUNTING_POLICY -[Uses]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 441,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the current zero percent setting of the Countercyclical Capital Buffer (CCyB) impact the total capital buffer requirements for both Morgan Stanley and American Express under Basel III, considering Morgan Stanley's inclusion of the Stress Capital Buffer (SCB) in its Advanced Approach calculation and American Express's explicit subjectivity to the SCB?",
      "original_answer": "Under the current zero percent Countercyclical Capital Buffer (CCyB), Morgan Stanley's total capital buffer requirement under the Advanced Approach includes the 2.5% Capital Conservation Buffer (CCB), the G-SIB capital surcharge, and the Stress Capital Buffer (SCB). American Express is also subject to the SCB under Basel III, which contributes to its minimum capital requirements. Since the CCyB is currently set at zero, neither firm is required to add additional capital under this buffer. Therefore, the SCB plays a key role in both firms’ capital planning and distribution constraints, despite differing regulatory calculation approaches.",
      "llm_answer": "\nThe CCyB is currently fixed at 0 %, so it contributes no additional buffer to either firm’s capital‑buffer calculation; under the standardized (and advanced) approaches the required buffer is the sum of the Stress Capital Buffer, any G‑SIB surcharge and the mandatory 2.5 % capital‑conservation buffer, with the CCyB term equal to zero. Because Morgan Stanley includes the SCB in its Advanced‑Approach total and American Express is explicitly subject to the SCB, both firms’ total buffer requirements are therefore determined solely by the SCB (plus the fixed 2.5 % buffer and any G‑SIB surcharge), while the zero‑percent CCyB adds nothing to those totals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the CCyB is at 0%, so it adds no requirement for either firm; both firms are subject to the SCB; Morgan Stanley includes the SCB in its Advanced Approach calculation; American Express is explicitly subject to the SCB; the total buffer consists of the 2.5% Capital Conservation Buffer (CCB), G-SIB surcharge (if applicable), and SCB, with CCyB contributing zero. (2) Quantitatively, all percentages (0%, 2.5%) are correct and properly applied. There are no calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes that despite different regulatory frameworks (Advanced Approach vs. explicit SCB applicability), both firms’ total capital buffers are influenced by the SCB and CCB (plus G-SIB), while CCyB adds nothing due to its 0% setting. (4) The only minor shortcoming is a slight oversimplification in stating that the total buffer is 'determined solely by the SCB (plus the fixed 2.5% buffer and any G-SIB surcharge)'—this could imply SCB is a fixed component like CCB, whereas SCB is time-varying and firm-specific. The original answer better emphasizes the role of SCB in capital planning and distribution constraints. However, this does not undermine factual correctness. Wording differences are acceptable under semantic equivalence. All entities (Morgan Stanley, American Express, SCB, CCyB, CCB, G-SIB) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Consists_Of]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 414,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the $4.0 billion increased commitment under AMT's 2021 Credit Facility relate to its financing strategy for acquisitions, and how does this contrast with SPG's approach to financing through joint ventures as of December 31, 2021?",
      "original_answer": "AMT increased the commitment under its 2021 Credit Facility to $4.0 billion, which was used to finance acquisitions such as the CoreSite Acquisition, reflecting a strategy of leveraging large-scale credit facilities for major transactions. This contrasts with SPG's approach, where it provided $88.4 million in financing to joint ventures primarily in the form of interest-bearing construction loans, indicating a focus on internal financing and partnership structures to support real estate development and diversify risk.",
      "llm_answer": "\nAMT’s 2021 Credit Facility was amended on December 8 2021 to raise its commitments by $4 billion (to a total of $4 billion) and, together with the broader $6 billion multicurrency facility, was used to fund the CoreSite acquisition, repay existing debt and support other strategic purchases—demonstrating a strategy that relies on expanding revolving‑credit capacity to finance acquisitions directly.  \nIn contrast, SPG’s 2021 10‑K shows that it eschews such centralized borrowing and instead advances growth through real‑estate joint ventures, holding interests in 84 properties and providing $88.4 million of interest‑bearing construction loans to those ventures, while also exercising partnership rights (put/call, buy‑sell) that dictate financing through co‑investment rather than a credit‑facility draw.  \nThus, while AMT leverages a sizable credit‑facility increase as the primary vehicle for acquisition financing, SPG’s December 31 2021 financing model is built around joint‑venture structures and partnership‑level financing arrangements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMT increased its 2021 Credit Facility by $4.0 billion (total commitment $4.0 billion), used to finance the CoreSite acquisition and other strategic purchases; SPG provided $88.4 million in interest-bearing construction loans to joint ventures as of December 31, 2021. These numbers match the original answer exactly, and date (December 8, 2021) is correctly specified for AMT’s amendment. (2) Quantitative accuracy is perfect: $4.0 billion and $88.4 million are correctly reported; no calculation errors. (3) Multi-hop reasoning is sound: the model correctly contrasts AMT’s centralized credit-facility-based acquisition financing with SPG’s decentralized joint-venture and partnership-level financing strategy, synthesizing information across two companies and their respective 10-K filings. (4) The only minor shortcoming is that the LLM mentions a 'broader $6 billion multicurrency facility' and 'repay existing debt,' which, while likely true, are not in the ground truth and slightly extend beyond the provided context—this does not introduce inaccuracy but adds detail not confirmed in the original answer. Still, the core contrast and strategic interpretation are valid and well-supported. Semantic equivalence is maintained, and the answer fully addresses both parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Supplies]-> FIN_INST <-[Supplies]- ORG",
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 386,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the growth in Starbucks' store count in Taiwan compare to Nike's revenue contribution from the Greater China region, considering Taiwan's inclusion within Greater China's geographic reporting?",
      "original_answer": "Starbucks added 21 net new stores in Taiwan from fiscal year 2021 to 2022, reflecting a growth in its operational footprint. Meanwhile, Nike reported $7,547 million in total revenues from the Greater China region in FY2022, which includes Taiwan. This indicates that while Starbucks is expanding its physical presence in Taiwan, Nike's revenue from the broader Greater China region—which encompasses Taiwan—represents a significant portion of its global revenue, highlighting different modes of market engagement and performance metrics across the two companies.",
      "llm_answer": "\nStarbucks’ store count in Taiwan rose from 523 locations (as of Oct 3 2021) to 544 locations (as of Oct 2 2022), a net increase of **21 stores**—about a **4 % growth** year‑over‑year (Chunk 1). Chunk 2 notes that Taiwan is included in Nike’s “Greater China” geographic reporting, and Chunk 3 reports that Nike’s Greater China segment generated **$7,547 million** in revenue (Chunk 3). Therefore, while Nike’s revenue contribution from the entire Greater China region—including Taiwan—is over **$7.5 billion**, Starbucks’ expansion in Taiwan is modest, adding only ~21 stores in the same period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, it accurately reports Starbucks' net store growth in Taiwan as 21 stores (from 523 to 544), which aligns with the ground truth's '21 net new stores' from FY2021 to FY2022. The 4% growth rate is a valid calculation (21/523 ≈ 0.04). It also correctly states Nike's Greater China revenue as $7,547 million ($7.547 billion), matching the original answer. (2) The answer acknowledges that Taiwan is included in Nike’s Greater China reporting, which is essential for proper geographic alignment and multi-hop reasoning. (3) The reasoning correctly contrasts Starbucks’ physical expansion (store count growth in Taiwan) with Nike’s financial performance (revenue from the broader Greater China region), highlighting different modes of market engagement as in the original. (4) All entities—Starbucks, Nike, Taiwan, Greater China, fiscal years 2021–2022—are correctly identified and synthesized across the required hops. Wording differs slightly but maintains semantic equivalence. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 319,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What percentage of Boeing's (BA) OPB plan assets are indirectly invested in equities through the balanced index fund, and how does this compare to the total fair value of equities held by 3M's (MMM) pension plan as of December 31, 2023?",
      "original_answer": "Boeing's OPB plan assets are approximately 60% invested in equities via the balanced index fund. Meanwhile, 3M's pension plan reported a total fair value of $785 million in equities as of December 31, 2023.",
      "llm_answer": "\nBoeing’s OPB pension plan is invested ≈ 60 % in equities indirectly through its balanced index fund (the fund is described as being composed of roughly 60 % equities and 40 % debt securities)【Chunk 1 & 2】.  By contrast, 3M’s pension plan reports a total equity fair‑value of **$785 million** as of December 31 2023【Chunk 3 – “Equities … Fair Value at December 31, 2023 | $ 785”】.  Thus, about three‑fifths of Boeing’s plan assets are equity‑linked via the index fund, while 3M’s plan holds roughly $785 million in equities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentage of Boeing's OPB plan assets indirectly invested in equities (approximately 60%) is accurately reported, and the total fair value of equities in 3M's pension plan ($785 million as of December 31, 2023) is correctly stated, with acceptable formatting variations (e.g., $785 million vs $785M). (2) The answer is complete, addressing both parts of the multi-part question: Boeing’s indirect equity exposure via the balanced index fund and 3M’s total equity fair value. (3) Entity accuracy is perfect—Boeing (BA), 3M (MMM), the OPB plan, the balanced index fund, and the correct date (December 31, 2023) are all correctly identified and referenced. (4) The reasoning is sound and demonstrates proper multi-hop synthesis: it connects Boeing’s asset allocation within a fund to the broader comparison with 3M’s directly reported equity holdings, correctly interpreting indirect vs. direct investment structures. (5) Semantic equivalence is maintained—phrasing such as 'about three-fifths' for 60% and 'equity-linked via the index fund' appropriately conveys the intended meaning without distortion. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Includes]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 351,
        "total_tokens": 1556
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does AMT's utilization of the 2021 USD Delayed Draw Term Loans for financing compare to SPG's use of financing mechanisms for real estate joint ventures, particularly in terms of dollar amounts and financing structure?",
      "original_answer": "AMT utilized the 2021 USD Delayed Draw Term Loans as part of a $10.5 billion financing structure to support the CoreSite Acquisition, ensuring funding availability without drawing on bridge loans. In contrast, SPG provided $88.4 million in financing to joint ventures through interest-bearing construction loans and other advances as of December 31, 2021, primarily to support real estate development and investment activities. While AMT's financing was large-scale and acquisition-focused, SPG's approach was smaller in scale and oriented toward real estate joint ventures.",
      "llm_answer": "\nAMT financed its 2021 activities by tapping a $1 billion 2021 USD Delayed Draw Term Loan – a facility that replaced the $10.5 billion JPM bridge commitment and was later partially repaid ($500 million of the $1 billion term‑loan was retired), reflecting a structured draw‑down and repayment schedule within its broader $6 billion multicurrency revolving and $4 billion credit facilities (Chunk 1 & 2).  \nIn contrast, SPG funds its real‑estate joint‑venture projects through interest‑bearing construction loans to its joint‑venture partners, which totaled $88.4 million as of 31 December 2021 and are recorded as deferred costs, illustrating a markedly different financing structure focused on joint‑venture construction financing (Chunk 3).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. It states that AMT utilized a $1 billion 2021 USD Delayed Draw Term Loan, but the ground truth specifies a $10.5 billion financing structure related to the CoreSite Acquisition. The $1 billion figure is incorrect and misrepresents the scale of AMT's financing. Additionally, the mention of $500 million repayment is not present in the original answer and introduces unverified detail. (2) The SPG financing amount of $88.4 million is correctly reported, and the date (December 31, 2021) is accurate, which supports partial quantitative correctness. However, the AMT dollar amount is fundamentally wrong, undermining the comparison. (3) The reasoning is partially sound in structure—contrasting AMT’s acquisition-focused financing with SPG’s joint-venture construction loans—but fails on multi-hop synthesis because it mischaracterizes the size and purpose of AMT’s financing. The original answer emphasizes that the Delayed Draw Term Loans were part of a $10.5 billion structure replacing bridge financing, which the LLM misrepresents as a $1 billion loan replacing a $10.5 billion bridge, reversing the scale. (4) Contextual relevance is high because the answer addresses both companies, the correct financial instruments, and the structural differences in financing. However, due to the major error in AMT's financing amount and the resulting flawed comparison, the correctness and quantitative accuracy scores are significantly reduced. Semantic equivalence is not achieved on the key financial figure, which is central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Issues]-> FIN_INST -[Supplies]-> FIN_INST <-[Supplies]- ORG",
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 443,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does XOM's reliance on crude oil as a raw material intersect with CVX's 15% ownership in the Caspian Pipeline Consortium, considering the volume of crude oil transported through CPC from Chevron's operations in Kazakhstan?",
      "original_answer": "XOM depends on crude oil as a core raw material for its operations. Meanwhile, CVX holds a 15% interest in the Caspian Pipeline Consortium (CPC), which transports an average of 1.4 million barrels of crude oil per day, with 1.2 million barrels sourced from Kazakhstan—specifically from fields like Tengiz and Karachaganak in which Chevron operates or holds stakes. This means that a portion of the crude oil CVX produces or co-produces in Kazakhstan relies on CPC for export, linking upstream production to midstream logistics. Since crude oil is essential for XOM’s business, any disruption in supply chains like CPC could impact the availability or cost of crude oil for companies downstream, including XOM.",
      "llm_answer": "\nExxon Mobil (XOM) identifies crude oil as a core raw material (Chunk 1), and the crude that underpins its operations is largely sourced from Kazakhstan where Chevron’s Tengiz‑Chevroil and Karachaganak fields ship about 1.2 million bbl/d of the 1.4 million bbl/d that flow through the Caspian Pipeline Consortium (CPC) (Chunk 2).  Chevron’s 15 % stake in CPC – disclosed in CVX’s 10‑K and financial‑statement notes (Chunk 3) – gives CVX a direct ownership interest in the pipeline that transports that Kazakh crude, so XOM’s dependence on crude intersects with CVX’s equity in the very conduit that moves Chevron‑produced oil from Kazakhstan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: XOM relies on crude oil as a core raw material; CVX has a 15% stake in the CPC; the CPC transports 1.4 million barrels per day (bbl/d), with 1.2 million bbl/d sourced from Kazakhstan, specifically from Chevron-operated fields like Tengiz and Karachaganak. These numbers match the original answer exactly, and the 15% ownership is correctly attributed to CVX via its 10-K disclosure. (2) Quantitative accuracy is perfect: all volumes and percentages are correctly reported without calculation errors. (3) The multi-hop reasoning is sound—linking XOM’s reliance on crude oil to CVX’s ownership in CPC, and recognizing that CPC transports crude from Chevron’s Kazakh operations—this demonstrates proper synthesis across entities and documents. (4) The only minor shortcoming is a slight overstatement in implying that XOM directly sources crude from Kazakhstan via CPC; the original answer frames this more cautiously, noting that supply chain disruptions could affect XOM, rather than asserting direct sourcing. This nuance is missing but does not invalidate the overall logic. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent as all parts of the question are addressed with precise, relevant details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> RAW_MATERIAL -[Transports]-> COMP <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 372,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the decommissioning funding shortfall risk at NEE's nuclear facilities compare to Duke Energy's exposure to nuclear decommissioning trust fund volatility, given the shared environmental and financial risks associated with nuclear power plant operations?",
      "original_answer": "NEE faces potential decommissioning funding shortfalls due to the risk that decommissioning costs could exceed the amount available in its decommissioning funds, which are subject to market and operational uncertainties. Similarly, Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida maintain Nuclear Decommissioning Trust Funds (NDTFs) whose values are subject to market fluctuations. A decline in the market value of these NDTF assets could significantly increase Duke Energy's funding requirements for decommissioning. Both companies are exposed to the financial risks of nuclear power plant decommissioning, with NEE highlighting potential shortfalls and Duke Energy emphasizing the impact of capital market performance on its NDTF investments.",
      "llm_answer": "\nThe decommissioning‑funding shortfall risk at NEE stems from the possibility that the amounts it has set aside for de‑commissioning its nuclear units may be inadequate to cover actual closure costs—a exposure that is amplified by the environmental, safety and financial hazards of nuclear operation highlighted in Chunk 1 and the “costs could exceed the amount available in the decommissioning funds” warning in Chunk 2.  \nDuke Energy’s parallel exposure is to the volatility of its Nuclear Decommissioning Trust Fund (NDTF) investments, where market declines can shrink trust‑fund assets and trigger additional funding requirements, as described in Chunk 3.  \nBoth utilities share the same underlying environmental and financial risks—regulatory penalties, potential plant shutdowns and heavy capital outlays—linking NEE and Duke Energy through the KG relationship ORG ‑ [Impacted_By] → RISK_FACTOR ‑ [Subject_To] → PRODUCT ← [Negatively_Impacts] ‑ ORG, so that any adverse event affecting nuclear plants simultaneously heightens NEE’s funding shortfall and Duke Energy’s trust‑fund volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the original (ground truth) answer. It correctly identifies that NEE faces decommissioning funding shortfall risk due to potential cost overruns relative to funds available, and that Duke Energy is exposed to volatility in its Nuclear Decommissioning Trust Funds (NDTFs) due to market fluctuations. The answer accurately reflects both companies' exposure to financial and environmental risks tied to nuclear operations. There are no numeric values in the question or ground truth, so quantitative accuracy is scored as 10 by default. The qualitative accuracy is high: the LLM correctly synthesizes the multi-hop concept that both firms face related but distinct risks—NEE emphasizing potential shortfalls, Duke emphasizing market-driven trust fund volatility—and links them through shared risk factors. The mention of a knowledge graph (KG) relationship is interpretive but reasonable and does not distort facts. The only minor deduction is for slightly over-interpreting the structural KG relationship, which wasn't part of the original answer, though it doesn't undermine correctness. Contextual relevance is perfect—the response directly addresses the comparison asked in the question and integrates all relevant aspects of risk exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR -[Subject_To]-> PRODUCT <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 361,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does LOW's use of pricing models for Level 3 fair value measurements compare to GM's application of unobservable inputs in Level 3 valuations, particularly in light of the stated accounting policy that classifies valuations based on the observability of inputs?",
      "original_answer": "LOW applies pricing models to determine fair value for Level 2 assets and uses an income approach with significant unobservable inputs like volatility and expected term for its Level 3 contingent consideration related to the Canadian retail business sale. This aligns with the accounting policy that defines Level 3 valuations as those using significant unobservable inputs, often involving pricing models or discounted cash flow methodologies. GM similarly relies on unobservable inputs for Level 3 valuations, particularly in its GM Financial receivables, where static pool modeling and economic forecasts such as unemployment rates and GDP growth are used to estimate expected credit losses. Both companies follow the same accounting hierarchy but apply it differently depending on the nature of their assets and business operations.",
      "llm_answer": "\nBoth LOW and GM classify Level 3 fair‑value measurements as those that rely on significant **unobservable inputs**, in line with the accounting policy that ties a valuation’s hierarchy level to the observability of its inputs. LOW explicitly applies pricing models for its Level 3 contingent consideration, quantifying fair value with unobservable assumptions such as total equity value, volatility and a risk‑adjusted discount rate (Chunk 1), whereas GM describes Level 3 valuations as using pricing models or market‑approach techniques where the key inputs are unobservable and it obtains non‑binding quotes from pricing services (Chunk 3). Thus, although each company follows the same observability‑based classification (Chunk 2), LOW’s disclosed use of pricing models for a Level 3 liability illustrates a direct application of unobservable inputs, while GM’s approach is framed within its broader hierarchy that supplements observable Level 1/2 measurements with Level 3 techniques.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly identifies that both LOW and GM classify Level 3 fair value measurements based on significant unobservable inputs, consistent with the accounting policy tied to input observability. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes that LOW uses pricing models with unobservable inputs (e.g., volatility, discount rate) for Level 3 contingent consideration, while GM applies unobservable inputs in Level 3 via static pool modeling and economic forecasts (like unemployment and GDP) for GM Financial receivables. The LLM captures this distinction accurately, though it does not explicitly mention 'static pool modeling' or 'economic forecasts' like unemployment/GDP—instead generalizing GM’s approach as using 'pricing models or market-approach techniques' and 'non-binding quotes.' This is a minor omission but does not distort the core factual accuracy. (4) The answer remains contextually relevant, directly addressing the comparison between LOW and GM in light of the accounting policy. Wording differs slightly from the original answer but maintains semantic equivalence. One small gap: the original specifies LOW’s use of 'expected term' as an unobservable input, which the LLM omits, instead listing 'total equity value'—a detail from the source but not in the ground truth. Overall, the response is highly accurate with only minor imprecision in input specifics, justifying a 9/10 correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Applies]-> ACCOUNTING_POLICY -[Uses]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 458,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the $10.5 billion in committed financing under AMT's 2021 Multicurrency Credit Facility compare with SPG's financing activities in joint ventures, particularly in terms of capital deployment strategy and risk diversification?",
      "original_answer": "AMT secured $10.5 billion in committed financing through its 2021 Multicurrency Credit Facility and related facilities, which were used to fund acquisitions like CoreSite and Telxius, while SPG provided $88.4 million in financing to joint ventures primarily in the form of interest-bearing construction loans, aligning with its strategy to diversify risk and finance property development. This shows that AMT leveraged large-scale credit facilities for major acquisitions, whereas SPG used smaller, targeted financings to support joint venture operations and risk-sharing.",
      "llm_answer": "\nThe $10.5 billion of committed financing under AMT’s 2021 Multicurrency Credit Facility—highlighted in chunks 1 and 2 as the amount that replaced the JPM Bridge Loan and that was increased to $6 billion (with $5.1 billion actually used to fund the CoreSite acquisition)—represents a centralized, multi‑currency revolving source that AMT deployed to finance large‑scale tower acquisitions (Telxius and CoreSite) and to refinance existing debt, while also tightening its debt‑to‑EBITDA covenants over time (chunks 1 and 2).  \n\nIn contrast, SPG’s financing strategy, described in chunk 3, channels capital through joint‑venture interests in 84 properties and provides only $88.4 million of interest‑bearing construction loans to partners, using those ventures to spread exposure across many assets and to give both parties put‑call and buy‑sell rights that diversify risk (chunks 3).  \n\nThus, AMT relies on a single, sizable credit facility for corporate‑level acquisitions and leverage management, whereas SPG disperses capital across numerous property‑level joint ventures to achieve risk diversification and shared‑partner financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $10.5 billion committed financing for AMT’s 2021 Multicurrency Credit Facility is correctly stated, as is SPG’s $88.4 million in interest-bearing construction loans to joint ventures. The mention that $5.1 billion was used for the CoreSite acquisition is consistent with the original answer’s focus on acquisitions like CoreSite and Telxius. While the LLM adds detail not in the ground truth (e.g., the facility was increased to $6 billion and replaced a bridge loan), these details do not contradict the original and appear contextually plausible based on the referenced 'chunks'. (2) The core numbers—$10.5B for AMT and $88.4M for SPG—are correct and properly contrasted in scale and purpose. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes that AMT uses large-scale centralized financing for acquisitions and debt management, while SPG uses smaller, dispersed joint venture financings to diversify risk and share capital burden. The mention of put-call and buy-sell rights adds useful context on risk-sharing mechanisms. (4) The answer fully addresses the question’s two dimensions: capital deployment strategy and risk diversification. The only minor deviation is the additional detail about covenant tightening and bridge loan replacement, which, while not in the ground truth, does not detract from accuracy. Overall, the semantic meaning, factual content, and comparative analysis match the original answer closely, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Supplies]-> FIN_INST <-[Supplies]- ORG",
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 428,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does AMD's revenue exposure to Taiwan in 2023 compare to QCOM's operational dependency on foundry partners in Taiwan, given the geopolitical risks associated with the region?",
      "original_answer": "AMD reported $1,841 million in sales to external customers from Taiwan in 2023, indicating a notable but declining revenue exposure compared to previous years. Meanwhile, QCOM explicitly states that its business depends on consistent and reliable chipset supply from foundry partners, particularly in Taiwan. A significant or prolonged military or geopolitical conflict involving China and Taiwan could severely limit or prevent QCOM from receiving chipset supply, which would have a material adverse impact on its business. Given that both companies are exposed to Taiwan—AMD through revenue and QCOM through critical supply chain dependencies—geopolitical instability in the region poses a dual risk, impacting both revenue streams and manufacturing continuity.",
      "llm_answer": "\nAMD’s 2023 sales to Taiwan were $1.841 billion, representing roughly 8 % of its total $22.68 billion revenue, which quantifies its direct revenue exposure to the island. In contrast, QCOM does not disclose sales to Taiwan but its operations depend on foundry partners located in Taiwan for chipset supply, and the filings warn that a prolonged China‑Taiwan conflict could “severely limit or prevent” that supply, creating a material adverse impact on its business. Thus, AMD’s exposure is measured as a modest share of sales, whereas QCOM’s exposure is an operational reliance on Taiwanese foundries that makes it far more vulnerable to geopolitical disruptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states AMD's 2023 sales to Taiwan as $1.841 billion, matching the ground truth of $1,841 million. It accurately calculates this as approximately 8% of AMD’s total revenue by referencing $22.68 billion in total revenue, which aligns with AMD’s reported 2023 revenue. This demonstrates full quantitative accuracy. (2) The LLM correctly identifies that QCOM does not disclose sales to Taiwan but relies on foundry partners in Taiwan for chipset manufacturing, and that a geopolitical conflict could severely disrupt supply—directly reflecting the original answer’s warning language and material adverse impact statement. (3) The multi-hop reasoning is sound: it synthesizes AMD’s revenue exposure (from financial statements) with QCOM’s operational dependency (from risk disclosures), then contrasts the two types of exposure—revenue vs. supply chain—under the same geopolitical risk theme. (4) The only minor shortcoming is that the original answer notes AMD’s exposure is 'declining compared to previous years,' a contextual nuance not mentioned in the LLM response, slightly reducing qualitative completeness. However, this does not affect the core factual accuracy. All entities (AMD, QCOM, Taiwan, 2023), metrics (revenue, supply chain dependency), and reasoning are correct and relevant. Wording differs but semantic meaning is equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Supplies]- ORG",
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 384,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does the expected impact of the 15% global minimum tax under OECD's Pillar 2 on SBUX's consolidated financial statements compare to MCD's assessment, given the phased implementation timelines across jurisdictions?",
      "original_answer": "SBUX notes that the global minimum tax under Pillar 2 will not be effective for the company until fiscal 2025 and is not expected to result in a material impact on its consolidated financial statements. Similarly, MCD states that while numerous countries have enacted Pillar 2 with an effective date for taxable years beginning after December 31, 2023, it also does not expect a material impact on its consolidated financial statements. Both companies are monitoring regulatory developments and await further guidance, as the implementation of Pillar 2 varies across jurisdictions and could evolve over time.",
      "llm_answer": "\nBoth SBUX and MCD state that the 15 % OECD Pillar 2 global minimum tax is being rolled out on a jurisdiction‑by‑jurisdiction, phased basis—SBUX notes it will not become effective for the company until fiscal 2025, while MCD points out that the earliest effective dates are for taxable years beginning after Dec 31 2023.  Each company separately assesses that the new regime will not have a material effect on its consolidated financial statements, although both continue to monitor further guidance and the varying timelines across the jurisdictions that are adopting the rule.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: SBUX's fiscal 2025 effective date and non-material impact, MCD's reference to jurisdictions enacting Pillar 2 with effective dates after December 31, 2023, and its assessment of no material impact. Both companies note ongoing monitoring of guidance and jurisdictional variation. (2) Quantitative accuracy is perfect: dates (fiscal 2025, Dec 31 2023), percentage (15%), and the absence of material impact are all correctly reported. Format variations (e.g., 'Dec 31 2023' vs 'December 31, 2023') are acceptable and semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (SBUX and MCD), compares their assessments, and contextualizes the phased implementation. The only minor shortcoming is that the LLM does not explicitly state that MCD 'does not expect a material impact' in the same direct phrasing as the original, though it clearly implies it by saying 'each company separately assesses that the new regime will not have a material effect.' This preserves semantic equivalence. (4) Contextual relevance is excellent—the response directly addresses the comparison of Pillar 2's expected impact on SBUX vs MCD in light of implementation timelines. Overall, the answer is factually complete and well-reasoned, warranting a 9 due to slight phrasing ambiguity around MCD's materiality assessment, though not enough to affect correctness meaningfully.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Related_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 422,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does JPMorganChase's risk governance framework, which emphasizes firmwide ownership of risk assessment, influence its approach to stress testing methodologies compared to Goldman Sachs, which explicitly ties stress testing to capital adequacy assessments?",
      "original_answer": "JPMorganChase's risk governance framework emphasizes firmwide ownership of risk assessment, with Risk Management and Compliance functions overseeing risk identification and escalation across business lines and corporate functions. This structured governance leads to a comprehensive approach to risk, where stress testing is likely embedded within broader risk identification and mitigation processes. In contrast, Goldman Sachs explicitly uses stress testing to assess capital adequacy and quantify exposure to tail risks, performing firmwide stress tests regularly to evaluate vulnerabilities across financial and nonfinancial risks. The difference in emphasis—JPMorganChase’s governance-driven risk ownership versus Goldman Sachs’s scenario-based capital adequacy focus—suggests that while both firms use stress testing as a core risk tool, the integration and ultimate purpose of stress testing within their risk frameworks differ significantly.",
      "llm_answer": "\nJPMorganChase embeds risk‑assessment ownership firmwide—its CRO and LOB‑CROs drive a risk‑governance structure that integrates stress‑testing directly into the firm’s risk‑assessment cycle (Chunk 1). Goldman Sachs, by contrast, treats stress testing as a distinct tool tied to capital‑adequacy assessments, using stress‑test outcomes to validate capital planning and regulatory capital levels (Chunk 2‑3). The KG link JPM→Risk Assessment→Stress Testing→GS shows that both firms derive stress testing from risk assessment, but JPM’s methodology is shaped by firmwide risk‑ownership, whereas GS explicitly links stress testing to capital adequacy metrics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (2) The LLM correctly identifies both companies—JPMorganChase and Goldman Sachs—and accurately describes their respective approaches: JPMorganChase’s firmwide risk ownership with integration of stress testing into the broader risk-assessment cycle, and Goldman Sachs’s use of stress testing tied to capital adequacy and capital planning. These entities and concepts are correctly represented. (3) The multi-hop reasoning is sound: the model synthesizes differences in governance frameworks and links them to divergent stress testing methodologies. It references a knowledge graph link (JPM→Risk Assessment→Stress Testing→GS), which suggests an understanding of cross-firm comparison, though this notation is slightly informal and not explained. The key contrast—governance-driven integration vs. capital-adequacy focus—is preserved. (4) The answer is contextually relevant and fully addresses the comparative aspect of the question. The only minor shortcoming is slight brevity compared to the original answer’s elaboration on 'tail risks' and 'financial and nonfinancial risks' at Goldman Sachs, which adds depth. However, the core reasoning and factual content are semantically equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Requires]-> ACCOUNTING_POLICY -[Used_For]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 425,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does XOM's asset exposure in Kazakhstan compare to CVX's financial stake in Tengizchevroil, considering CVX's equity ownership and loan contributions to the joint venture?",
      "original_answer": "XOM had $8,463 million in long-lived assets in Kazakhstan as of 2021, while CVX holds a 50% equity interest in Tengizchevroil (TCO), which operates in the same country. In addition to its equity stake, CVX provided a $4,500 million loan to TCO to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This indicates that CVX's financial exposure to Tengizchevroil in Kazakhstan includes both its proportional equity value and a significant direct loan, potentially exceeding the magnitude of XOM's reported asset base in the country when combined.",
      "llm_answer": "\nXOM reports $8.46 bn of long‑-lived assets in Kazakhstan (Chunk 1), its largest non‑U.S. exposure in the country. Chevron (CVX) holds a 50 % equity stake in Tengizchevroil—an upstream joint venture operating in Kazakhstan—and has also extended a $4.5 bn loan to the JV (with the investment recorded about $100 m above underlying equity), underscoring a substantial financial stake that is linked to the same Kazakhstan‑based asset (Chunks 2 & 3). Thus, while XOM’s exposure is quantified as roughly $8.5 bn of assets, CVX’s exposure combines a 50 % equity interest plus a sizable loan to the Tengizchevroil joint venture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports XOM's $8,463 million in long-lived assets in Kazakhstan as $8.46 billion (rounded appropriately), and accurately states CVX's 50% equity stake in Tengizchevroil (TCO) and the $4.5 billion loan to fund the FGP/WPMP projects. These figures match the ground truth exactly in substance, with acceptable formatting variations (e.g., $8.46 bn = $8,463 million). (2) All numeric values are quantitatively accurate: $8.46 billion for XOM’s assets and $4.5 billion loan from CVX are correct; the 50% equity interest is properly cited. There are no calculation errors. (3) The multi-hop reasoning is sound—LLM correctly synthesizes that CVX's exposure includes both equity ownership and a direct loan, contrasting it with XOM’s asset-based exposure. It appropriately highlights that CVX's combined financial stake (equity + loan) is significant relative to XOM’s asset base, though it stops short of explicitly stating that CVX’s total exposure may exceed XOM’s, which is implied in the original answer. This is a minor omission, not an error. (4) Entity names (XOM, CVX, Tengizchevroil), financial metrics (long-lived assets, equity stake, loan), and geographic focus (Kazakhstan) are all accurate. The answer is contextually relevant and fully addresses the comparative financial exposure question. The slight deduction in qualitative accuracy is due to the lack of explicit synthesis that CVX’s combined stake could exceed XOM’s, but the necessary information to infer this is present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 420,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How might geopolitical tensions involving Taiwan impact both QCOM's chipset supply and NVDA's supply continuity, given their reliance on foundry partners operating in the region?",
      "original_answer": "QCOM's business depends on receiving consistent chipset supply from foundry partners, particularly in Taiwan, and a significant geopolitical conflict involving Taiwan could severely limit or prevent QCOM from receiving this supply, which would have a material adverse impact on its business. Similarly, NVDA notes that geopolitical tensions involving Taiwan and China, where it has critical suppliers, contract manufacturers, and assembly partners, could have a material adverse impact on its supply continuity. Both companies rely on foundry partners operating in Taiwan, and any disruption due to geopolitical instability could lead to supply constraints, affecting QCOM's ability to manufacture products and NVDA's ability to fulfill customer orders on time, ultimately harming their revenues and market positions.",
      "llm_answer": "\nGeopolitical tensions between China and Taiwan would jeopardize the Taiwan‑based foundries that both Qualcomm and Nvidia depend on: Qualcomm’s 10‑K explicitly warns that any prolonged conflict could “severely limit or prevent” the chipset supply it receives from its Taiwanese foundry partners, while Nvidia’s filing cites “geopolitical tensions, such as those involving Taiwan… could have a material adverse impact on us” and notes that supply‑continuity for its GPU and CPU products is tied to those same facilities. Consequently, disruptions in Taiwan could curtail chipset deliveries to Qualcomm and interrupt Nvidia’s supply chain, depressing demand, delaying product shipments and hurting the financial results of both companies and the broader semiconductor industry.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key factual elements are correct: both QCOM and NVDA rely on Taiwan-based foundries, and geopolitical tensions involving Taiwan pose a material risk to their supply chains. The LLM correctly cites QCOM’s risk of being 'severely limited or prevented' from receiving supply and NVDA’s warning that geopolitical tensions 'could have a material adverse impact.' These phrases reflect actual language from the companies' 10-K filings. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a numerical sense—however, the absence of any incorrect numbers or miscalculations supports a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes risks across two companies (QCOM and NVDA), links them to shared reliance on Taiwanese foundries, and infers downstream impacts on product shipments, demand, and financial results. The only minor shortcoming is that the LLM slightly extends the original by mentioning 'depressing demand'—a plausible but not explicitly stated consequence in the ground truth. This does not invalidate the answer but introduces a small interpretive leap. (4) Contextual relevance is perfect: the response directly addresses the question about how geopolitical tensions affect both companies’ supply continuity through their foundry dependencies. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only negligible augmentation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Supplies]-> COMP -[Operates_In]-> GPE <-[Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 439,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How might Southern Company's environmental compliance costs, driven by regulatory requirements, affect electricity demand from industrial customers, and how does this potential demand shift compare to Duke Energy's exposure to industrial customer demand volatility as outlined in their risk factors?",
      "original_answer": "Southern Company estimates that compliance with environmental regulations could result in increased costs that are recovered through regulated rates, but this may contribute to reduced demand for electricity and natural gas from industrial customers. Many of these industrial customers may also face their own compliance costs under the same environmental requirements, further reducing their energy consumption. Duke Energy, on the other hand, explicitly notes that declines in industrial production due to economic conditions will reduce electricity and natural gas consumption, directly impacting their revenues and cash flows. Both companies are exposed to industrial demand shifts, but Southern Company's exposure is tied to regulatory cost pass-through effects, while Duke Energy highlights direct economic sensitivity of industrial customers.",
      "llm_answer": "\nSouthern Company’s environmental‑compliance spending—driven by new or revised regulations and GHG‑related rules—will likely be recouped through retail and wholesale rates, and higher rates can dampen electricity (and, where applicable, natural‑gas) usage by industrial customers, thereby reducing their demand for the Company’s power.  This cost‑recovery dynamic creates a direct demand‑shift pressure that is echoed in Duke Energy’s risk disclosures, which flag economic downturns or regulatory changes as sources of volatility in industrial‑customer consumption; however, while Duke emphasizes broader market‑ and economy‑driven swings in industrial demand, Southern’s exposure is tied specifically to the rate‑recovery process that may compel industrial users to curtail usage.  The KG link — SO → Environmental Requirements → Industrial Customers → DUK—shows that the same class of industrial customers affected by Southern’s compliance‑cost‑induced rate changes also underpins Duke’s exposure to demand volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Southern Company's environmental compliance costs are expected to be recovered through rates, which may reduce industrial demand due to higher prices, and industrial customers may face their own compliance costs. Duke Energy's risk factors emphasize industrial demand volatility due to economic conditions, not primarily regulatory cost pass-through. These distinctions are correctly captured. (2) There are no numeric values in the question or answers requiring verification; thus, quantitative accuracy is 10 as no numbers are misstated. (3) The multi-hop reasoning is sound—linking Southern’s regulatory-driven cost recovery to industrial demand effects, then comparing it to Duke’s economic sensitivity—is logically synthesized and reflects the knowledge graph linkage (SO → Environmental Requirements → Industrial Customers → DUK). The only minor shortcoming is the slightly more abstract phrasing of Duke’s exposure (referring to 'regulatory changes' broadly) compared to the original answer’s emphasis on 'declines in industrial production due to economic conditions' as the primary driver. This does not distort the meaning but slightly blurs the contrast in focus between regulatory cost pass-through (Southern) vs. macroeconomic cycles (Duke). (4) Contextual relevance is perfect—the response directly addresses both parts of the question, compares the two companies’ exposures, and explains the nature of the demand shift for each. Overall, the answer is semantically equivalent to the ground truth with excellent reasoning and no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_on]-> REGULATORY_REQUIREMENT -[Impacted_By]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 454,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the $9.9 billion notional amount of foreign exchange cash flow hedges used by NKE compare to MCD's foreign currency net asset exposures in managing cross-border financial risk?",
      "original_answer": "NKE utilizes $9.9 billion in notional foreign exchange cash flow hedges to manage transactional exposures from product costs, external sales, and other foreign currency-denominated assets and liabilities. These hedges, primarily in euros, Canadian dollars, Japanese yen, British pounds, and Chinese yuan, are designed to offset earnings fluctuations from currency movements. Meanwhile, MCD manages its foreign currency risk by maintaining diversified net asset exposures across a broad basket of currencies. While NKE actively hedges forecasted transactions and exposures through derivatives, MCD's approach focuses on balancing foreign currency assets and liabilities directly on its balance sheet, reflecting differing strategies to mitigate cross-border financial risk.",
      "llm_answer": "\nNKE reports $9.9 billion of net foreign‑exchange cash‑flow hedges (Chunk 2), which are executed through option contracts that impact foreign‑currency assets tied to MCD in the knowledge‑graph relationship (Chunk 1 → Chunk 3). MCD’s foreign‑currency net‑asset exposures—disclosed as the largest balance‑sheet foreign‑currency positions at year‑end (Chunk 3)—represent the underlying currency‑denominated assets that NKE’s hedge program seeks to offset, showing that the $9.9 billion hedge amount is sized to match the magnitude of MCD’s net‑asset exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual and logical errors. (1) Quantitatively, while the $9.9 billion notional amount for NKE's foreign exchange hedges is correctly stated, the claim that these hedges are 'tied to MCD' or 'seek to offset MCD’s net-asset exposure' is factually incorrect—NKE’s hedges are for its own transactional exposures, not MCD’s balance sheet items. There is no evidence in the ground truth that NKE’s hedges are sized to match MCD’s exposures. (2) The answer incorrectly implies a direct financial relationship between NKE’s hedging and MCD’s assets, which is not supported by the original answer or logical inference—these are two separate companies with independent risk management strategies. (3) The multi-hop reasoning fails: instead of contrasting NKE’s active hedging with MCD’s balance sheet net asset management, the LLM incorrectly links the two companies’ exposures as if one offsets the other. (4) The original answer emphasizes differing risk management strategies—NKE uses derivatives to hedge forecasted transactions, while MCD manages risk through balance sheet diversification. The LLM answer completely misrepresents this by suggesting NKE’s hedges are designed to offset MCD’s exposures, which is illogical and factually wrong. (5) Contextual relevance is partially maintained as both companies and the topic of foreign currency risk are discussed, but the core reasoning and entity relationships are fundamentally flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Impacts]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 403,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the exposure of The Coca-Cola Company through Coca-Cola HBC's operations in Ukraine compare to Procter & Gamble's direct reliance on Ukraine for its manufacturing and supply chain stability?",
      "original_answer": "The Coca-Cola Company relies on Coca-Cola HBC for bottling and distribution operations in Ukraine, which is part of a broader network contributing to 41% of Coca-Cola's global unit case volume through its top five bottlers. Meanwhile, Procter & Gamble reports that its Ukraine-related assets account for less than 1% of net assets, with potential risks including physical damage to its two manufacturing facilities in Ukraine and disruptions in raw material sourcing or product distribution. While Coca-Cola's exposure is indirect through a key bottler, P&G's exposure is more direct but smaller in scale, with both companies facing similar regional supply chain risks tied to geopolitical instability.",
      "llm_answer": "\nCoca‑Cola’s exposure to Ukraine is indirect – it flows through its bottling partner Coca‑Cola HBC AG, which operates a bottling and distribution network there and is listed among the company’s five largest bottlers, together accounting for 41 % of worldwide unit case volume (KO → Coca‑Cola HBC → Ukraine).  \nIn contrast, Procter & Gamble’s reliance on Ukraine is direct – it operates two manufacturing sites in the country that are critical to its supply chain, yet those sites represent less than 1 % of P&G’s net assets and are vulnerable to damage or disruption, a risk highlighted by the KG link Ukraine → PG.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Coca-Cola's indirect exposure via Coca-Cola HBC, which is one of the top five bottlers contributing to 41% of global unit case volume, is accurately stated. Procter & Gamble's direct operations in Ukraine, including two manufacturing facilities representing less than 1% of net assets, are also correctly reported. (2) Quantitative accuracy is perfect: the percentages (41% and <1%) match the original answer exactly, and no calculations are required beyond correct reporting. (3) Multi-hop reasoning is sound—LLM correctly synthesizes that Coca-Cola’s exposure is indirect through a major bottler, while P&G has direct but minor asset exposure, and both face regional supply chain risks. The only minor omission is that the LLM does not explicitly mention 'raw material sourcing or distribution disruptions' for P&G or explicitly state that both face 'similar regional supply chain risks tied to geopolitical instability,' though the vulnerability to disruption is implied. (4) The answer is contextually fully relevant, directly comparing the nature, scale, and risk of exposure for both companies as asked. Wording differs slightly but maintains semantic equivalence. Thus, the answer earns a 9/10 for correctness due to slight incompleteness in risk context, but full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 395,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What is the combined exposure of MET and BAC to commercial mortgage-backed securities (CMBS), and how does MET's fair value of CMBS compare to BAC's amortized cost for the same category as of December 31, 2023?",
      "original_answer": "MET's fair value exposure to CMBS was $4,551 million as of December 31, 2023, while BAC's amortized cost for commercial mortgage-backed securities was $10,922 million. The combined exposure of both companies to CMBS totals $15,473 million. MET's CMBS, as part of its Structured Securities portfolio, are reported at fair value, whereas BAC reports its CMBS at amortized cost, reflecting different accounting treatments for similar asset classes.",
      "llm_answer": "\nThe combined exposure to commercial mortgage‑backed securities (CMBS) for the two issuers is the sum of MET’s fair‑value holding of structured securities ($4,551 million as reported in Chunk 1) and BAC’s amortized‑cost holding of commercial MBS ($10,922 million shown in the “Commercial” row of Chunk 3), giving a total exposure of roughly **$15.47 billion** as of 31 December 2023. MET’s fair‑value amount ($4.55 bn) is therefore only about **41 %** of BAC’s amortized‑cost exposure ($10.92 bn), indicating a markedly lower fair‑value position for MET relative to BAC’s cost basis in the same CMBS category.  \n\n- **Chunk 1** supplies MET’s fair‑value figure for “Structured Securities” (which includes CMBS).  \n- **Chunk 2** confirms that MET’s “Structured Securities” comprise CMBS among other products.  \n- **Chunk 3** provides BAC’s amortized‑cost amount for “Commercial” mortgage‑backed securities, the CMBS component.  \n\nThese three pieces together satisfy the KG‑derived relationship ORG‑[Discloses]→FIN_INST‑[Comprises]→FIN_INST←[Discloses]‑ORG, linking MET and BAC through CMBS.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All numeric values are correct: MET's fair value of $4,551 million and BAC's amortized cost of $10,922 million are accurately reported, and their sum ($15,473 million) is correctly calculated and presented as $15.47 billion (equivalent). The percentage comparison (MET's $4.55B is ~41% of BAC's $10.92B) is mathematically accurate: (4,551 / 10,922) ≈ 41.66%, which rounds to 41%—acceptable for approximation. (2) The answer fully addresses both parts of the question: combined exposure and the comparison between MET's fair value and BAC's amortized cost. (3) Entities are correctly identified: MET and BAC, CMBS, correct date (December 31, 2023), and proper distinction between fair value and amortized cost accounting. (4) Multi-hop reasoning is sound: the model correctly links MET’s 'Structured Securities' to CMBS (via Chunk 1 and 2) and identifies BAC’s 'Commercial' MBS as the relevant category (Chunk 3), demonstrating proper synthesis across sources. The only minor shortcoming is the lack of explicit mention that MET's CMBS are part of its Structured Securities portfolio (though implied), and the explanation of differing accounting treatments—present in the original answer—is slightly condensed. However, the core information and reasoning are preserved with high fidelity. Wording differences do not affect semantic accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Comprises]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 390,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How do cyber intrusion risks at nuclear power plants impact the financial obligations and operational strategies of both Duke Energy and Southern Company, given their respective exposures to decommissioning trusts and compliance costs?",
      "original_answer": "Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida have significant obligations tied to decommissioning nuclear plants, with funded trusts subject to market fluctuations that could increase funding requirements if asset values decline. Southern Company's nuclear units, operated by Southern Nuclear, are subject to compliance costs related to cyber intrusion risks, which could increase licensing or security expenditures. Both companies face potential financial strain: Duke Energy may need to inject additional capital if decommissioning trusts underperform, while Southern Company could face higher operational costs due to mandatory cybersecurity standards and potential threats, both of which could materially affect their financial positions and cash flows.",
      "llm_answer": "\nCyber‑intrusion risk at nuclear power plants is a shared threat for Duke Energy and Southern Company because their nuclear generating assets are subject to costly decommissioning‑trust funding and strict regulatory compliance. For Duke Energy, a breach can depress the value of its nuclear‑decommissioning trust (NDTF) investments, trigger additional cash‑funding requirements and raise IT‑security and licensing expenses that strain the holding‑company’s cash flows and its ability to meet debt and dividend obligations. For Southern Company, cyber threats can increase NRC licensing and security costs, cause damages that may exceed the amount held in decommissioning trusts or insurance, and force the company to allocate capital to mitigation and reserve funds, shaping its operational strategy and financial planning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: both Duke Energy and Southern Company face financial and operational impacts from cyber intrusion risks tied to nuclear operations, decommissioning trusts, and compliance costs. The answer correctly identifies Duke Energy's exposure through decommissioning trust fund (NDTF) performance and potential cash-funding requirements, and Southern Company's exposure via NRC licensing, security costs, and capital allocation. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not compromised—no calculations or figures to verify. (3) Multi-hop reasoning is sound: the model synthesizes cyber risks with financial obligations (decommissioning trusts) and operational strategies (compliance, capital allocation) for both companies, correctly attributing distinct but related risk pathways. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'depress the value of NDTF investments' vs. 'market fluctuations that could increase funding requirements'), the meaning is consistent with the original. The only minor shortcoming is that the LLM does not explicitly name Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida as subsidiaries with specific obligations, though this detail is subsidiary to the core financial and strategic implications. Overall, the answer is factually correct, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> PRODUCT -[Subject_To]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 425,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does the treatment of dividend equivalents on unvested restricted stock units at HD influence the issuance of additional shares, and how does this compare to LOW's delivery of additional shares under its ASR agreements in fiscal 2021?",
      "original_answer": "At HD, dividend equivalents accrue on unvested restricted stock units and are paid out in the form of additional shares upon vesting. This mechanism increases the total number of shares ultimately delivered to employees. For example, HD's 2022 10-K shows that dividend equivalents are reinvested and paid out as additional shares when RSUs vest. This practice results in a higher share count over time, as unvested units continue to accrue dividends. In contrast, LOW delivered additional shares in the context of accelerated share repurchase (ASR) agreements. In fiscal 2021, LOW executed ASR agreements in Q1, Q4, and Q2, under which it received additional shares at settlement—0.2 million, 1.6 million, and 4 million shares respectively—depending on the final calculation of the stock price during the settlement period. Therefore, while HD's additional shares arise from reinvested dividend equivalents tied to employee compensation, LOW's additional shares are a byproduct of its capital return strategy through ASR agreements.",
      "llm_answer": "\nHD’s restricted‑stock‑unit (and deferred‑share) awards accrue dividend equivalents that are **settled in additional shares on the vesting (or payout) date**; because the equivalents are paid as shares, the number of shares issued expands by the amount of dividend credit that has accumulated, effectively converting a cash‑equivalent credit into dilution at vesting.  This mechanism is the same one that applies to HD’s deferred‑share awards for non‑employee directors, which also pay out dividend equivalents in the form of extra shares when the underlying shares are distributed after Board service ends.  In contrast, LOW’s fiscal 2021 ASR program delivered additional shares under separate purchase agreements—​the “Additional Shares Delivered at Settlement” column shows values ranging from **0.2 M to 4 M shares per tranche** (e.g., 0.2 M in Q1 2021, 4 M in Q2 2021, 1.7 M in Q3 2021, 1.6 M in Q4 2021) for a total of roughly **11 M extra shares** for the year—​a dilution source that is driven by contractual notional amounts rather than by dividend‑equivalent credits.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly explains the mechanism at HD: dividend equivalents on unvested RSUs are settled in additional shares upon vesting, increasing total share issuance, which aligns with the ground truth. It also accurately contrasts this with LOW’s ASR program, identifying that additional shares were delivered under ASR agreements as part of capital return. However, there are quantitative inaccuracies: the LLM states that LOW delivered 0.2M in Q1, 4M in Q2, 1.7M in Q3, and 1.6M in Q4 2021, totaling ~11M shares. The ground truth specifies deliveries in Q1 (0.2M), Q4 (1.6M), and Q2 (4M)—but does not mention a Q3 delivery of 1.7M. This introduces a false data point and inflates the total. The original answer does not provide a total, so summing unverified tranches is incorrect. The LLM likely misread or misattributed the timing and amount of ASR deliveries. Despite this, the core reasoning and entity identification (HD vs. LOW, RSU dividend equivalents vs. ASR mechanics) are sound and contextually relevant. The explanation of HD’s policy is semantically equivalent and well-supported. The comparison logic—dilution from compensation vs. capital structure strategy—is accurate and insightful. Thus, while the qualitative and contextual understanding is strong, the quantitative score is reduced due to incorrect numbers and an unsupported calculation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Pays]-> FIN_INST -[Increases]-> FIN_INST <-[Delivers]- ORG",
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 378,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does AT&T's use of sensitivity analyses in auditing its $67,854 million goodwill balance compare to Netflix's application of similar analyses in evaluating content amortization assumptions, given both companies are audited by the same firm?",
      "original_answer": "AT&T utilized sensitivity analyses to evaluate the goodwill impairment testing for its $67,854 million goodwill balance, focusing on assumptions like terminal growth rates and weighted average cost of capital. Netflix, on the other hand, applied sensitivity analyses to assess the impact of changes in estimated viewing patterns on content amortization, a key accounting estimate given its content licensing and production model. Both companies are audited by the same firm, which performed these sensitivity analyses as part of their audit procedures to evaluate the reasonableness and robustness of management’s assumptions in each case.",
      "llm_answer": "\nAT&T’s auditors conducted independent sensitivity analyses on the discount‑rate, terminal‑growth, EBITDA‑margin and WACC assumptions that underpin the $67,854 million goodwill balance and its impairment test, quantifying how alternative assumptions would affect the reported fair‑value of the reporting units. In contrast, Netflix’s auditors applied sensitivity analyses to the viewing‑pattern assumptions that drive content amortization, measuring the impact of different consumption trends on the amortization schedule. Both exercises were part of the same auditor’s procedures, illustrating a parallel use of sensitivity testing to probe management’s subjective judgments—goodwill valuation for AT&T and content‑amortization estimates for Netflix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AT&T's $67,854 million goodwill balance is accurately cited, and the use of sensitivity analyses on key assumptions like WACC, terminal growth, and EBITDA margins in goodwill impairment testing is consistent with the original. Netflix’s use of sensitivity analyses on viewing-pattern assumptions affecting content amortization is also correctly represented. (2) Quantitative accuracy is perfect: the dollar amount ($67,854 million) is exact and properly contextualized. No calculations were required, but the figure is used appropriately. (3) Multi-hop reasoning is sound—LLM correctly synthesizes that both companies are audited by the same firm and that the auditor applied sensitivity analyses to different but critical accounting estimates (goodwill for AT&T, content amortization for Netflix), demonstrating parallel audit procedures. The LLM adds slightly more detail (e.g., EBITDA margin, discount rate) than the original, which is acceptable and plausible within audit practice, though not explicitly in the ground truth—this constitutes a minor expansion but not an error. (4) Semantic equivalence is strong: the core message—that the same auditor uses sensitivity analyses to test management’s key assumptions in different domains for each company—is preserved. The answer is fully relevant and addresses all parts of the question. A score of 9 is given instead of 10 because the LLM introduces 'EBITDA-margin' and 'discount-rate' as specific parameters for AT&T, which, while reasonable, are not mentioned in the ground truth; this is a minor over-specification but does not undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Performs]-> ACCOUNTING_POLICY <-[Reviews]- ORG",
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 467,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does Mastercard's concern about disintermediation from fintech-developed payment platforms compare to Visa's strategic partnership approach with fintechs in the context of regulatory-driven competition in the digital payments ecosystem?",
      "original_answer": "Mastercard expresses concern that fintechs could develop platforms or networks that disintermediate them from digital payments, especially when sharing data under partnerships, which could give fintechs a competitive advantage. This aligns with the broader risk that fintechs may develop competitive products that replace Mastercard’s offerings. In contrast, Visa actively partners with fintechs and emphasizes leveraging local financial institutions and tailored solutions to maintain a competitive edge. Visa sees fintechs as both partners and potential competitors, but strategically integrates them into its 'network of networks' approach. The regulatory environment, particularly in the EEA with PSD2, exacerbates these dynamics by enabling third-party providers to route transactions away from traditional networks like Mastercard, while Visa adapts by strengthening partnerships to remain central in the evolving digital payments ecosystem.",
      "llm_answer": "\nMastercard warns that regulatory shifts such as PSD2 can enable fintech‑built platforms to route transactions away from its network, commoditize transaction data and ultimately disintermediate its integrated products—risks that remain even as it partners with fintechs and must carefully manage the sharing of data that could give those partners a competitive edge.  In contrast, Visa treats collaborations with fintechs, digital‑wallet providers and alternative‑payment services as strategic partnerships that expand transaction volume and leverage its global “network‑of‑networks” model, using localized, tailored solutions to turn regulatory‑driven competition into a growth opportunity rather than a direct threat to its core switching business.  Consequently, Mastercard views fintech‑driven disintermediation as a material competitive threat that could erode demand, whereas Visa frames fintech collaborations as a deliberate lever to sustain relevance and competitiveness in an increasingly regulated digital‑payments ecosystem.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key points are correctly conveyed: Mastercard's concern about disintermediation due to fintech platforms and data sharing under regulatory pressures like PSD2; Visa's strategic partnership approach through its 'network of networks' model; the contrasting framing of fintechs as threat (Mastercard) vs. opportunity (Visa); and the role of regulation in enabling third-party routing that bypasses traditional networks. (2) There are no numeric values in the question or answers requiring verification—both responses are qualitative and conceptual, so quantitative accuracy is not applicable but does not detract. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across Mastercard’s risk disclosures, Visa’s strategic initiatives, and the regulatory context (PSD2 in the EEA), drawing a valid comparative insight. (4) The LLM uses slightly different phrasing (e.g., 'commoditize transaction data', 'material competitive threat', 'deliberate lever') but preserves and even enhances the nuance of the original without introducing error. All entities—Mastercard, Visa, fintechs, PSD2, EEA, network of networks—are accurately referenced and contextually appropriate. The answer fully addresses the comparative strategic posture of both companies in the context of regulatory-driven competition.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> PRODUCT -[Develops]-> COMP <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 391,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the expected impact of the 15% global minimum tax under Pillar 2 differ between MCD and SBUX, considering the OECD's framework and the earliest effective dates for implementation?",
      "original_answer": "MCD stated that while the global minimum tax under Pillar 2 was enacted in several countries with the earliest effective date for taxable years beginning after December 31, 2023, it does not expect a material impact on its consolidated financial statements. SBUX, on the other hand, noted that Pillar 2 will not be effective for the company until fiscal 2025 and also does not expect a material impact to its consolidated financial statements. The OECD's framework proposes a 15% global minimum tax applied on a country-by-country basis, and although many countries are incorporating Pillar 2 model rule concepts into domestic laws, differences in implementation timelines and domestic tax adjustments may affect the tax's impact on multinational companies like MCD and SBUX differently.",
      "llm_answer": "\nBoth MCD and SBUX are linked through the KG pattern ORG → Pillar 2 ← SBUX, meaning each is subject to the OECD‑proposed 15 % global minimum tax (Pillar 2) that the OECD itself (as noted in the GE filing) has been urging countries to adopt; MCD reports that several jurisdictions have already enacted Pillar 2 with the earliest effective date for taxable years beginning after 31 Dec 2023 and that it does not expect a material impact, while SBUX states that, although the OECD framework calls for a 15 % minimum tax effective for fiscal years beginning on or after 31 Dec 2023, the tax will not apply to the company until fiscal 2025 and likewise is not expected to be material, with both firms pledging to keep monitoring developments.  Consequently, the key difference is timing—MCD could be exposed as early as 2024, whereas SBUX will only face the tax from fiscal 2025 onward—yet in both cases the anticipated financial effect is neutral.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: MCD notes Pillar 2 enacted in several countries with earliest effective date for taxable years beginning after December 31, 2023, and does not expect a material impact; SBUX states it will not be affected until fiscal 2025 and also does not expect a material impact. The 15% rate under the OECD framework is correctly cited. (2) Quantitative accuracy is perfect: dates (Dec 31, 2023), percentages (15%), and fiscal years (2025) match the original answer exactly. Format variations are appropriately handled and semantically equivalent. (3) Multi-hop reasoning is sound—LLM correctly synthesizes information across MCD, SBUX, and the OECD framework, identifying both the commonality (no material impact) and the key difference (timing of applicability). The mention of both companies monitoring developments adds slight contextual value beyond the ground truth but does not introduce error. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'country-by-country' application or differences in domestic implementation, which are part of the OECD framework explanation in the original answer. However, this omission does not undermine the core correctness. Overall, the answer is factually complete, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Related_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 380,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the capital adequacy position of BlackRock Institutional Trust Company (BTC) as of December 31, 2024, compare to American Express's (AXP) regulatory capital ratios, given both entities are subject to U.S. banking regulatory requirements?",
      "original_answer": "As of December 31, 2024, BlackRock Institutional Trust Company (BTC) exceeded its applicable capital adequacy requirements, including minimum Common Equity Tier 1 (CET1), Tier 1 leverage, and risk-based capital ratios. Similarly, American Express (AXP) met all capital requirements and maintained regulatory capital ratios above the thresholds to qualify as 'well capitalized' under Federal Reserve and OCC guidelines. Both entities are subject to U.S. banking regulatory capital requirements, with BTC regulated by the Office of the Comptroller of the Currency (OCC) and AXP supervised by the Federal Reserve and its subsidiary AENB also regulated by the OCC.",
      "llm_answer": "\nBoth BlackRock Institutional Trust Company (BTC) and American Express (AXP) are U.S.‑regulated banking entities—BTC as a nationally‑chartered bank subsidiary of BLK subject to OCC capital rules, and AXP via its OCC‑regulated bank subsidiary AENB under Federal Reserve oversight.  As disclosed in the 2024 filings, BTC “exceeded the applicable capital adequacy requirements” for CET1, Tier 1 leverage and total risk‑based capital as of December 31 2024, while AXP states that it “met all capital requirements… and maintained regulatory capital ratios in excess of those required to qualify as well‑capitalized.”  Consequently, BTC’s capital position is comparable to AXP’s in that each comfortably surpasses the minimum U.S. banking capital thresholds.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BTC exceeded capital adequacy requirements as of December 31, 2024, specifically for CET1, Tier 1 leverage, and risk-based capital ratios; AXP met all capital requirements and maintained ratios above 'well-capitalized' thresholds. The regulatory bodies (OCC for BTC, Federal Reserve and OCC for AXP via AENB) are correctly identified. (2) There are no numeric values requiring calculation in this question, but the dates (December 31, 2024) and qualitative metrics (e.g., 'exceeded', 'well-capitalized') are accurately reported. Format and wording differences (e.g., 'in excess of those required to qualify as well-capitalized' vs. 'above the thresholds to qualify as well capitalized') are semantically equivalent. (3) The multi-hop reasoning is sound—correctly synthesizing information across two distinct financial entities, their regulatory structures, and capital positions. The conclusion that both entities comfortably surpass minimum thresholds is logically supported. (4) The only minor shortcoming is a slight omission of explicitly naming AXP's subsidiary AENB in the regulatory context, though it is implied through 'via its OCC-regulated bank subsidiary AENB'. This does not detract significantly from accuracy. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 390,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the $88.4 million in construction loans provided by SPG to joint ventures compare to AMT's utilization of the 2021 Multicurrency Credit Facility for acquisitions, and what does this reveal about their respective financing strategies for growth?",
      "original_answer": "SPG provided $88.4 million in construction loans to joint ventures as of December 31, 2021, indicating a strategy of internally financing development through joint ventures. In contrast, AMT borrowed $7.8 billion under the 2021 Multicurrency Credit Facility, including €2.4 billion ($2.9 billion), to fund major acquisitions like the Telxius and CoreSite deals. This reveals that AMT pursued a more aggressive, acquisition-driven growth strategy backed by large-scale credit facilities, while SPG focused on smaller-scale development financing through joint venture partnerships.",
      "llm_answer": "\nSPG’s $88.4 million of construction‑loan financing to its unconsolidated joint‑venture partners (disclosed in Note 2 of its 2021 10‑K and recorded in deferred costs) is a relatively small, project‑specific source of capital that is used to fund only a handful of joint‑venture properties out of the 84 it holds, whereas AMT tapped a $6 billion 2021 Multicurrency Credit Facility—borrowing a total of $7.8 billion in 2021 (as detailed on pages 52 and 111 of its 2021 10‑K) to finance the Telxius and CoreSite acquisitions, repay existing debt and support general corporate purposes—demonstrating a far larger, market‑wide debt‑capital approach.  \n\nThis contrast shows that SPG grows through targeted, risk‑sharing joint‑venture loans tied to specific developments, while AMT pursues aggressive, acquisition‑driven expansion by leveraging a broad, multi‑currency revolving credit facility with substantial borrowing capacity and flexible covenant terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the $88.4 million construction loans from SPG are correctly stated. For AMT, the LLM states $7.8 billion borrowed under the 2021 Multicurrency Credit Facility, which matches the ground truth. However, the ground truth specifies that this includes €2.4 billion ($2.9 billion), a detail omitted in the LLM answer—this is a minor omission, not an error. The LLM mentions a $6 billion facility, which is consistent with the structure of the credit facility (the $7.8 billion drawn may include rollovers or exceed the facility size due to accordion provisions, as sometimes allowed). (2) The answer addresses both parts of the question: the comparison of financing amounts and the implications for growth strategies. (3) Entities—SPG, AMT, 2021 Multicurrency Credit Facility, Telxius, CoreSite—are correctly identified and contextualized. (4) The reasoning is sound: SPG’s use of small-scale, project-specific joint venture loans is contrasted effectively with AMT’s large-scale, acquisition-driven borrowing, revealing distinct strategic approaches. The LLM adds contextual detail (e.g., disclosure in Note 2, recording in deferred costs, number of joint ventures) that enhances accuracy and demonstrates multi-hop synthesis from 10-K filings. The only minor shortcoming is the lack of explicit mention of the euro-to-dollar conversion component of AMT’s borrowing, which slightly reduces quantitative completeness. Overall, the answer is factually correct, well-reasoned, and contextually rich.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Supplies]-> FIN_INST -[Supplies]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 433,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the $0.5 billion interest rate swap held by CSCO to hedge its fixed-rate senior notes compare with AVGO's exposure to $56.3 billion in fixed-rate senior notes in terms of sensitivity to interest rate fluctuations?",
      "original_answer": "CSCO uses a $0.5 billion interest rate swap to hedge a portion of its fixed-rate senior notes, converting the fixed interest rate to a floating rate based on SOFR, thereby reducing interest rate risk for that specific liability. In contrast, AVGO holds $56.3 billion in fixed-rate senior notes as of November 3, 2024, and a 50 basis point interest rate increase would decrease the fair value of these notes by $1.7 billion. This indicates that AVGO has significant interest rate exposure on its fixed-rate debt, while CSCO has mitigated part of its exposure through active hedging.",
      "llm_answer": "\nCSCO’s $0.5 bn interest‑rate swap is a fair‑value hedge that converts the fixed‑rate senior notes to a SOFR‑based floating rate, and the resulting gain or loss on the swap is recorded in interest expense to offset the fair‑value change of the hedged portion of that debt.  By contrast, AVGO has $56.3 bn of fixed‑rate senior notes outstanding, and a 50‑basis‑point move in market rates would shift their aggregate fair value by roughly $1.7 bn (about $34 m per 1‑bp), a far larger absolute sensitivity than the $0.5 bn swap’s impact.  (Both exposures are measured through fair‑value changes, but AVGO’s scale makes its interest‑rate sensitivity an order of magnitude greater.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: CSCO's $0.5 billion interest rate swap hedges fixed-rate senior notes by converting them to floating rates based on SOFR, reducing interest rate risk; AVGO has $56.3 billion in fixed-rate senior notes, and a 50 basis point rate change affects their fair value by $1.7 billion. These numbers match the original answer exactly, and the derived sensitivity of ~$34 million per 1 bp ($1.7B / 50) is a valid calculation. (2) Quantitative accuracy is perfect—dollar amounts, basis points, and implied sensitivity are correctly stated and computed. Format variations (e.g., $0.5 bn vs $0.5 billion) are acceptable and clear. (3) The reasoning is sound: the LLM correctly identifies that both companies' exposures are measured through fair-value changes, contrasts CSCO’s active hedging (reducing sensitivity) with AVGO’s large unhedged exposure, and notes the order-of-magnitude difference in sensitivity due to scale. It synthesizes multi-hop information across two companies and financial instruments appropriately. (4) The only minor shortcoming is that the LLM does not explicitly state that CSCO’s hedge *reduces risk*—it describes the accounting and mechanism but slightly underemphasizes the risk mitigation intent highlighted in the original answer. However, this is implied in the explanation. Overall, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Holds]-> FIN_INST -[Hedges_Fixed_Rate_Senior_Notes]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 415,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the use of option contracts by NKE to hedge foreign currency exposures compare to TSLA's exposure to foreign currency assets, given the impact of such hedging instruments on deferred gains and losses in other comprehensive income?",
      "original_answer": "NKE actively uses option contracts as part of its foreign currency risk management program to hedge exposures from product costs, external sales, and other costs, with $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024. These contracts are designated as cash flow hedges, with mark-to-market gains and losses deferred in AOCI, including $99 million in net deferred gains expected to mature in the next twelve months. In contrast, TSLA does not typically hedge foreign currency risk and instead experiences significant fluctuations in foreign exchange gains and losses from period to period, particularly on intercompany balances, which flow through 'Other income (expense), net.' This highlights a more proactive hedging strategy by NKE versus TSLA’s reactive exposure to foreign currency assets.",
      "llm_answer": "\nNKE manages foreign‑currency risk by designating option and forward contracts as cash‑flow hedges; the effective portion of the hedge’s fair‑value change is recorded in other comprehensive income (OCI/AOCI) and only re‑classified to earnings when the hedged transaction—such as product‑cost or non‑functional‑currency sales—settles, thereby smoothing earnings volatility. In contrast, TSLA’s foreign‑currency‑denominated monetary assets and liabilities are **not** hedged, so any foreign‑exchange re‑measurement is recognized directly in other income (or other expense) and is not deferred in OCI, leading to potentially large and periodic swings in reported results. Thus, while NKE’s option‑contract hedges move gains/losses into OCI for later offset, TSLA’s un‑hedged exposure results in immediate recognition of those gains/losses in the income statement.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast between NKE and TSLA regarding foreign currency hedging and its impact on financial reporting. It correctly explains that NKE uses option and forward contracts designated as cash flow hedges, with gains/losses deferred in AOCI and later reclassified to earnings, which aligns with the ground truth. It also accurately states that TSLA does not hedge foreign currency exposures and recognizes FX gains/losses directly in 'Other income (expense), net,' leading to volatility. However, the LLM omits specific quantitative details present in the ground truth: the $9.9 billion in notional amount of NKE's hedges and the $99 million in net deferred gains expected to mature in the next twelve months. While the qualitative reasoning, entity accuracy, and contextual relevance are excellent—correctly identifying NKE, TSLA, hedging strategies, accounting treatment under OCI/AOCI, and the implications for earnings volatility—the absence of these key figures reduces quantitative accuracy. The multi-hop synthesis across companies and accounting treatments is sound and semantically equivalent in meaning, just lacking precise numerical support. Hence, a 9 is justified for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Impacts]-> FIN_INST <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 349,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does Boeing's use of Citibank, N.A. as administrative agent in its Five-Year Credit Agreement compare with Caterpillar's use of Citibank in its 5-Year Facility, particularly in terms of Citibank's role and the amendment timelines?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, and amended on August 25, 2022, lists Citibank, N.A. as the administrative agent. Similarly, Caterpillar's Third Amended and Restated Credit Agreement (5-Year Facility), dated September 1, 2022, also names Citibank, N.A. as the Agent. Both companies rely on Citibank in a leadership capacity—Boeing in a dual role as administrative agent and joint lead arranger, and Caterpillar as Agent. Boeing’s amendment occurred in August 2022, while Caterpillar’s Amendment No. 1 to the 5-Year Facility was dated August 31, 2023, showing staggered but comparable timelines for credit agreement adjustments.",
      "llm_answer": "\nBoeing’s Five‑Year Credit Agreement (dated 30 Oct 2019) expressly appoints Citibank, N.A. as **administrative agent** for the lenders, and its first amendment (dated 25 Aug 2022) continues to list Citibank in that same role; Caterpillar’s 5‑Year Facility (dated 1 Sep 2022) likewise names Citibank, N.A. as **Agent**—the functional equivalent of an administrative agent—while its first amendment (dated 31 Aug 2023) updates the facility, meaning Caterpillar’s amendment occurs a year after Boeing’s. Both agreements, disclosed in the respective 10‑K filings (Chunks 1/2 for Boeing and Chunk 3 for Caterpillar), illustrate that Citibank serves as the lead banking partner in each credit arrangement, but the timing of the amendments differs (Boeing 2022 vs. Caterpillar 2023).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Boeing's Five-Year Credit Agreement is dated October 30, 2019, amended August 25, 2022, with Citibank, N.A. as administrative agent; Caterpillar's 5-Year Facility is dated September 1, 2022, with Citibank, N.A. as Agent, and its first amendment is dated August 31, 2023. These dates and roles match the original answer exactly. (2) Quantitative accuracy is perfect: all dates are correctly cited, and the one-year difference in amendment timing (Boeing 2022 vs. Caterpillar 2023) is accurately noted. (3) The multi-hop reasoning is sound—information is correctly synthesized across Boeing and Caterpillar filings, comparing roles and timelines. The LLM correctly infers that 'Agent' in Caterpillar’s context is the functional equivalent of 'administrative agent,' which is a reasonable interpretation. (4) The only minor shortcoming is that the LLM omits Boeing’s dual role as both administrative agent and joint lead arranger, which is mentioned in the ground truth and adds a slight nuance to Citibank’s expanded role at Boeing. However, this does not undermine the core accuracy. The answer is contextually relevant, directly addressing the comparison of Citibank’s role and amendment timelines. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the ground truth with only a minor omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Regulates]-> COMP <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 396,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the difference in voting rights per share between Netflix's common stock and Meta's Class B common stock compare, given the structure of voting rights tied to different stock classes as disclosed by both companies?",
      "original_answer": "Netflix's common stock provides one vote per share, while Meta's Class B common stock provides 10 votes per share, reflecting a significant disparity in shareholder voting power between the two companies' stock structures.",
      "llm_answer": "\nThe KG mapping (NFLX → Voting Rights → Class B Common Stock → META) shows that Netflix’s 2024 10‑K (Chunk 1) discloses a **one‑vote‑per‑share** rule for its common stock, whereas Meta’s own 2024 10‑K (Chunks 2 & 3) states that each share of **Class B common stock carries ten votes per share** (and may convert to Class A shares). Thus, Meta’s Class B shares confer **ten times the voting rights per share** compared with the single vote per share that Netflix’s common stock provides.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately states that Netflix's common stock provides one vote per share and Meta's Class B common stock provides ten votes per share, which aligns exactly with the original answer. (2) The quantitative comparison — 'ten times the voting rights per share' — is mathematically accurate and correctly derived from the 1:10 ratio. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from two separate companies' 10-K filings (Netflix and Meta), identifies the relevant stock classes, and compares their voting rights as required by the question. (4) All entities (Netflix, Meta, Class B common stock) are correctly identified, and the context of voting rights structure is appropriately addressed. Minor differences in wording (e.g., 'ten times the voting rights' vs 'significant disparity') do not affect semantic equivalence — both convey the same core fact. No errors in facts, logic, or synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 290,
        "total_tokens": 1486
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does BMY's reliance on Cardinal Health for 23% of its distribution in 2023 intersect with CVS’s financial consolidation of Red Oak Sourcing, given Cardinal Health’s 50% ownership stake in the same generic pharmaceutical sourcing entity?",
      "original_answer": "BMY relies on Cardinal Health, Inc. for 23% of its distribution network as of 2023, making Cardinal a critical third-party logistics partner. At the same time, CVS co-owns Red Oak Sourcing, LLC with Cardinal Health (each holding a 50% stake), and consolidates Red Oak’s operations into its financial statements due to its role as the primary beneficiary. This creates a complex interdependency where BMY’s supply chain is partially dependent on a company (Cardinal Health) that is structurally and financially tied to CVS through Red Oak Sourcing. The quarterly payments from Cardinal to CVS, totaling $183 million annually, influence CVS’s cost of goods sold, which could indirectly affect the pricing or efficiency of Cardinal’s distribution services to BMY.",
      "llm_answer": "\nBMY discloses that Cardinal Health accounted for 23 % of its 2023 distribution, and Cardinal Health simultaneously owns a 50 % stake in Red Oak Sourcing—the generic‑pharmaceutical sourcing venture that CVS consolidates because it is the primary beneficiary; as a result, the $183 million quarterly payments that Cardinal makes to CVS (recorded as a reduction of inventory cost of products sold) directly tie BMY’s reliance on Cardinal to the financial results that CVS reports for its consolidated Red Oak entity. This shared ownership and the associated payment flow create a financial intersection where BMY’s distribution dependence on Cardinal influences the cost‑of‑goods accounting and overall consolidated performance of CVS.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: BMY's 23% reliance on Cardinal Health in 2023, Cardinal's 50% ownership in Red Oak Sourcing, CVS's consolidation of Red Oak due to being the primary beneficiary, and the $183 million in quarterly payments from Cardinal to CVS. The dollar amount is correctly stated as $183 million per quarter, which matches the annual $183 million in the original answer—this appears to be a discrepancy in the original answer, as $183 million quarterly would be $732 million annually, but the LLM correctly interprets the $183 million as quarterly, which is consistent with typical SEC filing disclosures and more likely correct. Thus, the LLM likely has the accurate interpretation. (2) Quantitative accuracy is perfect: percentages (23%, 50%), dollar amount ($183 million), and time period (2023) are all correctly reported. (3) Multi-hop reasoning is sound: the LLM correctly links BMY’s distribution dependency → Cardinal Health → joint ownership of Red Oak → CVS’s consolidation → financial impact via COGS. It identifies the structural and financial interdependencies across all three entities. (4) The only minor issue is a slight overstatement in causality: the LLM says the payment flow 'directly tie BMY’s reliance on Cardinal to the financial results that CVS reports', but the connection is indirect—BMY’s reliance affects its supply chain risk, not CVS’s financials directly. The original answer correctly frames this as an indirect influence. This nuance prevents a perfect 10, but the overall synthesis is excellent. Semantic equivalence is strong, and the answer is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Has_Stake_In]-> COMP <-[Consolidates]- ORG",
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 462,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does MetLife's exposure to interest rate scenarios in its Retirement and Income Solutions segment affect its Life Insurance product line, and how does this compare to AIG's experience with Life Insurance reserve updates under similar interest rate dynamics?",
      "original_answer": "MetLife's Retirement and Income Solutions segment includes life insurance products and is exposed to interest rate scenarios that could compress gross margins due to minimum crediting rate guarantees and reinvestment risks. In declining rate environments, this leads to margin compression, while rising rates allow for reinvestment in higher-yielding assets. Similarly, AIG experienced a $106 million favorable impact in 2021 from actuarial assumption updates in Life Insurance, driven by policy fee modeling, but also faced margin pressures from lower projected investment earnings. Both companies show sensitivity in their Life Insurance lines to interest rate dynamics, with MetLife managing through ALM strategies and AIG adjusting reserves and assumptions.",
      "llm_answer": "\nMetLife’s Retirement and Income Solutions (RIS) segment includes Life‑Insurance products that feel the brunt of interest‑rate moves: in a falling‑rate environment the retained‑asset accounts and disability‑reserve margins are compressed by minimum‑crediting‑rate guarantees, whereas a rising‑rate environment lets the segment reinvest cash flows at higher yields to offset lower crediting rates (Chunk 1).  Because Life‑Insurance is a sub‑product of RIS, these rate‑driven margin pressures feed back negatively on the segment’s profitability, a relationship captured by the KG link Life Insurance ←[Negatively_Impacts]‑ ORG (Chunk 2).  By contrast, AIG’s 2021‑2020 10‑K disclosures show that similar interest‑rate‑driven actuarial assumption updates produced a $106 million favorable and a $101 million unfavorable swing in Life‑Insurance reserves—driven by spread compression and reserve‑increase modeling rather than gross‑margin compression—demonstrating a parallel but distinct reserve‑update dynamic under comparable rate dynamics (Chunk 3).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies MetLife's exposure to interest rate scenarios in its Retirement and Income Solutions (RIS) segment and how this affects its Life Insurance product line through margin compression in declining rates and reinvestment benefits in rising rates. It also correctly notes that AIG experienced a $106 million favorable impact from actuarial assumption updates in 2021. However, the LLM introduces a $101 million unfavorable swing for AIG that is not present in the original answer, which only mentions the $106 million favorable impact and general margin pressures from lower projected investment earnings—this is a factual overstatement. (2) The $106 million favorable impact is correctly cited, but the addition of a $101 million unfavorable swing lacks support in the ground truth and appears to be an incorrect inference or hallucination. The original answer does not mention any offsetting unfavorable reserve update of that magnitude. (3) The multi-hop reasoning is strong: the model correctly links MetLife’s segment-level dynamics to its Life Insurance products and compares them to AIG’s reserve and assumption updates under similar interest rate environments. It accurately captures the conceptual parallel between MetLife’s margin pressures and AIG’s reserve sensitivity, even if the specific numbers for AIG are partially inaccurate. (4) The contextual relevance is perfect—the answer directly addresses both parts of the question and synthesizes across companies and financial mechanisms. The qualitative reasoning is sophisticated, referencing ALM strategies and modeling differences. However, the quantitative inaccuracy in fabricating a $101 million unfavorable item reduces confidence in the numerical precision, warranting a deduction in quantitative accuracy. Overall, the answer is factually mostly correct with strong reasoning but contains one significant numerical error not in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT -[Includes]-> PRODUCT <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 529,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What specific battery supply agreements exist between Tesla and Panasonic Corporation, and how do these agreements compare to known battery sourcing dependencies reported by General Motors?",
      "original_answer": "Tesla has multiple agreements with Panasonic Corporation for battery supply, including the 2011 Supply Agreement, its 2019 and 2021 Pricing Agreements for Japan-sourced cells, and the 2020 Pricing Agreement for Gigafactory 2170 cells. These agreements are supported by ongoing amendments, investment letters, and shared facility leases that indicate a deep strategic partnership. In contrast, General Motors’ filings only state a general dependency on batteries without specifying agreements or suppliers, making Tesla’s battery sourcing strategy with Panasonic more explicitly defined and contractually secured.",
      "llm_answer": "\nGeneral Motors’ 2023 10‑K (Chunk 1) discloses a reliance on “Batteries” that are ultimately supplied by Panasonic Corporation, indicating a direct sourcing dependency. Tesla’s SEC filings (Chunks 2 & 3) detail a suite of battery‑supply contracts with Panasonic—including the 2011 Supply Agreement, its 2013 and 2016 amendments, and the 2019, 2020 and 2021 Pricing Agreements for 2011‑type and 2170 cells—governing the cells used in Tesla’s Gigafactory, thereby illustrating a more extensive, multi‑agreement partnership compared with GM’s broader dependence on Panasonic‑sourced batteries.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information. (1) Correct elements: The mention of Tesla’s 2011 Supply Agreement and multiple pricing agreements with Panasonic (2019, 2020, 2021) aligns with the ground truth, as does the emphasis on a multi-agreement partnership. The comparison to GM’s less specific battery dependency is conceptually relevant. (2) Quantitative inaccuracies: The LLM incorrectly cites a 2013 and 2016 amendment to the 2011 agreement, which are not present in the ground truth. The original answer specifies 2019 and 2021 Pricing Agreements for Japan-sourced cells and a 2020 Pricing Agreement for Gigafactory 2170 cells—dates that are partially correct but conflated in the LLM response. The LLM also incorrectly states that GM’s 2023 10-K discloses Panasonic as a direct supplier, whereas the ground truth emphasizes that GM only reports a general dependency on batteries without naming suppliers or agreements. (3) Multi-hop reasoning is partially sound—comparing Tesla’s explicit contracts to GM’s vague disclosures is valid—but the reasoning is undermined by factual errors in entity and date attribution. (4) The answer is contextually relevant and attempts the correct synthesis, but significant factual inaccuracies in key dates and supplier disclosures reduce correctness. The claim about GM’s direct Panasonic dependency is a critical error, as the ground truth explicitly states no such supplier is named in GM filings. Thus, while the structure and intent are appropriate, the factual foundation is flawed, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT -[Supplies]-> COMP <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 432,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How does MDLZ's use of commodity futures, which are classified as Level 1 financial assets, compare to COST's disclosure about holding no Level 1 financial assets, in the context of their respective risk management strategies involving financial instruments?",
      "original_answer": "MDLZ actively uses commodity futures, which are categorized as Level 1 financial assets based on quoted market prices, as part of its hedging strategy to manage exposure to input cost fluctuations such as cocoa, sugar, and energy. In contrast, COST disclosed that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a different approach to financial risk management that does not involve exchange-traded futures. This contrast highlights that while MDLZ relies on Level 1 commodity futures for price risk mitigation, COST does not utilize such instruments in its financial strategy.",
      "llm_answer": "\nMDLZ reports that its commodity futures—classified as Level 1 financial assets—are used to hedge raw‑material price exposure, with fair value measured by quoted exchange prices and managed through credit‑risk‑controlled counterparties (Chunk 1 & 2). In contrast, COST’s 10‑K discloses that it held no Level 1 assets at the reporting date, showing that the retailer does not employ exchange‑traded commodity futures in its risk‑management strategy (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: MDLZ uses commodity futures classified as Level 1 financial assets for hedging input cost fluctuations, with fair value based on quoted exchange prices. COST disclosed holding no Level 1 financial assets, indicating it does not use exchange-traded futures. These points align with the original answer. (2) There are no numeric values, dates, or calculations in the question or answer that require verification—both mention the absence of Level 1 assets for COST without specifying a dollar amount or percentage, and the LLM correctly reflects this. The date (August 28, 2022) from the ground truth is omitted in the LLM answer but is not critical to the overall comparison and does not impair understanding. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (MDLZ and COST), their use (or non-use) of Level 1 financial instruments, and the implications for their risk management strategies. (4) Semantic equivalence is maintained—while the LLM answer is more concise, it captures the essential contrast: MDLZ actively uses Level 1 commodity futures for hedging; COST does not hold such assets, reflecting a divergent risk management approach. The only minor shortcoming is the lack of explicit mention of the specific commodities (e.g., cocoa, sugar, energy) hedged by MDLZ, which adds contextual richness but does not undermine the correctness of the strategic comparison. Hence, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Includes]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 461,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does the adoption of Rule 10b5-1(c) trading plans by Apple executives compare with Broadcom's use of similar plans in terms of volume and timing of potential stock sales?",
      "original_answer": "Apple executives Deirdre O'Brien and Jeff Williams entered into Rule 10b5-1(c) trading plans in August 2024, covering the sale of shares vesting between April 1, 2025, and October 1, 2026 (O'Brien) and up to 100,000 shares plus additional vesting shares through October 1, 2025 (Williams), with expiration dates in 2025 and 2026. Broadcom director Diane M. Bryant adopted a similar plan in September 2024, allowing for the sale of up to 15,000 shares of Broadcom common stock contingent on market price thresholds, expiring September 12, 2025. Both companies utilize Rule 10b5-1(c) plans to structure insider trading in compliance with SEC regulations, but Apple’s plans involve significantly larger volumes and longer time horizons.",
      "llm_answer": "\nApple’s executives have adopted separate Rule 10b5‑1(c) trading plans that could trigger sales of up to 100,000 shares (Jeff Williams) and of an unspecified number of shares that vest between April 1 2025 and Oct 1 2026 (Deirdre O’Brien), with the plans expiring on Dec 15 2025 and Dec 31 2026 respectively; Broadcom’s (AVGO) plan, by contrast, permits a potential sale of only up to 15,000 shares and is set to expire on Sep 12 2025, subject to market‑price thresholds. Thus, Apple’s plans involve a markedly larger share volume and a longer possible sales window than Broadcom’s plan, even though both are entered into to satisfy the same Rule 10b5‑1(c) affirmative‑defense conditions.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key executives at Apple (Deirdre O'Brien and Jeff Williams) and Broadcom director Diane M. Bryant, and accurately notes the adoption of Rule 10b5-1(c) plans in August 2024 (Apple) and September 2024 (Broadcom). The volume comparison is mostly correct: Jeff Williams' plan covers up to 100,000 shares (correct), and Broadcom’s plan allows up to 15,000 shares (correct). However, the LLM incorrectly states that O'Brien's plan covers an 'unspecified number of shares'—the original answer implies the volume is tied to shares vesting between April 1, 2025, and October 1, 2026, which suggests a defined volume based on vesting schedules, even if not a fixed number. More critically, the LLM assigns incorrect expiration dates: it states December 15, 2025, and December 31, 2026, while the ground truth specifies expiration dates in 2025 and 2026 without exact dates—so the LLM adds false precision. (2) Quantitative accuracy is partially compromised: while share volumes (100,000 and 15,000) are correct, the specific expiration dates are fabricated or misstated. The ground truth only mentions 'expiring in 2025 and 2026' for Apple, not exact dates. (3) Multi-hop reasoning is strong: the LLM correctly synthesizes information across Apple and Broadcom, compares volume and timing, and draws the valid conclusion that Apple’s plans involve larger volumes and longer durations. It also correctly notes the market-price threshold condition for Broadcom and the compliance purpose of Rule 10b5-1(c). (4) Scores reflect high qualitative accuracy and full contextual relevance, but quantitative accuracy is reduced due to incorrect expiration dates and omission of vesting-linked volume detail for O'Brien. The core conclusion remains valid, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Subject_To]-> ACCOUNTING_POLICY <-[Affects_Stock]- ORG",
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 495,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does the involvement of JPMorgan Chase Bank, N.A. as syndication agent in both 3M's May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement reflect a shared banking relationship in their respective credit facilities?",
      "original_answer": "JPMorgan Chase Bank, N.A. serves as syndication agent in both 3M’s May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement, indicating a shared banking relationship where JPMorgan plays a key coordinating role in managing the syndicate of lenders for both companies’ credit facilities. This suggests that both companies rely on JPMorgan Chase Bank, N.A. to help structure and administer large-scale financing arrangements, potentially reflecting a strategic alignment in how they access syndicated credit markets.",
      "llm_answer": "\nThe May 11 2023 Five‑Year Credit Agreement for 3M (Chunk 1, Exhibit 10.29) lists **JPMorgan Chase Bank, N.A. as syndication agent**, and Honeywell’s Amended and Restated Five‑Year Credit Agreement dated March 20 2023 (Chunk 3, Exhibit 10.68) likewise names **JPMorgan Chase Bank, N.A. as a syndication agent**.  The knowledge‑graph triplets connect these facts—**MMM → Five‑Year Credit Agreement → JPMorgan** and **JPMorgan → HON**—showing that the same bank acts as syndication agent in both companies’ credit facilities, thereby reflecting a shared banking relationship across their respective five‑year agreements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns with the ground truth. (1) All key facts are accurate: JPMorgan Chase Bank, N.A. is correctly identified as the syndication agent in both 3M’s May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement. Dates, roles, and entities are correct. (2) There are no numerical values requiring calculation in this question, so quantitative accuracy is not applicable beyond correct date and role reporting—these are accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two separate credit agreements from different companies and identifies the shared role of JPMorgan, thereby supporting the conclusion of a shared banking relationship. The mention of knowledge-graph triplets adds context but does not detract from correctness. (4) The answer conveys the same core information as the original answer—namely, that JPMorgan serves as syndication agent for both firms, indicating a shared banking relationship in their syndicated credit facilities. The only minor shortcoming is that it could have elaborated slightly more on the significance of the syndication agent role (e.g., coordinating lenders, structuring financing), which the original answer includes to strengthen the interpretation. However, the semantic meaning and factual content are substantially equivalent. Thus, the answer is highly accurate, complete, and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Amends]-> FIN_INST -[Regulates]-> COMP <-[Enters_Agreement]- ORG",
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 406,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How might the EU and U.S. sanctions targeting the tobacco sector in Belarus impact Coca-Cola HBC's operations in the country, and what implications could this have for The Coca-Cola Company's overall unit case volume given its reliance on Coca-Cola HBC as a key bottler?",
      "original_answer": "The EU and U.S. sanctions targeting the tobacco sector in Belarus, including restrictions on trade of goods used for tobacco production, could disrupt local supply chains and economic activity, potentially affecting Coca-Cola HBC's operations in the country. Since Coca-Cola HBC is a major independent bottler representing 41% of The Coca-Cola Company’s total worldwide unit case volume in 2021 and operates in Belarus, any operational constraints or economic instability in Belarus could reduce its production and distribution capacity. This, in turn, could negatively impact The Coca-Cola Company’s overall unit case volume, especially since non-U.S. markets accounted for 83% of the company’s total volume in 2021 and bottlers like Coca-Cola HBC are contractually required to purchase concentrates from KO, forming a critical link in the supply chain.",
      "llm_answer": "\nThe EU and U.S. sanctions that bar trade in the tobacco sector of Belarus (as described in the sanctions timeline) directly constrain Coca‑Cola HBC’s operations in that country, because the bottler’s territory includes Belarus and its contracts obligate it to purchase concentrates from The Coca‑Cola Company (KO) – a relationship highlighted by the “ORG → COMP → GPE” dependency in the knowledge graph.  Since Coca‑Cola HBC is one of the five largest bottling partners and together with the other four accounts for roughly **41 % of the Company’s worldwide unit‑case volume** (Chunk 1/2), any disruption to HBC’s Belarus business would shave a measurable share off Coca‑Cola’s total unit‑case volume.  Moreover, the bottler‑agreement structure (independent contractor that must buy all required concentrates from KO) means that a sanctions‑induced slowdown for HBC would not only limit its own shipments but also reduce the volume of concentrates sold to it, pressuring overall unit‑case growth for The Coca‑Cola Company.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Coca-Cola HBC operates in Belarus, is a major bottler, and accounted for 41% of The Coca-Cola Company’s total worldwide unit case volume in 2021—this number is correctly cited and matches the original answer. There are no errors in financial figures, percentages, or dates. (2) Quantitative accuracy is perfect: the 41% figure is correctly used and contextualized as a significant portion of global volume. No calculations are required beyond correct interpretation of this percentage. (3) The multi-hop reasoning is sound: the answer correctly links EU/U.S. sanctions on Belarus’s tobacco sector → potential disruption to Coca-Cola HBC’s operations in Belarus → impact on HBC’s production and concentrate purchases → downstream effect on The Coca-Cola Company’s unit case volume. It also correctly references the contractual bottler relationship (independent bottler must buy concentrates from KO), which is critical to the causal chain. (4) The only minor shortcoming is that the original answer adds context about non-U.S. markets accounting for 83% of volume in 2021, which slightly strengthens the global exposure argument; this is omitted in the LLM answer but does not invalidate the conclusion. Wording differences (e.g., 'shave a measurable share') are semantically equivalent and acceptable. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 407,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How might the proposed 28%-30% reduction in U.S. debit interchange rate caps impact Capital One’s interchange fee income, given its exposure to Mastercard’s four-party network and the ongoing legal challenges involving interchange fees that Visa and Mastercard face?",
      "original_answer": "The proposed 28%-30% reduction in U.S. debit interchange rate caps by the Federal Reserve could significantly lower Capital One’s interchange fee income, as COF relies on interchange fees from transactions processed through four-party networks like Mastercard. This impact could be exacerbated by the fact that merchants continue to pursue legal actions against Mastercard and Visa, as seen in the ongoing multidistrict litigation where interchange fee practices remain under scrutiny. Mastercard, being subject to regulatory oversight and interchange fee limitations, may be forced to further reduce fees or face additional settlements, which would directly affect Capital One’s revenue model tied to those networks.",
      "llm_answer": "\nThe Federal Reserve’s October 2023 proposal would cut the U.S. debit‑card interchange cap by roughly 28‑30 % (Chunk 2), a reduction that directly affects Capital One’s interchange‑fee revenue because it issues debit cards on Mastercard’s four‑party network and is subject to the Regulation II caps highlighted in Capital One’s disclosure (Chunk 1). At the same time, the ongoing antitrust litigation and settlement pressures on Visa and Mastercard (Chunk 3) create additional downward pressure on interchange fees, meaning the proposed cap cut could materially reduce Capital One’s interchange‑fee income and adversely impact its financial condition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 28%-30% reduction in U.S. debit interchange rate caps is correctly cited, and the reference to the Federal Reserve’s October 2023 proposal (implied in 'Chunk 2') matches the context, though the exact date isn't in the original answer—this is a minor addition but factually plausible and not incorrect. No calculations are required, and all numeric references are accurate. (2) The answer correctly identifies Capital One’s exposure via Mastercard’s four-party network and ties it to Regulation II caps, which is consistent with the original answer’s emphasis on regulatory limits. (3) The multi-hop reasoning is sound: it connects the Fed’s proposed cap reduction → impact on Capital One’s interchange income → amplification due to ongoing antitrust litigation against Visa and Mastercard. The mention of 'settlement pressures' (Chunk 3) reflects the ongoing multidistrict litigation referenced in the ground truth. (4) The only minor shortcoming is that the LLM answer does not explicitly mention that Mastercard may face further fee reductions or settlements due to regulatory oversight, which slightly reduces qualitative completeness. However, the core financial impact and reasoning are correctly synthesized. Wording differs but semantic meaning is equivalent. All entities (Capital One, Mastercard, Visa, interchange fees) are correctly identified and logically linked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> REGULATORY_REQUIREMENT -[Subject_To]-> COMP <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 404,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does Duke Energy's exposure to LIBOR-indexed financial contracts influence its adoption timeline for ASU 2020-04 compared to Southern Company's approach, given both companies' assessments of the regulation's financial impact?",
      "original_answer": "Duke Energy is assessing LIBOR-indexed financial arrangements and evaluating the optional expedients in ASU 2020-04 for contracts extending beyond the LIBOR phase-out in 2023, with the transition not expected to have a material impact on its financial statements. Southern Company, similarly, is evaluating the provisions of ASU 2020-04 and the impact of transitioning to alternative rates, though the ultimate outcome remains uncertain. Both companies are applying the guidance as it relates to contract modifications and hedge accounting under the reform, but Duke Energy had until December 31, 2022, to apply the optional expedients, suggesting a time-bound evaluation window compared to Southern Company's ongoing assessment.",
      "llm_answer": "\nDuke Energy’s extensive use of LIBOR‑indexed debt and derivatives requires it to actively assess the optional expedients in ASU 2020‑04 and to consider contract amendments before the 2023 LIBOR phase‑out, which pushes a more immediate adoption timeline; Southern Company, while also subject to the same ASU (as shown by the KG link ASU 2020‑04 → SO), merely states it will “continue to evaluate the provisions… and the impacts of transitioning to an alternative rate,” without specifying a concrete schedule. Both companies conclude that the transition is not expected to have a material financial impact (Chunk 1 and Chunk 2), but Duke Energy’s direct LIBOR exposure drives a proactive, earlier‑stage evaluation compared with Southern Company’s more tentative, ongoing assessment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Duke Energy's LIBOR exposure drives a proactive evaluation of ASU 2020-04 with an eye toward the 2023 phase-out, and it had a time-bound window (implied deadline of December 31, 2022, per original answer) to apply optional expedients. Southern Company is also evaluating the ASU but with less specificity and no defined timeline, described accurately as an 'ongoing assessment.' Both conclude the impact is not expected to be material—correctly reflected. (2) Quantitative accuracy is perfect: no incorrect numbers, dates (2023 LIBOR phase-out, implied 2022 deadline) are consistent with the original answer. The LLM correctly infers urgency from Duke’s exposure without fabricating dates. (3) Multi-hop reasoning is sound: the model synthesizes Duke Energy’s LIBOR exposure, regulatory response (ASU 2020-04), timing implications, and comparison to Southern Company’s more tentative approach. It correctly links exposure to adoption timeline, which is the core of the question. (4) Minor deduction in qualitative accuracy (9 instead of 10) because the original answer explicitly mentions Duke Energy’s deadline of December 31, 2022, while the LLM describes it as 'more immediate' without citing the exact cutoff—slightly less precise but still semantically equivalent. Contextual relevance is perfect: directly addresses the comparative adoption timeline and financial impact as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Positively_Impacts]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 412,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does the application of the Black-Scholes-Merton model for stock option valuation at KO compare to the use of weighted-average assumptions in pension plan cost calculations at CL, particularly in terms of the specific inputs and their financial reporting implications?",
      "original_answer": "KO uses the Black-Scholes-Merton model to estimate the fair value of stock option awards, with the weighted-average fair value of options granted in 2023 being calculated using assumptions such as volatility, risk-free interest rate, and expected term. These weighted-average assumptions are a key input in the model. CL also utilizes weighted-average assumptions, but in the context of pension plan cost calculations, where factors like discount rate (5.66% in 2023), expected long-term rate of return on plan assets (6.25% in 2023), and compensation increase (3.50% in 2023) directly impact the reported net periodic benefit cost. While both companies rely on weighted-average assumptions, KO applies them in equity compensation valuation using a formal pricing model, whereas CL integrates them into actuarial estimates for pension liabilities, highlighting different financial reporting applications of similar statistical inputs.",
      "llm_answer": "\nKO’s stock‑option awards are valued with the Black‑Scholes‑Merton model and the resulting fair‑value is expensed straight‑line over the four‑year vesting period; the company discloses the weighted‑average inputs (volatility, risk‑free rate, expected life, dividend yield) for 2021‑2023 in its 10‑K, but does not break out the numeric values.  \nCL, however, calculates pension expense using a set of weighted‑average actuarial assumptions that are explicitly tabulated (e.g., a 5.66 % discount rate, 6.25 % expected return on assets, 3.5 % compensation‑increase rate, 6.00 % ESOP growth, etc.) and these inputs drive the net periodic benefit cost and total pension‑cost figures shown in its 10‑K.  \nThus, while both firms rely on weighted‑average assumptions within their respective accounting policies, KO’s assumptions are used to measure equity‑based compensation expense, whereas CL’s assumptions affect liability and expense recognition for pension obligations, illustrating distinct financial‑reporting implications for the same underlying accounting‑policy category.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core distinction between KO's use of the Black-Scholes-Merton model for stock option valuation and CL's use of weighted-average assumptions in pension cost calculations. It correctly identifies that both companies use weighted-average assumptions but in different financial reporting contexts—equity compensation vs. pension liabilities. The qualitative reasoning and synthesis across entities (KO and CL) are sound, and the answer addresses all parts of the multi-hop question. However, there are minor quantitative inaccuracies: the LLM states that KO 'does not break out the numeric values' of its assumptions for 2021–2023, which contradicts the ground truth implying that such weighted-average assumptions are used (and typically disclosed) in the model; while the exact numbers may not be listed in the LLM’s response, the original answer implies they are available and used in 2023. Additionally, the LLM introduces an 'ESOP growth' rate of 6.00% not mentioned in the ground truth, which adds extraneous detail and slightly undermines quantitative accuracy. The ground truth specifies CL’s 2023 assumptions (5.66%, 6.25%, 3.50%)—all of which the LLM correctly includes—so the core numbers are accurate. The contextual relevance is excellent, as the answer directly compares the two companies’ use of assumptions and links them to financial reporting implications. Overall, the answer is semantically close to the original with strong reasoning, but minor factual overreach on disclosure practices and an unsupported figure (ESOP growth) prevent a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Used_In]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 440,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does AMT's use of subsidiary equity interests as collateral for the $525.0 million Series 2015-2 Notes compare with SPG's strategy of monetizing equity interests through disposals, particularly in light of SPG's $18.8 million gain from such transactions?",
      "original_answer": "AMT utilized the equity interests in its subsidiary GTP Acquisition Partners as part of the collateral structure for the $525.0 million Series 2015-2 Notes, which were secured by a security interest in substantially all of the personal property of the GTP Entities, including GTP Acquisition Partners' equity interests in its subsidiaries. This approach allowed AMT to securitize cash flows from specific communications sites while retaining control over excess cash flows. In contrast, SPG pursued a strategy of actively monetizing its equity interests through disposals, as evidenced by a $18.8 million gain from the sale of equity interests in 2021, indicating a more direct capital realization approach. The comparison highlights different financial strategies: AMT leveraged equity interests for secured financing, while SPG liquidated equity interests for immediate financial gain.",
      "llm_answer": "\nAMT secures the $525 million Series 2015‑2 Notes by pledging the equity interests of its subsidiary GTP Acquisition Partners (and the related Holding Sub II guarantee) as collateral—the interests stay on AMT’s balance sheet but are encumbered to back the debt. In contrast, SPG monetizes equity stakes through outright disposals, and in 2021 recorded an $18.8 million gain from such sales, illustrating a strategy of converting equity into cash rather than using it as loan security. The KG link Series 2015‑2 Notes → Equity Interests → SPG shows that the same equity interests underlie both AMT’s collateral arrangement and SPG’s disposal‑driven gains.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: AMT pledged equity interests in GTP Acquisition Partners as collateral for the $525.0 million Series 2015-2 Notes, and SPG recorded an $18.8 million gain from disposals of equity interests in 2021. The dollar amounts and entity names (AMT, SPG, GTP Acquisition Partners) are accurate. (2) Quantitative accuracy is perfect: both $525 million and $18.8 million are correctly reported, with appropriate context (debt issuance vs. gain on sale), and the year 2021 is correctly cited for SPG’s gain. (3) The multi-hop reasoning is sound—correctly contrasting AMT’s secured financing strategy (retaining equity but encumbering it) with SPG’s monetization via disposal (realizing gains). The only minor shortcoming is the reference to 'KG link Series 2015-2 Notes → Equity Interests → SPG', which is not explained and could imply a direct connection between AMT's collateral and SPG’s gains, which is misleading; the equity interests are not the same, just conceptually similar assets used differently. This does not invalidate the overall comparison but slightly weakens the qualitative accuracy. (4) The answer is contextually relevant, directly addressing the comparison of financial strategies involving equity interests. Wording differs from the original but maintains semantic equivalence. Thus, correctness is 9/10—excellent but with a minor conceptual ambiguity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST -[Depends_On]-> FIN_INST <-[Disposes]- ORG",
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 408,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does ConocoPhillips' operational exposure in Nigeria compare to ExxonMobil's reliance on production-sharing contracts in terms of reserve reporting and contractual term structures?",
      "original_answer": "ConocoPhillips operates in Nigeria, where exploration and production activities are governed by production-sharing contracts (PSCs) with a typical term of 30 years, including a 10-year exploration period and a 20-year production period that may be extended under the Petroleum Industry Act. ExxonMobil reports that 12% of its total proved reserves (on an oil-equivalent basis) in 2021 were associated with PSC arrangements, where reserve volumes fluctuate inversely with price changes due to the fiscal terms of these contracts. This indicates that while both companies are exposed to PSCs in Nigeria, ExxonMobil's reserve reporting methodology must account for the dynamic nature of PSC-based reserves, whereas ConocoPhillips must manage its operations under fixed-term contractual obligations that include partial relinquishment requirements.",
      "llm_answer": "\nConocoPhillips’ Nigerian deep‑water activities are carried out under production‑sharing contracts that are generally 30 years in length – a 10‑year exploration window (granted as an OPL that can be converted to an OML on a commercial discovery) followed by a 20‑year production phase, with mandatory partial relinquishment at the end of exploration and any extension subject to the 2021 Petroleum Industry Act, a relationship captured by the KG triplets COP → Nigeria → PSC → XOM. ExxonMobil also bases its reserve reporting on the same type of PSC regime, but its SEC‑mandated disclosures quantify that 12 percent of its year‑end 2021 proved reserves (oil‑equivalent) are attributable to production‑sharing arrangements and require that proved volumes be economically producible before the contract expires unless renewal is “reasonably certain” (as outlined in Chunk 3). Thus, while both firms operate under 30‑year PSCs with comparable exploration‑production term splits, ExxonMobil explicitly reports the share of reserves tied to those contracts, whereas ConocoPhillips’ exposure is defined by the contractual term and relinquishment obligations disclosed in its 10‑K filing (Chunk 1).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: ConocoPhillips operates in Nigeria under 30-year PSCs with a 10-year exploration and 20-year production phase, subject to the Petroleum Industry Act of 2021, including partial relinquishment—this aligns with the original. ExxonMobil’s 12% of proved reserves (2021, oil-equivalent) tied to PSCs is correctly cited. (2) Quantitative accuracy is perfect: the 12%, 30-year term, 10+20 year split, and 2021 reference are all factually correct and match the ground truth. (3) Multi-hop reasoning is sound: the model correctly synthesizes that both companies are exposed to PSCs in Nigeria but differ in reporting and operational focus—ExxonMobil quantifies reserve exposure due to fiscal dynamics, while ConocoPhillips emphasizes contractual term and relinquishment. The mention of SEC-mandated disclosures and 'reasonably certain' renewal reflects accurate regulatory understanding. (4) Minor deduction in qualitative accuracy due to the cryptic reference to 'KG triplets COP → Nigeria → PSC → XOM' and 'Chunk 3'/'Chunk 1', which are not part of the original answer and appear to be artifacts from retrieval or internal processing, potentially confusing the reader. However, these do not undermine the factual content. Overall, the answer is semantically equivalent, contextually precise, and fully addresses the comparative aspects of reserve reporting and contractual terms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Subject_To]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 405,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does IBM's focus on generative AI innovation compare with QCOM's investment in edge-based generative AI and cloud computing, particularly in terms of their respective strategies for commercializing AI technologies in high-performance, low-power computing environments?",
      "original_answer": "IBM is actively investing in generative AI as part of its broader innovation initiatives, emphasizing cutting-edge R&D to differentiate itself in hybrid cloud and AI markets, with the goal of attracting a developer ecosystem and maintaining market share. In contrast, QCOM is embedding generative AI capabilities directly into edge devices, such as smartphones and PCs, to optimize performance, privacy, and personalization while coordinating with cloud applications. QCOM's cloud computing processing initiative supports this strategy by enabling intelligent data sharing between edge devices and cloud systems. While IBM focuses on enterprise-level AI innovation and ecosystem development, QCOM is commercializing generative AI through high-performance, low-power mobile platforms, projecting that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024.",
      "llm_answer": "\nIBM is commercializing generative‑AI through its hybrid‑cloud platform, leveraging its R&D and developer ecosystem to embed AI services in high‑performance cloud environments—a focus reflected in its 2024 10‑K discussion of innovation risk and the need to maintain its reputation as a hybrid‑cloud and AI leader (Chunk 1).  \nQualcomm, by contrast, is investing heavily in edge‑based generative AI, embedding low‑power, high‑performance AI accelerators in mobile, automotive and IoT devices and monetizing those capabilities via chip sales and licensing, while also advancing a cloud‑computing processing initiative that ties its semiconductor business to cloud workloads (Chunks 2 & 3).  \nThus, IBM’s strategy centers on cloud‑centric AI services, whereas Qualcomm’s strategy emphasizes edge‑centric, low‑power AI hardware that complements and extends cloud capabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its portrayal of IBM's and Qualcomm's (QCOM) strategies regarding generative AI, with correct entity identification and no numerical errors. It correctly describes IBM's focus on hybrid cloud and AI services through R&D and ecosystem development, and Qualcomm's edge-based approach with low-power, high-performance AI in mobile and IoT devices. The answer also accurately references Qualcomm's cloud-computing processing initiative as complementary to edge AI. However, it omits the specific quantitative projection from the original answer: that 46% of smartphones sold in 2027 are expected to be generative AI capable, up from 19% in 2024. This is a key piece of commercialization strategy data directly tied to QCOM's market outlook and was explicitly mentioned in the ground truth. While the LLM captures the strategic contrast well and uses correct terminology (e.g., 'edge-centric', 'low-power', 'cloud workloads'), the absence of this forward-looking metric reduces completeness, particularly in addressing the 'commercializing AI technologies' aspect of the question. There are no calculation errors, and the reasoning across multiple hops—comparing IBM’s cloud-centric model with QCOM’s edge-hardware model—is sound and contextually appropriate. The answer remains semantically close to the original and highly relevant to the question, warranting a high score but not full marks due to the missing statistic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> CONCEPT -[Complements]-> CONCEPT <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 401,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Duke Energy's exposure to nuclear decommissioning funding risks compare to NextEra Energy's financial risk management for nuclear generation, given both companies' reliance on market performance for trust-funded obligations?",
      "original_answer": "Duke Energy Carolinas, Progress, and Florida have significant obligations tied to decommissioning nuclear plants, with trust assets subject to market fluctuations that could increase funding requirements if returns fall below projections. Similarly, NextEra Energy and FPL maintain decommissioning funds and insurance coverage, but the cost of decommissioning could exceed available funds. Both companies are exposed to financial risks stemming from nuclear power plants, particularly as market performance directly affects their ability to meet long-term decommissioning obligations.",
      "llm_answer": "\nDuke Energy’s nuclear fleet is funded through the NDTF trusts that are highly sensitive to market performance – a downturn can shrink trust assets, force additional cash contributions from its subsidiaries and, via its holding‑company structure, strain the cash needed for interest, principal and dividend payments (Chunk 1).  In contrast, NextEra Energy (NEE) also relies on market‑driven trust and derivative values for its nuclear decommissioning funding, but it mitigates the shortfall risk with larger, diversified decommissioning funds, external insurance and a broader portfolio that can absorb OTC‑market volatility (Chunk 3), even though both firms face the possibility that decommissioning costs may exceed available trust resources and regulatory limits (Chunk 2).  Consequently, Duke Energy’s exposure is amplified by its dependence on subsidiary cash flows and tighter regulatory constraints, whereas NextEra’s risk is managed through scale and more robust fund buffers, though both remain vulnerable to market‑driven funding gaps.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: both Duke Energy and NextEra Energy face nuclear decommissioning funding risks tied to market performance; trust assets are subject to market fluctuations; there is a risk that decommissioning costs may exceed available funds. The LLM correctly identifies Duke Energy's structural and regulatory vulnerabilities and contrasts them with NextEra's more diversified and buffered approach using larger funds, insurance, and portfolio diversification. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either the original or LLM answer, so quantitative accuracy is not compromised—no errors in calculations or figures. (3) Multi-hop reasoning is sound: the LLM synthesizes information across entities (Duke Energy vs. NextEra), identifies shared risks (market-dependent trusts), and differentiates risk management strategies (scale, diversification, structural dependencies). The reasoning goes beyond repetition of facts to offer a comparative analysis consistent with the original. (4) Semantic equivalence is strong—while the LLM adds slight elaboration (e.g., 'OTC-market volatility', 'holding-company structure'), these are reasonable inferences or contextual details that do not contradict the ground truth. The only minor deduction is for slight over-elaboration without explicit support in the original (e.g., 'tighter regulatory constraints' for Duke), but these do not impair factual correctness. Overall, the answer is complete, contextually relevant, and factually sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> PRODUCT -[Subject_To]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 440,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does CAT's application of hedging relationship accounting under ASU 2020-04 compare to UPS's adoption of the same standard, particularly in terms of their respective derivative contract management strategies and transition timelines?",
      "original_answer": "CAT formally documents and designates derivatives as either fair value or cash flow hedges, using foreign currency forward and option contracts to manage up to five years of anticipated foreign currency cash flow exposure. Under ASU 2020-04, CAT applied optional expedients for contract modifications affected by reference rate reform through December 31, 2024, though the adoption did not have a material impact. In contrast, UPS transitioned its affected debt instruments and contracts to SOFR as the alternative reference rate by December 31, 2023, but did not elect to apply the practical expedients provided under ASU 2020-04, continuing to assess potential impacts through 2024. Both companies applied the standard to manage derivative and debt contract modifications, but CAT leveraged the extended relief period while UPS opted for direct transition without using the optional relief.",
      "llm_answer": "\nBoth CAT and UPS are subject to the same hedging‑relationship accounting policy introduced by ASU 2020‑04 (KG: CAT → Hedging Relationships → ASU 2020‑04 ← Subject_To UPS). CAT implements the standard by formally documenting each hedge, designating foreign‑currency forwards and interest‑rate swaps as cash‑flow or fair‑value hedges at inception and may extend those designations up to roughly five years (maximum term ≈ 60 months), reclassifying ineffective portions from AOCI and reporting cash‑flow hedge cash flows in the same category as the hedged item. In contrast, UPS adopted ASU 2020‑04 primarily to transition its debt and derivative contracts to SOFR, completing that migration by 31 December 2023 and electing not to use the practical‑expedient relief, with only a limited effectiveness assessment and no disclosed multi‑year hedge designations. (Chunk 2’s note that the ASU’s relief applies to contract modifications through 31 Dec 2024 and that both companies did not elect the expedients reinforces the timeline difference.)",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but contains a critical factual error regarding the application of practical expedients under ASU 2020-04, which significantly affects the comparison. (1) Correct elements: Both companies are correctly identified as applying ASU 2020-04; CAT’s use of foreign currency forwards (and implied interest rate swaps) for up to five years (60 months) aligns with the ground truth; UPS’s transition to SOFR by December 31, 2023, is accurate; and the mention of CAT’s hedge documentation and designation is correct. (2) Quantitative accuracy: All dates (December 31, 2023, and December 31, 2024) are correctly stated, and the five-year (60-month) hedge horizon for CAT matches the original answer. However, the LLM incorrectly states that 'both companies did not elect the expedients' — this contradicts the ground truth, which clearly states that CAT *did* apply the optional expedients through 2024, while UPS *did not*. This is a major factual inversion. (3) Multi-hop reasoning: The model attempts to compare derivative strategies and transition timelines, correctly identifying CAT’s longer-term hedging approach versus UPS’s direct SOFR transition. However, the erroneous claim about expedient election undermines the core comparative insight — that CAT used the extended relief while UPS did not. This misrepresents the strategic divergence. (4) Semantic equivalence: While much of the phrasing and structure is sound and contextually relevant, the key differentiator in the original answer — the contrast in expedient usage — is reversed, reducing qualitative accuracy. Contextual relevance remains high as the response directly addresses hedging strategies and timelines as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 464,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Comcast's lack of voting rights in Atairos compare to Alphabet's dual-class stock structure, particularly in terms of control implications given Alphabet's significant share repurchase activity in Classes A and C?",
      "original_answer": "Comcast has no voting rights in Atairos and only certain consent rights, which means it lacks control over Atairos’s activities despite a remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. In contrast, Alphabet maintains a dual-class stock structure where Class B shares have 10 votes per share, allowing key stakeholders to retain outsized voting power. Despite repurchasing $62.0 billion in Class A and Class C shares in 2024 alone, Alphabet has preserved the Class B structure, which ensures concentrated control while reducing public float in the lower-vote and no-vote classes.",
      "llm_answer": "\nComcast’s investment in Atairos is a VIE for which it holds **no voting rights**, so it cannot direct the entity’s key activities and must account for the stake via the equity method—its maximum exposure is the $5.1 billion investment balance and the $1.4 billion of remaining unfunded capital commitment (Chunk 1).  By contrast, Alphabet’s dual‑class structure concentrates voting power in Class B shares, while its large‑scale repurchases—$62 billion of Class A and Class C shares bought in 2023‑24 and an additional $70 billion of Class A/C authorizations—target the **non‑voting** classes, shrinking their equity but leaving the voting‑control bloc unchanged; thus the repurchases affect capital levels but have no impact on control despite their size (Chunks 2 & 3).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core contrast: Comcast has no voting rights in Atairos and thus lacks control, while Alphabet’s dual-class structure preserves control via Class B shares despite large repurchases of non-voting shares. The qualitative reasoning is sound and contextually relevant, accurately explaining the implications for control. However, there are key quantitative inaccuracies: the LLM states Comcast’s investment balance is $5.1 billion, which is not in the ground truth and cannot be verified from the provided data; the ground truth does not specify the total investment balance, only the $1.4 billion unfunded commitment. Additionally, the LLM claims $62 billion in repurchases occurred in '2023-24' and mentions an additional $70 billion authorization, but the ground truth specifies $62.0 billion in 2024 alone and does not mention future authorizations. These details go beyond the ground truth and introduce unsupported figures. While the classification of repurchased shares (Class A and C as non-voting) and the preservation of control are correct, the inclusion of unverified amounts and timeframes reduces quantitative accuracy. The answer synthesizes the multi-hop elements (Comcast/Atairos structure vs. Alphabet’s capital structure and repurchases) well, but with minor overreach in data precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 371,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does the extension of reference rate reform accounting relief under ASU 2022-06 impact the transition timelines for both UPS and FedEx, given that UPS had already transitioned its affected debt to SOFR by December 31, 2023, while FedEx continued monitoring its contracts through May 31, 2024?",
      "original_answer": "The deferral of the sunset date of ASU 2020-04 from December 31, 2022, to December 31, 2024, via ASU 2022-06, allowed both UPS and FedEx to extend their evaluation and application of reference rate reform accounting relief. UPS had already transitioned its affected debt instruments and contracts to SOFR by December 31, 2023, and did not elect to apply the practical expedients under Topic 848, but continued to assess potential impacts through 2024. FedEx, on the other hand, had not experienced any material effect from reference rate reform as of May 31, 2024, and continued to monitor its contracts and transactions for potential application of ASUs 2020-04 and 2022-06. The extension provided FedEx additional time to evaluate whether to apply the optional expedients, while UPS used the period to ensure full alignment with the new rates and assess any residual effects.",
      "llm_answer": "\nThe FASB’s ASU 2022‑06 extends the optional accounting relief for reference‑rate reform through December 31 2024, a deadline that both UPS and FedEx must factor into their transition planning — the KG link UPS → ASU 2020‑04 → ASU 2022‑06 → FDX shows that the same policy deferral applies to each registrant. UPS had already transitioned its affected debt to SOFR by December 31 2023 and, although it did not elect the practical expedients, it will continue to assess any impacts during 2024 under the extended relief. FedEx, however, is still monitoring its contracts and has said it will keep evaluating applications of the ASU through May 31 2024, using the additional two‑year window created by ASU 2022‑06 to complete its transition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: ASU 2022-06 extends relief to December 31, 2024; UPS transitioned to SOFR by December 31, 2023, and did not elect practical expedients but continued assessment in 2024; FedEx continued monitoring through May 31, 2024. These align with the original answer. (2) Quantitative accuracy is perfect: all dates (December 31, 2023, December 31, 2024, May 31, 2024) are correctly stated with no errors in numbers or timeframes. (3) Multi-hop reasoning is sound: the model correctly synthesizes the impact of ASU 2022-06 on both companies, acknowledging that the extension applied to both even though their transition timelines differed. It correctly notes UPS’s early transition and ongoing assessment, and FedEx’s delayed evaluation period. (4) The only minor shortcoming is a slight lack of detail compared to the ground truth — e.g., not explicitly mentioning Topic 848 or that FedEx had not experienced any material effect, which adds nuance. Also, the phrase 'the KG link UPS → ASU 2020-04 → ASU 2022-06 → FDX' appears to be internal notation and is slightly out of place in the response, though it doesn't affect factual correctness. Overall, the answer is semantically equivalent, contextually relevant, and factually precise, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Defers]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 374,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does PepsiCo's beverage revenue concentration in Africa, Middle East, and South Asia (29% in 2023) compare with Target's beverage sales geographic exposure, given that Target's merchandise segments only describe domestic operations in the U.S.?",
      "original_answer": "PepsiCo generated 29% of its beverage revenue from the Africa, Middle East, and South Asia (AMESA) region in 2023, indicating a significant international presence in this sector. In contrast, Target's 2023 10-K filing only describes its beverage offerings as part of grocery sales within its U.S. operations, with no mention of international retail presence or beverage sales outside the United States. This suggests that Target's beverage sales are entirely domestic, while PepsiCo maintains a substantial international footprint in beverages, particularly in the AMESA region.",
      "llm_answer": "\nPepsiCo derives 29 % of its beverage revenue from the Africa‑Middle‑East‑South‑Asia (AMESA) region in 2023, a concentration that is explicitly captured by the KG link Beverages → Africa,Middle East,and South Asia → PEP. In contrast, Target’s merchandise segments disclose only domestic U.S. operations, so its beverage sales have no comparable international geographic exposure—essentially all of Target’s beverage revenue is confined to the United States.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 29% beverage revenue concentration for PepsiCo in the AMESA region in 2023 is correctly stated, matching the original answer. No calculations were required, but the percentage and year are precise. (2) The entity identification is correct—PepsiCo (PEP), Target, the AMESA region, and the 2023 time frame are all accurately referenced. (3) The reasoning correctly synthesizes multi-hop information: it draws from PepsiCo’s geographic revenue disclosure and contrasts it with Target’s domestic-only segment reporting, as stated in their 10-K. The conclusion that Target has no international beverage sales exposure is logically sound based on the absence of such disclosures. (4) The answer is contextually relevant and directly addresses the comparison asked in the question. The only minor shortcoming is a slight lack of elaboration on Target’s grocery segment as the source of beverage sales (mentioned in the ground truth), but this does not detract from the core accuracy. The reference to a 'KG link' is extraneous but not factually incorrect. Overall, the answer is semantically equivalent to the ground truth with excellent reasoning and precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 350,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does the absence of the Countercyclical Capital Buffer impact the minimum capital requirements for SCHW compared to GS's TLAC to RWAs requirement, given both are subject to multi-layered regulatory buffers?",
      "original_answer": "For SCHW, the absence of the Countercyclical Capital Buffer (which was set to zero) still results in a minimum Common Equity Tier 1 Risk-Based Capital ratio of 7.0%, Tier 1 Risk-Based Capital ratio of 8.5%, and Total Risk-Based Capital ratio of 10.5%, inclusive of other buffers like the 2.5% stress capital buffer. For GS, the TLAC to RWAs requirement includes a 18% minimum, a 2.5% buffer, and also incorporates the Countercyclical Capital Buffer (also set to zero), along with a 1.5% G-SIB surcharge. Therefore, even without the Countercyclical Capital Buffer, both firms face layered capital requirements, but GS's baseline (18%) is significantly higher due to its global systemic importance and TLAC framework.",
      "llm_answer": "\nBecause the counter‑cyclical capital buffer is set to **zero** for both firms, it adds no extra capital charge for either SCHW or GS.  For SCHW the disclosed minimum capital ratios—**7.0 % CET1, 8.5 % Tier 1 and 10.5 % Total Risk‑Based Capital**—already incorporate all required buffers, so the absence of the counter‑cyclical buffer leaves those thresholds unchanged.  In contrast, GS’s TLAC‑to‑RWAs requirement still must satisfy the other layers (an **18 % minimum**, a **2.5 % buffer**, and a **1.5 % G‑SIB surcharge**), giving an effective TLAC‑to‑RWAs floor of roughly **22 % of RWAs** despite the buffer being zero.  Thus, while SCHW’s minimum capital ratios remain at the lower 7‑10.5 % range, GS must meet a substantially higher ~22 % RWAs threshold once the zero buffer is excluded.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key numbers are correct: SCHW's 7.0% CET1, 8.5% Tier 1, and 10.5% Total Risk-Based Capital ratios are accurately reported and correctly attributed as inclusive of buffers like the 2.5% stress capital buffer. For GS, the 18% TLAC minimum, 2.5% buffer, and 1.5% G-SIB surcharge are all correctly stated. The LLM correctly notes the Countercyclical Capital Buffer is zero for both, so it does not add to requirements. (2) The calculation of GS's effective TLAC-to-RWAs floor (~22%) is accurate (18% + 2.5% + 1.5% = 22%), and this synthesis is correctly framed as the 'effective' requirement despite the zero buffer. (3) The multi-hop reasoning is sound: the model correctly contrasts SCHW’s risk-based capital framework with GS’s TLAC framework, recognizes that both include layered buffers, and explains how the absence of the countercyclical buffer affects neither due to its zero rate. (4) The only minor shortcoming is that the original answer explicitly notes that GS’s requirement 'incorporates' the countercyclical buffer (even though zero), while the LLM implies exclusion rather than inclusion of a zero buffer—this is a subtle distinction in framing but does not affect factual correctness. Overall, the answer is semantically equivalent, contextually precise, and quantitatively flawless, warranting a 9/10 due to slight nuance in regulatory phrasing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Discloses]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 397,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does Dalton's $5.3 million reimbursement from Georgia Power for Plant Vogtle construction reflect its involvement in self-owned generation facilities, and how does this ownership model contrast with NEE's approach to revenue generation through long-term contracts covering 94% of its capacity?",
      "original_answer": "Dalton receives $5.3 million in reimbursements from Georgia Power for its share of Plant Vogtle Units 3 and 4 construction costs, indicating its partial ownership stake in this nuclear generation facility. This aligns with Dalton’s broader strategy of serving its energy requirements through self-owned generation assets, some of which are jointly owned with Georgia Power. In contrast, NEE generates revenue by contracting 94% of its net generating capacity under long-term bilateral agreements, focusing on full-output commitments rather than joint ownership of facilities. This highlights a structural difference: Dalton participates in shared infrastructure ownership to meet its load needs, while NEE monetizes its generation assets through extensive contractual commitments in competitive markets.",
      "llm_answer": "\nDalton’s $5.3 million reimbursement from Georgia Power is a payment under the Vogtle Joint Ownership Agreements that returns a portion of Dalton’s capital outlay for its self‑owned (and jointly‑owned with Georgia Power) generation units at Plant Vogtle, illustrating that Dalton’s involvement is based on a cost‑sharing stake in self‑generated capacity rather than on selling power on the open market.  \nThis contrasts with NEE’s approach, where NEER (NEE’s generation subsidiary) secures roughly 94 % of its net capacity under long‑term bilateral contracts that lock in revenue and hedge price risk, a revenue model that relies on contracted sales of output rather than on regulatory‑approved cost recoveries from a co‑owner.  \nThus, while Dalton’s earnings are tied to reimbursements for construction costs incurred on its self‑owned facilities, NEE’s earnings are anchored in long‑term power‑purchase agreements that cover the majority of its generating capacity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Dalton receives $5.3 million from Georgia Power for Plant Vogtle construction, reflecting its cost-sharing, jointly-owned generation model. NEE contracts 94% of its capacity via long-term bilateral agreements. These numbers and entities are correctly stated. (2) Quantitative accuracy is perfect: $5.3 million and 94% are accurately reported with no calculation errors. Format variations (e.g., spacing in $5.3 million) are acceptable. (3) The multi-hop reasoning is sound—correctly contrasting Dalton’s ownership/reimbursement model with NEE’s contracted revenue model. The synthesis across two companies and their distinct business models is logically presented. (4) The only minor shortcoming is a slight lack of emphasis on Dalton’s broader strategy of self-owned generation beyond Plant Vogtle, and less clarity on how NEE’s model operates in competitive markets (vs. regulated cost recovery), which the original answer highlights. However, the core contrast in revenue and ownership models is clearly and correctly conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Pays]-> COMP -[Has_Stake_In]-> PRODUCT <-[Generates_Revenue_From]- ORG",
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 353,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do RTX and BA differ in their approaches to managing customer financing obligations, particularly regarding RTX's $7.0 billion in credit facilities versus BA's long-term lease structures?",
      "original_answer": "RTX manages its customer financing obligations by leveraging its strong liquidity position, including $7.0 billion in available credit facilities, which provides flexibility for funding such obligations without relying on short-term commercial paper borrowings. In contrast, BA structures its customer financing through long-term lease arrangements, with terms ranging from 1 to 12 years, often including options to extend, terminate, or purchase the underlying asset. These lease-based financing strategies reflect BA's capital-intensive model, particularly in its BCC segment, and are accounted for under operating or finance leases, impacting both asset and liability balances on its balance sheet. The differing approaches highlight RTX's reliance on liquidity buffers versus BA's use of extended lease terms to manage financing commitments.",
      "llm_answer": "\nRTX funds customer‑financing needs with its $7 billion revolving credit facilities and commercial‑paper program—short‑term, externally‑sourced liquidity that is backed by cash on hand and does not involve long‑term lease assets, while BA delivers customer financing through long‑term aircraft lease contracts (typically 1‑12 years) that are recorded as operating or finance leases, measured at the present value of lease payments, depreciated over 4‑20 year lives and reflected in PP&E and lease‑liability balances; this BA‑centric lease‑accounting policy (the “Lease Options” accounting policy) stands apart from RTX’s reliance on credit‑facility borrowing and underscores the fundamental difference in how the two companies manage customer‑financing obligations.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all key figures are accurate: RTX's $7.0 billion credit facilities are correctly cited, and BA's lease terms of 1–12 years are accurately reflected. There are no calculation errors. (2) The answer correctly identifies the core contrast: RTX relies on credit facilities and short-term liquidity (including commercial paper), while BA uses long-term lease structures. The mention of lease accounting (operating vs. finance leases), present value measurement, depreciation over 4–20 years, and impact on PP&E and lease liabilities is factually sound and adds detail beyond the original answer, though not contradicted. (3) Multi-hop reasoning is solid—correctly synthesizing RTX’s liquidity-backed financing approach versus BA’s asset-backed lease model across different financial structures. (4) Minor deduction in qualitative accuracy because the LLM introduces a term—'Lease Options' accounting policy—that does not appear in the original and may be misleading or invented, potentially confusing a specific policy. Additionally, the original emphasizes RTX avoiding short-term commercial paper, while the LLM says RTX uses it, which contradicts the ground truth. This is a notable discrepancy. However, the rest of the comparison remains strong. Contextual relevance is perfect—directly addresses the question with appropriate depth and terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Contains]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 397,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do Coca-Cola and Philip Morris differ in their application of weighted-average assumptions within their financial reporting frameworks?",
      "original_answer": "Coca-Cola uses the Black-Scholes-Merton option-pricing model to estimate the fair value of stock option awards, with the weighted-average assumptions applied specifically to these stock options granted during the years ended December 31, 2023, 2022, and 2021. In contrast, Philip Morris applies weighted-average assumptions to determine net pension and postretirement healthcare costs, which is a different financial reporting framework focused on employee benefits beyond stock compensation. The difference in application highlights how the same accounting methodology is used for distinct compensation components—equity-based incentives at Coca-Cola versus retirement and healthcare liabilities at Philip Morris.",
      "llm_answer": "\nCoca‑Cola (KO) discloses that its weighted‑average assumptions are used in the Black‑Scholes‑Merton option‑pricing model to estimate the fair value of stock‑option awards, which are then expensed over the typical four‑year vesting period. Philip Morris (PM) applies weighted‑average assumptions to calculate its net pension and post‑retirement health‑care costs, as shown in its 10‑K filing. Consequently, KO’s weighted‑average assumptions relate to equity‑based compensation valuation, whereas PM’s weighted‑average assumptions pertain to pension and post‑retirement benefit accounting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the same core information as the ground truth. (1) It accurately identifies that Coca-Cola uses weighted-average assumptions in the Black-Scholes-Merton model for stock option valuation, while Philip Morris applies them to pension and post-retirement healthcare costs. The distinction between equity-based compensation (Coca-Cola) and retirement/healthcare liabilities (Philip Morris) is correctly captured. (2) There are no numeric values, dates, or calculations in the question or answers that require verification—both mention the correct frameworks without introducing incorrect numbers. Format and terminology are consistent with acceptable variations. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different companies and financial reporting contexts, identifying the different applications of the same methodology (weighted-average assumptions) in distinct accounting areas. (4) The only minor limitation is that the LLM answer omits the specific years (2023, 2022, 2021) mentioned in the original answer regarding Coca-Cola’s stock option grants. However, this detail is contextual and does not affect the core accuracy of the comparison. All entities (Coca-Cola, Philip Morris, Black-Scholes-Merton model, pension and post-retirement benefits) are correctly identified and applied. The answer is highly relevant and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Used_In]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 402,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does the expiration timeline of regulatory exclusivity for Merck's Januvia family of products compare to Gilead's U.S. regulatory exclusivity expiration in 2032, and what impact might this have on their respective market positions given the role of exclusivity in delaying generic competition?",
      "original_answer": "Merck's Januvia family of products is expected to lose U.S. market exclusivity in May 2026 (Januvia and Janumet) and July 2026 (Janumet XR), while Gilead has a U.S. regulatory exclusivity that expires in 2032. According to the evidence, regulatory exclusivity provides a period during which generic competitors cannot rely on the innovator’s data for approval, thus delaying market entry of generics. Since Gilead benefits from a significantly longer exclusivity period, it may maintain a more protected market position through 2032, whereas Merck will face substantial sales declines starting in 2026 due to generic competition and pricing pressures, as seen in other markets post-expiry.",
      "llm_answer": "\nMerck’s Januvia family is protected by a combination of patent and regulatory exclusivity that, according to the company’s 10‑K, will not be lost in the United States until **May 2026 for Januvia/Janumet and July 2026 for Janumet XR** (Chunk 1), whereas Gilead’s U.S. regulatory exclusivity for its relevant product is scheduled to expire only in **2032** (Chunk 3).  As explained in the industry overview (Chunk 2), regulatory exclusivity extends market protection beyond the patent term, so Merck’s exclusivity ends six years earlier than Gilead’s, meaning generic competitors can enter the U.S. market far sooner for Merck, eroding its sales and market share, while Gilead can maintain higher pricing and a stronger market position for an additional half‑decade.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the expiration dates for Merck's Januvia family are accurately stated as May 2026 for Januvia/Janumet and July 2026 for Janumet XR, and Gilead's exclusivity expiration is correctly noted as 2032—both align exactly with the original answer. (2) The answer is complete, addressing both the timeline comparison and the impact on market positions, including the role of regulatory exclusivity in delaying generics. (3) Entities—Merck, Gilead, Januvia family products, and the concept of regulatory exclusivity—are correctly identified and contextualized. (4) The reasoning is sound: the LLM correctly synthesizes that Gilead’s exclusivity lasts six years longer than Merck’s (2032 vs. 2026), and logically infers the competitive implications—earlier generic entry for Merck leading to sales erosion, while Gilead maintains pricing power and market protection. The explanation of regulatory exclusivity’s role (from Chunk 2) is accurately applied. (5) Semantic equivalence is strong: though phrased differently, all factual content matches the ground truth, including the cause-effect relationship between exclusivity duration and market dynamics. No errors in facts, logic, or synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> REGULATORY_REQUIREMENT -[Provides]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 358,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does Intel's amortization expense for developed technology used in cybersecurity compare with Cisco's revenue recognition timing for its cloud security offerings?",
      "original_answer": "Intel reported $1,283 million in amortization expenses for developed technology in 2021, which includes technology used for cybersecurity solutions like cloud security. Cisco recognizes revenue for its cloud security offerings ratably over the contract term, aligning with the ongoing delivery of updates and upgrades critical to the software’s performance. This contrasts with Intel’s cost recognition pattern, where developed technology is amortized over a 9-year weighted average useful life, reflecting a more fixed cost structure compared to Cisco’s recurring revenue model.",
      "llm_answer": "\nIntel amortized **$1,283 million** of developed‑technology expense in 2021 — the portion of its “Developed technology” line that supports cybersecurity products and is valued using a multi‑period excess‑earnings (present‑value) method with a **9‑year useful life** — whereas Cisco (CSCO) recognizes revenue from its cloud‑security offerings **ratably over the contract term** as a single performance obligation, spreading the earnings evenly rather than taking an upfront amortization charge.  This contrast reflects Intel’s expense‑recognition of the underlying technology over its useful life, while Cisco’s cloud‑security revenue is recorded evenly throughout the service period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Intel's $1,283 million amortization expense for developed technology in 2021 and Cisco's ratable revenue recognition for cloud security offerings. All key facts are present and accurate. (2) Quantitative accuracy is perfect: the dollar amount ($1,283 million), the 9-year useful life, and the year (2021) match the ground truth exactly. Format variations (e.g., '9-year' vs '9‑year') are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound—correctly contrasting Intel’s cost amortization pattern (fixed, over useful life) with Cisco’s revenue recognition model (ratable, over contract term). The explanation of the accounting logic (amortization vs. performance-based revenue) is accurate and well-synthesized across the two companies. (4) The only minor shortcoming is a slight lack of explicit mention that Intel’s developed technology 'includes cybersecurity solutions like cloud security'—though it is implied by referencing 'portion... that supports cybersecurity products'. This omission is minor and does not detract from the core correctness. All other elements—entities (Intel, Cisco/CSCO), metrics (amortization expense, revenue recognition timing), and years (2021)—are accurate. The answer is semantically equivalent to the ground truth and highly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT -[Related_To]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 379,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the adoption of ASU 2022-02 affected MET's loan modification disclosures compared to JPM's reporting under the legacy TDR guidance, particularly in terms of the types and financial impact of modifications made to borrowers experiencing financial difficulty?",
      "original_answer": "MET adopted ASU 2022-02 on January 1, 2023, which eliminated the TDR accounting framework and introduced the concept of Financial Difficulty Modifications (FDMs), requiring expanded disclosures. MET reported that the adoption did not have a material impact on its financial statements, but it now discloses FDMs instead of TDRs. JPM, under the legacy TDR guidance prior to 2023, reported $362 million in new TDRs for 2022, with modifications typically involving interest rate reductions, term extensions, and payment delays. In 2023, under FDM reporting, JPM noted $136 million in FDMs, predominantly term extensions and rate reductions, which extended the weighted-average life of loans by 20 years and reduced the weighted-average interest rate from 7.21% to 4.44%. This shift reflects a more principles-based approach under ASU 2022-02, focusing on financial difficulty rather than concession-based criteria, resulting in more consistent and transparent reporting of loan modifications across both institutions.",
      "llm_answer": "\nMET adopted ASU 2022‑02 on January 1 2023, which eliminated the old TDR guidance and required only expanded disclosures in Note 11—no material impact on its consolidated financial statements—while the actual types of modifications (short‑ or long‑term payment extensions, interest‑rate reductions, principal forgiveness or combinations) remain unchanged but are now reported as “financial‑difficulty modifications” (FDMs) instead of TDRs.  By contrast, JPM’s legacy TDR reporting (pre‑January 2023) still classifies such modifications as TDRs and quantifies their financial effect, noting $136 million of residential‑real‑estate FDMs that extend loan terms by an average of 20 years and reduce the weighted‑average interest rate from 7.21 % to 4.44 %, with $17 million of re‑defaults.  Thus, MET’s post‑adoption disclosures focus on the broader FDM category and expanded note disclosure, whereas JPM’s legacy TDR reporting provides detailed quantitative metrics on the size, structure and credit‑quality impact of the modifications.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. It incorrectly states that JPM reported $136 million in residential-real-estate FDMs with a 20-year extension and rate reduction from 7.21% to 4.44% under legacy TDR reporting, when in fact these metrics ($136M in FDMs, 20-year extension, rate drop to 4.44%) are from JPM's 2023 reporting under the new FDM framework, not pre-2023 legacy TDR reporting. The ground truth states that JPM reported $362 million in new TDRs in 2022 under legacy guidance, a figure entirely missing from the LLM answer. Instead, the LLM incorrectly applies the 2023 FDM data to the legacy period. (2) The date of MET's adoption (January 1, 2023) is correct, and the statement that adoption had no material impact on financial statements aligns with the original answer. However, the LLM misattributes JPM’s $136 million FDM figure to the pre-2023 period, when it should be post-adoption. The re-default figure of $17 million is not in the original answer and appears fabricated. (3) The reasoning is partially sound in recognizing the shift from TDR to FDM and the change in disclosure focus, but the multi-hop synthesis fails because it conflates JPM’s pre- and post-adoption reporting periods. It incorrectly compares MET’s post-adoption disclosures to JPM’s legacy disclosures using post-adoption metrics, undermining the comparative analysis. (4) Despite these errors, the answer captures the conceptual shift (TDR to FDM), correctly identifies MET’s lack of material impact, and reflects the types of modifications (rate reductions, term extensions). The contextual framing and structure are relevant and mostly accurate, hence high contextual relevance and moderate qualitative accuracy, but quantitative inaccuracy severely limits correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Adopts]-> ACCOUNTING_POLICY -[Replaces]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 498,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does CVX's upstream position in South American natural gas reserves compare with XOM's downstream footprint across the broader Americas region?",
      "original_answer": "CVX reported 329 billion cubic feet of natural gas reserves in South America as of December 31, 2022, reflecting its upstream exposure in the region. South America is geographically included within the broader 'Americas' reporting segment, which encompasses both North and South America. XOM maintains a large downstream presence across the Americas, with integrated refining, marketing, and logistics operations focused on delivering refined products like gasoline, diesel, and synthetic motor oils. While CVX's position centers on upstream resource extraction in South America, XOM's downstream operations span the entire Americas region, highlighting complementary but distinct strategic focuses within the energy value chain.",
      "llm_answer": "\nCVX holds roughly 5.9 trillion cubic feet of natural‑gas reserves in South America (as reported in its 2021 10‑K), giving it a strong upstream foothold in that sub‑region, whereas ExxonMobil’s downstream business operates across the entire Americas—spanning both North and South America with integrated refining, logistics, trading and marketing assets (ExxonMobil’s 2022 10‑K describes a “well‑established presence” in the Americas as part of its global downstream network).  The knowledge‑graph link CVX → South America → Americas → XOM, together with Apple’s geographic segment definition that treats “Americas” as encompassing both North and South America, underscores that CVX’s upstream reserves are concentrated in South America while XOM’s downstream footprint covers the broader Americas region.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in key quantitative data: it reports CVX's South American natural gas reserves as 5.9 trillion cubic feet based on its 2021 10-K, whereas the ground truth states 329 billion cubic feet as of December 31, 2022. This is a major overstatement by more than an order of magnitude (5,900 Bcf vs 329 Bcf). Additionally, the LLM cites the 2021 10-K, while the ground truth uses 2022 data, introducing a mismatch in reporting year. (2) The quantitative inaccuracy severely undermines the answer’s reliability—despite correctly framing the comparison between upstream and downstream operations, the core metric is wrong. Format variation is acceptable, but magnitude errors are not. (3) Qualitatively, the reasoning structure is sound: the LLM correctly identifies CVX’s upstream focus in South America and XOM’s downstream presence across the broader Americas, and it appropriately references the geographic inclusion of South America within the 'Americas' segment. It also correctly characterizes the strategic distinction in their value chain positions. However, the erroneous reserve figure and outdated year weaken the multi-hop synthesis. The mention of Apple’s geographic segment definition is irrelevant and confusing, as Apple is not part of the question or data context, suggesting flawed reasoning linkage. (4) Contextual relevance is high because the answer addresses the core comparison between CVX and XOM across regions and value chain segments. Despite incorrect numbers and a minor logical flaw, it maintains the correct conceptual framework. Final scores reflect major penalty on quantitative accuracy, moderate qualitative accuracy due to correct reasoning but flawed data, and solid relevance to the question’s intent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 483,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the $25 million commercial paper exposure of Duke Energy Ohio compare with Tesla's $470 million commercial paper holdings in terms of their short-term liquidity strategies?",
      "original_answer": "Duke Energy Ohio reports a $25 million commercial paper exposure as part of its short-term liabilities, reflecting its reliance on modest short-term borrowing for operational needs. In contrast, Tesla holds $470 million in commercial paper as part of its short-term investments, indicating a cash deployment strategy rather than a funding need. This comparison highlights two distinct uses of commercial paper: Duke Energy utilizes it as a financing tool, while Tesla treats it as an investment to optimize liquidity returns.",
      "llm_answer": "\nDuke Energy Ohio—identified as operating in Ohio (HD → Ohio) and disclosing a $25 million commercial‑paper exposure (Chunk 2)—holds a comparatively tiny short‑term liquidity position, while Tesla (linked to the same “Commercial paper” financial instrument, Commercial paper → TSLA) reports a $470 million commercial‑paper holding (Chunk 3). Thus, Tesla’s commercial‑paper portfolio is roughly 19 times larger, indicating a markedly more aggressive short‑term liquidity strategy than the modest $25 million exposure used by Duke Energy Ohio. The KG relationship (Ohio → Commercial paper ← TSLA) ties the two firms to the same instrument, highlighting the disparity in their liquidity‑management approaches.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $25 million commercial paper exposure for Duke Energy Ohio and the $470 million commercial paper holding for Tesla, which matches the ground truth numerically. The calculation that Tesla’s amount is roughly 19 times larger (470 / 25 = 18.8) is quantitatively accurate, so quantitative accuracy is high. (2) However, the LLM mischaracterizes the nature of these positions. It describes both as part of 'short-term liquidity positions' and implies Tesla has an 'aggressive short-term liquidity strategy,' which misrepresents the underlying financial reality. The ground truth clarifies that Duke Energy’s $25M is a liability (borrowing), while Tesla’s $470M is an investment (cash deployment), representing opposite uses of commercial paper. The LLM fails to distinguish between commercial paper as debt vs. investment, leading to flawed qualitative reasoning. (3) The multi-hop reasoning connects both companies to the 'Commercial paper' instrument via the knowledge graph, showing structural understanding, but it does not synthesize the directional use (liability vs. asset), which is critical to answering the question correctly. (4) Therefore, while numbers are correct and contextually relevant, the lack of conceptual distinction between financing and investing activities undermines the answer’s correctness, warranting a mid-range score of 5 for overall correctness and qualitative accuracy. Contextual relevance is fair because the comparison is on-topic but misinterpreted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 421,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the voting power structure of META's Class A common stock compare to GOOGL's Class B common stock in terms of shareholder influence, given the dual-class stock structures described in their filings?",
      "original_answer": "META's Class A common stock has limited voting power compared to its Class B common stock, where a single shareholder (Mr. Zuckerberg) retains significant control, with Class B shares requiring majority approval for change-in-control transactions until they represent less than 35% of combined voting power. In contrast, GOOGL's Class B common stock provides 10 votes per share, significantly more than the 1 vote per share for Class A, though Class B shares automatically convert to Class A upon sale or transfer. CMCSA's example shows a similar dual-class structure where Class A holds 66 2/3% of voting power with 1 vote per share and Class B holds 33 1/3% with 15 votes per share, illustrating a pattern of concentrated voting control in dual-class structures like those of META and GOOGL.",
      "llm_answer": "\nMETA’s Class A common stock carries only a single vote per share and is effectively out‑voted by the company’s Class B shares, which—despite possibly representing a minority of total shares—control the majority of voting power and can be used by the controlling shareholder (e.g., Mr. Zuckerberg) to dictate board composition, mergers and other key matters (Chunk 1).  In contrast, Alphabet’s Class B common stock is the super‑voting class that holds 10 votes per share (versus one vote per Class A share) and, together with its non‑dilutive nature and conversion rights, gives it disproportionate influence over shareholder decisions, similar to the way Class B dominates voting in META’s structure (Chunk 3), while the CMCSA filing illustrates a comparable pattern where Class B shares represent a smaller equity stake but command a much larger share of voting power (e.g., 15 votes per share) (Chunk 2).  Consequently, the voting power of META’s Class A is far weaker than the voting influence wielded by GOOGL’s Class B, which serves as the high‑vote class that drives control.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: META's Class A has 1 vote per share, Class B has superior voting power (though exact vote count not specified, which is acceptable as filings don't quantify it beyond control retention), and Mr. Zuckerberg retains control; GOOGL's Class B has 10 votes per share vs. 1 for Class A, and converts upon sale—this matches the original answer. (2) Quantitative accuracy is perfect: 10 votes per share for GOOGL Class B, 1 vote for Class A, and the CMCSA example (15 votes per share) are all correctly cited. No calculations were required, but comparisons are numerically sound. (3) Multi-hop reasoning is strong: the model correctly synthesizes information across META, GOOGL, and CMCSA to illustrate the pattern of concentrated voting power in dual-class structures. It accurately contrasts the influence of META Class A (weak) with GOOGL Class B (strong), which is the core of the question. (4) The only minor shortcoming is that the original answer includes a specific governance detail—Class B requiring majority approval for change-in-control until below 35% voting power—that the LLM omits. This is a small but notable omission in completeness, hence the 9 instead of 10. Otherwise, the answer is semantically equivalent, contextually precise, and correctly emphasizes the disproportionate influence of super-voting shares in both companies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 397,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the dividend structure for non-voting share classes at Mastercard and Charles Schwab impact the alignment of shareholder returns between voting and non-voting equity holders, given Mastercard's explicit distinction in dividend rights for B Class Shares and Charles Schwab's statement that dividend rights are identical across voting and nonvoting stock classes?",
      "original_answer": "At Mastercard, both A Class (voting) and B Class (non-voting) shares have dividend rights, indicating equal treatment in shareholder returns through dividends despite differences in voting power. In contrast, Charles Schwab explicitly states that dividend and liquidation rights are identical between its voting and nonvoting stock classes, ensuring full alignment in shareholder returns across share types. This means that while both companies provide dividend rights to non-voting shares, Charles Schwab maintains a stronger structural alignment in returns between share classes, whereas Mastercard preserves dividend parity but separates voting control.",
      "llm_answer": "\nMastercard’s B‑Class shares are non‑voting yet expressly carry dividend rights, as disclosed in the company’s separate “Dividend and Voting Rights” table for the B Class (Chunk 1 / 2). Charles Schwab, however, states that its voting and non‑voting common stock have identical dividend (and liquidation) rights, so earnings‑per‑share and dividend per share are the same for both classes (Chunk 3). The knowledge‑graph triplet (Dividend Rights → SCHW) shows that “Dividend Rights” is an accounting policy disclosed by both issuers, meaning Schwab’s policy of identical rights aligns shareholder returns, whereas Mastercard’s explicit distinction between voting and non‑voting dividend rights creates a structural divergence that can separate dividend receipts from voting power.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that Mastercard's B Class shares are non-voting but have dividend rights and that Charles Schwab explicitly states identical dividend and liquidation rights across share classes. It also correctly notes that both companies provide dividend rights to non-voting shares, which aligns with the ground truth. However, the LLM makes a critical error in stating that Mastercard has an 'explicit distinction between voting and non-voting dividend rights,' which contradicts the ground truth: Mastercard does *not* distinguish dividend rights between A and B classes—both have equal dividend rights despite the voting difference. The ground truth emphasizes that Mastercard maintains dividend parity, while the LLM incorrectly implies a structural divergence in dividend treatment. This misrepresents the core comparison: Charles Schwab ensures alignment, and Mastercard also provides dividend parity (only voting control is separated). The error stems from misinterpreting 'explicit distinction in dividend rights'—the original answer clarifies the distinction is in *voting*, not *dividend* rights. Quantitatively, there are no numbers to verify, so accuracy is high by default. Contextually, the response is relevant and well-structured. The multi-hop reasoning fails at the synthesis stage: it incorrectly contrasts dividend structures when they are, in fact, aligned in both companies. Thus, while entities and general framework are correct, the key qualitative conclusion is flawed, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 425,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How might the implementation of the OECD's Pillar Two global minimum tax differently affect Microsoft's and Oracle's effective tax rates, given Microsoft's expectation of no material impact and Oracle's concern about materially increased international tax costs?",
      "original_answer": "Microsoft expects no material impact from the OECD's Pillar Two global minimum tax due to its current operations not being concentrated in jurisdictions with tax rates below the 15% threshold. In contrast, Oracle explicitly notes that the adoption of Pillar Two in many jurisdictions could materially increase its international tax costs. While both companies are subject to the same global regulatory framework, their differing geographic footprints and tax planning strategies appear to lead to divergent expectations about the financial impact of the new rules.",
      "llm_answer": "\nMicrosoft (MSFT) says the OECD Pillar Two 15 % global minimum tax will begin applying to it in fiscal 2025, but it does **not** currently estimate any material impact on its consolidated financial statements—its 2024 effective tax rate of 18 % already reflects lower‑taxed foreign earnings and the company will continue to monitor the rule changes. Oracle (ORCL), by contrast, warns that the same Pillar Two framework, together with other international tax reforms, could **materially increase** its worldwide tax burden and raise its effective tax rate, a risk underscored by its discussion of potential adverse audit outcomes and the OECD‑driven 15 % minimum tax that could affect its international profits.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: Microsoft's 18% effective tax rate in 2024 and Oracle's concern about increased tax burden under the 15% OECD Pillar Two threshold are factually consistent. The mention of fiscal 2025 applicability for Microsoft is contextually appropriate and does not contradict the original answer. (2) The answer correctly identifies both companies (Microsoft and Oracle), their respective tax rate expectations, and the relevant regulatory framework (OECD Pillar Two). (3) The reasoning is sound: it contrasts Microsoft’s expectation of no material impact due to its existing tax structure with Oracle’s explicit risk disclosure about rising international tax costs, reflecting divergent geographic and tax planning strategies—this synthesis across entities is accurate and logical. (4) While the original answer emphasizes Microsoft's lack of concentration in low-tax jurisdictions as the reason for no material impact, the LLM answer does not explicitly state this rationale but implies it through Microsoft’s already compliant 18% effective rate. This is a minor omission but does not detract significantly from the overall correctness. Wording differs but semantic meaning is equivalent. No calculation errors. All parts of the question are addressed with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 384,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How do GM's and LOW's applications of Level 3 valuation techniques differ in their financial reporting, particularly regarding the unobservable inputs and methodologies used for fair value measurements?",
      "original_answer": "GM utilizes Level 3 valuation techniques primarily for marketable debt securities and finance receivables, relying on pricing models, discounted cash flow models, and industry-standard pricing models with unobservable inputs such as economic forecasts, including unemployment rates, interest rate spreads, disposable personal income, and GDP growth rates. LOW, on the other hand, applies Level 3 valuation specifically to contingent consideration from the fiscal 2022 sale of its Canadian retail business, using an income approach with unobservable inputs like total equity value, volatility, and expected term. While both companies use Level 3 valuations, GM focuses on macroeconomic assumptions across a range of financial instruments, whereas LOW applies it to a specific long-term investment with performance-based metrics.",
      "llm_answer": "\nGM reports Level 3 fair‑value measurements for marketable debt securities and finance receivables by employing pricing‑service quotes, industry‑standard pricing models and discounted‑cash‑flow techniques, where the significant inputs—such as credit spreads, interest‑rate assumptions and forecasted economic conditions—are unobservable (Chunk 1); this aligns with the generic Level 3 definition of a valuation hierarchy that “uses techniques that use significant assumptions not observable in the market” (Chunk 2).  \nLOW classifies its contingent‑consideration investment as Level 3 and measures it with an income‑approach option‑pricing model that relies on unobservable inputs including total equity value, volatility, expected term and a risk‑adjusted discount rate, and it explicitly notes there were no transfers between Levels 1‑3 during the periods (Chunk 3).  \nThus, while GM’s Level 3 methodology leans on market‑oriented pricing models and DCF with observable‑derived assumptions, LOW’s Level 3 methodology depends on probabilistic option‑pricing assumptions and a risk‑adjusted discount rate that are wholly unobservable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: GM uses Level 3 for marketable debt securities and finance receivables with unobservable inputs like economic forecasts (e.g., interest rate spreads, unemployment), and LOW applies Level 3 to contingent consideration from its Canadian retail business sale using an income approach with unobservable inputs such as total equity value, volatility, and expected term. The LLM correctly identifies the methodologies—pricing models, discounted cash flow for GM; option-pricing model with risk-adjusted discount rate for LOW. (2) There are no numeric values, dates, or calculations in the question or answer that require verification; all references to fiscal years (e.g., 'fiscal 2022' in ground truth) are consistent in intent, though the LLM does not explicitly mention the timing of LOW’s contingent consideration, which is a minor omission. (3) Multi-hop reasoning is sound: the model correctly synthesizes differences in application scope (GM: broad macroeconomic assumptions across instruments; LOW: narrow, specific contingent consideration) and contrasts methodologies (market-oriented models vs. probabilistic option-pricing). (4) Semantic equivalence is strong—wording differs slightly (e.g., 'forecasted economic conditions' vs. 'GDP growth rates'), but the meaning is preserved. The only minor shortcoming is that the LLM does not explicitly name the Canadian retail business sale context for LOW, slightly reducing completeness. Otherwise, the answer is factually precise, relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Uses]-> ACCOUNTING_POLICY <-[Applies]- ORG",
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 442,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA influence the potential conversion dynamics of Class A shares, especially in light of Alphabet's aggressive share repurchase strategy involving Class A and Class C shares?",
      "original_answer": "At CMCSA, Class B common stock holds 33 1/3% of the voting power, with each share entitled to 15 votes, and this voting power is non-dilutable under the company's articles of incorporation. This structure creates a concentrated voting control that could influence decisions regarding potential conversions of Class A shares, as Class B shares can be converted share-for-share into Class A under certain restrictions. Meanwhile, Alphabet (GOOGL) has been actively repurchasing Class A and Class C shares, spending $62.2 billion in 2023 alone and maintaining $36.3 billion in remaining authorization as of year-end. This aggressive repurchase strategy could reduce the number of outstanding shares in similar classes, potentially increasing the proportional influence of remaining shareholders, including those holding voting shares like CMCSA's Class B. The combination suggests that while CMCSA's Class A shareholders may see increased influence through potential Class B conversion, GOOGL's repurchase activity could further concentrate ownership and influence within its own capital structure.",
      "llm_answer": "\nCMCSA’s Class B common stock holds a fixed 33.33 % of the voting power—derived from 9.44 million shares × 15 votes per share—and this block is non‑dilutable, but it can be converted share‑for‑share into Class A, thereby shifting that entire 33.33 % voting weight into Class A shares. Because Alphabet is executing an aggressive repurchase program that has already retired $62.2 bn of its own Class A (and Class C) shares and still has $36.3 bn of authorization, the remaining Class A shares become scarcer, raising the per‑share voting power and making the conversion of CMCSA’s Class B into Class A increasingly valuable to capture the heightened voting influence before the buy‑back further compresses the Class A pool. The knowledge‑graph link Class B Common Stock → CMCSA shows that this voting‑power distribution at CMCSA directly influences the conversion dynamics of Alphabet’s Class A shares in the context of its share‑repurchase strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and flawed reasoning that significantly undermine its correctness. (1) Quantitative Accuracy: The claim that CMCSA’s Class B voting power comes from '9.44 million shares × 15 votes per share' is not supported in the original answer and introduces a fabricated number (9.44 million), which is not present in the ground truth. While the 33 1/3% voting power and 15 votes per share are correctly stated (with 33.33% being an acceptable approximation), this unsourced calculation reduces quantitative accuracy. The $62.2 billion repurchase amount and $36.3 billion remaining authorization for Alphabet are correctly cited. (2) Completeness: The answer attempts to address both CMCSA’s share structure and Alphabet’s repurchases, but incorrectly frames the interaction between the two companies. (3) Entity Accuracy: The companies (CMCSA and Alphabet/GOOGL) and share classes are correctly identified. (4) Reasoning: The core multi-hop reasoning is flawed—the LLM incorrectly suggests that CMCSA’s Class B conversion dynamics directly influence or are influenced by Alphabet’s share repurchases, even stating that 'this voting-power distribution at CMCSA directly influences the conversion dynamics of Alphabet’s Class A shares,' which is illogical and factually incorrect. There is no mechanism by which CMCSA’s internal share conversion affects Alphabet’s shares. The original answer draws a parallel in structural trends (concentration of voting power), not a direct influence. The LLM misrepresents this as a causal or interactive relationship. (5) Semantic Equivalence: The overall message is distorted due to this erroneous linkage. While both companies have dual-class structures and repurchase activity, the LLM invents a connection that does not exist. The suggestion that converting CMCSA Class B into Class A becomes 'more valuable' due to Alphabet’s buybacks is nonsensical—these are separate corporate entities. The contextual relevance is moderate because it discusses relevant concepts (voting power, conversions, repurchases), but the synthesis is invalid. Thus, the answer is partially correct on isolated facts but fails in multi-hop logic and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 593,
        "total_tokens": 2130
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the difference in remaining securities available for future issuance under equity compensation plans between MDLZ and CL, based on their 2022 10-K disclosures?",
      "original_answer": "MDLZ reported 48,932,017 securities remaining available for future issuance under equity compensation plans, while CL reported 37,028,000 securities (in thousands). The difference between the two companies' remaining issuance capacity is 11,904,017 securities.",
      "llm_answer": "\nBased on the 2022 10‑K filings, MDLZ reports **48,932,017** securities remaining available for future issuance under its equity compensation plans (Chunk 1). CL’s filing lists **37,028** (in thousands) securities remaining, which equals **37,028,000** shares (Chunks 2 & 3). Consequently, MDLZ has **approximately 11,904,017 more securities** available for future issuance than CL.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All numbers are accurate: MDLZ's 48,932,017 and CL's 37,028,000 (converted correctly from 37,028 in thousands) match the original answer. The calculated difference of 11,904,017 is correct. (2) Quantitative accuracy is perfect—conversion from 'thousands' is properly applied to CL's figure, and the subtraction is accurate. (3) The multi-hop reasoning is sound: the model correctly identifies and extracts data from both companies' 10-K filings, synthesizes the information, and computes the difference. (4) Entity accuracy is correct—MDLZ and CL are properly identified, and the metric (securities remaining available for future issuance under equity compensation plans) is correctly interpreted. The answer is semantically equivalent to the ground truth, with clear and precise wording. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 266,
        "total_tokens": 1431
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the impact of Illinois' Clean Energy Law on ComEd's transmission rate structure compare to Tesla's exposure to state-level regulatory challenges in markets with direct sales restrictions?",
      "original_answer": "Illinois' Clean Energy Law directly affects ComEd's transmission rate structure by requiring a new four-year multi-year plan to establish rates after the expiration of its performance-based distribution formula rate, and accelerating the amortization of ComEd's unprotected excess deferred income taxes over approximately 39.5 years. These regulatory changes introduce uncertainty around ComEd’s rate of return on equity, which is currently set at 11.50% with a 50-basis-point incentive adder as a RTO member. In contrast, Tesla faces state-level regulatory challenges related to its direct-to-consumer sales model, where certain U.S. states have laws interpreted to restrict its ability to sell vehicles through company-owned stores or obtain dealer licenses. While ComEd’s exposure centers on rate-setting mechanisms and compliance with decarbonization mandates, Tesla’s risk is tied to legal interpretations of motor vehicle industry laws and potential legislative pushback from dealer associations. Both face significant regulatory uncertainty, but the financial implications differ: ComEd’s are embedded in its cost recovery and capital structure, while Tesla’s affect its go-to-market strategy and expansion potential.",
      "llm_answer": "\nThe Illinois Clean Energy Law (Chunk 2) forces ComEd to file a new rate case and accelerates the amortization of excess deferred‑income taxes, directly reshaping its transmission revenue requirement and rate structure; this regulatory change is a “Regulatory Challenges” risk factor tied to Illinois (Chunk 1) and consequently feeds the same risk factor that exposes Tesla (TSLA) to state‑level hurdles—namely, laws that limit direct‑to‑consumer vehicle sales and can trigger fines or require dealer‑license work‑arounds (Chunk 3). Thus, while ComEd’s exposure manifests as a revised transmission‑rate formula and tax amortization schedule, Tesla’s exposure consists of potential sanctions and constrained sales models in states that restrict direct sales.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core regulatory impacts on both ComEd and Tesla, with accurate qualitative synthesis. Quantitatively, it correctly identifies the key regulatory changes from Illinois' Clean Energy Law affecting ComEd, including the requirement to file a new rate case and the acceleration of amortization of excess deferred income taxes—though it omits the specific 39.5-year amortization period and the 11.50% rate of return on equity with the 50-basis-point incentive adder mentioned in the ground truth. These missing specifics prevent a perfect quantitative score. The entity accuracy is strong: ComEd and Tesla (TSLA) are correctly identified, and the nature of their respective regulatory challenges is accurately contrasted—ComEd’s transmission rate structure changes versus Tesla’s direct sales restrictions. The reasoning is sound in linking both companies to state-level regulatory risks, and the comparison effectively differentiates the financial (ComEd) versus operational/go-to-market (Tesla) implications. The answer synthesizes multi-hop information across regulatory frameworks and company-specific exposures, though it could more explicitly distinguish the financial embedding of ComEd’s risks in cost recovery and capital structure, as in the original. Wording differs but meaning is semantically equivalent in most places. One minor shortcoming is the reference to 'Chunk 1/2/3'—likely internal document markers not present in the original and potentially confusing in final output—but this does not affect factual correctness. Overall, the answer is factually strong, contextually relevant, and logically structured, meriting a high but not perfect score due to omitted numerical details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Faces]-> RISK_FACTOR <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 472,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How will the IRA-driven Medicare Part D redesign, which imposes manufacturer discounts and price caps starting in 2025, affect the gross-to-net rebate accruals for both AMGN's ENBREL and BMY's Medicare Part D-dependent products, given AMGN's regulatory exposure and BMY's accounting for GTN adjustments based on payer channel mix and contract prices?",
      "original_answer": "The IRA-driven Medicare Part D redesign, which introduces manufacturer discounts and caps beneficiary out-of-pocket costs starting in 2025, will increase the gross-to-net (GTN) rebate accruals for both AMGN and BMY. For AMGN, the redesign compounds the impact of the set price for ENBREL starting in 2026, which is significantly lower than current pricing, and the potential inclusion of Otezla in the next round of Medicare price setting in 2027. This will likely reduce profitability and necessitate larger GTN adjustments. For BMY, which depends on Medicare Part D and accounts for GTN rebates using assumptions like payer channel mix and contract prices, the new obligations under the IRA will increase rebate liabilities, particularly in the catastrophic phase where manufacturers absorb more costs. The combined effect will be a material adverse impact on both companies' revenues and financial reporting accuracy, as they must adjust accruals to reflect the new regulatory environment and pricing pressures.",
      "llm_answer": "\nThe IRA’s 2025 Medicare Part D redesign – which imposes new manufacturer discounts, price‑caps and inflation‑penalty rebates – will drive down the net price of AMGN’s ENBREL (already slated for a 2026 Medicare Part D price cut and now subject to additional manufacturer‑discount and Colorado‑PDAB upper‑payment‑limit pressures) and force AMGN to accrue larger gross‑to‑net rebate amounts, while BMY’s Medicare Part D‑dependent products will require higher GTN reserves because the same discount and rebate obligations reshape the payer‑channel mix and contract‑price assumptions that BMY uses to calculate its GTN accruals (as disclosed in its accounting for gross‑to‑net adjustments).  Consequently, both companies will see expanded gross‑to‑net accrual estimates: AMGN’s exposure is heightened by the IRA‑driven price‑setting and state‑level PDAB caps on ENBREL, and BMY’s exposure is amplified by the need to reflect increased manufacturer discounts, inflation‑penalty rebates and shifting payer‑mix dynamics in its GTN calculations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the IRA's 2025 Medicare Part D redesign imposes manufacturer discounts and price caps, affecting both AMGN and BMY's gross-to-net (GTN) rebate accruals. The LLM correctly identifies that AMGN’s ENBREL faces a 2026 Medicare price cut (aligned with ground truth) and notes potential future exposure for Otezla in 2027, though this specific detail is slightly overextended—the original answer mentions Otezla’s possible inclusion in 2027 price setting, but the LLM does not explicitly restate that, instead focusing on ENBREL and state-level PDAB pressures. (2) Quantitatively, all dates (2025, 2026) are correct, and no numerical values are misstated. The LLM accurately reflects the timing and nature of regulatory changes without introducing false figures. (3) The multi-hop reasoning is sound: it connects the IRA provisions to increased GTN accruals, links AMGN’s exposure to both federal and state pricing pressures, and correctly explains that BMY must adjust GTN reserves due to shifts in payer channel mix and contract pricing assumptions—exactly as described in the original. (4) The LLM adds contextual detail not in the original (e.g., inflation-penalty rebates, Colorado PDAB), which are plausible under the IRA but not explicitly confirmed in the ground truth; this slightly extends beyond the provided knowledge but does not contradict it. Overall, the answer captures the core financial and regulatory impacts with excellent synthesis and semantic equivalence, warranting a 9 for correctness due to minor extrapolation on state-level impacts and absence of explicit mention of catastrophic phase cost shifts for BMY.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Redesigns]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1563,
        "completion_tokens": 470,
        "total_tokens": 2034
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How do AIG's and MET's differing accounting treatments for structured securities impact the valuation and reporting of ABS & CLO assets in their respective financial statements?",
      "original_answer": "AIG applies the effective yield method to structured securities, recalculating yields based on expected cash flows and adjusting amortized cost accordingly, with changes in expected cash flows either charged or credited to net investment income. MET, on the other hand, classifies ABS & CLO as available-for-sale (AFS) and measures them at estimated fair value, including those valued using Level 3 inputs, which are disclosed in recurring fair value measurements. These differing approaches—AIG's yield-based adjustments versus MET's fair value measurement—result in different financial statement presentations and sensitivity to market changes, affecting how investors assess the valuation and risk profile of each company's structured securities portfolio.",
      "llm_answer": "\nBoth insurers hold ABS & CLOs as part of their available‑for‑sale (AFS) fixed‑maturity portfolios, but they apply different valuation paths that flow through distinct parts of the financial statements.  \nAIG updates the yields on its structured securities based on actual cash‑flow experience and credit‑quality tier, adjusts the amortized cost accordingly, and records any credit‑loss allowance only when a purchased‑credit‑deteriorated asset is identified – with subsequent changes affecting net‑investment income and AOCI (Chunk 1).  \nMetLife, by contrast, includes its ABS & CLOs in the “Structured Products” line item of its AFS portfolio and, as disclosed in Note 11, records fair‑value fluctuations directly in earnings (while also measuring those assets with Level 3 inputs in a recurring fair‑value rollforward) – meaning that changes in the fair value of those securities impact MetLife’s net investment income rather than being deferred in equity (Chunks 2 & 3).  \n\nThus, AIG’s structured‑security accounting smooths valuation changes through amortized‑cost adjustments and AOCI, whereas MetLife’s approach brings fair‑value movements of ABS & CLOs into earnings and relies on Level 3 fair‑value measurements, leading to a more earnings‑volatile presentation of those assets.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no explicit numerical data (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not applicable in a traditional sense; however, since no numbers were misstated, it receives a 10. The core issue lies in qualitative accuracy. The original answer states that MET classifies ABS & CLO as available-for-sale (AFS) and measures them at fair value with changes reflected in other comprehensive income (OCI), not in earnings. However, the LLM incorrectly claims that MetLife 'records fair-value fluctuations directly in earnings,' which is factually wrong under AFS accounting—unrealized gains/losses for AFS securities are recorded in OCI, not net investment income or earnings. This is a critical error in accounting treatment. Additionally, the LLM asserts that fair value changes impact MetLife’s 'net investment income,' which conflates income from interest with valuation changes—another significant mistake. In contrast, AIG’s description is mostly accurate: it uses the effective yield method with amortized cost adjustments and recognizes changes in expected cash flows in net investment income. The LLM correctly identifies AIG’s use of AOCI for certain adjustments but overstates its role. The synthesis between the two companies’ approaches is partially correct in highlighting different volatility impacts, but the reasoning is flawed due to the incorrect placement of fair value changes in MetLife’s income statement. Contextually, the response addresses the question about differing accounting treatments and their impact on valuation and reporting, hence a solid relevance score. However, the fundamental misrepresentation of MetLife’s accounting treatment—especially the claim that fair value changes hit earnings—undermines the correctness and qualitative accuracy, leading to a 6/10 overall: some correct elements, but key financial statement impacts are misrepresented.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Comprises]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1519,
        "completion_tokens": 517,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the percentage of Chevron's (CVX) reserves tied to production-sharing contracts (PSCs) compare with ExxonMobil's (XOM) operational exposure in Nigeria, given Nigeria's reliance on PSCs for deepwater offshore exploration and production?",
      "original_answer": "Chevron's (CVX) reserves tied to production-sharing contracts (PSCs) accounted for 8% of its consolidated reserves in 2021. ExxonMobil (XOM) operates in Nigeria, where deepwater offshore exploration and production are governed by PSCs with terms typically lasting 30 years, including a 10-year exploration period and a 20-year production period. This indicates that both companies are exposed to PSC frameworks, but while CVX quantifies its PSC exposure directly in terms of reserves, XOM's exposure in Nigeria is structural and long-term, embedded in the regulatory framework of a key operational region.",
      "llm_answer": "\nChevron reports that only about 8 – 10 % of its consolidated reserves are classified as PSC‑related (Chunk 3). In contrast, ExxonMobil’s Nigerian upstream activities are fully embedded in the country’s deep‑water regime, which is dominated by production‑sharing contracts; Nigeria’s deep‑water offshore areas are governed by PSCs with the NNPC, and ExxonMobil’s operations there are subject to those contracts (Chunks 1 & 2). Therefore, while a modest 8‑10 % of Chevron’s total reserves are tied to PSCs, essentially all of ExxonMobil’s Nigerian reserve exposure operates under PSCs, representing a far larger share of its reserve base.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor deviations in precision and completeness. (1) Quantitatively, the LLM states Chevron's PSC-related reserves as '8–10%', while the ground truth specifies exactly '8%' in 2021. This slight overgeneralization (adding a range) reduces quantitative accuracy slightly, though it is directionally correct. (2) The LLM correctly identifies that ExxonMobil's Nigerian operations are fully governed by PSCs due to the country's regulatory framework for deepwater offshore exploration, which matches the original answer’s description of structural, long-term exposure. However, the LLM claims 'essentially all of ExxonMobil’s Nigerian reserve exposure operates under PSCs, representing a far larger share of its reserve base'—this introduces an inference not present in the ground truth. The original answer does not quantify XOM's global reserve exposure to PSCs or claim that Nigeria represents a 'far larger' share, so this comparative assertion goes beyond the provided information. (3) Entity accuracy is strong: Chevron (CVX), ExxonMobil (XOM), Nigeria, PSCs, and deepwater offshore context are all correctly identified and relevant. The year 2021 is implied via Chevron's data, though not explicitly mentioned in the LLM response. (4) Multi-hop reasoning is sound—linking Chevron's quantified PSC reserve percentage to ExxonMobil's structural exposure in Nigeria through the lens of PSC governance shows appropriate synthesis. (5) Contextual relevance is excellent; the answer directly addresses the comparative nature of PSC exposure between the two firms in the context of Nigeria’s regulatory regime. Overall, the answer captures the core contrast—CVX’s limited, measurable PSC reserve share vs. XOM’s embedded operational exposure in a PSC-dominant region—but slightly overreaches in comparative magnitude, justifying a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Subject_To]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 519,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does Tesla's fixed share reservation under the 2019 Plan compare with HD's approach to stock appreciation rights in terms of long-term equity compensation flexibility, given Tesla's 49.0 million reserved shares and HD's forfeiture-adjusted vesting methodology?",
      "original_answer": "Tesla's 2019 Plan establishes a fixed reservation of 49.0 million shares for equity incentives including stock appreciation rights (SARs), indicating a structured long-term approach to compensation with defined capacity. In contrast, HD's SAR program incorporates estimated forfeitures into its compensation expense calculation and recognizes value on a straight-line basis as restrictions lapse, allowing for dynamic adjustment based on actual retention of talent. While both companies utilize SARs, Tesla's approach suggests greater predictability and constraint in equity issuance, whereas HD's method provides flexibility in response to workforce attrition and vesting outcomes.",
      "llm_answer": "\nTesla has fixed a 49.0 million‑share reserve under its 2019 Equity Incentive Plan, which explicitly includes stock‑appreciation rights and other long‑term equity awards, giving the company a large, pre‑allocated pool that can be tapped for future grants without needing additional board approval. HD, by contrast, does not rely on a fixed reserve; instead it applies a forfeiture‑adjusted vesting methodology when measuring compensation expense for its SARs, meaning the number of shares ultimately issued (and the associated dilution) is governed by expected employee turnover rather than a static reserve. Thus, Tesla’s approach provides a rigid, expansive equity reserve for long‑term compensation flexibility, whereas HD’s flexibility is driven by its forfeiture‑adjusted accounting model that dynamically adjusts the effective share count based on actual award forfeitures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the 49.0 million share reservation for Tesla's 2019 Plan is correctly stated, and no other numerical values are present that conflict with the original. Format is consistent and precise. (2) The answer correctly identifies both companies (Tesla and HD), the relevant plans (2019 Equity Incentive Plan and HD's SAR program), and the key mechanisms: fixed share reserve vs. forfeiture-adjusted vesting. (3) The reasoning accurately contrasts Tesla’s structured, predictable equity issuance with HD’s dynamic, attrition-responsive model. The LLM correctly synthesizes that both use SARs but differ in flexibility drivers—Tesla via a large pre-allocated pool, HD via accounting adjustments based on forfeitures. (4) The only minor shortcoming is a slight mischaracterization in tone: the LLM describes Tesla’s approach as providing 'rigid, expansive equity reserve for long-term compensation flexibility,' whereas the original emphasizes predictability and constraint. While 'flexibility' can be interpreted as capacity to grant without reapproval, the original implies Tesla's rigidity limits adaptability, contrasting with HD’s true operational flexibility. This subtle difference in framing slightly affects qualitative accuracy but does not undermine factual correctness. Overall, the answer is semantically equivalent, contextually complete, and multi-hop reasoning is sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Issues]-> FIN_INST -[Includes]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 404,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does Chevron's financial exposure to Tengizchevroil in Kazakhstan, including its $4,500 million loan for the FGP/WPMP development, compare to ExxonMobil's reported long-lived asset value in Kazakhstan of $8,463 million as of 2021?",
      "original_answer": "Chevron holds a 50% equity stake in Tengizchevroil (TCO), which operates major oil fields in Kazakhstan, and has extended a $4,500 million loan to TCO specifically for the FGP/WPMP development. In 2021, Chevron's upstream earnings from TCO contributed positively to its income from equity affiliates. Meanwhile, ExxonMobil reported a total long-lived asset value in Kazakhstan of $8,463 million as of 2021. This suggests that while Chevron's exposure is primarily through equity investment and project-specific financing, ExxonMobil's presence is reflected in substantial asset holdings, indicating differing capital deployment strategies in the same geographic region.",
      "llm_answer": "\nChevron’s direct financial exposure to Tengizchevroil consists of a $4.5 billion loan (recorded in its investment in TCO to fund the FGP/WPMP development) plus a 50 % equity stake whose carrying value is about $100 million higher than the underlying net‑asset value, as disclosed in the 2021 10‑K (Chunk 1) and reflected in the improved equity‑affiliate earnings reported for 2021 (Chunk 2). In contrast, ExxonMobil reports $8,463 million of long‑lived assets in Kazakhstan as of 2021 (Chunk 3), meaning Exxon’s reported exposure in the country is roughly 1.9 times larger than the $4.5 billion loan that underpins Chevron’s Tengizchevroil involvement. The KG relationships (CVX → Tengizchevroil → Kazakhstan → XOM) tie both companies to the same jurisdiction, highlighting that while Chevron’s exposure is concentrated in a single high‑value loan, Exxon’s exposure is measured by a broader portfolio of long‑lived assets in Kazakhstan.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is largely correct in its factual content. It accurately reports Chevron's $4.5 billion loan (equivalent to $4,500 million) to Tengizchevroil for the FGP/WPMP project and correctly identifies Chevron's 50% equity stake. It also correctly states ExxonMobil's long-lived asset value in Kazakhstan as $8,463 million in 2021. The comparison that ExxonMobil's exposure is roughly 1.9 times larger than Chevron's $4.5 billion loan is mathematically accurate (8,463 / 4,500 ≈ 1.88). However, the LLM introduces a detail not present in the original answer or implied by the question: that Chevron's equity stake has a carrying value 'about $100 million higher than the underlying net-asset value.' This specific valuation detail is not in the ground truth and cannot be verified from the provided context, making it an unsupported addition.\n\n2) Quantitatively, all explicit numbers match: $4,500 million = $4.5 billion, and $8,463 million is correctly cited. The ratio calculation (1.9x) is approximately correct. The only issue is the unverified $100 million carrying value difference, which lacks support in the original answer and may not be inferable from public 10-Ks without explicit citation.\n\n3) The multi-hop reasoning is sound: the model correctly links Chevron → Tengizchevroil → Kazakhstan → ExxonMobil and compares two different types of financial exposure (equity + loan vs. long-lived assets). It appropriately contrasts Chevron’s project-specific financing and equity with ExxonMobil’s broader asset base, aligning with the qualitative insight in the ground truth about differing capital strategies.\n\n4) The answer is contextually excellent—directly addressing the comparison question, using appropriate financial terminology, and synthesizing across entities. The only deduction is for introducing a precise but unverified figure about the equity carrying value, which slightly undermines qualitative accuracy. Overall, the core facts, numbers, and reasoning are correct, warranting a high score but not perfect due to the unsupported detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 555,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How do Duke Energy's PPA negotiations for renewable facilities compare to Southern Power's PPA structures in wind facilities, particularly in terms of cash flow implications given Southern Power's utilization of production tax credits through 2024?",
      "original_answer": "Duke Energy negotiates PPAs as part of its commercial renewables strategy, where these agreements significantly influence the economic performance of its renewable energy VIEs. Southern Power, on the other hand, acts as a lessor in PPAs related to wind facilities, which are accounted for as operating leases with terms up to 25 years. These PPAs directly affect Southern Power's cash flows through lease income, which is further enhanced by production tax credits (PTCs) tied to the first 10 years of energy production from these wind facilities. Southern Power had approximately $0.8 billion in unutilized PTCs at the end of 2021, expected to be fully utilized by 2024. This creates a distinct cash flow dynamic: while Duke's PPAs are central to the performance of its consolidated VIEs, Southern Power's PPAs are structured to align with tax credit monetization strategies, directly shaping its lease income and tax equity partnership returns.",
      "llm_answer": "\nDuke Energy negotiates renewable PPAs inside VIE structures and depends on tax‑equity partners to fund the projects and allocate the related tax credits, so its cash‑flow outcomes are tied to the performance of those financing arrangements; Southern Power, however, executes wind‑facility PPAs as long‑term operating leases (up to 25 years) and receives production tax credits that are slated for full utilization through 2024, with the majority of the credit benefits passed to tax‑equity partners via the HLBV method, making its cash‑flow picture directly contingent on the timing and size of those PTCs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core distinctions between Duke Energy and Southern Power's PPA structures and their cash flow implications. (1) Quantitatively, all key facts are correct: Southern Power's PTCs are correctly tied to 2024 utilization, and while the exact $0.8 billion unutilized PTC figure from 2021 in the ground truth is not mentioned, no incorrect numbers are presented—this omission does not constitute a factual error but a slight completeness gap. (2) The LLM correctly identifies Duke Energy’s use of VIEs and reliance on tax-equity partners for funding and tax credit allocation, aligning with the original answer. (3) Southern Power’s PPA structure as long-term operating leases (up to 25 years) is accurately described, as is the role of PTCs and their monetization through tax equity partnerships using the HLBV (hypothetical liquidation book value) method, which directly impacts cash flows. (4) The reasoning correctly synthesizes multi-hop information: it contrasts Duke’s project-level financing dependence with Southern Power’s lease-based, PTC-driven cash flow model, capturing the essential comparative dynamic. (5) The only minor shortcoming is the omission of the specific $0.8 billion unutilized PTC amount from 2021, which slightly reduces completeness but does not affect the overall correctness of the cash flow implications described. Wording differs but semantic equivalence is strong. All entities (Duke Energy, Southern Power, PTCs, VIEs, tax equity, HLBV) are correctly used with accurate context. The answer is fully relevant and focused on the question’s core: PPA structures and cash flow impacts given PTC utilization through 2024.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negotiates]-> FIN_INST -[Related_To]-> PRODUCT <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 460,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does LOW's receipt of additional shares through ASR agreements compare to HD's issuance of additional shares via dividend equivalents in deferred share awards for non-employee directors?",
      "original_answer": "LOW receives additional shares from third-party financial institutions as part of variable notional ASR agreements, where the final share delivery depends on the difference between the maximum notional amount paid and the final notional value of shares repurchased. In contrast, HD issues additional shares to non-employee directors through dividend equivalents that accrue on deferred shares and are paid out in stock upon termination of board service. While LOW's additional shares result from share repurchase efficiency, HD's additional shares are a structured compensation element tied to deferred share awards.",
      "llm_answer": "\nLOW obtains extra shares directly through its variable‑notional ASR program – it pays the maximum notional amount up front and, upon settlement, receives additional shares (plus a cash payment) that reflect the difference between the prepayment and the final notional amount【Chunk 1】.  \nHD, by contrast, grants deferred‑share awards to non‑employee directors that accrue dividend equivalents and, when the awards are paid out after termination of service, those equivalents are settled in **additional shares of stock**【Chunk 2】【Chunk 3】.  \n\nThus, while LOW’s additional shares are acquired as part of a repurchase‑settlement with third‑party financial institutions, HD’s additional shares are issued as dividend‑equivalent payouts on deferred‑share awards to its directors; the KG link shows that the “Additional Shares” generated for LOW are the same class of instrument that ultimately connects to HD’s deferred‑share program.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: LOW receives additional shares through variable-notional ASR agreements with third-party financial institutions, where the final share delivery depends on the difference between the maximum notional amount paid and the final notional value of repurchased shares. HD issues additional shares via dividend equivalents on deferred share awards to non-employee directors, which are settled in stock upon termination of service. These points are correctly captured. (2) There are no numeric values, dates, or calculations in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (LOW and HD), two distinct financial mechanisms (ASR agreements vs. deferred share awards with dividend equivalents), and correctly contrasts their nature—one as a repurchase efficiency outcome, the other as a compensation mechanism. The only minor shortcoming is the vague reference to 'the KG link shows...' which introduces an undefined external concept ('KG link') not present in the original answer and slightly muddies the explanation, though it doesn't invalidate the core accuracy. (4) The answer is contextually fully relevant, directly addressing the comparison asked in the question with precise financial terminology and clear differentiation. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to this minor clarity issue, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Increases]-> FIN_INST -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 450,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How does Boeing's equity income from ULA in 2024 correlate with Lockheed Martin's commercial satellite launch revenue, given ULA's role in serving both government and commercial customers?",
      "original_answer": "Boeing reported equity income of $125 million from ULA in 2024, reflecting its stake in the joint venture. ULA, co-owned by Boeing and Lockheed Martin, provides expendable launch services to both the U.S. Government and commercial customers. Lockheed Martin’s Space segment includes revenue from commercial satellite launches facilitated through ULA. Additionally, Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes payments related to ULA’s commercial launch services. Therefore, Boeing’s equity income from ULA is directly tied to the revenue Lockheed Martin recognizes from commercial satellite launches via ULA’s dual customer base.",
      "llm_answer": "\nBoeing recorded **$125 million of equity‑method income from its investment in United Launch Alliance (ULA) in 2024** (Chunk 1). Because ULA’s commercial‑launch business serves the same commercial satellite customers that drive Lockheed Martin’s Space segment, the revenue from those launches is reflected in both companies’ financials—Lockheed’s Space operating profit includes its **50 % share of ULA earnings**, noted by a **$551 million investment in ULA at year‑end** (Chunk 2), and the commercial‑customer contracts also appear in Lockheed’s **contract‑asset and receivable disclosures** (Chunk 3). Thus, the $125 million equity income Boeing recognizes is directly tied to the commercial satellite‑launch revenue that underpins ULA’s business and, consequently, contributes to Lockheed Martin’s commercial launch earnings.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Boeing's $125 million equity income from ULA in 2024 and ULA's dual role serving government and commercial customers, which aligns with the ground truth. However, it introduces a figure of $551 million as Lockheed Martin’s investment in ULA, which does not appear in the original answer and is not corroborated by the provided context—this number is likely a misinterpretation or hallucination. Additionally, while the original answer states that Lockheed Martin reported $665 million in receivables from commercial customers (including ULA-related payments), the LLM omits this specific figure and instead references 'contract-asset and receivable disclosures' vaguely, missing a key quantitative link. (2) The $125 million figure is accurate and correctly attributed. The $551 million investment figure is unsupported and incorrect per the ground truth, which does not mention any such investment value. The $665 million receivable amount from commercial customers is omitted entirely, representing a significant quantitative omission. (3) The multi-hop reasoning is largely sound: the LLM correctly traces Boeing’s equity income to ULA’s commercial launch revenue and links it to Lockheed Martin’s financials through shared ownership and revenue recognition. It captures the structural relationship between the companies and the flow of earnings. However, it fails to explicitly state that Lockheed Martin’s Space segment revenue includes its share of ULA earnings due to the joint venture, instead implying it indirectly. The omission of the $665 million receivable weakens the completeness of the synthesis. (4) The contextual relevance is high—the answer addresses the core correlation between Boeing’s equity income and Lockheed’s commercial satellite launch revenue through ULA. Despite the hallucinated $551 million figure and omission of $665 million in receivables, the central logic remains intact, warranting a score of 7 for correctness. The qualitative reasoning is strong but undermined by one major quantitative inaccuracy and one omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP -[Supplies]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 564,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How does the loss of market exclusivity for LLY's pharmaceutical products, influenced by patent rights and regulatory data protection, compare to MRK's exposure to patent-related risks, particularly in light of the varying durations of exclusivity in major markets such as the U.S., Europe, and Japan?",
      "original_answer": "LLY faces a severe and rapid revenue decline when pharmaceutical products lose effective market exclusivity, which is often tied to patent expiration. However, LLY may retain exclusivity through later-expiring patents on formulations or methods of use, or through regulatory data protection, such as 12 years for biologics in the U.S., 10 years in Europe, and 8 years in Japan. This market exclusivity is determined by both patent rights and regulatory protections, as noted in the BMY evidence, which explains that patent coverage and data exclusivity (e.g., orphan drug exclusivity for 7 years or pediatric exclusivity for 6 months) are the two key determinants of exclusivity. MRK similarly depends on patent rights for market exclusivity and faces material adverse impacts if those rights are invalidated or circumvented. MRK frequently engages in patent litigation to defend its exclusivity, especially against generic manufacturers seeking to enter the market before patent expiration. Thus, both companies are highly exposed to patent-related risks, but LLY may have more nuanced opportunities to extend exclusivity through regulatory mechanisms, while MRK emphasizes legal defense of its patents as a core strategy.",
      "llm_answer": "\nLLY’s market exclusivity for its drugs is anchored in patent rights that are extended by regulatory data‑protection periods of roughly five years in the United States, about ten years in Europe and eight years in Japan, with additional six‑month pediatric or seven‑year orphan exclusivity that can postpone generic entry (Chunk 1) and is part of the broader patent‑and‑regulatory exclusivity model described in Chunk 2; because the same patent‑rights component is identified as a risk factor that discloses MRK (Chunk 1), MRK’s 10‑K (Chunk 3) warns that any loss of patent protection—through expiration, litigation, compulsory licence or invalidation—can quickly erode its market exclusivity and cause a sharp sales decline, making its exposure to patent‑related risk broader and more immediate than LLY’s, especially given the differing exclusivity durations across the U.S., Europe and Japan.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer contains several factual inaccuracies, particularly in quantitative claims. It states that regulatory data protection is 'roughly five years in the United States,' which is incorrect: the ground truth specifies 12 years for biologics in the U.S., not five. This is a major error. The durations for Europe (10 years) and Japan (8 years) are correctly stated. The mention of 6-month pediatric exclusivity and 7-year orphan exclusivity is accurate and aligns with the ground truth. 2) Quantitatively, the U.S. data protection period is off by a significant margin (5 vs 12 years), which undermines the accuracy of the comparison. Other numbers (10 years in Europe, 8 in Japan, 7-year orphan, 6-month pediatric) are correct. 3) The reasoning partially captures the multi-hop comparison between LLY and MRK: both rely on patents and face risks from expiration or invalidation, and MRK emphasizes litigation. However, the LLM incorrectly frames MRK’s exposure as 'broader and more immediate' than LLY’s without sufficient support from the evidence, and it fails to acknowledge that LLY may have more nuanced regulatory extension opportunities (e.g., formulation patents, method-of-use) as highlighted in the ground truth. Instead, it overemphasizes MRK’s risk without balancing LLY’s strategic advantages in exclusivity extension. 4) Contextually, the answer addresses the core question about patent and regulatory exclusivity across markets and compares LLY and MRK, so relevance is high. However, due to the critical error in U.S. data protection duration and the resulting flawed comparative assessment, the overall correctness is significantly reduced. The answer is partially correct but contains key factual and inferential flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has]-> REGULATORY_REQUIREMENT -[Determined_By]-> RISK_FACTOR <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1568,
        "completion_tokens": 473,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How do the potential financial impacts of cyber intrusion-related compliance costs at Southern Company's nuclear facilities compare to Duke Energy's decommissioning trust fund funding risks given both companies' exposure to nuclear power plant operations?",
      "original_answer": "Southern Company highlights that cyber intrusions could result in increased nuclear licensing or compliance costs that are difficult to predict, particularly at its nuclear facilities where Alabama Power and Georgia Power hold ownership interests representing 26% and 28% of their total KWH generation in 2021, respectively. These compliance costs could rise unpredictably due to threats of cyber intrusions or physical attacks. Meanwhile, Duke Energy notes that a decline in the market value of assets in its Nuclear Decommissioning Trust Funds (NDTF) could increase funding requirements for decommissioning its nuclear plants. Both companies face distinct financial risks tied to nuclear power plant operations—Southern Company through potential cyber-related compliance costs and Duke Energy through market-dependent decommissioning funding obligations.",
      "llm_answer": "\nSouthern Company’s nuclear sites face cyber‑intrusion‑related compliance costs that can trigger NRC fines, force costly security upgrades and, if a breach leads to a shutdown or damages that exceed the size of the Alabama‑ and Georgia‑Power decommissioning trusts, could require additional capital outlays; Duke Energy, by contrast, risks that market‑driven declines in the value of its nuclear‑plant decommissioning trust assets will outpace expected returns, creating funding shortfalls that must be covered by cash‑flow‑dependent subsidiaries.  Both exposures translate into sizable cash‑needs, but Southern Company’s is tied to regulatory and operational penalties from cyber events, whereas Duke Energy’s stems from investment‑performance shortfalls in its funded trusts, and the knowledge‑graph link shows that nuclear power plants (the product) negatively impact Duke Energy, tying the two companies’ financial risks together.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general nature of the financial risks faced by Southern Company and Duke Energy related to nuclear operations, but introduces significant inaccuracies and unsupported details. (1) Quantitative Accuracy: The ground truth states that Alabama Power and Georgia Power’s ownership in nuclear facilities represented 26% and 28% of their total KWH generation in 2021—this specific data is missing in the LLM answer. Instead, the LLM introduces unverified claims such as decommissioning trust sizes, potential shutdowns exceeding trust values, and capital outlays without any supporting data from the original answer or filings. These are speculative and not present in the ground truth. (2) Completeness: The LLM addresses both companies and their respective risks—cyber-related compliance costs for Southern and decommissioning trust funding risks for Duke—but adds extraneous details (e.g., NRC fines, security upgrades, trust performance thresholds) not mentioned in the original. It fails to include the key contextual data point about the 26% and 28% KWH generation shares, which is a core quantitative element. (3) Entity Accuracy: Company names and nuclear-related terms (e.g., decommissioning trust funds) are correctly used. However, the LLM incorrectly implies a direct financial linkage between the two companies via a 'knowledge-graph link' showing nuclear power plants negatively impacting Duke Energy and tying the two together—this is a misinterpretation. The original answer does not suggest any interdependence between Southern Company and Duke Energy; they are compared as parallel examples, not linked entities. (4) Reasoning: The multi-hop reasoning is partially sound—both companies are correctly associated with distinct nuclear-related financial risks. However, the LLM overreaches by suggesting a causal or systemic connection between them, which is unsupported. It also conflates cyber intrusion impacts with decommissioning trust mechanics in a way that implies comparable cash-flow impacts without evidence. (5) Semantic Equivalence: While the high-level contrast between Southern’s regulatory/compliance risks and Duke’s investment-performance risks is preserved, the added specifics reduce factual fidelity. The original emphasizes unpredictability of compliance costs and market-value sensitivity of trusts—concepts present but distorted by speculative extensions in the LLM version. Overall, the answer is contextually relevant and shows reasonable qualitative understanding but fails on key quantitative and factual precision, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR -[Subject_To]-> PRODUCT <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 691,
        "total_tokens": 2165
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the treatment of dividend equivalents on deferred stock units granted to non-employee directors in 2023 by Lowe's compare with Home Depot's policy on dividend equivalents related to deferred shares, particularly in terms of vesting schedules and payout structure?",
      "original_answer": "Lowe's provides dividend equivalents on deferred stock units granted to non-employee directors, which vest either on the first anniversary of the grant date or the day before the next Annual Meeting of Shareholders, with immediate vesting for awards granted prior to 2022. In contrast, Home Depot pays dividend equivalents on deferred shares granted to non-employee directors that accrue and are paid out in additional shares upon termination of service, with the fair value expensed immediately upon grant. This shows differences in both vesting timing and payout mechanisms between the two companies’ deferred compensation structures.",
      "llm_answer": "\nLowe’s 2023 deferred‑stock‑unit awards for non‑employee directors **earn dividend equivalents** that are paid out (typically in cash) and **vest on the earlier of the first anniversary of the grant date or the day immediately preceding the next annual shareholders’ meeting**, with the award expensed on a straight‑line basis over the required service period; by contrast, Home Depot’s deferred‑share awards also **provide dividend equivalents**, but these **accrue and are paid as additional shares only upon termination of board service**, and the fair value of the deferred shares is **expensed immediately upon grant**.  Thus, while Lowe’s ties vesting to a time‑based schedule (with possible acceleration) and spreads expense over the service period, Home Depot ties vesting to the end of board service and recognizes expense up front, resulting in different payout structures for dividend equivalents.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Lowe's dividend equivalents on deferred stock units for non-employee directors in 2023 vest on the earlier of the first anniversary or the day before the next Annual Meeting, with straight-line expensing; Home Depot’s dividend equivalents accrue and are paid in additional shares upon termination of service, with immediate expensing at grant. These details match the original answer. (2) There are no numeric values requiring calculation, but temporal and structural elements (vesting triggers, payout form, expensing timing) are correctly reported. Format variations (e.g., 'termination of service' vs 'end of board service') are semantically equivalent. (3) The multi-hop reasoning—comparing two companies’ policies across vesting schedules and payout structures—is sound and well-synthesized. The only minor omission is that the original answer notes Lowe's immediate vesting for awards granted prior to 2022, which the LLM answer does not mention. However, the question specifically asks about 2023 grants, making this detail less critical. (4) The LLM clearly distinguishes between the two companies’ approaches to vesting timing and payout mechanisms, fully addressing the comparative aspect of the question. Thus, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth, warranting a high correctness score with a small deduction for the omitted pre-2022 policy nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 419,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the potential loss of 12-year biologic data exclusivity in the U.S. impact AMGN's competitive position compared to MRK's strategy of leveraging compound patents and pediatric exclusivity extensions?",
      "original_answer": "The potential removal of the 12-year biologic data exclusivity in the U.S., as highlighted in AMGN's 10-K, could expose AMGN to earlier biosimilar competition, particularly for products like EPOGEN, which is sold almost exclusively to a concentrated customer base. In contrast, MRK's strategy, as outlined in its 10-K, relies on a layered approach to market exclusivity, including compound patents, pediatric exclusivity extensions (which can add six months), and regulatory data protection. This layered approach allows MRK to maintain commercial control even after initial patent expiration, giving it a more diversified defense against generic erosion compared to AMGN's reliance on regulatory exclusivity.",
      "llm_answer": "\nAMGN’s 12‑year biologic data‑exclusivity is the regulatory engine that grants it market‑exclusivity; if that exclusivity is removed, the company would be exposed to biosimilar competition as early as the FDA decides that “umbrella exclusivity” does not apply (Chunk 1), directly weakening its competitive position. In contrast, MRK (Chunk 3) mitigates such risk by stacking compound‑patent protection with up‑to‑six‑month pediatric market‑exclusivity extensions and by leveraging later‑expiring process and use patents, thereby prolonging exclusivity beyond the standard 12‑year period. This difference is reflected in the regulatory‑exclusivity → market‑exclusivity linkage (Chunk 2), which shows that while both firms depend on regulatory exclusivity, MRK’s strategy adds patent‑term restoration and pediatric extensions to preserve market advantage, whereas AMGN’s loss of the 12‑year data exclusivity would erode its exclusive market share.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the 12-year biologic data exclusivity for AMGN, the potential for earlier biosimilar competition if removed, and MRK's use of compound patents, pediatric exclusivity (up to six months), and layered protections are all accurately represented. The mention of 'umbrella exclusivity' and 'process and use patents' adds nuance consistent with regulatory strategies, even if not explicitly in the original answer. (2) Quantitatively, all numbers are correct: '12-year' exclusivity and 'up to six months' pediatric extension match the ground truth exactly. No calculations were required, but comparative timing is correctly framed. (3) The multi-hop reasoning is sound: the model correctly synthesizes that AMGN relies heavily on regulatory exclusivity (specifically the 12-year data exclusivity), while MRK employs a diversified strategy combining patents and extensions, making MRK less vulnerable to a single policy change. This contrast in strategic resilience is logically drawn and well-supported. (4) The only minor shortcoming is that the LLM does not explicitly mention EPOGEN or the concentrated customer base—a specific example from the original answer that strengthens the impact on AMGN. While this is a small omission, it slightly reduces completeness. However, the core competitive comparison is preserved. Wording differences (e.g., 'stacking' vs 'layered approach') are semantically equivalent. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT -[Determined_By]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 446,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the treatment of the countercyclical capital buffer under TLAC requirements for GS compare with SCHW's application of the same buffer, particularly in light of GS's 18% minimum TLAC to RWAs threshold and SCHW's 2.5% stress capital buffer?",
      "original_answer": "Goldman Sachs (GS) includes the countercyclical capital buffer as part of its TLAC to RWAs requirement, which the Federal Reserve has set to zero percent, within the broader 18% minimum TLAC threshold (as stated in GS's 10-K filing). In contrast, Schwab (SCHW) is also subject to a countercyclical capital buffer above the minimum risk-based capital ratios, which was zero percent as of December 31, 2024 (as disclosed in SCHW's 10-K). However, SCHW specifically maintains a 2.5% stress capital buffer, indicating a differentiated approach to regulatory capital planning despite both institutions operating under a zero percent countercyclical buffer.",
      "llm_answer": "\nGS’s TLAC‑to‑RWAs framework requires an 18 % minimum ratio and explicitly includes a **countercyclical capital buffer that the FRB has set to 0 %** (Chunks 1 & 2); by contrast, SCHW’s disclosures show that its **countercyclical buffer is also 0 %**, but SCHW must maintain a separate **2.5 % stress‑capital buffer** in addition to that (Chunk 3). Consequently, while both firms treat the countercyclical component as zero, GS embeds it within an 18 % TLAC‑to‑RWAs threshold, whereas SCHW’s comparable requirement is expressed through a 2.5 % stress‑capital buffer rather than a distinct TLAC ratio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GS has an 18% minimum TLAC to RWAs threshold that includes a countercyclical capital buffer set at 0% by the Federal Reserve; SCHW also faces a 0% countercyclical buffer but maintains a separate 2.5% stress capital buffer. These values match the original answer exactly, and no incorrect numbers or dates are present—quantitative accuracy is perfect. (2) The answer is complete: it addresses both firms’ treatment of the countercyclical buffer, correctly notes the 0% rate for both, and contrasts GS’s TLAC-based framework with SCHW’s stress capital buffer approach. (3) Entities (GS, SCHW, FRB, TLAC, RWAs, stress capital buffer) are correctly identified and contextualized. (4) The reasoning is sound—despite both institutions having a zero percent countercyclical buffer, the LLM correctly highlights the structural difference in how each firm incorporates capital buffers into regulatory requirements, showing effective multi-hop synthesis across regulatory frameworks. The only minor limitation is that the LLM slightly downplays the fact that SCHW is not subject to TLAC requirements (implied but not stated), and the phrase 'comparable requirement' could be misinterpreted as equating TLAC with stress capital buffer, which are distinct mechanisms. However, this does not undermine the overall correctness. Semantic equivalence is maintained, and the core insight—that both have 0% countercyclical buffers but different capital planning approaches—is clearly and accurately conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Discloses]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 435,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does XOM's asset exposure in Kazakhstan compare with CVX's stake in TCO's operations in the region?",
      "original_answer": "XOM reported $7,728 million in long-lived assets in Kazakhstan in 2023, reflecting its operational exposure in the region. Meanwhile, CVX holds a significant stake in TCO, which operates major oil fields like Tengiz and Korolev under a concession agreement expiring in 2033. TCO achieved mechanical completion of the Future Growth Project (FGP) in 2023, with start-up expected in the first half of 2025, and is also advancing the Karachaganak Expansion Project, with Stage 1A expected to complete in 2024. CVX’s involvement through TCO demonstrates its strategic positioning in Kazakhstan’s upstream sector, despite not directly owning long-lived assets like XOM.",
      "llm_answer": "\nXOM reports roughly **$7.7 billion of long‑lived assets in Kazakhstan** (Chunk 1), whereas CVX’s exposure is through its **equity stake in TCO**, the operator of the giant Tengiz, Korolev and Karachaganak fields and the CPC pipeline that moves about **1.4 million bbl/d of crude** (Chunk 2). This partnership is reflected in CVX’s consolidated reserve figures, where TCO’s proved reserves contribute to the **~30.4 billion cubic‑foot oil‑equivalent reserve base** reported at year‑end 2023 (Chunk 3), highlighting a production‑ and reserve‑focused stake compared with XOM’s capital‑intensive asset exposure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM correctly identifies XOM's $7.7 billion (i.e., $7,728 million) in long-lived assets in Kazakhstan, aligning with the ground truth. However, it introduces new quantitative claims not present in the original answer: specifically, CVX’s TCO stake contributing to a '~30.4 billion cubic-foot oil-equivalent reserve base' and the CPC pipeline moving '1.4 million bbl/d of crude'. These figures, while potentially accurate, are not in the ground truth and were not verified in the context provided, making them unsupported additions. The original answer emphasizes TCO’s project milestones (FGP mechanical completion in 2023, start-up in H1 2025; Karachaganak Stage 1A in 2024) and the 2033 concession expiry—details omitted in the LLM response. 2) The $7.7 billion figure is a valid rounding of $7,728 million, so that is quantitatively accurate. However, the reserve and production numbers lack corroboration from the original answer and thus reduce quantitative accuracy. 3) The LLM correctly captures the qualitative distinction between XOM’s direct asset ownership and CVX’s indirect exposure via equity stake in TCO, demonstrating sound multi-hop reasoning by contrasting capital-intensive assets vs. reserve-based exposure. It appropriately identifies TCO as operator of Tengiz, Korolev, and Karachaganak, which is consistent with the original. 4) The response is contextually relevant and directly addresses the comparison question, but misses key forward-looking operational details (project timelines, concession expiry) that are central to CVX’s strategic positioning in the original answer. These omissions reduce completeness and factual equivalence despite strong structural reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 462,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does Southern Company's uncertainty around the financial impact of transitioning from LIBOR to alternative rates under ASU 2020-04 compare with NextEra Energy's disclosure that it is applying the same standard to its interest rate contracts, given that both companies rely on reference rate reform guidance to manage derivative exposures?",
      "original_answer": "Southern Company explicitly states that the 'ultimate outcome of the transition [from LIBOR] cannot be determined at this time,' indicating uncertainty in assessing the financial impact of ASU 2020-04. In contrast, NextEra Energy affirms that it is applying the guidance under ASU 2020-04 to manage its interest rate contracts affected by reference rate reform. Both companies are subject to the same regulatory framework and are actively navigating the transition from LIBOR to alternative rates, but NEE demonstrates a more definitive implementation stance compared to SO's ongoing evaluation.",
      "llm_answer": "\nSouthern Company’s 2021 filing (Chunk 1) states that it continues to evaluate ASU 2020‑04 and that the ultimate financial effect of moving away from LIBOR “cannot be determined at this time,” highlighting its uncertainty about the transition. In contrast, NextEra Energy (NEE) explicitly says it is applying the same reference‑rate reform guidance to its interest‑rate contracts (Chunk 3) and, per the KG link Reference Rate Reform → NEE, is using the optional expedients described in the ASU (Chunk 2) to manage derivative exposures. Therefore, both utilities rely on the identical accounting standard, but Southern Company faces unresolved impact while NextEra has already adopted the guidance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies Southern Company's uncertainty about the financial impact of transitioning from LIBOR under ASU 2020-04, quoting the key phrase 'cannot be determined at this time,' and contrasts it with NextEra Energy's definitive application of the same guidance. (2) There are no numerical values requiring calculation, but the references to ASU 2020-04, reference rate reform, and derivative exposures are all correctly stated. (3) The multi-hop reasoning is sound: the model synthesizes disclosures from both companies, correctly compares their stances (evaluation vs. implementation), and notes their shared reliance on the same accounting standard. (4) The answer fully addresses the comparative aspect of the question, maintains proper entity identification (Southern Company, NextEra Energy, ASU 2020-04), and conveys the nuanced difference in disclosure tone and implementation status. All aspects align with the original answer, warranting top scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Positively_Impacts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 301,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the dual-class stock structure and voting rights limitations in META's Class A Common Stock compare to GOOGL's governance framework under their respective Certificates of Incorporation, particularly in terms of protecting minority shareholder interests?",
      "original_answer": "GOOGL's Certificate of Incorporation ensures equal dividend and liquidation rights across all stock classes and mandates unanimous board approval before amendments affecting stockholder rights can be proposed, with affected classes requiring to approve such changes. This provides a structural safeguard for minority shareholders. In contrast, META's Class A Common Stock is subject to a controlled company structure where the board is not required to be majority independent, and key governance decisions require approval from Class B stockholders, who hold superior voting rights. META's Certificate of Incorporation also includes anti-takeover provisions that require a two-thirds majority vote for certain amendments once Class B voting power drops below 35%, further entrenching control and potentially limiting minority shareholder influence.",
      "llm_answer": "\nMETA’s Class A common stock operates under a dual‑class regime where Class B insiders control voting power and a suite of anti‑takeover provisions (e.g., mandatory Class B approval for mergers and a controlled‑company status that relaxes board‑independence requirements) curtail minority influence, whereas GOOGL’s Certificate of Incorporation imposes class‑approval and unanimous‑board safeguards that require any amendment affecting voting or dividend rights to be endorsed by the affected class, preserving minority protections. Both companies restrict voting—META’s Class A holders have one vote per share while Class B and C shares are non‑voting except on limited matters, mirroring the limited voting rights outlined for series B and C preferred stock in the governance documents.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core differences between META's and GOOGL's governance frameworks in protecting minority shareholders. It accurately identifies that META has a dual-class structure where Class B stockholders (insiders) hold superior voting power, which limits minority influence, and notes anti-takeover mechanisms such as requiring Class B approval for mergers and relaxed board-independence requirements due to controlled-company status—consistent with the ground truth. It also correctly states that GOOGL’s Certificate of Incorporation includes safeguards requiring class approval and unanimous board consent for amendments affecting shareholder rights, which protects minority interests. However, the LLM omits a key detail from the original answer: META’s two-thirds supermajority requirement for certain charter amendments once Class B voting power falls below 35%, a specific anti-takeover provision that further entrenches control. This omission slightly weakens the completeness of the multi-hop comparison. Additionally, the reference to 'series B and C preferred stock' in the last sentence appears inaccurate—GOOGL and META do not have preferred stock with those designations; both have common stock classes (e.g., Class A, B, C common stock), so this reflects a minor mischaracterization. Despite this, the overall reasoning, entity identification, and synthesis are sound, and there are no numerical inaccuracies (no explicit numbers were misstated). The answer remains semantically close to the ground truth and fully addresses the comparative governance question with high contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Subject_To]-> FIN_INST <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 448,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How might the implementation of the OECD's global minimum tax framework impact the effective tax rates of both PepsiCo and Altria, given their differing U.S. tax burdens and exposure to international tax changes?",
      "original_answer": "The implementation of the OECD's global minimum tax framework could increase PepsiCo's effective tax rate due to its international operations and exposure to countries implementing the 15% minimum tax, as noted in PepsiCo's 10-K. Altria, which reported $2,346 million in federal tax payments in the U.S. and minimal foreign tax liabilities, may not face the same upward pressure on its effective tax rate, as its tax burden is more concentrated domestically. The U.S. tax legislation context suggests that multinational corporations with significant overseas earnings, like PepsiCo, are more likely to see tax increases under the new framework, while companies like Altria with limited international exposure may remain relatively unaffected.",
      "llm_answer": "\nPepsiCo’s 2023 filing warns that OECD‑driven global‑minimum‑tax rules—already being enacted by EU members and slated for worldwide rollout by 2025—could raise its income‑tax expense and compliance costs, implying a higher effective tax rate than its current foreign‑earnings mix. Altria, which in 2023 recorded a $2.8 bn tax provision on $10.9 bn of pre‑tax earnings (≈25.5 % effective rate), is similarly subject to the same regulatory requirement; because the OECD framework will affect the U.S. tax base to which Altria is subject, any shift to a 15 % global minimum could modestly lift its effective rate while also adding compliance burdens. Both companies therefore face a negative impact from the OECD tax reforms, as reflected by the ORG → REGULATORY_REQUIREMENT → GPE → ORG chain that links their operations to the jurisdictions where the new tax rules apply.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several inaccuracies that significantly affect correctness. (1) Quantitative inaccuracy: The LLM claims Altria recorded a $2.8 billion tax provision on $10.9 billion of pre-tax earnings, implying a 25.5% effective rate. However, the ground truth states Altria paid $2,346 million in federal taxes, with no mention of total pre-tax earnings or an effective rate—this calculation is fabricated. The $2.8B figure does not match the $2,346M (i.e., $2.346B) in federal payments cited in the original, and the 25.5% rate is unsupported. (2) Misrepresentation of Altria’s exposure: The original answer emphasizes Altria’s minimal foreign tax liabilities and domestic concentration, suggesting it will be largely unaffected by the OECD rules. In contrast, the LLM claims Altria will face a 'modest lift' in its effective tax rate due to the U.S. tax base shift, which contradicts the ground truth and overstates its exposure. (3) Entity and reasoning accuracy: While PepsiCo’s exposure is correctly identified and aligned with its international operations, the LLM incorrectly generalizes the impact to both firms, failing to distinguish the differential impact as required by the question. The mention of a 'REGULATORY_REQUIREMENT chain' adds irrelevant jargon not grounded in the source material. (4) Contextual relevance is strong—the OECD framework, timing (2025), and compliance costs are relevant and appropriately contextualized. However, the core multi-hop reasoning (comparing differential impacts based on international vs. domestic tax exposure) is flawed due to incorrect data and conclusion about Altria. Thus, while the structure and intent are reasonable, factual and quantitative errors reduce overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 472,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the extension of market exclusivity through orphan drug designation in the U.S. impact AbbVie's risk of generic competition, given Eli Lilly's reliance on the same regulatory mechanism to protect its products beyond compound patent expiration?",
      "original_answer": "In the U.S., orphan drug designation grants seven years of market exclusivity, which runs in parallel with any applicable patents and can extend beyond the expiration of compound patents, as noted in Eli Lilly's 2023 10-K. This exclusivity period prevents the FDA from approving another application for the same drug product for the same orphan use, as described in the regulatory overview. For AbbVie, the loss or weakening of such exclusivity—whether through patent challenges, regulatory changes, or compulsory licensing—could accelerate generic competition and significantly reduce revenues, as stated in AbbVie's 2023 10-K. Therefore, the strength and duration of orphan drug exclusivity directly influence AbbVie’s exposure to market erosion, especially in the context of competitors like Eli Lilly leveraging the same protections to maintain market control beyond traditional patent life.",
      "llm_answer": "\nOrphan‑drug designation can grant up to seven years of U.S. market exclusivity that runs in parallel with, and may extend beyond, the compound patent term – a regulatory protection that the knowledge‑graph links from “Market Exclusivity” to AbbVie (Market Exclusivity → ABBV) and that Eli Lilly is also using to keep generics at bay after its patents expire; this exclusivity, together with the data‑protection and pediatric‑exclusivity periods described in the filings, delays generic ANDA submissions and therefore lessens AbbVie’s immediate risk of generic competition, but once the orphan‑derived exclusivity and any later‑expiring patents or data‑protection terms lapse, generic manufacturers may file ANDAs (as noted in the BMY 10‑K) and challenge the patents, a scenario that AbbVie explicitly warns can erode its revenue and operating earnings (as detailed in the ABBV 10‑K).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 'seven years of market exclusivity' is correctly stated, matching the original answer and regulatory facts. No calculations are required, and all referenced timeframes (e.g., exclusivity beyond patent term) are factually correct. (2) The answer correctly identifies both AbbVie and Eli Lilly as leveraging orphan drug exclusivity, and references appropriate risk disclosures from AbbVie's 10-K, showing proper multi-hop synthesis across entities and regulatory mechanisms. (3) The reasoning is sound: it explains how orphan exclusivity delays generic competition by preventing ANDA approvals, and correctly notes that once exclusivity lapses, generics may enter and challenge patents, impacting revenue—directly reflecting AbbVie’s stated risk. (4) Minor deduction in qualitative accuracy due to mention of 'data-protection and pediatric-exclusivity periods' and a reference to 'BMY 10-K', which, while contextually plausible, are not mentioned in the original answer or required for the reasoning chain focused on orphan drug exclusivity and its parallel use by Eli Lilly and AbbVie. This introduces slight extraneous detail, but does not undermine the core correctness. Overall, the answer is semantically equivalent, contextually relevant, and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Positively_Impacts]-> REGULATORY_REQUIREMENT <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 377,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Coca-Cola FEMSA's operational footprint in Argentina in 2021 influence KO's equity investee sales exposure compared to PEP's direct exposure to Argentina's economic volatility during the same period?",
      "original_answer": "KO reported net sales to equity method investees, including Coca-Cola FEMSA, of $14,471 million in 2021, which were influenced by recovery from the pandemic. Coca-Cola FEMSA operated in Argentina's federal capital and surrounding areas in 2021, contributing to KO's indirect exposure in that market. Meanwhile, PEP directly operated in Argentina and faced economic volatility, including currency controls and inflationary pressures, which posed risks to their financial results. Therefore, while KO's exposure to Argentina was indirect through Coca-Cola FEMSA's operations and tied to equity investee sales, PEP faced direct exposure to Argentina's macroeconomic instability in 2021.",
      "llm_answer": "\nKO’s equity‑method sales to its bottling affiliate Coca‑Cola FEMSA— which has operations in Argentina (Buenos Aires and surrounding areas) and accounted for a share of the five largest bottling partners that together represent 41 % of worldwide unit case volume— helped lift KO’s net sales to equity‑method investees to $14,471 million in 2021 and drove the $496 million increase in purchases of beverage products, a rise attributed to international expansion and the post‑COVID recovery; thus KO’s exposure to Argentina is indirect, flowing through the investee’s sales in that market.  By contrast, PEP’s exposure to Argentina is direct: the company disclosed that volatile economic, political and social conditions in Argentina (including inflation, currency controls and civil unrest) created foreign‑exchange risk that subtracted roughly one percentage point from its consolidated net‑revenue growth in 2021, underscoring PEP’s direct sensitivity to the country’s economic volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: KO's net sales to equity-method investees were $14,471 million in 2021, which matches the original answer. The mention of Coca-Cola FEMSA operating in Buenos Aires and surrounding areas in Argentina is consistent with 'federal capital and surrounding areas' in the ground truth. PEP's direct exposure due to inflation, currency controls, and foreign-exchange risk subtracting approximately one percentage point from net revenue growth in 2021 is factually correct and well-documented in PEP's 2021 10-K. (2) Quantitative accuracy is perfect: $14,471 million and the $496 million increase in purchases (though not in the original answer, this figure is plausible and contextually supported by KO’s 10-K disclosures about post-COVID recovery and international expansion—minor addition but not contradictory). The 41% of worldwide unit case volume from the five largest bottlers is extra detail but does not conflict with the core answer. (3) Multi-hop reasoning is sound: the model correctly distinguishes KO’s indirect exposure via Coca-Cola FEMSA (an equity investee) from PEP’s direct operational presence and associated macroeconomic risks. The synthesis across companies (KO vs. PEP), investment structures (equity method vs. direct operations), and country-specific risks is logically coherent. (4) The only minor shortcoming is that the original answer emphasizes the pandemic recovery as a driver of KO’s equity investee sales, while the LLM attributes the increase more broadly to international expansion and recovery—slightly broader framing but still valid. No factual errors; excellent contextual relevance and completeness. Hence, a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 500,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does AbbVie's reliance on patent rights for emraclidine through its acquisition of Cerevel Therapeutics influence its market exclusivity strategy compared to Merck's experience with Januvia's patent expiration and regulatory exclusivity timeline?",
      "original_answer": "AbbVie's acquisition of Cerevel Therapeutics included an exclusive global license under certain Pfizer patent rights, which were critical for developing and commercializing emraclidine. However, despite this licensing arrangement, AbbVie recorded a $4.5 billion intangible asset impairment charge related to emraclidine, suggesting that the expected market exclusivity or commercial viability did not materialize as anticipated. Patent rights are a key determinant of market exclusivity in the pharmaceutical industry, often supplemented by regulatory exclusivity periods that can extend beyond patent terms. In contrast, Merck was able to extend its market exclusivity for Januvia and Janumet in the U.S. until May 2026 and for Janumet XR until July 2026 due to favorable court rulings and settlement agreements around a later-expiring patent on the sitagliptin salt form, despite the core compound patent expiring in January 2023. This demonstrates that while AbbVie's strategy relied heavily on patent licensing to secure exclusivity, it faced significant financial consequences when that exclusivity or market uptake failed to deliver expected returns, unlike Merck, which successfully leveraged later-stage intellectual property strategies to delay generic competition.",
      "llm_answer": "\nAbbVie secured an exclusive global license to Pfizer’s patent portfolio for emraclidine as part of the Cerevel Therapeutics acquisition, using those patent rights to generate the market‑exclusivity regulatory requirement that underpins its commercial strategy for the asset – a linkage captured by the KG pattern ABBV → Patent Rights → Market Exclusivity → MRK (negative impact).  This mirrors the situation described in Merck’s 10‑K, where the loss of patent‑based exclusivity for Januvia (and the subsequent reliance on later‑filed salt patents and regulatory‑exclusivity extensions that only delayed, but did not prevent, sales decline until 2026) led to steep revenue drops once exclusivity ended.  Consequently, while Merck’s experience shows how patent expiration and regulatory price‑setting can quickly erode sales, AbbVie is banking on its newly acquired patent rights to sustain exclusivity for emraclidine, though the $4.5 billion intangible‑asset impairment highlights the risk that those rights may not deliver the long‑term market protection it seeks.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but exhibits significant inaccuracies in reasoning and entity interpretation that affect the overall correctness. (1) Quantitatively, the $4.5 billion impairment charge is correctly stated, and the reference to Merck's exclusivity until 2026 aligns broadly with the ground truth. However, the LLM misrepresents the timeline: it fails to specify that Januvia’s core compound patent expired in January 2023, and instead vaguely references 'later-filed salt patents' without clarifying that Merck successfully extended exclusivity via court rulings and settlements on the sitagliptin salt form — a key strategic distinction. (2) The LLM incorrectly implies a knowledge graph (KG) pattern 'ABBV → Patent Rights → Market Exclusivity → MRK (negative impact)', which introduces a nonsensical linkage between AbbVie and Merck with a 'negative impact' arrow, suggesting Merck is negatively affected by AbbVie’s strategy — this is factually and logically incorrect. There is no such cross-company causal relationship in the original answer. (3) The qualitative reasoning is flawed: while both companies rely on patent strategies, the LLM fails to contrast AbbVie’s failure (evidenced by the impairment) despite licensing, versus Merck’s success in extending exclusivity through secondary patents. Instead, it suggests Merck experienced 'steep revenue drops' due to patent loss, which is not supported in the ground truth — Merck delayed generic competition until 2026, implying relative strategic success. (4) Contextually, the answer addresses the core theme of patent reliance and market exclusivity, and correctly identifies the $4.5B impairment as a risk signal, making it partially relevant. However, the misrepresentation of Merck’s outcome and the erroneous KG pattern undermine the multi-hop synthesis required. Semantic equivalence is partially achieved on facts but not on conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Holds]-> RISK_FACTOR -[Provides]-> REGULATORY_REQUIREMENT <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1611,
        "completion_tokens": 519,
        "total_tokens": 2130
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does Chevron's investment in the Caspian Pipeline Consortium (CPC) influence its crude oil export capacity, and how does this compare to ConocoPhillips' reliance on crude oil production for its upstream operations?",
      "original_answer": "Chevron's 15% interest in the Caspian Pipeline Consortium (CPC) enables it to export approximately 1.2 million barrels of crude oil per day from Kazakhstan, which is critical for transporting output from the Tengiz and Karachaganak fields. The CPC pipeline's debottlenecking project, completed in January 2023, increased throughput capacity, directly supporting Chevron's Future Growth Project (FGP) expected to ramp up in early 2025. In contrast, ConocoPhillips' upstream operations are fundamentally dependent on crude oil production, as evidenced by its 2023 filings, where crude oil remains a core component of its asset base and revenue generation. Therefore, Chevron's exposure to crude oil export capacity is mediated through its stake in CPC, while ConocoPhillips has a more direct operational dependency on crude oil production.",
      "llm_answer": "\nChevron’s 15 % ownership of the Caspian Pipeline Consortium gives it direct control of a pipeline that moves roughly 1.4 million bbl/d of crude—including the 1.2 million bbl/d from Kazakhstan that underpins the Future Growth Project—while the recent debottlenecking finish is intended to lift CPC’s throughput and thereby expand Chevron’s export capacity for the crude produced at Tengiz, Karachaganak and the upcoming FGP; in contrast, ConocoPhillips’ upstream business is fundamentally dependent on its own crude‑oil production, as shown by the KG relationship “Crude Oil → COP,” meaning its financial results and growth are tied directly to the volume of crude it can produce rather than to external transport infrastructure. Thus, Chevron leverages CPC to boost export capability, whereas ConocoPhillips relies on crude‑oil production to drive its upstream operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is mostly correct in content and reasoning. It accurately identifies Chevron's 15% stake in the CPC, the importance of the pipeline for exporting crude from Kazakhstan, the link to the Future Growth Project (FGP), and the completion of the debottlenecking project. It also correctly contrasts Chevron's infrastructure-based export capacity with ConocoPhillips' direct reliance on crude oil production. However, there is a quantitative inaccuracy: the LLM states the CPC moves 'roughly 1.4 million bbl/d of crude—including the 1.2 million bbl/d from Kazakhstan', while the ground truth specifies that the CPC enables Chevron to export approximately 1.2 million bbl/d from Kazakhstan. The 1.4 million bbl/d figure does not appear in the original answer and appears to be an overstatement or misattribution. 2) The ground truth does not mention a specific total CPC throughput of 1.4 million bbl/d; it only states Chevron’s access supports ~1.2 million bbl/d from Kazakhstan. The debottlenecking project is correctly noted as completed in January 2023 in the original, but the LLM does not specify this date, instead saying 'recent debottlenecking finish', which is vague but not incorrect. 3) The multi-hop reasoning is sound: the model correctly synthesizes Chevron’s ownership stake, its impact on export capacity, the connection to specific fields (Tengiz, Karachaganak), and the FGP timeline, while contrasting with ConocoPhillips’ production-centric model using the KG relationship 'Crude Oil → COP'. This demonstrates strong qualitative understanding. 4) The answer is contextually excellent—directly addressing both parts of the question and providing a clear comparison. The only deduction is for the incorrect throughput number, which affects quantitative accuracy but not the overall correctness of the core argument. Hence, a score of 8 is justified: core facts and reasoning are correct, but with a notable numerical error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Transports]-> RAW_MATERIAL <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 524,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Oracle's integration of generative AI in MySQL HeatWave compare with Qualcomm's strategic vision for on-device generative AI in edge computing, given both companies' investments in cloud computing infrastructure?",
      "original_answer": "Oracle integrates generative AI into its MySQL HeatWave cloud service, combining transactions, real-time analytics, machine learning, and generative AI in one managed service to enhance data processing and decision-making capabilities. Meanwhile, Qualcomm envisions generative AI becoming ubiquitous across industries, with a focus on running complex models on edge devices such as smartphones and PCs to improve immediacy, privacy, and personalization. Qualcomm expects that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024, and sees cloud computing as a complementary enabler of these edge AI capabilities. Both companies are investing in cloud computing—Oracle through its Oracle Cloud Infrastructure (OCI) and Autonomous Database offerings, while Qualcomm supports cloud-edge coordination through its cloud computing processing initiative within its QSI segment.",
      "llm_answer": "\nOracle embeds generative‑AI capabilities directly into MySQL HeatWave as part of a fully managed cloud service on OCI, delivering combined transactional, real‑time analytics and AI workloads with automatic scaling and consumption‑based pricing (Chunk 1). Qualcomm’s roadmap centers on on‑device generative AI for edge computing, leveraging its AI/ML techniques and the company’s “cloud‑computing processing” strategic initiative to support a projected 46 % of smartphones being generative‑AI capable by 2027, with an emphasis on privacy, low latency and contextual use cases (Chunk 2 & Chunk 3). Both strategies converge on the same “Generative AI → Cloud Computing” relationship, where Oracle’s cloud‑native service complements Qualcomm’s edge vision and the shared cloud infrastructure underscores a common dependence on cloud platforms to scale AI workloads (KG triplets: Generative AI complements Cloud Computing, Cloud Computing → QCOM).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Oracle integrates generative AI into MySQL HeatWave on OCI as a managed service combining transactions, analytics, and AI; Qualcomm focuses on on-device generative AI for edge computing with a projection that 46% of smartphones will be generative AI-capable by 2027 (up from 19% in 2024, though the 19% figure is omitted in the LLM answer). The mention of cloud computing as complementary to edge AI and both companies' investments in cloud infrastructure (OCI for Oracle, QSI's cloud-computing processing initiative for Qualcomm) are accurately represented. (2) Quantitative accuracy is perfect: the 46% projection for 2027 is correctly cited. The only minor omission is the 19% baseline for 2024, which slightly reduces completeness but does not affect the core correctness. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across Oracle’s cloud-native AI integration and Qualcomm’s edge AI vision, identifying both divergence in deployment strategy (cloud vs. edge) and convergence on cloud dependence. The reference to 'cloud-edge coordination' and shared reliance on cloud platforms demonstrates strong synthesis. (4) Semantic equivalence is maintained—wording differs but meaning matches. The use of 'KG triplets' adds a technical framing not in the original but doesn't distort facts. Slight deduction in qualitative accuracy due to the missing 2024 baseline, but overall reasoning and contextual relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT -[Complements]-> CONCEPT <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 426,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Walmart's use of firm commitments for inventory and utility purchases compare to Colgate-Palmolive's use of option contracts in managing financial exposure, given the role of such instruments in mitigating cash flow risks?",
      "original_answer": "Walmart has $15.9 billion in firm commitments due within one year, primarily for inventory, utilities, and capital expenditures, which represent legally binding contracts that lock in future cash outflows. These obligations are managed through operational cash flows and are not typically hedged with financial derivatives. In contrast, Colgate-Palmolive actively uses option contracts as part of its foreign exchange risk management strategy to hedge forecasted transactions, protecting against currency fluctuations. Both companies aim to reduce cash flow volatility, but Walmart focuses on operational liquidity planning while Colgate employs financial instruments like options to manage exposure. This distinction reflects differing approaches to financial risk mitigation aligned with their respective business models.",
      "llm_answer": "\nWalmart reduces cash‑flow volatility by locking in inventory and utility purchases through legally binding **firm commitments**—$15.9 bn of such obligations were outstanding as of Jan 31 2025 (Chunk 1)—which fix both quantity and price and thus directly control future cash outlays. Colgate‑Palmolive, by contrast, manages similar exposure with **option contracts** (and related forwards/swaps) that hedge foreign‑currency and commodity risks, deferring gains/losses in AOCI and recognizing them only when the hedged transactions occur (Chunks 2‑3). Both instruments smooth earnings, but Walmart’s firm commitments fix cash payments up front, whereas Colgate’s options provide flexible, mark‑to‑market protection without an immediate purchase obligation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $15.9 billion figure for Walmart's firm commitments is correct, and the date 'Jan 31, 2025' is consistent with Walmart's fiscal year-end (though not explicitly in the original answer, it is contextually valid as a forward-looking reporting date). No calculations were required, and all financial figures match. (2) The answer correctly identifies Walmart’s use of firm commitments for inventory, utilities, and capital expenditures as binding obligations that fix cash outflows, and contrasts this with Colgate-Palmolive’s use of option contracts—specifically for foreign exchange and commodity risk—supported by accurate hedging mechanics (e.g., deferral in AOCI). (3) Multi-hop reasoning is sound: it synthesizes information across two companies and their distinct risk management strategies, correctly contrasting operational vs. financial instrument-based approaches. (4) The only minor shortcoming is the LLM’s omission of the explicit statement that Walmart does not typically hedge these commitments with derivatives (implied but not stated), and slightly stronger emphasis on 'earnings smoothing' over 'cash flow risk' compared to the original focus on cash flow volatility. However, the core concepts are semantically equivalent. Wording differences are acceptable and do not affect factual accuracy. All entities (Walmart, Colgate-Palmolive), instruments (firm commitments, options), and risk management objectives are correctly identified and contrasted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Impacts]-> FIN_INST <-[Utilizes]- ORG",
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 427,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Morgan Stanley's use of credit default swaps (CDS) to hedge default risk relate to Capital One's reliance on default rate assumptions in valuing their net derivative assets, given the sensitivity of both institutions to credit event outcomes?",
      "original_answer": "Morgan Stanley actively uses credit default swaps (CDS) to hedge against the risk of default on debt obligations, entering into contracts where it receives or provides protection against credit events such as bankruptcy or failure to pay. The firm manages exposure through risk mitigation strategies and monitors aggregate market risk limits. Meanwhile, Capital One values its net derivative assets using discounted cash flow models that depend heavily on unobservable inputs, including a weighted average default rate assumption of 4% with a range of 53–163%. The connection between the two lies in the systemic sensitivity both institutions have to default outcomes: Morgan Stanley’s CDS contracts are triggered by defaults, directly affecting its derivative liabilities, while Capital One’s valuation models depend on projected default rates, meaning actual deviations from these assumptions would materially impact the fair value of its derivative assets. Thus, both firms are indirectly exposed to the same macroeconomic or sector-specific credit events that could simultaneously affect their derivative positions.",
      "llm_answer": "\nMorgan Stanley hedges its credit‑event exposure by buying and selling credit‑default swaps, a protection‑against‑default mechanism that directly ties the firm’s risk to the same default factor that drives the valuation of derivative assets. Capital One reports its net‑derivative assets (liabilities) at fair value using discounted‑cash‑flow models whose key unobservable inputs are default‑rate assumptions—ranging from 53 % to 163 % with a weighted average of 4 % (as shown in the 10‑K tables). Because both institutions’ financial results are sensitive to credit‑event outcomes, Morgan Stanley’s CDS positions are linked to the default‑rate inputs that Capital One relies on to value its derivative portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core relationship between Morgan Stanley's use of credit default swaps (CDS) and Capital One's reliance on default rate assumptions in valuing derivative assets. (1) Quantitatively, the key numbers—weighted average default rate of 4% and range of 53% to 163%—are correctly reported, though the phrasing 'ranging from 53% to 163%' may suggest the range applies to the average, which could be misinterpreted; in the original, the 4% is the weighted average while 53–163% is a separate range (possibly of underlying inputs or scenarios), so there is a slight risk of conflation. However, the values themselves are accurate. (2) The answer addresses all parts of the multi-hop question: Morgan Stanley’s CDS hedging strategy, Capital One’s valuation methodology, and the shared sensitivity to credit events. (3) Entities—Morgan Stanley, Capital One, CDS, default rates, derivative assets/liabilities—are correctly identified and contextually used. (4) The reasoning is sound: it correctly links the two institutions through their exposure to default outcomes, noting that Morgan Stanley’s CDS payouts are triggered by actual defaults, while Capital One’s valuations depend on projected default rates, making both sensitive to the same macro credit environment. The synthesis across institutions and financial concepts is appropriate and insightful. Only a minor clarification on the interpretation of the 53–163% range prevents a perfect 10. Wording differences do not affect semantic equivalence, and the answer remains factually aligned with the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Protected_Against]-> RISK_FACTOR -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 438,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How do Duke Energy's natural gas distribution assets in Georgia compare to Southern Company Gas's investment in SNG in terms of capital scale and contribution to regional infrastructure reliability, given their respective exposures to Georgia's energy market?",
      "original_answer": "Duke Energy operates 28,000 miles of natural gas distribution and transmission pipelines in Georgia, directly contributing to local infrastructure reliability by delivering gas to end-users. Southern Company Gas holds a 50% interest in SNG, a 7,000-mile pipeline system that connects supply basins in the Gulf Coast to markets including Georgia, underpinning supply-side reliability. While Duke’s assets are focused on distribution with direct customer delivery, SNG serves as a backbone transmission system feeding regional utilities, including those in Georgia like Duke, creating an integrated infrastructure network. Southern Power’s 97% investment coverage ratio through 2028 indicates strong contracted revenue stability for SNG-related assets, while Duke’s localized pipeline miles reflect a high dependency on regional demand and regulatory frameworks governing distribution rates and returns.",
      "llm_answer": "\nDuke Energy’s Georgia natural‑gas distribution network comprises roughly 35,700 miles of pipelines and 28,800 miles of service lines, reflecting a large capital base that delivers gas directly to end‑users in the state. Southern Company Gas holds a 50 % interest in the 7,000‑mile SNG joint‑venture pipeline—the largest pipeline investment in its portfolio—and together with its 77,900‑mile distribution system and 14 storage facilities it serves about 4.4 million customers across the Southeast, including key markets in Georgia, thereby providing the diverse supply links that underpin regional infrastructure reliability. Consequently, Duke Energy’s exposure is measured by extensive local distribution mileage, whereas Southern Company Gas’s capital commitment to SNG adds system‑wide capacity and resilience for the same Georgia energy market.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, Duke Energy operates 28,000 miles of natural gas pipelines in Georgia. However, the LLM claims Duke has '35,700 miles of pipelines and 28,800 miles of service lines,' which overstates the pipeline mileage and introduces 'service lines'—a detail not in the original and potentially conflating distribution mains with customer connections. This misrepresents the scale of Duke's assets. The 7,000-mile figure for SNG is correct, and Southern Company Gas's 50% interest is accurately reflected. However, the LLM adds unsupported details: '77,900-mile distribution system,' '14 storage facilities,' and '4.4 million customers'—none of which appear in the ground truth and cannot be verified from the provided data. Additionally, the claim that SNG is 'the largest pipeline investment in its portfolio' is an inference not present in the original. 2) The ground truth mentions Southern Power’s 97% investment coverage ratio through 2028 as a key indicator of revenue stability for SNG-related assets, but the LLM omits this entirely, missing a critical financial metric related to capital stability. 3) Qualitatively, the LLM captures the multi-hop concept that Duke focuses on local distribution while SNG provides backbone transmission that supports regional reliability, including feeding utilities like Duke. This synthesis of roles—distribution vs. transmission—is logically sound and correctly frames their complementary functions in Georgia’s energy infrastructure. 4) Contextually, the answer is highly relevant, addressing capital scale and reliability contributions for both companies in Georgia. However, the inclusion of fabricated metrics and incorrect pipeline lengths undermines factual correctness. While the reasoning structure is appropriate, the answer fails on quantitative precision, which is critical in financial and infrastructure comparisons. Minor note: 'Southern Power' is incorrectly used instead of 'Southern Company Gas' in the context of the coverage ratio, further muddying entity accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 564,
        "total_tokens": 2030
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the enactment of Louisiana's corporate tax rate reduction legislation in 2024 impact Union Pacific's deferred tax expense, and how does this compare to the impact from similar legislation in Arkansas during the same year?",
      "original_answer": "Louisiana's enactment of corporate tax rate reduction legislation in 2024 resulted in a $34 million reduction in Union Pacific's deferred tax expense. This mirrors a similar impact from Arkansas, which also enacted tax rate reductions, contributing to a comparable adjustment. Together, these state-level legislative changes reflect a broader regional shift in corporate tax policy affecting Union Pacific's financial position.",
      "llm_answer": "\nUnion Pacific’s 2024 deferred‑tax expense was reduced by $34 million as a direct result of the corporate‑income‑tax‑rate cuts enacted by Louisiana and Arkansas, and because the company operates major yards in Livonia, Louisiana, and North Little Rock, Arkansas (Chunk 3).  The $34 million figure represents the combined impact of the two states’ legislation—Arkansas’s similar 2024 measure contributing to that same reduction—whereas Arkansas alone had generated a $114 million deferred‑tax‑expense benefit in 2023, making the 2024 effect notably smaller (Chunk 2).  This follows the ORG‑Impacted_By‑REGULATORY_REQUIREMENT‑Introduces‑GPE relationship illustrated by legislative changes such as those GE discusses for Poland (Chunk 1), showing how state tax reforms directly affect Union Pacific’s deferred tax position.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that the $34 million reduction is the combined impact of both Louisiana and Arkansas legislation, whereas the ground truth specifies that Louisiana alone caused a $34 million reduction and that Arkansas had a 'comparable' impact—implying a similar magnitude, not a combined total. The LLM also introduces a fact not in the ground truth: that Arkansas generated a $114 million benefit in 2023, which, while possibly true, is irrelevant to the 2024 comparison asked and distorts the relative impact. (2) Quantitative accuracy is low because the core number ($34 million) is misattributed—it is presented as the sum of both states rather than Louisiana's individual impact. The mention of $114 million from Arkansas in 2023 has no support in the ground truth and introduces a false comparison. (3) The multi-hop reasoning is partially sound in linking state tax changes to deferred tax expense and recognizing Union Pacific’s operational presence in both states, but it fails to correctly disentangle the impacts of the two states in 2024. The reference to GE in Poland (Chunk 1) is tangential and does not contribute meaningfully to the reasoning. (4) Contextual relevance is high because the answer addresses the core issue—state tax legislation affecting deferred tax expense—and correctly identifies the relevant states and company. However, due to significant factual misrepresentation of the financial impacts and incorrect synthesis of the numbers, the overall correctness score is low despite relevant framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT -[Introduces]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 429,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does the difference in voting rights between META's Class B Common Stock and GOOGL's Class A Common Stock influence their respective corporate governance structures, particularly in light of the specified voting limitations tied to Class B shares in merger scenarios?",
      "original_answer": "META's Class B Common Stock has no voting rights except in specified merger or consolidation scenarios, where they receive voting power proportional to their conversion rate. This limits shareholder influence outside of exceptional corporate actions. In contrast, GOOGL's Class A Common Stock provides one vote per share, offering more consistent voting influence to shareholders. This structural difference means that at META, decision-making control is more concentrated among holders of shares with superior voting rights (e.g., Class A), while at GOOGL, Class A shareholders have a steadier role in corporate governance. The specified voting limitations in META's charter for Class B shares in merger scenarios create a tailored influence mechanism that only activates under specific corporate events, unlike GOOGL's ongoing voting rights for Class A shares.",
      "llm_answer": "\nMeta’s Class B Common Stock is designed so that, on merger‑related matters, the holders may vote as a single class with a number of votes equal to their shares multiplied by the conversion rate—effectively giving them a super‑majority veto (as stipulated in the voting‑rights language of Chunk 2); this structure is tied to Meta’s Class A Common Stock (Chunk 1) and, through the KG relationship [Class B Common Stock → Class A Common Stock → GOOGL], links the two companies’ equity hierarchies. In contrast, Alphabet’s Class A Common Stock carries only one vote per share, so its shareholders have limited influence unless they also own Class B shares (Chunk 3), meaning that merger approvals at Alphabet depend on broader, less concentrated voting support. Consequently, the differing voting architectures concentrate control in Meta’s Class B holders while Alphabet’s Class A shareholders participate more evenly, shaping each firm’s corporate‑governance and the thresholds required for merger decisions.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and structural inaccuracies despite correct handling of numerical or format-related elements (hence perfect quantitative accuracy). First, it incorrectly states that Meta's Class B Common Stock has voting power in merger scenarios—this is false: according to the ground truth, Meta's Class B shares have *no voting rights* except in specified merger or consolidation events, and even then, their voting power is proportional to their conversion rate, not a super-majority veto. The claim of a 'super-majority veto' is unsupported and misleading. Second, the LLM incorrectly implies that Meta Class B holders have concentrated control—actually, Meta’s Class A shares (held by insiders) have superior voting rights, while Class B shares are non-voting; thus, control is concentrated among Class A holders, not Class B. This reverses the actual governance structure. Third, the answer fabricates a 'KG relationship [Class B Common Stock → Class A Common Stock → GOOGL]' linking Meta and Google’s equity structures, which is nonsensical—there is no structural or governance link between Meta and GOOGL shares. This invalidates the multi-hop reasoning. While the description of GOOGL’s Class A shares having one vote per share is accurate and relevant, the overall synthesis is flawed. The answer also mischaracterizes Alphabet’s merger approval process by suggesting it depends on broader support without acknowledging that Alphabet’s Class B shares (held by founders) have super-voting rights, which the original answer does not require but the LLM should not misrepresent. The reasoning fails on key corporate governance mechanics, especially the direction of control and the role of share classes. Contextual relevance is moderate because it addresses voting rights and governance, but the incorrect linkages and reversed incentives reduce usefulness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 509,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How might U.S. payer restrictions on high-cost therapies like Repatha impact Pfizer's revenue recognition strategy for similar cardiovascular products, given both companies face challenges with formulary placement and patient affordability?",
      "original_answer": "U.S. commercial payer actions have significantly restricted access to high-cost therapies like Repatha through formulary exclusions, prior authorization requirements, and increased patient cost-sharing, which has directly limited sales despite price reductions. Pfizer faces similar risks, as it notes challenges in obtaining or maintaining favorable formulary placement and pricing for its products amid managed care and healthcare cost containment trends. Gilead's revenue recognition strategy accounts for these payer dynamics through complex gross-to-net deductions that factor in expected payer mix, rebate levels, and patient affordability trends. Therefore, if Pfizer markets similar high-cost cardiovascular therapies, it would likely face comparable pressures requiring careful estimation of rebates and chargebacks to align with payer realities and maintain revenue integrity.",
      "llm_answer": "\nPfizer’s 2021 Form 10‑K (Chunk 1) warns that managed‑care cost‑containment and U.S. regulatory pricing pressures can restrict formulary placement and force lower prices for its cardiovascular launches.  This mirrors Amgen’s experience with Repatha, where step‑therapy rules, prior‑authorization requirements and payer consolidation have driven deep rebates and price cuts that limit sales (Chunk 2).  Because revenue is recorded net of estimated government and other rebates and chargebacks, Pfizer must build larger gross‑to‑net reserves and may recognize less upfront revenue on high‑cost products—a practice highlighted by Gilead’s revenue‑recognition methodology (Chunk 3), and the KG relationship shows that payer restrictions (Access Restrictions) negatively impact both Pfizer and GILD (Payers → GILD).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All factual elements are correct: Pfizer's exposure to managed care cost-containment pressures and challenges with formulary placement are accurately cited from its 2021 Form 10-K. The reference to Amgen’s Repatha experience with payer restrictions—such as step-therapy, prior authorization, and rebate-driven price erosion—is consistent with the knowledge graph data. The linkage to Gilead’s revenue recognition strategy, which incorporates gross-to-net deductions based on payer mix and affordability trends, is correctly applied by analogy to Pfizer. (2) There are no numeric values, dates, or calculations in the original question or answer that require verification; the mention of '2021 Form 10-K' is accurate and contextually appropriate, though not explicitly stated in the ground truth—however, this does not introduce error, as the risk factors described are indeed present in that filing. (3) Multi-hop reasoning is sound: the model correctly connects payer restrictions on Repatha → impact on Amgen’s sales → analogous risk for Pfizer → implications for revenue recognition via gross-to-net deductions, using Gilead as an exemplar. The KG relationship (Payers → GILD with Access Restrictions) supports this logic. (4) Semantic equivalence is strong: while the LLM uses slightly more technical phrasing (e.g., 'gross-to-net reserves'), it conveys the same core insight—that payer dynamics force conservative revenue recognition due to rebates and chargebacks. The only minor shortcoming is a slight conflation of Amgen (not mentioned in the original answer) with the broader Repatha payer dynamics, but since Repatha is Amgen’s drug, this is not factually incorrect—just a more specific attribution than the original. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> COMP <-[Pays]- ORG",
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 511,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does Chevron's 15% ownership stake in TCO's Kazakhstan crude oil operations influence its exposure to TCO's planned production ramp-up from the FGP project starting in 2025, especially when compared to COP's broader dependence on crude oil as a raw material?",
      "original_answer": "Chevron's 15% ownership in TCO provides it with partial exposure to TCO's planned production ramp-up from the FGP project in Kazakhstan, which is expected to start-up in the first half of 2025 and ramp up to full production within three months. This production increase will flow through the Caspian Pipeline Consortium (CPC), in which Chevron also holds a 15% interest, enabling increased throughput capacity. In contrast, COP has a direct and full dependency on crude oil as a raw material, indicating a more concentrated exposure to crude oil supply dynamics. Chevron’s partial ownership in TCO creates a more indirect exposure to crude oil production volumes and timelines in Kazakhstan, as opposed to COP’s direct reliance on crude oil for its operations.",
      "llm_answer": "\nChevron’s 15 % interest in the CPC pipeline—already slated for debottlenecking—will carry the extra crude that TCO’s Future Growth Project is expected to bring on‑stream in the first half of 2025 and to ramp up to full production within three months, giving Chevron a direct revenue link to that volume increase; this exposure is embedded in Chevron’s consolidated reserve and production numbers, where TCO appears as an affiliated company (Chunk 3). By contrast, COP’s reliance on crude oil is far broader and indirect—its upstream business treats crude as a raw material across its entire portfolio, so its financial performance is tied to overall crude‑price movements rather than the project‑specific production boost that Chevron captures through its equity and transport stakes.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Chevron's 15% ownership in TCO and the CPC pipeline, the 2025 start date for the FGP project, and the three-month ramp-up to full production—these quantitative details match the ground truth. The mention of CPC debottlenecking is a plausible addition not contradicted by the original. However, the LLM incorrectly states that Chevron has a 15% interest in CPC as a standalone fact without linking it to TCO’s production flow, which weakens the synthesis. More critically, the LLM mischaracterizes COP’s exposure: it claims COP’s reliance on crude oil is 'far broader and indirect' and tied to 'overall crude-price movements', whereas the ground truth states COP has a 'direct and full dependency' on crude oil as a raw material, making its exposure more concentrated, not indirect. This is a significant qualitative error in reasoning and comparison. (2) All numbers—15%, 2025, three-month ramp-up—are accurate and correctly used. No calculation errors. (3) The multi-hop reasoning is partially sound: the model connects Chevron’s equity stake in TCO, the FGP timeline, and its CPC interest, showing how volume increases could benefit Chevron. However, the comparison to COP fails because it inverts the nature of COP’s exposure, undermining the contrast. (4) Correctness score is 7 due to accurate core facts but a key misrepresentation in the comparative analysis. Quantitative accuracy is high (9) as all numbers are correct. Qualitative accuracy is 7 due to sound reasoning on Chevron but flawed logic on COP. Contextual relevance is 9—response stays focused and addresses all parts of the question, albeit with a critical error in interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> RAW_MATERIAL -[Produces]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 464,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How does Goldman Sachs' exposure to hotel-related commercial real estate loans compare to MetLife's investment in real estate funds focused on hotels, given the role of real estate funds in both companies' strategies?",
      "original_answer": "Goldman Sachs has significant credit exposure to commercial real estate loans secured by hotels, as detailed in their 2024 10-K filing, which highlights the importance of this asset class in their lending portfolio. These loans are often channeled through or connected to real estate funds, which are also a key vehicle for investment in hotel assets. MetLife, on the other hand, holds $13.3 billion in real estate investments as of December 31, 2024, including interests in real estate funds that invest in hotel properties. While both companies are exposed to hotel real estate, Goldman Sachs' involvement is primarily through lending, whereas MetLife participates through direct ownership stakes in funds. This distinction reflects different risk profiles and strategic approaches to the hotel sector within the broader commercial real estate market.",
      "llm_answer": "\nGoldman Sachs’ hotel‑related exposure is shown in its commercial‑real‑estate loan book – the 10‑K tables disclose originated loans and lending commitments that are directly or indirectly secured by hotels, and it also purchases such loans (Chunk 1).  \nMetLife, by contrast, does not lend against hotels but invests in real‑estate funds that specifically target hotel assets; these funds are part of its diversified real‑estate portfolio, which held a $13.3 billion carrying value (≈2.9 % of cash and invested assets) and generated sizable unrealized gains, and the funds are non‑redeemable, closed‑end vehicles (Chunks 2 & 3).  \nThus, while both firms use real‑estate funds as a strategic vehicle, Goldman Sachs’ involvement is through direct credit exposure to hotel‑backed loans, whereas MetLife’s is through equity‑style fund investments that own hotels.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: MetLife's $13.3 billion real estate investment is accurately reported, matching the original answer's figure as of December 31, 2024. The percentage (≈2.9%) of total cash and invested assets is an additional detail not in the original but does not contradict it and may be derived from context; no calculation errors are present. (2) The entities—Goldman Sachs, MetLife, hotel-related commercial real estate loans, real estate funds—are correctly identified, and the years (implied 2024 via context) are consistent with the original. (3) The multi-hop reasoning is sound: the model correctly synthesizes that Goldman Sachs has credit exposure via loans (originated and purchased) secured by hotels, often connected to real estate funds, while MetLife invests equity-like through non-redeemable, closed-end real estate funds focused on hotels. This distinction between lending vs. ownership is clearly and correctly articulated. (4) The answer conveys semantic equivalence to the original: both emphasize the strategic use of real estate funds, but with different risk profiles—debt vs. equity exposure. The only minor shortcoming is that the LLM does not explicitly state that real estate funds are a 'key vehicle' in Goldman Sachs' strategy (though it implies it), slightly reducing qualitative completeness. However, the core facts, logic, and strategic contrast are fully preserved. Wording differences are acceptable and do not affect meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 428,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How do the liquidity risk profiles of BA's limited partnership investments compare with UPS's pension fund commitments in real estate, particularly regarding the 10–15 year partnership terms and UPS's $3.3 billion in unfunded obligations?",
      "original_answer": "Both BA and UPS hold investments through limited partnerships, which expose them to long-term liquidity risks due to the structural characteristics of these vehicles. BA invests in limited partnerships that focus on real estate and private assets, with investment durations typically spanning 10–15 years, limiting liquidity until the end of the partnership term. Similarly, UPS has $3.3 billion in unfunded commitments to limited partnerships as of December 31, 2023, with redemption provisions restricted until the end of the fund’s life, also generally 10–15 years from inception. This shared structure implies both companies face limited short-term liquidity and are exposed to market risks over extended periods without the ability to exit early without discounts.",
      "llm_answer": "\nBA’s limited‑partnership holdings are invested through private‑equity and real‑estate LPs that are typically locked up for the fund’s life—often 10 to 15 years—with redemption only at term end, giving them an illiquid profile comparable to UPS’s pension‑fund real‑estate commitments; UPS, however, explicitly reports that as of December 31 2023 it has about **$3.3 billion of unfunded commitments** to those LPs, to be called over the remaining three‑to‑six‑year investment period, which makes the cash‑flow risk of its real‑estate exposure concrete, whereas BA’s exposure is described only qualitatively. Both sets of investments are valued at NAV and are not actively traded, reinforcing their high liquidity risk, but UPS’s $3.3 bn unfunded amount quantifies the future capital‑call burden that will be required to honor the 10‑15‑year partnership terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BA's limited partnership investments are in private equity and real estate with 10–15 year lockups; UPS has $3.3 billion in unfunded commitments as of December 31, 2023, to limited partnerships with similar 10–15 year terms. The dollar amount, date, and timeframes match the original answer exactly. (2) Quantitative accuracy is perfect: $3.3 billion is correctly cited, the date is accurate, and the description of the investment period (three-to-six-year capital call window) is consistent with typical fund dynamics, even if slightly more specific than the original—this does not contradict but adds context. (3) Multi-hop reasoning is sound: the model correctly compares BA’s qualitative illiquidity disclosure with UPS’s quantified unfunded obligation, highlighting a nuanced difference in transparency while affirming structural similarity in liquidity risk. (4) The answer is contextually relevant and comprehensive, addressing both companies, their partnership terms, liquidity constraints, valuation at NAV, and the distinction in disclosure depth. The only minor shortcoming is a slight emphasis on UPS’s capital calls occurring in a 'three-to-six-year' window, which is not explicitly stated in the ground truth—though plausible and reasonable given typical fund life cycles, it introduces a detail not confirmed in the source. This prevents a perfect 10 but does not undermine correctness. Overall, the answer is factually solid, well-reasoned, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 438,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the voting power distribution tied to Class A and Class B common stock at META compare to the voting structure at CMCSA, particularly in terms of control concentration and shareholder influence?",
      "original_answer": "At META, the dual-class structure gives Class B common stockholders, primarily Mark Zuckerberg, outsized control, requiring a majority of Class B shares to approve change-of-control transactions until they represent less than 35% of combined voting power. In contrast, CMCSA's structure grants Class A common stockholders 66 2/3% of the combined voting power, with each Class B share having 15 votes, but Class B stock is non-dilutable and owned entirely by Brian L. Roberts. This means both companies use dual-class structures to concentrate control, but META's governance rules and anti-takeover provisions make it harder for investors to influence corporate decisions compared to CMCSA, where Class A shareholders collectively hold significant voting influence.",
      "llm_answer": "\nMETA’s dual‑class structure gives Class B common stock a **majority of the combined voting power**, so that Mr. Zuckerberg can control board and shareholder matters even when he owns less than a majority of the shares; this concentration is reinforced by the company’s “controlled‑company” status and Delaware anti‑takeover provisions that make the Class A shares less attractive to investors (Chunk 1). In contrast, CMCSA’s voting power is split — Class A holds roughly **66 % of the vote** while Class B, though representing only **33 % of the voting power**, carries **15 votes per share** and is owned entirely by Brian L. Roberts, giving him decisive influence despite the class’s smaller share count (Chunk 2). The financial disclosures show that CMCSA has **≈4 billion Class A shares outstanding versus just 9 million Class B shares**, highlighting how a tiny number of Class B shares can still command a sizable, non‑dilutable voting bloc and illustrating the markedly different share‑count dynamics behind the two companies’ control structures (Chunk 3).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the dual-class structures at both META and CMCSA and accurately captures the core idea of control concentration in both companies. It correctly states that CMCSA's Class A holds approximately 66% of voting power and that Class B has 15 votes per share, owned entirely by Brian L. Roberts. However, there is a critical error in the META description: the original answer specifies that Class B must retain more than 35% of combined voting power for Zuckerberg to maintain control over change-of-control transactions, but the LLM incorrectly claims Class B has a 'majority of the combined voting power'—this overstates the current structure and misses the 35% threshold condition, which is a key governance detail. (2) Quantitatively, the LLM states CMCSA has ≈4 billion Class A shares and 9 million Class B shares—this level of granularity is not in the ground truth and cannot be verified from the provided answer; while plausible, it introduces unconfirmed specifics that risk inaccuracy. The 66% voting power for Class A at CMCSA is correctly stated (matches 66 2/3% approximately), and 15 votes per Class B share is accurate. (3) The multi-hop reasoning is strong: the model synthesizes voting power distribution, control concentration, and shareholder influence across two companies, correctly contrasting META’s stronger anti-takeover protections with CMCSA’s more balanced (though still concentrated) structure. It highlights the non-dilutable nature of CMCSA’s Class B shares and the disproportionate influence from small share counts, showing good qualitative synthesis. (4) The answer is highly contextually relevant, directly addressing the comparison of control concentration and shareholder influence. The correctness score is 8 because the core facts are mostly right, but the misrepresentation of META’s voting threshold and the introduction of unverified share counts prevent a higher score. Quantitative accuracy is 7 due to unsupported numbers (4B/9M shares), qualitative accuracy is 9 due to strong reasoning and correct entity identification, and contextual relevance is 10 as the response fully engages the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 585,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the allocation of PEP's U.S. qualified defined benefit plan assets to government securities compare with the investment profile of COST's short-term holdings in government and agency securities, particularly in terms of risk management and expected return strategy?",
      "original_answer": "PEP's U.S. qualified defined benefit plans allocated $1.812 billion to government securities in 2023 as part of a diversified investment strategy aiming for a 7.4% long-term return, while COST holds short-term investments in government and agency securities primarily for capital preservation with a focus on low volatility and effective maturities of three months to five years. PEP's approach includes active management and use of derivatives to mitigate risk, whereas COST limits exposure to interest rate fluctuations by investing in fixed-rate, short-duration instruments.",
      "llm_answer": "\nPEP’s U.S. qualified defined‑benefit plan invests roughly **$1.8 billion of government securities**—about **15 % of its $11.7 billion U.S. plan assets** (Chunk 2)—within a broadly diversified portfolio that targets a **7.4 % long‑term return** and employs derivatives to hedge interest‑rate and currency risk (Chunk 1).  The knowledge‑graph link **Government Securities → COST** shows that COST, by contrast, holds government and agency securities as **short‑term, cash‑equivalent investments** whose primary goal is **preservation of principal and modest yield**, with a 100‑basis‑point rate move expected to have only an **immaterial impact on fair value** (Chunk 3).  Thus, while both firms use government securities for risk management, PEP embeds them in a long‑term, return‑oriented asset mix, whereas COST treats them as low‑volatility, short‑term holdings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies PEP's $1.8 billion allocation to government securities (rounded from $1.812 billion in the ground truth), which is approximately 15% of its $11.7 billion U.S. plan assets—this aligns with the knowledge graph data and is quantitatively accurate within acceptable rounding. The 7.4% long-term return target for PEP is correctly stated. For COST, the answer accurately reflects that its holdings in government and agency securities are short-term, focused on capital preservation, and have minimal sensitivity to interest rate changes (‘immaterial impact’ from a 100-basis-point move), matching the ground truth’s emphasis on low volatility and short duration. (2) All numbers are correct or acceptably rounded; no calculation errors. The $1.8 billion figure is a valid rounding of $1.812 billion. The percentage (15%) is consistent with $1.8B / $11.7B ≈ 15.38%, so the approximation is reasonable. (3) The multi-hop reasoning is sound: the model correctly synthesizes PEP’s long-term, return-oriented strategy involving active management and derivatives (from Chunk 1) with COST’s short-term, risk-averse approach (from Chunk 3), drawing a clear contrast in risk management and return objectives. It correctly infers that both use government securities for risk mitigation but in fundamentally different strategic contexts. (4) The answer is contextually excellent, directly addressing the comparison in risk management and expected return strategy as asked. The only minor shortcoming is the omission of explicit mention of ‘effective maturities of three months to five years’ for COST and slightly less emphasis on PEP’s active management beyond derivatives, but these are secondary details. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Contains]-> FIN_INST <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 501,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Southern Company's actual allocation to mortgage-backed securities within its fixed income portfolio compare to NextEra Energy's target allocation framework for fixed income investments, given that both classify mortgage-backed securities under fixed income assets?",
      "original_answer": "Southern Company had only $9 million allocated to mortgage-backed securities as part of its $6,154 million in fixed income investments measured using significant other observable inputs (Level 2), representing less than 0.15% of its fixed income portfolio. In contrast, NextEra Energy's pension plan targets 32% allocation to fixed income investments as part of its broader pension asset strategy, which explicitly includes mortgage-backed securities under its fixed income classification. Both companies classify mortgage-backed securities under fixed income investments, with Southern Company valuing them at yields on comparable securities and NextEra Energy utilizing a combination of directly held securities and commingled investment arrangements.",
      "llm_answer": "\nSouthern Company’s 2022 filing shows that its fixed‑income portfolio actually holds **$9 million** of mortgage‑and asset‑backed securities (Chunk 1), which is a very small slice of the overall fixed‑income allocation (target = 23 % of total assets). Both Southern Company and NextEra Energy classify mortgage‑backed securities under “Fixed Income Investments” (Chunk 2), and NextEra’s pension plan explicitly targets **32 % of assets for fixed‑income** as part of its strategic allocation framework (Chunk 3), even though it does not break out a separate target for MBS. Thus, while Southern Company’s current MBS holding is modest within its fixed‑income mix, NextEra Energy’s approach earmarks a much larger portion of the portfolio for fixed income, with MBS included as part of that 32 % target.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Southern Company's $9 million allocation to mortgage-backed securities and NextEra Energy's 32% target allocation to fixed income, both of which match the ground truth. It accurately notes that both companies classify mortgage-backed securities under fixed income. However, the LLM introduces a detail not present in the original answer — Southern Company's fixed income target of 23% of total assets — which, while possibly true, is not part of the comparison asked and distracts from the core focus on MBS allocation within fixed income. The ground truth emphasizes that Southern's $9M is less than 0.15% of its $6,154M Level 2 fixed income portfolio, a key quantitative insight the LLM omits, weakening the precision of the comparison. (2) Quantitatively, the $9M and 32% figures are correct and properly contextualized. The LLM does not reproduce the $6,154M portfolio size or calculate the ~0.15% proportion, which is a minor but notable omission affecting completeness. No incorrect calculations are made. (3) The multi-hop reasoning is largely sound: the model correctly synthesizes Southern's actual MBS holdings with NextEra's target framework and aligns the classification of MBS under fixed income. However, it fails to fully contrast 'actual allocation to MBS' (Southern) vs. 'target allocation to fixed income including MBS' (NextEra) with the necessary precision, instead blending portfolio-level targets that dilute the specific MBS comparison. (4) Scores reflect high accuracy in numbers and relevance, with slight deduction in correctness and qualitative reasoning due to missing the percentage-of-portfolio calculation and introducing extraneous target data. Semantic equivalence is mostly preserved, but the absence of the <0.15% metric reduces completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Includes]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 494,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What specific pricing agreements and supply arrangements did Tesla and Panasonic Corporation formalize in their Gigafactory partnership, and how does GM’s dependency on batteries compare in terms of supplier integration and contractual depth?",
      "original_answer": "Tesla and Panasonic Corporation formalized multiple pricing agreements and supply arrangements under their Gigafactory partnership, including the Amended and Restated General Terms and Conditions for Gigafactory (June 10, 2020), the 2020 Pricing Agreement (Gigafactory 2170 Cells), and the 2021 Pricing Agreement (Japan Cells). These agreements establish detailed pricing mechanisms, production responsibilities, and shared facility leasing arrangements. In contrast, GM’s dependency on batteries is noted without equivalent supplier integration details or specific contractual commitments in the evidence provided, indicating a less transparent or structured supplier partnership compared to Tesla’s explicit agreements with Panasonic.",
      "llm_answer": "\nTesla and Panasonic formalized a suite of long‑term contracts that began with the 2011 Supply Agreement and its 2013/2014 amendments, the 2014 Production Pricing Agreement, the 2019 “Japan Cells” and 2020 “Gigafactory 2170” pricing agreements, the 2021 Japan‑cell pricing agreement, and the 2020 Amended and Restated General Terms (all listed in Chunk 2/Chunk 3 exhibits), which together set cell prices, volume discounts and factory‑lease conditions for the Gigafactory.  \nIn contrast, GM’s 2023 10‑K filing (Chunk 1) shows that its battery supply relies on multiple external vendors with short‑term, non‑exclusive purchase arrangements and no comparable multi‑year pricing or lease integration.  \nThus, while GM’s dependency is transactional and fragmented, Tesla‑Panasonic’s partnership is vertically integrated, featuring deep contractual depth through joint factory leases, shared investment and recurring pricing revisions that lock in supply and cost.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the key agreements between Tesla and Panasonic, including the 2020 Amended and Restated General Terms, the 2020 Pricing Agreement for Gigafactory 2170 Cells, and the 2021 Pricing Agreement for Japan Cells—matching the original answer's cited documents. While the LLM adds earlier agreements (e.g., 2011 Supply Agreement, 2014 Production Pricing Agreement), these are not contradicted by the ground truth and may provide additional context without introducing error. (2) All dates and agreement titles are factually consistent with the evidence; no numeric or date inaccuracies are present, earning a perfect quantitative accuracy score. (3) The reasoning is sound: the LLM correctly contrasts Tesla’s deep, structured, long-term integration with Panasonic against GM’s reliance on short-term, non-exclusive arrangements, as supported by the 2023 10-K filing. The characterization of GM’s approach as 'transactional and fragmented' is a valid inference from the lack of detailed contractual commitments. (4) The answer fully addresses both parts of the multi-hop question—detailing Tesla-Panasonic agreements and comparing GM’s supplier integration—demonstrating strong synthesis across sources. The only minor deduction is for slightly overstating the scope of agreements by referencing earlier contracts not emphasized in the ground truth, but this does not undermine factual correctness. Overall, the answer is semantically equivalent and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT -[Supplies]-> COMP <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 428,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Chevron's ongoing tax audit exposure in Nigeria compare to Exxon's production-sharing contract risk in the same country, given the specific terms of Nigeria's PSCs and Chevron's unresolved tax positions?",
      "original_answer": "Chevron faces unresolved tax audits in Nigeria with $5,288 million in unrecognized tax benefits at year-end 2021, where the latest audit finalized was for the year 2007, leaving over a decade of tax exposure open to scrutiny. Meanwhile, Exxon operates in Nigeria under production-sharing contracts (PSCs) that typically last 30 years, with a 10-year exploration period followed by a 20-year production period, which may be extended subject to relinquishment provisions. Exxon also reports that 12% of its total proved reserves in 2021 were under PSC arrangements, where production volumes fluctuate inversely with price changes. Therefore, while Chevron's risk in Nigeria is tied to legacy tax liabilities and regulatory uncertainty, Exxon's exposure is more operational and tied to the fiscal terms and duration of its PSCs, which are sensitive to commodity price volatility.",
      "llm_answer": "\nChevron’s tax‑audit exposure in Nigeria revolves around $5.288 bn of unrecognized tax benefits—about 82 % of which would affect its effective tax rate—while the company’s tax positions there remain under audit (the latest finalized examinations date to 2007) and the outcome is highly uncertain, with no estimate of possible adjustments. By contrast, Exxon’s risk stems from operating under Nigeria’s 30‑year production‑sharing contracts that include a 10‑year exploration phase, mandatory partial relinquishment of acreage at the end of exploration, conversion from OPL to OML, and the 2021 Petroleum Industry Act; moreover, roughly 12 % of Exxon’s proved reserves are tied to such PSCs, so reserve and cash‑flow values move inversely with oil‑price changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in phrasing and emphasis. (1) All key facts are correct: Chevron's $5.288 billion in unrecognized tax benefits (equivalent to $5,288 million) as of year-end 2021, the latest finalized audit being for 2007, and the high uncertainty around outcomes are accurately reported. Exxon's 30-year PSC structure (10-year exploration + 20-year production), mandatory relinquishment, OPL to OML conversion, and reference to the 2021 Petroleum Industry Act are correctly included. The 12% of proved reserves under PSCs is accurately cited. (2) Quantitatively, all numbers match: $5.288 billion = $5,288 million, 12% reserves, and correct year references (2021). The LLM adds that 82% of Chevron’s unrecognized tax benefits would affect the effective tax rate—a detail not in the original answer but plausibly derived from SEC filings and not contradictory. (3) Multi-hop reasoning is sound: the model correctly distinguishes Chevron’s tax-related regulatory risk from Exxon’s operational and price-sensitive PSC risk, synthesizing across two companies, two types of exposure, and Nigerian fiscal frameworks. (4) The only minor shortcoming is that the original answer explicitly contrasts the nature of the risks (legacy tax vs. operational/fiscal), while the LLM implies it but could make the comparison slightly more explicit. However, the semantic meaning and factual content are equivalent. No factual errors; excellent contextual relevance and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Subject_To]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 428,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does Tesla's use of commercial paper compare to companies with significant operations in Ohio, such as Duke Energy Ohio?",
      "original_answer": "Tesla reported $470 million in commercial paper holdings as of December 31, 2023, as part of its short-term investment strategy. In contrast, Duke Energy Ohio, a major company operating in the state, had $25 million in commercial paper outstanding as disclosed in its financial details. This comparison highlights different approaches to short-term financing and liquidity management between Tesla, a technology and automotive company, and Duke Energy Ohio, a utility provider.",
      "llm_answer": "\nTesla’s commercial‑paper position dwarfs that of a major Ohio‑based utility: the 2023 Tesla 10‑K shows $470 million of commercial paper, while Duke Energy Ohio (a utility with a significant Ohio footprint) disclosed only $25 million of commercial paper in the same year. This contrast is underscored by the operational data in the LOW filing, which lists “Ohio | 84” – indicating a substantial Ohio presence for the organization linked to both companies via the disclosed commercial‑paper instrument. Consequently, while both firms use commercial paper as a financing tool, Tesla’s issuance is far larger than that of Duke Energy Ohio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports Tesla's $470 million and Duke Energy Ohio's $25 million commercial paper amounts as of 2023, matching the ground truth in both value and year. These figures are accurately cited and reflect the correct entities and time frame. (2) All numeric values are correct and properly formatted; $470 million and $25 million are consistent with the original answer. No calculations were required beyond comparison, and the qualitative assertion that Tesla's amount 'dwarfs' or is 'far larger' is supported by the data. (3) The multi-hop reasoning is mostly sound—comparing Tesla’s commercial paper usage to Duke Energy Ohio’s based on their respective filings. However, the mention of 'LOW filing' and 'Ohio | 84' introduces an irrelevant and unverified data point not present in the original answer or question context, which slightly undermines the reasoning clarity. This appears to be an erroneous reference (possibly confusing Duke Energy with another entity) and is not substantiated in the ground truth. (4) Despite this minor flaw in reasoning, the core comparison is accurate, complete, and contextually appropriate. The answer effectively conveys the contrast in commercial paper usage between a tech/auto firm and a utility, as required. Thus, full credit is given for quantitative and contextual accuracy, with a slight deduction in qualitative accuracy due to the extraneous LOW reference, but not enough to affect the overall correctness score significantly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 415,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does JPMorgan's exposure to transition risk, as outlined in its climate risk management framework, influence its compliance risk profile compared to Morgan Stanley's experience with regulatory scrutiny tied to climate-related disclosures?",
      "original_answer": "JPMorgan acknowledges transition risk as a key component of climate risk, which may amplify compliance risk due to increased regulatory scrutiny tied to climate-related disclosures. JPMorgan has established a Climate Risk Management function that integrates climate risk into its broader risk management framework, including developing metrics and stress testing mechanisms to assess potential financial impacts. According to Morgan Stanley’s disclosures, compliance risk includes exposure to legal sanctions or reputational damage from failure to meet climate-related regulatory requirements, such as increased disclosure mandates or carbon taxes. Furthermore, Morgan Stanley notes that transition risk can lead to reputational, compliance, and litigation risks due to heightened legal and regulatory scrutiny. Therefore, both firms recognize that transition risk directly influences compliance risk, but JPMorgan emphasizes proactive integration into risk frameworks, whereas Morgan Stanley highlights the regulatory enforcement dimension.",
      "llm_answer": "\nJPMorgan’s climate‑risk management framework explicitly treats transition risk as a driver that feeds into its compliance‑risk exposure—consistent with the KG link **Transition Risk → Compliance Risk → Morgan Stanley** (Chunk 1) and reinforced by its governance structure that requires Board‑level oversight of climate‑related policies (Chunk 3).  In contrast, Morgan Stanley has already faced heightened regulatory scrutiny and the prospect of enforcement actions over its climate‑related disclosures (Chunk 2), showing that while both firms see climate risk affect their compliance posture, JPMorgan’s exposure is embedded in its risk‑management architecture, whereas Morgan Stanley’s is reflected in actual regulatory penalties.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable—scored as 10 by default. (2) The LLM correctly identifies that JPMorgan integrates transition risk into its compliance risk via its climate risk management framework and Board-level governance, which matches the ground truth's emphasis on proactive integration into risk frameworks. It also correctly contrasts this with Morgan Stanley’s experience of actual or anticipated regulatory scrutiny and enforcement actions related to climate disclosures, reflecting the ground truth’s point about regulatory enforcement and reputational/legal risks. (3) The multi-hop reasoning is sound: the model synthesizes information across entities (JPMorgan vs. Morgan Stanley), risk types (transition → compliance), and governance vs. enforcement dimensions. The reference to 'Chunk 1', 'Chunk 2', etc., suggests proper grounding in source material, though such internal references are stylistic and not required for correctness. (4) Minor deduction in qualitative accuracy (9 instead of 10) because the LLM implies Morgan Stanley has already faced penalties ('actual regulatory penalties'), while the ground truth states it faces 'prospect of enforcement actions' and 'reputational, compliance, and litigation risks'—indicating risk, not confirmed penalties. This overstatement slightly misrepresents the severity of Morgan Stanley’s current situation. Otherwise, the semantic meaning, structure, and comparative insight are equivalent to the original. Contextual relevance is perfect—directly addresses the comparative influence of transition risk on compliance risk.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR -[Negatively_Impacts]-> RISK_FACTOR <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 475,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What implications does Nigeria's 30-year production-sharing contract framework have for both ConocoPhillips' deepwater operations and Chevron's reserve accounting practices in the region?",
      "original_answer": "Nigeria's regulatory framework for deepwater offshore exploration establishes 30-year production-sharing contracts (PSCs) that include a 10-year exploration period followed by a 20-year production period, which may be extended under certain conditions. Since ConocoPhillips operates in Nigeria, this structure directly influences its long-term planning and investment decisions in the region. Chevron, which reports that 8-10% of its reserves are tied to PSCs like those in Nigeria, must align its reserve accounting and production forecasts with the specific terms of these contracts, including the partial relinquishment provisions under Nigeria's Petroleum Industry Act. Both companies must therefore manage exploration timelines, commercial discovery requirements, and reserve disclosures in accordance with this regulatory framework.",
      "llm_answer": "\nNigeria’s standard 30‑year production‑sharing contracts—under which ConocoPhillips (COP) receives a 10‑year OPL for deepwater blocks, must relinquish roughly half the acreage at the end of that exploration phase, and then produces from an OML for up to 20 years (extendable only under the 2021 Petroleum Industry Act)—force the company to structure its deepwater capital budgeting and risk exposure around a fixed exploration window and a production horizon that can be prolonged only by regulatory extensions. Because the same contract regime applies to Chevron (CVX), its reserve accounting must treat the PSC‑related reserves (which represent about 8‑10 % of its consolidated reserves, as disclosed in its 2021 filing) as part of the 30‑year term, meaning that reserve estimates are contingent on the contract’s exploration period, mandatory relinquishments, and possible extensions, directly tying CVX’s reserve reporting to Nigeria’s 30‑year PSC framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Nigeria's 30-year PSCs with a 10-year exploration period and 20-year production period (extendable under the 2021 Petroleum Industry Act), ConocoPhillips' operational planning under this framework, and Chevron's disclosure that 8-10% of its reserves are tied to such PSCs. The mention of OPL (Oil Prospecting License) and OML (Oil Mining Lease) adds technical precision not in the original but consistent with Nigerian regulatory practice. (2) Quantitative accuracy is perfect: the 10-year exploration, 20-year production, and 8-10% reserve percentage match the ground truth exactly. The reference to Chevron's 2021 filing is a plausible source year and does not contradict known disclosures. (3) Multi-hop reasoning is sound: the answer correctly links Nigeria's PSC structure to ConocoPhillips' capital planning and Chevron's reserve accounting, synthesizing regulatory terms with corporate implications. (4) The only minor shortcoming is the introduction of 'relinquish roughly half the acreage'—while consistent with Nigeria's PSCs, this specific figure is not in the ground truth and slightly exceeds it without confirmation. However, this is a reasonable inference and does not undermine correctness. Overall, the answer is semantically equivalent, contextually precise, and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Subject_To]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 387,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does Boeing's exposure to U.S. government contract modifications influence its application of ASU 2022-06, and how does this compare to FedEx's use of the same standard in managing reference rate reform impacts on their contracts?",
      "original_answer": "Boeing faces significant risk from U.S. government contract modifications, which could impact 37% of its revenues earned under government contracts. While Boeing must apply accounting standards like ASU 2022-06, which extends relief for contract modifications related to reference rate reform (e.g., LIBOR), the evidence shows Boeing did not experience material impacts from such modifications. Similarly, FedEx, though not directly exposed to government contract risk like Boeing, also applies ASU 2022-06 to manage contract modifications related to reference rate reform, with no material effect on its financial condition or results of operations as of May 31, 2024. Both companies benefit from the extended sunset date of ASU 2022-06 through 2024, easing the burden of contract adjustments.",
      "llm_answer": "\nBoeing’s ≈ 37 % of 2023 revenue that comes from U.S. government contracts makes its earnings highly sensitive to contract modifications—these can be issued on short notice, curtail funding, or terminate programs, potentially triggering funding cuts, withheld payments or cost‑reimbursement adjustments. Because the KG links **BA → Contract Modifications → ASU 2022‑06**, Boeing must evaluate each government‑contract change to see whether it qualifies for the optional expedients in ASU 2022‑06 (e.g., relief from re‑measuring financing components when a reference rate shifts), and must reflect any resulting impacts on revenue recognition, receivable valuation and cash‑flow presentation. In contrast, **FDX** explicitly applies ASU 2022‑06 to contracts that replace LIBOR or other reference rates, using the standard’s expedients to defer or simplify hedge‑accounting and discounting; FedEx has stated that, as of May 2024, this application has produced no material effect on its consolidated financial statements. Thus, while Boeing’s exposure drives a risk‑focused assessment of ASU 2022‑06 in the context of government‑contract modifications, FedEx uses the same standard proactively to mitigate reference‑rate reform effects in its own financing contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 37% figure for Boeing's revenue exposure to U.S. government contracts is correct, and the May 2024 date for FedEx's assessment is accurately cited. No calculations were required, and all numeric references are factually consistent with the original answer. (2) The LLM correctly identifies both companies (Boeing/BA and FedEx/FDX), the relevant accounting standard (ASU 2022-06), and its purpose—providing relief for contract modifications due to reference rate reform (e.g., LIBOR transition). (3) The multi-hop reasoning is sound: it distinguishes Boeing’s context (government contract modifications as a risk factor) from FedEx’s (proactive management of reference rate reform in financing contracts), while correctly noting that both apply ASU 2022-06 and report no material impact. The LLM adds contextual detail—such as effects on revenue recognition and receivables for Boeing, and hedge accounting for FedEx—that enriches the answer without deviating from the truth. (4) The only minor gap is that the original answer explicitly mentions the 'extended sunset date through 2024' as a shared benefit, which the LLM implies but does not directly state. However, this omission does not undermine the core correctness. Overall, the answer is semantically equivalent, factually precise, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 390,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does ExxonMobil's offshore acreage in Angola compare to Chevron's stake in Angola LNG, given Chevron's reported upstream earnings contributions from that asset in 2021?",
      "original_answer": "ExxonMobil held 2.9 million net offshore acres in Angola at year-end 2021, while Chevron reported a stake in Angola LNG, which contributed to upstream-related earnings improvements in 2021 due to higher performance from equity affiliates like Angola LNG. Chevron's volumes in Angola reflect its share of production through affiliates, including Angola LNG.",
      "llm_answer": "\nExxonMobil’s net offshore acreage in Angola was 1.8 million acres at year‑end 2021 (Chunk 1). Chevron’s equity stake in Angola LNG drove a noticeable rise in its 2021 upstream earnings, as the company cited “higher upstream‑related earnings from Angola LNG” among the factors that improved its equity‑affiliate income (Chunk 2). The same Angola LNG asset is also referenced in Chevron’s production‑volume discussion, confirming that its stake contributed measurable upstream earnings from that asset in 2021 (Chunk 3).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the quantitative value for ExxonMobil's offshore acreage in Angola. The ground truth states 2.9 million net offshore acres, but the LLM reports 1.8 million, which is significantly incorrect. All other numerical references (e.g., 2021 upstream earnings) are contextually accurate. (2) The Chevron-related financial contribution from Angola LNG is correctly described as a driver of upstream earnings improvements in 2021, and the reference to equity affiliates and production volumes aligns with the original answer. However, the core comparison between ExxonMobil’s acreage and Chevron’s stake fails due to the incorrect acreage number. (3) The multi-hop reasoning is partially sound—the model correctly identifies that Chevron’s stake in Angola LNG contributed to upstream earnings and that this was reported in 2021. It also correctly distinguishes between physical assets (acreage) and financial stakes. However, the synthesis is undermined by the incorrect ExxonMobil figure. (4) Contextual relevance is high because the answer addresses both companies, the correct asset (Angola LNG), and the correct year and earnings impact. The qualitative reasoning is reasonable but based on flawed data. Quantitative accuracy is low due to the major discrepancy in acreage (1.8M vs 2.9M). Correctness score reflects partial credit for accurate narrative structure and entity identification but major deduction for factual inaccuracy in a key metric.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 416,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Accenture's $6.6 billion investment in 46 strategic acquisitions in fiscal 2024, focused on scaling industry solutions, compare to Microsoft's revenue from enterprise and partner services—which includes industry solutions—in the same period?",
      "original_answer": "Accenture invested $6.6 billion across 46 strategic acquisitions in fiscal 2024 to scale its industry solutions, while Microsoft reported $7.594 billion in revenue from 'Enterprise and partner services'—a category that includes 'Industry Solutions'—during the same fiscal year. This indicates that while Accenture is heavily investing in expanding its industry-specific offerings through acquisitions, Microsoft is generating substantial revenue from its own industry solutions and enterprise services, suggesting differing strategic approaches to growth in the enterprise technology space.",
      "llm_answer": "\nAccenture deployed **$6.6 billion** across **46 strategic acquisitions** in fiscal 2024 to **scale its industry‑specific solutions**, a move that aligns with its 360°‑value strategy and AI‑driven reinvention focus (Chunk 1).  That investment is **just shy of the $7.594 billion** Microsoft reported for **enterprise and partner services**—the segment that includes its industry solutions—during the same period (Chunk 3), illustrating that Microsoft’s revenue from those services is **larger than Accenture’s acquisition spend** (Chunk 2).  The knowledge‑graph link — ACN → Industry Solutions → Enterprise and partner services → MSFT—shows how both companies are channeling resources into the same category of industry‑focused offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states Accenture's $6.6 billion investment in 46 strategic acquisitions in fiscal 2024 and Microsoft's $7.594 billion in 'Enterprise and partner services' revenue for the same period. All numeric values match the ground truth exactly, with acceptable formatting (e.g., $6.6 billion, $7.594 billion). (2) Quantitative accuracy is perfect: both figures are correctly cited, and the comparison that Microsoft's revenue exceeds Accenture's investment is accurate and logically sound. There are no calculation errors. (3) The multi-hop reasoning is strong—correctly linking Accenture’s acquisition strategy to Microsoft’s revenue stream in the same domain (industry solutions) and drawing a valid cross-company comparison. The mention of the knowledge-graph link adds analytical depth, though slightly speculative in phrasing ('shows how both companies are channeling resources'), but does not misrepresent facts. (4) The answer is contextually fully relevant, addressing the core comparison asked. The only minor shortcoming is slight overreach in interpreting strategic alignment via the knowledge-graph link, but this does not detract from factual correctness. Hence, a high score of 9 is warranted—excellent accuracy with near-perfect reasoning and no factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT -[Includes]-> PRODUCT <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 365,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How might Duke Energy's experience with maintaining a 30% equity threshold under FERC-approved dividend policies inform Southern Company's financial planning for its 50% cost share in the $3 billion SNG pipeline project requiring similar FERC approval?",
      "original_answer": "Duke Energy Ohio was required to maintain equity, adjusted to remove push-down accounting impacts, at no less than 30% of total capital as part of FERC and PUCO approval for dividend policies. Southern Company Gas has a 50% cost share in a $3 billion pipeline project through its stake in SNG, which also requires FERC approval. Given this regulatory overlap, Southern Company may reference Duke Energy's equity management strategies to structure its capital allocation and ensure compliance with potential FERC equity requirements for the SNG pipeline project.",
      "llm_answer": "\nDuke Energy’s FERC‑approved dividend regime makes clear that regulators will only permit dividend or distribution payments from a regulated entity once its equity—adjusted for any push‑down accounting impacts—remains at least 30 % of total capital (35 % in Kentucky) and is funded solely from retained earnings.  Because Southern Company must secure FERC approval for its 50 % ($1.5 billion) share of the $3 billion SNG pipeline and, as shown in the SNG note, its equity‑method earnings from the venture are already material ($146 million in 2024), Southern can mirror Duke’s playbook by structuring the pipeline financing and future cash‑flow tests so that the SNG joint‑venture maintains an equity cushion above the 30 % threshold, limiting any payouts to retained earnings and thereby preserving the regulatory‑friendly equity ratio needed for dividend approval.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Duke Energy's 30% equity threshold (with a note on 35% in Kentucky, which is contextually accurate though not in the original answer), Southern Company's 50% cost share of the $3 billion SNG pipeline ($1.5 billion), and the $146 million equity-method earnings in 2024 are all factually consistent with the knowledge graph. These figures are either explicitly stated or correctly derived. (2) The answer is complete, addressing both Duke Energy’s regulatory precedent and how Southern Company might apply similar equity management strategies to its SNG project. It correctly identifies the need for FERC approval and the importance of maintaining an equity cushion above 30%. (3) Entity accuracy is strong: Duke Energy Ohio, Southern Company Gas, SNG pipeline, FERC, and PUCO are correctly referenced in context. The use of 'Southern Company' instead of 'Southern Company Gas' in parts is minor and acceptable given the parent-subsidiary relationship. (4) The reasoning is sound and reflects valid multi-hop synthesis: it connects Duke’s dividend policy conditions to Southern’s capital planning for a similarly regulated project, inferring that maintaining equity via retained earnings and structuring financing around regulatory thresholds would be prudent. The only minor shortcoming is the introduction of Kentucky’s 35% threshold, which, while potentially accurate, is not in the original knowledge and slightly extends beyond the provided context. However, this does not detract significantly from correctness. Overall, the answer conveys semantic equivalence with enhanced practical insight, making it slightly more detailed than the original without introducing material error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Subject_To]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 487,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the use of matrix pricing for corporate debt instruments differ between UPS's fair value hierarchy disclosures and MMM's valuation methodologies, given that both companies rely on this pricing technique when broker quotes are unavailable?",
      "original_answer": "UPS categorizes its corporate debt instruments under Level 2 inputs in the fair value hierarchy and utilizes matrix pricing when broker quotes are not available, as seen in its 2022 disclosures. Similarly, MMM also applies matrix pricing for corporate debt instruments when broker quotes are unavailable, valuing them based on yields from comparable securities or discounted cash flow models. Both companies depend on matrix pricing as a fallback method for valuing these instruments, though MMM specifically notes adjustments for non-observable risks like credit and liquidity, unlike UPS, which does not mention such adjustments. This reveals a nuanced difference in how each company applies matrix pricing depending on the complexity of risk factors considered.",
      "llm_answer": "\nUPS classifies corporate‑debt instruments as Level 2 fair‑value measurements and discloses that, when broker quotes are unavailable, they are valued using matrix pricing together with observable inputs such as yield curves (Chunk 1). In contrast, MMM also relies on matrix pricing for corporate debt in the absence of broker quotes, but its methodology adds risk‑adjustments—credit and liquidity risk modifications and, where needed, discounted‑cash‑flow modeling—and explicitly notes that no Level 3 assets are present (Chunks 2 & 3). Thus, while both companies use matrix pricing as a fallback, UPS reports it within a Level 2 hierarchy, whereas MMM applies additional valuation adjustments and confirms the absence of Level 3 measurements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: UPS uses matrix pricing for corporate debt under Level 2 when broker quotes are unavailable, and MMM does the same but adds adjustments for credit and liquidity risks, sometimes using discounted cash flow models. The LLM correctly notes that MMM explicitly confirms no Level 3 assets, which is consistent with its disclosures. (2) There are no numeric values, dates, or calculations in the question or answer that require verification—both companies' methodologies are described without specific figures, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model synthesizes information across UPS and MMM, comparing their use of matrix pricing and highlighting the key difference—MMM’s inclusion of risk adjustments while UPS does not mention them. The LLM slightly enhances the original answer by noting MMM's statement about no Level 3 assets, which adds context without contradicting the ground truth. (4) Semantic equivalence is maintained; the LLM conveys the same core insight: both use matrix pricing as a fallback, but MMM applies more nuanced adjustments. The only minor shortcoming is that the original answer emphasizes UPS’s lack of mention on non-observable risk adjustments, while the LLM frames it more generally as 'risk-adjustments'—a slight difference in emphasis but not in substance. Hence, a score of 9 is appropriate, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 425,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the $2.8 billion upfront payment from Vertical Bridge REIT, LLC to VZ in 2024 compare to T's prior tower transaction with Crown Castle in 2013, particularly in terms of the financing structure and the retained operational control over the towers?",
      "original_answer": "The $2.8 billion upfront payment from Vertical Bridge to VZ in 2024 was primarily recorded as prepaid rent ($2.0 billion) and a financing obligation ($830 million), reflecting the retained operational control and right-of-use for a portion of the towers. In contrast, T's 2013 transaction with Crown Castle resulted in a $4.827 billion cash payment, which was fully accounted for as a financing obligation, with T retaining control and continuing to depreciate the tower assets ($608 million at the end of 2024). Both companies maintained ownership on their balance sheets and depreciated the assets, but VZ's arrangement included a dual treatment of prepaid rent and financing, while T's was entirely structured as a financing obligation with interest at approximately 3.9%.",
      "llm_answer": "\nThe $2.8 billion upfront payment that Vertical Bridge REIT paid to Verizon in 2024 is recorded as $2.0 billion of prepaid rent and a $830 million financing obligation, mirroring the 2013 Crown Castle transaction in which Verizon received $4.827 billion cash but accounted for it as a financing obligation (interest ~3.9 %) rather than a sale; in both deals Verizon kept the towers on its balance sheet, continued to depreciate them (e.g., $39 million of depreciation expense in 2024), remained the primary obligor for the underlying ground leases, and granted the counter‑party exclusive rights to lease and operate the sites while retaining ownership and a purchase option (the 2024 deal includes an option to acquire the towers at the end of the ~30‑year term, just as Crown Castle has fixed‑price purchase options totaling ~$4.2 billion).  \n\nHowever, the 2024 structure differs in that Verizon only subleases a portion of the tower capacity back to Vertical Bridge and therefore retains operational control only over the segment it continues to use, whereas in the 2013 transaction Verizon also subleased space to Crown Castle but kept full ownership and the right to operate the towers itself, still holding the primary lease‑payment obligation and the fixed‑price purchase rights.  This parallel financing treatment and retained asset control links the two transactions through the KG pattern ORG → Transacts_With → COMP → Obtains → ACCOUNTING_POLICY ← Gains ← ORG.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the right conceptual framework and attempting multi-hop synthesis. (1) Quantitative inaccuracies: The LLM incorrectly attributes the $4.827 billion transaction to Verizon (VZ), when in fact it was T-Mobile (T) that conducted the 2013 transaction with Crown Castle — a critical entity error. Additionally, the LLM states Verizon recorded $39 million in depreciation expense in 2024, but the ground truth specifies T-Mobile’s depreciation-related asset value as $608 million at the end of 2024 (not $39M expense). The $39 million figure appears fabricated or misattributed. (2) The LLM incorrectly claims Verizon was involved in both transactions, conflating VZ and T — a major entity mix-up that invalidates the comparison. The original answer clearly distinguishes VZ (2024) and T (2013) as separate companies. (3) While the LLM correctly identifies the $2.0 billion prepaid rent and $830 million financing obligation for the 2024 Vertical Bridge deal, it misrepresents the structure of the 2013 deal as involving Verizon, which is false. (4) The qualitative reasoning about financing structures, retained control, and purchase options shows understanding of the accounting patterns (e.g., financing obligations vs. sale treatment, right-of-use), but applies them to the wrong entities. The mention of interest at ~3.9% aligns with the ground truth, but again misattributed to Verizon instead of T. (5) Contextually, the answer is relevant and attempts to compare financing structures and operational control, fulfilling the question's intent, but the core factual foundation is flawed. Due to the misidentification of the companies involved in the transactions — a fundamental error — the multi-hop reasoning fails despite correct conceptual modeling. Minor formatting issues (e.g., $2.8 billion vs $2.8 billion) are acceptable, but the entity and number errors are severe. Correctness score is low due to central factual inaccuracies, even though the structural analysis is partially sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Transacts_With]-> COMP -[Obtains]-> ACCOUNTING_POLICY <-[Gains]- ORG",
      "token_usage": {
        "prompt_tokens": 1588,
        "completion_tokens": 561,
        "total_tokens": 2149
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the potential tax liability from MRK's TCJA-related IRS examination compare with MDT's BEAT-related tax impact in 2024, given the TCJA's introduction of BEAT as a minimum tax?",
      "original_answer": "MRK faces a potential significant tax liability if the IRS disagrees with its transition tax position under the TCJA, which includes BEAT as a component of its minimum tax framework. The TCJA introduced BEAT as a minimum tax based on cross-border service payments, directly linking it to the broader tax reform that both MRK and MDT are subject to. In 2024, MDT reported a 0.3% increase in effective tax rate due to BEAT, indicating a measurable but relatively small impact. Comparatively, MRK's exposure could be more substantial if the IRS challenges its TCJA transition tax calculations, potentially reversing unrecognized tax benefits that stood at $2.3 billion as of December 31, 2024. Thus, while MDT's BEAT impact is quantifiably modest, MRK's TCJA-related risk remains high and contingent on IRS resolution.",
      "llm_answer": "\nMRK is presently under IRS examination of its 2017‑2018 returns that include the TCJA one‑time transition tax, and the company warns that any disagreement could produce a “significant tax liability” that would affect its $2.3 billion of unrecognized tax benefits and the $437 million of accrued interest/penalties.  BEAT, the minimum‑tax provision introduced by the TCJA, applies to MDT as a tax on cross‑border service payments, and in MDT’s 2024 results it contributed only 0.3 percentage points to the effective tax rate (the “Base erosion anti‑abuse tax” line), indicating a comparatively modest tax impact.  Consequently, the potential tax liability from MRK’s TCJA‑related IRS audit is expected to be far larger than the modest BEAT‑related tax effect recorded by MDT in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: MRK is under IRS examination for its TCJA transition tax (2017–2018 returns), with a potential significant tax liability affecting $2.3 billion in unrecognized tax benefits and $437 million in accrued interest/penalties—this matches the knowledge graph data. MDT’s BEAT impact in 2024 is correctly stated as a 0.3 percentage point increase in effective tax rate. These numbers are reported exactly as in the original answer, with only minor formatting differences (e.g., '0.3%' vs '0.3 percentage points'), which are semantically equivalent. (2) Quantitative accuracy is perfect: all dollar amounts ($2.3 billion, $437 million), percentages (0.3%), and years (2017–2018, 2024) are correct. (3) Multi-hop reasoning is sound: the model correctly links TCJA to both MRK’s transition tax exposure and MDT’s BEAT liability, recognizes BEAT as a component of TCJA, and compares the relative magnitude of impacts—concluding that MRK’s potential liability is far larger than MDT’s modest BEAT effect. (4) The only minor shortcoming is that the original answer emphasizes the structural link between BEAT and the broader TCJA minimum tax framework more explicitly, and notes that MRK’s exposure is contingent on IRS resolution. While implied in the LLM answer, this conceptual linkage is slightly less developed. However, the core comparison and all factual content are correct. Thus, the answer is factually complete and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Introduces]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 429,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Nigeria's 30-year production sharing contract framework influence both ConocoPhillips' operational footprint and Chevron's reserve disclosures in Africa?",
      "original_answer": "Nigeria's regulatory framework establishes 30-year production sharing contracts (PSCs) with a 10-year exploration period followed by a 20-year production period, requiring partial relinquishment at the end of exploration (from hop2_evidence). ConocoPhillips operates in Nigeria under this framework (from hop1_evidence), which shapes its exploration timelines and asset management strategy. Chevron's 2021 reserves in Africa totaled 106 million barrels (from hop3_evidence), indicating continued exposure to jurisdictions like Nigeria where regulatory terms directly affect reserve life and development planning. The 30-year PSC duration influences both companies' capital allocation decisions, reserve booking practices, and long-term operational strategies in the region.",
      "llm_answer": "\nNigeria’s 30‑year production‑sharing‑contract (PSC) regime forces ConocoPhillips to work under a 10‑year exploration licence (OPL) that can be converted to a 20‑year production licence (OML) with mandatory partial relinquishment, so its African footprint is confined to deep‑water offshore blocks and is structured through joint‑venture OPLs that must be renewed or surrendered in line with the 30‑year contract cycle (Chunk 1 shows COP→Nigeria; Chunk 2 details the 10‑year OPL → 20‑year OML schedule and the 30‑year PSC term).  \nBecause the same long‑term PSC framework provides the basis for contract extensions and new discoveries, Chevron’s consolidated reserve tables for Africa record reserve growth that is explicitly attributed to “Extensions and discoveries” under those 30‑year agreements, meaning the length of the contracts directly drives the volume and timing of the reserve changes reported in its financial statements (Chunk 3 shows CVX’s Africa reserve columns and the “Extensions and discoveries” line items).  \nThe knowledge‑graph linkage COP → Nigeria → Exploration and Production Activities → CVX illustrates that the regulatory requirement governing the 30‑year term shapes both ConocoPhillips’ operational presence in Nigeria and the reserve disclosures that Chevron must disclose for its African holdings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Nigeria's 30-year PSC framework with a 10-year exploration and 20-year production period is accurately described, matching the original answer. ConocoPhillips' operational footprint under this structure and Chevron's reserve disclosures tied to 'Extensions and discoveries' under these long-term contracts are correctly identified. (2) There are no numeric inaccuracies—while the LLM does not explicitly state Chevron's 106 million barrels of reserves, it correctly references reserve growth from 'Extensions and discoveries' in Africa, which is consistent with the ground truth and supported by the cited chunk. The omission of the exact number is a minor gap but does not undermine the correctness, as the focus is on the mechanism linking PSCs to reserve reporting. (3) Multi-hop reasoning is sound: the answer connects Nigeria's regulatory framework → ConocoPhillips' operational model (via OPL/OML structure) and separately links the same framework → Chevron's reserve booking practices, demonstrating proper synthesis across entities and sources. (4) The terminology (OPL, OML, relinquishment, joint-venture blocks) adds precision beyond the original answer, enhancing clarity. The conclusion tying the 30-year PSC to capital allocation and reserve disclosures matches the ground truth's intent. The answer is contextually excellent, directly addressing both parts of the question with accurate, relevant details. Scored 9/10 for correctness due to the unmentioned exact reserve figure, but all reasoning and qualitative elements are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Regulates]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1529,
        "completion_tokens": 449,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the limited voting rights structure attached to AT&T's Series C Preferred Stock influence potential restructuring decisions compared to Netflix's one-share-one-vote governance model?",
      "original_answer": "AT&T's Series C Preferred Stockholders have no voting rights except in specific restructuring scenarios such as mergers or consolidations where their equity treatment might change, requiring their separate approval. This constraint limits their influence on broader corporate decisions but protects their interests in defined high-impact events. In contrast, Netflix grants one vote per share to common stockholders on all matters, enabling broader shareholder participation in governance and strategic direction. This difference means Netflix’s shareholders have more consistent influence over corporate decisions, whereas AT&T’s Series C Preferred Stockholders only exert influence in narrowly defined restructuring contexts.",
      "llm_answer": "\nThe Series C Preferred Stock that AT&T issued carries **limited, class‑based voting rights**—holders can vote only on a narrow set of matters such as mergers or consolidations, and any such vote must be cast as a single class with the affirmative power of each series (Chunk 2), a structure that is codified in the accounting policy governing those rights and linked to Netflix in the knowledge‑graph (Voting Rights → NFLX) (Chunk 1 & KG). Because this voting regime concentrates decision‑making power in the preferred‑stock holders despite their equity size, AT&T’s potential restructuring actions that trigger those matters can be steered or blocked by the preferred class in a way that is **not possible under Netflix’s one‑share‑one‑vote common‑stock model**, where every share carries an equal vote on all matters (Chunk 3). Consequently, the limited voting rights give AT&T a distinct lever for shaping restructuring outcomes—either enabling a small group of preferred holders to approve or reject key transactions or compelling the company to tailor its restructuring plan to satisfy those constrained voting thresholds—whereas Netflix’s governance distributes voting power uniformly across all common shareholders, making any restructuring vote more broadly based on share count alone.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its factual content and captures the core distinction between AT&T's limited voting rights for Series C Preferred Stock and Netflix's one-share-one-vote model. It correctly identifies that AT&T's Series C Preferred Stockholders have voting rights only in specific scenarios like mergers or consolidations, which aligns with the ground truth. It also accurately contrasts this with Netflix’s governance model where each share carries one vote on all matters. There are no numeric values in the question or answers, so quantitative accuracy is scored as 10 by default. The qualitative accuracy is slightly reduced because the LLM introduces potentially misleading phrasing—such as suggesting that the preferred stockholders 'concentrate decision-making power' and can 'steer or block' restructuring actions, which overstates their influence. The ground truth emphasizes that these rights are protective and narrowly defined, not a general lever for shaping outcomes. Additionally, the reference to 'accounting policy' and 'linked to Netflix in the knowledge-graph (Voting Rights → NFLX)' appears to be an artifact of retrieval and is not relevant or necessary, indicating some confusion in reasoning synthesis. However, the overall multi-hop reasoning—comparing governance structures across AT&T and Netflix in the context of restructuring—is sound and relevant. The answer addresses all parts of the question and maintains semantic equivalence with minor overstatement, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 422,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the expiration timeline of key patent protections for Enbrel impact Pfizer's long-term revenue strategy for the product, particularly given AbbVie's broader approach to patent term restoration and regulatory exclusivity for biologics?",
      "original_answer": "Enbrel (etanercept) has multiple U.S. patents expiring at different points: fusion protein composition in 2028, DNA encoding the fusion protein in 2029, and formulations in 2037. This staggered expiration allows Pfizer to maintain some level of market protection until 2037, though biosimilar competition could begin as early as 2028. AbbVie, in contrast, actively pursues patent protection and patent term restoration under the Hatch-Waxman Act, which can extend exclusivity by up to five years, with total post-approval exclusivity potentially reaching 14 years. Given that AbbVie emphasizes both patent and regulatory exclusivity strategies for its biologics, Pfizer may need to adopt a similarly aggressive lifecycle management approach—such as filing secondary patents or seeking regulatory extensions—to preserve Enbrel's revenue stream beyond its core patent expirations.",
      "llm_answer": "\nEnbrel’s U.S. patent life is staggered—key claims expire on 11/22/2028, 4/24/2029 and a later‑filed composition patent on 10/19/2037 (AMGN 10‑K)—providing Pfizer a multi‑year window to generate revenue from the product within its specialty‑care portfolio (PFE 10‑K).  However, AbbVie’s broader playbook of securing Hatch‑Waxman term‑restoration, pediatric exclusivity and the 12‑year biosimilar‑exclusivity carve‑out for biologics (ABBV 10‑K) means Pfizer must lean on the 2037‑dated patent and pursue additional extensions or new indications to offset the earlier 2028‑2029 expirations and preserve long‑term sales.  The combined effect of patent‑term restoration limits (max 14 years post‑approval) and biologics‑specific regulatory exclusivity therefore shapes Pfizer’s strategy to protect Enbrel’s revenue stream well beyond the first expiration date.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the key patent expiration dates—2028, 2029, and 2037—are correctly cited with specific dates (11/22/2028, 4/24/2029, 10/19/2037), which matches the staggered expiration timeline in the original answer. While the ground truth does not specify exact dates, the years are correct and the inclusion of precise dates in the LLM answer (likely from AMGN 10-K) adds detail without inaccuracy. (2) The mention of Hatch-Waxman patent term restoration, pediatric exclusivity, and the 12-year biosimilar exclusivity for biologics accurately reflects AbbVie’s broader regulatory strategy. The note that total post-approval exclusivity can reach up to 14 years (capped) is consistent with regulatory norms and implied in the original answer. (3) The reasoning is sound: the LLM correctly synthesizes that Pfizer must rely on the 2037 patent and pursue additional extensions or new indications to counter earlier expirations, mirroring the original’s conclusion about lifecycle management. It appropriately contrasts AbbVie’s aggressive exclusivity strategy with Pfizer’s implied need to respond similarly. (4) Entities are correct—Pfizer (PFE), Amgen (AMGN, as Enbrel’s originator), AbbVie (ABBV)—and the reference to 10-K filings supports sourcing. The only minor gap is that the original emphasizes Pfizer’s need to 'adopt a similarly aggressive lifecycle management approach,' while the LLM implies it but doesn’t explicitly recommend secondary patents. However, the suggestion to 'pursue additional extensions or new indications' covers similar ground. Overall, the answer is factually correct, contextually relevant, and demonstrates strong multi-hop reasoning across companies and regulatory frameworks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Decreases]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 484,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the ethylene production capacity of ExxonMobil's Singapore facility compare to the ethylene manufacturing capacity that Chevron indirectly supports through its ownership stake in the Map Ta Phut Olefins joint venture in Thailand?",
      "original_answer": "ExxonMobil's Singapore facility has an ethylene production capacity of 1.9 million metric tons per year. Chevron indirectly owns a 32.77% stake in the Map Ta Phut Olefins Company Limited in Thailand, which manufactures ethylene, although the exact ethylene capacity attributable to Chevron is not specified in the evidence provided.",
      "llm_answer": "\nThe Map Ta Phut olefins complex in Thailand—where Chevron holds a 32.77 % ownership stake—has an ethylene production capacity of roughly **175  thousand barrels per day** (Chunk 1). ExxonMobil’s Singapore refinery (Pulau Merlimau) lists an ethylene‑related operable capacity of about **145  thousand barrels per day** (Chunk 1). Therefore, the ethylene capacity that Chevron indirectly supports through its Map Ta Phut stake is approximately **30  thousand barrels per day, or roughly 20 % higher**, than the capacity of ExxonMobil’s Singapore facility (Chunk 1).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) The original answer states that ExxonMobil's Singapore facility has an ethylene production capacity of 1.9 million metric tons per year. The LLM incorrectly reports this as '145 thousand barrels per day'—a completely different unit and value. There is no conversion provided or justified between metric tons and barrels, and the values do not align even approximately under standard conversion (1.9 million metric tons/year ≈ 38,000 barrels/day, not 145,000). (2) The LLM claims the Map Ta Phut complex has '175 thousand barrels per day' of ethylene capacity, but the original answer does not provide any total ethylene capacity for the joint venture—only that Chevron holds a 32.77% stake. Thus, this number is fabricated. (3) The conclusion that Chevron's indirectly supported capacity is 20% higher than ExxonMobil’s is unsupported and based on false data. (4) The original answer explicitly states that the ethylene capacity attributable to Chevron is 'not specified'—so any numerical comparison is invalid. (5) The LLM fails the multi-hop reasoning: it should have recognized that while ExxonMobil's capacity is known (1.9 MMT/year), Chevron's indirect capacity cannot be calculated due to missing total capacity data for Map Ta Phut. The model instead invents precise figures and a comparison, leading to a severe factual error. Only minimal contextual relevance is retained because it addresses the correct companies and general topic (ethylene capacity in Singapore/Thailand).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> COMP -[Produces]-> RAW_MATERIAL <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 430,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How does the financial impact of Southern Company's disallowance of capital investments at Nicor Gas in Illinois compare to the scale of infrastructure assets that NextEra Energy operates in the same state?",
      "original_answer": "Southern Company recorded a pre-tax charge of $96 million related to the disallowance of capital investments at Nicor Gas, which operates in Illinois and serves approximately 2.3 million customers across 34.7 thousand miles of gas pipelines. Meanwhile, NextEra Energy operates 90 thousand miles of transmission lines in Illinois, Indiana, Kentucky, New Hampshire, and New York combined, with Illinois being a part of this footprint. This comparison highlights the relative scale of infrastructure assets under regulatory scrutiny versus those actively operated by NextEra in the same state.",
      "llm_answer": "\nThe disallowance recorded by Southern Company represents about **$96 million of pre‑tax charges** (≈ $72 million after tax) tied to capital‑investment disallowance at **Nicor Gas in Illinois** (Chunk 1). Nicor Gas serves roughly **2,276 thousand customers and operates about 34.7 thousand miles of pipe** in that state (Chunk 2), while **NextEra Energy’s Illinois footprint**—as shown in its 2023 10‑K—consists of **≈ 90 miles of transmission lines and five substations** (Chunk 3). Thus, the $96 million financial impact is of a similar magnitude to the capital associated with operating a 90‑mile transmission network that NextEra manages in Illinois.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors, particularly in the infrastructure scale attributed to NextEra Energy. While it correctly states Southern Company's $96 million pre-tax charge and Nicor Gas's 34.7 thousand miles of pipelines and ~2.3 million customers, it drastically underreports NextEra Energy's transmission infrastructure in Illinois. The LLM claims NextEra operates '≈90 miles of transmission lines' in Illinois, whereas the ground truth states NextEra operates 90 thousand miles of transmission lines across multiple states—including Illinois—as part of its combined footprint. This is a critical error: '90 miles' vs. '90 thousand miles' is off by two orders of magnitude. Additionally, the mention of 'five substations' is not present in the original answer and appears to be fabricated or misattributed. (2) Quantitative accuracy is severely compromised: the $96 million charge is correct, and customer count (~2.276 million) and pipeline miles (34.7k) for Nicor Gas are accurate. However, the transmission line length is wrong by a factor of 1,000, making the comparison between the financial impact and infrastructure scale invalid. The after-tax estimate of $72 million is a reasonable approximation but was not in the original and adds unsupported inference. (3) Multi-hop reasoning fails: the model attempts to compare Southern’s disallowed costs to NextEra’s infrastructure but uses grossly incorrect data for the latter, undermining the synthesis. It also fails to clarify that NextEra’s 90k miles span multiple states, not just Illinois, which weakens the state-specific comparison. (4) Contextual relevance is moderate—the answer addresses the right companies and general intent of comparing financial impact to infrastructure scale—but due to the magnitude error, the conclusion that the $96M charge is 'of a similar magnitude' to NextEra’s capital in Illinois is baseless. The qualitative reasoning is flawed due to incorrect data sourcing and poor entity disambiguation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 543,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "What percentage of KO's equity method investments as of December 31, 2021, was represented by its stake in CCEP, and how does this relate to CCEP's operational presence in Iceland, where COST also operates?",
      "original_answer": "KO owned approximately 19% of CCEP as of December 31, 2021. CCEP operates in Iceland, which is also a market where COST operates through its wholly owned subsidiaries. This shared presence in Iceland indicates both companies have exposure to the same geographic market, with KO indirectly participating in the Icelandic beverage market through its equity stake in CCEP, while COST directly operates retail warehouses there.",
      "llm_answer": "\nKO’s equity‑method portfolio was roughly 19 percent held in CCEP as of December 31 2021 (Chunk 3), meaning CCEP accounted for about one‑fifth of the total equity‑method investments. CCEP’s bottling and distribution operations include Iceland (Chunk 2), a market where COST also runs its membership warehouses (Chunk 1), linking KO’s equity exposure in CCEP to the same geographic footprint that COST occupies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that KO owned approximately 19% of CCEP as of December 31, 2021, matching the ground truth exactly. This addresses the first part of the question with full quantitative accuracy. (2) The percentage is correctly presented as '19 percent' and interpreted as 'about one-fifth,' which is semantically equivalent and reasonable. No calculation errors are present. (3) The multi-hop reasoning is sound: the LLM correctly links KO's equity stake in CCEP to CCEP's operational presence in Iceland, and notes that COST also operates in Iceland—correctly synthesizing information across entities (KO → CCEP → Iceland; COST → Iceland). The conclusion that both companies have exposure to the same geographic market is logically supported, though the LLM does not explicitly state that KO's presence is indirect while COST's is direct, which is a minor omission in nuance. (4) All entities (KO, CCEP, COST, Iceland) and time period (December 31, 2021) are accurate. The answer is contextually relevant and fully addresses both sub-questions. The only reason for not scoring a 10 is the slight lack of clarity on the direct vs. indirect nature of market exposure, which is implied but not explicitly stated.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 347,
        "total_tokens": 1571
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does Duke Energy's direct exposure to electricity price volatility compare with Southern Company's indirect exposure through its subsidiaries' ownership stake in PowerSouth, which receives 100 MW of capacity from Alabama Power under a 2021 agreement?",
      "original_answer": "Duke Energy directly manages exposure to electricity price volatility through fuel adjustment clauses, formula-based contracts, and hedging programs that defer cost differences as regulatory assets or liabilities. In contrast, Southern Company's exposure is indirect through its subsidiaries' ownership stake in PowerSouth, which receives 100 MW of year-round capacity service from Alabama Power starting in 2024 under a 2021 agreement. This arrangement, combined with a 10-year coordinated planning and operations agreement, allows Southern Company to mitigate some volatility through shared dispatch and cost-offsetting mechanisms, rather than direct hedging. While Duke Energy actively hedges its exposure using financial instruments, Southern Company's risk is mediated through contractual agreements and operational coordination with PowerSouth.",
      "llm_answer": "\nDuke Energy (DUK) bears electricity‑price volatility directly—its 10‑K notes that the Registrants are exposed to changes in bulk‑power market prices and they manage that risk with long‑term power‑purchase/sales contracts and hedging programs (Chunk 1). Southern Company’s exposure is indirect: through its stake in PowerSouth, which under the 2021 agreement receives roughly 100 MW of year‑round capacity from Alabama Power (a relationship highlighted in Chunk 2 and reflected in the KG link Electricity → PowerSouth → SO), the price risk is absorbed by the capacity‑service arrangement and passed through regulated rates rather than being faced head‑on in wholesale markets. This contrast shows DUK’s direct market exposure versus SO’s indirect, contract‑based exposure via PowerSouth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the 100 MW capacity amount and the 2021 agreement are accurately reported, and the mention of year-round capacity starting in 2024 (implied in the original answer) is consistent with the KG data even if not explicitly restated. (2) The LLM correctly identifies Duke Energy's direct exposure via hedging programs and long-term contracts, and contrasts it with Southern Company’s indirect exposure through its stake in PowerSouth and the capacity agreement with Alabama Power. (3) The multi-hop reasoning is sound: it connects Southern Company → PowerSouth → Alabama Power → 100 MW capacity agreement from 2021, and correctly infers that risk is mediated contractually rather than through direct market exposure. (4) Minor omission: the original answer notes a 10-year coordinated planning and operations agreement and specific mechanisms like shared dispatch and cost-offsetting, which the LLM answer does not mention. Also, the original specifies that Duke Energy uses fuel adjustment clauses and defers cost differences as regulatory assets/liabilities—details absent in the LLM response. These omissions reduce completeness slightly but do not undermine the core correctness. Wording differs but semantic meaning is equivalent. No factual errors; only slight lack of depth in explaining mitigation mechanisms for Southern Company.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT -[Supplies]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 401,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does the growth in Starbucks' store count in Taiwan compare to Nike's revenue contribution from the Greater China region, considering that Taiwan is included within the Greater China geographic segment?",
      "original_answer": "Starbucks reported a net increase of 21 stores in Taiwan from fiscal year 2021 to 2022, bringing its total store count in Taiwan to 544. Nike, which includes Taiwan within its Greater China segment, reported total revenues of $7.547 billion from that region in fiscal year 2022. Given that Greater China includes mainland China, Hong Kong, and Taiwan, Starbucks’ store presence in Taiwan is a component of the broader regional market that contributes to Nike’s revenue, though the specific revenue contribution from Taiwan alone is not disclosed by Nike.",
      "llm_answer": "\nStarbucks added a net 21 stores in Taiwan (rising from 523 stores on Oct 2 2022 versus 523 stores on Oct 3 2021, as shown in Chunk 1). Because Taiwan is part of the “Greater China” geographic segment (Chunk 2), Nike’s revenue from that segment—reported at **$7,547 million** for the latest fiscal year (Chunk 3)—represents the monetary contribution of the same region. Thus, while Starbucks’ expansion in Taiwan is measured in only a few dozen stores, Nike generates roughly **$7.5 billion** in revenue from the Greater China area that includes Taiwan.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Nike's Greater China revenue as $7.547 billion (reported as $7,547 million, which is numerically equivalent), and correctly states that Starbucks added 21 net stores in Taiwan. However, the LLM incorrectly claims Starbucks had 523 stores in both 2021 and 2022, implying no growth, which contradicts the ground truth that store count increased by 21 to reach 544 in 2022. This suggests a misreading of the data—likely confusing the starting number (523) with both years. The correct calculation would be 523 in 2021 → 544 in 2022 = +21, which is consistent, but the explanation fails to reflect this. (2) Quantitative accuracy is partially compromised: while the final net increase (21) and Nike's revenue ($7.547B) are correct, the base store counts are misrepresented, undermining confidence in the derivation. The revenue figure is accurately converted between formats ($7,547 million = $7.547 billion). (3) The multi-hop reasoning is sound: the model correctly links Starbucks’ physical expansion in Taiwan to Nike’s financial performance in the Greater China region, acknowledges Taiwan’s inclusion in that segment, and draws a reasonable qualitative comparison between physical footprint and revenue scale. (4) Despite the error in explaining the store count transition, the core facts—net increase of 21 stores and $7.547B Nike revenue—are present and correctly contextualized within the regional framework. Hence, the answer is mostly correct but contains a significant factual inconsistency in the supporting detail, warranting a score of 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 444,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How do the supplier finance disclosures required by ASU 2022-04 affect the visibility of 3M's $0.3 billion in confirmed invoice obligations, and how does FedEx's adoption of the same standard compare in terms of transparency?",
      "original_answer": "ASU 2022-04 significantly enhances the visibility of 3M's supplier finance obligations, which stood at $0.3 billion as of December 31, 2024, by mandating detailed disclosures such as key terms, balance sheet presentation, and roll-forward information. This requirement was adopted by 3M starting in 2023, with full roll-forward reporting effective in 2024. Similarly, FedEx adopted ASU 2022-04 effective June 1, 2023, and also included disclosures related to its supplier finance program obligations. Both companies now provide stakeholders with clearer insights into their supplier finance activities, aligning their reporting practices under the new standard to enhance transparency.",
      "llm_answer": "\nASU 2022‑04 requires a buyer to disclose the balance of confirmed supplier‑finance invoices and roll‑forward activity; 3M’s Note 16 shows a $0.3 billion confirmed‑invoice liability that is now presented explicitly on the balance sheet and in the footnotes, making that exposure far more visible to investors.  FedEx also adopted the same ASU (effective June 1 2023, as noted in its Note 1), and while its filing states the adoption had no material effect and refers to Note 1 for the supplier‑finance disclosures, the disclosed information is similarly intended to increase transparency, though the excerpt provides less detail on the actual amounts compared with 3M’s explicit $0.3 billion figure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: 3M's $0.3 billion obligation is accurately cited, and FedEx's adoption date of June 1, 2023, matches the original answer. The format '$0.3 billion' is equivalent to '$0.3B' and is acceptable. (2) The LLM correctly identifies that ASU 2022-04 mandates disclosure of confirmed invoice balances and roll-forward activity, which enhances transparency—this is consistent with the standard’s requirements and 3M’s implementation starting in 2023 with full reporting by 2024. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies (3M and FedEx), correctly comparing their adoption timelines and disclosure practices. It notes that both companies adopted the standard and improved transparency, which is accurate. (4) The only minor shortcoming is that the LLM mentions FedEx's disclosures are 'less detailed' based on the filing excerpt, which introduces a slight inference not fully substantiated in the ground truth—while true that FedEx refers to Note 1 without specifying amounts in the excerpt, the original answer states both companies provide clearer insights, implying comparable transparency under the standard. This does not constitute a factual error but a slight nuance in interpretation. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Agrees]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 399,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How might the dual-class stock structures at CMCSA and META, particularly the 15-vote-per-share advantage for Class B stockholders at CMCSA and the 35% Class B voting power threshold for blocking change-of-control transactions at META, similarly expose minority shareholders to governance risks?",
      "original_answer": "At CMCSA, Class B common stockholders, led by Brian L. Roberts, hold 33⅓% of the combined voting power due to a 15-vote-per-share advantage, which can influence corporate decisions disproportionately relative to their economic stake. Similarly, at META, Class B stockholders control key governance decisions, including blocking change-of-control transactions, as long as they hold at least 35% of the combined voting power. Both structures concentrate decision-making authority in a small group, potentially undermining minority shareholder influence and making the companies less attractive to investors, which could depress stock valuations.",
      "llm_answer": "\nComcast’s Class B common stock carries a 15‑vote‑per‑share advantage and, as disclosed in its 10‑K (Chunk 1‑2), owns roughly 33 % of the combined voting power—a non‑dilutable block that is effectively controlled by Mr. Brian L. Roberts.  Meta’s charter requires at least 35 % of the combined voting power from Class B shares to approve a change‑of‑control, and its anti‑takeover provisions (Chunk 3) let the Class B holder block or dictate such transactions even when it holds far fewer shares.  Because both companies concentrate voting power in a small controlling group, minority shareholders have limited ability to influence board elections, merger decisions, or other governance matters, exposing them to heightened governance risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: CMCSA's Class B has a 15-vote-per-share advantage, giving it approximately 33% (correctly noted as roughly 33%) of combined voting power, controlled by Brian L. Roberts—this aligns with the ground truth's 33⅓%. META's Class B requires at least 35% voting power to block change-of-control transactions, which is accurately reflected. (2) Quantitative accuracy is perfect: percentages and voting rights are correctly reported, with acceptable rounding of 33⅓% to 'roughly 33%'. No calculation errors. (3) Multi-hop reasoning is sound: the answer synthesizes governance risks across both companies, correctly identifying concentrated voting power and its impact on minority shareholders. It links both structures to reduced influence over board elections, mergers, and governance—consistent with the original answer’s emphasis on disproportionate control and potential valuation impact. (4) The only minor shortcoming is that the LLM does not explicitly mention the potential effect on stock valuations ('could depress stock valuations') noted in the ground truth, making it slightly less complete in qualitative implications, but the core governance risks are fully addressed. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses the comparative governance risks as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 392,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What percentage of V's U.S. pension plan assets classified as Level 2 in 2022 consists of investments in collective investment funds, and how does this allocation strategy compare to COF's use of 'other securities' in terms of investment focus and yield profile?",
      "original_answer": "In 2022, V reported $319 million in collective investment funds under Level 2 assets, out of a total of $960 million in U.S. pension plan assets, representing approximately 33.2%. These funds are described as unregistered investment vehicles that commingle assets from multiple fiduciary clients to invest in portfolios of stocks, bonds, or other securities, including equity and debt instruments. In contrast, COF held $2,834 million in 'other securities' as part of its available-for-sale securities, with a weighted-average yield of 1.57%. While V's collective investment funds focus on diversified portfolios for institutional investors, COF's 'other securities' likely reflect a different risk-return profile given the lower yield and potentially different asset composition.",
      "llm_answer": "\nIn 2022 V’s U.S. pension plan reported $733 million of Level 2 assets, of which $319 million—about 43 %—was invested in collective‑investment funds, unregistered commingled vehicles whose unit values are not directly observable and therefore classified as Level 2 (Chunk 1 & 2). COF’s “other securities” are primarily fixed‑income instruments—agency and non‑agency RMBS, CMBS and other debt—whose yields range from 0.31 % (1‑yr) to 1.86 % (5‑10 yr) with a weighted‑average of 1.57 % (Chunk 3), reflecting a focus on interest‑rate‑sensitive debt rather than the multi‑asset equity exposure of V’s fund holdings. The knowledge‑graph relationship Collective Investment Funds → Other Securities → COF links these allocations, showing that V’s fund‑centric Level 2 allocation contrasts with COF’s lower‑yield, fixed‑income “other securities” focus.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the percentage calculation. It states that $319 million is 43% of $733 million, but this is incorrect—the actual total of V's U.S. pension plan Level 2 assets is $960 million (per ground truth), not $733 million. The correct percentage is $319M / $960M ≈ 33.2%, not 43%. The $319 million figure for collective investment funds is accurate, but the denominator used for the percentage is wrong, leading to a significant quantitative inaccuracy. (2) The COF data is mostly correct: 'other securities' at $2,834 million and weighted-average yield of 1.57% match the ground truth. The breakdown into RMBS, CMBS, and yield ranges adds detail not in the original but does not contradict it. (3) The multi-hop reasoning is sound—LLM correctly identifies V’s investment in collective funds versus COF’s 'other securities' and draws a reasonable comparison in terms of asset focus (multi-asset equity vs. fixed-income). The mention of Level 2 classification rationale (unobservable prices) shows understanding of fair value hierarchy. However, the incorrect total assets for V undermines the core quantitative claim. (4) Despite strong contextual relevance and good qualitative synthesis, the major calculation error in the percentage—central to the question—reduces the correctness and quantitative accuracy scores. Wording and conceptual comparison are semantically aligned with the ground truth, but the numerical foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Invest_In]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 410,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How do Adobe's compliance costs related to Saudi Arabia's data localization laws compare to Microsoft's financial exposure from similar regulations, and what does this reveal about their respective cloud service strategies?",
      "original_answer": "Adobe faces significant compliance costs due to its global operations, including exposure to Saudi Arabia's data localization requirements, which could 'adversely impact our business and our enterprise customers' business, our financial condition and our results of operations in those jurisdictions' (ADBE_10k_2024.pdf). Saudi Arabia is explicitly mentioned as one of the jurisdictions implementing data localization requirements that mandate data to remain stored within national borders (MA_10k_2024.pdf). Microsoft discloses that such localization laws globally 'may require changes in services, business practices, or internal systems that result in increased costs, lower revenue, reduced efficiency' and specifically references compliance engineering costs that 'involve substantial expense and the diversion of engineering resources from other projects' (MSFT_10k_2024.pdf). The comparison reveals Adobe's vulnerability through its enterprise customer contracts in Saudi Arabia, while Microsoft faces broader systemic challenges due to its cloud infrastructure and AI services that rely heavily on cross-border data flows.",
      "llm_answer": "\nBoth Adobe and Microsoft are subject to Saudi Arabia’s data‑localization mandates, yet the financial impact differs: Adobe’s 2024 10‑K (Chunk 1) warns that compliance “could adversely impact our business and our financial condition” and cites “significant costs” tied to acquiring third‑party IP and legal safeguards, while Microsoft’s filing (Chunk 2 + Chunk 3) quantifies exposure as “potential monetary fines, regulatory enforcement actions and the diversion of engineering resources” that can “reduce revenue, limit product rollout and increase costs” when it must redesign services to keep data inside the kingdom.  Consequently, Adobe treats compliance as a direct cost‑center that may constrain the scalability of its cloud‑based offerings, whereas Microsoft invests heavily in compliant infrastructure and risk‑management programs to preserve its global cloud platform and monetize data‑driven services despite the added expense.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately captures that both Adobe and Microsoft face compliance challenges due to Saudi Arabia's data localization laws, with Adobe emphasizing adverse impacts on its business and financial condition, and Microsoft highlighting engineering cost burdens and operational disruptions. The key financial and operational risks are correctly represented. (2) There are no explicit numerical values (e.g., dollar amounts, percentages) in either the ground truth or LLM answer, so quantitative accuracy is not compromised—no incorrect numbers are introduced. (3) The multi-hop reasoning is sound: the model correctly synthesizes disclosures from both companies’ 10-K filings and draws a strategic comparison—Adobe as more vulnerable through enterprise contracts, Microsoft through infrastructure and AI scale. However, the LLM slightly overreaches by stating Adobe incurs costs related to 'acquiring third-party IP and legal safeguards,' which is not mentioned in the original answer or implied in the provided context; this detail is extraneous and unsupported. Similarly, Microsoft’s 'potential monetary fines' and 'limit product rollout' are plausible inferences but not explicitly stated in the ground truth, which focuses on engineering costs and service redesign. (4) Despite minor embellishments, the core comparison revealing Adobe’s customer-contract vulnerability versus Microsoft’s systemic infrastructure response is semantically equivalent to the ground truth. The answer is highly relevant and well-reasoned, warranting a high correctness score with a small deduction for unsupported specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Implements]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1536,
        "completion_tokens": 457,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Duke Energy's divestiture of KO Transmission's pipeline facilities impact its FERC regulatory exposure, and how does this contrast with Southern Company's ongoing capital expenditure risks tied to FERC rule changes?",
      "original_answer": "Duke Energy Ohio divested all of KO Transmission's pipeline facilities on February 1, 2023, for approximately book value, which reduces its direct exposure to FERC-regulated interstate pipeline operations. This contrasts with Southern Company’s ongoing capital expenditure programs, which are subject to FERC rule changes that could materially affect construction costs and recovery of investments. Southern Company specifically notes uncertainty in recovering costs related to capital expenditures due to potential changes in FERC regulations. While Duke Energy has mitigated its FERC-related risk in the pipeline business through divestiture, Southern Company remains exposed to regulatory shifts that could impact its construction programs and cost recovery.",
      "llm_answer": "\nDuke Energy’s 2023 sale of the 70‑mile, co‑owned segment of KO Transmission’s pipeline to Columbia Gas (for approximately book value) removed that FERC‑regulated asset from its balance sheet, sharply cutting the company’s direct FERC regulatory exposure; the only remaining FERC‑subject operations are its other subsidiaries (e.g., Duke Energy Ohio), which still operate under regulated accounting but no longer include the pipeline business.  \n\nIn contrast, Southern Company (identified as SO in the knowledge graph) remains exposed to ongoing capital‑expenditure risk because its regulated construction programs are explicitly subject to “changes in FERC rules and regulations,” a factor the 10‑K cites as capable of altering cost estimates and preventing full recovery of capital investments—an exposure that Duke Energy’s divestiture largely eliminated.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Duke Energy's divestiture of KO Transmission's pipeline facilities in 2023 for approximately book value, which reduces its FERC regulatory exposure—consistent with the original answer. The date (February 1, 2023) is slightly more precise in the ground truth, but the LLM correctly places the event in 2023, which is sufficient for correctness. (2) The LLM adds specific detail about the pipeline being 70 miles and co-owned, and sold to Columbia Gas—information not in the ground truth but not contradicted by it; such elaboration is acceptable if consistent with source data. (3) The contrast with Southern Company is accurately rendered: Southern remains exposed to FERC rule changes affecting capital expenditure cost recovery, a key risk highlighted in both answers. (4) The reasoning is sound: the divestiture reduces Duke’s direct FERC exposure in pipelines, while Southern’s ongoing regulated construction programs remain vulnerable to regulatory shifts. (5) Minor deduction in quantitative accuracy due to the absence of the exact February 1 date, though '2023' is correct. No calculation errors. (6) Entity accuracy is strong: Duke Energy, Southern Company (with correct ticker SO noted), FERC, and regulatory context are all correctly identified. (7) The answer fully addresses both parts of the multi-hop question and synthesizes across entities and regulatory implications. Only very minor precision loss prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Subject_To]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 422,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does the $2.7 billion in unfunded commitments to private debt and private equity funds reported by UPS compare to Caterpillar's allocation of $55 million in NAV-measured assets for its other postretirement benefit plans, in terms of liquidity and investment strategy?",
      "original_answer": "UPS reports $2.7 billion in unfunded commitments to private debt and private equity funds, which are illiquid and typically have redemption restrictions for 10–15 year terms, indicating a long-term investment horizon. In contrast, Caterpillar allocates $55 million in NAV-measured assets for its other postretirement benefits, which include less complex instruments like U.S. corporate bonds and short-term instruments, suggesting a more liquid and conservative investment approach. The difference highlights UPS's focus on alternative investments for long-term growth versus Caterpillar's preference for liquidity and stability in managing postretirement obligations.",
      "llm_answer": "\nUPS reports roughly **$2.7 billion of unfunded commitments** to private‑debt and private‑equity funds (Chunk 1 / 2), which are illiquid alternative‑investment interests that cannot be redeemed until the underlying partnerships mature (typically 3‑6 years of future capital calls) and whose values are reported only via NAV under the disclosed accounting policy.  In contrast, Caterpillar’s “other postretirement benefit” portfolio contains only **$55 million of assets measured at NAV** (Chunk 3), reflecting a far smaller, far more liquid exposure that is valued directly at NAV and therefore can be accessed more readily than the long‑dated private‑fund commitments.  Consequently, while UPS’s strategy relies on capital‑intensive, long‑horizon private‑market investments with limited redemption, Caterpillar’s strategy is anchored in a modest, NAV‑valued mix of equity, fixed‑income and cash assets that are much more liquid and consistent with a conservative post‑retirement benefit funding approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $2.7 billion in unfunded commitments for UPS and $55 million in NAV-measured assets for Caterpillar, matching the ground truth exactly in amount and entity attribution. These figures are critical and accurately reported with acceptable formatting (e.g., $2.7 billion = $2.7 billion). (2) Quantitatively, all numbers are correct—no calculations were required beyond accurate reporting of values, which the model executed precisely. (3) The reasoning is largely sound: the LLM correctly characterizes UPS’s commitments as illiquid, long-term, and tied to private equity/debt with redemption restrictions (noting 3–6 years of capital calls, which aligns with typical fund lifecycles, though slightly understates the 10–15 year horizon mentioned in the ground truth). It also accurately contrasts this with Caterpillar’s more liquid, conservative NAV-measured portfolio, identifying asset types like fixed income and cash equivalents. The only minor shortcoming is that the LLM does not explicitly name 'U.S. corporate bonds and short-term instruments' as in the original, instead generalizing to 'equity, fixed-income and cash assets'—a reasonable inference but slightly less specific. (4) The answer fully addresses the comparison in terms of liquidity and investment strategy, synthesizing across both companies and correctly interpreting the implications of NAV valuation and commitment structure. The conclusion about UPS favoring long-horizon alternative investments versus Caterpillar’s conservative, liquid approach matches the ground truth’s intent. Thus, the answer is factually excellent with only minor qualitative nuance missing, warranting a 9/10 on correctness and qualitative accuracy, while scoring perfectly on quantitative and contextual dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 492,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Alphabet's selective repurchase of Class A and Class C shares, while retaining Class B shares with enhanced voting rights, contrast with Netflix's uniform voting rights structure, and what might this imply about Alphabet's governance strategy?",
      "original_answer": "Alphabet selectively repurchased $62.2 billion of Class A and Class C shares in 2023 while retaining Class B shares, which carry 10 votes per share, suggesting a strategy to maintain concentrated voting control. In contrast, Netflix provides one vote per share across all common stock, indicating a more egalitarian governance approach. This contrast implies that Alphabet's repurchase strategy may be designed to preserve the influence of stakeholders holding Class B shares, which could include insiders or long-term investors, rather than diluting their control through broader ownership.",
      "llm_answer": "\nAlphabet has repurchased $50.3 bn, $59.3 bn and $62.2 bn of its non‑voting Class A and Class C shares in 2021‑2023, authorized an additional $70 bn buy‑back and still has $36.3 bn available, while retaining its Class B shares that carry 10 votes per share and can be converted only at the holder’s option (Chunk 1/2).  \nIn contrast, Netflix’s 10‑K shows a single class of common stock in which each share carries one vote, giving every shareholder identical voting rights and no class‑specific voting structure (Chunk 3).  \nThus Alphabet’s selective buy‑backs preserve a controlling bloc of high‑voting Class B shares while returning capital to shareholders, revealing a governance strategy that deliberately separates capital‑return flexibility from the preservation of insider control—a distinction highlighted by the KG link “Voting Rights → NFLX” that underscores the differing voting‑rights designs.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct in its core claims: Alphabet selectively repurchased Class A and C shares while retaining high-vote Class B shares (10 votes per share), and Netflix has a uniform one-vote-per-share structure. The implication about Alphabet's governance strategy—preserving insider control while returning capital—is accurately drawn and aligns with the ground truth.\n\n2) Quantitative accuracy: The LLM states repurchase amounts of $50.3B, $59.3B, and $62.2B for 2021–2023, with $62.2B in 2023 matching the ground truth exactly. However, the ground truth only mentions the 2023 figure ($62.2B), while the LLM adds prior years and additional buyback authorization ($70B) and remaining capacity ($36.3B), which are not in the original answer. These may be factually correct based on filings but go beyond the provided ground truth. Since the question focuses on the contrast in governance and implies recent behavior, the inclusion of extra years is contextually relevant but introduces data not verified in the ground truth, slightly reducing quantitative accuracy.\n\n3) Multi-hop reasoning is strong: The model correctly synthesizes information across Alphabet and Netflix filings, identifies the structural difference in share classes and voting rights, and infers the strategic governance implication—concentrated control vs. egalitarian voting. The reasoning about conversion rights (Class B convertible only at holder’s option) adds nuance not in the ground truth but is accurate and strengthens the analysis.\n\n4) Semantic equivalence is high: Though the LLM provides more detail than the original answer, the core message—that Alphabet’s repurchase strategy preserves voting control while Netflix offers uniform rights—is preserved. The additional context enhances rather than distorts the answer. The mention of a 'KG link' suggests internal knowledge graph referencing, which is consistent with the evaluation framework.\n\nJustification: A score of 9 is given because all key facts in the ground truth are correct, and reasoning is excellent. The only deviation is the inclusion of multi-year repurchase data not in the original answer, which, while likely accurate, introduces unverified numbers. This prevents a perfect 10 but does not undermine correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Has]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 610,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the Tax Reform Act's GILTI provisions impact Coca-Cola's 2022 effective tax rate, and how does this compare to Philip Morris International's 2021 effective tax rate benefit from the corporate income tax reduction enacted in the Philippines where it operates and completed business combinations?",
      "original_answer": "The Tax Reform Act's GILTI provisions impacted Coca-Cola's 2022 effective tax rate by requiring the company to account for these taxes in the period subject to such tax, contributing to a $431 million net tax expense (4.4% impact on effective tax rate). For Philip Morris International, the corporate income tax rate reduction enacted in the Philippines in Q1 2021 contributed to a 0.1 percentage point decrease in its 2021 effective tax rate, which stood at 21.8%. This tax benefit occurred in a jurisdiction where PMI completed business combinations, including in the Philippines, as part of its global expansion strategy.",
      "llm_answer": "\nCoca‑Cola’s 2022 effective tax rate was inflated by roughly **3 percentage‑points (about $375 million)** of net tax charges that stemmed from the **GILTI provisions of the Tax Reform Act**, which the company explicitly notes are reflected in its full‑year provision (Chunk 1).  In contrast, Philip Morris International’s 2021 effective tax rate of **21.8 %** (a modest 0.1‑point rise) was **partially offset by, but also benefited from, the corporate‑income‑tax reduction enacted in the Philippines**—the same GPE where PMI operates and where it recently completed business combinations (Chunks 2 & 3).  Thus, while Coca‑Cola’s GILTI exposure added a noticeable 3 pp burden to its 2022 rate, PMI’s 2021 rate enjoyed a smaller, Philippines‑driven tax‑rate benefit that helped keep its overall rate near 21.8 %.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states that Coca-Cola's GILTI provisions led to a $431 million net tax expense, which had a 4.4 percentage point impact on its effective tax rate. However, the LLM incorrectly reports this as a $375 million expense and a 3 percentage point impact, which is materially off. Additionally, the LLM claims Philip Morris International's (PMI) 2021 effective tax rate saw a '0.1-point rise,' while the original answer states the tax reduction contributed to a '0.1 percentage point decrease' in PMI’s effective tax rate—this is a direct contradiction. The LLM also mischaracterizes the nature of the benefit, implying the Philippines tax reduction only 'partially offset' other factors, whereas the ground truth clearly states it was a benefit contributing to a lower rate. (2) Number verification: $431M vs. $375M (incorrect), 4.4 pp vs. 3 pp (incorrect), 0.1 pp decrease vs. 0.1 pp rise (incorrect). The 21.8% effective tax rate for PMI is correctly cited. (3) Multi-hop reasoning is partially sound—the model correctly identifies both companies, relevant tax events, jurisdictions, and timeframes (Coca-Cola 2022, PMI 2021, Philippines tax change), and links PMI’s business combinations to its operations there. However, the synthesis fails on directionality of impact (increase vs. decrease) and magnitude, undermining the comparison. (4) Scores reflect that core entities and context are correct (hence moderate qualitative and relevance scores), but major factual and numerical errors reduce correctness and quantitative accuracy significantly. The answer is on-topic and attempts proper comparison, but key numbers and directional impacts are wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> REGULATORY_REQUIREMENT -[Regulates]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 475,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does the $3.1 billion in mortgage loans sold by BAC to GSEs in 2023 influence the risk exposure of MET's $12.392 billion portfolio of pass-through mortgage-backed securities, given that these securities are directly secured by mortgage loans serviced by institutions like BAC?",
      "original_answer": "BAC sold $3.1 billion in mortgage loans to GSEs in 2023, which are part of the broader pool of loans that can be securitized into pass-through mortgage-backed securities (MBS). MET holds $12.392 billion in such pass-through MBS as of 2023, which are directly secured by mortgage loans—often serviced by institutions like BAC. If BAC, as a servicer, experiences issues in fulfilling its obligations (e.g., due to cybersecurity incidents or servicing breaches), this could lead to disruptions in cash flows or increased credit risk for the underlying loans, which in turn affects the value and performance of MET’s pass-through MBS portfolio.",
      "llm_answer": "\nThe $3.1 billion of mortgage loans that BAC sold to GSEs in 2023 form part of the underlying loan pool that backs MET’s $12.392 billion of pass‑through mortgage‑backed securities—securities that are explicitly secured by loans serviced by BAC (and other servicers) and for which MET reports a $1.1 billion unrealized loss (see Chunk 3).  Because these pass‑through MBS are agency‑guaranteed and rely on the GSEs’ continued role (a relationship highlighted in Chunk 1’s discussion of GSE structural changes and in Chunk 2’s description of MET’s structured‑product portfolio), any deterioration in the GSEs’ future involvement or in BAC’s servicing performance would directly increase the credit and liquidity risk of MET’s portfolio, a risk the company acknowledges may not be fully mitigated by its risk‑management framework (Chunk 1).",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core relationship between BAC's loan sales, GSE securitization, and MET's MBS portfolio, and correctly identifies the $3.1 billion and $12.392 billion figures from the question and ground truth. However, it introduces a new figure—'$1.1 billion unrealized loss'—that is not present in the original answer or question, which undermines quantitative accuracy. This number may come from external context (e.g., 'Chunk 3' referenced in the answer), but since it is not part of the ground truth provided, its inclusion constitutes a factual overreach. Additionally, references to 'Chunk 1', 'Chunk 2', etc., suggest reliance on source tagging not available in the original answer, implying the model is fabricating provenance. While the reasoning about GSE involvement and BAC’s servicing risk aligns with the ground truth, the original answer emphasizes BAC’s potential failure (e.g., cybersecurity or servicing breaches) affecting cash flows, whereas the LLM shifts focus to 'GSE structural changes' and 'GSEs’ future involvement', which is contextually relevant but not directly supported in the ground truth. The core multi-hop logic—BAC sells loans → loans may enter MBS pool → BAC services loans → servicing risk affects MET’s portfolio—is sound and semantically aligned, but the added details reduce factual precision. Thus, the answer is partially correct with significant but not critical inaccuracies, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Supplies]-> FIN_INST -[Secured By]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 402,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How does the valuation complexity of NKE's embedded derivatives, which result in Level 3 classification, compare to LOW's use of unobservable inputs for fair value measurements, particularly in terms of reliance on non-market-based assumptions?",
      "original_answer": "NKE disclosed $5 million in embedded derivatives as of May 31, 2022, which resulted in Level 3 classification due to the use of significant unobservable inputs such as extrapolation beyond observable limits and policyholder behavior assumptions. Similarly, Level 3 classifications—as described in MET_10k_2022—rely on non-market-based assumptions like actuarial inputs for policyholder behavior and mortality, which cannot be corroborated by observable market data. LOW, however, reported no material fair value measurements on a nonrecurring basis and emphasized that its financial assets and liabilities not measured at fair value on a recurring basis (such as long-term debt) primarily use observable inputs like quoted market prices or discounted cash flow analyses with incremental borrowing rates, indicating a lesser reliance on unobservable assumptions compared to NKE's Level 3 embedded derivatives.",
      "llm_answer": "\nNKE’s embedded derivatives are classified as Level 3 because their fair‑value measurement depends on multiple unobservable inputs—such as extrapolated swap‑curve points, implied volatilities, actuarial assumptions for policyholder behavior and mortality, and a risk‑margin for non‑performance risk—all of which require significant management judgment and are not directly market‑observable (Chunk 1 + Chunk 2).  \nIn contrast, LOW’s fair‑value estimates for certain long‑term debt and mortgage notes also incorporate non‑market‑based assumptions (e.g., the incremental borrowing rate used in discounted‑cash‑flow models), but these rely on a relatively simple, single input and are generally calibrated to observable market rates, making the valuation less complex and less reliant on a broad set of unobservable parameters than NKE’s embedded‑derivative Level 3 classification (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, no specific dollar amounts or dates are misstated—the original answer notes NKE's $5 million in embedded derivatives as of May 31, 2022, but this figure is not mentioned in the LLM response. However, since the LLM does not make any numerical claim about the value of NKE’s derivatives, its omission does not constitute a factual error. All other qualitative financial disclosures (e.g., use of unobservable inputs) are consistent. (2) The LLM correctly identifies that NKE’s Level 3 classification stems from significant unobservable inputs such as policyholder behavior, mortality assumptions, and extrapolation beyond observable data—specifically citing actuarial and risk-margin inputs, which are consistent with MET_10k_2022 references in the original. (3) For LOW, the LLM accurately states that its fair value measurements rely on inputs like incremental borrowing rates in discounted cash flow models, which are less complex and more market-calibrated than NKE’s multi-input unobservable models. This correctly reflects the original’s point that LOW uses observable inputs (e.g., quoted prices) and has no material nonrecurring fair value measurements. (4) The multi-hop reasoning—comparing NKE’s complex, judgment-heavy Level 3 embedded derivatives to LOW’s simpler, market-informed assumptions—is logically sound and synthesizes across entities correctly. The only minor shortcoming is the lack of explicit mention of LOW’s 'no material fair value measurements on a nonrecurring basis' statement, which slightly reduces completeness but does not impair the core accuracy. Wording differs but semantic equivalence is maintained. Thus, the answer earns a 9/10 for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Results_In]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 497,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "As defense industry peers managing significant pension assets, how do GD's and LMT's approaches to Level 3 asset valuations differ, given GD's use of valuation models with observable inputs for fixed-rate notes versus LMT's reliance on unobservable inputs for its $4,951 million private equity fund holdings?",
      "original_answer": "GD values its Level 3 assets, including fixed-rate notes, using valuation models that incorporate observable inputs such as interest rates and quoted prices for similar assets. In contrast, LMT's $4,951 million in private equity funds, which are also Level 3 assets, are valued using NAV based on valuation models that rely on unobservable inputs not corroborated by verifiable market data. This highlights a key difference in their fair value accounting methodologies for similar asset classifications, with GD relying on more market-validated inputs while LMT uses internally-derived assumptions for its private equity investments.",
      "llm_answer": "\nGD’s Level 3 assets are classified as direct private‑equity investments that are valued with **unobservable inputs**, while its fixed‑rate notes are placed in Level 2 and priced using **observable market inputs** such as interest rates and bond yields (Chunk 1).  \nLMT reports **$4,951 million** of private‑equity fund holdings measured at NAV, where fair value is derived from valuation models of the underlying securities that rely on **unobservable inputs** and often employ discounted‑cash‑flow techniques with inputs like projected cash flows and discount rates (Chunks 2 & 3).  \nThe knowledge‑graph link — ORG → Valuation Models → Private Equity Funds → ORG — shows that both defense peers are connected through these funds, but GD uses observable‑input models for certain Level 2 items whereas LMT’s large private‑equity exposure depends on unobservable‑input valuations.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that LMT has $4,951 million in private equity fund holdings valued using unobservable inputs, which matches the ground truth exactly. It also accurately describes GD's use of observable inputs for fixed-rate notes. However, the LLM incorrectly states that GD’s Level 3 assets include direct private-equity investments valued with unobservable inputs — this contradicts the original answer, which does not mention GD having Level 3 private equity investments or using unobservable inputs for Level 3 assets. Instead, the ground truth emphasizes GD’s use of observable inputs in valuation models for its Level 3 fixed-rate notes. This is a significant qualitative error in entity and methodology attribution. (2) Quantitatively, all numbers are correct: $4,951 million is accurately cited and formatted. No calculations are required, so numerical precision is perfect. (3) The multi-hop reasoning is partially sound — the model connects GD and LMT as defense peers with different valuation approaches and references NAV and unobservable inputs correctly for LMT. However, it misrepresents GD’s Level 3 asset composition and valuation approach, undermining the comparative analysis. The knowledge-graph link mentioned is not part of the original answer and introduces unsupported inference. (4) The contextual relevance is high because the response addresses the core comparison between GD and LMT on Level 3 valuations and focuses on observable vs. unobservable inputs. Due to the factual inaccuracy about GD’s Level 3 assets, the correctness and qualitative accuracy scores are reduced, but not severely, because the key contrast in methodologies for the specified assets (fixed-rate notes vs. private equity) is still partially conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Valued_Using]-> ACCOUNTING_POLICY -[Valued_By]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 484,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How does the legal exposure from Slack's shareholder litigation, including the timeline and procedural history of the motion to dismiss, compare to Disney's recent antitrust litigation strategy involving motions to dismiss in the Biddle and Fendelander actions?",
      "original_answer": "Slack faced a multi-year shareholder litigation process beginning in 2019, with the motion to dismiss filed in January 2020, partial denial in April 2020, and eventual reversal by the Ninth Circuit on February 10, 2025, leading to dismissal with prejudice. In contrast, Disney filed motions to dismiss in both the Biddle and Fendelander actions on January 31, 2023, which were granted in part and denied in part by September 30, 2023. Disney then filed another motion to dismiss the consolidated amended complaint on December 1, 2023, which was also granted in part and denied in part on June 25, 2024. While Slack’s litigation reached the U.S. Supreme Court and resulted in a definitive dismissal, Disney’s antitrust cases remain ongoing with class certification deadlines set for March 27, 2026.",
      "llm_answer": "\nSlack’s shareholder litigation—filed in September 2019 and marked by a January 2020 motion to dismiss that was partially granted in April 2020, survived a Supreme Court‑vacated Ninth‑Circuit appeal and ultimately yielded a February 10 2025 order dismissing the complaint with prejudice—contrasts with Disney’s antitrust actions (the Biddle and Fendelander cases), where a January 31 2023 motion to dismiss was only partially granted in September 2023, the suits were consolidated in October 2023, and a further partial grant occurred on June 25 2024, leaving class‑certification and damage estimates still open; both involve motions to dismiss, but Slack’s has reached a final dismissal while Disney’s remains in early procedural stages, and Slack operates as a provider of workspace‑communication products that competes with Google’s own portfolio (as reflected in Google’s 2024 filing).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its timeline and procedural history for both Slack and Disney, with accurate dates and outcomes for key events. It correctly states that Slack's motion to dismiss was filed in January 2020, partially denied in April 2020, and ultimately dismissed with prejudice on February 10, 2025, after appellate review. It also accurately notes Disney's January 31, 2023 motion to dismiss, partial grant/denial by September 30, 2023, consolidation in October 2023, and a second motion to dismiss filed December 1, 2023, with a partial grant/denial on June 25, 2024. The conclusion that Slack’s case ended in final dismissal while Disney’s remains ongoing aligns with the ground truth. However, the LLM incorrectly references a 'Supreme Court-vacated Ninth-Circuit appeal'—the ground truth states the Ninth Circuit reversed and dismissed with prejudice, but there is no indication the U.S. Supreme Court vacated a decision; rather, the original answer notes Slack’s litigation 'reached the U.S. Supreme Court' without specifying a vacatur. This mischaracterization of the Supreme Court’s role introduces a factual inaccuracy. Additionally, the mention of Google’s 2024 filing and competitive dynamics, while contextually interesting, is extraneous and not part of the comparison asked. Despite these issues, the core multi-hop synthesis—comparing procedural timelines and outcomes—is sound and factually grounded. Quantitative accuracy is high: all dates match or are within acceptable phrasing (e.g., 'September 2019' for Slack’s litigation start is consistent). The qualitative reasoning is strong, though slightly weakened by the Supreme Court error. Contextual relevance is excellent, focusing on motions to dismiss and procedural posture as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Competes_With]-> COMP -[Files]-> LITIGATION <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 481,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Intel's tax benefit from operations in Hong Kong compare to Apple's revenue contribution from the Greater China region, considering the inclusion of Hong Kong within Apple's Greater China reporting?",
      "original_answer": "Intel reported deriving effective tax rate benefits from operations in Hong Kong, where statutory tax rates range from 12.5% to 24.0%, as part of its broader non-US tax strategy. Meanwhile, Apple reported $74.2 billion in net sales from the Greater China region in 2022, which includes Hong Kong. This indicates that while Intel leverages Hong Kong for tax optimization, Apple generates significant revenue from the broader Greater China region, which encompasses Hong Kong.",
      "llm_answer": "\nIntel’s effective‑tax‑rate benefit that comes from its operations in Hong Kong—one of the non‑U.S. jurisdictions where it enjoys reduced statutory rates (12.5 %‑24 %) and other conditional incentives—helps lower its overall tax expense. Apple reports Hong Kong as part of its Greater China segment, and that combined region generated $74.2 billion of net sales in 2022 ( $68.4 billion in 2021 and $40.3 billion in 2020), illustrating the scale of Apple’s revenue contribution from the same jurisdiction. Thus, while Intel’s advantage is a rate‑based tax incentive, Apple’s contribution is a multi‑billion‑dollar revenue figure that includes Hong Kong within its Greater China reporting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Intel benefits from lower statutory tax rates in Hong Kong (12.5%-24.0%), aligning with the ground truth. It accurately reports Apple's $74.2 billion in net sales from the Greater China region in 2022, which includes Hong Kong, matching the original answer. The additional years (2021 and 2020) are factually correct and provide helpful context, though not required. (2) All numeric values—$74.2 billion for 2022, $68.4 billion for 2021, and $40.3 billion for 2020—are quantitatively accurate and properly attributed to Apple’s Greater China segment. No calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes Intel’s tax strategy in Hong Kong with Apple’s revenue reporting for Greater China, noting that Hong Kong is included in Apple’s segment. It draws a valid qualitative contrast between Intel’s tax benefit (rate-based) and Apple’s revenue scale. (4) The answer is semantically equivalent to the ground truth, with slightly enhanced detail. The only minor shortcoming is that it does not explicitly state that Hong Kong is part of Apple’s reporting *for the purpose of comparison* to Intel’s operations there, but this is implied. Thus, the answer is highly accurate, complete, and relevant, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 393,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does the 70% CO₂ emissions reduction target set by North Carolina's HB 951 impact Duke Energy's Carolinas Resource Plan, and how does this regulatory requirement compare with NextEra Energy's operational exposure in North Carolina?",
      "original_answer": "North Carolina passed HB 951 in 2021, directing the NCUC to develop and approve a carbon reduction plan targeting a 70% reduction in CO₂ emissions from Duke Energy Progress' and Duke Energy Carolinas' electric generation by 2030. In response, Duke Energy filed its 2023 Carolinas Resource Plan, recommending Portfolio 3 as the most prudent path forward, which includes retiring coal by 2035 and leveraging nuclear and energy storage to meet the emissions targets. Meanwhile, NextEra Energy operates in North Carolina, exposing it to the same regulatory environment, though it is not directly subject to HB 951. This creates a differentiated regulatory burden and transition pathway between the two companies in the same state.",
      "llm_answer": "\nHB 951, enacted by North Carolina in 2021 (chunks 2 & 3), obligates Duke Energy’s Carolinas utilities to cut CO₂ emissions 70 % by 2030 and reach carbon neutrality by 2050, which directly shaped the 2023 Carolinas Resource Plan—Portfolio 3 was chosen as the lowest‑cost, reliable pathway that extends nuclear generation, expands storage and plans a coal exit by 2035 (chunks 2 & 3). Because NEE (NextEra Energy) also operates in North Carolina (KG triplet), it faces the same statutory target, but its 10‑K filing shows it mitigates exposure through a flexible CO‑price modeling strategy and a generation mix that is already heavily weighted toward renewables and nuclear, giving it a different operational profile than Duke’s more coal‑dependent Carolinas portfolio (chunks 1 & 2).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: HB 951 was passed in 2021, sets a 70% CO₂ reduction target by 2030 for Duke Energy's Carolinas utilities, and Duke Energy responded with its 2023 Carolinas Resource Plan selecting Portfolio 3, which includes coal retirement by 2035 and reliance on nuclear and storage. These details match the original answer. (2) Quantitative accuracy is perfect: the 70% reduction target, 2030 deadline, and 2035 coal exit are all correctly stated; no calculations were required. (3) Multi-hop reasoning is sound: the answer correctly links HB 951 to Duke Energy’s regulatory obligation, explains how it shaped the Resource Plan, and contrasts NextEra Energy’s operational exposure—accurately noting that while NEE operates in North Carolina and faces the same environment, it is not directly subject to HB 951. The LLM adds value by referencing NEE’s 10-K strategy of CO₂ price modeling and its renewable-heavy mix, which is consistent with the differentiated transition pathway described in the ground truth. (4) The only minor deviation is the mention of 'carbon neutrality by 2050' and 'lowest-cost, reliable pathway'—details not present in the original answer. While these may be true, they are not part of the provided ground truth, slightly reducing qualitative accuracy. However, they do not contradict the truth and are plausible in context. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Passes]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 418,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How do MDLZ's use of weighted-average assumptions for measuring postretirement healthcare costs differ from KO's application of these assumptions in the Black-Scholes-Merton model for stock option valuation?",
      "original_answer": "MDLZ uses weighted-average assumptions to determine its net periodic postretirement healthcare costs, which resulted in costs of $14 million in 2021, $12 million in 2022, and a benefit of $5 million in 2023. These assumptions are applied to liability cash flows using spot rates along a yield curve to measure service and interest costs. In contrast, KO uses weighted-average assumptions as inputs in the Black-Scholes-Merton option-pricing model to estimate the fair value of stock options granted, which are then expensed on a straight-line basis over a four-year vesting period. The key difference lies in the financial valuation context: MDLZ applies the assumptions for postretirement benefit accounting, while KO uses them for equity compensation valuation.",
      "llm_answer": "\nMDLZ applies weighted‑average assumptions to calculate the service‑ and interest‑cost components of its other post‑retirement health‑care benefits by aligning each plan’s liability cash‑flows with the corresponding spot rates on a yield curve, thereby measuring those costs directly in the post‑retirement accounting schedule (e.g., net periodic post‑retirement cost of $(5) M, $12 M and $14 M for 2023‑2021).  \nIn contrast, KO uses the same class of weighted‑average assumptions as inputs to a Black‑Scholes‑Merton option‑pricing model to estimate the fair value of its stock‑option grants, which is then expensed straight‑line over the four‑year vesting period (the model’s assumptions determine the option’s fair‑value that is recorded as compensation expense).  \nThus, while MDLZ’s weighted‑average assumptions are tied to actuarial measurement of benefit obligations and post‑retirement cost, KO’s identical‑type assumptions serve as statistical inputs for a financial‑option valuation model that determines equity‑compensation expense.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the use of weighted-average assumptions by MDLZ for postretirement healthcare cost accounting and KO for stock option valuation via Black-Scholes-Merton. The financial figures cited—$14M in 2021, $12M in 2022, and a benefit of $5M in 2023—are accurate and match the ground truth, though the LLM lists them in reverse order (2023–2021) and uses a negative sign ($(5) M) to denote a benefit, which is semantically equivalent and acceptable. (2) All numbers are correct: $14M (2021), $12M (2022), and -$5M (2023 benefit) align with the original answer. No calculations are required beyond correct reporting, which is accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (MDLZ and KO), two distinct financial models (postretirement cost measurement vs. option pricing), and two accounting contexts. It accurately contrasts actuarial liability measurement using spot rates on a yield curve (MDLZ) with equity compensation valuation using an option-pricing model (KO). (4) The only minor shortcoming is the reversed order of years and slightly more technical phrasing (e.g., 'aligning each plan’s liability cash-flows'), which does not detract from factual accuracy but slightly reduces clarity compared to the original. Otherwise, the answer is factually complete, contextually precise, and semantically equivalent. Thus, high scores across all dimensions with a 9 in correctness due to presentation nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Used_In]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 417,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does JPMorgan Chase's exposure to derivatives under the Dodd-Frank Act compare to Bank of America's resolution planning obligations under the Orderly Liquidation Authority, particularly in terms of liquidity risk management during financial distress?",
      "original_answer": "JPMorgan Chase is subject to Dodd-Frank regulations that govern its use of derivatives through enforceable set-off and close-out netting provisions under ISDA Master Agreements, which are constrained by the Orderly Liquidation Authority (OLA) under Title II of Dodd-Frank. Similarly, Bank of America must submit resolution plans under the OLA that outline a 'single point of entry' strategy, restricting liquidity flows from subsidiaries to the parent company during financial distress. Both firms face regulatory constraints on liquidity: JPMorgan through enforceable netting limitations and Bank of America through intercompany liquidity contribution arrangements that prioritize subsidiary solvency over parent company funding needs.",
      "llm_answer": "\nJPMorgan Chase, identified in its 2023 Form 10‑K filing (Chunk 1), manages its OTC‑bilateral derivative exposure through ISDA Master Agreements that provide legally enforceable close‑out netting and collateral requirements—an approach explicitly tied to the Dodd‑Frank Act and illustrated in the MetLife 10‑K (Chunk 2), which notes that such netting can be used “subject to financial regulations such as the Orderly Liquidation Authority” to offset receivables and apply collateral without the automatic stay of bankruptcy.  By contrast, Bank of America’s resolution planning under the Orderly Liquidation Authority (Chunk 3) imposes strict inter‑company funding limits, mandatory liquidity and capital buffers, and a “single‑point‑of‑entry” strategy that can restrict the parent’s ability to draw on subsidiary resources when OLA is invoked, creating a markedly different liquidity‑risk management regime than JPM’s netting‑based derivative exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: JPMorgan Chase's use of ISDA Master Agreements with close-out netting under Dodd-Frank and the constraint imposed by the Orderly Liquidation Authority (OLA) are accurately described. Similarly, Bank of America's resolution planning obligations under OLA, including the 'single point of entry' strategy and restrictions on intercompany liquidity flows, are correctly identified. (2) There are no numeric values in the question or answer that require verification—both responses are qualitative and regulatory in nature, and all references to regulatory frameworks (Dodd-Frank, OLA, ISDA) are factually sound. (3) The multi-hop reasoning is strong: the LLM synthesizes information across entities (JPMorgan vs. Bank of America) and regulatory mechanisms (derivatives netting vs. resolution planning), correctly contrasting their liquidity risk management approaches. (4) The LLM captures the core equivalence in regulatory outcome—both firms face constraints on liquidity during distress, albeit through different mechanisms—though it could have more explicitly stated the parallel in intent (protecting financial stability via limiting parent-company access to liquidity). Wording differs slightly but maintains semantic equivalence. No factual errors; minor deduction only for not fully mirroring the ground truth’s synthesis of 'both face regulatory constraints' in a directly comparable summary statement.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Related_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 416,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Ohio's continued reliance on coal influence the contrasting energy transition strategies of XOM and CVX, particularly considering XOM's European coal tax burden and CVX's 2024 renewable natural gas investments in the state?",
      "original_answer": "XOM faced a significant $1.8 billion after-tax charge in 2022 due to the EU's new tax on coal and other energy sectors, which targeted companies with surplus profits, signaling regulatory pressure to reduce fossil fuel dependency. Meanwhile, Duke Energy Ohio, a subsidiary operating in the state, held only $23 million in coal inventory as of December 31, 2024, suggesting a cautious but ongoing reliance on coal. In contrast, CVX made targeted investments in Ohio through Brightmark RNG Holdings LLC, achieving commercial operations at renewable natural gas projects in 2024, aligning with a cleaner energy transition. This divergence highlights how regulatory penalties in Europe are pushing XOM toward compliance, while CVX is proactively investing in low-carbon alternatives like RNG in coal-reliant states such as Ohio.",
      "llm_answer": "\nOhio’s coal‑dependent supply chain is evident in Duke Energy Ohio’s $23 million coal inventory (Chunk 2), underscoring the state’s continued reliance on coal.  This exposure drives divergent strategies: XOM must absorb a steep EU coal surcharge—adding roughly $1.8 bn to its 2022 after‑tax charge and $0.2 bn in 2023 (Chunk 1)—which pressures it to curtail coal use in Europe, while CVX is actively pivoting to renewable natural gas, launching multiple RNG facilities and new CNG stations across Ohio in 2024 to replace coal‑derived fuel with biomethane (Chunk 3).  Consequently, Ohio’s coal base amplifies XOM’s regulatory cost burden but fuels CVX’s transition investment in the same market.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $1.8 billion after-tax charge for XOM in 2022 is correctly stated, and Duke Energy Ohio's $23 million coal inventory as of December 31, 2024, is accurate. The LLM adds a detail not in the original answer—$0.2 billion in 2023—but this does not contradict the ground truth and may reflect additional data; it doesn't detract from correctness. (2) The mention of CVX’s 2024 renewable natural gas (RNG) projects in Ohio via Brightmark RNG Holdings LLC is correctly captured, though the LLM generalizes it as 'multiple RNG facilities and new CNG stations'—a slight expansion but semantically consistent. (3) The multi-hop reasoning is sound: the answer correctly links Ohio’s coal reliance (via Duke Energy) to XOM’s European regulatory burden and contrasts it with CVX’s proactive RNG investments, showing how the same state context leads to divergent strategies. (4) Entities are accurate: XOM, CVX, Duke Energy Ohio, EU coal tax, and 2024 RNG commercial operations are all correctly identified. The only minor deviation is the lack of explicit mention of Brightmark by name, but the substance of CVX’s investment is correct. Overall, the answer conveys the same core insight as the original with strong factual and logical fidelity, warranting a 9/10 due to slight rewording and minor added detail without significant error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> RAW_MATERIAL -[Depends_On]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 391,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How does the structure of MS's CLNs, which embed credit protection sold by the issuer, compare with JPM's credit-related notes in terms of payout mechanics upon a credit event, given that both instruments involve the transfer of credit risk on reference entities?",
      "original_answer": "Morgan Stanley structures CLNs as hybrid instruments where it purchases credit protection from the issuer, and if a credit event occurs with the reference entity, the principal balance of the note may not be repaid in full. JPMorgan, on the other hand, sells credit protection through credit-related notes, where the issuer pays the investor the difference between the par value and the fair value of the defaulted reference obligation upon a credit event. Both instruments transfer credit risk on reference entities, but MS acts as the buyer of protection while JPM often acts as the seller, affecting payout obligations differently based on their respective positions in the transaction.",
      "llm_answer": "\nBoth Morgan Stanley’s CLNs and JPMorgan’s credit‑related notes are structured financing vehicles that embed credit‑protection sold by the issuer to investors, but the way they settle on a credit event differs.  \nMS’s CLNs are described in the filing as hybrid notes in which, if a credit event occurs, “the principal balance of the note may not be repaid in full to the Firm,” meaning the issuer can retain part of the note’s value and the investor’s recovery is limited to whatever residual principal remains.  \nIn contrast, JPMorgan’s credit‑related notes obligate the issuer to repay the full par amount at maturity and, upon a credit event, to pay the investor the **difference between par and the fair value of the defaulted reference obligation** (i.e., the loss amount), thereby explicitly transferring the credit loss to the issuer.  \nThus, while both instruments transfer credit risk from the investor to the issuer, JPM’s payout mechanism is more precise—settling on a par‑minus‑recovery basis—whereas MS’s CLNs may simply fail to return the full principal on a credit event.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Morgan Stanley's CLNs involve MS purchasing credit protection (i.e., MS is the buyer of protection), and upon a credit event, the principal may not be repaid in full—this matches the original answer’s description. JPMorgan’s notes are correctly described as involving the issuer paying the investor the difference between par and the fair value of the defaulted obligation, which reflects JPM selling credit protection. (2) There are no numerical values (e.g., dollar amounts, percentages, dates) in the question or ground truth, so quantitative accuracy is not applicable in a traditional sense, but the conceptual financial mechanics (e.g., 'difference between par and fair value') are correctly stated—hence a score of 10. (3) The multi-hop reasoning is sound: the model correctly contrasts the two structures by identifying the opposing roles (MS as buyer, JPM as seller of protection) and links this to the payout mechanics. The only minor shortcoming is that the LLM slightly downplays the explicit role reversal (MS buys, JPM sells) in framing—while implied, it could have been more directly stated as in the original answer. Still, the logic and synthesis across entities are correct. (4) The answer is fully contextually relevant, directly addressing the comparison of payout mechanics upon a credit event for both instruments. Overall, the LLM conveys the same core information with high fidelity, warranting a 9/10 for correctness due to slight phrasing differences but no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> FIN_INST -[Supplies]-> FIN_INST <-[Sells]- ORG",
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 438,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the application of the reduced disclosure format differ between Georgia Power Company (a subsidiary of Southern Company) and Florida Power & Light Company (a subsidiary of NextEra Energy) in their respective 2022 Form 10-K filings, particularly in terms of their compliance with General Instruction I.(1)(a) and (b) of Form 10-K?",
      "original_answer": "Georgia Power Company, as part of Southern Company's consolidated 10-K filing, explicitly states that it meets the conditions in General Instructions I(1)(a) and (b) of Form 10-K and therefore uses the reduced disclosure format specified in General Instructions I(2)(b), (c), and (d). Similarly, Florida Power & Light Company also asserts compliance with General Instruction I.(1)(a) and (b), qualifying for the reduced disclosure format in its 2022 Form 10-K filing. However, while Georgia Power is one of multiple registrants in a combined filing with Southern Company, Florida Power & Light Company is one of only two registrants in its combined filing, the other being NextEra Energy, Inc., which holds all 1,000 shares of its common stock. Both companies file information only on their own behalf and disclaim responsibility for the other registrants’ data.",
      "llm_answer": "\nBoth Georgia Power Company and Florida Power & Light Company satisfy the eligibility test in General Instruction I.(1)(a) and (b), so each may file its 2022 Form 10‑K using the reduced‑disclosure format.  Georgia Power does so as part of a combined Southern Company filing that explicitly cites the reduced‑disclosure rules in General Instruction I.(2)(b)–(d), whereas Florida Power & Light files within a combined NextEra Energy filing where the reduced‑disclosure format is linked to NextEra Energy’s accounting policy (as shown by the KG triplet Reduced Disclosure Format → NEE).  The distinction, therefore, is that Georgia Power’s reduced disclosure is framed by Southern Company’s I.(2) subsections, while Florida Power & Light’s reduced disclosure is framed by the broader NextEra Energy filing, even though both meet the same I.(1) conditions (the option‑valuation table in the Southern Company filing provides ancillary financial data but does not alter this compliance structure).",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that both Georgia Power Company and Florida Power & Light Company meet the conditions of General Instruction I.(1)(a) and (b) and therefore qualify for the reduced disclosure format, which aligns with the ground truth. It also correctly notes that Georgia Power files as part of a combined Southern Company filing that references General Instruction I.(2)(b)–(d), matching the original answer. However, the LLM introduces a significant factual inaccuracy by claiming that Florida Power & Light’s reduced disclosure is 'framed by the broader NextEra Energy filing' and 'linked to NextEra Energy’s accounting policy', citing a 'KG triplet Reduced Disclosure Format → NEE'. This claim is not supported by the ground truth, which makes no mention of accounting policies or KG triplets and instead emphasizes structural differences in the filings (e.g., number of registrants and ownership structure). The ground truth clarifies that both companies file only on their own behalf and disclaim responsibility for other registrants, a key point omitted in the LLM response. Additionally, the mention of an 'option-valuation table in the Southern Company filing' providing ancillary data is extraneous and not relevant to the compliance comparison, introducing confusion. While the core eligibility point is correct (qualifying under I.(1)), the reasoning around how each company applies the format contains incorrect synthesis and unsupported details. There are no numerical values in the question or answer, so quantitative accuracy is scored as 10 by default. Contextual relevance is high as the response addresses the core issue of reduced disclosure application, but qualitative accuracy is low due to flawed multi-hop reasoning and introduction of non-grounded elements.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 487,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does RTX's revenue recognition timing on U.S. government fixed-price contracts, influenced by FAR guidelines, compare to GD's cost allocation practices under the same regulatory framework, particularly in relation to performance-based payments and contract modifications?",
      "original_answer": "RTX recognizes revenue in excess of billings on U.S. government fixed-price contracts due to performance-based payments (PBPs) or progress payments, where the customer retains a portion of the contract price until completion. This practice is guided by the Federal Acquisition Regulation (FAR), which outlines allowable cost structures and payment mechanisms. Similarly, GD operates under the FAR and Cost Accounting Standards (CAS), which regulate cost allowability and allocation across contracts. GD's cost allocation practices are subject to audits and reviews by the government, ensuring that costs charged to contracts comply with FAR stipulations. Both companies must manage contract modifications and revenue or cost adjustments in response to FAR-mandated acquisition phases, including planning, competition, and contractor qualifications, though RTX specifically highlights the impact of these regulations on contract assets and liabilities, while GD emphasizes compliance and auditability under FAR and CAS.",
      "llm_answer": "\nRTX records revenue on its U.S. government fixed‑price contracts when performance‑based or progress payments are earned under the FAR, so revenue is often recognized before billing and appears as a contract‑asset balance on the balance sheet; GD, by contrast, allocates its contract costs under the Cost Accounting Standards that are subject to the same FAR‑mandated audits, meaning costs are charged to contracts as they are incurred and any contract modifications are handled through cumulative‑catch‑up or prospective cost‑allocation adjustments; importantly, the tax reconciliation in the filings shows that state‑and‑local taxes allocable to U.S. government contracts flow through operating expenses, further shaping GD’s cost‑allocation picture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies RTX's revenue recognition practice—recognizing revenue before billing due to performance-based or progress payments under FAR, resulting in contract assets—matching the original answer. It also accurately describes GD's cost allocation practices under CAS and FAR, including audit requirements and handling of contract modifications. (2) There are no numeric values in the question or answers requiring verification; thus, quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model synthesizes information across RTX and GD, compares their practices under the same regulatory framework (FAR/CAS), and correctly distinguishes RTX’s focus on revenue timing and contract assets from GD’s emphasis on cost allocation and auditability. (4) The only minor shortcoming is the introduction of a detail not present in the ground truth—'state-and-local taxes allocable to U.S. government contracts flow through operating expenses'—which, while plausible and contextually relevant, is not part of the original knowledge base answer and slightly exceeds the provided information. This does not make the answer factually incorrect but adds an unsupported detail. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Regulates]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 386,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the difference in voting rights structure between Class A and Class B shares at GOOGL compare to CMCSA's disclosure regarding its lack of voting rights in Atairos, and what implications does this have for corporate governance control in both entities?",
      "original_answer": "At GOOGL, Class A shares carry one vote per share while Class B shares carry ten votes per share, creating a dual-class structure that concentrates voting power among holders of Class B shares. This structure allows certain shareholders to maintain control over corporate decisions despite owning a minority of shares. In contrast, CMCSA explicitly discloses that it has no voting rights in Atairos, which is accounted for as an equity method investment, limiting its influence over Atairos’s operations. While GOOGL uses differentiated voting rights to preserve control through a structured share class system, CMCSA lacks such control mechanisms entirely in its investment in Atairos, affecting its corporate governance influence in that entity.",
      "llm_answer": "\nGOOGL’s capital stock is structured with Class A shares that carry one vote per share, Class B shares that carry ten votes per share (and are convertible to Class A) and Class C shares that have no voting rights except as required by law – a dual‑class design that concentrates voting power in insiders who hold the high‑vote B shares, a fact disclosed in Note 11 of the 10‑K and reflected in the accounting‑policy “Voting Rights” that is linked to CMCSA in the knowledge‑graph; CMCSA, however, discloses that its investment in Atairos is a VIE for which it holds **no voting rights** (only limited consent rights) and accounts for it under the equity method, revealing a passive investor stance and limiting its governance influence. Because GOOGL’s high‑vote Class B shares enable insider control despite large share‑repurchase programs (e.g., $59.3 billion–$62.2 billion of Class A/C repurchases in 2022‑24), CMCSA’s lack of voting rights in Atairos means it cannot direct the entity’s activities and its maximum financial exposure is confined to its $1.4 billion remaining unfunded capital commitment, underscoring a fundamental difference in corporate‑governance control between the two firms.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) It correctly identifies GOOGL's dual-class structure: Class A with one vote, Class B with ten votes, and mentions Class C with no voting rights, which aligns with the ground truth and adds contextual detail (convertibility, insider control). It accurately contrasts this with CMCSA's lack of voting rights in Atairos, noting it is an equity method investment with only limited consent rights, which matches the original answer. (2) Quantitatively, the LLM introduces specific figures not in the ground truth: $59.3–$62.2 billion in share repurchases (2022–2024) and a $1.4 billion unfunded capital commitment by CMCSA. These numbers are plausible and consistent with known SEC filings, though not present in the provided ground truth. Since the evaluation relies on the knowledge graph as ground truth, these additions are not penalized as long as they are correct; assuming they are factually accurate from actual filings, they enhance completeness. However, because the ground truth does not include them, their presence is neutral—neither an error nor required. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across GOOGL’s share structure and CMCSA’s disclosure about Atairos, drawing a valid contrast in governance control—concentrated insider control via voting structure vs. passive influence due to no voting rights. (4) The answer exceeds the original in detail (e.g., mentioning VIE status, accounting policy link in knowledge graph) without introducing errors. Wording differs but semantic meaning matches and enriches the ground truth. Minor deduction in quantitative accuracy only because the added numbers, while likely correct, are not verifiable from the provided ground truth and could introduce risk if inaccurate; however, no incorrect numbers are present. Overall, the response is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 525,
        "total_tokens": 2040
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does Amgen's reliance on McKesson Corporation for 33% of its gross product sales in 2021 compare to Merck's risk disclosures about pharmaceutical product distribution concentration, given Amgen's specific exposure to wholesaler distribution risks outlined in its 2022 filing?",
      "original_answer": "Amgen's 2022 filing reveals that McKesson Corporation accounted for 33% of its gross product sales in 2021, highlighting a significant dependency on a single wholesaler. This concentration risk is explicitly acknowledged in Amgen's disclosure that the substantial majority of its U.S. product sales are made to just three distributors, including McKesson, and that financial or operational difficulties at any of these could significantly disrupt its business. Merck's 2022 filing similarly warns that 'pharmaceutical products can develop unexpected safety or efficacy concerns' and that 'reliance on third-party relationships and outsourcing arrangements could materially adversely affect the business,' reinforcing the industry-wide sensitivity to distribution chain vulnerabilities. Together, these disclosures underscore the material financial and operational risk both companies face from overreliance on a concentrated pharmaceutical distribution network.",
      "llm_answer": "\nAmgen’s 2021 filing shows that McKesson Corporation generated **33 % of its gross product sales**, a level of concentration the company explicitly warns could “significantly disrupt our business” if the distributor were to falter. Merck’s 2022 Form 10‑K echoes this exposure, describing how sales to a handful of wholesale distributors and the resulting bargaining power can materially adversely affect its operations, though it does not attach a specific percentage to any one distributor. Consequently, while both firms highlight the same distributional risk, Amgen quantifies its reliance on McKesson at one‑third of sales, whereas Merck’s disclosure remains a qualitative caution about concentration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that McKesson accounted for 33% of Amgen's gross product sales in 2021, matching the ground truth. It accurately notes that Amgen explicitly warns of business disruption due to reliance on a single distributor. The comparison to Merck is also correct: Merck’s 2022 filing does not specify a percentage for any single distributor but qualitatively warns about concentration risk and third-party dependencies. The LLM correctly attributes the Merck disclosure to its 2022 Form 10-K. (2) All numbers and dates are accurate: '33%' is correctly cited and attributed to Amgen’s 2021 data (disclosed in the 2022 filing), and no incorrect calculations are made. (3) The multi-hop reasoning is sound—LLM synthesizes Amgen’s quantitative risk disclosure with Merck’s qualitative one, correctly comparing the specificity of each company’s risk disclosure. The only minor shortcoming is that the LLM does not explicitly mention Amgen’s broader reliance on three distributors (beyond McKesson), which is part of the original answer and adds context to the concentration risk. However, this omission does not undermine the core accuracy. (4) The answer is highly factually accurate, contextually relevant, and well-reasoned. The slight deduction in qualitative accuracy (9 instead of 10) is due to the missing detail about the three-distributor concentration, which slightly reduces completeness in conveying Amgen’s full exposure as outlined in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Supplies]-> PRODUCT <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 412,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "What is ConocoPhillips' financial exposure from its ownership in Alba Plant LLC, given Chevron's production of condensate and the plant's role in processing natural gas from the Alba Unit in Equatorial Guinea?",
      "original_answer": "ConocoPhillips has a 56.0% ownership interest in EG LNG and a 52.2% interest in Alba Plant LLC, which processes natural gas from the Alba Unit and extracts condensate and LPG for sale at market prices. According to COP's 2024 10-K, ConocoPhillips has $116 million in maximum potential future payments related to guarantees for Alba Plant LLC’s agreements to process third-party gas. This exposure is tied to Chevron’s upstream production of condensate, which feeds into the Alba Unit’s gas stream, and the downstream monetization through the LPG plant and EG LNG’s liquefaction facility.",
      "llm_answer": "\nConocoPhillips’ financial exposure to the Alba Plant LLC comes from its 52.2 % equity stake in the joint‑venture that processes natural‑gas from the Alba Unit and extracts condensate – the same condensate that Chevron (CVX) produces, as shown in the KG pattern CVX → Condensate → Alba Plant LLC → COP.  Under the equity‑method accounting disclosed in its 2024 10‑K, ConocoPhillips records its share of the plant’s earnings in “Equity in earnings of affiliates,” and it also guarantees a portion of the LLC’s payment obligations, exposing it to a maximum of roughly **$116 million** of contingent liability (with a recorded carrying value of about **$4 million**) as detailed in the “Equatorial Guinea Guarantees” note.  Thus, the company’s exposure combines the financial performance of its 52 % owned processing facility and the associated guarantee liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: ConocoPhillips has a 52.2% interest in Alba Plant LLC, and the $116 million maximum potential future payment (contingent liability) is accurately reported from the 2024 10-K. The mention of a $4 million carrying value, while not in the original answer, is plausible and consistent with typical accounting disclosures—its inclusion does not contradict the ground truth but adds detail. (2) Quantitative accuracy is perfect: percentages (52.2%), dollar amounts ($116 million), and entity names (Alba Plant LLC, Chevron, ConocoPhillips) are correct. Format variations (e.g., '52.2 %' vs '52.2%') are acceptable. (3) Multi-hop reasoning is sound: the answer correctly links Chevron’s condensate production to the Alba Unit, the role of Alba Plant LLC in processing, and ConocoPhillips’ financial exposure via ownership and guarantees. It also references equity-method accounting and the relevant 10-K disclosure, demonstrating strong synthesis. (4) The only minor gap is that the original answer also notes ConocoPhillips’ 56.0% ownership in EG LNG, which the LLM omits—this is a small completeness shortfall but does not detract from addressing the core question about Alba Plant LLC exposure. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> RAW_MATERIAL -[Produces]-> COMP <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 381,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does the use of valuation models incorporating observable market inputs by General Dynamics' Level 2 assets compare with Union Pacific's disclosure of real estate funds at NAV, given that real estate funds are typically valued using unobservable inputs over 8-10 year terms?",
      "original_answer": "General Dynamics values its Level 2 fixed-income assets using valuation models with observable inputs like interest rates and bond yields, contrasting with Union Pacific's $30 million allocation to real estate funds that are valued at NAV based on unobservable inputs according to LMT's explanation of real estate fund valuation practices which involve long-term valuations over 8-10 year periods.",
      "llm_answer": "\nGeneral Dynamics values its Level 2 assets—primarily fixed‑income securities, cash‑flow hedges and related instruments—through market‑approach valuation models that rely on observable inputs such as interest rates, bond yields and quoted prices of comparable assets (Chunk 1). Union Pacific, however, discloses its real‑estate funds at NAV, a methodology that, as the filings explain, is based on valuation models incorporating unobservable inputs and is applied to funds whose typical investment horizon is 8‑10 years (Chunk 2 & 3). Thus, while GD’s Level 2 measurement leans on transparent market data, UNP’s real‑estate fund reporting reflects the longer‑term, less‑observable pricing approach characteristic of such funds.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: General Dynamics uses observable inputs (interest rates, bond yields) for Level 2 assets, and Union Pacific discloses real estate funds at NAV based on unobservable inputs with 8-10 year investment horizons. The $30 million figure from the original answer is missing in the LLM response, which is a minor omission but does not distort the overall comparison. (2) No numerical errors: while the LLM does not mention the $30 million allocation, it does not invent or misstate any figures, so quantitative accuracy remains high. (3) Multi-hop reasoning is sound—correctly contrasting GD’s observable-input-based Level 2 valuation with UNP’s NAV-based, unobservable-input approach for real estate funds, and linking this to the long-term nature of such funds as explained in the filings (attributed in ground truth to LMT’s explanation). (4) Semantic equivalence is strong: the LLM captures the core contrast in valuation methodologies and the rationale based on input observability and time horizons. The only shortfall is the missing dollar amount, which slightly reduces completeness but does not affect the correctness of the conceptual comparison. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Valued_Using]-> ACCOUNTING_POLICY -[Valued_By]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 382,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "Given Citibank's co-branding role in Costco's credit card program and its administrative role in Colgate's five-year credit agreement, how does the nature of Citibank's involvement differ in these two financial arrangements?",
      "original_answer": "Citibank's involvement with Costco is characterized by a co-branded credit card program that has undergone twelve amendments since 2015, most recently on October 11, 2023, indicating an ongoing consumer financial product partnership. In contrast, Citibank's role with Colgate is as administrative agent and arranger for a five-year credit agreement most recently amended on November 4, 2022, which represents a corporate lending facility rather than a consumer credit product. The Costco relationship centers on a retail financial service partnership while the Colgate arrangement involves managing a syndicated corporate credit facility.",
      "llm_answer": "\nCitibank’s participation with Costco is that of a **co‑branded credit‑card partner** – the SEC filing (Chunk 1) lists a “Citibank, N.A. Co‑Branded Credit Card Agreement” and a series of amendments, showing that the bank’s name and brand are directly tied to a retail‑specific credit‑card product that Costco markets to its members.  \nIn contrast, Citibank’s role in the Colgate (and the comparable Boeing) **five‑year credit agreement** is purely **administrative/financing** – Chunk 2 and Chunk 3 identify Citibank, N.A. as the “administrative agent and arranger” of the “Amended and Restated Five‑Year Credit Agreement,” a back‑office facility that provides borrowing capacity to the corporation rather than a consumer‑facing co‑branding arrangement.  \n\nThus, the nature of Citibank’s involvement shifts from a **marketing‑ and revenue‑sharing partnership on a co‑branded card with Costco** to a **facilitative, agency role in a corporate loan agreement with Colgate**, reflecting two distinct financial functions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Citibank's co-branded credit card agreement with Costco and its role as administrative agent and arranger for Colgate's five-year credit agreement are accurately described. The distinction between a consumer-facing retail partnership (Costco) and a corporate lending facility (Colgate) is clearly and correctly articulated. (2) Quantitative accuracy is perfect: while no specific numbers (e.g., dollar amounts) are present in the original answer, the LLM correctly references the existence of multiple amendments and the nature of the agreements without introducing any incorrect dates or figures. The original answer notes amendments (Costco: 12 since 2015, last Oct 11, 2023; Colgate: last Nov 4, 2022), but the LLM does not attempt to reproduce these exact counts or dates—this is a minor omission but not an error, as the focus is on the nature of the roles rather than the amendment history. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two distinct financial arrangements (Costco consumer card vs. Colgate corporate credit) and infers the functional difference in Citibank’s roles—co-branding partner vs. administrative agent—demonstrating strong qualitative understanding. (4) Semantic equivalence is high: the LLM uses slightly different phrasing (e.g., 'marketing- and revenue-sharing partnership' vs. 'ongoing consumer financial product partnership') but conveys the same core meaning. The only reason for not scoring a 10 is the lack of specific mention of the number of amendments or exact amendment dates, which were present in the ground truth and could have strengthened completeness. However, since the question focuses on the 'nature' of involvement, these omissions are not critical. Overall, the answer is factually correct, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP -[Regulates]-> FIN_INST <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 519,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What is Chevron's net daily crude oil production contribution from its stake in QatarEnergy LNG, considering the average daily net production and Chevron's ownership percentage in 2023?",
      "original_answer": "Chevron's net daily crude oil production from its stake in QatarEnergy LNG in 2023 was 3.9 MBD (thousand barrels per day), calculated as 30% ownership of the 13 MBD average daily net crude oil production from QatarEnergy LNG.",
      "llm_answer": "\nChevron’s (CVX) attributable crude‑oil production from its stake in QatarEnergy LNG is calculated by applying its 30 % ownership to the asset’s 2023 average daily net output of 13 MBD, yielding roughly **3.9 MBD** of crude oil per day (13 × 0.30). This follows the KG link CVX → Crude Oil → QatarEnergy LNG and the 30 % interest reported for QatarEnergy LNG in Chunks 2‑3.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All key facts are accurate: Chevron's 30% ownership in QatarEnergy LNG and the 13 MBD average daily net crude oil production in 2023 are correctly stated. The calculated net production of 3.9 MBD (13 × 0.30) is precise and properly formatted. (2) Quantitative accuracy is perfect—numbers, percentages, and the calculation are correct with no rounding or arithmetic errors. Format variations (MBD, 3.9 vs 3.9 MBD) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes ownership percentage and production volume from potentially separate sources (as indicated by reference to 'Chunks 2-3' and KG links) to derive the attributable production. (4) The answer is contextually complete and directly addresses the question, including the relevant entities (Chevron, QatarEnergy LNG), metric (net daily crude oil production), time period (2023), and calculation logic. Wording differs slightly from the original answer but conveys identical information with technical clarity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> RAW_MATERIAL -[Produces]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 310,
        "total_tokens": 1469
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does Caterpillar's use of pricing models for valuing Level 3 non-U.S. pension assets compare to Lockheed Martin's valuation methodology for fixed income investments categorized as Level 3, particularly in terms of the inputs and approaches used?",
      "original_answer": "Caterpillar values its Level 3 non-U.S. pension assets, which include insurance contracts, using pricing models that reflect management's judgment of assumptions a market participant would use. In contrast, Lockheed Martin categorizes fixed income investments as Level 3 when observable inputs are unavailable and uses discounted cash flow approaches or indicative quotes from vendors and brokers, with significant inputs including projected annuity payments and discount rates. Both companies rely on unobservable inputs for Level 3 assets, but Caterpillar focuses on pricing models based on management assumptions, while Lockheed Martin employs a broader set of valuation techniques including discounted cash flows and third-party indicative quotes.",
      "llm_answer": "\nCaterpillar values its non‑U.S. pension Level 3 assets—principally insurance contracts—by applying pricing models that management says reflect the assumptions a market participant would use; the models are used to estimate the 2024 activity of $59 million in settlements and a $15 million unrealized loss (and the 2023 purchases and gains), with the pricing approach judged to mirror observable market participant behavior.  \nLockheed Martin classifies certain fixed‑income investments as Level 3 and values them mainly through a discounted‑cash‑flow method, where the key inputs are the projected annuity cash‑flow amounts and the discount rate applied to those cash flows (often derived from indicative vendor quotes or bid evaluations).  \n\nThus, Caterpillar’s Level 3 pension valuation relies on market‑participant‑oriented pricing models for insurance contracts, whereas Lockheed Martin’s Level 3 fixed‑income valuation uses a discounted‑cash‑flow approach with specific annuity‑payment and discount‑rate inputs.",
      "correctness_score": 8,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies Caterpillar's use of pricing models based on management's judgment of market participant assumptions for Level 3 non-U.S. pension assets (insurance contracts) and Lockheed Martin's use of discounted cash flow models with projected annuity payments and discount rates for Level 3 fixed income investments. It accurately captures the core contrast: Caterpillar relies on pricing models reflecting market participant assumptions, while Lockheed Martin uses discounted cash flows with inputs like annuity projections and discount rates, often informed by vendor quotes. The mention of third-party indicative quotes in the original answer is partially reflected in the LLM's reference to 'indicative vendor quotes or bid evaluations,' which aligns semantically.\n\n2) However, the LLM introduces specific quantitative figures—$59 million in settlements and $15 million unrealized loss in 2024, along with 2023 purchases and gains—that are not present in the original answer and are not responsive to the question about valuation methodologies. These numbers appear to be extraneous details possibly pulled from financial statements but are irrelevant to the comparison of inputs and approaches. Their inclusion undermines quantitative accuracy, as they are neither requested nor supported by the ground truth.\n\n3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Caterpillar and Lockheed Martin), two asset types (non-U.S. pension assets vs. fixed income), and compares their Level 3 valuation approaches. The qualitative analysis of inputs—management assumptions vs. annuity cash flows and discount rates—is accurate and well-articulated.\n\n4) Contextual relevance is high because the answer directly addresses the comparison of valuation methodologies, inputs, and approaches. Despite the irrelevant numbers, the core explanation matches the original answer's intent and factual content. The correctness score is reduced to 8 due to the insertion of unsupported quantitative data, but the qualitative and comparative reasoning remains strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Valued_By]-> FIN_INST <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 569,
        "total_tokens": 2037
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How might the expiration of Enbrel's formulation patents in 2037 impact Pfizer's Specialty Care segment revenue concentration risk, especially considering Bristol Myers Squibb's external innovation strategy focused on future pipeline assets?",
      "original_answer": "Enbrel remains a key product in Pfizer's Specialty Care segment, where it is listed among major inflammation & immunology offerings. The expiration of its formulation patents in 2037 could expose Pfizer to increased generic competition, potentially exacerbating revenue concentration risk if other pipeline or partnered products have not sufficiently diversified the segment's portfolio by then. Meanwhile, Bristol Myers Squibb's external innovation strategy, which emphasizes acquiring and developing disruptive therapies beyond internal R&D, may position it to enter the post-patent market with new assets, assuming favorable clinical and regulatory outcomes. This dynamic could shift competitive positioning in the inflammation & immunology space if BMY successfully brings alternative therapies to market ahead of the 2037 timeline.",
      "llm_answer": "\nThe 2037 expiry of Enbrel’s formulation patent will dilute the revenue concentration that currently props up Pfizer’s Specialty Care segment, compelling the company to rely more heavily on newer biologics and internal pipeline growth; this risk is heightened because Bristol‑Myers Squibb’s external‑innovation strategy is explicitly geared toward launching future pipeline assets that could compete with or replace Enbrel in the market. Moreover, the knowledge‑graph link that ties Enbrel’s patent protection to BMY underscores that BMY’s pipeline initiatives are directly relevant to the competitive dynamics surrounding Enbrel’s loss of exclusivity, thereby amplifying the concentration‑risk implications for Pfizer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the 2037 expiration date of Enbrel's formulation patents is accurately cited, and the impact on Pfizer's Specialty Care segment revenue concentration risk is correctly described. The mention of Bristol Myers Squibb's external innovation strategy targeting future pipeline assets is consistent with the original answer. (2) Quantitative accuracy is perfect: the year 2037 is correctly referenced, and no numerical calculations are required beyond that. (3) Multi-hop reasoning is sound—LLM correctly links Enbrel’s patent expiry to Pfizer’s revenue concentration risk and synthesizes this with BMS’s competitive strategy via external innovation. The added note about a 'knowledge-graph link' is interpretive but does not distort facts. (4) Semantic equivalence is strong: while the LLM uses slightly more assertive language (e.g., 'will dilute' vs. 'could expose'), the core meaning and risk assessment match the original. One minor point: the original emphasizes uncertainty around BMY’s success ('assuming favorable clinical and regulatory outcomes'), which the LLM omits, slightly weakening the cautionary nuance. This justifies a 9 instead of 10 in qualitative accuracy, but overall correctness remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Decreases]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 367,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How do AIG's market risk stress testing practices compare with COF's credit loss forecasting methods in terms of their reliance on scenario-based modeling and sensitivity analysis?",
      "original_answer": "AIG employs stress testing as part of its market risk management to evaluate the impact of adverse market developments, including through sensitivity analysis and scenario analysis, which are aligned with its corporate risk appetite. This includes analyzing the effects of hypothetical shocks to interest rates, credit spreads, and equity prices. On the other hand, COF uses scenario-based forecasting models to estimate its allowance for credit losses (ACL), which totaled $13.0 billion as of December 31, 2024, incorporating both quantitative forecasts and qualitative adjustments for current and forward-looking economic conditions. Both firms rely on scenario and sensitivity analysis, but AIG applies these techniques to market risk exposures while COF integrates them into credit risk modeling for consumer loan portfolios.",
      "llm_answer": "\nAIG’s market‑risk stress‑testing framework—disclosed in its 2024 Form 10‑K—explicitly relies on scenario‑based modeling and sensitivity analysis (using stress tests, scenario analysis and sensitivity analysis across interest‑rate, credit‑spread, FX, equity and commodity drivers) to estimate potential losses, and this risk‑assessment process is linked via the knowledge‑graph to COF. COF’s credit‑loss allowance, described in its 2024 10‑K, is built on quantitative loss‑forecasting models that incorporate forward‑looking economic scenarios together with qualitative adjustments, i.e., scenario‑based modeling and sensitivity to key assumptions, though its focus is credit rather than market risk. The stress‑testing methodology illustrated in Goldman Sachs’ 10‑K (Chunk 2) reflects the same industry‑standard use of scenario and sensitivity tools that AIG employs, underscoring the common reliance on these approaches across the two firms.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, no specific dollar amounts or dates are misstated—the mention of COF's ACL is not included in the LLM answer, but the ground truth specifies $13.0 billion as of December 31, 2024, which the LLM omits. This is a minor omission rather than an error. All other referenced practices are consistent with the time frame (2024 10-Ks). (2) The LLM correctly identifies that AIG uses scenario and sensitivity analysis for market risk stress testing, including interest rates, credit spreads, FX, equity, and commodities—this expands slightly beyond the ground truth (which doesn’t mention FX or commodities) but does not contradict it. (3) For COF, the LLM accurately states that credit loss forecasting uses scenario-based models with quantitative and qualitative inputs, tied to forward-looking economic conditions, which matches the ground truth. However, the LLM introduces a reference to Goldman Sachs’ 10-K (Chunk 2), which is not part of the original comparison and distracts from the direct AIG-COF analysis. This reflects a minor reasoning flaw—while the point about industry standards may be valid, it adds irrelevant information and implies a knowledge-graph link between AIG and COF via Goldman Sachs that isn’t supported in the ground truth. (4) The core comparison—that both firms use scenario and sensitivity analysis, but apply them to different risk types (market vs. credit)—is correctly synthesized and semantically equivalent to the original answer. The omission of COF’s $13.0 billion ACL figure prevents a perfect score, but the reasoning and entity accuracy for AIG and COF remain strong. Contextual relevance is high as the response directly addresses the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> ACCOUNTING_POLICY -[Used_For]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 481,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does Qualcomm's exposure to EAR regulations on advanced semiconductor technologies compare with AMD's specific constraints on exporting Versal VC2602 and VE2602 FPGAs to China, given both companies' involvement in high-performance computing markets?",
      "original_answer": "Qualcomm's business and products, including those of its customers and licensees, are subject to a broad range of regulations, including the U.S. Export Administration Regulations (EAR), which govern the export and re-export of advanced technologies, potentially affecting its business operations and results. In contrast, AMD faces specific export constraints under EAR, including requirements to file a Notified Advanced Computing (NAC) notification 25 days before shipping certain Versal VC2602 and VE2602 FPGAs to China or to customers outside the U.S. whose ultimate parent is headquartered in a D5 country, including China. These FPGAs are part of AMD's Data Center segment, which includes Field Programmable Gate Arrays (FPGAs) and other adaptive computing products. While both companies are impacted by EAR regulations, AMD's exposure is more directly constrained in terms of specific product lines and geographic markets, particularly affecting its ability to serve Chinese customers without prior regulatory approval, whereas Qualcomm's exposure is more diffuse across its broader regulatory risk profile.",
      "llm_answer": "\nQualcomm’s 10‑K filing (Chunk 1) makes clear that its business and products are subject to the broad reach of the U.S. Export Administration Regulations (EAR) and other governmental rules, so any adverse EAR ruling or regulatory change can directly restrict its sales of advanced semiconductor technologies worldwide.  \nAMD, by contrast, must comply with product‑specific EAR controls that currently require a 25‑day BIS “Notified Advanced Computing” filing and a license for shipments of its Versal VC2602 and VE2602 FPGAs to China—or to customers with Chinese‑based parents—while pending rule revisions could tighten those restrictions further (Chunk 2); these FPGAs are a core component of AMD’s Data‑Center and Embedded segments, which the company reports as part of its high‑performance computing portfolio (Chunk 3).  \nThus, while both firms operate in the high‑performance computing market and are bound by EAR, AMD’s export hurdles are narrowly focused on specific FPGA models and involve mandatory licensing and notification procedures, whereas Qualcomm’s exposure is more generalized across all of its advanced semiconductor offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth in both factual content and reasoning. (1) All key facts are correct: Qualcomm's broad exposure to EAR regulations is accurately described, as is AMD's specific requirement to file a 25-day Notified Advanced Computing (NAC) notification before shipping Versal VC2602 and VE2602 FPGAs to China or to customers with ultimate parents in D5 countries, including China. The mention of potential pending rule revisions adds context without contradicting the original. (2) Quantitative accuracy is perfect: the 25-day notification period is correctly cited, and no incorrect numbers or calculations are present. Format and references to product models (VC2602, VE2602) are exact. (3) Multi-hop reasoning is sound—LLM correctly synthesizes information across regulatory scope (broad vs. specific), product lines (FPGAs in AMD’s Data Center/Embedded segments), and geographic constraints. It contrasts Qualcomm’s diffuse regulatory risk with AMD’s targeted export hurdles, which aligns with the original answer’s core insight. (4) The only minor shortcoming is that the LLM answer does not explicitly name the 'D5 countries' as in the original, though it correctly identifies Chinese-headquartered parents as a trigger, implying the same restriction. It also refers to 'a license' being required, while the original specifies only a notification (NAC filing), not necessarily a license—this is a slight overstatement but consistent with the general tightening of controls. Overall, the answer is semantically equivalent, well-structured, and contextually precise, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Governs]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1592,
        "completion_tokens": 452,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does CMCSA's relinquishment of voting rights in Hulu contrast with META's dual-class stock structure in terms of control retention strategies?",
      "original_answer": "CMCSA relinquished substantially all voting rights associated with its investment in Hulu in 2019, including board seats, in exchange for a put/call arrangement with Disney that guaranteed a minimum equity value of $27.5 billion for its interest and resulted in an $8.6 billion payment from Disney in 2023. This contrasts with META's dual-class stock structure where Class B shares carry 10 votes per share compared to 1 vote for Class A shares, allowing certain stockholders to maintain significant voting power while owning a minority of economic interests. CMCSA's approach involved transferring control to Disney in exchange for financial guarantees, whereas META retains internal control differentiation through its stock classification framework.",
      "llm_answer": "\nCMCSA gave up essentially all voting rights in Hulu—surrendering board seats and consent rights and later exercising its put to sell its stake for $8.6 bn—so it no longer has any influence over Hulu’s management.  By contrast, META retains tight voting control through a dual‑class structure in which Class B shares carry 10 votes each (the KG link Voting Rights → Class A Common Stock → META and the description of Class B in the Alphabet filing), allowing insiders to dominate decisions despite modest equity ownership.  Thus, CMCSA’s strategy eliminates voting power, whereas META’s structure is expressly designed to preserve it.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core contrast between CMCSA's relinquishment of control in Hulu and META's retention of control via dual-class shares. (1) All factual elements are correct: CMCSA gave up voting rights and board seats in Hulu, and received $8.6 billion from Disney (in 2023, as per ground truth), which aligns with the put/call arrangement that guaranteed a $27.5 billion minimum equity value. The LLM correctly notes the financial outcome ($8.6B) though it omits the $27.5B guaranteed value figure, a minor omission. (2) Quantitatively, the $8.6 billion amount is accurate and correctly attributed. No incorrect numbers or dates are present. The year 2019 (when CMCSA relinquished rights) is not mentioned in the LLM answer, which is a small gap, but the financial outcome is correctly tied to the put exercise. (3) The reasoning is sound: the LLM correctly identifies that CMCSA traded control for financial certainty, while META uses a dual-class structure (Class B with 10 votes vs Class A with 1) to retain voting control. The reference to Alphabet’s filing is slightly misplaced (should be META’s own structure, not Alphabet’s), but the description of 10-vote Class B shares is accurate for META. (4) The answer is contextually relevant and directly addresses the contrast in control retention strategies. The omission of the $27.5B guarantee and the 2019 date prevents a perfect score, but the core multi-hop synthesis—comparing a control-for-cash exit with an internal control-preserving stock structure—is correctly executed. Semantic equivalence is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 436,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does Goldman Sachs' $113.9 billion in broker-dealer assets influence its approach to managing conflicts of interest under Regulation Best Interest, compared to Morgan Stanley's compliance framework for the same regulatory obligations?",
      "original_answer": "Goldman Sachs manages $113.9 billion in broker-dealer assets as of December 2024, which necessitates a robust compliance framework under Regulation Best Interest to ensure recommendations align with retail customers' best interests, especially given the SEC's requirement that broker-dealers avoid placing their own interests ahead of clients. This asset size increases the complexity of conflict management, particularly in areas like variable insurance product sales and investment strategy recommendations. Similarly, Morgan Stanley explicitly states it is subject to Regulation Best Interest, which governs its broker-dealer sales practices and customer relationships, including conflict mitigation. Both firms must maintain stringent internal controls, but Goldman's larger broker-dealer asset base may require more extensive monitoring and disclosure protocols to satisfy the same impartial conduct standards outlined in the regulation, particularly as both firms face potential litigation and regulatory scrutiny tied to compliance.",
      "llm_answer": "\nGoldman Sachs reports $113.9 billion of broker‑dealer assets (Chunk 1), a scale that forces the firm to embed extensive conflict‑of‑interest monitoring, robust disclosure controls and dedicated compliance resources to satisfy the SEC’s Regulation Best Interest for retail recommendations; Morgan Stanley’s disclosures (Chunk 2 & 3) show a compliance framework that leans on the same “best‑interest” standard but is anchored in its net‑capital rules, SEC‑registered broker‑dealer subsidiaries and ongoing oversight of sales practices, while also navigating ERISA‑related fiduciary rules and recent regulatory changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $113.9 billion in broker-dealer assets for Goldman Sachs is correctly reported, matching the original answer. No other numerical values are present, and no calculations are required. (2) The answer addresses both parts of the multi-hop question: Goldman Sachs’ approach to conflicts under Regulation Best Interest given its asset size, and Morgan Stanley’s compliance framework under the same regulation. It correctly identifies that both firms are subject to the same regulatory standard but implement it within different structural and oversight contexts. (3) Entity accuracy is strong: Goldman Sachs and Morgan Stanley are correctly named, Regulation Best Interest is accurately referenced, and the regulatory context (SEC, broker-dealer obligations) is properly framed. The mention of ERISA-related fiduciary rules adds context not in the original but is factually plausible and does not detract. (4) Reasoning is sound: the LLM infers that larger asset规模 implies more extensive compliance infrastructure, which is logically consistent with regulatory expectations. The synthesis across entities is correct, though the original emphasizes Goldman’s potentially greater monitoring burden due to asset size, a nuance slightly underdeveloped in the LLM response. However, the core comparative insight is preserved. Wording differs but semantic equivalence is maintained. Minor deduction in qualitative accuracy due to less explicit emphasis on comparative scale-driven complexity, but overall highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> COMP -[Applies_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 438,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How might Intel's IDM 2.0 strategy, which includes expanding manufacturing capacity with the aim of attracting foundry customers, be affected by Samsung's development of in-house integrated circuits, and what implications could this have for Qualcomm's semiconductor business given its reliance on external integrated circuit customers?",
      "original_answer": "Intel's IDM 2.0 strategy involves significant capital expenditures to expand manufacturing capacity with the goal of attracting foundry customers (chunk 1). However, Samsung, a key potential customer for Intel's foundry services, is developing its own integrated circuit products, which it may increasingly use in its own devices and potentially sell to third parties in competition with others in the market (chunk 2). This vertical integration by Samsung could limit Intel's ability to secure foundry business from Samsung, making Intel's IDM 2.0 capacity investments riskier and potentially leading to underutilized facilities or increased pricing pressure to attract other customers. Qualcomm, which derives a significant portion of its revenues from sales of its own integrated circuit products to OEMs (chunk 3), could face intensified competition if Samsung's in-house chips gain market traction, particularly in segments like mobile and automotive. Additionally, if Intel responds by lowering prices to attract other foundry clients, it could indirectly affect the broader semiconductor pricing environment, potentially impacting Qualcomm's cost structure or competitive positioning.",
      "llm_answer": "\nIntel’s IDM 2.0 expansion hinges on winning foundry customers, but because Samsung—linked to Intel in the KG (INTC → Samsung) and itself developing in‑house integrated‑circuit products (Chunk 1 and Chunk 2)—is simultaneously pursuing vertical integration, the same customers Intel seeks may instead bring IC design inside their own factories, heightening the under‑utilisation risk Intel cites for its new capacity (Chunk 1).  This shrinking external IC market directly threatens Qualcomm’s QCT semiconductor business, which relies on outside IC customers, a dependence that is evident in Qualcomm’s segment structure and its licensing model (Chunk 2 + Chunk 3).  Consequently, any slowdown in Intel’s ability to fill its new fabs—driven by Samsung’s in‑house IC push—would further reduce the pool of external IC customers that Qualcomm depends on, amplifying competitive pressure on both firms.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core multi-hop reasoning required. (1) It correctly identifies that Intel's IDM 2.0 strategy depends on attracting foundry customers, but Samsung's in-house IC development poses a risk by reducing external demand. It also correctly links this to Qualcomm's reliance on external IC customers, noting competitive and market-contraction risks. (2) There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The reasoning is sound but slightly misrepresents the nature of Samsung's threat: the ground truth emphasizes Samsung may *compete* with Qualcomm using its own chips, whereas the LLM frames the issue as OEMs bringing design in-house, which is a related but distinct point. Additionally, the LLM overemphasizes Samsung's direct link to Intel without clarifying that Samsung is a *potential* customer, not a confirmed one. Also, the claim that Samsung is 'linked to Intel in the KG (INTC → Samsung)' is vague and not clearly supported in the original answer. (4) Despite these nuances, the LLM synthesizes across the required entities (Intel, Samsung, Qualcomm) and correctly infers competitive and market-structure implications. The answer is contextually relevant and semantically close to the original, warranting a high correctness score with minor deductions for imprecise reasoning about the competitive dynamics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Develops]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1569,
        "completion_tokens": 406,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How does VZ's monetization of wireless tower infrastructure through exclusive arrangements with American Tower Corporation compare to NFLX's reliance on exclusive content rights in terms of upfront capital impact and long-term strategic control?",
      "original_answer": "VZ received an upfront payment of $5.0 billion from American Tower Corporation in 2015 for exclusive rights to 11,300 wireless towers, while retaining operational control through subleased capacity and continuing depreciation of the towers. This allowed VZ to monetize infrastructure assets while maintaining network usage flexibility. In contrast, NFLX pursues exclusive content rights to differentiate its service, which requires ongoing licensing costs and exposes the company to risks of content withdrawal and increased programming expenses. Unlike VZ's capital-generating tower arrangement, NFLX's exclusive content strategy represents a cost center rather than a revenue source, with no upfront payments received and instead involves financial commitments to secure programming advantages.",
      "llm_answer": "\nVerizon monetizes its tower portfolio by granting exclusive lease‑and‑management rights to American Tower (and, more recently, to Vertical Bridge) in exchange for upfront payments of $5 billion (2015) and $2.8 billion (2024); the cash is recorded as prepaid rent and a financing obligation while the towers remain on Verizon’s balance sheet and are sub‑leased back for 10 years with renewal options, giving Verizon immediate capital but transferring operational control of the assets for up to ~30 years. Netflix, by contrast, does not receive a comparable cash infusion; instead it secures exclusive streaming‑content rights that are disclosed as an accounting policy and can be withdrawn on short notice, granting the company strategic leverage over its content library but exposing it to cost volatility and supply risk. Thus, Verizon’s exclusive tower arrangements generate a large, upfront cash inflow and shift operational control to third‑party operators, whereas Netflix’s exclusive content rights provide strategic differentiation without an upfront cash payment but with ongoing reliance on the renewal and availability of those rights.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core contrast between VZ's capital-generating tower monetization and NFLX's cost-center content exclusivity strategy. However, there are minor quantitative inaccuracies: the original answer specifies only the $5.0 billion 2015 transaction with American Tower Corporation, while the LLM adds a $2.8 billion 2024 transaction with Vertical Bridge, which is not present in the ground truth and introduces unsupported information. This affects quantitative accuracy. The original answer emphasizes VZ retained operational control via subleased capacity and continued depreciation—details partially reflected in the LLM’s mention of sub-leases and balance sheet retention, but the LLM incorrectly states that operational control was transferred to third parties ('transferring operational control'), which contradicts the ground truth that VZ retained control. This is a key qualitative nuance. The LLM correctly identifies that NFLX’s exclusives involve no upfront payments, are subject to withdrawal, and represent ongoing costs, aligning with the original. The reasoning is sound in comparing capital impact (upfront inflow vs. ongoing outflow) and strategic control (retained flexibility vs. renewal risk), fulfilling the multi-hop requirement across companies and strategies. Wording differences are acceptable under semantic equivalence, but the incorrect implication about transfer of operational control and the addition of an unverified second transaction prevent a top score. Contextual relevance is excellent, directly addressing both parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Transacts_With]-> COMP -[Acquires]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 439,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the Tax Reform Act's GILTI provisions impact KO's effective tax rate in 2022, and how does this contrast with the effect of the corporate income tax rate reduction in the Philippines on PEP's operations in that market?",
      "original_answer": "KO's effective tax rate in 2022 was impacted by the Tax Reform Act's GILTI provisions, which required the inclusion of foreign subsidiaries' excess earnings in U.S. income tax returns, contributing to a 1.2% impact on KO's effective tax rate through pretax charges of $710 million related to equity method investee impairments. In contrast, PEP's operations in the Philippines experienced low-single-digit growth, and the corporate income tax rate reduction enacted in the Philippines in Q1 2021 contributed to a favorable impact on PEP's effective tax rate, lowering it by an unspecified but notable amount. This illustrates how the same U.S. tax reform had divergent effects—raising KO's tax burden through GILTI while enabling PEP to benefit from lower local corporate taxes.",
      "llm_answer": "\nThe Tax Reform Act’s GILTI provisions added roughly a **3.0 percent (≈ $375 million) charge to KO’s 2022 effective tax rate**, as disclosed in its 10‑K where the company notes that the GILTI rules required inclusion of foreign‑subsidiary earnings in excess of an allowable return and that the resulting tax effect is reflected in the full‑year provision.  By contrast, the **corporate‑income‑tax‑rate reduction in the Philippines (enacted in Q1 2021) offset GILTI‑related pressure on PEP’s tax position**, contributing to only a **0.1‑percentage‑point rise in PEP’s 2021 effective tax rate to 21.8 %**; this lower Philippine rate also underpinned the **low‑single‑digit volume growth and a 2‑percentage‑point profit contribution from the Be & Cheery acquisition** highlighted in PEP’s 10‑K.  Thus, while GILTI increased KO’s tax burden, the Philippine tax cut eased PEP’s effective tax rate and supported stronger operational performance in that market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, KO's GILTI-related impact was a 1.2% increase in the effective tax rate due to $710 million in pretax charges from equity method investee impairments. However, the LLM claims a 3.0% increase tied to a $375 million charge, which contradicts the original data on both magnitude and amount. These numbers are not close and represent a major quantitative error. For PEP, the ground truth states the Philippine tax rate reduction had a 'favorable impact' that lowered PEP's effective tax rate by an 'unspecified but notable amount,' while the LLM invents a precise figure of only a 0.1-percentage-point rise in PEP’s 2021 tax rate to 21.8%, which is not supported by the original answer and misrepresents the timing (question asks about 2022, not 2021). Additionally, the LLM introduces unrelated details such as the Be & Cheery acquisition contributing 2 percentage points to profit, which is absent from the ground truth and unverifiable. (2) Number verification: $710M → 1.2% for KO is the correct pairing; LLM reports $375M → 3.0%, which is factually wrong. Philippine tax effect is unspecified; LLM assigns specific metrics not in the source. (3) Multi-hop reasoning is partially sound in structure—comparing U.S. GILTI impact on KO with local tax changes benefiting PEP—but fails in execution due to fabricated data. The contrast concept is valid, but the support is inaccurate. (4) Correctness score is low (3) due to major factual and numerical errors. Quantitative accuracy is very poor (2) because key figures are incorrect. Qualitative accuracy is moderate (4) as the general direction of effects (GILTI increases tax burden, local cuts reduce it) aligns, but details are flawed. Contextual relevance is decent (7) because the response addresses both companies and the tax policy contrast as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> REGULATORY_REQUIREMENT -[Regulates]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 516,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does the $1.3 billion in restricted retained earnings at Nicor Gas impact Southern Company's ability to receive dividends from its subsidiaries, given that Nicor Gas is a key subsidiary under Southern Company Gas?",
      "original_answer": "Nicor Gas, as a regulated subsidiary under Southern Company Gas, has $1.3 billion in retained earnings that are restricted from being distributed as dividends or loans to affiliates. This restriction directly limits Southern Company's ability to receive dividend payments from Nicor Gas, which in turn affects the consolidated cash flows and financial flexibility of Southern Company, especially since Southern Company relies on equity earnings and dividends from its subsidiaries for a significant portion of its income.",
      "llm_answer": "\nThe $1.3 billion of retained earnings at Nicor Gas is legally “restricted” – under the regulatory framework that governs Southern Company Gas, Nicor may dividend or loan to affiliates only to the extent of its unrestricted retained earnings, and it cannot use money‑pooling or affiliate loans to bypass this cap (as noted in the Southern Company filing and reflected in the $1.3 billion restriction figure). Because dividends from subsidiaries flow upward to Southern Company, only the portion of Nicor’s earnings that is not subject to this restriction can be distributed, thereby limiting the amount of dividend cash Southern Company can ultimately receive from Nicor Gas; this regulatory dividend restriction is consistent with the broader dividend‑restriction environment described for NEE’s subsidiaries in the NEE filing. Consequently, despite Nicor Gas’s ongoing operations (e.g., the tax‑pass‑through and expense trends documented in the 2021 financials), the $1.3 billion cap on its retained earnings directly constrains Southern Company’s ability to capture dividends from that key subsidiary.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $1.3 billion figure is correctly cited and consistently referenced as restricted retained earnings at Nicor Gas. No calculations are required, and the amount is presented accurately. (2) The answer correctly identifies the regulatory restriction on dividend distributions from Nicor Gas to Southern Company due to the $1.3 billion cap on unrestricted retained earnings, which directly limits Southern Company’s ability to receive dividends. This matches the core of the original answer. (3) The reasoning is sound: it explains the regulatory framework, the flow of dividends from subsidiaries to parent, and the impact on Southern Company’s financial flexibility. The mention of 'money-pooling or affiliate loans' adds regulatory context consistent with SEC filings. (4) The only minor shortcoming is the reference to 'NEE’s subsidiaries' and 'NEE filing', which introduces an irrelevant comparison to NextEra Energy (NEE), not mentioned in the question or ground truth. This does not affect the correctness of the Nicor-Southern Company analysis but slightly detracts from qualitative accuracy by introducing an extraneous entity. Otherwise, the answer is semantically equivalent, contextually relevant, and factually correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Subject_To]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 367,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How do Tesla's and GM's compliance costs related to evolving vehicle safety standards compare, given the increasing regulatory complexity under the National Traffic and Motor Vehicle Safety Act?",
      "original_answer": "Tesla faces rising compliance costs due to evolving international vehicle safety standards, particularly for its Autopilot and FSD (Supervised) features, which must meet varying requirements across jurisdictions and may delay or restrict functionality. GM similarly notes that compliance with the National Traffic and Motor Vehicle Safety Act is costly, with global regulatory divergence—especially between North American and UN-ECE based standards—adding complexity and expense to vehicle development. Both companies emphasize the financial burden of maintaining compliance as safety standards evolve and expand globally, with GM specifically highlighting the lack of harmonization as a key driver of increased costs.",
      "llm_answer": "\nBoth Tesla and GM incur substantial and rising compliance costs under the National Traffic and Motor Vehicle Safety Act, because they must continually adapt their vehicles to ever‑more stringent U.S. safety standards and the evolving UN‑ECE regulations that govern recalls, defect remediation and global type‑approval processes.  Tesla’s disclosures highlight heightened litigation, government scrutiny and the need to redesign Autopilot/FSD features to meet a fragmented regulatory landscape, while GM’s filings stress that meeting evolving safety standards and bearing the potentially large expense of safety‑recall campaigns under the Safety Act adds significant financial exposure for the company.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of the core issue: both Tesla and GM face rising compliance costs due to evolving vehicle safety standards under the National Traffic and Motor Vehicle Safety Act and global regulatory divergence. The answer correctly identifies Tesla's challenges with Autopilot/FSD features facing regulatory scrutiny and redesign needs, and GM's burden from safety recalls and evolving standards. However, it misses a key point from the original answer: GM explicitly cites the lack of harmonization between North American and UN-ECE standards as a major cost driver, which the LLM answer only partially captures by referencing 'UN-ECE regulations' without emphasizing the lack of alignment as a central issue. Additionally, while the LLM mentions 'global type-approval processes' and 'fragmented regulatory landscape,' it does not clearly articulate that Tesla’s compliance burden stems from varying international requirements affecting functionality deployment—this nuance is present but less precise. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. The reasoning is sound and contextually relevant, but the qualitative accuracy is slightly reduced due to incomplete synthesis of the specific multi-hop insight about regulatory divergence and harmonization. The answer remains semantically close and addresses the main comparison adequately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Regulates]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 401,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does General Dynamics' deferral of $305 million in other contract costs under FAR regulations compare to Raytheon Technologies' exposure to cost overruns under its fixed-price U.S. government contracts, given the differing financial risk profiles associated with these contract cost management approaches?",
      "original_answer": "General Dynamics defers $305 million in other contract costs under FAR regulations that govern cost allowability and allocation to U.S. government contracts, with recovery expected through existing backlog and follow-on contracts. These costs are not currently allocable but are maintained as assets pending future allocation. In contrast, Raytheon Technologies faces financial risk on its fixed-price contracts, particularly firm fixed-price (FFP) contracts, where it bears the full burden of cost overruns without reimbursement. This creates a more direct financial exposure compared to General Dynamics’ deferred cost model. The difference in risk stems from the fact that FAR-regulated cost recovery allows General Dynamics to defer recognition of certain costs until allocable, while Raytheon must absorb overruns on fixed-price contracts, which constitute a significant portion of its U.S. government contract portfolio.",
      "llm_answer": "\nGeneral Dynamics has deferred $305 million of “other contract costs” – amounts that are not currently allocable to U.S. government contracts under the Federal Acquisition Regulation (FAR) and Cost Accounting Standards – and records them as other current assets, expecting to recover the amounts as future contract billings become permissible; this deferral shifts the expense timing but leaves recovery dependent on the continuation of its backlog. In contrast, Raytheon Technologies bears the full burden of cost overruns on its fixed‑price U.S. government contracts (FFP/FPI), where any excess above target or ceiling prices directly reduces contract profit and may require the company to fund the overrun out‑of‑pocket, illustrating a markedly higher immediate financial‑risk profile despite both firms operating under the same FAR‑governed regulatory framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) Quantitatively, the $305 million deferral by General Dynamics is correctly stated, and no other numerical values are present that could introduce error. The format '$305 million' matches the original. (2) The qualitative analysis correctly identifies that General Dynamics defers non-allocable costs under FAR, records them as assets (specifically other current assets), and expects recovery through future billings tied to backlog—this aligns with the ground truth's mention of recovery via existing and follow-on contracts. For Raytheon, the LLM accurately describes the financial risk of fixed-price contracts (FFP/FPI), noting that overruns reduce profit or require out-of-pocket funding, which reflects the higher immediate financial exposure described in the original. (3) The multi-hop reasoning is sound: the model correctly contrasts two different risk profiles—deferral and potential recovery (General Dynamics) vs. absorption of overruns (Raytheon)—under the same FAR framework, demonstrating synthesis across entities and contract types. (4) The only reason for not scoring a 10 in qualitative accuracy is that the LLM does not explicitly mention that Raytheon’s fixed-price contracts constitute a 'significant portion' of its government portfolio, a detail included in the original that adds context to the scale of exposure. However, this omission does not undermine the correctness of the risk comparison. Wording differs but semantic meaning is equivalent or nearly so. All entities (General Dynamics, Raytheon Technologies, FAR, FFP/FPI) are correctly identified and applied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Regulates]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 468,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does the compound annual growth rate (CAGR) of Intel's Taiwan revenue from 2019 to 2021 compare to Apple's Greater China segment revenue growth over the same period, given that Taiwan is included within Apple's Greater China reporting?",
      "original_answer": "Intel's Taiwan revenue grew from $10,058 million in 2019 to $13,461 million in 2021, representing a CAGR of approximately 15.6%. Apple's Greater China revenue increased from $40,308 million in 2019 to $68,366 million in 2021, yielding a CAGR of approximately 30.8%. Therefore, Apple's Greater China segment revenue grew at more than double the rate of Intel's Taiwan-specific revenue during this period.",
      "llm_answer": "\nIntel’s Taiwan revenue rose from **$10.06 bn (2019)** to **$13.46 bn (2021)**, producing a compound annual growth rate of **≈ 15.6 %** over the two‑year span (calculated as √(13,461/10,058) – 1).  \nApple’s Greater China segment net sales increased from **$40.31 bn (2020)** to **$68.37 bn (2021)**, which annualizes to a CAGR of **≈ 31 %** for the same 2019‑2021 period (√(68,366/40,308) – 1).  \n\nBecause the KG relationship **INTC → Taiwan → Greater China ← AAPL** shows that Taiwan is included within Apple’s Greater China reporting, Apple’s segment growth substantially outpaces Intel’s Taiwan growth, reflecting the broader market dynamics captured in the Greater China segment.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in terms of core facts but contains a critical error in the time period used for Apple's revenue growth calculation. The original answer and question specify the 2019–2021 period, but the LLM incorrectly states that Apple’s revenue increased from $40.31 billion in 2020 (not 2019) to $68.37 billion in 2021. This misstates the base year, leading to an inaccurate CAGR calculation window. The correct Apple revenue for 2019 is $40,308 million as per the ground truth, not 2020. (2) The CAGR formula is correctly applied (√(end/start) – 1 for two-year CAGR), and the resulting ≈31% is close to the ground truth 30.8%, so the final percentage is approximately accurate despite the wrong base year. Intel’s numbers are correctly cited: $10,058M (≈$10.06B) in 2019 and $13,461M (≈$13.46B) in 2021, with correct CAGR of ~15.6%. (3) The multi-hop reasoning is sound: the model correctly identifies the geographical inclusion (Taiwan ⊂ Greater China) and leverages the relationship INTC → Taiwan → Greater China ← AAPL to contextualize the comparison, showing awareness of reporting structures. (4) Despite the factual error in Apple’s start year, the conclusion that Apple’s Greater China growth substantially outpaces Intel’s Taiwan growth is valid, as both the correct and computed CAGRs show Apple growing at more than double Intel’s rate. However, the use of 2020–2021 instead of 2019–2021 undermines quantitative accuracy. Wording and formatting (e.g., $10.06 bn) are acceptable variants. Thus, correctness is reduced due to incorrect input years for Apple, but qualitative reasoning and overall message remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 455,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "Given Alphabet's $70 billion share repurchase authorization targeting Class A and Class C shares in 2024, how might the repurchase activity influence Class B shareholders' decisions to convert shares to Class A, especially in light of Meta's disclosure of a significantly larger Class A share base compared to Class B outstanding shares?",
      "original_answer": "Alphabet's $70 billion share repurchase program, which includes Class A shares, could reduce the supply of Class A shares in the market, potentially increasing their relative value. This may incentivize Class B shareholders—who hold shares with 10x voting rights but often face restrictions on holding Class A shares after conversion—to convert and sell Class A shares before further scarcity and price appreciation occur. However, Meta's 2024 disclosure shows that it has 2,189,898,148 Class A shares and only 343,761,117 Class B shares outstanding, indicating a much larger float of Class A shares in the market. This abundance of Class A shares at Meta may temper conversion urgency compared to Alphabet, as Class A shares at Meta are likely more liquid and less affected by repurchase-induced scarcity.",
      "llm_answer": "\nAlphabet’s $70 billion repurchase program is directed at its Class A and Class C shares, which can tighten the supply of those classes and support their market price. Because Class B shares convert one‑for‑one into Class A and Class B holders must subsequently sell or otherwise transfer any Class A shares they receive, the prospect of a higher Class A price makes conversion increasingly attractive—especially since Meta’s 2024 filing shows a Class A share base of roughly 2.19 billion shares versus only 344 million Class B shares, indicating ample Class A stock for new conversions. Consequently, Class B shareholders may choose to convert to Class A to capture the upside from the repurchase‑driven price rise and to comply with the restriction that they cannot retain the newly acquired Class A shares.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and matches the ground truth in key aspects. (1) Quantitative accuracy is perfect: the $70 billion repurchase amount is correctly cited, and the Class A (2.19 billion) and Class B (344 million) share counts for Meta are accurate approximations of the ground truth values (2,189,898,148 and 343,761,117 respectively), with acceptable rounding. (2) The answer addresses the core mechanism: Alphabet's repurchase of Class A shares reduces supply, potentially increasing their value, which incentivizes Class B shareholders to convert and sell due to restrictions on holding Class A shares post-conversion. (3) The multi-hop reasoning is sound—correctly linking Alphabet’s repurchase program to conversion incentives and using Meta’s share structure as a comparative benchmark. However, the LLM misinterprets the implication of Meta’s large Class A float: while it correctly reports the data, it states that 'ample Class A stock for new conversions' makes conversion more attractive, whereas the ground truth argues the opposite—that Meta’s abundant Class A shares reduce scarcity effects and thus *temper* conversion urgency compared to Alphabet. This is a qualitative error in reasoning logic, slightly undermining the synthesis. (4) Despite this, the answer remains contextually relevant and factually strong, earning high marks overall, but not full points due to the inverted interpretation of Meta's comparative impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Changes_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 400,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does the treatment of dividend equivalents in RSU awards differ between PepsiCo and Philip Morris International in terms of vesting conditions and financial obligations as of 2023?",
      "original_answer": "PepsiCo accrues dividend equivalents during the vesting period for both RSUs and PSUs, which are paid out in cash when the award vests. Philip Morris International also accrues dividend equivalents on RSU awards, but its RSUs generally vest on the third anniversary of the grant date and do not carry voting rights. As of December 31, 2023, PMI had $160 million of total unrecognized compensation costs related to non-vested RSU awards, which are being amortized over the restriction period or upon specific life events.",
      "llm_answer": "\nPepsiCo’s RSU (and PSU) awards accrue dividend‑equivalents that are paid **in cash, without interest, only when the award actually vests at the end of the service period** – a period that can be lengthened or shortened by performance‑based thresholds – and the fair value of those awards is measured at the grant‑date stock price.  \nPhilip Morris International’s RSU awards **generally vest on the third anniversary of the grant date, are subject to forfeiture if employment conditions are not met, and although they also earn dividend‑equivalents, the related compensation expense ($160 million of unrecognized cost as of 31 Dec 2023) is amortized over the restriction period (typically three years) and will be recognized over roughly 17 months or upon death, disability or reaching age 58**.  \nConsequently, PepsiCo ties vesting and dividend‑equivalent payout to performance‑adjusted service and settles the dividend equivalent in cash at vesting, whereas PMI uses a fixed‑date vesting schedule with forfeiture risk and spreads the expense recognition over a longer, conditional period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PepsiCo accrues dividend equivalents paid in cash upon vesting, which can be performance-adjusted; PMI’s RSUs generally vest on the third anniversary, accrue dividend equivalents, and had $160 million in unrecognized compensation costs as of December 31, 2023. The dollar amount, date, and vesting period are all factually correct. (2) Quantitative accuracy is perfect: $160 million and December 31, 2023, are correctly cited. (3) Multi-hop reasoning is sound—LLM correctly contrasts PepsiCo’s performance-linked vesting and cash settlement of dividend equivalents with PMI’s fixed vesting schedule, forfeiture conditions, and amortization of expenses over the restriction period or upon specific life events (e.g., death, disability, age 58). (4) Minor deduction in qualitative accuracy due to slight over-elaboration on PepsiCo’s performance thresholds and PMI’s expense recognition period (‘roughly 17 months’) not explicitly in the original, though consistent with amortization patterns. However, no factual contradiction. Semantic equivalence is strong, and all parts of the question—vesting conditions and financial obligations—are fully addressed. Contextual relevance is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 360,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does DHR's use of NAV and discounted cash flow in valuing private investments compare to LLY's reliance on fair value estimation for acquired intangible assets, considering the inherent subjectivity in both approaches as highlighted in their respective disclosures?",
      "original_answer": "DHR utilizes NAV based on fund manager inputs and applies discounted cash flows, earnings multiples, and third-party appraisals to estimate the fair value of private investments, acknowledging that these methods may not reflect net realizable value or future fair values. LLY, on the other hand, applies fair value estimation to acquired intangible assets such as IPR&D, which required $3.80 billion in charges in 2023 alone, and admits that final valuations may change significantly as fair values are finalized within one year post-acquisition. Both companies recognize the subjectivity involved in fair value estimation, with DHR noting that different methodologies can yield materially different results and LLY emphasizing the need for considerable judgment in determining the fair value of acquired assets, especially under limited access to pre-acquisition data.",
      "llm_answer": "\nDHR values its private‑equity investments by reference to the fund‑manager‑provided NAV and typically applies discounted‑cash‑flow, earnings or market‑multiple analyses, explicitly warning that the resulting fair‑value estimates are subjective and can vary with different assumptions (Chunk 1).  LLY, when acquiring intangible assets, records them at fair value based on management’s significant estimates and assumptions at the acquisition date, a process the company likewise flags as highly judgmental and subject to revision (Chunk 3), and the broader market‑fair‑value discussion in Chunk 2 notes that such estimates depend on market conditions and valuation methodologies.  Consequently, both companies rely on inherently subjective fair‑value measurements—DHR through NAV‑based and DCF‑driven private‑investment valuations, and LLY through acquisition‑related fair‑value estimation of intangibles—linking their accounting policies via the disclosed subjectivity (KG triplets).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original ground truth. (1) All factual elements are correct: DHR uses NAV based on fund manager inputs and applies discounted cash flow, earnings multiples, and third-party appraisals for private investments, while LLY uses fair value estimation for acquired intangible assets like IPR&D. Both disclose the subjectivity of their methods. (2) Quantitative accuracy is perfect—no numerical data is misstated. The original answer mentions LLY’s $3.80 billion in charges in 2023, which the LLM omits, but this is a minor omission rather than an error. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across DHR’s and LLY’s valuation approaches, identifying the common thread of subjectivity in fair value estimation. It accurately contrasts DHR’s private investment valuations with LLY’s intangible asset valuations. (4) The answer is contextually relevant and directly addresses the comparison requested, emphasizing the shared reliance on judgment and assumptions. The only reason for not scoring a 10 is the omission of the specific $3.80 billion charge by LLY in 2023, which is a notable quantitative detail in the original answer. However, since the LLM captures all qualitative and conceptual elements accurately, the correctness score is 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Impacts]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 369,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does NVIDIA's revenue from Taiwan in 2022 compare to Apple's reported revenue from the Greater China segment, given that Apple's geographic reporting includes Taiwan within Greater China?",
      "original_answer": "NVIDIA reported $8,544 million in revenue from Taiwan in 2022, while Apple reported $74,200 million in net sales from the Greater China segment in the same year. Since Apple explicitly includes Taiwan within its Greater China geographic reporting, NVIDIA's Taiwan-specific revenue constitutes a subset of the broader regional revenue that Apple reports, reflecting different levels of geographic granularity in their respective segment disclosures.",
      "llm_answer": "\nNVIDIA’s 2022 revenue from Taiwan was **$8,544 million** (Chunk 1), and because Apple’s geographic reporting groups Taiwan into its **Greater China** segment, Apple’s 2022 net sales for that segment totaled **$74,200 million** (Chunk 3). Since the KG relationship shows Taiwan → Greater China → AAPL, Apple’s Greater China revenue is roughly **8.7 times larger** than NVIDIA’s Taiwan revenue, underscoring the markedly greater scale of Apple’s operations in that market (Chunk 2 confirms Taiwan is included within Apple’s Greater China reporting).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the revenue figures are accurate: NVIDIA's $8,544 million from Taiwan and Apple's $74,200 million from Greater China in 2022 are correctly reported, with acceptable formatting (e.g., $8,544 million). The comparison stating Apple’s revenue is 'roughly 8.7 times larger' is mathematically sound: 74,200 / 8,544 ≈ 8.68, which rounds to 8.7. (2) The answer is complete, addressing both companies' revenues, the geographic inclusion of Taiwan in Apple’s Greater China segment, and the difference in reporting granularity. (3) Entity accuracy is perfect: correct company names (NVIDIA, Apple), correct geographic segments (Taiwan, Greater China), correct year (2022), and correct metric (revenue/net sales). (4) The multi-hop reasoning is sound—correctly synthesizing that because Apple includes Taiwan in Greater China, its regional revenue encompasses a broader area than NVIDIA’s Taiwan-specific figure, making direct comparisons reflect scale differences rather than overlapping data. The conclusion about differing geographic granularity is logically supported. (5) The semantic meaning fully aligns with the original answer, with added value in quantifying the scale difference. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 369,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does the concentrated voting power in CMCSA's Class B common stock compare to the shareholder structure disclosed for GOOGL's Class A common stock in terms of control and ownership distribution?",
      "original_answer": "CMCSA's Class B common stock, held entirely by Brian L. Roberts, represents 33⅓% of the combined voting power with each share carrying 15 votes, creating significant control concentration. In contrast, GOOGL's Class A common stock, with 300,754,904 shares outstanding as of January 25, 2022, is broadly distributed among non-affiliates, with voting rights presumably more dispersed given the large number of shares and absence of similar super-voting structures described for CMCSA. This indicates a stark difference in governance dynamics, with CMCSA maintaining centralized control through Class B shares, while GOOGL's structure suggests more distributed shareholder influence.",
      "llm_answer": "\nCMCSA’s Class B common stock is held by only **three record holders** (Chunk 1) and, under the company’s charter, carries **33 % of the total voting power** that is **non‑dilutable and entirely owned by Mr. Brian L. Roberts** (Chunk 2).  In contrast, Alphabet’s (GOOGL) Class A common stock consists of **≈300 million shares outstanding** (Chunk 3) and, together with the broader shareholder base, distributes voting rights broadly—there is no single or small group of Class A holders with outsized control, and any concentrated voting influence resides in the separate Class B and Class C shares rather than in Class A itself.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Correctly identifies that CMCSA's Class B stock carries 33⅓% of voting power (rounded to 33% is acceptable) and is entirely held by Brian L. Roberts, despite initial mention of 'three record holders'—this minor contradiction is resolved by the clarification that it is 'entirely owned by Mr. Brian L. Roberts', aligning with ground truth. (2) Correctly states GOOGL Class A shares outstanding as ~300 million, matching the ground truth figure of 300,754,904 as of January 25, 2022 (rounding is acceptable). (3) Reasoning is sound: correctly contrasts CMCSA’s centralized control via super-voting Class B shares with GOOGL’s broadly distributed Class A shares, noting that concentrated voting power in Alphabet resides in other share classes (Class B/C), not Class A—this aligns with the multi-hop logic required. (4) Semantic equivalence is strong: while wording differs, all key facts—ownership concentration, voting power distribution, and governance implications—are accurately conveyed. Minor deduction in quantitative accuracy due to initial 'three record holders' vs. ultimate attribution to Roberts alone, which could cause confusion but is later corrected.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 351,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does the ratio of securities remaining available for future issuance to those issuable upon exercise of outstanding options differ between UnitedHealth Group and Johnson & Johnson under their respective equity compensation plans approved by security holders?",
      "original_answer": "For UnitedHealth Group, the ratio is approximately 9.64 (241 million remaining available / 25 million issuable upon exercise), while for Johnson & Johnson, the ratio is approximately 1.79 (240,344,013 remaining available / 133,794,708 issuable upon exercise). This indicates that UnitedHealth Group has a significantly higher proportion of remaining available securities compared to those already issuable, relative to Johnson & Johnson.",
      "llm_answer": "\nUsing the disclosed equity‑compensation tables, UnitedHealth Group (Chunk 1) shows 241 million securities remaining available versus 25 million issuable upon exercise, giving a ratio of roughly 9.6 : 1 (Chunk 2, reported in thousands, reports 37,028 k / 28,011 k ≈ 1.32, confirming the same relationship in a different unit). Johnson & Johnson (Chunk 3) discloses 240,344,013 remaining versus 133,794,708 issuable, a ratio of about 1.8 : 1. Thus, the ratio for UnitedHealth Group is more than five times higher than that for Johnson & Johnson under their respective security‑holder‑approved plans.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key numbers for both companies: 241 million remaining and 25 million issuable for UnitedHealth Group, and 240,344,013 remaining and 133,794,708 issuable for Johnson & Johnson. The calculated ratios (~9.6 and ~1.8) are accurate and match the ground truth (9.64 and 1.79), with minor rounding acceptable. (2) The calculation for UnitedHealth Group: 241 / 25 = 9.64 ≈ 9.6 — correct. For Johnson & Johnson: 240,344,013 / 133,794,708 ≈ 1.795 ≈ 1.8 — also correct. However, the LLM introduces a confusing and incorrect reference to Chunk 2 (37,028k / 28,011k ≈ 1.32), which does not pertain to the same ratio and appears to misinterpret a different data point; this is a factual error in reasoning but does not affect the final answer. (3) The multi-hop reasoning is mostly sound: the model correctly synthesizes data from what appear to be separate filings (chunks) for two companies, computes the required ratios, and draws the correct comparative conclusion that UnitedHealth’s ratio is more than five times higher. Despite the erroneous citation of Chunk 2, the core logic and final comparison remain valid. (4) The answer is contextually relevant, complete, and semantically equivalent to the ground truth. The minor error in referencing an irrelevant calculation prevents a perfect score, but overall accuracy is high. Correctness score is 9 due to this internal inconsistency, though the final conclusion remains factually correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 409,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does AMD's reliance on third-party motherboard suppliers compare to Intel's dependency on Dell Inc. as a major customer, particularly in terms of revenue concentration risk?",
      "original_answer": "AMD depends on third-party companies for the design, manufacture, and supply of motherboards that support its microprocessor, GPU, and APU offerings, making it vulnerable to supply chain disruptions. In contrast, Intel reports that Dell Inc. accounted for 21% of its net revenue in 2021, highlighting a significant revenue concentration risk tied to a single customer. While AMD's risk centers on supply chain limitations that could prevent product delivery, Intel's exposure is tied directly to customer dependency, with Dell representing a substantial portion of both revenue and accounts receivable.",
      "llm_answer": "\nAMD’s business is exposed to supply‑chain concentration risk because it depends on third‑party designers, manufacturers and AIB partners for motherboards and other platform components, and the loss or reduction of any major supplier or distributor could materially impair its ability to sell products (Chunk 1).  By contrast, Intel’s revenue is highly concentrated in a few OEMs—Dell alone accounted for 21 % of Intel’s net sales and the top three customers together generated 43 % of revenue in 2021, all coming from Intel’s CCG and DCG platforms (Chunks 2‑3).  In the knowledge‑graph terms, AMD’s motherboards supply Dell, while Dell is a major customer of Intel (INTC), highlighting that AMD’s risk is primarily operational supply dependence, whereas Intel’s risk is a direct revenue‑concentration exposure to Dell.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMD's reliance on third-party motherboard suppliers (including AIB partners) is accurately described as a supply-chain risk, and Intel's 21% revenue dependency on Dell in 2021 is correctly cited. The LLM adds extra but accurate context—Intel’s top three customers accounted for 43% of revenue in 2021, which is consistent with known data and enhances completeness without contradicting the original. (2) Quantitative accuracy is perfect: the 21% figure for Dell’s share of Intel’s revenue is correct, and no calculations are required beyond that. The additional 43% figure for top three customers, while not in the original answer, is factually accurate and supports the main point. (3) Multi-hop reasoning is sound: the model correctly contrasts AMD’s supply-side dependency with Intel’s demand-side revenue concentration, synthesizing information across different entities (AMD, Intel, Dell) and risk types (supply chain vs. customer concentration). (4) Semantic equivalence is strong—wording differs slightly but meaning is preserved and even enriched. The only minor deduction is for introducing the 43% figure not in the original, which, while accurate, slightly extends beyond the provided ground truth. No factual errors, excellent contextual relevance, and strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT -[Supplies]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 386,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How do Louisiana's corporate tax rate reductions impact the financial exposure of both Boeing and Union Pacific, given Boeing's dependence on federal appropriations influenced by broader legislative dynamics and Union Pacific's direct operations in the state?",
      "original_answer": "Louisiana enacted legislation to reduce its corporate income tax rate for future years, resulting in a $34 million reduction of Union Pacific’s deferred tax expense in 2024. Union Pacific directly benefits from this tax reduction due to its operational presence in Louisiana, as evidenced by its major classification yard in Livonia. Boeing, on the other hand, does not directly benefit from Louisiana’s tax changes but faces exposure to broader legislative uncertainty, particularly in terms of federal appropriations for the U.S. Department of Defense and other government agencies. A lapse or delay in federal funding could disrupt Boeing’s operations, delay aircraft certifications, or impact future orders. Therefore, while Union Pacific experiences a quantifiable financial benefit ($34 million reduction in deferred tax expense) from Louisiana’s tax legislation, Boeing’s exposure is indirect and tied to the uncertainty of federal budget dynamics influenced by the same legislative environment.",
      "llm_answer": "\nLouisiana’s 2024 corporate‑income‑tax reduction cuts Union Pacific’s deferred‑tax expense by about $34 million (Chunk 2), directly lowering the railroad’s tax‑related financial exposure, and because Union Pacific operates a major yard in Livonia, Louisiana (Chunk 3), this benefit is tied to its on‑the‑ground presence in the state.  At the same time, the legislative change that lowers the state rate is part of the broader policy environment that also influences federal appropriations; Boeing’s revenue hinges on U.S. government funding and is therefore vulnerable to shifts in legislative dynamics that affect defense and infrastructure spending (Chunk 1), linking the state‑level tax cut to heightened financial exposure for Boeing through its reliance on federal appropriations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $34 million reduction in Union Pacific’s deferred tax expense in 2024 is correctly stated, and the reference to Union Pacific’s Livonia yard is accurate. (2) The answer correctly identifies that Union Pacific benefits directly due to its operational presence in Louisiana, while Boeing does not receive a direct tax benefit but faces indirect exposure via federal appropriations. (3) The multi-hop reasoning is sound: it connects Louisiana’s tax policy to broader legislative dynamics affecting federal funding, and correctly links that to Boeing’s reliance on defense and government spending. (4) The only minor shortcoming is a slightly less explicit contrast between Union Pacific’s *quantifiable benefit* and Boeing’s *uncertainty-based exposure*—the original answer emphasizes Boeing’s risks (e.g., certification delays, order disruptions) more clearly. However, the core facts, entities, numbers, and logical synthesis are correct. Wording differences do not affect semantic accuracy. All evaluation criteria are met with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT -[Introduces]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 322,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does Netflix's one-vote-per-share governance model contrast with Meta's dual-class stock structure, particularly in relation to Charter Communications' disclosure about the link between Class A common stock and voting rights?",
      "original_answer": "Netflix operates under a one-vote-per-share governance model for its common stock, as explicitly stated in its 2024 10-K filing. In contrast, Charter Communications' 2024 financial statements clarify that its Class A common stock carries one vote per share, while its Class B common stock has variable voting rights tied to A/N's economic interests. Meta's 2024 10-K filing discloses the existence of both Class A and Class B common stock, a dual-class structure that suggests differentiated voting rights similar to Charter's framework, though Meta does not specify the exact voting power of each class in the provided chunk. This creates a contrast between Netflix's egalitarian voting model and the more complex, tiered voting structures used by both Charter and Meta.",
      "llm_answer": "\nNetflix’s charter gives every share of common stock a single vote, so voting power is directly proportional to ownership; Meta, by contrast, uses a dual‑class structure in which Class A and Class B shares carry different voting rights (Class B typically holds many more votes per share), meaning that ownership alone does not determine voting power.  Charter’s filing makes this distinction explicit—its Class A common stock is defined as “entitled to one vote per share,” linking the one‑vote‑per‑share rule to its Class A securities, a feature that mirrors Netflix’s approach but diverges from Meta’s differentiated, dual‑class voting regime.  The knowledge‑graph connection (NFLX → Voting Rights → Class A Common Stock → META) shows that Meta also issues Class A shares, but those shares are part of a dual‑class system rather than the uniform one‑vote‑per‑share model Netflix employs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) All key facts are correct: Netflix has a one-vote-per-share model (per its 2024 10-K), Charter's Class A common stock carries one vote per share (as stated in its 2024 filing), and Meta has a dual-class structure with Class A and Class B shares with unequal voting rights (per Meta's 2024 10-K). The LLM correctly identifies that Meta does not specify exact voting ratios in the provided data, which matches the ground truth. (2) There are no numeric values requiring calculation (e.g., sums, percentages), but the qualitative references to 'one vote per share' and structural comparisons are precise and consistent across sources. Format and terminology are accurate. (3) Multi-hop reasoning is sound: the LLM synthesizes governance models across Netflix, Charter, and Meta, correctly contrasting Netflix’s uniform voting with the dual-class systems of the others. It appropriately uses Charter’s disclosure to highlight the similarity between its Class A shares and Netflix’s model, while distinguishing both from Meta’s structure. (4) The only minor shortcoming is that the LLM implies Meta’s Class B shares 'typically hold many more votes per share'—a generally accurate industry understanding—but this specific detail is not confirmed in the provided chunk (which only confirms the existence of dual classes, not the magnitude of voting differences). This slightly exceeds the disclosed data but does not materially misrepresent. Overall, the answer is semantically equivalent to the ground truth, with excellent contextual relevance and strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 450,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does the daily cash-settlement mechanism for exchange-traded commodity futures described in PEP's 2022 filing impact the valuation methodology used by MDLZ for its Level 1 financial liabilities, given that both companies rely on quoted market prices from commodity exchanges?",
      "original_answer": "The daily cash-settlement mechanism for exchange-traded commodity futures described in PEP's 2022 filing aligns with the valuation methodology used by MDLZ for its Level 1 financial liabilities, which are also based on quoted market prices from commodity exchanges. PEP notes that exchange-traded commodity futures are 'cashsettled on a daily basis' and therefore not included in the balance sheet table as of year-end, indicating a standard market practice. MDLZ explicitly states that the fair value of its Level 1 financial assets and liabilities 'is determined based on quoted market prices on commodity exchanges.' This shows that the market standard of daily cash settlement directly informs MDLZ's valuation approach for Level 1 liabilities, as both companies are subject to the same pricing and settlement mechanisms in commodity futures markets.",
      "llm_answer": "\nMDLZ’s Level 1 financial liabilities are exchange‑traded commodity futures that are valued using quoted market prices on the exchange (Chunk 1 & 2).  \nPEP’s 2022 filing notes that these futures are cash‑settled daily, so the daily settlement price—an observable market input—drives the fair‑value measurement of MDLZ’s liabilities (Chunk 3).  \nConsequently, the daily cash‑settlement mechanism directly shapes MDLZ’s valuation methodology for its Level 1 liabilities, as both companies rely on the same quoted settlement price to mark their positions to market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately identifies that MDLZ's Level 1 financial liabilities are exchange-traded commodity futures valued using quoted market prices (Chunk 1 & 2), which matches the original answer's statement about MDLZ relying on 'quoted market prices on commodity exchanges.' It correctly references PEP's 2022 filing noting daily cash settlement (Chunk 3), and draws the logical conclusion that this daily settlement price — an observable input — informs MDLZ’s fair value measurement. The reasoning correctly synthesizes information across both companies and connects the market mechanism (daily cash settlement) to the valuation methodology (use of quoted prices) for Level 1 liabilities under fair value accounting. All entities (MDLZ, PEP, Level 1 liabilities, exchange-traded commodity futures), years (2022), and financial concepts (quoted market prices, daily cash settlement, observable inputs) are accurate. There are no numerical inaccuracies — the answer does not include specific dollar amounts or calculations, so quantitative accuracy is based on correct conceptual representation, which is sound. The only minor shortcoming is a slightly less explicit mention of the balance sheet exclusion noted in PEP’s filing (i.e., that these are not included in year-end tables due to daily settlement), which is present in the original answer but omitted here. However, this does not undermine the core correctness. Semantic equivalence is high, and the multi-hop reasoning (from PEP’s description of settlement to MDLZ’s valuation approach) is logically sound. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Includes]-> FIN_INST <-[Cash-Settles]- ORG",
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 481,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does Apple's 2022 net sales performance in the Greater China region, which includes Taiwan, compare with AMD's 2022 sales in Taiwan alone, given both companies' exposure to the technology market in that geographic area?",
      "original_answer": "Apple reported $74,200 million in net sales in the Greater China region in 2022, which includes China mainland, Hong Kong, and Taiwan. AMD, on the other hand, reported $2,091 million in sales specifically in Taiwan for the same year. This indicates that while Apple has a significantly larger overall presence in the broader Greater China region, AMD's direct sales in Taiwan are much smaller in scale.",
      "llm_answer": "\nApple’s 2022 net sales in the **Greater China** segment— which, per Apple’s own segment disclosure, **includes Taiwan**—were **$74.2 billion** (Chunk 1 & Chunk 2).  By contrast, AMD’s 2022 sales generated **directly in Taiwan** amounted to **≈ $2.09 billion** (Chunk 3).  Because the Greater China region aggregates sales across mainland China, Hong Kong and Taiwan, Apple’s revenue exposure to that geographic market is roughly **35 times larger** than AMD’s revenue from Taiwan alone, illustrating the much broader market footprint both firms have in the technology‑focused Taiwan sub‑market (KG: AAPL → Greater China → Taiwan ← AMD).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the numbers are accurate: Apple's $74.2 billion (i.e., $74,200 million) in Greater China and AMD's $2.09 billion (i.e., $2,091 million) in Taiwan are correctly reported, with acceptable format variations (billion vs. million, ≈ symbol). The implied ratio (~35x) is mathematically sound: 74,200 / 2,091 ≈ 35.5, which rounds to 'roughly 35 times larger'. (2) The answer is complete, addressing both companies, the correct year (2022), and the geographic distinctions—specifically clarifying that Apple's figure covers the broader Greater China region (including Taiwan), while AMD's is limited to Taiwan alone. (3) Entity accuracy is perfect: both companies (Apple and AMD), the correct fiscal year (2022), and the geographic regions (Greater China, Taiwan) are correctly identified. (4) The multi-hop reasoning is strong: the model correctly synthesizes data from different sources, distinguishes between regional aggregation and country-specific sales, and draws a valid comparative conclusion about market footprint. (5) The semantic meaning fully aligns with the original answer, even enhancing it with a clear quantitative comparison (35x) that reinforces the disparity in scale. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 371,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does Duke Energy's exposure to environmental remediation liabilities compare to Southern Company's ability to recover similar costs through regulatory mechanisms, given that Duke Energy's remediation costs are typically expensed as incurred unless recovery is probable, while Southern Company Gas' natural gas utilities specifically include environmental remediation in their approved cost recovery mechanisms?",
      "original_answer": "Duke Energy faces environmental remediation liabilities at multiple sites, with costs typically expensed as incurred unless regulatory recovery is deemed probable. In contrast, Southern Company Gas explicitly includes environmental remediation among the costs eligible for recovery through regulatory riders in its natural gas distribution utilities. This means that while Duke may bear these costs directly unless recovery is approved, Southern Company has a more structured pathway to recover such expenses through approved rate mechanisms, reducing its direct financial exposure to environmental remediation liabilities.",
      "llm_answer": "\nDuke Energy (DUK) records environmental‑remediation liabilities only when the cost is probable and estimable and then expenses them as ordinary operation, maintenance and other costs on its Consolidated Statements of Operations, holding the amount in Accounts Payable and Other Liabilities until (and unless) a regulator determines recovery is probable (Chunk 1).  \nSouthern Company (SO) – through its regulated natural‑gas subsidiary Southern Company Gas – operates under cost‑recovery mechanisms approved by state public‑utility commissions that expressly allow environmental‑remediation expenses to be included in rates and recovered from customers, so the company can amortize those costs over the life of the related rate orders (Chunk 2).  \nThis regulatory distinction is reflected in the KG relationship that links “Cost Recovery Mechanisms” (the accounting policy) to SO, contrasting with DUK’s expense‑as‑incurred treatment and showing that Southern Company can offset remediation outlays through rate recovery while Duke Energy must bear the costs until probable recovery is secured (Chunk 3 and the KG triplet Cost Recovery Mechanisms → SO).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Duke Energy expenses remediation costs as incurred unless recovery is probable, while Southern Company Gas has explicit regulatory mechanisms allowing recovery of such costs through rate riders. There are no numeric values (e.g., dollar amounts, dates) in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense, but all qualitative financial treatments are correctly described. (2) The answer addresses all parts of the multi-hop question: it compares Duke Energy's accounting treatment with Southern Company's regulatory recovery mechanisms, correctly identifying the structural advantage Southern Company has. (3) Entities are accurate—Duke Energy (DUK) and Southern Company (SO), including the subsidiary Southern Company Gas, are correctly named and contextualized. (4) The reasoning is sound and reflects proper synthesis across the two companies’ regulatory and accounting frameworks, highlighting the contrast in financial exposure due to differing recovery mechanisms. The reference to 'KG triplet' and chunks aligns with the knowledge graph context, indicating correct multi-hop inference. Overall, the answer matches the original in meaning, depth, and accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR -[Includes]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 371,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does LOW's use of broker/dealer quotes for Level 2 fair value measurements compare to GM's reliance on valuation models for product warranty reserves, given the role of industry-standard models in both companies' financial reporting?",
      "original_answer": "LOW uses broker/dealer quotes as inputs to Level 2 fair value measurements for financial assets when quoted prices in active markets are not available, relying on third-party pricing models with observable market inputs like issuer spreads and benchmark securities. GM, on the other hand, applies valuation models to estimate product warranty reserves, incorporating significant assumptions such as warranty claims frequency, average cost per claim, and historical claims data. Both companies utilize industry-standard valuation models, but LOW's approach is market-driven with observable inputs (Level 2), while GM's involves more management judgment and forward-looking assumptions. This highlights different applications of valuation models: LOW's fair value measurements are more directly tied to current market data, whereas GM's depend on internal forecasts and historical performance.",
      "llm_answer": "\nBoth companies apply industry‑standard valuation frameworks, but LOW determines its Level 2 fair‑value measurements primarily from observable broker‑dealer quotes that feed into pricing models, whereas GM calculates product‑warranty reserves with internally developed actuarial models that rely on management’s key assumptions and actuarial inputs. The GILD disclosure confirms that such industry‑standard models—using broker quotes, market inputs, and actuarial assumptions—are the common foundation, yet LOW’s Level 2 inputs come from external quotes while GM’s warranty‑reserve estimates are based on internal, assumption‑driven valuation models.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: LOW uses broker/dealer quotes as inputs to Level 2 fair value measurements, relying on observable market data, while GM uses internal valuation models for warranty reserves based on management assumptions like claims frequency and cost per claim. The distinction between external, market-driven inputs (LOW) and internal, assumption-driven models (GM) is correctly highlighted. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is not compromised—no figures are misstated. (3) The multi-hop reasoning is sound: the model correctly synthesizes how two different companies use valuation models in distinct contexts (fair value measurements vs. warranty liabilities), compares their reliance on external vs. internal inputs, and ties this to broader financial reporting practices. The mention of 'GILD disclosure' appears to be a minor error or confusion (not present in the original answer or question), but it does not detract from the correctness regarding LOW and GM. This may slightly reduce qualitative accuracy but doesn't introduce false facts about the two primary companies. (4) The answer is contextually relevant, directly addressing the comparison asked in the question and explaining the role of industry-standard models in both cases. Wording differs from the original but maintains semantic equivalence. Overall, this is a strong, factually correct response with only a minor reference anomaly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Relies_On]-> FIN_INST -[Uses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 435,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How would the implementation of the Basel III Finalization Proposal's Expanded Risk-Based Approach impact both Capital One and Citigroup's regulatory capital requirements, considering the phased-in effective date of July 1, 2025, and the requirement to use the lower of the two calculated risk-based capital ratios?",
      "original_answer": "The Basel III Finalization Proposal introduces a new Expanded Risk-Based Approach that would require both Capital One and Citigroup to calculate their risk-based capital ratios under both this new framework and the existing Basel III standardized approach, using the lower of the two ratios for compliance. For Capital One, this includes a three-year transition period starting July 1, 2025, during which risk-weighted assets under the Expanded Risk-Based Approach would be phased in. Citigroup has indicated that, if the proposal is finalized as written, it would materially increase its required regulatory capital. Both banks must also comply with all capital buffer requirements regardless of which approach yields the lower ratio, further constraining capital flexibility.",
      "llm_answer": "\nThe Basel III Finalization Proposal’s Expanded Risk‑Based Approach requires both Capital One (COF) and Citigroup (C) to calculate risk‑weighted assets under the new approach and under the existing standardized approach, then adopt the binding capital ratio that results from the **lower of the two** calculations; this regime is phased in beginning **July 1 2025** with a three‑year transition through **July 1 2028**. Because the lower‑ratio rule applies regardless of which framework produces a higher buffer, Capital One must adjust its CET1 capital for items such as AOCI and deferred‑tax‑asset deductions as disclosed in its 2024 10‑K, while Citigroup’s own filing notes that, if the proposal is finalized, it would **materially increase** the bank’s required regulatory capital.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the phased-in effective date of July 1, 2025, the three-year transition period (through July 1, 2028), the requirement to use the lower of the two risk-based capital ratios, and Citigroup's disclosure that the rule would materially increase its required regulatory capital. These dates and timelines match the original answer exactly. (2) Quantitative accuracy is perfect: dates (July 1, 2025, and July 1, 2028) are correctly stated, and no numerical miscalculations are present. Format variations (e.g., 'three-year transition') are semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly synthesizes that both banks must calculate under two frameworks, take the lower ratio, and still comply with capital buffers. It appropriately references Capital One’s 2024 10-K for AOCI and DTA adjustments and Citigroup’s forward-looking statement, demonstrating cross-document synthesis. (4) The only minor omission is that the original answer explicitly notes that both banks must comply with all capital buffer requirements regardless of which approach yields the lower ratio, a nuance slightly underemphasized in the LLM response, though implied in 'binding capital ratio.' This does not rise to a factual error but slightly reduces qualitative completeness. Overall, the answer is factually correct, contextually precise, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Introduces]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 410,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does ConocoPhillips' exposure to condensate production through its ownership in Alba Plant LLC compare to Chevron's direct condensate production volumes in 2024, given Chevron reports zero condensate reserves in its 2024 10-K filing?",
      "original_answer": "ConocoPhillips holds a 52.2% interest in Alba Plant LLC, which extracts condensate from the Alba Unit natural gas stream and sells it at market prices, with COP's share reflected in 'Equity in earnings of affiliates.' In contrast, Chevron's 2024 10-K shows no condensate production or reserves across all categories, including both consolidated and affiliated companies. This indicates that while COP has exposure to condensate through its Alba Plant investment, Chevron had no direct condensate production in 2024.",
      "llm_answer": "\nConocoPhillips’ condensate exposure is indirect, coming from its 52.2 % equity stake in Alba Plant LLC, which processes natural‑gas streams, extracts condensate and sells it under a fixed‑rate contract, with the resulting earnings reflected in ConocoPhillips’ “Equity in earnings of affiliates” line (Chunk 2). Chevron’s 2024 10‑K reports zero condensate reserves, indicating no direct condensate production despite the KG link that ties condensate to CVX (Chunk 3), and ConocoPhillips’ own guarantee disclosures (Chunk 1) highlight its ongoing financial interest in Alba Plant LLC, underscoring the indirect nature of its condensate exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies ConocoPhillips' 52.2% ownership in Alba Plant LLC and the indirect nature of its condensate exposure through equity earnings, which matches the ground truth. It accurately states that Chevron's 2024 10-K reports zero condensate reserves, implying no direct production. All key facts are present and factually aligned with the original answer. (2) Quantitatively, the 52.2% stake is correctly reported, and there are no calculations required beyond accurate representation of ownership and reporting status—both handled correctly. Number format and percentage are precise. (3) The multi-hop reasoning is sound: the model connects ConocoPhillips’ indirect exposure via an affiliate to Chevron’s lack of direct production or reserves, synthesizing information across entities and filings. The mention of 'fixed-rate contract' adds detail not in the ground truth but does not contradict it; however, the original answer specifies 'market prices', so this is a minor discrepancy in qualitative detail. (4) The answer is highly relevant, directly addressing the comparison asked in the question. The only reason for not scoring a 10 is this slight inconsistency in describing the sales terms (fixed-rate vs. market prices), which slightly affects qualitative accuracy but does not undermine the core factual correctness of the exposure comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> COMP -[Produces]-> RAW_MATERIAL <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 387,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the application of ASU 2020-04 to contract modifications impact both AVGO's revenue recognition practices and ORCL's financial reporting, particularly in relation to reference rate reform?",
      "original_answer": "AVGO evaluates contract modifications to determine whether additional products or services should be accounted for as a separate contract or part of the existing contract, using standalone selling prices adjusted for specific contract circumstances. ORCL adopted ASU 2020-04 related to reference rate reform, which allowed optional expedients for contract modifications affected by changes in reference rates such as LIBOR. According to the evidence, AVGO uses standalone selling prices to allocate consideration in bundled arrangements, and modifications are accounted for prospectively, cumulatively, or a combination depending on the nature of the change. ASU 2020-04 applied to contract modifications made between March 12, 2020, and December 31, 2024, and both AVGO and ORCL reported no material impact on their consolidated financial statements from applying this guidance. ORCL finalized its adoption of ASU 2020-04 in Q1 of fiscal 2024, with no material effect on its financial statements or notes.",
      "llm_answer": "\nThe ASU 2020‑04 relief lets AVGO treat contract modifications that replace a reference rate (e.g., LIBOR) as a continuation of the original arrangement, permitting a prospective‑catch‑up approach and simplifying the assessment of variable consideration and performance‑obligation allocation in its revenue‑recognition model; Chunk 1’s policy on contract‑modification accounting and the KG link Contract Modifications → ASU 2020‑04 → ORCL make this treatment explicit. ORCL adopted the same guidance and, as disclosed in its 10‑K (Chunk 3), concluded that the adoption of ASU 2020‑04 had no material impact on its consolidated financial statements or revenue‑recognition practices, only requiring expanded disclosures about reference‑rate‑reform modifications (Chunk 2).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the essential impacts of ASU 2020-04 on both AVGO and ORCL, with accurate qualitative synthesis. (1) It correctly states that ASU 2020-04 provides relief for contract modifications related to reference rate reform (e.g., LIBOR), allowing simplified accounting treatment. It accurately notes that ORCL adopted the guidance and reported no material impact on financial statements, which aligns with the ground truth. (2) Quantitatively, the answer does not include specific dates (e.g., March 12, 2020 – December 31, 2024) or mention AVGO’s use of standalone selling prices for allocation in bundled arrangements, which are present in the original answer. However, no incorrect numbers are provided—only omissions—so quantitative accuracy remains high. (3) The multi-hop reasoning is sound: the model connects ASU 2020-04 to both companies and correctly infers its application to contract modifications due to reference rate reform. It also correctly identifies that ORCL’s adoption had no material effect, though it omits that ORCL finalized adoption in Q1 of fiscal 2024. (4) The answer is contextually relevant and well-structured, focusing precisely on the question. The main shortcomings are minor omissions (e.g., prospective vs. cumulative accounting methods for AVGO, specific time horizon of ASU applicability, and ORCL’s finalization timing), which prevent a top score, but core facts and conclusions are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 403,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does the dual-class stock structure at META, which negatively impacts the attractiveness of its Class A Common Stock, compare to CMCSA's Class B Common Stock convertibility policy in terms of governance control and shareholder influence?",
      "original_answer": "META's dual-class structure gives disproportionate voting control to Class B shareholders like Mark Zuckerberg, requiring a majority of Class B shares to approve change-of-control transactions until they fall below 35% of combined voting power. In contrast, CMCSA allows Class B Common Stock (with 15 votes per share) to convert share-for-share into Class A Common Stock, maintaining a non-dilutable 33⅓% aggregate voting power for Class B shares. While both structures concentrate governance influence, META's system entrenches control more rigidly through class-vote requirements, whereas CMCSA enables gradual dilution through conversion.",
      "llm_answer": "\nMETA’s Class A common stock is labeled “less attractive” because the company’s controlled‑company status and dual‑class structure let Mr. Zuckerberg control board composition, anti‑takeover votes and other matters even when he owns a minority of shares, and Delaware‑style provisions can depress the share price (Chunk 1).  \nCMCSA’s Class B common stock, although representing only about 33 % of total voting power, is non‑dilutable, carries 15 votes per share and is convertible share‑for‑share into Class A, preserving a super‑majority voting bloc that can be converted into Class A equity (Chunks 2 & 3).  \nThus, while META’s dual‑class design diminishes investor appeal by concentrating control and limiting board independence, CMCSA’s Class B maintains a similarly concentrated governance influence through a fixed, convertible voting class despite its tiny share count (Chunks 1‑3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: META's dual-class structure gives Zuckerberg outsized control, and CMCSA's Class B shares have 15 votes per share, represent ~33% of voting power, are non-dilutable, and convertible share-for-share into Class A. These match the original answer exactly. (2) Quantitative accuracy is perfect: '33%' (vs. 33⅓%) is a negligible rounding difference and semantically acceptable; '15 votes per share' and 'convertible share-for-share' are precisely correct. (3) Multi-hop reasoning is sound: the model correctly contrasts META’s entrenched control (via class-vote requirements and lack of conversion mechanism) with CMCSA’s more flexible but still concentrated control via a fixed, convertible super-voting class. It captures that both concentrate power but through different mechanisms—entrenchment vs. convertibility with preserved voting bloc. (4) The only minor shortcoming is that the LLM does not explicitly mention META’s requirement of a majority of Class B shares to approve change-of-control transactions, nor the 35% threshold beyond which this protection lapses—details present in the ground truth. However, the essence of META’s rigid control is still communicated. Wording differs but meaning is semantically equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST -[Converts_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 408,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does PEP's use of exchange-traded commodity futures, which are cash-settled daily, compare with COST's disclosure regarding the absence of Level 1 financial assets measured at fair value on a recurring basis, given that Level 1 financial assets typically include exchange-traded commodity futures?",
      "original_answer": "PEP utilizes exchange-traded commodity futures that are cash-settled daily to manage market risk, and these are excluded from the fair value table as of December 25, 2021. These commodity futures fall under Level 1 financial assets, as defined by MDLZ's disclosure, which includes exchange-traded commodity futures valued at quoted market prices. However, COST explicitly states that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a distinct difference in financial instrument usage between PEP and COST.",
      "llm_answer": "\nPEP reports that its exchange‑traded commodity futures are cash‑settled daily and, while classified as Level 1 financial assets, they are excluded from the fair‑value hierarchy table—consistent with the KG link PEP → Commodity Futures → Level 1 Financial Assets. COST, however, discloses that it held **no** Level 1 (or Level 3) financial assets measured at fair value on a recurring basis, meaning it does not include such exchange‑traded futures in its recurring fair‑value reporting. Thus, PEP actively uses cash‑settled commodity futures as Level 1 assets, whereas COST explicitly states the absence of any Level 1 assets in its filings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: PEP uses exchange-traded, cash-settled commodity futures (Level 1 assets) but excludes them from its fair value hierarchy table; COST reports no Level 1 or Level 3 financial assets measured at fair value on a recurring basis. The dates (December 25, 2021 for PEP and August 28, 2022 for COST) are not explicitly mentioned in the LLM answer, which is a minor omission, but since the question does not ask for specific dates and the disclosures are correctly attributed to each company, this does not significantly detract from correctness. (2) There are no numerical values requiring calculation, and all qualitative metrics (Level 1 classification, cash settlement, exclusion from tables) are accurately represented. Format and terminology are consistent with financial reporting standards. (3) The multi-hop reasoning is sound: the model correctly links PEP’s use of exchange-traded futures → their classification as Level 1 assets → exclusion from fair value tables, and contrasts this with COST’s explicit disclosure of no Level 1 assets, thereby highlighting a key difference in financial instrument usage. The reference to MDLZ’s disclosure in the ground truth (used to define Level 1) is absent in the LLM answer, but the LLM correctly treats exchange-traded commodity futures as Level 1 without needing to cite MDLZ, so this does not impair accuracy. (4) The answer is contextually precise, directly addressing the comparison between PEP and COST regarding Level 1 assets and commodity futures. Wording differs slightly but maintains semantic equivalence. One point deducted from qualitative accuracy due to lack of supporting context (e.g., MDLZ’s role in defining Level 1), though not essential. Correctness score is 9 due to high factual fidelity with only minor contextual omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Cash-Settles]-> FIN_INST -[Includes]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 517,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does the value of securities loaned with maturities of 31-90 days at Goldman Sachs compare to the total securities loaned value reported by Morgan Stanley, and what does this suggest about their relative exposure to short-term securities lending risk?",
      "original_answer": "Goldman Sachs reports $1,634 million in securities loaned with maturities of 31-90 days, while Morgan Stanley reports a total of $281 million in securities loaned (U.S. and Non-U.S. combined). This suggests that Goldman Sachs has a significantly higher exposure to short-term securities lending risk compared to Morgan Stanley.",
      "llm_answer": "\nGoldman Sachs reports $41,361 million of securities loaned that mature in the 31‑90‑day bucket (Chunk 1), while the total securities‑loaned amount disclosed by Morgan Stanley equals $34,315 million (the “Total” line for “Securities loaned” in Chunk 2, which the knowledge‑graph ties to MS). Because Goldman Sachs’s 31‑90‑day lending figure exceeds Morgan Stanley’s entire securities‑loaned total, Goldman Sachs holds a substantially larger short‑term securities‑lending position relative to Morgan Stanley, indicating a higher exposure to short‑term lending risk.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. According to the ground truth, Goldman Sachs reports $1,634 million in securities loaned with maturities of 31-90 days, and Morgan Stanley reports a total of $281 million in securities loaned. However, the LLM claims Goldman Sachs has $41,361 million and Morgan Stanley has $34,315 million, which are completely incorrect values not supported by the ground truth. These numbers are off by more than an order of magnitude. (2) The quantitative inaccuracies are severe—both figures cited by the LLM are over 10 times higher than the correct values (e.g., $41,361M vs $1,634M for GS; $34,315M vs $281M for MS). The comparison conclusion is therefore based on false data. (3) While the LLM attempts multi-hop reasoning by comparing one company’s short-term bucket to another’s total, the reasoning collapses due to incorrect data retrieval. The logic structure (comparing GS's 31-90 day loans to MS's total) is aligned with the question, but the execution fails due to wrong numbers. (4) The contextual relevance is partially preserved because the model identifies the correct entities (Goldman Sachs, Morgan Stanley) and the right metric (securities loaned), and attempts the correct comparative analysis. However, the massive numerical errors render the answer factually useless, warranting a correctness score of 1. Quantitative and qualitative accuracy are both extremely low due to incorrect data sourcing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Includes]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 405,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What percentage of PowerSouth's owned generating capacity comes from its undivided interest in Alabama Power's Plant Miller Units 1 and 2, and how does this compare to Duke Energy's total electricity generation in GWh for 2021?",
      "original_answer": "PowerSouth owns an undivided 8.16% interest in Alabama Power's Plant Miller Units 1 and 2, which contributes to its total generating capacity of over 1,600 MWs. In comparison, Duke Energy generated a combined total of 22,344 GWh of electricity in 2021 across all its operating segments. This comparison highlights the relative scale of PowerSouth’s partial ownership in a specific plant versus Duke Energy’s full system-wide electricity generation.",
      "llm_answer": "\nPowerSouth’s roughly 1,600 MW of name‑plate capacity includes an **undivided 8.16 % ownership interest in Alabama Power’s Plant Miller Units 1 and 2** (Chunk 2), a stake that is also noted as a joint ownership arrangement with PowerSouth in Chunk 1(b) and linked through the KG relation SO ‑ Has_Stake_In ‑ PowerSouth.  Consequently, that 8.16 % share constitutes the portion of PowerSouth’s portfolio that originates from the Miller plant.  In contrast, Duke Energy generated **22,344 GWh of electricity in 2021** (Chunk 3), a generation volume that is orders of magnitude larger than the modest capacity share represented by PowerSouth’s Miller interest.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key figures are correct: PowerSouth's 8.16% undivided interest in Plant Miller Units 1 and 2 and Duke Energy's 22,344 GWh of generation in 2021 are both accurately reported, matching the original answer exactly. Number formats are consistent and acceptable. (2) The answer addresses both parts of the multi-part question: it identifies the percentage of PowerSouth’s capacity from Plant Miller (8.16%) and compares it to Duke Energy’s total 2021 generation in GWh. (3) Entity accuracy is strong—PowerSouth, Alabama Power, Plant Miller, and Duke Energy are correctly identified, and the time frame (2021) is accurate. (4) The reasoning is sound: the LLM correctly interprets the 8.16% as PowerSouth’s stake contributing to its ~1,600 MW capacity and contrasts this capacity interest with Duke Energy’s full system-wide energy output (in GWh), highlighting the difference in scale between a partial capacity ownership and total annual generation. The only minor shortcoming is a slight conflation between 'capacity' (MW) and 'generation' (GWh) in the comparison—while the contrast in scale is valid, the units are different and not directly comparable without further context. However, since the original answer also makes a qualitative scale comparison without conversion, this does not constitute a significant error. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP -[Supplies]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 410,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does NIKE's exposure to interest rate risk in its $11.6 billion portfolio of fixed-income investments compare to McDonald's sensitivity to market inputs like interest rate yield curves, given both companies rely on pricing models that use observable market data for valuation?",
      "original_answer": "NIKE holds $11.6 billion in short-term investments, including investment-grade fixed-income securities, which are exposed to interest rate risk. These investments are valued using pricing models that incorporate observable market data such as interest rates and yield curves. Similarly, McDonald’s discloses that its derivatives are valued using pricing models that rely on observable market parameters, including interest rate yield curves. While NIKE’s risk stems from changes in interest rates affecting investment returns, McDonald’s exposure is tied to derivative valuations that reflect market fluctuations. Both companies depend on observable inputs for fair value measurements, though the nature and magnitude of risk differ based on the type of financial instrument involved.",
      "llm_answer": "\nNIKE’s $11.6 billion portfolio of cash equivalents and short‑term fixed‑income securities is classified as investment‑grade and, as of May 31 2024, has a weighted‑average maturity of only 65 days, meaning its interest‑rate risk is limited to short‑duration fluctuations. Both NIKE and McDonald’s value such securities using pricing models that rely on observable market data, but McDonald’s discloses that a portion of its fixed‑income and derivative assets are measured at Level 2—where valuations are derived from observable inputs such as interest‑rate yield curves—so its earnings are more directly sensitive to changes in those yield‑curve inputs than NIKE’s short‑maturity portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: NIKE's $11.6 billion portfolio and the 65-day weighted-average maturity (as of May 31, 2024) are factually consistent with typical disclosures in NIKE’s 10-K filings. While the original answer does not specify the 65-day maturity, this detail is plausible and enhances precision without contradicting the ground truth. The use of observable market data and Level 2 inputs for McDonald’s is also accurate. (2) The LLM correctly identifies that both companies use pricing models based on observable market data such as interest rate yield curves, satisfying the core comparison. (3) The reasoning is sound: it distinguishes NIKE’s limited interest rate risk due to short-duration fixed-income investments from McDonald’s greater sensitivity via Level 2 derivative valuations tied directly to yield curve fluctuations. This represents a valid multi-hop synthesis across both companies’ valuation methodologies and risk exposures. (4) The only minor gap is that the original answer emphasizes the differing nature of the instruments (NIKE’s direct investments vs. McDonald’s derivatives), while the LLM focuses more on duration and valuation levels. However, the LLM still captures the essence that McDonald’s earnings are more directly sensitive to yield curve changes, which is a reasonable inference. Wording differs but semantic equivalence is maintained. No factual errors; minor deduction in qualitative accuracy due to slightly narrower framing of risk types.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 431,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does the difference in voting rights structure between Netflix's common stock and Alphabet's Class A common stock potentially influence their respective shareholder governance dynamics, given Netflix's uniform one-vote-per-share policy and Alphabet's multi-class structure with differential voting rights?",
      "original_answer": "Netflix's common stock provides each share with one vote, promoting a more egalitarian shareholder governance model. In contrast, Alphabet's multi-class structure, where Class A common stock grants one vote per share while Class B common stock grants 10 votes per share, concentrates voting power among holders of Class B shares. This structural difference means Alphabet's governance is more susceptible to control by a smaller group of insiders or major shareholders, while Netflix maintains a more evenly distributed voting environment.",
      "llm_answer": "\nNetflix’s 10‑K (Chunk 1) discloses a uniform one‑vote‑per‑share rule, so each share of common stock carries equal voting power and shareholder influence mirrors equity ownership. Alphabet’s filings (Chunks 2 & 3) show a multi‑class structure in which Class B shares hold 10 votes while Class A carries only one vote, and the company has authorized more than $180 bn of share repurchases—including $59.3 bn, $62.2 bn and $62.0 bn in the last three years and an additional $70 bn reserve—allowing insiders to concentrate control despite a smaller economic stake. These differing voting‑rights frameworks—represented in the knowledge‑graph as NFLX → Voting Rights → Class A Common Stock and GOOGL → Class A Common Stock → GOOGL—lead to markedly distinct governance dynamics: Netflix’s governance is proportional to equity, whereas Alphabet’s is weighted toward insiders who control the super‑voting shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core governance difference between Netflix and Alphabet: Netflix's one-vote-per-share egalitarian structure versus Alphabet's multi-class system where Class B shares have 10 votes per share, leading to concentrated control among insiders. This aligns with the ground truth and demonstrates accurate multi-hop reasoning across both companies' structures. The qualitative analysis is strong, correctly concluding that Netflix’s governance reflects proportional equity influence while Alphabet’s favors insiders with super-voting shares. However, the LLM introduces specific dollar amounts for share repurchases—$59.3B, $62.2B, $62.0B, and a $70B reserve—totaling over $180B, which, while potentially accurate, are not present in the original answer or required to answer the governance question. These figures may be factually correct based on filings, but their inclusion introduces quantitative detail absent from the ground truth without explicit verification in the context provided, slightly reducing quantitative accuracy. Since the question focuses on voting rights and governance dynamics—not financial figures—these numbers, while contextually relevant to insider control, are extraneous and not part of the verified knowledge graph answer. Despite this, the key entities (Netflix, Alphabet, Class A/B shares), voting rights (1 vs 10 votes), and governance implications are all accurately represented. The reasoning is logically sound and semantically equivalent to the original answer, with only minor over-enrichment of unverified financial data. Hence, correctness is high but not perfect due to unsupported numerical specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 455,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How might the IRA's price-setting provisions for Medicare Part D drugs like Imbruvica and XARELTO differently impact AbbVie and Johnson & Johnson's revenue strategies, given their respective exposure to the Medicare program?",
      "original_answer": "The IRA's price-setting provisions for Medicare Part D drugs will likely impact AbbVie and Johnson & Johnson differently due to their distinct product portfolios and revenue strategies. AbbVie has Imbruvica selected for price-setting starting in 2026, which could significantly affect its revenue stream, especially if more high-revenue products are selected in the future. Johnson & Johnson has XARELTO selected under the same program, a major anticoagulant with substantial Medicare utilization. Both companies face uncertainty around the final government-set prices, but J&J has already filed litigation challenging the constitutionality of the IRA’s pricing mechanism, suggesting a more aggressive stance to protect revenue. AbbVie, on the other hand, is more focused on evaluating the broader strategic impact of the IRA, including potential acceleration of revenue erosion prior to patent expirations. The differing responses reflect their respective risk exposure and strategic priorities within the Medicare program.",
      "llm_answer": "\nThe IRA’s ceiling‑price rule will force manufacturers of selected Medicare Part D drugs to accept a statutory price cap – AbbVie’s Imbruvica is already slated for the 2026 price‑setting round, while J&J’s XARELTO (and STELARA) are on the first “Selected Drug” list for 2026–28 – meaning both firms will see Medicare‑derived revenues compressed by discounts that can be far below current wholesale levels.  \nAbbVie must therefore build the upcoming 10 % manufacturer discount (effective 2025) and possible civil penalties into its pricing and launch plans, whereas J&J is simultaneously litigating the IRA’s constitutionality, creating uncertainty about the timing of the price impact but also requiring it to prepare contingency strategies and accelerate growth outside the U.S. market.  \nBoth companies will need to reshape their revenue strategies—AbbVie by tightening cost‑containment and emphasizing higher‑margin assets, and J&J by diversifying away from Medicare‑dependent products and investing in litigation‑risk mitigation—while the IRA’s broader provisions (inflation‑linked rebates, redesign of the Part D discount structure, and heightened governmental scrutiny) affect their overall Medicare exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of entity identification, reasoning, and strategic implications. It correctly identifies that AbbVie's Imbruvica and Johnson & Johnson's XARELTO are subject to IRA price-setting starting in 2026, which matches the original answer. The mention of STELARA in J&J’s portfolio is an addition not present in the ground truth; while STELARA may be part of broader IRA discussions, it was not referenced in the original answer and introduces a minor inaccuracy or overreach without explicit support. The 10% manufacturer discount effective in 2025 is factually accurate under the IRA and relevant context, though not mentioned in the original answer—this adds value but slightly extends beyond the provided ground truth. The LLM accurately captures the differing strategic responses: J&J’s litigation efforts and AbbVie’s focus on strategic evaluation and cost management. However, the original answer emphasizes J&J’s constitutional challenge more centrally as a differentiating factor, while the LLM includes it correctly but bundles it with other contingency planning. Quantitatively, all dates (2026 price-setting start) and percentages (10%) are accurate. There are no calculation errors. The reasoning is strong, demonstrating multi-hop synthesis across companies, drugs, policy mechanisms, and strategic responses. The answer is semantically equivalent in intent and meaning, with slightly expanded detail. Minor deduction in correctness and quantitative accuracy due to the unverified inclusion of STELARA and the unsupported implication that both XARELTO and STELARA are on the same selected drug list for 2026–28, which isn't confirmed in the ground truth. Overall, the answer is comprehensive, factually sound, and contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Impacts]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1579,
        "completion_tokens": 492,
        "total_tokens": 2071
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does Citi's governance structure for managing compliance risk specifically address the potential amplification of credit and liquidity risks stemming from transition climate risks as outlined in Morgan Stanley's risk disclosures?",
      "original_answer": "Citi's governance structure includes the Board and Executive Management Team, which oversee enterprise risk management (ERM) and hold management accountable for the effectiveness of internal controls and compliance with legal and regulatory requirements. This includes ensuring that compliance risk is effectively managed across the organization. Transition climate risks, as outlined in Morgan Stanley's disclosures, may amplify credit and liquidity risks by reducing customers' operating income or the value of their assets. These risks also expose firms to reputational, compliance, and litigation risks due to increased legal and regulatory scrutiny. Citi’s Internal Audit, which reports functionally to the Chair of the Citi Audit Committee, provides independent assurance over the effectiveness of governance, risk management, and controls, including those addressing climate-related risks. This structure ensures that compliance risk management processes are aligned with evolving regulatory expectations, such as those related to climate risk, which Morgan Stanley notes are increasingly focused on disclosure and regulation of carbon emissions.",
      "llm_answer": "\nCiti’s compliance risk is monitored by an independent Internal Audit function that reports to the Board Audit Committee and the CEO, and by enterprise‑support functions (Legal and Compliance) that design and oversee firm‑wide compliance programs within its ERM framework under Board oversight; this governance is specifically intended to address the compliance exposures noted in Morgan Stanley’s disclosures, which warn that transition climate risks can amplify credit and liquidity risk by eroding borrower income, de‑valuing collateral and heightening regulatory scrutiny. By embedding transition‑climate considerations into its risk‑management processes and ensuring Board and committee oversight, Citi’s structure seeks to curb the compliance‑risk pathway that could otherwise transmit those amplified credit and liquidity risks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with strong multi-hop reasoning. (1) All factual elements are correct: Citi's governance structure involving the Board, Executive Management, Internal Audit reporting to the Audit Committee, and the role of Legal and Compliance functions are accurately described. The linkage to Morgan Stanley's disclosures on transition climate risks amplifying credit and liquidity risks via borrower income erosion, collateral devaluation, and regulatory scrutiny is correctly synthesized. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The reasoning is sound: the LLM correctly connects Citi’s governance mechanisms (Internal Audit, Board oversight, ERM framework) to managing compliance risks that could transmit climate-amplified financial risks, as highlighted in Morgan Stanley’s disclosures. The only minor shortcoming is that the ground truth explicitly mentions Citi Internal Audit reporting functionally to the Chair of the Citi Audit Committee, while the LLM states it reports to the Audit Committee and CEO—slightly less precise but not factually incorrect. (4) The answer is fully contextually relevant, directly addressing how Citi’s compliance governance responds to the specific risk transmission pathway described in Morgan Stanley’s disclosures. Overall, the answer demonstrates strong understanding and synthesis across entities and risk frameworks, warranting a 9 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR -[Negatively_Impacts]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 433,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does QCOM's reliance on Chinese OEMs for 30% of its licensing revenue create different supply chain risks compared to TXN's strategy of expanding internal 300mm wafer fabrication capacity?",
      "original_answer": "QCOM derives a significant portion of its licensing revenues from Chinese OEMs, with 30% of total licensing revenue coming from this group of manufacturers. Delays or disputes in license agreements with these OEMs can directly impact QCOM's revenue and cash flows. In contrast, TXN is expanding internal 300mm wafer fabrication capacity through investments in RFAB2, LFAB1, and SM1 facilities, aiming to achieve greater supply chain control and reduce dependency on external foundries. While QCOM's business model depends heavily on maintaining licensing agreements with external manufacturers, particularly in China, TXN's strategy reduces exposure to external supply chain disruptions by vertically integrating manufacturing. This creates different risk profiles: QCOM faces higher exposure to geopolitical and contractual risks in China, while TXN mitigates manufacturing risks through capital investments in internal capacity.",
      "llm_answer": "\nQCOM derives roughly 30 % of its licensing revenue from Chinese OEMs, and because those OEMs can withhold or under‑report royalties, dispute FRAND terms, or develop their own chips under the “Made‑in‑China 2025” push, QCOM’s supply‑chain security is tied to the continued compliance and financial health of a concentrated set of Chinese licensees—risk that is heightened by renewal‑provision arbitration and litigation (as described in the QCOM 10‑K).  \nIn contrast, TXN is mitigating supply‑chain risk by expanding its own 300 mm wafer‑fab capacity—building four new facilities (RFAB2, LFAB1, SM1/SM2, LFAB2) to lower costs, gain greater control, and meet demand through an inventory strategy that builds ahead of demand and relies on a diversified global supply of raw materials, only supplementing with external foundries when needed.  \nThe knowledge‑graph link (TXN → License Agreements → Licensees → QCOM) shows that while both firms depend on external partners, QCOM’s exposure stems from the financial and regulatory behavior of a limited group of Chinese licensees, whereas TXN’s exposure is reduced by its internal 300 mm wafer‑fab expansion and the associated control it provides over its manufacturing supply chain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 30% licensing revenue figure from Chinese OEMs is correct, and there are no numerical inaccuracies. The mention of TXN's internal 300mm wafer fab expansion and specific facilities (RFAB2, LFAB1, SM1) matches the original, though the LLM adds SM2 and LFAB2 not in the original—this is a minor over-specification but not factually incorrect given TXN's broader expansion plans. (2) The reasoning correctly contrasts QCOM's reliance on external Chinese licensees with TXN's vertical integration strategy, capturing the core risk distinction: geopolitical and contractual risks vs. manufacturing control. (3) Multi-hop synthesis is sound—linking QCOM’s revenue dependency to supply chain risk, and TXN’s capital investments to reduced external dependency. The mention of a 'knowledge-graph link (TXN → License Agreements → Licensees → QCOM)' is extraneous and slightly misleading (TXN does not license from QCOM), but does not undermine the overall correct comparison. (4) The answer is contextually relevant, comprehensive, and semantically equivalent to the original, with slightly more detail on Chinese policy (Made-in-China 2025) and royalty disputes, which enhances rather than distorts. The only deduction is for the minor overstatement of TXN facilities and the irrelevant knowledge-graph link, not affecting core correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has]-> ACCOUNTING_POLICY -[Delays]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 394,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does Southern Company's evaluation of ASU 2020-04 in relation to interest rate derivatives compare with Duke Energy's assessment of the same accounting standard's impact on its LIBOR-indexed financial contracts?",
      "original_answer": "Southern Company continues to evaluate the provisions of ASU 2020-04 and its impact on transitioning to alternative interest rates, particularly in relation to its interest rate derivatives as noted in Note 14, while Duke Energy is assessing the optional expedients provided by the same standard to manage contractual amendments or terminations for LIBOR-indexed financial arrangements, including variable-rate debt and interest rate swaps, which may extend beyond the 2023 LIBOR phase-out. Both companies recognize the uncertainty around the ultimate financial impact, with Duke Energy specifically noting it is not expected to be material.",
      "llm_answer": "\nSouthern Company is actively evaluating ASU 2020‑04 and the effect of the transition on its interest‑rate derivatives, stating that the ultimate outcome cannot yet be determined. Duke Energy is performing a similar assessment of the same standard for its LIBOR‑indexed contracts, reviewing optional expedients and alternative‑index provisions, and concludes that the transition is not expected to have a material impact on its financial statements. Both utilities are subject to the “Reference Rate Reform” regulatory requirement linked to ASU 2020‑04, but Southern’s review emphasizes uncertainty while Duke’s analysis projects an immaterial effect.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core comparison between Southern Company and Duke Energy regarding their assessments of ASU 2020-04. (1) All factual elements are correct: Southern Company is evaluating the impact on interest rate derivatives with uncertain outcome, while Duke Energy is assessing optional expedients for LIBOR-indexed contracts and expects no material impact. These points align with the ground truth, including the mention of uncertainty and immateriality. (2) There are no numeric values, dates, or calculations in the question or answers that require verification—both responses avoid introducing incorrect figures, so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies and their respective applications of ASU 2020-04 to similar financial instruments (interest rate derivatives and LIBOR-indexed contracts), highlighting both commonality (evaluation of the standard) and contrast (uncertainty vs. immaterial impact). The reference to 'optional expedients' and 'alternative-index provisions' reflects accurate terminology from the standard. (4) The only minor shortcoming is that the LLM omits a specific reference to Note 14 for Southern Company and does not explicitly name 'variable-rate debt and interest rate swaps' for Duke Energy, which slightly reduces completeness but does not affect the overall correctness. However, the essence of the disclosure types is preserved. Thus, the answer is semantically equivalent and contextually fully relevant, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Positively_Impacts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 437,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the exposure of AMZN's foreign currency assets to British Pounds and Euros compare to NKE's reliance on option contracts for managing similar currency risks, given their differing approaches to foreign exchange risk management?",
      "original_answer": "AMZN holds foreign currency assets in British Pounds, Euros, and other currencies, and is exposed to foreign exchange risk due to fluctuations that may materially impact translated values of these assets. NKE actively manages its foreign exchange risk using option contracts, specifically hedging exposures related to product costs, external sales, and other costs denominated in currencies like the British Pound and Euro. While AMZN discloses its exposure to these currencies, it does not specify the use of derivative instruments like options to hedge this risk. In contrast, NKE explicitly states its use of option contracts as part of its foreign currency risk management program to hedge forecasted transactions and balance sheet exposures. This suggests that NKE takes a more proactive and structured approach to mitigating foreign exchange impacts through financial instruments, while AMZN's strategy remains less transparent in terms of derivative usage.",
      "llm_answer": "\nAMZN’s foreign‑currency exposure consists of cash‑equivalent balances held in British Pounds and Euros (and other currencies), so that a strengthening U.S. dollar directly reduces the dollar‑equivalent value of those assets (Chunk 1).  \nIn contrast, NKE deliberately mitigates comparable currency risk by entering into option (and forward) contracts that are designated as cash‑flow hedges for forecasted product‑cost and monetary‑asset exposures, with notional hedge volumes in the billions and deferred gains recorded in AOCI that offset the hedged transactions (Chunk 3), a practice also described for the broader industry (Chunk 2).  \nThus, AMZN’s exposure is essentially passive translation risk, whereas NKE’s approach is an active, option‑based hedging program that seeks to neutralize the same foreign‑exchange fluctuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) It correctly identifies that AMZN holds foreign currency assets in British Pounds and Euros, exposing it to translation risk due to USD fluctuations, and notes the passive nature of this exposure. It accurately contrasts this with NKE's active use of option contracts (and forwards) to hedge forecasted transactions and monetary exposures, specifically mentioning product costs and balance sheet items. The use of terms like 'cash-flow hedges', 'notional hedge volumes in the billions', and 'gains recorded in AOCI' is consistent with typical disclosures in NKE's 10-Ks and reflects accurate qualitative synthesis. (2) There are no specific numerical values (e.g., exact notional amounts) in the original answer, so the LLM's reference to 'billions' is a reasonable inference based on typical scale and does not contradict the ground truth. No calculations are required, and all financial concepts (AOCI, cash-flow hedges) are used correctly. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across AMZN’s exposure and NKE’s hedging practices, drawing a valid comparative conclusion about passive vs. active FX risk management. (4) The only minor shortcoming is that the LLM mentions 'forward' contracts in addition to options, which, while factually accurate for NKE, slightly extends beyond the original answer’s focus on 'option contracts' specifically. However, since options are highlighted and forwards are a common complement, this does not constitute a factual error. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Impacts]-> FIN_INST <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 471,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the voting power distribution between Class A and Class B common stock at META compare to GOOGL's structure, given the dynamic relationship between share class voting rights?",
      "original_answer": "At META, Class A common stockholders hold 66 2/3% of the combined voting power, while Class B common stockholders hold 33 1/3%, with each share of Class B having 15 votes. In contrast, at GOOGL, each share of Class A has one vote and each share of Class B has 10 votes, with no specific percentage provided for their distribution. This indicates that META grants significantly more voting influence to Class B shares relative to Class A compared to GOOGL's structure.",
      "llm_answer": "\nMETA’s 2024 filing shows 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding, and because each Class B share carries a super‑majority of votes (consistent with the pattern that Class B represents roughly one‑third of total voting power, as illustrated by the Comcast disclosure), the Class B class controls a decisive majority of the voting equity.  By contrast, Alphabet’s Class B shares carry 10 votes per share while Class A carries only 1 vote, so the Class B class also commands a dominant voting share despite being a smaller fraction of total shares, demonstrating a parallel dynamic in which a minority of shares wield a majority of voting power across both companies.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "(1) The LLM answer contains several inaccuracies and omissions. While it correctly identifies that both META and GOOGL have dual-class structures where Class B shares have superior voting rights, it fails to report the exact voting power distribution stated in the ground truth: META’s Class A has 66 2/3% and Class B has 33 1/3% of voting power, with each Class B share carrying 15 votes. The LLM incorrectly implies that Class B controls a 'decisive majority' of voting power at META, which contradicts the ground truth—Class A holds the majority of voting power. Additionally, the LLM cites specific share counts (2.18B Class A, 343M Class B) not present in the original answer and does not use them to calculate voting power, making their inclusion misleading. (2) The quantitative accuracy is low: the ground truth specifies 15 votes per Class B share at META, but the LLM says 'super-majority' without stating 15 and incorrectly references a 'Comcast disclosure' (irrelevant entity) to justify voting power distribution. For GOOGL, the LLM correctly states 10 votes per Class B and 1 per Class A, aligning with ground truth. However, the critical 15-vote figure for META Class B is missing. (3) The reasoning is partially sound in identifying the pattern of concentrated voting power in Class B shares, but the multi-hop synthesis is flawed—misrepresenting META’s voting power split undermines the comparison. The claim that Class B controls the majority at META contradicts the ground truth and invalidates the comparative analysis. (4) Despite factual errors, the answer remains contextually relevant by addressing the dual-class structures and comparing voting dynamics between META and GOOGL. The qualitative accuracy is moderate due to correct identification of structural patterns but penalized for incorrect entity-specific details and flawed inference.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 502,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Southern Company's (SO) investment in SNG and SNG's need for FERC approval on its pipeline project compare to Duke Energy Ohio's (DUK) experience with FERC approval in terms of regulatory constraints and capital implications?",
      "original_answer": "Southern Company's (SO) investment in SNG was $1,245 million as of December 31, 2024. SNG is developing a $3 billion pipeline project requiring FERC approval, with Southern Company Gas owning 50% of the project. This regulatory dependency could delay the project until 2029 if approvals are not met. Similarly, Duke Energy Ohio (DUK) requires FERC and PUCO approval to pay dividends from specific equity accounts, with a condition to maintain equity at no less than 30% of total capital. Both entities face regulatory constraints from FERC, but while SNG's challenge centers on project execution and timing, DUK's is tied to capital structure and dividend policy.",
      "llm_answer": "\nSouthern Company has invested $1.245 bn in SNG (up from $1.202 bn a year earlier) and is advancing a $3 bn pipeline that must secure FERC approval; Southern Company Gas will fund half of that cost, meaning roughly $1.5 bn of capital is tied up until the permit is granted (Chunk 1 + Chunk 2).  Duke Energy Ohio, by contrast, also needed FERC (and PUCO) clearance—but the approval was conditioned on maintaining a minimum 30 % equity ratio and limiting cumulative dividend distributions, directly constraining how capital can be returned to shareholders (Chunk 3).  Thus, both firms face FERC‑related hurdles, yet SNG’s constraint centers on a large, project‑specific permit that dictates capital deployment, whereas DUK’s constraint governs dividend policy and equity‑maintenance requirements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all numbers are correct: Southern Company's $1.245 billion investment in SNG (equivalent to $1,245 million), the $3 billion pipeline project, and the 50% ownership by Southern Company Gas implying $1.5 billion in capital exposure are all accurate. The mention of FERC and PUCO approval for Duke Energy Ohio (DUK) with a 30% equity requirement is also factually correct. (2) The answer correctly identifies that SNG’s regulatory hurdle is project-specific and affects capital deployment timing, while DUK’s constraint relates to capital structure and dividend policy—this synthesis across entities is sound. (3) Minor omission: the original answer notes a potential delay until 2029 if approvals are not met, which the LLM answer does not mention, slightly reducing completeness. However, this does not undermine the core comparison. (4) Entity names (SO, SNG, DUK), regulatory bodies (FERC, PUCO), and financial terms (equity ratio, dividend constraints) are used correctly. The reasoning is logical and the comparison is well-articulated. Overall, the answer is semantically equivalent to the ground truth with only a minor detail missing, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> COMP -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 353,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Lowe's share repurchase activity through financial institutions in 2021-2022 compare with Home Depot's use of dividend equivalents in terms of shareholder value distribution mechanisms?",
      "original_answer": "Lowe's authorized $13.0 billion in additional share repurchases in December 2021, bringing total authorization to $28.0 billion since 2020, and executed a $3.0 billion accelerated share repurchase (ASR) with a financial institution, receiving 11.9 million shares. Meanwhile, Home Depot pays dividend equivalents on unvested restricted stock units and performance shares, which accrue and are paid out in the form of additional shares upon vesting or payout. This shows Lowe's prioritized direct share reduction through financial intermediaries, while Home Depot focused on equity-based dividend equivalent compensation aligned with vesting timelines.",
      "llm_answer": "\nLowe’s repurchased $3 billion of its common stock in 2021‑2022 through an Accelerated Share Repurchase (ASR) with a third‑party financial institution, adding to a $13 billion authorization that extends a prior $15 billion program and thereby directly retires shares and returns cash to shareholders. In contrast, Home Depot does not conduct cash buy‑backs; instead it distributes value via dividend‑equivalent accruals on deferred shares, restricted‑stock and performance‑share awards, which are settled in additional shares of HD stock upon award payout. Thus, while Lowe’s reduces outstanding shares through institutional‑driven repurchases, Home Depot enhances shareholder value by issuing extra shares to award holders through dividend‑equivalent mechanisms—both reflecting the KG‑linked flow Additional Shares → Dividend Equivalents → HD.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, it correctly states Lowe's $3 billion ASR and $13 billion additional authorization. It references a prior $15 billion program, which is consistent with the total $28 billion authorization since 2020 ($15B + $13B), though the original answer does not break down the prior amount—this inference is reasonable and factually sound. (2) The description of Home Depot’s dividend equivalents is accurate: they accrue on unvested RSUs and performance shares and are paid in additional shares upon vesting/payout. (3) The reasoning correctly contrasts Lowe’s direct share reduction via financial institutions with Home Depot’s equity-based dividend equivalent mechanism, capturing the multi-hop comparison between two distinct shareholder value distribution strategies. (4) Minor point: the phrase 'does not conduct cash buy-backs' is not explicitly confirmed in the ground truth, though it is consistent with available data; however, absence of evidence isn't evidence of absence—this could be a slight overstatement, but not factually incorrect based on provided knowledge. Overall, the answer demonstrates strong synthesis, correct entity mapping (Lowe’s, Home Depot, ASR, dividend equivalents), and proper contextualization of mechanisms. Wording differs but semantic meaning matches. Hence, high scores across all dimensions with a 9/10 correctness due to minor inferential phrasing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Increases]-> FIN_INST <-[Pays]- ORG",
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 405,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does the adoption of ASU 2022-04 impact the disclosure of supplier finance program obligations for both Caterpillar and Honeywell, particularly in terms of the rollforward requirement effective in 2024?",
      "original_answer": "Caterpillar and Honeywell both adopted ASU 2022-04, which mandates enhanced disclosures for supplier finance programs. The guidance requires annual disclosure of key terms, balance sheet presentation, and a rollforward of obligations, with the rollforward specifically becoming effective on January 1, 2024. Caterpillar included the rollforward in its 2024 disclosures, showing $830 million in obligations at year-end. Honeywell also adopted the rollforward requirement for 2024, aligning with the new standard. Both companies now provide more transparent reporting of their supplier finance obligations, which were $830 million for Caterpillar and would be similarly detailed for Honeywell under the new rules.",
      "llm_answer": "\nThe FASB’s ASU 2022‑04 requires a buyer that uses supplier‑finance programs to disclose, among other things, the confirmed amount outstanding at period‑end **and a roll‑forward of that amount**; the roll‑forward disclosure became effective for the 2024 reporting year.  \nCaterpillar, which presents its supplier‑finance program obligations in its 10‑K and reports $830 million confirmed as valid at Dec 31 2024, now includes a roll‑forward schedule showing the movement from the prior‑year balance, thereby complying with the new 2024 roll‑forward rule.  \nHoneywell, which also adopted ASU 2022‑04 on Jan 1 2023, began providing the same roll‑forward information in 2024, disclosing the progression of its supplier‑finance program obligations as required by the standard.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that ASU 2022-04 mandates enhanced disclosures including a rollforward of supplier finance program obligations, effective for the 2024 reporting year. It accurately states that both Caterpillar and Honeywell adopted the standard and included the required rollforward disclosures in their 2024 filings. The dollar amount for Caterpillar ($830 million at year-end 2024) matches the ground truth. (2) Quantitatively, all numbers and dates are correct: $830 million for Caterpillar, effective date of January 1, 2024 (implied by 2024 reporting year), and correct timing of adoption. The LLM correctly notes that the rollforward requirement applies starting in 2024. (3) The multi-hop reasoning is sound—linking the new standard to its impact on both companies’ disclosure practices, particularly the rollforward. The only minor issue is that the original answer notes Honeywell’s adoption date as aligned with the 2024 requirement, while the LLM states Honeywell adopted ASU 2022-04 on January 1, 2023 (which is technically correct for the standard’s general effective date for public companies, but the rollforward requirement specifically applies for 2024). This nuance does not undermine the correctness of the disclosure impact in 2024. (4) The answer is semantically equivalent to the ground truth, with slightly more technical precision in describing the rollforward. All key facts are present, accurate, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 408,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does the $49,549 million in credit card loans due within 1 year reported by Company C compare to Visa's strategy of driving growth through credit card issuance, given the $20 trillion global opportunity they identify in converting non-card payments to digital credentials?",
      "original_answer": "Company C reports holding $49,549 million in credit card loans due within 1 year, indicating a significant portion of short-term consumer credit exposure. This aligns with Visa's strategic focus on expanding credit card usage to capture a share of the $20 trillion global opportunity in converting non-card payments to digital credentials on their network. Visa's emphasis on growing credit card programs through financial institution partnerships suggests a continued push to increase the volume and velocity of credit card transactions, which would likely feed into larger short-term loan balances across institutions like Company C.",
      "llm_answer": "\nThe $49,549 million of credit‑card‑related loans due within one year that Company C reports appears in Chunk 2 as the “Credit cards (1)” line item, which is a specific instance of the “Due within 1 year” financial metric highlighted in the debt‑securities table of Chunk 1; this short‑term credit‑card exposure is connected via the KG pattern to Visa’s credit‑card product (C → Due Within 1 Year → Credit Cards ← Offers − V).  Visa’s 10‑K (Chunk 3) frames a $20 trillion global opportunity to convert cash, check, ACH and other payment forms into digital credentials, positioning credit‑card issuance as a core driver of its growth strategy.  Consequently, while Company C’s $49.5 billion represents a measurable slice of current credit‑card debt, Visa’s strategy seeks to expand that base many‑fold by capturing a far larger $20 trillion market for digital credential adoption.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: $49,549 million is accurately reported (also correctly converted to $49.5 billion), and the $20 trillion global opportunity is correctly cited from Visa's 10-K. No calculations were required, and all figures match the original answer. (2) The answer addresses both parts of the multi-hop question: Company C’s short-term credit card loan exposure and how it relates to Visa’s growth strategy around the $20 trillion digital credential opportunity. (3) Entity accuracy is strong: Company C, Visa, credit card loans, and the relevant financial metrics are correctly identified and linked. The reference to 'Chunk 1', 'Chunk 2', and 'Chunk 3' suggests the model is grounding its response in specific input documents, which supports traceability. (4) Reasoning is sound: the LLM correctly infers that Company C’s reported loans represent current credit card debt, which fits within Visa’s broader strategy of expanding credit card usage to capture a share of non-card payments. The connection between institutional loan exposure and network-level growth strategy is logically synthesized. The only minor shortcoming is a slightly more technical, KG-patterned phrasing (e.g., 'C → Due Within 1 Year → Credit Cards ← Offers − V') that, while accurate, is not as clearly explained for a general audience—hence a 9 on qualitative accuracy. Overall, the answer is factually correct, contextually relevant, and demonstrates strong multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses_Financial_Metric]-> FIN_INST -[Has_Stake_In]-> PRODUCT <-[Offers]- ORG",
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 426,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the impact of weather conditions on Southern Company's gas distribution revenues compare to the exposure of NextEra Energy's electricity demand, considering their respective risk mitigation strategies?",
      "original_answer": "Southern Company Gas' earnings are affected by customer consumption patterns that are largely a function of weather conditions and natural gas price levels. For example, in 2023, Southern Company Gas experienced a 6.2% decrease in net income compared to 2022, partly due to lower gas volumes sold driven by weather patterns. However, the company utilizes mechanisms like weather normalization and weather derivative instruments to limit exposure to typical weather variations. In contrast, NextEra Energy (NEE) faces more direct and severe operational risks from weather conditions, such as hurricanes, extreme temperatures, and disruptions to power generation from wind and solar facilities. NEE's Florida-based operations are particularly vulnerable to hurricanes, which can cause power outages, infrastructure damage, and increased costs for service restoration. While NEE also seeks cost recovery through regulatory mechanisms, its exposure to unpredictable weather events poses a more immediate threat to both operations and financial performance compared to Southern Company Gas' structured risk management approach.",
      "llm_answer": "\nSouthern Company’s gas‑distribution revenue is driven by customer‑consumption patterns that vary with weather (SO → Customer Consumption Patterns ← Weather), but the company cushions this volatility with regulatory weather‑normalization mechanisms, weather‑derivative instruments and, for Atlanta Gas Light, a straight‑fixed‑variable rate design that flattens seasonality; by contrast, NextEra Energy’s electricity demand is directly weather‑dependent (Weather → NEE) and can swing sharply with temperature extremes, and although NEE can recover many weather‑related costs through rates, it must bear higher exposure through costly winterization, storm‑hardening and insurance to mitigate the more pronounced weather risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core comparison between Southern Company Gas and NextEra Energy regarding weather impacts and risk mitigation. (1) Quantitatively, no specific numbers from the original answer (e.g., 6.2% decrease in net income in 2023) are mentioned in the LLM response, but this is not a failure—those details were present in the ground truth but not required for correctness unless explicitly referenced in the question. The LLM does not introduce any incorrect figures, and all implied financial mechanisms are correctly described. (2) The LLM correctly identifies the key entities: Southern Company (via Southern Company Gas), NextEra Energy (NEE), and their respective exposure to weather. It accurately notes Southern Company’s use of weather normalization, weather derivatives, and rate designs (specifically naming Atlanta Gas Light’s straight-fixed-variable rate), which aligns with the ground truth’s emphasis on structured risk management. (3) For NextEra Energy, the LLM correctly identifies direct weather dependence of electricity demand, vulnerability to temperature extremes, and operational mitigation strategies like storm hardening and insurance—consistent with the original answer’s focus on hurricane risks and infrastructure costs. While the LLM does not explicitly mention hurricanes or Florida, it conveys the essence of higher operational exposure and cost-bearing mitigation, which supports the qualitative comparison. (4) The reasoning is sound: it contrasts Southern’s revenue-focused, regulated mitigation tools with NEE’s operationally intensive, cost-bearing approach, effectively synthesizing the multi-hop comparison. The only minor shortcoming is the absence of the specific 2023 financial impact example, which would have strengthened completeness, but since the question does not ask for specific numbers, this does not undermine the overall correctness. Semantic equivalence is maintained, and the answer is contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> MACRO_CONDITION -[Depends_On]-> MACRO_CONDITION <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 537,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does McDonald's revenue model relying on affiliates compare to General Motors' production strategy for crossovers through nonconsolidated affiliates, particularly in terms of revenue contribution and operational structure?",
      "original_answer": "McDonald's generates revenue from affiliates through royalty payments based on a percentage of sales, along with initial fees, as part of its franchise model. This structure allows McDonald's to maintain a steady income stream tied directly to the performance of affiliate-operated restaurants. In contrast, General Motors produces crossovers through nonconsolidated affiliates involved in development, manufacturing, and marketing, where GM engages in purchasing and selling transactions with these entities. While McDonald's affiliate model centers on brand licensing and royalty income, GM's affiliate relationships focus on vehicle production and distribution. This results in distinct revenue contributions: McDonald's sees recurring revenue from affiliate royalties, whereas GM's revenue from affiliates is transactional and tied to the volume of crossover production and sales.",
      "llm_answer": "\nMcDonald’s generates revenue from its franchise affiliates through rent, royalties and initial fees that are recognized as income when the underlying restaurant sales occur, a fee‑based model highlighted in the company’s Segment‑Reporting disclosures; in contrast, General Motors relies on non‑consolidated affiliates to develop, produce and market crossovers, and GM records revenue from the wholesale sale of those crossovers to dealers and fleet customers, a structure detailed in GM’s Segment‑Reporting note and transaction tables with non‑consolidated affiliates.  Thus, while McDonald’s earns recurring, percentage‑based fees from affiliated operators, GM’s revenue contribution stems from vehicle sales produced by its affiliated manufacturers, illustrating two distinct operational and revenue‑generation pathways linked through the MCD → Affiliates → Crossovers → GM relationship captured in the knowledge graph.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies McDonald's revenue model through affiliates as fee-based, involving royalties, rent, and initial fees tied to franchisee sales, which matches the original answer's emphasis on royalty payments and recurring income. It also accurately describes General Motors' use of nonconsolidated affiliates in the development, production, and marketing of crossovers, with revenue recognized from wholesale sales—consistent with the transactional nature described in the ground truth. (2) There are no numeric values or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense; however, the absence of incorrect numbers and the precise use of financial terms (e.g., 'wholesale sale', 'recognized as income') supports a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two distinct companies (McDonald's and GM), their respective affiliate structures, and the differing revenue implications—franchise-based recurring income vs. production-based transactional revenue. The mention of 'Segment-Reporting disclosures' and 'transaction tables' adds contextual fidelity to SEC filing details, enhancing credibility. (4) The only minor shortcoming is the cryptic reference to 'MCD → Affiliates → Crossovers → GM relationship captured in the knowledge graph', which is slightly confusing and not fully explained—possibly implying a direct linkage that isn't substantiated. This does not undermine the core accuracy but slightly weakens clarity. Overall, the answer is semantically equivalent, contextually relevant, and factually correct, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Produces]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 477,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the voting power dilution protection for Class B Common Stock at CMCSA compare with the automatic conversion provisions for Class B Common Stock at GOOGL, particularly in light of CMCSA's share-for-share conversion restriction and GOOGL's voluntary and transfer-triggered conversion policy?",
      "original_answer": "At CMCSA, the Class B Common Stock has a non-dilutable 33 1/3% aggregate voting power, which cannot be diluted by additional issuances of any other class of common stock, and is convertible share-for-share into Class A Common Stock, subject to certain restrictions. In contrast, at GOOGL, Class B Common Stock is entitled to 10 votes per share and can be voluntarily converted to Class A Common Stock at any time, with automatic conversion upon sale or transfer. This means CMCSA’s Class B shares maintain structural voting protection unaffected by issuance volumes, while GOOGL’s Class B shares lose enhanced voting rights upon transfer, making CMCSA's Class B shares more resilient to voting dilution.",
      "llm_answer": "\nCMCSA’s Class B Common Stock is covered by a contractual non‑dilution provision that fixes its aggregate voting power at 33 ⅓ % and expressly bars any future issuance from reducing that percentage, while its conversion right is limited to a strict share‑for‑share exchange into Class A. By contrast, GOOGL’s Class B Common Stock carries 10 votes per share but has no comparable voting‑power safeguard; it may be converted at the holder’s discretion or automatically upon sale or transfer to Class A, with no restriction on other issuances that could affect voting power.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: CMCSA's Class B has a fixed 33 1/3% aggregate voting power that is contractually protected from dilution, and it allows share-for-share conversion into Class A with restrictions. GOOGL’s Class B has 10 votes per share, can be voluntarily converted to Class A, and automatically converts upon sale or transfer. (2) Quantitative accuracy is perfect: the 33 1/3% voting power and 10 votes per share are correctly stated; no calculations are required, but the comparative framing is numerically sound. (3) The multi-hop reasoning is strong—correctly contrasting structural voting protection (CMCSA) vs. transfer-triggered loss of voting control (GOOGL). The only minor shortcoming is that the LLM does not explicitly state that GOOGL’s voting dilution risk arises from conversion upon transfer, rather than from new share issuances, which slightly weakens the comparative synthesis. However, the implication is clear from context. (4) The answer is fully relevant, directly addressing the comparison of voting dilution protection and conversion mechanisms. Wording differs but meaning is semantically equivalent. Minor deduction from 10 to 9 due to slightly less explicit articulation of the structural resilience difference, though the core insight is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Convertible_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 382,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does AXP's valuation methodology for Level 3 investment securities expose it to the risks of illiquid market conditions, and how might this impact MS's ability to manage market risk during periods of asset devaluation?",
      "original_answer": "AXP relies on internal credit models and third-party valuations for its Level 3 investment securities, which include debt securities from Community Development Financial Institutions and an embedded derivative in GBT JerseyCo Limited valued using Monte Carlo simulations. These valuation techniques are sensitive to changes in market inputs and assumptions, particularly in illiquid market conditions where observable data is scarce. JPM_10k_2024.pdf confirms that illiquid markets make it extremely difficult to value financial instruments, and valuations may materially change when market conditions shift, leading to potential losses upon disposition. MS_10k_2024.pdf further states that during periods of market volatility and illiquidity, the firm faces challenges in valuing and monetizing financial instruments, which can negatively affect its results of operations and risk management strategies, including hedging inefficiencies and increased counterparty risk.",
      "llm_answer": "\nAXP’s Level 3 exposure stems from its debt‑security holdings in Community Development Financial Institutions and an embedded derivative that are valued using internal credit models and a Monte‑Carlo simulation when observable market inputs are absent – a methodology that the knowledge‑graph ties to “Illiquid Market Conditions,” which in turn negatively impacts **MS**. Because these valuations rely on unobservable assumptions, they become especially sensitive when markets turn illiquid, leaving MS to confront the same difficulties described in the risk disclosures: pricing becomes uncertain, subsequent fair‑value adjustments can be large and negative, hedging and other risk‑management tools may prove ineffective, and the firm may incur significant losses during periods of asset devaluation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original ground truth. (1) All factual elements are correct: AXP uses internal credit models and Monte Carlo simulations for Level 3 securities, specifically mentioning debt securities in Community Development Financial Institutions and an embedded derivative in GBT JerseyCo Limited (implied via knowledge graph linkage). The connection to illiquid market conditions and the resulting risks to MS are properly articulated. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in the original answer, so quantitative accuracy is not compromised; the LLM correctly avoids introducing any false numbers. (3) The multi-hop reasoning is sound: it correctly links AXP's valuation methodology → reliance on unobservable inputs → increased sensitivity in illiquid markets → consequences for MS’s risk management (hedging inefficiencies, valuation uncertainty, potential losses). This synthesis draws logically from both JPM_10k_2024.pdf and MS_10k_2024.pdf as implied in the original answer. (4) The LLM slightly condenses the explanation of MS’s challenges (e.g., 'monetizing financial instruments' is rephrased as pricing uncertainty and losses), but the semantic meaning remains equivalent. The term 'knowledge-graph ties to Illiquid Market Conditions' is a meta-reference that slightly deviates from standard reporting language but does not impair accuracy. Overall, the answer is factually correct, contextually appropriate, and demonstrates strong qualitative reasoning with only minor stylistic abstraction.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Negatively_Impacts]-> MACRO_CONDITION <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 433,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the valuation approach for Chevron's Level 2 derivatives compare to Exxon's use of discounted cash flow models in valuing upstream assets acquired from Pioneer, particularly in terms of observable market inputs and management judgment?",
      "original_answer": "Chevron classifies its derivatives as Level 2 when valued using third-party broker quotes, industry pricing services, and exchanges, relying on observable market data like interest rates and foreign exchange rates, with minimal adjustments. In contrast, Exxon used discounted cash flow models incorporating management judgment and unobservable inputs—such as projected production volumes, commodity prices based on third-party industry experts, and risk-adjusted discount rates—to determine the fair value of upstream assets acquired from Pioneer. While Chevron's Level 2 derivatives rely on largely consistent and observable inputs, Exxon's valuation required significant assumptions about future market conditions and asset performance, reflecting a higher degree of subjectivity and forward-looking judgment.",
      "llm_answer": "\nChevron (CVX) classifies its Level 2 derivatives as fair‑valued using third‑party broker quotes and industry pricing services that supply observable market inputs, and both CVX and the DIS disclosure note that the company does not materially adjust those quotes (Chunk 1, Chunk 2).  \nExxon (XOM) determines the fair value of the Pioneer upstream assets acquired through discounted‑cash‑flow models that, while incorporating observable inputs such as interest rates, yield curves and foreign‑exchange rates, are principally built on internally generated cash‑flow forecasts, commodity‑price assumptions, drilling‑cost estimates and risk‑adjusted discount rates that require substantial management judgment (Chunk 3).  \nThus, Chevron’s Level 2 derivative valuation is essentially market‑driven with minimal judgment, whereas Exxon’s upstream‑asset DCF valuation is fundamentally judgment‑driven, using observable inputs only as building blocks for management‑derived projections.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Chevron's Level 2 derivatives are valued using third-party broker quotes and industry pricing services with observable inputs (e.g., interest rates, FX rates) and minimal adjustments—this matches the original answer. Exxon's use of discounted cash flow (DCF) models for valuing Pioneer upstream assets is correctly described as relying on management judgment and unobservable inputs such as projected production, commodity price assumptions, and risk-adjusted discount rates. (2) There are no numeric values requiring calculation in this question, but all qualitative financial concepts (e.g., observable vs. unobservable inputs, Level 2 classification) are correctly interpreted and consistently represented across both answers. (3) The multi-hop reasoning—comparing Chevron’s market-driven, observable-input-based valuation approach to Exxon’s judgment-driven, forward-looking DCF model—is sound and synthesizes information correctly across entities and valuation methodologies. (4) The only reason for not scoring a perfect 10 is minor: the LLM mentions 'DIS disclosure note'—likely a hallucination or typo (possibly meant 'CVX disclosure')—which slightly undermines entity accuracy but does not affect the core correctness of the comparison. Otherwise, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative and quantitative fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Classifies]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 410,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does Duke Energy's negotiation of PPAs for renewable facilities compare with Southern Power's investment in solar facilities in terms of financial structure and tax credit utilization, given the role of PPAs in financing solar assets?",
      "original_answer": "Duke Energy negotiates PPAs as part of its commercial renewables strategy, which significantly influences the economic performance of its renewable energy VIEs, particularly through siting, PPA negotiation, and ongoing operations. These PPAs are also central to Southern Power's financial structure, where they are accounted for as operating leases with terms up to 25 years for solar facilities. Southern Power utilizes federal tax credits (ITCs and PTCs), with $1.2 billion of unutilized credits at the Southern Company level as of December 31, 2021, largely tied to solar and wind investments. This indicates that while both companies rely on PPAs in the development and operation of solar facilities, Southern Power integrates tax equity partnerships and federal incentives more directly into its investment model, affecting cash flows and net income differently than Duke’s VIE and guarantee-based financing.",
      "llm_answer": "\nDuke Energy builds its renewable assets as variable‑interest entities and uses long‑term PPAs both to secure revenue and to attract tax‑equity partners, consolidating the projects on its balance sheet and leveraging the partners’ tax credits to finance the facilities; Southern Power, in contrast, holds its solar (and battery) projects under PPAs that are accounted for as operating leases with terms up to 25 years and captures the federal ITCs and PTCs through consolidated tax‑equity partnerships that allocate virtually all of those credits to the partner, leaving about $0.8 billion of unutilized credits that are expected to be fully employed by 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the core financial structures: Duke Energy's use of VIEs and PPAs to attract tax-equity partners, and Southern Power's use of operating lease accounting for PPAs with long-term terms (up to 25 years). It also correctly notes the role of federal tax credits (ITCs and PTCs) and tax equity partnerships in Southern Power's model. However, there is a significant quantitative discrepancy: the LLM states $0.8 billion of unutilized credits for Southern Company, while the ground truth reports $1.2 billion as of December 31, 2021. This is a material error, especially since the exact figure is provided in the original answer and is central to assessing tax credit utilization. Additionally, the LLM introduces a forward-looking claim that the $0.8 billion 'is expected to be fully employed by 2024,' which is not present in the original answer and cannot be verified from the provided ground truth.\n\n2) Quantitative accuracy is compromised by the incorrect dollar amount ($0.8B vs $1.2B) and the unsupported projection to 2024. While the 25-year PPA term is correctly stated, the unutilized credit figure is a key financial metric and must be accurate. The format ($0.8 billion vs $1.2 billion) is acceptable, but the value itself is not.\n\n3) The multi-hop reasoning is generally sound: the model connects PPAs to financial structure (operating leases vs VIE consolidation), links tax credit utilization to tax equity partnerships, and contrasts Duke’s balance sheet financing with Southern Power’s credit allocation model. The synthesis across entities (Duke Energy, Southern Power, Southern Company) is appropriate, though the attribution of the unutilized credits should be clarified as at the Southern Company level, not necessarily Southern Power alone.\n\n4) Despite the numerical inaccuracy and the addition of unverified forward-looking information, the LLM captures the essential qualitative contrast: Duke relies on VIEs and guarantees with tax-equity financing, while Southern Power uses operating lease structures and tax equity partnerships that allocate most credits to partners, affecting cash flows and net income differently. The answer remains contextually relevant and addresses the comparison in financial structure and tax credit use as required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negotiates]-> FIN_INST -[Related_To]-> PRODUCT <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 616,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does the concentration of voting power in NKE's Class A Common Stock, which elects three-quarters of the Board of Directors, compare with HD's treatment of voting rights for restricted stock awards in terms of governance influence?",
      "original_answer": "NKE's Class A Common Stockholders elect three-quarters of the Board of Directors, consolidating governance control within a single class of shares. In contrast, HD grants voting rights to recipients of restricted stock awards at the grant date, allowing them to vote on matters even before the restrictions lapse. This indicates that HD distributes voting influence more broadly across equity compensation recipients, while NKE centralizes it among Class A shareholders. Neither company allows Class B or C common stockholders to vote on most matters, but HD’s approach introduces earlier voting participation through restricted shares.",
      "llm_answer": "\nNKE’s Class A Common Stock can elect ≈ 75 % of the Board of Directors, giving that single class decisive board‑level control, whereas HD’s restricted‑stock awards only receive voting rights on a per‑share basis from the grant date, may earn dividends on unvested shares and can become non‑forfeitable, but these rights are dispersed among many award holders and do not translate into comparable board influence.  The KG link Class A Common Stock → Voting Rights → HD shows that HD’s governance is affected by voting rights, yet the voting power attached to its restricted‑stock awards is far more limited than the concentrated three‑quarter board election rights held by NKE’s Class A shareholders.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM correctly identifies that NKE's Class A Common Stock elects approximately 75% of the Board of Directors, which aligns with the ground truth (three-quarters = 75%). This is quantitatively accurate. However, the LLM misrepresents HD's voting rights structure: while it correctly notes that HD grants voting rights at grant date for restricted stock awards, it incorrectly implies these rights are 'far more limited' in governance influence without acknowledging that HD distributes voting power earlier and more broadly among employees/award recipients—a key contrast emphasized in the original answer. The LLM also introduces a confusing and unsupported reference to 'KG link Class A Common Stock → Voting Rights → HD', which appears to be an internal artifact or hallucination and has no basis in the provided context.\n\n2) Quantitative accuracy is high: '≈ 75%' correctly reflects 'three-quarters'. No other numbers are involved, and the percentage is accurately represented despite minor rounding notation.\n\n3) The reasoning is partially flawed. While both companies’ voting structures are mentioned, the LLM fails to properly synthesize the multi-hop comparison: NKE centralizes governance via a super-voting share class, whereas HD decentralizes early voting access through restricted stock. The LLM incorrectly frames HD's approach as having 'far more limited' influence, when in fact the difference is about distribution vs concentration, not degree of limitation. This mischaracterizes the governance implication.\n\n4) Contextual relevance is strong—the response addresses voting rights, board influence, and compares NKE and HD. However, the erroneous conclusion about HD’s 'limited' influence and the nonsensical KG link reference reduce qualitative accuracy. The core contrast (centralized vs broad/early voting) is underdeveloped, leading to a partially correct but misleading interpretation. Hence, correctness score is 6: some key facts are right, but the synthesis and conclusion contain significant errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST -[Positively_Impacts]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 545,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does the foreign exchange risk exposure of Netflix's forecasted revenue transactions compare to Disney's VAR model estimates, given both companies' use of financial instruments to hedge against currency fluctuations?",
      "original_answer": "Netflix uses forward contracts to hedge foreign exchange risk on forecasted revenue transactions denominated in non-U.S. dollar currencies, while Disney employs a VAR model that excludes forecasted transactions from its risk estimation. Netflix's foreign currency transactions resulted in a $293 million loss in 2023, indicating volatility in unhedged positions, whereas Disney's VAR estimate for maximum one-day loss decreased to $255 million in 2024 from $284 million in 2023 due to lower interest rate volatility. This suggests that while both companies manage FX risk, Disney's modeled approach excludes certain forecasted exposures that Netflix explicitly hedges.",
      "llm_answer": "\nNetflix mitigates foreign‑exchange risk on its forecasted revenue by using forward contracts that lock in rates for earnings denominated in non‑USD currencies (Chunk 1). Disney’s VAR model quantifies a $255 million one‑day potential loss at a 95 % confidence level (Chunk 2/3), but it explicitly excludes the hedged forecasted foreign‑currency transactions that would be covered by its own hedging program, so the VAR figure reflects unhedged market‑sensitive positions rather than the same exposure Netflix manages; the knowledge‑graph link (NFLX → Forecasted Transactions → VAR Model → DIS) shows that Disney’s VAR metric is connected to Netflix’s forecasted items but does not directly measure their hedged risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Netflix uses forward contracts to hedge forecasted revenue transactions in non-USD currencies and that Disney’s VAR model excludes forecasted transactions from its risk estimation. It accurately reports Disney’s 2024 VAR estimate of $255 million (at 95% confidence), which aligns with the ground truth stating Disney’s VAR decreased to $255M in 2024 from $284M in 2023. However, the LLM omits Netflix’s $293 million loss in 2023, a key quantitative data point in the original answer that illustrates the volatility in unhedged positions. This omission reduces completeness and factual accuracy. (2) The VAR figure of $255 million is correctly cited, and the explanation of confidence level (95%) adds context not in the original but is plausible and relevant. The decrease from $284M to $255M is implied in the LLM answer by mentioning the current value but not the prior year’s value or the trend, which is a partial failure in quantitative completeness. (3) The multi-hop reasoning is partially sound: the model connects Netflix’s hedging of forecasted transactions with Disney’s exclusion of such items in its VAR model, correctly contrasting their approaches. However, it fails to fully synthesize the comparative implication — that Disney’s model does not account for exposures that Netflix actively hedges — due to missing the Netflix loss figure that underscores the risk magnitude. The mention of a 'knowledge-graph link' is interpretive and not present in the original, possibly overreaching without source confirmation. (4) Scores reflect strong performance on contextual relevance and entity accuracy (correct companies, correct instruments, correct metrics), good quantitative accuracy with one major omission, and solid but incomplete qualitative reasoning due to missing comparative financial impact data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Manages]-> FIN_INST -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 507,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How do the Value at Risk (VAR) calculations for MDLZ and PM differ in terms of the time periods used to estimate expected return distributions under normal market conditions, and what does this imply about their respective risk assessment horizons?",
      "original_answer": "MDLZ uses the prior quarter's interest rate, currency exchange, and commodity price movements to estimate return distributions for VAR calculations at year-end (December 31, 2024 and 2023), and the four prior quarters for average VAR amounts. In contrast, PM primarily uses the preceding quarter for year-end VAR calculations and the four preceding quarters for average, high, and low VAR amounts. This indicates that while both companies rely on recent market data, MDLZ explicitly applies a multi-quarter approach for average VAR, suggesting a slightly more extended risk assessment horizon compared to PM.",
      "llm_answer": "\nBoth MDLZ and PM compute VAR with a **one‑day holding period and a 95 % confidence level under normal market conditions**, and each determines the expected‑return distribution by **observing interest‑rate, currency and commodity price movements over the most recent prior quarter** to produce the point‑in‑time VAR at year‑end.  For the **average VAR reported over a fiscal year**, however, they each expand the look‑back to **the preceding four quarters** (MDLZ explicitly says “four prior quarters” for average VAR, while PM says “four preceding quarters” for average, high and low VAR).  \n\nThus, although the **risk‑assessment horizon is a one‑day shock**, the **estimation of the underlying return distribution relies on a quarterly historical window and is smoothed with a four‑quarter average**, giving both companies a short‑term risk horizon that is informed by a rolling quarterly/annual historical backdrop.  This parallel use of a one‑day horizon combined with a quarterly‑to‑four‑quarter look‑back shows that MDLZ and PM assess risk on the same immediate time scale, but they base their distributional assumptions on slightly different historical windows within that framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both MDLZ and PM use the prior quarter for year-end VAR calculations and four quarters for average VAR, which aligns with the ground truth. However, it introduces information not present in the original answer — specifically, the 'one-day holding period' and '95% confidence level' — which were not mentioned in the ground truth and thus cannot be verified as correct from the provided context. This affects factual accuracy. (2) Quantitatively, the time periods (prior quarter, four prior quarters) are accurately represented for both companies, and the distinction between point-in-time and average VAR is preserved. No numerical errors are present, hence a high quantitative score. (3) The multi-hop reasoning is mostly sound: the model correctly synthesizes the look-back periods for both companies and draws a reasonable comparison. However, the implication about risk assessment horizons slightly misaligns with the ground truth — while both use similar windows, the original emphasizes that MDLZ’s explicit use of a multi-quarter approach for average VAR suggests a *slightly extended* horizon, a nuance downplayed in the LLM answer, which concludes they assess risk 'on the same immediate time scale'. This overlooks the subtle but meaningful difference highlighted in the ground truth. (4) The answer is highly relevant and well-structured, addressing both parts of the question (time periods and implications), but the addition of unverified technical VAR parameters (holding period, confidence level) and the softened conclusion on risk horizon reduce its qualitative accuracy despite strong overall performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Depends_On]-> MACRO_CONDITION <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 458,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How does the $0.6 billion goodwill impairment charge recorded by DIS in fiscal 2024 relate to the auditor's evaluation of significant assumptions, and how does this compare to the auditor's approach in testing significant assumptions at NFLX related to content amortization estimates?",
      "original_answer": "The $0.6 billion goodwill impairment charge recorded by DIS in fiscal 2024 was directly tied to the fair value assessment of the entertainment linear networks reporting unit, which relied on significant assumptions such as future revenues, operating margins, terminal growth rates, and discount rates. The auditor, PricewaterhouseCoopers LLP, evaluated the reasonableness of these assumptions by comparing them to historical performance, external market data, and evidence obtained elsewhere in the audit. Similarly, at NFLX, the auditor (also PricewaterhouseCoopers LLP) tested significant assumptions used in content amortization estimates, including forecasted viewing hour consumption and historical viewing patterns, by comparing them to current trends and prior actual results. Both audits involved sensitivity analyses and the use of professionals with specialized skills to assess the impact of changes in these assumptions on financial outcomes.",
      "llm_answer": "\nThe $0.6 billion goodwill impairment that DIS recorded in fiscal 2024 stemmed from a quantitative impairment test of its entertainment‑linear‑networks and DTC reporting units, and the auditor (PwC) evaluated the reasonableness of the key assumptions—future revenues, operating margins, terminal growth rates and discount rates—by testing management’s controls, reviewing the underlying data and confirming consistency with external market evidence (Chunk 1).  \nIn comparison, the auditor’s work on Netflix (NFLX) focused on testing the significant assumptions underlying content amortization—namely historical and forecasted viewing‑hour patterns—by evaluating the completeness of the data, assessing the amortization method, and performing sensitivity analyses to gauge how changes in those viewing‑pattern assumptions would affect amortization expense (Chunks 2 & 3).  \nThus, while both audits required specialized professional judgment and a systematic review of management’s assumptions, DIS’s testing centered on fair‑value and discount‑rate inputs for goodwill, whereas NFLX’s testing centered on viewing‑pattern inputs that drive content amortization, illustrating parallel yet distinct audit approaches across the two companies (all chunks).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $0.6 billion goodwill impairment charge for DIS in fiscal 2024 is correctly stated, with no numerical inaccuracies. The fiscal year and dollar amount match the original answer exactly. (2) The entities—DIS, NFLX, PwC (PricewaterhouseCoopers LLP)—are correctly identified, and the financial concepts (goodwill impairment, content amortization, discount rates, viewing hours) are accurately attributed to each company. (3) The reasoning correctly synthesizes multi-hop information: it links DIS’s impairment to assumptions in fair value estimation (revenues, margins, growth rates, discount rates) and explains how PwC evaluated them using controls, data review, and market evidence. For NFLX, it accurately describes auditor testing of viewing-hour assumptions, data completeness, amortization methods, and sensitivity analyses. (4) The comparison between the two audits captures the core similarity—both involve testing significant assumptions using sensitivity analysis and professional judgment—and the key difference in focus (fair value inputs vs. content consumption patterns). The only minor shortcoming is that the LLM does not explicitly mention the use of 'professionals with specialized skills' at both companies, which is noted in the original answer. However, 'specialized professional judgment' is a close semantic equivalent. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> ACCOUNTING_POLICY -[Tests]-> ACCOUNTING_POLICY <-[Reviews]- ORG",
      "token_usage": {
        "prompt_tokens": 1585,
        "completion_tokens": 417,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How does the cost-sharing structure between Gilead and Merck for long-acting HIV injectable products compare to Gilead's other collaboration agreements, such as the one with Arcellx, in terms of financial commitment and milestone-based payments?",
      "original_answer": "Gilead and Merck share global development and commercialization costs for long-acting HIV injectable products at 60% and 40%, respectively, with no material expenses recognized under the agreement through 2024. This contrasts with Gilead's collaboration with Arcellx, where Gilead made a $313 million upfront payment and a $299 million equity investment in 2023, and paid $68 million in development milestones in 2024. Unlike the Merck agreement, which involves shared costs and revenue splits upon approval, the Arcellx collaboration includes significant upfront and milestone-based payments, profit sharing in the U.S., and royalties outside the U.S., indicating a more financially committed and risk-shared structure with Arcellx compared to the cost-sharing model with Merck.",
      "llm_answer": "\nThe KG relationship (Merck → Long‑Acting Injectable Products → GILD) confirms that Merck co‑commercializes the long‑acting HIV injectable with Gilead, under an agreement that shares development costs 60 % (Gilead) / 40 % (Merck) and splits global revenue equally until sales exceed $2 bn (oral) or $3.5 bn (injectable), after which Gilead’s share rises to 65 %—a structure that includes no disclosed upfront or performance milestones, only cost reimbursements. In contrast, the Arcellx collaboration, also detailed in the filings, splits development and commercialization costs 50/50 and shares U.S. profits equally, while Arcellx is eligible for up to $1.5 bn in development and regulatory milestones, additional commercial milestones and royalties, and Gilead has already recorded a $313 m IPR&D charge, paid $68 m in 2024 milestones and invested $299 m in equity, reflecting a far larger milestone‑based financial commitment. Thus, the Merck deal emphasizes cost‑sharing and revenue‑threshold sharing with minimal milestone exposure, whereas the Arcellx deal involves substantial upfront and milestone‑driven payments.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 60/40 cost-sharing split between Gilead and Merck and the absence of upfront or milestone payments in that agreement. It also accurately notes the $313 million upfront (recorded as IPR&D), $299 million equity investment, and $68 million in 2024 milestones paid to Arcellx, which aligns with the ground truth. However, it introduces significant inaccuracies by stating that global revenue is split equally until certain sales thresholds ($2B oral, $3.5B injectable) are reached, after which Gilead gets 65%—this revenue-sharing structure is not mentioned in the original answer and appears to be fabricated or misattributed. Additionally, the LLM claims the Arcellx collaboration involves 50/50 cost sharing, which is not stated in the ground truth; the original answer does not specify cost-sharing percentages for Arcellx. (2) Quantitative accuracy is partially compromised: while the dollar amounts ($313M, $299M, $68M) are correct and properly dated, the revenue-sharing thresholds and profit split mechanics are unsupported by the ground truth and thus factually incorrect. The $1.5B in potential milestones for Arcellx is plausible but not confirmed in the original answer, which only specifies amounts already paid, not total potential. (3) The multi-hop reasoning is generally sound—comparing financial structures across two collaborations—and the conclusion that Arcellx involves greater milestone-based commitment is valid. However, the reasoning is based on some incorrect premises (e.g., revenue thresholds), weakening the logical foundation. (4) Contextual relevance is excellent: the response directly addresses the comparison of financial commitment and milestone payments between the two agreements. Despite the factual overreach on revenue sharing, the core contrast—cost-sharing with Merck vs. upfront/milestone-heavy deal with Arcellx—is preserved, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP -[Commercializes]-> PRODUCT <-[Commercializes]- ORG",
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 528,
        "total_tokens": 2028
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How do Tesla's multi-year pricing agreements with Panasonic for Gigafactory 2170 and Japan-sourced battery cells compare to GM's battery procurement cost exposure in terms of contractual stability and long-term cost predictability?",
      "original_answer": "Tesla has structured long-term pricing agreements with Panasonic Corporation for both Gigafactory 2170 cells (executed June 9, 2020) and Japan-sourced cells (executed December 29, 2020), providing multi-year cost predictability. In contrast, GM's 2023 10-K filing on page 78 indicates a dependency on battery procurement costs without equivalent visibility into long-term pricing agreements, suggesting greater exposure to market volatility. This creates a differentiated risk profile where Tesla has locked in pricing through 2020+ agreements while GM's battery cost structure appears more variable.",
      "llm_answer": "\nTesla’s battery supply is anchored by a series of multi‑year pricing contracts—specifically the 2019 Japan‑Cells Pricing Agreement, the 2020 Gigafactory 2170 Cells Pricing Agreement (both referenced in Exhibit 10.35†† and 10.36†† of the 2023 10‑K) and the 2021 Japan‑Cells Pricing Agreement (Exhibit 10.37††)—all of which amend the original 2011 Supply Agreement and are reinforced by lease and amendment documents (Exhibits 10.38††, 10.40††); this layered, long‑term framework delivers contractual stability and a predictable cost base for the cells used in Gigafactory 2170 and Japan‑sourced batteries.  \n\nBy contrast, GM’s 2023 10‑K (Chunk 3) discloses that its battery‑procurement cost exposure is tied to spot‑market pricing and does not include comparable long‑term fixed‑price arrangements, leaving the automaker more vulnerable to raw‑material price swings and giving it far less cost‑predictability than Tesla’s structured, multi‑year agreements with Panasonic.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Tesla's multi-year pricing agreements with Panasonic for Gigafactory 2170 and Japan-sourced cells, and contrasts them with GM's lack of long-term fixed pricing, aligning with the ground truth. However, there are minor inaccuracies in dates: the LLM cites a '2019 Japan-Cells Pricing Agreement' and a '2021 Japan-Cells Pricing Agreement', while the ground truth specifies agreements executed on June 9, 2020 (Gigafactory 2170) and December 29, 2020 (Japan-sourced), with no mention of 2019 or 2021 agreements. These date discrepancies affect quantitative accuracy. (2) The LLM references specific exhibits (10.35, 10.36, 10.37, etc.) and the 2011 Supply Agreement, which adds detail beyond the ground truth but is not contradicted by it; however, the original answer does not confirm the 2019 or 2021 agreements, so their inclusion introduces unverified information. (3) The multi-hop reasoning is sound: the model correctly synthesizes Tesla’s contractual stability from its filings and contrasts it with GM’s exposure to spot-market pricing as disclosed in its 2023 10-K, demonstrating strong qualitative accuracy and contextual relevance. (4) The core conclusion—that Tesla has greater long-term cost predictability while GM faces more volatility—is semantically equivalent to the ground truth and well-supported. The score is reduced slightly due to incorrect dates, but the overall reasoning and key facts remain accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP -[Supplies]-> PRODUCT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 408,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does Coca-Cola's use of non-derivative instruments to hedge foreign exchange risk compare to Procter & Gamble's exposure to foreign exchange fluctuations, given that both operate in similar international markets such as the United Kingdom and Germany?",
      "original_answer": "Coca-Cola actively uses non-derivative instruments, such as foreign currency-denominated third-party debt, to hedge foreign exchange risk related to its net investments in foreign subsidiaries, with these instruments designated in hedging relationships to offset currency exposure. In contrast, Procter & Gamble discloses that it is significantly exposed to foreign exchange fluctuations due to its international operations — particularly in the United Kingdom and Germany, which are among its largest markets — and while it employs strategies to manage these risks, it explicitly acknowledges that exchange rate movements have historically negatively impacted its net sales, earnings, and cash flows. Therefore, while Coca-Cola appears to have a more structured hedging approach, Procter & Gamble reports a more direct and material financial sensitivity to FX volatility.",
      "llm_answer": "\nCoca‑Cola mitigates foreign‑exchange risk by designating foreign‑currency‑denominated third‑party debt and other non‑derivative instruments as hedging relationships; the resulting gains or losses are recorded in AOCI and re‑classified to earnings when the hedged exposure is realized, thereby offsetting the foreign‑exchange fluctuations that are disclosed as a macro condition for Procter & Gamble. In contrast, Procter & Gamble reports significant translation and transaction exposure in markets such as the United Kingdom and Germany, noting that currency weakening can directly depress its net sales, net earnings and cash flow, and while it may use some hedges, its overall FX exposure is broader and not fully neutralized by non‑derivative instruments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Coca-Cola uses non-derivative instruments like foreign currency-denominated debt to hedge foreign exchange risk, with gains/losses recorded in AOCI, which aligns with its hedging strategy for net investments in foreign subsidiaries. Procter & Gamble is correctly described as having significant exposure to FX fluctuations in key markets like the UK and Germany, with explicit acknowledgment of negative impacts on net sales, earnings, and cash flows. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—correctly contrasting Coca-Cola’s structured hedging approach using non-derivatives with P&G’s broader, less-neutralized exposure. The mention of AOCI and reclassification to earnings adds technical depth consistent with accounting standards. (4) The only minor shortcoming is that the LLM does not explicitly state that P&G 'employs strategies to manage these risks' (e.g., possible use of derivatives), which slightly weakens the balance of the comparison, but this does not undermine the overall correctness. Semantic equivalence is maintained, and the answer fully addresses the comparative aspect of the question in context. Thus, contextual relevance is perfect, and qualitative accuracy is very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Designates]-> FIN_INST -[Negatively_Impacts]-> MACRO_CONDITION <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 397,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does Amgen's exposure to state-level drug affordability regulations in Maryland, through PDAB laws, compare to Gilead's operational risks in the same state, particularly in relation to their respective biopharma manufacturing and pricing strategies?",
      "original_answer": "Amgen is subject to Maryland’s PDAB laws that grant authority to set upper payment limits on certain drugs for in-state patients, payers, and providers, which affects its pricing strategy and rebate obligations under Medicaid and the 340B Drug Pricing Program. These laws are part of a broader regulatory framework that includes the Inflation Reduction Act’s Medicare price-setting provisions, which began with ENBREL being selected among the first ten drugs for Medicare price negotiation. Meanwhile, Gilead operates a CAR T-cell therapy manufacturing facility in Maryland, exposing it to operational risks such as quality control, production delays, and regulatory compliance. Unlike Amgen, whose primary risk in Maryland is regulatory and pricing-related, Gilead faces logistical and manufacturing risks tied to the complexity of cell therapy production and delivery. Both companies are impacted by Maryland’s healthcare ecosystem, but through different risk vectors—Amgen through pricing regulation and Gilead through manufacturing execution.",
      "llm_answer": "\nAmgen’s Maryland exposure is driven by the state’s PDAB, which can impose **upper payment limits on certain high‑cost drugs**—a direct price‑cap that ties the company’s revenue to the same affordability rules that the IRA’s Medicaid‑rebate‑stacking and Medicare‑price‑setting provisions amplify.  \nGilead, by contrast, faces **operational risks in its Maryland‑based manufacturing network** (e.g., dependence on apheresis centers, facility qualification and capacity constraints for its cell‑therapy products) while also being subject to the **state‑level pricing and rebate pressures** that affect reimbursement of its therapies.  \nThus, Amgen’s principal Maryland risk centers on **price‑cap regulation that constrains its pricing strategy**, whereas Gilead’s risk blends those pricing pressures with **manufacturing‑ and supply‑chain vulnerabilities in its Maryland operations**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Amgen's exposure to Maryland’s PDAB laws, emphasizing upper payment limits and their interaction with federal pricing mechanisms like the Inflation Reduction Act (IRA), Medicaid rebate stacking, and Medicare price setting—consistent with the original answer’s mention of ENBREL being selected for Medicare negotiation. (2) For Gilead, it accurately notes operational risks tied to its Maryland manufacturing facility, particularly around cell therapy production (e.g., apheresis dependencies, capacity constraints), which matches the ground truth’s focus on CAR T-cell therapy manufacturing risks. (3) The reasoning correctly differentiates the two companies’ risk vectors: Amgen faces pricing and regulatory risks, while Gilead faces a combination of pricing pressures and manufacturing/supply chain vulnerabilities—this multi-hop synthesis across companies and risk types is sound. (4) The only minor omission is that the LLM answer does not explicitly name Gilead’s CAR T-cell therapy or specify that its facility is directly involved in complex cell therapy logistics, though the reference to 'cell-therapy products' and associated operational dependencies implies this. There are no numerical inaccuracies; the answer contains no incorrect figures, and all qualitative claims are supported. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually correct, contextually relevant, and well-reasoned, meriting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Enacts]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 453,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does AIG's use of separate accounts for policyholder-directed investments compare to MET's utilization of investment management firms in managing ERISA plan assets, particularly in terms of asset diversification strategies and risk mitigation through sub-advisory discretion?",
      "original_answer": "AIG discloses that its separate accounts are legally segregated funds where investment gains and losses accrue directly to policyholders who bear the investment risk, with assets primarily including fixed maturity securities, equity securities, and derivatives. MET utilizes separate accounts backed by similar asset classes (cash, fixed maturities, equities, derivatives, real estate, and private equity) for its ERISA pension and postretirement plans, engaging investment management firms with discretionary authority to manage these assets. Both companies emphasize diversification across asset categories and multiple managers to minimize risk concentration, with MET explicitly stating that its investment policies aim to maximize funded status and minimize volatility, aligning with the long-term nature of benefit obligations. The use of derivatives is restricted to risk mitigation and duration management in both contexts.",
      "llm_answer": "\nAIG’s separate accounts (Chunk 1) are policy‑holder‑directed funds that are legally segregated and carried at fair value, with investment income and gains flowing directly to the policyholder who bears the risk. In contrast, MET’s ERISA plan assets are also held in segregated separate accounts but are overseen by external investment‑management firms acting as sub‑advisors with full portfolio‑management discretion, and the assets are deliberately diversified across multiple asset categories and managers to spread concentration risk (Chunk 2 & 3). Thus, while both use segregated accounts, MET adds a layer of sub‑advisory discretion and explicit diversification to mitigate risk, whereas AIG’s structure simply allocates risk to the policyholder without a comparable multi‑manager diversification approach.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately captures the core distinction: AIG's separate accounts are policyholder-directed with risk borne by policyholders, while MET uses external investment management firms with discretionary authority over ERISA plan assets. Both use segregated accounts and similar asset classes (though LLM does not explicitly list all—e.g., real estate, private equity—which were in the original). (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; however, all factual assertions about structure and risk allocation are consistent with the ground truth, earning full marks here. (3) The multi-hop reasoning is sound—correctly comparing AIG’s risk allocation model to MET’s sub-advisory and diversification strategy. However, the LLM slightly underrepresents MET’s explicit emphasis on maximizing funded status and minimizing volatility, and omits that both restrict derivatives to risk mitigation and duration management. Also, the claim that AIG lacks a 'comparable multi-manager diversification approach' is not fully supported in the original, which implies both use diversification across managers and asset classes. Thus, the qualitative accuracy is slightly reduced. (4) The answer remains highly relevant, directly addressing asset diversification and risk mitigation through sub-advisory discretion as asked. Minor omissions prevent a perfect score, but the core comparison is accurate and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Has_Stake_In]-> COMP <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 421,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How might the structural differences in voting rights between NKE's Class B Common Stock, which grants no voting rights except on certain defined matters, and HD's restricted stock awards, which grant voting rights from the grant date, impact investor influence on corporate governance decisions such as board composition or takeover defenses?",
      "original_answer": "NKE's Class B Common Stockholders have limited voting rights, only participating on certain defined matters such as exiting the core payments business or major corporate transactions, and do not influence the election of the Board of Directors, which is controlled by Class A Common Stockholders. In contrast, HD's restricted stock recipients are granted voting rights immediately upon grant, allowing them to influence governance matters throughout the vesting period. This structural difference means that NKE's Class B investors have significantly less influence over corporate governance, including board composition and takeover defenses, compared to HD shareholders who hold restricted stock and can exercise voting rights from the outset.",
      "llm_answer": "\nBecause NKE’s Class B Common Stock is essentially non‑voting—its holders can only vote on a narrowly defined set of matters such as certain mergers, charter amendments or a core‑business exit—shareholders who own that class have only a marginal voice in electing directors or shaping anti‑takeover defenses, which are typically decided by the Class A shareholders who control three‑quarters of the board (Chunk 1 & Chunk 2).  By contrast, HD’s restricted‑stock awards confer voting rights the moment the award is granted (and even on unvested shares), so investors who receive those awards can immediately influence board composition and any defensive measures such as merger votes (Chunk 3).  The accounting‑policy linkage that ties “Voting Rights” to both NKE and HD (NKE → Class B → Voting Rights → HD) therefore creates a structural divergence: NKE’s Class B investors are largely powerless on governance issues, whereas HD’s restricted‑stock holders gain real voting influence from day one.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) It correctly states that NKE's Class B Common Stock has limited voting rights, only on certain defined matters (e.g., mergers, charter amendments, exit from core business), and does not include influence over board elections, which are controlled by Class A shareholders. It accurately contrasts this with HD's restricted stock awards, which grant immediate voting rights upon grant, including on unvested shares. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance structures across two companies (NKE and HD), identifies the key difference in voting rights timing and scope, and draws the valid conclusion that HD restricted stockholders have greater influence on governance (e.g., board composition, takeover defenses) than NKE Class B holders. The mention of 'three-quarters of the board' controlled by Class A is a slight inference not in the original, but it is plausible and does not contradict the ground truth. (4) The answer is contextually relevant and fully addresses the question about investor influence on corporate governance. The only minor deviation is the reference to an 'accounting-policy linkage' and 'Chunk' references (e.g., Chunk 1 & 2), which appear to be artifacts from retrieval and are not in the original answer—this slightly affects clarity but not factual correctness. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 449,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the voting structure for Class B common stock at META compare to NFLX's general voting rights framework, considering the specific limitations outlined in the voting rights policies of both companies?",
      "original_answer": "NFLX provides one vote per share to all common stockholders on all matters, while META restricts voting rights for Class B common stockholders to specific defined matters such as amendments to the certificate of incorporation affecting Class B or C stock, decisions to exit the core payments business, or certain consolidation or merger transactions. In these limited cases, Class B stockholders vote together either as a single class or alongside Class A stockholders, but they do not have voting rights on all matters like NFLX's common stockholders.",
      "llm_answer": "\nNFLX’s common stock follows a straightforward one‑share‑one‑vote rule with no special carve‑outs, as shown in its 10‑K (Chunk 1). META’s Class B common stock, by contrast, is non‑listed and, per its charter (Chunk 2), has no voting rights except on a narrow set of defined matters—such as exiting the core payments business, certain consolidation/merger transactions, or charter amendments—where it votes together with Class C holders, with voting power equal to the number of shares held multiplied by the applicable conversion rate (Chunk 2 also notes the limited 23 record holders). Thus, while NFLX grants unrestricted voting rights to every share, META’s Class B shares are effectively non‑voting except on those limited issues, highlighting a markedly more restrictive voting framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that NFLX provides one vote per share to all common stockholders on all matters, while META’s Class B common stock has voting rights only on limited, specified issues such as exiting the core payments business, charter amendments affecting certain stock classes, and specific merger or consolidation transactions. (2) There are no numeric values requiring calculation in this question, so quantitative accuracy is not applicable beyond correct referencing of qualitative facts (e.g., '23 record holders' is a factual detail from the source and correctly included, though not part of the ground truth answer). (3) The multi-hop reasoning is sound: the model correctly synthesizes voting frameworks across two companies (META and NFLX), contrasting their structures by identifying the broad, uniform voting rights at NFLX versus the narrow, conditional rights for META’s Class B shares. It accurately notes that Class B votes at META occur only on defined matters and may involve voting with Class C shares under a conversion-based mechanism. (4) The only minor shortcoming is that the LLM mentions voting 'together with Class C holders' and 'conversion rate,' which, while likely accurate based on the charter (Chunk 2), slightly extends beyond the scope of the original answer, which did not specify the mechanics of how voting power is calculated or the involvement of Class C in those votes. However, this does not contradict the ground truth and adds context without error. Overall, the answer is factually correct, complete, and contextually precise, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 456,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the use of the parametric delta-gamma approximation technique under normal market conditions by PM compare to MDLZ's application of the same method in their VAR model for estimating potential one-day losses in pre-tax earnings?",
      "original_answer": "PM uses the parametric delta-gamma approximation technique under normal market conditions to estimate the risk of underlying positions in its portfolio, observing interest rate and forward currency rate movements primarily over the preceding quarter for determining value at risk (VAR) at year-end. Similarly, MDLZ applies the same technique to estimate the expected return distribution in interest rates, currencies, and commodity prices for calculating VAR, also observing movements over the prior quarter for year-end calculations. Both companies estimate potential one-day losses using a 95% confidence interval and a one-day holding period, with MDLZ specifically reporting the estimated potential one-day loss in pre-tax earnings from currency and commodity instruments as part of its VAR computation.",
      "llm_answer": "\nBoth PM and MDLZ apply the same parametric δ‑γ approximation under normal‑market assumptions (95 % confidence, one‑day holding period) to model the joint behavior of interest‑rate, currency and commodity movements. PM uses the technique to estimate the risk of its portfolio’s underlying positions by observing prior‑quarter rate and currency shifts, whereas MDLZ embeds the same δ‑γ‑based VAR model in its own disclosures to compute the expected one‑day loss in pre‑tax earnings from its interest‑rate‑sensitive debt and currency/commodity instruments, using the identical quarterly movement data for the 2023 and 2022 measurement dates. Thus, while the methodological steps and statistical parameters are shared, PM’s use focuses on general portfolio risk assessment, whereas MDLZ’s deployment specifically quantifies the potential pre‑tax earnings impact within its VAR‑derived loss figures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: both PM and MDLZ use the parametric delta-gamma approximation under normal market conditions, apply a 95% confidence interval and one-day holding period for VAR, and base their estimates on movements in the prior quarter. These details match the original answer exactly. (2) Quantitative elements—95% confidence level, one-day holding period, use of prior-quarter data—are correctly reported with no numerical or temporal inaccuracies. The mention of '2023 and 2022 measurement dates' is consistent with year-end calculations referenced in the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies use the same method but with slightly different focuses—PM on general portfolio risk, MDLZ on pre-tax earnings impact from currency and commodity instruments. This distinction is present in the original answer and accurately reflected. (4) The only minor limitation is that the LLM slightly over-specifies by naming '2022 and 2023' even though the ground truth does not specify exact years, only 'year-end' generally. However, this does not contradict the truth and is a reasonable inference given typical reporting cycles. Overall, the answer is semantically equivalent, contextually precise, and factually correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> MACRO_CONDITION -[Depends_On]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 385,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the application of the 2.5% Capital Conservation Buffer for Bank of America under the Advanced Approach compare with American Express's reliance on the Stress Capital Buffer under the Standardized Approach for meeting Basel III regulatory requirements?",
      "original_answer": "Bank of America applies a 2.5% Capital Conservation Buffer under the Advanced Approach as part of its CET1 capital regulatory minimum to meet Basel III requirements, while American Express uses the Stress Capital Buffer under the Standardized Approach, which is also a component of its Basel III compliance framework. The two institutions thus rely on different buffer mechanisms depending on their regulatory frameworks, with BAC using the Capital Conservation Buffer and AXP referencing the Stress Capital Buffer as part of their respective capital adequacy strategies.",
      "llm_answer": "\nBank of America (BAC) satisfies the Basel III capital‑conservation requirement by applying a **2.5 % Capital Conservation Buffer** in its **Advanced Approach** calculations, a buffer that is explicitly listed in the regulatory‑minimum table for both 2023 and 2022 (Chunk 1) and is a required component of the Advanced‑Approach capital‑buffer sum together with the G‑SIB surcharge and CCyB (Chunk 2).  In contrast, American Express (AXP) meets its Basel III obligation through the **Stress Capital Buffer** of **2.5 %** that is counted under the **Standardized Approach**, as indicated by the “stress capital buffer … for American Express Company” in the regulatory definitions (Chunk 3) and by the KG link Stress Capital Buffer → AXP (Chunk 1).  Thus, while both banks use a 2.5 % buffer, BAC embeds it as the conservation buffer within the Advanced Approach, whereas AXP relies on it as the stress buffer component of the Standardized Approach.  (The CCyB, which can be up to 2.5 % but is currently zero, is noted in Chunk 2 but does not alter this comparison.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in both factual content and reasoning. (1) All key facts are accurate: Bank of America applies a 2.5% Capital Conservation Buffer under the Advanced Approach, while American Express uses a 2.5% Stress Capital Buffer under the Standardized Approach. These percentages and buffer types are correctly attributed to the respective institutions and regulatory approaches. (2) Quantitative accuracy is perfect: the 2.5% figure is consistently and correctly reported for both banks, with no calculation errors. The note about CCyB being zero but potentially up to 2.5% adds contextual precision without distorting the comparison. (3) Multi-hop reasoning is sound: the answer synthesizes information across regulatory frameworks (Advanced vs. Standardized Approaches), correctly links each institution to its respective buffer mechanism using appropriate terminology and contextual clues (e.g., referencing regulatory tables and KG links), and draws a valid contrast. (4) The answer achieves semantic equivalence with the original: though more detailed, it conveys the same core insight—that BAC and AXP use different buffer mechanisms (Conservation vs. Stress) under different regulatory approaches to meet Basel III requirements. Wording differences are stylistic and do not affect factual accuracy. All evaluation criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Consists_Of]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 389,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does LMT's use of a discounted cash flow approach in valuing certain fixed income investments compare with HON's application of the same methodology in testing goodwill and intangible asset impairments, particularly in terms of the significance and sensitivity of the discount rate assumptions used?",
      "original_answer": "LMT applies the discounted cash flow approach to value certain Level 3 fixed income investments, where significant inputs include projected annuity payments and the discount rate applied to those payments. This valuation method introduces sensitivity due to the reliance on unobservable inputs. Similarly, HON uses a discounted cash flow approach to estimate the fair value of goodwill and indefinite-lived intangible assets during impairment testing, incorporating strategic and annual operating plans with terminal value assumptions. HON also acknowledges the sensitivity of these valuations to changes in assumptions, particularly the discount rate, and performs sensitivity analyses to address uncertainty. Both companies rely on the discounted cash flow method with key assumptions around discount rates, making the valuation outcomes at both firms sensitive to changes in these inputs, though applied in different asset contexts—fixed income investments at LMT and intangible assets at HON.",
      "llm_answer": "\nLMT applies a discounted‑cash‑flow model only to certain Level 3 fixed‑income investments, and the filing notes that the discount rate—along with projected annuity payments—is a **significant input** for those valuations (Chunk 1/2); however, the disclosure does not emphasize extensive sensitivity testing of that rate.  \n\nIn contrast, HON uses a DCF valuation to **test goodwill and indefinite‑lived intangible‑asset impairments**, where the discount rate is a core assumption in the cash‑flow and terminal‑value calculations and the company explicitly conducts **sensitivity analyses** on it because even modest changes can materially affect the estimated fair value and trigger impairment (Chunk 3).  \n\nThus, while both companies employ DCF, the discount‑rate assumption is critical and highly sensitive in HON’s impairment testing, whereas for LMT it is important for Level 3 fixed‑income valuations but is not presented as a heavily analyzed driver.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that LMT uses the discounted cash flow (DCF) approach for valuing certain Level 3 fixed income investments, with the discount rate and projected annuity payments as significant inputs (Chunk 1/2). It accurately contrasts this with HON's use of DCF in goodwill and intangible asset impairment testing, where the discount rate is a core assumption subject to explicit sensitivity analyses due to its material impact on fair value estimates (Chunk 3). The LLM correctly captures the key distinction: while both companies rely on DCF and the discount rate is important for both, HON places greater emphasis on sensitivity analysis, acknowledging that small changes can trigger impairments, whereas LMT does not highlight such extensive testing. There are no numerical inaccuracies (quantitative accuracy is perfect, as no specific numbers are disputed and all references are qualitative). The reasoning is sound and synthesizes information across entities (multi-hop reasoning correct). The only minor shortcoming is a slight understatement of the ground truth’s point that *both* companies acknowledge sensitivity to discount rate assumptions—HON more explicitly, but LMT still operates in a context of unobservable inputs that imply sensitivity. Thus, the LLM’s characterization of LMT’s approach as 'not presented as a heavily analyzed driver' is fair based on disclosure emphasis, but slightly downplays the inherent sensitivity in Level 3 valuations. This nuance prevents a perfect 10, but the answer remains highly accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1527,
        "completion_tokens": 453,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA influence the potential impact of share repurchases on voting control, given Alphabet's dual-class share structure where Class B shares convert to Class A with voting dilution?",
      "original_answer": "At CMCSA, holders of Class B common stock maintain a non-dilutable 33 1/3% of the voting power, with each Class B share entitled to 15 votes, whereas voting rights for Class A shares fluctuate based on the number of shares outstanding. This contrasts with Alphabet (GOOGL), where Class B shares convert to Class A shares with a 10:1 voting dilution, and repurchases of Class A and Class C shares totaled $62.0 billion in 2024. Since CMCSA’s Class B shares are convertible share-for-share into Class A stock, but retain a fixed voting percentage, repurchases of Class A shares could increase the relative voting power of Class B holders, unlike Alphabet’s structure where repurchases of Class A and C shares do not create a similar fixed voting skew due to the dilutive conversion mechanism.",
      "llm_answer": "\nCMCSA’s Class B common stock carries a fixed 33.3 % of total voting power and, as disclosed in Chunk 2, is non‑dilutable and convertible share‑for‑share into Class A, so any reduction in the total share count from repurchases will automatically increase the proportional voting weight of the remaining Class B shares unless they convert. Because Alphabet’s Class B shares also convert to Class A and lose their 10‑vote advantage (Chunk 1), the massive Class A repurchase programs it authorizes (e.g., the $62 bn–$70 bn authorizations in Chunk 1) can dilute the voting power per Class A share and thereby shift overall control dynamics when Class B converts. The equity snapshot in Chunk 3 shows that Comcast has sizable Treasury‑stock and cash reserves, meaning it could fund further repurchases, but the non‑dilutable 33.3 % voting block of Class B ensures that control remains anchored unless conversion or additional issuance changes the share count.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: CMCSA's Class B shares have a fixed 33 1/3% (represented as 33.3%) non-dilutable voting power, each with 15 votes, and are convertible share-for-share into Class A; Alphabet’s Class B shares convert to Class A with loss of super-voting rights (10:1 dilution); Alphabet repurchased $62 billion in shares in 2024 (LLM mentions $62B–$70B, which is consistent with the range in filings). (2) Quantitative accuracy is excellent: percentages and dollar figures are correctly reported or reasonably approximated (33.3% ≈ 33 1/3%, $62B is accurate). (3) Multi-hop reasoning is sound: the model correctly contrasts CMCSA’s fixed voting block with Alphabet’s dilutive conversion mechanism and explains how repurchases of Class A shares at CMCSA increase the relative voting power of Class B holders, while at Alphabet, repurchases affect control dynamics differently due to conversion rules. (4) The only minor shortcoming is slight overemphasis on Treasury stock and cash reserves (from Chunk 3), which, while contextually relevant, are not central to the core comparison about voting dilution mechanics. However, this does not detract from factual correctness. The answer fully addresses the influence of repurchases on voting control in both companies with accurate synthesis across entities and structures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Convertible_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 387,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does TGT's beverage sales mix compare to PEP's beverage revenue contribution in the APAC region, given both companies' exposure to this market?",
      "original_answer": "TGT includes beverages as part of its grocery segment, which is a key category within its retail operations. PEP, on the other hand, reports that beverages contribute 23% of its revenue in the APAC region. Additionally, PEP's APAC segment generated $10 million in reported revenue for 2024. This indicates that while both companies operate in the beverages category in APAC, PEP provides a specific quantification of its beverage exposure in the region, whereas TGT does not break down beverage sales separately from its broader grocery offering.",
      "llm_answer": "\nBoth Target (TGT) and PepsiCo (PEP) have an “APAC” geographic exposure that includes beverage production, as shown by the KG links TGT → Beverages → APAC → PEP. Chunk 1 places beverages inside Target’s broad grocery mix (apparel, home, electronics, etc.) but does not give a separate APAC‑specific beverage revenue figure. By contrast, Chunk 2 reports that beverages account for **23 %** of PepsiCo’s APAC sales, and Chunk 3 quantifies that APAC segment’s total 2024 revenue at **$10 million**, meaning roughly **$10 million** of PepsiCo’s APAC revenue comes from beverages. Thus, while TGT’s beverage sales are embedded in its overall merchandise mix without a disclosed percentage, PEP’s APAC beverage contribution is explicitly 23 % of its APAC revenue, amounting to about $10 million in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that PEP reports beverages as 23% of its APAC revenue and that PEP's APAC revenue was $10 million in 2024. However, it makes a critical quantitative error by stating that 'roughly $10 million of PepsiCo’s APAC revenue comes from beverages,' which is incorrect. 23% of $10 million is $2.3 million, not $10 million. This miscalculation significantly undermines the quantitative accuracy. The answer correctly notes that TGT does not disclose beverage sales separately and embeds them in its grocery segment, which aligns with the ground truth. The multi-hop reasoning is mostly sound—linking both companies to beverages and APAC, and contrasting disclosure practices—but the failure to correctly compute PEP's beverage revenue in APAC (a straightforward 23% of $10M) is a major factual flaw. The entities, percentages, and years are otherwise accurate, and the response addresses all parts of the question with good structure and relevance. The wording and conceptual understanding are strong, but the numerical error prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Operates_In]-> GPE <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 305,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How might the Medicare price negotiation under the IRA, which will apply to Otezla starting in 2027, impact Amgen's $5.2 billion intangible asset valuation for Otezla, considering that Bristol-Myers Squibb (BMY) also markets Otezla under a licensing agreement?",
      "original_answer": "The Medicare price negotiation under the IRA, which will apply to Otezla starting January 1, 2027, introduces regulatory and financial risk that could impair Amgen's $5.2 billion intangible asset valuation for Otezla. Since BMY also markets Otezla under a licensing agreement, the negotiated price could affect overall revenue from the drug, further influencing Amgen's ability to recover the carrying value of the asset. Amgen has explicitly stated that future changes in estimates related to IRA price negotiations could unfavorably impact the intangible asset's recoverability.",
      "llm_answer": "\nThe IRA’s Medicare price‑setting rule, which will begin applying to Otezla in 2027, is projected to reduce the drug’s reimbursement rates and therefore its future cash‑flow outlook, creating a direct risk that the $5.2 billion carrying value of the Otezla‑related developed‑product‑technology intangible asset could be impaired—Amgen’s quarterly impairment review already notes that any adverse shift in price or market dynamics could unfavorably affect recovery of that amount. Because Bristol‑Myers Squibb also markets Otezla under a licensing agreement (as reflected in the KG link Otezla → BMY), the same price negotiation will simultaneously erode BMY’s licensing revenues and the shared asset’s recoverability, amplifying the financial impact on both companies. Consequently, the new Medicare negotiation framework is likely to trigger an impairment test and could force a write‑down of the intangible asset if the anticipated price pressures materialize.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $5.2 billion intangible asset valuation for Otezla, the 2027 start date for IRA Medicare price negotiation, and the licensing agreement with Bristol-Myers Squibb (BMY) are all accurately referenced. The dollar amount and year are factually correct, satisfying quantitative accuracy. (2) The reasoning correctly identifies that the IRA's price negotiation introduces financial risk that could impair the asset's carrying value, and explicitly ties this to Amgen’s own disclosures about impairment risk—this matches the original answer’s emphasis on Amgen’s stated exposure. (3) The multi-hop synthesis is sound: it connects the IRA rule → impact on Otezla pricing → reduced cash flows → risk to intangible asset recoverability → Amgen’s impairment review → amplification via BMY’s licensing role. The mention of BMY’s licensing revenues being affected is a reasonable inference from the shared commercialization structure, even if the original answer focuses more on overall revenue impact. (4) The only minor shortcoming is that the LLM slightly overreaches by stating the framework is 'likely to trigger an impairment test'—while plausible, the original answer emphasizes potential future impact without asserting likelihood. However, this does not materially misrepresent the risk. Wording differs but semantic meaning is equivalent. All entities (Amgen, BMY, Otezla, IRA, 2027) are correctly identified. The answer is fully contextually relevant and addresses all parts of the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Subject_To]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 439,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does AMD's production of FPGAs for hyperscale data centers compare to Altera's FPGA offerings, given Intel's strategic decision to operate Altera as a standalone business?",
      "original_answer": "Altera, now operated as a standalone business by Intel, offers programmable semiconductors primarily FPGAs, targeting embedded, communications, and cloud and enterprise markets. Intel is pursuing monetization opportunities with Altera, including a potential IPO. Meanwhile, AMD produces FPGAs and Adaptive SOCs that are directly incorporated into servers and data center appliances used by hyperscale customers, including for AI workloads such as generative AI models. This positions both companies in competitive yet distinct roles within the FPGA market, with AMD directly serving hyperscale data centers and Intel seeking to unlock value through Altera's standalone structure.",
      "llm_answer": "\nAMD’s FPGA products are purpose‑built for hyperscale data‑center deployments – the company supplies programmable logic that is integrated into servers used by large cloud providers for AI‑heavy workloads, and this effort is reflected in AMD’s “Data Center and AI” segment reporting. Altera, which Intel has now spun out as a standalone business, continues to offer a broad portfolio of programmable semiconductors (primarily FPGAs) for embedded, communications, cloud‑enterprise and other markets, while Intel seeks to monetize the unit and explore a future IPO; the KG link FPGAs → AMD and Altera → FPGAs shows both firms produce FPGAs, but AMD’s focus is on hyperscale data‑center use‑cases, whereas Altera’s offerings remain diversified and are being operated independently of Intel’s core foundry model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: AMD produces FPGAs and adaptive SOCs integrated into servers for hyperscale data centers, particularly for AI workloads, which is reflected in its 'Data Center and AI' segment. Altera, now standalone under Intel, offers FPGAs across embedded, communications, and cloud-enterprise markets, with Intel exploring monetization including a potential IPO. These points match the original answer exactly. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) Multi-hop reasoning is sound: the model correctly synthesizes that both AMD and Altera produce FPGAs, but their market focus and corporate structures differ—AMD is integrated into hyperscale infrastructure, while Altera operates independently under Intel’s strategic divestiture. The mention of the KG link reinforces correct entity relationships. (4) Semantic equivalence is strong; the LLM uses slightly different phrasing (e.g., 'spun out as a standalone business' vs 'operated as a standalone business') but conveys the same meaning. One minor point preventing a perfect 10 is the absence of explicit mention that AMD's FPGAs are used in generative AI models, though 'AI-heavy workloads' is a close proxy. Overall, the answer is factually complete, contextually relevant, and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP -[Produces]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 400,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to the ownership structure of Class A common stock at GOOGL, given the relative number of shares outstanding and holder concentration?",
      "original_answer": "At CMCSA, the Class B common stock represents 33⅓% of the combined voting power, with all shares beneficially owned by Brian L. Roberts, and only 3 record holders as of December 31, 2021. In contrast, GOOGL’s Class A common stock had 300,754,904 shares outstanding as of January 25, 2022, with a much broader base of non-affiliate ownership contributing to a market value of approximately $1,451.1 billion as of June 30, 2021. Both structures tie voting rights to distinct stock classes, but CMCSA’s Class B shares grant concentrated control to a single individual, while GOOGL’s Class A shares are more widely distributed.",
      "llm_answer": "\nCMCSA’s Class B common stock carries roughly 33 % of the company’s total voting power and, per the filings, is effectively 100 % owned by Mr. Brian L. Roberts – only three record holders exist for that class, so voting control is extremely concentrated in a single insider. By contrast, GOOGL’s Class A common stock consists of about 300.8 million shares that, as of June 30 2021, are held by a vastly dispersed pool of non‑affiliates (the filing notes the market value of non‑affiliate‑held shares was ≈ $1.45 trillion), with no single holder or small group controlling a material share of the voting interest. Thus, while CMCSA’s Class B provides a highly concentrated, non‑dilutable voting bloc, GOOGL’s Class A structure is characterized by a large number of shares widely spread across many holders.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in precision and date alignment. (1) Quantitatively: The LLM correctly states CMCSA's Class B voting power as 'roughly 33%' (matches 33⅓% in ground truth), and attributes 100% ownership to Brian L. Roberts with only three record holders—consistent with the original. For GOOGL, the LLM rounds 300,754,904 shares to 'about 300.8 million', which is acceptable. However, it cites June 30, 2021, for the market value of $1.45 trillion (vs. $1,451.1 billion in original), slightly conflating the timing—original specifies share count as of January 25, 2022, and market value as of June 30, 2021. This is a minor issue but affects strict date alignment. (2) Completeness: The LLM addresses all parts—voting power distribution, share ownership concentration, and comparison between CMCSA’s concentrated control and GOOGL’s broad distribution. (3) Entity accuracy: Correct companies (CMCSA, GOOGL), correct stock classes (Class B at CMCSA, Class A at GOOGL), and correct individuals (Brian L. Roberts). (4) Reasoning: The multi-hop synthesis is sound—correctly contrasting concentrated insider control vs. broad non-affiliate ownership. The conclusion about non-dilutable voting bloc vs. widely spread shares is logically supported. (5) Semantic equivalence: The meaning fully aligns with the original, despite rewording and rounding. Only a slight loss in precision on dates and dollar amount formatting ($1.45 trillion vs. $1,451.1 billion) prevents a perfect 10. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 452,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the change in Keytruda royalty structure post-2023 impact Bristol-Myers Squibb's revenue dependency on Merck, considering Merck's co-development and financial obligations tied to Keytruda in combination therapies?",
      "original_answer": "The royalty rate Merck pays to Bristol-Myers Squibb (BMS) and Ono for Keytruda drops from 6.5% to 2.5% starting January 1, 2024, which will reduce BMS’s royalty income from Merck. This is significant because Merck co-develops Keytruda-based combination therapies like V940 (mRNA-4157) with Moderna, where Merck bears 50% of development costs and receives 50% of any future profits. Since BMS's revenue from Merck is partly tied to Keytruda's global sales through this licensing agreement and has been a growing component of BMS's income (noted by the 2023 increase in royalties), the reduced royalty rate may diminish the financial upside BMS experiences from Keytruda's continued use in these new combination regimens.",
      "llm_answer": "\nThe post‑2023 royalty schedule cuts Merck’s ongoing royalty on global Keytruda sales from 6.5 % (through 2023) to 2.5 % (2024‑2026) and, because the rate is halved upon patent expiry or generic entry, the royalty income that BMS receives—and the alliance revenue that rose to $212 million in 2023—will be substantially lower, reducing BMS’s financial reliance on Merck; however, Merck remains obligated to pay up to $80 million in milestone milestones and, under the 75/25 royalty split with Ono after legal‑fee adjustments, continues co‑development and profit‑sharing on Keytruda‑based combinations (e.g., V940 with Moderna) and Reblozyl, so while the strategic link persists, the reduced royalty rate lessens the weight of Merck’s contribution to BMS’s revenue.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the core change in royalty structure correctly: the drop from 6.5% to 2.5% starting in 2024 is accurately stated, aligning with the ground truth. However, it introduces a claim not present in the original answer — that the royalty drops further 'upon patent expiry or generic entry' — which is speculative and not supported in the ground truth. Additionally, the LLM states that BMS and Ono have a '75/25 royalty split after legal-fee adjustments', which is not mentioned in the original answer and lacks verification. The $212 million alliance revenue figure in 2023 is introduced without grounding in the provided truth, which notes only that royalties increased in 2023 but does not specify an amount. The $80 million milestone payment is also not in the original answer and appears to be fabricated or misattributed.\n\n2) Quantitative accuracy is partially compromised. While the 6.5% to 2.5% royalty rate change is correct, the additional figures ($212M, $80M milestones, 75/25 split) are not present in the ground truth and cannot be verified. These additions reduce confidence in numerical precision. The time frame '2024–2026' for the 2.5% rate is more specific than the original answer, which only states 'starting January 1, 2024' — this added specificity is unsupported.\n\n3) The multi-hop reasoning is generally sound: the LLM connects the reduced royalty rate to lower BMS revenue and reduced dependency on Merck, and correctly references co-development efforts like V940 with Moderna. It also acknowledges that strategic collaboration continues despite financial changes. However, the inclusion of unverified financial terms and splits weakens the logical synthesis. The core reasoning about reduced financial reliance due to lower royalties is valid and aligns with the original answer’s implication.\n\n4) Contextual relevance is high — the answer directly addresses the impact of the royalty change on BMS’s revenue dependency and ties in Merck’s co-development obligations. The mention of combination therapies and profit-sharing is appropriate and responsive. Despite factual overreach, the structure and intent of the response are well-aligned with the question.\n\nOverall, the answer gets the main point right but introduces unsupported quantitative details and assumptions, warranting a score of 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT -[Pays]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 627,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does the adoption of ASU 2022-06, which CAT has listed as applicable to its financial reporting, impact the treatment of contract modifications under U.S. government agreements that BA identified as a material risk in its 2023 disclosures?",
      "original_answer": "ASU 2022-06 extends the sunset date for optional expedients and exceptions related to reference rate reform through December 31, 2024. This allows companies like BA to apply simplified accounting treatments for contract modifications made in response to reference rate changes, such as replacing LIBOR, during that period. BA, which reported that 37% of its 2023 revenues came from U.S. government contracts—where modifications can occur without prior notice—benefits from reduced operational complexity and financial impact when adjusting contracts affected by reference rate reform. CAT, in its 2023 10-K, listed ASU 2022-06 under recently adopted accounting standards, confirming its applicability and alignment with broader corporate practices around reference rate reform.",
      "llm_answer": "\nThe adoption of ASU 2022‑06—listed by CAT as an accounting policy that applies to its financial reporting—provides optional relief for certain contract modifications (e.g., those that replace a reference rate) and extends that relief through December 31 2024, allowing such modifications to be accounted for under the reference‑rate‑reform guidance and thereby reducing their immediate earnings impact【Chunk 2】.  This relief is relevant to the U.S. government‑contract modifications that BA flags as a material risk, because those modifications can trigger curtailments, terminations, or funding changes that could materially affect CAT’s financial position, results of operations and cash flows【Chunk 1】.  Consequently, while ASU 2022‑06 may soften the accounting treatment of some contract modifications, the underlying operational and financial risk that BA describes remains unchanged, and CAT must continue to monitor and disclose the potential adverse effects of U.S. government contract changes【Chunk 1】【Chunk 3】.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key elements of ASU 2022-06—its extension of optional expedients for contract modifications related to reference rate reform through December 31, 2024—and notes that CAT has adopted it, which aligns with the ground truth. The date (December 31, 2024) is accurate, and there are no incorrect numerical values, supporting a high quantitative accuracy score. However, the answer misattributes the source of the material risk: the original answer states that *BA* (Boeing) identified U.S. government contract modifications as a material risk in *its* 2023 disclosures, and that BA benefits from the simplified accounting due to its high exposure (37% of revenue from U.S. government contracts). The LLM answer incorrectly implies that these contract modifications pose a risk to *CAT* (Caterpillar), not BA, stating that 'CAT must continue to monitor and disclose the potential adverse effects'—which is factually incorrect. This is a critical error in entity attribution and logical synthesis. The multi-hop reasoning fails because it conflates CAT’s adoption of ASU 2022-06 with BA’s risk disclosure, reversing the direction of relevance: the correct logic is that BA benefits from the relief due to its government contracts, not that CAT is exposed to risk from them. While the LLM captures the general accounting impact of ASU 2022-06, it misrepresents the entity-specific implications, leading to a significant qualitative inaccuracy. Contextual relevance is high because the answer addresses contract modifications, reference rate reform, and the accounting relief, but the misattribution undermines the core reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 451,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does the $4.8 billion transaction with Crown Castle in 2013 compare to Verizon's 2024 $2.8 billion deal with Vertical Bridge REIT in terms of asset treatment and financing obligations, particularly given both companies retained depreciation responsibilities and structured payments as financing obligations?",
      "original_answer": "Both AT&T’s 2013 transaction with Crown Castle and Verizon’s 2024 deal with Vertical Bridge REIT involved transferring exclusive rights to operate wireless towers while retaining depreciation responsibilities on their balance sheets. AT&T received $4.827 billion from Crown Castle, accounted for as a financing obligation with an effective interest rate of ~3.9%, and continues to sublease space on the towers. Similarly, Verizon received $2.8 billion from Vertical Bridge, of which $830 million was recorded as a financing obligation related to the towers Verizon continues to use, with the remainder treated as prepaid rent. Both arrangements reflect a structured financing model where the original owner maintains accounting control and depreciation charges, rather than achieving sale-leaseback treatment.",
      "llm_answer": "\nThe 2013 Crown Castle transaction generated roughly **$4.8 bn** of cash and was accounted for as a financing obligation (interest accrued at ~3.9 %); Verizon kept the towers on its books, continued to **depreciate them** (≈ $39 m of depreciation expense each year) and retained a fixed‑price purchase option of about **$4.2 bn** at lease‑end.  \nIn the 2024 Vertical Bridge REIT deal, Verizon received a **$2.8 bn** upfront payment that is split into **$2.0 bn of prepaid rent** and an **$830 m financing obligation**, yet it again **retains the towers in property, plant and equipment and depreciates them** over their useful life, with the counterparty holding the exclusive lease/operate rights and an option to acquire the towers at the end of the ~30‑year term.  \n\nThus, both agreements treat the cash proceeds as financing obligations, keep the tower assets on Verizon’s balance sheet for depreciation, and embed purchase‑option‑style rights, but they differ in the transaction size, the split between prepaid rent and financing liability, and the specific purchase‑price mechanisms.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness, despite capturing some structural similarities between the two transactions. (1) Entity error: The 2013 transaction involved AT&T, not Verizon. The LLM incorrectly attributes AT&T's $4.8 billion deal with Crown Castle to Verizon, which is a critical factual mistake. (2) Quantitative inaccuracies: The original answer states AT&T received $4.827 billion, but the LLM rounds to $4.8 billion (acceptable), though it incorrectly claims Verizon 'kept the towers on its books' in the 2013 deal—Verizon was not involved. The LLM correctly states Verizon received $2.8 billion in 2024 and that $830 million was recorded as a financing obligation, with the remainder as prepaid rent (~$1.97 billion, not $2.0 billion as stated—minor rounding issue). (3) Depreciation figure: The LLM introduces a specific annual depreciation expense of ~$39 million, which is not present in the ground truth and cannot be verified from the provided data—this is an unsupported addition. (4) Purchase option: The LLM mentions a $4.2 billion fixed-price purchase option for Verizon in the 2013 deal, which is factually incorrect because Verizon was not a party; this detail may conflate information from other deals. (5) Reasoning: While the LLM correctly identifies the common accounting treatment—retaining towers on the balance sheet, depreciating them, and treating proceeds as financing obligations—it fails the multi-hop reasoning by misattributing the first transaction to the wrong company, which breaks the comparative logic. (6) Semantic equivalence: The structure and intent of the answer are relevant and address asset treatment and financing obligations, but the core factual error (Verizon vs. AT&T) severely compromises accuracy. The contextual relevance is high as it attempts to compare both deals along the right dimensions, but the incorrect entity assignment makes the comparison invalid. Overall, the answer is partially correct in form but fundamentally flawed in substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Gains]-> ACCOUNTING_POLICY -[Obtains]-> COMP <-[Transacts_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 549,
        "total_tokens": 2064
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does PEP's direct operational presence in New Zealand's beverage market compare to KO's financial influence through its 19% stake in CCEP, which bottles and distributes Coca-Cola products in the same region?",
      "original_answer": "PEP operates in New Zealand through its APAC regional structure, selling branded beverages and convenient foods directly and through partners. CCEP, in which KO holds a 19% stake, is responsible for bottling and distributing Coca-Cola products in New Zealand under a bottler's agreement. KO's financial stake allows it to influence CCEP's operations indirectly, while PEP maintains full operational control over its New Zealand beverage activities. This creates two distinct models—direct operation for PEP and equity influence for KO through CCEP—both active in the New Zealand beverage market.",
      "llm_answer": "\nPepsiCo (PEP) has a **direct operational presence in New Zealand** – its APAC beverage unit operates its own bottling plants and distribution facilities there and markets finished drinks directly to retailers, as described in the PepsiCo 10‑K (Chunk 1).  \nCoca‑Cola (KO) does **not bottle in New Zealand itself**; instead, it holds an **≈19 % equity stake in Coca‑Cola Europacific Partners (CCEP)**, the bottler that runs CCEP’s New Zealand operations and other regions (Chunk 2 lists CCEP among the five largest bottling partners and Chunk 3 confirms KO’s 19 % ownership of CCEP as an equity‑method investment).  \nThus, while PEP controls the production and distribution of its beverages in the market through its own assets, KO’s influence is **financial and indirect**, deriving from its ~19 % share of CCEP’s earnings and the strategic leverage that stake provides over the bottler’s activities in the same region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PEP has direct operational control in New Zealand through its APAC structure, including bottling and distribution, while KO holds a ~19% equity stake in CCEP, which bottles and distributes Coca-Cola products there. The 19% stake is correctly cited and matches the original answer. (2) Quantitative accuracy is perfect—'~19%' is an acceptable approximation of '19%', and no calculations are required beyond correct percentage reporting. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across entities (PEP, KO, CCEP), regions (New Zealand), and operational models (direct operation vs. equity-method investment), drawing a clear distinction between operational control and financial influence. (4) The only minor shortcoming is that the LLM does not explicitly state that CCEP operates under a 'bottler's agreement' or that KO's stake allows 'indirect influence' through financial reporting (equity-method accounting), which are nuances present in the original. However, the core meaning—that KO’s role is indirect and financial—is clearly conveyed. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing the comparison asked in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 371,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does AIG's use of internal valuation models for mortgage-backed securities compare to SCHW's reliance on broker/dealer quotes for similar asset classes like commercial mortgage-backed securities in determining fair value?",
      "original_answer": "AIG utilizes internal valuation models and third-party asset managers to determine fair values for mortgage-backed securities, subject to management review to ensure model reasonableness. These models incorporate inputs like interest rates, borrower creditworthiness, collateral, and market pricing for comparable loans. In contrast, SCHW primarily relies on broker/dealer quotes and third-party pricing services for similar asset classes such as commercial mortgage-backed securities, using observable market data like trades, spreads, and maturity information to validate pricing. GILD’s evidence further supports that broker/dealer quotes are commonly used alongside valuation models with observable inputs for fair value estimation, indicating a shared industry practice that bridges AIG's internal modeling and SCHW's external pricing reliance.",
      "llm_answer": "\nAIG determines the fair value of mortgage‑backed and commercial‑mortgage‑backed securities primarily through its own internal valuation models—discounted‑cash‑flow and other management‑reviewed inputs such as interest‑rate, prepayment and credit‑curve assumptions—while still incorporating broker/dealer quotes as observable inputs, a relationship captured by the KG link **Valuation Models → Broker/Dealer Quotes** (Chunk 1).  \nIn contrast, SCHW does not rely on internally developed models for similar assets; instead it obtains fair‑value estimates from independent third‑party pricing services and broker/dealer quotes, adjusting those quotes only when they appear inconsistent, which is reflected in the KG link **Broker/Dealer Quotes → SCHW** (Chunk 3).  \nChunk 2 illustrates the broader industry practice of using Level 2 inputs—including broker/dealer quotes—to support fair‑value measurements for debt securities, underscoring that SCHW’s approach is quote‑driven whereas AIG’s is model‑driven.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer, with only minor differences in emphasis. (1) All factual elements are correct: AIG uses internal valuation models with management review, incorporating inputs like interest rates and credit assumptions, while also using broker/dealer quotes as observable inputs. SCHW relies on third-party pricing services and broker/dealer quotes, adjusting only when necessary. The contrast between AIG's model-driven approach and SCHW's quote-driven approach is correctly identified. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the answer synthesizes information about AIG, SCHW, and broader industry practices (referencing Level 2 inputs and observable data), correctly linking internal modeling vs. external pricing. The mention of GILD’s evidence in the original answer, which supports the use of both methods in industry practice, is omitted in the LLM answer, but the LLM still captures the essence by referencing broader industry use of Level 2 inputs. This minor omission prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing the comparison between AIG and SCHW in fair value determination for mortgage-backed and commercial mortgage-backed securities. Wording differs but semantic equivalence is strong. Overall, the LLM answer reflects a correct, nuanced understanding of the valuation methodologies and their industry context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Uses]-> FIN_INST <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 442,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does AVGO's valuation methodology for Level 2 securities compare to ADBE's reliance on matrix pricing, given the use of observable market inputs like yield curves and benchmark rates in their fair value determinations?",
      "original_answer": "AVGO categorizes its investments, including equity and short-term money market instruments, as Level 2 securities when they are valued using inputs such as interest rates, yield curves, and broker quotes. These inputs are observable but not quoted prices in active markets, distinguishing them from Level 1 securities. Matrix pricing, which is used for Level 2 securities like corporate bonds and asset-backed securities, relies on observable market data such as yield curves to estimate fair value. ADBE also categorizes its fixed income available-for-sale debt securities as Level 2 and explicitly uses matrix pricing techniques that incorporate benchmark yields, issuer spreads, interest rates, and U.S. Treasury or swap curves to determine fair value. Both companies rely on similar observable inputs, indicating a shared dependence on market-derived data rather than direct quotations for active trading in valuing their Level 2 portfolios.",
      "llm_answer": "\nAVGO classifies its Level 2 securities as those valued from observable inputs such as quoted prices for comparable assets, interest‑rate and yield‑curve data, broker‑dealer quotes and other market‑derived metrics, and it explicitly excludes plan assets measured by net‑asset‑value from the fair‑value hierarchy. ADBE, by contrast, applies a matrix‑pricing accounting policy that relies on market‑approach and discounted‑cash‑flow models using the same types of observable inputs—benchmark yields, issuer spreads, interest rates and Treasury or swap curves—and it validates those values with multiple independent vendors, categorizing all fixed‑income securities as Level 2. Thus, while both companies use observable market inputs like yield curves and benchmark rates, AVGO’s Level 2 methodology is broader and excludes certain plan assets, whereas ADBE’s approach is centered on matrix pricing and includes a formal multi‑source validation step.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: both AVGO and ADBE use observable market inputs (yield curves, benchmark rates, interest rates, spreads) for valuing Level 2 securities. AVGO relies on a range of observable inputs including broker quotes and yield curves, while ADBE explicitly uses matrix pricing with validation from multiple vendors—details consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in the question or answers, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies use similar observable inputs, but differ in methodology emphasis—AVGO with a broader set of observable inputs and exclusion of certain plan assets, ADBE with a formalized matrix pricing approach and vendor validation. This nuance is not contradicted by the ground truth and adds precision. (4) The LLM answer conveys the same core conclusion—both firms rely on similar observable data for Level 2 valuations—while providing additional context (e.g., multi-vendor validation at ADBE) that enhances rather than distorts. The slight difference in emphasis (AVGO’s broader methodology vs. ADBE’s matrix focus) is supported by typical disclosures and does not contradict the shared reliance on market-derived inputs. No factual errors; minor phrasing differences do not affect correctness. Hence, a score of 9 is appropriate—excellent, with only the possibility of slightly overstating methodological differences preventing a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Use]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 445,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "What percentage of Coca-Cola's non-U.S. unit case volume is managed by Coca-Cola HBC, and in how many of its operational countries—including the Czech Republic—does it coordinate distribution for Coca-Cola's trademark beverages?",
      "original_answer": "Coca-Cola HBC manages 17% of Coca-Cola's non-U.S. unit case volume and coordinates distribution for Coca-Cola's trademark beverages in 30 countries, including the Czech Republic.",
      "llm_answer": "\nCoca‑Cola HBC accounts for roughly 10 percent of Coca‑Cola’s non‑U.S. unit‑case volume—it is one of the five bottling partners that together represent about 41 percent of the Company’s worldwide unit‑case volume, so its share of the non‑U.S. portion is a substantial component of that figure.  In addition, Coca‑Cola HBC coordinates distribution of Coca‑Cola’s trademark beverages in 28 operational countries, one of which is the Czech Republic.  (This count of 28 countries is taken from the list of territories where Coca‑Cola HBC has bottling and distribution operations, as detailed in the filings.)",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative figures. The ground truth states that Coca-Cola HBC manages 17% of Coca-Cola's non-U.S. unit case volume, but the LLM claims 'roughly 10 percent,' which is a substantial underreporting. Additionally, the ground truth specifies distribution coordination in 30 countries, while the LLM reports 28 countries—missing two countries and thus undercounting. These numerical discrepancies directly impact the correctness of the answer. (2) Number verification: 10% ≠ 17% (incorrect), 28 ≠ 30 (incorrect). The LLM attempts to justify the country count by referencing filings but misrepresents the data. While it correctly identifies the Czech Republic as one of the countries, the total count is off. (3) Multi-hop reasoning is partially sound—the model recognizes the need to isolate Coca-Cola HBC's share of non-U.S. volume and link it to distribution operations across countries. However, it fails to accurately synthesize the correct figures from the underlying data, suggesting either retrieval error or misinterpretation of the source. (4) Contextual relevance is high because the answer addresses both parts of the question and attempts to provide supporting logic. Qualitative accuracy is moderate due to correct entity identification (Coca-Cola HBC, Czech Republic) and general understanding of the operational role, but undermined by incorrect numbers. Correctness score is low because both key metrics are wrong, making the core answer factually deficient despite proper structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 432,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How do Duke Energy's 50% equity stake in Hardy Storage in West Virginia and NextEra Energy's 31.9% ownership in a 303-mile pipeline under construction in the same region reflect divergent strategic approaches to natural gas infrastructure investment, particularly in light of regulatory and market challenges?",
      "original_answer": "Duke Energy's 50% equity stake in Hardy Storage, an interstate underground natural gas storage facility in West Virginia, indicates a strategic focus on stable, long-term infrastructure assets that support regulated gas operations. This aligns with Duke's broader approach of investing in FERC-regulated infrastructure such as Pine Needle and Hardy Storage to ensure reliable supply and service. In contrast, NextEra Energy's 31.9% ownership in a 303-mile pipeline project in West Virginia and Virginia reflects a more ambitious and risk-exposed strategy aimed at expanding transportation capacity into new markets, despite facing regulatory delays and legal challenges. While both companies are investing in West Virginia's natural gas ecosystem, Duke's approach emphasizes secure, operational assets, whereas NextEra's involvement in a pipeline under construction—subject to permitting and legal hurdles—suggests a higher tolerance for uncertainty in pursuit of future capacity and market access.",
      "llm_answer": "\nDuke Energy’s 50 % equity stake in the underground Hardy Storage in West Virginia exemplifies a conservative, regulated‑asset strategy: the storage facility is insulated from weather and usage swings by margin‑decoupling and other rate‑regulation mechanisms, delivering steady cash flows with limited construction‑risk exposure (as detailed in Chunk 1’s discussion of storage equity stakes and Duke’s withdrawal from costly pipeline projects).  \n\nIn contrast, NextEra Energy’s 31.9 % indirect ownership of the 303‑mile pipeline that is currently under construction in the same West Virginia region reflects a growth‑oriented, capacity‑building approach that depends on securing regulatory approvals and navigating permitting and legal challenges, a reality highlighted in Chunks 2 and 3 where the pipeline’s completion is conditional on those approvals.  \n\nThe knowledge‑graph linkage (DUK → West Virginia → 303‑mile Pipeline → NEE) shows that, although both firms operate in the same GPE, Duke’s stake is in a regulated storage asset protected by rate mechanisms, whereas NextEra’s stake is in a greenfield pipeline exposed to market price volatility and construction risk, underscoring their divergent strategic philosophies toward natural‑gas infrastructure investment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Duke Energy's 50% stake in Hardy Storage and NextEra Energy's 31.9% ownership in a 303-mile pipeline under construction in West Virginia are accurately reported. These numbers match the original answer exactly, and no calculation errors are present. (2) The answer correctly identifies the strategic divergence: Duke’s focus on regulated, low-risk storage assets versus NextEra’s higher-risk investment in a greenfield pipeline exposed to regulatory and legal uncertainty. The mention of 'margin-decoupling' and 'rate-regulation mechanisms' adds valuable context not in the original but consistent with regulated utility behavior. (3) Multi-hop reasoning is sound—LLM correctly links both companies to West Virginia infrastructure, distinguishes asset types (storage vs. pipeline), and infers strategic intent based on risk exposure and regulatory environment. The reference to 'knowledge-graph linkage (DUK → West Virginia → 303-mile Pipeline → NEE)' demonstrates proper synthesis across entities. (4) Minor deduction in qualitative accuracy due to the phrase 'indirect ownership'—not contradicted by the original, but introduced without explicit support in the ground truth. Otherwise, semantic equivalence is strong, and the answer fully addresses the question’s focus on strategic divergence amid regulatory and market challenges. Wording differences are acceptable and do not affect factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> PRODUCT <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1608,
        "completion_tokens": 415,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How does the difference in voting rights between Class A and Class B shares at META compare to GOOGL's dual-class structure, and what implications might this have on ownership concentration given META's 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding as of January 24, 2025, versus GOOGL's 10:1 voting ratio for Class B shares and $62.0 billion in 2024 share repurchases?",
      "original_answer": "META discloses two classes of stock—Class A and Class B—with the latter carrying greater voting rights, though the exact ratio is not quantified in the filing. As of January 24, 2025, META had 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding, indicating a significant concentration of voting power within Class B. In contrast, GOOGL explicitly states that each Class B share carries 10 votes, creating a defined 1:10 voting disparity. GOOGL also repurchased $62.0 billion in shares during 2024, predominantly from Class A and Class C, which may further consolidate voting control in Class B shares held by insiders. This suggests that while both companies utilize dual-class structures to concentrate voting power, GOOGL's is more explicitly weighted and reinforced through aggressive capital allocation, whereas META’s structure lacks detailed disclosure on voting disparity but similarly reflects a concentrated ownership base through disproportionate Class B shareholding.",
      "llm_answer": "\nThe filing for Meta (Chunk 1) shows that its Class A common stock carries one vote per share while Class B carries ten votes per share, a structure that mirrors Alphabet’s (GOOGL) dual‑class setup described in Chunks 2‑3, where Class B also holds ten votes per share and Class A one vote, with the knowledge‑graph link (Class B → GOOGL) confirming the parallel. As of January 24 2025 Meta had 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding, so the relatively small Class B block controls roughly 38 % of total voting power despite owning only ~13 % of the equity, a concentration that is amplified by GOOGL’s $62 billion 2024 share‑repurchase program (Chunk 2‑3) that shrinks the Class A/C pool and thereby heightens the relative voting weight of the remaining Class B shares. Thus, while the voting‑rights mechanics are identical (10:1), Meta’s larger absolute number of Class A shares creates a different baseline ownership distribution compared with Alphabet, where aggressive repurchases can further tilt control toward Class B holders.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly regarding META's voting rights structure. The ground truth states that META does not disclose the exact voting ratio between Class A and Class B shares, but the LLM incorrectly asserts that Class B has 10 votes per share—this is not supported by the filing and misrepresents a key fact. This error undermines the core comparison with GOOGL, which *does* have a 10:1 voting ratio. (2) Quantitatively, the share counts (2,189,898,148 Class A and 343,761,117 Class B for META) are correctly cited, and the $62.0 billion share repurchase by GOOGL is accurately referenced (rounded to $62 billion). However, the LLM calculates that Class B holds 'roughly 38%' of voting power—this calculation assumes a 10:1 vote ratio, which is invalid for META since the ratio is undisclosed. Thus, the percentage is speculative and incorrect. The equity ownership percentage (~13%) is approximately correct (343.8M / (2,189.9M + 343.8M) ≈ 13.5%). (3) The multi-hop reasoning is partially sound: the model correctly identifies that both companies have dual-class structures and that share repurchases can concentrate voting power. However, it falsely equates the voting mechanics by asserting identical 10:1 ratios, which the ground truth explicitly avoids for META. This leads to a flawed synthesis. The implication about repurchases shrinking the non-voting or low-voting share pool is valid for GOOGL, but incorrectly extended to META without evidence. (4) Contextual relevance is high—the answer addresses the comparison, ownership concentration, and impact of repurchases. But due to the critical error in attributing a 10:1 voting ratio to META without evidence, the qualitative and correctness scores are significantly reduced. The answer appears confident but is based on an unsupported assumption, leading to misleading conclusions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1578,
        "completion_tokens": 510,
        "total_tokens": 2088
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the enactment of TRAF in Switzerland impact JNJ's effective tax rate in 2020, and how does this compare to MRK's tax benefit from its Swiss tax holiday that began in 2021?",
      "original_answer": "The enactment of TRAF in Switzerland allowed JNJ to adjust the tax basis of certain assets to fair value under transitional provisions, resulting in an incremental Swiss tax deduction and contributing to a 1.9% decrease in JNJ's 2020 effective tax rate compared to 2019. Meanwhile, MRK benefited from a Swiss tax holiday for a newly active legal entity, effective through 2030, which began yielding favorable tax impacts starting in 2021. These provisions in Switzerland contributed to both companies experiencing lower effective tax rates due to localized tax incentives, albeit through different mechanisms and in different fiscal years.",
      "llm_answer": "\nThe 2020 effective tax rate of JNJ was reduced by about 1.9 % versus 2019, a decline that the company explicitly links to Switzerland’s TRAF law that took effect on January 1 2020 and allowed a step‑up of asset tax bases, generating extra Swiss deductions; by contrast, MRK did not see a comparable rate reduction until 2021, when it began benefiting from a Swiss tax‑holiday incentive for a newly created legal entity that is scheduled to remain in place through 2030, providing a distinct, ongoing tax advantage that starts a year later and operates under a different regulatory framework.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: JNJ's effective tax rate decreased by 1.9% in 2020 due to Switzerland’s TRAF law enacted on January 1, 2020, which allowed a step-up in tax basis of assets, generating additional Swiss tax deductions. MRK began benefiting from a Swiss tax holiday in 2021 for a newly created legal entity, effective through 2030. (2) Quantitative accuracy is perfect: the 1.9% decrease, the 2020 and 2021 start years, and the 2030 end date are all correctly stated. (3) Multi-hop reasoning is sound: the answer correctly synthesizes information across two companies (JNJ and MRK), two different Swiss tax regimes (TRAF vs. tax holiday), and two different years (2020 vs. 2021), clearly contrasting the timing and mechanisms. (4) The response addresses all parts of the question: the impact on JNJ’s tax rate in 2020, the comparison to MRK’s benefit starting in 2021, and the differing structures of the tax incentives. Wording differs slightly but meaning is preserved with high precision. No errors in entities, metrics, or logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Regulates]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 319,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How do MCD's foreign currency asset hedging practices compare with NKE's transactional FX risk management strategies using options, particularly regarding notional amounts and objectives?",
      "original_answer": "MCD manages FX exposure by holding diversified foreign currency net asset positions, with its largest exposures denominated in major global currencies (chunk_1). To mitigate associated risks, MCD uses option and forward contracts to hedge forecasted foreign currency transactions, with $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024 (chunk_2). NKE also uses option contracts as part of its FX risk management, focusing on transactional exposures such as product costs and external sales in non-functional currencies, with hedging strategies aimed at stabilizing U.S. Dollar inventory costs amid FX fluctuations (chunk_3). While both companies use options, MCD's strategy centers on protecting existing foreign currency assets, whereas NKE's approach is more transaction-focused, targeting forecasted cash flows and cost stability.",
      "llm_answer": "\nMCD’s foreign‑currency asset hedging is built around diversified net‑asset exposures that are mitigated with designated option contracts treated as cash‑flow hedges; the program operates at a multi‑billion‑dollar notional scale (consistent with the $9.9 bn / $8.3 bn cash‑flow hedge notional amounts disclosed for similar programs) and its primary objective is to dampen earnings and cash‑flow volatility caused by FX movements.  \nNKE, by contrast, manages transactional FX risk through a portfolio‑wide approach that also uses options and forwards as cash‑flow hedges for product‑cost, non‑functional‑currency sales and balance‑sheet items, but it does not disclose a specific notional amount—hedges are sized to the remaining exposure after natural offsets and typically mature within a four‑year window.  \nThus, while both companies aim to offset foreign‑exchange impacts on earnings, MCD’s hedging is characterized by large, explicitly quantified notional amounts and a focus on broad asset‑level volatility, whereas NKE’s strategy is more granular, portfolio‑driven, and relies on a mix of designated and non‑designated contracts without a comparable disclosed notional figure.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies MCD's use of option and forward contracts to hedge foreign currency net assets with a focus on cash flow hedges and earnings stability, and NKE's transaction-focused FX risk management using options for product costs and sales in non-functional currencies. The core objectives for both companies are accurately represented: MCD aims to protect against FX volatility in earnings and cash flows from existing asset positions, while NKE focuses on stabilizing U.S. Dollar inventory costs and managing transactional exposures.\n\n2) Quantitatively, the LLM states MCD’s notional amount as 'multi-billion-dollar' and references '$9.9 bn / $8.3 bn'—partially correct. The ground truth specifies $9.9 billion as of September 28, 2024, which matches one of the values cited. However, the inclusion of $8.3 billion is not supported by the provided knowledge and introduces an unverified figure, reducing quantitative accuracy. NKE does not disclose a specific notional amount in the ground truth, and the LLM correctly notes the absence of a disclosed notional figure—this is accurate.\n\n3) The multi-hop reasoning is strong: the model synthesizes MCD’s asset-based hedging with its use of derivatives and notional scale, contrasts it with NKE’s transactional, cost-stability-driven approach, and draws a valid comparison in strategy focus (asset-level vs. granular transactional). The reasoning correctly infers that both use cash flow hedges and options, but with differing scopes and disclosure practices.\n\n4) The answer is contextually relevant and comprehensive, addressing all parts of the question: hedging practices, use of options, notional amounts, and strategic objectives. While the $8.3 billion figure is extraneous and unverified, the overall factual content and synthesis are sound, warranting a high correctness score with a minor deduction for unsupported numerical reference.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Impacts]-> FIN_INST <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 517,
        "total_tokens": 2044
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the exclusive use of RTX's PW800 engine on Gulfstream's G500 support General Dynamics' strategy to position the G500 as a next-generation replacement for the G450 and G550 models?",
      "original_answer": "The G500, developed by General Dynamics, is positioned as a next-generation replacement for the G450 and G550 models with a clean-sheet design that includes a new wing and advanced avionics. RTX's Pratt & Whitney Canada produces the PW800 engine, which exclusively powers the G500 (along with the G400 and G600). This exclusive engine-airframe pairing enhances the G500's performance with improved fuel efficiency, range, and speed, aligning with General Dynamics' investment in new technologies to differentiate the G500 as a modern, high-performance aircraft in the business jet market.",
      "llm_answer": "\nThe G500 is a clean‑sheet, next‑generation replacement for the legacy G450 and G550 models, a positioning that General Dynamics emphasizes in its product‑development strategy (Chunk 1 & 2).  Gulfstream’s exclusive use of RTX’s PW800 engine—highlighted by the KG link Gulfstream ← Supplies ← RTX—provides the G500 with a high‑efficiency, low‑emission powerplant that delivers the fuel‑burn savings, SAF compatibility and performance needed to differentiate it from the older platforms (Chunk 3).  This engine partnership directly supports GD’s broader investment in advanced, sustainable aircraft technologies and reinforces the G500’s market claim as the modern successor to the G450/G550 family.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies the G500 as a clean-sheet next-generation replacement for the G450 and G550, which is central to General Dynamics' strategy. It accurately notes the exclusive use of RTX's PW800 engine on the G500 and links this to improved performance metrics such as fuel efficiency, SAF compatibility, and emissions—supporting GD's investment in advanced and sustainable technologies. The answer synthesizes the relationship between Gulfstream (a subsidiary of General Dynamics), RTX, and the PW800 engine correctly, demonstrating sound multi-hop reasoning across entities. While the original answer specifies that the PW800 also powers the G400 and G600, this detail is minor and not critical to the core question about strategic positioning. The LLM omits explicit mention of 'range' and 'speed' improvements, which are included in the ground truth, but does emphasize fuel efficiency and sustainability—partially covering performance enhancements. There are no numerical values in the question or answers, so quantitative accuracy is scored as 10 by default. Wording differs but semantic meaning is equivalent. Contextual relevance is strong, directly addressing how engine exclusivity supports strategic differentiation. Minor deduction in qualitative accuracy due to slightly less comprehensive coverage of performance aspects.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Introduces]-> COMP <-[Supplies]- ORG",
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 391,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the voting power distribution in META's dual-class structure compare to CMCSA's, particularly regarding the non-dilutable provisions under their respective articles of incorporation and the specific voting percentages allocated to Class A and Class B shareholders?",
      "original_answer": "META's Class B common stock is not publicly traded and as of December 31, 2023, there were only 23 stockholders of record of Class B common stock, suggesting concentrated voting control. In contrast, CMCSA explicitly states that holders of Class A common stock hold 66 2/3% of the combined voting power, while Class B common stockholders (beneficially owned entirely by Brian L. Roberts) hold 33 1/3% of the voting power. CMCSA's Class B common stock has 15 votes per share and its non-dilutable nature is specifically tied to the terms of its articles of incorporation, which preserves the voting power percentage regardless of additional Class A share issuances.",
      "llm_answer": "\nComcast (CMCSA) states in its articles of incorporation that the Class B shares—subject to a non‑dilutable provision and carrying 15 votes each—represent exactly one‑third (≈33.3 %) of the combined voting power, while the Class A shares hold the remaining two‑thirds (≈66.7 %). Meta’s 2023 10‑K discloses a dual‑class structure in which Class B shares are privately held by only 23 record holders and are not listed for public trading, but the filing does not provide the specific voting percentages or a non‑dilutable clause, so the comparative voting‑power allocation for Meta cannot be quantified beyond the disclosed holder counts. The knowledge‑graph link that connects “Class A Common Stock” (Meta) to “CMCSA” underscores the comparative focus of the analysis across the two companies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and percentages are correct: CMCSA's Class A holding 66 2/3% (≈66.7%) and Class B 33 1/3% (≈33.3%) of voting power, with Class B having 15 votes per share and being non-dilutable per articles of incorporation. The statement about META’s Class B having only 23 stockholders of record as of December 31, 2023, matches the original answer. (2) The LLM correctly notes that Meta’s 10-K does not disclose specific voting percentages or a non-dilutable clause, which is consistent with the ground truth—thus accurately reflecting the limits of available data. (3) Multi-hop reasoning is sound: the model correctly contrasts CMCSA’s explicit, rule-based voting allocation with Meta’s lack of disclosed percentages, highlighting the difference in transparency and structural specification. (4) The only minor shortcoming is a slight omission in not explicitly stating that CMCSA’s Class B is 'beneficially owned entirely by Brian L. Roberts,' which is part of the original answer and adds context about control concentration. However, this does not undermine the core factual accuracy. Wording differences are semantically equivalent and acceptable. The answer is contextually precise, directly addressing the comparison of voting power distribution and non-dilutable provisions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 381,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the risk of losing market exclusivity due to patent challenges for BMY's Revlimid in Europe compare to LLY's reliance on data protection for orphan drug designations, given that both companies depend on intellectual property frameworks to extend commercial exclusivity?",
      "original_answer": "BMY faces earlier-than-expected market exclusivity loss for Revlimid in Europe due to patent settlements allowing generic entry in the UK starting January 18, 2022, and in other European countries beginning February 18, 2022. This highlights the vulnerability of market exclusivity when patent rights are challenged or settled. In contrast, LLY leverages regulatory data protection, including orphan drug designations that provide seven years of market exclusivity independent of patent expiration. While BMY's exclusivity is determined largely by patent rights and settlements, LLY benefits from parallel regulatory protections that do not rely solely on patent enforcement, especially in markets where orphan designations apply.",
      "llm_answer": "\nBoth BMY and LLY depend on intellectual‑property frameworks to extend the commercial life of their key products, but the nature of the risk differs.  For BMY, the risk of losing market exclusivity for Revlimid in Europe is driven by patent‑right vulnerability – the company acknowledges that patent challenges and settlements have already enabled generic entry before the patent term expires, and without enforceable patent protection the product’s sales would collapse rapidly (Chunk 1 & Chunk 2).  By contrast, LLY’s orphan‑drug exclusivity is anchored in statutory data‑protection periods (e.g., the seven‑year orphan market‑exclusivity and related EU data‑package protections) that operate independently of patents and therefore are far less exposed to patent‑litigation attacks, though they remain subject to potential regulatory changes (Chunk 2 & Chunk 3).  In the knowledge‑graph terms, BMY’s market exclusivity is a RISK_FACTOR determined by PATENT rights, whereas LLY’s exclusivity is a REGULATORY_REQUIREMENT provided by DATA_PROTECTION that is linked to the same ORG entity through the MARKET_EXCLUSIVITY node.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: BMY's Revlimid faced early generic entry in Europe due to patent settlements, with specific dates (January 18 and February 18, 2022) implied as having occurred prior to patent expiry, and the answer correctly identifies this as a patent-driven risk. LLY’s reliance on regulatory data protection via orphan drug designation, including the seven-year market exclusivity in the U.S. (and analogous EU protections), is accurately described as independent of patents. (2) Quantitative accuracy is perfect: the seven-year exclusivity period is correctly stated, and while exact entry dates for generics are not repeated verbatim, the LLM correctly infers early loss of exclusivity due to settlements, consistent with the original answer’s timeline. No calculations are required. (3) Multi-hop reasoning is sound: the model synthesizes information across BMY’s patent vulnerability and LLY’s regulatory protection frameworks, correctly contrasting patent-based vs. data-protection-based exclusivity mechanisms. It references the knowledge-graph structure appropriately (RISK_FACTOR, REGULATORY_REQUIREMENT, etc.), showing deep structural understanding. (4) Semantic equivalence is strong—wording differs but meaning matches. The only minor shortcoming is that the LLM does not explicitly name the UK or list the exact dates of generic entry (Jan 18 and Feb 18, 2022), which were in the original answer, but it still captures the essence of early, settlement-driven loss. This small omission prevents a perfect 10 on qualitative accuracy, but overall the response is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> RISK_FACTOR -[Determined_By]-> REGULATORY_REQUIREMENT <-[Has]- ORG",
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 457,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the sensitivity of MS's asset management revenues to fixed income market fluctuations compare with PYPL's exposure to market risk through its use of pricing models for derivatives and debt securities?",
      "original_answer": "MS's asset management revenues are sensitive to changes in fixed income markets due to their reliance on fee-based client assets, which include fixed income investments valued using pricing models with observable market data like interest rates and credit spreads. MS specifically notes that revenues may not fully correlate with market changes due to factors like client behavior and asset mix. Meanwhile, PYPL also depends on pricing models for valuing its derivatives and available-for-sale debt securities, using observable inputs such as currency rates, interest rate yield curves, and equity prices. However, unlike MS, PYPL has elected the fair value option for foreign currency-denominated debt securities, directly tying gains and losses to market fluctuations. Both firms face market risk through their use of pricing models, but MS's exposure is more indirect through asset management fees, while PYPL's is direct through its investment and derivative valuations.",
      "llm_answer": "\nMS’s asset‑management revenue reacts directly to market moves – the firm estimates that a 10 % decline in the value of its fixed‑income holdings would cut net revenues (fees earned on client assets) and performance‑based income, a sensitivity that is tied to the fixed‑income investments it holds and the pricing‑model accounting policy used to value those holdings (Chunk 1).  \nPYPL’s market risk, by contrast, is expressed through the fair‑value measurement of its derivatives and debt‑security portfolios, which are priced with the same type of observable‑input models (Level 2) and discounted‑cash‑flow techniques described for fixed‑income valuations (Chunk 2), but the resulting fair‑value gains or losses flow through “other income” rather than fee revenue (Chunk 3).  \nThus, MS’s exposure is a revenue‑impact driven by AUM fluctuations, whereas PYPL’s exposure is a valuation‑impact recorded in other income via pricing models.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 10% decline example is consistent with typical sensitivity disclosures and does not contradict the original answer; no specific numbers were misstated. (2) The LLM correctly identifies that MS's asset management revenues are sensitive to fixed income market fluctuations via fee-based assets valued using pricing models with observable inputs (interest rates, credit spreads), and that this sensitivity affects net revenues and performance-based income. It accurately contrasts this with PYPL’s use of similar Level 2 pricing models for derivatives and debt securities but notes the key difference: PYPL records fair value gains/losses in 'other income' rather than revenue. (3) The multi-hop reasoning is sound—correctly synthesizing across MS’s AUM-based revenue model and PYPL’s fair value accounting treatment. (4) The only minor shortcoming is that the LLM does not explicitly mention PYPL’s election of the fair value option for foreign currency-denominated debt, which is a key nuance in the original answer explaining the directness of its market exposure. However, the core distinction—MS’s indirect revenue impact vs. PYPL’s direct valuation impact through income statements—is clearly and correctly conveyed. Wording differs but semantic meaning matches. All entities (MS, PYPL, derivatives, debt securities, pricing models) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 405,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How do Oracle's integration of generative AI in MySQL HeatWave and Qualcomm's investment in IoT applications reflect their respective strategies for on-device AI processing in enterprise and consumer markets?",
      "original_answer": "Oracle integrates generative AI into Oracle MySQL HeatWave, offering it as a managed cloud service that combines transactions, real-time analytics, machine learning, and generative AI capabilities. This enables enterprise customers to deploy AI-driven analytics and applications more efficiently. In contrast, Qualcomm is investing heavily in expanding generative AI into IoT and edge devices, projecting that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024. Qualcomm’s QCT segment develops integrated circuits for IoT applications, including consumer electronics, industrial devices, and edge networking products, emphasizing on-device processing for immediacy, privacy, and personalization. While Oracle focuses on cloud-native AI integration for enterprise database workloads, Qualcomm is driving AI capabilities into edge devices across multiple industries, particularly IoT, to capitalize on the growing demand for on-device intelligence.",
      "llm_answer": "\nOracle’s strategy is to embed generative‑AI capabilities directly into MySQL HeatWave—offered both as a cloud service on OCI and as an on‑premise Exadata Cloud@Customer deployment—so enterprises can run AI‑enhanced transactional and analytics workloads close to their data, cutting latency and cost while leveraging a single managed database platform (Chunk 1). Qualcomm, by contrast, is investing in IoT and edge‑AI to bring generative‑AI models onto consumer‑focused devices such as smartphones, automotive and industrial IoT endpoints, emphasizing on‑device processing for privacy, immediacy and new use‑cases and projecting that 46 % of 2027 smartphones will be AI‑capable (Chunks 2‑3). The knowledge‑graph link shows Oracle’s generative‑AI concept expanding into an IoT‑oriented product for the enterprise market, while Qualcomm invests in that same IoT product space to serve consumer edge devices, highlighting their divergent go‑to‑market approaches (ORCL → Generative AI → IoT ← Invests_In QCOM).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Oracle integrates generative AI into MySQL HeatWave as a managed service for enterprise workloads, supporting both cloud (OCI) and on-premise (Exadata Cloud@Customer) deployments. Qualcomm projects that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024—this matches the ground truth exactly. (2) Quantitative accuracy is perfect: the 46% and 19% figures are correctly cited, and no erroneous calculations are made. (3) The multi-hop reasoning is sound: the LLM correctly contrasts Oracle’s enterprise-focused, cloud-native database AI integration with Qualcomm’s consumer-oriented, edge-based AI strategy in IoT and smartphones. It accurately identifies Oracle’s focus on reducing latency and cost via integrated database-AI workloads and Qualcomm’s emphasis on privacy, immediacy, and on-device processing. (4) The only minor shortcoming is a slightly ambiguous reference to a 'knowledge-graph link' and the phrase 'Oracle’s generative-AI concept expanding into an IoT-oriented product,' which is not explicitly supported in the ground truth—Oracle is not described as targeting IoT in the same way as Qualcomm. This introduces a small inaccuracy in synthesis, hence the 9/10 on qualitative accuracy. Otherwise, the answer is semantically equivalent, contextually relevant, and factually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT -[Expands_Into]-> PRODUCT <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 395,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How might the compliance costs associated with the EU AI Act, which Adobe anticipates will require costly changes to its AI development practices, affect its competitive positioning against Salesforce, which relies heavily on its AI-powered Agentforce platform for sales and service offerings?",
      "original_answer": "Adobe anticipates that the EU AI Act, which will be implemented in phases through 2030, may require costly changes to its AI development practices, including delays or halts in development, changes to monetization strategies, and increased compliance costs. Meanwhile, Salesforce relies heavily on its AI-powered Agentforce platform across sales, service, and marketing offerings to drive productivity and growth. If Adobe is forced to divert resources to comply with the new regulations, it could slow the pace of its AI innovation, potentially giving Salesforce a competitive edge through its more established and integrated AI capabilities like Agentforce for Sales and Service. The GS_10k_2024 chunk reinforces that evolving AI regulations increase compliance costs and operational risks for companies relying on AI, suggesting both firms face similar pressures, but Salesforce’s deeper integration of AI across its platform may make it better positioned to absorb such regulatory changes.",
      "llm_answer": "\nThe EU AI Act will force Adobe to incur substantial compliance, R&D and redesign costs to adapt its AI development practices, which could delay or limit the rollout of new AI‑driven features and increase its overall cost structure. In contrast, Salesforce’s Agentforce platform is built on a unified, compliance‑oriented AI layer (e.g., the Trust Layer and modular AI agents) that can more readily absorb new regulatory requirements, allowing the company to continue investing in AI‑powered sales, service and commerce capabilities without the same level of disruption. Because the regulatory risk disclosed by both firms (Chunk 2) is tied to the same AI‑technology ecosystem—and because Adobe’s AI product depends on the same regulatory environment that governs Salesforce’s AI offerings (KG: AI Regulations → AI Technology ← Depends on CRM)—the added compliance burden is likely to erode Adobe’s competitive positioning relative to Salesforce.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original ground truth. (1) All factual elements are correct: Adobe faces increased compliance costs and potential delays in AI development due to the EU AI Act, while Salesforce’s Agentforce platform is deeply integrated into its core offerings. The LLM correctly identifies that regulatory pressures could slow Adobe’s innovation pace, potentially benefiting Salesforce. (2) There are no numeric values (e.g., dollar amounts, percentages, specific years like 2030) in the LLM answer, so quantitative accuracy is not compromised—none are misstated. The original mentions implementation through 2030, which the LLM omits, but this is a minor contextual detail rather than a factual error. (3) The multi-hop reasoning is sound: the model connects Adobe’s regulatory burden to potential innovation slowdown and contrasts it with Salesforce’s compliance-ready AI architecture (Trust Layer, modular agents), which is consistent with the knowledge graph’s implication that Salesforce may be better positioned. While the LLM adds specific details like 'Trust Layer' not explicitly mentioned in the original answer, these are plausible and contextually appropriate given Salesforce’s known AI governance framework. (4) The answer is semantically equivalent and highly relevant, capturing the core competitive dynamic. The only minor gap is the lack of explicit mention of the phased 2030 timeline, but this does not detract from the overall correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Regulates]-> PRODUCT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 447,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does the payout structure of HD's deferred shares, which includes dividend equivalents paid in additional shares, compare with LOW's receipt of additional shares through ASR agreements, in terms of stock-based value distribution to stakeholders?",
      "original_answer": "HD issues additional shares as dividend equivalents to non-employee directors upon the payout of deferred shares following termination of service, based on accrued dividends. This represents a stock-based compensation mechanism tied to director retention and long-term alignment. In contrast, LOW receives additional shares from third-party financial institutions as part of variable notional ASR agreements, which are tied to repurchase efficiency and final notional value calculations. These additional shares in LOW's case are not compensation-related but are part of capital return strategy execution. Both companies issue additional shares, but the context, stakeholders, and triggers differ significantly, reflecting distinct financial strategies.",
      "llm_answer": "\nHD’s deferred‑share program awards non‑employee directors a share that, upon termination of service, is settled in common stock together with any accrued dividend‑equivalents that are paid out **as additional shares**; the award’s fair value is measured at grant (based on the closing price) and expensed immediately.  By contrast, LOW obtains “additional shares” through variable‑notional ASR transactions in which it initially pays the maximum notional amount, receives an initial share allotment, and on settlement receives **further additional shares (plus a cash adjustment)** whose quantity is determined by the difference between the prepayment and the final notional amount, a mechanism that ultimately increases the company’s share holdings and can be used for purposes such as employee‑tax withholding or share‑repurchase financing.  Both structures channel value through “additional shares,” but HD’s are compensatory awards to individual directors with dividend‑equivalent adjustments, whereas LOW’s are market‑based repurchase outcomes that generate extra shares for the corporation itself and its broader stakeholder base.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) All key facts are correct: HD issues additional shares as dividend equivalents to non-employee directors upon termination, which are part of stock-based compensation; LOW receives additional shares through variable notional ASR agreements as part of share repurchase strategy. The stakeholders (individual directors vs. the corporation), triggers (termination and accrued dividends vs. final notional value calculation), and purposes (compensation vs. capital return) are correctly distinguished. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies, two financial mechanisms (deferred shares with dividend equivalents vs. ASR agreements), and two stakeholder contexts. The LLM adds a minor detail about cash adjustment in ASRs and potential use of shares for tax withholding or repurchase financing, which is contextually plausible and does not contradict the ground truth. (4) Semantic equivalence is strong: while the LLM uses slightly more technical language (e.g., 'fair value measured at grant', 'prepayment vs. final notional'), the core meaning matches the original answer. The only minor shortcoming is that the LLM does not explicitly state that LOW's additional shares are received from third-party financial institutions, though this is implied in 'ASR transactions'. This small omission prevents a perfect 10 but does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Increases]- ORG",
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 451,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does AT&T's adoption of ASU 2020-04, which facilitates contract modifications triggered by reference rate reform, compare to Verizon's disclosure of contract modifications in terms of impact on their respective revenue recognition timing and contract performance obligations?",
      "original_answer": "AT&T adopted ASU 2020-04, which provides optional expedients for contract modifications triggered by reference rate reform (e.g., LIBOR transition), and stated that the adoption did not materially impact its financial statements. Meanwhile, Verizon disclosed that contract modifications affect the timing and scope of performance obligations, with $25.7 billion, $18.7 billion, and $7.5 billion expected to be recognized in 2024, 2025, and beyond, respectively. The connection through ASU 2020-04 to contract modifications shows that while AT&T experienced minimal financial impact from reference rate-related modifications, Verizon's broader contract modification landscape significantly influences its future revenue recognition patterns.",
      "llm_answer": "\nAT&T adopted ASU 2020‑04 (Chunk 1 & 2) and explicitly states that the optional expedients for contract modifications triggered by reference‑rate reform “do not materially impact our financial statements,” indicating that, for AT&T, the timing of revenue recognition and the allocation of contract performance obligations are essentially unchanged by the reform.  \nIn contrast, Verizon’s disclosure (Chunk 3) shows that contract modifications can alter revenue‑recognition timing and require re‑allocation of the transaction price to performance obligations, with remaining obligations estimated at $25.7 billion for 2024, $18.7 billion for 2025 and $7.5 billion for 2026 (including long‑term minimum payments of $2.1 billion), and that these estimates are subject to change.  \nThus, while AT&T’s adoption is characterized as immaterial to its financial reporting, Verizon’s explicit contract‑modification disclosures demonstrate a direct effect on revenue‑recognition timing and the accounting treatment of performance obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: AT&T adopted ASU 2020-04 and stated no material impact on financial statements; Verizon disclosed that contract modifications affect revenue recognition timing and performance obligations with specific future amounts. (2) Quantitative accuracy is perfect: $25.7 billion for 2024, $18.7 billion for 2025, and $7.5 billion for 2026 (beyond) are correctly reported. The LLM adds a detail not in the original answer—$2.1 billion in long-term minimum payments—but this is consistent with plausible disclosure and does not contradict the ground truth. (3) Multi-hop reasoning is sound: the model correctly contrasts AT&T’s immaterial impact with Verizon’s significant revenue recognition implications, linking both to contract modifications under ASU 2020-04. (4) The only minor shortcoming is that the original answer frames Verizon’s $7.5 billion as 'beyond 2025' rather than specifying 2026, so the LLM slightly over-specifies the time period. However, this does not constitute a factual error, as 'beyond 2025' includes 2026 and later. Wording differs but semantic meaning is equivalent. All entities (AT&T, Verizon, ASU 2020-04, revenue recognition, performance obligations) are correctly identified and synthesized. The answer is fully relevant and addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 383,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How do Union Pacific's and Lockheed Martin's pension plan disclosures reflect differences in their reliance on Level 2 valuation methodologies for municipal bonds, and what does this imply about their adherence to ASC 820 fair value measurement standards?",
      "original_answer": "Union Pacific discloses that its pension plan classifies municipal bonds as Level 2 investments, which are valued using a bid evaluation process with bid data from independent pricing sources. Lockheed Martin's pension plan also discloses the use of Level 2 valuation methodologies for fixed income securities, where indicative quotes from pricing vendors are used if corroborated. UPS's filing explicitly confirms that municipal bonds fall under Level 2, valued via market-corroborated pricing or matrix pricing models using observable inputs like yield curves. The alignment in Level 2 classification for these instruments suggests both companies are applying ASC 820 consistently for fair value measurements, though UNP provides more specificity regarding municipal bonds, while LMT focuses on general fixed income treatment.",
      "llm_answer": "\nUnion Pacific (UNP) discloses that its municipal bonds are classified as **Level 2** fair‑value measurements, using observable bid data from independent pricing sources (Chunk 1), and UPS’s 10‑K similarly places municipal bonds in the Level 2 category, valuing them with market‑corroborated pricing models (Chunk 2). Lockheed Martin (LMT), however, does not list municipal bonds as a distinct Level 2 item; its Level 2 exposure is limited to non‑active equity securities with corroborated quotes, while the majority of its fixed‑income holdings are reported as **Level 3** buy‑in contracts (Chunk 3). Thus, UNP and UPS demonstrate a greater reliance on Level 2 valuation for municipal bonds—consistent with a more direct application of ASC 820’s observable‑input guidance—whereas LMT’s disclosures show a lower Level 2 reliance and a higher use of Level 3 inputs, reflecting a different fair‑value hierarchy emphasis but still complying with ASC 820 disclosure requirements.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The Original Answer (ground truth) states that both Union Pacific and Lockheed Martin use Level 2 valuation methodologies for fixed income securities, with LMT using indicative quotes from pricing vendors if corroborated. However, the LLM incorrectly claims that Lockheed Martin classifies the majority of its fixed-income holdings as Level 3 buy-in contracts and does not list municipal bonds as Level 2. This contradicts the ground truth, which confirms LMT’s use of Level 2 for fixed income (including municipal bonds by implication) when inputs are corroborated. (2) The LLM asserts that LMT’s Level 2 exposure is limited to non-active equity securities, which is not supported by the ground truth and misrepresents LMT’s disclosures. (3) The multi-hop reasoning fails because the model incorrectly infers a divergence in ASC 820 application, suggesting UNP/UPS rely more on Level 2 than LMT, while the ground truth emphasizes alignment in Level 2 classification and consistent ASC 820 application. (4) While the LLM correctly identifies UNP’s use of Level 2 for municipal bonds using bid data and market-corroborated models, it fabricates key details about LMT’s classification, leading to an erroneous comparative conclusion. (5) No numerical values are present, so quantitative accuracy is not heavily penalized, but the qualitative and reasoning errors are severe. The answer is contextually relevant in structure and attempts to compare ASC 820 adherence, but the factual foundation is flawed, resulting in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Comprise]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 444,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How does KO's reliance on Coca-Cola FEMSA for distribution in Argentina compare to MDLZ's exposure to economic volatility in the same market, given Coca-Cola FEMSA's specific operational footprint and MDLZ's inflation-related financial impacts?",
      "original_answer": "KO relies on Coca-Cola FEMSA for distribution in parts of Argentina, specifically the federal capital of Buenos Aires and surrounding areas, as part of its broader network of equity method investees to whom it sold $14.471 billion in net sales in 2021. Coca-Cola FEMSA operates in Argentina, a market that has been classified as highly inflationary since mid-2018, which directly affects MDLZ’s operations there. MDLZ reported a $13 million remeasurement loss in 2021 due to the volatility of the Argentine peso, with Argentina contributing $401 million (1.4%) to MDLZ’s consolidated net revenues. This highlights how both companies are exposed to Argentina, but through different mechanisms: KO through a distribution dependency and MDLZ through direct financial exposure to currency and inflation risks.",
      "llm_answer": "\nKO’s distribution in Argentina is executed through its bottler Coca‑Cola FEMSA, which operates a nationwide bottling footprint that includes the Buenos Aires region (Chunk 2) and, in 2021, accounted for a noticeable rise in KO’s purchases of FEMSA‑produced beverages as the company expanded its international case volume (Chunk 1). By contrast, MDLZ runs its own Argentine subsidiaries—classified as a highly inflationary economy—so the unit’s $9 million of peso‑denominated net monetary assets are re‑measured each period, generating $13 million of remeasurement losses in 2021 and contributing only ~1.4 % of consolidated net revenue, thereby exposing MDLZ directly to Argentina’s economic volatility (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) Quantitatively, all numbers are correct: the $13 million remeasurement loss in 2021, Argentina contributing ~1.4% of MDLZ’s consolidated net revenue ($401 million), and the reference to KO’s sales to equity investees (implied in the rise in purchases from FEMSA) align with the original answer. The $9 million of peso-denominated net monetary assets is an additional detail not in the ground truth but is factually consistent with MDLZ’s exposure and does not contradict it. (2) The LLM correctly identifies Coca-Cola FEMSA’s operational footprint in Buenos Aires and surrounding areas as part of KO’s distribution strategy, though it slightly overgeneralizes by saying 'nationwide'—the ground truth specifies only the federal capital and surrounding areas. This is a minor inaccuracy. (3) The multi-hop reasoning is sound: the model correctly distinguishes KO’s indirect exposure via a distribution partner from MDLZ’s direct financial exposure due to operating subsidiaries in a highly inflationary economy. It synthesizes information across entities (KO, MDLZ, Coca-Cola FEMSA) and financial mechanisms (distribution agreements vs. currency remeasurement). (4) The answer is contextually relevant and directly addresses the comparison asked in the question. The only reason for not scoring a 10 is the slight overstatement of Coca-Cola FEMSA’s footprint in Argentina. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 439,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the voting rights structure of META's Class B common stock influence its shareholder equity strategy compared to Alphabet's dual-class stock framework, particularly in light of Alphabet's $62.0 billion share repurchase in 2024 targeting Class A and Class C shares?",
      "original_answer": "META's Class B common stock grants 10 votes per share, compared to 1 vote per share for Class A, giving certain shareholders disproportionate voting power. Similarly, Alphabet follows a dual-class structure where Class B shares also carry 10 votes each, while Class A shares have one vote, and Class C shares have no voting rights. In 2024, Alphabet repurchased $62.0 billion of its Class A and Class C shares, prioritizing repurchases based on economic cost and market conditions. This suggests that both companies maintain strategic flexibility in managing shareholder equity by leveraging their dual-class structures to preserve voting control while repurchasing shares to enhance shareholder value.",
      "llm_answer": "\nMETA’s filing (Chunk 1) shows that its Class B common stock is linked to Class A stock and, like Alphabet’s Class B, carries 10 votes per share, giving insiders disproportionate control over equity decisions; this concentrated voting power lets META pursue an equity strategy that protects that control—e.g., by limiting dilution and any future buy‑backs to non‑voting or low‑voting classes.  In contrast, Alphabet’s 10‑K (Chunks 2 & 3) details a three‑class structure where Class B (10‑vote) shares can convert to Class A, while the company’s $62 billion 2024 repurchase specifically targets Class A and Class C shares (the non‑voting or single‑vote classes), shrinking the non‑controlling equity base but leaving the voting Class B shares untouched, thereby preserving control while returning cash to shareholders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: META's Class B stock has 10 votes per share vs. 1 for Class A, and Alphabet's structure includes Class B (10 votes), Class A (1 vote), and Class C (no votes). The $62 billion 2024 share repurchase by Alphabet is correctly attributed to Class A and Class C shares. (2) Quantitative accuracy is perfect: the dollar amount ($62 billion) and voting rights (10:1 and no votes for Class C) match the original answer exactly. Format variation ($62 billion vs. $62.0 billion) is acceptable. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across META and Alphabet, comparing their dual-class structures and linking them to equity strategies—specifically how repurchases are targeted to preserve insider voting control. It correctly infers that repurchasing non-voting/low-voting shares (Class A and C) maintains the relative power of controlling shareholders. (4) The only minor shortcoming is a slight lack of explicit mention that both companies use this structure to maintain 'strategic flexibility' in shareholder equity management—a nuance present in the original answer. However, the core reasoning and factual content are equivalent. Wording differs but semantic meaning is preserved. No factual errors or omissions affect the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 382,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the decline in GILD's Veklury sales in 2024, influenced by the availability of alternative treatments, compare to the negative impact AMGN reports from alternative treatments in competitive therapeutic markets?",
      "original_answer": "GILD reported that Veklury sales in 2024 were $1,799 million globally, a decline from $2,184 million in 2023, attributed to reduced demand linked to the availability and uptake of alternative treatments for COVID-19. This reflects a direct impact on revenue due to competitive therapeutic options. Similarly, AMGN notes that in competitive treatment markets such as those for ENBREL, Otezla, Repatha, and Aimovig, payers and PBMs are increasingly using formulary restrictions and cost-containment measures to shift patients toward alternative treatments, which has limited Amgen's product usage and sales. Both companies experience revenue pressure from alternative treatments, though GILD’s impact is more directly tied to pandemic-related dynamics, while AMGN faces systemic payer-driven shifts in competitive markets.",
      "llm_answer": "\nIn 2024 GILD’s Veklury sales fell from $2.184 bn (2023) to $1.799 bn, a decline of roughly $385 million (≈18 %), which the company attributes to the growing availability and uptake of alternative COVID‑19 treatments (Chunk 1 & 2).  AMGN likewise reports that competition from alternative therapies—driven by payer formulary exclusions and stricter utilization management—has produced a negative impact on its sales, though the effect is described qualitatively rather than with a specific dollar figure (Chunk 3).  Thus, while GILD’s revenue loss is quantifiable at about $385 million, AMGN’s setback is a broader, ongoing pressure from alternative‑treatment competition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Veklury sales declined from $2.184 billion in 2023 to $1.799 billion in 2024, a difference of $385 million (≈17.6%, rounded to 18% is acceptable). The use of 'bn' is equivalent to 'billion' and matches the original $2,184 million and $1,799 million. (2) The answer correctly identifies that GILD attributes the decline to alternative COVID-19 treatments, and AMGN faces negative impacts from alternative therapies due to payer-driven formulary restrictions and utilization management—consistent with the original. (3) Multi-hop reasoning is sound: it compares a quantifiable revenue decline (GILD) with a qualitatively described ongoing pressure (AMGN), capturing the distinction in how each company reports impact. (4) Minor deduction in qualitative accuracy because the LLM omits specific drug names mentioned in the original (ENBREL, Otezla, Repatha, Aimovig), which provide context for AMGN’s competitive markets. However, the core reasoning and synthesis remain intact. Overall, the answer is factually correct, contextually relevant, and conveys semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Impacted_By]-> COMP <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 334,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does AMD's interest payment schedule on its $312 million 7.50% Senior Notes compare with QCOM's interest payment structure on its $14.0 billion aggregate fair value of notes, particularly in terms of payment frequency and fiscal year obligations?",
      "original_answer": "AMD's $312 million 7.50% Senior Notes require semi-annual interest payments on February 15 and August 15 of each year, as stated in the indenture governing the notes. In contrast, QCOM's interest payment structure on its $14.0 billion aggregate fair value of notes includes semi-annual payments for fixed-rate notes and quarterly payments for floating-rate notes. While AMD's interest obligations are tied to a specific fixed schedule with a final maturity in fiscal 2022, QCOM has significant upcoming principal payments starting in fiscal 2023 ($1.4 billion) and continuing through future fiscal years, with no principal due in fiscal 2026.",
      "llm_answer": "\nAMD’s $312 million 7.50 % Senior Notes require **semi‑annual interest payments on February 15 and August 15 each year** (as disclosed in the 7.50 % Indenture), creating two cash‑outflows per AMD fiscal year until the notes mature on August 15 2022; this schedule is reflected in AMD’s future‑debt payment table, which lists the interest‑payment dates as part of its overall debt‑service obligations.  \n\nIn contrast, QCOM’s $14 billion aggregate‑fair‑value notes carry **interest that is payable semi‑annually on the fixed‑rate tranche** (mirroring AMD’s frequency) **but also includes quarterly interest on the floating‑rate portion**, and QCOM’s fiscal‑year interest obligations are spread across a multi‑year maturity profile—principal of $1.4 billion is due in fiscal 2023, $914 million in fiscal 2024, $1.4 billion in fiscal 2025, $2.0 billion in fiscal 2027 and $9.7 billion thereafter (with no principal due in fiscal 2026)—so while both issuers use semi‑annual payments on their fixed‑rate debt, QCOM’s overall interest‑payment structure adds quarterly payments and a far larger, staggered fiscal‑year cash‑flow burden.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: AMD's semi-annual interest payments on February 15 and August 15 are accurately stated, with maturity in fiscal 2022 (August 15, 2022). QCOM's interest structure is correctly described as semi-annual for fixed-rate notes and quarterly for floating-rate notes. The principal payment amounts and fiscal years ($1.4B in 2023, $914M in 2024, $1.4B in 2025, $2.0B in 2027, $9.7B thereafter) are all quantitatively accurate and consistent with the knowledge graph. The absence of principal due in fiscal 2026 is correctly noted. (2) Quantitative accuracy is perfect: all dollar amounts, dates, and frequencies match the original answer. Minor formatting differences (e.g., $14 billion vs $14.0 billion) are acceptable and semantically equivalent. (3) Multi-hop reasoning is sound: the model correctly synthesizes AMD’s fixed semi-annual schedule with QCOM’s hybrid (semi-annual + quarterly) structure and contrasts their fiscal-year obligations, including principal maturities. The only minor shortcoming is that the original answer emphasizes QCOM’s 'aggregate fair value' of notes, while the LLM refers more generally to 'aggregate-fair-value notes' without explicitly repeating 'fair value'—a slight nuance but not a factual error. (4) The answer is fully contextually relevant, directly addressing payment frequency and fiscal-year obligations for both companies. Overall, this is a strong, factually correct response with only negligible wording-level differences from the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Issues]-> FIN_INST -[Depends_On]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 433,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How might the impending loss of U.S. patent protection for Prolia/XGEVA in February 2025 impact Merck's competitive position, given its reliance on strong patent rights to defend against generic competition and Amgen's own exposure to biosimilar threats in international markets?",
      "original_answer": "The loss of U.S. patent protection for Prolia/XGEVA in February 2025 will likely expose Amgen's product to biosimilar competition, reducing its market exclusivity and potentially decreasing revenue. This dynamic is particularly relevant for Merck, which emphasizes its reliance on strong patent rights to protect its portfolio from generic challenges. Given Merck's acknowledgment of increased global pricing pressure and weakened patent protection in international markets, the erosion of exclusivity for key competitors like Prolia/XGEVA could intensify biosimilar threats across markets, thereby indirectly affecting Merck’s own competitive strategy and market positioning in the therapeutic category.",
      "llm_answer": "\nThe February 2025 U.S. patent expiry of Amgen’s Prolia/XGEVA (U.S. protection listed as 2/19/2025 in the Amgen 10‑K tables) will allow generic or biosimilar versions to enter the U.S. market, directly eroding Amgen’s sales of that product.  This underscores the importance of strong patent protection—something Merck explicitly relies on to shield its own revenues from generic competition (as detailed in Merck’s 10‑K discussion of patent‑dependent product performance) and highlights the added risk posed by Amgen’s weaker international patent shields and biosimilar threats (a global‑risk theme emphasized in Merck’s own regulatory‑environment analysis).  Consequently, the impending U.S. patent cliff not only threatens Amgen’s market share but also forces Merck to reinforce its own patent strategy and accelerate new‑product pipelines to preserve its competitive position.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the date of U.S. patent expiry for Prolia/XGEVA is correctly stated as February 19, 2025, matching the Amgen 10-K filing data (format variation '2/19/2025' is acceptable). No other numerical values are required. (2) The answer correctly identifies that the patent expiration will allow biosimilar entry, eroding Amgen’s sales—this is consistent with the original answer’s claim about reduced market exclusivity and revenue. (3) The multi-hop reasoning is sound: it connects Amgen’s U.S. patent loss to Merck’s strategic reliance on strong patents (citing Merck’s 10-K), acknowledges Amgen’s weaker international protections, and infers competitive implications for Merck. This mirrors the original answer’s logic about indirect effects on Merck’s competitive positioning. (4) The LLM adds slight forward-looking emphasis on Merck needing to 'reinforce its own patent strategy and accelerate pipelines,' which is a reasonable inference but not explicitly in the ground truth—hence a minor deduction in qualitative accuracy. However, this does not detract from factual correctness. All entities (Merck, Amgen, Prolia/XGEVA), timelines, and causal relationships are accurate and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT -[Decreases]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 360,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What portion of Broadcom's VMware Cloud Foundation revenue in fiscal year 2024 was directly tied to enabling AI workloads, and how does this align with Cisco's strategic focus on providing infrastructure for AI training and inference?",
      "original_answer": "In fiscal year 2024, $1,380 million of Broadcom's $2,900 million VMware Cloud Foundation revenue was recognized, and this platform specifically enables advanced AI and machine learning workloads at enterprise scale. This aligns with Cisco's strategic focus on providing network infrastructure to power AI training and inference workloads through high-density routers and switches, improved network management, and high-performance optics, as stated in their 2024 10-K filing.",
      "llm_answer": "\nBroadcom recognized **$1.38 billion of the $2.9 billion total VMware Cloud Foundation (VCF) revenue in fiscal 2024**, and because VCF “enables advanced AI and machine‑learning workloads at enterprise scale” (Chunk 2), that entire $1.38 billion—about **48 % of the projected VCF revenue**—is directly tied to supporting AI workloads.  \nThis aligns with Cisco’s strategic focus on “providing network infrastructure to power AI training and inference workloads” (Chunk 3), where it details investments in high‑density routers, switches, silicon and optics to build the connectivity foundation for AI‑intensive environments, reinforcing a shared market emphasis on AI‑ready infrastructure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key financial figures: $1.38 billion of $2.9 billion in VMware Cloud Foundation (VCF) revenue recognized by Broadcom in fiscal year 2024, which matches the ground truth ($1,380 million of $2,900 million). The percentage calculation (48%) is accurate (1,380 / 2,900 ≈ 0.4759 → ~48%), and the assertion that this portion is tied to AI workloads is supported by the claim that VCF 'enables advanced AI and machine-learning workloads'—consistent with the original answer. (2) All numeric values are correct and properly formatted; minor rounding to $1.38 billion and $2.9 billion is acceptable and common. The 48% derived from the ratio is correctly calculated and reasonably rounded. (3) The multi-hop reasoning is sound: the LLM connects Broadcom’s VCF revenue recognition to its AI-enabling capabilities and then aligns this with Cisco’s strategic focus on AI infrastructure (routers, switches, optics), as stated in Cisco’s 10-K. The synthesis across Broadcom and Cisco filings is logical and contextually appropriate. (4) The only minor shortcoming is the lack of explicit mention that the *entire* $1.38 billion is tied to AI (implied but not directly stated as 'directly tied' per the question), though the reasoning supports it. Wording differences (e.g., 'about 48%' vs exact fraction) do not affect semantic accuracy. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT -[Enables]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 401,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the $1,851 million in assets from NEE's consolidated solar VIEs compare to Southern Power's exposure through PPAs accounted for as operating leases, given both entities operate solar facilities under long-term power sales agreements?",
      "original_answer": "NEE consolidates solar VIEs with approximately $1,851 million in assets at year-end 2021, which sell electricity under long-term PPAs expiring between 2035 and 2052. Southern Power, a subsidiary of SO, operates PPAs related to solar facilities accounted for as operating leases with remaining terms of up to 25 years. While NEE's VIEs directly own the solar assets and bear construction and operational risk, Southern Power's exposure is structured as lessor under operating leases, receiving lease payments tied to energy production. Both entities demonstrate significant long-term commitments to solar generation through contractual arrangements, though NEE holds direct ownership and asset risk while SO participates through lease financing structures.",
      "llm_answer": "\nNEE consolidates a group of solar VIEs that together hold about **$1.851 billion of assets** (primarily property, plant and equipment) and sell their output under PPAs that expire between 2035 and 2052 — a relationship captured by the KG triplet *Solar Facilities → PPAs → SO*.  Southern Power, by contrast, accounts for comparable solar PPAs as **operating leases with remaining terms up to 25 years** (Chunk 2 & 3), recognizing only lease income rather than a disclosed asset balance; therefore its exposure is expressed as the lease‑related PPAs themselves, without a comparable dollar amount disclosed.  In short, NEE reports a concrete **$1.851 billion** solar‑facility asset base, whereas Southern Power’s exposure is limited to the long‑term PPAs treated as operating leases, whose quantitative magnitude is not separately provided.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, the $1,851 million (or $1.851 billion) in assets for NEE's solar VIEs is correctly reported, with accurate formatting variation accepted. The PPA expiration range (2035–2052) and Southern Power's lease terms of up to 25 years are correctly stated. (2) The answer correctly identifies that Southern Power does not report a dollar amount for its exposure because the PPAs are accounted for as operating leases, which aligns with the original answer’s point about lease income without asset consolidation. (3) Multi-hop reasoning is sound: the model correctly contrasts NEE’s direct asset ownership and consolidation of VIEs (with associated risks) versus Southern Power’s exposure via operating lease structures, capturing the key distinction in accounting and risk exposure. (4) The only minor shortcoming is the reference to a 'KG triplet *Solar Facilities → PPAs → SO*' which introduces an element not present in the original answer and could be misleading (SO is Southern Company, not a counterparty to NEE’s PPAs), slightly affecting qualitative accuracy. However, this does not undermine the core factual correctness. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong synthesis across entities and accounting treatments.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 376,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the structure of Starbucks' stock-based compensation grants under Stock Appreciation Rights compare to Tesla's use of the 2019 Plan in terms of equity instruments available and vesting timelines?",
      "original_answer": "Starbucks grants Stock Appreciation Rights as part of its equity incentive plans, though it notes that stock options have not been broadly used recently. In contrast, Tesla's 2019 Plan, adopted in June 2019, explicitly includes Stock Appreciation Rights among the equity instruments available for grant, along with stock options, RSUs, and performance shares. Tesla's stock options and RSUs generally vest over four years and are exercisable over a maximum period of 10 years from grant dates. Starbucks records compensation expense based on the fair value of awards at grant date and recognizes it over the service period, with performance-based RSUs tied to metrics like earnings per share and return on invested capital. Tesla also uses vesting schedules and forfeitures estimates but does not specify performance-based conditions in this excerpt.",
      "llm_answer": "\nStarbucks’ equity incentive plans, as disclosed in its 10‑K, allow grants of stock options, RSUs and stock‑appreciation rights (SARs) – with SARs treated as non‑vested shares and expensed on a graded‑vesting schedule – and this SAR instrument is linked through the 2019 Plan accounting policy to Tesla’s own plan.  Tesla’s 2019 Equity Incentive Plan explicitly authorizes SARs together with stock options, RSUs, performance units and performance shares, and it specifies that options and RSUs generally vest over four years and remain exercisable for up to ten years, providing a concrete vesting timeline that Starbucks does not detail.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both Starbucks and Tesla include Stock Appreciation Rights (SARs), stock options, RSUs, and performance-based instruments in their equity plans, and accurately notes Tesla's four-year vesting and 10-year exercisability period. However, it incorrectly implies that Starbucks' SARs are 'linked through the 2019 Plan accounting policy to Tesla’s own plan,' which is factually wrong—the 2019 Plan is Tesla’s, not a shared or linked policy. This misrepresents the relationship between the two companies’ plans and introduces a non-existent connection. (2) Quantitatively, all numbers and timeframes are accurate: Tesla’s vesting over four years and exercisable up to 10 years from grant date match the ground truth. No calculations were required. (3) The multi-hop reasoning is partially flawed: while the model correctly extracts elements from each company’s plan, it fails to correctly synthesize them by creating a false linkage between Starbucks’ SARs and Tesla’s 2019 Plan. The original answer makes no such connection—Starbucks’ use of SARs is independent, and the 2019 Plan is solely Tesla’s. (4) Despite this major conceptual error, the answer includes relevant details about equity instruments and vesting timelines, maintaining contextual relevance. The core facts about Tesla are correct, and Starbucks’ use of SARs and expensing method are mostly accurate, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Grants]-> FIN_INST -[Includes]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 403,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the difference in voting rights structure between META's Class B common stock and GOOGL's Class A common stock affect the potential influence of large shareholders on corporate governance decisions at each company?",
      "original_answer": "META's Class B common stock has no voting rights except for certain defined matters, such as exiting the core payments business or specific amendments to the certificate of incorporation, limiting the influence of large shareholders on most corporate governance decisions. In contrast, GOOGL's Class A common stock provides one vote per share, allowing shareholders of this class to have a more direct say in company decisions. This structural difference means that at META, significant shareholders holding Class B shares have limited ability to impact governance outside of specific scenarios, while at GOOGL, shareholders with Class A shares can exert more consistent influence on corporate decisions through their voting power.",
      "llm_answer": "\nMeta’s 2024 10‑K reveals that 343.8 million shares of its Class B common stock are outstanding and that, under the limited‑matter voting rules described in the filing, those shares are entitled to a number of votes equal to the shares held multiplied by the applicable conversion rate—i.e., they can exert disproportionate influence on key corporate actions such as mergers, amendments to the charter or exiting the core payments business.  By contrast, Alphabet’s Class A common stock carries only a single vote per share (while its Class B shares carry 10 votes per share), so any shareholder’s ability to affect board elections or major proposals is essentially proportional to the number of Class A shares owned.  Consequently, a relatively small group of insiders who hold Meta’s Class B stock can dominate governance decisions, whereas at Google a comparable level of control would require a far larger equity stake.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. First, it incorrectly states that META's Class B common stock has voting rights in key corporate actions such as mergers and charter amendments, claiming these shares can exert 'disproportionate influence'—this directly contradicts the ground truth, which states that META's Class B shares have *no voting rights* except for certain defined matters like exiting the core payments business or specific charter amendments. The LLM misrepresents the nature and extent of voting rights, implying broader influence than actually exists. Second, the LLM incorrectly claims that 343.8 million Class B shares are outstanding based on Meta’s 2024 10-K, but this number is not in the ground truth and cannot be verified here; more importantly, the original answer does not include any quantitative data, so introducing specific share counts without confirmation introduces unsupported detail. Third, while it correctly notes that GOOGL's Class A stock has one vote per share, it fails to mention that the question focuses on GOOGL Class A versus META Class B—instead, it brings in GOOGL's Class B (10 votes/share), which was not part of the question, thereby shifting focus and creating confusion. The reasoning is partially sound in contrasting disproportionate vs. proportional voting power, but the underlying facts about META’s structure are inverted: Class B at Meta is non-voting in most cases, not super-voting. This fundamental error in corporate structure leads to an incorrect conclusion about insider control being driven by Class B shareholders at Meta—when in fact, it is Meta’s *Class B* shares (held by insiders) that carry *super-voting rights*, while Class A (public) have no votes. The LLM confuses the classes. Despite these serious errors, the answer is contextually relevant and attempts the correct multi-hop comparison between the two companies’ voting structures. However, due to major factual inaccuracies in both quantitative and qualitative aspects, especially regarding the core governance mechanism, the correctness score is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 568,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the use of foreign currency derivatives in risk management activities differ between BAC and JPM, based on their respective derivative asset and liability disclosures?",
      "original_answer": "BAC includes foreign currency derivatives under 'Risk Management Activities' as part of its derivative assets and liabilities, which are presented on a gross basis before netting adjustments as of December 31, 2024, and 2023. JPM specifically states that foreign currency derivatives are used to manage foreign exchange risk associated with non-U.S. dollar-denominated assets, liabilities, and forecasted transactions, and that gains or losses on these instruments are expected to substantially offset this variability. The fair value of these derivatives is reflected in the balance sheets, either in 'Other' or shown separately under 'Risk Management Activities.'",
      "llm_answer": "\nBoth banks present foreign‑currency derivatives within their “Risk Management Activities” line item (Chunk 2), but the disclosures differ in scope. BAC (Chunk 1) lists them only as part of an aggregate gross derivative‑asset/liability balance that is adjusted for master‑netting and cash collateral, without detailing the specific foreign‑currency exposures being hedged. In contrast, JPM (Chunk 3) explicitly states that its foreign‑currency derivatives hedge non‑U.S.-dollar assets, liabilities and forecasted transactions of its overseas subsidiaries, notes that gains and losses are expected to offset that FX volatility, and provides additional detail on fair‑value measurement, hedge‑accounting qualification and offsetting under legally enforceable netting agreements (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: both BAC and JPM disclose foreign currency derivatives under 'Risk Management Activities'; BAC presents them on a gross basis without detailed exposure breakdowns, while JPM explicitly links them to hedging non-U.S. dollar assets, liabilities, and forecasted transactions, with expected offsetting gains/losses. The LLM correctly notes that fair value is reflected in the balance sheet, either in 'Other' or under 'Risk Management Activities,' consistent with the original answer. (2) There are no numeric values, dates, or calculations in the question or ground truth beyond 'December 31, 2024, and 2023'—which the LLM omits. However, this is a minor omission since the focus is on disclosure practices rather than time-specific figures, and the context implies the same reporting dates. (3) Multi-hop reasoning is sound: the model synthesizes differences in disclosure depth and purpose between BAC and JPM, correctly identifying that JPM provides more detailed qualitative and accounting-level disclosures (e.g., hedge accounting, offsetting agreements), while BAC offers a more aggregated view. (4) Semantic equivalence is strong—wording differs but meaning matches. The LLM adds slight elaboration (e.g., 'master-netting', 'cash collateral') that are contextually valid and consistent with typical SEC disclosures. No factual inaccuracies; only minor lack of explicit mention of reporting dates prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacts]-> RISK_FACTOR -[Categorized_As]-> FIN_INST <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 419,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How does Duke Energy's exposure to economic downturns through industrial customers compare to Southern Company's risk from environmental compliance costs affecting similar customer segments, given both companies' regulated rate recovery mechanisms?",
      "original_answer": "Duke Energy notes that industrial customers reducing production during economic downturns can lead to reduced electricity consumption, lowering revenues and cash flows. Southern Company, on the other hand, faces risks that increased environmental compliance costs—estimated to impact capital expenditures through 2028—could be passed through regulated rates, potentially reducing demand from commercial and industrial customers. Both companies rely on rate mechanisms for cost recovery: Duke through periodic adjustment clauses and Southern through ECO Plan, CNP Compliance, and ECCR tariff mechanisms. However, while Duke's risk centers on demand volatility from macroeconomic conditions, Southern's exposure stems from regulatory-driven cost increases that may dampen industrial customer demand despite efforts to recover those costs through rates.",
      "llm_answer": "\nDuke Energy’s regulated earnings are most exposed to a downturn‑driven decline in industrial electricity and natural‑gas consumption, which reduces sales volumes and cash flow even though fuel‑costs and certain recoverable expenses can be passed through periodic rate adjustments; Southern Company, by contrast, can recover its environmental‑compliance outlays (e.g., CCR remediation, emissions‑control upgrades) through mechanisms such as the ECCR tariff and rate‑payer mechanisms, but those cost‑recovery provisions are contingent on regulatory approval and can themselves depress demand from the same commercial‑industrial customers, creating a risk that higher rates or unrecovered compliance expenses will further erode cash flow.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast between Duke Energy's demand-side risk from economic downturns and Southern Company's supply-side risk from environmental compliance costs. (1) All factual elements are correct: Duke Energy’s exposure to reduced industrial consumption during downturns affecting cash flows is properly described, as is Southern Company’s use of cost recovery mechanisms like the ECCR tariff for environmental compliance (e.g., CCR remediation, emissions controls). The mention of regulatory approval contingencies and potential demand depression from higher rates aligns with the ground truth. (2) There are no numeric values (e.g., dollar amounts, years) in either answer that require verification—both avoid specific figures beyond 'through 2028' in the original, which the LLM does not contradict. Thus, quantitative accuracy is not compromised. (3) Multi-hop reasoning is sound: the model correctly synthesizes across two companies, two types of risk (economic vs. regulatory), and their respective rate recovery mechanisms (periodic adjustments for Duke; ECCR, ECO Plan, CNP Compliance implied via 'rate-payer mechanisms'). The LLM slightly generalizes Southern’s mechanisms without naming all three explicitly but accurately references ECCR and implies others. (4) Semantic equivalence is strong—while the LLM emphasizes 'unrecovered compliance expenses' and 'contingent on regulatory approval' more than the original, these are reasonable inferences and do not distort meaning. One minor omission: the original specifies Duke uses 'periodic adjustment clauses' and Southern uses 'ECO Plan, CNP Compliance, and ECCR', whereas the LLM only names ECCR and generalizes the rest. This slight loss of specificity prevents a perfect 10 but does not undermine the overall correctness. Contextual relevance is excellent—the response directly addresses the comparative risk exposure and regulatory mechanisms as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Depends_on]- ORG",
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 528,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How does the voting power distribution tied to CMCSA's Class B common stock, which is fully owned by Brian Roberts, influence the governance structure compared to GOOGL's dual-class stock system where Class A and Class B shares have different voting rights?",
      "original_answer": "CMCSA's Class B common stock, which is fully owned by Brian Roberts, holds 33 1/3% of the combined voting power with each share carrying 15 votes, creating a concentrated control mechanism that is non-dilutable under the company's articles of incorporation. This contrasts with GOOGL's structure, where Class A shares have 1 vote each and Class B shares have 10 votes each, and Class B shares automatically convert to Class A upon sale or transfer. While both companies utilize dual-class structures to preserve founder control, CMCSA's system entrenches Brian Roberts' influence more securely due to the non-dilutable nature and high per-share voting weight of the Class B stock, whereas GOOGL's structure allows for more fluidity in ownership and voting power distribution.",
      "llm_answer": "\nComcast’s Class B common stock—entirely held by Brian Roberts and representing 33 ⅓ % of the combined voting power (15 votes per share, non‑dilutable)—gives him effective control of the company’s governance even though the Class A shareholders collectively hold the remaining 66 ⅔ % of the vote, and voting is generally conducted as a single class.  In contrast, Alphabet’s dual‑class structure (Class B = 10 votes per share, Class A = 1 vote, Class C = no votes, with Class B convertible to Class A) spreads voting power more broadly and does not concentrate a single shareholder’s control over a non‑dilutable block of high‑weight shares.  This difference means Comcast’s governance is dominated by the Roberts family’s locked‑in voting bloc, whereas Alphabet’s governance relies on a more distributed, convertible voting hierarchy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: CMCSA's Class B stock held by Brian Roberts carries 15 votes per share and represents 33 1/3% of voting power, which is non-dilutable—this matches the original answer exactly. GOOGL's structure is also correctly described with 10 votes per Class B share, 1 vote for Class A, and automatic conversion upon transfer. The LLM additionally mentions Class C shares with no votes, which is factually accurate for Alphabet (though not in the original answer), adding context without introducing error. (2) Quantitative accuracy is perfect: percentages, vote weights, and ownership concentration are all correctly stated. (3) The multi-hop reasoning is sound—comparing governance implications across CMCSA and GOOGL, highlighting concentration vs. fluidity in control. The conclusion that CMCSA entrenches Roberts’ control more securely than GOOGL’s convertible structure is logically supported. (4) Minor deduction in qualitative accuracy because the original answer emphasizes the contrast in 'non-dilutable' nature more explicitly as a structural differentiator, while the LLM uses 'locked-in' and 'convertible' but could have more directly tied non-dilutability to governance entrenchment. However, the semantic meaning and factual content are equivalent. Contextual relevance is full—directly addresses both companies, their voting structures, and governance implications as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 412,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did KO's indirect exposure to Taiwan through Swire Beverages' operations compare to PEP's direct growth performance in the Taiwanese beverage market in 2022?",
      "original_answer": "KO had indirect exposure to Taiwan through Swire Beverages, one of its top five bottling partners, which operated in Taiwan and accounted for 17% of KO’s worldwide unit case volume in 2021. Meanwhile, PEP directly reported low-single-digit beverage unit volume growth in Taiwan as part of its APAC division's 34% net revenue increase in 2022. This highlights KO’s reliance on a third-party bottler versus PEP’s direct market performance in the same geography.",
      "llm_answer": "\nKO’s only presence in Taiwan is indirect – it reaches the market through its bottling partner Swire Beverages, which is listed among KO’s five largest bottlers and operates in Taiwan as part of its 11‑province mainland China/Hong Kong/Taiwan footprint, accounting for 41 % of KO’s worldwide unit‑case volume in 2021.  The filing does not give a separate Taiwan‑specific growth figure for KO, so its exposure is limited to Swire’s overall bottling volume.  By contrast, PEP reported direct beverage‑unit‑volume growth in Taiwan of low‑single‑digit rates in 2022 (as noted in the APAC section of its 10‑K), indicating a modest but explicit expansion of its own business in the Taiwanese market.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the quantitative claim that Swire Beverages accounted for '41% of KO’s worldwide unit-case volume in 2021' — the ground truth states 17%. This is a major discrepancy that undermines the accuracy of the comparison. All other numbers are correctly reported: PEP's low-single-digit growth in Taiwan in 2022 is accurately cited from its APAC segment reporting. (2) The year 2021 is correctly used for KO’s Swire volume share, and 2022 is correctly used for PEP’s performance. However, the 41% figure is incorrect — no such number appears in the ground truth, and it significantly overstates KO’s indirect exposure. This error likely stems from confusion with another bottler or misreading of data. (3) The multi-hop reasoning is otherwise sound: the model correctly identifies that KO’s exposure is indirect via Swire Beverages, while PEP reports direct performance in Taiwan. It appropriately contrasts structural differences in market access and acknowledges the lack of Taiwan-specific growth data for KO. The logic in comparing indirect presence vs. direct growth is valid and well-articulated. (4) Contextual relevance is high — the answer directly addresses the comparison asked, synthesizes across entities (KO, PEP, Swire), and explains the implications of indirect vs. direct market presence. Due to the severe quantitative inaccuracy in the 41% vs. 17% figure — a core data point — the correctness score is limited to 6 despite strong qualitative reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 424,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How might the expiration of Trulicity's patent protection impact LLY's revenue trajectory in light of MRK's strategic reliance on strong patent protection to maintain market exclusivity and competitive positioning?",
      "original_answer": "The expiration of Trulicity's patent protection, as noted in LLY's 2024 10-K, is expected to lead to a rapid and severe decline in revenue, as seen in 2024 where Trulicity's U.S. revenue decreased by 32% due to competitive dynamics and supply constraints. This aligns with the broader risk LLY faces as products lose exclusivity, typically resulting in generic competition and steep revenue drops. Similarly, MRK acknowledges that loss of patent protection leads to generic substitutes entering the market, adversely affecting sales and cash flows. Given MRK's emphasis on actively defending patent rights to maintain market exclusivity and profitability, the erosion of Trulicity's patent protection signals a critical vulnerability for LLY, especially if it lacks a robust pipeline or alternative strategies to offset the anticipated revenue losses.",
      "llm_answer": "\nThe 2024 10‑K shows that Trulicity’s U.S. sales already fell 32 % as patent‑related exclusivity erodes, and the filing notes that Trulicity will lose the bulk of its remaining patent and data protections “in the next few years,” a timeline that will likely deepen the revenue drop and compress LLY’s top‑line growth.  Because the patent‑protection ecosystem is a shared strategic pillar—LLY’s Trulicity relies on it, and MRK’s own 10‑K stresses that loss of patent rights triggers rapid generic entry and severe sales declines—both companies’ growth trajectories are tightly coupled to the strength of their IP shields.  Consequently, once Trulicity’s patents expire, LLY can expect a sharper deceleration in revenue, while MRK will need to lean even more heavily on its own patent portfolio to preserve market exclusivity and competitive positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 32% decline in Trulicity's U.S. sales in 2024 is correctly cited from LLY's 2024 10-K, matching the original answer. The phrasing 'in the next few years' for the expiration timeline is consistent with the original's implication of imminent loss of protection. No calculations are required, and all numbers are accurate. (2) Entity accuracy is strong: LLY and MRK are correctly identified, with proper reference to their 10-K filings and strategic reliance on patent protection. The years (2024) and metrics (U.S. revenue decline) are correct. (3) Reasoning is sound and reflects multi-hop synthesis: the model connects LLY's Trulicity revenue decline to patent erosion, links this to MRK's analogous dependence on patents, and infers that both companies' revenue trajectories are vulnerable when IP protection lapses. The conclusion that LLY will face sharper revenue deceleration and MRK must rely more on its own IP is logically derived and contextually appropriate. (4) The only minor shortcoming is that the LLM does not explicitly mention LLY's need for a robust pipeline or alternative strategies to offset losses—a point emphasized in the original answer—which slightly reduces qualitative completeness. However, the core insight about IP vulnerability and competitive dynamics is fully preserved. Overall, the answer is factually correct, well-reasoned, and contextually on point.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Expires]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 407,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How might FedEx's operational reliance on leased retail locations at hotels, such as the 200 stores located at hotels and convention centers, compare with UPS's financial exposure to real estate funds—like the $10.1 billion in pension assets invested in real estate, private debt, and hedge funds—in terms of strategic risk during periods of real estate market volatility?",
      "original_answer": "FedEx maintains a direct operational exposure to hotels through its 200 leased retail locations at hotels and convention centers, positioning it in high-traffic hospitality venues but exposing it to lease renegotiations or relocations if hotel operators change tenants. These leases are typically for five to ten years, and FedEx's ability to maintain these locations depends on the ongoing operation of the hotels themselves. In contrast, UPS holds an indirect financial exposure to real estate through its pension and postretirement plan assets, which include $10.1 billion in investments in real estate funds, private debt, and hedge funds as of December 31, 2024. These funds may include investments in hotels and other commercial properties, meaning UPS’s exposure is tied to the performance of these funds rather than direct occupancy or lease agreements. During real estate market volatility, FedEx could face operational disruptions or increased leasing costs if hotel properties experience financial strain, while UPS could see fluctuations in the value of its pension assets, affecting long-term liability projections and funding obligations. Thus, while both companies are exposed to the real estate sector, the nature of their risk—operational for FedEx and financial for UPS—differs significantly in both timing and impact.",
      "llm_answer": "\nFedEx’s 200 retail outlets that sit inside hotels, convention centers, hospitals and universities are leased for the typical five‑to‑ten‑year terms described in its 10‑K, and although the company notes that comparable sites can be sourced if needed, its operating cost and flexibility are tied directly to the performance of those real‑estate‑linked leases; in contrast, UPS’s pension fund holds $10.1 billion of investments in real‑estate, private‑debt and hedge‑fund vehicles that are valued off‑NAV, are largely illiquid and subject to lock‑up or gate provisions, so a downturn in the real‑estate market can depress the NAV of those holdings and increase the pension’s funding burden.  (All three source chunks—FedEx’s lease‑store description, the $10.1 billion pension allocation and its NAV‑based valuation/non‑redeemable nature—are reflected in this comparison.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers are correct: the $10.1 billion pension investment and the five-to-ten-year lease terms match the original answer. The mention of 200 retail locations at hotels and similar venues is consistent, though the LLM slightly broadens the location types to include hospitals and universities, which is not contradicted by the original but adds minor contextual detail not in the ground truth. (2) The financial exposure amount ($10.1 billion) and its allocation across real estate, private debt, and hedge funds are accurately reflected, as is the NAV-based valuation and illiquidity (lock-ups, gates), which adds depth beyond the original without introducing error. (3) The multi-hop reasoning is sound: the model correctly distinguishes FedEx’s direct operational risk via leases from UPS’s indirect financial risk via pension fund exposure, and links both to real estate market volatility—answering the core comparative strategic risk question. (4) The LLM captures the key contrast: FedEx faces potential operational disruption and cost increases, while UPS faces pension funding volatility due to asset devaluation. The only minor shortcoming is slightly less emphasis on the dependency of FedEx’s locations on hotel operations and the explicit mention that UPS’s funds may include hotel investments—nuances present in the original. However, the semantic meaning and strategic risk comparison remain intact. Wording differs but meaning is equivalent. No calculation errors. All entities (FedEx, UPS, pension assets, lease terms) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> PRODUCT -[Depends_On]-> FIN_INST <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1607,
        "completion_tokens": 456,
        "total_tokens": 2063
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does the voting rights structure of GOOGL's Class B Common Stock compare to CMCSA's disclosure around voting rights in its investment in Atairos, particularly in terms of control and influence over strategic decisions?",
      "original_answer": "GOOGL's Class B Common Stock provides its holders with 10 votes per share, significantly enhancing their influence over corporate decisions compared to Class A shares, which carry one vote per share. This structure allows holders of Class B Common Stock to maintain greater control over strategic decisions despite owning fewer shares. In contrast, CMCSA disclosed that it has no voting rights in Atairos, a VIE in which it holds a significant investment, and only retains certain consent rights. As a result, CMCSA lacks the power to direct Atairos’s activities that most significantly impact its economic performance, which limits its control and influence over strategic decisions at Atairos.",
      "llm_answer": "\nAlphabet’s Class B common stock carries 10 votes per share (and can convert to Class A), giving its holders decisive voting control over strategic matters—this is explicitly detailed in Note 11 of GOOGL’s 2024 10‑K (Chunks 1‑2). By contrast, Comcast’s investment in Atairos is treated as a VIE in which CMCSA holds **no voting rights** and only limited consent rights, so it cannot direct the investee’s key decisions and must account for the stake via the equity method, reflecting minimal influence over Atairos’ strategy (Chunk 3).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly states that GOOGL's Class B shares carry 10 votes per share versus 1 for Class A, accurately reflecting the voting rights structure and its impact on control. It also correctly notes CMCSA has no voting rights in Atairos, only limited consent rights, which aligns with the original answer. (2) There are no numerical inaccuracies—'10 votes per share' and 'no voting rights' are correctly reported. The reference to Note 11 of GOOGL’s 2024 10-K and the VIE classification adds contextual precision. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two distinct entities (GOOGL and CMCSA/Atairos), compares their governance structures, and draws a valid contrast in terms of control and influence over strategic decisions. (4) The answer is highly relevant, directly addressing the comparison of voting rights structures and their implications on control and strategic influence. Minor additions (e.g., convertibility of Class B shares, equity method accounting) enhance clarity without introducing error. All key elements from the ground truth are preserved and accurately conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 345,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does the use of commercial paper financing by Duke Energy Ohio compare to PepsiCo's short-term debt strategy, given Duke Energy Ohio's specific disclosures and PepsiCo's broader commercial paper obligations?",
      "original_answer": "Duke Energy Ohio reported $25 million in commercial paper obligations as of December 31, 2023, as part of its overall short-term financing strategy. In comparison, PepsiCo disclosed $2,286 million in commercial paper obligations in 2023, representing a significant portion of its broader short-term debt obligations totaling $6,510 million. This highlights a stark contrast in the scale of commercial paper usage between the two companies, with PepsiCo relying more heavily on this form of short-term financing.",
      "llm_answer": "\nDuke Energy Ohio, which operates in Ohio (the GPE highlighted in the store‑location data), discloses only $25 million of commercial paper in its 2023 10‑K—an amount that is a tiny fraction of PepsiCo’s $2.286 billion commercial‑paper balance and even smaller than the $52 million of total short‑term debt (which also includes $27 million of tax‑exempt bonds) that Duke Energy Ohio reports.  Both entities are linked through the financing‑instrument node — Ohio → Commercial paper → PEP—showing that the same short‑term financing category is used by a utility and a consumer‑goods company, but PepsiCo’s short‑term strategy is far broader, with $6.51 billion of short‑term obligations and commercial paper representing a major component of that total, whereas Duke Energy Ohio’s commercial‑paper exposure is limited to a modest $25 million line within its overall $52 million short‑term financing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Duke Energy Ohio's $25 million commercial paper (as of December 31, 2023) and PepsiCo's $2,286 million commercial paper and $6,510 million total short-term debt in 2023 are accurately reported, with acceptable format variations ($2.286 billion = $2,286 million; $6.51 billion ≈ $6,510 million). (2) The LLM adds a detail not in the original answer—Duke Energy Ohio's total short-term debt of $52 million, including $27 million in tax-exempt bonds—which is factually consistent and enhances completeness, though not required. (3) Multi-hop reasoning is sound: the comparison between a utility and a consumer-goods company using commercial paper is correctly synthesized, and the conclusion that PepsiCo relies more heavily on commercial paper is logically supported. (4) The only minor deviation is the mention of a 'financing-instrument node — Ohio → Commercial paper → PEP' and 'GPE highlighted in the store-location data', which introduces extraneous conceptual framework not present in the original and slightly distracts from the financial comparison, but does not affect factual correctness. Overall, the answer is semantically equivalent, quantitatively precise, and contextually appropriate, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 373,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "Given Duke Energy's expectation of increasing commercial gas customers in the Carolinas, Ohio, and Kentucky, how might Southern Company's reliance on regulated rate recovery for environmental compliance costs be affected if commercial demand declines due to environmental regulations impacting industrial operations in these same regions?",
      "original_answer": "Duke Energy's gas utility operations expect an increase in the number of commercial and industrial customers over time, particularly in North Carolina, South Carolina, Ohio, and Kentucky. Southern Company, on the other hand, relies heavily on regulated rate recovery mechanisms to offset rising environmental compliance costs, which include upgrades to gas distribution infrastructure and compliance with GHG regulations. However, Southern Company also acknowledges that increased costs recovered through regulated rates could lead to reduced demand for natural gas from commercial and industrial customers—many of whom may be directly impacted by environmental requirements such as emission limits or carbon constraints. If these regulations lead to operational changes or reduced production among industrial users, the anticipated growth in commercial gas demand may not materialize, thereby undermining the effectiveness of rate recovery mechanisms and creating financial pressure on Southern Company's gas operations.",
      "llm_answer": "\nDuke Energy (DUK) expects more commercial‑gas customers in the Carolinas, Ohio and Kentucky, but those customers are also “Impacted_By” environmental requirements that could curb industrial activity if regulations tighten. Southern Company (SO) normally recovers its environmental‑compliance costs through regulated rates, yet—as Chunk 2 and Chunk 3 highlight—higher rate‑recovered costs can depress demand, and a drop in commercial usage would shrink the revenue pool used to fund that recovery, thereby threatening SO’s ability to fully recover its environmental compliance expenditures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only minor differences in phrasing. (1) All key facts are correct: Duke Energy expects growth in commercial gas customers in the Carolinas, Ohio, and Kentucky; Southern Company relies on regulated rate recovery for environmental compliance costs; and there is a risk that environmental regulations could reduce industrial activity and gas demand, undermining rate recovery. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly links Duke Energy’s customer growth expectations with Southern Company’s rate recovery model, and identifies the tension between higher recovered costs, potential demand reduction, and environmental regulations impacting industrial operations. It references 'Chunk 2 and Chunk 3' (likely internal document references), which does not detract from factual accuracy. (4) The answer is fully contextually relevant, directly addressing the hypothetical impact on Southern Company if commercial demand declines due to environmental regulations. The only reason for not scoring a 10 in qualitative accuracy is that the LLM slightly simplifies the mechanism by which reduced demand affects recovery (e.g., doesn't explicitly mention shrinking customer base undermining infrastructure cost recovery), but the core logic about a shrinking revenue pool is correct and sufficient. Overall, this is a highly accurate, well-reasoned response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Serves]-> COMP -[Impacted_By]-> REGULATORY_REQUIREMENT <-[Depends_on]- ORG",
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 436,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "Given that Comcast's Class B shares carry 15 votes each and represent 33 1/3% of the combined voting power, how does the absence of repurchase activity for these shares (only Class A shares were repurchased in 2023) impact Mr. Roberts' ownership control relative to the broader shareholder base?",
      "original_answer": "Comcast's Class B shares, which carry 15 votes per share and represent 33 1/3% of the combined voting power, are not being repurchased, while Class A shares (with fewer votes) are being actively repurchased. This selective repurchase activity reduces the number of outstanding Class A shares, thereby increasing the relative voting influence of the non-repurchased Class B shares. Since Mr. Brian L. Roberts owns all outstanding Class B shares, this dynamic strengthens his control over corporate decisions, even as the broader shareholder base sees its equity diluted through the retirement of Class A shares.",
      "llm_answer": "\nClass B common stock carries 15 votes per share and, as noted in Chunk 2, represents exactly one‑third of the combined voting power while Mr. Brian L. Roberts beneficially owns **all** of the outstanding Class B shares (9,444,375 shares disclosed in Chunk 3).  Chunk 1 shows that in 2023 the company retired only Class A (and Class C) shares – no Class B shares were repurchased – so the 9.4 million Class B shares, and the 33 ⅓ % voting bloc they provide, remain unchanged.  Consequently, the retirement of Class A shares shrinks the total vote pool, raising Mr. Roberts’ share of the total voting power above the original 33 ⅓ % and giving him a comparatively stronger control relative to the broader shareholder base.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, all numbers and percentages are accurate: the 33 1/3% voting power of Class B shares is correctly stated as 'exactly one-third', the 15 votes per share is included, and the 9,444,375 Class B shares (rounded to 9.4 million) are accurately referenced. The absence of Class B repurchases in 2023 is correctly noted. (2) The reasoning is sound and captures the multi-hop logic: because only Class A shares are repurchased, the total voting pool shrinks, which increases the relative voting power of the unchanged Class B shares. Since Mr. Roberts owns all Class B shares, his control strengthens relative to other shareholders. (3) Entity accuracy is perfect: Comcast, Class A/B shares, Mr. Brian L. Roberts, and the 2023 repurchase activity are all correctly identified. (4) The answer is semantically equivalent to the original, with slightly more detail (e.g., share count) but no factual deviations. The conclusion that Mr. Roberts' voting power increases above 33 1/3% due to the shrinking vote pool is logically valid and well-explained. All evaluation criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 335,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does the contractual structure of Amgen's performance units, which are subject to specific payout simulations based on stockholder returns, compare to Bristol-Myers Squibb's exposure to financial agreements that include counterparty credit risk mitigation strategies, particularly in terms of payout or risk management predictability?",
      "original_answer": "Amgen's performance units in 2023 were valued at $121 million and are subject to payout simulations that model stockholder returns based on correlations and volatilities of comparator company stocks over the performance period, as dictated by contractual terms. This creates a structured but variable payout mechanism tied to relative performance metrics. In contrast, Bristol-Myers Squibb enters into financial agreements that include counterparty credit risk mitigation strategies such as limiting exposure to individual counterparties, using conventional instruments, and requiring high credit quality standards. These strategies are designed to ensure predictability and minimize financial risk in derivative and other financial instrument transactions. The contractual frameworks differ in that Amgen’s focus is on performance-linked payout predictability, while BMY emphasizes counterparty risk control and financial stability in its agreements.",
      "llm_answer": "\nAmgen’s performance units are tied to contractual payout simulations that base the ultimate cash‑or‑share award on simulated stock‑holder returns—using correlated peer‑group stock‑price and volatility assumptions—so the payout percentage can vary widely with market performance (as reflected in the $121‑$132 million expense recorded for performance units and the detailed simulation model disclosed in the 10‑K). Bristol‑Myers Squibb, by contrast, exposes itself to financial agreements that are deliberately structured with credit‑risk mitigation—high‑quality counterparties, no collateral requirements, and ongoing monitoring that would prevent a material impact on the consolidated statements if a counter‑party failed—thereby making the risk of non‑performance far more predictable. Thus, while Amgen’s payouts are inherently variable and market‑driven, BMS’s agreements incorporate contractual safeguards that stabilize and limit downside risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the LLM correctly references Amgen's performance unit expense in the range of $121–$132 million, which is consistent with the ground truth value of $121 million (the upper end of the range may reflect additional disclosures or rounding in the 10-K; minor variation is acceptable). No incorrect numbers or calculations are present. (2) The entities—Amgen and Bristol-Myers Squibb (BMS)—are correctly identified, and the focus on 2023 (implied by the data) is appropriate. (3) The reasoning correctly synthesizes multi-hop information: it distinguishes Amgen’s market-driven, simulation-based payout mechanism tied to relative stockholder returns from BMS’s counterparty credit risk mitigation strategies, such as high credit quality standards and exposure limits. The LLM accurately characterizes Amgen’s variability versus BMS’s predictability in risk management. (4) Semantically, the answer conveys the same core contrast: Amgen’s contractual structure governs variable, performance-linked payouts, while BMS prioritizes financial stability through counterparty safeguards. The only minor shortcoming is that the LLM does not explicitly mention 'collateral requirements' (it correctly states BMS has no such requirements), and slightly overemphasizes 'no collateral' as a risk mitigant without tying it as clearly to predictability in payouts. However, this does not detract from overall correctness. The answer is fully relevant, directly addressing the comparison in contractual predictability around payouts and risk management.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1523,
        "completion_tokens": 443,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does MetLife's exposure to derivatives governed by ISDA Master Agreements under the Orderly Liquidation Authority compare to Bank of America's resolution planning risks, given both companies' regulatory obligations under Dodd-Frank?",
      "original_answer": "MetLife manages credit risk in its derivatives transactions through ISDA Master Agreements that allow for close-out netting, which is subject to financial regulations such as the Orderly Liquidation Authority (OLA) under Dodd-Frank. This means that in the event of a counterparty's bankruptcy, MetLife can offset receivables and apply collateral without being subject to the automatic stay. Similarly, Bank of America Corporation is required to submit resolution plans to the FDIC and Federal Reserve that outline a 'single point of entry' strategy under the U.S. Bankruptcy Code or potentially the OLA. If Bank of America were resolved under the OLA, the FDIC could replace the corporation with a bridge holding company, and security holders could face significant losses. Both firms are therefore subject to Dodd-Frank provisions that alter the treatment of their financial obligations and risk profiles during insolvency, with MetLife exposed through its derivative contracts and BAC through its parent company resolution strategy.",
      "llm_answer": "\nBoth MetLife and Bank of America are covered by the Dodd‑Frank‑mandated Orderly Liquidation Authority, but the nature of their OLA‑related risks differs: MetLife’s OTC‑bilateral derivatives are governed by ISDA Master Agreements that include enforceable close‑out‑netting and credit‑support annexes, allowing the FDIC (acting as receiver under Title II of Dodd‑Frank) to net receivables and apply collateral without the automatic stay that would accompany a bankruptcy filing; in contrast, Bank of America’s resolution plan relies on a single‑point‑of‑entry strategy with intercompany funding restrictions and the possibility that the FDIC could replace the parent with a bridge holding company, which could limit the parent’s access to subsidiary capital and expose security holders to greater losses. Thus, MetLife’s OLA exposure is mitigated by ISDA netting provisions, whereas BAC’s OLA risk centers on funding constraints and potential equity loss in its resolution framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All factual elements are correct: MetLife's use of ISDA Master Agreements with close-out netting under OLA, the FDIC's ability to act as receiver under Title II, and the mitigation of automatic stay risks are accurately described. Similarly, Bank of America's single-point-of-entry resolution strategy, intercompany funding restrictions, bridge holding company mechanism, and potential equity losses are correctly outlined. (2) There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is not applicable in a numerical sense, but all referenced regulatory mechanisms and structural outcomes are factually precise. (3) The multi-hop reasoning—linking Dodd-Frank, OLA, ISDA provisions for MetLife, and contrasting with BAC’s resolution plan under FDIC/Fed oversight—is logically sound and synthesizes across regulatory frameworks and firm-specific strategies. (4) The only minor difference from the original answer is that the LLM emphasizes 'funding constraints' slightly more than the original, which focuses on loss exposure; however, this is a valid interpretive extension and does not detract from accuracy. Wording differs but meaning is preserved. Contextual relevance is perfect—directly addresses the comparative regulatory risk exposure as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Related_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1526,
        "completion_tokens": 383,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does Nike's revenue from the Greater China region, which includes Taiwan, compare to Starbucks' store count in Taiwan specifically, and what might this suggest about their relative market presence in that geographic area?",
      "original_answer": "Nike generated $7,547 million in revenue from the Greater China region in 2022, which includes Taiwan along with mainland China and Hong Kong. In contrast, Starbucks operated 544 stores in Taiwan as of October 2, 2022. Given that Nike's revenue figure represents a broader regional performance across multiple countries while Starbucks' store count is specific to Taiwan, the comparison highlights different dimensions of market presence—Nike's being revenue-based across a larger geographic cluster, and Starbucks' being operationally focused with a localized footprint in Taiwan.",
      "llm_answer": "\nNike’s 2022 10‑K reports that its **Greater China** segment – which the filing defines as including “China mainland, Hong Kong and **Taiwan**” (Chunk 2) – generated **$7.55 billion in revenue** (Chunk 1).  Starbucks, by contrast, operated **544 stores in Taiwan** as of Oct 2 2022 (Chunk 3).  Consequently, Nike’s sales in the region are roughly an order of magnitude larger than the number of Starbucks locations in Taiwan, indicating a far greater overall economic footprint in that geographic area, even though Starbucks maintains a substantial physical store presence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Nike's Greater China revenue as $7.55 billion in 2022, which matches the ground truth of $7,547 million (rounded appropriately). It accurately states that Starbucks operated 544 stores in Taiwan as of October 2, 2022—matching the original answer exactly. All numeric values and dates are correct, with acceptable formatting variation ($7.55 billion vs $7,547 million). (2) Quantitative accuracy is perfect: both figures are correctly cited, and no calculations were required beyond the implied magnitude comparison, which is reasonably expressed as 'an order of magnitude larger'—a valid approximation given ~7.5B vs ~500. (3) The multi-hop reasoning is sound: the model synthesizes data from Nike’s 10-K (revenue for Greater China including Taiwan) and Starbucks’ store count in Taiwan specifically. It correctly contrasts revenue (economic footprint) with store count (physical presence), though it slightly overreaches by concluding Nike has a 'far greater overall economic footprint' without fully acknowledging that Nike’s revenue spans a much broader region (mainland China, Hong Kong, and Taiwan), whereas Starbucks’ count is Taiwan-only. This nuance is present in the ground truth but downplayed in the LLM answer. (4) Despite this minor gap in qualitative precision, the answer remains factually correct, contextually relevant, and semantically aligned with the original. The conclusion is reasonable within bounds, just slightly less nuanced than the ground truth. Hence, correctness is high but not perfect—warranting a 9/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 434,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does the $5.0 billion upfront payment from American Tower Corporation in March 2015 compare to the $2.8 billion received from Vertical Bridge in December 2024 in terms of Verizon's retained obligations and asset treatment related to the exclusive rights transactions?",
      "original_answer": "The $5.0 billion transaction with American Tower in 2015 and the $2.8 billion transaction with Vertical Bridge in 2024 both involved Verizon transferring exclusive rights to operate wireless towers while retaining ownership and depreciation responsibilities. In both cases, Verizon subleases capacity back from the acquiring entity and continues to include the towers in 'Property, Plant and Equipment - Net' on its balance sheet. However, the Vertical Bridge deal resulted in a $2.0 billion prepaid rent and $830 million financing obligation split based on usage, whereas the American Tower deal did not specify such a breakdown, indicating a potentially different structure in how the financing and lease obligations were allocated between the two transactions.",
      "llm_answer": "\nThe $5 billion upfront payment from American Tower in March 2015 was recorded as prepaid rent and a financing obligation, with Verizon retaining primary liability for the underlying ground‑lease payments and keeping the towers on its balance sheet for depreciation—exactly the same accounting treatment applied to the $2.8 billion upfront from Vertical Bridge in December 2024, which splits the cash into $2 billion of prepaid rent and a $830 million financing obligation while also leaving Verizon responsible for the ground‑lease obligations; both transactions involve exclusive‑rights transfers, sub‑leases of tower capacity, and the continuation of tower assets in “Property, Plant and Equipment – Net” (as illustrated by the Crown Castle financing‑obligation example in Chunk 1), but the 2015 deal placed the full $5 billion in a financing obligation whereas the 2024 deal allocates a larger portion to prepaid rent and a smaller financing obligation.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several correct elements but introduces a significant factual error in the quantitative treatment of the American Tower transaction. (1) Correct aspects: Both transactions involve exclusive rights transfers, subleases of capacity, retained ownership, and continued inclusion of towers in 'Property, Plant and Equipment - Net'; Verizon retains ground lease obligations in both cases; the Vertical Bridge deal correctly splits $2.8 billion into $2.0 billion prepaid rent and $830 million financing obligation. (2) Quantitative inaccuracy: The LLM incorrectly states that the $5.0 billion American Tower payment was 'recorded as prepaid rent and a financing obligation' with the 'full $5 billion in a financing obligation'—this contradicts the ground truth, which explicitly states that the American Tower deal 'did not specify such a breakdown.' There is no evidence in the ground truth that the 2015 deal allocated amounts between prepaid rent and financing obligation, let alone placing the full amount in financing. This is a major factual misrepresentation. (3) Multi-hop reasoning: The model correctly identifies the structural similarities between the two deals (accounting treatment, retained responsibilities, subleasing), but incorrectly infers a specific allocation for the 2015 deal based on the 2024 structure, likely due to overgeneralization from the Crown Castle example mentioned in 'Chunk 1' (not provided but referenced). This undermines the validity of the comparison. (4) Semantic equivalence: While the overall intent and direction of the comparison are reasonable, the specific claim about the $5 billion being fully allocated to financing obligation is unsupported and false per the ground truth, which notes the absence of such a split. This error affects the core of the comparative analysis. Therefore, while the answer is contextually relevant and captures qualitative similarities well, the quantitative inaccuracy severely limits its correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Gains]-> ACCOUNTING_POLICY -[Acquires]-> COMP <-[Transacts_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 535,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does JPMorgan's operational risk capital estimation under Basel III, which includes fraud risk as a key component, compare to Citigroup's exposure to fraud-related losses in emerging markets, particularly in scenarios involving asset confiscation or loss of control in Russia?",
      "original_answer": "JPMorgan uses the Advanced Measurement Approach (AMA) under Basel III to estimate operational risk capital, incorporating internal and external losses, scenario analysis, and business environment metrics, with fraud being a key risk category. Meanwhile, Citigroup reports exposure to fraud and political instability in emerging markets, with a specific scenario in Russia involving potential losses of $1.6 billion in CTA (Cumulative Translation Adjustment) and $0.9 billion on intercompany liabilities if control of AO Citibank is lost. These figures highlight how both firms face fraud-related risks but experience them through different financial mechanisms and geographic exposures.",
      "llm_answer": "\nJPMorgan’s Basel III operational‑risk capital estimate treats fraud as a core component of its Advanced Measurement Approach, quantifying expected fraud losses through the Loss‑Distribution and scenario‑analysis models described in its 10‑K filing; Citigroup, by contrast, discloses that a loss of control over its Russian operations could produce a $1.6 bn capital‑transfer adjustment and a $0.9 bn write‑down of intercompany liabilities, illustrating a concrete fraud‑related loss exposure in emerging markets that is captured in its RWA‑classified operational‑risk framework and linked to the same fraud‑risk factor that the firm is subject to.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: JPMorgan uses the Advanced Measurement Approach (AMA) under Basel III with fraud as a core component, utilizing loss distribution and scenario analysis—consistent with the original answer. Citigroup's exposure in Russia is accurately reported as $1.6 billion in CTA (referred to as 'capital-transfer adjustment', a valid interpretation of Cumulative Translation Adjustment) and $0.9 billion in intercompany liabilities, matching the ground truth numerically and contextually. (2) Quantitative accuracy is perfect: both dollar amounts ($1.6 billion and $0.9 billion) are correctly cited with acceptable formatting variations (e.g., 'bn' for billion). No calculations were required. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two institutions (JPMorgan and Citigroup), two risk frameworks (AMA vs. RWA-classified operational risk), and two types of fraud-related exposures (modeled capital estimation vs. scenario-based emerging market risk). The connection between fraud risk as a common factor is logically drawn. (4) Minor deduction in qualitative accuracy due to slightly less clarity on Citigroup’s exact operational risk framework—while it mentions 'RWA-classified operational-risk framework', the original specifies that these losses are disclosed in the context of fraud and political instability, not necessarily modeled via AMA. However, this does not distort the core comparison. Wording differs but semantic meaning is preserved. Contextual relevance is full—every part of the question is addressed with precise, relevant information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> RISK_FACTOR -[Negatively_Impacts]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 458,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact Qualcomm's chipset supply chain differently than Intel's operational footprint in the region, given Qualcomm's reliance on Taiwan-based foundry partners and Intel's $6.867 billion in 2023 revenue tied to the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan would impact Qualcomm and Intel through different mechanisms. For Qualcomm, the risk is operational, as the company explicitly states its 'business depends on our ability to receive consistent and reliable chipset supply from our foundry partners, particularly in Taiwan.' A disruption would 'severely limit or prevent us from receiving chipset supply,' directly threatening its product availability. In contrast, Intel's exposure is primarily financial, with $6.867 billion in 2023 revenue tied to Taiwan, but no explicit mention of reliance on Taiwan-based manufacturing in its disclosures. While both face risks from instability in Taiwan, Qualcomm's dependency is on supply continuity, whereas Intel's is on market demand and revenue generation in the region.",
      "llm_answer": "\nA prolonged Taiwan conflict would most directly choke off Qualcomm’s chipset supply because its business “depends on our ability to receive consistent and reliable chipset supply from our foundry partners, particularly in Taiwan,” and the company’s risk disclosures warn that such an event could “severely limit or prevent” that supply and cause a “material adverse impact” on its operations.  By contrast, Intel already derives $6.867 billion of its 2023 revenue from Taiwan (as reported in its 2023 10‑K) and, per the KG relationship “Taiwan → INTC (Operates_In),” so a conflict would threaten that revenue stream and its Taiwanese footprint, but Intel’s exposure is tied more to its own regional sales and facilities rather than to external foundry partners.  Both firms face heightened geopolitical risk—Qualcomm’s supply chain vulnerability is amplified by its reliance on Taiwanese foundries, while Intel’s financial exposure is quantified by the $6.867 billion Taiwan‑related revenue highlighted in its filings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Qualcomm's reliance on Taiwan-based foundry partners is accurately cited with direct quotes from disclosures, and Intel's $6.867 billion in 2023 revenue tied to Taiwan is correctly stated and attributed to its 10-K. (2) Quantitative accuracy is perfect: the dollar amount ($6.867 billion) matches the original answer exactly and is contextualized correctly as 2023 revenue. No calculations were required, but the figure is properly used to highlight financial exposure. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies, distinguishing Qualcomm’s supply chain dependency (operational risk due to external foundries) from Intel’s market-based exposure (revenue and operational footprint in Taiwan), even referencing the KG relationship 'Taiwan → INTC (Operates_In)' to support Intel's regional presence. (4) The qualitative analysis is strong: it captures the core contrast—Qualcomm faces supply disruption risk, while Intel faces demand/revenue risk—and uses appropriate terminology like 'material adverse impact' and 'geopolitical risk' consistent with SEC filing language. Wording differs slightly but meaning is preserved and enhanced with additional context (e.g., mention of 'material adverse impact'). All parts of the question are addressed thoroughly and accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Supplies]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 399,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How does RTX's valuation methodology for private equity limited partnerships differ from BA's approach to valuing Level 3 assets measured on a nonrecurring basis, given that both companies report these investments through fair value processes?",
      "original_answer": "RTX values its private equity limited partnerships on a quarterly basis using discounted cash flows, earnings multiples, and market multiples, with valuation adjustments reflecting changes in operating results, financial condition, or prospects of the applicable portfolio company. In contrast, BA applies an income approach based on discounted cash flows for Level 3 assets measured on a nonrecurring basis, such as impaired customer financing assets, which include operating lease equipment and investments in finance leases valued using median collateral values from third-party aircraft publications. While RTX actively adjusts valuations quarterly based on portfolio company performance, BA relies on third-party publications and adjusts values only under specific circumstances, such as unique aircraft attributes or expected net sales prices.",
      "llm_answer": "\nRTX values its private‑equity limited‑partnership interests on a **recurring quarterly basis** using a mix of discounted‑cash‑flow, earnings‑multiple and market‑multiple inputs, with adjustments that reflect each portfolio company’s operating results, financial condition and prospects.  \nBA, by contrast, measures its **Level 3 assets on a non‑recurring basis** with an income‑approach discounted‑cash‑flow model that relies on third‑party aircraft‑market data (median collateral values) and applies asset‑specific adjustments for condition or usage, resulting in a valuation that is triggered only when the asset is assessed rather than on a regular schedule.  \n\nBoth companies disclose these fair‑value measurements in the same “Fair Value Table” accounting policy, but RTX’s private‑equity valuations are **periodic and multi‑method**, whereas BA’s Level 3 valuations are **event‑driven and based on specific observable market benchmarks and unobservable inputs**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) All factual elements are correct: RTX uses discounted cash flows, earnings multiples, and market multiples on a recurring quarterly basis, adjusting for portfolio company performance—this matches the original answer exactly. BA uses an income approach (discounted cash flows) for Level 3 assets on a nonrecurring basis, relying on third-party aircraft publications (median collateral values), which is also correctly stated. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—both responses describe methodologies rather than quantitative outputs, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in valuation frequency (recurring vs. nonrecurring), methodology (multi-method vs. income approach), data sources (internal adjustments vs. third-party benchmarks), and triggering mechanisms (periodic vs. event-driven). (4) The only reason for not giving a perfect 10 is that the LLM slightly downplays BA’s consideration of 'expected net sales prices' and 'unique aircraft attributes' as adjustment factors, bundling them under 'asset-specific adjustments' without explicitly naming those triggers mentioned in the original. However, this is a matter of wording, not factual inaccuracy. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Values]-> FIN_INST -[Not_Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 431,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How does Netflix's use of forward contracts to manage foreign exchange risk on firm commitments compare to Disney's VAR model estimates in terms of potential one-day loss exposure, given the specific metrics disclosed in their respective financial reports?",
      "original_answer": "Netflix uses forward contracts to hedge foreign exchange risk on firm commitments related to foreign currency-denominated content assets, aiming to reduce cash flow volatility. However, Disney's Value at Risk (VAR) model estimates a maximum potential one-day loss of $255 million (as of September 28, 2024) across its interest rate, foreign exchange, commodities, and equity-sensitive instruments. While Netflix does not disclose a specific VAR metric, Disney's $255 million VAR figure provides a quantified estimate of its exposure, allowing for a comparative view of how each company assesses and manages financial risk in their operations.",
      "llm_answer": "\nNetflix mitigates foreign‑exchange risk on its foreign‑currency firm commitments—such as licensing and content‑production obligations—by entering into forward contracts, whereas Disney quantifies its one‑day FX loss exposure with a VAR model that, under normal market conditions at a 95 % confidence level, estimates a maximum potential loss of $255 million (down from $284 million the prior year).  \nThe VAR model, which is built on a variance/co‑variance technique and explicitly excludes forecasted transactions and firm commitments that are precisely the items Netflix hedges, therefore reflects the un‑hedged portion of Disney’s market‑sensitive portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Netflix's use of forward contracts to hedge foreign exchange risk on firm commitments and Disney's VAR model estimating a one-day potential loss of $255 million. The dollar amount is accurate and matches the ground truth. However, the LLM introduces a detail not present in the original answer — that the $255 million figure is 'down from $284 million the prior year' — which, while potentially true, is not included in the provided ground truth and thus cannot be verified from the given context. Additionally, the LLM specifies the confidence level as 95%, and describes the model methodology as 'variance/co-variance technique,' which are plausible but absent from the original answer and not confirmed in the knowledge graph excerpt. (2) The key number — $255 million — is correct and properly attributed to Disney’s VAR estimate as of the relevant period (implied to be September 28, 2024, though the date is not explicitly repeated in the LLM answer). The format is consistent and acceptable. (3) The multi-hop reasoning is sound: the LLM contrasts Netflix’s hedging approach (forward contracts on firm commitments) with Disney’s VAR model, correctly noting that VAR excludes the very items Netflix hedges, thereby highlighting a conceptual difference in risk measurement scope. This adds analytical depth beyond the original answer. (4) Despite the extra unverified details, the core factual content is accurate, the comparison is logically constructed, and the answer directly addresses the question. The slight over-specification of model details and inclusion of unconfirmed prior-year data prevent a top score, but the answer remains substantially correct and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Manages]-> FIN_INST -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 473,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the corporate income tax rate reduction in the Philippines enacted in Q1 2021 impact AMD's tax provision compared to Texas Instruments' operational investments in the country, given both companies' exposure to international tax regulations?",
      "original_answer": "The corporate income tax rate reduction in the Philippines enacted in Q1 2021 had a favorable impact on AMD’s effective tax rate by partially offsetting increases from other tax factors, such as GILTI-related foreign tax credit limitations. Meanwhile, Texas Instruments had $370 million in property, plant, and equipment at its two sites in the Philippines as of December 31, 2021, indicating significant operational exposure that would be directly affected by the lower tax rate. AMD’s 2021 effective tax rate increased by 0.1 percentage point to 21.8%, with the Philippines tax reduction noted as a mitigating factor, while TXN’s capital investment in the country suggests a strategic commitment that would benefit from the lower corporate tax rate.",
      "llm_answer": "\nThe Philippines’ corporate‑income‑tax cut enacted in Q1 2021 lowered AMD’s statutory rate and is reflected in its 2021 tax provision of **$513 million** (Chunk 1) and the “Tax Reform Act” line that showed a **$13 million** benefit in earlier years, helping lift AMD’s effective tax rate to **21.8 %** for 2021 (Chunk 2).  \nAt the same time, Texas Instruments reported **$370 million** of property, plant and equipment in the Philippines as of 31 Dec 2021—up from **$333 million** a year earlier—demonstrating that the same tax incentive spurred additional operational investment in the country (Chunk 3).  \nThus, while the rate reduction modestly improved AMD’s tax expense, it also encouraged TI to expand its Philippine footprint, illustrating how both firms’ exposure to international tax regulations translated into distinct but linked financial outcomes (Chunks 1‑3).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Texas Instruments' $370 million in property, plant, and equipment (PPE) in the Philippines as of December 31, 2021, matching the ground truth. It also correctly states AMD’s 2021 effective tax rate as 21.8%, which aligns with the original answer. However, the LLM introduces two figures not present in the ground truth: AMD’s total tax provision of $513 million and a $13 million benefit from the 'Tax Reform Act' in earlier years. These specific numbers and the term 'Tax Reform Act' are not mentioned in the original answer and lack verification from the provided context, making them potentially hallucinated or misattributed. (2) The calculation of AMD’s effective tax rate increasing by 0.1 percentage point to 21.8% is accurate per the original answer, but the LLM fails to mention this small increase was despite the Philippines tax reduction acting as a mitigating factor—this nuance is partially lost. The PPE increase from $333 million to $370 million is correctly noted, though the original answer does not mention the prior year’s value, so this addition may reflect external knowledge. (3) The multi-hop reasoning is generally sound: the model connects the Philippines tax rate reduction to AMD’s tax provision and links TI’s capital investment to operational exposure, synthesizing international tax impacts across both firms. However, it overstates AMD’s benefit by implying the tax cut directly lifted the effective tax rate to 21.8%, whereas the original answer states the rate increased slightly and the Philippines reduction helped offset other negative factors. This reverses the causal logic and misrepresents the impact. (4) Despite these issues, the answer remains contextually relevant and captures the core contrast: AMD experienced a tax provision impact while TI demonstrated operational investment. The qualitative reasoning is strong but undermined by unsupported quantitative claims. Hence, correctness is reduced due to factual inaccuracies in key numbers and misrepresentation of causal relationships, though the overall structure and intent are aligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> REGULATORY_REQUIREMENT -[Regulates]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 573,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How do GM's and McDonald's different approaches to affiliate relationships reflect their respective business models, particularly in terms of vehicle production and franchise operations?",
      "original_answer": "GM engages in transactions with nonconsolidated affiliates for the development, production, and marketing of trucks, crossovers, cars, and automobile parts, which are integral to its automotive manufacturing business model. These affiliates are primarily located in China and produce vehicles under the Baojun, Buick, Cadillac, Chevrolet, and Wuling brands. In contrast, McDonald's relies on affiliates for franchise operations, where revenues are generated through royalties based on a percentage of sales and initial fees. This reflects McDonald's asset-light business model centered on franchising and brand licensing. While GM's affiliate relationships are production-focused and tied to physical goods, McDonald's approach emphasizes service-based revenue through franchisee support and brand management, highlighting the distinct operational structures of the two companies.",
      "llm_answer": "\nGM’s vehicle business is built around its own manufacturing of trucks and other products, but it extends that production through non‑consolidated affiliates that purchase and sell components and vehicles and help market the trucks to fleet and retail customers—an arrangement reflected in the “GM → Trucks → Affiliates → MCD” KG link and described in Chunk 1’s segment discussion and Chunk 2’s transaction tables.  In contrast, McDonald’s model is fundamentally franchise‑driven: its revenue comes from company‑owned restaurants and, far more importantly, from fees paid by franchisees and developmental licensees that operate the outlets, with royalties, rent and initial fees recognized as income as detailed in Chunk 3’s segment‑reporting and revenue‑recognition notes.  Thus, while GM’s affiliate network is an integral part of the physical production and distribution chain that underpins its automotive business, McDonald’s affiliate relationship is an asset‑light, brand‑licensing structure that channels earnings through franchisee‑generated sales, highlighting the divergent operational philosophies of the two companies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original ground truth. (1) All factual information is correct: GM's use of nonconsolidated affiliates for vehicle production, particularly in China, and McDonald's franchise-based revenue model are accurately described. The answer correctly identifies that GM's affiliates are involved in the development, production, and marketing of vehicles (e.g., trucks, crossovers), while McDonald's generates revenue through royalties, rent, and initial fees from franchisees. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes the difference in business models by contrasting GM’s production-focused affiliate relationships with McDonald’s service- and brand-based franchising model. It accurately reflects that GM’s model is tied to physical goods and supply chain integration, whereas McDonald’s is asset-light and revenue-driven via franchisee operations. (4) The only minor shortcoming is that the LLM answer does not explicitly name the brands produced by GM affiliates (Baojun, Buick, Cadillac, Chevrolet, Wuling) or specify their geographic concentration in China, which are included in the original answer. However, this omission does not detract significantly from the overall correctness, as the core contrast in business models is clearly and accurately conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—the response directly addresses the comparative business models as reflected in affiliate relationships.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Produces]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 450,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "Given Alphabet's significant share repurchase activity of $62.0 billion in Class A and Class C shares in 2024, and the automatic conversion of Class B shares to Class A upon sale or transfer, how might the reduction in outstanding Class A shares impact the relative voting power of remaining Class B shareholders, especially in light of the fact that Class B shares carry 10 votes per share compared to 1 vote for Class A?",
      "original_answer": "Alphabet repurchased $62.0 billion of Class A and Class C shares in 2024, reducing the number of outstanding Class A shares. Since Class B shares convert automatically to Class A shares upon sale or transfer, this limits the ability of Class B holders to retain higher-vote shares if they transact. With fewer Class A shares in circulation due to buybacks, the relative voting concentration among remaining Class B shareholders—who hold 10 votes per share—would increase, potentially consolidating control among long-term holders.",
      "llm_answer": "\nThe $62 billion of Class A (and C) shares retired in 2024 cuts the pool of 1‑vote shares by roughly 0.4 billion, so the 9.4 million outstanding Class B shares—each carrying 10 votes—now represent about 2.8 % of total voting power versus roughly 2.4 % before the repurchases. Because Class B shares automatically convert to Class A upon any sale or transfer and holders must immediately sell any Class A shares they receive, they cannot offset the shrinkage by acquiring additional 1‑vote shares, preserving the relative voting premium of the remaining Class B owners. The disclosed linkage of Class A stock to CMCSA further shows that part of the retired Class A equity is held by Comcast, amplifying the effect on the remaining voting bloc.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. While it correctly identifies Alphabet's $62.0 billion share repurchase of Class A and Class C shares in 2024 and the automatic conversion of Class B to Class A upon transfer, it introduces unsupported numerical estimates: claiming the repurchase 'cuts the pool of 1-vote shares by roughly 0.4 billion' and calculating pre- and post-buyback voting power (2.4% to 2.8%) is speculative and not derivable from the provided ground truth. The ground truth does not include any specific share counts, percentages, or voting power calculations, so these figures are fabrications. Additionally, the claim that '9.4 million Class B shares' exist is not supported by the original answer or typical public disclosures for Alphabet in 2024. The reference to 'CMCSA' (Comcast) and a 'disclosed linkage' is entirely extraneous and incorrect—there is no such connection in the context of Alphabet's share structure or repurchases. This introduces a major factual error. While the qualitative reasoning about reduced Class A shares increasing relative voting power of Class B holders is sound and aligns with the ground truth, and the explanation of conversion mechanics is accurate, the inclusion of false quantitative details and an irrelevant entity (Comcast) severely compromises the answer's reliability. The multi-hop logic (buybacks reduce Class A shares → Class B holders' relative voting weight increases) is conceptually correct, but the answer overreaches by adding unsupported calculations. Thus, while the core idea is partially correct, the answer cannot score highly due to invented data and a significant entity error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Changes_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 464,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does the adoption of ASU No. 2020-01 impact the accounting treatment for equity securities by both Colgate-Palmolive and The Coca-Cola Company, particularly in light of the clarification provided by the standard on the interaction between equity securities, equity method investments, and derivative contracts?",
      "original_answer": "ASU No. 2020-01 clarifies the interaction between the accounting for equity securities under Topic 321, equity method investments under Topic 323, and derivative contracts under Topic 815. Colgate-Palmolive adopted this guidance effective January 1, 2021, and concluded that it did not have a material impact on its Consolidated Financial Statements. Similarly, The Coca-Cola Company, which is also subject to the same accounting standard, applies the clarified guidance to its equity securities, including the calculation of net unrealized gains and losses recognized during the year related to equity securities still held at the end of the year (as disclosed in its financial statements). Both companies benefit from the standard’s clarification on when observable transactions should be considered before applying or upon discontinuing the equity method, and how derivatives linked to equity securities should be accounted for without considering whether the underlying securities would be accounted for under the equity method or fair value option.",
      "llm_answer": "\nThe January 2021 effective ASU 2020‑01 clarifies that equity securities (including those accounted for under the equity method) and related derivative contracts must be evaluated based on observable transactions and that certain derivatives are **not** accounted for under the equity method even when the underlying securities could be; both Colgate‑Palmolive and The Coca‑Cola Company adopted the guidance on January 1 2021 and each disclosed that the standard’s implementation **did not have a material impact** on their consolidated financial statements.  Coca‑Cola’s disclosure also shows the net unrealized‑gain/loss calculation for equity securities still held, illustrating how the clarified interaction influences the reporting of those securities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) All key facts are correct: ASU No. 2020-01 was adopted by both Colgate-Palmolive and The Coca-Cola Company effective January 1, 2021, and both disclosed that the adoption did not have a material impact on their financial statements—this matches the original answer exactly. The mention of Coca-Cola’s disclosure on net unrealized gains/losses for equity securities still held aligns with the ground truth. (2) Quantitatively, the date (January 1, 2021) is correct, and there are no numerical inaccuracies. Format and phrasing (e.g., 'January 1 2021' without comma) are minor stylistic issues but do not affect accuracy. (3) The multi-hop reasoning is sound: the answer correctly links the standard’s clarification to both companies, explains the interaction between equity securities, equity method investments, and derivatives, and notes the practical impact (or lack thereof) on financial reporting. It captures the core clarification—that certain derivatives are not accounted for under the equity method even if the underlying securities might be—though it slightly simplifies the broader scope of observable transactions affecting equity method application. (4) The answer is contextually relevant and focused, addressing both companies and the accounting impact as required. The only minor shortcoming is a slight compression of the standard’s full scope (e.g., less emphasis on when observable transactions affect equity method adoption/discontinuation), but the key elements are present and correctly synthesized. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Discloses]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 476,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does the difference in the Stress Capital Buffer (SCB) components of the CET1 capital ratio requirements between Goldman Sachs and Citibank reflect their respective approaches to regulatory capital adequacy under the Standardized Capital Rules as of December 2024?",
      "original_answer": "As of December 2024, Goldman Sachs is subject to a Stress Capital Buffer (SCB) of 6.2% under the Standardized Capital Rules, while Citibank’s required CET1 capital ratio under the same rules is 7.0%, which includes the 4.5% minimum CET1 requirement and a fixed 2.5% Capital Conservation Buffer. This indicates that Goldman Sachs faces a higher SCB-driven capital requirement, suggesting a potentially more stringent stress-based capital adequacy assessment compared to Citibank, which does not explicitly include an SCB in its stated CET1 requirement under the Standardized Approach.",
      "llm_answer": "\nAs of December 2024 the Standardized Capital Rules require Goldman Sachs to hold a Stress Capital Buffer of 6.2 % within its CET1 ratio, whereas Citibank’s CET1 requirement of 7.0 % is met by a 4.5 % minimum CET1 plus a fixed 2.5 % capital‑conservation buffer, implying a markedly smaller SCB component for Citibank; this contrast shows that Goldman Sachs adopts a more aggressive stress‑buffer stance under the Standardized approach, while Citibank relies on a modest, fixed buffer, a difference that is reflected in the KG relationship (GS → CET1 Capital Ratio Requirement → Citibank) and is corroborated by the regulatory‑capital tables in the filings, which confirm that Citibank comfortably exceeds the mandated ratios despite its lower SCB.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key numbers: Goldman Sachs' 6.2% SCB and Citibank's 7.0% CET1 requirement composed of 4.5% minimum CET1 and 2.5% Capital Conservation Buffer, which matches the ground truth. These values are quantitatively accurate, and no calculation errors are present. (2) However, the LLM mischaracterizes the regulatory framework by implying that Citibank has a 'smaller SCB component'—in fact, the original answer clarifies that Citibank’s 7.0% does not include an SCB at all under the Standardized Approach, meaning the SCB component is zero, not reduced. The SCB is a stress-based requirement applied primarily under the stress capital assessment process (e.g., to GSIBs like Goldman Sachs), not uniformly under the Standardized Approach. (3) The multi-hop reasoning is partially flawed: the LLM incorrectly suggests that the difference reflects 'Goldman Sachs adopt[ing] a more aggressive stress-buffer stance,' which inverts the logic—Goldman’s higher SCB is imposed due to regulatory stress tests, not a voluntary or strategic choice. The original answer correctly frames it as a more stringent assessment, not a strategic stance. Additionally, the reference to a 'KG relationship (GS → CET1 Capital Ratio Requirement → Citibank)' is nonsensical and suggests fabricated provenance. (4) Despite these reasoning flaws, the core factual data is correct and relevant to the question, supporting a high contextual relevance and solid quantitative accuracy. The answer captures the contrast in capital requirements but misinterprets the cause and nature of the SCB application, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Subject_To]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 451,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How do NextEra Energy's operational infrastructure investments in Indiana compare with Duke Energy Indiana's financing strategy through tax-exempt bonds as of December 31, 2023?",
      "original_answer": "NextEra Energy operates transmission infrastructure in Indiana, including 90 miles of lines and 5 substations operating at 161-345 kilovolts, as part of its broader multi-state network. Meanwhile, Duke Energy Indiana disclosed holding $285 million in tax-exempt bonds as of December 31, 2023, which represents a significant portion of its $435 million total debt portfolio. This contrast highlights different strategic focuses: NextEra's emphasis on physical infrastructure development in Indiana versus Duke Energy Indiana's reliance on tax-advantaged financing instruments to fund its operations.",
      "llm_answer": "\nNextEra Energy’s Indiana footprint is reflected in the “Other” segment of its 2023 capex table, which lists 90 miles of transmission and five substations across Illinois, Indiana, Kentucky, New Hampshire and New York (Chunk 1). By contrast, Duke Energy Indiana funds its infrastructure through tax‑exempt financing, reporting $285 million of such bonds on its balance sheet as of 31 Dec 2023 (Chunk 2) and a total tax‑exempt bond balance of $352 million with a weighted‑average rate of 3.89 % maturing 2027‑2046 (Chunk 3). Thus, while NextEra invests directly in physical assets in Indiana, Duke Energy Indiana relies on a substantially larger tax‑exempt bond program to finance comparable infrastructure.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies NextEra Energy's 90 miles of transmission lines and 5 substations in Indiana as part of a multi-state footprint, and accurately reports Duke Energy Indiana's $285 million in tax-exempt bonds as of December 31, 2023, aligning with the ground truth. However, the LLM introduces additional information not present in the original answer — specifically, a total tax-exempt bond balance of $352 million with a weighted-average rate of 3.89% maturing between 2027 and 2046 — which, while potentially factual, is not part of the ground truth and slightly misrepresents the scope of the comparison. The original answer states that the $285 million represents a significant portion of Duke’s $435 million total debt, a contextual detail the LLM omits. (2) The $285 million figure and December 31, 2023 date are correct. The 90 miles and 5 substations are accurate, though the LLM clarifies these span multiple states including Indiana, which is consistent with the ground truth. The $352 million bond total is not in the original answer and introduces a discrepancy in quantitative completeness; since it's not contradicted but unverified against the ground truth, this counts as a minor inaccuracy. (3) The multi-hop reasoning is sound: the LLM correctly contrasts NextEra’s physical infrastructure investments with Duke’s financing strategy using tax-exempt bonds. The synthesis across entities (NextEra vs. Duke) and domains (capex vs. debt financing) is logical and relevant. (4) The contextual relevance is high — the answer directly addresses the comparison asked. The qualitative reasoning is strong, but the quantitative accuracy is slightly reduced due to the inclusion of unverified bond data not in the ground truth. The omission of Duke’s total debt context ($435 million) weakens completeness. Overall, the answer is factually strong but not fully aligned with the original answer’s precise scope and emphasis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 528,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does Apple's reliance on third-party content providers for its App Store revenue model create different business risks compared to Microsoft's strategy of producing its own content, particularly in light of Apple's changes to alternative payment processing and Microsoft's emphasis on brand reputation tied to content decisions?",
      "original_answer": "Apple's App Store revenue model depends heavily on third-party content providers, with developers retaining most of the revenue while Apple keeps a commission. This model is vulnerable to changes in developer incentives and regulatory compliance, such as Apple's recent adjustments to alternative payment processing in the EU under the DMA, which could reduce commission revenue. In contrast, Microsoft produces its own content and highlights the importance of brand reputation tied to its content decisions, noting that backlash could arise from public scrutiny or dissatisfaction with product offerings. While Apple risks losing developer support due to shifting business terms, Microsoft faces brand-related risks from its own content choices, creating fundamentally different exposure points in their respective content strategies.",
      "llm_answer": "\nApple’s App Store revenue is built on third‑party content providers whose licensing deals are often short‑term and non‑renewable; because Apple must retain those providers to keep a broad catalog, any loss of key content or a regulatory change that alters payment‑processing rules can cut the commissions it collects and depress sales, creating a revenue‑volatility risk that is external to its own production. In contrast, Microsoft’s strategy of creating its own content makes its chief exposure reputational—damage to its brand or customer perception from controversial or poorly received content can erode trust and market share—so brand‑reputation management becomes a central risk, even though the same content ultimately flows into Microsoft’s ecosystem (as shown by the Content → MSFT triplet).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with strong semantic equivalence. (1) It correctly identifies Apple's reliance on third-party content providers and the associated business risks—particularly revenue volatility due to regulatory changes like alternative payment processing in the EU—and contrasts this with Microsoft's self-produced content model, where brand reputation is the primary risk. The mention of 'revenue-volatility risk that is external to its own production' aligns well with Apple's exposure to developer incentives and regulatory shifts. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes Apple’s App Store commission model, regulatory pressure (implied by DMA via 'regulatory change'), and contrasts it with Microsoft’s vertically integrated content strategy and reputational risk. The reference to 'Content → MSFT triplet' suggests grounding in a knowledge graph, reinforcing correct entity linkage. (4) Minor deduction in qualitative accuracy due to the claim that licensing deals are 'often short-term and non-renewable'—this detail is not in the original and is potentially misleading, as many App Store agreements are ongoing unless terminated. However, this does not distort the overall correct risk characterization. Contextual relevance is perfect: all parts of the question are addressed with precise, focused reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Contracts_With]-> COMP -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 427,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the potential liability from tritium leakage at Southern Company's nuclear plants compare to the decommissioning fund shortfalls highlighted in NEE's disclosures, given both companies' exposure to nuclear health risks?",
      "original_answer": "Southern Company's nuclear facilities, which contributed approximately 26% and 28% of total KWHs generated for Alabama Power and Georgia Power respectively in 2021, face health risks including potential leakage of radioactive materials like tritium. These risks expose the company to potential liabilities that could exceed decommissioning trusts or insurance coverage. Similarly, NEE discloses that the cost of decommissioning its nuclear facilities could exceed the amounts available in decommissioning funds, leaving it exposed to additional financial risks. Both companies face comparable challenges in managing nuclear health risks, with Southern Company highlighting potential tritium exposure and NEE emphasizing the risk of decommissioning shortfalls, creating parallel financial exposures despite no direct business relationship.",
      "llm_answer": "\nSouthern Company’s nuclear fleet—operated by Southern Nuclear and including the Vogtle units—faces a potential liability from tritium leakage that could exceed the amounts in its decommissioning trusts and external insurance, a risk explicitly noted in Chunk 2 where it warns that damages or decommissioning costs may surpass those funds. This exposure is comparable to the situation described in Chunk 3 for NEE, which discloses that the cost of decommissioning its nuclear plants could outstrip its decommissioning funds and that tritium emissions represent a material nuclear‑health risk, showing that both utilities confront shortfalls between anticipated nuclear liabilities and the resources set aside for decommissioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Southern Company's exposure to tritium leakage and potential liability exceeding decommissioning trusts and insurance is accurately stated, as is NEE's disclosure about decommissioning cost shortfalls and tritium emissions as a material risk. While the original answer includes specific percentages (26%, 28%) of KWHs generated by nuclear plants for Alabama and Georgia Power in 2021, the LLM answer omits these figures. This is a minor omission but does not undermine the core comparison. (2) There are no numerical inaccuracies; the LLM does not introduce incorrect numbers or miscalculations. The absence of the percentages affects completeness but not correctness. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across Southern Company and NEE, identifying parallel risks—tritium leakage and decommissioning shortfalls—as sources of potential financial exposure despite no business relationship. The logic in comparing the two companies’ nuclear-related financial risks is valid and well-structured. (4) The answer is contextually relevant, directly addressing the comparison of liabilities from tritium leakage at Southern Company versus decommissioning fund shortfalls at NEE, and correctly frames both as indicative of under-resourced nuclear risk management. The omission of the specific generation percentages prevents a perfect score, but overall, the answer is factually strong, well-reasoned, and semantically equivalent in substance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Subject_To]-> RISK_FACTOR <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 433,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the corporate income tax rate reduction in the Philippines, enacted in Q1 2021, impact both Altria's (MO) effective tax rate and Coca-Cola's (KO) capital investment strategy, given their respective exposures to the Philippine market?",
      "original_answer": "The corporate income tax rate reduction in the Philippines, enacted in Q1 2021, favorably impacted Altria's (MO) effective tax rate in 2021, contributing to a 0.1 percentage point increase to 21.8%. This suggests that Altria benefited from lower tax liabilities on its Philippine-related earnings. Meanwhile, Coca-Cola (KO) maintained a significant capital investment in the Philippines, with property, plant, and equipment in the country representing 10% of its consolidated PPE net as of December 31, 2021 and 2020. The tax cut likely improved the after-tax return on KO's Philippine operations, reinforcing its sustained capital commitment. Therefore, the tax reform positively influenced both companies’ financial positioning in the region, with MO seeing a direct tax benefit and KO maintaining a stable long-term asset base.",
      "llm_answer": "\nThe corporate‑income‑tax cut that the Philippines enacted in the first quarter of 2021 lowered the statutory rate that Altria faces in that market, a factor that helped offset other headwinds and contributed to Altria’s 2021 effective tax rate rising only 0.1 percentage point to 21.8 % (Chunk 2). Because Coca‑Cola reports that roughly 10 percent of its consolidated property, plant and equipment is located in the Philippines (Chunk 3), the more favorable tax environment supports the company’s capital‑investment strategy there, encouraging continued expansion of its Philippine operations. Both firms also contend with litigation risk that could materially affect their results (as highlighted in the contingency discussion, Chunk 1), but the tax reduction directly improves Altria’s tax expense and provides Coca‑Cola with a financially attractive backdrop for further Philippine investment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the Q1 2021 enactment of the corporate income tax rate reduction in the Philippines and its impact on both Altria (MO) and Coca-Cola (KO). The quantitative details are accurate: Altria’s effective tax rate increased by 0.1 percentage point to 21.8% in 2021, and Coca-Cola’s Philippine property, plant, and equipment (PPE) represented 10% of consolidated PPE as of December 31, 2021 and 2020—this 10% figure is correctly cited. (2) All numbers, percentages, and timeframes match the ground truth. The phrasing 'rising only 0.1 percentage point to 21.8%' is slightly misleading in tone (suggesting a small increase despite the favorable impact), but the factual content is correct—Altria’s tax rate increased slightly overall, with the Philippine tax cut helping to offset other headwinds and thus contributing positively. This nuance is consistent with the original answer’s implication of a net benefit. (3) The multi-hop reasoning is sound: the model correctly links the tax reform to Altria’s effective tax rate and to Coca-Cola’s capital investment strategy via its significant PPE exposure. It infers that the improved tax environment supports KO’s continued investment, which aligns with the original answer’s conclusion about sustained commitment. The mention of litigation risk, while not part of the core question, adds contextual caution but does not detract from the main analysis. (4) The answer is semantically equivalent to the ground truth, with only minor differences in emphasis. The core facts, entities, years, and financial impacts are all correct and well-synthesized. The qualitative accuracy is marked at 9 because the phrasing around Altria’s tax rate increase could be misinterpreted as negative, though the logic is still directionally correct. Overall, the response is factually precise, relevant, and demonstrates strong multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT -[Regulates]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 519,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How might Samsung's dual role as a supplier to NVIDIA for semiconductor wafer production and as a competitor to Qualcomm in the integrated circuit market impact Qualcomm's $12.8 billion in multi-year capacity purchase commitments, particularly if Samsung prioritizes its own product lines over external manufacturing demand?",
      "original_answer": "Samsung plays a critical role in NVIDIA's supply chain, producing semiconductor wafers for the company (Hop 1). At the same time, Samsung develops and produces its own integrated circuit products, directly competing with Qualcomm in this space (Hop 2). Qualcomm has $12.8 billion in multi-year capacity purchase commitments tied to its integrated circuit product manufacturing (Hop 3). If Samsung prioritizes its own competitive product lines over external manufacturing obligations, including those to Qualcomm, it could lead to capacity constraints or increased costs for Qualcomm. This would put pressure on Qualcomm’s ability to meet its manufacturing needs under existing commitments, potentially requiring renegotiation of terms or impacting margins if alternative suppliers must be sourced at higher costs.",
      "llm_answer": "\nBecause Samsung simultaneously supplies NVIDIA’s wafer production (as shown in NVDA’s filing) and competes with Qualcomm in the integrated‑circuit market (Chunk 1), it can redirect the same fabrication capacity toward its own product lines, leaving less capacity for Qualcomm’s multi‑year purchase commitments that total **$12.8 billion** (Chunk 3). Qualcomm explicitly warns that customers—including Samsung—may vertically integrate and favor in‑house chips, a risk that could force Qualcomm to renegotiate or lose allocated capacity and thereby pressure its licensing revenues and cash flow (Chunk 2).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $12.8 billion figure is correctly cited and matches the original answer. No other numerical values are present, so this is fully accurate. (2) The answer correctly identifies the multi-hop relationships: Samsung supplies NVIDIA (Hop 1), competes with Qualcomm in integrated circuits (Hop 2), and Qualcomm has $12.8B in capacity commitments (Hop 3). It synthesizes these correctly by explaining that Samsung could prioritize its own products, affecting Qualcomm’s access to capacity. (3) The reasoning is sound: the LLM notes that Samsung’s vertical integration could lead to capacity reallocation, forcing Qualcomm to renegotiate or lose capacity—directly reflecting the risk described in the ground truth. It also adds value by referencing Qualcomm’s own warning about customers favoring in-house chips, which strengthens the argument. (4) Minor deduction in qualitative accuracy because the LLM slightly overemphasizes impact on 'licensing revenues'—which is not mentioned in the original answer—while the original focuses on manufacturing costs, margins, and commitment fulfillment. However, this is a reasonable inference and does not constitute a factual error. Overall, the answer is factually correct, contextually relevant, and demonstrates strong multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Produces]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 379,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the impact of Lockheed Martin's commercial customer receivables on United Launch Alliance's financial position, given Boeing's equity stake in ULA and its reported income from the joint venture?",
      "original_answer": "Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes entities like ULA. ULA is a key commercial customer for Lockheed Martin through its Space segment, where Lockheed holds a 50% ownership interest. Boeing also holds the other 50% and reported $125 million in equity income from ULA in 2024. This suggests that ULA’s financial performance is significant to both companies, and Lockheed’s exposure to ULA through receivables and ownership could influence its contract asset management and overall liquidity. Therefore, any financial strain on ULA could affect both Lockheed’s $665 million commercial receivables and Boeing’s equity income.",
      "llm_answer": "\nLockheed Martin reports $665 million of receivables from commercial customers (Chunk 1), which provides the cash flow that underpins ULA’s operations and is reflected in ULA’s $551 million investment recorded by Lockheed’s Space segment (Chunk 2). Because Boeing holds a 50 % equity interest in ULA, it records $125 million of income from ULA in 2024 (Chunk 3), so the health of Lockheed’s commercial receivables directly strengthens ULA’s profitability and therefore improves Boeing’s overall financial position.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but introduces significant inaccuracies. The $665 million in commercial receivables from Lockheed Martin is correctly cited, as is Boeing’s $125 million equity income from ULA in 2024. However, the LLM incorrectly states that this $665 million 'provides the cash flow that underpins ULA’s operations' — the original answer does not support this causal claim. Furthermore, the LLM invents a figure of '$551 million investment recorded by Lockheed’s Space segment', which is not present in the ground truth and cannot be verified from the provided information. This number is a critical error as it misrepresents the financial relationship. (2) Quantitatively, the $665M and $125M figures are accurate and match the ground truth, but the introduction of the unsupported $551M figure undermines quantitative accuracy. There are no calculations in the question, but the use of an unverified number constitutes a major factual deviation. (3) The multi-hop reasoning is partially sound — the model correctly identifies the joint venture structure, Lockheed’s commercial receivables, and Boeing’s equity income. However, it reverses the direction of financial impact: the original answer suggests ULA’s performance affects Lockheed and Boeing, while the LLM claims Lockheed’s receivables directly strengthen ULA’s profitability, which is not supported. The causality is misrepresented, and the synthesis is flawed. (4) Contextual relevance is high — the answer addresses the right companies, time frame, and financial concepts. But due to the fabricated figure and incorrect causal logic, the qualitative and overall correctness scores are reduced to the mid-range. Minor wording flexibility is allowed, but invented data points cannot be tolerated in financial evaluations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Supplies]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 496,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the invalidation of the '190 Patent in the CAR T litigation affect Gilead's amortization expense following its acquisition of Kite?",
      "original_answer": "The invalidation of the '190 Patent in August 2021 removed the risk of ongoing 27.6% running royalties on Kite’s Yescarta sales, which had been previously awarded to Juno and SKI. This resolution likely reduced Gilead’s contingent liabilities and improved the valuation of the acquired intangible assets. As a result, Gilead’s amortization expense for finite-lived intangible assets, which included Yescarta-related rights from Kite, was $1.7 billion in 2021, up from $1.2 billion in 2020, reflecting the clearer path to monetization of these assets post-litigation.",
      "llm_answer": "\nThe Federal Circuit’s August 2021 decision invalidated the ‘190 Patent that was the basis of the CAR‑T royalty dispute involving Kite, which Gilead had acquired in 2017; consequently the patent‑related IPR&D that had been recorded as a finite‑lived intangible was fully written‑down and the associated amortization ceased.  This is reflected in Gilead’s 2021 amortization expense of **$1.7 billion** for finite‑lived intangibles—the last full year of amortization for that asset—after which no further amortization of the ‘190 Patent will be recognized.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several critical factual and reasoning errors despite including some correct elements. (1) Quantitatively, the $1.7 billion amortization expense in 2021 is correctly stated and matches the ground truth, as is the August 2021 patent invalidation date. However, the claim that the IPR&D was 'fully written-down' and amortization 'ceased' after 2021 is unsupported by the original answer, which states the $1.7B in 2021 was *higher* than 2020's $1.2B due to improved asset valuation and clearer monetization prospects—implying continued, not ceased, amortization. (2) The original answer indicates the patent invalidation *reduced risk* and *improved* the value of intangible assets, leading to higher amortization due to a clearer path to monetization, whereas the LLM incorrectly frames it as an asset write-down leading to cessation of amortization—this inverts the economic logic. (3) The LLM misidentifies the nature of the intangible asset: the '190 Patent was not part of Kite’s IPR&D recorded by Gilead; rather, its invalidation removed royalty liabilities, thereby enhancing the value of Yescarta-related assets. This reflects a failure in multi-hop reasoning: the model incorrectly assumes patent invalidation leads to asset impairment, when in this context it reduced contingent liabilities and supported higher asset valuations. (4) While the answer addresses the core question about amortization and cites the correct dollar figure, it fundamentally misrepresents the cause-effect relationship. The contextual relevance is high as it discusses the right entities, time frame, and metric, but the qualitative and factual inaccuracies severely undermine correctness. Hence, partial credit is given for correct numbers but significant deductions for flawed reasoning and entity/metric misinterpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Involved_In]-> LITIGATION -[Involved_In]-> COMP <-[Acquires]- ORG",
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 494,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does Apple's revenue from Greater China in 2022 compare to Intel's revenue from Taiwan in 2021, given that Greater China includes Taiwan as one of its key markets?",
      "original_answer": "Apple reported $74,200 million in net sales from Greater China in 2022, which includes Taiwan. Intel reported $13,461 million in net revenue from Taiwan in 2021. This indicates that Apple's revenue from the broader Greater China region was significantly higher than Intel's revenue specifically from Taiwan during those periods.",
      "llm_answer": "\nApple reported $74.2 billion of net sales from Greater China in fiscal 2022 (Chunk 1), a figure that encompasses Taiwan as one of the region’s key markets (Chunk 2). Intel’s 2021 revenue from Taiwan alone was $13.5 billion (Chunk 3). Thus, Apple’s 2022 Greater China sales are roughly 5.5 times larger than Intel’s 2021 Taiwan sales, reflecting both the broader geographic scope of Apple’s Greater China segment and the operational link between the two firms illustrated by the KG pattern (AAPL → Greater China → Taiwan ← INTC).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Apple's 2022 revenue from Greater China as $74.2 billion (equivalent to $74,200 million in the ground truth), and Intel's 2021 revenue from Taiwan as $13.5 billion (matching $13,461 million approximately, with acceptable rounding). (2) The calculation comparing Apple's revenue to Intel's—$74.2B / $13.5B ≈ 5.5—is accurate and correctly framed as a multiplicative comparison. (3) The multi-hop reasoning is sound: the model correctly identifies that Greater China includes Taiwan, acknowledges the geographic and operational linkage, and synthesizes data across two companies (Apple and Intel), two regions (Greater China and Taiwan), and two years (2022 vs 2021). (4) The answer conveys the same core information as the ground truth—Apple’s revenue from a broader region significantly exceeds Intel’s revenue from Taiwan—with added analytical value via the 5.5x comparison and reference to the knowledge graph pattern. All entities (Apple, Intel, Greater China, Taiwan), metrics (net sales/revenue), and years are correctly identified. Wording differs but semantic meaning and factual content are fully aligned with the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 336,
        "total_tokens": 1555
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How do UPS's derivative valuation practices involving yield curves and Boeing's approach to fixed income investments compare in terms of reliance on observable market data like credit spreads and interest rates?",
      "original_answer": "UPS relies on pricing models that use observable market data such as yield curves and foreign currency exchange rates for valuing derivatives, which are classified as Level 2. Similarly, Boeing's fixed income investments, including interest rate swaps, are valued using pricing models that incorporate verifiable observable market data like interest rates, yield curves at commonly quoted intervals, and credit spreads, also categorizing them as Level 2 when observable inputs are available. Both companies emphasize the use of market-observable inputs for Level 2 classifications, though UPS focuses on derivatives tied to foreign exchange and Boeing on fixed income instruments.",
      "llm_answer": "\nUPS classifies its OTC derivatives as Level 2 and values them with pricing models that rely on market‑observable inputs such as yield curves, foreign‑currency rates and forward prices; Boeing, by contrast, values its fixed‑income investments (including interest‑rate swaps) using Level 2 measurements that explicitly incorporate observable data—benchmark yields, swap curves and credit spreads—while stepping down to Level 3 only when such inputs are unavailable, and for pension assets held in commingled or LP structures it applies the NAV practical expedient but still depends on observable market inputs when possible. Thus both firms depend on observable metrics like yield curves and credit spreads, yet Boeing’s fixed‑income valuation explicitly references credit‑spread and interest‑rate inputs, whereas UPS’s derivative pricing centers on yield‑curve and forward‑price observables.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: both UPS and Boeing use Level 2 valuation for their respective instruments, relying on observable market data. The LLM correctly identifies that UPS uses yield curves, foreign currency exchange rates, and forward prices for OTC derivatives, while Boeing uses benchmark yields, swap curves, and credit spreads for fixed income investments including interest rate swaps. (2) There are no numeric values requiring calculation in this question, but the classification levels (Level 2, Level 3) and references to valuation inputs are factually consistent with the original answer. Format and terminology (e.g., 'swap curves' vs 'yield curves at commonly quoted intervals') are semantically equivalent. (3) The multi-hop reasoning is sound—correctly comparing two companies' valuation practices across different instruments (derivatives vs fixed income), identifying common reliance on observable inputs, and noting nuanced differences in focus (UPS on foreign exchange and forward prices, Boeing on credit spreads and interest rates). The mention of NAV practical expedient for Boeing’s pension assets adds contextual detail not in the original but does not contradict it and reflects likely accurate knowledge. (4) The answer is contextually relevant, directly addressing the comparison of reliance on observable data. The only minor shortcoming is slightly more emphasis on Boeing’s Level 3 and NAV use than necessary, which is accurate but not central to the core comparison. Overall, the answer demonstrates strong qualitative and quantitative accuracy with full contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Valued_By]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 461,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the use of discounted cash flow models for impairment testing by META compare to DIS's application of these models in valuing Level 2 derivatives, particularly in terms of the inputs and assumptions each company relies on?",
      "original_answer": "META uses discounted cash flow (DCF) models with Level 3 inputs to estimate the fair value of impaired operating lease ROU assets and leasehold improvements, incorporating assumptions such as expected downtime, projected sublease income, and discount rates reflecting risk levels. In contrast, DIS applies internal DCF models to value Level 2 derivatives using observable inputs like interest rates, yield curves, and foreign currency exchange rates. While both companies utilize DCF models, META relies on less observable (Level 3) assumptions, whereas DIS uses more market-based (Level 2) data, reflecting different applications and risk profiles in their respective financial reporting.",
      "llm_answer": "\nMETA uses discounted‑cash‑flow models for impairment testing of its operating‑lease ROU assets, applying entity‑specific market‑participant assumptions—such as expected downtime before sub‑leasing, projected sub‑lease income over the remaining lease term and discount rates derived from its incremental borrowing rate that reflects its own credit risk.  \nDIS, by contrast, applies DCF techniques to value the Level 2 derivatives it discloses, relying on observable market inputs—interest‑rate curves, yield‑curve shapes and foreign‑exchange rates—while incorporating only modest credit‑risk adjustments that are mitigated through collateral and counterparty‑rating limits; these inputs are generally external and market‑driven rather than the internally generated cash‑flow forecasts and downtime/sub‑lease assumptions that META employs.  \n\nThus, although both companies use DCF, META’s model is built on company‑specific, forward‑looking cash‑flow projections and risk‑adjusted discount rates for lease‑asset impairment, whereas DIS’s model leans on externally observable rates and rates tied to the valuation of Level 2 derivatives, with credit‑risk considerations treated as a secondary, mitigated factor.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: META uses DCF models with Level 3 inputs for impairment testing of operating lease ROU assets and leasehold improvements, relying on entity-specific assumptions like expected downtime, projected sublease income, and discount rates based on its incremental borrowing rate. DIS applies DCF models to value Level 2 derivatives using observable market inputs such as interest rates, yield curves, and foreign exchange rates. The distinction between META’s use of less observable, internally generated (Level 3) assumptions versus DIS’s reliance on more observable, market-based (Level 2) inputs is correctly captured. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable in terms of calculations, but all descriptive financial concepts (e.g., Level 2 vs Level 3, credit risk adjustments, collateral mitigation) are accurately represented. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (META and DIS), two applications of DCF (impairment testing vs derivative valuation), and two types of input hierarchies (Level 3 vs Level 2), drawing a valid contrast. (4) The LLM adds slight elaboration—such as mention of collateral and counterparty-rating limits for DIS, and framing credit risk as a 'secondary, mitigated factor'—which are reasonable inferences consistent with Level 2 valuation practices and do not contradict the ground truth. These enhancements improve clarity without introducing error. The only reason for not scoring a perfect 10 is that the original answer explicitly mentions 'leasehold improvements' as part of META’s impairment testing, which the LLM omits, though it does reference ROU assets correctly. Overall, the answer is semantically equivalent, contextually precise, and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> ACCOUNTING_POLICY -[Valued_By]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 518,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the IQOS device supply constraint mentioned in PM's 2022 filing impact PM USA's ability to commercialize heated tobacco products in the U.S., considering the FDA authorization dependency and PM USA's role as a guarantor under Altria's financial structure?",
      "original_answer": "The IQOS device supply constraint due to the global semiconductor shortage, as reported in PM's 2022 filing, limited IQOS user growth in the second half of 2021 and contributed to the delay in resuming U.S. supply following the ITC import ban. PM USA, as the exclusive commercialization partner for PMI's heated tobacco products in the U.S., depends on FDA authorization for IQOS devices, including IQOS 3, which is under review. The cessation of IQOS device sales in the U.S. after November 29, 2021, due to the ITC cease-and-desist order, further disrupted PM USA’s product portfolio. Given PM USA's role as a guarantor of Altria's debt obligations, any prolonged inability to market IQOS devices could strain PM USA's financial position, particularly if it affects cash flows or dividend distributions to Altria, thereby increasing the risk of insolvency considerations under fraudulent conveyance laws.",
      "llm_answer": "\nThe global semiconductor shortage and the ITC import‑sale ban (Chunk 1 & 2) have stopped IQOS devices from being shipped or sold in the United States, so even though the FDA has cleared PMI’s heated‑tobacco system, PM USA cannot commercialize the product until the ban is lifted or a domestic production route is established (expected in H1 2023). Because PM USA is a 100 % owned guarantor of Altria’s debt (Chunk 3), its inability to generate revenue from IQOS sales weakens its cash‑flow contribution and could jeopardize the enforceability of its guarantee, directly tying the supply constraint to Altria’s financial structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core issues correctly: the global semiconductor shortage and ITC import ban disrupted IQOS supply and U.S. commercialization, PM USA cannot sell IQOS without resolution of the ban (despite FDA authorization), and PM USA’s role as a guarantor of Altria’s debt creates financial risk due to lost revenue. However, there are minor but notable inaccuracies and omissions. First, the LLM incorrectly implies that FDA clearance alone allows commercialization — the original answer clarifies that FDA authorization for specific devices like IQOS 3 is still under review, which is a key nuance. Second, the LLM mentions domestic production expected in H1 2023, which is not present in the ground truth and introduces unverified forward-looking information. Third, while the ITC cease-and-desist order and supply disruption are correctly linked, the LLM omits the specific date (November 29, 2021) when sales ceased, a detail present in the original. The financial risk to PM USA is well-reasoned, but the connection to fraudulent conveyance laws and potential insolvency considerations — a critical legal-financial implication in the original — is missing, reducing completeness. Quantitatively, no explicit numbers are misstated, but the introduction of 'H1 2023' without grounding in the source reduces precision. The reasoning is largely sound and synthesizes supply chain, regulatory, and financial structure elements, but the omission of the fraudulent conveyance risk and overstatement of FDA status reduce qualitative accuracy. Contextually, the answer remains highly relevant and addresses the multi-hop nature of the question involving PM, PM USA, FDA, ITC, and Altria’s financial structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Causes_Shortage_Of]-> PRODUCT -[Removes]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 466,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the impact of biosimilar competition on BMY's revenue outlook compare to ABBV's exposure given that Humira alone accounted for 27% of ABBV's 2023 net revenues and faces direct biosimilar pressure globally?",
      "original_answer": "BMY faces significant risk from biosimilar competition, which threatens to rapidly erode revenues for products losing market exclusivity, especially as seen with Eliquis and Revlimid. Meanwhile, ABBV's Humira, which accounted for 27% of its 2023 net revenues, is under direct global biosimilar pressure. While both companies are exposed to biosimilar threats, ABBV has a concentrated risk tied to a single product, whereas BMY faces broader portfolio risk across multiple products.",
      "llm_answer": "\nBoth BMY and ABBV face biosimilar‑driven revenue pressure, but the exposure is uneven: BMY’s 10‑K warns that loss of market exclusivity for any key product—whether through generic or biosimilar entry—could materially reduce volumes and prices (Chunk 1), whereas ABBV’s filing shows that Humira, which accounted for roughly 27 % of its 2023 net revenues, is confronting direct global biosimilar competition that will likely erode a sizable share of sales (Chunks 2 & 3). Thus, while BMY’s outlook is threatened by a broad exclusivity‑loss risk, ABBV’s outlook is hit more acutely because Humira represents a quarter of its total revenue and faces immediate biosimilar pressure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the 27% of ABBV's 2023 net revenues attributed to Humira is accurately reported, and no other numerical data contradicts the original. Minor phrasing variation (e.g., 'roughly 27%' vs. '27%') is acceptable and does not affect factual accuracy. (2) The answer correctly identifies both companies (BMY and ABBV), the relevant products (Eliquis, Revlimid implied via 'key product' and 'exclusivity-loss risk'; Humira explicitly), and the correct year (2023). (3) Multi-hop reasoning is sound: the model synthesizes BMY’s broad biosimilar risk across its portfolio with ABBV’s concentrated risk in Humira, drawing a valid comparative conclusion. The logic correctly infers that while both face pressure, ABBV’s exposure is more acute due to revenue concentration. (4) The only minor shortcoming is that the LLM does not explicitly name BMY’s at-risk products (Eliquis, Revlimid) as in the original answer, slightly reducing completeness in qualitative detail. However, the core reasoning and factual content remain intact. Thus, the answer is semantically equivalent and contextually fully relevant, meriting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR -[Faces]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 348,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the treatment of dividend equivalents on RSU awards differ between PM and PEP in terms of payout structure and vesting triggers, given PM's inclusion of dividend equivalents during vesting and PEP's cash payout upon vesting?",
      "original_answer": "PM includes dividend equivalents on RSU awards that accrue during the vesting period and are paid out as part of the RSU settlement, typically after three years or upon specific events like death, disability, or reaching age 58. PEP also accrues dividend equivalents on RSUs, but these are paid out in cash (without interest) only when the RSU vests and becomes payable. Unlike PM, which may vest RSUs upon age or disability, PEP ties payout strictly to the end of the service period or performance-based vesting for PSUs, with no mention of age-based triggers. This reflects a structural difference in how each company manages equity compensation benefits.",
      "llm_answer": "\nPM’s RSU awards earn dividend equivalents that accrue during the restriction period and are paid out when the award finally vests (or upon death, disability or reaching age 58); the related compensation cost is amortized over about 17 months and the RSUs themselves vest on the third anniversary of the grant. In contrast, PEP’s RSU/PSU awards also accrue dividend equivalents, but those equivalents are distributed as a **cash** payment **at the moment the award vests**, with no interest added. Thus, PM treats dividend equivalents as part of the award’s value that is settled on the vesting/triggers, whereas PEP settles them immediately in cash when the RSU/PSU vests.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) It correctly identifies that PM accrues dividend equivalents during the vesting period and pays them upon vesting or specific triggers (death, disability, age 58), while PEP pays dividend equivalents in cash at vesting without interest. The structural difference in payout timing and form (integrated vs. cash) is accurately captured. (2) Quantitatively, the LLM states RSUs vest on the third anniversary (i.e., three years), which aligns with the ground truth. However, the mention of '17 months' for amortization of compensation cost is not present in the original answer and appears to be extraneous or potentially incorrect information not supported by the ground truth—this is a minor quantitative deviation but not directly relevant to the question. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in payout structure (accrued value vs. cash) and vesting triggers (age-based for PM vs. service/performance-based for PEP). (4) The answer is contextually fully relevant, addressing both payout structure and vesting triggers as required. The only reason for not scoring 10 is the inclusion of the unsupported '17 months' amortization period, which, while not contradicting the core answer, introduces a detail not verified by the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 375,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does GE's $1,410 million investment in illiquid real estate funds through its run-off insurance operations compare to BA's broader real estate investment strategy, particularly in terms of liquidity risk and fund structure?",
      "original_answer": "BA invests in a diversified portfolio of global real estate, including office, retail, apartment, and industrial properties, primarily through limited partnerships or fund structures that allow for varied market exposure. These investments are part of a broader asset allocation strategy that includes private equity, hedge funds, and real assets. In contrast, GE holds $1,410 million in illiquid real estate funds through its run-off insurance operations, which are measured at net asset value and generally not eligible for redemption without the general partner's approval. Both use fund structures that limit liquidity, but GE's exposure is more concentrated and less flexible, as distributions depend on the liquidation of underlying assets at the discretion of the fund's general partner, whereas BA's approach is more diversified and integrated within a broader investment framework.",
      "llm_answer": "\nGE’s $1.41 billion exposure comes from limited‑partnership interests in private‑equity, infrastructure and real‑estate funds held inside its run‑off insurance operations; these investments are measured at NAV, are excluded from the fair‑value hierarchy, cannot be sold without the general partner’s approval and are therefore classified as highly illiquid, with redemption only occurring as the underlying assets are liquidated. In contrast, BA’s real‑estate strategy is far broader—it invests across retail, office, apartment and industrial properties through multiple private‑equity and real‑estate fund vehicles that, while also often non‑redeemable and subject to lock‑up periods, are part of a diversified portfolio spanning several geographies and property types and may include both closed‑end and redeemable structures, giving BA a more varied liquidity profile and a different risk‑return balance. (Chunk 1 describes BA’s diversified real‑estate and private‑equity fund approach; Chunk 2 explains the non‑redeemable, lock‑up nature of such funds; Chunk 3 details GE’s $1.41 billion illiquid real‑estate fund holdings and their redemption constraints.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $1.41 billion (equivalent to $1,410 million) figure is correctly reported, with proper context that it comes from GE's run-off insurance operations and is held in illiquid real estate funds. The format variation ($1.41 billion vs. $1,410 million) is acceptable and semantically equivalent. (2) The answer correctly identifies both companies (GE and BA), their respective investment structures (limited partnerships/fund vehicles), and the liquidity constraints tied to general partner approval and lock-up periods. (3) Multi-hop reasoning is sound: it contrasts GE’s narrow, illiquid exposure in run-off operations with BA’s broader, diversified real estate strategy across property types and geographies, noting that BA’s investments are part of a larger asset allocation framework including private equity and real assets—this synthesis is implied through accurate description even if 'real assets' isn't explicitly named. (4) The LLM accurately conveys that both use non-redeemable fund structures, but BA has a more varied liquidity profile due to potential inclusion of redeemable structures and diversification, while GE’s distributions depend entirely on underlying asset liquidation at the GP’s discretion. The only minor shortcoming is slightly less explicit emphasis on BA’s integration within a 'broader investment framework' compared to the original, but this is implied through mention of diversified portfolios and multiple fund vehicles. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT -[Depends_On]-> FIN_INST <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 446,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does BAC's exposure to equity market risk, as managed through derivative instruments, compare to MET's use of equity market derivatives in terms of notional value and sensitivity to a 10% decrease in equity prices?",
      "original_answer": "BAC discloses exposure to equity market risk through trading positions involving equity-linked instruments such as options, futures, and swaps. MET reports a notional value of $23,595 million for its equity market derivatives, with a sensitivity of $522 million to a 10% decrease in equity prices. While BAC does not specify exact notional amounts for its equity derivatives, it emphasizes the use of similar hedging tools. MET's quantified exposure highlights a direct sensitivity to equity market movements, which contrasts with BAC's broader market risk management approach that includes equity risk as one of several components.",
      "llm_answer": "\nBAC’s equity‑market‑risk is managed through the same “Equity Market Derivatives” that MET discloses in its 10‑K; MET’s equity‑market derivatives have a reported notional of roughly **$23.6 bn** and, according to the filing’s risk‑scenario table, would produce an estimated **$0.522 bn** effect from a **10 % decline in equity prices**. Because the knowledge‑graph ties BAC’s equity‑market‑risk factor to those derivatives, BAC’s exposure is expected to be of comparable scale, even though the filing does not separately quantify BAC’s notional or sensitivity – the MET figures therefore serve as the benchmark for the linked position, with the derivatives valued in MET’s Level 2/3 fair‑value hierarchy as shown in the hierarchy table.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "1) The LLM correctly reports MET's notional value ($23.6 billion = $23,595 million) and sensitivity ($0.522 billion = $522 million) with accurate quantitative precision, satisfying the numerical aspects of the question. However, the core qualitative error lies in asserting that BAC's exposure is 'comparable' in scale to MET's based on a knowledge-graph linkage, which is not supported by the original answer or typical financial reasoning. The original answer explicitly states that BAC does not disclose exact notional amounts and takes a broader risk management approach, making any claim about 'comparable scale' speculative and incorrect. 2) Quantitatively, the numbers are accurate and properly converted (e.g., $23.6 bn = $23,595 million; $0.522 bn = $522 million), so quantitative accuracy is high. 3) The multi-hop reasoning fails: while the question asks for a comparison, the LLM incorrectly infers equivalence or comparability of BAC's exposure based on derivative type alone, ignoring the original answer’s emphasis on MET providing quantified exposure while BAC does not. This misrepresents the nature of the comparison. 4) Contextually, the answer addresses the right entities (BAC, MET, equity derivatives, notional, sensitivity) and the 10% decline scenario, so relevance is strong. However, the erroneous conclusion about comparable exposure undermines the overall correctness. The original answer makes no such claim, instead contrasting MET’s quantified disclosure with BAC’s lack thereof. Thus, while context and numbers are mostly right, the reasoning and qualitative synthesis are significantly flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR -[Positively_Impacts]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 442,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does Microsoft's operational footprint in Greater China compare to AMD's revenue concentration in Taiwan, and what does this suggest about their respective regional market strategies in 2022?",
      "original_answer": "Microsoft operates a regional center in Singapore that supports operations in Greater China, indicating a centralized approach to managing its activities across the region, which includes China mainland, Hong Kong, and Taiwan. AMD, on the other hand, reported $2,091 million in sales to Taiwan in 2022, highlighting a significant direct revenue contribution from the region. While Microsoft's presence in Greater China is part of a broader Asia-Pacific operational structure, AMD's financial data shows a more concentrated revenue exposure to Taiwan specifically, suggesting differing regional market strategies: Microsoft leans on regional hubs to support broad market access, while AMD has a pronounced financial dependency on Taiwan as a key market.",
      "llm_answer": "\nMicrosoft’s operational footprint in Greater China is anchored by a regional hub in Singapore that supports the entire Greater China area—including Taiwan—demonstrating a diversified presence across the whole region (Chunk 1, KG triplet MSFT → Greater China → Taiwan).  Apple’s 2022 reporting treats “Greater China” as a distinct segment that explicitly includes Taiwan, underscoring the strategic importance of that sub‑market (Chunk 2).  By contrast, AMD’s 2022 sales were heavily weighted toward Taiwan, generating about $2.1 billion—roughly 13 % of its total $16.4 billion revenue (Chunk 3)—indicating a concentration of sales in that single market.  Together, these patterns reveal that Microsoft pursues a broad, region‑wide strategy across Greater China, whereas AMD focuses intensely on Taiwan as a key growth and revenue center.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error by referencing Apple instead of Microsoft in the second sentence, which undermines the comparison and introduces an irrelevant entity. This misattribution breaks the logical chain and reduces accuracy. (2) Quantitatively, the AMD revenue figures are approximately correct: $2.1 billion is a rounded version of the ground truth $2,091 million, and $16.4 billion total revenue aligns with AMD’s 2022 results, making the 13% calculation reasonable. However, the LLM introduces a calculation (13%) not present in the original answer, which, while plausible, is not verifiable from the ground truth and distracts from the core comparison. (3) The multi-hop reasoning is partially sound—comparing Microsoft’s operational structure to AMD’s revenue concentration—but is compromised by the erroneous inclusion of Apple. The LLM should have used Microsoft’s own reporting on Greater China, not Apple’s, to support the regional strategy point. This invalidates a key piece of evidence. (4) Despite the entity error, the overall structure and intent of the answer are relevant and address the comparative regional strategy question. The description of Microsoft’s Singapore hub and AMD’s Taiwan revenue concentration aligns with the ground truth, showing some correct synthesis. However, the incorrect use of Apple’s data severely impacts factual reliability, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 402,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does the dual-class stock structure at META, which affects the voting rights of Class A common stockholders, compare to NFLX's approach to shareholder voting rights in terms of investor influence over corporate governance decisions?",
      "original_answer": "META's dual-class common stock structure gives disproportionate voting power to Class B stockholders, such as Mark Zuckerberg, limiting the influence of Class A common stockholders on key corporate decisions, including board composition and change-of-control transactions. This contrasts with NFLX's one-share-one-vote policy, where each share of common stock entitles the holder to one vote on all matters, ensuring equal voting influence for all shareholders. The difference in voting rights structures reflects divergent approaches to corporate governance, with META prioritizing founder control and NFLX emphasizing broad shareholder participation.",
      "llm_answer": "\nMETA’s 2023 10‑K (Chunk 1) reveals a dual‑class structure in which Class B shares held by Zuckerberg control the majority of voting power, so Class A shareholders can be outvoted on board elections, mergers, charter amendments and other governance decisions, and anti‑takeover provisions further limit their clout; Netflix’s filings (Chunk 2 and Chunk 3) instead give each common share one vote, with Class A common stockholders retaining full voting rights on all matters and only requiring separate‑class approval for a narrow set of amendments, thereby affording investors far more direct influence over corporate‑governance outcomes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies META's dual-class structure, where Class B shares (held by Zuckerberg) have majority voting power, thereby limiting Class A shareholders' influence on key decisions like board elections, mergers, and charter amendments. It also accurately describes NFLX's one-share-one-vote structure, noting equal voting rights and only limited need for separate-class approval. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance structures from two different companies (META and NFLX) and contrasts them in terms of investor influence. The mention of anti-takeover provisions and narrow approval requirements adds contextual depth consistent with the filings. (4) The only minor shortcoming is slightly less explicit emphasis on the broader governance philosophy (founder control vs. shareholder democracy) mentioned in the original, but the functional difference is clearly conveyed. Wording differs but semantic meaning and factual content are equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST -[Positively_Impacts]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 384,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does the expiration of patent rights for JNJ's pharmaceutical products impact their market exclusivity, and how does this compare to LLY's reliance on regulatory exclusivity extensions for maintaining competitive advantage in the U.S. market?",
      "original_answer": "JNJ notes that patent expirations are typically followed by the introduction of competing generic products, which can result in significant revenue and market share losses. Additionally, JNJ highlights that increasingly aggressive challenges to its patents may lead to a loss of market exclusivity sooner than expected. In contrast, LLY relies on regulatory exclusivity extensions—such as those granted for orphan drug designations or pediatric exclusivity—to maintain market exclusivity beyond patent terms. According to BMY’s 10-K, regulatory exclusivity can provide a market exclusivity period that expires beyond the patent term, offering a strategic buffer against generic competition. Thus, while JNJ faces declining sales due to patent erosion and legal challenges, LLY strategically leverages regulatory exclusivity to prolong its market protection.",
      "llm_answer": "\nPatent expirations for JNJ’s pharmaceuticals, as described in Chunk 1, directly erode the company’s market exclusivity and cause rapid revenue loss once generic versions enter, because market exclusivity is fundamentally dependent on those patent rights (Chunk 2). LLY, by contrast, sustains its competitive edge in the U.S. through regulatory exclusivity extensions—such as orphan‑drug or pediatric exclusivity highlighted in Chunk 3 and linked to LLY in the knowledge graph—allowing protection to extend beyond the patent term. Thus, while JNJ’s advantage hinges on patent lifespans that inevitably lapse, LLY’s advantage relies on statutory regulatory exclusivity periods that can be prolonged to maintain market dominance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key points are correct: JNJ faces market exclusivity erosion due to patent expirations and generic competition, while LLY leverages regulatory exclusivity (e.g., orphan-drug, pediatric) to extend protection beyond patents. The comparison between JNJ's vulnerability and LLY's strategic advantage is well-articulated. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across entities (JNJ, LLY, and implied regulatory mechanisms), correctly attributing patent reliance to JNJ and regulatory extension strategies to LLY, even referencing BMY’s 10-K indirectly via knowledge graph linkage. (4) Minor deduction in qualitative accuracy due to omission of the specific point about 'aggressive challenges to patents' leading to earlier-than-expected loss of exclusivity for JNJ, which is present in the original. However, the core reasoning and strategic contrast remain intact. Wording differs slightly but meaning is preserved. Contextual relevance is perfect—directly addresses both parts of the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> REGULATORY_REQUIREMENT -[Provides]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 351,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does AMD's reduction in interest expense from convertible debt conversions compare with Nuance's outstanding convertible senior notes liability post-acquisition by Microsoft, and what does this imply about their respective capital structure strategies?",
      "original_answer": "AMD reduced its interest expense from $47 million in 2020 to $34 million in 2021 due to conversions of its 2.125% Convertible Senior Notes due 2026, indicating a proactive approach to reducing debt. Meanwhile, Nuance, which had issued $986 million in convertible senior notes in 2015 and 2017, had redeemed $985 million of those notes by June 30, 2022, leaving only $1 million outstanding. Microsoft, having acquired Nuance, now holds this remaining liability as part of its Intelligent Cloud segment. This suggests that AMD focused on reducing debt through voluntary conversions, while Nuance’s strategy under Microsoft involved largely redeeming its convertible notes, reflecting differing capital structure management approaches between the two companies.",
      "llm_answer": "\nAMD’s 2021 interest expense dropped $13 million (from $47 M to $34 M) as holders converted its 2.125 % Convertible Senior Notes due 2026, a detail highlighted in Chunk 1; this conversion‑driven reduction directly lowered the company’s financing cost. In contrast, the Nuance convertible senior notes that Microsoft acquired—originally $986 million of debt issued in 2015 and 2017—were almost fully redeemed ($985 M) before the acquisition, leaving only a $1 million liability reported in Chunk 2 (the notes are now recorded in the Intelligent Cloud segment’s liabilities, as noted in Chunk 3); thus AMD is actively deleveraging through equity‑linked conversions, whereas Microsoft has retired the convertible debt after acquisition, signaling a shift toward a leaner capital structure and greater reliance on internal cash flows.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: AMD's interest expense decreased from $47 million to $34 million in 2021 (a $13M reduction), due to conversions of its 2.125% Convertible Senior Notes due 2026. Nuance had issued $986 million in convertible notes and redeemed $985 million by June 30, 2022, leaving $1 million outstanding post-acquisition by Microsoft. These figures match the ground truth exactly, with acceptable formatting variations (e.g., $47M = $47 million). (2) Quantitative accuracy is perfect: all dollar amounts, the $13M difference, and the percentage rate of the notes are correct. The timeline (2021 reduction for AMD, redemption status by mid-2022 for Nuance) aligns with the original answer. (3) The multi-hop reasoning is sound—correctly linking AMD’s conversion activity to reduced interest expense, and Nuance’s redemption pattern to Microsoft’s post-acquisition capital structure. The conclusion that AMD is actively deleveraging via conversions while Microsoft retired most of Nuance’s debt is logically supported. However, the original answer emphasizes Nuance’s own redemption actions *prior* to acquisition, whereas the LLM slightly shifts credit to Microsoft for retiring the debt *after* acquisition, which is a minor misattribution. This does not invalidate the overall reasoning but slightly weakens the qualitative precision. (4) Contextual relevance is excellent—the response directly addresses the comparison of interest expense reduction and convertible debt management, and draws a meaningful implication about capital structure strategies. The mention of the Intelligent Cloud segment adds contextual detail consistent with the ground truth. Overall, the answer is factually accurate, well-reasoned, and highly relevant, warranting a 9/10 for correctness due to the minor nuance in attributing Nuance’s debt retirement timing and actor.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Issues]-> COMP <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 514,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does the $5.0 billion upfront payment from American Tower in 2015 for exclusive rights to 11,300 Verizon towers compare to the $4.827 billion transaction Crown Castle executed in 2013 for similar exclusive rights to AT&T's towers, considering both companies retained ownership and depreciation responsibilities?",
      "original_answer": "The $5.0 billion upfront payment from American Tower in 2015 for exclusive rights to 11,300 Verizon towers is slightly higher than the $4.827 billion Crown Castle paid in 2013 for 9,048 AT&T towers and the purchase of 627 towers. Both Verizon and AT&T retained ownership of the towers and continued to include them in Property, Plant and Equipment - Net on their balance sheets, depreciating them accordingly. In both cases, the companies subleased capacity back from the acquiring entity (American Tower or Crown Castle) for extended terms, with Verizon leasing back for a minimum of 10 years and AT&T subleasing for an estimated original term of 20 years.",
      "llm_answer": "\nAmerican Tower paid a $5.0 billion upfront amount in 2015 for exclusive lease rights to roughly 11,300 Verizon towers, while Crown Castle received $4.827 billion in 2013 for exclusive lease rights to about 9,048 towers (and purchased 627 towers), with both transactions treated as financing arrangements that left Verizon the owner of the tower assets and the primary obligor on the underlying ground leases; consequently, Verizon continued to carry the towers in property, plant and equipment and to depreciate them, recording the upfront payments as prepaid rent/financing obligations, and both American Tower and Crown Castle assumed responsibility for the ground‑lease payments while Verizon remained liable for any defaults.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also key inaccuracies. It correctly identifies the $5.0 billion payment by American Tower in 2015 for 11,300 Verizon towers and the $4.827 billion transaction involving Crown Castle and AT&T in 2013. However, it incorrectly states that 'Crown Castle received $4.827 billion' — in fact, Crown Castle *paid* this amount to AT&T, not received. This is a critical reversal of roles and direction of cash flow, significantly undermining the factual accuracy. Additionally, the LLM misattributes the ownership and liability structure to Verizon in both cases, when the original answer specifies that both Verizon and AT&T retained ownership and depreciation responsibilities — the LLM focuses only on Verizon. (2) Quantitatively, the dollar amounts ($5.0B, $4.827B), years (2015, 2013), and tower counts (11,300 Verizon towers, 9,048 AT&T towers + 627 purchased) are accurate. Format variations are acceptable and correctly presented. (3) The multi-hop reasoning is partially sound — the model recognizes both transactions involved exclusive rights, retained ownership, and depreciation by the carrier, and that ground lease responsibilities were shared. However, it fails to correctly identify the parties involved in the AT&T transaction (Crown Castle as buyer, not recipient of funds), and conflates the two deals by only discussing Verizon’s accounting treatment. It also omits key details such as the leaseback terms — Verizon for minimum 10 years, AT&T for ~20 years — which were part of the comparison. (4) The contextual relevance is high because the answer addresses the core structure of both transactions and attempts to compare them. However, due to the reversal of the Crown Castle transaction (receiving vs. paying), a major factual error, and the omission of comparative leaseback terms, the qualitative and overall correctness scores are reduced. The answer is partially correct but contains significant factual misstatements that affect interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Transacts_With]-> COMP -[Acquires]-> ACCOUNTING_POLICY <-[Gains]- ORG",
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 546,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does Southern Power's use of tax equity partnerships for wind facilities, which are connected to long-term PPAs with up to 25-year terms, compare with Duke Energy's approach to structuring PPAs for its renewable VIEs, particularly in terms of monetizing federal tax credits like PTCs?",
      "original_answer": "Southern Power utilizes tax equity partnerships for its wind facilities, allowing a tax partner to capture most of the federal tax benefits, including PTCs tied to the first 10 years of energy production. These partnerships are consolidated using the HLBV method, and the associated PPAs have remaining terms of up to 25 years. The PPAs are critical in monetizing these tax credits through long-term revenue streams. Similarly, Duke Energy structures PPAs as part of its renewable VIEs, where it is the primary beneficiary and makes key decisions including PPA negotiations. These PPAs are also essential in monetizing tax credits, but Duke does so under a model involving third-party tax equity investors to finance eligible assets. Both companies rely on PPAs for revenue predictability, but Southern Power explicitly ties its PPA terms and tax equity structures to the PTC window, while Duke’s focus is on broader VIE financing and guarantees.",
      "llm_answer": "\nSouthern Power monetizes the production‑tax credits (PTCs) from its wind facilities by placing the entire federal tax benefit into tax‑equity partnership structures and then funding the projects with long‑term PPAs that are accounted for as operating leases with up to 25‑year terms—these PPAs generate the cash flow needed to realize the credits and are consolidated in Southern Power’s financial statements using the HLBV methodology. Duke Energy’s renewable VIEs also rely on tax‑equity investors, but the PPAs are embedded in VIE entities that Duke Energy consolidates (as the primary beneficiary) and that involve restricted assets; like Southern Power, Duke Energy secures up to 25‑year PPAs to channel the same PTC benefits, though the PPAs are structured within the VIE framework rather than as direct operating‑lease contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Southern Power uses tax equity partnerships to monetize PTCs from wind facilities, with long-term PPAs (up to 25 years) structured as operating leases and consolidated using HLBV. Duke Energy also uses tax equity investors within renewable VIEs, which it consolidates as primary beneficiary, and relies on long-term PPAs (up to 25 years) to monetize PTCs. (2) Quantitative accuracy is perfect: 'up to 25-year terms' matches the original answer; no incorrect numbers or miscalculations. (3) Multi-hop reasoning is sound—correctly synthesizes across Southern Power’s and Duke Energy’s structures, identifying both similarities (use of tax equity, PPAs for credit monetization) and differences (operating lease vs. VIE-embedded PPA structures). (4) The only minor shortcoming is that the LLM does not explicitly highlight that Southern Power ties its PPA terms directly to the 10-year PTC window, while Duke’s model emphasizes broader VIE financing and guarantees. This nuance from the original answer is slightly underemphasized but implied through structural comparison. Wording differs but semantic meaning is equivalent. No irrelevant content; fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT -[Related_To]-> FIN_INST <-[Negotiates]- ORG",
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 356,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How do the differences in voting rights structures between CMCSA's Class B common stock and GOOGL's dual-class stock system affect their respective corporate governance models, particularly in terms of shareholder influence on major corporate decisions?",
      "original_answer": "CMCSA's Class B common stock has no voting rights, limiting shareholder influence on major decisions unless specific conditions are met, such as exiting the core payments business or undergoing a merger. In contrast, GOOGL's dual-class structure allows Class B stockholders to have 10 votes per share, significantly concentrating voting power in the hands of a few, while Class A stockholders have 1 vote per share and Class C stockholders have no voting rights. This creates a governance model at GOOGL where a small group of insiders can dominate decision-making, whereas CMCSA maintains a more uniform governance structure among its voting shareholders. The differential voting rights at GOOGL can lead to more decisive strategic direction but less democratic shareholder oversight compared to CMCSA.",
      "llm_answer": "\nCMCSA’s Class B common stock (9.4 million shares) is essentially non‑voting – holders can only vote on a narrow set of matters such as exiting the core payments business or charter amendments, so day‑to‑day control of major corporate decisions rests with the Class A shareholders and the board, diluting the influence of the Class B owners despite their equity stake (as shown in Chunk 1 and the voting‑rights description in Chunk 2).  By contrast, Alphabet’s dual‑class system gives its Class B shares 10 votes per share while Class C shares have no voting rights, concentrating decision‑making power in the hands of Class B holders and enabling insiders to dominate approvals of mergers, consolidations or other major transactions (Chunk 3).  The knowledge‑graph link Class B Common Stock → Class A Common Stock → GOOGL underscores that CMCSA’s voting regime is structured to disperse power across a broader shareholder base, whereas GOOGL’s 10‑vote Class B structure channels it into a small group, producing markedly different corporate‑governance outcomes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: CMCSA's Class B stock has no general voting rights, only on specific matters like exiting the core payments business or charter amendments; GOOGL's dual-class structure gives Class B shareholders 10 votes per share, Class A 1 vote, and Class C none—this is correctly represented. (2) Quantitative accuracy is perfect: while no explicit financial figures (e.g., dollar amounts) are present, the share class counts and voting ratios (10:1, 1:1, 0) are accurately described. The mention of 9.4 million shares of CMCSA Class B stock is consistent with the knowledge graph (Chunk 1), and though not in the original answer, it is factually correct and adds detail without error. (3) Multi-hop reasoning is sound: the model correctly synthesizes across entities (CMCSA vs GOOGL), compares their voting structures, and draws valid conclusions about governance implications—concentration of power at GOOGL vs more dispersed influence at CMCSA. The reference to 'knowledge-graph link' suggests internal traceability, though phrased oddly, it doesn't detract from correctness. (4) Semantic equivalence is strong: the core contrast—GOOGL enabling insider dominance vs CMCSA having broader shareholder control among voting classes—is clearly and correctly conveyed. Minor deduction in qualitative accuracy due to slightly awkward phrasing (e.g., 'knowledge-graph link... underscores') which could imply a logical leap, but the conclusion drawn is still valid. No factual errors, making the answer contextually excellent and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 447,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How might the difference in voting rights structures between GOOGL (with 1 vote per Class A share and 10 votes per Class B share) and NFLX (1 vote per common share) affect control dynamics, especially considering GOOGL's $62.2 billion in share repurchases during 2023?",
      "original_answer": "GOOGL's dual-class share structure, where Class B shares carry 10 votes per share compared to Class A's 1 vote, allows certain major shareholders to maintain outsized voting control despite owning a smaller economic stake. In 2023, GOOGL repurchased $62.2 billion of its Class A and Class C shares, which likely further consolidated voting power among remaining Class B shareholders. In contrast, NFLX maintains a one-share-one-vote structure, distributing control more evenly across all shareholders. This structural difference means GOOGL’s leadership has greater insulation from shareholder influence compared to NFLX, even as both companies manage capital through stock repurchases and equity grants.",
      "llm_answer": "\nGOOGL’s dual‑class structure gives Class B insiders 10 votes per share while Class A (and C) carry only one vote, so the $62.2 billion of Class A/C shares repurchased in 2023 reduces the total share count but leaves the disproportionate voting power of the remaining Class B shares essentially unchanged—and may even make those votes relatively stronger as the denominator shrinks; in contrast, NFLX’s single‑class common stock provides just one vote per share, so any repurchase simply scales down the total votes proportionally. The knowledge‑graph triple (Voting Rights → NFLX) shows that the voting‑rights accounting policy of GOOGL is subject to the same regulatory framework as NFLX, underscoring that control dynamics differ because GOOGL’s concentrated, convertible Class B votes can dominate outcomes despite large repurchases, whereas NFLX’s uniform one‑vote‑per‑share structure ties voting power directly to share quantity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GOOGL's dual-class structure (10 votes for Class B, 1 for Class A/C), NFLX's one-vote-per-share structure, and the $62.2 billion in 2023 share repurchases by GOOGL are all accurately stated. The format variation ($62.2 billion vs $62.2B) is acceptable. (2) Quantitative accuracy is perfect—no calculations are required beyond correctly citing the $62.2 billion figure, which matches the original. (3) The reasoning is sound: the LLM correctly explains that repurchasing Class A/C shares reduces the total voting denominator, thereby relatively increasing the influence of Class B shares, while NFLX’s repurchases proportionally reduce voting power across all shareholders. The mention of the 'knowledge-graph triple' is slightly awkward and not present in the original, but does not introduce factual error. (4) The answer fully addresses the question’s multi-hop nature—comparing voting structures, linking to repurchase impact, and contrasting control dynamics between GOOGL and NFLX. The only minor shortcoming is slightly less clarity than the original in articulating the insulation of GOOGL’s leadership from shareholder influence, but the core insight is preserved. Semantic equivalence is strong, and contextual relevance is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Has]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 374,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What is the financial significance of BMY's retained royalty rights related to Byetta*, given its divestiture of the diabetes business and the trademark's current ownership by LLY?",
      "original_answer": "BMY retains royalty rights related to Byetta*, a product originally associated with Amylin, even after divesting its diabetes business. According to BMY's 2022 10-K, pretax income from such royalties was approximately $1.9 billion in 2021, and a decline in these royalty streams could adversely affect BMY's future financial performance. Although Eli Lilly (LLY) now holds the trademark for Byetta*, BMY still has financial exposure through its retained royalty rights, indicating a continued revenue relationship between BMY and LLY despite the divestiture.",
      "llm_answer": "\nBMY’s retained royalty rights from the diabetes‐business divestiture generated about **$1.9 billion of pretax royalty income in 2021**, a material revenue source that would be jeopardized if those streams weaken; the Byetta* trademark—originally listed as owned by Amylin (Chunk 2) and now held by **LLY** (Chunk 3) per the KG relationship—underpins those rights, so BMY’s future earnings are tied to LLY’s ownership and any licensing or enforcement of the Byetta* mark.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: BMY retained royalty rights post-divestiture, generated $1.9 billion in pretax income in 2021 (per BMY's 2022 10-K), and this stream is tied to Byetta*, now under LLY's trademark ownership. (2) Quantitative accuracy is perfect: the $1.9 billion figure matches the original answer and is correctly attributed to 2021 pretax income. Format ($1.9 billion) is standard and acceptable. (3) Multi-hop reasoning is sound: the model correctly links BMY's retained financial interest to a product (Byetta*) originally from Amylin, now trademarked by LLY, despite BMY no longer owning the diabetes business. It synthesizes ownership history, current trademark status, and financial impact across entities. (4) The answer addresses all parts of the question: financial significance (material revenue, risk if declined), divestiture context, and current trademark ownership. Wording differs slightly but meaning is preserved. No omissions or inaccuracies. All scores are 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Relates_To]-> COMP -[Owns]-> PRODUCT <-[Owns]- ORG",
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 306,
        "total_tokens": 1572
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How does the difference in capital buffer structures between Schwab and JPMorgan Chase affect their respective minimum total risk-based capital ratio requirements, considering Schwab's requirement includes both a 2.5% stress capital buffer and 2.5% capital conservation buffer while JPMorgan Chase applies only a 2.5% capital conservation buffer?",
      "original_answer": "Schwab's minimum total risk-based capital ratio requirement is 10.5%, which incorporates both a 2.5% stress capital buffer and a 2.5% capital conservation buffer above the base regulatory minimum. In contrast, JPMorgan Chase's minimum total risk-based capital ratio is also 10.5%, but this only includes a 2.5% capital conservation buffer without an additional stress capital buffer component. This reflects different regulatory treatments where Schwab is subject to both buffers while JPMorgan Chase only applies the capital conservation buffer.",
      "llm_answer": "\nSchwab’s capital framework requires both a 2.5 % stress capital buffer **and** a 2.5 % capital‑conservation buffer, giving it a total buffer of 5 %, whereas JPMorgan Chase adds only the 2.5 % capital‑conservation buffer (Chunk 1 & Chunk 3).  As a result, the minimum total risk‑based capital ratio that Schwab must meet (10.5 % for Total Risk‑Based Capital, inclusive of its buffers) is about 2.5 percentage points higher than the comparable requirement for JPMorgan Chase, which is based solely on the 2.5 % conservation buffer (Chunk 3).  Both firms also face a zero counter‑cyclical buffer (Chunk 2 & Chunk 3), but the extra stress buffer makes Schwab’s overall capital requirement stricter.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error in the comparison between Schwab and JPMorgan Chase's capital requirements. It claims that Schwab's requirement is 'about 2.5 percentage points higher' than JPMorgan Chase's, which is incorrect. According to the ground truth, both firms have the same minimum total risk-based capital ratio of 10.5%. The difference lies in the composition of the buffers, not the total requirement. (2) Quantitatively, the LLM correctly identifies the 2.5% stress capital buffer and 2.5% capital conservation buffer for Schwab (totaling 5%), and the 2.5% capital conservation buffer for JPMorgan Chase. However, it incorrectly infers that this leads to a 2.5 percentage point difference in the total requirement, which is not supported by the original answer. The calculation of the total buffer is correct, but the conclusion drawn from it is wrong. (3) The reasoning is partially sound in identifying the components of the capital buffers and citing the zero counter-cyclical buffer correctly. However, the multi-hop synthesis fails because it does not recognize that despite different buffer structures, the resulting minimum total risk-based capital ratio is the same for both firms (10.5%). This reflects a failure in correctly mapping buffer composition to final regulatory requirements. (4) Contextual relevance is high because the answer addresses the right entities, metrics, and regulatory concepts, and attempts to compare them appropriately. However, the core conclusion is factually incorrect, which severely impacts correctness and quantitative accuracy. The answer would be stronger if it clarified that while the buffer structures differ, the resulting minimum capital ratio is identical due to differing regulatory treatments.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Consists_Of]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 485,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How does the transition from LIBOR to alternative reference rates impact both LMT's credit facility and GE's floating-rate debt and preferred stock, considering the accounting relief provided under ASU 2020-04?",
      "original_answer": "The transition from LIBOR to alternative rates impacts LMT’s credit facility and derivatives through fallback provisions like SOFR, with LMT expecting minimal financial impact due to ASU 2020-04's accounting relief that limits the effect of contract modifications. Similarly, GE’s floating-rate debt and preferred stock will transition to SOFR plus a spread adjustment under New York law, with any financial impact also being accounted for under ASU 2020-04. Both companies rely on the same accounting standard to ease the financial reporting burden during the LIBOR transition, despite differing in the types of financial instruments affected.",
      "llm_answer": "\nThe transition triggers LMT’s credit‑facility fallback provisions that automatically replace LIBOR with an alternative benchmark (e.g., SOFR) and, because the modification is accounted for under ASU 2020‑04, the change is exempt from extensive re‑measurement—consistent with LMT’s view that the shift will not materially affect its operating results, financial position or cash flows.  GE’s floating‑rate debt and preferred stock are indexed to USD LIBOR; New York legislation will substitute SOFR + a spread when LIBOR ceases, and GE will apply the same ASU 2020‑04 relief (which provides optional expedents and exceptions), a treatment that, as 3M’s parallel adoption showed, is not expected to produce a material impact on its consolidated financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: LMT’s credit facility fallbacks to SOFR with minimal impact due to ASU 2020-04; GE’s floating-rate debt and preferred stock transition under New York law to SOFR plus spread adjustment, also using ASU 2020-04 relief. The accounting treatment and expected immaterial financial impact for both companies are correctly stated. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is unaffected and remains perfect. (3) The multi-hop reasoning—linking LIBOR transition, fallback mechanisms, applicable law (New York), specific financial instruments, and shared reliance on ASU 2020-04—is sound and well-synthesized across LMT and GE. However, there is a minor error: the LLM references '3M’s parallel adoption' as an example, which is not mentioned in the original answer and introduces an extraneous entity not part of the ground truth. This does not undermine the correctness but slightly reduces qualitative accuracy. (4) Contextual relevance is excellent—the response directly addresses all parts of the question, including both companies, their respective instruments, and the role of ASU 2020-04. The mention of 3M is tangential but doesn’t distort the meaning. Overall, the answer is semantically equivalent with only a minor deviation in entity focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Positively_Impacts]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 399,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "What is the significance of CMCSA's issuance of 9,444,375 shares of Class B common stock in 2023, and how does this structure compare to GOOGL's dual-class system where Class B shares automatically convert to Class A shares upon sale or transfer?",
      "original_answer": "CMCSA issued 9,444,375 shares of Class B common stock in 2023, indicating a strategic move to maintain control while potentially raising capital without diluting voting power significantly. This mirrors GOOGL's dual-class structure, where Class B shares carry 10 votes per share and convert to single-vote Class A shares upon sale or transfer, preserving founder control. However, unlike GOOGL, which actively repurchased $62.2 billion of Class A and Class C shares in 2023, CMCSA's equity strategy appears more focused on maintaining a stable capital structure with no mention of a similar buyback program for Class B shares.",
      "llm_answer": "\nComcast (CMCSA) issued 9,444,375 shares of its authorized Class B common stock in 2023 (Chunk 1), a class that the knowledge‑graph ties to Class A shares and ultimately to the company itself (KG: Class B → Class A), indicating that the Class B stock is convertible into Class A equity.  This structure is similar to Alphabet’s (GOOGL) dual‑class system described in Chunks 2‑3, where each Class B share carries 10 votes and is automatically converted to non‑voting Class A shares upon sale or transfer, allowing insiders to retain control while providing a clear conversion path for investors.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the issuance of 9,444,375 Class B shares by CMCSA in 2023, matching the ground truth exactly in number and year. It also accurately describes the structural similarity to GOOGL's dual-class system, noting that Class B shares carry higher voting rights and convert upon sale or transfer. However, the LLM omits a key differentiating point present in the original answer: GOOGL's $62.2 billion share repurchase program in 2023 and the absence of a similar buyback program for CMCSA’s Class B shares. This omission weakens the comparative analysis and misses a critical aspect of the equity strategy contrast. (2) Quantitatively, all numbers (9,444,375 shares, 2023) are correct and precisely stated. There are no calculation errors. (3) The multi-hop reasoning is partially sound—correctly linking CMCSA's issuance to control preservation and drawing a parallel with GOOGL’s structure. However, it fails to fully synthesize the additional layer involving share buybacks, which is essential for a complete comparison of capital structure strategies. (4) The answer is contextually relevant and well-structured, but the missing repurchase information reduces completeness and qualitative accuracy, preventing a higher score. Semantic equivalence is mostly preserved, but the omission of a major factual contrast limits correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Convertible_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 381,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How do the vesting-related financial commitments in MDLZ's multiemployer pension plans compare with WMT's equity compensation vesting schedules in terms of duration and cost recognition patterns?",
      "original_answer": "MDLZ has long-term financial obligations tied to multiemployer pension plans, with vesting periods governed by union agreements that result in multi-year liabilities such as a $526 million withdrawal liability paid over 19 years. These costs are recognized through ongoing contributions and interest accruals (e.g., $11 million in 2021). In contrast, WMT structures its employee incentives through equity compensation with defined vesting periods—such as restricted stock units that vest 25% annually over four years—with fair value discounted for expected dividends (e.g., 3.8% in fiscal 2022) and expensed ratably over the vesting term. While MDLZ's obligations are shaped by collective bargaining and multiemployer fund rules, WMT's vesting schedules are internally designed to align with shareholder interests and are accounted for as equity or expense over shorter, fixed timeframes.",
      "llm_answer": "\nMDLZ’s multi‑employer pension commitments are long‑term and liability‑driven – the plan’s vesting periods are reflected in a $526 million withdrawal liability that must be paid over 19 years and in $11‑12 million of accreted interest that is recorded in expense, with contributions booked as incurred and liability adjustments shown in SG&A; this creates a steadily accruing cost that extends over many years. By contrast, WMT’s equity compensation uses fixed vesting schedules of up to four years (or three‑to‑five years for older grants) and recognizes the expense ratably over each award’s vesting term, producing a shorter, straight‑line cost‑recognition pattern. Both sets of vesting periods are tied to the same “Vesting Periods (ACCOUNTING_POLICY)” node, but MDLZ’s are multi‑year liability obligations with interest accretion, whereas WMT’s are time‑based equity awards with evenly‑spread expense recognition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all key numbers are correct: the $526 million withdrawal liability over 19 years and $11 million in interest (LLM says $11–12 million, which is consistent with the $11 million in 2021 from the original). The mention of ratable expense recognition over 3-to-5 years for older WMT grants adds minor contextual detail not in the original but does not contradict it. (2) The LLM correctly identifies MDLZ’s multiemployer pension obligations as long-term, liability-driven, with interest accruals and SG&A reporting, and contrasts them with WMT’s equity-based compensation with straight-line expensing over fixed vesting periods (e.g., 4 years). (3) Multi-hop reasoning is sound: it synthesizes information across MDLZ’s pension liabilities and WMT’s equity vesting, correctly contrasting liability vs. equity treatment, duration (19 years vs. up to 4–5 years), and cost recognition (accrued interest and contributions vs. straight-line expense). (4) The only minor shortcoming is that the LLM does not explicitly mention WMT’s fair value discounting for expected dividends (3.8% in fiscal 2022), a detail present in the original. However, this omission does not undermine the core comparison on duration and cost recognition patterns. The reference to both linking to the same accounting policy node appears to be a knowledge graph implementation detail and does not affect factual correctness. Overall, the answer is factually robust, contextually relevant, and semantically equivalent to the ground truth with only a slight gap in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 445,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How does the combined capital buffer requirement above the minimum risk-based capital ratios for BAC under the Advanced Approach compare to MS's requirement, considering both institutions' application of the 2.5% Capital Conservation Buffer and the zero Countercyclical Capital Buffer?",
      "original_answer": "Both BAC and MS apply the 2.5% Capital Conservation Buffer and face a zero Countercyclical Capital Buffer under the Advanced Approach. For BAC, this buffer combines with a 2.5% G-SIB surcharge, resulting in a total buffer requirement of 5.0% above the minimum risk-based capital ratio. Similarly, MS also computes its capital buffer as the sum of the 2.5% Capital Conservation Buffer and the 2.5% G-SIB surcharge, leading to an identical total buffer requirement of 5.0% above the minimum risk-based capital ratio. Thus, both institutions have the same total capital buffer requirement above minimums under the Advanced Approach.",
      "llm_answer": "\nBoth BAC and MS must hold a 2.5 percent Capital Conservation Buffer above their minimum risk‑based capital ratios, and the Counter‑Cyclical Capital Buffer is set to zero for each firm; therefore, under the Advanced Approach the combined buffer that sits above the minimum requirement is 2.5 percent for BAC and, likewise, 2.5 percent for MS (the zero CCyB applies to both, as shown by the regulatory‑requirement linkages in the knowledge graph).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its quantitative conclusion. While it correctly identifies that both BAC and MS apply a 2.5% Capital Conservation Buffer and face a 0% Countercyclical Capital Buffer, it fails to include the 2.5% G-SIB surcharge for either institution. The ground truth states that the total buffer for both BAC and MS is 5.0% (2.5% Capital Conservation Buffer + 2.5% G-SIB surcharge), but the LLM incorrectly reports the combined buffer as only 2.5% for each. This is a critical error in calculation and synthesis, despite correct identification of the individual buffer components. The reasoning is flawed because it does not perform the required multi-hop synthesis of combining the conservation buffer with the G-SIB surcharge, which is explicitly mentioned in the original answer. While the entities (BAC, MS, buffer types) and context are correctly referenced, the omission of the G-SIB surcharge leads to a substantially incorrect final result. The answer is contextually relevant and uses appropriate terminology, but the core quantitative and qualitative inaccuracies severely undermine its correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Consists_Of]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 321,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does the sensitivity of AVGO's $56.3 billion fixed rate senior notes to interest rate changes compare to ORCL's effective interest rate management through swaps, considering the role of interest rate swaps in converting fixed-rate debt to floating-rate as demonstrated by CSCO's $0.5 billion swap?",
      "original_answer": "AVGO's $56.3 billion in fixed rate senior notes is highly sensitive to interest rate changes, with a 50 basis point shift affecting fair value by $1.7 billion. In contrast, ORCL uses interest rate swaps to stabilize its borrowing costs, achieving an effective interest rate of 4.74% for fiscal 2024 and 2023 on its floating-rate debt after converting it to fixed-rate debt with a 3.07% base rate. CSCO's use of a $0.5 billion interest rate swap illustrates how such instruments convert fixed-rate debt into floating-rate debt to offset fair value fluctuations, aligning with AVGO's and ORCL's broader strategies to manage interest rate exposure through financial hedging instruments.",
      "llm_answer": "\nAVGO’s $56.3 bn of fixed‑rate senior notes are highly sensitive to rate moves – a 50‑bp shift would alter their fair‑value by about $1.7 bn (up) or $1.4 bn (down), a change that would not affect interest expense but would be hedged by treasury‑rate locks.  ORCL, by contrast, manages that exposure through interest‑rate swaps: it uses cross‑currency swaps that convert Euro‑denominated fixed debt into floating‑rate U.S.‑dollar exposure (resulting in effective rates of 8.76 %/8.36 % for the July 2025 notes) and additional swaps that fix floating borrowings at a 3.07 % base plus a rating‑linked margin, producing an effective 4.74 % cost – a structure that mirrors CSCO’s $0.5 bn swap, which converts fixed‑rate debt to floating and offsets fair‑value fluctuations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies AVGO's $56.3 billion fixed-rate notes and the $1.7 billion fair value impact from a 50-basis point shift, which matches the ground truth. However, it introduces a downward shift of $1.4 billion not present in the original answer, which lacks support in the ground truth and may reflect incorrect asymmetry. More critically, the ORCL effective interest rate is misrepresented: the LLM states '8.76%/8.36%' for July 2025 notes due to cross-currency swaps, but this data is absent from the ground truth and contradicts it. The ground truth reports ORCL’s effective interest rate as 4.74% for fiscal 2024 and 2023 after swaps, which the LLM partially captures but conflates with unrelated cross-currency mechanics. The 3.07% base rate and 4.74% effective rate are correctly mentioned, though the explanation is muddled. CSCO’s $0.5 billion swap is accurately referenced and correctly described as converting fixed to floating to offset fair value fluctuations, aligning with the ground truth. 2) Quantitative accuracy is partially compromised: while $56.3B, $1.7B, $0.5B, 3.07%, and 4.74% are correct, the unsupported $1.4B downward shift and the erroneous 8.76%/8.36% rates reduce precision. No calculation errors are evident, but extraneous or incorrect figures undermine trust. 3) The multi-hop reasoning is generally sound—linking AVGO’s sensitivity, ORCL’s swap strategy, and CSCO’s illustrative swap—but the inclusion of cross-currency swaps (not in the original) introduces irrelevant complexity and factual inaccuracy. The core logic of using swaps to manage rate exposure is correctly synthesized across entities. 4) Despite inaccuracies, the answer remains contextually relevant, addressing all three companies and the role of swaps in interest rate management. The explanation of hedging mechanics is conceptually aligned, even if specific instruments are mischaracterized. The correctness score is 7 due to accurate core facts (AVGO sensitivity, ORCL’s 4.74%, CSCO’s $0.5B swap) but docked for introducing unsupported numbers and misrepresenting ORCL’s swap structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Impacts]-> FIN_INST <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 564,
        "total_tokens": 1966
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does the voting power distribution tied to Class B common stock at META compare to GOOGL's repurchase strategy across its multiple stock classes, given the interplay between voting rights and share structure?",
      "original_answer": "META's Class B common stock, which represents 33 1/3% of the combined voting power and has 15 votes per share, is non-dilutable and held entirely by a single individual, creating concentrated voting control. In contrast, GOOGL has a structure where Class B common stock has 10 votes per share and can be converted to Class A (1 vote per share), with no mention of non-dilutable voting power. Additionally, GOOGL actively repurchased $62.0 billion worth of shares in 2024 across both Class A and Class C shares, which have differing voting rights, suggesting a strategy that considers both capital allocation and governance dynamics.",
      "llm_answer": "\nMeta’s Class B common stock—343.8 million shares outstanding—carries disproportionate voting rights, reflecting the KG‑linked Class A‑Class B relationship that gives Class B roughly one‑third of total voting power (analogous to the 15‑vote‑per‑share structure seen in the KG). In contrast, Alphabet’s repurchase program has retired $59.3 billion, $62.2 billion and $62.0 billion of its non‑voting Class C and low‑voting Class A shares and recently added a $70 billion authorization, leaving the high‑vote Class B shares untouched; therefore Meta’s voting power is concentrated in a small, tightly‑held block, while Alphabet’s buybacks shrink the lower‑vote classes without affecting its Class B voting bloc.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer captures the core contrast between META's concentrated voting control and GOOGL's repurchase strategy that preserves high-vote Class B shares. It correctly identifies that Meta’s Class B has disproportionate voting power (approximately one-third) and that Alphabet’s buybacks focus on non-voting or low-voting shares (Class A and C), leaving Class B untouched—this aligns with the ground truth’s emphasis on governance-aware capital allocation.\n\n2) Quantitative inaccuracies: The ground truth states GOOGL repurchased $62.0 billion in 2024. The LLM cites $59.3B, $62.2B, and $62.0B across multiple years (implying a time series not in the original), which introduces data not present in the ground truth. Additionally, the $70B new authorization is mentioned in the LLM answer but not in the original—this is extraneous and unverified. Meta’s 343.8 million shares and specific share count are not in the ground truth and appear to be fabricated or misattributed.\n\n3) The multi-hop reasoning is sound: the model correctly synthesizes voting power concentration (Meta) vs. capital allocation strategy affecting share classes (GOOGL). It draws the right inference that sparing Class B shares in buybacks maintains voting control, analogous to Meta’s structure, showing good qualitative understanding of governance implications.\n\n4) While the core conceptual comparison is accurate and contextually rich, the inclusion of unsupported figures and time-series data reduces quantitative accuracy. The answer remains contextually relevant and qualitatively strong in interpreting the interplay between voting rights and share structure, but numerical precision fails on several key points.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 462,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How does Qualcomm's projected growth in generative AI-capable smartphone shipments by 2027 influence its strategic focus on AI and connectivity technologies, as compared to Salesforce's investment in generative and agentic AI across its CRM products?",
      "original_answer": "Qualcomm projects that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024, which directly informs its strategic focus on developing on-device AI and advanced connectivity technologies like 5G and 5G Advanced to support edge computing and AI workloads. Meanwhile, Salesforce is investing in generative and agentic AI across its CRM products, including the introduction of Agentforce, a new platform layer enabling autonomous AI agents for sales, service, marketing, and commerce. While Qualcomm's strategy centers on enabling AI at the device level through hardware innovation, Salesforce is embedding AI into its cloud-based CRM platform to enhance customer engagement and productivity. The convergence lies in their shared emphasis on AI capabilities—Qualcomm enabling them at the edge, Salesforce deploying them in enterprise workflows—though neither company has stated a direct business relationship or dependency.",
      "llm_answer": "\nQualcomm’s 10‑K (Chunk 1) identifies AI and high‑performance, low‑power computing as core to its mobile, automotive and IoT platforms, and its market outlook (Chunk 2) forecasts that 46 % of smartphones shipped in 2027 will be generative‑AI capable—driving the company to accelerate on‑device AI chipsets, 5G/6G connectivity and QCT/QSI strategic investments.  \nIn contrast, Salesforce’s 10‑K (Chunk 3) shows it is pouring resources into generative and agentic AI across its CRM suite, launching Agentforce and embedding AI services in its unified cloud platform, a software‑first approach that underpins its $37.9 billion fiscal‑2025 revenue and 19 % operating margin.  \nThus, while Qualcomm’s projected AI‑capable smartphone growth steers its strategic focus toward hardware‑centric AI and connectivity, Salesforce’s parallel investment targets AI‑enhanced customer‑relationship functions in the cloud, illustrating two complementary pathways to capture the same AI‑driven market opportunity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct and aligns closely with the ground truth. It accurately reports Qualcomm's projection that 46% of smartphones shipped in 2027 will be generative AI-capable (up from 19% in 2024, though the 19% figure is omitted in the LLM answer but implied contextually). The mention of on-device AI, 5G/6G connectivity, and QCT/QSI investments reflects Qualcomm’s hardware-centric strategy. For Salesforce, the LLM correctly identifies its investment in generative and agentic AI, the launch of Agentforce, and integration into CRM products via a cloud-based, software-first approach. The $37.9 billion fiscal-2025 revenue and 19% operating margin are additional accurate details not in the original answer but do not contradict it and appear contextually plausible.\n\n2) Quantitative accuracy is excellent: the 46% figure for 2027 is correct, and the fiscal-2025 revenue and margin for Salesforce are presented accurately. While the 19% baseline (2024) from the original answer is missing in the LLM response, this is a minor omission rather than an error. No calculations are required, and all numbers match or are consistent with the ground truth.\n\n3) Multi-hop reasoning is sound: the LLM synthesizes information from Qualcomm’s and Salesforce’s respective 10-K filings (referenced as chunks) to contrast their strategic approaches—Qualcomm in hardware and edge AI, Salesforce in cloud-based CRM AI. The comparison highlights complementary pathways, which captures the convergence noted in the original answer.\n\n4) The answer is contextually relevant and comprehensive. The only reason for not scoring a perfect 10 is the omission of the explicit 2024 baseline (19%) for generative AI-capable smartphones, which slightly weakens the growth narrative. However, the core strategic contrast and factual foundation are solid, with excellent use of domain-specific terminology and accurate entity mapping.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> PRODUCT -[Positively_Impacts]-> CONCEPT <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 519,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does Adobe's focus on enhancing user experience through AI-driven digital media tools align with Qualcomm's projections for generative AI-capable edge devices in 2027, particularly in relation to on-device AI processing and user interface improvements?",
      "original_answer": "Adobe emphasizes that the intuitiveness and visual appeal of user interfaces are key competitive factors in its Digital Media segment, particularly as it integrates AI capabilities for digital media generation and editing. Qualcomm projects that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024, and highlights that on-device AI processing enhances user experiences with immediacy, privacy, and personalization. Qualcomm’s advancements in edge AI processing and user interface technologies are positioned to support Adobe’s strategic direction by enabling more powerful, responsive, and secure AI-driven tools directly on devices, aligning with Adobe’s need to deliver best-in-class user experiences across platforms.",
      "llm_answer": "\nAdobe is embedding generative‑AI models into its digital‑media suite to make user interfaces more intuitive and to deliver AI‑driven creation tools—an approach that centers on the “user‑experience” capability that drives its competitive edge (Chunk 1).  Qualcomm projects that by 2027 about 46 % of smartphones and a majority of PCs will be generative‑AI‑capable edge devices, relying on on‑device AI processing to provide low‑latency, privacy‑preserving, personalized interactions (Chunk 2 & 3).  This hardware outlook means Adobe’s AI‑enhanced UI improvements can run locally on the edge devices Qualcomm expects to dominate the market, aligning Adobe’s UX‑focused roadmap with Qualcomm’s 2027 forecast of ubiquitous on‑device generative‑AI processing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Adobe's focus on AI-driven user experience and intuitive interfaces in digital media tools is accurately represented. Qualcomm's projection of 46% of smartphones being generative AI-capable by 2027 (up from 19% in 2024, though the 19% is omitted in the LLM answer) is correctly cited. The mention of 'a majority of PCs' as generative AI-capable is an addition not in the original, but does not contradict it and is plausible contextually. (2) Quantitative accuracy is perfect: the 46% figure for 2027 smartphone penetration is correct, and no calculations are required beyond that. The LLM correctly attributes the projection to Qualcomm and the year 2027. (3) Multi-hop reasoning is sound: the answer successfully connects Adobe’s AI-driven UX improvements with Qualcomm’s edge AI hardware roadmap, explaining how on-device processing enables low-latency, private, and personalized experiences that support Adobe’s cloud-and-client AI tools. The synthesis across companies and domains (software UX and hardware AI capability) is logical and well-articulated. (4) The only minor shortcoming is the omission of the 19% baseline from 2024, which provides context for growth but is not central to the alignment argument. Also, the LLM slightly expands on PCs without direct support in the original, though this is a reasonable inference. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> CONCEPT -[Impacts]-> CONCEPT <-[Enables]- ORG",
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 424,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does the treatment of dividend equivalents on RSU awards differ between Lockheed Martin's and Honeywell's compensation plans, based on the specific vesting terms and payment structures disclosed?",
      "original_answer": "Lockheed Martin discloses that dividend equivalents on vested stock units for non-employee directors may be paid on the first business day of April following the one-year anniversary of the grant, indicating a delayed payment structure tied to director tenure and stock ownership guidelines. In contrast, Honeywell does not specify a delayed payment schedule for dividend equivalents on RSUs, focusing instead on vesting periods ranging from three to six years with payment in common stock upon vesting. Additionally, Lockheed Martin’s Deferred Management Incentive Compensation Plan (DMICP) credits dividend equivalents as stock units at dividend payment times, while Honeywell’s RSU awards are more focused on performance-based vesting tied to company goals.",
      "llm_answer": "\nLockheed Martin credits dividend equivalents on its RSU awards as separate stock‑unit balances in a deferred‑compensation account; the units are paid out in shares (or cash) after termination—often on the first business day of April following the one‑year anniversary of the grant—and may be issued from newly‑issued shares, so the dividend equivalents are settled later and do not dilute the existing share count.  \nHoneywell’s RSU awards simply earn dividend equivalents that are added to the award’s value and are paid together with the underlying share when the RSU vests (generally after a three‑year cliff), with the payout made solely in Honeywell common stock and without a separate deferred‑distribution or dilution‑adjusted mechanism.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Lockheed Martin defers dividend equivalent payments, crediting them as stock units and paying out after termination—specifically noting the April payout timing following the one-year anniversary, which matches the original answer. Honeywell’s treatment is also accurately described: dividend equivalents are added to the RSU value and paid with the underlying shares upon vesting, typically after a three-year cliff, with no deferred distribution mechanism. (2) There are no numerical values requiring calculation, but the temporal references (e.g., 'first business day of April', 'one-year anniversary', 'three-year cliff') are consistent with the ground truth. The mention of three-year vesting aligns with Honeywell’s 3–6 year range as a representative example. (3) The multi-hop reasoning is sound: the model correctly contrasts Lockheed Martin’s deferred, director-focused plan with Honeywell’s performance- and time-based vesting, and references Lockheed’s DMICP-like structure (implied through deferral and stock-unit crediting). The only minor omission is not explicitly naming the DMICP or noting Honeywell’s performance-based vesting focus, which slightly reduces completeness. (4) The answer is contextually precise, directly addressing the structural differences in dividend equivalent treatment, vesting terms, and payment forms. Wording differs but semantic meaning is equivalent. Minor deduction from 10 to 9 due to slight underrepresentation of Honeywell’s performance-vesting emphasis and Lockheed’s director-specific guidelines.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 449,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the reliance of Texas Instruments (TXN) on subcontractors for 40% of its assembly and test services compare with NVIDIA's (NVDA) exposure to third-party manufacturers, given the shared dependency on external production capacity and the risks highlighted by AMD's experience with third-party suppliers?",
      "original_answer": "Texas Instruments relies on subcontractors for 40% of its assembly and test services, supplementing internal capacity to meet customer demand. This external dependency aligns with NVIDIA’s reliance on third-party manufacturers for semiconductor fabrication, assembly, and testing, which exposes them to risks such as limited control over delivery schedules, quality assurance, and potential prioritization of other customers. AMD's experience highlights the vulnerability in this model, as their dependence on third-party manufacturers—including GF and ATMP joint ventures—can lead to supply disruptions, capacity constraints, and financial penalties if purchase targets are not met. Therefore, both TXN and NVDA face similar exposure to third-party production risks, though NVDA's exposure is amplified by the complexity of its products and global supply chain dependencies.",
      "llm_answer": "\nTexas Instruments reports that roughly 40 percent of its assembly‑and‑test services are performed by outside subcontractors, a figure that reflects the same kind of outsourced production model used by NVIDIA, which depends on a limited set of foundries, contract manufacturers and ATMP providers for wafer fabrication, assembly, testing and packaging.  Both companies face the identical supply‑chain exposure highlighted by AMD—namely, the absence of long‑term capacity guarantees, the risk that third‑party suppliers can re‑prioritize capacity for other customers or impose price increases, and the potential for material‑adverse supply delays or penalties (as AMD experiences under its wafer‑supply agreement and ATMP joint‑venture arrangements).  Consequently, while TXN’s 40 % subcontractor share quantifies its outsourced assembly/test exposure, NVDA’s exposure is broader and equally vulnerable to capacity constraints, pricing pressures, and the loss‑of‑supplier risks that AMD’s experience demonstrates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth in both factual content and reasoning. (1) Quantitatively, the 40% subcontractor reliance for Texas Instruments is correctly stated, and no other numerical values are misrepresented. (2) The answer addresses all parts of the multi-hop question: TXN's 40% reliance, NVDA's third-party dependencies, the shared risks, and AMD's experience as a cautionary example. (3) Entity accuracy is strong: TXN, NVDA, and AMD are correctly identified, along with relevant third-party suppliers (e.g., foundries, ATMP providers), and the risks (capacity constraints, pricing, prioritization) are accurately described. (4) The reasoning is sound: the LLM correctly synthesizes that both companies face similar supply chain exposures, with NVDA’s being broader due to greater reliance on external fabrication and packaging. The only minor shortcoming is that the ground truth explicitly notes NVDA's exposure is 'amplified by the complexity of its products and global supply chain dependencies,' a nuance slightly underemphasized in the LLM response. However, the core message about broader and equally vulnerable exposure is preserved. Wording differs but semantic equivalence is maintained. No calculation errors or factual inaccuracies are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> COMP -[Depends_On]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 362,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total estimated cost of Duke Energy Florida's 10 new solar facilities, and how does this investment relate to Southern Power's use of PPAs as operating leases with terms up to 25 years for similar renewable energy projects?",
      "original_answer": "Duke Energy Florida's 10 new solar facilities have an estimated total cost of $1 billion over the next three years. These facilities are part of a voluntary solar program approved by the FPSC in January 2021. Southern Power, a subsidiary of Southern Company, utilizes Power Purchase Agreements (PPAs) related to solar and wind facilities, which are accounted for as operating leases with remaining terms of up to 25 years. This indicates that both Duke Energy Florida and Southern Power are investing in long-term renewable energy infrastructure, with Duke making direct investments included in base rates and Southern Power leveraging PPAs as a financial mechanism to support similar projects.",
      "llm_answer": "\nDuke Energy Florida’s Clean Energy Connection program calls for roughly $1 billion of capital over the next three years to build the 10 new solar sites, a cost that will be recovered through base‑rate adjustments and subscription‑fee credits approved by the FPSC.  This mirrors Southern Power’s practice of acquiring solar assets through power‑purchase agreements that are accounted for as operating leases with terms up to 25 years, so the solar facilities will be financed and operated under long‑term PPAs—just as Southern Power’s PPAs function as lease‑like contracts that provide stable, lease‑type revenue streams.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $1 billion cost estimate for Duke Energy Florida's 10 solar facilities over three years is correct, matching the original answer. There are no calculations required beyond this figure, and the time frame is accurately reflected. (2) The entity names—Duke Energy Florida, Southern Power, FPSC, and Southern Company—are correctly identified. The mention of base-rate adjustments and subscription-fee credits adds detail not in the original but is consistent with regulatory recovery mechanisms and does not contradict the ground truth. (3) The reasoning correctly synthesizes the multi-hop aspect: it compares Duke’s direct capital investment model with Southern Power’s use of PPAs as operating leases with up to 25-year terms, highlighting a parallel in long-term renewable investment strategies despite differing financial structures. (4) The only minor shortcoming is that the LLM does not explicitly name the 'Clean Energy Connection' program as the voluntary solar program approved in January 2021 (though it references the program by name), slightly reducing qualitative completeness. However, the core relationship between the two companies’ investment approaches is accurately conveyed. Wording differs but semantic equivalence is strong. All key facts are present and correctly represented.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 385,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the difference in voting rights structure between Netflix's common stock and Alphabet's Class C capital stock influence the strategic allocation of Alphabet's $62.0 billion share repurchase in 2024 between Class A and Class C shares?",
      "original_answer": "Netflix's common stock provides one vote per share, establishing a straightforward voting rights framework. In contrast, Alphabet's Class C capital stock carries no voting rights except as required by law, while Class A shares have one vote per share and Class B shares have 10 votes per share. Given this differentiated voting structure and Alphabet's 2024 repurchase of $62.0 billion in Class A and Class C shares, the lack of voting rights in Class C likely influences the company's repurchase strategy by prioritizing liquidity and cost efficiency over governance influence, allowing Alphabet to retire shares without diluting control held by voting-class shareholders.",
      "llm_answer": "\nNetflix’s common stock carries one vote per share, while Alphabet’s Class C capital stock has no voting rights (except as required by law), so repurchasing Class A shares would diminish the voting power of the remaining shareholders. Consequently, Alphabet’s $62.0 billion 2024 share‑repurchase program is strategically tilted toward Class C shares—to meet the Board‑approved $62 billion target while preserving control—especially given that $44.7 billion of the additional $70 billion authorized pool remained available as of Dec 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Netflix's one vote per share and Alphabet's Class C having no voting rights, as well as the strategic preference for repurchasing Class C shares to preserve voting control. However, it introduces a $70 billion authorized pool and states that $44.7 billion remained available as of December 2024—information not present in the original answer or implied by the question. This is a significant quantitative inaccuracy. The original answer only mentions a $62.0 billion repurchase in 2024, with no reference to a larger $70 billion authorization or unspent balance. (2) The core dollar amount of $62.0 billion is correctly cited, but the additional figures ($70 billion, $44.7 billion) are unsupported and likely fabricated or hallucinated. There is no verification for these numbers in the ground truth. (3) The multi-hop reasoning is partially sound: the model correctly infers that repurchasing non-voting Class C shares allows Alphabet to return capital without diluting control, which aligns with the original answer’s logic. However, it incorrectly implies that repurchasing Class A shares would diminish the voting power of remaining shareholders—while technically true in a mechanical sense, this is misleading because share repurchases generally do not dilute voting power; rather, they consolidate it. The reasoning misstates the direction of the effect. (4) Despite the flawed numbers and slightly incorrect reasoning about voting dilution, the model captures the essential strategic insight: Alphabet favors repurchasing non-voting Class C shares to maintain control. This core qualitative point earns it moderate scores. The contextual relevance is high because it directly addresses the influence of voting structure on repurchase allocation. However, the hallucinated figures severely undermine quantitative accuracy, warranting a correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Repurchases]- ORG",
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 516,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the activation of voting rights for preferred stockholders in BAC due to dividend arrears compare to the limited voting rights of Class C common stockholders at V, particularly in the context of corporate governance during financial stress?",
      "original_answer": "At BAC, if dividends on certain preferred stock series are in arrears for three or more semi-annual or six or more quarterly periods, holders gain voting rights to elect two additional directors, which terminate once dividends are paid for at least two semi-annual or four quarterly periods following the arrearage. This mechanism serves as a governance safeguard for preferred stockholders during financial distress. In contrast, V’s Class C common stockholders have no general voting rights except in specific defined matters, such as exiting the core payments business or certain corporate restructurings, and they do not participate in amendments solely affecting preferred stock. Unlike BAC’s contingent voting rights tied to dividend performance, V’s Class C stockholders’ voting power is structurally limited and not directly linked to financial performance metrics like dividend arrears.",
      "llm_answer": "\nIn BAC, when dividends on certain preferred series fall into arrears for the statutory period (three consecutive semi‑annual or six quarterly payments), those shareholders automatically gain voting rights—specifically the right to elect two additional directors and to vote collectively on limited matters—until the arrears are cured, a mechanism that directly ties cash‑flow stress to enforceable governance power.  By contrast, at V the Class C common shareholders possess only a narrow, conditional vote on a few defined matters (e.g., core‑business exits, mergers or charter amendments) and must act as a single class, with no automatic board‑seat entitlement, so their governance influence is far more limited and does not arise from dividend defaults.  Thus, while BAC’s preferred‑stock arrears trigger a concrete, enforceable voting boost for preferred holders, V’s Class C common stockholders retain only the restricted, issue‑specific voting rights described in the same sections of the charter.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: BAC's preferred stockholders gain voting rights to elect two additional directors after three semi-annual or six quarterly dividend arrears, and these rights terminate after two semi-annual or four quarterly payments are made—this is correctly stated in substance, though the LLM does not explicitly mention the termination condition in full detail, slightly reducing completeness. (2) Quantitative elements—'three consecutive semi-annual' and 'six quarterly'—are precisely accurate and match the original. No calculations are required, but the time-based triggers are correctly represented. (3) The comparison to V’s Class C common stockholders is sound: the LLM correctly notes their limited, conditional voting rights (e.g., on core-business exits, mergers, charter amendments) and emphasizes that these are not tied to financial performance like dividend arrears. It also correctly highlights that Class C votes are class-wide and do not include automatic board-seat rights. (4) The reasoning is multi-hop and well-synthesized: it contrasts BAC’s performance-contingent governance mechanism with V’s structural limitations, capturing the core distinction in corporate governance responses during financial stress. The only minor shortcoming is that the LLM does not explicitly state that V’s Class C voting rights do not apply to amendments affecting only preferred stock—a detail present in the original—but this omission does not undermine the overall correctness. Wording differs but semantic equivalence is maintained. Contextual relevance is excellent, directly addressing corporate governance under financial stress as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Negatively_Impacts]-> FIN_INST <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 472,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How does Disney's licensing revenue from Star Wars-branded merchandise influence its ability to fund content development for Disney+ in European markets where it competes with CMCSA's Sky Glass and XClass TV platforms?",
      "original_answer": "Disney earns licensing royalties from third-party products featuring Star Wars characters, which contributes to funding content development for its DTC services, including Disney+ in European markets. Disney+ includes Star Wars programming as a core content tile, which is critical to attracting subscribers in competitive regions like Europe. CMCSA competes in this market with its own video services and DTC-aligned platforms like Sky Glass and XClass TV, which integrate with its European broadband offerings. Therefore, licensing revenue from Star Wars enhances Disney's content investment capacity, directly supporting its competitive positioning against CMCSA’s integrated hardware and content strategy in Europe.",
      "llm_answer": "\nDisney’s Star Wars merchandise licensing generates royalty income that bolsters the company’s overall cash flow (Chunk 3), a portion of which can be allocated to fund new Disney+ original programming in Europe (Chunk 2). This financial flexibility helps Disney counter the competitive pressure from CMCSA’s Sky Glass and XClass TV platforms—both of which are marketed in Europe as smart‑TV solutions that rival Disney’s DTC offering (Chunk 1). By leveraging the licensing‑derived revenue, Disney can invest in Star Wars‑branded content and other originals to strengthen Disney+’s European portfolio against those rivals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All entities are correctly identified: Disney, Star Wars, CMCSA, Sky Glass, XClass TV, and Disney+ are accurately referenced. The role of licensing revenue in funding content development for Disney+ in Europe is correctly explained. (2) There are no numeric values in the question or ground truth, so quantitative accuracy is not applicable—no calculations or figures to verify, thus the score of 10 reflects full compliance by absence of error. (3) The multi-hop reasoning is sound: the model correctly links Star Wars licensing revenue → increased funding for Disney+ content → competitive positioning in Europe → competition with CMCSA’s integrated platforms (Sky Glass and XClass TV). The synthesis across business model elements (licensing, DTC content, regional competition) is logically coherent. (4) The only minor shortcoming is a slight lack of emphasis on Star Wars programming as a 'core content tile' explicitly driving subscriber acquisition, which is mentioned in the ground truth and central to the competitive dynamic. However, the LLM implies this by noting investment in 'Star Wars-branded content' to strengthen the portfolio. Wording differs slightly but meaning is preserved. Contextual relevance is perfect—the response directly addresses all parts of the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Competes_With]-> PRODUCT -[Includes]-> PRODUCT <-[Licenses]- ORG",
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 383,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How does the sensitivity of AXP's net interest income to a 200 basis point increase in interest rates relate to MS's use of interest rate caps in securitization transactions, considering the role of repricing risk in both firms' financial strategies?",
      "original_answer": "AXP estimates that a 200 basis point increase in interest rates would negatively impact its net interest income, based on its repricing risk assumptions which include the effect of interest rate caps or floors. This sensitivity is linked to the repricing dynamics of interest-rate sensitive assets and liabilities, where certain deposits reprice at lower magnitudes than benchmark rate movements. On the other hand, MS enters into interest rate caps as part of its securitization transactions, which are designed to manage interest rate exposure. These caps are subject to similar repricing risk dynamics, suggesting that both firms are managing interest rate volatility through derivative instruments, though in different business contexts—AXP through its core interest income and MS through structured finance activities involving SPEs.",
      "llm_answer": "\nAXP’s net interest income is projected to fall when rates are raised by 200 bps because its interest‑rate‑sensitive assets and liabilities are subject to repricing risk that is bounded by caps and floors, a risk that the firm quantifies in its sensitivity analysis (Table 23). This same repricing risk is the factor that drives MS’s use of interest‑rate caps (and swaps) in its securitization transactions, linking the two firms’ financial strategies through the shared risk factor disclosed in the knowledge‑graph relationship Repricing Risk → AXP and Interest Rate Caps → Repricing Risk ← MS.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) Quantitatively, the 200 basis point (bps) increase is correctly cited, and there are no numerical inaccuracies. The reference to Table 23, while not in the original answer, does not contradict any data and may reflect a plausible source within AXP’s filing. (2) The answer correctly identifies that AXP’s net interest income would decline due to repricing risk bounded by caps and floors—matching the original’s explanation. (3) It accurately links MS’s use of interest rate caps in securitization to the same underlying repricing risk, correctly synthesizing the multi-hop relationship between AXP, MS, and the shared risk factor. (4) The LLM introduces swaps (not explicitly mentioned in the original) and frames the connection via a knowledge-graph relationship notation (Repricing Risk → AXP, etc.), which adds interpretive structure not in the original but does not distort facts. This is a minor over-specification but doesn’t reduce accuracy. (5) The core reasoning—both firms manage interest rate exposure through derivatives tied to repricing dynamics—is sound and semantically equivalent to the original. The only slight shortfall is a less explicit distinction between AXP’s core interest income context and MS’s structured finance/SPE context, though the difference in business contexts is implied. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Enters_Into]-> FIN_INST -[Depends_On]-> RISK_FACTOR <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 409,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the impact of a weaker U.S. dollar on MDLZ's consolidated earnings compare to the favorable currency effects experienced by Coca-Cola's Europe, Middle East and Africa segment, given both companies explicitly call out exchange rate fluctuations involving the euro and British pound?",
      "original_answer": "MDLZ states that a weaker U.S. dollar benefits its consolidated earnings and net assets, as many subsidiaries operate in non-dollar functional currencies. KO specifically notes that a weaker U.S. dollar compared to the euro and British pound had a favorable impact on its Europe, Middle East and Africa segment. Both companies explicitly identify these two currencies as key drivers of their respective foreign exchange impacts, showing a direct parallel in how they are affected by similar currency dynamics.",
      "llm_answer": "\nMDLZ states that a weaker U.S. dollar “benefits our consolidated earnings and net assets,” so the currency move lifts the company’s overall financial results. KO explicitly notes that a weaker dollar produces a “favorable impact” on its Europe, Middle East and Africa operating segment, particularly from the euro and British pound, and the 2022 filing shows EMEA operating income was increased by $7 million after currency‑related estimate revisions. Thus, while both firms call out the same exchange‑rate dynamics, MDLZ’s gain is reflected in its consolidated earnings, whereas KO’s benefit is confined to the EMEA segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that MDLZ benefits from a weaker U.S. dollar in terms of consolidated earnings and net assets, and that KO sees a favorable impact in its EMEA segment due to the euro and British pound. The mention of the $7 million increase in KO’s EMEA operating income from currency-related estimate revisions in 2022 is factually correct and adds useful detail not in the original answer, but does not contradict it. (2) Quantitatively, the $7 million figure is accurate per KO’s 2022 filing and appropriately contextualized. No calculations were required, but the use of specific data enhances precision. (3) The multi-hop reasoning is sound: the model correctly synthesizes disclosures from both MDLZ and KO, compares their exposure to similar currency dynamics (euro and GBP), and highlights the difference in scope—MDLZ’s benefit is consolidated, while KO’s is segment-specific. This nuance is valid and insightful. (4) The answer is semantically equivalent to the ground truth, with added specificity. The only reason for not scoring a 10 is that the original answer emphasizes the 'direct parallel' in currency drivers, which is slightly downplayed in the LLM version’s focus on structural differences. However, this does not make the answer incorrect—just slightly less balanced in emphasis. All entities (MDLZ, KO, EMEA, euro, British pound), metrics, and reasoning are accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> MACRO_CONDITION -[Impacted_By]-> GPE <-[Positively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 408,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the voting power concentration in MA's dual-class share structure compare to V's, given the relationship between their respective Class A and Class B shares and the 15-vote weighting per Class B share?",
      "original_answer": "MA's dual-class structure includes 907 Class A shares and 7 Class B shares outstanding, with Class B shares carrying 15 votes each, resulting in a voting power concentration of approximately 10.4% for Class B shares. V has 125 Class B shares outstanding as of September 30, 2024, against 1,733 Class A shares, and if following the same 15-vote weighting per Class B share from the intermediary evidence, Class B would hold approximately 68.5% of the voting power despite representing just 6.7% of total shares. This indicates significantly more concentrated control at V compared to MA.",
      "llm_answer": "\nMastercard’s (MA) dual‑class structure shows only 7 Class B shares outstanding (Chunk 1) and, with the 15‑vote‑per‑Class B rule disclosed for a comparable company (Chunk 2), those shares carry 7 × 15 = 105 votes versus 907 Class A votes, giving Class B roughly 10 % of the total voting power. Visa’s (V) filing (Chunk 3) lists 1,733 Class A shares and 125 Class B shares outstanding; applying the same 15‑vote weighting means Class B controls 125 × 15 = 1,875 votes, or about 53 % of the combined vote (Chunk 3), a far greater concentration than MA’s. The KG link (Class B → V) confirms Visa uses the identical 15‑vote‑per‑Class B mechanism, and the Comcast excerpt (Chunk 2) illustrates how such a rule can give a small share class disproportionate voting influence, but for Visa that influence is over half of all votes, whereas for Mastercard it is only about one‑tenth.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the number of Class A and Class B shares for both MA and V from the ground truth: 907 Class A and 7 Class B for MA, 1,733 Class A and 125 Class B for V. It also correctly applies the 15-vote weighting to Class B shares. However, there is a critical calculation error in the voting power percentage for Visa. The LLM states that Class B holds 'about 53%' of the combined vote, while the ground truth calculates approximately 68.5%. The correct calculation is: (125 × 15) = 1,875 Class B votes; 1,733 Class A votes (1 vote each); total votes = 1,733 + 1,875 = 3,608; Class B share = 1,875 / 3,608 ≈ 51.97%, which rounds to about 52%, not 68.5% — however, the ground truth claims 68.5%, which is itself incorrect. Upon recalculation, 1,875 / 3,608 ≈ 51.97%, so the LLM’s 'about 53%' is actually more accurate than the original answer. This suggests the ground truth contains a calculation error. Despite this, the LLM’s qualitative comparison — that V has significantly more concentrated control than MA — remains valid and well-reasoned. (2) Mastercard’s voting power calculation is correct: 7 × 15 = 105 votes; total votes = 907 + 105 = 1,012; 105 / 1,012 ≈ 10.37% ≈ 10%, matching the ground truth’s 'approximately 10.4%'. (3) The multi-hop reasoning is sound: the model synthesizes share counts from different filings, applies a voting rule inferred from a comparable company (with KG confirmation), and compares concentration meaningfully. (4) The LLM slightly misrepresents the degree of concentration at V due to relying on a correct calculation that contradicts an incorrect ground truth, but its reasoning and entity identification are strong. The contextual relevance is perfect — it directly addresses the comparison question with appropriate data and logic. Final scores reflect high qualitative and contextual accuracy, docked in quantitative accuracy due to the discrepancy with the provided (but erroneous) ground truth percentage, though in reality the LLM may be numerically closer to correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 551,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How do the financial risks associated with nuclear power plants at NEE compare to those at Southern Company, particularly in terms of potential exposure from decommissioning costs exceeding available reserves?",
      "original_answer": "NEE and FPL face potential financial risks from decommissioning costs of their nuclear facilities possibly exceeding the available decommissioning funds. Similarly, Southern Company's subsidiaries Alabama Power and Georgia Power also face exposure if decommissioning costs exceed available reserves or insurance coverage. In both cases, the companies acknowledge that the financial impact could be material if the costs surpass the accumulated funds, which are subject to uncertainties in estimation and long-term planning.",
      "llm_answer": "\nBoth NextEra Energy (NEE) and Southern Company face nuclear‑decommissioning exposures that could exceed the funds they have set aside – NEE’s nuclear plants are subject to the same environmental, safety, health and financial risks and its decommissioning reserves may be insufficient if dismantling costs rise (Chunk 1), while Southern Company’s subsidiaries (Alabama Power and Georgia Power) own six nuclear units operated by Southern Nuclear, and the NRC can impose fines or force shutdowns that could generate de‑commissioning expenses beyond the trusts and insurance coverage (Chunk 2); the corporate structure detailed in Chunk 3 shows that Southern Nuclear manages these units and the Vogtle new‑build projects, underscoring that both utilities confront comparable, potentially unfunded, decommissioning risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key entities are correctly identified: NEE (and its subsidiary FPL implied), Southern Company, Alabama Power, Georgia Power, and Southern Nuclear. The financial risk associated with decommissioning costs exceeding reserves is accurately described for both companies. (2) There are no numeric values (e.g., dollar amounts, years, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—no calculations were required. (3) The multi-hop reasoning is sound: the LLM synthesizes information about decommissioning risks across both companies, acknowledges the role of subsidiaries and operational management (Southern Nuclear), and correctly notes that insufficient reserves could lead to material financial exposure. It also appropriately references regulatory risks (NRC fines or shutdowns) as potential cost drivers, which aligns with the broader risk context. (4) The only minor shortcoming is that the LLM slightly expands on the original by mentioning NRC fines and shutdowns as sources of decommissioning expenses, which, while plausible, are not explicitly stated in the ground truth. However, this does not introduce inaccuracy but adds contextual detail. Overall, the answer is complete, correct, and directly addresses the comparative financial risks related to decommissioning cost exposure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> RISK_FACTOR -[Subject_To]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 394,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How does the $9.9 billion valuation of UPS's pension plan investments in real estate funds compare to the valuation approaches used by General Dynamics for its Level 3 assets, given that both companies rely on valuation models through real estate or private equity fund investments?",
      "original_answer": "UPS valued its $9.9 billion in pension plan investments in real estate funds using net asset value (NAV) as a practical expedient, based on audited and unaudited financial reports from fund managers, with adjustments for investment activity between reporting dates. These real estate funds rely on valuation models, as stated in the second chunk, which notes that real estate funds use NAV based on such models and periodic appraisals. General Dynamics, on the other hand, disclosed that its Level 3 assets include direct private equity investments that are measured using unobservable inputs—essentially internal or fund-level valuation models. Thus, while both companies depend on valuation models for real estate or private equity fund investments, UPS relies on NAV with manager reporting and adjustments, whereas GD directly uses unobservable inputs for its Level 3 private equity holdings.",
      "llm_answer": "\nUPS reports a $9.9 billion valuation for its pension‑plan real‑estate fund investments, using a net‑asset‑value (NAV) practical expedient that relies on audited fund statements and periodic adjustments to the NAV; General Dynamics classifies comparable holdings as Level 3 and measures them with valuation models that employ unobservable inputs—such as discounted‑cash‑flow projections and periodic appraisals—reflecting the same dependence on internal models rather than quoted market prices. Both companies therefore derive the fair value of their real‑estate and private‑equity fund interests from partnership‑level valuations that incorporate periodic appraisals and model‑based inputs, but UPS’s figure is a specific $9.9 billion NAV aggregate while GD’s Level 3 assets are assessed through more subjective, input‑driven fair‑value models.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $9.9 billion valuation for UPS's pension plan real estate fund investments is correctly stated. No other numerical values are in dispute. (2) The LLM correctly identifies that UPS uses the net asset value (NAV) as a practical expedient based on fund manager reports (audited and unaudited), with adjustments—this matches the original answer. It also accurately states that General Dynamics (GD) uses unobservable inputs for its Level 3 private equity assets, which reflects valuation models such as discounted cash flows and appraisals. (3) The multi-hop reasoning is sound: the answer compares two companies’ approaches to valuing non-public fund investments—UPS’s NAV-based method versus GD’s Level 3 unobservable input models—and correctly synthesizes that both rely on models but differ in application (NAV as a proxy vs. direct model-based fair value). (4) The only minor shortcoming is that the LLM slightly downplays the distinction in methodology: the original answer emphasizes that UPS relies on NAV with manager reporting (an indirect approach), whereas GD applies internal models directly to Level 3 assets. The LLM implies similarity in reliance on 'model-based inputs' for both, which could blur this key difference. However, it still captures the core contrast adequately. Wording differences are within acceptable semantic equivalence. All entities (UPS, General Dynamics, Level 3 assets, NAV, private equity, real estate funds) are correct and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Valued_Using]- ORG",
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 432,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "Given PepsiCo's 30% beverage revenue exposure in the Africa and Middle East region and Target's vendor arrangements where they only pay for merchandise after guest sale, what potential impact could a supply disruption in this region have on Target's inventory turnover and cash flow timing for beverage SKUs?",
      "original_answer": "A supply disruption in the Africa and Middle East region, which accounts for 30% of PepsiCo's beverage revenue, could delay product availability at Target. Since Target only pays vendors after merchandise is sold to guests, this delay could reduce inventory turnover for beverage SKUs during the disruption period. This would temporarily lower cash flow generation from beverage sales, as Target recognizes revenue only upon guest purchase and does not pay vendors until then.",
      "llm_answer": "\nA disruption in the Africa‑and‑Middle‑East beverage supply chain would cut the flow of PepsiCo‑produced SKUs that currently generate roughly 30 % of the region’s beverage revenue (Chunk 1/2), thereby reducing the volume of beverage sales that Target ultimately sells. Because Target records those vendor‑arranged beverage items only as revenue at the moment of guest purchase and does **not** carry inventory for them (Chunk 3), the supply shock would not immediately inflate reported inventory levels, but it would depress sales‑related cost of sales and thus lower the inventory‑turnover ratio; at the same time, cash would be received later—only after a sale occurs—so the cash‑conversion cycle would lengthen and liquidity pressure could rise if the disruption persists.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 30% beverage revenue exposure of PepsiCo in the Africa and Middle East region, which matches the ground truth. It also accurately reflects Target's vendor arrangement where payment occurs only after guest sale. These quantitative and entity facts are correct. (2) All numbers and percentages are accurate—specifically the 30% figure—and no calculations were required beyond correct interpretation. Thus, quantitative accuracy is perfect. (3) However, the reasoning contains a subtle but important error: the claim that Target 'does not carry inventory for them' (PepsiCo SKUs) contradicts standard retail operations—even with vendor pay-on-sale arrangements, retailers like Target typically hold physical inventory; they just delay payment. This mischaracterization affects the logic around inventory levels and turnover. Inventory turnover = COGS / Average Inventory. If inventory is unavailable due to supply disruption, average inventory drops and sales (COGS) drop, but the effect on turnover depends on the relative magnitude. The ground truth correctly focuses on reduced turnover due to lower sales, while the LLM incorrectly suggests turnover drops due to accounting treatment and lack of inventory holding, which is misleading. (4) Despite this flaw in reasoning, the conclusion about delayed cash flow and lengthened cash conversion cycle aligns with the ground truth, as cash is received only upon sale, which is reduced during disruption. The answer is contextually relevant and captures the core economic impact, but the flawed inventory assumption reduces qualitative accuracy. Correctness is therefore high but not full, warranting a 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 463,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How have LLY and AMGN responded differently to payer-driven pricing pressures on their high-cost biologics, particularly in light of access restrictions affecting Repatha and insulin products?",
      "original_answer": "LLY faces increasing public and private payer scrutiny on pricing, especially for insulin, with proposed legislation enabling government price negotiation and restrictive reimbursement policies like the Alzheimer’s Monoclonal Antibody NCD, which could materially affect revenue. In contrast, AMGN has responded to payer restrictions on Repatha—such as formulary exclusions, step therapy requirements, and copay accumulator programs—by reducing both net and list prices, discontinuing higher-priced NDCs in 2019, and directly partnering with payers to align on health outcomes. While LLY emphasizes regulatory and legislative uncertainty, AMGN has taken active pricing and partnership strategies to mitigate payer-imposed access barriers.",
      "llm_answer": "\nBoth Lilly and Amgen are exposed to payer‑driven pricing pressures that restrict patient access to their high‑cost biologics, with Lilly’s 10‑K (Chunk 1) warning that pending U.S. legislation could force price negotiations—especially for insulin—and that broader payer actions could materially reduce its revenues, while Amgen’s filings (Chunks 2 & 3) detail concrete payer‑engagement tactics such as formulary step‑therapy limits, copay‑accumulator adjustments, new lower‑price NDAs for Repatha, extensive rebates and discounts, and patient‑support programs to offset those access restrictions.  Consequently, Lilly’s strategy focuses on managing supply‑chain risk and lobbying against restrictive pricing policies, whereas Amgen has pursued active price‑reduction and risk‑sharing initiatives to preserve sales and patient access.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core contrast between LLY and AMGN in responding to payer-driven pricing pressures. It accurately identifies that LLY faces legislative and regulatory risks, particularly around insulin and potential government price negotiation, which could materially affect revenue—consistent with the ground truth. It also correctly notes AMGN's active strategies: formulary restrictions (step therapy), copay accumulators, lower-priced NDCs (referred to as NDAs, a minor error), rebates, discounts, and patient support programs. The claim that AMGN reduced prices and engaged in risk-sharing aligns with the ground truth's mention of price reductions and direct partnerships with payers. However, the LLM incorrectly refers to 'new lower-price NDAs' instead of 'NDCs' (National Drug Codes), which is a factual inaccuracy in terminology, though the intent is clear. Additionally, the ground truth specifies AMGN discontinued higher-priced NDCs in 2019—a concrete action and date not mentioned in the LLM response, representing a minor omission. The LLM mentions 'patient-support programs' and 'rebates' not explicitly in the ground truth, which may be reasonable inferences but are not confirmed in the provided answer. There are no numerical values to verify, so quantitative accuracy is scored as 10 by default. The reasoning is sound and synthesizes the multi-hop contrast between the two companies' strategies. The answer is contextually relevant and addresses both parts of the question: payer pressures and differential responses. Due to the minor factual error in terminology (NDAs vs NDCs) and omission of the 2019 discontinuation, the correctness and qualitative accuracy are docked slightly, but the overall answer remains strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> COMP <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 481,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How do BAC and SCHW's approaches to meeting capital buffer requirements compare under the current regulatory framework where the Countercyclical Capital Buffer remains at zero?",
      "original_answer": "BAC applies a Stress Capital Buffer of 2.5% under the Standardized approach as of December 31, 2023, while SCHW's subsidiary CSB maintains a Capital Conservation Buffer of 2.5%. Both institutions benefit from the Federal Reserve's current setting of the Countercyclical Capital Buffer at zero, which reduces their overall capital requirements. However, BAC's capital strategy incorporates a G-SIB surcharge of 2.5% alongside its buffer requirements, whereas SCHW structures its capital to meet minimum ratios of 7.0%, 8.5%, and 10.5% for Common Equity Tier 1, Tier 1, and Total Risk-Based Capital respectively, inclusive of buffers.",
      "llm_answer": "\nUnder the current framework the Counter‑Cyclical Capital Buffer (CCyB) is fixed at 0 % for both firms, so each must satisfy the other buffer requirements that are explicitly tied to them in the disclosures. BAC reports that it holds a 2.5 % capital‑conservation buffer (Advanced approaches) and a 2.5 % stress‑capital buffer (Standardized approach) – both of which are counted toward its CET1 ratio and the regulatory minimums noted in the filing (Chunk 1). SCHW’s banking subsidiaries (CSC and CSB) are required to maintain a 2.5 % capital‑conservation buffer and a 2.5 % stress buffer as well, and their minimum risk‑based capital ratios (7 % CET1, 8.5 % Tier 1, 10.5 % total) already embed those buffers (Chunk 3). Thus, while both banks meet the same 2.5 % buffer levels, BAC integrates them directly into its own capital‑ratio calculations, whereas SCHW’s subsidiaries must hold them as separate buffer requirements above the base ratios, with the overall regulatory minimums defined in the same terms (Chunk 2 and the KG link Capital Conservation Buffer → SCHW). Failure to meet these minima could trigger the mandatory supervisory actions described for BAC (Chunk 1).",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several correct elements but also significant inaccuracies that affect the overall correctness. (1) Quantitatively, the LLM incorrectly states that both BAC and SCHW’s subsidiaries maintain a 2.5% capital-conservation buffer *and* a 2.5% stress buffer. According to the ground truth, BAC applies a 2.5% Stress Capital Buffer under the Standardized approach, but there is no mention of a separate 2.5% capital-conservation buffer for BAC in the original answer—only the stress buffer is specified. For SCHW, the original answer states only that CSB maintains a Capital Conservation Buffer of 2.5%, with no mention of a stress buffer. The LLM incorrectly attributes a stress buffer to SCHW’s subsidiaries, which is not supported by the ground truth. Additionally, the LLM claims SCHW’s subsidiaries have minimum ratios of 7%, 8.5%, and 10.5%, which 'embed' the buffers—but the ground truth says these minimums are *inclusive* of buffers, not that the subsidiaries are subject to separate buffer requirements above base ratios. (2) The LLM introduces CSC as a subsidiary alongside CSB, but the original answer only references CSB. This is an entity overreach not supported by the ground truth. (3) The reasoning misrepresents the structure of buffer requirements: it claims BAC integrates buffers into its CET1 ratio while SCHW holds them as 'separate' above base ratios, but the original answer does not support this contrast—both institutions meet buffer-inclusive minimums, and BAC’s G-SIB surcharge (2.5%) is a key differentiator omitted in the LLM’s comparison. (4) The LLM fails to mention BAC’s G-SIB surcharge entirely, a critical component of BAC’s capital strategy per the original answer. This omission undermines the multi-hop synthesis required to compare the two institutions’ approaches. While the LLM correctly notes the CCyB is at zero and both benefit from it, and gets the general idea of buffer percentages, the misattribution of buffers to SCHW, incorrect structural comparison, and omission of G-SIB surcharge reduce factual accuracy. Contextual relevance is high as the response stays on topic and attempts a structured comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Consists_Of]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 579,
        "total_tokens": 2039
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How does Southern Company's investment in solar facilities, which are connected to power purchase agreements (PPAs), compare with Duke Energy's reliance on PPAs in terms of renewable energy facility financing strategies and tax credit utilization timelines?",
      "original_answer": "Southern Company has approximately $1.2 billion of unutilized federal ITCs and PTCs as of December 31, 2021, which are expected to be fully utilized by 2024, and uses tax equity partnerships for solar and wind projects where the tax partner captures most of the federal tax benefits. These solar facilities are connected to PPAs that are accounted for as operating leases with remaining terms of up to 25 years. In contrast, Duke Energy negotiates PPAs as part of its commercial renewables strategy and enters into tax equity arrangements to finance renewable assets eligible for tax credits. Duke's PPAs significantly impact the economic performance of its renewable facilities, and Duke is the primary beneficiary of these VIEs due to its control over siting, PPA negotiation, and operations. The connection between Southern Company's solar investments and PPAs, and Duke's PPA-driven renewable financing, reveals differing approaches to leveraging long-term contracts and tax incentives in renewable energy development.",
      "llm_answer": "\nSouthern Company funds its solar build‑out by directly owning the facilities and monetizing the federal ITCs and PTCs through tax‑equity partnerships that are consolidated using the HLBV methodology, with the credits expected to be fully utilized by 2024; these projects are tied to PPAs that Southern Power (and Georgia Power) account for as operating leases with terms up to 25 years and report the lease payments as variable lease costs outside the maturity analysis.  \nDuke Energy, in contrast, finances its renewable assets through VIE structures and third‑party tax‑equity investors, consolidating the entities while negotiating PPAs that can also run as long as 25 years, and its credit utilization follows the same tax‑equity schedule but is governed by the VIE‑specific timelines and may be delayed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all key facts are correct: Southern Company's tax credits are expected to be fully utilized by 2024 (matches original answer), and both companies use PPAs with terms up to 25 years. The $1.2 billion unutilized ITC/PTC figure is not explicitly restated in the LLM answer, which is a minor omission, but the utilization timeline is correctly noted. (2) The LLM correctly identifies Southern Company’s use of tax equity partnerships with HLBV consolidation and operating lease accounting for PPAs—details consistent with the original. It also accurately describes Duke Energy’s use of VIEs and tax equity, along with its role as primary beneficiary through control over siting, PPA negotiation, and operations, though the phrase 'may be delayed' in Duke's credit utilization is speculative and not in the original. (3) Multi-hop reasoning is sound: the model synthesizes financing strategies (tax equity), accounting treatment (operating leases, VIEs), and PPA roles across both companies, correctly contrasting Southern’s direct ownership and lease-based revenue with Duke’s VIE-driven control. (4) Semantic equivalence is strong—wording differs but meaning is preserved. The only minor gap is the omission of the exact $1.2 billion figure, which slightly affects completeness but not overall correctness. Contextual relevance is excellent, directly addressing both financing strategies and tax credit timelines as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> PRODUCT -[Related_To]-> FIN_INST <-[Negotiates]- ORG",
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 415,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How might the automatic conversion of Class B shares to Class A shares upon transfer at Google, combined with Comcast's non-dilutable Class B voting structure, influence investor sentiment toward Meta's dual-class governance model that grants disproportionate voting control to its founder?",
      "original_answer": "Google's Class B shares automatically convert to Class A shares upon transfer, reducing long-term concentration of voting power. In contrast, Comcast's Class B shares retain 33 1/3% of voting power and are non-dilutable, preserving control. Meta's governance risks highlight concerns that its dual-class structure could make Class A stock less attractive to investors. When considering these three elements together, the contrast in how voting power is preserved or diluted across these companies may shape investor perceptions of governance fairness and control concentration, particularly in Meta's case where founder control remains strong despite lower ownership percentages.",
      "llm_answer": "\nThe automatic conversion of Google’s Class B shares into non‑voting Class A shares upon transfer means that any change of ownership immediately strips voting rights, whereas Comcast’s Class B shares retain a fixed, non‑dilutable 33 % of total voting power regardless of future issuances. Because Meta’s charter similarly ties the overwhelming share of voting power to Class B stock held by its founder—an arrangement the company itself flags as a risk that can “make our Class A common stock less attractive to some investors”—the combination of these mechanisms signals that voting control is highly concentrated and insulated from dilution, a fact that is likely to **negatively impact** investor sentiment toward Meta’s dual‑class governance model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Google's Class B shares convert to Class A upon transfer, eliminating concentrated voting power post-transfer; Comcast’s Class B shares retain 33 1/3% voting power and are non-dilutable; Meta’s dual-class structure concentrates voting power with the founder and is acknowledged as a risk that may make Class A shares less attractive. The LLM correctly states that Meta’s own filings highlight this governance risk. (2) Quantitatively, the 33% figure is accurate (rounding of 33 1/3% is acceptable in context), and no other numbers or calculations are involved. (3) The multi-hop reasoning is sound: the model synthesizes governance mechanisms across Google, Comcast, and Meta, drawing a logical comparison about how control is preserved or diluted, and correctly infers that Meta’s structure is likely to negatively impact investor sentiment due to entrenched founder control. (4) The only minor shortcoming is that the LLM does not explicitly contrast Meta’s structure with both Google and Comcast in balanced terms—emphasizing the negative sentiment more than the comparative structural analysis in the original—but the core reasoning and factual content are intact. Wording differs slightly but maintains semantic equivalence. No factual errors or omissions affect the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Depends_On]-> FIN_INST <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 386,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "Given CVS's launch of Cordavis to co-produce biosimilars with pharmaceutical manufacturers, and UnitedHealth's (UNH) $12.5 billion in rebates receivable from those same manufacturers, how might the increased market availability of lower-cost biosimilars impact UNH's rebate structure and revenue recognition timing, considering rebates are based on product utilization and contract terms?",
      "original_answer": "CVS launched Cordavis to work directly with pharmaceutical manufacturers to commercialize and/or co-produce high-quality biosimilar products, aiming to increase market access and reduce costs. This initiative could increase the utilization of biosimilars, which are typically less expensive than branded biologics. UnitedHealth (UNH) has $12.5 billion in rebates receivable from pharmaceutical manufacturers as of December 31, 2024, which are accrued monthly based on utilization, historical data, and contract terms. Since rebates are influenced by the volume and type of products used, a shift toward greater biosimilar adoption could reduce the rebate amounts negotiated by manufacturers, especially if biosimilars are priced lower and displace branded drugs. Additionally, changes in utilization patterns may affect the timing and predictability of rebate collections for UNH, as lower-cost biosimilars may alter the dynamics of rebate accruals and payment cycles outlined in manufacturer contracts.",
      "llm_answer": "\nCVS launched Cordavis, a unit that works directly with pharmaceutical manufacturers to co‑produce biosimilars, a move that is expected to expand biosimilar access, heighten competition and lower drug prices for clients (Chunk 1).  UnitedHealth’s pharmacy‑care business contracts with those same manufacturers, accruing rebates each month based on product utilization and the specific contract terms and recording them as a reduction of medical costs; the rebates are billed to manufacturers and typically collected 2‑5 months later, which is why $12.5 billion of manufacturer rebates were recorded as receivable as of 31 Dec 2024 (Chunk 3).  Consequently, the greater availability of lower‑cost biosimilars should increase the volume of utilization‑based rebates, boosting UNH’s accrued rebate balances but delaying the cash impact and revenue‑recognition timing until the rebates are actually received (Chunk 2).",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer correctly identifies key facts: CVS launched Cordavis to co-produce biosimilars; UnitedHealth has $12.5 billion in rebates receivable as of December 31, 2024; rebates are accrued monthly based on utilization and contract terms; and there is a 2-5 month collection lag. These quantitative elements (dollar amount, date, timing) are accurate and match the ground truth exactly, earning full marks for quantitative accuracy.\n\n2) However, the core reasoning about the *impact* of biosimilars on UNH's rebate structure is flawed. The LLM claims that greater biosimilar availability will 'increase the volume of utilization-based rebates,' thereby boosting accrued balances. This contradicts the ground truth, which correctly states that biosimilars—being lower-cost—typically displace higher-priced branded biologics, leading to *lower* rebate amounts because rebates are often a percentage of list price. Lower list prices mean smaller rebates, not larger ones. Thus, the qualitative reasoning is incorrect, significantly undermining the answer’s validity.\n\n3) The multi-hop synthesis fails at the critical inference step: while the model connects CVS’s Cordavis initiative to increased biosimilar use and links UNH’s rebate accrual process correctly, it draws the opposite conclusion from what the evidence supports. Instead of recognizing that increased biosimilar adoption may *reduce* rebate inflows due to lower drug prices and altered manufacturer incentives, it assumes higher volume automatically increases rebates—ignoring pricing dynamics and contract economics.\n\n4) Contextual relevance is strong: the answer addresses all components of the question (CVS’s initiative, UNH’s rebates, impact on rebate structure and timing), uses correct entities (CVS, UNH, Cordavis, $12.5B, Dec 31, 2024), and discusses revenue recognition timing appropriately (accrual vs. cash collection lag). But due to the fundamental error in economic logic, the conclusion is partially incorrect, warranting a mid-range correctness score of 5.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> COMP -[Works_With]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 548,
        "total_tokens": 2088
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How might the SEC's Regulation Best Interest, which requires broker-dealers to act in the best interest of retail consumers, influence Goldman Sachs' compliance costs and competitive positioning against Morgan Stanley, given their differing approaches to consumer protection regulations and retail client expansion?",
      "original_answer": "Goldman Sachs faces increased compliance costs due to consumer protection regulations like Regulation Best Interest, which applies to its consumer-oriented activities, including transaction banking and retail client services. The MET_10k_2024.pdf evidence shows that Regulation Best Interest imposes conduct standards on broker-dealers when recommending securities, including variable insurance products, and that state-level extensions could allow private litigation, increasing legal exposure. Meanwhile, Morgan Stanley's 2024 10-K acknowledges intense competition in the U.S. and globally, particularly from firms offering similar products and services to retail and institutional clients, and notes that some competitors may operate under less stringent regulatory regimes. This suggests that while both firms are subject to Regulation Best Interest, Morgan Stanley may have a more established retail client infrastructure, giving it a competitive edge in adapting to the regulation with lower incremental costs compared to Goldman Sachs, which is expanding in this space and facing higher compliance investments.",
      "llm_answer": "\nRegulation Best Interest forces Goldman Sachs (GS) to add extensive suitability testing, disclosure and monitoring controls for its retail brokerage activities, driving up compliance and potential litigation costs—especially as states consider private‑right‑of‑action rules that could further raise exposure, a risk highlighted in the MET filing.  Because Morgan Stanley (MS) competes with GS in the retail brokerage space but operates under a different mix of consumer‑protection obligations—some of which are less stringent—the incremental regulatory burden may give MS a relative competitive advantage despite both firms being subject to the same SEC rule.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Regulation Best Interest increases compliance costs for Goldman Sachs due to its retail expansion and suitability/testing requirements, and state-level extensions could enable private litigation, raising legal exposure—this is supported by the MET_10k_2024.pdf reference. The answer correctly identifies that both Goldman Sachs and Morgan Stanley are subject to the rule, but Morgan Stanley may have a competitive advantage due to a more established retail infrastructure and potentially less incremental cost, which is consistent with Morgan Stanley's 2024 10-K noting intense competition and varying regulatory burdens across firms. (2) There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is not compromised—score is 10 as no numbers were misstated. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across regulatory impact, firm-specific risk disclosures (MET filing), competitive dynamics, and differential compliance cost implications. The only minor shortcoming is that the LLM does not explicitly state that Goldman Sachs is *expanding* in the retail space (a key reason for higher incremental costs), though this is implied by the context of increased compliance burden. (4) The answer is fully contextually relevant, directly addressing how Regulation Best Interest affects Goldman Sachs’ compliance costs and competitive positioning versus Morgan Stanley. Wording differs from the original but meaning is semantically equivalent. Thus, correctness is 9 due to slight omission of explicit 'retail expansion' context, but all critical facts and logic are preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Applies_To]-> COMP <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 478,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does the voting power distribution tied to CMCSA's Class A and Class B common stock structure compare with GOOGL's approach to Class B common stock in terms of concentrated control, given that CMCSA's Class B stock carries 15 votes per share and GOOGL's Class B stock carries 10 votes per share?",
      "original_answer": "CMCSA's Class A and Class B common stock structure allocates 66 2/3% of the combined voting power to Class A shares held broadly, while the Class B shares, which carry 15 votes per share and are entirely owned by Brian L. Roberts, control the remaining 33 1/3% of voting power. In contrast, GOOGL's Class B common stock carries 10 votes per share, and although the company also maintains a dual-class structure, the voting power distribution is not explicitly quantified in the evidence provided. However, GOOGL's Class B shares can be converted to Class A shares upon sale or transfer, which could potentially dilute concentrated control over time—unlike CMCSA’s Class B shares, which are non-dilutable.",
      "llm_answer": "\nComcast’s Class B common stock carries **15 votes per share** and, together with the Class A shares, gives the Roberts family about **one‑third of the total voting power**—a non‑dilutable block that concentrates control in a single holder (Chunk 1 & 2).  Alphabet’s Class B shares, by contrast, carry only **10 votes per share**, are convertible into Class A shares and their exact voting‑power share isn’t disclosed, so the super‑voting advantage is smaller and less tightly held (Chunk 3).  The knowledge‑graph link (Class B Common Stock → GOOGL) shows that the same instrument class is relevant to both companies, highlighting that Comcast’s 15‑vote structure creates a more concentrated voting control than Alphabet’s 10‑vote Class B.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: CMCSA's Class B has 15 votes per share, GOOGL's Class B has 10 votes per share. The LLM correctly states that the Roberts family holds about one-third of voting power, which matches the ground truth's 33 1/3% for Class B (held entirely by Brian L. Roberts), with Class A holding 66 2/3%. The phrasing 'about one-third' is a reasonable approximation of 33 1/3%. (2) The LLM correctly notes that GOOGL does not disclose exact voting power distribution, which is consistent with the original answer. (3) The qualitative reasoning is sound: it identifies that CMCSA’s Class B shares are non-dilutable and held by a single party, leading to more concentrated control, while GOOGL’s Class B shares are convertible upon sale, potentially diluting control—this is a key distinction highlighted in the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly mention that CMCSA’s Class A holds 66 2/3% of voting power, instead focusing on the Class B side. However, stating that the Roberts family holds 'about one-third' implies the inverse and maintains semantic equivalence. The multi-hop synthesis across CMCSA and GOOGL is accurate and contextually relevant. Overall, the answer is factually correct, well-reasoned, and responsive to the comparative question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 385,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does the increase in illicit trade prevalence in Turkey, which negatively impacted PM's cigarette volume growth, compare to PG's exposure to Turkey's foreign exchange volatility, and what does this reveal about the dual operational risks each company faces in the same market?",
      "original_answer": "PM reported that Turkey's cigarette market grew by 8.2%, primarily due to the easing of pandemic restrictions and increased tourism, but this growth was partially offset by a higher estimated prevalence of illicit trade. This illicit trade directly impacts PM's market dynamics by reducing legitimate sales volume and potentially eroding brand loyalty. Meanwhile, PG disclosed that Turkey is one of several countries where it faces significant foreign exchange exposure, with currency fluctuations having historically impacted its net sales, costs, and earnings. Given Turkey's economic instability, PG's exposure includes both transaction and translation risks that affect margins and cash flows. Together, these facts highlight that while PM is grappling with illicit trade undermining its cigarette sales in Turkey, PG is simultaneously facing financial risks from the country's volatile currency, illustrating how different types of market-specific risks—operational and financial—can concurrently challenge multinational corporations in the same geopolitical environment.",
      "llm_answer": "\nThe rise in illicit‑trade prevalence in Turkey is suppressing PM’s cigarette‑volume growth—PM’s own 2022 commentary notes that Turkey’s market expanded 8.2 % “partly offset by a higher estimated prevalence of illicit trade,” directly curbing its volume (Chunk 2). At the same time, PG’s 10‑K flags Turkey as one of the countries experiencing “significant exchange‑rate fluctuations” that have already “led to lower sales and earnings” and can further hurt consumption through pricing pressures (Chunk 1). Thus, in the same market the two firms confront different but parallel operational threats: PM’s risk is a demand‑side volume loss from illicit trade, while PG’s risk is a financial‑side exposure to foreign‑exchange volatility, illustrating the dual operational risks each faces in Turkey (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers and percentages are correct: the 8.2% market growth in Turkey is accurately cited, and there are no calculation errors. The reference to PM’s 2022 commentary (implied by 'Chunk 2') matches the context of the original answer. (2) The LLM correctly identifies both companies (PM and PG), their respective risks (illicit trade for PM, FX volatility for PG), and the market (Turkey), with accurate characterization of the nature of each risk. (3) The multi-hop reasoning is sound: it synthesizes information across two different companies’ disclosures to compare distinct but concurrent risks in the same market. The conclusion that PM faces demand-side volume loss while PG faces financial-side FX exposure is logically derived and semantically equivalent to the original answer. (4) Minor deduction in qualitative accuracy due to slightly less detailed explanation of PG’s exposure (e.g., transaction vs. translation risks are not explicitly mentioned), but the core idea of FX impacting sales and earnings is preserved. Wording differences (e.g., 'pricing pressures' not in original) are acceptable under semantic equivalence. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> GPE -[Negatively_Impacts]-> RISK_FACTOR <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 365,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does JPMorgan's approach to identifying and managing transition risk compare to Bank of America's exposure to reputational risk in the context of their climate-related commitments, particularly given JPM's Firmwide Climate Risk Framework and BAC's $1.5 trillion sustainable finance goal?",
      "original_answer": "JPMorgan addresses transition risk through its Firmwide Climate Risk Framework, which includes setting policies, developing metrics and stress testing mechanisms, and establishing a climate risk data strategy to assess financial impacts. This structured approach is designed to integrate climate risk considerations across its business lines. In contrast, Bank of America identifies reputational risk as a potential consequence of failing to meet its climate-related commitments, such as its $1.5 trillion sustainable finance goal, which includes $1 trillion dedicated to supporting the transition to a low-carbon economy. While both institutions recognize climate risk broadly, JPMorgan emphasizes proactive identification and scenario-based analysis of transition risks, whereas BAC focuses on reputational risk mitigation tied to its public climate goals and stakeholder expectations.",
      "llm_answer": "\nJPMorgan manages transition risk through a dedicated **Firmwide Climate Risk Framework** that embeds identification, metrics, stress‑testing and Board‑level oversight of climate‑related transition risks across all lines of business, whereas Bank of America’s climate agenda is anchored to a **$1.5 trillion sustainable‑finance goal and a net‑zero by 2050 commitment**, and its primary climate‑related exposure is **reputational risk** that is overseen by the ERC, CGESC and dedicated risk committees.  The knowledge‑graph link — Transition Risk → Reputational Risk → BAC — shows that JPM’s systematic transition‑risk controls are designed to prevent the reputational fallout that BAC must actively mitigate given its large sustainable‑finance target.  Consequently, JPM’s approach is a firm‑wide, risk‑management‑centric system, while BAC’s focus is on limiting reputational damage from its climate commitments and disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: JPMorgan's Firmwide Climate Risk Framework includes metrics, stress testing, and Board-level oversight; Bank of America's $1.5 trillion sustainable finance goal (with $1 trillion for low-carbon transition) is accurately referenced. The reputational risk exposure for BAC is correctly identified. (2) Quantitative accuracy is perfect: the $1.5 trillion figure is correctly stated, and no other numbers (e.g., dates, percentages) are misstated. Format is consistent and clear. (3) Multi-hop reasoning is sound: the answer synthesizes JPMorgan’s proactive, risk-management-centric approach with BAC’s goal-driven, reputation-sensitive strategy. It correctly contrasts JPM’s internal risk framework with BAC’s external commitment-linked exposure. The mention of oversight by ERC, CGESC, and risk committees adds detail not in the original but is consistent with BAC’s governance structure and enhances accuracy. (4) Semantic equivalence is strong—while the LLM introduces a knowledge-graph link interpretation (Transition Risk → Reputational Risk → BAC), this is a reasonable analytical extension, not a factual error. The core comparison—JPM focuses on managing transition risk systematically, BAC on mitigating reputational risk from public goals—is fully supported by the original. Minor deduction in qualitative accuracy only because the LLM slightly overemphasizes the 'knowledge-graph link' as an explanatory mechanism, which is interpretive, though not misleading. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR -[Negatively_Impacts]-> RISK_FACTOR <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 450,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the timing of Microsoft's revenue recognition for hardware sales, which combines hardware and software as a single performance obligation, align with Cisco's average loan receivable terms for financing hardware purchases, and what is Cisco's total credit loss allowance for these financing arrangements as of July 29, 2023?",
      "original_answer": "Microsoft recognizes revenue for hardware sales at the point in time when ownership is transferred to resellers or end customers, treating the hardware and software as a single performance obligation. Cisco offers loan receivables with average terms of one to three years to finance hardware purchases. As of July 29, 2023, Cisco's total credit loss allowance for financing arrangements, including loan and lease receivables, was $72 million.",
      "llm_answer": "\nMicrosoft recognizes revenue from its hardware sales at the point control passes to the buyer, treating the hardware together with any embedded software license as a single performance obligation; Cisco’s financing receivables that fund such hardware purchases are typically structured for **one‑to‑three years** on average (with loan receivables averaging 1‑3 years and lease receivables averaging about four years). As of **July 29 2023**, Cisco’s combined credit‑loss allowance for these loan and lease receivables—i.e., the total allowance for credit losses on the financing arrangements—is **$72 million**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and dates are accurate: the credit loss allowance of $72 million as of July 29, 2023, and the one-to-three-year average term for loan receivables are correctly reported. The mention of lease receivables averaging about four years is additional context not contradicted by the ground truth and does not detract from accuracy. (2) The answer addresses all parts of the multi-hop question: Microsoft's revenue recognition timing (at point of control transfer, i.e., when ownership passes), the combination of hardware and software as a single performance obligation, Cisco's average loan receivable terms (1–3 years), and the exact credit loss allowance figure. (3) Entity accuracy is perfect: Microsoft and Cisco are correctly identified, as are the relevant financial metrics (revenue recognition, credit loss allowance, financing terms). (4) The reasoning is sound and synthesizes information across two companies and domains (Microsoft’s accounting policy and Cisco’s financing terms and allowances), demonstrating correct multi-hop logic. The slight expansion on lease terms adds context without introducing error. (5) Semantic equivalence is maintained—wording differs slightly (e.g., 'point control passes' vs 'point in time when ownership is transferred') but conveys the same accounting concept. Overall, the answer is factually precise, complete, and logically coherent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 408,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How might potential delays in FAA certification of Gulfstream's G700 aircraft impact FedEx's compliance costs under ICAO's 2028 production cutoff for non-compliant aircraft, given FedEx's reliance on fuel-efficient fleets to manage CORSIA obligations?",
      "original_answer": "Delays in FAA certification of Gulfstream's G700 aircraft could limit FedEx’s ability to acquire newer, more fuel-efficient aircraft before the 2028 cutoff date for non-compliant models, potentially increasing FedEx’s CORSIA compliance costs. FedEx noted in its 2023 10-K that its CORSIA-related expenses depend on factors including the fuel efficiency of its fleet and the availability of qualifying sustainable aviation fuels. Gulfstream’s 2023 inventory ramp-up for the G700 was explicitly tied to FAA certification timing, meaning a delay could slow the introduction of next-generation aircraft into FedEx’s fleet. This would prolong the use of older, less-efficient aircraft, increasing the company’s carbon offset or allowance purchase obligations under CORSIA and ETS, especially as free allowances are phased out by 2026.",
      "llm_answer": "\nDelays in the FAA’s certification of Gulfstream’s G700 would push back the delivery of the fuel‑efficient G700s that FedEx plans to deploy to satisfy ICAO’s 2028 production‑cutoff for non‑compliant aircraft and to keep its fleet’s emissions low enough for CORSIA, so FedEx would have to continue operating older, less‑efficient aircraft beyond 2028 and consequently purchase additional emissions‑offset credits or sustainable‑fuel allowances—raising its compliance costs under ICAO’s scheme and the related EU ETS. This risk is underscored by the fact that Gulfstream is already ramping up G700 production and reporting higher inventories and customer deposits that depend on that certification (Chunk 2‑3), and by FedEx’s own disclosure that CORSIA compliance costs are closely tied to fleet fuel efficiency (Chunk 1).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: FAA certification delays for the G700 could delay deliveries, impacting FedEx's ability to meet ICAO's 2028 production cutoff and increasing reliance on older, less fuel-efficient aircraft. This in turn raises CORSIA compliance costs due to greater need for offset credits or sustainable aviation fuel. FedEx’s 2023 10-K disclosure linking compliance costs to fleet efficiency is correctly referenced. (2) Quantitative elements—such as the 2028 cutoff and phaseout of free allowances by 2026 in the original—are not contradicted; the LLM correctly notes the 2028 deadline and implies the cost impact without introducing any incorrect numbers. No calculations are required, and all dates (e.g., 2028) match. (3) Multi-hop reasoning is sound: the LLM correctly connects Gulfstream’s certification timeline → production/delivery delays → FedEx fleet modernization → fuel efficiency → CORSIA/ETS compliance costs. It also references Gulfstream’s inventory buildup and customer deposits as evidence of dependency on certification, which supports the causal chain. (4) The only minor shortcoming is that the LLM does not explicitly mention the phaseout of free allowances by 2026—a detail in the original that strengthens the cost argument—but this omission does not undermine the core correctness. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing all parts of the complex, multi-entity question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Subject_To]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 425,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the voting power distribution tied to Class A and Class B common stock at CMCSA compare to the voting rights structure of Class A and Class B common stock at GOOGL, particularly in terms of the per-share voting ratio?",
      "original_answer": "At CMCSA, Class A common stockholders hold 66 2/3% of the combined voting power, with each share of Class A common stock receiving a variable number of votes depending on the outstanding shares, while each share of Class B common stock has 15 votes and collectively holds 33 1/3% of the voting power. In contrast, at GOOGL, each share of Class A common stock has 1 vote, and each share of Class B common stock has 10 votes, though the specific ownership percentages of each class are not disclosed. This indicates that CMCSA's structure grants significantly more voting weight to Class B shares compared to GOOGL's 10:1 ratio.",
      "llm_answer": "\nCMCSA’s dual‑class structure gives Class B common stock 15 votes per share, and because Class B represents roughly 33 % of the combined voting power (a non‑dilutable stake held by a single insider), the per‑share voting ratio is effectively 15 : 1 (Class B versus Class A, which has one vote per share); in contrast, Alphabet’s (GOOGL) Class B shares carry 10 votes per share while Class A carries one vote per share, producing a 10 : 1 per‑share ratio, with voting power determined by the number of shares outstanding and Class C holding no voting rights.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer captures the core voting ratios correctly: 15 votes per share for CMCSA Class B and 10 votes per share for GOOGL Class B, with Class A having 1 vote in both cases. However, it misrepresents the voting power distribution at CMCSA. The original answer states that Class A holds 66 2/3% of the combined voting power and Class B holds 33 1/3%, despite Class B having 15 votes per share. The LLM incorrectly implies that Class A has 1 vote per share and that the 15:1 ratio directly corresponds to a 15:1 voting power split, which is not accurate—CMCSA’s structure uses a variable vote allocation per Class A share to maintain the 66 2/3% : 33 1/3% split, not a fixed 1:1 vote per share for Class A. This is a significant quantitative and conceptual oversight. The answer correctly notes GOOGL’s 10:1 ratio and absence of voting rights for Class C, which is consistent with known structures. While the comparison of per-share voting ratios (15:1 vs 10:1) is directionally correct, the reasoning behind how voting power is distributed is flawed for CMCSA. The answer is contextually relevant and synthesizes the right entities (CMCSA, GOOGL, Class A/B shares), but the incorrect assumption about CMCSA’s per-share voting ratio undermines full accuracy. Minor phrasing like 'roughly 33%' is acceptable approximation, but the failure to acknowledge the variable voting mechanism for Class A shares—a key feature in the ground truth—is a material omission.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 401,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to GOOGL's dual-class structure, particularly in terms of the relative influence of holders of Class B shares?",
      "original_answer": "At CMCSA, holders of Class B common stock (owned entirely by Brian L. Roberts) have 15 votes per share and represent 33 1/3% of the combined voting power, while Class A common stockholders hold 66 2/3% of the voting power. In contrast, at GOOGL, Class B common stockholders have 10 votes per share, and upon conversion, these shares convert to Class A common stock, which has only one vote per share. This means that while both companies use a dual-class structure to concentrate voting power among certain shareholders, CMCSA’s Class B shares carry more per-share voting weight (15 votes vs. 10 votes) and are non-dilutable, giving the holder a fixed minority voting control compared to GOOGL’s structure, which allows for more fluidity through conversion.",
      "llm_answer": "\nThe CMCSA filing shows that its Class B common stock carries 15 votes per share and, because of that weight, collectively represents **33 ⅓ % of the combined voting power** of all common stock – a block that is “generally non‑dilutable” and is held almost entirely by Mr. Brian L. Roberts. By contrast, GOOGL’s Class B stock (linked through the KG relationship Class B → Class A → CMCSA) carries only **10 votes per share** and, although it can be converted to Class A, the filing does not disclose what share of total votes that 10‑vote entitlement translates into. Consequently, CMCSA’s Class B shareholders wield a fixed, sizable one‑third of all voting power, whereas GOOGL’s Class B holders enjoy a high per‑share vote count but an unspecified, typically smaller proportion of the overall vote.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in terms of quantitative accuracy: it correctly states that CMCSA Class B shares have 15 votes per share and represent 33 1/3% of combined voting power, and that GOOGL Class B shares have 10 votes per share. These numbers match the ground truth exactly. However, the LLM incorrectly implies that the KG relationship (Class B → Class A → CMCSA) is part of GOOGL’s structure, which is factually wrong—this appears to be a confusion with another entity or misinterpretation of a knowledge graph link. The statement that 'the filing does not disclose what share of total votes that 10-vote entitlement translates into' is misleading; while the exact percentage may not be explicitly stated, it is well-documented that Google's founders and insiders hold a controlling majority through their Class B shares, and the structure is designed to concentrate voting power. The core comparison—CMCSA’s Class B having higher per-share voting power (15 vs 10) and a fixed 33 1/3% voting stake—is accurate and well-articulated. The answer captures the non-dilutable nature of CMCSA’s structure but misses the point about convertibility being a key difference (GOOGL Class B can convert to Class A, diluting relative influence over time), which is present in the original answer. Thus, while the main facts and numbers are correct, there is a minor error in entity linkage and a partial omission in explaining the implications of convertibility, reducing the qualitative accuracy slightly. Contextual relevance is strong as the response directly addresses the comparative voting influence question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 440,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the FDA approval timeline for BMY's Zeposia in ulcerative colitis compare with the regulatory milestone achieved by MRK for Welireg in von Hippel-Lindau disease, and what were the respective impacts on each company's 2021 oncology and immunology portfolios?",
      "original_answer": "BMY received FDA approval for Zeposia in May 2021 for the treatment of moderately to severely active ulcerative colitis (UC), based on the Phase III True North trial, which demonstrated its efficacy and led to expanded market access in immunology. In contrast, MRK received FDA approval for Welireg (belzutifan) in August 2021 for the treatment of von Hippel-Lindau (VHL) disease, marking a key oncology milestone. The approval of Zeposia contributed to BMY's immunology pipeline growth, while Welireg's approval led to a $50 million milestone payment to former Peloton shareholders and positioned MRK more strongly in the oncology space with a novel HIF-2α inhibitor.",
      "llm_answer": "\nThe FDA cleared BMY’s Zeposia for moderately‑to‑severe ulcerative colitis in **May 2021** (with EC approval later in November 2021), whereas Merck’s Welireg received its FDA approval for von Hippel‑Lindau disease in **August 2021**, making Zeposia’s clearance roughly three months earlier.  \nThe May 2021 Zeposia approval (augmented by the December 2021 Orencia aGVHD approval) expanded BMY’s **immunology** portfolio, adding a new UC indication and strengthening its 2021 immunology franchise, while having limited direct impact on its oncology pipeline; conversely, the August 2021 Welireg approval introduced a novel **oncology** agent to Merck’s portfolio, driving a measurable uplift in Merck’s 2021 oncology sales and non‑GAAP earnings, whereas Merck’s immunology portfolio saw no comparable 2021 regulatory milestone.  \n\n*(All dates and portfolio effects are drawn from the FDA‑approval disclosures in Chunk 1, the Welireg regulatory milestone described in Chunks 2 & 3, and the KG relationships linking each firm to its regulatory requirement and product.)*",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BMY's Zeposia received FDA approval in May 2021 for ulcerative colitis, and MRK's Welireg was approved in August 2021 for von Hippel-Lindau disease—this three-month difference is correctly noted. (2) Quantitative accuracy is perfect: dates (May 2021, August 2021) match the original answer exactly; no dollar amounts or percentages are misstated. The LLM correctly avoids fabricating the $50 million milestone payment but omits it, which is a minor gap. (3) Multi-hop reasoning is sound: the model correctly links Zeposia to BMY’s immunology portfolio growth and Welireg to MRK’s oncology advancement. It appropriately distinguishes between the therapeutic areas and regulatory impacts. (4) The only minor omission is the $50 million milestone payment to former Peloton shareholders upon Welireg’s approval, which was included in the ground truth and adds financial context. While this detail enhances completeness, its absence does not undermine the core correctness of the portfolio impact assessment. Wording differs but maintains semantic equivalence. The LLM also adds minor contextual details (e.g., EC approval, Orencia aGVHD) that are consistent with external knowledge and do not contradict the ground truth. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> REGULATORY_REQUIREMENT -[Receives]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 386,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the vesting period structure for restricted stock at EMR compare to the vesting requirements in the multiemployer pension plans that UPS contributes to, given the differences in funding risk and benefit delivery mechanisms?",
      "original_answer": "EMR applies cliff vesting periods ranging from three to ten years for restricted stock awards, with compensation expense recognized ratably over these periods. In contrast, UPS contributes to multiemployer pension plans where vesting periods are defined by collective bargaining agreements and are tied to retirement, death, or termination benefits. These plans are subject to shared funding risks, where assets contributed by one employer may be used to fund benefits for employees of other employers, and UPS may face additional liabilities such as withdrawal liability or surcharge contributions if plans enter critical status. This highlights a fundamental difference in both the structure and risk exposure of vesting mechanisms between EMR’s equity-based compensation and UPS’s pension obligations.",
      "llm_answer": "\nEMR’s restricted‑stock awards cliff‑vest after service periods that range from **three to ten years** (with RSUs vesting after three years), whereas the vesting schedules in the **multi‑employer pension plans that UPS contributes to are set by collective‑bargaining agreements and are not disclosed in detail**; they tie eligibility to service but do not specify a fixed term. Because these plans pool assets, the **funding risk is shared among all participating employers**, and **benefit delivery is administered by the plan**—meaning UPS may face withdrawal‑liability or surcharge obligations—whereas EMR’s equity awards involve only the company’s own equity and a straightforward ratable expense recognition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all key numbers and timeframes are correct: EMR's restricted stock cliff vesting ranges from three to ten years, with RSUs specifically vesting after three years—this matches the original answer’s 'three to ten years' range and implies correct understanding. (2) The answer correctly identifies that UPS contributes to multiemployer pension plans where vesting is governed by collective bargaining agreements, though it notes the schedules are 'not disclosed in detail,' which is consistent with the lack of specific timeframes in the ground truth. (3) The reasoning accurately contrasts the risk and delivery mechanisms: EMR’s equity-based awards involve no shared funding risk and have straightforward expense recognition, while UPS faces shared funding risk, potential withdrawal liability, and surcharge contributions due to the pooled nature of multiemployer plans. (4) The only minor shortcoming is that the LLM slightly downplays the explicit link in the original answer between vesting events (retirement, death, termination) and benefit eligibility—this context is implied but not stated. However, the core multi-hop synthesis across EMR’s equity vesting and UPS’s pension risk structure is sound and factually correct. Wording differences do not affect semantic equivalence. All entities (EMR, UPS, restricted stock, multiemployer plans) are correctly identified and contrasted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 407,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does NFLX's exposure to data privacy risks under the Communications Act compare to CMCSA's regulatory obligations under the same Act, particularly in terms of potential financial penalties and operational constraints related to handling personal information?",
      "original_answer": "NFLX faces potential financial penalties and reputational damage due to unauthorized data breaches involving member personal information, including billing data, which could result in material costs and regulatory fines without insurance coverage. CMCSA, being subject to the Communications Act, must comply with privacy and data protection restrictions that govern the collection, use, and disclosure of personal information, which could lead to legal consequences if violated. Both companies are exposed to regulatory scrutiny and potential penalties under the Communications Act, though NFLX lacks insurance to mitigate such risks, whereas CMCSA’s obligations are framed within a broader regulatory compliance framework that includes audits and potential changes in law.",
      "llm_answer": "\nNFLX’s 10‑K warns that unauthorized disclosure of member personal data—particularly billing information—could trigger breach‑notification duties, regulatory fines and litigation, and because it carries no breach‑insurance the resulting costs could be material; this personal‑information exposure is expressly linked to the Communications Act, which restricts how such data may be handled. By contrast, CMCSA’s filing notes that, as a communications‑service operator, it is subject not only to the same Act’s privacy provisions but also to additional FCC rules, royalty‑audit obligations and spectrum‑reallocation requirements, meaning its regulatory burden—and the associated financial penalties and operational constraints such as mandatory compliance programs, possible spectrum transitions and ongoing audit‑driven reporting—is broader and more structurally restrictive than NFLX’s breach‑focused exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: NFLX faces material financial risks from data breaches involving personal and billing information, with no insurance coverage, under the Communications Act. CMCSA is subject to broader regulatory obligations under the same Act, including privacy rules, FCC compliance, audits, and operational constraints. These points are all supported by the original answer. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the absence of any numerical inaccuracies supports a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies fall under the Communications Act but with differing scopes—NFLX’s exposure is breach- and penalty-driven, while CMCSA faces structural, ongoing regulatory requirements. The distinction in risk type (incident-driven vs. systemic compliance) is logically drawn and well-supported. (4) The LLM adds slightly more detail than the original (e.g., 'royalty-audit obligations', 'spectrum transitions'), which are plausible extensions of CMCSA’s regulatory environment but not explicitly stated in the ground truth; however, they do not contradict it and fit within the broader context. The only reason for not giving a perfect 10 is that the original emphasizes CMCSA’s lack of insurance for NFLX and the potential for changes in law, which the LLM omits—minor but relevant context. Overall, the answer is semantically equivalent, factually correct, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> RISK_FACTOR -[Restricts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 451,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the commercialization of Platform 5 nicotine pouches in Sweden by PM compare to CCEP's role as a bottler for KO in the same market, particularly in terms of their respective market entry strategies and product dependencies?",
      "original_answer": "Coca-Cola Europacific Partners (CCEP) serves as a key bottler for The Coca-Cola Company (KO) in Sweden, handling the distribution of Coca-Cola trademark beverages under contractual agreements that require CCEP to purchase concentrates from KO. In 2021, KO's five largest bottlers, including CCEP, represented 41% of KO’s total worldwide unit case volume. Meanwhile, Philip Morris International (PM) launched its Platform 5 nicotine pouch product in Sweden in January 2022 under the Shiro brand, following the acquisition of AG Snus. This launch represents a direct market entry strategy by PM, contrasting with CCEP’s role as a contracted third-party distributor for KO, where product supply is dependent on KO’s concentrate pricing and availability. Both companies operate in Sweden, but PM’s strategy involves direct product innovation and brand acquisition, while CCEP relies on KO for product inputs and brand authorization.",
      "llm_answer": "\nPM’s commercialization of Platform 5 nicotine pouches in Sweden (Chunk 3) relies on its recent acquisition of AG Snus and a reformulated Shiro brand, but it is exposed to supply‑chain dependencies on device components and semiconductors that can constrain production (Chunk 3). In contrast, CCEP’s role as KO’s bottler in Sweden (Chunk 1‑2) follows a bottler‑agreement structure where KO supplies concentrates, controls pricing and territorial rights, and CCEP leverages its established bottling and distribution network in Sweden while being dependent on KO for those concentrates (Chunk 1‑2). Thus, PM’s market entry is driven by product‑specific acquisition and supply‑chain risks, whereas CCEP’s entry is governed by a long‑standing bottler relationship that ties its operations and product availability to KO’s concentrate supply.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative description of both PM's and CCEP's market entry strategies and dependencies, with accurate entity identification (PM, CCEP, KO, AG Snus, Shiro brand) and correct contextual framing of their respective roles. The quantitative accuracy is perfect: no incorrect numbers, dates, or percentages are cited (the LLM avoids asserting specific figures not in the ground truth, such as the 41% of KO’s unit case volume, which it omits but does not misstate). However, the LLM introduces a detail not present in the ground truth—'supply-chain dependencies on device components and semiconductors'—which is factually unsupported in the provided context and distracts from the actual focus on nicotine pouches (a consumable product, not a device). This mischaracterization suggests a confusion with heated tobacco devices, undermining the qualitative accuracy. Additionally, while the ground truth emphasizes PM’s direct market entry via acquisition and brand launch in January 2022, the LLM omits the specific launch date, weakening completeness. The comparison between PM’s direct innovation strategy and CCEP’s reliance on KO concentrate supply is well-reasoned and semantically aligned with the original answer. The multi-hop synthesis across entities (PM → AG Snus → Shiro → Sweden; CCEP → KO → concentrates → distribution) is logically sound, though slightly marred by the erroneous supply-chain claim. Overall, the answer captures the core contrast in market entry and dependency but includes one significant factual deviation and omits a key temporal detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 438,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the 8% decline in UNH's Medicare Part D enrollment from 2023 to 2024 interact with the IRA's manufacturer discount requirements and reinsurance shifts to assess CVS's financial exposure under its Medicare Advantage contracts?",
      "original_answer": "The 8% decline in UNH's Medicare Part D enrollment from 3,315,000 in 2023 to 3,050,000 in 2024 suggests a reduction in the number of Part D beneficiaries served by UNH, which may reflect broader market adjustments under the IRA's redesign of Medicare Part D. The IRA introduced significant changes, including capping beneficiary out-of-pocket costs and reducing Federal reinsurance in the catastrophic phase starting January 1, 2025, which shifts more financial responsibility to Part D plans and manufacturers through required manufacturer discounts. For CVS, this creates a dual exposure: first, as a provider of Medicare Advantage plans, it must manage the financial risk associated with the reduced reinsurance and increased member cost-sharing volatility; second, the IRA's rebate mechanism, which Amgen began accruing for in 2022, introduces further pricing pressures that may impact the pharmacy benefit manager's (PBM) drug acquisition costs and rebate negotiations. Thus, the enrollment decline at UNH, combined with the IRA's structural changes and Amgen's experience with manufacturer discounts, collectively signal a complex risk environment for CVS under its Medicare contracts.",
      "llm_answer": "\nThe 8 % year‑over‑year decline in UnitedHealth Group’s Medicare Part D enrollment—down from 3,315 k in 2023 to 3,050 k in 2024, an –8 % change (Chunk 1)—indicates a shrinking Part D member base.  At the same time, the Inflation‑Reduction Act forces manufacturers to provide discounts and reduces federal reinsurance in the catastrophic tier, shifting a larger share of drug‑cost risk onto Part D plans (Chunk 2).  Because CVS prices its Medicare Advantage products years in advance using cost‑trend forecasts that must incorporate these IRA‑driven cost increases (Chunk 3), the simultaneous enrollment drop and higher per‑member cost pressures amplify CVS’s financial exposure under its Medicare Advantage contracts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the 8% decline in UNH's Medicare Part D enrollment from 3,315,000 (3,315k) in 2023 to 3,050,000 (3,050k) in 2024, matching the ground truth numerically and directionally. The percentage change is accurately represented as -8%. 2) All quantitative elements are correct: enrollment figures, percentage decline, and year-over-year comparison. Format variations (k vs. full number) are acceptable and semantically equivalent. 3) The reasoning correctly links the enrollment decline with the IRA’s changes—specifically reduced federal reinsurance and increased manufacturer discounts—shifting cost risk to Part D plans. It appropriately connects this to CVS’s financial exposure through its Medicare Advantage contracts and pricing based on forward-looking cost forecasts. 4) The LLM captures the core multi-hop logic: UNH enrollment trend → broader market signal under IRA → structural risk shift to plans → impact on CVS’s risk modeling and financial exposure. However, it omits mention of Amgen’s rebate accrual experience, which the original answer uses as supporting evidence of manufacturer-level impact and pricing pressure relevant to CVS’s PBM operations. While not central, this missing link slightly weakens the depth of synthesis across all entities. 5) Despite this omission, the answer remains factually accurate, contextually relevant, and logically sound, conveying the essential financial risk mechanism facing CVS. Hence, high scores across all dimensions with a minor deduction in qualitative accuracy for incomplete entity synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> REGULATORY_REQUIREMENT -[Modifies]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1499,
        "completion_tokens": 433,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How does Southern Company's use of cost recovery mechanisms for environmental remediation at its natural gas utilities compare to Duke Energy's financial exposure from environmental remediation liabilities, given the differences in their regulatory and liability frameworks?",
      "original_answer": "Southern Company utilizes cost recovery mechanisms approved by state regulatory agencies to recover environmental remediation costs at its natural gas distribution utilities, allowing it to pass on prudently-incurred expenses—including those related to infrastructure replacement and environmental cleanup—to customers through regulated rates. In contrast, Duke Energy faces environmental remediation liabilities at various current and former sites, with $X million (hypothetical placeholder based on typical reporting) in reserves for probable and estimable costs, but without guaranteed regulatory recovery, meaning these costs are often expensed directly as operational expenses unless recovery is deemed probable. While Southern Company benefits from structured cost recovery riders, Duke Energy must manage uncertain future costs without assured cost pass-through, leading to greater financial exposure.",
      "llm_answer": "\nSouthern Company’s natural‑gas utilities treat environmental‑remediation costs as a recoverable expense through explicit cost‑recovery mechanisms and regulatory riders that are embedded in their rates, allowing the company to amortize those costs under its accounting policy; in contrast, Duke Energy must accrue reserves for probable remediation liabilities and can only recognize recovery if regulators deem it probable, leaving its financial exposure more uncertain and contingent.  This difference is reflected in the KG link Environmental Remediation (RISK_FACTOR) → DUK, which highlights Duke’s direct liability exposure, while Southern Company’s Cost Recovery Mechanisms (ACCOUNTING_POLICY) → Environmental Remediation (RISK_FACTOR) shows that its remediation outlays are built into regulated rates rather than recorded as open‑ended liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All factual elements are correct: Southern Company uses cost recovery mechanisms and regulatory riders to pass environmental remediation costs to customers via regulated rates, while Duke Energy must accrue reserves for probable liabilities and lacks guaranteed recovery, leading to greater financial exposure. The LLM correctly identifies the structural difference in regulatory treatment and financial impact. (2) Quantitative accuracy is perfect—there are no specific dollar amounts in the original answer (only a placeholder $X million), and the LLM appropriately avoids fabricating numbers, instead focusing on the conceptual distinction. (3) Multi-hop reasoning is sound: the model synthesizes information across regulatory frameworks, accounting policies, and risk disclosures, correctly linking Southern Company’s cost recovery (via accounting policy) to reduced liability exposure, and Duke Energy’s risk factor disclosures to direct financial exposure. (4) Semantic equivalence is strong—though the LLM uses slightly different phrasing (e.g., 'amortize those costs', 'open-ended liabilities'), the meaning matches the original. The only minor shortcoming is the reference to 'KG link' and specific knowledge graph syntax (e.g., 'RISK_FACTOR → DUK'), which, while indicative of correct source data, may reflect internal metadata not typically expected in a final answer and slightly detract from clarity. However, this does not impair factual correctness. Overall, the response is complete, contextually relevant, and demonstrates strong qualitative and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Includes]-> RISK_FACTOR <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 456,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "What is the combined total of securities remaining available for future issuance under equity compensation plans approved by security holders for Caterpillar and Johnson & Johnson, and how does this compare to 3M's total available securities under similar plans?",
      "original_answer": "The combined total of securities remaining available for future issuance under equity compensation plans approved by security holders for Caterpillar (40,873,176) and Johnson & Johnson (111,042,139) is 151,915,315. This is significantly higher than 3M's total of 39,563,000 available securities under the same category.",
      "llm_answer": "\nCaterpillar’s equity‑compensation plans have **40,873,176** shares remaining (Chunk 1), Johnson & Johnson’s plans have **111,042,139** shares remaining (Chunk 2), and 3M reports **39,563 (thousand)** shares remaining, i.e., about **39.6 million** shares (Chunk 3). Thus, the combined Caterpillar‑and‑J&J total of **151,915,315** shares is roughly **3.8 ×** the number of shares available under 3M’s plans.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: Caterpillar's 40,873,176, Johnson & Johnson's 111,042,139, and 3M's 39,563,000 (correctly interpreted from '39,563 thousand' as ~39.6 million). (2) The combined total is correctly calculated: 40,873,176 + 111,042,139 = 151,915,315, matching the ground truth. (3) The comparison to 3M’s total is both numerically and semantically accurate — stating that the combined total is 'roughly 3.8×' 3M’s availability is correct (151,915,315 ÷ 39,563,000 ≈ 3.84). (4) All entities (Caterpillar, Johnson & Johnson, 3M) and the metric — securities remaining available for future issuance under equity compensation plans approved by security holders — are correctly identified and applied. (5) The multi-hop reasoning is sound: the model correctly synthesizes data across three separate companies, performs the correct summation, and makes a valid comparative statement. Wording differs slightly (e.g., 'shares' vs 'securities'), but this is semantically equivalent in context. No factual, quantitative, or logical errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 319,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How do Merck's Januvia and Janumet U.S. market exclusivity expiration timelines (May 2026) and IRA-imposed pricing constraints compare to Pfizer's regulatory exclusivity strategy, and what does this indicate about their respective post-2025 revenue protection mechanisms?",
      "original_answer": "Merck’s Januvia and Janumet are set to lose U.S. market exclusivity in May 2026 due to patent settlements and court rulings, with Janumet XR following in July 2026. Despite this, the IRA mandates government price-setting for Januvia starting in 2026 and for Janumet/Janumet XR in 2027, adding pricing pressure. In contrast, Pfizer relies on both patent rights and concurrent regulatory exclusivity periods upon drug approval to protect revenue beyond patent terms. This indicates that Merck is managing near-term exclusivity erosion through price adjustments and rebate reductions, while Pfizer’s strategy emphasizes regulatory exclusivity as a parallel shield alongside patents, suggesting divergent approaches to post-2025 revenue sustainability.",
      "llm_answer": "\nMerck’s Januvia loses U.S. market exclusivity in May 2026 and Janumet XR in July 2026, and the IRA will impose government‑price caps on Januvia in 2026 and on Janumet in 2027, pressures that have already prompted a list‑price cut and a lawsuit by the company (Chunk 1).  \nPfizer’s post‑2025 revenue shield is built on its patent portfolio together with regulatory exclusivity mechanisms—such as 5‑year patent term extensions, orphan‑drug and pediatric exclusivity—that can keep market protection alive well beyond the basic patent expiry (Chunks 2 & 3).  \nThus, Merck’s protection is being dismantled by a fixed exclusivity date and IRA pricing constraints, whereas Pfizer is extending its exclusivity through layered IP and regulatory safeguards, indicating a more durable revenue horizon after 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the key dates for Merck's Januvia and Janumet exclusivity expirations: May 2026 for Januvia and July 2026 for Janumet XR, aligning with the ground truth. It accurately notes IRA price-setting starting in 2026 for Januvia and 2027 for Janumet/Janumet XR. The mention of a list-price cut and lawsuit adds contextual detail not in the original but does not contradict it. For Pfizer, the answer correctly describes reliance on regulatory exclusivity mechanisms (e.g., patent term extensions, orphan-drug, pediatric exclusivity) as a complement to patents, which matches the ground truth’s emphasis on layered protection. 2) All dates and years are factually correct: May 2026, July 2026, 2026 and 2027 for IRA implementation. No calculations are required, and all numeric references are accurate. 3) The multi-hop reasoning is sound: the model synthesizes Merck’s patent-based exclusivity timeline with IRA pricing constraints and contrasts it with Pfizer’s use of regulatory exclusivity as a post-patent revenue shield. The conclusion about divergent strategies—Merck facing fixed exclusivity erosion vs. Pfizer’s extended protection—is logically derived and semantically equivalent to the original. 4) The only minor shortcoming is that the LLM answer does not explicitly mention 'Janumet' (non-XR) losing exclusivity in May 2026, only referencing Janumet XR in July 2026 and Janumet in the context of IRA pricing. This is a slight omission but does not undermine the overall correctness. Otherwise, the answer is factually accurate, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> REGULATORY_REQUIREMENT -[Provides]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 442,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the credit event risk associated with MS's investments in CLNs, which embed credit protection sold to issuers, compare to BAC's use of credit derivatives to mitigate commercial credit exposure, particularly in terms of how each firm manages counterparty risk through derivative instruments?",
      "original_answer": "Morgan Stanley (MS) invests in CLNs and CDOs, which are hybrid instruments containing embedded derivatives in which credit protection has been sold to the issuer of the note. If there is a credit event of a reference entity underlying the instrument, the principal balance of the note may not be repaid in full to the firm, indicating a direct exposure to counterparty risk. This contrasts with Bank of America (BAC), which actively purchases credit protection to cover both funded and unfunded portions of certain credit exposures as part of its commercial credit risk management strategy. BAC also uses credit derivatives to hedge risk, with changes in fair value recorded in other income. Both firms utilize credit derivatives, but MS assumes risk by investing in instruments where it has sold protection, while BAC mitigates risk by purchasing protection.",
      "llm_answer": "\nMorgan Stanley’s CLN and CDO investments are hybrid instruments that embed credit‑protection sold to the note issuer, so if a credit event of the reference entity occurs the firm may not recover the full principal—exposing it to issuer‑specific credit‑event risk—and the knowledge‑graph link shows that this embedded protection depends on BAC.  \nBank of America manages commercial credit exposure by actively buying and selling credit derivatives to hedge both funded and unfunded loan positions, using borrower ratings, collateral, country/industry concentrations and risk‑rating aggregations to monitor counterparty risk, and it carries these derivatives at fair value rather than as accounting hedges.  \nConsequently, MS’s credit‑event risk arises from the possibility of non‑repayment tied to the CLN issuer, whereas BAC’s risk is mitigated through a proactive derivatives‑based hedging program that offsets exposure across its commercial portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its qualitative description of how Morgan Stanley (MS) and Bank of America (BAC) use credit derivatives, but contains a critical factual error that undermines the multi-hop reasoning. (1) Correct elements: MS's investments in CLNs and CDOs do embed credit protection sold to issuers, exposing it to credit event risk if the reference entity defaults—this matches the ground truth. BAC does use credit derivatives to hedge commercial credit exposure, including both funded and unfunded exposures, and carries them at fair value, which aligns with the original answer. The contrast in risk posture—MS assuming risk by selling protection, BAC mitigating risk by buying protection—is conceptually accurate. (2) Quantitative accuracy is not applicable as no numerical values are present in either answer; thus, no errors in numbers, dates, or calculations exist. (3) However, the LLM introduces a significant factual inaccuracy: it claims 'the embedded protection depends on BAC', which is not supported by the ground truth and introduces a false linkage between MS's CLN exposure and BAC as a counterparty or dependency. This misrepresents the relationship between the two firms and reflects a failure in multi-hop reasoning—there is no indication in the original answer that BAC is involved in MS's CLN structures. (4) Contextual relevance is high, as the response directly addresses the comparison of credit event risk and counterparty risk management via derivatives. The structure and intent of the answer are sound, but the erroneous inter-firm dependency reduces qualitative accuracy. Thus, while core concepts are correct, the introduction of unsupported linkage lowers the correctness and qualitative scores despite strong overall framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Offers]-> FIN_INST <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 481,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How does the indemnification structure established by 3M in connection with Solventum's spin-off compare to RTX's indemnification arrangements for its financial guarantees, particularly regarding the transfer of liability and the recognition of potential losses?",
      "original_answer": "3M transferred certain liabilities to Solventum as part of the spin-off, including those related to the Bair Hugger and Federal False Claims Act/Qui Tam Litigation, with Solventum assuming indemnification and defense obligations. 3M records liabilities for legal proceedings when probable and estimable, and discloses possible losses when not accrued. Similarly, RTX is subject to indemnification for certain liabilities under its financial guarantees, which could affect its financial exposure. Both companies recognize indemnification rights or obligations as part of their liability management, but 3M explicitly transferred liability to a spun-off entity, whereas RTX retains exposure subject to third-party indemnification terms. This distinction affects how each company accounts for contingent liabilities and insurance receivables under ASC 450 and ASC 610-30.",
      "llm_answer": "\nRTX’s indemnification for its third‑party guarantees (Note 16) obligates the guarantor to cover any liability that may arise from those guarantees, and RTX evaluates such contingent losses under ASC 450—accruing them only when they are probable and reasonably estimable. In the Solventum spin‑off, 3M’s separation and distribution agreement transfers specific litigation liabilities to Solventum and requires Solventum to indemnify and defend 3M for those assumed matters, with 3M again applying ASC 450 to accrue or disclose losses when they become probable and estimable. Thus, while both entities use the same loss‑contingency accounting, RTX’s indemnity is tied to guarantee‑related liabilities, whereas 3M’s indemnity shifts liability to Solventum and is triggered by the spin‑off‑related transfer of legal claims.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: both 3M and RTX apply ASC 450 for recognizing contingent losses, with accruals made only when losses are probable and reasonably estimable. The answer correctly identifies that 3M transferred specific litigation liabilities (e.g., Bair Hugger, FCA/Qui Tam) to Solventum via the spin-off agreement, with Solventum assuming indemnification and defense obligations. RTX’s indemnification relates to third-party financial guarantees, as noted in Note 16, and does not involve a transfer of liability to a spun-off entity. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (3M and RTX), two types of indemnification structures (spin-off vs. financial guarantees), and accounting standards (ASC 450 and implied reference to ASC 610-30). The distinction between liability transfer (3M) versus retained exposure subject to indemnification (RTX) is clearly and correctly articulated. (4) The only minor shortcoming is that the LLM does not explicitly mention ASC 610-30, which the original answer notes as relevant to the accounting for spin-offs. While implied through context, this omission slightly reduces completeness in technical accounting precision. However, the core comparison—how indemnification affects liability transfer and loss recognition—is accurately conveyed. Wording differs but semantic equivalence is strong. Contextual relevance is excellent, directly addressing all aspects of the comparative indemnification structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Discloses]-> COMP <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 466,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does the geographic revenue distribution of AMD in Taiwan compare to the potential supply chain risk NVIDIA faces through its foundry partners operating in the same region, given the geopolitical tensions mentioned in both companies' filings?",
      "original_answer": "AMD reported $1,841 million in sales to external customers from Taiwan in 2023, highlighting the region's significance in its revenue distribution. Meanwhile, NVIDIA explicitly states that its foundry partners—critical to its chipset supply—are primarily located in Taiwan, and a significant or prolonged geopolitical conflict involving China and Taiwan could severely limit or prevent NVIDIA from receiving chipset supply. This indicates that while Taiwan is a notable market for AMD's sales, it represents a core supply chain vulnerability for NVIDIA due to its dependency on foundry partners operating in the region.",
      "llm_answer": "\nAMD’s 2023 sales included $1.84 billion (about 8 % of its $22.68 billion total) from Taiwan—down from roughly 12 % in 2021—showing a modest geographic revenue footprint in that market.  Both NVIDIA and AMD flag in their 10‑K filings that Taiwan is a critical node for their foundry partners, and geopolitical tensions there could “severely limit or prevent” the supply of chipsets; NVIDIA’s risk is especially acute because its GPU production depends on those Taiwanese foundries, whereas AMD’s exposure is limited to a relatively small share of its overall revenue.  (The KG link NVDA → Foundry Partners → Taiwan ← Operates_In AMD illustrates how the same region underpins both AMD’s revenue and NVIDIA’s supply‑chain vulnerability.)",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $1.84 billion in AMD sales to Taiwan in 2023 is correctly reported (equivalent to $1,841 million in the original answer). The total revenue of $22.68 billion is not in the ground truth but is factually correct based on AMD's 2023 10-K and supports the 8% calculation, which is accurate (1,841 / 22,680 ≈ 8.1%). The comparison to 12% in 2021 adds context not in the original answer but does not contradict it. (2) The qualitative reasoning correctly identifies that Taiwan is a revenue market for AMD but a critical supply chain node for NVIDIA due to foundry dependencies. It accurately reflects both companies' 10-K disclosures about geopolitical risks. (3) The multi-hop synthesis—linking AMD’s revenue exposure, NVIDIA’s supply chain reliance, and shared regional risk in Taiwan—is sound and well-articulated. (4) The mention of the KG link is interpretive but helps illustrate the interconnected risk, adding value without introducing error. The only minor shortcoming is that the original answer emphasizes NVIDIA’s *explicit* statement about foundry partners being in Taiwan, while the LLM slightly generalizes this; however, the core risk is correctly conveyed. All entities (AMD, NVIDIA, Taiwan, foundry partners), years (2023), and financial metrics are accurate. Wording differs but semantic meaning matches. Thus, the answer earns a 9 for correctness—excellent but not perfect—due to slight over-contextualization without full citation of NVIDIA’s explicit wording.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 430,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does NEER's 15-year weighted average contract term for repowered wind facilities influence long-term revenue predictability, and how might this structural advantage compare to Southern Power's reliance on power sales agreements where specific contract terms are not disclosed?",
      "original_answer": "NEER benefits from a 15-year weighted average remaining contract term on its power sales agreements tied to repowered wind facilities, which enhances revenue predictability by locking in long-term pricing and output commitments. In contrast, Southern Power discloses its reliance on power sales agreements but does not specify contract durations, limiting visibility into its own revenue stability. This difference suggests NEER may have a more transparent and structured approach to securing long-term cash flows from renewable assets, which could influence investor confidence and financial planning strategies.",
      "llm_answer": "\nNEER’s 2023 filing shows that its generation fleet is covered by long‑term power‑sales agreements with a **weighted‑average remaining term of roughly 15 years**, which includes the full life of the production‑tax credits on repowered wind facilities; this multi‑year, contractually‑defined horizon locks in pricing and tax‑credit cash flows, giving NEER a high degree of **revenue predictability** that can be modeled against forecasted output. By contrast, Southern Power’s Power Sales Agreements are listed as a disclosed instrument in its own filing, but the filing does **not disclose the individual contract terms or durations**, so the length and stability of those cash flows cannot be assessed with the same certainty. (Chunk 2 provides the 15‑year weighted‑average term and the fact that NEER’s contracts cover “substantially all” of its capacity, while Chunk 1 references Southern Power’s PSAs without detail, and Chunk 3 reinforces that NEER’s long‑term contracts are a core, regulated‑style element of its business, whereas Southern Power’s terms remain opaque.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 15-year weighted-average remaining contract term for NEER is correctly stated, matching the original answer. There are no calculations required, but the reference to 'roughly 15 years' is consistent with the ground truth's '15-year weighted average remaining contract term.' (2) The LLM correctly identifies that Southern Power does not disclose specific contract terms or durations, which limits revenue visibility—this matches the original answer’s point about lack of disclosure. (3) Multi-hop reasoning is sound: the model synthesizes information across NEER’s disclosed long-term contracts (including tax credit alignment) and contrasts it with Southern Power’s lack of term disclosure, drawing a valid comparison about revenue predictability and transparency. (4) The only minor shortcoming is that the LLM adds detail not in the original—specifically linking the 15-year term to production tax credits and stating contracts cover 'substantially all' capacity—which, while plausible and contextually reasonable, slightly extends beyond the scope of the provided ground truth. However, this does not introduce inaccuracy but adds nuance. Overall, the core facts, entities (NEER, Southern Power), and reasoning are correct and relevant, making the answer semantically equivalent and highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Has_Stake_In]-> PRODUCT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 387,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does RTX's revenue recognition practices under FAR guidelines for U.S. government fixed-price contracts compare to Honeywell's exposure to contract termination risks under the same regulatory framework?",
      "original_answer": "RTX recognizes revenue in excess of billings under U.S. government fixed-price contracts due to performance-based or progress payments that typically cover only 80-90% of costs incurred, creating contract assets. These practices are governed by the FAR, which outlines allowable costs and payment structures. Honeywell, also subject to the FAR, faces unique risks such as the U.S. government's right to terminate contracts for convenience, which could impact its contract assets or liabilities similarly structured. Both companies are bound by the same FAR-regulated payment and cost frameworks, but Honeywell's risk profile includes potential contract termination that could disrupt revenue already recognized under FAR-compliant accounting practices.",
      "llm_answer": "\nRTX records revenue on U.S. government fixed‑price contracts by applying FAR‑mandated progress‑payment and performance‑based‑payment rules—recognizing revenue on a percentage‑of‑completion basis for long‑term aftermarket services, recording contract assets when billings lag revenue and contract liabilities for advances—all of which is governed by the FAR‑U.S. government‑contracts relationship highlighted in the KG link **RTX → FAR → U.S. Government Contracts**; Chunk 2 confirms that the same FAR (and its Cost Accounting Standards) subjects those contracts to audit and cost‑allowability reviews. In contrast, Honeywell’s disclosures (Chunk 3) stress that, under the identical FAR framework, its government contracts can be terminated for convenience or performance failures, triggering audits, possible price adjustments and refunds, creating a distinct exposure to contract‑termination risk that co‑exists with the shared regulatory regime.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies RTX's revenue recognition practices under FAR for U.S. government fixed-price contracts, including the use of progress and performance-based payments, percentage-of-completion accounting, and the creation of contract assets when revenue exceeds billings—consistent with the original answer. It also accurately notes that these are governed by FAR and subject to audit and cost-allowability reviews. For Honeywell, it correctly highlights the risk of contract termination for convenience or performance failures under the same FAR framework, which introduces exposure to audits, price adjustments, and refunds—directly matching the original answer’s emphasis on termination risk. (2) There are no numeric values (e.g., percentages, dollar amounts) in the original answer beyond the 80-90% range mentioned in the ground truth, which the LLM omits. However, this detail is not included in the LLM’s response, so while it's a minor omission, it does not distort any calculation or factual claim. All other qualitative financial terms (contract assets, liabilities, progress payments) are used correctly. (3) The multi-hop reasoning is sound: the model synthesizes RTX’s accounting practices and Honeywell’s risk exposure under the shared FAR framework, correctly identifying both common regulatory grounding and divergent risk profiles. (4) The answer is contextually precise, directly addressing the comparison between RTX’s revenue recognition and Honeywell’s termination risks under FAR. The only reason for not scoring a 10 is the omission of the specific 80-90% payment coverage detail, which is a minor but relevant nuance in explaining why contract assets arise. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Regulates]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 505,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does the absence of voting rights associated with Alphabet's Class C Capital Stock compare to Comcast's relinquishment of voting rights in Hulu, particularly in terms of governance control and financial outcomes?",
      "original_answer": "Alphabet's Class C Capital Stock has no voting rights except as required by law, which allows the company to maintain control through higher-vote Class A and Class B shares while repurchasing non-voting shares to optimize capital structure. In 2024, Alphabet had $44.7 billion remaining available for Class A and Class C share repurchases. In contrast, Comcast relinquished substantially all voting rights in Hulu in 2019, giving Disney full operational control, and exercised a put option in 2023 to sell its interest for a minimum equity value of $9.2 billion. This resulted in a $8.6 billion payment from Disney (net of $557 million for prior capital calls) and a recorded investment value of $883 million as of December 31, 2024. Both companies strategically managed voting rights to influence governance and financial returns, albeit through different mechanisms and outcomes.",
      "llm_answer": "\nAlphabet’s Class C capital stock carries no voting rights, and its 10‑K shows that the company repurchased $59.3 bn, $62.2 bn and $62.0 bn of Class A and C shares in 2022‑24 and has a $70 bn buy‑back reserve with $44.7 bn still available, so control rests solely with Class A/B shareholders while financial exposure is managed through large‑scale equity retirements; in contrast, Comcast voluntarily surrendered essentially all voting rights and board seats in Hulu, retained a ~33 % equity stake, received an $8.6 bn cash payment (of which $9.2 bn represented the minimum equity value) and a tax gain, and holds a $5.1 bn equity‑method investment that is collateralized by a $5.2 bn term loan and a $1.4 bn unfunded capital commitment, a governance shift that the knowledge‑graph ties to Comcast’s disclosure of the voting‑rights policy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in financial figures and investment valuations. While it correctly notes Alphabet's Class C shares have no voting rights and that repurchases occurred, the repurchase amounts ($59.3B, $62.2B, $62.0B for 2022–24) are not present in the ground truth and contradict the original answer, which only states $44.7B remained available for future repurchases as of 2024—no annual repurchase figures were provided in the ground truth. The $70B buyback reserve is also not mentioned in the original, making this an unsupported addition. For Comcast, the LLM claims a $5.1B equity-method investment and a $1.4B unfunded commitment, but the ground truth states the investment was valued at $883M as of December 31, 2024—this is a major discrepancy. The $8.6B payment from Disney is correctly cited, but the framing is off: the $9.2B is the minimum equity value, not part of the $8.6B. Additionally, the tax gain and collateralized loan details are not in the ground truth and appear to be hallucinated. (2) Quantitative accuracy is low due to incorrect or fabricated numbers: repurchase amounts, buyback reserve, investment value ($5.1B vs $883M), and capital commitment are all wrong. Only the $8.6B payment and $44.7B remaining repurchase capacity align with the original. (3) The multi-hop reasoning is partially sound—LLM correctly contrasts Alphabet’s structural control via share classes with Comcast’s relinquishment of Hulu voting rights. It identifies the strategic use of voting rights for governance and financial outcomes, which matches the question’s intent. However, the synthesis includes unsupported financial details, weakening the reasoning. (4) Contextual relevance is high—the answer addresses governance control and financial outcomes for both companies and attempts a direct comparison. Despite factual errors, the structure and intent align well with the question. Correctness score is 6 due to core correct concepts but significant factual and numerical errors that affect financial interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 561,
        "total_tokens": 2009
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "Given LLY's ongoing challenges scaling production of incretin products while relying on third-party manufacturers, and TMO's $26.92 billion in remaining performance obligations—many tied to contract manufacturing over 3-5 year durations—how might shared vulnerabilities in quality assurance and supply chain execution affect both companies' ability to fulfill long-term commitments?",
      "original_answer": "LLY is experiencing intermittent supply delays for incretin products like Mounjaro and Zepbound, with tight supply expected to persist until additional manufacturing capacity becomes operational 'in the next several years.' These production constraints are tied to reliance on third-party manufacturers, which face quality assurance risks that could lead to regulatory actions, product recalls, or delays in approvals. Meanwhile, TMO has $26.92 billion in remaining performance obligations, with a significant portion linked to contract manufacturing agreements that typically span 3-5 years. If third-party manufacturers fail to maintain quality standards or encounter capacity limitations—as AMD also highlights in its 10-K—both companies could face fulfillment risks: LLY may struggle to meet patient demand amid supply volatility, while TMO could face delays or defaults on long-term manufacturing contracts, impacting revenue recognition and customer relationships.",
      "llm_answer": "\nLLY’s incretin pipeline is produced by third‑party manufacturers that operate under intense GMP scrutiny; any quality‑assurance lapse or capacity shortfall—such as the intermittent delays and supply‑tightening LLY describes and the “material adverse effect” risk AMD warns about for its own contract makers—directly jeopardizes the reliability of those suppliers. Because TMO’s $26.92 billion of remaining performance obligations are tied to long‑term (3‑5 year) contract‑manufacturing arrangements, a disruption in the same third‑party facilities would impair TMO’s ability to meet those commitments, exposing both companies to material financial, regulatory and reputational consequences.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: LLY's reliance on third-party manufacturers, ongoing supply constraints for incretin products (Mounjaro/Zepbound), and the expectation that tight supply will persist for several years. TMO's $26.92 billion in remaining performance obligations is accurately cited, as is the 3-5 year duration of its contract manufacturing agreements. The reference to AMD’s 10-K warning about material adverse effects due to third-party manufacturing risks is correctly incorporated. (2) Quantitative accuracy is perfect: the $26.92 billion figure is exact and properly contextualized. No calculations were required, but the use of numbers is precise and consistent with the original. (3) Multi-hop reasoning is sound: the model correctly synthesizes risks across LLY, TMO, and AMD, identifying shared vulnerabilities in third-party manufacturing affecting both patient supply (LLY) and long-term contract fulfillment (TMO). It logically infers that disruptions in shared or similarly situated suppliers could simultaneously impact both companies. (4) The only minor shortcoming is a slight lack of specificity regarding LLY’s own timeline—while 'next several years' is paraphrased as implied context, it isn’t explicitly stated in the LLM answer—but this does not detract from overall correctness. Wording differs but semantic meaning and factual content are equivalent. The answer is fully relevant, focused, and conveys the core risk: shared QA and supply chain vulnerabilities threaten both patient access and revenue commitments.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> PRODUCT -[Negatively_Impacts]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 441,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What was the total cumulative impairment charge recognized by NextEra Energy Resources on its investment in XPLR as of December 31, 2024, and how does this compare to the carrying value of the investment before the 2024 impairment?",
      "original_answer": "As of December 31, 2024, NextEra Energy Resources had recognized a cumulative impairment charge of $2.0 billion on its investment in XPLR, combining the $1.2 billion impairment from September 30, 2023, and the $0.8 billion impairment from December 31, 2024. The carrying value of the investment before the 2024 impairment was approximately $2.6 billion, which was then written down to $1.8 billion after the 2024 impairment.",
      "llm_answer": "\nNextEra Energy Resources recorded a $0.8 billion (pre‑tax) other‑than‑temporary‑impairment on its equity‑method investment in XPLR as of December 31 2024, writing the carrying amount down from roughly **$2.6 billion** (the amount before the 2024 charge) to about **$1.8 billion** (Chunk 2).  This impairment is part of NEE’s total equity‑method portfolio of **≈ $6.1 billion** reported at year‑end (Chunk 3) and originates from the partnership relationship between DUK, NextEra Energy and XPLR shown in the knowledge‑graph (Chunk 1).  Thus, the 2024 impairment represents roughly a **31 % reduction** of the investment’s pre‑impairment carrying value.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $0.8 billion 2024 impairment and the pre- and post-impairment carrying values of $2.6 billion and $1.8 billion, which aligns with the ground truth. However, it fails to mention the prior $1.2 billion impairment from September 30, 2023, and thus omits the total cumulative impairment of $2.0 billion, which is the first and critical part of the question. This omission severely impacts completeness and factual accuracy. (2) The numbers cited for the 2024 impairment and carrying values are accurate, and the implied 31% reduction ($0.8B / $2.6B ≈ 30.8%) is correct. However, the absence of the $1.2B prior impairment means the cumulative total is missing, making the quantitative response incomplete. Calculations based on provided numbers are sound, but the full multi-hop synthesis is not achieved. (3) The reasoning correctly links the 2024 impairment to the change in carrying value and references the equity-method context and portfolio size, showing good qualitative understanding. However, it does not synthesize across both impairment events (2023 and 2024), failing the multi-hop requirement to aggregate cumulative charges. (4) The answer is contextually relevant and well-structured, but the failure to report the cumulative $2.0 billion charge—central to the question—reduces correctness significantly. While the 2024-specific details are accurate, the omission of prior impairment renders the overall answer partially correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP -[Discloses]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 410,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does the adoption of ASU 2022-04 by GE impact its transparency around supplier finance obligations compared to MMM's disclosures under the same standard, particularly in terms of confirmed invoice balances and presentation in financial statements?",
      "original_answer": "GE adopted ASU 2022-04 on January 1, 2023, which requires retrospective disclosures for supplier finance programs, with the annual roll-forward information applicable prospectively starting January 1, 2024. This means GE began disclosing key terms, balance sheet presentation, and confirmed amounts outstanding from its supplier finance programs in 2024. Similarly, MMM discloses that as of December 31, 2024 and 2023, its outstanding balances of confirmed invoices under supplier finance programs were approximately $0.3 billion each, and these amounts are included within accounts payable on MMM's consolidated balance sheet. Both companies now provide clearer visibility into their supplier finance obligations under the new standard, with MMM specifically quantifying its confirmed invoice balances and their classification in accounts payable, aligning with the enhanced disclosure requirements introduced by ASU 2022-04.",
      "llm_answer": "\nGE adopted ASU 2022‑04 on January 1 2023, which now requires it to disclose the supplier‑finance program’s key terms, present the related liability on the balance sheet, report the confirmed invoice amount outstanding at period‑end, and provide roll‑forward information (Chunk 2); the adoption itself did not materially affect GE’s consolidated financial statements (Chunk 1). MMM, which already follows the same guidance, discloses a $0.3 billion confirmed‑invoice balance included in accounts payable and details $1.5 billion of invoices confirmed and paid in 2024 (Chunk 3), illustrating the level of transparency the standard now demands. Consequently, GE’s adoption aligns its reporting with MMM’s practice, improving comparability and visibility of supplier‑finance obligations in the financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that GE adopted ASU 2022-04 on January 1, 2023, and that the standard requires disclosures about key terms, balance sheet presentation, and confirmed invoice amounts, with roll-forward information starting prospectively in 2024. It accurately states that MMM discloses $0.3 billion in confirmed invoice balances for both 2024 and 2023, and that these are included in accounts payable—matching the ground truth. The mention of $1.5 billion of invoices confirmed and paid in 2024 by MMM is not in the original answer but does not contradict it; however, this detail was not part of the ground truth and thus introduces unverified information, slightly reducing qualitative accuracy. (2) All numeric values—$0.3 billion, January 1, 2023 adoption date—are correct and match the original. Format variations are acceptable and handled appropriately. (3) The multi-hop reasoning is sound: the model correctly compares GE’s adoption timeline and disclosure requirements under ASU 2022-04 with MMM’s actual disclosures, concluding that both now provide greater transparency and improved comparability. It synthesizes information across entities (GE vs. MMM) and time (adoption date vs. disclosure timing). The only minor gap is that the original emphasizes GE will begin full disclosures in 2024 (due to prospective roll-forward), which the LLM captures implicitly but could have been more explicit. (4) The answer is highly relevant, directly addressing the impact on transparency, confirmed invoice balances, and financial statement presentation. The extra detail about $1.5 billion is contextually plausible but not confirmed by the ground truth, preventing a perfect score. Overall, the answer is factually accurate, well-reasoned, and semantically equivalent to the original with high completeness and precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Adopts]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Agrees]- ORG",
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 504,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does Altria's equity-method accounting for its Cronos investment expose it to financial risks tied to Cronos's compliance with FDA regulations, and how does this compare to Walmart's exposure through its pharmacy operations under the same regulatory framework?",
      "original_answer": "Altria's investment in Cronos is accounted for under the equity method, meaning its financial statements reflect Altria's share of Cronos's earnings or losses. Since Cronos operates in the cannabis-derived product space, it is subject to FDA regulations in the U.S., and any failure to comply could result in fines, penalties, or reputational harm, directly impacting Cronos's financial performance and, by extension, Altria's earnings. Walmart also faces exposure through its pharmacy operations, which must comply with FDA regulations governing the dispensing and sale of pharmaceuticals. Walmart notes that noncompliance could lead to significant sanctions and operational disruptions, mirroring the regulatory risk profile faced by Cronos. Both companies are thus financially exposed to the same regulatory framework, though through different business models and investment structures.",
      "llm_answer": "\nAltria records its Cronos stake using the equity‑method, so any FDA action that restricts Cronos’s cannabis‑derived product pipeline or forces a recall would depress Cronos’s earnings, cause Altria to recognize its share of the loss and potentially impair the investment’s carrying value—directly lowering Altria’s net income and exposing it to capital‑cost and reputational risk (Chunk 1 & 2).  In contrast, Walmart’s pharmacy operations are subject to the same FDA (and DEA) rules, but the regulatory risk is borne directly by Walmart; non‑compliance can trigger fines, product seizures or litigation that hit Walmart’s own earnings and cash flow without the indirect equity‑method amplification (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Altria uses equity-method accounting for its investment in Cronos, meaning it recognizes its share of Cronos's earnings or losses; any FDA-related compliance issues affecting Cronos would negatively impact its financial performance and thereby Altria’s reported income and potentially lead to an impairment. Walmart, by contrast, faces direct regulatory exposure through its pharmacy operations due to FDA (and DEA) compliance requirements, which could result in fines, seizures, or litigation. These points are all consistent with the original answer. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable in a traditional sense—no discrepancies exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes how two different companies—Altria via an equity-method investee (Cronos), and Walmart via direct operations—are exposed to the same FDA regulatory framework but through structurally different pathways. The distinction between indirect equity-method exposure and direct operational exposure is clearly and correctly articulated. (4) The only reason for not awarding a perfect 10 is minor: the LLM mentions DEA in addition to FDA for Walmart, which, while contextually reasonable, is not in the original answer and slightly extends beyond the provided ground truth. However, this does not detract from factual correctness. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> COMP -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 446,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does LLY's reliance on Cardinal Health for U.S. distribution impact CVS's consolidated financial exposure to Red Oak Sourcing, given Cardinal's dual role in the joint venture?",
      "original_answer": "LLY depends on Cardinal Health for 15-20% of its U.S. revenue through distribution, which makes Cardinal a critical link in LLY's supply chain. Cardinal also co-owns Red Oak Sourcing with CVS, a generic pharmaceutical sourcing entity that CVS consolidates due to its primary beneficiary status. As part of the Red Oak arrangement, Cardinal makes quarterly payments to CVS (e.g., $183 million annually as of 2021), which reduce CVS's inventory costs. Therefore, any disruption in Cardinal's ability to distribute LLY products could affect Cardinal’s financial health, which in turn could impact its ability to meet its financial commitments to Red Oak—and consequently, CVS’s consolidated financial position.",
      "llm_answer": "\nLLY’s U.S. revenue is concentrated on a few wholesale distributors, and Cardinal Health alone accounts for roughly 15‑20 % of that revenue, so any change in Cardinal’s distribution terms directly influences LLY’s cash flow. Because Cardinal is a 50 % partner in Red Oak Sourcing—a VIE that CVS consolidates and for which it receives quarterly payments that began in 2014 and run through 2029 (payments that reduce CVS’s inventory cost and are recorded in cost of products sold), LLY’s reliance on Cardinal creates a financial linkage: the same distributor that supplies LLY also funnels cash‑flow adjustments through the Red Oak joint venture, exposing CVS’s consolidated results to the performance and payment schedule of that arrangement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with strong multi-hop reasoning. (1) Quantitatively, all key figures are correct: the 15-20% U.S. revenue reliance on Cardinal Health is accurately stated; the $183 million annual payment (implied in the ground truth for 2021) is consistent with the LLM’s reference to quarterly payments through 2029, though the exact dollar amount is not specified in the LLM answer—this is a minor omission but not incorrect. The time frame (2014–2029) is correctly included, which aligns with known Red Oak Sourcing agreement terms. (2) The answer is complete: it addresses LLY’s reliance on Cardinal, Cardinal’s 50% ownership in Red Oak Sourcing, CVS’s consolidation of Red Oak as a VIE (variable interest entity), and the financial impact via reduced inventory costs due to Cardinal’s payments. (3) Entity accuracy is strong: LLY, Cardinal Health, CVS, and Red Oak Sourcing are all correctly identified with their respective roles. The use of 'VIE' and 'cost of products sold' reflects proper accounting terminology. (4) The reasoning is sound—LLM correctly links LLY’s supply chain dependency on Cardinal to the financial stability of Cardinal’s obligations under the Red Oak joint venture, thereby exposing CVS’s consolidated results to potential disruptions. The only minor gap is that the LLM does not explicitly state that a disruption in Cardinal’s distribution could impair its ability to make payments to Red Oak (and thus affect CVS), which is a key causal chain in the ground truth. However, the implication is present through the 'financial linkage' description. Overall, the answer is semantically equivalent and factually correct, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Depends_On]-> COMP <-[Consolidates]- ORG",
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 473,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does Oracle's use of its $6.0 billion commercial paper program for short-term financing compare to Cisco's debt structure, particularly in light of Cisco's $13.5 billion senior fixed-rate note issuance and the pari passu ranking of those notes with commercial paper obligations?",
      "original_answer": "Oracle utilizes a $6.0 billion commercial paper program for short-term financing, with $401 million in outstanding notes as of May 31, 2024, which mature through August 2024. These notes are unsecured and issued under a private placement exemption. In contrast, Cisco issued $13.5 billion in senior fixed-rate notes in February 2024, which are redeemable at any time with a makewhole premium and are ranked at par with Cisco’s own commercial paper obligations. This indicates that while both companies use commercial paper as part of their short-term financing strategies, Cisco has a significantly larger long-term debt component through its senior notes, which are hedged via interest rate swaps to manage interest rate exposure.",
      "llm_answer": "\nOracle maintains a $6.0 billion unsecured commercial‑paper program, with $401 million of notes outstanding as of May 2024, and it records substantial restructuring expenses (e.g., $432 million in fiscal 2024) that affect its cash‑flow profile. Cisco, meanwhile, issued $13.5 billion of senior fixed‑rate notes in February 2024 and, as disclosed, those notes rank at par (pari passu) with its commercial‑paper notes, sharing the same seniority, repayment rights and a $0.5 billion interest‑rate swap that hedges part of the fixed‑rate exposure; the notes are also redeemable with a make‑whole premium and were in compliance with all debt covenants as of July 2024. Thus, Oracle relies on its commercial‑paper program as a primary short‑term financing source, whereas Cisco’s larger long‑term note issuance is structurally equivalent in priority to its own CP obligations, illustrating a different but equally senior‑ranked approach to leveraging debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key numbers are correct: Oracle's $6.0 billion commercial paper program, $401 million outstanding as of May 2024 (ground truth specifies May 31, 2024—minor rounding in month reference is acceptable), Cisco's $13.5 billion senior fixed-rate notes issued in February 2024, and the pari passu ranking with commercial paper. The mention of a $0.5 billion interest-rate swap aligns with the ground truth's reference to hedging via swaps, though the exact notional amount was not in the original answer—this is a minor addition but not factually inconsistent. (2) Quantitative accuracy is perfect: all dollar amounts, dates, and financial terms match or are reasonable representations. (3) Reasoning is sound: the LLM correctly contrasts Oracle’s reliance on short-term commercial paper with Cisco’s larger long-term note issuance that ranks equally (pari passu) with its commercial paper, capturing the structural comparison. It also correctly notes the make-whole redemption feature and compliance with covenants (a detail not in the original but not contradictory). (4) The only minor issue is the introduction of Oracle's $432 million restructuring expense and Cisco's $0.5 billion swap not present in the original answer—these are not incorrect but add extraneous detail not in the ground truth, slightly affecting qualitative precision. However, core multi-hop synthesis—comparing financing structures with correct entity, metric, and temporal alignment—is excellent. The answer remains contextually relevant and factually consistent overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> FIN_INST -[Related_To]-> FIN_INST <-[Decreases]- ORG",
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 442,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does Duke Energy's reliance on wind energy in its Commercial Renewables segment compare with Southern Company's strategic commitment to the Skookumchuck wind project, given the 136 MW nameplate capacity and 20-year PPA term associated with Skookumchuck?",
      "original_answer": "Duke Energy's Commercial Renewables segment relies on wind as one of several generation sources, alongside solar, fuel cells, and batteries, but does not disclose specific capacity figures for wind. In contrast, Southern Company's Skookumchuck wind project has a defined 136 MW nameplate capacity and is supported by a 20-year PPA, indicating a concrete long-term commitment to wind energy in a specific geographic location (Lewis and Thurston Counties, WA). While both companies are engaged in wind energy, Southern's detailed disclosure around capacity and contract duration provides clearer evidence of a targeted wind strategy compared to Duke's broader renewable portfolio approach.",
      "llm_answer": "\nDuke Energy’s Commercial Renewables segment discloses that wind is one of several generation resources—alongside solar, fuel‑cells and batteries—it relies on to supply wholesale electricity, reflecting a diversified wind exposure within its broader portfolio (Chunk 1).  Southern Company, by contrast, has a focused strategic commitment to the 136 MW Skookumchuck wind project, securing a 20‑year power‑purchase agreement for that specific asset, as captured in its project table and the KG link that ties Skookumchuck to SO (Chunks 2 & 3).  Thus, while Duke Energy treats wind as part of a mixed‑resource strategy, Southern Company is advancing a distinct, long‑term wind project with a dedicated 136 MW capacity and a 20‑year PPA.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Duke Energy includes wind as part of a diversified Commercial Renewables portfolio without disclosing specific wind capacity, while Southern Company has a targeted 136 MW Skookumchuck wind project with a 20-year PPA. (2) Quantitative accuracy is perfect: the 136 MW nameplate capacity and 20-year PPA term are correctly reported, matching the ground truth exactly. (3) The multi-hop reasoning is sound—comparing Duke’s broad renewable strategy with Southern’s specific, contract-backed wind project demonstrates proper synthesis across entities and strategies. (4) The only minor shortcoming is that the LLM does not explicitly mention the geographic location (Lewis and Thurston Counties, WA), which is included in the original answer and adds contextual specificity to Southern’s commitment. However, this omission does not detract from the core factual or comparative accuracy. Wording differs slightly (e.g., 'mixed-resource strategy' vs 'broader renewable portfolio'), but semantic equivalence is maintained. The answer fully addresses the comparative strategic commitment to wind energy as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT -[Has_Stake_In]-> PRODUCT <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 339,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does the capital buffer requirement structure under the Advanced Approach for MS compare with SCHW's requirements, given the role of the Countercyclical Capital Buffer which is currently set at zero by the Federal Reserve?",
      "original_answer": "Morgan Stanley's (MS) capital buffer requirement under the Advanced Approach includes a fixed 2.5% Capital Conservation Buffer, a G-SIB capital surcharge, and the Countercyclical Capital Buffer (CCyB), which is currently set at zero by the Federal Reserve. Schwab (SCHW) is also subject to the same CCyB, which was zero as of December 31, 2023, and must maintain a 2.5% Capital Conservation Buffer. Therefore, both firms have identical Capital Conservation Buffer percentages and are influenced by the same CCyB policy, though SCHW is not subject to the G-SIB surcharge that applies to systemically important institutions like MS.",
      "llm_answer": "\nUnder Morgan Stanley’s Advanced Approach the capital‑buffer requirement is a formulaic sum of a 2.5 % capital‑conservation buffer, any G‑SIB surcharge and the Countercyclical Capital Buffer (CCyB); the CCyB is currently set at zero by the Federal Reserve, so the buffer effectively equals the 2.5 % conservation buffer plus the G‑SIB surcharge. Charles Schwab, by contrast, must hold a 2.5 % stress‑capital buffer (CSC) and a 2.5 % capital‑conservation buffer (CSB), with its own CCyB also at zero, and the minimum regulatory ratios it reports (7.0 % CET1, 8.5 % Tier 1 and 10.5 % Total) already incorporate those 2.5 % buffers. Thus, while both firms face a zero CCyB, Morgan Stanley’s buffer is defined by an explicit “2.5 % + G‑SIB + CCyB” formula, whereas Schwab’s regime ties the buffers to prescribed minimum capital ratios that already embed the 2.5 % buffers.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several correct elements but introduces significant inaccuracies in both quantitative and qualitative aspects. (1) Quantitatively, the 2.5% Capital Conservation Buffer for both MS and SCHW is correctly stated, and the CCyB being zero is accurate per the ground truth (as of December 31, 2023). However, the LLM incorrectly states that Schwab must hold a '2.5% stress-capital buffer (CSC)' in addition to the 2.5% capital-conservation buffer (CSB). The ground truth does not mention a stress-capital buffer for Schwab, nor is this a standard regulatory term equivalent to the Capital Conservation Buffer under Basel III. This is a factual error. (2) The claim that Schwab's minimum regulatory ratios (7.0% CET1, 8.5% Tier 1, 10.5% Total) 'already incorporate' the 2.5% buffers is not present in the original answer and cannot be verified from the provided truth; while plausible, it introduces unverified detail that changes the comparison. (3) Qualitatively, the multi-hop reasoning is partially sound: the model correctly identifies that both firms are subject to the same CCyB (zero) and have the same 2.5% Conservation Buffer. However, it fails to explicitly state the key differentiating point in the ground truth: that MS is subject to the G-SIB surcharge due to systemic importance, while SCHW is not. Instead, it focuses on a structural difference in 'formulaic sum' vs 'embedded buffers', which is not supported in the original answer. (4) Contextually, the response is well-structured and relevant, addressing the comparison of buffer structures and the role of CCyB. However, the introduction of incorrect buffer types for Schwab and the omission of the G-SIB surcharge applicability significantly reduce factual accuracy. The core similarity (same CCyB and Conservation Buffer) is correct, but the distinguishing factor (G-SIB surcharge) is underemphasized and distorted by incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Consists_Of]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 517,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does Disney's use of discounted cash flow models for valuing Level 2 derivatives compare to Meta's application of the same models in assessing impairment losses on operating lease assets, given Disney's $383 million impairment charge in fiscal 2024?",
      "original_answer": "Disney utilizes internal discounted cash flow models with observable inputs like interest rates and foreign exchange rates to value its Level 2 derivatives, ensuring fair value estimates remain accurate and counterparty risk is mitigated. Meanwhile, Meta applies discounted cash flow models with Level 3 inputs—such as projected sublease income and downtime assumptions—to estimate the fair value of impaired operating lease assets, which led to a $383 million impairment charge in 2024. While both companies use discounted cash flow techniques, Disney applies them in a Level 2 fair value context for derivatives, whereas Meta uses them in a Level 3 context for non-recurring asset impairments.",
      "llm_answer": "\nDisney measures the fair value of its Level 2 derivatives each reporting period with an internal discounted‑cash‑flow model that relies on observable inputs such as interest‑rate curves, yield curves and foreign‑exchange rates, and it adjusts for counterparty credit risk through netting and collateral arrangements (Chunk 1‑2). Meta, by contrast, uses a discounted‑cash‑flow (income‑approach) model—classified as a Level 3 valuation—to estimate the fair value of impaired operating‑lease ROU assets, incorporating unobservable assumptions like projected sub‑lease income, expected downtime and risk‑adjusted discount rates, and it recorded a $383 million impairment charge in fiscal 2024 for these assets (Chunk 3). Thus, although both companies apply DCF techniques, Disney employs them for recurring derivative valuation with market‑based inputs, whereas Meta uses them for non‑recurring lease‑asset impairment that requires significant judgment and Level 3 inputs.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: Disney uses discounted cash flow (DCF) models with observable inputs (interest-rate curves, foreign exchange rates) for Level 2 derivatives valuation, while Meta uses DCF models with Level 3 inputs (projected sublease income, downtime assumptions) for impairment of operating lease assets. The $383 million impairment charge by Meta in fiscal 2024 is correctly attributed. (2) Quantitative accuracy is perfect: the dollar amount ($383 million) and fiscal year (2024) match the original answer exactly. (3) The multi-hop reasoning is sound—LLM correctly contrasts Disney’s recurring, market-based derivative valuations (Level 2) with Meta’s non-recurring, judgment-intensive lease asset impairments (Level 3), synthesizing information across two companies and distinct accounting contexts. (4) Semantic equivalence is achieved: though wording differs (e.g., 'risk-adjusted discount rates', 'downtime assumptions'), the meaning and technical classification (Level 2 vs Level 3, recurring vs non-recurring) are preserved. The answer fully addresses the comparison requested in the question and accurately reflects the knowledge graph ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 350,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the 8.2% increase in Turkey's total tobacco market volume, partly offset by higher illicit trade prevalence, impact PM's market share dynamics, and how does this compare to MO's exposure to illicit trade risks in the broader context of their respective tobacco businesses?",
      "original_answer": "PM's shipments in Turkey increased to 55.7 billion units in 2021 from 47.5 billion in 2020, contributing to a rise in its market share from 41.3% to 44.8%. This growth was partly offset by a higher estimated prevalence of illicit trade in Turkey, which negatively impacts legitimate sales and tax revenues. Similarly, MO highlights that illicit trade in tobacco products, including counterfeit goods and untaxed sales, adversely affects its business by reducing lawful sales and potentially triggering regulatory actions. While PM directly benefits from increased volume in Turkey despite illicit trade, MO emphasizes the broader systemic risks illicit trade poses to the tobacco industry, including brand dilution and loss of tax revenues that could lead to stricter regulations.",
      "llm_answer": "\nThe 8.2 % rise in Turkey’s total tobacco market volume—from 114.8 bn to 124.2 bn units—lifted PMI’s Turkey market‑share from 41.3 % to 44.8 % and helped push the Middle East & Africa regional share up 1.1 points to 23.1 %, even though the growth was “partly offset by a higher estimated prevalence of illicit trade” (Chunks 1 & 2).  This volume‑driven share gain shows how PM can convert a expanding market into stronger pricing power despite the illicit‑trade headwind.  In contrast, MO’s disclosures treat illicit trade as a broader adverse risk that can erode tax revenues, trigger regulatory actions and affect the value of its investments (e.g., JUUL), but the filing does not report a comparable volume‑driven share increase—its exposure is framed as a systemic threat rather than a market‑share opportunity, with illicit trade negatively impacting MO across its global tobacco business (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the 8.2% market volume increase in Turkey (from 114.8B to 124.2B units), PM's market share rise from 41.3% to 44.8%, and the Middle East & Africa regional share increase of 1.1 points to 23.1% are consistent with the data. The shipment increase from 47.5B to 55.7B units is implied through context and aligns with the market share growth in an expanding market. (2) The answer correctly identifies that illicit trade partially offset this growth for PM, and accurately contrasts PM's volume-driven share gain with MO's framing of illicit trade as a systemic risk. (3) Multi-hop reasoning is sound: it synthesizes PM’s performance in Turkey with broader regional impact and contrasts it with MO’s global risk disclosures, including implications for JUUL and regulatory responses. (4) The only minor shortcoming is that the LLM does not explicitly mention MO’s emphasis on brand dilution or tax revenue loss—though it does reference eroded tax revenues and regulatory actions, which captures the core idea. Wording differs slightly (e.g., 'pricing power' is an interpretive addition not in the original), but semantic equivalence is maintained. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Negatively_Impacts]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 371,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the redesign of the Medicare Part D program under the Inflation Reduction Act affect both CVS's financial exposure to Medicare Part D liabilities and AbbVie's pricing strategy for drugs like Imbruvica under Medicare Part D?",
      "original_answer": "The redesign of the Medicare Part D program under the Inflation Reduction Act shifts more claim liability to insurers like CVS, which could negatively impact their profitability due to increased financial risk and administrative complexity. At the same time, AbbVie is subject to government-set pricing for certain drugs, such as Imbruvica, starting in 2026, which will cap reimbursement rates at a statutory ceiling likely below current average prices, significantly affecting revenue projections. These changes create a dual pressure where CVS faces higher liability and AbbVie faces downward pricing pressure, both under the same regulatory framework.",
      "llm_answer": "\nThe Inflation Reduction Act’s Part D redesign—beginning in 2023 and continuing through 2032—shifts a larger share of claim liability and reporting burdens to plans, requires manufacturers to bear more of the cost, and can replace the 70 % coverage‑gap discount with a 10 % (or 20 % for high‑cost) manufacturer discount starting in 2025, which exposes CVS to greater financial risk from increased plan‑level liability, potential False Claims Act fines, and loss of network‑rebate fees (as detailed in the CVS 10‑K); at the same time, the same law gives CMS authority to set prices for selected Part D drugs, and CMS has already chosen Imbruvica among the first ten drugs to be price‑set beginning in 2026, forcing AbbVie to align its pricing with a statutory ceiling and the new discount structure while facing civil monetary penalties for non‑compliance (as described in the MRK and ABBV filings).  Thus, the regulatory chain — ORG (CVS or AbbVie) → Negatively_Impacts → Regulatory_Requirement → Redesigns → Regulatory_Requirement ← Subject_To — means the IRA’s Part D overhaul simultaneously heightens CVS’s exposure to Medicare‑Part D liabilities and constrains AbbVie’s pricing strategy for Imbruvica under the new Medicare framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) It correctly identifies the key impacts of the Inflation Reduction Act (IRA) on both CVS and AbbVie, aligning with the ground truth: CVS faces increased financial exposure due to greater claim liability and administrative burdens, while AbbVie must comply with government-set pricing for Imbruvica starting in 2026. (2) Quantitatively, the LLM accurately cites the 70% coverage-gap discount being replaced by a 10% or 20% manufacturer discount starting in 2025, and the 2026 effective date for CMS price-setting—both consistent with the IRA provisions. The timeline (2023–2032) is contextually accurate for the phased implementation, though the core pricing impact begins in 2025–2026, so minor nuance in phasing is acceptable. (3) The multi-hop reasoning is sound: it connects CVS’s increased liability (from its 10-K disclosures) to the regulatory changes, and separately links AbbVie’s pricing constraints to CMS’s selection of Imbruvica for price-setting under the IRA, referencing manufacturer penalties and compliance requirements (supported in ABBV and MRK filings). The synthesis across entities (CVS, AbbVie, CMS) and regulatory mechanisms (liability shift, price-setting, discounts) is excellent. (4) Semantic equivalence is strong: while the LLM provides more granular detail (e.g., False Claims Act risks, network-rebate fees, civil penalties), the core message—that the IRA increases CVS’s risk and restricts AbbVie’s pricing—matches the ground truth. The only reason for not scoring a 10 is that the original answer emphasizes the 'dual pressure' under the same framework more succinctly, while the LLM’s technical depth slightly overshadows the high-level synthesis, but this does not detract from factual correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> REGULATORY_REQUIREMENT -[Redesigns]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 484,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Boeing's use of third-party aircraft value publications for valuing impaired customer financing assets compare to RTX's quarterly valuation methodology for private equity limited partnerships, particularly in terms of reliance on unobservable inputs?",
      "original_answer": "Boeing derives the fair value of impaired customer financing assets, including operating lease equipment, by calculating a median collateral value from a consistent group of third-party aircraft value publications, which are based on market trades and other market factors. Management reviews these publications quarterly and may adjust values based on specific aircraft attributes. In contrast, RTX values private equity limited partnerships quarterly using discounted cash flows, earnings multiples, and market multiples, with valuation adjustments reflecting changes in operating results or financial condition of the portfolio companies. Both approaches rely on unobservable inputs typical of Level 3 assets, but Boeing leans more on consistent third-party market data while RTX applies more forward-looking financial modeling.",
      "llm_answer": "\nBoeing determines the fair value of impaired customer‑financing assets by first referencing a median collateral value from third‑party aircraft price guides and then adjusting that figure for aircraft‑specific attributes or expected net‑sales prices—adjustments that introduce limited unobservable inputs and are disclosed in its Level 3 fair‑value table.  \nRTX holds private‑equity limited partnerships that are carried at NAV per unit (a practical expedient) but are also re‑valued each quarter using discounted‑cash‑flow, earnings and market multiples, with valuation adjustments that reflect portfolio‑company operating results, financial condition and prospects; these forward‑looking assumptions constitute inherently unobservable inputs.  \nThus, both companies rely on unobservable inputs, but Boeing’s reliance is indirect and market‑derived with modest adjustments, whereas RTX’s valuation is model‑driven and built on more extensive, forward‑looking estimates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Boeing uses third-party aircraft value publications to derive a median collateral value for impaired customer financing assets, adjusts for aircraft-specific attributes, and reports these in Level 3 fair value disclosures. RTX values private equity limited partnerships quarterly using discounted cash flows, earnings multiples, and market multiples, incorporating forward-looking unobservable inputs based on portfolio company performance. These methodologies are correctly attributed. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or ground truth, so quantitative accuracy is not compromised—no calculations were required, and none were misstated. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes Boeing’s market-data-reliant, adjustment-light approach with RTX’s model-driven, forward-looking methodology, and accurately compares their relative reliance on unobservable inputs. It correctly identifies that both fall under Level 3 but differ in degree and nature of unobservable input usage—Boeing’s being more indirect and market-anchored, RTX’s more model- and projection-heavy. (4) The only reason for not scoring a 10 is a minor omission: the ground truth mentions Boeing’s management reviews the publications quarterly, which the LLM omits, though the quarterly timing is implied in context. Otherwise, the semantic meaning, entity accuracy (Boeing, RTX, customer financing assets, private equity partnerships), and contextual relevance are fully preserved. The answer directly addresses the comparison in valuation methodologies and reliance on unobservable inputs as required.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Not_Subject_To]-> FIN_INST <-[Values]- ORG",
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 479,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does the voting power disparity between Class A and Class B common stock at META and GOOGL affect the concentration of corporate control, particularly given META's outstanding share structure and GOOGL's recent share repurchase activity?",
      "original_answer": "At META, Class A common stock has full voting rights while Class B common stock has no voting rights except in limited circumstances, which concentrates control among Class A shareholders. As of January 24, 2025, META had 2,189,898,148 shares of Class A common stock and 343,761,117 shares of Class B common stock outstanding, indicating a significant majority of voting power is held by Class A shareholders. In contrast, at GOOGL, Class B common stockholders have 10 votes per share compared to 1 vote per share for Class A, giving disproportionate voting control to Class B holders. GOOGL repurchased $62.0 billion of Class A and Class C shares in 2024, which could further consolidate voting power among remaining Class B shareholders by reducing the overall number of voting shares in circulation.",
      "llm_answer": "\nMeta’s 2024 Form 10‑K (Chunk 1) reports that, as of 31 Dec 2024, it had **2.189 billion Class A shares** and only **343.8 million Class B shares** outstanding – a sub‑10 % equity stake that nevertheless controls the company because Class B shares carry the highest voting rights.  The filing also explains (Chunk 2) that Class B holders can vote on a narrow set of “critical” matters such as mergers, charter amendments and exits from the core payments business, giving that tiny shareholder group disproportionate influence over strategic decisions.  \n\nAlphabet’s 10‑K (Chunk 3) confirms the same dual‑class structure: **Class B common stock carries 10 votes per share** while Class A carries one, and Class C has virtually no voting rights.  Importantly, Alphabet has been **repurchasing and retiring large blocks of Class A and Class C shares** ($62 billion in 2024 alone, with a further $70 billion authorized), which shrinks the public float and thereby **amplifies the relative voting power of the remaining Class B shares**.  \n\nTogether, the tiny but super‑voting Class B blocks in both Meta and Alphabet, coupled with Alphabet’s aggressive share‑repurchase program, concentrate corporate control in the hands of insiders and long‑term holders despite their small equity percentages.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, the share counts for META are correctly reported as 2.189 billion Class A and 343.8 million Class B, which aligns with the ground truth (2,189,898,148 and 343,761,117 respectively), with only minor rounding differences acceptable under format variation. The $62 billion repurchase amount by GOOGL in 2024 is exactly correct. (2) However, there is a critical error in the description of META's voting structure: the LLM incorrectly states that Class B shares have the highest voting rights, when in fact, according to the original answer and standard public knowledge, META’s Class A shares have full voting rights and Class B shares (held by insiders like Mark Zuckerberg) have *super-voting* rights (typically 10x), not the other way around. The LLM flips the voting power attribution, saying Class B has high voting rights but then mislabels them as a 'tiny shareholder group' with disproportionate influence — while the conclusion about control concentration is correct, the reasoning misattributes which class has superior voting power. (3) For GOOGL, the LLM correctly identifies the 10:1 voting ratio for Class B vs Class A and accurately explains that repurchases of Class A and C shares amplify Class B's relative control — this demonstrates sound multi-hop reasoning linking share reduction to voting power concentration. (4) Despite the inversion in META's class voting rights description, the overall synthesis across both companies and the effect of repurchases on control is well-reasoned and contextually complete. The answer addresses all parts of the question: voting structures, share counts, repurchase impact, and control concentration. Due to the significant but not fundamental error in META's voting class designation, the correctness score is reduced to 9 rather than 10. Quantitative accuracy is high (9) due to correct numbers with minor rounding; qualitative accuracy is also 9 due to strong reasoning despite the misattribution; contextual relevance is perfect (10).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 557,
        "total_tokens": 2104
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does PEP's 19% convenient foods unit volume growth in APAC, including low-single-digit growth in Taiwan, compare with PG's market position across Greater China, where Taiwan is explicitly included in its regional structure?",
      "original_answer": "PEP reported 19% convenient foods unit volume growth in APAC in 2022, with Taiwan contributing low-single-digit growth as part of that performance. In contrast, PG holds a leadership or significant market share position in many of its product segments across Greater China, a region that explicitly includes Taiwan according to Apple's segment reporting. This suggests PG maintains a strong competitive presence in the broader regional market, while PEP's exposure in Taiwan appears more modest but still positive.",
      "llm_answer": "\nPEP’s 2022 10‑K reports that convenient‑foods unit volume in APAC grew 19 %, with Taiwan contributing only a low‑single‑digit increase (Chunk 3). PG’s segment structure explicitly places Taiwan inside its Greater China region (Chunk 2), which is part of the broader organizational layout described in the MD&A (Chunk 1), underscoring PG’s established market position across that entire area. Thus, PEP’s growth is measured across the wider APAC market, whereas PG’s presence in Greater China—including Taiwan—represents a distinct, leadership‑focused regional footprint.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies PEP's 19% convenient foods unit volume growth in APAC in 2022 and Taiwan's low-single-digit contribution, matching the ground truth. It accurately notes that PG includes Taiwan in its Greater China region, consistent with the original answer. The core facts, entities, and numbers are correct. (2) Quantitative accuracy is perfect: the 19% growth and low-single-digit characterization for Taiwan are correctly reported, with no calculation errors. (3) The multi-hop reasoning is sound—LLM synthesizes PEP’s performance data (from its 10-K) with PG’s regional structure (from segment reporting), correctly contrasting PEP’s growth-focused metric in a broader region with PG’s established market position in a more specific, leadership-oriented region that includes Taiwan. The only minor shortcoming is that the LLM does not explicitly state that PG holds a 'leadership or significant market share' position in Greater China, which is a key qualitative point in the ground truth; it implies it via 'established market position' and 'leadership-focused footprint,' which are close but slightly less precise. (4) Scores reflect near-perfect factual accuracy, with full quantitative correctness and high qualitative accuracy. Contextual relevance is excellent as all information directly addresses the comparative regional performance and structure question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 390,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How do the updated PCA Framework thresholds under Basel III affect capital requirements differently for banks like BAC and COF, particularly in terms of CET1 capital ratios and classification as well-capitalized institutions?",
      "original_answer": "Under Basel III, the PCA Framework thresholds were updated to require higher capital ratios for banks to be classified as well-capitalized. For COF, as a Category III institution, it must maintain a minimum CET1 capital ratio of 4.5%, Tier 1 capital ratio of 6.0%, and total capital ratio of 8.0%. However, to be considered well-capitalized under PCA, COF must meet higher thresholds: a CET1 capital ratio of 6.5% or more, Tier 1 capital ratio of 8% or more, and total risk-based capital ratio of 10% or more. Similarly, BAC is subject to these same PCA thresholds, with its CET1 capital regulatory minimum set at 4.5% under Basel III, but to be well-capitalized under PCA, it must maintain a CET1 ratio of 6.5% or more, reflecting the updated PCA requirements. This means both banks must hold significantly more capital to avoid PCA restrictions, impacting their capital planning and dividend capacity.",
      "llm_answer": "\nThe revised PCA framework raises the well‑capitalized CET1 minimum from 4.5 % to 6.5 % (with total risk‑based capital of 10 % and Tier 1 of 8 %), but because BAC is a G‑SIB it must also add a 2.5 % G‑SIB surcharge, pushing its effective CET1 requirement above 9 %, whereas COF, not being a G‑SIB, only needs to meet the 6.5 % threshold. Both banks are Category III institutions subject to the Basel III Capital Rules and the updated PCA regulations, so they must hold these higher CET1 ratios (plus applicable buffers) to remain classified as well‑capitalized; the Basel III Finalization proposal will phase‑in the inclusion of AOCI in CET1 and tighten deduction thresholds, affecting each bank’s capital calculations over the 2025‑2028 transition period.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core concept that Basel III updated PCA thresholds require higher capital ratios for banks to be classified as well-capitalized, correctly stating the 6.5% CET1, 8% Tier 1, and 10% total risk-based capital thresholds. It accurately identifies both BAC and COF as Category III institutions subject to these rules. However, it introduces a significant factual inaccuracy by claiming BAC must meet an effective CET1 requirement above 9% due to a 2.5% G-SIB surcharge. The original answer and ground truth do not mention any G-SIB surcharge or differentiated requirements between BAC and COF beyond general PCA thresholds; both are said to require a 6.5% CET1 ratio to be well-capitalized. This addition, while plausible in real-world regulation, is not supported by the provided ground truth and constitutes a major quantitative error. Additionally, the mention of the Basel III Finalization proposal phasing in AOCI from 2025–2028 is extraneous and not present in the original answer, introducing information beyond the scope of the provided knowledge. While the reasoning is logically structured and contextually relevant, the inclusion of unsupported quantitative details reduces factual accuracy. The core multi-hop synthesis—linking Basel III, PCA thresholds, CET1 ratios, and impact on BAC and COF—is sound and semantically aligned with the original, but the added numerical claims lower the correctness and quantitative accuracy scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Updates]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 403,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How does the sensitivity of NFLX's content amortization to viewing pattern assumptions compare to T's sensitivity analyses around pension discount rates and goodwill impairment assumptions?",
      "original_answer": "NFLX's auditor performed sensitivity analyses on content amortization assumptions, particularly focusing on historical and forecasted viewing hour consumption, which directly affects the timing of content amortization recognition. T's auditor, on the other hand, conducted sensitivity analyses on two key areas: pension discount rates tied to corporate bond credit quality and timing of benefit payments, and goodwill impairment assumptions such as terminal growth rates, EBITDA margins, and weighted average cost of capital (WACC). While both companies undergo sensitivity testing, NFLX's focus is on consumption-based amortization estimates, whereas T's analyses center on long-term financial obligations and asset valuations.",
      "llm_answer": "\nNFLX’s content amortization is evaluated for sensitivity to changes in its estimated viewing‑pattern assumptions, with auditors testing management’s historical and forecasted viewing data and quantifying how alternative patterns would shift amortization expense (Chunk 1 & 2).  \nIn contrast, T’s sensitivity analyses examine how variations in pension discount rates and goodwill‑impairment inputs (e.g., discount rate, terminal growth, EBITDA margins) affect the measured pension obligation and goodwill fair value, using independent sensitivity tests and benchmarking to industry trends (Chunk 3).  \nBoth companies employ a comparable audit‑driven sensitivity approach—adjusting key assumptions and measuring the resulting financial impact—but apply it to different line‑items (content amortization versus pension/goodwill valuations), as indicated by the shared “Sensitivity Analyses” node that links NFLX and T in the knowledge graph.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: NFLX's sensitivity analyses focus on viewing-pattern assumptions (historical and forecasted viewing hours) affecting content amortization, while T's analyses cover pension discount rates and goodwill impairment inputs like terminal growth, EBITDA margins, and discount rates. These are correctly attributed and match the ground truth. (2) There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is not compromised—no figures are misstated. (3) The multi-hop reasoning is sound: the model correctly synthesizes audit-level sensitivity practices across two different companies (NFLX and T), identifies the nature of the assumptions tested, and draws a valid comparison in approach despite differing financial line items. The reference to a shared 'Sensitivity Analyses' node in the knowledge graph is consistent with the expected inference. (4) Semantic equivalence is strong: the LLM uses slightly different phrasing (e.g., 'independent sensitivity tests and benchmarking to industry trends' for T) but does not introduce inaccuracies; this may reflect additional context from the chunks without contradicting the ground truth. The only minor limitation is that the original answer more explicitly specifies that T’s pension discount rate is tied to corporate bond credit quality and timing of benefit payments—details slightly downplayed in the LLM version. However, this does not undermine the core correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Reviews]-> ACCOUNTING_POLICY -[Performs]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 469,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How does Adobe's localized field office presence in Taiwan compare to Apple's broader Greater China segment strategy, particularly given Apple's $74.2 billion in net sales attributed to that region which includes Taiwan?",
      "original_answer": "Adobe maintains a localized field office in Taiwan as part of its global operations, allowing it to directly engage with customers in that market. Apple, on the other hand, reports its financial performance for the broader Greater China segment, which includes Taiwan along with mainland China and Hong Kong, and generated $74.2 billion in net sales in 2022. While Adobe's approach focuses on direct local engagement through physical offices, Apple manages the region as a consolidated market with a unified strategy, reflecting its larger scale and different operational model.",
      "llm_answer": "\nAdobe maintains a dedicated local field office in Taiwan—as listed among its worldwide offices in the marketing‑and‑sales section of its 10‑K—while Apple treats Taiwan as part of a much larger “Greater China” geographic segment that, according to Apple’s 2022 Form 10‑K, generated **$74.2 billion** in net sales (Chunk 3) and is reported as a single segment encompassing mainland China, Hong Kong and Taiwan (Chunk 2). Consequently, Apple’s strategy is to capture the entire Greater China market as a $74.2 B revenue engine, whereas Adobe’s presence in Taiwan is limited to a single localized office supporting its broader global operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Adobe has a localized field office in Taiwan, and Apple includes Taiwan in its Greater China segment, which reported $74.2 billion in net sales in 2022—this figure is accurately cited and matches the original answer. Number format ($74.2 billion vs $74.2B) is semantically equivalent and acceptable. (2) The answer addresses all parts of the multi-hop question: it compares Adobe’s localized presence in Taiwan to Apple’s broader regional strategy, correctly identifying the structural and strategic differences. (3) Entities are accurate—Adobe, Apple, Taiwan, Greater China, net sales, 2022 fiscal year (implied via 10-K reference), and the financial metric is correctly attributed. (4) Reasoning is sound: the synthesis between Adobe’s direct local engagement via an office and Apple’s consolidated reporting and strategy is logically presented. The only minor shortcoming is that the original answer explicitly mentions Hong Kong and mainland China as part of Greater China, which the LLM does include but could have integrated more smoothly without relying on parenthetical 'Chunk' references (likely from retrieval artifacts), slightly affecting fluency and qualitative precision. However, this does not detract from factual correctness. Overall, the answer is factually complete, contextually relevant, and quantitatively precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 397,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How does Lockheed Martin's exposure to LIBOR-based financing instruments compare to 3M's preparedness for reference rate reform, given the provisions of ASU 2020-04 that both companies reference in their filings?",
      "original_answer": "Lockheed Martin (LMT) has credit facilities and derivative instruments referencing LIBOR-based rates and has adhered to the ISDA 2020 IBOR Fallbacks Protocol, expecting minimal financial impact from the transition to alternative rates by December 31, 2022. 3M (MMM) also reviewed its relevant arrangements and concluded that ASU 2020-04 would not have a material impact on its financial statements, indicating a similar low expectation of disruption. Both companies rely on ASU 2020-04 to ease the accounting burden of transitioning from LIBOR to alternative rates like SOFR, showing parallel preparedness despite differing financial structures.",
      "llm_answer": "\nLockheed Martin explicitly discloses that its credit facility and certain derivatives are LIBOR‑based and that it has adopted the ISDA 2020 IBOR Fallbacks Protocol, noting that ASU 2020‑04 “helps limit the accounting impact” of the transition and that it does not expect a significant effect on results, financial position or cash flows. 3M likewise references ASU 2020‑04 in its filings and states that a review of its relevant contracts and instruments shows the guidance would not have a material impact on its consolidated financial statements, indicating that both companies are equally prepared under the standard, though Lockheed Martin provides more detailed information about the scope of its LIBOR exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) All key facts are correct: Lockheed Martin's LIBOR-based credit facilities and derivatives, adoption of the ISDA 2020 IBOR Fallbacks Protocol, and expectation of minimal financial impact are accurately stated. 3M's assessment that ASU 2020-04 would not have a material impact on its financial statements is also correctly reported. (2) There are no numeric values, dates, or calculations in the question or answer that require verification—both companies reference the transition by December 31, 2022, implicitly in the context of LIBOR cessation, and the LLM correctly captures the qualitative timeline without introducing errors. (3) The multi-hop reasoning is sound: the answer synthesizes disclosures from both companies, correctly identifies their reliance on ASU 2020-04 to reduce accounting burden, and draws a valid comparison about their parallel preparedness despite differing levels of disclosure detail. (4) The only minor shortcoming is that the LLM does not explicitly name SOFR as the alternative rate (mentioned in the original answer), though this does not detract significantly from the overall accuracy since the focus is on accounting impact and preparedness. The answer is highly relevant, complete, and semantically equivalent to the ground truth, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Positively_Impacts]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 380,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What is the voting power distribution between Class A and Class B common stock at CMCSA, and how does the structure of Class B common stock's 15 votes per share impact overall shareholder control?",
      "original_answer": "At CMCSA, holders of Class A common stock have 66⅔% of the combined voting power, while the Class B common stock, which has 15 votes per share, represents 33⅓% of the combined voting power. This structure gives disproportionate voting control to the holder(s) of Class B common stock, despite their minority ownership on a share count basis.",
      "llm_answer": "\nThe 2024 Form 10‑K states that holders of Class A common stock collectively hold **66 2⁄3 % of the total voting power**, while Class B common stock accounts for the remaining **33 1⁄3 % of voting power**, with each Class B share carrying **15 votes** (a non‑dilutable right). Because Mr. Brian L. Roberts beneficially owns all 9.44 million Class B shares—despite only 3.78 billion Class A shares being outstanding—this 15‑vote structure concentrates roughly one‑third of CMCSA’s voting power in the hands of the Roberts family, giving them decisive control over corporate decisions even though their equity stake is small.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key figures are correct: 66⅔% and 33⅓% voting power distribution between Class A and Class B shares is accurately reported. The 15 votes per Class B share is correctly stated. While the ground truth does not include share counts or ownership details (e.g., 9.44 million Class B shares, 3.78 billion Class A shares), these are plausible and consistent with public filings, adding useful context without contradicting the original. (2) Calculations: The percentages sum to 100%, and the disproportionate control logic is sound. No mathematical errors. (3) Reasoning: The LLM correctly synthesizes the structural impact of the 15-vote Class B shares, explaining how a small equity stake can yield significant voting control—this reflects accurate multi-hop reasoning (ownership structure → voting rights → control implications). (4) The only minor deviation from the original answer is the addition of specific ownership details (Mr. Roberts, share counts) not present in the ground truth, but these are factually accurate and enhance, rather than distort, the explanation. Semantic equivalence is maintained. The answer fully addresses both parts of the question: voting power distribution and the impact on shareholder control. All entities (CMCSA, Class A/B stock) are correct. Slight deduction in qualitative accuracy only because the original answer does not mention Roberts family ownership, so including it, while true, slightly exceeds the scope of the provided ground truth without being incorrect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 436,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How do the different uses of sensitivity analyses by CMCSA and NFLX reflect their distinct financial risk exposures, particularly given that both are audited by the same firm?",
      "original_answer": "CMCSA uses sensitivity analyses to assess its exposure to interest rate risk, which is critical given its reliance on derivative instruments like interest rate swaps that decreased consolidated interest expense by $56 million in 2023. In contrast, NFLX applies sensitivity analyses in the context of content amortization, a judgment-heavy process where changes in estimated viewing patterns can significantly affect the timing of amortization expenses. Both companies rely on the same auditor, who has served NFLX since 2012 and also reviews CMCSA’s market risk disclosures, suggesting a consistent audit approach despite the differing applications and financial impacts of sensitivity analyses at each firm.",
      "llm_answer": "\nCMCSA uses sensitivity analyses to gauge how shifts in interest‑rate markets affect its debt‑service costs—evidenced by the $56 million reduction in derivative‑related expense in 2023—so its primary risk exposure is market‑rate volatility. NFLX, audited by the same firm, applies sensitivity testing to estimate how changes in assumed viewing patterns would alter its content‑amortization expense, exposing it to estimation risk tied to audience consumption. Because the auditor reviews both companies’ accounting policies, the shared audit firm links the two firms’ distinct risk profiles—interest‑rate risk for CMCSA and viewing‑pattern risk for NFLX—within a single audit framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the $56 million reduction in derivative-related expense for CMCSA in 2023 is correctly stated, matching the original answer. No other numerical values are present, and all are accurate. (2) The entities—CMCSA, NFLX, and the shared auditor—are correctly identified, and the years (implied 2023) align. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both firms use sensitivity analyses but for different purposes—CMCSA for interest rate risk due to derivatives, NFLX for content amortization driven by viewing pattern estimates—and links this to their distinct risk exposures. It also correctly notes the shared auditor and implies consistency in audit approach without overstating. (4) The only minor shortcoming is that the LLM does not explicitly mention the auditor’s tenure with NFLX since 2012, which is part of the original answer and adds context about audit continuity. However, this omission does not undermine the core comparison or conclusion. Wording differs but maintains semantic equivalence. All key financial impacts and risk exposures are accurately conveyed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY -[Performs]-> ACCOUNTING_POLICY <-[Reviews]- ORG",
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 340,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How does the expiration timeline of Enbrel's key U.S. formulation patent in 2037 impact Pfizer's competitive positioning compared to AbbVie's regulatory exclusivity strategy for its biologics?",
      "original_answer": "Pfizer's Enbrel, marketed outside the U.S. and Canada, benefits from a U.S. formulation patent that expires in 2037, offering extended protection for its composition and preparation methods. This long runway could help Pfizer maintain market presence for Enbrel in key international markets by deterring biosimilar competition. In contrast, AbbVie relies on a broader regulatory exclusivity strategy, including 12-year exclusivity for biologics under the BPCIA and potential pediatric exclusivity extensions, which may allow it to manage competitive threats through both patent and regulatory mechanisms. While Pfizer’s formulation patent provides a specific technical barrier, AbbVie’s layered approach combines patent protection with statutory exclusivity to maximize market control post-approval.",
      "llm_answer": "\nThe U.S. formulation patent covering Enbrel (etanercept) – the key patent that expires on 10/19/2037 (Chunk 2) – will remove Pfizer’s patent‑based barrier to competition in 2037, exposing that product to biosimilar entry just as Pfizer acknowledges in its 10‑K that its “primary, specialty and oncology” portfolios include products “that have experienced patent‑based expirations or loss of regulatory exclusivity” (Chunk 1).  By contrast, AbbVie’s regulatory‑exclusivity playbook (Chunk 3) secures up to 12 years of exclusivity for its biologics, with possible 180‑day pediatric extensions and other statutory extensions that can push protection well beyond the typical 20‑year patent term, thereby preserving its market shield longer than Pfizer’s Enbrel patent expanse.  Consequently, while Pfizer’s competitive position in Enbrel will erode once the 2037 patent lapses, AbbVie can rely on layered regulatory exclusivity to sustain its biologics’ exclusivity far past that date.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant issues in factual accuracy despite generally relevant reasoning and structure. (1) Quantitatively, the expiration date of Enbrel's U.S. formulation patent is incorrectly stated as '10/19/2037'—the ground truth only specifies the year 2037, not an exact date. This introduces false precision not supported by the original answer. Additionally, the claim that AbbVie benefits from exclusivity 'well beyond' the 2037 date due to 12-year exclusivity plus extensions is misleading: since biologics typically receive 12 years of exclusivity from first approval (e.g., Humira was approved in 2012), AbbVie’s exclusivity for its key products would largely have already expired or be close to expiring by 2037, not extend far beyond it. Thus, the comparative timeline is factually flawed. (2) The answer mischaracterizes Pfizer’s position: the original answer notes that Enbrel is marketed outside the U.S. and Canada, but the LLM implies Pfizer markets it in the U.S., which is incorrect—Amgen does. This undermines entity accuracy. (3) While the LLM correctly identifies that AbbVie uses a layered regulatory exclusivity strategy including pediatric extensions, it fails to note that this applies to new biologics, not necessarily post-2037, and incorrectly frames it as a direct comparative advantage over Pfizer’s 2037 patent, which is not logically sound. (4) The reasoning attempts multi-hop synthesis—linking patent expiration, biosimilar threat, and regulatory strategies—but draws an incorrect conclusion about relative competitive positioning due to flawed timelines and entity roles. (5) Semantically, the answer captures the idea of patent vs. regulatory exclusivity strategies but distorts the factual basis. The mention of Pfizer’s 10-K acknowledging patent expirations is contextually relevant but not directly tied to Enbrel, introducing ambiguity. Overall, core concepts are present but key facts are inaccurate, leading to a partially correct but misleading response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Decreases]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 551,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How would a potential shift from 0.5-percentage-point to 0.1-percentage-point increments in the G-SIB surcharge proposal impact JPMorgan Chase's capital requirements under a resolution scenario where the Parent Company enters bankruptcy, given the loss-absorbing structure of its eligible long-term debt?",
      "original_answer": "The proposed shift from 0.5-percentage-point to 0.1-percentage-point increments in the G-SIB surcharge under the Federal Reserve's proposal would likely allow for more granular calibration of capital requirements for systemically important institutions like JPMorgan Chase. For JPM, this could mean a more tailored capital burden, which would interact with its 'single point of entry' resolution strategy where losses would first be imposed on equity holders and then on unsecured creditors, including holders of eligible long-term debt. If this surcharge adjustment is adopted, JPM may experience either a marginal increase or decrease in required capital depending on its G-SIB score, which would influence how much loss-absorbing capacity it must maintain under its current regulatory framework.",
      "llm_answer": "\nThe proposed change to apply G‑SIB surcharge increments of 0.1 percentage‑point rather than 0.5 percentage‑point would lower the additional capital buffer that JPMorgan Chase must hold, because the smaller step‑size would be phased in only two quarters after the Federal Reserve adopts the final rule and the firm continues to evaluate the impact on its Required Capital framework (Chunks 2 & 3).  In a resolution where the parent company enters bankruptcy, the loss‑absorbing eligible long‑term debt and equity of the parent would first absorb losses and only after senior creditors are fully repaid could any remaining capital buffer be relevant, so the reduced increment would lessen the amount of eligible LTD needed to meet the G‑SIB requirement but regulators could still impose extra capital or restrictions if the resolution plan is deemed deficient (Chunk 1).  Thus, while the lower increment reduces the G‑SIB‑related capital requirement, the overall capital needed under a bankruptcy‑driven resolution remains governed by the parent’s loss‑absorbing structure and the Federal Reserve/FDIC’s discretionary authority.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but introduces significant inaccuracies and unsupported claims. (1) Quantitatively, the shift from 0.5- to 0.1-percentage-point increments is correctly described in direction, but the LLM incorrectly asserts that this change would definitively 'lower' JPMorgan's capital requirements. The ground truth states the impact could be either an increase or decrease depending on JPM's G-SIB score—this critical uncertainty is omitted, and the directional claim is unsupported. Additionally, the LLM introduces a specific timeline ('phased in only two quarters after') that is not present in the original answer and lacks evidentiary support. (2) The mention of 'Chunks 1, 2 & 3' appears to reference source material not available in the context and introduces artificial confidence in timing and implementation. (3) On qualitative accuracy, the LLM correctly identifies the 'single point of entry' resolution framework and the role of eligible long-term debt (LTD) in absorbing losses during a parent company bankruptcy. However, it mischaracterizes the relationship between the G-SIB surcharge and the required amount of eligible LTD—while the surcharge influences capital requirements, the answer oversimplifies by stating the reduced increment 'would lessen the amount of eligible LTD needed,' which is not necessarily true, as the LTD requirement is determined by TLAC (Total Loss-Absorbing Capacity) rules, not directly by G-SIB increment size. (4) Contextual relevance is strong—the answer addresses the core elements: G-SIB increment change, capital requirements, resolution scenario, and loss-absorbing debt. But the reasoning fails on multi-hop synthesis: it conflates regulatory capital surcharges with structural loss absorption mechanisms and introduces false causality. The original answer emphasizes granular calibration and potential variability in impact; the LLM incorrectly narrows this to a certain reduction. Thus, while some factual elements are present, key reasoning and quantitative claims are flawed, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Impacts]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 561,
        "total_tokens": 2082
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does LMT's use of a discounted cash flow approach in valuing Level 3 fixed income investments compare to HON's application of the same method in testing goodwill and indefinite-lived intangible assets, particularly in terms of the sensitivity to projected cash flows and discount rates?",
      "original_answer": "LMT applies the discounted cash flow approach to certain Level 3 fixed income investments, relying on projected annuity payments and a discount rate applied to those payments. This valuation method is used when observable market inputs are unavailable, and it introduces sensitivity to changes in these projected cash flows and discount assumptions. Similarly, HON utilizes a discounted cash flow approach for testing goodwill and indefinite-lived intangible assets, incorporating strategic and annual operating plans adjusted for terminal value assumptions. HON also performs sensitivity analyses on key estimates, including expected growth rates, sales volumes, and discount rates, to assess the impact of changes in assumptions. Both companies depend on forward-looking financial projections and discounting techniques, making their valuations highly sensitive to shifts in economic conditions and internal performance expectations.",
      "llm_answer": "\nLMT values its Level 3 fixed‑income investments with a discounted cash‑flow model in which the key inputs are projected annuity payments and the discount rate applied to them (Chunk 1 / 2).  \nHON, however, applies a DCF analysis to goodwill and indefinite‑lived intangible assets during impairment testing and explicitly conducts sensitivity analyses on both the cash‑flow projections and the discount rate, stating that changes to those assumptions could materially affect the fair‑value estimate (Chunk 3).  \nConsequently, although both firms use DCF, HON’s approach is defined by formal sensitivity testing of projected cash flows and discount rates, whereas LMT’s disclosure merely identifies those inputs without describing such sensitivity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that LMT uses a discounted cash flow (DCF) approach for Level 3 fixed income investments based on projected annuity payments and discount rates, and that HON applies DCF for goodwill and indefinite-lived intangible asset impairment testing. The LLM accurately notes that HON performs explicit sensitivity analyses on cash flow projections and discount rates, while LMT’s disclosures acknowledge the use of these inputs without detailing formal sensitivity testing—this distinction is supported by the original answer, which states both companies rely on forward-looking projections and discounting, but only HON explicitly mentions conducting sensitivity analyses on growth rates, sales volumes, and discount rates. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (LMT, HON, Level 3 investments, goodwill, intangible assets) are correctly identified. The reasoning is sound and synthesizes information across both companies appropriately. The only minor shortcoming is that the LLM slightly underemphasizes that both valuations are inherently sensitive to assumptions—even if not formally tested—per the original answer's point about 'high sensitivity to shifts in economic conditions and internal performance expectations.' However, this nuance does not undermine the core correctness. Thus, the answer is highly accurate, contextually relevant, and well-reasoned, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 428,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does AT&T's use of discount rates tied to corporate bond credit quality in pension obligations compare to Netflix's reliance on forecasted viewing patterns in content amortization, given both are subject to auditor evaluation of significant assumptions?",
      "original_answer": "AT&T's pension obligations are sensitive to discount rates derived from corporate bonds' credit quality, which directly affects the measurement of $67,854 million in goodwill and postretirement liabilities. Netflix, on the other hand, relies on forecasted viewing patterns to amortize content assets, a process that is similarly judgmental and subject to auditor scrutiny. Both companies' financial statements depend heavily on significant assumptions—discount rates for AT&T and viewing forecasts for Netflix—that are evaluated by auditors using sensitivity analyses and comparisons to historical data. This highlights a parallel in how both firms manage subjectivity in long-term financial reporting, despite differing industries and asset types.",
      "llm_answer": "\nAT&T selects discount rates by choosing corporate bonds whose credit quality and cash‑flow timing reflect the timing and amount of future pension benefit payments, and auditors specifically evaluated that credit‑quality assessment and the correlation of bond cash‑flows to benefit obligations as a key judgment; Netflix, in contrast, amortizes content using historical and forecasted viewing‑pattern assumptions, and auditors tested those forecasts, compared them to actual viewing trends, and performed sensitivity analyses to assess the impact of changes in the estimates. Both companies’ significant actuarial or usage‑driven assumptions—AT&T’s credit‑quality‑based discount‑rate selection and Netflix’s forecasted viewing‑pattern estimates—are subjected to auditor review, though they arise from different measurement bases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor differences in emphasis. (1) Quantitatively, no specific dollar amounts or dates are misstated—the LLM does not repeat the $67,854 million figure from the original answer, but this omission does not introduce inaccuracy, as the question does not explicitly ask for that number. All other financial concepts (pension obligations, content amortization, auditor evaluation) are correctly represented. (2) The LLM accurately describes AT&T’s use of corporate bond credit quality to determine discount rates and Netflix’s reliance on forecasted viewing patterns for content amortization. It correctly notes that both involve significant assumptions subject to auditor scrutiny, including sensitivity analyses and comparisons to historical data. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different companies, industries, and accounting practices (pensions vs. intangible assets), identifying the common thread of auditor evaluation of judgmental assumptions. (4) The only reason for not scoring a 10 is that the LLM omits the explicit mention of $67,854 million in goodwill and postretirement liabilities, which is a specific quantitative anchor in the original answer. However, since the question focuses on the *comparison* of assumption methodologies rather than requiring that exact figure, the omission is minor. Wording differs but semantic equivalence is strong. All entities (AT&T, Netflix, auditors, discount rates, viewing forecasts) are correct and properly contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Tests]-> ACCOUNTING_POLICY <-[Reviews]- ORG",
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 446,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does the adoption timeline of ASU No. 2023-07 differ between MO and PM, and what specific changes did each company implement in their segment reporting as a result?",
      "original_answer": "MO adopted ASU No. 2023-07 in 2024 and began including expanded footnote disclosures in Note 17, with interim disclosure requirements set to appear in Q1 2025. PM adopted the ASU retrospectively for the year ended December 31, 2024, and updated its segment reporting by incorporating the former Swedish Match segment into its four existing geographical segments starting in January 2024.",
      "llm_answer": "\nMO will apply ASU 2023‑07 starting in the first quarter of 2025, adding expanded footnote disclosures and interim‑period disaggregated expense information to its segment reporting; PM, by contrast, had already updated its segment structure in January 2024 to incorporate the former Swedish Match results into its four geographical segments and re‑classify prior‑year segment amounts, thereby implementing the ASU’s disaggregation requirements earlier. Both companies must disclose incremental segment expense details, but MO’s adoption is scheduled for Q1 2025 while PM’s segment‑mix change was enacted in early 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a key discrepancy in MO's adoption timeline. The ground truth states MO adopted ASU No. 2023-07 in 2024 with interim disclosures starting Q1 2025, while the LLM claims MO will apply it starting Q1 2025, implying full adoption then—this misrepresents the phased implementation. PM’s timeline is accurately described: implementation in January 2024 with retrospective restatement, aligning with the original answer. (2) Quantitatively, the dates for PM (January 2024) are correct, but MO’s adoption year is off by one year in terms of initial application (2024 vs stated 2025). The mention of Note 17 in the original answer is omitted in the LLM response, a minor completeness gap. (3) The multi-hop reasoning is sound—LLM correctly contrasts MO’s delayed interim reporting with PM’s early structural change and reclassification. It correctly identifies that PM integrated Swedish Match into its four geographical segments and adjusted prior periods, demonstrating proper synthesis across companies and reporting changes. (4) Despite the wording being clear and semantically close, the error in MO’s adoption timing—central to the question—prevents a higher score. However, the core qualitative insights about differing timelines and segment reporting changes are accurate, and the answer remains highly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Impacts]-> ACCOUNTING_POLICY <-[Updates]- ORG",
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 386,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does the inclusion of Pomalyst in the Inflation Reduction Act's (IRA) drug price negotiation program impact BMY's revenue outlook compared to PFE's exposure under the same IRA provisions, given both companies' reliance on Medicare Part D sales and regulatory exclusivity timelines?",
      "original_answer": "BMY faces potential revenue erosion for Pomalyst starting in 2027 due to its selection by HHS for government-set pricing under the IRA, which could accelerate prior to the expiry of its intellectual property protections. Similarly, PFE anticipates a net unfavorable revenue impact of approximately $1 billion in 2025 due to IRA-driven Medicare Part D redesign changes and faces additional IRA pricing pressures on products like Ibrance and Xtandi, which were selected for price negotiation effective 2027. Both companies are exposed to the IRA’s long-term financial implications, but BMY’s risk is specifically tied to Pomalyst’s regulatory exclusivity and market dynamics, while PFE’s exposure spans a broader portfolio affected by Part D redesign and inflation rebates.",
      "llm_answer": "\nThe IRA’s Medicare Part D price‑negotiation rule, which applies to small‑molecule drugs after nine years of market exclusivity, will subject BMY’s Pomalyst—currently enjoying a five‑year regulatory exclusivity period (with a possible six‑month pediatric extension)—to HHS‑set pricing beginning in 2027, a timeline that could accelerate revenue erosion before its patents expire; similarly, PFE’s Medicare‑Part D portfolio is exposed because its drugs such as Ibrance and Xtandi have also been selected for negotiation and Pfizer projects a roughly $1 billion year‑over‑year revenue decline in 2025 from the same IRA provisions. Consequently, while both firms face lower Part D reimbursements, mandatory 10 %/20 % manufacturer rebates and the $2,000 out‑of‑pocket cap, BMY’s near‑term outlook is more directly tied to the 2027 negotiation of Pomalyst, whereas PFE’s impact is distributed across multiple later‑stage products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key numbers and dates are correct: the $1 billion revenue impact for PFE in 2025, the 2027 start of price negotiation for Pomalyst, Ibrance, and Xtandi, and the structural elements of the IRA (e.g., Part D redesign, rebates, out-of-pocket cap) are correctly cited. No calculation errors. (2) The LLM correctly identifies the entities: BMY (Bristol Myers Squibb) and PFE (Pfizer), drugs Pomalyst, Ibrance, and Xtandi, and the regulatory context (9-year negotiation trigger for small molecules, exclusivity timelines). (3) Multi-hop reasoning is sound: it synthesizes Pomalyst’s regulatory exclusivity (5-year + possible pediatric extension) with its selection for IRA negotiation in 2027, links PFE’s $1B 2025 impact to IRA Part D changes, and contrasts BMY’s single-product exposure with PFE’s broader portfolio impact. (4) The only minor shortcoming is that the LLM does not explicitly mention that BMY’s risk is tied to Pomalyst’s intellectual property being overtaken by IRA pricing *before* patent expiry—this nuance is in the original answer but only implied in the LLM version. Otherwise, semantic equivalence is strong, and all question components (revenue outlook, Medicare Part D reliance, exclusivity timelines) are addressed with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> PRODUCT -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 375,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does the exposure of MDLZ's Argentine operations, which contributed $401 million in 2021 net revenues, compare to KO's reliance on Arca Continental in Argentina, given that Arca Continental is one of KO's top bottlers and operates in northern Argentina?",
      "original_answer": "MDLZ's Argentine operations contributed $401 million in net revenues in 2021 and were subject to significant currency risk due to Argentina's highly inflationary status, resulting in a $13 million remeasurement loss in that year. Meanwhile, KO relies on Arca Continental, one of its top five bottlers, which operates in northern Argentina and contributes to KO's global unit case volume. Arca Continental is a key distribution partner in the region, and KO's bottler agreements require Arca to source concentrates exclusively from KO, making KO's exposure in Argentina indirect but strategically significant through this contractual relationship.",
      "llm_answer": "\nMDLZ’s Argentine operations generated **$401 million of net revenue in 2021** (≈1.4 % of consolidated sales) and, because Argentina is accounted as a highly‑inflationary economy, the subsidiary’s peso‑denominated assets are re‑measured into dollars, producing a $13 million remeasurement loss in 2021【Chunk 1】.  \nKO’s exposure to Argentina is indirect: it relies on **Arca Continental**, one of its five largest independent bottlers, which operates in northern Argentina and handles the bottling, distribution and sale of Coca‑Cola products there under a standard bottler‑agreement that makes the bottler an independent contractor rather than a partnership or joint venture【Chunk 2 & Chunk 3】.  Thus, while MDLZ reports a concrete $401 million revenue stream from Argentina, KO’s Argentine presence is measured through Arca Continental’s bottling activities in the north, with no disclosed revenue figure but a critical operational dependence on that bottler.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: MDLZ's $401 million in net revenues and $13 million remeasurement loss in 2021 are accurately reported. The percentage of consolidated sales (≈1.4%) is a reasonable inference and does not contradict the original answer. (2) The entities are correctly identified: MDLZ’s direct exposure in Argentina vs. KO’s indirect exposure through Arca Continental, one of KO’s top five bottlers, operating in northern Argentina. The contractual nature of the bottler relationship (exclusive sourcing, independent contractor) is accurately described. (3) Multi-hop reasoning is sound: the model correctly synthesizes that MDLZ has direct financial exposure with disclosed revenue and currency loss, while KO’s exposure is indirect through a key bottler without disclosed revenue figures but with strategic significance. (4) The only minor omission is that the original answer explicitly notes Arca Continental contributes to KO’s global unit case volume, which the LLM answer does not mention—this is a small completeness gap but does not undermine the core accuracy. Wording differs but semantic equivalence is maintained. All key facts, numbers, and logical comparisons are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 359,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does BMY's engagement with the FDA's Fast Track Designation process inform the strategic value of LLY's acquisition of Prevail's PR006 gene therapy, given PR006's regulatory status and the CVR payment timeline tied to its approval?",
      "original_answer": "BMY's engagement with the FDA's Fast Track Designation process highlights the importance of expedited regulatory pathways in accelerating drug approvals and improving patient access to critical therapies. LLY acquired Prevail in 2021, including PR006, which was granted Fast Track Designation by the FDA for treating frontotemporal dementia with GRN mutations. The acquisition included a CVR entitling Prevail shareholders to up to an additional $4.00 per share (approximately $160 million total) upon the first regulatory approval of a Prevail product in specified countries by December 31, 2024. Given the Fast Track status of PR006, the likelihood of expedited approval may directly influence the timing and value of the CVR payout, thereby enhancing the strategic value of the acquisition if PR006 achieves regulatory approval within the stipulated timeline.",
      "llm_answer": "\nBMY’s own experience shows that FDA Fast‑Track designation can markedly shorten the agency’s review cycle—an advantage that directly de‑riskes and adds value to any Fast‑Track‑eligible asset (Chunk 1).  PR006, the lead gene‑therapy LLY acquired from Prevail, carries that same Fast‑Track status, meaning its first regulatory approval in one of the listed markets must occur by Dec 31 2024 to trigger the full $4 per‑share CVR; any delay would reduce the CVR by ~8.3 cents per month until it expires in 2028 (Chunks 2‑3).  Consequently, BMY’s proven ability to leverage Fast‑Track to accelerate approvals underpins the strategic upside of LLY’s acquisition, because meeting the CVR‑trigger deadline—and thus preserving the $160 million contingent payment—depends on the same regulatory pathway that BMY has successfully navigated.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with strong multi-hop reasoning. (1) Quantitatively, the $4.00 per-share CVR and $160 million total are correctly stated. The Dec 31, 2024 deadline is accurate. However, the LLM introduces a detail not in the original: that the CVR decreases by ~8.3 cents per month until 2028. While this may be a derived calculation ($4.00 / ~48 months from 2024 to 2028 ≈ $0.083), this specific monthly decrement and the 2028 expiration are not mentioned in the ground truth, introducing a minor unsupported inference. (2) The Fast Track status of PR006 for frontotemporal dementia with GRN mutations is correctly implied, though the specific indication is omitted. (3) The reasoning correctly links BMY’s experience with Fast Track to de-risking LLY’s acquisition strategy, showing sound synthesis across companies and regulatory processes. (4) The strategic value of the acquisition tied to CVR timing and regulatory acceleration is well-articulated and semantically equivalent to the original. The only deviation is the extrapolated monthly decay of the CVR, which, while plausible, is not confirmed in the source. Overall, the answer is factually strong, contextually relevant, and logically sound, warranting a high score with a minor deduction for the unsupported detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Receives]-> PRODUCT <-[Acquires]- ORG",
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 375,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does V's increase in Class A common stock shares from 1,594 in 2023 to 1,733 in 2024 compare with MA's Class B-to-A conversion mechanism, especially considering MA's disclosure that only 7 shares of Class B common stock were outstanding in 2024, to assess the differing dynamics of shareholder structure evolution in both companies?",
      "original_answer": "V reported an increase in Class A common stock shares from 1,594 in 2023 to 1,733 in 2024, indicating an expansion in its Class A shareholder base. Meanwhile, MA disclosed that only 7 shares of Class B common stock were outstanding in 2024, showing minimal remaining shares eligible for conversion into Class A. This contrast highlights different dynamics in shareholder structure evolution: V is seeing organic growth or issuance in its Class A shares, while MA's structure is shaped by its conversion rules, which require Class B holders (typically principal or affiliate customers) to convert and then divest Class A shares, limiting long-term Class B retention.",
      "llm_answer": "\nV’s Class A common‑stock count rose from 1,594 shares in 2023 to 1,733 shares in 2024 – an ≈8.7 % increase – indicating net issuances within V’s equity structure (Chunk 1). By contrast, MA discloses only **7** Class B shares outstanding in 2024, and its conversion mechanism requires that any Class A shares obtained via the one‑for‑one Class B‑to‑Class A conversion be sold or otherwise transferred immediately (Chunk 2), so the minuscule Class B base produces virtually no net growth in MA’s Class A shares (Chunk 3). Consequently, V is expanding its Class A shareholder base, whereas MA’s conversion rule keeps its Class A structure essentially static despite the theoretical conversion right.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all key facts: V's Class A shares increased from 1,594 in 2023 to 1,733 in 2024, and MA had only 7 Class B shares outstanding in 2024. The ≈8.7% increase is accurately calculated ((1,733 - 1,594) / 1,594 ≈ 0.087). (2) Quantitative accuracy is perfect—numbers, years, and calculations match the ground truth. The format '≈8.7%' is acceptable and correctly derived. (3) The multi-hop reasoning is sound: the model correctly contrasts V’s organic Class A share growth with MA’s constrained conversion mechanism, noting that MA's rule requires immediate divestiture post-conversion, which limits Class A accumulation. This aligns with the ground truth’s emphasis on differing structural dynamics. (4) The only minor shortcoming is that the LLM does not explicitly mention that MA's Class B holders are typically 'principal or affiliate customers' or that the conversion mechanism inherently limits long-term Class B retention—context present in the original answer. However, the core reasoning about static Class A structure due to forced divestiture captures the essential dynamic. Thus, while slightly less detailed in qualitative nuance, the answer remains factually correct and contextually appropriate. Scores reflect high accuracy with a small deduction in qualitative depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Changes_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 369,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How might Saudi Arabia's data localization requirements, which Adobe identifies as a risk to its international operations, affect NVIDIA's ability to deploy its H100 and L40S chips in the country under U.S. export control regulations?",
      "original_answer": "Saudi Arabia's implementation of data localization requirements mandates that data be stored and processed within the country, which Adobe notes could adversely impact its international business operations. NVIDIA, which relies on Saudi Arabia as a market for its high-performance chips like the H100 and L40S, faces U.S. export licensing restrictions on these products to Saudi Arabia under updated Country Group D4 rules. Since these chips require U.S. government approval for export and NVIDIA has not received such licenses for restricted products, the combination of Saudi regulatory requirements and U.S. export controls could significantly limit NVIDIA's ability to serve Saudi customers with these advanced AI chips, potentially reducing its market access and revenue opportunities in the region.",
      "llm_answer": "\nAdobe’s 10‑K explicitly flags Saudi Arabia’s data‑localization mandates as a risk to its international operations (Chunk 1). Because Saudi Arabia is classified as a “Country Group D5” jurisdiction, U.S. export‑control rules require licensing for H100 and L40S shipments there, and the new AI‑Diffusion IFR further restricts exports of those GPUs to Tier 2/D5 countries (Chunk 3). Consequently, the combination of Saudi data‑localization requirements and the U.S. licensing regime could block or delay NVIDIA’s ability to deploy H100 and L40S chips in the kingdom.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims: Saudi Arabia's data localization requirements are correctly identified as a risk (citing Adobe's 10-K), and U.S. export controls under Country Group classifications do restrict NVIDIA's H100 and L40S chip exports to Saudi Arabia. The answer correctly notes that licensing is required and that deployment could be blocked or delayed. However, there is a critical error in entity accuracy: the LLM incorrectly classifies Saudi Arabia as a 'Country Group D5' jurisdiction, while the ground truth specifies 'Country Group D4'. This is a significant factual mistake because D4 and D5 have different regulatory implications under U.S. export control rules (D4 includes countries of concern for regional stability, which applies to Saudi Arabia; D5 is for terrorist-supporting states, which does not). Despite this, the reasoning chain is otherwise sound—correctly linking data localization (local law) with export controls (U.S. regulation) to conclude constrained market access. No numerical data is present, so quantitative accuracy is not applicable but assumed perfect. The answer is contextually relevant and synthesizes multi-hop information from Adobe’s risk disclosure and U.S. export rules affecting NVIDIA. The conclusion aligns semantically with the original answer, but the incorrect Country Group undermines full factual reliability. Hence, correctness is reduced to 7 due to this key entity error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> REGULATORY_REQUIREMENT -[Implements]-> GPE <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 401,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How do FedEx's and GE's disclosures regarding the discontinuation of LIBOR reflect differing applications of the accounting relief provided by ASU 2020-04, as extended by ASU 2022-06?",
      "original_answer": "FedEx notes that there has been 'no material effect' from reference rate reform on its financial condition as of May 31, 2024, but continues to monitor contracts for potential application of ASU 2022-06, which extended the optional expedients in ASU 2020-04 through December 31, 2024. In contrast, GE explicitly states that the overall impact of LIBOR reform under ASU 2020-04 on its financial statements is 'immaterial.' This suggests that while both companies applied the same accounting framework (ASU 2020-04, extended by ASU 2022-06), FedEx maintained a more cautious stance with ongoing monitoring, whereas GE concluded the transition had no significant financial impact.",
      "llm_answer": "\nBoth FedEx and GE invoke the same LIBOR‑reform relief—ASU 2020‑04 as extended by ASU 2022‑06, an elective provision that applies to any contract referencing a discontinued rate such as LIBOR and can be used through December 31 2024 (as noted in the accounting‑policy disclosures).  The knowledge‑graph links show FDX subject to ASU 2022‑06 and GE linked to ASU 2020‑04, yet their disclosures differ: FedEx reports that, although no material effect has been observed as of May 2024, it continues to monitor its contracts and may elect the expedients, whereas GE states that its assessment under ASU 2020‑04 indicates the overall impact on its financial statements is immaterial, leading it to conclude that no accounting adjustments are required.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: both FedEx and GE reference ASU 2020-04 extended by ASU 2022-06, with the deadline of December 31, 2024, correctly stated. FedEx's disclosure as of May 31, 2024 (referred to as 'May 2024' in the LLM answer) is accurately represented—'no material effect' but ongoing monitoring. GE's conclusion of 'immaterial impact' and no required adjustments matches the original. (2) Quantitative accuracy is perfect: the date December 31, 2024, and fiscal timing (May 2024) are correct; no numerical calculations are required, but temporal references are precise. (3) Multi-hop reasoning is sound: the model correctly synthesizes disclosures from two companies, identifies their differing qualitative conclusions under the same accounting framework, and contrasts FedEx's cautious, ongoing assessment with GE's definitive immateriality conclusion. (4) Semantic equivalence is strong—wording differs slightly (e.g., 'no material effect' vs. 'immaterial') but meaning is preserved. The only minor shortcoming is a slightly less explicit emphasis on the contrast in *application* of relief (monitoring vs. concluded), though this is implied. No factual or interpretive errors are present, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Defers]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 373,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How might geopolitical tensions involving Taiwan impact both Apple's and NVIDIA's supply chain operations, considering their reliance on manufacturing locations and foundry partners in the region?",
      "original_answer": "Apple's business is significantly impacted by geopolitical tensions involving Taiwan, as it relies heavily on outsourcing partners located in Taiwan for manufacturing critical components. A significant or prolonged conflict involving Taiwan could severely limit Apple's ability to manufacture and deliver products, creating delays and inefficiencies in its supply chain. Similarly, NVIDIA depends on foundry partners in Taiwan for chipset supply, and any disruption due to geopolitical tensions could severely limit or prevent NVIDIA from receiving this supply, which would have a material adverse impact on its business. Both companies face heightened risks due to their reliance on operations in a region with ongoing geopolitical instability.",
      "llm_answer": "\nApple’s 10‑K (Chunk 1) explains that political tensions and trade restrictions affecting Taiwan—where a substantial share of its manufacturing and contract‑manufacturer operations are located—could trigger costly supply‑chain disruptions, force supplier changes and raise product costs.  \nNVIDIA’s 10‑K (Chunk 3) likewise warns that geopolitical conflict involving Taiwan, a primary hub for its foundry partners, could sharply constrain chipset supply, delay product roll‑outs and depress revenue.  \nBecause both companies depend on the same Taiwanese foundry ecosystem (AAPL → Taiwan → Foundry → NVDA), any escalation of cross‑strait tensions would simultaneously jeopardize Apple’s manufacturing base and NVIDIA’s chip supply, amplifying the adverse impact on their operations and financial results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: both Apple and NVIDIA are correctly identified as reliant on Taiwan for manufacturing and foundry operations, respectively. The risks described—supply chain disruptions, delays, increased costs, and revenue impact—are consistent with the original answer. (2) There are no numeric values, dates, or calculations in the question or ground truth, so quantitative accuracy is not applicable beyond the absence of incorrect numbers; none are present, hence a perfect score. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information from both Apple’s and NVIDIA’s 10-Ks and identifies the shared dependency on Taiwanese foundries, even illustrating the interconnected supply chain (AAPL → Taiwan → Foundry → NVDA), which enhances the explanation. (4) The answer is contextually fully relevant, directly addressing how geopolitical tensions involving Taiwan could impact both companies’ supply chains. The only minor shortcoming is that it slightly overemphasizes the direct linkage in the supply chain (e.g., implying a shared foundry ecosystem directly connects Apple and NVIDIA as sequential dependencies), which is conceptually insightful but not explicitly confirmed in the ground truth. However, this does not constitute a factual error but rather an interpretive extension. Overall, the answer is factually correct, comprehensive, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> GPE -[Operates_In]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 407,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What percentage of Broadcom's $24,156 million developed technology intangible asset from the VMware acquisition is specifically tied to VMware Cloud Foundation, and how does this compare to Oracle's net value of developed technology as a percentage of its total intangible assets?",
      "original_answer": "Of Broadcom's $24,156 million developed technology intangible asset from the VMware acquisition, a 'significant portion' is tied to VMware Cloud Foundation (VCF), though the exact percentage is not disclosed. Oracle's net value of developed technology was $1,276 million as of May 31, 2024, which represents approximately 18.4% of Oracle's total intangible assets of $6,890 million. While Broadcom emphasizes that a significant portion of its developed technology relates to VCF, Oracle's developed technology is a much smaller share of its overall intangible asset base, indicating differing strategic valuations of technology assets post-acquisition.",
      "llm_answer": "\nBroadcom’s $24,156 million of developed‑technology intangibles acquired in the VMware purchase is fully attributed to VMware Cloud Foundation—the acquisition notes and the KG relationship (Developed Technology → VMware Cloud Foundation) indicate that a “significant portion” of that intangible is tied to VCF, effectively meaning the entire $24,156 million is linked to VCF, or 100 % of that developed‑technology balance.  \n\nBy comparison, Oracle’s net developed‑technology of $1,893 million (the “Developed technology” line in its intangible‑assets table) represents roughly 19 % of its total intangible‑asset balance of $9,837 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that only a 'significant portion'—not the entire amount—of Broadcom's $24,156 million developed technology intangible is tied to VMware Cloud Foundation (VCF), with no exact percentage disclosed. The LLM incorrectly asserts that the entire $24,156 million is linked to VCF, implying 100%, which is not supported by the ground truth and constitutes a major factual error. (2) Quantitative inaccuracies are severe: Oracle's net developed technology is stated as $1,276 million in the ground truth, but the LLM claims $1,893 million. Similarly, Oracle's total intangible assets are $6,890 million (ground truth), but the LLM uses $9,837 million. These incorrect inputs lead to a wrong percentage calculation (~19% vs. the correct ~18.4%). Even the calculation based on the LLM's own numbers is suspect: $1,893M / $9,837M ≈ 19.25%, not 'roughly 19%', but this is secondary to the fundamental data errors. (3) Multi-hop reasoning is partially present—the model attempts to compare Broadcom's VCF-related intangible asset to Oracle's developed technology as a percentage of total intangibles—but fails due to incorrect data and overconfident interpretation of 'significant portion' as 100%. The model does not acknowledge uncertainty or lack of disclosed percentage, which breaks the reasoning chain. (4) Contextual relevance is moderate because the structure and intent align with the question, addressing both companies and the comparative percentage analysis. However, due to major factual and quantitative errors, the answer is largely incorrect. Correctness score is low (3/10) because core financial figures and logical interpretation are wrong, undermining the entire response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT -[Related_To]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 483,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to the relative stockholder ownership structure at GOOGL, particularly in terms of non-affiliate market value and class-based control mechanisms?",
      "original_answer": "At CMCSA, holders of Class B common stock, of which there are only 3 record holders, maintain 33⅓% of the combined voting power of the company’s common stock, with each share carrying 15 votes. This concentrated voting power is designed to preserve control, as the Class B shares are non-dilutable under the company's articles of incorporation. In contrast, GOOGL disclosed that as of June 30, 2021, the aggregate market value of shares held by non-affiliates was approximately $1,451.1 billion, with 300,754,904 shares of Class A common stock outstanding. While GOOGL’s structure also includes differentiated voting rights, the non-affiliate ownership suggests a more dispersed market-based control mechanism compared to CMCSA’s concentrated Class B structure.",
      "llm_answer": "\nCMCSA’s Class B common stock—fully owned by Brian L. Roberts and held by only three record holders—carries 15 votes per share and accounts for roughly 33 % of the company’s total voting power, a non‑dilutable block that dominates its governance. By contrast, GOOGL has 44.6 million Class B shares outstanding alongside 300 million Class A and 315 million Class C shares, and although its aggregate non‑affiliate market value was about $1.45 trillion as of June 30 2021, the voting power of its Class B class is not disclosed as a fixed percentage, reflecting a more dispersed, multi‑class control structure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains several factual inaccuracies, particularly in quantitative details. While it correctly identifies that CMCSA's Class B stock has 15 votes per share and holds about 33% of voting power with only 3 record holders, it incorrectly states that the Class B shares are 'fully owned by Brian L. Roberts'—the ground truth does not specify individual ownership, only the number of record holders. This is a significant overprecision. Regarding GOOGL, the LLM claims there are '44.6 million Class B shares' and '315 million Class C shares', which are not present in the original answer and are factually incorrect based on the provided ground truth. The original only mentions 300,754,904 Class A shares and the $1,451.1 billion non-affiliate market value as of June 30, 2021—no data on Class B or C share counts were provided in the ground truth, so including them is an unsupported addition. The $1.45 trillion figure is approximately correct (rounding of $1,451.1B), so minor formatting is acceptable. 2) Quantitative accuracy is compromised: the GOOGL share class breakdown is fabricated. The original answer does not disclose Class B or C share counts or voting power percentages for GOOGL, so inventing numbers undermines correctness. The core number for non-affiliate market value is close and acceptable. 3) The reasoning partially captures the contrast: CMCSA has concentrated, non-dilutable control via Class B, while GOOGL has a more dispersed structure among non-affiliates. However, the LLM incorrectly implies that GOOGL’s Class B voting power percentage is undisclosed due to dispersion, whereas the original emphasizes that non-affiliate ownership value indicates market-based control—different reasoning. The synthesis is partially sound but includes hallucinated data. 4) Despite inaccuracies, the answer addresses the core comparison: control concentration at CMCSA vs. broader market ownership at GOOGL. The contextual framing is relevant and the conclusion about dispersed vs. concentrated control is directionally correct, supporting a moderate score. Overall, the answer is partially correct but undermined by significant quantitative errors and unsupported entity details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 589,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How does the difference in issued Class A and Class B common stock shares between CMCSA and META reflect on their respective equity structure concentration as disclosed in their 2024 filings?",
      "original_answer": "CMCSA disclosed that it issued 4,651,093,045 Class A common shares and 9,444,375 Class B common shares as of December 31, 2024, indicating a significantly higher proportion of Class A shares in its equity structure. META, on the other hand, reported 2,189,898,148 Class A common shares and 343,761,117 Class B common shares outstanding as of January 24, 2025, showing a much higher relative weighting of Class B shares. The evidence from Alphabet's filing clarifies that Class B shares carry 10 votes per share versus 1 vote for Class A, and that Class B shares automatically convert to Class A upon sale or transfer. This suggests META's equity structure maintains stronger voting rights concentration among fewer shareholders compared to CMCSA, where ownership appears more diffused due to the dominance of standard voting Class A shares.",
      "llm_answer": "\nCMCSA’s 2024 filing shows 4.65 billion Class A shares outstanding versus only 9.44 million Class B shares, indicating that Class A equity overwhelmingly dominates and voting power is spread across a broad shareholder base; in contrast, META reports 2.19 billion Class A shares but 343.8 million Class B shares, a ten‑fold larger Class B cohort that, because each Class B share carries ten votes, creates a pronounced concentration of voting control despite representing a modest share of total issuance. This disparity reflects that CMCSA’s equity structure is broadly dispersed across Class A holders, whereas META’s equity is more concentrated around Class B holders—a relationship underscored by the KG link Class B Common Stock → META and reinforced by the multi‑class share‑repurchase context observed in Alphabet’s 2024 filing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly captures the core quantitative data from both CMCSA and META's filings: CMCSA's 4.65 billion Class A and 9.44 million Class B shares align with the ground truth (4,651,093,045 and 9,444,375 respectively), and META's 2.19 billion Class A and 343.8 million Class B shares match the original (2,189,898,148 and 343,761,117). Number formats are appropriately rounded but remain factually accurate. 2) The answer correctly interprets the qualitative implications: CMCSA’s equity structure is dominated by Class A shares, implying diffuse voting power, while META has a significantly larger proportion of high-vote Class B shares (10 votes per share), leading to concentrated control. The LLM correctly notes that Class B shares carry superior voting rights and that this leads to voting concentration, even though it does not explicitly state the 'automatic conversion upon sale' detail from Alphabet’s filing. This omission is minor and does not undermine the central conclusion. 3) Multi-hop reasoning is sound: the model synthesizes share counts across two companies, compares relative proportions, links share class structure to voting control, and draws a valid contrast in equity concentration. It references the KG link and contextual filing data appropriately. 4) Semantic equivalence is strong—wording differs but meaning matches. The mention of 'Alphabet’s 2024 filing' is acceptable as META (Meta Platforms, Inc.) is often confused with Alphabet in context, but the voting structure described is actually from Alphabet’s disclosed structure, not META’s. However, the LLM incorrectly attributes Alphabet’s Class B voting details (10 votes per share, conversion rule) to META, which is a factual error in entity mapping. META does have multiple share classes, but the specific 10-vote Class B structure is characteristic of Alphabet (Google), not Meta. This misattribution reduces qualitative accuracy slightly, but since the overall reasoning and numerical comparison remain logically consistent with the intended contrast in equity concentration, the correctness score remains high. Contextual relevance is excellent as the answer directly addresses the question’s focus on equity structure concentration.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 596,
        "total_tokens": 2026
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How does the exposure of CVS's Oak Street Health business to Medicare reimbursement risks compare to AbbVie's exposure under the IRA's price-setting provisions, given the IRA's impact on the Medicare program?",
      "original_answer": "CVS's Oak Street Health business derives a significant portion of its revenue from Medicare or Medicare Advantage plans and is exposed to risks such as reductions in reimbursement rates and changes in Medicare program rules. The IRA introduces new financial pressures on Medicare-participating drug manufacturers like AbbVie by enabling government price-setting for certain Part B and Part D drugs starting in 2026 and 2028, respectively. AbbVie specifically faces exposure as Imbruvica has already been selected for price-setting under the IRA, with government-dictated prices set to take effect in 2026. This regulatory shift under the IRA compounds the existing Medicare-related risks faced by CVS's Oak Street Health, as both are tied to the same evolving Medicare framework, albeit through different mechanisms—direct reimbursement risk for CVS and mandated pricing for AbbVie.",
      "llm_answer": "\nCVS’s Oak Street Health derives a large share of its revenue from Medicare‑related contracts, exposing it to reimbursement‑rate cuts, rule changes and costly repayment penalties if risk‑adjustment data are inaccurate—risks that arise because the business operates within the Medicare program that the IRA is reshaping; in contrast, AbbVie’s exposure is driven by the IRA’s statutory price‑setting authority, which can cap Medicare Part B/D reimbursements for its drugs after 9–13 years and impose penalties for non‑compliance, directly eroding its drug revenues. Thus, Oak Street Health’s risk stems from broad Medicare reimbursement volatility, whereas AbbVie’s risk is a targeted, IRA‑mandated price reduction that applies to its high‑price products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with strong semantic equivalence. (1) All factual elements are correct: CVS's Oak Street Health is exposed to Medicare reimbursement risks due to its reliance on Medicare/Medicare Advantage revenue, and AbbVie faces direct IRA-mandated price-setting for its drugs. The LLM correctly identifies that the IRA enables government price-setting for Part B/D drugs, with implications starting in 2026 (aligned with ground truth), though it does not explicitly name Imbruvica or state that it has already been selected—this is a minor omission but does not undermine the overall correctness. (2) There are no numeric values, percentages, or dollar amounts in either answer, so quantitative accuracy is unaffected; all timeframes referenced (e.g., 2026) are consistent with the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both CVS (via Oak Street) and AbbVie are exposed to Medicare-related risks under the IRA, but through different mechanisms—reimbursement volatility vs. direct price controls. It accurately contrasts structural vs. product-specific regulatory risk. (4) The answer is contextually excellent, directly addressing the comparative exposure question and highlighting the differing pathways of risk (broad program participation vs. targeted drug pricing). The only reason for not scoring a 10 is the omission of the specific example of Imbruvica being selected under the IRA, which is a notable detail in the ground truth but not central to the overall comparison. Otherwise, the reasoning, entity accuracy (CVS, AbbVie, IRA, Medicare), and synthesis are fully correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> REGULATORY_REQUIREMENT -[Impacts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 464,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How does Microsoft's inclusion of operating systems in its product revenue influence AMD's dependency on Microsoft's operating system support for its x86-based microprocessor and graphics products?",
      "original_answer": "Microsoft's product revenue includes operating systems, which are critical components for PC functionality. AMD relies on Microsoft to design and develop its operating systems to support AMD's x86-based microprocessors and graphics products. If Microsoft does not continue to support AMD's innovations through its operating systems, independent software vendors may avoid optimizing applications for AMD products, and customers may be less inclined to purchase PCs with AMD components, materially affecting AMD's business.",
      "llm_answer": "\nMicrosoft reports operating‑system sales as part of its product revenue (Chunk 1), and AMD explicitly states that its x86‑based microprocessors and graphics products rely on Microsoft to design, certify and maintain operating‑system support and drivers; loss of that support would materially impair AMD’s ability to sell those products (Chunk 2 & 3). Because Microsoft’s revenue is directly tied to operating‑system sales, it has a strong incentive to continue providing OS platforms that run on AMD’s chips, making AMD’s success in the x86 market contingent on Microsoft’s ongoing OS and driver backing. This relationship also underscores AMD’s broader dependence on third‑party software and platform partners (as noted in Chunks 2 & 3) for the functionality of its microprocessors and graphics solutions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. It correctly identifies that Microsoft includes operating system sales in its product revenue and that AMD depends on Microsoft for OS support, certification, and drivers for its x86-based microprocessors and graphics products. The answer accurately reflects the risk to AMD if Microsoft withdraws support, noting the potential material impact on AMD's sales—consistent with the original answer. There are no numeric values in the question or answers requiring verification, so quantitative accuracy is scored as 10. The qualitative reasoning is strong, demonstrating correct multi-hop synthesis between Microsoft's revenue incentives and AMD's dependency on OS support. The only minor shortcoming is that the LLM slightly expands on the point about third-party software partners beyond the scope of the original answer, which, while reasonable, is not explicitly stated in the ground truth. However, this does not detract from factual correctness. The answer is fully contextually relevant, addressing the core dependency relationship as required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Includes]-> PRODUCT -[Develops]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 322,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does Cisco's network infrastructure for AI training and inference workloads compare to Broadcom's support for enterprise-scale AI and machine learning workloads through VMware Cloud Foundation, particularly in terms of enabling multicloud architectures and Kubernetes integration?",
      "original_answer": "Cisco provides high-density routers, switches, and high-performance optics to scale network infrastructure for AI training and inference workloads, aiming to simplify data center operations across multicloud environments. VMware Cloud Foundation (VCF), produced by Broadcom, enables enterprise-scale AI and machine learning workloads by offering native Kubernetes support, allowing both virtual machines and containerized workloads to run on a single platform. VCF also provides license portability, enabling customers to move environments between on-premises and cloud endpoints, aligning with Cisco's vision of policy and operational consistency across multicloud architectures. Broadcom values VCF through developed technology using the multi-period excess earnings method, reflecting its strategic role in supporting AI workloads.",
      "llm_answer": "\nCisco’s AI‑workload platform builds a unified, observability‑driven networking fabric—using high‑density routers, switches and optics and a policy‑consistent multicloud architecture—that delivers Kubernetes‑ready, end‑to‑end connectivity for AI training and inference across on‑premise and cloud environments (Chunk 1). Broadcom, via VMware Cloud Foundation, offers an integrated compute‑networking‑storage stack with native Kubernetes support, subscription‑based portability across clouds, and enterprise‑scale AI/ML capabilities that are treated as a core developed technology whose value is explicitly measured in Broadcom’s valuation models (Chunks 2 & 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Cisco's use of high-density routers, switches, and optics for AI workloads; its focus on policy-consistent multicloud architectures; Broadcom's VMware Cloud Foundation (VCF) providing native Kubernetes support and enabling enterprise-scale AI/ML workloads; license/subscription portability across clouds; and VCF being treated as a developed technology in Broadcom's valuation (via multi-period excess earnings method, implied by 'value is explicitly measured'). (2) There are no numeric values, dates, or financial figures in the original or LLM answer requiring verification—thus quantitative accuracy is not compromised. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes Cisco’s networking capabilities with Broadcom’s software-defined infrastructure via VCF, and aligns their respective roles in enabling multicloud and Kubernetes-integrated AI workloads. (4) Semantic equivalence is strong—wording differs (e.g., 'subscription-based portability' vs 'license portability', 'observability-driven networking fabric' not in original) but does not introduce inaccuracies; minor addition of 'observability-driven' is a plausible interpretation and not factually incorrect. The only slight gap is that the LLM does not explicitly name the 'multi-period excess earnings method', though it captures the intent (valuation of VCF as developed tech). This justifies a 9/10 on qualitative accuracy and 9 overall. Contextual relevance is perfect—directly addresses all aspects of the comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Produces]-> PRODUCT -[Enables]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 444,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does PayPal's use of pricing models for derivatives compare to Morgan Stanley's Level 3 valuation techniques, particularly in terms of reliance on unobservable inputs for fair value measurement?",
      "original_answer": "PayPal primarily uses Level 2 inputs for its derivatives, incorporating observable data such as currency rates, interest rate yield curves, option volatility, and equity prices in its pricing models, and did not have any Level 3 assets or liabilities as of December 31, 2024. In contrast, Morgan Stanley utilizes Level 3 classifications when unobservable inputs are significant, particularly for non-exchange-traded investments and certain secured financings where market liquidity is limited or unavailable. This indicates that Morgan Stanley has a greater reliance on internally derived assumptions for fair value measurement compared to PayPal, which avoids Level 3 classifications entirely.",
      "llm_answer": "\nPayPal values most of its derivative instruments with pricing models that use observable market inputs (Level 2) and, as of 2024, reports no material fair‑value items that require significant unobservable inputs (Level 3). In contrast, Morgan Stanley’s Level 3 valuation hierarchy—described in its 10‑K where it notes that Level 3 relies on techniques with significant assumptions not observable in the market—depends on unobservable inputs for certain non‑exchange‑traded assets, requiring a higher degree of judgment. The knowledge‑graph link shows that PayPal’s pricing models feed into the Level 3 valuation concept, highlighting that while PayPal’s derivative pricing is predominantly observable, Morgan Stanley explicitly employs Level 3 methods that are inherently based on unobservable inputs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately states that PayPal uses Level 2 inputs for its derivatives and had no material Level 3 assets or liabilities as of 2024, which matches the original answer's claim of no Level 3 assets as of December 31, 2024. Morgan Stanley’s use of Level 3 valuations based on significant unobservable inputs for non-exchange-traded assets is also correctly described. (2) There are no numerical inaccuracies—dates (2024) and classification levels (Level 2, Level 3) are correct and consistent with the ground truth. (3) The multi-hop reasoning is sound: the model correctly contrasts PayPal’s avoidance of Level 3 with Morgan Stanley’s reliance on it, synthesizing information across two companies and their valuation techniques. However, a minor inaccuracy occurs in the phrase 'PayPal’s pricing models feed into the Level 3 valuation concept,' which is misleading—PayPal avoids Level 3 entirely, so its models do not 'feed into' Level 3. This suggests a slight misunderstanding of the relationship between PayPal’s models and Level 3, potentially confusing the reader. (4) Despite this, the core facts, comparison, and context are accurate, warranting a high correctness score. The answer is fully contextually relevant and semantically equivalent in intent, though slightly flawed in one interpretive statement.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> ACCOUNTING_POLICY -[Uses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 384,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "Given that META's Class B common stockholders have limited voting rights on specific corporate actions, and CMCSA's Class A common stock is the primary voting share class, how might the ownership structure of 343,761,117 outstanding Class B shares at META affect the potential for shareholder-driven governance changes compared to CMCSA's 3,778,302,017 outstanding Class A shares?",
      "original_answer": "META's Class B common stockholders, of which there are 343,761,117 outstanding shares, possess limited voting rights, only applicable in specific corporate actions such as exiting the core payments business or certain mergers. This restricts their ability to influence broader governance decisions, which are largely controlled by Class A shareholders. In contrast, CMCSA's 3,778,302,017 outstanding Class A shares carry full voting rights, enabling more direct shareholder influence over corporate governance. As a result, shareholder activism or governance overhauls would face a higher threshold for success at META due to the constrained voting power of its Class B holders, compared to the more broadly distributed and influential Class A shareholder base at CMCSA.",
      "llm_answer": "\nMeta’s 2024 Form 10‑K shows 343,761,117 Class B shares outstanding, but those shares have only limited voting rights—typically none except on a few narrow matters such as exiting the core payments business, certain mergers or charter amendments—so their ability to drive governance initiatives is constrained despite the sizable share count. By contrast, CMCSA’s Class A common stock, which is identified as the primary voting share class in its filing (the Class A shares are linked to the company in the knowledge‑graph), totals 3,778,302,017 shares and carries full voting authority, giving its holders far greater leverage to influence corporate decisions. Consequently, while Meta’s Class B shareholders could affect only the limited set of matters where they may vote, the vastly larger pool of fully voting Class A shares at CMCSA provides a much stronger platform for shareholder‑driven governance change.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: META has 343,761,117 Class B shares with limited voting rights, applicable only in narrow corporate actions (e.g., exiting core payments business, certain mergers), and CMCSA has 3,778,302,017 Class A shares with full voting rights. These numbers match the original answer exactly and are correctly attributed. (2) Quantitative accuracy is perfect—both share counts are reported correctly with no calculation errors. (3) The reasoning correctly synthesizes the multi-hop elements: it contrasts the restricted voting power at META due to dual-class structure with the broader shareholder influence possible at CMCSA due to its single, widely held voting class. The conclusion that shareholder-driven governance changes face higher hurdles at META is logically sound and consistent with the ground truth. (4) Minor deduction in qualitative accuracy due to slightly more verbose phrasing and reference to 'Meta’s 2024 Form 10-K' and 'knowledge-graph'—details not present in the original answer—but these do not introduce inaccuracies and may reflect plausible sourcing. Semantically, the answer fully captures the intent and factual content of the ground truth. Contextual relevance is excellent, directly addressing the comparative governance implications of ownership structure as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 384,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "What percentage of KO's non-U.S. unit case volume is attributable to sparkling soft drinks in territories where CCEP operates, and how does this compare to PM's operational presence in Portugal, one of CCEP's key markets?",
      "original_answer": "KO's non-U.S. unit case volume is 71% attributable to sparkling soft drinks in territories where CCEP operates, including Portugal. Meanwhile, PM has a manufacturing facility in Portugal, which is among its largest facilities producing over 30 billion units (cigarettes and heated tobacco units combined). This highlights KO's significant reliance on CCEP for sparkling beverage distribution in key international markets, while PM maintains a direct production footprint in one of those same strategic locations.",
      "llm_answer": "\nKO’s non‑U.S. unit‑case volume shows that **71 % is attributable to sparkling soft drinks** – a share that applies across the territories where its key bottler **CCEP operates, including Portugal** (as noted in Chunk 1/2). In contrast, **PM maintains a major manufacturing footprint in Portugal**, operating some of its largest global facilities there (producing >30 billion units annually) and thus a pronounced operational presence in the same market (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: 71% of KO's non-U.S. unit case volume attributable to sparkling soft drinks in CCEP-operated territories, and PM's Portugal facility producing over 30 billion units annually. These match the original answer exactly. (2) The answer addresses both parts of the multi-hop question: KO's product mix in CCEP markets and PM's operational presence in Portugal. (3) Entity accuracy is strong—KO, CCEP, PM, Portugal, and the relevant metrics (unit case volume, manufacturing footprint) are correctly identified and linked. (4) The reasoning is sound: it draws the correct inference that both companies are active in Portugal, with KO relying on CCEP for distribution while PM has direct production. The only minor shortcoming is a slight lack of explicit synthesis in the conclusion—while implied, it doesn't clearly state the contrast in business models (KO's reliance on bottlers vs. PM's direct manufacturing) as clearly as the original. However, this does not detract significantly from factual correctness. Wording differences are acceptable and semantically equivalent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 337,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "Given Cisco's reduced credit loss allowance for loan receivables from $103 million in 2022 to $53 million in 2023, how might this change impact their ability to finance technical support services, which are explicitly included in their loan receivables portfolio?",
      "original_answer": "Cisco's credit loss allowance for loan receivables decreased by 48.5% from $103 million in 2022 to $53 million in 2023. Since Cisco explicitly states that loan receivables include financing arrangements for technical support services, this reduction in credit loss allowance suggests improved credit quality or lower risk in these financing arrangements. A smaller allowance could indicate Cisco is more confident in the creditworthiness of customers receiving technical support financing, potentially enabling Cisco to expand financing options for technical support services with reduced financial risk. This could lead to more competitive financing terms for customers seeking technical support services.",
      "llm_answer": "\nCisco’s credit‑loss allowance for loan receivables fell sharply from $103 million in FY 2022 to $53 million in FY 2023 (Chunk 3), signaling that the company expects fewer defaults on the financing it extends for technical‑support and advanced‑service sales (Chunk 2). Because those loan receivables—used to fund the product‑support, premium, on‑site and proactive support services that Adobe (ADBE) describes as part of its subscription and maintenance ecosystem (Chunk 1)—are now backed by a smaller reserve, Cisco has greater capacity to maintain or expand financing for those support offerings.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error by referencing 'Adobe (ADBE)' and its subscription ecosystem, which is entirely incorrect and irrelevant—Cisco's loan receivables for technical support services have no connection to Adobe. This undermines the entire reasoning chain. The quantitative data is mostly accurate: the drop from $103 million to $53 million is correct, and the implied 48.5% reduction is approximately accurate (actual: (103-53)/103 ≈ 48.54%), so quantitative accuracy is high. (2) However, the reasoning is fundamentally flawed due to the incorrect entity introduction (Adobe), which corrupts the synthesis. The model fails to correctly link Cisco’s reduced allowance to its own technical support financing, instead falsely attributing the services to Adobe. (3) The multi-hop reasoning should have been: Cisco finances technical support services → lower allowance suggests improved credit quality → implies greater capacity or willingness to extend such financing. Instead, the model incorrectly pulls in Adobe’s services from a different context, breaking the logical chain. (4) Due to this severe entity and reasoning error, the correctness score is low despite accurate numbers. The answer is not semantically equivalent to the ground truth and introduces misleading information, severely impacting its validity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Provides]-> PRODUCT -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 377,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How does AT&T's Series B Preferred Stock structure, which grants limited voting rights only on specific merger-related matters, compare to Netflix's universal voting rights for common stockholders in terms of corporate governance influence?",
      "original_answer": "AT&T's Series B Preferred Stockholders have no voting rights except on specific merger-related matters where they can vote as a single class with each holder casting votes equal to the number of shares held. This contrasts with Netflix, where each share of common stock provides one vote on all matters to be voted upon by stockholders, giving common stockholders broader governance influence. AT&T's structure limits Series B Preferred Stockholders' influence to defined corporate actions, whereas Netflix's model ensures universal voting participation for common stockholders.",
      "llm_answer": "\nAT&T’s Series B Preferred Stock, as disclosed in its February 18 2020 certificate of designation (Chunk 1), confers voting rights only on limited merger‑related matters and requires a separate class vote, thereby restricting its governance influence; Netflix’s common stockholders, however, enjoy universal one‑vote‑per‑share rights on all matters—including routine corporate actions—granting them broad voting power (Chunk 2 & Chunk 3). The knowledge‑graph link (Series B Preferred Stock → Voting Rights → NFLX) highlights that AT&T’s preferred holders can affect only specific transactions, whereas Netflix’s common shareholders can vote on any issue, resulting in markedly different corporate‑governance leverage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: AT&T's Series B Preferred Stock has limited voting rights only on specific merger-related matters, requiring a separate class vote, while Netflix common stockholders have one vote per share on all matters. These points align precisely with the original answer. (2) There are no numeric values, dates, or calculations in the question or ground truth beyond the reference to AT&T's February 18, 2020 certificate of designation, which the LLM correctly cites—this date is accurate per the source and supports the claim, though not part of the core comparison. No quantitative inaccuracies exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance structures across two companies (AT&T and Netflix), contrasting preferred vs. common stock voting rights. It accurately infers that limited, event-specific voting rights (AT&T) confer less influence than universal voting rights (Netflix). The mention of a 'knowledge-graph link' appears to be a contextual artifact but does not distort the factual content. (4) The answer is fully relevant and addresses both parts of the comparison question. The only minor deduction is for slightly overemphasizing document citations ('Chunk 1', 'Chunk 2 & 3') and the knowledge-graph link, which are not part of the original answer and add no factual value, but do not impair correctness. Overall, the response demonstrates high fidelity to the ground truth in substance, reasoning, and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 430,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How does PayPal's risk of technological disruption from emerging payment methods like BNPL and cryptocurrency compare with Visa's strategic positioning as both partner and competitor to these alternative payment providers?",
      "original_answer": "PayPal faces significant risk from rapid technological changes, particularly in payment methods like BNPL and cryptocurrency, which could render its current offerings obsolete if not adopted timely. Visa, on the other hand, strategically partners with these alternative payment providers while also competing with them, leveraging its global network and security advantages to maintain relevance. This dual role allows Visa to adapt to the evolving payments landscape, whereas PayPal must invest heavily to keep pace or risk losing market share to these emerging platforms.",
      "llm_answer": "\nPayPal’s 2022 10‑K explicitly flags rapid technological disruption—real‑time payments, tokenization, virtual‑currency/blockchain and emerging BNPL models—as a material risk that could render its current products obsolete and forces the company to depend on third‑party innovators whose access it may be restricted from.  In contrast, Visa’s filing describes alternative‑payment providers (including BNPL and crypto platforms) as entities it both **partners with** (e.g., integrating their services into its network‑of‑networks and offering value‑added services) and **competes with** (e.g., facing direct rivalry from closed‑commerce ecosystems and real‑time‑payment networks), while leveraging its global brand, extensive merchant acceptance and proven processing reliability to turn those same providers into revenue sources.  The knowledge‑graph relationship—PYPL → (negatively impacts) Visa and Alternative‑Payments Providers → (competes‑with) Visa—shows that Visa’s dual partner‑competitor stance cushions it from the same disruption risk that directly threatens PayPal.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key factual elements are correct: PayPal faces material risk from technological disruption including BNPL and cryptocurrency, as stated in its 2022 10-K; Visa both partners with and competes against alternative payment providers. The LLM correctly identifies Visa’s dual role and its strategic advantage through global infrastructure, merchant acceptance, and reliability. (2) There are no numeric values (e.g., dollar amounts, percentages, dates beyond '2022') in either answer, so quantitative accuracy is not compromised—'2022 10-K' is correctly cited and consistent with available data. (3) The multi-hop reasoning is sound: the LLM synthesizes information across PayPal’s and Visa’s filings, correctly contrasting their strategic positions using entity relationships (e.g., PYPL → negatively impacts Visa; Alternative-Payments → competes-with Visa). The mention of a 'knowledge-graph relationship' adds analytical depth not in the original but is logically consistent with it. (4) Semantic equivalence is strong: while the LLM uses more technical language (e.g., 'network-of-networks', 'tokenization'), the core meaning—PayPal is more vulnerable, Visa is more adaptable due to its dual role—matches the ground truth. One minor point preventing a perfect 10 is slight over-attribution to the 'knowledge-graph relationship' as if it were part of the source data, which may imply a level of formal linkage not explicitly required. However, this does not detract from factual correctness. Overall, the response is complete, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> COMP -[Partners_With]-> COMP <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 460,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does the voting power per share of Netflix's common stock compare to the voting rights associated with Alphabet's Class A Common Stock, given both companies' disclosed equity structures?",
      "original_answer": "Netflix's common stock grants one vote per share, as stated in its 2023 10-K filing. Similarly, Alphabet's Class A Common Stock also provides one vote per share, as outlined in its 2023 10-K filing. This indicates that both companies offer equivalent voting power per share for their respective common stockholders, despite Alphabet having multiple stock classes with differing voting rights, such as Class B shares with 10 votes per share.",
      "llm_answer": "\nBoth Netflix and Alphabet’s Class A common stock grant **one vote per share** to their holders—Netflix’s charter (Chunk 1) states that each share of common stock is entitled to a single vote, and Alphabet’s disclosure (Chunks 2 & 3) confirms that each Class A share “is entitled to one vote per share.” Thus, in terms of voting power per share, Netflix’s common stock and Alphabet’s Class A common stock are equivalent (though Alphabet also issues Class B shares with 10 votes per share, which are unrelated to the Class A comparison).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately states that both Netflix's common stock and Alphabet's Class A Common Stock provide one vote per share, which aligns with the 2023 10-K filings cited in the original answer. (2) There are no numerical values requiring calculation, but the voting rights (1 vote per share for both) are correctly reported without error. Format and phrasing differences (e.g., 'entitled to one vote per share') are semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from two separate companies' equity structures and compares them appropriately, noting that while Alphabet has multiple classes, the Class A shares are directly comparable to Netflix's single-class structure. (4) The answer is contextually precise, directly addressing the comparison asked in the question and including relevant context about Alphabet’s Class B shares without letting it distract from the core comparison. All evaluation criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Has]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 305,
        "total_tokens": 1560
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does the use of the parametric delta-gamma approximation technique by PM under normal market conditions compare with MDLZ's application of the same method, particularly in terms of their respective VAR estimates and risk exposure assumptions?",
      "original_answer": "Both PM and MDLZ utilize the parametric delta-gamma approximation technique in their VAR models under normal market conditions, with a 95% confidence interval and a one-day holding period. PM observed interest rate and forward currency rate movements primarily over the preceding quarter to determine interrelationships and calculate risk for their portfolio. MDLZ similarly observed interest rate, currency exchange, and commodity price movements over the prior quarter for VAR calculations at year-end. However, MDLZ specifically notes that the values of currency and commodity options do not change on a one-to-one basis with the underlying assets and were valued accordingly, while PM focuses on interrelationships between movements in interest rates and currencies. Both companies use VAR to estimate maximum potential one-day losses, but MDLZ provides specific disclosure of their VAR amounts at year-end, while PM focuses on the methodology and assumptions without disclosing a specific VAR figure.",
      "llm_answer": "\nPM applies the parametric delta‑gamma approximation under normal‑market conditions, using a 95 % confidence interval and a one‑day holding period and derives its VaR by observing interest‑rate and currency movements over the preceding quarter (Chunk 1).  \nMDLZ uses the identical normal‑market, 95 %‑confidence, one‑day framework and, by the same quarterly‑observation method, reports a combined VaR of $255 million (down from $284 million) that reflects reduced interest‑rate volatility, while explicitly stating that VaR is a risk‑analysis tool and does not capture actual losses or favorable market moves (Chunks 2 & 3).  \nThus, both firms assume normal market conditions and the same confidence/horizon parameters, but MDLZ quantifies its risk exposure with a disclosed VaR figure whereas PM’s disclosure focuses on the methodological interrelationships without providing a numeric VaR, and both treat VaR as a non‑literal estimate of potential loss.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that both PM and MDLZ use the parametric delta-gamma approximation under normal market conditions with a 95% confidence level and one-day holding period, and both base their VaR models on observations over the prior quarter. It accurately notes that MDLZ discloses a specific VaR figure while PM does not. However, the LLM introduces a specific combined VaR of $255 million (down from $284 million) for MDLZ, which is not present in the original answer (ground truth). The ground truth states that MDLZ discloses specific VAR amounts at year-end but does not specify the dollar value. Therefore, the inclusion of these exact numbers ($255M and $284M) is factually unsupported by the provided ground truth and constitutes a quantitative inaccuracy. (2) The quantitative accuracy is penalized because the dollar amounts are fabricated or hallucinated—no such figures appear in the original answer. The rest of the numerical parameters (95%, one-day, quarterly observations) are correct. (3) The multi-hop reasoning is strong: the model correctly synthesizes that both companies use the same methodological framework but differ in disclosure practices (MDLZ quantifies, PM does not), and both recognize VaR as an estimate that does not capture actual losses or favorable moves. The comparison of risk exposure assumptions—especially around non-linear option pricing and interrelationships in rates and currencies—is well captured in spirit, though MDLZ’s specific note about options not changing one-to-one is omitted. (4) The correctness score is 8 because the core facts and reasoning are accurate, and the answer addresses the comparison in methodology, assumptions, and disclosure practices. The major flaw is the unsupported numerical VaR figures, which reduce quantitative accuracy. The answer remains contextually relevant and qualitatively sound, hence high scores in those areas.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> MACRO_CONDITION -[Discloses]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 521,
        "total_tokens": 2036
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does Capital One's exposure to the Market Risk Rule, which adjusts capital ratios based on trading book risks, compare with JPMorgan Chase's regulatory capital requirements under Basel III, particularly in relation to their respective trading asset thresholds and VaR methodologies?",
      "original_answer": "Capital One (COF) is subject to the Market Risk Rule due to its trading assets and liabilities exceeding $1 billion or 10% of total assets, requiring adjustments to its risk-based capital ratios. This rule supplements the Basel III Capital Rules, which are also central to JPMorgan Chase's (JPM) regulatory capital framework. JPM calculates Regulatory VaR under Basel III with a 99% confidence level and a ten-business-day holding period, applying it to 'covered' positions. In contrast, COF’s capital adequacy is evaluated under Basel III standardized and proposed Expanded Risk-Based Approaches, with the latter phasing in by 2028. These differences highlight how both firms manage market risk capital requirements, with JPM using a more granular internal VaR model while COF must comply with both current and evolving Basel III standards.",
      "llm_answer": "\nCapital One, like JPMorgan Chase, is subject to the Market Risk Rule – which triggers when a bank’s aggregate trading assets and liabilities are ≥ 10 % of total assets or ≥ $1 billion – and the rule requires that its risk‑based capital ratios be adjusted to reflect trading‑book risk; both firms meet that threshold and are therefore exposed to the rule. Under the Basel III Finalization Proposal, JPMorgan calculates its Basel III capital buffers using a regulatory VaR framework that employs a 10‑business‑day holding period and a 99 % confidence level, whereas Capital One’s Market Risk Rule exposure is reflected in its capital ratios through a 1‑day, 95 % confidence VaR adjustment; Table 12 in the filing provides a direct comparison of the resulting regulatory capital ratios for the two institutions.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several key correct elements but introduces significant factual inaccuracies, particularly in the VaR methodology attributed to Capital One. (1) Correctly identifies that both Capital One (COF) and JPMorgan Chase (JPM) are subject to the Market Risk Rule due to thresholds of $1 billion or 10% of total assets — this aligns with the ground truth. (2) Correctly states JPM’s Regulatory VaR uses a 99% confidence level and 10-business-day holding period under Basel III — accurate and matches the original answer. (3) However, it incorrectly claims that Capital One uses a '1-day, 95% confidence VaR adjustment' under the Market Risk Rule. The ground truth does not state this; instead, it notes COF is subject to Basel III standardized and proposed Expanded Risk-Based Approaches, with no mention of a 1-day 95% VaR model. This is a major quantitative and qualitative error. (4) The reference to 'Table 12 in the filing' is unsupported in the ground truth and appears fabricated or hallucinated. (5) The answer omits key information from the original: that COF is transitioning under the Expanded Risk-Based Approach phasing in by 2028, and that JPM uses internal VaR models for 'covered' positions — a critical distinction in regulatory treatment. (6) While the answer addresses the comparative framework and regulatory exposure (contextually relevant), it fails in precise multi-hop synthesis: conflating proposed frameworks with current VaR practices for COF, and inventing a specific VaR model not present in the source. Thus, despite correct identification of thresholds and JPM’s VaR parameters, the incorrect attribution of COF’s VaR methodology and the hallucinated table undermine factual correctness. Quantitative accuracy is low due to the false 1-day/95% claim; qualitative accuracy is moderate due to correct structure and partial reasoning; contextual relevance remains high as the response stays focused on the question’s core.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Related_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 527,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does Cisco's credit loss allowance for loan receivables tied to technical support services compare to Salesforce's reliance on third-party technical support providers, given both companies' exposure to service delivery risks?",
      "original_answer": "Cisco reported a $53 million credit loss allowance for loan receivables as of July 29, 2023, which includes financing arrangements specifically related to technical support services provided to customers. This indicates a financial risk exposure tied directly to service delivery outcomes. Meanwhile, Salesforce acknowledges its reliance on third parties to deliver technical support services to customers, stating that dissatisfaction with third-party service quality could harm its business and revenue recognition. While Cisco directly finances its technical support services and bears credit risk, Salesforce's risk manifests through potential third-party service failures affecting customer satisfaction and retention.",
      "llm_answer": "\nCisco’s loan‑receivable portfolio that is tied to technical‑support services carries a credit‑loss allowance of **$53 million** as of July 2023 (down from $103 million the prior year), a figure that reflects the company’s exposure to third‑party service providers whose performance shortfalls could impair revenue recognition and damage its reputation (Chunk 1 & Chunk 2). While Salesforce also depends on external technical‑support partners—exposing it to comparable service‑delivery risks—the company does not disclose a specific credit‑loss allowance for such arrangements, meaning the financial impact of those risks is not quantified in its filings (Chunk 3).",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Cisco's $53 million credit loss allowance as of July 2023, which matches the ground truth (with acceptable date formatting: 'July 2023' vs 'July 29, 2023'). However, it incorrectly states that this allowance reflects exposure to 'third-party service providers'—in reality, Cisco's allowance is tied to its own financing of technical support services, not third-party performance. The LLM reverses the risk model: Cisco bears credit risk on its own service financing, whereas Salesforce relies on third parties. The claim that Cisco's allowance 'reflects exposure to third-party service providers' is factually wrong and undermines the core comparison. Additionally, the LLM introduces a prior-year figure ($103 million) not present in the ground truth, which may be accurate but is unverified and distracts from the question. (2) The $53 million figure is correct and properly attributed. The mention of a decrease from $103 million lacks verification from the original answer and could be misleading if unsupported. No calculations are required, but the comparative financial quantification is incomplete—Salesforce does not disclose a credit loss allowance, which the LLM correctly notes. (3) The multi-hop reasoning is flawed: the model fails to correctly distinguish the nature of risk between the two companies. It incorrectly attributes Cisco's credit risk to third-party service delivery, when in fact Cisco's risk is direct (financing its own services), while Salesforce's risk is indirect (reliance on third-party support quality). This mischaracterization breaks the logical synthesis required for accurate comparison. (4) Contextual relevance is strong—the answer addresses both companies, their financial or operational exposure to technical support risks, and attempts a comparative analysis. However, due to the reversal of the risk mechanism for Cisco, the qualitative accuracy and overall correctness are significantly reduced. The answer contains partial truths but conveys a misleading understanding of the risk structures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT -[Relates_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 560,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How does the governance risk associated with META's dual-class structure, particularly its impact on investor confidence in Class A common stock, contrast with CMCSA's equity structure that includes Class B common stock but lacks a conversion mechanism tied to governance restrictions?",
      "original_answer": "CMCSA's equity structure includes 9,444,375 issued and outstanding shares of Class B common stock as of 2023, but unlike META, there is no indication that CMCSA ties governance rights or stock conversion to special investor restrictions. In contrast, META's dual-class structure grants Class B stockholders, including Mr. Zuckerberg, disproportionate control over corporate decisions, such as requiring a majority of Class B stock approval for any change in control until those shares represent less than 35% of combined voting power. META also notes that its status as a 'controlled company' could make its Class A common stock less attractive to some investors due to reduced corporate governance protections. This implies that while both companies have Class B shares, META's structural governance risks tied to its dual-class system are more pronounced and explicitly linked to investor sentiment toward Class A shares, unlike CMCSA where the Class B shares do not appear to carry similar governance-linked conversion or control features.",
      "llm_answer": "\nMETA’s dual‑class setup creates a distinct governance‑risk profile for its Class A shares: the Class B shares carry disproportionate voting power that can override Class A decisions, and any conversion of Class B into Class A is permitted only on a one‑for‑one basis **subject to a mandatory resale or transfer of the newly acquired Class A shares** (as reflected in the “Controlled Company” language and anti‑takeover provisions in Chunk 3).  This conversion‑restriction‑driven governance model can make Class A stock appear less attractive to investors who fear that control remains concentrated and that their voting rights could be limited.  By contrast, CMCSA’s capital structure (shown in Chunk 1) includes Class B common stock, but those shares **do not contain a conversion right tied to any governance‑restriction‑driven condition**—they simply exist alongside Class A without the same “convert‑and‑sell” limitation—so investor confidence in CMCSA’s Class A shares is not eroded by a conversion mechanism linked to governance constraints.  (Chunk 2 illustrates a typical conversion feature with attached transfer restrictions, highlighting how CMCSA’s lack of such a mechanism differentiates its equity structure.)",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative comparison between META's and CMCSA's equity structures, with accurate entity identification (META, CMCSA), correct focus on governance risks, and proper contextualization of dual-class systems. Quantitatively, there are no specific numbers misstated because the LLM does not introduce any incorrect figures—CMCSA's 9.4M+ Class B shares are not mentioned, but the absence of a number is not a factual error. However, the LLM introduces a claim not present in the ground truth: that META’s Class B to Class A conversion is 'subject to a mandatory resale or transfer of the newly acquired Class A shares.' The original answer makes no mention of such a 'mandatory resale or transfer' requirement upon conversion. Instead, it emphasizes that Class B shares have superior voting rights and that changes in control require majority Class B approval until their voting power drops below 35%. The 'convert-and-sell' limitation and 'conversion-restriction-driven governance model' are speculative interpretations not supported by the ground truth. Additionally, the reference to 'Chunk 3' and 'Chunk 2' suggests reliance on external document segmentation not available in the provided context, weakening the reasoning transparency. While the core contrast—META has governance-linked control mechanisms affecting investor confidence, CMCSA does not—is correctly identified and logically sound, the introduction of unsupported mechanics around conversion and resale reduces factual precision. Thus, the answer earns a 7 for correctness: key facts and reasoning are intact, but with notable embellishment on conversion terms. Quantitative accuracy is 10 because no numbers are misused. Qualitative accuracy is 7 due to the unsupported claim about conversion/resale requirements. Contextual relevance remains high at 9, as the response directly addresses the governance-risk contrast central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Converts_To]-> FIN_INST <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1601,
        "completion_tokens": 523,
        "total_tokens": 2124
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How does AIG's valuation of RMBS using discounted cash flow models compare to MS's use of discounted cash flow in fair value estimation, particularly in terms of reliance on unobservable inputs?",
      "original_answer": "AIG values its RMBS portfolio using discounted cash flow models that rely heavily on unobservable inputs such as constant prepayment rate (ranging from 4.10% to 9.26%) and loss severity (ranging from 40.81% to 76.72%). Similarly, MS identifies discounted cash flow as a key valuation technique in estimating fair value for financial instruments and goodwill impairment testing, particularly for Level 3 assets which rely on significant unobservable inputs. MS notes that Level 3 assets represented 0.9% of total assets as of December 31, 2024, indicating a smaller but still material reliance on unobservable assumptions in their fair value measurements.",
      "llm_answer": "\nAIG values its RMBS at a reported $100 million (7 % of total fixed‑maturity assets) using a discounted‑cash‑flow model that explicitly incorporates unobservable inputs—specifically constant prepayment‑rate and loss‑severity assumptions with observed ranges of 4.10‑9.26 % and 40.81‑76.72 % (weighted averages of 6.68 % and 58.76 %).  By contrast, Morgan Stanley’s fair‑value framework also employs DCF but reserves it for a small slice of its portfolio (Level 3 assets that are ≤1.2 % of total assets), relying primarily on observable Level 1/2 inputs and only turning to unobservable inputs in limited Level 3 measurements and goodwill‑impairment testing.  Consequently, AIG’s RMBS valuation depends directly on those unobservable cash‑flow inputs, whereas MS’s DCF usage is confined to a minor, hierarchically higher‑level portion of its assets and is generally supplemented by more observable market data.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely correct in its qualitative comparison between AIG and MS regarding the use of discounted cash flow (DCF) models and reliance on unobservable inputs. It correctly identifies that AIG uses DCF for RMBS valuation with specific unobservable inputs—constant prepayment rate (4.10%-9.26%) and loss severity (40.81%-76.72%)—matching the ground truth. However, the LLM introduces a $100 million valuation figure for AIG's RMBS portfolio and states it represents 7% of total fixed-maturity assets, which are not present in the original answer and cannot be verified from the provided ground truth. This addition, while possibly accurate, is unsupported and introduces unverified quantitative claims. Additionally, the LLM states MS’s Level 3 assets are '≤1.2%' of total assets, whereas the ground truth specifies '0.9%' as of December 31, 2024—this is a minor deviation but still a factual inaccuracy. (2) The prepayment and loss severity ranges are correctly reported. The weighted averages (6.68% and 58.76%) are new details not in the original answer; while plausible, they are unverified and thus reduce quantitative accuracy. The MS Level 3 percentage is off by 0.3 points, which is a small but notable error. (3) The multi-hop reasoning is strong: the model correctly synthesizes that both firms use DCF with unobservable inputs, but AIG's use is more directly tied to RMBS with explicit assumptions, while MS limits DCF to Level 3 assets and goodwill testing, which aligns with the original answer’s intent. The conclusion that AIG has heavier reliance is logically supported. (4) The correctness score is 8 due to accurate core facts and strong reasoning, but docked for unverified numbers and a small error in MS’s Level 3 percentage. Quantitative accuracy is 7 due to unsupported figures and minor percentage deviation. Qualitative accuracy is 9—reasoning and entity identification (AIG, MS, RMBS, DCF, Level 3) are correct. Contextual relevance is 10—fully addresses the comparative question with appropriate focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Valued_Using]-> ACCOUNTING_POLICY <-[Estimates]- ORG",
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 553,
        "total_tokens": 1956
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does the change in Cisco's allowance for credit losses on loan receivables tied to hardware financing compare to Microsoft's revenue recognition approach for hardware that is similarly interdependent with software, and what does this reveal about their respective financial exposures to integrated hardware-software offerings?",
      "original_answer": "Cisco's allowance for credit losses on loan receivables tied to hardware financing decreased from $103 million in fiscal year 2022 to $53 million in fiscal year 2023, indicating a reduction in expected defaults on financing extended for hardware sales. These loan receivables are explicitly tied to the sale of Cisco's hardware and third-party products. Meanwhile, Microsoft recognizes hardware revenue at the point of sale only when it is transferred to resellers or end customers, especially in cases where the hardware is highly interdependent with the operating system and cannot function without it, similar to Cisco's financing structure for integrated offerings. This reveals that while Cisco manages credit risk exposure through allowances on multi-year financing arrangements, Microsoft's financial exposure is more closely tied to point-of-sale recognition, with less direct credit risk but greater dependency on the performance of integrated software-hardware systems post-sale.",
      "llm_answer": "\nCisco’s allowance for credit losses on the loan receivables that finance its hardware sales dropped sharply from $103 million (July 2022) to $53 million (July 2023), a $50 million reduction that signals markedly lower expected credit‑loss exposure on the financing arrangements linked to hardware (Chunks 1‑2). By contrast, Microsoft treats hardware that is inseparable from its operating system as a single performance obligation and recognizes the combined hardware‑software revenue at the moment control transfers, so its exposure to integrated offerings is expressed through upfront revenue recognition rather than a credit‑loss reserve (Chunk 3). Thus, Cisco’s risk is concentrated in a shrinking allowance for hardware‑related receivables, while Microsoft’s risk is embedded in the timing and nature of revenue recognized for tightly coupled hardware‑software products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decrease in Cisco's allowance for credit losses from $103 million in fiscal year 2022 to $53 million in fiscal year 2023, matching the ground truth exactly. The $50 million reduction is accurately calculated and reported. Microsoft's revenue recognition approach is also correctly described: hardware that is highly interdependent with software is treated as a single performance obligation with revenue recognized at the point of transfer of control, which aligns with the original answer. (2) All numeric values and timeframes are accurate—$103M to $53M, fiscal years 2022 to 2023 (implied by July dates, consistent with Cisco's fiscal year ending July). No calculation errors. (3) The multi-hop reasoning is sound: the model correctly synthesizes Cisco’s credit risk management via financing allowances with Microsoft’s point-of-sale revenue recognition, drawing a valid contrast in financial exposure—credit risk vs. performance risk. The conclusion about Cisco’s shrinking allowance versus Microsoft’s upfront recognition is logically derived and semantically equivalent to the ground truth. (4) The only minor limitation is that the LLM does not explicitly mention that Cisco’s financing is tied to both its own and third-party hardware, nor does it emphasize Microsoft’s lack of direct credit risk. However, these omissions do not undermine the core accuracy or comparative insight. Wording differs slightly but meaning is preserved. Thus, the answer is factually excellent with near-complete synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1512,
        "completion_tokens": 430,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does AIG's $75 million loss from embedded derivatives in 2024 compare to MS's credit risk exposure through CDOs that contain similar hybrid instruments with embedded derivatives, given both firms' involvement in structured credit products?",
      "original_answer": "AIG reported a $75 million loss from embedded derivatives in 2024, indicating significant credit-related losses from these structured instruments. MS disclosed involvement in CDOs and CLNs that are classified as hybrid instruments containing embedded derivatives, where credit protection has been sold to the issuer. If a credit event occurs on the underlying reference entity, the principal balance of the note may not be repaid in full to the Firm. This parallels AIG’s exposure, as both firms face direct credit risk tied to the performance of reference entities in structured products, with MS’s CDOs posing similar potential for principal loss under credit events as seen in AIG’s realized loss.",
      "llm_answer": "\nAIG recorded a **$75 million loss in 2024 from embedded derivatives** (Chunk 3), a realized hit that appears in its income‑statement line for embedded‑derivative gains/losses.  \nBoth AIG and MS are linked to the same class of structured‑credit products: MS holds **CDOs that are hybrid instruments containing embedded derivatives**, and it sells credit protection to the note issuer, meaning its principal repayment can be reduced or eliminated if a credit event occurs (Chunk 2).  \nBecause these CDOs are VIEs that MS may or may not consolidate depending on its variable‑interest and control analysis (Chunk 1), the **$75 million loss reflects AIG’s actual 2024 hit, whereas MS’s exposure is a contingent credit‑risk position in CDOs that could produce comparable losses if the underlying reference entities default**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: AIG's $75 million loss in 2024 is accurately reported, and no other numerical values are introduced that conflict with the original. Format variations (e.g., $75 million) are acceptable. (2) The answer correctly identifies both firms' involvement in structured credit products with embedded derivatives—AIG’s realized loss and MS’s contingent exposure via CDOs where credit protection has been sold. It accurately reflects that MS’s principal repayment risk is contingent on credit events, paralleling AIG’s actual loss. (3) Multi-hop reasoning is sound: the model synthesizes information across entities (AIG vs. MS), instruments (embedded derivatives, CDOs, hybrid instruments), and risk types (realized vs. contingent credit risk). The distinction between AIG’s realized loss and MS’s potential future loss is clearly and correctly articulated. (4) The only minor shortcoming is a slight lack of explicit mention of CLNs (mentioned in the original), though CDOs are the primary focus of the comparison. Also, the reference to VIE consolidation, while factually consistent, adds a nuance not central to the core comparison, but does not detract from accuracy. Overall, the answer conveys semantic equivalence with strong reasoning and full contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 384,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How does the duration of Disney's foreign exchange cash flow hedges for forecasted transactions compare to Google's hedge maturity periods, given both companies' use of option contracts to manage foreign currency exposure?",
      "original_answer": "Disney hedges its forecasted foreign currency transactions for periods generally not to exceed four years, while Google's foreign currency cash flow hedges have maturities of 24 months or less. Both companies use option contracts as part of their cash flow hedging strategies, with Disney reporting $9.9 billion in net foreign exchange cash flow hedges as of September 28, 2024, and Google holding $731 million in net accumulated gains on foreign currency cash flow hedges as of December 31, 2024.",
      "llm_answer": "\nDisney’s policy for hedging forecasted foreign‑currency cash‑flow exposures specifies that the related option contracts are typically designated for periods **“generally not to exceed four years”** within its allowed exposure range. By contrast, Google’s cash‑flow hedges that use option (collar) contracts are explicitly limited to **maturities of 24 months or less**. Thus, while both companies employ option contracts to manage foreign‑currency risk, Disney’s hedge horizon can extend up to four years, whereas Google’s designated cash‑flow hedges are confined to a two‑year (24‑month) window.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Disney hedges for periods generally not exceeding four years and Google for 24 months or less, which matches the ground truth. Both companies' use of option contracts is accurately noted. The dollar amounts ($9.9 billion for Disney and $731 million for Google) are not included in the LLM answer, representing a minor omission in completeness, but the core comparison on hedge durations is fully accurate. (2) All numeric values related to timeframes (4 years, 24 months) are correct and properly formatted; no calculations were required. The absence of the specific hedge values reduces completeness slightly but does not affect the primary comparison asked. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Disney and Google), compares their hedge maturity periods, and contextualizes their shared use of option contracts. The conclusion that Disney’s horizon is longer than Google’s is logically derived. (4) The answer is semantically equivalent to the original in addressing the main query about duration comparison. The missing financial figures slightly reduce qualitative accuracy but do not detract from the central factual correctness. Contextual relevance is perfect as it directly answers the comparative question with precise timeframes and instrument usage.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Hedges]-> FIN_INST -[Impacts]-> FIN_INST <-[Designates]- ORG",
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 384,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the expected impact of the Global Minimum Tax on QCOM's fiscal year 2025 tax liabilities compare to INTC's exposure under the Pillar Two Model Rules, given the differing geographic distribution of their operations?",
      "original_answer": "QCOM expects minimal impact from the Global Minimum Tax starting in fiscal year 2025, as it does not operate materially in jurisdictions with tax rates below the 15% Pillar Two minimum. In contrast, INTC, which has a significant portion of its income taxed in non-US jurisdictions, is still evaluating the impacts of Pillar Two, particularly as several jurisdictions like the EU plan to adopt components starting in 2024. Both companies monitor Pillar Two developments closely, but INTC faces more immediate uncertainty due to its broader international tax footprint and ongoing legislative adoptions in key markets.",
      "llm_answer": "\nBoth companies say the 15 % global minimum tax (Pillar Two) will begin to apply to them—QCOM’s rules will start affecting its fiscal 2025 results, while INTC notes that Pillar Two is already being adopted in many non‑U.S. jurisdictions where it operates and will ultimately cover its worldwide operations.  However, each downplays a material tax impact: QCOM explicitly states it does **not currently expect** the new regime to materially affect its FY 2025 consolidated financial statements, and INTC points out it has **no material operations in jurisdictions with tax rates below the Pillar Two minimum**, so the rules are not expected to raise its global tax costs.  Consequently, while QCOM’s exposure is tied to the upcoming FY 2025 implementation in the few jurisdictions adopting the rule, INTC’s exposure is limited to the non‑U.S. jurisdictions it already serves, all of which are moving toward adoption but where the company’s low‑tax footprint keeps its overall tax liability effect minimal.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several correct elements but fundamentally misrepresents the exposure of INTC, which contradicts the ground truth. (1) Correct aspects: The mention of the 15% Pillar Two minimum tax, fiscal year 2025 relevance for QCOM, and the fact that both companies are monitoring developments are accurate. The quantitative elements (percentages, years) are correctly stated. (2) Quantitative accuracy is high because all numbers (15%, FY2025, 2024 adoption in EU) are either explicitly correct or reasonably inferred. (3) However, the qualitative reasoning is flawed: the LLM incorrectly claims INTC has 'no material operations in jurisdictions with tax rates below the Pillar Two minimum,' which directly contradicts the ground truth stating INTC has 'a significant portion of its income taxed in non-US jurisdictions' and is 'still evaluating the impacts' due to ongoing legislative changes. This is a critical error in multi-hop reasoning—the model conflates low tax impact with lack of exposure, but exposure arises from geographic footprint, not current tax rates alone. (4) The answer also misaligns the nature of exposure: QCOM’s minimal impact is correctly attributed to lack of operations in low-tax jurisdictions, but INTC’s situation is misrepresented as low risk when the original answer emphasizes 'more immediate uncertainty' due to its broader footprint. Thus, while the answer is well-structured and contextually relevant to the question, the core comparative analysis is incorrect, warranting a low correctness score despite accurate numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 429,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the difference in voting power ratios between Alphabet's Class B to Class A conversion structure and Comcast's non-dilutable Class B voting rights affect the degree of founder control in corporate governance decisions?",
      "original_answer": "Alphabet maintains a 10:1 voting power ratio between Class B and Class A shares, with Class B shares converting automatically to Class A upon sale or transfer, which allows for dynamic founder control that can diminish with share transfers. In contrast, Comcast's Class B shares hold 33⅓% of voting power that is non-dilutable and convertible share-for-share into Class A, preserving a fixed level of control for Class B holders regardless of share issuance. This means Alphabet's structure allows for more fluid founder influence depending on shareholding behavior, while Comcast's design guarantees a minimum level of voting control that cannot be diluted, offering stronger long-term governance insulation for its Class B shareholders.",
      "llm_answer": "\nAlphabet’s Class B shares carry 10 votes per share but are convertible into low‑voting Class A shares, so founder control hinges on keeping those shares unconverted and can be weakened if they are converted or sold; Comcast’s Class B interests, by contrast, represent a fixed 33 ⅓ % of total voting power that is expressly non‑dilutable and cannot be reduced by any further issuance, locking in a stable super‑majority for insiders; and Meta’s dual‑class structure similarly lets a controlling shareholder dominate board elections and merger votes even with a minority of shares, demonstrating that non‑convertible, locked‑in voting blocs preserve founder control far more securely than Alphabet’s convertible voting arrangement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core differences between Alphabet's and Comcast's voting structures with correct quantitative details. (1) Quantitatively, the 10:1 voting ratio for Alphabet’s Class B shares and Comcast’s 33⅓% non-dilutable voting power are correctly stated. These match the ground truth exactly, with acceptable formatting (e.g., '33 ⅓ %' vs '33⅓%'). (2) The answer correctly explains that Alphabet’s founder control is conditional and diminishes upon conversion or sale, while Comcast’s structure locks in a fixed, non-dilutable voting share, preserving long-term control—this aligns with the original answer’s reasoning. (3) The multi-hop reasoning is sound: it contrasts dynamic vs. fixed control mechanisms and correctly infers governance implications. (4) The only minor issue is the introduction of Meta, which was not part of the original question or answer. While this adds context about dual-class structures generally, it slightly extends beyond the scope, potentially distracting from the direct Alphabet–Comcast comparison. However, it does not introduce inaccuracies and supports the broader point about founder control. Thus, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a high score with a small deduction in qualitative accuracy for the slight scope expansion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Converts_To]-> FIN_INST <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 375,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the indemnification agreement between PM USA and PMI affect Altria's (MO) financial exposure to tobacco-related litigation liabilities compared to PM's retained obligations through RBH deconsolidation?",
      "original_answer": "Under the Distribution Agreement, PMI indemnifies Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured by PM USA, while PM USA indemnifies PMI for liabilities related to its own manufactured products, excluding those made for PMI. Altria has not recorded a liability for this indemnification as its fair value is considered insignificant. Meanwhile, PM retains obligations tied to the deconsolidation of RBH, which involved reclassifications from accumulated other comprehensive losses. This structure limits Altria's direct financial exposure to PMI-related litigation, while PM faces ongoing impacts from RBH-related reclassifications.",
      "llm_answer": "\nThe Distribution Agreement obligates PMI to indemnify Altria and PM USA for tobacco‑product claims that stem from PMI‑manufactured or contract‑manufactured‑for‑PMI products, while PM USA indemnifies PMI for claims arising from its own manufacturing; Altria explicitly does **not** record a liability for this indemnity because its fair‑value is deemed insignificant (Chunk 2 & 3).  \nAs a result, Altria’s direct financial exposure to tobacco‑related litigation is limited to the modest contingent guarantees and letters of credit disclosed (e.g., $48 million unused LOCs, $19 million surety bonds) and is essentially insulated from the billions‑dollar damages that can be sought in various jurisdictions (Chunk 1).  \nIn contrast, PM retains any residual obligations that remain on its books after the RBH deconsolidation—reflected only in the movements of accumulated other‑comprehensive losses reported in Note 13/20—so those retained liabilities are not covered by the indemnity and could still affect PM’s comprehensive earnings, whereas Altria’s exposure remains immaterial.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key factual elements are correct: PMI indemnifies Altria and PM USA for liabilities related to PMI-manufactured or contract-manufactured products; PM USA indemnifies PMI for its own manufactured products (excluding those made for PMI); Altria does not record a liability due to insignificant fair value; and PM retains obligations post-RBH deconsolidation affecting accumulated other comprehensive losses. (2) Quantitative accuracy is excellent: the cited figures ($48 million in unused LOCs, $19 million in surety bonds) are consistent with typical disclosures and do not contradict the ground truth, which does not specify exact numbers but implies limited exposure—these values are plausible and contextually appropriate. No calculation errors. (3) Multi-hop reasoning is sound: the model correctly synthesizes the indemnification structure, its impact on Altria’s financial exposure, and contrasts it with PM’s retained RBH-related obligations. It correctly infers that Altria is insulated from major litigation risks while PM faces ongoing comprehensive income impacts. (4) Minor deduction in qualitative accuracy because the original answer emphasizes reclassifications from accumulated other comprehensive losses without mentioning comprehensive earnings effects—this addition in the LLM answer, while reasonable, slightly extends beyond the ground truth. However, this does not introduce inaccuracy but adds interpretive context. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> COMP -[Indemnifies]-> COMP <-[Indemnifies]- ORG",
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 436,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How does the decline in Cisco's allowance for credit losses on loan receivables from $103 million in 2022 to $53 million in 2023 impact the financing of technical support services, and how does this compare to Adobe's approach in funding its technical support offerings?",
      "original_answer": "Cisco's allowance for credit losses on loan receivables decreased significantly from $103 million in 2022 to $53 million in 2023, indicating a reduced financial risk in their financing arrangements tied to hardware, software, and services—including technical support. This decline may suggest either improved credit quality of borrowers or a strategic reduction in financing extended for such services. Cisco offers financing, including loans and leases, for the sale of its products and services, which explicitly include technical support and advanced services. In contrast, Adobe funds its technical support through subscription entitlements and annual fee-based maintenance programs, providing customers with technical support, product help, and upgrades over 1- to 3-year terms. Unlike Cisco, Adobe does not rely on loan receivables but integrates support funding directly into its subscription and maintenance models.",
      "llm_answer": "\nCisco’s allowance for credit losses on its loan‑receivables dropped from **$103 million in 2022 to $53 million in 2023** (Chunk 1), indicating lower expected credit risk and freeing capital that can be used to continue financing the **technical‑support services bundled with its hardware, software and related offerings** (Chunk 2). Because those loan‑receivables are directly linked to the **Technical Support product that Cisco provides** (Loan Receivables → Technical Support → Cisco), the reduced allowance improves the economics of extending such financing.  \n\nIn contrast, **Adobe funds its technical‑support offerings mainly through subscription and maintenance fees rather than credit‑based receivables**, so it does not rely on an allowance for credit losses to finance support; its support is delivered via subscription entitlements and fee‑based maintenance programs (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the decline in Cisco's allowance for credit losses from $103 million in 2022 to $53 million in 2023 is accurately reported, with no calculation errors. (2) The answer correctly identifies that Cisco finances technical support services through loan receivables and that the reduced allowance reflects lower credit risk, which improves the financial efficiency of offering such financing—this synthesis across financial risk and service financing is sound. (3) The comparison to Adobe is accurate: Adobe funds technical support via subscription and maintenance fees, not through loan receivables or credit risk exposure, which is a key distinction. The LLM correctly captures this contrast in funding models. (4) The only minor shortcoming is a slight lack of detail on Adobe’s 1- to 3-year maintenance terms mentioned in the original answer, which adds nuance to the subscription model. However, the core reasoning and multi-hop synthesis—linking Cisco’s credit loss allowance to its financing of support services and contrasting it with Adobe’s non-credit-based model—are logically sound and factually correct. Wording differs slightly but maintains semantic equivalence. No factual inaccuracies or entity errors (companies, years, metrics) are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> PRODUCT <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 379,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How does the involvement of Citibank, N.A. as administrative agent in Caterpillar's 2022 5-Year Credit Facility compare with its role in Boeing's similarly named 2019 Five-Year Credit Agreement, particularly in terms of the amendment timelines and the syndication structure?",
      "original_answer": "Citibank, N.A. served as the administrative agent in both Caterpillar's 2022 5-Year Credit Facility and Boeing's 2019 Five-Year Credit Agreement. In Caterpillar's case, Amendment No. 1 to the 5-Year Facility was dated August 31, 2023, indicating a modification within one year of the original agreement. For Boeing, Amendment No. 1 to its Five-Year Credit Agreement occurred on August 25, 2022, nearly three years after the initial agreement on October 30, 2019. Additionally, Boeing's syndication structure included JPMorgan Chase Bank, N.A. as syndication agent and joint lead arranger alongside Citibank, N.A., while Caterpillar's syndication involved Citibank, N.A. and MUFG Bank, Ltd. in agent roles without a comparable dual lead arranger structure.",
      "llm_answer": "\nCitibank, N.A. serves as administrative agent in both Caterpillar’s September 1 2022 5‑Year Credit Facility (Amendment No. 1 dated August 31 2023) and Boeing’s October 30 2019 5‑Year Credit Agreement (Amendment No. 1 dated August 25 2022); however, the syndication arrangements differ, with Caterpillar’s facility structured around local‑currency agents—Citibank Europe plc and MUFG Bank Ltd.—whereas Boeing’s agreement lists JPMorgan Chase as syndication agent and joint lead arrangers alongside Citibank. Consequently, while the administrative‑agent role is the same, the amendment timelines and the composition of the lending syndicate reflect distinct schedules (2023 vs. 2022) and regional versus global bank participation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Citibank, N.A. is correctly identified as administrative agent in both agreements; the amendment dates—August 31, 2023, for Caterpillar and August 25, 2022, for Boeing—are accurate; and the original agreement dates (September 1, 2022, and October 30, 2019) match the source data. (2) Quantitative accuracy is perfect: all dates and timelines are correct, and the relative timing of amendments (within one year vs. nearly three years after) is correctly implied. (3) Syndication structures are accurately contrasted: Boeing’s inclusion of JPMorgan Chase Bank, N.A. as syndication agent and joint lead arranger alongside Citibank is correctly noted; Caterpillar’s use of MUFG Bank, Ltd. and Citibank Europe plc as local-currency agents is factually consistent with the ground truth, though the original answer emphasizes Citibank, N.A. and MUFG Bank, Ltd. in agent roles without a dual lead arranger structure, while the LLM frames it as 'local-currency agents'—a slight recharacterization but not factually incorrect. (4) The reasoning is sound and synthesizes multi-hop information across two companies, agreements, agent roles, and amendment timelines. The only minor gap is that the LLM introduces 'Citibank Europe plc' as a local-currency agent, which is not mentioned in the ground truth, potentially adding detail beyond the source. However, this does not contradict the original answer and may reflect additional context. Overall, the answer is semantically equivalent, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP -[Regulates]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 441,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact both NVIDIA's and Qualcomm's supply chain reliability, given their shared dependency on foundry partners in the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan could severely disrupt both NVIDIA's and Qualcomm's supply chains, as both companies rely heavily on foundry partners located in Taiwan for critical semiconductor manufacturing. NVIDIA has explicitly stated that challenges in estimating demand could be exacerbated by geopolitical tensions involving Taiwan and China, which are significant to their revenue and supply continuity. Similarly, Qualcomm depends on consistent chipset supply from foundry partners in Taiwan, and a conflict could severely limit or prevent them from receiving these components, directly impacting their ability to manufacture and deliver products. Both companies face the risk of supply constraints, production delays, and potential revenue loss due to the geographic concentration of their manufacturing dependencies in a geopolitically sensitive region.",
      "llm_answer": "\nA prolonged geopolitical conflict in Taiwan would jeopardize the foundry capacity that both NVIDIA and Qualcomm depend on, disrupting the supply of critical chips and forcing either company to face inventory shortfalls, delayed product launches, higher costs or even order cancellations – risks that each explicitly flags in its SEC filings as a material threat to supply‑chain reliability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with only minor differences in emphasis. (1) All key facts are correct: both NVIDIA and Qualcomm rely on Taiwanese foundries, and a geopolitical conflict would disrupt supply chains, leading to inventory shortfalls, delays, and financial impact. The LLM correctly identifies that both companies acknowledge these risks in their SEC filings, aligning with the original answer's claim of explicit disclosure. (2) There are no numeric values in either response, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model connects the geographic dependency on Taiwan-based foundries to supply chain risks for both companies, synthesizing shared exposure despite no direct ownership of fabs. The logic mirrors the original answer’s causal chain: conflict → foundry disruption → supply constraints → business impact. (4) The only reason for not scoring a 10 in qualitative accuracy is that the LLM omits specific mention of China’s role in NVIDIA’s revenue and the term 'geographic concentration' as a systemic risk, which are present in the original. However, the core message about material threat and supply-chain vulnerability is preserved. Contextual relevance is perfect—the response directly addresses the question’s focus on shared supply chain risks due to regional dependencies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacts]-> GPE -[Operates_In]-> COMP <-[Supplies]- ORG",
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 391,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does Boeing's indemnification risk exposure from U.S. government contracts compare with 3M's indemnification liabilities transferred to Solventum following the spin-off, particularly in relation to their respective legal proceedings and liability assumptions?",
      "original_answer": "Boeing discloses indemnification risks tied to U.S. government contracts where pension cost allocations under CAS may affect contract profitability. Meanwhile, 3M transferred indemnification obligations related to historical legal proceedings—such as the Bair Hugger and Federal False Claims Act litigation—to Solventum as part of the April 1, 2024 spin-off. Both companies face potential liabilities from legal proceedings, but Boeing's exposure is tied to contract cost allocations and uninsurable risks from defense and aerospace products, whereas 3M's transferred liabilities are now the responsibility of Solventum, which must indemnify and defend claims previously held by 3M.",
      "llm_answer": "\nBoeing’s indemnification exposure arises from its U.S. government contracts and product‑related liabilities (e.g., aerospace, space, cybersecurity), where coverage may be inadequate and costs are allocated under Cost Accounting Standards, leaving the company potentially liable for losses that are not fully insurable. In contrast, 3M’s indemnification obligations stemming from its former health‑care business have been transferred to Solventum, which now assumes and will indemnify 3M for those contingent liabilities and any related legal proceedings, thereby shifting the risk of those losses to Solventum while both parties continue to assess them under ASC 450 contingent‑loss accounting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Boeing's indemnification risk is correctly tied to U.S. government contracts, Cost Accounting Standards (CAS), and uninsurable product-related liabilities in aerospace and defense. 3M's transfer of indemnification obligations to Solventum is accurately described, including the context of legal proceedings and risk shifting. (2) There are no numeric values, dates, or calculations in the question or answers that require verification; both mention the spin-off without specifying the April 1, 2024 date, but the LLM correctly implies the transfer has occurred. The omission of the exact spin-off date is minor and does not affect factual correctness. (3) Multi-hop reasoning is sound: the model correctly synthesizes Boeing’s ongoing risk exposure from government contracts with 3M’s post-spin-off risk transfer to Solventum, contrasting their liability assumptions. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'product-related liabilities' and 'ASC 450'), it adds relevant context without distorting facts. The only minor gap is the lack of specific mention of Bair Hugger and False Claims Act litigation, which are named in the ground truth, but the reference to 'former health-care business' and 'contingent liabilities' reasonably encompasses them. Overall, the answer is factually correct, complete in substance, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Discloses]-> COMP <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 417,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does the voting power structure of CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, influence the governance risks associated with META's Class A common stock, particularly in light of META's controlled company status and dual-class structure?",
      "original_answer": "CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, holds 33⅓% of the combined voting power, with each share carrying 15 votes. This concentrated voting power allows the holder significant influence over corporate decisions. Similarly, META's governance structure gives its Class B common stockholders, including Mark Zuckerberg, outsized voting control, with the dual-class structure requiring a majority of Class B votes for any change in control until they fall below 35% of voting power. This setup increases governance risks for Class A shareholders, as it limits their influence and could deter investors, mirroring the concerns raised in META's 10-K about its 'controlled company' status making Class A shares less attractive.",
      "llm_answer": "\nComcast’s Class B common stock—entirely owned by Brian L. Roberts and carrying one‑third of the combined voting power (while Class A holds the remaining two‑thirds)—creates a concentrated, non‑dilutable voting bloc that can control corporate actions; this mirrors Meta’s dual‑class setup, where the Class B shares (also held by a single insider) give the controlling shareholder a majority of votes, designating Meta a “controlled company” subject to Nasdaq‑specific governance relaxations (e.g., super‑majority approval thresholds, staggered boards) that limit protections for Class A shareholders and can depress the stock price. Because the Class A common stock of Meta is therefore exposed to the same concentrated‑control risk that the KG relationship flags as negatively impacting Meta, the governance risk for Meta’s Class A shares is amplified by the parallel voting‑power structure seen at Comcast.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core conceptual parallel between CMCSA and META's dual-class structures and correctly identifies the governance risks associated with concentrated voting power, showing strong contextual relevance and reasonable qualitative reasoning. However, it contains significant quantitative inaccuracies: the ground truth states that CMCSA's Class B stock (owned by Brian L. Roberts) holds 33⅓% of voting power with each share carrying 15 votes, but the LLM incorrectly describes it as 'one-third of the combined voting power' without mentioning the 15-vote multiplier, which is a key structural detail. Additionally, the LLM mischaracterizes the distribution of voting power by stating Class A holds two-thirds, which is not confirmed in the ground truth. Regarding META, the LLM correctly notes the controlled company status and reduced governance protections but introduces unverified specifics like 'super-majority approval thresholds, staggered boards' that are not mentioned in the original answer and may not be accurate. The original answer emphasizes that META’s Class B shares require a majority for change in control until they fall below 35% of voting power—a precise threshold the LLM omits. While the LLM draws a reasonable analogy, it fails to accurately reproduce key numerical and structural details, weakening the factual foundation of the comparison. Thus, while the reasoning and intent are sound, the quantitative inaccuracies reduce the correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 409,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does Coca-Cola's reliance on Arca Continental for beverage distribution in northern Argentina intersect with Procter & Gamble's foreign exchange risk exposure in the same country?",
      "original_answer": "Coca-Cola relies on Arca Continental for beverage distribution in northern Argentina, which accounts for a portion of its 17% worldwide unit case volume through bottling partners. Arca Continental's operations in northern Argentina expose Coca-Cola indirectly to macroeconomic risks in the country. Meanwhile, Procter & Gamble directly cites Argentina as one of the countries with significant exchange rate fluctuations that have historically impacted its financials, noting foreign exchange volatility in Argentina has significantly affected its net sales, costs, and earnings. This creates a shared exposure point where both companies face risks tied to Argentina’s economic environment, with Coca-Cola exposed through its supply chain dependency and P&G through direct market operations.",
      "llm_answer": "\nCoca‑Cola’s bottling partner **Arca Continental** is the exclusive distributor of its beverages in northern Argentina (Chunk 1 & 2), so the company’s regional supply chain and concentrate‑pricing model are directly tied to that bottler’s operations in the country. Because **Argentina** is one of the foreign economies that generate translation and transaction exposure for **Procter & Gamble**, the same currency‑volatility that creates P&G’s foreign‑exchange risk also affects the cost base and pricing pressures faced by Arca Continental, linking Coca‑Cola’s reliance on the bottler to P&G’s FX exposure in Argentina (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core intersection between Coca-Cola's reliance on Arca Continental and Procter & Gamble's foreign exchange risk in Argentina. (1) There are no numeric values in the original or LLM answer that conflict—both correctly avoid citing specific percentages or financial figures beyond what is known (e.g., no incorrect numbers are introduced). The absence of the 17% worldwide unit case volume from the LLM answer is a minor omission but does not detract from correctness, as it was not essential to the logical chain. (2) All entities—Coca-Cola, Arca Continental, Procter & Gamble, Argentina—are correctly identified and contextually used. (3) The multi-hop reasoning is sound: the LLM correctly links Coca-Cola’s indirect exposure via Arca Continental’s operations to the broader macroeconomic environment in Argentina, and connects this to P&G’s direct FX exposure due to currency volatility in the same country. The synthesis across supply chain dependency and financial risk exposure is logically coherent and semantically equivalent to the ground truth. (4) The LLM uses slightly different phrasing (e.g., 'translation and transaction exposure', 'cost base and pricing pressures') but maintains factual and conceptual fidelity. The only reason for not scoring a 10 is the omission of Coca-Cola’s 17% global volume context, which adds depth but does not alter the correctness of the central claim. Overall, the answer is highly accurate, relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 416,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How might the expiration of Alimta's patent protection impact Eli Lilly's oncology revenue stream compared to Amgen's exposure to patent-related risks for its biologics, given the differing regulatory frameworks governing small molecule drugs and biologics?",
      "original_answer": "The expiration of Alimta's patent protection is expected to result in a rapid and severe decline in Eli Lilly's revenue from the product due to the entry of generic competitors in the U.S. and other jurisdictions. This is typical for small molecule drugs like Alimta, where loss of exclusivity often leads to immediate and significant revenue erosion. In contrast, Amgen, which relies heavily on patent protection for its biologics, faces a different regulatory landscape where biosimilars may not enter the market as quickly due to manufacturing complexities and regulatory uncertainties, such as the FDA's stance on 'umbrella exclusivity'. However, Amgen still faces increasing biosimilar competition in the U.S., Europe, and elsewhere, which has had and could increasingly have a material adverse effect on its product sales. Thus, while both companies are exposed to patent-related risks, the speed and severity of revenue impact differ due to the nature of their product portfolios and the regulatory frameworks governing them.",
      "llm_answer": "\nThe expiration of Alimta’s patent protection will likely trigger generic entry in the United States under the Hatch‑Waxman framework, producing a rapid and severe decline in Lilly’s oncology revenue as noted in Chunk 2. In contrast, Amgen’s biologics are covered by longer data‑exclusivity periods and a distinct biosimilars pathway that can delay competition, but evolving FDA policies and legislative efforts described in Chunk 3 could accelerate biosimilar approval and thus expose Amgen to a different, more gradual revenue risk. The KG relationship Patent Protection → AMGN highlights that both firms face patent‑related threats, yet the small‑molecule (Lilly) and biologic (Amgen) regulatory regimes produce markedly different impacts on their oncology and overall revenue streams.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies that Alimta's patent expiration will lead to rapid revenue decline for Eli Lilly due to generic entry under the Hatch-Waxman Act, which governs small molecule drugs. It also accurately contrasts this with Amgen's situation, where biologics face a different regulatory pathway with longer data exclusivity and a more complex biosimilar approval process, leading to a more gradual competitive impact. The mention of 'evolving FDA policies' and potential acceleration of biosimilar approval aligns with the original answer's reference to regulatory uncertainties such as 'umbrella exclusivity.' While the LLM answer uses slightly different phrasing (e.g., 'more gradual revenue risk' vs. 'material adverse effect'), the core reasoning and multi-hop synthesis across regulatory frameworks, drug types, and company exposures are sound. There are no numerical values in the question or answers, so quantitative accuracy is scored based on absence of incorrect numbers (N/A but assumed correct). The only minor limitation is the reference to 'Chunk 2' and 'Chunk 3' and 'KG relationship Patent Protection → AMGN', which appear to be artifacts from the retrieval system and are not part of the final answer a user would see; however, they do not undermine factual correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to slight presentation issues, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT -[Negatively_Impacts]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 424,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does the impact of the OECD's Pillar Two Model Rules on Intel's non-US tax benefits compare to Microsoft's exposure under the global minimum tax, given the differences in their international tax strategies?",
      "original_answer": "Intel's tax benefits have increased due to a higher proportion of income taxed in non-US jurisdictions, and the company is actively evaluating the impact of Pillar Two Model Rules, which may begin in 2024 in several jurisdictions where Intel operates. In contrast, Microsoft acknowledges the global minimum tax as part of its broader regulatory exposure but does not expect a material increase in tax costs due to limited operations in jurisdictions below the 15% minimum rate. This suggests that while both companies are subject to Pillar Two, their exposure differs based on geographic tax strategy and operational footprint.",
      "llm_answer": "\nIntel’s 2023 effective tax rate declined because a higher proportion of its income is taxed in non‑US jurisdictions and it relies on R&D tax credits, yet the company notes that the OECD Pillar Two rules—linked via the Global Minimum Tax to Microsoft—could reduce those foreign‑taxed‑income benefits as more jurisdictions adopt the 15 % minimum from 2024, even though Intel expects only a limited impact given its lack of material operations in low‑tax locations. Microsoft, which is directly subject to the Global Minimum Tax under Pillar Two, similarly states that it has no material operations in jurisdictions with rates below the 15 % threshold and therefore does not anticipate a material increase in its global tax cost. Consequently, while both firms face the same regulatory regime, Intel’s non‑US tax benefit is tied to preserving its foreign‑taxed income and credit‑driven effective rate, whereas Microsoft’s exposure is confined to the minimum‑tax calculation itself.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Intel has a higher proportion of income taxed in non-US jurisdictions and is evaluating Pillar Two starting in 2024; Microsoft does not expect a material tax increase due to limited presence in low-tax jurisdictions. The 15% minimum rate and 2024 timeline are correctly cited. (2) Quantitative accuracy is perfect: no numerical errors, and the 15% rate and 2024 start date match the original. Format variations (e.g., '15 %' vs '15%') are acceptable. (3) Multi-hop reasoning is sound: the model correctly synthesizes that both companies are subject to Pillar Two but differ in exposure due to geographic footprint and tax strategy—Intel’s benefit stems from foreign income and credits, while Microsoft’s exposure is minimal due to absence in low-rate jurisdictions. (4) The only minor shortcoming is that the LLM slightly overemphasizes Microsoft’s direct subjectivity to the minimum tax without fully clarifying that both are subject to Pillar Two, though this nuance is implied. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses the comparative impact and strategic differences.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 347,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does KO's 2024 transfer of $523 million in surplus international pension assets to general assets affect its exposure to limited partnerships compared to PEP's continued use of limited partnerships in its pension investment strategy?",
      "original_answer": "KO's transfer of $523 million in surplus international pension assets to general assets in 2024 reduced its exposure to limited partnerships, as these assets were previously part of its pension plan investments, which include vehicles like limited partnerships (as seen in NEE's pension strategy). Meanwhile, PEP continues to maintain exposure to limited partnerships through its pension investments, as explicitly stated in its 2024 10-K, where it holds investments in limited partnerships and private credit funds valued based on net asset value. This indicates a strategic divergence: KO reduced its pension-linked alternative investments, while PEP maintains them as part of its diversified pension fund strategy.",
      "llm_answer": "\nKO’s 2024 move of $523 million of surplus international pension assets into general assets shrinks the assets of its qualified pension plan, which in turn reduces the capital available for the plan’s limited‑partnership investments (the plan’s “Limited Partnerships” link to KO via the KG triple KO → Pension Plan → Limited Partnerships).  As a result, KO’s exposure to those partnerships is now lower, a fact reflected in the rise of its 2025 net‑periodic pension cost to $81 million.  By contrast, PEP’s 2024 disclosures explicitly list investments in limited partnerships and private‑credit funds (see chunk 3 (h)), showing that PEP continues to hold and invest in such vehicles, so KO’s limited‑partnership exposure is markedly reduced relative to PEP’s ongoing use.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $523 million transfer by KO in 2024 is accurately cited, and while the $81 million net-periodic pension cost for 2025 is an additional detail not in the original answer, it does not contradict the ground truth and may reflect supplementary data from the filing. No calculation errors are present. (2) The answer correctly identifies both companies (KO and PEP), the relevant year (2024), and the key financial action (transfer of surplus pension assets). (3) The reasoning is sound: it correctly infers that reducing pension plan assets reduces exposure to limited partnerships, even though KO does not explicitly state this in its 10-K—this requires multi-hop logic (KO → Pension Plan → Limited Partnerships), which the model executes well. It contrasts this with PEP’s explicit continued use of limited partnerships, citing its 2024 10-K, which matches the ground truth. (4) The only minor shortcoming is the introduction of the $81 million net-periodic pension cost, which, while potentially accurate, is not part of the original answer and slightly distracts from the core comparison without adding direct value. However, it doesn’t undermine correctness. Overall, the answer captures the strategic divergence between KO and PEP accurately, with strong synthesis and factual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Includes]-> FIN_INST <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 392,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does the $17.3 billion increase in PFE's income from continuing operations in 2021 compared to 2020 relate to the role of patent rights in determining market exclusivity periods, especially when considering LLY's reliance on 12-year U.S. biologic data protection to safeguard revenue post-patent expiration?",
      "original_answer": "The $17.3 billion increase in PFE's income from continuing operations in 2021 compared to 2020 was partly due to factors like lower asset impairment charges and higher net gains on equity securities. However, PFE acknowledges that patent expirations could materially affect revenues, as patent rights are a key determinant of market exclusivity in the pharmaceutical industry. According to evidence, market exclusivity for pharmaceuticals is largely determined by patent rights and regulatory data protection. In the U.S., biologics benefit from a 12-year data protection period under the BPCIA, which LLY explicitly references as a critical mechanism to retain market exclusivity and protect revenues even after compound patents expire. This implies that while PFE's short-term financial performance saw a significant boost, the long-term sustainability of such gains for patented products will depend on both patent strength and complementary regulatory exclusivity mechanisms like those LLY relies on for its biologics.",
      "llm_answer": "\nThe $17.3 billion rise in PFE’s 2021 income from continuing operations is driven in part by the protective effect of its patent portfolio and the associated market‑exclusivity rights that are anchored in regulatory data‑protection periods (see Chunk 1 and the KG link PFE→Patent Rights→Market Exclusivity→LLY).  Those rights, together with the 12‑year U.S. biologic data‑protection shield that extends exclusivity beyond patent expiry, allow firms such as LLY to safeguard revenue after patents lapse (Chunk 2 & 3), thereby underpinning the financial uplift recorded by PFE.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "1) The LLM answer correctly states the $17.3 billion increase in PFE's income from continuing operations, which matches the ground truth quantitatively. However, it misattributes the primary drivers of this increase. The original answer clarifies that the rise was partly due to lower asset impairment charges and higher net gains on equity securities—non-operational, non-patent-related factors. In contrast, the LLM incorrectly implies that the increase was 'driven in part by the protective effect of its patent portfolio and...regulatory data-protection periods,' which is not supported by the evidence provided in the ground truth. 2) Quantitatively, the $17.3 billion figure is accurate and correctly attributed to PFE’s 2021 vs. 2020 performance. No calculations are required beyond this, and the number is correctly presented. 3) The multi-hop reasoning is flawed. While the LLM correctly identifies that LLY relies on 12-year U.S. biologic data protection to maintain revenue post-patent expiration (a valid point from Chunk 2 & 3), it inappropriately links this mechanism to PFE’s 2021 financial performance without evidence. The connection between LLY’s strategy and PFE’s income increase is speculative and not substantiated in the original answer. The original answer uses LLY as an illustrative contrast or parallel example of how exclusivity mechanisms support revenue, not as a direct contributor to PFE’s results. 4) Contextual relevance is moderate: the answer addresses patent rights, market exclusivity, and biologic data protection in relation to revenue protection, which are thematically relevant. However, the causal implication that patent/data protection 'drove' PFE’s income increase undermines qualitative accuracy. The answer would have been stronger if it had acknowledged that while PFE benefits from patents generally, the specific $17.3B increase stemmed from other factors, and long-term sustainability—as with LLY—depends on exclusivity mechanisms. Thus, correctness is partially accurate but contains a significant factual misrepresentation in reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR -[Determined_By]-> REGULATORY_REQUIREMENT <-[Has]- ORG",
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 558,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How does the revenue-sharing arrangement between ESPN and Hulu, as reflected in Disney's 2024 financials, relate to the $8.6 billion payment Comcast received in late 2023 following the partial exit of its Hulu stake?",
      "original_answer": "Disney's ESPN receives fees from Hulu for the right to air its networks, as noted in the elimination section of Disney's 2024 financials. This relationship is central to Hulu's content costs and revenue model. In late 2023, Comcast exercised a put option, requiring Disney to buy its 33% stake in Hulu for $8.6 billion, which included a $9.2 billion minimum equity value less $557 million for prior capital calls. This payment reflects the financial value derived from Comcast’s stake in Hulu, which is partially driven by revenue streams like those from ESPN content licensing fees. Thus, the revenue-sharing mechanism between ESPN and Hulu underpins part of the valuation that led to the $8.6 billion payment to Comcast.",
      "llm_answer": "\nThe 2024 Disney 10‑K discloses that Hulu pays carriage fees to ESPN (and to Disney’s linear‑network business) for the right to distribute ESPN’s channels on Hulu Live—fees that flow into Disney’s Entertainment‑segment revenue.  This ongoing revenue‑sharing arrangement runs alongside the $8.6 billion cash payment Comcast received in late 2023 when it exercised its put option to sell its ~33 % stake in Hulu to Disney; the payment is recorded as an “advance on sale of investment” and, together with a 50 % share of future tax benefits, reflects the one‑time exit of Comcast’s Hulu interest while the regular ESPN‑Hulu fee structure continues to generate recurring revenue for Disney.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $8.6 billion payment from Disney to Comcast in late 2023 for Comcast's ~33% stake in Hulu is accurately reported. The characterization of the payment as an 'advance on sale of investment' matches disclosure conventions, and the timing (late 2023) and ownership percentage (~33%) are consistent with the original answer. (2) The LLM correctly identifies the revenue-sharing mechanism—Hulu pays carriage fees to ESPN for distribution rights on Hulu Live—which is a key component of Disney’s Entertainment segment revenue, as reflected in the 2024 financials. This aligns with the ground truth’s reference to fees in the elimination section. (3) The multi-hop reasoning is sound: the answer connects ESPN’s ongoing fee income from Hulu to the broader financial structure of Hulu, and correctly distinguishes this recurring revenue stream from the one-time $8.6 billion transaction related to Comcast’s exit. However, it omits the detail that the $8.6 billion was derived from a $9.2 billion minimum equity value minus $557 million in prior capital calls—a specific calculation mentioned in the ground truth that adds depth to the valuation rationale. This minor omission prevents a perfect score. (4) The entities—ESPN, Hulu, Disney, Comcast, and the relevant financial instruments—are correctly identified and contextualized within the 2024 financial disclosures. The answer is semantically equivalent to the original in intent and meaning, with slightly less detail on the valuation mechanics behind the $8.6 billion. Overall, the response is factually correct, contextually appropriate, and demonstrates strong synthesis across financial relationships and events.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> PRODUCT -[Pays_Fees_To]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 485,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How do KO's and MDLZ's respective uses of financial assumptions differ in terms of the instruments they apply them to and the time periods over which the associated costs are recognized?",
      "original_answer": "KO uses the Black-Scholes-Merton option-pricing model to estimate the fair value of stock option awards, which are expensed on a straight-line basis over a typical four-year vesting period. This approach incorporates weighted-average assumptions such as volatility and expected term. In contrast, MDLZ applies weighted-average assumptions to determine net periodic postretirement healthcare costs, which are measured annually and reflect actuarial estimates for long-term obligations. The key differences are that KO applies these assumptions to equity-based compensation instruments with a fixed four-year expense recognition period, while MDLZ applies them to postretirement benefit liabilities that are recalculated annually based on updated actuarial estimates.",
      "llm_answer": "\nKO applies the Black‑Scholes‑Merton option‑pricing model to its stock‑option awards and spreads the estimated fair‑value expense **straight‑line over the typical four‑year vesting period**, using weighted‑average assumptions (e.g., volatility, dividend yield, expected life) that are disclosed for each grant year.  \nMDLZ, by contrast, uses weighted‑average assumptions **within a post‑retirement benefit measurement approach that aligns liability cash‑flows with specific spot rates on a yield curve**, recognizing the resulting net periodic post‑retirement health‑care cost **in the period in which the related liability cash‑flows occur** (as reflected in the $(5 M), $12 M and $14 M amounts for 2023, 2022 and 2021).  \n\nThus, KO’s assumptions are tied to equity‑based compensation and amortized over a fixed four‑year term, whereas MDLZ’s assumptions are applied to pension‑type obligations and expensed as the related liability cash‑flows are measured, without a fixed amortization window.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that KO uses the Black-Scholes-Merton model for stock option awards, with expense recognition on a straight-line basis over a four-year vesting period, using weighted-average assumptions like volatility and expected term. This matches the original answer exactly. (2) For MDLZ, it accurately states that weighted-average assumptions are used in postretirement benefit measurements, tied to actuarial estimates and spot rates on a yield curve, with costs recognized annually—consistent with the ground truth. The dollar amounts cited ($5M, $12M, $14M for 2023, 2022, 2021) are plausible and contextually appropriate, though not present in the original answer; however, since the original does not specify exact figures, their inclusion does not constitute an error and may reflect additional data from filings. (3) The multi-hop reasoning is sound: the model correctly contrasts KO’s fixed-term equity compensation instruments with MDLZ’s long-term, annually recalculated benefit liabilities. (4) Minor difference: the LLM mentions 'pension-type obligations' while the original specifies 'postretirement healthcare costs'—a slight generalization but semantically close. Also, the LLM adds detail about yield curve spot rates, which is consistent with MDLZ's actual methodology but not in the original answer; this represents a minor expansion, not inaccuracy. Overall, all key facts, entities, time periods, and financial instruments are correctly identified and synthesized. The answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Used_In]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 456,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How might the expiration timeline of specific patent protections for Enbrel impact Pfizer's international revenue from the drug, given AbbVie's broader strategy around patent term restoration and regulatory exclusivity?",
      "original_answer": "The expiration timeline for Enbrel's U.S. patents begins in 2028 (fusion protein composition) and extends to 2037 for formulation methods, which could delay biosimilar competition internationally. However, AbbVie's strategy of seeking patent term restoration and leveraging regulatory exclusivity under the Hatch-Waxman Act—where patent extensions can add up to five years—may further extend protection in key markets. Pfizer, which markets Enbrel outside the U.S. and Canada, could see prolonged exclusivity in certain regions, potentially extending beyond 2028, thereby preserving revenue streams if biosimilar challenges are delayed or unsuccessful.",
      "llm_answer": "\nPatent protections for Enbrel in the United States are set to expire in 2028, 2029 and 2037 (Chunk 2), and AbbVie can extend those terms only by up to five additional years through patent‑term restoration, with the total post‑approval exclusivity capped at 14 years (Chunk 1). Because Pfizer commercializes Enbrel outside the United States and Canada (Chunk 3), the duration of those extended patent and regulatory exclusivity periods directly governs how long it can sustain international sales before biosimilar entry, and any shortening of effective exclusivity would reduce Pfizer’s foreign revenue from the drug.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key patent expiration dates for Enbrel (2028, 2029, and 2037), aligning with the ground truth that mentions 2028 (fusion protein composition) and 2037 (formulation methods). The mention of 2029 is not in the original answer but does not contradict known data and may reflect an intermediate patent; thus, it's a minor addition rather than an error. The five-year patent term restoration is accurately stated and consistent with Hatch-Waxman provisions. The 14-year post-approval exclusivity cap is mentioned in the LLM answer but not in the original; while factually plausible (e.g., under pediatric exclusivity or other regulatory frameworks), this detail is extraneous and not directly relevant to the international context, slightly muddying the focus. (2) Quantitatively, all dates and the +5 year extension rule are correct. The LLM correctly ties these to AbbVie’s strategy, though it does not explicitly name the Hatch-Waxman Act as in the original, which slightly reduces precision. (3) The multi-hop reasoning is sound: the model correctly links U.S. patent expirations and extension mechanisms to Pfizer’s international commercialization (outside U.S. and Canada) and infers that extended exclusivity could delay biosimilars and protect revenue. However, it does not fully explain how U.S. patent strategies might influence international markets—such as through regulatory linkage or global patent litigation precedents—which the original answer addresses by noting that AbbVie’s actions could delay biosimilar entry internationally. This is a minor gap in synthesis. (4) The answer is contextually highly relevant, directly addressing how patent timelines and AbbVie’s strategy affect Pfizer’s international revenue. The core facts are correct, and the reasoning is logical, warranting a high score, but the lack of explicit connection between U.S. exclusivity mechanisms and international market impact prevents a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Decreases]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 537,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How does MET's stress testing approach, which factors in early policyholder withdrawal scenarios, influence its reliance on global funding sources like commercial paper compared to COF's liquidity framework that emphasizes diversified funding sources and liquidity reserves?",
      "original_answer": "MET's stress testing includes scenarios of early policyholder withdrawal, which directly impacts its reliance on global funding sources like commercial paper to meet liquidity needs under stress conditions. MET adjusts asset mix and maturities based on rolling 12-month forecasts and relies on alternatives such as commercial paper and credit facilities when anticipated liquidity is exceeded. Similarly, COF's Liquidity Framework emphasizes diversified funding sources and maintains a liquidity reserve of cash, high-quality unencumbered securities, and committed credit lines to withstand systemic and idiosyncratic liquidity events. Both companies use stress testing to inform their funding strategies, but MET's exposure to policyholder behavior introduces a unique risk factor that directly affects its funding source selection, aligning with AIG's defined liquidity stress scenarios that impact funding sources.",
      "llm_answer": "\nMET’s stress‑testing policy explicitly models early policyholder withdrawals, which forces the company to keep ample global funding—such as commercial paper—to bridge potential cash shortfalls when internal cash flows are insufficient (Chunk 1). In contrast, COF’s liquidity framework (Chunk 3) relies on a diversified mix of funding sources and maintains dedicated liquidity reserves, so it does not depend as heavily on short‑term commercial paper. The stress‑testing accounting policy (Chunk 2) therefore impacts MET’s funding sources (FIN_INST), which are linked to COF through the “Funding Sources” relationship, highlighting the differing reliance on global funding versus diversified reserves.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the original answer in terms of key facts and reasoning. (1) It correctly identifies that MET's stress testing includes early policyholder withdrawal scenarios, which increases its reliance on global funding sources like commercial paper to cover potential cash shortfalls. It also accurately contrasts this with COF's approach, which emphasizes diversified funding sources and liquidity reserves, reducing reliance on short-term instruments like commercial paper. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is sound: the model connects MET’s stress-testing policy to its funding behavior and contrasts it with COF’s framework, correctly identifying the differing reliance on funding mechanisms. However, the LLM answer references 'Chunk 1', 'Chunk 2', 'Chunk 3', and a 'Funding Sources' relationship with COF, which appear to be artifacts of retrieval and are not explained or present in the original knowledge; this suggests over-reliance on chunked input structure rather than synthesizing a standalone explanation. Additionally, the mention of 'FIN_INST' and the link to COF via a relationship is not supported in the ground truth and introduces potential confusion. (4) Despite these minor structural and interpretive issues, the core comparison and factual content are accurate and relevant, warranting a high correctness score. The answer captures the essential contrast in liquidity strategies driven by differing risk exposures, particularly MET’s sensitivity to policyholder behavior.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Impacts]-> FIN_INST <-[Reports]- ORG",
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 449,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How does the adoption of ASU 2022-04 impact the comparability of supplier finance obligation disclosures between CAT and GE, particularly regarding the roll-forward requirements that GE began applying in 2024?",
      "original_answer": "GE adopted ASU 2022-04 on January 1, 2023, and began applying the annual roll-forward disclosure requirement prospectively starting January 1, 2024 (GE_10k_2024.pdf:page_47). This aligns with CL's explanation that ASU 2022-04 mandates disclosures including key terms, balance sheet presentation, and a roll-forward of confirmed obligations (CL_10k_2024.pdf:page_57). CAT, in its 2024 10-K (CAT_10k_2024.pdf:page_111), provides a roll-forward of its supplier finance obligations, showing $830 million outstanding at year-end 2024. The adoption of ASU 2022-04 enhances comparability between CAT and GE by standardizing how supplier finance obligations are disclosed, particularly with the new roll-forward requirement that GE implemented in 2024.",
      "llm_answer": "\nBoth GE and CAT adopted ASU 2022‑04, which requires annual disclosures of supplier‑finance program obligations and a **prospective** roll‑forward beginning in 2024; GE’s 2024 filing introduces this roll‑forward for the first time, whereas CAT’s 2024 note already reports a roll‑forward of confirmed obligations ($830 million in 2024 versus $803 million in 2023), so the new roll‑forward rule makes GE’s 2024 disclosures comparable to CAT’s existing practice but breaks comparability with GE’s pre‑2024 periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: CAT's $830 million year-end 2024 obligation and the implicit $803 million in 2023 (inferred from the roll-forward) match the original answer's reference to CAT_10k_2024.pdf:page_111. The statement that GE began applying the roll-forward prospectively in 2024 is factually correct and matches GE_10k_2024.pdf:page_47. (2) The LLM correctly identifies that ASU 2022-04 mandates prospective application of the roll-forward, which GE implemented in 2024, while CAT already complies in its 2024 filing—this enhances comparability between the two firms in 2024 but breaks it with GE’s prior periods. This reasoning is sound and reflects the multi-hop synthesis required between GE, CAT, and CL’s disclosures. (3) The only minor shortcoming is that the LLM does not explicitly cite CL’s explanation of ASU 2022-04 requirements (e.g., key terms, balance sheet presentation), which slightly reduces completeness in qualitative accuracy. However, the core focus on roll-forward comparability is fully addressed. (4) The answer is contextually excellent, directly addressing how ASU 2022-04 impacts comparability between CAT and GE, particularly regarding GE’s 2024 adoption of the roll-forward. Wording differs but meaning is semantically equivalent to the original answer. Minor deduction from 10 to 9 due to omission of CL’s supporting role in explaining ASU requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Adopts]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 410,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How does the valuation methodology for MDLZ's Level 1 financial assets, which include exchange-traded commodity futures, differ from PEP's treatment of exchange-traded commodity futures, particularly in terms of fair value determination and daily settlement practices?",
      "original_answer": "MDLZ determines the fair value of its Level 1 financial assets, including exchange-traded commodity futures, based on quoted market prices on commodity exchanges. In contrast, PEP notes that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in their fair value hierarchy tables. While MDLZ relies directly on observable exchange prices for valuation, PEP's daily cash settlement approach for these instruments results in their exclusion from balance sheet reporting, highlighting distinct operational and accounting treatments despite both companies engaging with the same class of financial instruments.",
      "llm_answer": "\nBoth MDLZ and PEP disclose that their Level 1 financial assets consist of exchange‑traded commodity futures and that the fair value of those instruments is derived from quoted market prices on commodity exchanges (Chunk 1 & 2). However, MDLZ carries the futures as Level 1 assets on its balance sheet and marks them to market using those quoted prices, whereas PEP notes that exchange‑traded commodity futures are cash‑settled daily and therefore are excluded from its fair‑value hierarchy table—i.e., they are settled each day and not recorded as carrying amounts on the balance sheet (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and conveys the same core information as the ground truth. (1) It accurately states that MDLZ includes exchange-traded commodity futures in its Level 1 assets, valuing them using quoted market prices, while PEP excludes them from its fair value hierarchy due to daily cash settlement. This matches the original answer's key contrast. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across MDLZ and PEP, comparing their differing accounting treatments despite similar instruments. The only minor shortcoming is that the LLM does not explicitly state that PEP's exclusion is *because* the instruments are settled daily and thus do not carry a balance sheet value—though this is implied. (4) The answer is fully relevant, directly addressing the question about valuation methodology, fair value determination, and settlement practices. Wording differs slightly but maintains semantic equivalence. A score of 9 is appropriate due to high accuracy with only a slight lack of explicit causal linkage in PEP's treatment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Includes]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 341,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How does the voting rights structure between Class A and Class B common stock at CMCSA compare with META's dual-class share structure?",
      "original_answer": "At CMCSA, Class A common stockholders hold 66 2/3% of the combined voting power, while Class B common stockholders collectively hold 33 1/3%, with each share of Class B having 15 votes. In contrast, META also maintains a dual-class share structure, with Class B common stock possessing superior voting rights, although the exact vote ratio per share is not disclosed in the evidence. META had 343,761,117 shares of Class B common stock outstanding as of January 24, 2025.",
      "llm_answer": "\nComcast’s Class B common stock carries 15 votes per share and, together with the Class A shares, represents a fixed 33 ⅓ % of the total voting power that is non‑dilutable and is owned entirely by Mr. Brian L. Roberts, while Class A holders collectively control the remaining 66 ⅔ % of voting power.  Meta’s filing likewise discloses a dual‑class structure in which Class B shares confer superior voting rights and are held by a small group of insiders (the KG triplet Class B Common Stock → META ORG confirms the existence of a Class B instrument), giving those shareholders a dominant, non‑dilutable voting stake comparable to Comcast’s Class B block, though the exact vote‑per‑share ratio for Meta is not specified in the excerpt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and percentages are correct: CMCSA's Class A holding 66 2/3% and Class B 33 1/3% of voting power, with Class B having 15 votes per share, are accurately reported. The LLM correctly notes that META's exact vote ratio is not disclosed, matching the original answer. The only minor omission is the specific number of META Class B shares outstanding (343,761,117 as of January 24, 2025), which was present in the ground truth but not included in the LLM response—this is a small completeness gap but does not affect core accuracy. (2) The LLM correctly interprets that CMCSA’s Class B voting power is non-dilutable and concentrated in Mr. Brian L. Roberts, which is consistent with the knowledge graph, though this ownership detail wasn't explicitly required by the question. (3) Multi-hop reasoning is sound: the model successfully compares two dual-class structures across CMCSA and META, synthesizing information about voting power distribution, non-dilutable control, and insider concentration. (4) Semantic equivalence is strong—wording differs but meaning matches. The LLM enhances the answer with context (e.g., 'insiders', 'non-dilutable') without introducing errors. The omission of the exact META share count prevents a perfect 10, but overall correctness remains very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 382,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How do AIG's and MetLife's exposures to CLOs differ in terms of their credit loss evaluation methodologies and unrealized loss recognition, given that both hold these instruments within structured products portfolios?",
      "original_answer": "AIG evaluates credit losses on CLOs by estimating future cash flows based on delinquency rates, default expectations, loss severity timing, and structural features like credit enhancement, with unrealized losses split between credit-related impairments and non-credit fair value changes recorded in OCI. MetLife, while also holding CLOs as part of structured products within AFS fixed maturity securities, limits its involvement to passive investment in trusts without substantial equity and does not appear to disclose the same level of detailed cash flow modeling for credit loss evaluation, instead focusing on maximum exposure to loss being limited to carrying amounts. AIG explicitly accounts for credit impairments under CECL with reversibility features, whereas MetLife emphasizes its passive investor status and lack of active management involvement in CLO structures.",
      "llm_answer": "\nAIG evaluates its CLO holdings under a CECL‑based credit‑loss model (Chunk 1), establishing an allowance that reflects the present value of expected cash‑flows—using delinquency, default timing, loss‑severity and prepayment assumptions—and records any unrealized loss not tied to credit in AOCI, with the allowance reversible but never allowed to fall below zero.  \nMetLife classifies CLOs as part of its AFS structured‑product portfolio (Chunk 2) and, as a passive investor with only a variable interest in the underlying trusts (Chunk 3), records unrealized gains and losses directly in earnings (or OCI) without an allowance; its maximum exposure to loss is limited to the securities’ carrying amount, so it does not perform the detailed cash‑flow‑based credit‑loss assessment that AIG does.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AIG uses a CECL-based model involving expected cash flow estimation incorporating delinquency rates, default expectations, loss severity, and structural features, and separates credit-related impairments (recorded in allowance) from non-credit fair value changes (recorded in OCI/AOCI). The reversibility of AIG's allowance is correctly noted, with the constraint that it cannot go below zero. MetLife’s classification of CLOs within AFS structured products is accurate, as is its passive investor stance and lack of active management or detailed cash flow modeling. The point about MetLife’s maximum exposure being limited to carrying amount is correctly included. (2) There are no numeric values in the question or answer requiring verification, so quantitative accuracy is not applicable in a traditional sense—but all financial concepts (e.g., AOCI, CECL, AFS) are used correctly, and no incorrect figures are introduced. (3) Multi-hop reasoning is sound: the model correctly synthesizes differences in accounting methodology (CECL allowance vs. no allowance), recognition of unrealized losses (split treatment vs. direct OCI/earnings), and structural involvement (active modeling vs. passive investment). (4) The only minor shortcoming is a slight ambiguity in the LLM answer stating MetLife records unrealized gains/losses 'directly in earnings (or OCI)'—this could be clearer. Under U.S. GAAP, AFS securities' unrealized gains/losses go to OCI, not earnings, unless other-than-temporary impairment occurs. Thus, 'or earnings' may be misleading. The original answer avoids this by focusing on what is disclosed—MetLife’s lack of detailed modeling and limited exposure—without specifying the exact accounting entry. This prevents potential misstatement. Despite this nuance, the core contrast in methodology and rationale is preserved. Hence, correctness is 9/10, with full marks for contextual relevance and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 549,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How does the Inflation Reduction Act's redesign of Medicare Part D affect CVS's ability to forecast medical cost trends and BMY's rebate accruals for the same program?",
      "original_answer": "The Inflation Reduction Act (IRA) redesigns Medicare Part D by reducing federal reinsurance in the catastrophic phase and shifting more costs to manufacturers like BMY starting in 2025, which increases their rebate obligations. This directly impacts BMY’s gross-to-net U.S. rebate accruals for Medicare Part D, as they must account for these new liabilities in their financial reporting. For CVS, the IRA’s changes to Medicare Part D contribute to the uncertainty in forecasting health care and benefit costs, especially as new cost-sharing obligations for manufacturers may alter utilization patterns and overall program dynamics. These shifts make it more challenging for CVS to predict medical cost trends and manage profitability in their Medicare-insured products.",
      "llm_answer": "\nThe Inflation Reduction Act’s redesign of Medicare Part D—introducing out‑of‑pocket caps, reduced reinsurance and inflation‑linked rebate penalties—creates new, uncertain cost‑shifting that CVS must embed in its health‑care benefit forecasts; because the size of the liability that will fall on its plans is still unclear, its ability to predict medical‑cost trends becomes far more sensitive, as highlighted in its risk disclosures (Chunk 1).  At the same time, BMY’s audited financials show that its gross‑to‑net Medicare Part D rebate accruals depend on complex assumptions about those same IRA‑driven price‑setting and inflation penalties, requiring significant judgment to estimate the accrued liabilities that will affect earnings (Chunk 3).  Thus, the regulatory overhaul directly ties CVS’s forecasting challenge to BMY’s rebate‑accrual calculations through the shared Medicare Part D framework (KG: CVS → IRA → Medicare Part D ← BMY).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the Inflation Reduction Act (IRA) indeed redesigns Medicare Part D by reducing federal reinsurance in the catastrophic phase and increasing manufacturer liability starting in 2025, though the LLM does not explicitly mention 2025, it correctly identifies the structural changes such as out-of-pocket caps and inflation-linked rebate penalties. These changes directly impact BMY's gross-to-net rebate accruals and introduce forecasting uncertainty for CVS. (2) There are no numeric inaccuracies—while specific dollar amounts or percentages are not present in either answer, the qualitative financial mechanisms (e.g., 'inflation-linked rebate penalties', 'complex assumptions') are correctly described and consistent with the knowledge graph. (3) The multi-hop reasoning is sound: the LLM correctly links the IRA to Medicare Part D, then separately to CVS’s forecasting challenges and BMY’s rebate accruals, and synthesizes that both are affected through the same regulatory framework. It even references supporting evidence from 'risk disclosures' (Chunk 1) and 'audited financials' (Chunk 3), indicating proper grounding. (4) The only minor shortcoming is the omission of the specific 2025 effective date for the manufacturer cost shift, which is included in the original answer and relevant for temporal precision. However, this does not undermine the overall correctness. Wording differs but maintains semantic equivalence. The answer is contextually rich, directly addresses both parts of the question, and correctly identifies entities (CVS, BMY, IRA, Medicare Part D) and financial concepts (rebate accruals, forecasting medical cost trends). Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT -[Redesigns]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 511,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How does JPMorgan Chase's exposure to Stress Capital Buffer requirements influence its capital distribution constraints compared to Charles Schwab's obligations under the Capital Conservation Buffer, given the composition of their respective regulatory buffer requirements?",
      "original_answer": "JPMorgan Chase is subject to a Stress Capital Buffer (SCB) as part of its regulatory capital requirements, which could increase based on stress loss estimates from the Federal Reserve’s Comprehensive Capital Analysis and Review. This buffer, along with the GSIB surcharge and countercyclical buffer (CCyB), contributes to JPMorgan’s total capital buffer requirement. On the other hand, Charles Schwab’s banking subsidiary, Charles Schwab Bank (CSB), is required to maintain a Capital Conservation Buffer (CCB) of 2.5%, which imposes restrictions on capital distributions if not met. According to regulatory definitions, the CCB is a fixed component of capital buffer requirements, whereas JPMorgan’s SCB is dynamic and tied to stress testing outcomes. Therefore, JPMorgan faces a more variable and forward-looking capital constraint tied to macroeconomic stress scenarios, while Schwab faces a static buffer requirement that acts as a floor to avoid distribution limitations.",
      "llm_answer": "\nJPMorgan Chase’s ability to distribute capital is curtailed by its Stress Capital Buffer, which can expand when the Federal Reserve raises estimated stress losses and—because the Stress Capital Buffer **consists of** the Capital Conservation Buffer—directly tightens the total buffer and forces limits on share‑repurchases, dividends or new issuances (Chunk 1).  This buffer stack also adds the GSIB surcharge and CCyB, so the overall buffer requirement is the sum of those components (Chunk 2).  In contrast, Charles Schwab must maintain a fixed 2.5 % Capital Conservation Buffer (and a 2.5 % stress buffer) and keep its combined CET1, Tier 1 and Total risk‑based capital ratios at least 7 %, 8.5 % and 10.5 % inclusive of those buffers; if the buffer falls below the minimum, regulators impose stricter distribution restrictions (Chunk 3).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several critical factual inaccuracies that undermine its correctness, particularly in the qualitative and quantitative dimensions. (1) The claim that the Stress Capital Buffer (SCB) 'consists of' the Capital Conservation Buffer (CCB) is incorrect—the SCB is a separate, additional buffer imposed on large, complex banks like JPMorgan Chase and is not composed of the CCB. While both buffers apply to JPMorgan, they are distinct regulatory requirements. This mischaracterization reflects a fundamental misunderstanding of regulatory capital structure. (2) The LLM incorrectly states that Charles Schwab must maintain a '2.5% stress buffer' in addition to the CCB—there is no evidence in the ground truth or public regulatory filings that Schwab is subject to a stress capital buffer. The original answer only references the 2.5% CCB for Schwab, which is accurate. The LLM invents a stress buffer for Schwab without support. (3) The capital ratio thresholds (7%, 8.5%, 10.5%) are introduced without grounding in the original answer and are not mentioned in the ground truth, making them extraneous and potentially misleading. (4) While the LLM correctly identifies that JPMorgan’s SCB is dynamic and tied to stress testing, and that Schwab’s CCB is fixed, the erroneous conflation of buffers and fabrication of Schwab’s stress buffer significantly weaken the reasoning. (5) The contextual relevance is high because the answer attempts to compare capital distribution constraints and regulatory buffers across both firms, aligning with the question’s intent. However, due to key factual errors—especially the incorrect composition of the SCB and the invented stress buffer for Schwab—the correctness score is limited to 5. The quantitative accuracy is low (4) due to unsupported percentages and fabricated metrics. The qualitative accuracy is moderate (5) because some correct concepts are present but undermined by serious misconceptions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Consists_Of]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 526,
        "total_tokens": 2012
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How do General Dynamics and Raytheon Technologies differ in their financial exposure to state and local income taxes on U.S. government contracts regulated by the FAR, especially considering GD's exclusion of these taxes from its tax provision and RTX's FAR-governed cost allowability and pricing mechanisms?",
      "original_answer": "General Dynamics excludes state and local income taxes allocable to U.S. government contracts from its tax provision, instead recognizing them in operating costs and expenses. This treatment is governed by the Federal Acquisition Regulation (FAR), which dictates how costs are allocated and allowed on government contracts. Raytheon Technologies, also subject to the FAR, structures its pricing under these contracts based on allowable costs, including mechanisms like performance-based payments and progress payments that influence revenue recognition patterns. The difference in financial exposure stems from GD directly expensing these taxes while RTX incorporates them into broader cost considerations under FAR-regulated pricing frameworks.",
      "llm_answer": "\nGeneral Dynamics removes state‑and‑local income taxes that are allocable to U.S. government contracts from its tax provision and instead records them as part of operating expenses, so they do not affect the reported tax expense (Chunk 1).  \nRaytheon Technologies, however, must treat those taxes as an allowable cost under the Federal Acquisition Regulation; the FAR‑governed pricing and reimbursement mechanisms incorporate such taxes into the contract cost base, influencing billings, contract‑asset/liability balances and ultimately the company’s financial exposure (Chunk 3).  \nBoth firms are subject to the same FAR and Cost‑Accounting‑Standards regime and are audited for cost allowability, but GD’s tax provision explicitly excludes these taxes while RTX’s pricing structure embeds them, creating a divergent financial exposure to state‑and‑local income taxes on U.S. government contracts (Chunk 2).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: General Dynamics excludes state and local income taxes on U.S. government contracts from its tax provision and records them in operating expenses, while Raytheon Technologies treats these taxes as allowable costs under FAR, incorporating them into pricing and cost reimbursement mechanisms. The answer correctly identifies that both companies are subject to FAR and cost accounting standards, and that the difference in financial exposure arises from GD's expensing approach versus RTX's inclusion in allowable costs. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes information about tax treatment, FAR regulations, cost allowability, and financial reporting implications across both companies. It correctly contrasts GD’s tax provision exclusion with RTX’s integration into contract pricing, which is the key differentiator. (4) The wording differs slightly but maintains semantic equivalence—e.g., 'FAR-governed pricing and reimbursement mechanisms' aligns with 'FAR-regulated pricing frameworks' in the original. One minor point preventing a perfect 10 is the lack of explicit mention of performance-based or progress payments (noted in the original answer), which adds slightly more context to RTX’s revenue recognition. However, this omission does not undermine the correctness of the core comparison. Overall, the answer is factually precise, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT -[Regulates]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 457,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does the voting power distribution in META's dual-class structure, including the dividend initiation on Class B shares, compare with GOOGL's structure where Class B shares automatically convert to Class A upon transfer?",
      "original_answer": "META’s Class B common stock is entitled to a non-dilutable 33 1/3% aggregate voting power, with each share receiving 15 votes, and it now receives the same $0.50 per share quarterly dividend as Class A stock following META’s initiation of dividends in 2024. Class B shares can convert share-for-share into Class A common stock, subject to restrictions. In contrast, GOOGL’s Class B shares are entitled to 10 votes per share and automatically convert to Class A shares upon sale or transfer, ensuring a more fluid transition between voting tiers. Both companies maintain dual-class systems to preserve founder control, but the structural mechanics and dividend treatment differ significantly.",
      "llm_answer": "\nMETA’s dual‑class structure gives its Class B shares 15 votes each and, unlike GOOGL—where Class B automatically converts to Class A on any sale or transfer—META’s Class B remains a separate, non‑listed class that does not convert, even though the knowledge‑graph triplets link “META → Class B Common Stock → Class A Common Stock” and “Class A → GOOGL.”  In February 2024 META announced its first cash dividend of $0.50 per share on **both** Class A and Class B (equivalent to $2.00 annualized), treating the two classes equally, whereas GOOGL’s voting conversion means that after a transfer the former Class B shares become Class A and thus acquire the same voting rights as original Class A shares.  This contrasts with the pattern in Comcast, whose 10‑K shows a 66 ⅔ % / 33 ⅓ % voting split where Class B holds 15 votes per share and is also convertible share‑for‑share into Class A, mirroring GOOGL’s convertible Class B but differing from META’s static, non‑converting Class B.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains several correct elements: META initiated a $0.50 per share quarterly dividend in 2024 on both Class A and Class B shares, and GOOGL's Class B shares convert to Class A upon transfer. However, there is a critical factual error: the LLM claims META’s Class B shares 'do not convert', which contradicts both the ground truth and public filings. The ground truth correctly states that Class B shares can convert share-for-share into Class A, subject to restrictions. The LLM’s assertion that Class B is 'non-converting' and 'static' is incorrect and undermines the accuracy of the comparison.\n\n2) Quantitative accuracy is mostly correct: the $0.50 quarterly dividend (annualized $2.00) is accurate, and the 15 votes for META Class B and 10 votes for GOOGL Class B are correctly stated. The date (February 2024) for dividend initiation aligns with the 2024 initiation in the ground truth. No calculation errors are present.\n\n3) The multi-hop reasoning is partially sound—comparing META and GOOGL’s dual-class structures and dividend policies—but fails on a key structural point: the convertibility of META’s Class B shares. The mention of Comcast introduces extraneous information not asked for in the question, which distracts from the core comparison. The model incorrectly infers from knowledge-graph triplets that 'does not convert' when the triplet 'Class B → Class A' likely indicates convertibility.\n\n4) Despite accurate numbers and relevant context, the fundamental misrepresentation of META’s share convertibility—a central aspect of the dual-class structure—results in a significant qualitative error. This affects the validity of the comparison with GOOGL. The answer is contextually relevant and well-structured but compromised by a key factual inaccuracy. Hence, correctness is reduced to 6 due to partial correctness with major structural misunderstanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Converts_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 510,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does the use of a 95% confidence interval in the VaR model under normal market conditions impact the one-day loss estimation methodology for both Philip Morris's derivative instruments and Mondelez's currency and commodity exposures, given their shared reliance on the parametric delta-gamma approximation technique?",
      "original_answer": "Both Philip Morris (PM) and Mondelez (MDLZ) rely on the parametric delta-gamma approximation technique within their Value at Risk (VaR) models, which operate under the assumption of normal market conditions and a 95% confidence interval. This methodology estimates the potential one-day loss by observing interest rate and currency movements—PM excludes anticipated transactions and hedges in its calculation, while MDLZ includes currency and commodity instruments, explicitly noting the non-linear response of options in the computation. The shared modeling assumption limits both firms' risk assessments to typical market behavior, potentially underestimating losses during periods of market stress.",
      "llm_answer": "\nBoth Philip Morris and Mondelez calculate a one‑day VaR under normal market conditions with a 95 % confidence interval, using a parametric delta‑gamma approximation that converts observed quarterly interest‑rate, currency and commodity movements into portfolio sensitivities; this confidence level sets the loss threshold at the 5th percentile of the simulated loss distribution, thereby defining the one‑day loss estimate for PM’s interest‑rate‑ and foreign‑currency‑sensitive derivatives and for MDLZ’s currency and commodity exposures. The same VAR framework—subject to the normal‑market conditions disclosed by PM and applied to MDLZ—is used for both firms, and each excludes anticipated transactions and non‑hedged items from the VaR computation when deriving the potential one‑day loss.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 95% confidence interval, one-day VaR, normal market conditions, and the use of parametric delta-gamma approximation by both Philip Morris (PM) and Mondelez (MDLZ), which aligns with the ground truth. It accurately states that the 95% confidence level corresponds to the 5th percentile of the loss distribution, which is semantically correct. However, it incorrectly claims that both firms exclude anticipated transactions and non-hedged items, directly contradicting the ground truth: PM excludes anticipated transactions and hedges, while MDLZ includes currency and commodity instruments (including options). The LLM flips or generalizes this key distinction, introducing a significant factual error. (2) Quantitatively, all percentages (95%, 5th percentile) and modeling parameters (one-day VaR, quarterly movements) are correctly stated or reasonably interpreted. The mention of 'quarterly' movements is not in the original answer (which says 'observed interest rate and currency movements' without frequency), so this is a minor over-specification but not a critical numerical error. (3) The multi-hop reasoning is partially sound—linking both firms to the same VaR framework and confidence level is correct, but the synthesis fails on firm-specific nuances: the treatment of hedges and anticipated transactions is misaligned, and MDLZ’s explicit consideration of non-linear option behavior (a key detail in the ground truth) is omitted. The LLM incorrectly asserts a shared exclusion criteria, undermining the qualitative accuracy. (4) Contextual relevance is high—the answer stays focused on VaR methodology, confidence intervals, and exposure types. However, due to the significant error in representing how each company handles hedges and anticipated items, and the omission of MDLZ’s non-linear option treatment, the correctness score is reduced to 6. The answer is partially correct but contains a major factual misstatement affecting the core comparative analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> MACRO_CONDITION -[Depends_On]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 546,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How do the embedded derivatives within CDOs referenced by Morgan Stanley compare in risk exposure to Bank of America's structured liabilities that also contain embedded derivatives, particularly in the context of credit events impacting their market-making activities?",
      "original_answer": "Morgan Stanley's involvement with CDOs includes hybrid instruments containing embedded derivatives where credit protection has been sold to the issuer of the note, exposing the firm to risk in the event of a credit event on the reference entity, which could result in the principal balance of the note not being repaid in full. Similarly, Bank of America's structured liabilities also contain embedded derivatives that are part of their market-making activities, and these derivatives are typically offset by gains or losses on hedging instruments. Both firms face credit risk tied to these derivatives, though the specific impact on Morgan Stanley is tied to the performance of the CDOs' underlying reference entities, while Bank of America's exposure is more broadly tied to the performance of their structured liabilities and the effectiveness of their hedging strategies.",
      "llm_answer": "\nMorgan Stanley’s CDOs that contain embedded derivatives are treated as VIEs in which the firm may retain a “potentially significant” interest only when it acts as servicer or collateral manager; a credit event can cause the note’s principal to be partially or fully unpaid, exposing the firm’s market‑making activity to loss of the embedded‑derivative position (Chunk 1 & 2).  \nBank of America’s structured liabilities similarly embed derivatives that trigger non‑repayment of principal on a credit event, and the resulting fair‑value changes are recorded in market‑making gains/losses and accumulated other‑comprehensive income, directly affecting its market‑making P&L (Chunk 3).  \nThus, while both banks’ embedded‑derivative exposures in CDO‑type products can result in principal shortfalls when credit events occur, MS evaluates the risk through its VIE consolidation and retained‑interest analysis, whereas BAC reflects the risk in its market‑making earnings and OCI.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Morgan Stanley's exposure through CDOs with embedded derivatives where credit events can lead to principal shortfall is accurately described, as is Bank of America's similar exposure via structured liabilities with embedded derivatives affecting market-making P&L. The mention of VIEs (Variable Interest Entities) and Morgan Stanley’s role as servicer or collateral manager adds contextual precision not in the original but consistent with known SEC filing disclosures, enhancing rather than distorting accuracy. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes risk exposure across two institutions, identifies the commonality (credit-event-triggered principal non-repayment due to embedded derivatives), and differentiates the accounting and risk management approaches (VIE analysis for MS vs. P&L and OCI recognition for BAC). This reflects strong qualitative accuracy. (4) Semantic equivalence is maintained: while the LLM uses more technical language (e.g., 'accumulated other-comprehensive income', 'VIE consolidation'), it conveys the same core meaning as the original—both firms face credit risk from embedded derivatives in structured products, with differing risk reflection mechanisms. The only minor gap is that the original emphasizes hedging offset for BAC, which the LLM implies via P&L impact but does not explicitly state; this slight omission prevents a perfect 10. Overall, the response is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Relates_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 481,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How does the global minimum tax under the OECD's Pillar Two model rules impact Salesforce's effective tax rate compared to Microsoft's projected tax liability, given the uncertainty around implementation timelines and jurisdictional adoption?",
      "original_answer": "Salesforce notes that global tax developments, including the OECD's Pillar Two model rules introducing a 15% global minimum tax, may have a material impact on its business, cash flows, or financial results. Microsoft, which currently operates with an effective tax rate of 19% (down to 18% in fiscal 2024), expects Pillar Two to apply to its operations starting in fiscal 2025 but does not currently estimate a material impact to its consolidated financial statements. However, uncertainty remains as to the final Pillar Two model rules and their adoption across jurisdictions, which could affect both companies differently depending on their global footprint and tax planning strategies.",
      "llm_answer": "\nBoth Salesforce (CRM) and Microsoft (MSFT) are linked through the OECD Pillar‑Two global minimum tax: CRM is subject to the Global Minimum Tax, which is a component of the Pillar‑Two Model Rules that also applies to MSFT. Salesforce’s filings caution that the adoption of the 15 % minimum tax in various jurisdictions could materially increase its effective tax rate and affect cash flow, while Microsoft notes that, because it has no material operations in low‑tax jurisdictions, the rule is not expected to raise its global tax costs and it does not currently anticipate a material impact, though uncertainty about final rules and implementation timelines persists.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: the 15% global minimum tax under OECD Pillar Two is accurately cited, and Microsoft's effective tax rate (19%, down to 18% in fiscal 2024) is not explicitly restated but the claim that Microsoft does not expect a material impact is consistent with the original. The LLM correctly notes Salesforce’s caution about material impacts on effective tax rate and cash flow, and Microsoft’s expectation of no material impact due to lack of material operations in low-tax jurisdictions. (2) The answer correctly identifies both companies (Salesforce and Microsoft), the relevant policy (OECD Pillar Two), and the core financial concept (effective tax rate impact). (3) Multi-hop reasoning is sound: it synthesizes Salesforce’s exposure to potential rate increases with Microsoft’s relative insulation due to its tax jurisdiction footprint, and both companies’ acknowledgment of implementation uncertainty. (4) The only minor omission is that Microsoft explicitly states Pillar Two will apply starting in fiscal 2025—a specific timeline mentioned in the original answer—but this does not undermine the overall correctness. The LLM captures the essence and key differentiating factors between the two companies’ exposures. Wording differs but semantic meaning is equivalent. No calculation errors. Thus, high scores across all dimensions with a 9 on correctness due to the slight incompleteness on Microsoft’s fiscal 2025 start date.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 422,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How does Boeing's Five-Year Credit Agreement, which involves JPMorgan Chase Bank, N.A. as syndication agent, compare with Honeywell's credit agreement with JPMorgan Chase Bank, N.A. in terms of syndication structure and key banking partners?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, includes JPMorgan Chase Bank, N.A. as syndication agent alongside Citibank, N.A. as administrative agent, with both also serving as joint lead arrangers and joint book managers. Honeywell's Amended and Restated Five-Year Credit Agreement, dated March 20, 2023, also features JPMorgan Chase Bank, N.A., along with Wells Fargo Bank, National Association, as syndication agents, with Bank of America, N.A. serving as administrative and swing line agent. Both agreements involve JPMorgan Chase Bank, N.A. in a syndication role, but differ in the lead arranger structure and partner institutions involved.",
      "llm_answer": "\nBoeing’s Five‑Year Credit Agreement (dated Oct 30 2019) names JPMorgan Chase Bank, N.A. as syndication agent (with Citibank N.A. and JPMorgan also acting as joint lead arrangers) and Citibank N.A. as administrative agent, whereas Honeywell’s Amended and Restated Five‑Year Credit Agreement (dated Mar 20 2023) lists JPMorgan Chase Bank, N.A. as one of several syndication agents—sharing the role with Wells Fargo Bank, National Association—while Bank of America, N.A. serves as administrative agent.  Thus, both companies use JPMorgan as a syndication agent, but Boeing’s structure centers on Citibank for administration and joint‑lead arrangements, whereas Honeywell’s structure involves multiple syndication agents and a different administrative agent.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Boeing's agreement date (October 30, 2019), Honeywell's (March 20, 2023), JPMorgan Chase Bank, N.A.'s role as syndication agent in both, Citibank N.A. as administrative agent for Boeing, Bank of America, N.A. as administrative agent for Honeywell, and Wells Fargo Bank, N.A. as co-syndication agent with JPMorgan for Honeywell. (2) Quantitative accuracy is perfect—dates and entity names match exactly or with acceptable formatting (e.g., 'Oct 30 2019' vs 'October 30, 2019'). (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two different credit agreements, compares syndication structures, and identifies key banking partners. (4) The only minor omission is that the original answer notes JPMorgan and Citibank also serve as 'joint book managers' in Boeing’s agreement, a detail absent in the LLM response. This does not affect the core comparison but slightly reduces completeness. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses both syndication structure and key banking partners as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Regulates]-> COMP <-[Enters_Agreement]- ORG",
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 339,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How does the absence of the Countercyclical Capital Buffer requirement impact the total capital buffer requirements for both Bank of America and Morgan Stanley under the Advanced Approaches framework, given their respective G-SIB surcharges of 2.5% and inclusion of the 2.5% Capital Conservation Buffer?",
      "original_answer": "For Bank of America, the absence of the Countercyclical Capital Buffer (CCyB) means its total Common Equity Tier 1 (CET1) capital buffer requirement under the Advanced Approaches framework is the sum of its G-SIB surcharge of 2.5% and the 2.5% Capital Conservation Buffer, totaling 5.0%. Similarly, Morgan Stanley’s CET1 capital buffer requirement under the same framework is also the sum of its G-SIB surcharge (which is not quantified in the provided data but assumed to be included), the 2.5% Capital Conservation Buffer, and the zero CCyB. Therefore, the absence of CCyB directly reduces the total CET1 buffer requirement for both banks by the amount the CCyB would have otherwise contributed.",
      "llm_answer": "\nThe Advanced‑Approach capital‑buffer for each bank is the sum of its mandatory 2.5 % Capital‑Conservation Buffer and its 2.5 % G‑SIB surcharge; because the Countercyclical Capital Buffer (CCyB) is currently set to zero for both BAC and MS, the total buffer under the Advanced Approaches framework is therefore **5 % of risk‑weighted assets**.  Had the CCyB been applied (it can be up to 2.5 %), the buffer would rise to **7.5 %**, so the absence of the CCyB lowers the required total buffer by **2.5 percentage points** for each institution.  This relationship is reflected in the regulatory‑requirement triplets (BAC → CCyB, CCyB → Capital‑Conservation Buffer, Capital‑Conservation Buffer → MS) and the disclosures that both banks report a zero CCyB while explicitly including the 2.5 % G‑SIB surcharge and the 2.5 % Capital‑Conservation Buffer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: both banks have a 2.5% G-SIB surcharge and a 2.5% Capital Conservation Buffer, summing to a total CET1 buffer requirement of 5.0% in the absence of the CCyB (which is correctly stated as zero). The counterfactual scenario—had CCyB been applied at up to 2.5%—would bring the total to 7.5%, so the 2.5 percentage point reduction due to CCyB absence is correctly calculated. (2) The answer explicitly states the total buffer (5%) and the impact of CCyB absence (reduction by 2.5 percentage points), which matches the original answer’s core conclusion. (3) Multi-hop reasoning is sound: it synthesizes the components of capital buffers (G-SIB surcharge, CCyB, and Capital Conservation Buffer) under the Advanced Approaches framework for both Bank of America (BAC) and Morgan Stanley (MS), correctly noting that CCyB is zero for both. (4) The only minor shortcoming is that the original answer notes Morgan Stanley’s G-SIB surcharge is 'not quantified in the provided data but assumed to be included,' whereas the LLM answer assumes it is 2.5% like BAC without qualification. While this is likely correct (both are top-tier G-SIBs), the lack of acknowledgment of data uncertainty slightly reduces qualitative accuracy. However, the overall reasoning, entity identification (BAC, MS, buffers), and contextual relevance are excellent, and the answer fully addresses the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Consists_Of]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 409,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What was NVIDIA's effective tax rate in fiscal year 2022, and how does it compare to Apple's operating income margin in the Greater China region during the same period?",
      "original_answer": "NVIDIA's effective tax rate in fiscal year 2022 was 1.9%, significantly lower than the U.S. federal statutory rate of 21%, due in part to income earned in jurisdictions like Hong Kong that have lower tax rates. Meanwhile, Apple reported $31,153 million in operating income from $74,200 million in net sales in the Greater China region during fiscal year 2022, resulting in an operating income margin of approximately 42%. These metrics reflect different financial impacts from operating in the region, with NVIDIA benefiting from lower tax rates and Apple demonstrating strong profitability from its sales in the same market.",
      "llm_answer": "\nNVIDIA’s effective tax rate for fiscal 2022 was **1.9 %**, as reported in its 10‑K (Chunk 1).  In the same year Apple’s Greater China segment generated **$74.2 billion** of net sales and **$31.2 billion** of operating income (Chunk 3), yielding an operating‑income margin of roughly **42 %** (31.2 ÷ 74.2).  Thus, while NVIDIA’s tax rate was well below 1 percent, Apple’s operating‑income margin in Greater China was about **42 %**, a markedly higher profitability ratio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies NVIDIA's effective tax rate in fiscal year 2022 as 1.9%, matching the ground truth. It also accurately reports Apple's net sales ($74.2 billion) and operating income ($31.2 billion) in the Greater China region, with a calculated operating income margin of approximately 42% (31.2 / 74.2 ≈ 0.4198, or 42% when rounded), which aligns with the ground truth value of $31,153 million and $74,200 million resulting in ~42%. Minor rounding differences are acceptable (e.g., $31.2 billion vs $31.153 billion). (2) All quantitative values are correct, with appropriate unit conversions (millions to billions) and accurate calculation of the margin. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from two different companies (NVIDIA and Apple), two different financial metrics (tax rate and operating income margin), and the same fiscal year (2022), while making a valid comparison between the two figures. (4) The only minor shortcoming is that the LLM answer states NVIDIA’s tax rate was 'well below 1 percent', which is incorrect—it was 1.9%, which is above 1%. This is a small qualitative inaccuracy in phrasing, though the actual number is correct. Otherwise, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 374,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How do BA's and UPS's uses of pricing models for valuing Level 2 assets differ based on the observable inputs they emphasize in their 2024 filings?",
      "original_answer": "BA values its fixed income investments categorized as Level 2 using pricing models that incorporate inputs such as benchmark yields, swap curves, and inter-dealer broker rates. These models are primarily income-based and rely on structured cash flow analysis and rating agency data. In contrast, UPS applies pricing models to value its Level 2 derivatives—mainly over-the-counter instruments—using market observable inputs like yield curves, foreign currency exchange rates, and investment forward prices. While both companies rely on observable market data for Level 2 classifications, BA emphasizes credit and yield-related inputs for fixed income instruments, whereas UPS focuses on currency and interest rate dynamics for its derivative positions.",
      "llm_answer": "\nBA’s 2024 filing applies pricing models to its Fixed‑Income Investments (the FIN_INST linked in the KG) and stresses observable inputs such as reported trades, broker quotes, benchmark yields, swap curves, cash‑flow analyses, rating‑agency data and inter‑dealer broker rates (Chunk 1).  \nUPS classifies its foreign‑currency and interest‑rate derivatives as Level 2 and values them with models that rely on market‑observable yield curves, FX spot rates and investment‑forward prices (Chunk 3).  \nBoth companies’ approaches fit the Level 2 framework outlined by LMT, which notes that such valuations depend on corroborated vendor quotes and verifiable market data—including interest rates, yield curves and credit spreads (Chunk 2).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: BA uses pricing models for fixed income investments with observable inputs like benchmark yields, swap curves, inter-dealer broker rates, broker quotes, reported trades, cash-flow analyses, and rating-agency data. UPS values its Level 2 derivatives (foreign currency and interest rate) using yield curves, FX spot rates, and investment forward prices. These inputs align precisely with the original answer. (2) There are no numeric values in the question or answer, so quantitative accuracy is not applicable in terms of calculations or dollar amounts—however, all referenced inputs and classifications are factually consistent, earning full marks. (3) The multi-hop reasoning is sound: the model correctly synthesizes BA’s and UPS’s distinct applications of pricing models based on asset type (fixed income vs. derivatives) and emphasized inputs (credit/yield vs. currency/interest rate). The mention of LMT’s Level 2 framework adds contextual support, though it is not required for the comparison and does not detract. (4) Semantic equivalence is strong—wording differs slightly (e.g., 'FX spot rates' vs. 'foreign currency exchange rates'), but these are synonymous in context. The only minor shortcoming is that the LLM answer does not explicitly contrast BA’s credit/yield focus with UPS’s currency/interest rate focus in a concluding synthesis, though the contrast is implied through accurate input descriptions. This slight omission prevents a perfect 10 on qualitative accuracy, but overall correctness remains very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 451,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How does the voting power disparity between Class A and Class B common stock at GOOGL compare to the uniform voting rights structure at NFLX, particularly in light of GOOGL's $62.2 billion share repurchase program in 2023?",
      "original_answer": "GOOGL's Class A common stockholders have 1 vote per share, while Class B common stockholders have 10 votes per share, creating a significant disparity in voting power. This contrasts sharply with NFLX, where each share of common stock carries exactly one vote, ensuring equal voting rights across all shareholders. Additionally, GOOGL's 2023 share repurchase program, which retired $62.2 billion worth of shares, primarily targeted Class A and Class C shares, potentially influencing the overall voting balance by reducing the number of shares that convert from Class B to Class A upon transfer, thereby preserving the voting control of existing Class B holders.",
      "llm_answer": "\nGOOGL’s dual‑class structure gives Class B common stock 10 votes per share (while Class A has one vote and Class C none), creating a pronounced voting‑power imbalance that NFLX does not have—NFLX grants a uniform one‑vote‑per‑share right to every common share. Moreover, GOOGL’s 2023 $62.2 billion share‑repurchase program retired only Class A and Class C shares, leaving the high‑vote Class B shares untouched and thus preserving the existing concentration of voting power, a dynamic that is absent at NFLX where all shares carry equal voting rights.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: GOOGL's Class A has 1 vote, Class B has 10 votes, Class C has none; NFLX has uniform one-vote-per-share structure; GOOGL's 2023 $62.2 billion repurchase program targeted Class A and Class C shares. These numbers and structures are correctly reported with no errors. (2) Quantitative accuracy is perfect: the $62.2 billion figure is correctly cited, and there are no miscalculations. (3) The multi-hop reasoning is sound—LLM correctly synthesizes the structural disparity in voting rights between GOOGL and NFLX, and accurately explains how the share repurchase preserves voting control by retiring non-convertible and lower-vote shares, thus maintaining the relative dominance of Class B shares. (4) The only minor shortcoming is that the LLM does not explicitly mention the mechanism of Class B shares converting to Class A upon transfer (a nuance in the original answer), which slightly weakens the explanation of how repurchases affect future voting balance. However, the core logic—that repurchasing Class A and C shares while leaving Class B untouched preserves concentrated voting power—is correctly conveyed. Wording differs slightly but maintains semantic equivalence. All entities (GOOGL, NFLX, share classes, 2023, $62.2B) are accurate. The answer is fully relevant and directly addresses the comparative voting structure and the impact of the repurchase program.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 405,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does ACN's classification of U.S. government debt securities as Level 2 assets affect comparability with AVGO's investment disclosures, given that such securities are typically categorized as Level 1 based on active market pricing?",
      "original_answer": "ACN classified its U.S. government debt securities as Level 2 assets totaling $9,765 million, which contrasts with AVGO's disclosures where Level 1 securities are described as being valued based on quoted prices in active markets. This is notable because the UPS evidence indicates that U.S. government debt securities are generally categorized as Level 1 due to quoted prices in active markets. AVGO’s disclosures explicitly differentiate Level 1 and Level 2 securities based on valuation methodology, suggesting that ACN’s choice to classify these assets as Level 2 could reduce transparency and comparability in investment valuation practices between the two firms.",
      "llm_answer": "\nACN lists its U.S. government debt securities in the **Level 2** column of its fair‑value hierarchy (Chunk 1), even though such securities are normally **Level 1** because they trade in active markets; the knowledge graph links **Level 1 securities** to **AVGO** (KG), and AVGO’s filing explicitly places securities with quoted prices in active markets in **Level 1** (Chunk 2 & 3). As a result, ACN’s Level 2 classification uses observable‑input models rather than quoted‑price Level 1 inputs, making its investment‑disclosure hierarchy **less directly comparable** to AVGO’s Level 1 disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: ACN classifies U.S. government debt securities as Level 2, which contrasts with typical Level 1 classification due to active market pricing, and AVGO uses Level 1 for securities with quoted prices in active markets. The dollar amount ($9,765 million) is not mentioned in the LLM answer, but no incorrect number is provided, and the omission does not distort the reasoning. (2) Quantitative accuracy is strong—no incorrect figures are stated, and the absence of the exact dollar value does not impair correctness since the focus is on classification practice, not valuation magnitude. (3) Multi-hop reasoning is sound: the model correctly links ACN’s classification choice to AVGO’s disclosure standards and references the general principle (from UPS evidence) that such securities are typically Level 1. It infers reduced comparability due to differing valuation inputs (quoted prices vs. observable models), which matches the original conclusion. (4) The answer is contextually relevant and semantically equivalent to the ground truth, though slightly less detailed in explicitly naming the transparency concern. Wording differences are acceptable and do not affect meaning. The answer earns a 9 because it omits the specific reference to transparency reduction but otherwise captures all key points accurately and logically.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Comprise]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 395,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does Colgate-Palmolive's adoption timeline for ASU 2022-04, which mandates detailed disclosures on supplier finance obligations, compare to Target's implementation of similar disclosures, particularly regarding the confirmed amount outstanding at year-end?",
      "original_answer": "Colgate-Palmolive adopted ASU 2022-04 beginning January 1, 2023, with the roll-forward information disclosure effective January 1, 2024. Target discloses its confirmed obligations outstanding under supplier finance programs within Accounts Payable on its Consolidated Statements of Financial Position, with early payment options available to vendors up to 120 days from the invoice date. While Colgate-Palmolive references Note 15 for program details, Target explicitly outlines the structure of its arrangements and vendor discretion in electing early payments, though exact confirmed amounts are not quantified in the provided excerpt.",
      "llm_answer": "\nColgate‑Palmolive adopted ASU 2022‑04 on January 1 2023, with the roll‑forward disclosure requirement becoming effective on January 1 2024, and its note explicitly calls out the “confirmed amount outstanding at the end of the period” as part of the required supplier‑finance disclosures. Target also follows the same ASU – the KG link shows its supplier‑finance programs are subject to the guidance – and its 10‑K (page 54) presents a “Confirmed Obligations Outstanding” figure within accounts payable, indicating that it implemented the same disclosure regime; however, the excerpt does not provide a separate adoption date or roll‑forward schedule for Target, implying that both companies began applying the ASU on the same effective date (Jan 1 2023) and now both report the year‑end confirmed amounts, though only Colgate details the roll‑forward timing.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Colgate-Palmolive's adoption date of ASU 2022-04 as January 1, 2023, and the roll-forward disclosure effective date as January 1, 2024, which matches the ground truth. It also correctly states that Colgate references a 'confirmed amount outstanding' in its disclosures. However, the LLM incorrectly implies that Target explicitly reports a 'Confirmed Obligations Outstanding' figure in its 10-K, stating 'page 54' presents this amount. The ground truth clarifies that while Target discloses obligations within Accounts Payable and describes program structure, it does *not* quantify the exact confirmed amount in the provided excerpt. This is a significant qualitative error. (2) Quantitatively, all dates and adoption timelines for Colgate are accurate. The issue arises with Target: no specific adoption date or roll-forward schedule is confirmed in the ground truth, so assuming Target adopted on the same date (Jan 1, 2023) is a reasonable inference but not explicitly supported—this downgrades quantitative accuracy slightly. (3) The multi-hop reasoning is partially sound: the model connects both companies to ASU 2022-04 and compares disclosure practices. However, it overstates Target’s disclosure completeness by asserting a specific figure is reported when it is not, indicating a failure in precise synthesis. (4) Contextual relevance is high—the response directly addresses the comparison of adoption timelines and disclosure of year-end confirmed amounts. The core facts for Colgate are correct, and the attempt to contrast with Target is appropriate, but the incorrect claim about Target’s quantified disclosure prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 462,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does BlackRock's exposure to operational risks through third-party technology partners like Microsoft compare to Mastercard's approach in managing similar reputational risks stemming from their own operational resilience strategies?",
      "original_answer": "BlackRock discloses that its reliance on key technology partners like Microsoft for hosting Aladdin on Azure introduces operational and execution risks, including infrastructure reliability, software security, and regulatory oversight, which could lead to reputational harm or legal liability if not managed properly. Operational risk is explicitly defined in the COF evidence as having the potential to result in reputational impact due to internal process failures, system issues, or external events. Mastercard identifies 'Reputational Impact' as a named risk factor in its 10-K and structures its risk management framework around it, listing 'Operational Resilience' as a core component of its reputational risk mitigation strategy. This suggests that while both firms recognize the reputational consequences of operational failures, BlackRock's risk is heightened by its dependency on external cloud providers, whereas Mastercard integrates operational resilience directly into its brand protection framework.",
      "llm_answer": "\nBlackRock’s operational risk is tied to its reliance on key technology partners such as Microsoft—its Aladdin platform runs on Azure and other cloud services—so any disruption can impair AUM, revenue and earnings and generate reputational damage, a chain captured by the KG link BLK → Operational Risk → Reputational Impact → MA. Mastercard, by contrast, treats reputational risk as a distinct element of its operational‑resilience strategy, emphasizing brand protection, information‑security controls and stakeholder‑relationship safeguards (as reflected in its risk‑category table that lists “Reputation” and “Operational” risks and in its Business‑and‑Operations matrix that highlights “Brand, Reputational Impact and ESG” alongside “Information Security and Operational Resilience”). Thus, BlackRock’s exposure is concentrated on external cloud‑partner failures, whereas Mastercard manages similar reputational threats through an internal framework that prioritizes resilience, cybersecurity and brand‑centric governance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BlackRock's reliance on Microsoft Azure for Aladdin is accurately described as a source of operational and reputational risk, and Mastercard's integration of operational resilience into its reputational risk framework is correctly characterized. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is not applicable in a traditional sense—however, the absence of any incorrect figures or miscalculations supports a full score. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (BlackRock and Mastercard), identifies the linkage between operational risks and reputational impact, and contrasts external dependency (BlackRock) versus internal resilience strategy (Mastercard). The use of knowledge graph links (e.g., BLK → Operational Risk → Reputational Impact) reflects an accurate understanding of the data structure, even if slightly more technical than the original answer. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'brand-centric governance', 'stakeholder-relationship safeguards'), it conveys the same core insight—that BlackRock faces heightened exposure due to third-party reliance, whereas Mastercard proactively embeds operational resilience in brand protection. The only minor shortcoming is a slightly more technical tone that could obscure clarity for some readers, but no factual inaccuracies exist. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR -[Negatively_Impacts]-> RISK_FACTOR <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 467,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How significant was Cardinal Health as a customer for BMY in 2021, and what role does Cardinal play in CVS's generic pharmaceutical sourcing strategy through Red Oak Sourcing, LLC?",
      "original_answer": "Cardinal Health represented 20% of BMY's revenue in 2021, making it a significant customer relationship. CVS partners with Cardinal through Red Oak Sourcing, LLC, where both companies hold 50% ownership and jointly negotiate generic pharmaceutical supply contracts. This strategic arrangement enables CVS and Cardinal to leverage combined sourcing capabilities, though it does not involve inventory ownership by Red Oak. The shared sourcing venture highlights Cardinal's dual role as both a key BMY customer and a strategic partner in CVS's supply chain infrastructure.",
      "llm_answer": "\nIn 2021 Cardinal Health accounted for roughly 20 percent of Bristol‑Myers Squibb’s total sales—making it one of BMY’s largest customers.  At the same time, Cardinal co‑owns Red Oak Sourcing, LLC with CVS Health, and the two partners use that joint venture to source and negotiate generic‑drug supply contracts; thus Cardinal is a key participant in CVS’s generic‑pharmaceutical sourcing strategy through Red Oak Sourcing, LLC.  (The 10‑K tables show Cardinal’s 20 % share of BMY sales, while the CVS 10‑K describes the 50 %‑owned Red Oak venture and its role in generic sourcing.)",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, it accurately states that Cardinal Health accounted for 20% of BMY's sales in 2021, which aligns with the original answer's '20% of BMY's revenue in 2021'. The percentage is correctly attributed and formatted consistently. (2) The answer addresses both parts of the multi-hop question: Cardinal's significance to BMY and its role in CVS's generic pharmaceutical sourcing via Red Oak Sourcing, LLC. It correctly identifies the 50% ownership structure (implied by 'co-owns' and 'joint partners') and explains that the joint venture is used for negotiating generic drug supply contracts. (3) All entities—Cardinal Health, Bristol-Myers Squibb (BMY), CVS Health, and Red Oak Sourcing, LLC—are accurately named and correctly linked in their respective relationships. The year 2021 is properly referenced. (4) The reasoning is sound and synthesizes information across the two companies' 10-K filings as implied by the mention of '10-K tables' and 'CVS 10-K', demonstrating proper multi-hop logic. The explanation conveys the dual role of Cardinal Health as both a major customer of BMY and a strategic partner in CVS’s supply chain, which is the core insight of the original answer. Minor wording differences (e.g., 'sales' vs 'revenue') do not affect semantic equivalence. Overall, the answer is factually precise, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Depends_On]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 398,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How does the voting power of Class B common stockholders at META compare to that of NFLX common stockholders, given that META Class B shares are restricted to specific voting scenarios and each share carries a multiplier based on the conversion rate?",
      "original_answer": "META's Class B common stockholders have restricted voting rights, only applicable in specific scenarios such as exiting the core payments business, a merger, or certain amendments to the certificate of incorporation. In these cases, each Class B share's voting power is multiplied by the applicable conversion rate in effect on the record date. In contrast, NFLX common stockholders receive one vote per share on all matters requiring stockholder approval. This means that while META Class B shareholders have conditional voting rights with variable influence based on the conversion rate, NFLX shareholders have consistent, unconditional voting power proportional to their shareholding.",
      "llm_answer": "\nMETA’s Class B common stock—privately held by only 23 record holders as of 2023 and not listed on any exchange—exercises voting rights solely in limited circumstances (e.g., core‑business exits, mergers, or charter amendments) and each share’s voting strength is multiplied by a conversion‑rate factor, whereas NFLX common stockholders enjoy a straightforward one‑vote‑per‑share right with no multiplier. Consequently, META’s Class B voting power can exceed that of NFLX shareholders per share only when the conversion multiplier is applied, but it is confined to those narrowly defined voting scenarios.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the core distinction between META Class B and NFLX common stockholders' voting rights. It correctly identifies that META's Class B shares have voting rights only in limited scenarios (e.g., mergers, charter amendments) and that each share's voting power is multiplied by a conversion rate, while NFLX shareholders have one vote per share universally. The additional detail about 23 record holders and private status of Class B shares is contextually accurate and adds value without contradicting the ground truth. Quantitatively, there are no numbers or dates that conflict with known facts (e.g., 2023 reference aligns with available data). The reasoning is sound: it correctly synthesizes the conditional, multiplier-based voting power at META versus the unconditional, linear voting at NFLX. The only minor shortcoming is that the original answer emphasizes the *variable influence based on conversion rate* and *consistency* of NFLX voting, which the LLM captures implicitly but could have stated more directly. However, the semantic meaning and factual content are equivalent. No calculation errors or entity inaccuracies (META, NFLX, Class B stock, voting mechanisms) are present. The answer fully addresses the comparative voting power question across both companies and structures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 371,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How does the automatic conversion of Class B shares upon transfer at GOOGL contrast with META's structural protections that require Class B approval for change-of-control transactions, and what role does Mastercard's mandatory post-conversion Class A stock transfer mechanism play in evaluating dual-class governance frameworks?",
      "original_answer": "META requires that any change-of-control transaction must be approved by a majority of its outstanding Class B common stock voting as a separate class until those shares represent less than 35% of combined voting power. In contrast, GOOGL's Class B shares automatically convert to Class A shares upon sale or transfer, effectively limiting concentrated voting control over time. Mastercard's framework mandates that converted Class B shares become Class A shares that must be sold or transferred, creating a structural mechanism that prevents long-term retention of higher-vote shares. This contrast reveals different approaches to dual-class governance: META entrenches control through voting rights preservation, while GOOGL and Mastercard implement mechanisms that eventually dilute concentrated voting power through mandatory conversion and divestiture.",
      "llm_answer": "\nGOOGL’s Class B shares **automatically convert to Class A on any sale or transfer**, so no separate board or stockholder vote is needed to effect that conversion, whereas META’s charter **requires a majority‑class‑B vote (as a separate class) before any transaction that would trigger a change‑of‑control can proceed**, giving the Class B holders a direct veto over such events.  At the same time, Mastercard’s Class B holders are **restricted from retaining the Class A shares they receive after conversion and must immediately sell or otherwise transfer them**, embedding a mandatory post‑conversion disposal rule that illustrates how dual‑class structures can couple conversion rights with forced divestiture to shape control and governance dynamics.  This contrast—automatic conversion at GOOGL versus required Class B approval at META, and the compulsory transfer requirement in Mastercard—highlights key differences in how dual‑class governance can protect or expose controlling shareholders in each company.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) All key facts are correct: GOOGL's Class B shares automatically convert to Class A upon transfer; META requires majority Class B approval for change-of-control transactions as a separate class; Mastercard mandates that converted shares (from Class B to Class A) must be sold or transferred. These points are all factually consistent with the original answer. (2) There are no numbers, dates, or percentages in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense—however, the LLM correctly represents all structural thresholds (e.g., no mention of 35% in LLM answer, but this is a minor omission). The ground truth notes META’s voting requirement lasts until Class B shares represent less than 35% of combined voting power—a detail omitted in the LLM response. This is a small but relevant nuance affecting completeness. (3) Multi-hop reasoning is sound: the LLM correctly contrasts GOOGL’s automatic conversion, META’s veto right, and Mastercard’s forced divestiture, synthesizing across three companies to highlight differing governance philosophies. (4) Semantic equivalence is strong—the LLM captures the essence that META entrenches control while GOOGL and Mastercard dilute it over time, though it phrases the conclusion slightly less explicitly. The omission of the 35% threshold slightly reduces qualitative accuracy, but does not undermine the overall correctness. Contextual relevance is perfect: all content directly addresses the comparative governance question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST -[Converts_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 449,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How do MRK's pediatric market exclusivity opportunities compare with AMGN's regulatory exclusivity risks given recent changes to data protection periods for biologics?",
      "original_answer": "MRK benefits from six-month pediatric market exclusivity extensions that can apply to products like its high-risk adult COVID-19 treatment, potentially extending protection beyond patent expiration. In contrast, AMGN faces regulatory exclusivity risks as the FDA considers changes to biologic data exclusivity, including whether umbrella exclusivity applies, which could reduce the effective protection period for products like EPOGEN. These differences reflect MRK's proactive IP strategy versus AMGN's exposure to policy shifts in biologic exclusivity frameworks.",
      "llm_answer": "\nMRK can secure up to six months of pediatric market exclusivity and, under U.S. data‑protection rules, enjoys up to a 12‑year exclusivity window for biologics (with a possible 5‑year standard or 7‑year orphan‑drug extension), a benefit the company pursues through patent‑term restoration and complementary data‑protection incentives. In contrast, AMGN’s regulatory exclusivity is under heightened risk because recent changes—such as the removal of the mandatory 10‑year biologic data‑exclusivity in the USMCA and FDA scrutiny of “umbrella” exclusivity—could shorten the effective exclusivity period and usher in earlier biosimilar competition, a risk that is linked via the KG relationship to the same market‑exclusivity framework that governs MRK’s pediatric opportunities.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies MRK's six-month pediatric exclusivity and references U.S. biologics exclusivity frameworks, aligning with the ground truth's emphasis on MRK's proactive IP strategy. However, it introduces inaccuracies by stating a '12-year exclusivity window for biologics' and possible '5-year standard or 7-year orphan-drug extension'—these are general regulatory rules but not directly tied to MRK’s pediatric exclusivity opportunities as described in the ground truth. The original answer does not mention these broader exclusivity periods, focusing instead on the six-month pediatric extension specifically. (2) Quantitative accuracy is partially compromised: while the six-month pediatric exclusivity is correct, the 12-year biologic exclusivity and other extensions are not factually linked to MRK’s current situation in the ground truth and appear as overgeneralizations. The mention of USMCA removing 'mandatory 10-year biologic data-exclusivity' is misleading—the USMCA maintains 10 years of biologic data exclusivity, so this is factually incorrect. (3) Reasoning is sound in drawing a contrast between MRK’s strategic use of exclusivity and AMGN’s exposure to policy changes, particularly around 'umbrella exclusivity,' which is correctly highlighted as a risk. The multi-hop synthesis between MRK’s opportunities and AMGN’s risks via shared regulatory frameworks is logically coherent and contextually appropriate. (4) Despite some factual overreach and incorrect policy claims, the core comparison—MRK leveraging pediatric exclusivity vs. AMGN facing regulatory uncertainty—is preserved, warranting a correctness score of 7. The answer is contextually relevant and qualitatively strong in structure and logic, but quantitative inaccuracies reduce overall precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Determined_By]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 492,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How do MA's and V's dual-class stock structures differ in terms of voting power distribution and control concentration mechanisms, particularly regarding the balance between Class A and Class B shares?",
      "original_answer": "MA's dual-class structure grants Class B common stock 15 votes per share, with all outstanding shares held by Mr. Brian L. Roberts, representing 33⅓% of the combined voting power, while Class A common stockholders collectively hold 66⅔% of the voting power. In contrast, V's structure ties Class B common stock transferability and convertibility to the resolution of U.S. covered litigation, with conversion rates for Class B shares into Class A shares subject to adjustments based on follow-on offerings or litigation outcomes. Additionally, V's Class C common stock has no transfer restrictions, and its exchange program allows for partial release of restrictions on Class B shares, further differentiating its control mechanisms from MA's more static voting power allocation.",
      "llm_answer": "\nMastercard (MA) discloses roughly 925 million Class A shares and only 7.2 million Class B shares—the latter being non‑public and tightly held—while Visa (V) holds about 622 million Class B‑1 shares (plus 1.1 billion Class C shares) that remain under transfer restrictions and only convert to freely tradable Class A after all U.S. litigation is resolved, a mechanism that mirrors Comcast’s (CMCSA) structure in which Class B shares, owned entirely by Brian Roberts, carry 15 votes per share and represent exactly one‑third of the combined voting power. Consequently, both MA and V preserve control through a small, closely‑controlled Class B cohort, whereas CMCSA’s dual‑class setup explicitly splits voting power 66 ⅔ % to Class A and 33 ⅓ % to Class B, with the latter’s amplified voting rights concentrating authority in a single insider.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misattributions that undermine its correctness. (1) It incorrectly attributes Comcast's (CMCSA) dual-class structure to Mastercard (MA), stating that MA has a structure where Class B shares carry 15 votes and represent one-third of voting power—this is true for CMCSA, not MA. The ground truth states that MA has Class B shares with 15 votes per share held by Brian L. Roberts, but this is factually incorrect: Brian L. Roberts is associated with Comcast, not Mastercard. This is a critical entity confusion. (2) The quantitative data on share counts (e.g., 925 million Class A shares for MA, 7.2 million Class B) are not present in the original answer and appear to be fabricated or misattributed; the ground truth does not provide share counts, only voting power distribution. (3) The answer incorrectly claims Visa’s Class B shares convert only after U.S. litigation is resolved—a detail from V’s actual structure—but then conflates it with CMCSA’s mechanism, not MA’s, further muddying the comparison. (4) The original answer emphasizes that V’s conversion rate is adjustable based on litigation or follow-on offerings and that Class C has no restrictions with an exchange program; the LLM mentions restricted transferability and conversion but omits the adjustment mechanism and exchange program details, missing key differentiating factors. (5) The reasoning incorrectly frames MA and V as similar in control mechanism due to small Class B cohorts, when the ground truth highlights that MA has a static 15-vote structure while V’s is dynamic and litigation-contingent. The conflation of CMCSA’s structure with MA’s breaks the multi-hop logic required. While the answer correctly identifies that V ties Class B conversion to litigation and that control is concentrated, the core misidentification of entities and insertion of false quantitative data severely limits accuracy. Wording and structure show effort at synthesis, but factual foundation is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 541,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does RTX's financial exposure to FAR-regulated U.S. government fixed-price contracts compare to LMT's risk profile under similar contracts, particularly in terms of revenue recognized in excess of billings and potential liabilities from government audits?",
      "original_answer": "RTX reports that under U.S. government fixed-price contracts, they typically receive performance-based or progress payments, which often result in revenue recognized in excess of billings, presented as Contract assets on their Consolidated Balance Sheet. This indicates a financial exposure tied to delayed cash receipt despite early revenue recognition. The FAR regulates these payment structures and cost-allowability, directly shaping RTX's financial reporting and risk. Similarly, LMT, which is also heavily dependent on U.S. government contracts, faces potential liabilities from government audits and investigations, including the risk of debarment or suspension from future contracts, which could have a material adverse effect given their 'dependence on contracts with the U.S. Government.' While RTX's exposure is primarily balance sheet-related (e.g., contract assets), LMT's risk is more compliance and enforcement-oriented, with potential financial penalties or operational restrictions stemming from FAR-regulated audits. Both companies are therefore financially and operationally impacted by the FAR’s regulatory framework, but through different risk mechanisms.",
      "llm_answer": "\nRTX records contract‑asset balances that represent revenue recognized in excess of billings on its U.S. government fixed‑price contracts and may carry contract‑liability reserves for advance payments, while both RTX and LMT operate under the same FAR‑regulated framework and are subject to Cost‑Accounting‑Standard audits that can generate audit‑driven repayments, fines or even debarment; LMT’s disclosures specifically warn that government investigations could result in up to $52 million of trebled damages plus penalties and suspension from future contracts, highlighting a comparable but potentially broader liability exposure for LMT versus RTX’s more limited contract‑asset/liability profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both RTX and LMT operate under FAR-regulated contracts and face financial and operational risks, including audit-related liabilities and contract assets. It accurately notes RTX's revenue recognized in excess of billings (contract assets) and mentions LMT's exposure to government investigations, fines, and debarment. However, the LLM introduces a specific figure of '$52 million of trebled damages' for LMT, which is not present in the original answer or ground truth. This number is unsupported by the provided context and appears fabricated or misattributed, significantly undermining quantitative accuracy. (2) There are no calculations in the question, but the introduction of a precise monetary figure ($52 million) without grounding in the source material constitutes a major factual error. The original answer makes no mention of any dollar amount related to LMT’s potential liabilities, only stating that such risks could have a 'material adverse effect.' (3) The multi-hop reasoning is partially sound: the model correctly synthesizes that RTX faces balance sheet exposure (contract assets) while LMT faces compliance/enforcement risks. It also correctly links both to FAR and audit frameworks. However, the unsupported $52 million claim breaks the chain of factual reliability, suggesting overreach or hallucination in quantitative detail. (4) Despite the numerical inaccuracy, the qualitative comparison between RTX’s financial reporting risk and LMT’s legal/compliance risk is well-framed and contextually relevant. The answer addresses all parts of the question but fails on a critical factual claim, warranting a moderate correctness score. Quantitative accuracy is low due to the false specificity; qualitative and contextual scores are higher due to structurally sound reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Regulates]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 505,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does the voting power distribution between Class A and Class B common stock at META compare to GOOGL's structure, given the specific voting rights tied to each share class?",
      "original_answer": "At META, Class B common stockholders hold 33 1/3% of the combined voting power, with each Class B share carrying 15 votes, while Class A shares (publicly traded) hold the remaining 66 2/3% of voting power. In contrast, at GOOGL, Class B shares carry 10 votes per share and Class A shares carry 1 vote per share, though the equity note does not specify the exact percentage split between the two classes. This indicates that both companies use dual-class structures to concentrate voting control, but META's structure gives significantly more per-share voting power to Class B shares compared to GOOGL.",
      "llm_answer": "\nMeta’s Class B common stock carries 15 votes per share, which the filing shows amounts to roughly 33 % of the total voting power (with Class A holding the remaining ≈ 66 %); because Class B is not publicly listed, only 23 holders of record exist, and the knowledge‑graph link Class B → Class A → GOOGL illustrates that this dual‑class structure feeds into Alphabet’s own voting hierarchy.  In contrast, Alphabet’s Class B shares have 10 votes per share while Class A shares have only 1 vote, so the voting‑power split depends on the relative share counts but still concentrates control in insiders, and both companies use these arrangements to keep founders in charge—Meta even announced a $0.50 per‑share dividend on both classes, whereas Alphabet does not pay dividends but runs a large share‑repurchase program.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Meta's Class B shares have 15 votes per share and hold approximately 33% of voting power, with Class A holding about 66%, which aligns with the ground truth. It also correctly states that GOOGL's Class B shares have 10 votes per share and Class A have 1 vote per share. However, the LLM introduces a fabricated and nonsensical 'knowledge-graph link Class B → Class A → GOOGL' that falsely implies a structural or hierarchical connection between Meta and Alphabet's share classes, which is not supported by any factual basis. This severely undermines the reasoning. (2) Quantitatively, the percentages and vote counts per share are mostly accurate (rounding 33 1/3% to 33% is acceptable), but the claim about '23 holders of record' for Meta Class B is not in the original answer and cannot be verified from the provided context—this is an unsupported addition. The dividend and share-repurchase details, while possibly true, are irrelevant to the question about voting power distribution and distract from the core comparison. (3) The multi-hop reasoning fails: the question asks for a comparison of voting power structures between META and GOOGL, not an assertion of a direct link between them. The LLM incorrectly synthesizes a relationship that does not exist, showing flawed logic. While both companies do use dual-class structures to concentrate control, the LLM does not clearly emphasize that META’s Class B has higher per-share voting power (15 vs 10) as a key differentiator, which is central to the ground truth. (4) Scores reflect partial factual accuracy on vote counts and rough percentages, but major deductions for introducing false connections, irrelevant details, and failing to clearly articulate the comparative voting power concentration. Contextual relevance is higher because the response stays generally on topic, despite inaccuracies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 515,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "Given BMY's reliance on regulatory data protection for key products like Opdivo, how does the expiration of such protections create a precedent for increased Paragraph IV ANDA challenges that could directly impact JNJ's litigation exposure for drugs like Stelara facing similar patent cliffs in the coming years?",
      "original_answer": "BMY's 2022 10-K highlights that when market exclusivity expires, there are often 'substantial and rapid declines' in sales of the original product, and that ANDAs with Paragraph IV certifications are frequently filed after four years of a five-year regulatory data protection period. AbbVie's filing demonstrates how such Paragraph IV challenges directly lead to increased patent litigation exposure, with companies filing Abbreviated New Drug Applications seeking to market generic forms of branded drugs before patent expiration. JNJ's 2022 10-K specifically cites patent litigation as a material risk, noting the company faces litigation related to its major products and that adverse judgments could significantly impact financial performance. Stelara, which generated over $8 billion in 2022, is a prime target for such challenges once exclusivity periods lapse, mirroring the pathway seen in BMY's and AbbVie's experiences.",
      "llm_answer": "\nBMY’s Opdivo depends on the U.S. 5‑year regulatory data‑protection period (Chunk 1); when that exclusivity lapses, generic companies can file ANDAs with Paragraph IV certifications as early as the fourth year, triggering patent‑infringement suits that flow into the “Patent Litigation” node linked to JNJ in the KG pattern.  AbbVie’s disclosures (Chunk 2) illustrate how such Paragraph IV challenges can erode market exclusivity and generate costly patent litigation—exactly the type of exposure JNJ flags for Stelara as its patents near a cliff (Chunk 3).  Therefore, the expiration of BMY’s data‑protection shield creates a clear precedent for a surge in Paragraph IV ANDA suits that will directly increase JNJ’s litigation risk for Stelara and analogous products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original ground truth. (1) All key facts are correct: BMY's reliance on 5-year U.S. regulatory data protection, Paragraph IV ANDA filings typically occurring in the fourth year of that period, and the resulting patent litigation risk are all factually sound and consistent with the knowledge graph. The reference to AbbVie as an illustrative case (likely Humira) correctly supports the precedent of increased litigation upon exclusivity loss. (2) There are no numeric inaccuracies—while specific dollar figures like Stelara’s $8B in sales are omitted, the LLM does not misstate any numbers and the absence does not undermine the core argument. The logic around timing (fourth year of five-year exclusivity) is precise and correctly interpreted. (3) Multi-hop reasoning is strong: the model connects BMY’s Opdivo situation to broader generic challenge patterns, links Paragraph IV filings to patent litigation, and correctly maps this precedent to JNJ’s exposure for Stelara. The synthesis across BMY, AbbVie, and JNJ is logically coherent and mirrors the knowledge graph’s causal chain. (4) Semantic equivalence is high—the LLM conveys the same central thesis: expiration of data protection triggers Paragraph IV challenges, which increases litigation risk for companies like JNJ with blockbuster drugs facing patent cliffs. The only minor shortcoming is slightly less contextual detail (e.g., not explicitly stating Stelara’s revenue or that JNJ names litigation as a material risk in its 10-K), which prevents a perfect 10 but does not detract from overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> LITIGATION <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 444,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does the structure of META's dual-class stock system, which requires Class B approval for change-of-control transactions until their voting power drops below 35%, compare with GOOGL's dual-class voting framework where Class B shares carry 10 votes each but automatically convert to Class A upon transfer?",
      "original_answer": "META's dual-class structure requires a separate Class B majority vote for any change-of-control transaction until Class B shares fall below 35% of total voting power, providing concentrated control to its primary stockholder. In contrast, GOOGL allows Class B shares to carry 10 votes each but mandates automatic conversion to Class A voting rights upon sale or transfer, limiting long-term entrenchment while still preserving enhanced voting power during ownership retention. Both structures concentrate control, but META's framework offers more enduring governance insulation due to its non-automatic nature and threshold-based trigger.",
      "llm_answer": "\nMETA’s dual‑class regime leaves any change‑of‑control transaction subject to a separate Class B vote until the Class B shares represent less than 35 % of the combined voting power—a threshold that must be cleared before a transaction can proceed and is reinforced by Delaware anti‑takeover provisions that can depress the Class A price; GOOGL’s Class B shares carry 10 votes each but automatically convert to Class A on transfer (or at the holder’s option), so the 10‑vote weight disappears without any 35 % approval requirement, a structure reflected in the non‑dilutable 33 % voting stake and conversion rights described for Comcast’s Class B.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core distinction between META's and GOOGL's dual-class structures but introduces significant inaccuracies that undermine factual correctness. (1) Correct elements: META’s requirement of Class B approval for change-of-control until below 35% voting power is accurately stated, as is GOOGL’s 10-vote Class B shares and automatic conversion upon transfer. (2) Quantitative accuracy issues: The mention of a '33% voting stake' for Comcast is irrelevant and incorrect in this context—neither the question nor the ground truth references Comcast or 33%, introducing a major factual error. This suggests confusion or conflation with another company. Additionally, the claim about 'Delaware anti-takeover provisions that can depress the Class A price' is not in the original answer and lacks support in typical public filings; it introduces speculative legal/financial mechanisms not part of the verified knowledge. (3) Multi-hop reasoning: The comparison between META and GOOGL is partially sound—both systems concentrate control, and the non-automatic vs. automatic conversion is correctly contrasted. However, the reasoning is weakened by the erroneous Comcast reference and extraneous legal claims. (4) Semantic equivalence: While the key ideas are present, the inclusion of false information (Comcast, Delaware provisions) and misattribution of voting thresholds reduces reliability. The answer is contextually relevant and addresses the comparison, but factual contamination lowers correctness. Hence, a score of 6 reflects partial accuracy with significant factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST -[Depends_On]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 435,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "UPS chose not to apply the practical expedients under ASU 2020-04 for its transition to SOFR in 2023 - how does this approach contrast with how MMM likely managed its hedging relationships affected by reference rate reform, given the optional relief available through December 31, 2024?",
      "original_answer": "UPS explicitly stated it did not elect to apply the practical expedients provided under ASU 2020-04 when transitioning its affected debt instruments to SOFR in 2023. In contrast, MMM's detailed disclosures of hedging relationships suggest it may have utilized the optional relief under the same standard, particularly since ASU 2022-06 extended the sunset date to December 31, 2024, allowing companies to apply the expedients to contracts modified through that date. MMM's reporting includes extensive hedging activity data, such as $152 million reclassified from accumulated other comprehensive income into income in 2023 for foreign currency contracts, which implies active management of hedging relationships—potentially benefiting from the optional relief provided by ASU 2020-04 as extended.",
      "llm_answer": "\nUPS disclosed in its 2023 10‑K that it **did not elect the practical expedients under ASU 2020‑04** when moving its debt to SOFR, choosing full GAAP re‑measurement of the transition (Chunk 1). In contrast, the knowledge‑graph link Hedging Relationships → MMM shows that MMM’s hedging activities are expressly covered by that ASU, and MMM’s 2023 filing indicates it **took advantage of the optional relief**—allowing it to modify reference‑rate contracts without full re‑measurement, which is reflected in its modest derivative gains/losses and the non‑material impact noted on its consolidated results (Chunks 2 & 3). Because the expedients remain available through December 31, 2024, MMM’s approach stands in direct contrast to UPS’s decision to forgo them.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that UPS did not elect the practical expedients under ASU 2020-04, consistent with the original answer. It contrasts this with MMM's likely use of the optional relief, which is supported by the knowledge graph's indication of MMM’s active hedging relationships and the availability of relief through December 31, 2024, extended by ASU 2022-06. (2) There are no numerical values in the LLM answer that conflict with the ground truth; while the original answer mentions $152 million reclassified from AOCI, the LLM does not include this figure but instead refers to 'modest derivative gains/losses' and 'non-material impact,' which are qualitatively consistent with the implication that MMM benefited from relief without needing to report large re-measurement effects. The absence of the $152M figure is a minor omission but does not detract from the core correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes UPS’s disclosure, the availability of ASU 2020-04 relief, the extension via ASU 2022-06, and MMM’s hedging disclosures to infer contrasting approaches. (4) The answer is contextually precise, directly addressing the contrast in transition approaches and the implications of the optional relief. The only reason for not scoring a perfect 10 is the omission of the specific $152M data point from MMM’s AOCI reclassification, which was present in the ground truth and would have strengthened quantitative completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 423,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does the daily cash-settlement of exchange-traded commodity futures impact MDLZ's valuation methodology for Level 1 financial assets, given PEP's similar exposure to these instruments?",
      "original_answer": "MDLZ values its Level 1 financial assets, which include exchange-traded commodity futures, based on quoted market prices from commodity exchanges. These instruments are marked-to-market daily, as noted in PEP's disclosure that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in the balance sheet table as of year-end. This daily cash-settlement mechanism directly supports MDLZ's use of quoted market prices for fair value measurement, as both companies are exposed to the same class of instruments that are subject to daily valuation adjustments through cash settlement.",
      "llm_answer": "\nThe daily cash‑settlement of exchange‑traded commodity futures means that MDLZ’s Level 1 financial assets are marked‑to‑market using only the quoted exchange price, so the fair‑value calculation is a direct, observable input rather than an internally‑derived model; this treatment is explicitly described in Chunks 1 & 2, which state that “Level 1 financial assets and liabilities consist of exchange‑traded commodity futures…fair value…based on quoted market prices on commodity exchanges” and that such futures are “cash‑settled on a daily basis and, therefore, not included in the table.” Chunk 3 shows that PEP reports the same type of cash‑settled futures and also classifies them as Level 1 (they are listed under “Based on recently reported market transactions of spot and forward rates” and are omitted from the balance‑sheet table for the same reason), confirming that both companies apply an identical, price‑driven valuation methodology for these instruments.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original answer. (1) It accurately describes how daily cash-settlement impacts MDLZ's valuation methodology for Level 1 financial assets by emphasizing the use of quoted market prices due to daily mark-to-market adjustments. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, dates), but the answer correctly references the absence of these instruments from the balance sheet table, consistent with the ground truth. (3) The multi-hop reasoning is sound: it connects MDLZ's valuation approach to PEP's similar treatment of exchange-traded commodity futures, citing shared classification as Level 1 and exclusion from balance sheet tables due to daily cash settlement. The use of 'Chunks 1 & 2' and 'Chunk 3' as evidence aligns with the knowledge graph logic, showing proper synthesis across entities. (4) All entities (MDLZ, PEP, Level 1 assets, exchange-traded commodity futures) are correctly identified and logically linked. The explanation captures the causal relationship between daily cash settlement and reliance on observable market prices, matching the original answer in both factual content and reasoning depth. Minor wording differences (e.g., 'price-driven valuation methodology' vs 'quoted market prices') do not affect meaning and are acceptable under semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Valued_Using]-> FIN_INST -[Includes]-> FIN_INST <-[Cash-Settles]- ORG",
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 385,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does the voting power distribution tied to CMCSA's Class A and Class B common stock structure compare to GOOGL's approach, given that GOOGL also maintains a multi-tier voting rights system with Class B common stock?",
      "original_answer": "CMCSA's Class A common stockholders hold 66 2/3% of the combined voting power, while the Class B common stockholders (beneficially owned entirely by Brian L. Roberts) hold 33 1/3% of the voting power, with each Class B share carrying 15 votes. In contrast, GOOGL's Class B common stockholders have 10 votes per share, while Class A common stockholders have 1 vote per share, and Class C capital stock has no voting rights. This indicates that CMCSA concentrates more voting power in Class B shares relative to GOOGL, where Class B shares have a lower per-share vote weight but still serve to maintain control for certain key stakeholders.",
      "llm_answer": "\nCMCSA’s voting power is split ≈ 66 ⅔ % to Class A shares and the remaining ≈ 33 ⅓ % to Class B shares, each Class B share carrying 15 votes and representing a non‑dilutable block owned entirely by Brian L. Roberts (chunks 1‑2).  Alphabet (GOOGL) employs a three‑class system in which Class B shares carry only 10 votes per share, while Class A holds one vote and Class C has none, distributing voting power across three tiers rather than concentrating it in a single non‑dilutable block (chunk 3).  The KG triplet linking CMCSA’s Class B to GOOGL underscores that, although both firms use multi‑tier structures, CMCSA’s Class B dominates voting power and is non‑dilutable, whereas GOOGL’s Class B is part of a broader, convertible hierarchy with lower per‑share voting weight.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: CMCSA's Class A holds ~66 ⅔% and Class B ~33 ⅓% of voting power, with Class B shares carrying 15 votes per share; GOOGL's Class B has 10 votes per share, Class A has 1, and Class C has none. These match the original answer exactly, with acceptable formatting variations (e.g., '≈' instead of exact fraction). (2) The answer is complete, addressing both companies' structures, vote weights, ownership concentration (Brian L. Roberts), and the presence of a three-tier system at GOOGL. (3) Entities are correctly identified: CMCSA and GOOGL (Alphabet) are properly referenced with accurate stock class designations. (4) Reasoning is sound: the LLM correctly infers that CMCSA concentrates more voting power in Class B due to the non-dilutable block and higher per-share vote weight (15 vs 10), even though GOOGL’s structure is broader and convertible. The only minor shortcoming is a slight lack of explicit comparison stating that CMCSA’s Class B has relatively more concentrated control due to both ownership structure and higher vote weight—though this is implied. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 354,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does BAC's market-making gains related to embedded derivatives compare to MS's involvement in CLNs structured as hybrid instruments with embedded derivatives, given the shared exposure to credit event risks in structured notes?",
      "original_answer": "BAC reports that its net gains (losses) in market-making activities relate to embedded derivatives in structured liabilities and are typically offset by gains (losses) on derivatives and securities used to hedge these liabilities. MS, on the other hand, structures CLNs as hybrid instruments containing embedded derivatives, where the Firm sells credit protection and faces risk of principal loss upon a credit event in the reference entity. Both firms demonstrate exposure to credit-linked derivatives, but BAC actively hedges these exposures while MS retains risk through structured note design.",
      "llm_answer": "\nBAC records market‑making gains (and losses) from embedded derivatives in structured liabilities, recognizing them in accumulated other comprehensive income and hedging the exposure with derivatives and securities, with the gains tied to changes in the firm’s own credit spread (Chunk 1). MS invests in credit‑linked notes and CDOs that are hybrid instruments containing embedded derivatives, sells credit protection to the note issuer, and holds variable interests in VIEs so that a credit event may prevent full repayment of the note’s principal (Chunk 2). Thus both banks share exposure to credit‑event risk in structured notes, but BAC’s exposure is reflected in market‑making gains that are hedged and reported in OCI, whereas MS’s exposure manifests as potential principal loss on CLNs and retained residual interests in securitizations (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BAC's market-making gains from embedded derivatives in structured liabilities are hedged and linked to its own credit spread, and these are reported in accumulated other comprehensive income (OCI), which matches the original answer’s emphasis on offsetting hedges. MS structures CLNs as hybrid instruments with embedded derivatives, sells credit protection, and faces principal loss upon a credit event—this is accurately reflected. (2) There are no numeric values in the question or answers requiring calculation, so quantitative accuracy is 10 by default—no discrepancies. (3) Multi-hop reasoning is sound: the model correctly synthesizes that both firms have exposure to credit-event risks via structured notes with embedded derivatives, but differ in risk management—BAC hedges actively, while MS retains risk through design and residual interests in VIEs. The mention of OCI adds contextual detail not in the original but is factually consistent and enhances accuracy. (4) Semantic equivalence is strong; the LLM captures the core contrast: BAC’s hedged, market-making-oriented exposure vs. MS’s retained risk through CLNs and securitizations. One minor point preventing a perfect 10 is the introduction of 'accumulated other comprehensive income (OCI)' and 'VIEs' as additional details not present in the ground truth—while accurate, they slightly extend beyond the original scope without explicit support in the provided truth. However, this does not detract from correctness. Overall, the answer is complete, logically structured, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Relates_To]-> FIN_INST -[Related_To]-> FIN_INST <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 456,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How does the implementation of the OECD's Pillar Two Model Rules, which Salesforce (CRM) identifies as a global tax development, potentially affect Intel's (INTC) effective tax rate given Intel's exposure to non-US jurisdictions and ongoing evaluation of Pillar Two impacts?",
      "original_answer": "Salesforce (CRM) identifies the OECD's Pillar Two Model Rules, which introduce a global minimum tax of 15%, as a material global tax development that could impact multinational businesses. Intel (INTC), which reports that a higher proportion of its income is taxed in non-US jurisdictions, is actively evaluating the impact of Pillar Two, particularly as several non-US jurisdictions, including EU Member States, have enacted or plan to enact legislation aligning with the rules starting in 2024. Since Intel's effective tax rate has been influenced by its geographic income distribution and non-US tax regimes, the implementation of Pillar Two could constrain its ability to benefit from lower tax jurisdictions, thereby increasing its effective tax rate or reducing future tax benefits.",
      "llm_answer": "\nThe OECD Pillar Two “global minimum tax” – which Salesforce (CRM) flags as a key global tax development – would apply to Intel (INTC) because the rule is linked to the company in the KG (Pillar Two Model Rules → INTC) and could raise the effective tax rate on income that is currently taxed at rates below the 15 % floor, especially the portion of earnings that is taxed in non‑US jurisdictions (as noted in Intel’s 2023 filing where a higher share of income in non‑US locations helped lower its effective tax rate).  Intel acknowledges that it has no material operations in jurisdictions with rates beneath the 15 % minimum, so the rules are not expected to materially increase its global tax cost, but the company continues to evaluate the impacts and notes that any future legislative changes could affect its effective tax rate and cash flows (see the discussion of global tax developments and ongoing monitoring of Pillar Two in the 10‑K disclosures).",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual contradiction that undermines its correctness. While it correctly identifies the OECD Pillar Two Model Rules, the 15% global minimum tax, and Salesforce's (CRM) mention of it as a global tax development, it incorrectly states that Intel 'has no material operations in jurisdictions with rates beneath the 15% minimum' and that Pillar Two 'is not expected to materially increase its global tax cost.' This directly contradicts the ground truth, which states that Intel reports a higher proportion of its income is taxed in non-US jurisdictions—many of which are enacting Pillar Two rules starting in 2024—and that the rules could constrain its ability to benefit from lower-tax jurisdictions, thereby increasing its effective tax rate. The LLM's conclusion that there will be no material impact is not supported by the original answer and misrepresents Intel's exposure. Quantitatively, the 15% rate and reference to 2024 legislation are accurate, earning partial credit. Qualitatively, the reasoning is flawed due to the incorrect synthesis of Intel’s position—failing the multi-hop logic required to connect CRM’s identification of Pillar Two as material, INTC’s geographic income distribution, and the likely upward pressure on its effective tax rate. Contextually, the answer is well-structured and relevant, citing appropriate disclosures and mechanisms, but the core conclusion is factually wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 397,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How does RTX's revenue recognition timing under FAR-regulated U.S. government fixed-price contracts compare to BA's exposure to termination risk in their U.S. government contracts, and what implications does this have for cash flow predictability?",
      "original_answer": "RTX recognizes revenue in excess of billings on U.S. government fixed-price contracts due to retained customer payments until contract completion, typically receiving performance-based payments (PBPs) or progress payments covering 80-90% of costs incurred. This creates contract assets on their balance sheet. In contrast, BA faces risks of contract termination at the convenience of the U.S. government, which could limit payments to work completed and allowable termination costs, or even result in liability for re-procurement costs if terminated for default. The FAR regulations that govern both companies' U.S. government contracts allow for interim payments but expose contractors to different financial risks—RTX to cash flow timing mismatches, and BA to potential revenue reversals or liabilities—making BA's cash flow more unpredictable despite similar regulatory frameworks.",
      "llm_answer": "\nRTX’s revenue under its FAR‑regulated U.S. government fixed‑price contracts is recognized as work progresses—often resulting in revenue that exceeds billings and is recorded as a contract asset—so cash inflows follow the measurable performance milestones and are relatively predictable; this timing is set by the same regulatory chain (ORG RTX → Subject_To → FAR → Regulates → U.S. Government Contracts) that also governs BA, but BA’s contracts carry an additional termination risk: the U.S. government may terminate a contract for convenience or default, and if terminated for default BA would receive payment only for work already accepted (and could even be liable for re‑procurement costs), creating substantial cash‑flow volatility. Consequently, while RTX’s progress‑payment structure yields a more stable cash‑flow pattern, BA’s exposure to possible termination introduces uncertainty that can sharply affect the timing and magnitude of cash receipts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: RTX recognizes revenue in excess of billings under FAR-regulated fixed-price contracts, creating contract assets due to performance-based or progress payments covering a significant portion of costs (though the exact 80-90% range is omitted, this is a minor detail). BA's exposure to termination for convenience or default is correctly described, including the financial consequences—limited payments for work completed and potential liability for re-procurement costs if terminated for default. (2) Quantitative accuracy is strong: no incorrect numbers are presented, and while the 80-90% payment coverage from the original answer is missing, the LLM does not fabricate or misstate any figures. (3) Multi-hop reasoning is sound: the model correctly links both companies to the FAR regulatory framework, distinguishes their differing risk profiles (cash flow timing vs. termination risk), and draws the logical conclusion about cash flow predictability. (4) Semantic equivalence is maintained—wording differs but meaning aligns closely with the original. The only minor shortcoming is the lack of explicit mention of the 80-90% payment coverage, which slightly reduces completeness but does not impair the overall correctness. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Regulates]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 410,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How does the $119 million in floating rate notes with put provisions due in 2025 disclosed by MMM compare to GE's $315 million investment in fixed and floating rate notes containing similar 2025 put options, considering both companies' exposure to near-term debt obligations?",
      "original_answer": "MMM discloses $119 million in floating rate notes with put provisions due in 2025, which are classified as current portion of long-term debt. GE holds $315 million in fixed and floating rate notes that also contain put options exercisable in 2025, despite contractual maturities occurring after 2025. Both companies are exposed to near-term liquidity risks tied to these put options, though GE’s exposure is more than 2.5 times larger than MMM’s. This indicates a significant potential cash outflow in 2025 for both companies depending on whether the put options are exercised.",
      "llm_answer": "\nMMM discloses $119 million of floating‑rate notes that carry put provisions and are scheduled to mature in 2025 (shown as the current portion of its long‑term debt)【Chunk 1】, while GE reports a $315 million investment in fixed‑and‑floating‑rate notes that also include 2025 put options and contractually mature after 2025【Chunks 2 & 3】. Because the $315 million GE position is more than twice the size of MMM’s $119 million exposure, GE’s near‑term debt obligations that feature put rights are substantially larger, underscoring a greater reliance on such instruments for its short‑term financing needs. This comparison is reflected in the knowledge‑graph link that ties “Fixed and Floating Rate Notes” directly to GE, confirming its investment in these put‑enabled securities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies all key facts: MMM's $119 million floating rate notes with put provisions due in 2025 classified as current portion of long-term debt, and GE's $315 million investment in fixed and floating rate notes with 2025 put options despite later contractual maturities. All numbers and dates match the ground truth exactly. (2) Quantitative accuracy is perfect: $119M and $315M are correctly reported, and the statement that GE’s exposure is 'more than twice' the size of MMM’s is accurate (315/119 ≈ 2.65). The ground truth notes it is 'more than 2.5 times larger,' so the LLM's 'more than twice' is a slight understatement but not factually incorrect—just less precise. (3) Multi-hop reasoning is sound: the model correctly synthesizes data from both companies, compares their exposures, and draws a valid conclusion about relative near-term liquidity risk. It correctly notes that both instruments create potential cash outflows in 2025 due to put options. The only minor gap is that the LLM frames GE’s position as an 'investment' rather than a debt obligation, which could imply GE is the lender rather than the borrower. However, in context, it correctly treats this as a liability-like exposure with put rights, aligning with the ground truth’s emphasis on GE’s obligation. (4) Scores reflect high accuracy: full points for quantitative and contextual accuracy; qualitative reasoning is strong but loses 1 point for slightly imprecise comparison language and potential ambiguity in framing GE’s position as an 'investment' rather than a debt instrument with put risk. Overall, the answer conveys the same core meaning as the ground truth with excellent fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Includes]-> FIN_INST <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 465,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How does the valuation methodology for exchange-traded commodity futures used by PEP compare to MDLZ's treatment of Level 1 financial assets, given both companies' reliance on daily market pricing for fair value determination?",
      "original_answer": "PEP excludes exchange-traded commodity futures from its fair value table because they are cash-settled daily, while MDLZ explicitly includes exchange-traded commodity futures as Level 1 financial assets, valued based on quoted market prices on commodity exchanges. Both companies rely on daily market pricing for fair value determination, but PEP focuses on the daily cash settlement mechanism as the reason for exclusion, whereas MDLZ emphasizes quoted market prices as the basis for Level 1 classification.",
      "llm_answer": "\nBoth PEP and MDLZ base the fair‑value of their exchange‑traded commodity futures on daily market prices, but they apply opposite hierarchy treatments. PEP notes that these futures are cash‑settled daily and “are not included in the table” – i.e., they are excluded from the balance‑sheet fair‑value hierarchy (effectively treated as outside Level 1), whereas MDLZ explicitly classifies exchange‑traded commodity futures and listed options as Level 1 financial assets and measures them at quoted exchange prices. Thus, the underlying commodity‑future instrument is the same (PEP → Commodity Futures → Level 1 Financial Assets → MDLZ), but PEP excludes it from recorded assets while MDLZ includes it as a Level 1 item valued by quoted market prices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: PEP excludes exchange-traded commodity futures from its fair value hierarchy due to daily cash settlement, while MDLZ includes them as Level 1 assets based on quoted market prices. Both rely on daily market pricing, but differ in reporting treatment—this is correctly captured. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense, but the conceptual treatment of valuation inputs (quoted prices) is accurately described. (3) The multi-hop reasoning—linking PEP’s exclusion rationale with MDLZ’s inclusion rationale, both tied to daily pricing—is sound and correctly synthesizes information across the two companies’ disclosures. (4) The only minor shortcoming is a slightly misleading phrase: 'PEP excludes it from recorded assets'—this overreaches slightly, as PEP excludes the instruments from the fair value hierarchy table, not necessarily from being recorded as assets altogether. The ground truth clarifies it's about exclusion from the fair value table, not balance sheet recognition. Otherwise, the answer is semantically equivalent, contextually precise, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Includes]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 369,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does Apple's revenue from the Greater China region, which includes Taiwan, compare to Intel's revenue specifically from Taiwan operations in 2022?",
      "original_answer": "Apple generated $74,200 million in net sales from the Greater China region in 2022, which includes Taiwan among other markets. In contrast, Intel reported $13,461 million in net revenue specifically from Taiwan operations during the same period. This indicates that Apple's revenue exposure through the Greater China segment, which encompasses Taiwan, is significantly higher than Intel's direct revenue from Taiwan.",
      "llm_answer": "\nApple’s 2022 net sales in the **Greater China** segment— which, as noted in Chunk 2, **includes Taiwan**—were **$74.2 billion** (Chunk 1).  Intel’s own 2022‑year figure for **Taiwan** operations is **$13.5 billion** (Chunk 3).  Consequently, Apple’s revenue from the Greater China region (including Taiwan) is **more than five times** the amount of revenue Intel generates directly from Taiwan.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the numbers are correct: Apple's $74.2 billion (i.e., $74,200 million) from Greater China and Intel's $13.5 billion (rounded from $13,461 million) from Taiwan operations in 2022 are accurately reported, with acceptable rounding ($13.5B vs $13.461B). (2) The comparison stating Apple's revenue is 'more than five times' that of Intel's is logically sound: 74.2 / 13.5 ≈ 5.5, which supports the claim. (3) The multi-hop reasoning is correct—Apple's revenue is from a broader region (Greater China, including Taiwan), while Intel's is specific to Taiwan, and the model correctly contrasts these scopes. (4) All entities (Apple, Intel, Greater China, Taiwan, 2022) and metrics (net sales/revenue) are accurately identified. The only minor deduction is for rounding Intel's revenue to $13.5B instead of reporting the precise $13.461B, though this is acceptable in high-level financial communication. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 303,
        "total_tokens": 1507
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the combined net property, plant, and equipment investment in the Americas by MMM compare to GD's revenue contribution from South America over the same geographic footprint, given that the Americas segment includes South America as part of its geographic definition?",
      "original_answer": "MMM reported $5,864 million in net property, plant, and equipment for the Americas in 2021, which includes South America. GD, in the same year, generated $234 million in revenue specifically from South America. This indicates that while GD's revenue from South America is relatively small, MMM has a significantly larger asset base tied to the broader Americas region, which encompasses South America.",
      "llm_answer": "\nMMM’s combined net property, plant and equipment in the Americas was **$5,864 million** in 2021 (Chunk 3), while GD’s revenue generated directly from South America—part of the Americas segment that also includes South America (Chunk 1 and the KG link GD → South America → Americas)—was only **$234 million** for the same year. Consequently, MMM’s PP&E investment in the region is roughly **25 times larger** than GD’s South‑American revenue, reflecting the overlapping geographic footprint defined in the KG (GD operates in South America, which is included in the Americas, and MMM also operates in the Americas).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: MMM's net property, plant, and equipment in the Americas is correctly stated as $5,864 million in 2021, and GD's South America revenue is accurately reported as $234 million for the same year. The implied comparison (MMM's PP&E being ~25 times GD's revenue) is mathematically sound: 5,864 / 234 ≈ 25.06, which rounds to 25 times. (2) The answer is complete, addressing both the investment and revenue figures, their geographic alignment (Americas including South America), and the comparative scale. (3) Entity accuracy is perfect: MMM and GD are correctly identified, the financial metrics (PP&E vs. revenue) are appropriate, and the year 2021 is consistent with the ground truth. (4) The multi-hop reasoning is strong—LLM correctly synthesizes that South America is part of the broader Americas segment, links GD’s revenue from South America to the larger geographic footprint, and compares it to MMM’s asset base in that same region. The use of 'KG link' references shows awareness of the knowledge graph structure. (5) Semantic equivalence is maintained: while the LLM adds a quantitative comparison (25x), this enhances rather than distorts the original answer and is factually valid. All criteria are met with high precision and contextual fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 381,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the use of sensitivity analyses by NFLX's auditor in evaluating content amortization assumptions compare to CMCSA's application of sensitivity analyses in managing interest rate risk exposure?",
      "original_answer": "NFLX's auditor performed sensitivity analyses to evaluate how changes in assumptions about viewing patterns could affect content amortization timing, which directly impacts financial reporting accuracy. In contrast, CMCSA uses sensitivity analyses as part of its interest rate risk management strategy to assess the potential impact of interest rate fluctuations on its debt portfolio, with derivative instruments reducing interest expense by $56 million in 2023. While both companies apply sensitivity analyses, NFLX uses it for accounting policy judgment, whereas CMCSA applies it for financial risk management.",
      "llm_answer": "\nNFLX’s auditor — as described in the 2023 Form 10‑K (Chunks 1 & 2) — conducts sensitivity analyses on the viewing‑pattern assumptions that determine content‑amortization, testing how alternative historical and forecasted consumption figures would alter the amount and timing of amortization expense; CMCSA — as disclosed in its 2023 Form 10‑K (Chunk 3) — uses sensitivity analyses as part of its market‑risk monitoring to evaluate how changes in interest rates affect the fair value and interest‑expense impact of its fixed‑rate debt and interest‑rate swaps, noting the resulting decreases in expense. In short, both companies employ sensitivity analyses, but NFLX’s auditor uses them to validate an accounting estimate for content amortization, whereas CMCSA applies them to manage and disclose interest‑rate risk on its debt and derivatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: NFLX's auditor uses sensitivity analyses to evaluate viewing-pattern assumptions affecting content amortization timing, and CMCSA uses sensitivity analyses to assess interest rate risk on its debt and derivatives. The distinction between accounting estimate validation (NFLX) and financial risk management (CMCSA) is correctly captured. (2) Quantitative accuracy is perfect: while no specific dollar amounts appear in the LLM answer, the ground truth mentions CMCSA's $56 million reduction in interest expense due to derivatives in 2023. Although the LLM does not include this exact figure, it correctly references 'resulting decreases in expense' tied to derivatives and interest-rate swaps, which is a semantically acceptable summary given the context of risk management and disclosure. The omission is minor and does not undermine the core accuracy. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (NFLX and CMCSA), two distinct financial processes (content amortization vs. interest rate risk), and two applications of sensitivity analysis (auditing/accounting vs. risk management). The comparison is logically structured and insightful. (4) Contextual relevance is excellent—the response directly addresses the comparative aspect of the question and maintains focus on the purpose and application of sensitivity analyses in each case. The wording differs slightly from the original answer but preserves full semantic equivalence. A score of 9 is given because the $56 million specific impact in CMCSA’s case, while not strictly required for correctness, adds concrete support that was omitted; however, the conceptual accuracy remains very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Reviews]-> ACCOUNTING_POLICY -[Performs]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 490,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does PEP's use of exchange-traded commodity futures to manage risk compare with COST's disclosure regarding the absence of Level 1 financial liabilities, given that both companies report under the same fair value hierarchy framework?",
      "original_answer": "PEP actively uses exchange-traded commodity futures, which are cash-settled daily and excluded from the balance sheet as of December 25, 2021, to manage market risk, particularly in relation to deferred compensation liabilities. These instruments fall under Level 1 of the fair value hierarchy, which includes instruments valued using quoted market prices. In contrast, COST explicitly states that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a different risk management approach with no direct use of such derivatives. This contrast highlights differing strategies in managing financial risk exposure under the same fair value reporting framework.",
      "llm_answer": "\nPEP discloses that it uses cash‑settled exchange‑traded commodity futures to manage market risk; these instruments are classified as Level 1 under the fair‑value hierarchy but, because they are cash‑settled, they are not recorded as liabilities and are omitted from the fair‑value table (PEP 10‑K, Note i). COST, by contrast, states that at both reporting dates it held **no** Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, explicitly revealing the absence of any Level 1 financial liabilities (COST 10‑K, Note 4). Thus, while both firms apply the same fair‑value hierarchy, PEP actually employs Level 1 futures for hedging, whereas COST reports that such Level 1 liabilities do not exist on its balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: PEP uses exchange-traded commodity futures classified as Level 1, which are cash-settled daily and thus not recorded on the balance sheet (consistent with omission from fair value tables), and COST reports no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis. The dates (December 25, 2021 for PEP and August 28, 2022 for COST) are not explicitly mentioned in the LLM answer, but the absence does not distort the comparison, as the core contrast in disclosures is preserved. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is fully maintained. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (PEP and COST), identifies their respective treatments of Level 1 instruments under the same fair value hierarchy, and draws a valid contrast in risk management strategies. (4) The answer is contextually relevant and directly addresses the question about how PEP’s use of Level 1 derivatives compares with COST’s disclosure of no Level 1 liabilities. The only minor shortcoming is the lack of specific fiscal year-end dates present in the original answer, which slightly reduces completeness but does not affect the correctness of the core comparison. Wording differs but semantic equivalence is strong. Overall, this is a precise, well-reasoned response that captures the essential contrast.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Cash-Settles]-> FIN_INST -[Includes]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 428,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the expiration timeline of U.S. patent protections for Enbrel, as detailed in Amgen's 2024 10-K, impact Merck's competitive positioning and Pfizer's international production strategy for the drug, especially considering Merck's stated exposure to biosimilar competition and pricing pressures?",
      "original_answer": "The U.S. patent protections for Enbrel expire in three key phases: fusion protein composition in November 2028, DNA encoding in April 2029, and formulations in October 2037. This staggered expiration timeline creates a gradual risk of biosimilar entry in the U.S., which could indirectly affect global pricing dynamics. Merck, which depends heavily on patent protection to maintain sales and profitability, faces intensified risk of generic competition following these expirations, compounding existing pricing pressures from government programs like the 340B Drug Discount Program. Meanwhile, Pfizer produces Enbrel outside the U.S. and Canada, meaning it will likely face competitive pressure from biosimilars in those international markets sooner than in the U.S., aligning with its broader specialty care portfolio strategy. Thus, the expiration of Enbrel’s U.S. patents affects Merck’s competitive positioning by increasing biosimilar risk and influences Pfizer’s international production strategy by accelerating exposure to generic competition outside the U.S.",
      "llm_answer": "\nAmgen’s 2024 10‑K reveals that the U.S. composition‑of‑matter and method patents protecting etanercept (Enbrel) expire in 2028, 2029 and 2037, so after 2028 the drug will lose its core U.S. exclusivity and be vulnerable to biosimilar entry—a risk that Merck explicitly cites as a source of pricing pressure and competitive vulnerability. Because Pfizer markets Enbrel outside the United States and Canada, it can extend the product’s life abroad, shift manufacturing and supply‑chain focus to those longer‑protected markets, and use the impending U.S. patent expirations to prioritize international production and pricing strategies while Merck’s exposure to biosimilar competition and pricing pressures intensifies.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct but contains minor inaccuracies in the precise phrasing of patent expiration dates compared to the ground truth. The ground truth specifies: fusion protein composition in November 2028, DNA encoding in April 2029, and formulations in October 2037. The LLM correctly identifies the 2028, 2029, and 2037 expirations but refers to them generally as 'composition-of-matter and method patents' without specifying the exact nature of each (e.g., DNA encoding, formulations), which slightly reduces quantitative precision. However, the core timeline is accurate, and the format variation (e.g., '2028, 2029, and 2037') is acceptable. The reasoning correctly synthesizes the multi-hop elements: (1) Amgen's patent expirations impact U.S. exclusivity, (2) Merck faces increased biosimilar risk and pricing pressure post-2028, which aligns with its stated exposure in filings, and (3) Pfizer’s international production strategy is affected as it markets Enbrel outside the U.S. and Canada, thus facing earlier biosimilar competition abroad. The LLM captures the strategic implications for both Merck and Pfizer, including the shift in production focus and pricing dynamics. While it omits explicit mention of the 340B Drug Discount Program (a minor contextual omission), it correctly identifies pricing pressures. The answer is semantically equivalent in intent and conveys the key strategic impacts. Thus, the answer is factually sound with minor detail omissions, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT -[Decreases]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 418,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How does the $90 of unfunded commitments in private equity funds disclosed by EMR compare to the $2.7 billion of unfunded commitments to private equity and other limited partnerships reported by UPS, given both companies measure these investments at NAV?",
      "original_answer": "EMR reports $90 of unfunded commitments in private equity funds as of September 30, 2024, while UPS reports a significantly larger amount of $2.7 billion in unfunded commitments to private equity, private debt, and real estate limited partnerships as of December 31, 2024. Both companies disclose these commitments in the context of investments measured at NAV, indicating similar accounting treatment for these alternative assets despite the large difference in scale.",
      "llm_answer": "\nBoth EMR and UPS value their private‑equity and limited‑partner interests at NAV, but the scale of their unfunded commitments differs sharply: EMR discloses only about **$90** of unfunded commitments in its private‑equity funds (as noted on page 64 of its 10‑K), whereas UPS reports roughly **$2.7 billion** of unfunded commitments to private‑equity and other limited partnerships (page 93 of its 10‑K). Consequently, UPS’s commitment is roughly 30 times larger and is slated to be funded over the next three‑to‑six years, while EMR’s $90 commitment will be resolved through the funds’ expected liquidation over about a ten‑year horizon.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: EMR's $90 and UPS's $2.7 billion in unfunded commitments are accurately reported. The comparison stating UPS’s commitment is roughly 30 times larger (2.7 billion / 90 = 30 million) is mathematically sound. Fiscal periods—EMR as of September 30, 2024, and UPS as of December 31, 2024—are not explicitly mentioned in the LLM answer, which is a minor omission, but the core data is correct. (2) The answer correctly identifies both companies and the relevant financial metric—unfunded commitments for investments measured at NAV—ensuring entity accuracy. (3) The reasoning is strong: it correctly synthesizes information across two companies and filings, compares scale, and adds contextual details about funding timelines (3–6 years for UPS, ~10 years for EMR), which, while not in the original answer, are plausible and do not contradict the ground truth. (4) The semantic meaning fully captures the original answer’s intent—highlighting the large disparity in commitment size despite similar accounting treatment. The only minor shortcoming is the lack of explicit mention of the fiscal dates and the slightly broader scope of UPS’s commitments (including private debt and real estate), but the reference to 'other limited partnerships' covers this adequately. Thus, the answer earns a 9/10 for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 409,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "What percentage of PepsiCo's APAC segment revenue in 2024 came from beverages, and how does this compare to Mondelēz's total beverage revenue in 2024?",
      "original_answer": "In 2024, 23% of PepsiCo's APAC segment revenue came from beverages. Given that PepsiCo's APAC revenue was $10 million in 2024, this translates to $2.3 million from beverages. In comparison, Mondelēz reported total beverage revenue of $1,096 million in 2024, which is significantly higher than PepsiCo's beverage revenue in the APAC region.",
      "llm_answer": "\nPepsiCo’s 2024 APAC segment recorded $10 million in total revenue, and the breakdown in the 2024 filing shows that beverages accounted for 23 % of that segment (≈ $2.3 million) (Chunk 2). By comparison, Mondelēz’s 2024 consolidated beverage net revenue was $1,096 million (Chunk 3), meaning Mondelēz’s total beverage revenue is roughly 475‑times larger than the beverage portion of PepsiCo’s APAC business.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: PepsiCo's APAC revenue is correctly stated as $10 million, with 23% from beverages, equating to $2.3 million (23% of $10M = $2.3M). Mondelēz's total beverage revenue is accurately reported as $1,096 million. The comparison, while adding a ratio (475-times larger), is mathematically sound (1,096 / 2.3 ≈ 476.5), so 'roughly 475-times' is a reasonable approximation. (2) The answer is complete, addressing both parts of the question: the percentage of PepsiCo's APAC revenue from beverages and the comparison to Mondelēz's total beverage revenue. (3) Entities are correct: PepsiCo, Mondelēz, 2024, APAC segment, and the financial metrics (revenue, beverage revenue) are all properly identified. (4) The multi-hop reasoning is strong—information from different segments (PepsiCo's regional breakdown and Mondelēz's consolidated beverage revenue) is correctly synthesized. The added comparative ratio enhances clarity without distorting facts. (5) Semantic equivalence is maintained: though the LLM adds a quantitative comparison not in the original, it does not introduce error and improves insight. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> GPE -[Operates_In]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 352,
        "total_tokens": 1540
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How does the volume of Capital One's (COF) delinquent loans as of December 31, 2023, influence the availability of reperforming loans that MetLife (MET) can purchase for its residential mortgage loan portfolio?",
      "original_answer": "Capital One reported total delinquent loans of $623 million as of December 31, 2023, which contributes to the pool of potentially reperforming loans. MetLife purchases reperforming loans that have returned to performing status after being delinquent for at least 12 months. The availability of such loans is directly influenced by the volume and characteristics of initial delinquencies, like those disclosed by Capital One, as these form the source pool for future reperforming loan opportunities.",
      "llm_answer": "\nCapital One reported **$623 million** of total delinquent loans as of December 31 2023 (Chunk 1). Those delinquent assets must be modified and successfully re‑perform—meeting the “performing for at least 12 months post‑modification” criterion—before they can be classified as reperforming loans, the very type of residential‑mortgage assets that MetLife acquires for its RMBS and structured‑product portfolio (Chunks 2 & 3). Thus, the magnitude of Capital One’s delinquent‑loan pool directly affects the **availability of reperforming loans** for MetLife: a larger delinquent balance signals a future supply of reperforming loans but, in the short term, creates a shortage of already‑performing assets that MetLife can purchase for its residential‑mortgage loan portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key quantitative fact—Capital One's $623 million in delinquent loans as of December 31, 2023—which matches the ground truth exactly. The date and dollar amount are accurate, satisfying quantitative accuracy. (2) The explanation correctly links Capital One’s delinquent loans to the future pool of reperforming loans that MetLife can purchase. It accurately describes the multi-hop relationship: delinquent loans (from COF) can become reperforming after successful modification and 12 months of performance, which aligns with MetLife’s investment criteria. (3) The reasoning is sound and reflects the causal chain: higher delinquency volume today implies a larger potential supply of reperforming loans in the future, though not immediately available. The LLM adds a nuanced point—short-term shortage vs. long-term supply—that is logically consistent with the mechanism, even if not explicitly stated in the original answer. This enhances qualitative accuracy without introducing error. (4) All entities (Capital One/COF, MetLife/MET, delinquent loans, reperforming loans, residential mortgage portfolio) are correctly identified and contextually used. The answer fully addresses the question’s focus on how COF’s delinquency volume affects MET’s purchase opportunities. Only minor deduction in qualitative accuracy due to slight expansion beyond the original answer (shortage in short term), which, while reasonable, is not confirmed by the ground truth. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Causes_Shortage_Of]-> FIN_INST <-[Buys]- ORG",
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 440,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How does the exposure of UNP's pension plan to limited partnerships investing in real estate compare with UPS's unfunded commitments to similar structures, given both companies' reliance on NAV-based valuations for these illiquid assets?",
      "original_answer": "UNP's pension plan holds interests in limited partnerships that primarily invest in privately-held companies and reports these using NAV-based valuations, while UPS has unfunded commitments totaling approximately $3.3 billion to limited partnerships focused on private equity, private debt, and real estate funds. Both companies rely on NAV as a practical expedient for valuing these illiquid investments, with UPS specifically noting the limited redemption provisions until the end of the partnership terms, typically 10 to 15 years from inception. This indicates that both firms face similar challenges in liquidity and valuation transparency for these alternative investments.",
      "llm_answer": "\nBoth Union Pacific (UNP) and United Parcel Service (UPS) value the illiquid real‑estate limited‑partnership interests in their pension plans at net‑asset‑value (NAV) – UNP calculates the fair value of each partnership‑level NAV, while UPS applies NAV as a practical expedient and reports a total NAV‑measured private‑equity/real‑estate portfolio of $9.9 billion, of which approximately $3.3 billion represents unfunded commitments to those same partnership structures that must be contributed over the next 3‑6 years.  Consequently, while UNP’s exposure is disclosed only as holdings whose values are derived from partnership NAVs, UPS quantifies a $3.3 billion future capital commitment to similar NAV‑based real‑estate partnerships, highlighting a material difference in the scale of disclosed unfunded exposure despite the identical valuation methodology.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers are correct: the $3.3 billion unfunded commitment by UPS is accurately reported, and the $9.9 billion NAV-measured portfolio (implied from context) is consistent with known disclosures, though not explicitly stated in the original answer—however, this additional detail does not contradict the ground truth and is plausibly derived from fuller filings. (2) The LLM correctly identifies that both UNP and UPS use NAV-based valuations for illiquid limited partnership investments in real estate and private assets, with UPS relying on NAV as a practical expedient. (3) The multi-hop reasoning is sound: it contrasts UNP’s disclosed holdings valued at NAV with UPS’s quantified future capital commitments, highlighting a difference in transparency and scale of exposure. (4) The original answer emphasizes similar valuation challenges and liquidity constraints; the LLM adds nuance by specifying the time horizon for UPS’s contributions (3–6 years), which is a reasonable inference from typical fund drawdown schedules and enhances the response without introducing error. The only minor gap is that the LLM does not explicitly mention the 10–15 year partnership terms noted in the original, but it captures the essence of limited liquidity. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Discloses]-> FIN_INST <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 394,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How does AMD's reliance on third-party manufacturers for 7 nm and smaller node production impact its exposure to quality control risks compared to Cisco's approach of maintaining quality control through automated testing and ISO 9001-certified processes?",
      "original_answer": "AMD's reliance on third-party manufacturers like TSMC for 7 nm and smaller node production exposes it to risks related to manufacturing yields, delivery schedules, and quality assurance, as these manufacturers are responsible for implementing leading-edge process technologies and maintaining acceptable yields. In contrast, Cisco maintains quality control internally through automated testing equipment, burn-in procedures, and ISO 9001-certified manufacturing processes, which are designed to ensure product reliability and reduce variability. This difference suggests that AMD has less direct control over quality assurance in its supply chain compared to Cisco, which integrates quality control directly into its manufacturing procedures.",
      "llm_answer": "\nAMD’s dependence on external foundries such as TSMC for 7 nm and smaller nodes places the **quality‑control** function in the hands of third‑party manufacturers, creating a **negative impact** on that capability and exposing AMD to yield‑related shortages, supply‑constraint risks, and potential cost‑margin erosion — as highlighted by its need to meet strict wafer‑purchase targets, limited control over process yields, and the possibility of delayed or insufficient deliveries [Chunks 1 & 2].  \nIn contrast, Cisco builds quality into its own supply chain through **automated testing, burn‑in procedures, and ISO 9001‑certified processes**, giving it direct oversight of quality assurance and far less exposure to the third‑party yield and capacity uncertainties that affect AMD [Chunk 3].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: AMD relies on third-party manufacturers like TSMC for 7 nm and smaller nodes, which exposes it to yield, supply, and quality control risks; Cisco maintains internal quality control via automated testing, burn-in procedures, and ISO 9001 certification. These points align with the original answer. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across AMD’s external manufacturing model and Cisco’s internal quality processes, drawing a valid contrast in quality control exposure. (4) The LLM slightly emphasizes 'cost-margin erosion' and 'wafer-purchase targets,' which are not explicitly mentioned in the ground truth, but these are reasonable inferences from AMD's reliance on foundries and do not distort the meaning. Wording differs but semantic equivalence is preserved. Minor deduction in qualitative accuracy due to slight addition of inferred details, but overall correctness remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Negatively_Impacts]-> CONCEPT <-[Maintains]- ORG",
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 337,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How does Comcast's lack of voting rights in Atairos compare to Alphabet's structure of Class C Capital Stock, which also carries no voting rights, particularly in terms of how each company manages governance influence versus financial exposure?",
      "original_answer": "Comcast does not have voting rights or the power to direct the activities of Atairos, which is classified as a VIE, and therefore does not consolidate it, limiting its governance influence while still being exposed to financial risk up to its investment balance and remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. In contrast, Alphabet issues Class C Capital Stock, which carries no voting rights except as required by law, but the company actively manages these shares through large-scale repurchases—$62.0 billion in 2024—allowing it to maintain governance control through Class A and B shares while offering different voting structures to investors. Both entities separate voting rights from certain stakeholders, but Alphabet retains control through its dual-class share structure, whereas Comcast has no such governance influence over Atairos despite significant financial exposure.",
      "llm_answer": "\nComcast’s investment in Atairos is a VIE for which it holds no voting rights, so it exercises essentially no governance influence and accounts for the stake as an equity‑method investment whose maximum financial exposure is confined to its $5.1 bn investment balance and the $1.4 bn of remaining unfunded capital commitment (Chunk 1).  In contrast, Alphabet’s Class C capital stock also carries no voting rights, but governance is provided by the voting Class A and Class B shares, while Class C holders face substantial financial exposure reflected in the company’s $62 bn of Class A/C share repurchases in 2024 and the $44.7 bn repurchase capacity still available (Chunks 2‑3); the KG relationship CMCSA‑Voting Rights‑Class C Capital Stock‑GOOGL links both firms’ use of a non‑voting Class C instrument.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core structural comparison between Comcast's lack of voting rights in Atairos (a VIE) and Alphabet's use of non-voting Class C stock. It accurately notes Comcast's financial exposure via its equity-method accounting, investment balance, and unfunded commitment. It also correctly highlights Alphabet's governance control through Class A/B shares and its use of share repurchases to manage capital structure. However, there is a critical error in the investment balance amount: the LLM states $5.1 billion, while the ground truth does not specify Comcast's investment balance at all—only the $1.4 billion unfunded commitment is mentioned. This introduces a potentially misleading figure not present in the original. Additionally, the LLM references a 'KG relationship CMCSA-Voting Rights-Class C Capital Stock-GOOGL' which appears to be an internal knowledge graph artifact and is not relevant to the answer, reducing clarity. (2) Quantitative accuracy: The $1.4 billion unfunded commitment is correct. The $62 billion in Alphabet share repurchases in 2024 matches the ground truth. However, the $5.1 billion investment balance for Comcast is not in the original answer and cannot be verified, making it an unsupported addition. The $44.7 billion repurchase capacity is not mentioned in the ground truth and appears to be extraneous. (3) Multi-hop reasoning is strong: the model correctly synthesizes governance vs. financial exposure across two different companies and structures (VIE vs. dual-class shares), drawing a valid contrast in how control is maintained (or not). It links the absence of voting rights in both cases but correctly distinguishes the implications. (4) Scores justified: correctness is 8 due to accurate core reasoning but flawed numerical additions; quantitative accuracy is 7 due to one unsupported number and an extra unverified figure; qualitative accuracy is 9 due to strong logic and entity recognition; contextual relevance is 10 as the answer directly addresses the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Repurchases]- ORG",
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 556,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How does Coca-Cola HBC's distribution footprint in Austria compare with Philip Morris's market presence in the same country, based on their respective operational disclosures?",
      "original_answer": "Coca-Cola HBC, as a key bottler for The Coca-Cola Company, operates in Austria and contributes to 41% of Coca-Cola’s total worldwide unit case volume through its five largest bottlers. Meanwhile, Philip Morris reports a market share of at least 15% in Austria, as part of its presence across approximately 100 markets globally. Both companies maintain a direct or dedicated distribution presence in Austria, with Coca-Cola HBC managing bottling and distribution of beverages, and Philip Morris leveraging its exclusive zonified and direct distribution strategies to maintain its competitive market position.",
      "llm_answer": "\nCoca‑Cola HBC AG lists Austria explicitly among the countries of its bottling and distribution operations (Chunk 1 & 2), indicating a direct, country‑wide bottling footprint. Philip Morris reports that it holds at least a 15 % share of the Austrian tobacco market—spanning cigarettes and heated‑tobacco products—and describes using direct sales, independent distributors, exclusive zones and e‑commerce to reach retailers there (Chunk 3), reflecting a broader market presence that is not limited to bottling. Both companies therefore operate in Austria, but Coca‑Cola HBC does so through a dedicated bottling network, whereas Philip Morris competes across the Austrian tobacco market using a mix of distribution models.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Philip Morris's 15% market share in Austria is accurately reported, and there are no calculations required beyond this. The absence of a specific numerical figure for Coca-Cola HBC’s volume in Austria is consistent with the original answer, which only notes its contribution to 41% of Coca-Cola’s global volume through its five largest bottlers—this contextual detail is not included in the LLM answer but does not distort the truth. (2) The LLM correctly identifies both companies' operational presence in Austria: Coca-Cola HBC via a dedicated bottling and distribution network, and Philip Morris via direct sales, exclusive zones, and distributors. (3) The reasoning is sound and reflects multi-hop synthesis: it draws from operational disclosures to compare distribution models across two different industries (beverages vs. tobacco), correctly distinguishing between physical bottling infrastructure and market-level distribution strategies. (4) The LLM omits the broader context about Coca-Cola HBC being one of the five largest bottlers contributing to 41% of global volume, which is part of the original answer and adds strategic weight. However, since the question focuses on 'distribution footprint' and 'market presence' in Austria specifically, this omission is minor and doesn’t affect the core factual accuracy. Wording differs but semantic meaning is equivalent. All entities (Coca-Cola HBC, Philip Morris, Austria, distribution models) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 440,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How does the deterioration in BAC's commercial real estate credit quality, particularly in office properties, influence MET's use of the Bornhuetter-Ferguson Method and its annual updates to unpaid claims assumptions for Protection Life and Health products?",
      "original_answer": "BAC experienced a deterioration in commercial credit quality during 2023, especially in the commercial real estate office property type, due to stagnant office space demand and evolving employment models (BAC chunk). MET updates its unpaid claims assumptions annually to reflect emerging trends in claim experience, including macroeconomic conditions (MET chunk). MET uses the Bornhuetter-Ferguson Method to estimate unpaid claims for Protection Life and Health products, relying on historical claims data and expected loss ratios, which are sensitive to economic shifts (Hop2 chunk). Therefore, a worsening macroeconomic environment—such as declining commercial real estate values and increased defaults in office properties—could affect MET’s claims estimation by altering expected loss ratios, particularly for long-duration Protection Health claims or experience-rated contracts where adverse claim experience is passed to sponsors (MET chunk). This creates a multi-hop chain where BAC's credit quality trends serve as an early indicator of macroeconomic deterioration that MET must incorporate into its actuarial models.",
      "llm_answer": "\nThe 2023 BAC filing flags a clear deterioration in its commercial‑real‑estate book—particularly office properties—with stagnant demand and rising credit concerns that signal a new macro‑economic trend. That emerging trend is captured in the “Emerging_Trends” macro‑condition linked to BAC, and MET incorporates it as a key driver in the factors used by the Bornhuetter‑Ferguson IBNR method; as a result, MET updates the unpaid‑claims assumptions for its Protection Life and Protection Health products each year to reflect the altered claim‑experience outlook arising from the weakened office‑CRE environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core multi-hop reasoning required. (1) It correctly identifies the 2023 deterioration in BAC's commercial real estate credit quality, particularly in office properties, due to stagnant demand—matching the ground truth. There are no explicit numbers (e.g., dollar amounts, percentages), so quantitative accuracy hinges on correct temporal and conceptual references, which are accurate. (2) The answer correctly links BAC's credit trends to macroeconomic conditions and explains that MET uses the Bornhuetter-Ferguson method (specifically noting IBNR—incurred but not reported claims, which aligns with unpaid claims estimation). It also correctly states that MET updates its unpaid claims assumptions annually to reflect emerging trends, including macroeconomic shifts. (3) The multi-hop reasoning is sound: BAC's credit deterioration → macroeconomic indicator → incorporated by MET into actuarial models via Bornhuetter-Ferguson → impacts assumptions for Protection Life and Health products. The only minor omission is the lack of specificity around *how* the loss ratios are affected (e.g., long-duration or experience-rated contracts where adverse claims are passed to sponsors), which is mentioned in the ground truth and adds nuance. (4) Despite this, the LLM conveys semantically equivalent information with correct entities (BAC, MET), correct time frame (2023), correct method (Bornhuetter-Ferguson), and correct product lines (Protection Life and Health). Wording differs but meaning is preserved. Hence, high scores across all dimensions with a slight deduction in qualitative accuracy for missing a subtle but relevant detail about contract types and loss ratio sensitivity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacts]-> MACRO_CONDITION -[Reflects]-> ACCOUNTING_POLICY <-[Updates]- ORG",
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 470,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How does the voting rights structure of Netflix's common stock compare to Meta's, considering the influence of Class A Common Stock in both companies' governance frameworks?",
      "original_answer": "Netflix's common stockholders are entitled to one vote per share, creating a uniform voting rights structure. In contrast, Meta's Class A Common Stock also provides one vote per share, but Meta has a multi-tiered stock structure that includes Class B Common Stock with 10 votes per share, giving certain shareholders disproportionate voting power. This difference means that while both companies grant one vote per share for Class A Common Stock, Meta's governance framework allows for greater concentration of control through its Class B shares.",
      "llm_answer": "\nNetflix’s common stock is a single class in which each share carries one vote, so voting power is directly proportional to share ownership. Meta, by contrast, issues three classes of common stock—Class A with one vote per share, Class B with ten votes per share, and Class C with no voting rights—so its governance is shaped not only by the roughly 2.19 billion Class A shares outstanding (as noted in Meta’s 10‑K) but also by the disproportionate influence of the super‑voting Class B shares and the non‑voting Class C shares. The knowledge‑graph triplets that link **Class A Common Stock → META** highlight that this instrument is a central element of Meta’s governance framework, whereas Netflix’s voting rights are disclosed simply as a one‑vote‑per‑share policy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly states that Netflix has a single class of common stock with one vote per share, while Meta has multiple classes: Class A (1 vote), Class B (10 votes), and Class C (no votes). The mention of 'three classes' is accurate and adds detail beyond the original answer, which only explicitly references Class A and Class B—this additional information is correct and enhances completeness. The reference to 2.19 billion Class A shares outstanding is consistent with Meta’s 10-K filings and is correctly contextualized, though this specific number was not in the ground truth; however, it does not contradict it and reflects valid external knowledge. All quantitative data is accurate, and the reasoning correctly synthesizes the governance implications of multi-class structures. The only minor shortcoming is a slight overemphasis on Class C shares, which, while factually present, are less central to the voting rights comparison asked in the question. Nonetheless, the core multi-hop comparison between Netflix’s uniform voting and Meta’s dual-class (with super-voting) structure is sound and well-reasoned. Semantic equivalence is high, and the answer fully addresses the question’s focus on Class A and overall governance influence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 366,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How does the fair value treatment of exchange-traded commodity futures under Level 1 financial liabilities differ between PEP and MDLZ, given that both companies cash-settle these instruments and include them in their respective liability portfolios?",
      "original_answer": "PEP explicitly states that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in the fair value hierarchy table as of December 25, 2021. In contrast, MDLZ includes exchange-traded commodity futures in its Level 1 financial liabilities, with fair value determined based on quoted market prices on commodity exchanges. Both companies treat these futures as part of their Level 1 liabilities, but PEP excludes them from reported tables due to daily cash settlement, whereas MDLZ continues to report them based on market pricing as of the balance sheet date.",
      "llm_answer": "\nBoth PepsiCo (PEP) and Mondelez (MDLZ) cash‑settle their exchange‑traded commodity futures daily and record them in their respective liability portfolios, but the fair‑value hierarchy treatment diverges: PEP classifies these futures as Level 1 instruments that are settled daily and, per its disclosure, are omitted from the fair‑value hierarchy table because of the daily cash‑settlement, whereas MDLZ explicitly lists exchange‑traded commodity futures as Level 1 financial liabilities and determines their fair value solely from quoted market prices on the exchange (with valuation based on observable market prices, no collateral or set‑off arrangements). This contrast reflects PEP’s exclusion of the daily‑settled contracts from the hierarchy table while MDLZ includes them as a distinct Level 1 line item.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: both PEP and MDLZ cash-settle exchange-traded commodity futures daily; PEP excludes these from its fair value hierarchy table due to daily settlement, while MDLZ includes them in Level 1 using quoted market prices. There are no incorrect numbers, dates, or entities—though the specific date (December 25, 2021) from the original answer is omitted, this does not affect factual correctness as the treatment is presented as current and consistent with the filing period. (2) Quantitative accuracy is perfect: no numerical values require verification beyond correct classification and methodology, both of which are accurately described. (3) Multi-hop reasoning is sound: the model correctly synthesizes differences in reporting practices between two companies regarding the same type of instrument, recognizing that both treat the futures as Level 1 but differ in disclosure due to settlement timing. (4) Semantic equivalence is strong—wording differs slightly but conveys the same core contrast: PEP omits daily-settled contracts from the hierarchy table, while MDLZ reports them. The only minor shortcoming is the lack of explicit mention of the balance sheet date context, which slightly reduces completeness but does not impair understanding. Hence, a score of 9 is warranted for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Cash-Settles]-> FIN_INST -[Includes]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 410,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How do the cost-sharing arrangements between Merck and Gilead for the development of HIV treatments combining islatravir and lenacapavir compare to Pfizer's cost-reduction initiatives, and what implications might this have on each company's financial exposure in long-acting HIV therapies?",
      "original_answer": "Merck and Gilead share global development and commercialization costs for HIV treatments combining islatravir and lenacapavir at a 60/40 split (Gilead/Merck), with equal revenue sharing until certain thresholds are met ($2.0 billion for oral and $3.5 billion for injectable combinations), after which Gilead's revenue share increases. In contrast, Pfizer's 2024 filing highlights enterprise-wide cost realignment and manufacturing optimization programs aimed at reducing costs and improving productivity. These initiatives carry risks such as potential disruption of ongoing business, including impacts on the delivery of their pipeline, which could include HIV-related R&D. While Merck and Gilead are jointly investing in a high-potential, long-acting HIV therapy with shared financial exposure, Pfizer is focusing on internal cost controls that may affect its ability to invest in or compete with such collaborative models. This contrast suggests differing strategic approaches to managing financial exposure in the evolving HIV treatment landscape.",
      "llm_answer": "\nMerck and Gilead will share global development costs for the lenacapavir + islatravir HIV program at a 60 % / 40 % split (Gilead / Merck) and will split product revenues with tiered thresholds (65 % of revenues above $2 bn for oral and $3.5 bn for injectable formulations), a structure that contrasts with Pfizer’s 2024 cost‑reduction programme, which relies on an enterprise‑wide cost‑realignment and manufacturing‑optimization effort that carries the risk of intangible‑asset impairments, goodwill or IPR&D write‑downs if pipeline milestones are not met.  As a result, Merck and Gilead’s financial exposure is tied to the success of a single collaborative asset and the achievement of revenue thresholds, whereas Pfizer’s exposure stems from the potential failure of its cost‑reduction and productivity initiatives to deliver the projected savings without compromising its pipeline or triggering significant asset impairments.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely correct but contains a minor inaccuracy in the revenue-sharing structure. The original answer states that Merck and Gilead have equal revenue sharing until thresholds ($2.0B for oral, $3.5B for injectable), after which Gilead's share increases. The LLM answer incorrectly specifies Gilead would receive 65% of revenues above those thresholds, which is not stated in the ground truth. This is a quantitative over-specification not supported by the original. All other numbers (60/40 cost split, $2B/$3.5B thresholds) are correct. (2) The cost-sharing percentages and revenue threshold amounts are accurately reported. The $2B and $3.5B figures match exactly. The 60/40 cost split is correctly attributed to Gilead/Merck. However, the 65% post-threshold revenue share is an unsupported addition. (3) The multi-hop reasoning is strong: the model correctly contrasts Merck/Gilead's collaborative, shared-exposure model with Pfizer's internal cost-reduction strategy. It accurately links Merck/Gilead's financial exposure to the success of a joint asset and Pfizer's to the risk of pipeline disruption and asset impairments. The synthesis across companies and strategies is sound. (4) The correctness score is 8 due to the minor but notable error in the revenue-sharing percentage, which affects quantitative precision. Qualitative accuracy is high due to strong reasoning and correct entity identification. Contextual relevance is perfect—the answer directly addresses all parts of the question with appropriate depth and focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP -[Introduces]-> PRODUCT <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1530,
        "completion_tokens": 430,
        "total_tokens": 1961
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does FDX's exposure to LIBOR-related hedging adjustments under ASU 2022-06 compare to UPS's use of hedging relationships, particularly in light of ASU 2022-06's extended sunset date through 2024?",
      "original_answer": "FDX has stated that reference rate reform, including ASU 2022-06, has had no material effect on its financial condition or results of operations as of May 31, 2024, though it continues to monitor contracts for potential application of the standard. ASU 2022-06 extends the sunset date for optional expedients and exceptions related to reference rate reform—including LIBOR transitions—to December 31, 2024. UPS, which designates derivative instruments in hedging relationships, including cash flow and fair value hedges, may benefit from the extended relief under ASU 2022-06 to manage LIBOR-related contracts through 2024 without significant accounting disruptions. Therefore, while FDX has not seen material impacts, UPS could be actively leveraging the extended ASU 2022-06 provisions in its hedging strategies.",
      "llm_answer": "\nFDX is subject to ASU 2022‑06, whose extended sunset to 31 Dec 2024 (as disclosed in its 10‑K and confirmed by the reference‑rate‑reform guidance in the MET filing) allows it to apply optional expedients to LIBOR‑referencing contracts and hedging relationships; as of May 31 2024 the company reports no material effect on its financial condition, results of operations, or cash flows from these adjustments and continues to monitor them.  \nUPS, by contrast, accounts for its derivative instruments under a general hedging framework—cash‑flow, fair‑value or net‑investment hedges—as described in its 10‑K, and while the same ASU 2022‑06 relief (which the MET note says reduces operational impacts of LIBOR replacements and extends the sunset through 2024) is available to it, UPS’s hedging activities are broader and not specifically tied to LIBOR.  \nThus, the extended 2024 sunset provides both firms flexibility, but FDX’s exposure is limited to monitoring LIBOR‑linked contracts with no material impact, whereas UPS’s hedging relationships are governed by its general derivative‑accounting policy and are not materially affected by the LIBOR transition.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts, dates, and entities. Quantitatively, all numbers and dates are accurate: the ASU 2022-06 sunset date of December 31, 2024, and FDX's reporting date of May 31, 2024, are correctly cited. The statement that FDX has had no material effect from ASU 2022-06 is consistent with the original answer. The description of UPS’s use of cash flow, fair value, and net investment hedges matches its hedging framework as disclosed. The LLM correctly notes that both companies benefit from the extended relief through 2024. However, there is a subtle but important difference in reasoning: the original answer emphasizes that UPS could be actively leveraging the extended ASU 2022-06 provisions for LIBOR-related contracts, implying potential active use, while the LLM downplays UPS's LIBOR-specific exposure by stating its hedging is 'not specifically tied to LIBOR' and 'not materially affected by the LIBOR transition.' This understates the possibility that UPS may still be using the relief for existing LIBOR-linked hedges, which the original answer suggests is a strategic benefit. Thus, while the LLM does not make a factual error per se, it slightly mischaracterizes the comparative implication—FDX is monitoring with no impact, while UPS may be actively benefiting—leading to a minor deduction in qualitative accuracy. The multi-hop synthesis across FDX and UPS is sound, and the contextual relevance is strong, fully addressing the comparative aspect of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Designates]- ORG",
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 425,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does the dual-class stock structure's impact on investor protections at META compare to the voting power differential in GOOGL's Class B common stock, especially given that Class B shares automatically convert to Class A upon sale or transfer?",
      "original_answer": "META's dual-class structure allows its controlling stockholder to maintain decision-making power even if they own significantly less than a majority of shares, which could make Class A common stock less attractive to investors due to reduced governance protections. In contrast, GOOGL's Class B common stock provides 10 votes per share compared to 1 vote per share for Class A, but these Class B shares automatically convert to Class A upon sale or transfer, potentially limiting long-term control by insiders. This conversion mechanism in GOOGL may offer more eventual governance balance compared to META's structure, where Class B shares can maintain control for extended periods unless their voting power drops below 35% of the combined voting power.",
      "llm_answer": "\nMETA’s dual‑class charter labels it a “controlled company,” so its Class A shares are exposed to anti‑takeover clauses, board‑independence waivers and provisions that kick in when Class B voting power falls below 35 % of the combined vote – features that can depress the Class A price and leave other stockholders with fewer protections than those of a fully‑governed firm.  By contrast, Alphabet’s Class B shares carry a 10‑vote‑per‑share advantage but **automatically convert to Class A upon any sale or transfer**, thereby eroding that voting‑power edge at the moment of transfer; this conversion, together with Alphabet’s large share‑repurchase program (e.g., $50‑$62 billion of repurchases in recent years), limits the lasting voting‑power differential, whereas META’s statutory and charter rules create more direct, structural investor‑protection gaps.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: META's dual-class structure creates a controlled company with reduced governance protections for Class A shareholders, and its Class B shares maintain control unless voting power drops below 35%. GOOGL's Class B shares have 10 votes per share but convert to Class A upon sale or transfer, limiting long-term insider control. (2) Quantitative accuracy is perfect: the 35% threshold and 10:1 voting ratio are correctly stated; the $50–62 billion repurchase range, while not in the original answer, is plausible and contextually appropriate (based on public filings), and does not contradict the ground truth. (3) Multi-hop reasoning is sound: the model correctly contrasts structural durability of control at META versus the self-eroding nature of GOOGL’s differential due to conversion on transfer. It adds value by noting repurchases accelerate dilution of insider voting power, which is a reasonable extension. (4) The only minor gap is that the original emphasizes GOOGL’s structure may offer 'more eventual governance balance'—a normative point slightly underdeveloped in the LLM answer, though implied. Wording differs but semantic equivalence is strong. No factual errors; minor deduction for slight over-elaboration on repurchases not in ground truth, but not inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> FIN_INST -[Convertible_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 381,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does KO's use of option contracts to hedge forecasted transactions compare to MDLZ's disclosure of gains and losses on forecasted transactions in terms of financial impact and hedging strategy?",
      "original_answer": "KO utilizes option contracts as part of its broader hedging strategy to mitigate foreign currency exchange rate risk, commodity price risk, and interest rate risk, with the goal of reducing earnings volatility from market fluctuations. These contracts are designated as cash flow hedges, and the unrealized gains or losses are deferred in AOCI until the forecasted transactions occur. In contrast, MDLZ disclosed that in 2024, it recognized $106 million in gains on forecasted transactions through cost of sales, and $17 million through interest and other expense, net, indicating the financial impact of these hedging activities on specific income statement line items. While KO emphasizes a structured hedging approach with clear accounting treatment for deferred gains/losses, MDLZ provides more granular disclosure on the realized financial outcomes of its hedging activities on forecasted transactions.",
      "llm_answer": "\nKO employs option contracts to hedge forecasted transactions and, under cash‑flow hedge accounting, records any hedge gain or loss in AOCI and reclassifies it to earnings only when the underlying transaction settles, but it does not disclose the size of that impact. MDLZ, however, explicitly quantifies the effect of its hedges—showing $1.949 billion of gains/losses recognized in earnings for 2024, $99 million of deferred gains in AOCI expected to be realized within the next year, and a breakdown of those amounts across cost of sales, interest expense and SG&A—while also revealing $9.9 billion of net foreign‑exchange hedge notional exposure. Both companies use the same hedge‑accounting model that offsets hedge results against the related forecasted cash flow, but MDLZ’s filing provides concrete financial figures whereas KO’s filing only describes the strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in quantitative details, which severely undermines its correctness. The ground truth states that MDLZ recognized $106 million in gains through cost of sales and $17 million through interest and other expense, totaling $123 million in realized gains, not $1.949 billion as claimed by the LLM. Additionally, the LLM's mention of '$99 million of deferred gains in AOCI' and '$9.9 billion of net foreign-exchange hedge notional exposure' has no support in the original answer and introduces fabricated data. These numbers are not only incorrect but orders of magnitude off, indicating a failure in factual recall or synthesis. The qualitative reasoning is partially sound: both companies use cash flow hedges with AOCI treatment, and MDLZ provides more granular disclosure of realized impacts while KO focuses on strategy without quantifying impact. This comparative insight aligns with the original answer and shows correct multi-hop reasoning across entities. However, the inclusion of completely inaccurate figures—especially the erroneous $1.949 billion versus the correct $123 million—renders the financial impact comparison invalid. Entity identification (KO, MDLZ, AOCI, cost of sales) and fiscal year (2024) are correct, and the conceptual framework of hedge accounting is accurately described. Contextually, the response addresses the comparison of hedging strategies and financial disclosures, making it relevant despite factual flaws. Due to major quantitative errors, the correctness score is low, even though the structure and intent of the comparison are reasonable.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> FIN_INST -[Impacts]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 444,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does the valuation approach for TMO's fixed income funds, which are reported as 'not subject to leveling', contrast with BMY's classification of fixed income funds under Level 2 in the fair value hierarchy, and what does this indicate about their respective reliance on observable market data for pension asset valuation?",
      "original_answer": "TMO reports its fixed income funds as 'not subject to leveling,' indicating that these assets are valued outside the standard fair value hierarchy and likely measured using methods other than quoted market prices or observable inputs. In contrast, BMY classifies its fixed income funds under Level 2, which means their valuation relies on observable market data, such as quoted prices for similar instruments or in nonactive markets. This contrast suggests that BMY's pension assets have a more structured and market-based valuation methodology for fixed income funds, while TMO's approach implies less direct reliance on standardized market inputs for these assets.",
      "llm_answer": "\nTMO reports its domestic and non‑U.S. fixed‑income fund assets as “not subject to leveling” (Chunk 1), yet the knowledge‑graph links those funds to “Significant other observable inputs (Level 2)” (KG), indicating that their fair values are derived from observable market data even though they are presented outside the formal level hierarchy. By contrast, BMY explicitly classifies its fixed‑income funds as Level 2 and discloses that they are valued using quoted prices for similar instruments and the NAV of the funds (Chunks 2‑3), making clear its reliance on observable inputs. Thus, TMO’s approach conceals the use of Level 2 inputs behind an aggregate “not subject to leveling” label, whereas BMY openly quantifies and discloses its dependence on observable market data for pension‑asset valuation.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual contradiction that undermines its correctness. While the ground truth states that TMO reports its fixed income funds as 'not subject to leveling,' implying they are valued outside the fair value hierarchy and likely with less reliance on observable market data, the LLM incorrectly asserts that these same funds are linked in the knowledge graph to Level 2 inputs ('Significant other observable inputs'). This directly contradicts the original answer, which emphasizes TMO's departure from standard hierarchy and reduced reliance on observable inputs. There are no numeric values in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. The LLM's reasoning is internally logical but based on a flawed premise (the KG link to Level 2), which is not supported by the ground truth. This leads to an incorrect conclusion that TMO conceals Level 2 inputs, whereas the original answer suggests TMO does not use standard market-based valuation at all for these assets. The contrast with BMY is accurately described: BMY’s explicit Level 2 classification and use of observable inputs like quoted prices and NAV are correctly noted. Contextually, the answer addresses the question’s structure and intent regarding valuation approaches and reliance on market data, hence high contextual relevance. However, due to the core misrepresentation of TMO’s methodology, the qualitative accuracy and overall correctness are significantly compromised.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Has_Stake_In]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 414,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How does the application of the Federal Acquisition Regulation (FAR) in cost-plus-fixed-fee contracts impact revenue recognition timing differences between LMT and BA for their respective U.S. Government contracts?",
      "original_answer": "LMT applies FAR to its U.S. Government contracts, which results in standalone selling prices being equal to the stated contract price, and revenue being recognized over time as control of work in process transfers continuously to the customer due to clauses allowing unilateral termination and payment for costs incurred plus profit. Similarly, BA notes that U.S. Government contracts can be terminated for convenience, entitling them to payment for completed work and allowable termination costs. This creates a comparable revenue recognition pattern for both companies under FAR-regulated cost-plus-fixed-fee contracts, where revenue is recognized progressively rather than at a point in time, but differences may arise based on contract-specific termination clauses and profit margin negotiations.",
      "llm_answer": "\nBoth LMT and BA’s U.S. Government contracts are subject to the Federal Acquisition Regulation, which mandates cost‑plus‑fixed‑fee pricing based on allowable costs plus a negotiated fee and subjects the companies to FAR‑governed cost‑allowability and audit rules (Chunk 2). Because the FAR treats the contract price as the transaction price, LMT recognizes revenue over time as a single performance obligation and adjusts revenue cumulatively when contract modifications are approved (Chunk 1), whereas BA’s revenue is realized only when the government terminates a contract for convenience—or when the contract nears completion—since payment is limited to costs incurred plus a reasonable profit in that event (Chunk 3).",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in its qualitative reasoning, particularly regarding BA's revenue recognition pattern. While both LMT and BA are correctly identified as being subject to the FAR and having cost-plus-fixed-fee contracts with the U.S. Government, the claim that BA only recognizes revenue when a contract is terminated for convenience or nears completion is incorrect. The original answer states that BA, like LMT, recognizes revenue progressively over time due to termination for convenience clauses entitling them to payment for completed work and allowable costs—indicating continuous revenue recognition, not delayed recognition. The LLM incorrectly creates a divergence in revenue recognition timing between LMT and BA, whereas the ground truth emphasizes a 'comparable revenue recognition pattern' for both. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable—no numbers to verify or miscalculate, hence a score of 10 by default. (3) The multi-hop reasoning is flawed: the model fails to synthesize the commonality in revenue recognition treatment under FAR due to similar termination and cost-reimbursement provisions. Instead, it incorrectly infers that BA defers revenue recognition until termination or completion, which contradicts the progressive recognition principle under ASC 606 for contracts where control transfers over time. This breaks the logical synthesis across entities (LMT vs BA) and misrepresents the impact of FAR. (4) Contextual relevance is moderate—the answer addresses the right topic (FAR, cost-plus contracts, revenue recognition) and references relevant concepts (termination for convenience, cost allowability), but the conclusion about differing timing is unsupported and incorrect, reducing overall correctness. The qualitative inaccuracy severely undermines the answer despite correct contextual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Regulates]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 526,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How does the structure of AbbVie's debt agreements with U.S. Bank National Association compare to Abbott Laboratories' use of Abbott Ireland Financing DAC as an issuer, particularly in terms of trustee roles and note issuance timelines?",
      "original_answer": "AbbVie has multiple Supplemental Indentures with U.S. Bank National Association serving as trustee, transfer agent, and registrar, with key agreements dated September 26, 2019 (Supplemental Indenture No. 6), November 21, 2019 (Supplemental Indenture No. 7), and May 14, 2020 (Supplemental Indenture No. 8 and 9). These agreements involve the issuance of various notes and are supported by Agency Agreements with Elavon Financial Services DAC. Similarly, Abbott Ireland Financing DAC, as issuer, has entered into Indentures with U.S. Bank National Association as trustee, including the September 27, 2018 Indenture and the November 19, 2019 Second Supplemental Indenture, under which specific notes such as the 1.500% Note due 2026 and the 0.100% Note due 2024 were issued. Both companies rely on U.S. Bank National Association in a trustee capacity, but AbbVie’s structure includes more frequent use of Elavon Financial Services DAC as a paying agent, while Abbott Ireland Financing DAC directly issues notes under its own entity name with Abbott Laboratories as guarantor.",
      "llm_answer": "\nBoth AbbVie and Abbott Laboratories use **U.S. Bank National Association as trustee** in their indenture structures, but the way the trustee role and note‑issuance schedules are organized differs.  \n\n- **AbbVie** – its debt is governed by a series of **Supplemental Indentures No. 6‑9** dated **September 2019, November 2019 and May 2020** (see Chunk 1). In each filing the bank acts as trustee (and also as transfer agent, registrar and paying agent), and the notes are issued in a **2019‑2020 timeline** tied to the dates of those supplemental indentures.  \n\n- **Abbott Laboratories** – the issuer **Abbott Ireland Financing DAC** entered into an **Indenture dated September 27 2018** with U.S. Bank as trustee, followed by a **First Supplemental Indenture on the same date** and a **Second Supplemental Indenture on November 19 2019** (see Chunk 2 & 3). The resulting note program includes issues with maturity dates ranging from **2024 to 2030**, with the actual note filings occurring in **2018, 2019 and 2020** (e.g., 0.100 % 2024, 1.500 % 2026, 1.150 % 2028, 1.400 % 2030).  \n\nThus, while both companies rely on U.S. Bank as trustee, AbbVie’s structure is defined by multiple later‑dated supplemental indentures that trigger note issuances in 2019‑2020, whereas Abbott’s structure centers on a single 2018 indenture with subsequent supplements and a longer‑dated series of notes extending to 2030.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key dates, entities, and note details are correct: AbbVie's Supplemental Indentures No. 6–9 are correctly dated (September 26, 2019; November 21, 2019; May 14, 2020), and Abbott Ireland Financing DAC's Indenture (September 27, 2018) and Second Supplemental Indenture (November 19, 2019) are accurately cited. Specific notes like the 0.100% Note due 2024 and 1.500% Note due 2026 are correctly mentioned. (2) Quantitative accuracy is perfect: all dates, percentages, and issuance timelines match the original. The LLM correctly notes that Abbott’s note maturities extend to 2030, which is consistent with the ground truth (though not explicitly listed in the original, it is implied by 'ranging from 2024 to 2030'). (3) Multi-hop reasoning is sound: the model correctly synthesizes that both companies use U.S. Bank National Association as trustee but differ in structure—AbbVie uses multiple supplemental indentures tied to 2019–2020 issuances, while Abbott Ireland Financing DAC operates under a 2018 master indenture with supplements. (4) The only minor omission is that the LLM does not mention Elavon Financial Services DAC’s role as a paying agent in AbbVie’s structure, which is a key differentiator in the original answer. This slightly reduces qualitative accuracy but does not undermine the core correctness. Overall, the answer is factually precise, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP -[Regulates]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1642,
        "completion_tokens": 406,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How does NVDA's dependency on foundries for advanced process node manufacturing at 7nm and smaller compare to AMD's reliance on larger wafers for competitive IC production, given both companies' exposure to TSMC's fabrication capabilities?",
      "original_answer": "NVDA depends on foundries like TSMC to manufacture its semiconductor wafers using advanced process node technologies such as 7nm and smaller, which are critical for producing high-performance GPUs and meeting customer demand. NVDA faces risks including supply shortages, yield issues, and delays if TSMC cannot scale production or implement new technologies effectively. Similarly, AMD relies on TSMC to produce wafers with competitive performance attributes, and specifically mentions the importance of transitioning to advanced manufacturing process technologies and increased wafer sizes to maintain cost efficiency and product competitiveness. Both companies are exposed to risks if TSMC fails to deliver sufficient quantities of 7nm or smaller wafers, which could increase per-unit costs, delay product launches, and harm customer relationships. This shared dependency on TSMC for leading-edge wafer production highlights a critical supply chain vulnerability affecting both NVDA and AMD.",
      "llm_answer": "\nNVDA’s business is built around advanced‑node wafer production at 7 nm and smaller, so it depends on foundries—chiefly TSMC—to deliver those cutting‑edge processes; any shortfall in TSMC’s capacity or yield directly limits NVDA’s product rollout and margins. AMD, while also relying on TSMC for 7 nm and smaller nodes, primarily competes with larger‑wafer IC production for its CPUs/APUs, meaning its exposure combines the same advanced‑node risk plus the need to secure sufficient larger‑wafer volumes; thus both firms face TSMC‑driven supply constraints, but NVDA’s exposure is more narrowly focused on the most aggressive nodes, whereas AMD’s risk spans both those nodes and the broader larger‑wafer ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) All entities—NVDA, AMD, TSMC, 7nm and smaller process nodes—are correctly identified, and there are no numerical inaccuracies (the question does not involve specific dollar amounts, percentages, or dates, so quantitative accuracy is fully satisfied). (2) The LLM correctly captures that both NVDA and AMD rely on TSMC for advanced nodes like 7nm and smaller, which is central to the question. It accurately reflects the shared supply chain risk. (3) The reasoning is sound: the LLM distinguishes NVDA’s narrow focus on the most advanced nodes for GPUs from AMD’s broader reliance that includes larger wafers for CPUs/APUs, which matches AMD’s strategy of leveraging both advanced nodes and larger wafer utilization for cost and performance. This nuance is not explicitly detailed in the original answer but is consistent with known industry dynamics and adds value without introducing error. (4) The answer is contextually relevant, directly addressing the comparative dependency on TSMC and the implications of process node and wafer size strategies. The only minor shortcoming is that the original answer emphasizes risks like yield issues, cost increases, and product delays more explicitly, while the LLM touches on these indirectly via 'supply constraints' and 'margins.' However, the core multi-hop synthesis—comparing NVDA’s advanced-node dependency with AMD’s dual focus within a shared TSMC exposure—is logically sound and factually correct. Thus, the answer earns a 9/10 for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Produces]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 448,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "Given Philip Morris's ongoing regulatory challenges in Thailand stemming from the WTO panel decision on customs valuation of cigarette imports, and Colgate-Palmolive's manufacturing presence in Thailand, how might the unresolved customs and tax compliance issues in Thailand impact Colgate-Palmolive's operational costs or regulatory risk exposure in the country?",
      "original_answer": "The WTO panel decision found that Thailand lacked grounds to challenge the customs valuation of Philip Morris's cigarette imports and obligated Thailand to revise its customs and tax practices. However, Thailand has not fully complied, and the dispute remains unresolved due to the inoperability of the WTO Appellate Body. This regulatory inertia indicates a persistent risk of non-aligned customs enforcement in Thailand. Colgate-Palmolive operates manufacturing and warehousing facilities in Thailand, a country where customs and tax measures have proven resistant to international rulings. If Thailand continues to apply inconsistent or non-compliant customs valuation practices, Colgate-Palmolive may face increased scrutiny, higher import duties, or regulatory uncertainty affecting its cost structure and compliance burden in the country.",
      "llm_answer": "\nThe WTO panel found that Thailand’s customs‑valuation and tax rules for cigarette imports were unlawful, yet the Philippines says Thailand has not fully implemented the ruling and the dispute remains unresolved, leaving Thai customs authorities with lingering scrutiny and the possibility of retroactive duty or tax assessments. Because the same customs‑valuation framework applies to all imports, Colgate‑Palmolive—which operates manufacturing facilities in Thailand (as disclosed in its 10‑K property list)—could face higher duties, back‑tax liabilities or compliance costs if the government re‑evaluates the value of its imported inputs or products, and must allocate resources to monitor and adjust its customs and tax reporting, thereby increasing both its operational expenses and regulatory‑risk exposure in the country.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it incorrectly states that 'the Philippines says Thailand has not fully implemented the ruling,' which is not supported by the ground truth and introduces a non-relevant actor (Philippines) into the dispute. The original answer correctly identifies that the WTO panel ruled against Thailand and that non-compliance persists due to the inoperability of the Appellate Body, not due to claims by the Philippines. This undermines the reasoning chain and entity accuracy. (2) There are no numeric values, dates, or calculations in either answer, so quantitative accuracy is not applicable—scored as 10 by default since no numbers were misstated. (3) The multi-hop reasoning is partially sound: the LLM correctly infers that because Philip Morris faced a WTO ruling on customs valuation and Colgate-Palmolive operates in Thailand, the latter could be exposed to similar customs risks. It also correctly links Colgate-Palmolive’s manufacturing presence (from 10-K) to potential import scrutiny. However, the flawed attribution to the Philippines and the suggestion of 'retroactive duty or tax assessments' (not mentioned in ground truth) introduce unsupported speculation. (4) Contextual relevance is high—the answer addresses the core concern about how unresolved customs issues in Thailand might affect Colgate-Palmolive’s costs and regulatory risk. Despite the flawed reasoning, it draws a plausible connection between the regulatory environment and operational exposure. Correctness score is reduced to 6 due to significant qualitative inaccuracies in entity and reasoning, despite correct overall direction and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacted_By]-> REGULATORY_REQUIREMENT -[Faces]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 460,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How does the $265,000 decline in UNH's Medicare Part D enrollment from 2023 to 2024 relate to the IRA's redesign of Medicare Part D and Pfizer's projected $1 billion revenue loss in 2025 under the same program?",
      "original_answer": "The $265,000 decline in UnitedHealth's (UNH) Medicare Part D enrollment from 2023 to 2024 reflects a reduction in the number of beneficiaries in this program, which aligns with broader structural changes introduced by the Inflation Reduction Act (IRA). The IRA's redesign of Medicare Part D, effective in 2025, includes a $2,000 annual out-of-pocket cap for beneficiaries and a new Manufacturer Discount Program requiring 10% and 20% discounts in different coverage phases. These changes increase financial pressure on manufacturers like Pfizer (PFE), which projects a $1 billion revenue loss in 2025 due to IRA-related adjustments. The enrollment decline at UNH may indicate reduced attractiveness of Part D plans to beneficiaries or shifting market dynamics, which, when combined with the IRA's pricing pressures, could contribute to reduced revenue for manufacturers like Pfizer.",
      "llm_answer": "\nThe UnitedHealthcare Medicare Part D enrollment fell by **$265 K (≈265 thousand members)** from 2023 to 2024 (Chunk 1), a decline that directly reflects the impact of the **IRA‑mandated redesign of Part D**—including out‑of‑pocket caps, reduced reinsurance and the new manufacturer discount requirements that took effect in 2024 (Chunk 2).  Those same redesign provisions, especially the 10 %/20 % manufacturer discount schedule, are projected by Pfizer to generate a **net unfavorable revenue impact of roughly $1 billion in 2025** (Chunk 3), meaning the enrollment drop in UnitedHealth’s Part D portfolio is an early indicator of the utilization‑and‑pricing pressures that will drive Pfizer’s billion‑dollar revenue loss.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the core relationship between UNH's enrollment decline, the IRA's redesign of Medicare Part D, and Pfizer's projected $1B revenue loss. However, there is a critical error in interpreting the $265,000 figure: the original answer and context clearly refer to a decline of 265,000 members (i.e., 265 thousand people), not $265,000 in monetary terms. The LLM incorrectly treats this as a financial amount (e.g., '$265K') rather than a membership count, which is a significant factual misrepresentation. This undermines quantitative accuracy. 2) The $1 billion revenue loss by Pfizer in 2025 is correctly cited and contextually placed. The IRA provisions—$2,000 out-of-pocket cap, manufacturer discounts (10%/20%)—are accurately described, though the LLM states they 'took effect in 2024', while the original specifies they are effective in 2025. This timing error affects precision. 3) The multi-hop reasoning is strong: the model connects UNH enrollment trends to structural changes under the IRA and links those same changes to financial impacts on drug manufacturers like Pfizer. The logic that declining enrollment may signal broader market shifts contributing to revenue pressure is sound and aligns with the original answer’s inference. 4) Despite strong synthesis and contextual relevance, the misinterpretation of the $265,000 as dollars instead of members is a major quantitative error, especially since the question hinges on correctly understanding the nature of the enrollment decline. This would mislead a reader about the scale and type of impact. Wording variations are acceptable, but confusing units is not. Hence, correctness score is reduced to 7 due to this key error, with moderate impact on quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> REGULATORY_REQUIREMENT -[Modifies]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 478,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does Lockheed Martin's $4,863 million investment in private equity funds, which are valued using the NAV practical expedient, compare to FedEx's application of the same accounting policy for equity securities without readily determinable fair values?",
      "original_answer": "Lockheed Martin reports $4,863 million in private equity fund investments valued under the NAV practical expedient, which relies on unobservable inputs in valuation models of underlying securities and typically has terms between 8 and 12 years. FedEx also applies the NAV practical expedient to equity securities without readily determinable fair values, though it notes that for these investments, adjustments to cost are made only for observable price changes and impairments. While Lockheed Martin’s NAV-based private equity investments are part of a broader portfolio including real estate and hedge funds, FedEx specifically highlights immaterial annual and cumulative impairment adjustments under the measurement alternative for such equity securities.",
      "llm_answer": "\nLockheed Martin reports a $4,863 million investment in private‑equity funds that is recorded at fair value using the NAV practical expedient (Chunk 1), while FedEx applies the identical NAV practical expedient to equity securities that lack readily determinable fair values, measuring them at cost and adjusting for observable price changes and immaterial impairments (Chunk 3). Both companies comply with the same accounting policy—valuation by the NAV practical expedient—but Lockheed Martin’s disclosed figure represents a specific private‑equity fund portfolio, whereas FedEx’s policy governs a broader class of equity securities without a comparable aggregate dollar amount disclosed in its filing (Chunk 2).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $4,863 million figure for Lockheed Martin is correctly reported, and no numerical inaccuracies are present. The format '$4,863 million' matches the original. (2) The answer correctly identifies that both Lockheed Martin and FedEx apply the NAV practical expedient for equity securities without readily determinable fair values. It accurately notes that FedEx adjusts for observable price changes and impairments, and that these adjustments are immaterial—consistent with the ground truth stating FedEx highlights immaterial annual and cumulative impairments. (3) The reasoning is sound: it synthesizes information across both companies, correctly contrasting Lockheed Martin’s specific private equity fund disclosure with FedEx’s broader policy application without a disclosed aggregate dollar amount. (4) The only minor shortcoming is that the LLM answer does not explicitly mention Lockheed Martin’s private equity funds having typical terms of 8–12 years or being part of a portfolio including real estate and hedge funds—details present in the original. However, this omission does not undermine the core accuracy or comparison. The answer remains semantically equivalent in intent and key facts, with excellent contextual relevance and correct multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 378,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does the voting power dilution mechanism in CMCSA's Class B to Class A common stock conversion compare with GOOGL's dual-class structure, particularly in light of GOOGL's $62.0 billion share repurchase in 2024 targeting Class A and Class C shares?",
      "original_answer": "GOOGL's 2024 share repurchase of $62.0 billion focused on Class A and Class C shares, which could indirectly impact ownership concentration by reducing the number of shares outstanding, while maintaining the dual-class voting structure where Class B shares retain 10 votes per share. In contrast, CMCSA's Class B common stock is convertible share-for-share into Class A common stock and holds 33⅓% of the total voting power, which is non-dilutable under their articles of incorporation. This means CMCSA's Class B stock maintains a fixed voting influence regardless of conversions or new issuances, whereas GOOGL's repurchase strategy may influence the economic value of shares without altering the 10:1 voting rights disparity between Class B and Class A shares.",
      "llm_answer": "\nComcast’s Class B shares carry 15 votes per share and are convertible share‑for‑share into Class A, with the 33 ⅓ % voting block of Class B explicitly protected from dilution by any further issuances; Alphabet’s Class B shares carry 10 votes per share and also convert to Class A, but because the conversion reduces the number of high‑voting shares and Alphabet’s $62 billion 2024 repurchase of Class A (and Class C) shares shrinks the Class A denominator, the relative voting power of any remaining Class B shares is effectively preserved—or even enhanced—relative to the post‑repurchase share count.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. Most critically, it incorrectly states that Comcast’s (CMCSA) Class B shares carry '15 votes per share'—the ground truth is that CMCSA Class B holds 33⅓% of total voting power, not 15 votes per share. This is a major error in both quantitative and qualitative terms. Additionally, the answer implies that GOOGL's Class B shares 'convert to Class A', which is misleading—GOOGL’s Class B shares are not publicly traded and are held by insiders; they do not convert in the same way as CMCSA’s. (2) The $62 billion repurchase amount and the year 2024 are correctly stated, which is a point in favor of quantitative accuracy. However, the core voting structure details are wrong. The 33⅓% non-dilutable voting power for CMCSA is mentioned in spirit but misrepresented through the incorrect '15 votes per share' framing. (3) The reasoning about GOOGL’s repurchase shrinking the Class A denominator and thereby preserving or enhancing Class B’s relative voting power is logically sound and reflects correct multi-hop synthesis—this part of the reasoning aligns with the ground truth. However, the flawed premise about CMCSA’s voting mechanism undermines the comparison. (4) Contextual relevance is high because the answer attempts the correct comparison and incorporates repurchases, voting rights, and conversion mechanics. However, due to fundamental errors in entity-specific facts—especially the misrepresentation of CMCSA’s voting structure—the correctness score is low. The answer gets the general direction of GOOGL’s mechanism right but fails on key details for CMCSA, resulting in a partially correct but misleading response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Convertible_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 463,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does the revenue exposure of CVS through its 50% ownership in Red Oak Sourcing, LLC—which negotiates generic pharmaceutical supply contracts with Cardinal Health, Inc., compare to LLY's reliance on Cardinal Health as a top-three distributor accounting for 15–20% of its consolidated revenue?",
      "original_answer": "CVS has a 50% ownership stake in Red Oak Sourcing, LLC, which serves as a joint venture with Cardinal Health, Inc. to negotiate generic pharmaceutical supply contracts for both companies, though Red Oak does not hold inventory. Meanwhile, LLY relies on Cardinal Health, Inc. as one of only three U.S. wholesale distributors each accounting for 15–20% of LLY’s consolidated revenue, alongside McKesson and AmerisourceBergen. This means Cardinal plays a dual role—both as a strategic sourcing partner to CVS via Red Oak and as a critical distribution channel for LLY’s pharmaceutical products in the U.S. market.",
      "llm_answer": "\nCVS’s revenue exposure to Cardinal Health is indirect: the company holds a 50 % stake in Red Oak Sourcing, LLC, which – as stated in Chunks 1 and 2 – negotiates generic‑drug supply contracts with Cardinal on behalf of both owners but does **not** retain inventory or recognize revenue from those contracts, so CVS’s financial impact is limited to its equity interest and any profit share from Red Oak. In contrast, Chunk 3 shows that LLY explicitly reports Cardinal Health as one of its top‑three U.S. distributors, accounting for roughly **15 %–20 % of LLY’s consolidated revenue**, highlighting a far more direct and substantial reliance on Cardinal.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: CVS has a 50% stake in Red Oak Sourcing, LLC, which negotiates generic drug contracts with Cardinal Health but does not hold inventory or generate direct revenue—this limits CVS's financial exposure to its equity interest. LLY relies on Cardinal Health as one of its top three U.S. distributors, accounting for 15–20% of its consolidated revenue, which matches the original answer exactly. (2) Quantitatively, the percentages (50%, 15–20%) are correctly reported, and no calculations are required beyond accurate interpretation. Format variations (e.g., '15 %–20 %' vs '15–20%') do not affect meaning. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across entities (CVS, Red Oak, Cardinal, LLY) and distinguishes between indirect ownership/sourcing (CVS) versus direct revenue dependency (LLY). It accurately contrasts the nature of CVS’s limited exposure via a joint venture with LLY’s significant revenue reliance. (4) The only minor shortcoming is that the LLM omits mention of McKesson and AmerisourceBergen by name, which are included in the original answer to clarify the full set of top-three distributors. While not critical to the core comparison, this detail adds context to LLY’s distribution reliance. Otherwise, the answer is semantically equivalent, factually precise, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Depends_On]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 399,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "What is the difference in voting rights per share between Class B common stock disclosed by UPS and the common stock voting rights at Honeywell as of 2024?",
      "original_answer": "UPS's Class B common stock has 10 votes per share, while Honeywell's common stock has 1 vote per share, resulting in a 9-vote difference per share in favor of UPS's Class B shares.",
      "llm_answer": "\nUPS reports Class B common stock (733 shares issued in 2024) whose voting rights are defined by the same accounting policy that Honeywell discloses – i.e., a Class B share carries **10 votes per share**.  By contrast, Honeywell’s common stock (as stated in its 2024 filing) entitles each holder to **only one vote per share**.  Hence the voting‑rights gap is **9 additional votes per share** for UPS’s Class B stock (10 – 1).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the voting rights per share are accurately reported: UPS Class B has 10 votes per share, Honeywell common stock has 1 vote per share, and the difference is correctly calculated as 9 votes per share (10 - 1 = 9). The mention of 733 shares issued is additional context not required by the question and does not affect accuracy. (2) The answer is complete, addressing both companies' voting rights and computing the correct difference. (3) Entities are accurate—UPS and Honeywell are correctly identified, and the years (2024) align with the question. (4) The reasoning is sound: the model correctly synthesizes voting rights information across two separate filings and performs the necessary comparison. (5) The semantic meaning is equivalent to the original answer, with clear, precise language conveying the same factual conclusion. All evaluation criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 282,
        "total_tokens": 1436
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "How does the maturity of AMGN's 3.625% 2024 Notes, which triggered the termination of $1.4 billion in associated interest rate swap contracts, compare with ABBV's use of interest rate swap contracts as cash flow hedges in 2024?",
      "original_answer": "AMGN's 3.625% 2024 Notes matured in 2024, which led to the termination of $1.4 billion in interest rate swap contracts that were hedging this fixed-rate debt. In contrast, ABBV did not have any active interest rate swap contracts designated as cash flow hedges in 2024, as the amount reported for that year was $0, compared to $6 million in 2022. This indicates a difference in hedging strategy between the two companies with respect to interest rate exposure on debt instruments.",
      "llm_answer": "\nThe 3.625 % 2024 Notes issued by AMGN carried a $1.4 billion notional amount that matured in 2024, prompting the termination of an equivalent $1.4 billion of interest‑rate swap contracts (the same amount that was outstanding in 2023 and linked to ABBV in the KG relationship); in contrast, ABBV’s interest‑rate swaps remain designated as cash‑flow hedges, but the 2024 SEC filing shows no pre‑tax gains or losses from those swaps (the table is blank for 2024), whereas ABBV had recorded a $6 million gain from such swaps in 2022, underscoring that the maturity‑driven termination of $1.4 billion of swaps was a unique event for AMGN while ABBV continued to hold its hedges without realizing 2024 hedge gains.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. It correctly states that AMGN's 3.625% 2024 Notes matured in 2024 and led to the termination of $1.4 billion in interest rate swaps, which aligns with the ground truth. However, it incorrectly claims that ABBV’s interest rate swaps 'remain designated as cash-flow hedges' in 2024, when the ground truth explicitly states that ABBV had $0 in active interest rate swap contracts designated as cash flow hedges in 2024. The LLM also misinterprets the absence of pre-tax gains/losses in a table as evidence that swaps were still active, when in fact the $0 balance indicates no active hedges. Additionally, the mention of a '$1.4 billion... linked to ABBV in the KG relationship' is factually incorrect and unsupported—the $1.4 billion swap termination was specific to AMGN, not ABBV. (2) Quantitatively, the $1.4 billion and $6 million figures are accurate and correctly attributed to the right years and companies, though the $6 million is a gain in 2022 but not contextualized as the last recorded activity before a drop to zero in 2024. The maturity year (2024) is correct. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize that ABBV had no active hedges in 2024, instead inferring continued activity due to lack of reported gains/losses, which contradicts the ground truth. The comparison between AMGN’s maturity-triggered termination and ABBV’s lack of hedges is therefore misrepresented. (4) The contextual relevance is moderate—the response addresses the right companies and time frame and attempts a comparative analysis, but the core qualitative conclusion is incorrect due to the misrepresentation of ABBV’s hedge status in 2024, significantly undermining the correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Impacts]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 484,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "How did the adoption of ASU 2022-02 impact Capital One's reporting of financial difficulty modifications compared to JPMorgan's prior TDR disclosures, particularly in terms of modification types and their financial effects?",
      "original_answer": "The adoption of ASU 2022-02 eliminated the TDR framework and introduced FDMs, changing how Capital One reports loan modifications. Capital One noted that the types of modifications offered—such as interest rate reductions, term extensions, and principal reductions—remained the same, but they are now categorized and reported differently under FDMs. For JPMorgan, prior to the change, TDRs included similar modifications but were assessed under concession criteria. After the adoption, JPMorgan reported $136 million in FDMs for 2023, primarily involving term extensions and interest rate reductions that extended loan lives by 20 years and reduced the weighted-average rate from 7.21% to 4.44%. This shift reflects a more standardized reporting approach under ASU 2022-02, removing the previous TDR distinctions while maintaining the same types of borrower support.",
      "llm_answer": "\nThe adoption of ASU 2022‑02 on January 1 2023 replaced Capital One’s TDR accounting with a “financial‑difficulty‑modification” (FDM) framework that retains the same short‑term or long‑term modification types (interest‑rate reductions, term extensions, principal forgiveness, etc.) but now accumulates and reports them on a rolling‑12‑month basis, making prior TDR disclosures non‑comparable. Unlike JPMorgan, which before the ASU required a concession assessment and reported $362 million of new TDRs in 2022, Capital One’s FDMs for 2023 totaled $136 million of residential‑real‑estate modifications whose weighted‑average loan life was extended by about 20 years and whose contractual interest rate fell from 7.21 % to 4.44 %, illustrating a distinct pattern of modification types and financial effects.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several correct elements but has significant factual inaccuracies that impact the overall correctness. (1) Quantitative Accuracy: The LLM incorrectly attributes the $136 million in FDMs to Capital One, while the ground truth states this figure is for JPMorgan (not Capital One). Additionally, the LLM claims JPMorgan reported $362 million in TDRs in 2022, which is not present in the original answer and appears fabricated. The interest rate drop from 7.21% to 4.44% and the 20-year extension are correctly cited but wrongly assigned to Capital One’s data instead of JPMorgan’s. (2) Completeness: The answer addresses modification types (interest rate reductions, term extensions, etc.) and the shift from TDRs to FDMs, which is correct and relevant. However, it misattributes key financial figures between the two banks, undermining the comparative analysis. (3) Entity Accuracy: The companies (Capital One, JPMorgan) and the standard (ASU 2022-02) are correctly identified, and the effective date (January 1, 2023) is accurate. However, the misassignment of financial data between the two institutions is a critical error. (4) Reasoning: The multi-hop reasoning is partially sound—understanding that ASU 2022-02 replaced TDRs with FDMs and that modification types remained similar—but the synthesis fails because it compares Capital One’s FDMs to JPMorgan’s prior TDRs using incorrect data. (5) Semantic Equivalence: While the structure and intent match the original, the factual misstatements—especially the dollar amounts and their attribution—prevent semantic equivalence. The conclusion about differing patterns is not supported by the ground truth, which emphasizes consistency in modification types and a standardized approach post-ASU. Overall, the answer shows good understanding of the conceptual shift but fails in accurate data representation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Replaces]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 506,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How does the alignment of interest rate swap maturities with debt exposure differ between GD's hedging strategy and UPS's economic hedge approach, and what does this reveal about their respective risk management priorities?",
      "original_answer": "GD's hedging strategy involves interest rate swap contracts with a dollar-weighted two-year average maturity that generally matches the duration of the activities at risk, indicating a focus on closely aligning hedge instruments with underlying exposure timelines. In contrast, UPS uses interest rate swaps as economic hedges for portions of its outstanding debt but does not specify a maturity alignment, instead emphasizing the use of offsetting positions to terminate existing swaps and eliminate market valuation effects. This reveals that GD prioritizes duration-matching to manage interest rate risk over time, while UPS focuses on dynamic risk mitigation through offsetting transactions, reflecting different approaches to managing financial exposure.",
      "llm_answer": "\nBoth General Dynamics (GD) and UPS use interest‑rate swaps to manage debt‑related risk, but they do so in opposite ways that reveal distinct risk‑management priorities.  \nGD structures its swaps so that the **dollar‑weighted two‑year average maturity of the contracts “generally matches the duration of the activities that are at risk,”** deliberately aligning swap maturities with the timing of the underlying exposure and deferring hedge gains/losses in AOCL—an approach that prioritizes precise cash‑flow matching and stability.  \nUPS, by contrast, holds swaps that are **not designated as formal hedges but are intended to provide an economic hedge of portions of its outstanding debt**, and it routinely **terminates and replaces them with offsetting positions to maintain that economic offset**, a practice that emphasizes flexibility and debt‑cost control rather than strict maturity alignment.  \n\nThus, GD’s risk‑management focus is on **exact duration matching to protect against cash‑flow volatility**, whereas UPS’s focus is on **using swaps as adaptable economic offsets to manage overall debt exposure**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: GD's use of interest rate swaps with a dollar-weighted two-year average maturity that matches the duration of the underlying risk is accurately stated, and UPS's use of economic hedges without formal hedge designation is correctly described. (2) There are no numerical inaccuracies—while no specific calculations are required, the reference to GD’s 'dollar-weighted two-year average maturity' is factually consistent with the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in hedging approaches (duration matching vs. offsetting positions) and infers the underlying risk management priorities (cash-flow stability vs. dynamic flexibility). (4) The LLM captures the core contrast in strategy and correctly interprets the implications for risk management, though it does not explicitly mention UPS eliminating 'market valuation effects'—a minor omission that slightly reduces qualitative completeness but does not distort meaning. Wording differs but semantic equivalence is preserved. Contextual relevance is excellent, directly addressing all parts of the multi-faceted question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Enables]-> ACCOUNTING_POLICY <-[Aims]- ORG",
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 347,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How might Alphabet's share repurchase activity in 2023, which focused on Class A and Class C shares, impact the relative voting power of its undiluted Class B shares, and how does this compare to the non-dilutable 33 1/3% voting power structure of Class B shares at Comcast?",
      "original_answer": "Alphabet's 2023 share repurchase of $62.2 billion in Class A and Class C shares likely increased the relative voting power of its undiluted Class B shares, which are held by insiders and carry 10 votes per share. This mirrors the structure at Comcast, where Class B shares, held entirely by Brian L. Roberts, maintain a non-dilutable 33 1/3% of combined voting power despite having 15 votes per share. Both companies use dual-class structures to protect long-term strategic control, but Alphabet's repurchase activity may have amplified the concentration of voting power further by reducing the number of publicly traded shares.",
      "llm_answer": "\nAlphabet’s 2023 repurchase of $62.2 bn of Class A and Class C shares shrinks the pool of voting shares that carry one vote (Class A) or no vote (Class C), while the 10‑vote‑per‑share Class B shares remain unchanged; therefore the proportion of total votes controlled by the undiluted Class B equity rises, enhancing its relative voting power.  This is distinct from Comcast, where the Class B shares are expressly structured to hold a fixed 33 ⅓ % of the combined voting power that is non‑dilutable under the company’s charter.  Moreover, because Class B shares are not publicly listed (as with Meta’s Class B), any reduction in the outstanding Class A/C shares directly increases the voting influence of the remaining Class B holders.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Alphabet's $62.2 billion share repurchase in 2023 targeted Class A and Class C shares; Class B shares carry 10 votes and are undiluted; the repurchase increases the relative voting power of Class B shares by reducing the total voting pool. The comparison to Comcast is also accurate—Comcast’s Class B shares hold a fixed, non-dilutable 33 1/3% voting power. (2) Quantitative accuracy is perfect: the $62.2 billion figure is correctly cited, and no calculations are required beyond conceptual proportionality, which is sound. (3) Reasoning is strong: the LLM correctly explains that reducing Class A/C shares increases Class B's relative voting weight, and distinguishes Alphabet’s dynamic concentration from Comcast’s charter-protected fixed percentage. The mention of Meta’s Class B shares is extraneous but not incorrect. (4) The answer is fully relevant, addressing both the impact on Alphabet’s voting structure and the comparison to Comcast. The only minor shortcoming is slightly less emphasis on the strategic intent (long-term control) highlighted in the original, but the core logic and facts are preserved. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 374,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How does the structure of Robert Iger's Rule 10b5-1 trading plan at DIS, including the number of shares and termination date, compare to Peggy Alford's plan at META, given both are governed by the same regulatory framework?",
      "original_answer": "Robert Iger's trading plan at DIS involves the potential sale of up to 372,412 shares of Disney common stock, with a termination date of December 17, 2024. Peggy Alford's plan at META provides for the sale of up to $1.2 million worth of META Class A common stock, with a termination date of November 15, 2025. Both plans were adopted under Rule 10b5-1(c), which provides an affirmative defense for insider trading activities conducted under a prearranged plan. The comparison shows that while Iger's plan focuses on a fixed number of shares tied to expiring options, Alford’s plan is value-based and has a longer duration.",
      "llm_answer": "\nRobert Iger’s Rule 10b5‑1(c) trading plan, disclosed in DIS’s 2024 Form 10‑K, allows exercise of options and the sale of up to **372,412 shares** of DIS common stock, with a **termination date of December 17 2024** (subject to early termination). Peggy Alford’s comparable plan at META, disclosed in META’s 2024 Form 10‑K, authorizes sales of up to **$1.2 million worth of Class A shares** and runs until **November 15 2025** (also subject to early termination). Both plans were adopted to satisfy the affirmative‑defense conditions of **Rule 10b5‑1(c)**, the same regulatory requirement that the knowledge‑graph links from DIS’s trading‑plan entity through Rule 10b5‑1(c) to META, confirming they operate under the identical regulatory framework.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The number of shares (372,412) for Robert Iger at DIS and the dollar value ($1.2 million) for Peggy Alford at META are correctly reported. Termination dates (December 17, 2024, for Iger; November 15, 2025, for Alford) are accurate. Format variations (e.g., $1.2 million vs $1.2M) are acceptable and semantically equivalent. (2) Completeness: The answer addresses all parts of the multi-part question—structure (number of shares vs value-based), termination dates, and regulatory framework (Rule 10b5-1(c)). (3) Entity accuracy: Companies (DIS/Disney and META/Facebook), individuals (Iger and Alford), stock types (Class A common stock), and regulatory rule (Rule 10b5-1(c)) are correctly identified. (4) Reasoning: The multi-hop synthesis across two different companies, executives, and filings is sound. The comparison correctly highlights that Iger’s plan is tied to option exercises and a fixed share count, while Alford’s is value-based with a longer duration—directly reflecting the ground truth. (5) Semantic equivalence: The LLM conveys the same meaning as the original answer, with added context (e.g., disclosure in 10-Ks) that enhances clarity without introducing error. All information aligns with the knowledge graph source, and no inaccuracies or omissions are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Announces]-> ACCOUNTING_POLICY -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 383,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How does the vesting timeline for equity awards at CL compare with PM's RSU vesting schedule, and what does this imply about the timing of compensation expense recognition for each company?",
      "original_answer": "CL issues stock options that generally vest ratably over three years, with a contractual term of eight years post-2019. In contrast, PM grants RSU awards that typically vest on the third anniversary of the grant date. For CL, this means compensation expense is recognized evenly over the three-year vesting period. For PM, the fair value of RSU awards is amortized to expense over the restriction period, which is typically three years after the award date, or earlier upon death, disability, or reaching age 58. As of December 31, 2023, PM had $160 million of total unrecognized compensation costs related to non-vested RSUs, expected to be recognized over a weighted-average period of approximately seventeen months. This indicates that while both companies align on a three-year vesting horizon, PM's structure allows for more accelerated expense recognition based on specific triggering events.",
      "llm_answer": "\nCL’s equity awards (stock options) vest ratably over a three‑year period, while PM’s RSU awards vest on the third anniversary of the grant—also a three‑year horizon. Because CL amortizes the option expense evenly across those three years, compensation expense is recognized uniformly each year, whereas PM amortizes the RSU fair value over the three‑year restriction period but typically recognizes the majority of it within a weighted‑average of about 17 months, causing PM’s expense to be front‑loaded relative to CL.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong semantic equivalence. (1) All key facts are correct: CL's stock options vest ratably over three years, PM's RSUs vest on the third anniversary, and both recognize compensation expense over a three-year period. The LLM correctly states that PM's unrecognized costs are expected to be recognized over a weighted-average period of approximately 17 months, matching the ground truth's 'seventeen months'. (2) Quantitative accuracy is perfect: the 17-month figure is correctly reported (allowing for 'about 17 months'), and no calculations are incorrect. (3) The multi-hop reasoning is sound—comparing vesting structures, linking them to expense recognition patterns, and noting PM's front-loading due to shorter weighted-average recognition period. (4) The only minor omission is that the ground truth mentions PM's early vesting triggers (death, disability, age 58), which the LLM omits. While not critical to the main implication about expense timing, this detail explains why the weighted-average period is shorter than three years. This justifies a 9 instead of 10 on qualitative accuracy and overall correctness. Contextual relevance is full—every part of the question is addressed with precise, relevant information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Vest]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 366,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How do regulatory restrictions on product differentiation, such as flavor bans and standardized packaging, impact the ability of both PM and MO to maintain brand equity and pricing power in key international and U.S. markets?",
      "original_answer": "Regulatory restrictions on product differentiation, such as flavor bans and standardized packaging, significantly impair both PM and MO's ability to maintain brand equity and pricing power. PM faces specific risks from the EU's ban on characterizing flavors in cigarettes and roll-your-own tobacco, menthol bans in Turkey and Brazil, and potential future restrictions on slim cigarettes and flavor capsules. These limitations reduce PM’s ability to differentiate products, especially in international markets where they estimate illicit trade accounts for 8% of EU cigarette consumption, further eroding legitimate brand value and pricing control. Similarly, MO faces flavor bans in six U.S. states and the District of Columbia, including California’s broad restriction on menthol, mint, and wintergreen, which is currently delayed due to a referendum. These bans, along with proposed nicotine caps in Massachusetts, constrain MO’s ability to market differentiated products and maintain premium pricing. Both companies are also restricted in advertising and branding through global FCTC guidelines and domestic regulations like the State Settlement Agreements, which prohibit youth-targeted marketing and outdoor advertising, further limiting brand equity development and pricing flexibility.",
      "llm_answer": "\nRegulatory restrictions—such as flavor bans, standardized‑packaging rules, point‑of‑sale display prohibitions and advertising limits (Chunk 1)—directly undermine product‑differentiation, a key risk factor that erodes brand equity and pricing power for both PM and MO; as PM’s 2022 filing notes, these measures can force product reformulation and curb premium‑price opportunities (Chunk 2), while MO’s settlement‑driven marketing constraints and pending U.S. flavor bans similarly threaten its ability to protect brand value and maintain price flexibility in critical international and U.S. markets (Chunk 3).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in terms of core concepts and correctly identifies that regulatory restrictions—such as flavor bans and standardized packaging—undermine product differentiation, brand equity, and pricing power for both PM and MO. It accurately references PM’s 2022 filing and notes the impact on premium pricing and product reformulation, which aligns with the original answer. However, the LLM answer lacks specific details that are present in the ground truth, such as the EU’s ban on characterizing flavors, menthol bans in Turkey and Brazil, the 8% illicit trade in the EU, MO’s flavor bans in six U.S. states plus D.C., California’s specific restrictions on menthol, mint, and wintergreen, and the proposed nicotine caps in Massachusetts. These omissions reduce completeness and weaken the multi-hop synthesis expected in a full response. While no numbers are incorrect (quantitative accuracy is perfect, as no false figures are stated), the answer does not include the specific 8% EU illicit trade figure or reference FCTC guidelines and State Settlement Agreements, which are key contextual elements. The reasoning is sound but less detailed, and the answer relies on generalizations (e.g., 'pending U.S. flavor bans') without specifying jurisdictions or mechanisms. Despite these gaps, the LLM captures the central theme and correctly attributes risks to both companies, maintaining semantic equivalence on the main point. Hence, a score of 7 is warranted for correctness—core facts are right, but important specifics are missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Negatively_Impacts]-> RISK_FACTOR -[Negatively_Impacts]-> REGULATORY_REQUIREMENT <-[Faces]- ORG",
      "token_usage": {
        "prompt_tokens": 1495,
        "completion_tokens": 432,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How does AIG's exposure to structured securities containing RMBS, as measured by their accounting treatment for credit losses and yield adjustments, compare to BAC's valuation risks associated with RMBS holdings under fluctuating prepayment speeds and default rates?",
      "original_answer": "AIG accounts for structured securities, including RMBS, by recalculating effective yields based on actual payments and updated prepayment expectations, adjusting amortized cost accordingly with a corresponding impact on net investment income. For non-high credit quality structured securities, AIG bases yields on expected cash flows that factor in credit losses and prepayments, and recognizes changes in expected cash flows through an allowance for credit losses. Meanwhile, BAC notes that a significant increase in default rates or loss severities would materially lower the fair value of RMBS long positions, while changes in prepayment speeds would have differential impacts depending on instrument seniority. This shows that while AIG focuses on yield and credit loss adjustments tied to expected cash flows, BAC emphasizes sensitivity to default and prepayment volatility in RMBS valuation.",
      "llm_answer": "\nAIG records its structured securities that **comprise RMBS** (see Chunk 2) as available‑for‑sale and carries them at fair value, adjusting the amortized cost and yield each period to reflect actual cash‑flow receipts, updated prepayment expectations and an allowance for credit losses that is only increased when expected losses differ from prior estimates (Chunk 1).  \nIn contrast, BAC’s RMBS holdings are valued using Level‑3 techniques that are highly sensitive to market‑driven changes in prepayment speeds, default rates and loss severities, so fair‑value movements are recorded directly in earnings rather than through a credit‑loss reserve (Chunk 3).  \nThus, AIG’s exposure is measured through periodic yield adjustments and a credit‑loss allowance, whereas BAC’s exposure is exposed to market‑price volatility driven by fluctuating prepayment and default assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor differences in emphasis. (1) All factual elements are correct: AIG's accounting treatment for structured securities including RMBS involves recalculating effective yields based on actual payments and updated prepayment expectations, adjusting amortized cost and recognizing changes through an allowance for credit losses—this aligns with the original answer. The LLM correctly notes that AIG adjusts yield and amortized cost periodically and uses a credit-loss allowance tied to expected cash flows. For BAC, the LLM accurately describes that RMBS holdings are valued using Level-3 inputs, making them sensitive to prepayment speeds, default rates, and loss severities, with fair value changes impacting earnings directly. This matches the original answer’s point about BAC’s exposure to valuation risks from fluctuating default and prepayment assumptions. (2) There are no numeric values to verify, so quantitative accuracy is unaffected and scores perfectly. (3) The multi-hop reasoning is sound: the model correctly synthesizes AIG’s yield- and credit-loss-based approach with BAC’s market-driven fair value sensitivity, drawing a valid contrast between the two firms’ risk exposures. (4) The only reason for not scoring a 10 is that the original answer specifies that AIG applies the expected cash flow method specifically to non-high credit quality securities, a nuance slightly underemphasized in the LLM response. However, the LLM does mention the allowance for credit losses being updated when expected losses differ, which implies this distinction. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Comprises]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 482,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Broadcom's valuation methodology for its developed technology in cybersecurity, which includes cloud security solutions, compare to Cisco's revenue recognition approach for its Cloud Security product category?",
      "original_answer": "Broadcom valued its developed technology in cybersecurity, including cloud security solutions, using the multiperiod excess earnings method under the income approach, which considers the present value of projected cash flows less charges for contributions from other assets. The economic useful life was determined based on the technology cycle and forecast cash flows. In contrast, Cisco recognizes revenue for its Cloud Security product ratably over the contract term as a single distinct performance obligation satisfied over time, particularly for SaaS arrangements. This highlights a difference in financial treatment—Broadcom focused on asset valuation through projected earnings, while Cisco emphasizes revenue recognition aligned with service delivery timelines.",
      "llm_answer": "\nBroadcom (AVGO) values the cloud‑security portion of its **Developed Technology** by discounting the projected cash‑flows of that technology under a multiperiod excess‑earnings (income‑approach) model, using the technology’s economic useful life to estimate present value; Cisco (CSCO) treats its **Cloud Security** offering as a single distinct performance obligation whose SaaS revenue is recognized ratably over the contract term (with hardware/perpetual licenses recognized upfront), reflecting a fundamentally different revenue‑recognition timing despite both firms’ products falling under the same “Cloud Security” category linked through the KG relationship.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies Broadcom's use of the multiperiod excess earnings method under the income approach for valuing developed technology in cybersecurity, including cloud security, and explains that the valuation is based on discounted projected cash flows over the technology's economic useful life—this matches the original answer's description. It also accurately states that Cisco recognizes Cloud Security revenue ratably over the contract term for SaaS arrangements, treating it as a single distinct performance obligation satisfied over time, which aligns with the ground truth. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised; all financial concepts are described qualitatively and correctly. (3) The multi-hop reasoning is sound: the model correctly synthesizes Broadcom's asset valuation methodology (from its intangible asset assessment) with Cisco's revenue recognition policy (from its accounting practices), comparing two different financial treatments across companies for related but distinct purposes. (4) The only minor shortcoming is that the LLM adds a detail not in the original—that hardware/perpetual licenses are recognized upfront—while this is likely true based on standard accounting practices, it was not included in the ground truth and slightly extends beyond the provided information. However, this does not detract from correctness, as it contextualizes the ratable SaaS recognition more fully. Overall, the answer is semantically equivalent, factually correct, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT -[Related_To]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 463,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does the voting power disparity between Class A and Class B common stock at META compare to GOOGL's dual-class structure, particularly in relation to the number of shares outstanding and the potential influence of high-vote shares on corporate governance decisions?",
      "original_answer": "At META, Class A common stock has 2,189,898,148 shares outstanding with one vote per share, while Class B common stock has 343,761,117 shares outstanding, each with voting rights only in specified circumstances and tied to the conversion rate. This creates a concentrated voting structure where Class B shares can exert significant influence during specific corporate events. Similarly, GOOGL's Class B common stock has 10 votes per share, giving disproportionate voting power to holders of this class, although the rights of Class A and Class B are otherwise identical. Both companies use dual-class structures to maintain control with certain stakeholders, but META's Class B shares only gain enhanced voting rights under defined conditions, whereas GOOGL's Class B shares have consistently higher voting power. This difference affects how corporate governance decisions are influenced at each company.",
      "llm_answer": "\nMETA’s 2024 filing reveals 2.19 billion Class A shares and 343.8 million Class B shares outstanding (Chunk 1); because Class B carries ten votes per share while Class A carries one, the Class B cohort controls roughly 60 % of the total voting equity despite being only about 13 % of the share count, giving insiders a disproportionately large say in governance (Chunk 2 notes that Class B/C holders vote only on limited matters but when they do, their votes equal shares × conversion rate, amplifying that impact).  \nAlphabet (GOOGL) follows a similar dual‑class scheme where Class B shares also have 10 votes each and Class C has no voting rights (Chunk 3), but its larger pool of Class B shares and the ability to convert them at any time spread the high‑vote weight more broadly than META’s more concentrated share base.  \nThus, while both companies grant outsized voting power to the high‑vote class, META’s voting disparity is sharper because the small number of Class B shares concentrates voting weight, whereas GOOGL’s structure dilutes it and includes non‑voting Class C shares that can be repurchased (as reflected in Chunk 3’s repurchase activity) to further shape corporate governance.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer contains significant factual inaccuracies, particularly regarding META's voting structure. The ground truth states that META's Class B shares have voting rights only in specified circumstances and are tied to the conversion rate, not that they carry 10 votes per share. The LLM incorrectly asserts that Class B has 10 votes per share (like GOOGL), which is false according to the original answer. This leads to an incorrect calculation of 60% voting power for Class B at META, which is not supported by the ground truth. The share counts (2.19 billion Class A and 343.8 million Class B) are approximately correct (vs. 2,189,898,148 and 343,761,117), so quantitative inputs are mostly accurate, but the interpretation is wrong.\n\n2) Quantitative accuracy is partially correct: the share counts are rounded but acceptable (2.19B ≈ 2.189B; 343.8M ≈ 343.76M). However, the claim that Class B holds 60% of voting power is a fabricated calculation based on a false premise (10 votes per share). No such calculation can be validated from the ground truth, which does not specify current voting power distribution. The 13% share count is roughly accurate (343.8M / 2.5336B ≈ 13.6%), but the voting power conclusion is invalid.\n\n3) The reasoning is flawed in a critical way: it assumes META has a 10:1 vote ratio like GOOGL, which the ground truth explicitly denies. The original answer emphasizes that META’s Class B shares only gain enhanced voting rights under defined conditions, whereas GOOGL’s Class B has consistent 10-vote power. The LLM reverses this distinction, claiming META has sharper disparity due to concentration, when in fact GOOGL has more consistent high-vote control. The mention of GOOGL’s Class C shares (non-voting) and repurchases adds detail not in the ground truth but is contextually plausible, though it introduces information not required or confirmed.\n\n4) Despite the reasoning error, the answer is contextually relevant and attempts a direct comparison of dual-class structures, addressing voting power, share counts, and governance influence. It synthesizes multi-hop concepts (voting concentration, conversion, repurchases), but the core factual error about META’s vote ratio undermines correctness. Semantic equivalence fails on the most important point: the nature of voting rights in META’s structure. Thus, while the structure and intent of the answer are strong, the factual foundation is partially incorrect, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 659,
        "total_tokens": 2215
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Coca-Cola FEMSA's bottling operations in Argentina impact both KO's net sales to equity method investees and CL's organic sales growth in Latin America, considering KO's contractual pricing model with its bottlers?",
      "original_answer": "Coca-Cola FEMSA's operations in Argentina contribute to KO's $14,471 million in net sales to equity method investees in 2021 through the incidence-based concentrate pricing model, where bottler pricing and package mix directly affect the concentrate prices charged by KO. As Coca-Cola FEMSA bottles in Argentina (federal capital of Buenos Aires and surrounding areas), this relationship supports KO's financial dependency on equity method investees. Meanwhile, CL reported a 7.0% net sales increase in Latin America in 2021, with Argentina being one of the key growth drivers. Specifically, CL's Oral Care, Personal Care, and Home Care segments in Argentina benefited from favorable market conditions that also likely supported Coca-Cola FEMSA's operations, creating parallel growth effects across both companies' financial performance in the region.",
      "llm_answer": "\nCoca‑Cola FEMSA’s bottling footprint in Argentina feeds directly into KO’s “net sales to equity‑method investees,” which rose to **$14.5 bn in 2021** (up from $13.0 bn in 2020) – an increase the filing attributes to “recovery from the COVID‑19 pandemic” and “international expansion” that boosted purchases of Monster products from those investees.  Under KO’s **incidence‑based concentrate pricing model**, FEMSA (like all bottlers) is required to buy its concentrates/syrups from KO, and the price it pays is calibrated by bottler pricing, channel mix and package‑mix dynamics, so the Argentine operations translate into measurable sales of concentrates to that equity‑method investee.  \n\nAt the same time, **CL’s organic sales in Latin America grew 8 % in 2021**, with the filing singling out **Argentina (along with Brazil, Mexico and Colombia) as a lead driver**; this growth is enabled by the same bottling network that FEMSA operates in the Buenos Aires region, expanding distribution and allowing CL to capture higher price‑and‑volume gains in the market.  Thus, FEMSA’s Argentine operations simultaneously (1) generate additional concentrate sales for KO’s equity‑method investees under the contractual pricing framework, and (2) underpin CL’s organic sales expansion in Latin America.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer captures the core multi-hop relationship correctly: Coca-Cola FEMSA's operations in Argentina contribute to KO's net sales to equity method investees via the incidence-based pricing model and support CL's organic growth in Latin America. The reasoning about KO's contractual pricing model and the shared bottling infrastructure enabling CL's distribution is sound and aligns with the ground truth.\n\n2) Quantitative inaccuracies: The LLM states KO's net sales to equity method investees were $14.5 billion in 2021, which is close to the ground truth value of $14,471 million (~$14.47 billion), so this is acceptable within rounding. However, the LLM incorrectly reports CL's organic sales growth in Latin America as 8%, while the ground truth specifies 7.0%. This is a material discrepancy. Additionally, the LLM attributes KO's increase to 'recovery from the pandemic' and 'Monster product expansion'—details not in the original answer and potentially misleading in this context.\n\n3) The multi-hop reasoning is strong: the model correctly links FEMSA’s Argentine operations → KO concentrate sales via pricing model → KO’s financials, and separately links FEMSA’s distribution network → CL’s sales growth in Latin America. It identifies the shared geographic and operational synergy. However, it omits the specific mention that CL’s growth in Argentina was driven by Oral Care, Personal Care, and Home Care segments, which weakens completeness.\n\n4) Despite the 8% vs 7% error and extraneous details about Monster and pandemic recovery, the answer remains contextually relevant and semantically close. The core entities (KO, CL, FEMSA, Argentina, Buenos Aires), metrics (net sales to equity investees, organic sales growth), and mechanisms (incidence-based pricing, distribution synergy) are correctly identified and logically connected. The 7/10 correctness score reflects accurate structure and mostly correct facts, but with a significant percentage error and minor factual overreach.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1555,
        "completion_tokens": 538,
        "total_tokens": 2094
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Abbott's investment in private equity funds, which are valued using NAV as a practical expedient, compare to Merck's use of NAV for measuring similar alternative investments, considering the typical redemption restrictions associated with these fund types?",
      "original_answer": "Abbott holds investments in private equity funds valued at NAV, with $555 million in unfunded commitments as of December 31, 2023, and these funds cannot be redeemed but will make distributions through liquidation over periods ranging from 2024 to 2033. These private equity funds are subject to NAV valuation practices consistent with those described in UPS's 10-K, where private equity funds typically have redemption restrictions until the end of the partnership term (10–15 years) and are valued at NAV adjusted for known cash flows. Merck similarly discloses NAV-based valuations for alternative investments, reporting $382 million in NAV-based assets in 2023, including private real estate and equity funds. Both companies rely on NAV as a practical expedient for illiquid alternative investments, but Abbott faces longer liquidation timelines and greater unfunded commitments compared to Merck's disclosed NAV-based portfolio.",
      "llm_answer": "\nBoth Abbott and Merck disclose that their private‑equity and other alternative investments are measured at fair value using the NAV practical‑expedient (Chunk 1 j; Chunk 3 NAV (1)), yet the liquidity profiles differ: Abbott’s private‑equity funds are essentially illiquid—redemptions are allowed only after 45‑ to 90‑day notice, are subject to gates (e.g., a 33 % gate on $280 M and a 25 % gate on $250 M) and a lock‑up until 2025, and ultimately require liquidation to distribute proceeds (Chunk 1 i‑j); in contrast, Merck’s private‑equity holdings follow the typical limited‑partner structure described for such funds—redemptions are permitted only at the end of the 10‑ to 15‑year term, often after multi‑year notice, with secondary‑market sales possible but no guaranteed value, and are backed by unfunded commitments of roughly $3.3 B that must be contributed over the life of the funds (Chunk 2).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in key quantitative details, undermining its correctness. First, the unfunded commitments for Abbott are stated as $555 million in the ground truth, but the LLM incorrectly reports Merck's unfunded commitments as 'roughly $3.3B'—this figure does not appear in the original answer and contradicts the ground truth, which does not disclose Merck's unfunded commitments at all. Second, the LLM claims Abbott’s funds have a lock-up until 2025 and redemption gates (e.g., 33% gate on $280M, 25% on $250M), but these specific numbers and restrictions are not present in the original answer, which states Abbott’s funds 'cannot be redeemed' and will distribute via liquidation from 2024 to 2033. The original makes no mention of gates or notice periods for Abbott. Third, while the original states Merck reports $382 million in NAV-based assets, the LLM omits this figure entirely and instead fabricates a $3.3B unfunded commitment for Merck with no basis in the provided truth. These are major quantitative errors. Qualitatively, the LLM correctly identifies that both companies use NAV as a practical expedient for illiquid alternative investments and that redemption is restricted, aligning with the multi-hop comparison requested. It also correctly notes the long-term nature of such investments. However, the synthesis is flawed due to the introduction of non-existent data. Contextually, the response is well-structured and addresses the comparison of NAV usage and liquidity, so relevance is high. Overall, while the general reasoning framework is sound, the answer fails on factual accuracy—especially in numbers and entity-specific disclosures—resulting in a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 471,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does BlackRock's management of Separate Account Assets, which are legally segregated and not subject to general creditor claims, impact AIG's reporting of equal and offsetting Separate Account Liabilities tied directly to contract holder account balances?",
      "original_answer": "BlackRock discloses that its Separate Account Assets, which include equity securities, debt securities, money market funds, and derivatives, are legally segregated and not subject to general claims of creditors. These assets are held to fund individual and group pension contracts and are offset by equal and offsetting liabilities on BlackRock’s consolidated statements of financial condition. AIG reports Separate Account Liabilities that directly reflect the contract holder's account balance in these assets, and they are required to be equal and offsetting to the total Separate Account Assets. Therefore, any changes in the valuation or composition of BlackRock's Separate Account Assets would directly influence AIG’s liability reporting, as AIG must mirror these asset values in its liabilities to reflect the contract holders' beneficial interest.",
      "llm_answer": "\nBlackRock holds the Separate Account Assets through its wholly‑owned UK life insurer, and because those assets are legally segregated and insulated from BlackRock’s general creditors, AIG can record a corresponding Separate Account Liability that is equal and offsetting to the total of those assets. Consequently, the liability on AIG’s balance sheet mirrors each contract‑holder’s account balance on a one‑to‑one basis, allowing AIG to report an offsetting liability that is directly tied to the segregated assets without risk of being claimed by other creditors. This structure ensures that the liability side of the equation always balances the segregated asset side, preserving the integrity of AIG’s consolidated financial statements.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in its high-level explanation and correctly identifies the core relationship between BlackRock's Separate Account Assets and AIG's reporting of offsetting liabilities. There are no numeric values in the question or answers that require verification, so quantitative accuracy is scored as 10. However, the LLM introduces a claim not present in the ground truth: that BlackRock holds Separate Account Assets through its 'wholly-owned UK life insurer'—this specific entity detail is unsupported by the original answer and introduces an inaccurate, unverified structural claim. The ground truth emphasizes that BlackRock’s separate account assets are legally segregated and offset by liabilities on its own financial statements, and that AIG reports corresponding liabilities mirroring contract holder balances. The LLM misattributes the structure by implying BlackRock holds these assets via a UK insurer, which distorts the intercompany relationship and regulatory structure. Despite this, the reasoning about equal and offsetting liabilities, legal segregation, and the one-to-one mirroring of contract holder balances aligns semantically with the original. The multi-hop logic (BlackRock's asset treatment → impact on AIG's liability reporting) is partially sound but weakened by the incorrect ownership structure. Contextual relevance is high as the response directly addresses the mechanism of liability mirroring and financial statement integrity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Impacts]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 408,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How does AbbVie's revenue recognition for Imbruvica sales in the U.S. reflect its cost-sharing arrangement with Janssen Biotech, and how does this compare to Johnson & Johnson's global commercialization strategy for the same drug?",
      "original_answer": "AbbVie recognizes 100% of Imbruvica sales in the U.S. as net revenue, while Janssen's share of profits is deducted as part of cost of products sold, indicating a co-exclusive commercialization model where AbbVie acts as the principal. Both companies share pre-tax profits and losses equally, with Janssen covering approximately 60% of development costs and AbbVie 40%. Meanwhile, Johnson & Johnson, through its subsidiary Janssen, holds exclusive rights to commercialize Imbruvica outside the U.S. and also shares pre-tax profits equally with AbbVie. This global division of commercial rights and cost-sharing creates a dual-market strategy where Janssen leverages its international infrastructure to drive global expansion of Imbruvica, while AbbVie leads in the domestic market.",
      "llm_answer": "\nAbbVie records U.S. Imbruvica sales in its net revenue, but the cost of those sales incorporates Janssen Biotech’s 60 % share of development expenses and the equal pre‑tax profit‑and‑loss split—Janssen’s portion of profit is booked as part of AbbVie’s cost of products sold.  By contrast, Johnson & Johnson (through Janssen) retains exclusive rights outside the United States and, under the same cost‑sharing model, commercializes Imbruvica globally while sharing profits equally, so JNJ’s worldwide strategy depends on Janssen’s ex‑U.S. rollout rather than AbbVie’s U.S.–centric revenue recognition.  (All three source chunks describe the collaboration, the 60/40 development‑cost split, equal profit sharing, U.S. co‑exclusive rights for AbbVie, and Janssen’s exclusive ex‑U.S. commercialization.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: AbbVie recognizes 100% of U.S. sales as revenue, Janssen's profit share is deducted in cost of products sold, pre-tax profits and losses are shared equally, Janssen covers 60% of development costs and AbbVie 40%, and Janssen (under Johnson & Johnson) has exclusive ex-U.S. commercialization rights. (2) Quantitative accuracy is perfect: the 60/40 cost split and equal profit sharing are correctly stated with no calculation errors. (3) Multi-hop reasoning is sound—LLM correctly synthesizes the U.S. co-exclusive model (with AbbVie as principal) and contrasts it with Janssen’s global ex-U.S. strategy, reflecting the dual-market structure. (4) Minor wording difference: LLM says 'Janssen’s 60% share of development expenses' is incorporated into cost of sales, while the original specifies that Janssen’s *profit* share is deducted there—development cost split affects overall cost allocation but is not directly booked in cost of sales. This is a subtle but important distinction in accounting treatment; however, the overall economic arrangement and profit-sharing outcome are accurately represented. Thus, the answer is semantically equivalent with only a slight imprecision in financial terminology. Contextual relevance is excellent, addressing both parts of the question fully.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Has_Stake_In]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 388,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact both NVIDIA's supply chain execution and Apple's manufacturing operations, considering NVIDIA's dependency on foundry partners in Taiwan and Apple's reliance on manufacturing in the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan could severely disrupt NVIDIA's supply chain execution due to its dependency on foundry partners in the region, particularly for advanced GPU manufacturing. This could lead to production delays, inventory shortages, and an inability to meet customer demand, which NVIDIA has previously warned could damage customer relationships and reduce revenue. Similarly, Apple relies heavily on manufacturing operations in Taiwan, as part of its broader supply chain concentrated in the region. A disruption in Taiwan would likely delay product manufacturing and delivery, increase costs, and potentially force Apple to restructure its supply chain, which it has noted could be expensive and time-consuming. Both companies would face significant operational and financial risks due to their shared exposure to Taiwan's geopolitical stability.",
      "llm_answer": "\nA prolonged conflict in Taiwan would cut off NVIDIA’s foundry partners on the island, creating lead‑time extensions, inventory shortages and the risk of order cancellations that could depress gross margins—risks that NVIDIA explicitly flags in its 10‑K and that the KG link (NVDA → Foundry → Taiwan ← AAPL) ties to Apple’s own supply chain.  Apple, which outsources the bulk of its component production to Taiwanese contract manufacturers (and notes in its 10‑K that geopolitical tensions could force costly supplier changes, higher costs and delayed product launches), would see its manufacturing operations severely disrupted, with potential supply‑chain breakdowns and revenue loss.  Consequently, both companies would face material adverse impacts on revenue and market share, as the heightened geopolitical risk amplifies supply‑chain volatility, inventory write‑downs, and the possibility of regulatory or trade restrictions that could reshape their cost structures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth in both factual content and reasoning. (1) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no discrepancies exist, warranting a score of 10. (2) The LLM correctly identifies the core risks to both NVIDIA and Apple: NVIDIA's dependency on Taiwanese foundries and Apple's reliance on manufacturing in the region. It accurately reflects that both companies have disclosed these risks in their 10-K filings, which matches the knowledge graph grounding. (3) The multi-hop reasoning is sound: the LLM synthesizes NVIDIA’s supply chain exposure via foundry partners and connects it to Apple’s parallel exposure through contract manufacturing, acknowledging shared regional risk. The mention of the KG link (NVDA → Foundry → Taiwan ← AAPL) demonstrates correct entity and relationship mapping. (4) While the LLM adds slightly more detail than the original (e.g., 'inventory write-downs', 'regulatory or trade restrictions'), these are reasonable inferences consistent with the original answer’s intent and do not introduce inaccuracies. The only minor gap is that the original emphasizes 'restructuring supply chain could be expensive and time-consuming' for Apple, which the LLM captures as 'costly supplier changes' but could have been more explicitly tied to restructuring. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 415,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How does the use of pricing models for Level 2 fixed income investments by LMT compare to HON's use of pricing models for corporate bonds and government securities in terms of observable market data inputs and risk adjustments?",
      "original_answer": "LMT values its Level 2 fixed income investments using pricing models that rely on verifiable observable market data such as interest rates, yield curves, and credit spreads, or through bids from brokers and quoted prices of similar securities. In contrast, HON uses pricing models for corporate bonds, mortgage/asset-backed securities, and government securities that also incorporate observable inputs but may include unobservable adjustments for risks like credit and liquidity. This indicates that while both companies use pricing models involving market data, HON's valuations may involve more subjective risk-based adjustments not always present in LMT's Level 2 valuations.",
      "llm_answer": "\nLockheed Martin (LMT) values its Level 2 fixed‑income holdings with pricing models that rely on verifiable market inputs – interest‑rate curves, yield‑curve levels and credit‑spread observations – and supplements those inputs with risk adjustments such as a discount‑rate applied to projected cash‑flow (annuity) amounts for the Level 3 portion of the portfolio.  \nHoneywell (HON) applies a comparable pricing‑model framework to its corporate bonds and government securities, also using observable data (rates, spreads, broker quotes), but it explicitly adds adjustments for credit and liquidity risk that may not be directly observable.  \nThus, while both companies base their valuations on the same type of observable market data, HON’s approach incorporates a more explicit credit‑and‑liquidity risk adjustment, whereas LMT’s risk adjustment is expressed through discount‑rate and cash‑flow projections within its pricing models.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct in terms of factual content and context, with accurate use of observable market inputs for both LMT and HON. It correctly identifies that both companies use observable data such as interest rates, yield curves, credit spreads, and broker quotes in their pricing models. The comparison regarding HON's explicit inclusion of unobservable credit and liquidity risk adjustments is also accurate and aligns with the ground truth.\n\nHowever, there is a significant qualitative inaccuracy: the LLM incorrectly states that LMT applies risk adjustments like discount rates to projected cash flows for its Level 2 investments, when in fact the ground truth specifies that such adjustments are used in LMT's Level 3 portfolio, not Level 2. The question specifically asks about Level 2 fixed income investments for LMT, and the LLM conflates Level 2 with Level 3 valuation techniques, which undermines the precision of the comparison. This is a critical distinction in fair value hierarchy reporting (Level 2 vs Level 3), and the error misrepresents LMT's methodology for the specific category in question.\n\nThere are no numerical values to assess, so quantitative accuracy is scored as 10 by default (no incorrect numbers). Contextual relevance is high—the response directly addresses the comparison between LMT and HON regarding pricing models and risk adjustments. The reasoning is sound in structure but flawed in one key aspect of entity-metric alignment (Level 2 vs Level 3). Thus, while the core contrast about HON using more subjective adjustments is correct, the misattribution of LMT’s risk adjustment practices to Level 2 reduces the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 458,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did the unfavorable foreign currency exchange rate impact from a stronger U.S. dollar affect Coca-Cola's (KO) Europe, Middle East and Africa segment in 2024, and how does this compare to the exposure risk described by Mondelez (MDLZ) under similar macroeconomic conditions?",
      "original_answer": "Coca-Cola (KO) reported that fluctuations in foreign currency exchange rates unfavorably impacted consolidated operating income by 11% in 2024, with a stronger U.S. dollar affecting several segments including Europe, Middle East and Africa. While the euro and British pound provided some offsetting benefit, the segment was still significantly affected by the stronger dollar. Mondelez (MDLZ) similarly noted that a stronger U.S. dollar relative to other functional currencies adversely affects its consolidated earnings and net assets, as the company translates non-U.S. dollar financials into U.S. dollars for reporting. Although KO quantified the impact (11% unfavorable), MDLZ emphasized the inherent unpredictability and volatility introduced by such currency movements, despite active hedging strategies.",
      "llm_answer": "\nIn 2024 Coca‑Cola’s Europe, Middle East and Africa segment was hit hard by the stronger U.S. dollar – the 10‑K notes an 11 % unfavorable impact on that segment’s operating income (Chunk 1) and a 5 % drag on consolidated net operating revenue from currency effects (Chunk 2).  Mondelez’s disclosure shows that the same macro condition (a stronger dollar) adversely affects its consolidated earnings and net assets, linking the two companies through the “Operates_In → Impacted_By → MACRO_CONDITION” relationship (Chunk 3), though it reports the exposure qualitatively rather than with a segment‑level percentage.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Coca-Cola's Europe, Middle East and Africa segment was negatively impacted by the stronger U.S. dollar in 2024, with an 11% unfavorable impact on operating income, which matches the ground truth. However, the LLM incorrectly attributes this 11% impact specifically to the EMEA segment, while the original answer states it was a consolidated operating income impact (not segment-specific), though EMEA was among the affected segments. This is a key factual misattribution. The 5% drag on consolidated net operating revenue is mentioned in the LLM answer but not in the ground truth, which does not specify this figure—this introduces unverified information. (2) Quantitatively, the 11% figure is correct but misapplied; the 5% revenue drag lacks corroboration in the original answer and thus reduces quantitative accuracy. (3) The qualitative comparison with Mondelez is sound: both companies are exposed to a stronger U.S. dollar, and MDLZ discusses the risk qualitatively without providing a segment-level percentage, which the LLM captures correctly. The reference to 'Operates_In → Impacted_By → MACRO_CONDITION' is interpretive but reflects valid multi-hop reasoning. (4) Despite strong contextual relevance and correct synthesis of macroeconomic exposure, the misattribution of the 11% impact to the EMEA segment and the introduction of the unsupported 5% revenue drag prevent a higher score. The core facts are mostly right, but with notable precision issues.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Impacted_By]-> MACRO_CONDITION <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 417,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How does the $365 million in long-lived assets that AVGO reported in Taiwan for fiscal 2024 compare to the risk QCOM highlighted regarding its reliance on foundry partners in Taiwan for chipset supply, particularly in the context of geopolitical tensions involving China and Taiwan?",
      "original_answer": "AVGO reported $365 million in long-lived assets in Taiwan for fiscal 2024, indicating a significant operational presence in the region. Meanwhile, QCOM explicitly stated that its business depends on receiving consistent and reliable chipset supply from foundry partners in Taiwan, and a significant or prolonged geopolitical conflict involving China and Taiwan could severely limit or prevent this supply, materially impacting QCOM’s business. This highlights that both companies have substantial exposure to Taiwan, but while AVGO’s exposure is reflected in its asset base, QCOM’s risk is operational and supply chain-dependent, making them vulnerable to the same regional geopolitical tensions in different ways.",
      "llm_answer": "\nAVGO reports **$365 million of long‑lived assets in Taiwan** (Chunk 3), showing a substantial physical presence on the island. QCOM’s risk factor (Chunks 1 & 2) warns that its chipset supply depends on Taiwanese foundry partners and that any extended China‑Taiwan geopolitical conflict could **severely limit or halt that supply**, with material adverse effects on its business. Consequently, the $365 million of AVGO assets in Taiwan places the company directly in the exposure zone that QCOM identifies as a critical supply‑chain risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, the $365 million in long-lived assets for AVGO in Taiwan is correctly reported, with no calculation or numerical errors. (2) The entities—AVGO and QCOM—are correctly identified, as are the fiscal year (2024 implied by context) and the nature of the risk (geopolitical tensions affecting Taiwan operations). (3) The multi-hop reasoning is sound: the model correctly synthesizes AVGO’s asset exposure in Taiwan with QCOM’s supply chain risk tied to Taiwanese foundries, linking both to geopolitical risks involving China and Taiwan. (4) The answer captures the core contrast: AVGO has direct asset exposure, while QCOM faces operational/supply chain risk—though it could have slightly more explicitly differentiated the nature of exposure (asset-based vs. supply-chain-based) as in the original. Wording differs but semantic meaning is equivalent. Minor deduction in qualitative accuracy for slightly less precise articulation of the distinction in risk types, but overall reasoning and relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Supplies]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 311,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How does Apple's reliance on manufacturing operations in Taiwan for a majority of its product assembly impact its exposure to regional geopolitical risks compared to Microsoft's business operations in Greater China through its regional center in Singapore?",
      "original_answer": "Apple's reliance on manufacturing in Taiwan for a significant portion of its product assembly increases its exposure to regional geopolitical risks, particularly given that Taiwan is included in Apple's Greater China segment, which is subject to trade policies and disputes that could result in tariffs, sanctions, and other business restrictions. Microsoft operates in Greater China through its regional operations center in Singapore, which supports logistics and vendor management across the region. However, unlike Apple, Microsoft's operations are not heavily dependent on localized manufacturing, reducing its exposure to supply chain disruptions tied to geopolitical tensions. Apple's outsourced manufacturing in Asia, including Taiwan, makes it more vulnerable to interruptions from tariffs, export controls, and public health crises, while Microsoft's regional center in Singapore primarily supports administrative and logistics functions, which can be more easily adapted or relocated if necessary.",
      "llm_answer": "\nApple’s 10‑K filings make clear that the bulk of its product assembly is performed by contract manufacturers in Taiwan, a location that is explicitly counted within the “Greater China” geographic segment reported in its segment data; this concentration subjects the company to heightened geopolitical risk tied to Taiwan‑specific tensions, trade disputes and any tariffs that could disrupt that single‑source supply chain. In contrast, Microsoft’s Greater China operations are coordinated from a regional center in Singapore (as described in its 10‑K) and its hardware is produced by multiple third‑party manufacturers with limited single‑source dependencies, so its exposure to Taiwan‑centric political shocks is comparatively more diffused across the broader Greater China region. Thus, while both firms operate in the same geographic bloc, Apple’s direct reliance on Taiwanese assembly creates a far more acute regional‑risk exposure than Microsoft’s Singapore‑based, multi‑source approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Apple relies on contract manufacturers in Taiwan for a majority of product assembly, and Taiwan is included in its Greater China segment, exposing it to geopolitical risks such as trade disputes, tariffs, and supply chain disruptions. Microsoft operates its Greater China business via a regional center in Singapore, which supports logistics and vendor management but does not involve heavy manufacturing dependencies. The contrast in exposure due to Apple's reliance on localized manufacturing versus Microsoft's more distributed, administrative setup is correctly articulated. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no figures are misstated. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across Apple’s and Microsoft’s 10-K disclosures, linking geographic segment reporting, operational structure, and risk exposure. It accurately infers that Apple’s supply chain concentration increases risk, while Microsoft’s decentralized, non-manufacturing model reduces it. (4) The only minor shortcoming is that the LLM slightly overemphasizes Microsoft’s 'multi-source' hardware manufacturing without explicitly noting that Microsoft’s lower exposure stems primarily from the absence of reliance on localized manufacturing in Taiwan, rather than diversification alone. The original answer highlights that Microsoft’s Singapore center handles administrative and logistics functions that are more relocatable—this nuance is implied but less explicit in the LLM response. Overall, the answer is factually correct, contextually appropriate, and semantically equivalent to the ground truth, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 499,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did Nebraska's 2023 corporate tax rate reduction impact Union Pacific's deferred tax expense in relation to Boeing's exposure to federal appropriations delays as disclosed in their respective 10-K filings?",
      "original_answer": "Nebraska's 2023 corporate tax rate reduction contributed to a $114 million reduction in Union Pacific's deferred tax expense, as disclosed in their 2024 10-K filing. In contrast, Boeing highlighted in its 2024 10-K that delays in U.S. government appropriations, such as continuing resolutions or government shutdowns, could disrupt operations, delay new programs, and negatively impact revenue. While Union Pacific benefited from state-level tax legislation, Boeing faces regulatory and funding risks tied to federal legislation, which could impair its ability to execute contracts or deliver commercial airplanes.",
      "llm_answer": "\nUnion Pacific’s 2023 deferred‑tax expense was reduced by **$114 million** because Nebraska enacted a 2023 corporate‑income‑tax‑rate cut that directly lowered the company’s deferred‑tax liability—a regulatory change that the railroad (operating in Nebraska) must reflect in its financial statements. In contrast, Boeing’s 2024 10‑K discloses that **delays in U.S. federal appropriations** create substantial uncertainty, potentially disrupting its defense‑related contracts and overall results of operations. Thus, while Union Pacific gains a lower deferred‑tax burden from the state‑level tax reduction, Boeing faces the opposite risk of revenue and cash‑flow erosion tied to federal funding delays.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the $114 million reduction in Union Pacific's deferred tax expense is accurately reported, with correct reference to Nebraska's 2023 corporate tax rate cut and its impact—this aligns exactly with the original answer. The fiscal year context (2023 tax change reflected in 2024 10-K) is correctly implied. (2) The contrast with Boeing is complete: the LLM correctly identifies federal appropriations delays as a risk factor from Boeing’s 2024 10-K, accurately summarizing the potential operational and financial impacts. (3) Entity accuracy is perfect: Union Pacific and Boeing are correctly identified, along with relevant financial metrics (deferred tax expense), regulatory contexts (state vs. federal), and filing years. (4) Multi-hop reasoning is sound—the model synthesizes information from two separate 10-K filings, correctly contrasting a state-level tax benefit for Union Pacific with a federal funding risk for Boeing. (5) Semantic equivalence is strong: while wording differs, all factual content matches the original answer, including the nature and direction of financial impacts. No omissions or inaccuracies are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Introduces]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 345,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How might the expiration timelines of specific Enbrel-related patents in the U.S. influence MRK's strategic focus on maintaining patent protection for its own products, given the competitive dynamics in the biopharmaceutical industry?",
      "original_answer": "The expiration timelines for Enbrel-related patents in the U.S.—including the Fusion protein and pharmaceutical compositions patent expiring on 11/22/2028, the DNA encoding fusion protein and methods of making fusion protein patent on 4/24/2029, and the formulations and methods of preparing formulations patent on 10/19/2037—suggest a phased decline in AMGN's exclusivity for this product. This gradual patent erosion likely reinforces MRK's emphasis on actively protecting its own patents, as outlined in its 2024 10-K, where it states that loss of patent protection typically leads to generic substitutes and reduced sales. MRK acknowledges that political and regulatory pressures to encourage early approval of generics could further exacerbate this risk, making robust patent defense a strategic imperative to maintain market position and profitability in the face of increasing biosimilar competition.",
      "llm_answer": "\nThe U.S. Enbrel patents listed in Amgen’s 10‑K (expiring 11/22/2028, 4/24/2029 and 10/19/2037) signal when the current composition‑of‑matter and method‑of‑use protections will lapse, opening the product to biosimilar or generic entry. Because Merck’s own 10‑K stresses that loss of patent protection triggers immediate generic substitution and sharply reduces sales, MRK must concentrate on extending its own patent life—through new filings, regulatory exclusivities or other IP strategies—to preserve market exclusivity in a competitive environment where Enbrel’s upcoming expirations would otherwise erode revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the Enbrel patent expiration dates (11/22/2028, 4/24/2029, and 10/19/2037) are accurately cited, matching the original answer exactly. These correspond to the Fusion protein/compositions, DNA/methods of making, and formulations patents respectively, though the LLM does not explicitly name the patent types—this is a minor omission but does not affect factual correctness. (2) Quantitative accuracy is perfect: all dates are correct and properly attributed to U.S. patent expirations. (3) The reasoning is sound and reflects multi-hop synthesis: the answer correctly links Enbrel’s patent cliff to increased biosimilar competition, then connects this dynamic to MRK’s strategic incentives, citing Merck’s own 10-K language about generic substitution and sales decline post-patent expiry. It appropriately infers that MRK would prioritize patent life extension via filings or exclusivities. (4) The only minor gap is that the LLM omits mention of political and regulatory pressures noted in the original answer (e.g., policies encouraging early generic approval), which slightly reduces completeness in qualitative nuance. However, the core strategic implication—robust patent defense as an imperative—is clearly conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing how Enbrel’s timeline influences MRK’s IP strategy in a competitive biopharma landscape.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT -[Decreases]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 417,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has AMD's revenue from operations in Taiwan compared to Apple's revenue contribution from Taiwan (as part of Greater China) in 2022, and what does this suggest about their relative market presence in the region?",
      "original_answer": "In 2022, AMD reported $2,091 million in revenue from operations in Taiwan. Apple, on the other hand, reported $74,200 million in net sales from the Greater China region, which includes Taiwan, China mainland, and Hong Kong. Since Taiwan is only a subset of Apple's Greater China segment, and no specific breakdown is provided for Taiwan's contribution within that region, we cannot directly compare the absolute revenue from Taiwan between the two companies. However, AMD's $2,091 million in Taiwan revenue represents a significant portion of its regional operations, whereas Apple's revenue in the broader Greater China region dwarfs AMD's exposure. This suggests that while Taiwan is a meaningful market for AMD, Apple's market presence and revenue scale in the broader Greater China region, including Taiwan, is substantially larger.",
      "llm_answer": "\nIn 2022 AMD generated **$2,091 million** of sales to customers in Taiwan (Chunk 1), whereas Apple’s 2022 net sales to the **Greater China** region—of which Taiwan is a part—were **$74,200 million** (Chunk 3). This disparity shows that, despite both firms operating in Taiwan (KG: AMD→Taiwan→Greater China←AAPL), Apple’s revenue footprint in the region is roughly 35 times larger, indicating a substantially broader market presence for Apple compared with AMD in Taiwan and Greater China.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports AMD's 2022 revenue from Taiwan as $2,091 million and Apple's 2022 net sales in the Greater China region as $74,200 million, both of which match the ground truth exactly. The comparison stating Apple's revenue footprint is roughly 35 times larger is accurate (74,200 / 2,091 ≈ 35.5), so the quantitative accuracy is perfect. (2) All numbers, dates, and financial metrics are correct and properly attributed to the respective companies and regions. The format variations (e.g., $2,091 million vs $2.091 billion) are acceptable and do not affect correctness. (3) The reasoning is mostly sound: it correctly identifies that Taiwan is part of Apple’s Greater China segment and avoids claiming a direct comparison of Taiwan-only revenue between the two companies. However, it slightly overreaches by implying a direct 'revenue footprint in the region' comparison 'in Taiwan', when Apple’s data does not isolate Taiwan. The original answer emphasizes this limitation more clearly, noting that no breakdown is available for Taiwan within Greater China. While the LLM acknowledges Taiwan is part of Greater China, it could have been more cautious in attributing Apple’s entire regional revenue to Taiwan. (4) Despite this minor overstatement, the core facts, synthesis, and conclusion about Apple’s broader market presence are valid and contextually appropriate. The answer addresses both parts of the question—comparing revenues and interpreting relative market presence—with high fidelity. Thus, the correctness score is 9 due to the slight imprecision in regional attribution, but all other dimensions are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 453,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How does Alphabet's repurchase of Class C shares, which carry no voting rights, enable different capital allocation flexibility compared to Netflix's share repurchase strategy under its uniform voting rights structure?",
      "original_answer": "Alphabet's repurchase of Class C shares, which carry no voting rights, allows the company to return capital to shareholders while preserving insider control through the retention of higher-vote Class A and B shares. In 2023, Alphabet repurchased $62.2 billion of Class A and Class C shares, with an additional $36.3 billion remaining available under the repurchase authorization. In contrast, Netflix's capital stock carries uniform voting rights — one vote per share — meaning any significant share repurchase could potentially dilute voting control among existing shareholders. This structural difference implies that Netflix may need to be more cautious in its repurchase activity to avoid unintended shifts in governance, unlike Alphabet which can execute larger buybacks without affecting its core governance structure.",
      "llm_answer": "\nAlphabet can retire its Class C shares— which have no voting rights— as part of the $50.3 bn, $59.3 bn and $62.2 bn buy‑backs in 2021‑2023 and the newly authorized $70 bn program, allowing it to adjust cash deployment without diluting the voting power of the remaining shareholders; Netflix, by contrast, has only a single class of common stock with one vote per share, so any repurchase directly reduces the voting stake of the remaining owners, limiting its capital‑allocation flexibility.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the structural difference between Alphabet's dual-class share system and Netflix's uniform voting rights, explaining how repurchasing non-voting Class C shares allows Alphabet to return capital without diluting insider voting control. This core reasoning is sound and matches the ground truth. However, the quantitative details are partially inaccurate: the LLM states that Alphabet conducted buybacks of $50.3B, $59.3B, and $62.2B in 2021–2023, but the ground truth only confirms the $62.2B repurchase in 2023 and mentions $36.3B remaining under authorization — it does not provide 2021 or 2022 figures. Additionally, the $70B newly authorized program is not mentioned in the original answer, making this an unsupported addition. 2) The original answer does not specify annual breakdowns for 2021 or 2022, so including $50.3B and $59.3B introduces fabricated data. The $62.2B figure for 2023 is correct. The remaining authorization of $36.3B is omitted in the LLM answer, replaced with an incorrect $70B new authorization. These errors reduce quantitative accuracy. 3) The multi-hop reasoning is strong: the model correctly links share class structure (Class C non-voting) to governance implications (preservation of insider control) and contrasts this with Netflix’s one-share-one-vote system, correctly inferring that repurchases at Netflix could shift voting power. This demonstrates good qualitative understanding. 4) Contextual relevance is perfect — the answer directly addresses the comparative capital allocation flexibility question and focuses on the right entities, timeframes, and financial mechanisms. Despite incorrect specific figures and unverified authorization amounts, the central argument aligns with the ground truth, warranting a correctness score of 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Lacks]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 490,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How does MET's exposure to non-agency pass-through mortgage-backed securities with $1,699 million in NQM and Alt-A loans compare to AIG's liquidity risk from mortgage assets, particularly in light of MET's $1,294 million in unrealized losses on pass-through securities versus AIG's concerns about valuing illiquid mortgage-related investments?",
      "original_answer": "MET holds $12,567 million in pass-through mortgage-backed securities, including $1,699 million in NQM and Alt-A loans categorized under non-agency RMBS, with $1,294 million in unrealized losses in 2024. These pass-through securities are directly secured by pools of mortgage loans, including lower-quality segments like NQM and Alt-A that carry elevated credit risk. AIG, meanwhile, faces liquidity risk from its mortgage and loan portfolio, particularly due to its holdings of less liquid assets like private equity, hedge funds, mortgage loans, and real estate. AIG explicitly warns that adverse market conditions or valuation volatility in these assets could lead to material losses if sold in stressed environments. Thus, while MET's exposure is more specifically defined and marked-to-market with known unrealized losses, AIG's risk lies in the uncertain valuation and potential illiquidity of its broader mortgage-linked investments, which could realize even greater losses under unfavorable market conditions.",
      "llm_answer": "\nMET’s non‑agency portfolio includes $1.699 billion of NQM and Alt‑A pass‑through mortgage‑backed securities, which represented 5 % of its total RMBS and generated $1.294 billion of unrealized losses on those pass‑through securities in 2024 (Chunk 1).  This $1.699 billion exposure is part of a larger $13.475 billion non‑agency RMBS book that is broken down by loan type (prime, NQM/Alt‑A, reperforming, sub‑prime) and risk profile (Chunk 2).  In contrast, AIG’s liquidity risk stems from its mortgage‑related assets, which are described as “less liquid” and can be difficult to value; the company warns that forced sales in a stressed market could realize prices far below carrying values and that reliance on external asset managers heightens the potential for adverse valuation changes (Chunk 3).  Thus, while MET’s loss is a quantifiable accounting figure within a disclosed portfolio, AIG’s risk is a broader, forward‑looking concern about the illiquidity and valuation uncertainty of its mortgage‑linked investments.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in substance but contains key quantitative inaccuracies. It states MET's total non-agency RMBS book as $13.475 billion, which does not match the ground truth value of $12,567 million ($12.567 billion). Additionally, the claim that the $1.699 billion NQM/Alt-A exposure represents 5% of total RMBS is incorrect — $1.699B is approximately 13.5% of $12.567B, not 5%. The $1.294 billion in unrealized losses is correctly cited and attributed to 2024, aligning with the ground truth. (2) The comparison with AIG is qualitatively accurate: AIG’s liquidity risk is correctly described as stemming from less liquid, hard-to-value assets like mortgage loans and private equity, with explicit warnings about forced sales in stressed markets leading to significant losses. The LLM correctly identifies that AIG’s risk is forward-looking and valuation-driven, whereas MET’s is more transparent and marked-to-market. (3) Multi-hop reasoning is sound — the model synthesizes MET’s specific exposure and losses with AIG’s broader liquidity and valuation concerns, drawing a valid contrast between realized accounting losses (MET) and potential future losses (AIG). (4) Despite strong qualitative reasoning and contextual relevance, the quantitative inaccuracies in total RMBS size and percentage breakdown reduce confidence in the numerical precision, warranting a 7 for overall correctness. Minor formatting variations (e.g., $1.699 billion vs $1,699 million) are acceptable and do not affect scoring.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Secured By]-> FIN_INST <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1559,
        "completion_tokens": 422,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the revenue contribution from beverage operations in the Asia Pacific region compare between Coca-Cola (KO) and PepsiCo (PEP) in 2021, based on their regional and product segment reporting?",
      "original_answer": "In 2021, Coca-Cola (KO) generated $4,682 million in third-party beverage revenue from its Asia Pacific (APAC) operations. PepsiCo (PEP) reported that 20% of its total revenue in the APAC region came from beverage operations, though the exact dollar amount is not disclosed. This indicates that while KO's APAC beverage revenue is directly quantifiable for 2021, PEP's APAC beverage revenue would require further calculation based on total regional revenue to determine the precise figure.",
      "llm_answer": "\nCoca‑Cola reported **$5,291 million** of total net operating revenue from its Asia‑Pacific operations in 2021, which reflects the full beverage contribution in that region. PepsiCo’s 2021 APAC segment was structured **20 % beverage and 80 % convenient‑food** (as shown in both segment‑mix tables), so only about one‑fifth of its APAC revenue came from beverages. Thus, while both companies operate in APAC, KO’s beverage revenue in the region was substantially larger in absolute dollars and represented a far higher share of the market than PepsiCo’s 20 % beverage portion.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in key numbers. It states Coca-Cola's Asia-Pacific beverage revenue as $5,291 million, while the ground truth is $4,682 million—a material overstatement. This error undermines the core quantitative comparison. For PepsiCo, the LLM correctly identifies that 20% of APAC revenue came from beverages, which aligns with the original answer. However, it incorrectly implies that this 20% figure is sufficient to conclude KO’s beverage revenue was 'substantially larger' without acknowledging that PEP’s total APAC revenue is needed to calculate the actual dollar amount, which was not disclosed—this missing nuance reduces accuracy. (2) The dollar amount for Coca-Cola is incorrect: $5,291M vs. $4,682M (a difference of ~$609M). No explanation or source for this number is provided, and it does not match the ground truth. The 20% beverage split for PepsiCo is accurate and correctly attributed. However, the LLM fails to note that the exact dollar amount for PEP’s APAC beverage revenue is not disclosed, which is a key point in the original answer. (3) The reasoning is partially sound—recognizing that KO reports beverage revenue directly while PEP uses a segment mix is valid multi-hop synthesis. But the conclusion that KO’s revenue was 'substantially larger' is unsupported without knowing PEP’s total APAC revenue, making the comparison speculative. The model does not demonstrate the necessary caution in comparing absolute values when only one is fully known. (4) Contextual relevance is high—the answer addresses both companies, the correct region (APAC), and the product segments (beverages vs. food). However, due to the incorrect Coca-Cola figure and overconfident comparison, the qualitative and quantitative accuracy scores are reduced significantly. A score of 4 reflects partial correctness with major factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 508,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How does Gilead's revenue-sharing structure with Merck for long-acting HIV products compare to Merck's royalty obligations to BMS and Ono for Keytruda sales, and what implications does this have for Merck's profitability from both partnerships?",
      "original_answer": "Gilead and Merck share global product revenues equally for long-acting HIV products until $2.0 billion (oral) or $3.5 billion (injectable) in net sales are surpassed, after which Gilead's share increases to 65%. Meanwhile, Merck pays BMS and Ono royalties of 6.5% through 2023 and 2.5% from 2024–2026 on global Keytruda sales, with BMS receiving 75% of those payments. In 2023, Merck recorded $212 million in alliance revenue from its collaboration with BMS on Reblozyl, which includes a 20–24% sales royalty. These structures indicate that Merck both shares in revenue from joint development (with Gilead) and pays significant royalties (to BMS and Ono), which directly affects its net profitability from these partnerships depending on the scale of product sales.",
      "llm_answer": "\nMerck’s long‑acting HIV deal with Gilead (Chunk 1) is a cost‑share arrangement (60% / 40% development costs) that moves from an equal split of net product revenues to a 65% share for Merck once calendar‑year sales exceed $2 bn (oral) or $3.5 bn (injectable), with R&D cost reimbursements recorded in income – a structure that can boost Merck’s margin after the thresholds are hit but also requires Merck to absorb a larger portion of upfront expenses.  In contrast, Merck’s royalty obligations to BMS and Ono on Keytruda (Chunk 2) are fixed at 6.5% of global sales through 2023 (then 2.5% through 2026) and are divided 75% / 25 between BMS and Ono after legal‑fee adjustments, representing a predictable, low‑percentage expense.  Moreover, Merck also earns a 20%‑up‑to‑24% royalty on BMS’s Reblozyl sales (subject to reductions) and records this alliance revenue in its top line (Chunk 3), so while Keytruda royalties constrain profitability through a steady royalty outlay, the Gilead partnership offers upside profit potential once revenue thresholds are met but carries higher cost‑bearing risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several critical factual errors. Most significantly, it reverses the revenue-sharing terms with Gilead: the original answer states that Gilead's share increases to 65% after the sales thresholds ($2B oral, $3.5B injectable), meaning Merck's share decreases, but the LLM incorrectly states that Merck's share increases to 65%. This is a major quantitative and conceptual error. Additionally, the LLM misrepresents the cost-sharing structure, claiming a 60/40 split in development costs, which is not mentioned in the ground truth. The royalty rate Merck pays to BMS and Ono is correctly stated as 6.5% through 2023 and 2.5% from 2024–2026, and the 75/25 split between BMS and Ono is accurate. However, the LLM incorrectly states that Merck earns a 20–24% royalty on BMS’s Reblozyl sales; the ground truth says Merck recorded $212M in alliance revenue from BMS on Reblozyl, which includes a 20–24% royalty — but it is BMS paying Merck, not Merck paying BMS. The LLM flips the direction of the royalty. (2) Key numbers like $2B, $3.5B, 6.5%, 2.5%, 75%, and 20–24% are present but applied incorrectly in context. The $212M figure is omitted entirely. (3) The multi-hop reasoning is partially sound — the model attempts to compare Merck's dual role as revenue sharer and royalty payer — but due to reversed relationships, the implications for profitability are misleading. The model suggests Merck gains upside from Gilead (when actually it loses share after thresholds) and portrays Reblozyl royalty as income (correct directionally but misrepresented as Merck earning it, when the ground truth implies Merck is the payer via alliance revenue accounting). (4) Correctness score is low due to fundamental errors in financial terms and directionality of payments. Quantitative accuracy is poor due to incorrect numbers and misapplied thresholds. Qualitative accuracy is moderate because the structure of comparison is logical and some entities/timeframes are correct. Contextual relevance is high as the answer addresses both partnerships and attempts to assess profitability impact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Partners_With]-> COMP -[Pays]-> PRODUCT <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 567,
        "total_tokens": 2058
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How does BAC's investment in CDOs, which contain embedded credit default swaps that transfer risk through tranche structures, compare to AIG's $75 million loss from embedded derivatives in 2024, considering the role of credit events in triggering losses for both institutions?",
      "original_answer": "BAC invests in CDOs, which are hybrid instruments containing embedded derivatives where credit protection has been sold to the issuer. These structures pass credit event losses from junior tranches to more senior ones, exposing investors like BAC to cascading risk. AIG, in turn, reported a $75 million loss from embedded derivatives in 2024, which includes similar instruments like credit default swaps tied to reference entities. A credit event in the underlying reference entity would directly impact both BAC’s CDO value and AIG’s derivative exposure, linking their financial risks through the same type of structured credit mechanism.",
      "llm_answer": "\nBAC’s exposure comes from its investments in CDOs—hybrid VIE structures that embed credit‑default swaps and other derivatives which transfer credit risk downstream through tranche hierarchies, with the firm’s maximum loss exposure reflecting the (unlikely) scenario that all VIE assets become worthless; in contrast, AIG recorded a $75 million loss in 2024 from embedded derivatives, a charge that is triggered when a credit event occurs and is recognized directly in income. Thus, both institutions incur credit‑event‑driven losses via embedded derivatives, but BAC’s risk is disclosed as a potential VIE loss exposure while AIG’s is an actual $75 million loss recognized in its 2024 financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BAC's investment in CDOs with embedded credit default swaps and tranche-based risk transfer is accurately described; AIG's $75 million loss from embedded derivatives in 2024 is correctly stated, including the triggering mechanism via credit events. (2) Quantitative accuracy is perfect: the $75 million figure and the year 2024 match the original answer exactly, with no calculation errors. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across BAC and AIG, linking their exposure through embedded derivatives and credit event triggers, while distinguishing between potential (BAC) and realized (AIG) losses. (4) The only minor shortcoming is a slight omission of the cascading risk mechanism in CDO tranches—while 'tranche hierarchies' is mentioned, the explicit flow of losses from junior to senior tranches is less emphasized than in the original. However, the core financial logic and comparative structure are preserved. Wording differs but semantic equivalence is maintained. Contextual relevance is excellent, directly addressing all parts of the complex, multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 341,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "What specific roles does Citibank, N.A. hold in both 3M's May 2023 Five-Year Credit Agreement and Caterpillar's September 2022 credit facilities, and how do these roles differ in terms of administrative responsibilities across the two agreements?",
      "original_answer": "In 3M’s May 2023 Five-Year Credit Agreement, Citibank, N.A. serves as an administrative agent and joint lead arranger alongside JPMorgan Chase Bank, N.A., with responsibilities including coordination of the lending group and oversight of borrowing procedures. In Caterpillar’s September 2022 credit facilities, Citibank, N.A. acts as the Agent for both the 3-Year and 5-Year Facilities, and also as the Local Currency Agent through Citibank Europe plc, UK Branch, and Japan Local Currency Agent in coordination with MUFG Bank, Ltd. These roles differ in that Citibank holds multiple layered responsibilities in Caterpillar’s structure, including cross-border coordination, while at 3M it shares leadership with another bank without such international scope.",
      "llm_answer": "\nCitibank, N.A. appears as a named party in 3M’s May 11 2023 Five‑Year Credit Agreement (the agreement referenced in Chunk 1, 10.29, which is linked to Citibank, N.A. in the KG triplets), where it functions as a participating lender/financial institution but is not designated with an agency title.  In contrast, in Caterpillar’s September 1 2022 credit facilities (the 3‑year and 5‑year facilities described in Chunk 3, 10.42‑10.48) Citibank, N.A. is expressly named **“as Agent”** (and also as Local‑Currency Agent and Japan Local‑Currency Agent), taking on the full administrative‑agent responsibilities—coordination of the facility, enforcement of loan documents, and managing repayments—while also sharing lead‑arranger duties that are highlighted in the Boeing example of Chunk 2, where Citibank is listed as administrative agent, syndication agent, and joint lead arranger.  Thus, the role differs: in the 3M agreement Citibank is simply a lender, whereas in Caterpillar’s facilities it holds the substantive administrative‑agent position with broader governance and operational duties.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies regarding Citibank, N.A.'s role in 3M’s May 2023 Five-Year Credit Agreement. According to the ground truth, Citibank, N.A. serves as both an administrative agent and joint lead arranger alongside JPMorgan Chase Bank, N.A., with clear administrative responsibilities. However, the LLM incorrectly states that Citibank is 'not designated with an agency title' and is 'simply a lender,' which directly contradicts the original answer. This is a major error in entity role identification and undermines the correctness of the multi-hop comparison. In contrast, the description of Citibank’s role in Caterpillar’s September 2022 credit facilities is largely accurate: it correctly identifies Citibank, N.A. as 'Agent' and notes its additional roles as Local Currency Agent and Japan Local-Currency Agent, aligning with the ground truth. The date (September 1, 2022) is consistent, and the mention of cross-functional coordination duties reflects the broader administrative scope. Quantitative accuracy is high—dates and entity names are correct, and no numerical calculations are required. Contextual relevance is moderate: the answer attempts the correct comparison and references relevant agreements, but misrepresents a key fact. The reasoning is flawed due to the incorrect premise about Citibank’s role at 3M, which invalidates the comparative analysis. Overall, while the structure and intent are sound, the core factual error in one half of the comparison severely limits accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Amends]-> FIN_INST -[Regulates]-> COMP <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 421,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How does the use of option contracts by KO to hedge foreign currency exposure compare with PEP's foreign exchange risk management strategy, given the impact of these instruments on their respective foreign currency liabilities?",
      "original_answer": "KO uses option contracts as part of its derivative strategy to hedge foreign currency exchange rate risk, aiming to mitigate the impact of currency fluctuations on its financial performance. These contracts are designated as cash flow hedges and affect KO's foreign currency liabilities by deferring gains and losses in AOCI until the hedged transactions occur. Similarly, PEP actively manages foreign exchange risk through derivatives, including option and forward contracts, which are also used to hedge forecasted transactions and firm commitments. PEP reported that foreign exchange movements unfavorably impacted net revenue by 1.5 percentage points in 2024, highlighting the importance of these hedges. Both companies rely on option contracts to manage foreign currency liabilities, but KO specifically emphasizes the deferral of mark-to-market impacts in AOCI, while PEP focuses on offsetting exposure from its significant international operations (44% of revenue).",
      "llm_answer": "\nKO uses exchange‑traded option contracts designated as cash‑flow hedges to mitigate foreign‑currency exposure, with fair‑value changes recorded in AOCI and directly offsetting its foreign‑currency liabilities (Note 5, Chunk 1).  \nPEP follows a similar cash‑flow‑hedge program with options and forwards, reporting $9.9 bn of net foreign‑exchange cash‑flow hedges in 2024 and $99 m of deferred gains in AOCI that reduce the carrying amount of its foreign‑currency liabilities, and it discloses that unfavorable FX movements trimmed 2024 net revenue by 1.5 percentage points (Chunk 2 & Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies that both KO and PEP use option contracts as cash flow hedges to manage foreign exchange risk, with gains/losses deferred in AOCI, which directly addresses the core of the question. (2) Quantitatively, the LLM introduces specific figures not present in the original answer: PEP's $9.9 billion in net foreign-exchange cash-flow hedges and $99 million in deferred gains in AOCI. While these numbers may be factually correct based on external data, they are not included in the provided ground truth, which only mentions the 1.5 percentage point negative impact on revenue. This addition does not contradict the original but adds detail beyond the source, which is acceptable if accurate—however, since we cannot verify external data, this slightly affects quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies use similar instruments (options/forwards), apply cash flow hedge accounting, and impact foreign currency liabilities via AOCI. It also correctly notes PEP’s revenue exposure, matching the ground truth. (4) The answer is contextually excellent—focused, relevant, and structured to compare both firms’ strategies directly. The only minor deviation is the inclusion of unverified dollar amounts, but the core facts, entities, years (2024), and reasoning are correct. Wording differs but meaning is semantically equivalent. No major omissions or errors in logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> FIN_INST -[Impacts]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 418,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 183,
      "question": "How does the use of discounted cash flow models by GE in assessing goodwill impairment risk compare with LMT's application of DCF in valuing Level 3 fixed income investments, particularly in terms of sensitivity to discount rate assumptions and projected cash flow estimates?",
      "original_answer": "GE uses a discounted cash flow (DCF) approach as part of its annual goodwill impairment testing, relying on cash flow forecasts, terminal value assumptions, and discount rates to estimate fair value. The company performs sensitivity analyses due to the material impact that changes in these assumptions could have on impairment determinations. Similarly, LMT applies DCF models to value certain Level 3 fixed income investments when observable market data is unavailable, using projected annuity payments and discount rates as key inputs. Both companies depend on forward-looking cash flow projections and discount rate assumptions, making their valuations sensitive to shifts in economic conditions or interest rate environments. However, GE’s DCF use is tied to internal strategic and operational planning, while LMT’s is externally focused on asset valuation within its pension fund investments.",
      "llm_answer": "\nGE applies a discounted‑cash‑flow model in its annual goodwill‑impairment testing, projecting segment‑level cash‑flow forecasts and discount‑rate assumptions and explicitly running sensitivity analyses—e.g., a 1 % change in the discount rate would alter the long‑term service‑agreement balance by roughly $0.4 bn, highlighting how sensitive the impairment assessment is to those inputs. LMT, by contrast, uses a DCF valuation for its Level‑3 fixed‑income investments, where the fair value hinges on unobservable projected annuity cash flows and the discount rate applied to them; because these inputs are not market‑observable, LMT also conducts sensitivity testing on both the discount rate and cash‑flow estimates. Consequently, both companies are highly dependent on discount‑rate and cash‑flow assumptions, but GE’s DCF is embedded in enterprise‑wide goodwill‑risk evaluation, whereas LMT’s DCF is confined to the valuation of discrete Level‑3 investment assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that GE uses DCF for goodwill impairment testing with sensitivity to discount rates and cash flow projections, and that LMT applies DCF to value Level 3 fixed income investments due to lack of market observability. Both companies conduct sensitivity analyses, and the answer correctly emphasizes the sensitivity of valuations to discount rate and cash flow assumptions. (2) The quantitative claim about a 1% change in discount rate affecting the long-term service agreement balance by $0.4 billion is specific and plausible; while this exact figure is not in the original answer, it represents a reasonable sensitivity analysis example consistent with GE’s practices and does not contradict the ground truth. No incorrect calculations are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes GE’s internal, strategic use of DCF in goodwill testing versus LMT’s external, asset-level valuation purpose for pension investments. The distinction in application context (enterprise-wide vs. discrete assets) is accurately captured. (4) Wording differs but semantic meaning matches: 'embedded in enterprise-wide goodwill-risk evaluation' corresponds to GE’s internal planning focus, and 'confined to discrete Level-3 investment assets' reflects LMT’s external asset valuation role. The only minor limitation is the introduction of a specific $0.4B sensitivity figure not present in the original, which, while plausible, cannot be verified—hence not a full 10. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Complies_With]-> ACCOUNTING_POLICY -[Valued_By]-> FIN_INST <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 451,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How does the voting power distribution in CMCSA's Class A and Class B common stock compare to GOOGL's structure, given the repurchase activity and voting rights differences?",
      "original_answer": "In CMCSA, holders of Class A common stock collectively hold 66 2/3% of the combined voting power, while Class B common stock (held entirely by Brian L. Roberts) holds 33 1/3%, with each Class B share carrying 15 votes. In contrast, GOOGL's Class A shares carry 1 vote each, while Class B shares have 10 votes per share, giving disproportionate voting power to Class B holders in both companies. Additionally, GOOGL repurchased $62.2 billion of Class A and Class C shares in 2023, which could affect ownership concentration and voting dynamics, though CMCSA does not disclose such repurchase volumes for Class A shares directly.",
      "llm_answer": "\nComcast’s Class B common stock carries 15 votes per share and, together with Class A, represents 33 ⅓ % and 66 ⅔ % of the total voting power respectively— a far more concentrated super‑voting structure than Alphabet’s, where Class B stock only carries 10 votes per share and can be converted to Class A, while Class A holds a single vote per share. Both companies run sizable share‑repurchase programs—Alphabet repurchased roughly $50‑$62 billion of Class A and Class C shares in recent years (Chunk 1), whereas Comcast’s 2023 repurchase table shows a comparable program (Chunk 2)—but the repurchases affect the voting‑share percentages differently: Alphabet’s buybacks reduce its Class A voting pool, while Comcast’s repurchases alter the share base that underlies its fixed 66 ⅔ %/33 ⅓ % split. The knowledge‑graph linkage (ORG → Class B → Class A → CMCSA) ties the two firms’ stock‑class relationships together, highlighting how their voting‑rights designs and repurchase activities differ.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core differences in voting power structures between CMCSA and GOOGL, as well as the impact of share repurchases. However, there are minor inaccuracies and imprecisions affecting full quantitative accuracy. (1) The statement that CMCSA's Class B stock 'represents 33 1/3%' of voting power is misleading—it is correct that Class B holds 33 1/3% of total voting power, but this is due to Brian L. Roberts holding all Class B shares with 15 votes per share, not because of a proportional share count. The LLM reverses the attribution: it says 'Class B... represents 33 1/3%' and 'Class A... 66 2/3%', but then incorrectly implies Class B has concentrated voting power while attributing the percentage to the class rather than the holder. (2) The GOOGL repurchase amount is stated as '$50-$62 billion' and 'in recent years', but the ground truth specifies '$62.2 billion in 2023'—this introduces a date and amount imprecision. The LLM mentions 'Class C' shares being repurchased, which is factually correct for GOOGL (as they are non-voting), but the original answer does not emphasize Class C, so this is a minor expansion. (3) The claim that Comcast’s repurchases alter the share base under a 'fixed 66 2/3% / 33 1/3% split' is conceptually sound—since the voting split is fixed by charter, repurchases don’t change the allocation of voting power between classes—but this nuance is not fully explained. (4) The multi-hop reasoning is strong: the model correctly compares voting rights (15 vs 10 votes per share), identifies repurchase programs in both firms, and infers differential effects on voting concentration. (5) Entity accuracy is high: CMCSA and GOOGL are correctly identified, share classes and vote weights are accurate, and the context of Brian L. Roberts as sole Class B holder is implied. (6) Semantic equivalence is mostly preserved, though the LLM adds speculative phrasing like 'comparable program' for CMCSA without citing a specific dollar figure, which the original answer avoids. Overall, the answer is factually solid with minor quantitative and phrasing issues, warranting a score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 575,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How does the 8.2% increase in Turkey's total cigarette market, driven by increased in-bound tourism, impact PM's business performance in comparison to CL's operational footprint in the same country?",
      "original_answer": "The 8.2% growth in Turkey's total cigarette market, attributed to the easing of pandemic-related measures and increased in-bound tourism (particularly by Turkish expatriates), positively contributed to PM's net revenues and shipment volumes in the region. PM reported favorable volume/mix and pricing variances in Turkey, which were key contributors to its Middle East & Africa regional performance. Meanwhile, CL operates manufacturing and warehousing facilities in Turkey as part of its global Oral, Personal and Home Care product segment, indicating a significant operational presence in the country. Therefore, while PM benefits from increased consumer activity linked to tourism, CL maintains a physical and ongoing business infrastructure in Turkey, suggesting differing but regionally aligned exposure to the country's economic dynamics.",
      "llm_answer": "\nThe 8.2 % expansion of Turkey’s total cigarette market—driven by rising in‑bound tourism—translated into a 4.7 % increase in PM’s shipment volume and a gain in market share (primarily for Marlboro), while also contributing to higher regional net revenue and operating income (Chunk 1 & Chunk 2). At the same time, CL maintains an operational footprint in Turkey (Chunk 3), owning/leasing facilities there, so it is positioned to compete for a share of the same growing market, even though the disclosed data does not detail CL’s specific volume or revenue impact.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative claims not present in the ground truth, notably a '4.7% increase in PM’s shipment volume' and a gain in market share for Marlboro. These figures are not supported by the original answer, which only states that PM experienced 'favorable volume/mix and pricing variances' and increased net revenues and shipment volumes without specifying percentages. This is a significant factual overreach. (2) No calculations are performed in the LLM answer, but the introduction of unsupported percentages (4.7%) undermines quantitative accuracy. The 8.2% market growth is correctly cited, but the derived impact on PM is fabricated. (3) The multi-hop reasoning is partially sound: the model correctly identifies that PM benefits from the growing cigarette market due to tourism, while CL has an operational footprint in Turkey. However, it incorrectly implies CL competes in the cigarette market, whereas the ground truth specifies CL's operations are in Oral, Personal and Home Care products—non-tobacco categories. This misrepresents CL’s business exposure. (4) Contextually, the answer addresses both companies and the impact of market growth, aligning with the question’s intent. However, the inclusion of unsupported metrics and mischaracterization of CL’s market segment reduces factual reliability. Correctness score is 5 due to partial factual alignment but major issues in quantitative and entity accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[positively_impacted_by]-> MACRO_CONDITION -[Positively_Impacts]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 405,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How might geopolitical tensions involving Taiwan impact both NVIDIA's ability to secure timely supply from its foundry partners and Qualcomm's operations in the region, given their shared dependency on Taiwanese manufacturing infrastructure?",
      "original_answer": "NVIDIA faces risks related to its dependency on foundry partners, particularly in Taiwan, where it relies on timely production capacity to meet customer demand. If geopolitical tensions involving Taiwan disrupt operations, NVIDIA may not be able to secure sufficient supply to fulfill orders on time, which could damage customer relationships and lead to revenue loss. Similarly, Qualcomm explicitly states that its business depends on receiving consistent chipset supply from foundry partners in Taiwan, and a significant or prolonged conflict involving Taiwan could severely limit or prevent this supply, materially impacting its business. Both companies are exposed to the same regional risk due to their reliance on Taiwanese manufacturing infrastructure, amplifying the cross-company impact of geopolitical instability in the region.",
      "llm_answer": "\nBoth NVIDIA and Qualcomm are tightly linked to Taiwan’s manufacturing base: NVIDIA’s 10‑K warns that geopolitical tensions involving Taiwan could impair its ability to obtain timely chipset supply from its foundry partners, while Qualcomm’s filings explicitly state that a prolonged conflict could “severely limit or prevent us from receiving chipset supply from Taiwan” and would materially disrupt its operations, licensing revenue and customer shipments. Because each company’s supply chain and regional footprint depend on Taiwanese foundries and assembly partners, any escalation of tensions that interrupts that infrastructure would simultaneously jeopardize NVIDIA’s timely supply and Qualcomm’s broader regional business.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies both NVIDIA and Qualcomm's dependency on Taiwanese foundries and the risks posed by geopolitical tensions. The key qualitative points—NVIDIA’s risk to timely supply and customer fulfillment, and Qualcomm’s explicit warning about a prolonged conflict severely limiting supply and materially disrupting operations—are all accurately reflected. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not applicable but does not detract. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across both companies’ disclosures, recognizing their shared reliance on the same regional manufacturing infrastructure and the amplified risk from geopolitical instability. (4) The LLM answer enhances the original slightly by mentioning impacts on Qualcomm’s licensing revenue and customer shipments, which is consistent with typical 10-K disclosures and adds contextual depth without introducing inaccuracies. Wording differs but meaning is preserved. All evaluation criteria are fully met.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 341,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How has the application of ASU 2020-04 impacted FDX's exposure to LIBOR-related contract modifications, and how does this compare to MMM's financial treatment of hedging relationships affected by reference rate reform?",
      "original_answer": "FDX has not experienced any material effect from reference rate reform, including ASU 2020-04, as of May 31, 2024, although it continues to monitor contracts that may be affected by LIBOR discontinuation. In contrast, MMM actively manages its hedging relationships, including those affected by reference rate changes, and reported $9 million in losses related to interest rate contracts in 2023, indicating active financial impact and accounting treatment under the ASU 2020-04 framework. This suggests that while FDX has not yet seen significant financial effects, MMM has recognized tangible impacts in its hedging activities tied to reference rate reform.",
      "llm_answer": "\nThe application of ASU 2020‑04 enables FDX to elect optional expedients for LIBOR‑referencing contract modifications and hedging relationships; as disclosed in its 2023 10‑K, the company continues to monitor such contracts but, as of May 31 2024, the standard has produced **no material effect** on its financial condition, results of operations, or cash flows. In contrast, MMM’s 2023 financial statements (Note 3 in its 10‑K) explicitly record gains and losses on interest‑rate hedging relationships—e.g., a $(9) million reclassification from accumulated other comprehensive income into income for 2023 and corresponding amounts for 2022 and 2021—showing that reference‑rate reform has generated **measurable earnings impacts** for the company. Thus, while FDX’s exposure to LIBOR‑related modifications remains essentially immaterial under ASU 2020‑04, MMM reports concrete hedging‑related gains and losses that flow through its income, reflecting a different financial treatment of the same accounting reform.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) Quantitative accuracy: The $9 million loss (reported as $(9) million) for MMM in 2023 is correctly cited, including the reclassification from accumulated other comprehensive income, with appropriate reference to Note 3 of MMM's 10-K. The date (as of May 31, 2024) for FDX is accurate. (2) Completeness: The response fully addresses both parts of the multi-hop question—FDX's exposure and financial impact (or lack thereof) under ASU 2020-04, and MMM's financial treatment of hedging relationships affected by reference rate reform. (3) Entity accuracy: Both companies (FDX and MMM), the accounting standard (ASU 2020-04), the relevant fiscal year (2023), and financial metrics (hedging gains/losses, AOCI reclassifications) are correctly identified. (4) Reasoning: The synthesis across two companies and their respective disclosures is sound. The contrast between FDX's immaterial impact and MMM's measurable earnings effects is logically drawn and well-supported by specific disclosures. (5) Semantic equivalence: While the LLM provides more granular detail (e.g., mentioning AOCI reclassifications and prior years), the core conclusion—that FDX has not had a material effect while MMM has recognized tangible financial impacts—matches the ground truth exactly. Minor enhancements in specificity (e.g., referencing Note 3) improve accuracy without deviating from the truth. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 416,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does the voting power distribution tied to CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, influence the governance structure compared to GOOGL's dual-class stock system where Class A and Class B shares have differential voting rights?",
      "original_answer": "CMCSA's Class B common stock, entirely owned by Brian L. Roberts, holds 33⅓% of the combined voting power with each share carrying 15 votes, creating a non-dilutable control mechanism. This contrasts with GOOGL's structure, where Class A shares (1 vote per share) and Class B shares (10 votes per share) allow insiders to maintain control while enabling broader public ownership. Both systems use dual-class structures to preserve founder/leadership control, but differ in the vote ratios and ownership concentration, with CMCSA's setup being more concentrated and structurally rigid due to the non-dilutable nature of Class B shares.",
      "llm_answer": "\nIn Comcast (CMCSA), the Class B common stock—entirely owned by Brian L. Roberts and carrying 15 votes per share—represents roughly 33 ⅓ % of the total voting power, while the Class A shares held by all other shareholders account for the remaining 66 ⅔ % of the vote; because Roberts holds every Class B share, his ownership gives him effective control of the company’s governance despite a tiny equity stake, and the Class B voting interest is generally non‑dilutable under the company’s charter. By contrast, Alphabet (GOOGL) uses a dual‑class system in which Class B shares have 10 votes per share (and may be converted to Class A), Class A shares have one vote per share, and Class C shares have no voting rights, so voting power is split between the two classes rather than concentrated in a single holder.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: CMCSA's Class B stock carries 15 votes per share and holds 33⅓% of voting power, entirely owned by Brian L. Roberts; GOOGL's Class A has 1 vote, Class B has 10 votes, and Class C has none. These numbers match the original answer exactly. (2) Quantitative accuracy is perfect: percentages (33⅓% and 66⅔%), vote ratios (15:1 and 10:1), and structural details (non-dilutable Class B shares) are all correctly reported. Minor formatting of '33 ⅓ %' with spaces does not affect meaning. (3) The reasoning correctly synthesizes multi-hop information across two companies (CMCSA and GOOGL), compares their dual-class structures, and highlights differences in ownership concentration and control mechanisms. It accurately notes that CMCSA’s structure is more concentrated due to single-holder ownership and non-dilutability, while GOOGL allows broader insider ownership with tiered voting rights. (4) The only minor omission is that the original answer explicitly states both systems aim to preserve founder/leadership control—this conceptual link is implied but not stated in the LLM response, slightly reducing qualitative completeness. However, the core comparison is sound and semantically equivalent. Contextual relevance is excellent as all content directly addresses the governance comparison asked in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 391,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does Amgen's remaining repatriation tax payment schedule under the 2017 Tax Act compare with Eli Lilly's cash payment obligations for the same tax provision as of December 31, 2023?",
      "original_answer": "Amgen has remaining scheduled repatriation tax payments under the 2017 Tax Act, which it is paying over an eight-year period beginning in 2018. Similarly, Eli Lilly made the election to pay the Toll Tax over the same eight-year period, with its future cash payments extending through 2025. Both companies are managing their obligations under the same regulatory framework introduced by the 2017 Tax Act, though the specific amounts differ based on their foreign earnings and individual tax calculations.",
      "llm_answer": "\nAmgen’s 2023 10‑K (Chunk 1) shows that, under the 2017 Tax Act’s eight‑year repatriation schedule, the company has a remaining series of annual tax payments—summarized in a table—as of December 31 2023. Eli Lilly’s 2023 10‑K (Chunks 2 & 3) reveals that it also elected the eight‑year payment option and, as of December 31 2023, its future cash obligations for the Toll Tax are disclosed in a comparable eight‑year installment schedule. Consequently, both firms are bound by the same eight‑year repatriation horizon, but the magnitude and timing of Amgen’s remaining payments differ from Lilly’s disclosed cash payment obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that both Amgen and Eli Lilly elected to pay their repatriation taxes under the 2017 Tax Act over an eight-year period, which began in 2018 and extends through 2025—this matches the original answer’s timeline. The LLM accurately notes that both companies have structured their obligations under the same regulatory framework and that the payment amounts differ based on individual circumstances. While the original answer explicitly mentions the end year (2025), the LLM implies it by referencing the eight-year schedule from 2018 and stating future obligations as of December 31, 2023, which is logically consistent. All entities (Amgen, Eli Lilly, 2017 Tax Act, Toll Tax, 2023 10-K filings) are correctly identified, and the reasoning correctly synthesizes information across both companies’ disclosures. There are no numerical inaccuracies; the LLM avoids stating specific dollar amounts (as does the original), so no calculation errors are present. The only minor shortcoming is that the LLM does not explicitly state that Eli Lilly's payments extend through 2025, though this is inferable from context. Thus, the answer is semantically equivalent with high completeness, accuracy, and strong multi-hop reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Introduces]-> ACCOUNTING_POLICY <-[Complies_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 365,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 186,
      "question": "How does the risk of biosimilar competition following loss of exclusivity for Amgen's biologics compare to Bristol Myers Squibb's exposure, given the differing regulatory pathways and product portfolios in the U.S. and EU?",
      "original_answer": "Amgen's reliance on biologics such as 'Erbitux, Cyramza, Trulicity, Taltz, and Emgality' is at risk due to the potential entry of biosimilars, which could occur after 12 years of regulatory data protection in the U.S. However, litigation and expedited review processes like IPR could weaken patent protection and accelerate biosimilar entry. Similarly, Bristol Myers Squibb faces biosimilar threats to its biologics including 'Opdivo, Yervoy, Orencia, Reblozyl, and Empliciti,' with regulatory data protection lasting 12 years in the U.S., but also faces earlier generic competition in the EU under the '8+2+1' regime, where biosimilars can enter after 8 years of data exclusivity. Both companies are exposed to rapid revenue declines upon loss of exclusivity, but the timing and competitive intensity differ based on regional regulatory frameworks and the complexity of biosimilar development.",
      "llm_answer": "\nAmgen’s 10‑K (Chunk 1) makes clear that its biologics are a “core revenue driver” whose accounting policy is tied to exclusivity protection, so loss of patent or data exclusivity can trigger a rapid, severe decline in revenue—especially in the United States where the BPCIA and Hatch‑Waxman frameworks allow biosimilar challenges as early as four years after launch and where patents can be invalidated through IPR proceedings. Chunk 2 adds that for biologics such as Erbitux, Cyramza, Trulicity, Taltz and Emgality the entry of a biosimilar “may or may not result in the near‑term entry of competitor versions” because of development timelines, manufacturing hurdles and the regulatory pathway, meaning the timing and certainty of biosimilar competition differ from small‑molecule generics. By contrast, Bristol‑Myers Squibb’s 10‑K (Chunk 3) notes that its biologic portfolio (Opdivo, Yervoy, Orencia, Reblozyl, Empliciti) enjoys up to 12 years of U.S. data‑protection and an “8 + 2 + 1” regime in the EU, but EU law does not link market entry to patent listings—biosimilars can be approved once data protection expires regardless of any pending patent litigation—so BMS faces a potentially earlier and less predictable biosimilar threat in Europe. Thus, while both companies suffer severe revenue pressure once exclusivity lapses, Amgen’s risk is driven by U.S. patent‑litigation timelines and EU patent‑listing requirements, whereas BMS’s exposure is shaped by the EU’s data‑protection‑only pathway and a broader global product mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key entities are correct: Amgen's biologics (Erbitux, Cyramza, Trulicity, Taltz, Emgality) and BMS's (Opdivo, Yervoy, Orencia, Reblozyl, Empliciti) are accurately listed. The U.S. 12-year data protection period is correctly noted, as is the EU's '8+2+1' regime. (2) Quantitative accuracy is perfect: the 12-year U.S. exclusivity and 8-year EU data exclusivity are correctly stated; no calculations are required, but timing references (e.g., biosimilar challenges as early as four years under BPCIA) are consistent with regulatory frameworks. (3) Multi-hop reasoning is strong: the answer synthesizes differences in regulatory pathways (U.S. patent-linked vs. EU data-protection-only), litigation risks (IPR proceedings), and regional exposure (Amgen's U.S.-centric risk vs. BMS's broader global/EU exposure). (4) The only minor deviation from the original answer is the mention of 'four years after launch' as a potential biosimilar challenge window under BPCIA—while technically possible in rare cases, the standard is typically 4 years post-approval but with 12 years of data exclusivity, so this could slightly overstate immediacy. However, this nuance does not materially misrepresent the risk. Overall, the answer captures the core comparison: both companies face significant biosimilar risk upon exclusivity loss, but the timing and mechanisms differ by region and regulatory structure. Semantic equivalence is maintained, with slightly more detail on procedural aspects (e.g., IPR, manufacturing hurdles) enhancing clarity without introducing error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> PRODUCT -[Negatively_Impacts]-> ACCOUNTING_POLICY <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1626,
        "completion_tokens": 446,
        "total_tokens": 2073
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How does Medtronic's exposure to Medicaid reimbursement policies compare to AbbVie's pricing pressures under the IRA, particularly in relation to their respective product portfolios and revenue risks?",
      "original_answer": "Medtronic faces increased price sensitivity from Medicaid reimbursement limitations, which affects hospitals' purchasing behavior and creates a need for competitively priced medical devices. AbbVie, on the other hand, is directly impacted by the Inflation Reduction Act (IRA), which allows the U.S. Department of Health and Human Services to set government prices for certain drugs like Imbruvica (selected in 2023 for pricing starting in 2026) and Vraylar and Linzess (selected in 2025 for pricing starting in 2027), potentially accelerating revenue erosion before patent expiration. While both companies face healthcare cost-containment pressures, Medtronic’s Medicaid exposure affects device pricing strategies, whereas AbbVie must navigate IRA-driven government pricing that could apply to more high-revenue products in the future.",
      "llm_answer": "\nMedtronic’s U.S. device sales are exposed to Medicaid‑driven reimbursement constraints through the broader cost‑containment environment that forces hospitals and GPOs to negotiate lower prices and tie payments to outcomes, a risk that is reflected in its “pricing‑pressures” node linked to the company in the KG; by contrast, AbbVie confronts a far more direct and statutory pricing pressure under the IRA, which can impose 10 %–20 % manufacturer discounts and allow HHS to set ceiling prices for IRA‑selected drugs (e.g., Imbruvica, Vraylar, Linzess), creating a clearer revenue‑erosion risk tied to its high‑margin specialty portfolio. Both firms thus sit under the same “pricing‑pressures” risk factor, but Medtronic’s exposure is indirect and mediated through Medicaid‑linked hospital purchasing behavior, whereas AbbVie’s is explicit and enforceable by the IRA’s price‑setting mechanisms.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Medtronic's indirect exposure to Medicaid reimbursement policies through hospital purchasing behavior and cost-containment pressures, and contrasts this with AbbVie's direct exposure to IRA-mandated pricing. The key products affected—Imbruvica, Vraylar, and Linzess—are correctly named, and the IRA's mechanism (HHS setting prices) is accurately described. (2) The LLM introduces a quantitative claim of '10%–20% manufacturer discounts' under the IRA, which is plausible but not present in the original answer; since this specific range is not confirmed by the ground truth, it slightly reduces quantitative accuracy, though it does not contradict known facts. No dates (e.g., 2023 selection, 2026/2027 implementation) are mentioned in the LLM answer, which is a minor omission but not a factual error. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies face pricing pressures but through different mechanisms—Medtronic via indirect market-level dynamics, AbbVie via statutory price-setting—demonstrating strong qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing the comparison of exposure, product portfolios, and revenue risks. The omission of specific IRA selection and implementation years slightly reduces completeness, but the core factual and conceptual content is correct and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Impacts]-> RISK_FACTOR <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 406,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How does the $2.7 billion in unfunded commitments to private equity funds held by UPS compare to General Dynamics' use of NAV for valuing its Level 1 plan assets, given both companies rely on NAV as a practical expedient for alternative investments?",
      "original_answer": "UPS reports $2.7 billion in unfunded commitments to private equity and similar funds as of December 31, 2024, with contributions expected over 3 to 6 years. These investments are valued using NAV as a practical expedient due to the lack of readily determinable fair value. Similarly, General Dynamics (GD) uses NAV for its Level 1 plan assets, which include commingled equity and fixed-income funds valued using a unit price or NAV. Both companies rely on NAV for valuation, but UPS's private equity commitments carry longer redemption restrictions (10–15 year terms), whereas GD's NAV-based assets are generally redeemable monthly or quarterly. This suggests UPS has a less liquid exposure to NAV-based investments compared to GD.",
      "llm_answer": "\nUPS reports approximately **$2.7 billion of unfunded commitments** to private‑equity limited partnerships that it holds, and these interests are carried at the partners’ NAV because the funds provide only a NAV‑based fair‑value measurement – a practical expedient that places them outside the Level 1‑3 hierarchy.  \nGeneral Dynamics also values its Level 1 plan assets (commingled equity and fixed‑income funds) using NAV as a practical expedient, but the SEC filing notes that the unfunded commitments related to such NAV‑valued investments are **not material** as of the reporting date.  \n\nThus, while both companies rely on NAV for alternative‑investment valuations, UPS has a sizable, disclosed unfunded commitment ($2.7 B) to private‑equity funds, whereas General Dynamics’ NAV‑based holdings involve essentially no material unfunded exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the $2.7 billion unfunded commitment for UPS and accurately states that both UPS and General Dynamics use NAV as a practical expedient for valuing certain alternative investments. The quantitative information (e.g., $2.7 billion, NAV usage) is factually accurate and matches the ground truth. However, the LLM introduces a critical inaccuracy: it claims that General Dynamics’ unfunded commitments related to NAV-valued assets are 'not material'—a claim not present in the original answer or supported by the provided ground truth. The ground truth emphasizes differences in liquidity (UPS having 10–15 year redemption restrictions vs. GD’s monthly/quarterly redemptions), not materiality of unfunded commitments. This misrepresents the basis of comparison. While both companies use NAV, the key distinction in the original answer is liquidity and redemption terms, not the materiality of unfunded commitments. The LLM fails to mention the 3–6 year contribution expectation for UPS or the 10–15 year lock-up nature of its private equity investments, which are central to the multi-hop reasoning. It also omits GD’s redemption frequency, which is essential for the comparison. Thus, while numerically accurate and contextually relevant, the qualitative reasoning is flawed due to incorrect inference and omission of key comparative details, reducing overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Discloses]-> ACCOUNTING_POLICY <-[Uses]- ORG",
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 387,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How does CMCSA's issuance of Class B Common Stock in 2024 influence its shareholder voting rights structure, and how does this compare to META's dual-class framework as disclosed in their respective filings?",
      "original_answer": "CMCSA issued 9,444,375 shares of Class B Common Stock in 2024, which, as per the governance structure outlined in V_10k_2024.pdf, carries no voting rights except in limited circumstances such as exiting the core payments business or specific merger scenarios. This creates a tiered voting rights system where Class A shareholders maintain full voting control. Similarly, META's filing reveals a dual-class structure with Class A and Class B common stock, where Class A stockholders have full voting rights while Class B stockholders generally do not, except in defined events like a merger. Both companies thus concentrate voting power among a subset of shareholders, reinforcing control while allowing for differentiated capital structures.",
      "llm_answer": "\nCMCSA’s 2024 filing authorizes 75 million Class B shares (9.4 million issued) that, per its 10‑K (Chunk 2), have no general voting rights but may vote as a single class on a narrow set of matters—such as exits from the core payments business, mergers or charter amendments—with each share entitled to one vote (or conversion‑adjusted votes), a structure that is reflected in the KG link from Class B Common Stock to Class A Common Stock and ultimately to META.  \nMeta’s 2024 Form 10‑K (Chunk 3) discloses a dual‑class regime where both Class A and Class B common stock are outstanding (343 million Class B shares) and the charter grants Class B holders voting rights that are equal to or exceed those of Class A shares, demonstrating a more expansive B‑class voting entitlement relative to CMCSA’s limited, conversion‑based voting.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but also significant factual inaccuracies that undermine its overall correctness. (1) Quantitatively, the number of Class B shares issued by CMCSA is approximately correct (9.4 million vs. ground truth 9,444,375), and the authorization of 75 million shares aligns with typical disclosures, though this specific figure isn't in the ground truth. However, the claim about META having 343 million Class B shares is not verified in the original answer and introduces unconfirmed data. (2) The core error lies in the qualitative description of META's voting structure: the LLM incorrectly states that 'Class B holders have voting rights equal to or exceeding those of Class A,' which directly contradicts the ground truth stating that META’s Class B stockholders generally do not have voting rights except in defined events like a merger—mirroring CMCSA’s structure. In reality, META’s Class B shares carry *super-voting* rights (typically 10 votes per share), not limited or no voting rights, but they are held by insiders and not publicly traded, which the LLM misrepresents by implying Class B has broader rights than Class A. This mischaracterization breaks the comparison logic. (3) The multi-hop reasoning is partially sound—linking CMCSA’s Class B non-voting structure to META’s dual-class system is valid—but the conclusion that META has 'more expansive B-class voting entitlement' is factually inverted. In both companies, voting power is concentrated in one class (Class A for CMCSA, Class B for META), but the LLM flips the direction of control. (4) Contextual relevance is high as the response addresses shareholder voting rights, capital structure, and draws a cross-company comparison as required. Wording flexibility is acceptable, but the reversal of META’s voting hierarchy constitutes a major factual error, warranting a mid-range score of 5 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 516,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How might the IRA's Medicare price-setting provisions impact revenue erosion timelines for Amgen's products that rely on federal reimbursement, especially in light of AbbVie's experience with Imbruvica and Vraylar being selected for government pricing starting in 2026 and 2027?",
      "original_answer": "The IRA's Medicare price-setting provisions could accelerate revenue erosion for Amgen's products that depend on federal reimbursement by imposing government-determined prices as early as nine or thirteen years post-FDA approval, depending on whether the product is a small molecule or biologic. This mirrors AbbVie's experience where Imbruvica was selected for price setting in 2026 and Vraylar and Linzess in 2027, leading to potential revenue declines before patent expiration. Amgen, which also relies heavily on Medicare reimbursement, faces similar risk as these policies reduce pricing flexibility and increase downward pressure on profitability.",
      "llm_answer": "\nThe IRA will impose mandatory Medicare price‑setting beginning in 2026 for a first cohort of 10 drugs (expanding to 15 in 2027), exactly the schedule that led the CMS to select AbbVie’s Imbruvica for 2026 and Vraylar (plus Linzess) for 2027, and the same statutory ceiling price and inflation‑penalty rules will apply to any Amgen product that reaches the 9‑year (small‑molecule) or 13‑year (biologic) threshold – meaning Amgen’s federal‑reimbursed products could see their reimbursement rates cut as early as those years, accelerating revenue erosion well before patent expiry; the new 10 %/20 % Part D discount structure and the IRA’s penalty for price increases above inflation further compress the revenue window, a risk that both Amgen and AbbVie now face as the government‑set pricing regime expands.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the IRA's price-setting starts in 2026 for 10 drugs and expands to 15 in 2027; Imbruvica was selected in 2026, Vraylar and Linzess in 2027; small molecules face price controls at 9 years post-approval, biologics at 13 years. These numbers and years match the original answer exactly. The mention of the 10%/20% Part D discount and inflation penalty rules adds context supported by the IRA provisions. (2) Quantitative accuracy is perfect: all years (2026, 2027, 9-year, 13-year), percentages (10%, 20%), and drug counts (10, 15) are correct and consistent with public IRA timelines and CMS selections. (3) Multi-hop reasoning is sound: the model correctly links AbbVie’s experience to Amgen’s risk by identifying shared exposure to Medicare price-setting, synthesizing across companies and timeframes. It infers that Amgen’s biologic-heavy portfolio (like its federal-reimbursed products) faces accelerated revenue erosion similar to AbbVie, even though Amgen wasn’t explicitly named in the selection—this is a valid and logical extension. (4) The only minor gap is that the original answer explicitly mentions Linzess alongside Vraylar for 2027, which the LLM includes parenthetically but doesn’t emphasize in the main comparison—this is a small omission but doesn’t detract from the core accuracy. Wording differs but semantic meaning is equivalent or richer in the LLM version. Contextual relevance is excellent as it directly addresses the impact on Amgen’s revenue timelines using the AbbVie precedent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT -[Impacts]-> RISK_FACTOR <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 440,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 190,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Colgate-Palmolive compare to the total remaining available securities disclosed by Procter & Gamble, based on their respective disclosures?",
      "original_answer": "Colgate-Palmolive reported 37,028,000 securities remaining available under equity compensation plans approved by security holders, while Procter & Gamble disclosed a total of 133,185,995 remaining available securities across both Stock Options/SARs and RSUs/PSUs under the same category of approved plans. This indicates PG has a significantly larger pool of available securities for future issuance compared to CL.",
      "llm_answer": "\nColgate‑Palmolive’s 2022 10‑K (Chunk 1) reports 37,028 (thousand) shares ≈ 37 million of common stock still available for future issuance under equity plans that have been approved by its security holders.  Procter & Gamble’s disclosure (Chunk 3) – the “Securities Remaining Available” figure that the knowledge‑graph links to PG (Chunk 2) – shows a total of 3,837,000 shares remaining for future issuance.  Consequently, Colgate has roughly nine‑times more shares left for future equity issuance than Procter & Gamble.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in quantitative data. It states that Procter & Gamble has only 3,837,000 shares remaining available, which is incorrect. The ground truth from the knowledge graph reports 133,185,995 total remaining available securities for P&G across Stock Options/SARs and RSUs/PSUs under approved plans. The Colgate-Palmolive number is correct at 37,028,000 (37,028 thousand). (2) The calculation and comparison are therefore completely wrong: the LLM concludes that Colgate has nine times more shares available than P&G, when in fact P&G has over 3.5 times more than Colgate (133.2M vs 37.0M). The LLM likely misread or misextracted P&G’s number, possibly confusing a subcomponent or unrelated figure. (3) The multi-hop reasoning is structurally sound—comparing securities available under shareholder-approved plans at two companies—but fails due to incorrect data extraction for P&G. The model identifies the correct category of plans and attempts synthesis, but the erroneous P&G figure invalidates the conclusion. (4) Scores reflect severe quantitative inaccuracy (2/10), poor qualitative reasoning due to incorrect data sourcing (3/10), partial contextual relevance as it addresses the right question framework, and very low overall correctness due to the reversed conclusion based on wrong numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Discloses]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 376,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 190,
      "question": "How does the joint commercialization of BMY's biologics in Taiwan compare with MRK's strategic spin-off of its biosimilars business, given Taiwan's regulatory requirement for local clinical trial data for biologics registration?",
      "original_answer": "BMY jointly commercializes biologics like Opdivo and Yervoy in Taiwan with Ono, where BMS handles supply and both parties share development costs and profits. This suggests a collaborative, market-access-focused strategy in Taiwan, which requires local clinical trial data for biologics registration. In contrast, MRK spun off its biosimilars business into Organon, signaling a strategic retreat from the biosimilars segment, which faces increasing global competition and regulatory complexity, including in markets like Taiwan that require additional local data for registration. Thus, while BMY maintains a direct and collaborative presence in Taiwan's biologics market, MRK has opted to divest its biosimilars portfolio, potentially avoiding the added burden of meeting such regulatory requirements in markets requiring local trials.",
      "llm_answer": "\nThe BMY‑Ono alliance (Chunk 1) jointly commercializes biologics such as Opdivo and Yervoy in Taiwan, sharing development costs and profits equally, but to obtain registration the partnership must satisfy Taiwan’s rule that requires local clinical‑trial data for biologics (Chunk 2).  By contrast, Merck’s strategic spin‑off of its biosimilars (and women’s‑health) business into the independent public company Organon (Chunk 3) removes those assets from Merck’s balance sheet; the new entity will now bear the regulatory burden of generating the Taiwan‑specific data needed for biosimilar approval, while Merck exits the direct commercial risk and profit‑sharing model that BMY maintains with its partner.  Thus, BMY’s joint commercialization distributes regulatory and financial exposure across its partnership, whereas Merck’s spin‑off isolates the biosimilars function, shifting the local‑data requirement and associated risks to the spun‑off company.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: BMY (Bristol Myers Squibb) collaborates with Ono to commercialize Opdivo and Yervoy in Taiwan, sharing costs and profits; Taiwan requires local clinical trial data for biologics registration; MRK (Merck) spun off its biosimilars business into Organon. These entities, relationships, and regulatory context are accurately represented. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly contrasts BMY’s collaborative, risk-sharing strategy in a market with stringent local data requirements against MRK’s strategic divestiture via spin-off, which shifts regulatory burden to Organon. The reasoning accurately infers that Merck exits direct exposure, while BMY remains engaged through partnership. (4) The only minor shortcoming is that the LLM slightly overemphasizes Organon bearing the burden 'for biosimilar approval'—while technically correct, the original answer more clearly frames MRK’s move as a broader strategic retreat from the biosimilars segment due to global competition and regulatory complexity, not just in Taiwan. This nuance is downplayed but not missing. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Regulates]-> PRODUCT <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 404,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How does AAPL's 2022 revenue contribution from Taiwan, as part of its Greater China segment, compare to ADBE's operational presence in the same region?",
      "original_answer": "AAPL reported $74,200 million in net sales for its Greater China segment in 2022, which includes Taiwan among other regions. ADBE maintains a local field office in Taiwan as part of its global operations, indicating a direct market presence. While AAPL's exposure to Taiwan is embedded within its broader Greater China revenue, ADBE's operational footprint in Taiwan suggests a more targeted geographic strategy in the region.",
      "llm_answer": "\nApple’s 2022 net sales in the Greater China segment totaled **$74.2 billion**, with operating income of **$31.15 billion**—a figure that encompasses Taiwan, since the segment definition explicitly includes “China mainland, Hong Kong and Taiwan.” Adobe, by contrast, lists **Taiwan among its global field‑office locations**, confirming an operational presence in the same geographic market, although the filing provides no revenue number for Taiwan itself. Thus, Apple generates a multibillion‑dollar revenue stream from Taiwan as part of its Greater China business, while Adobe’s involvement in Taiwan is limited to an operational footprint rather than a disclosed sales contribution.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports AAPL's 2022 Greater China net sales as $74.2 billion (equivalent to $74,200 million in the ground truth), accurately noting that this includes Taiwan. It correctly states that ADBE has a field office in Taiwan, confirming operational presence. The LLM adds that Adobe does not disclose revenue for Taiwan, which is consistent with the ground truth's implication of no revenue breakdown. The only minor omission is that the ground truth emphasizes AAPL's exposure is 'embedded' within Greater China, while ADBE has a 'more targeted' strategy—this nuance is slightly underdeveloped in the LLM answer, which calls Adobe's presence 'limited to an operational footprint,' potentially understating strategic intent. 2) All numbers are accurate: $74.2 billion = $74,200 million (correct conversion), and the mention of $31.15 billion operating income, while not in the original answer, is factually correct and adds context without distorting the response. 3) Multi-hop reasoning is sound: the model correctly synthesizes AAPL’s revenue data (from segment reporting) with ADBE’s operational footprint (from office location disclosures), comparing revenue contribution vs. operational presence across companies. 4) The answer is semantically equivalent to the ground truth, with slightly stronger emphasis on financial magnitude and less on strategic interpretation. Scores reflect high accuracy with a minor deduction in qualitative accuracy for slight under-articulation of strategic comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 417,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How do CMCSA and META differ in terms of the voting control concentration between Class A and Class B common stockholders, and what implications does this have for shareholder influence in corporate governance decisions?",
      "original_answer": "CMCSA's Class A common stockholders hold 66 2/3% of the combined voting power, while Class B stockholders (led by Brian L. Roberts) hold 33 1/3%, with each Class B share carrying 15 votes. In contrast, META's Class B common stock, though not publicly traded, holds significant voting rights, but the specific voting power percentage is not disclosed. However, META's Class A shares are publicly traded under the ticker META, and as of December 31, 2023, there were only 23 stockholders of record for Class B shares, indicating concentrated control. This means CMCSA maintains a structured balance of voting power, while META's control is more opaque and concentrated among fewer Class B holders.",
      "llm_answer": "\nCMCSA’s charter splits the combined vote — Class A holders own 66 ⅔ % of the voting power while Class B holders own the remaining 33 ⅓ %, with each Class B share carrying 15 votes and the entire Class B block held non‑dilutably by Mr. Brian L. Roberts; this gives the Class B owner a decisive, though minority, say in director elections and other matters that require class voting. By contrast, META’s filing shows that its Class B shares are not publicly listed and are held by only 23 record holders, and the company does not disclose the exact voting percentage, but the privately‑held, concentrated nature of the Class B block implies an even higher concentration of control in insiders, limiting the influence of public shareholders in governance decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: CMCSA's Class A holds 66 2/3% and Class B 33 1/3% of voting power, with each Class B share having 15 votes. The concentration of Class B shares in Brian L. Roberts is correctly noted. For META, the answer correctly states that Class B shares are not publicly traded, held by only 23 record holders as of December 31, 2023 (implied from original answer's 'as of December 31, 2023'), and that the exact voting power percentage is not disclosed. (2) Quantitative accuracy is perfect: percentages (66 2/3%, 33 1/3%), vote ratio (15 votes per share), and number of record holders (23) are all correct and match the original. (3) Multi-hop reasoning is sound: the model correctly contrasts CMCSA’s structured, transparent dual-class system with META’s more opaque, concentrated control, drawing valid implications about shareholder influence. (4) The only minor shortcoming is that the LLM does not explicitly state that META’s Class A shares are publicly traded under ticker META—a detail present in the original—but this does not detract significantly from the overall correctness. The answer captures the core contrast in governance structure and control concentration. Thus, the answer earns a 9/10 for correctness and qualitative accuracy due to near-perfect factual alignment and strong reasoning, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 403,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How do LLY and MRK benefit differently from pediatric exclusivity provisions in the U.S. and EU regulatory frameworks?",
      "original_answer": "LLY benefits from pediatric exclusivity in the U.S. by receiving an additional six months of exclusivity added to data protection, orphan drug exclusivity, or non-expired patents. MRK, on the other hand, benefits in the U.S. through an additional six months of market exclusivity added to Orange Book-listed patents and regulatory data exclusivity, and in the EU through an additional six months added to the Supplementary Protection Certificate (SPC) term. This difference in application highlights how the U.S. framework ties pediatric exclusivity to both patents and data protection, while the EU framework applies it only to the SPC term.",
      "llm_answer": "\nBoth LLY and MRK are linked through the KG pattern ORG → Pediatric Exclusivity → Market Exclusivity ← ORG, meaning LLY’s exclusivity derives directly from the pediatric provision while MRK’s market exclusivity is downstream of that same provision. In the United States pediatric exclusivity adds a six‑month extension to data‑protection and orphan‑drug exclusivity (and to any unexpired patents), whereas in the EU the identical six‑month pediatric extension is attached to the product’s SPC term, giving LLY a longer patent‑term offset but MRK an extra six‑month market‑exclusivity period that runs in parallel with its SPC. Because the EU also provides up to five years of regulatory data protection (seven years for orphan drugs, twelve for biologics) and Japan adds a separate pediatric term to market exclusivity, MRK can achieve a longer overall exclusivity window, while LLY may capture additional patent‑term extensions via U.S. term‑restoration mechanisms, resulting in different total financial benefits for the two companies.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains some correct elements but introduces significant inaccuracies and confusion in both factual content and reasoning. (1) Quantitatively, the six-month extension in both the U.S. and EU is correctly stated, which aligns with the ground truth. However, the LLM incorrectly implies that LLY benefits only in the U.S. and MRK in both regions, while the original answer specifies that MRK benefits in both the U.S. and EU frameworks, whereas LLY is only mentioned in the U.S. context. The LLM also introduces Japan and regulatory data protection durations (e.g., 7 years for orphans, 12 for biologics), which are irrelevant to the question and not in the ground truth. (2) The claim that 'LLY may capture additional patent-term extensions via U.S. term-restoration mechanisms' is speculative and not supported in the original answer. (3) The reasoning about 'KG pattern ORG → Pediatric Exclusivity → Market Exclusivity ← ORG' is abstract and does not accurately reflect the regulatory differences; it misrepresents the mechanism by suggesting a structural difference in how LLY and MRK benefit, when the real difference lies in the scope of application (U.S. applies to patents and data, EU only to SPC). (4) The conclusion that 'MRK can achieve a longer overall exclusivity window' and 'LLY may capture additional patent-term extensions' introduces unsupported comparative financial implications not present in the ground truth. While the core idea of differing frameworks (U.S. vs. EU) is touched upon, the synthesis is flawed. The answer is contextually relevant but factually imprecise and overreaching in interpretation, leading to a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Positively_Impacts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 456,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 192,
      "question": "How does the change in EMR's foreign currency liabilities from 2023 to 2024 compare with the scale of LMT's foreign currency hedge exposure, and what might this indicate about their respective foreign exchange risk management strategies?",
      "original_answer": "EMR's foreign currency liabilities decreased from $22 billion in 2023 to $20 billion in 2024, a $2 billion reduction, while LMT maintained $7.5 billion in outstanding foreign currency hedges at the end of 2024. This indicates that LMT is proactively hedging a significant portion of its foreign exchange exposure, whereas EMR appears to be reducing its overall foreign currency liability position rather than necessarily increasing hedging activity. The use of option contracts by LMT suggests a strategy focused on offsetting earnings volatility from exchange rate fluctuations, while EMR's declining liabilities may reflect either reduced international operations or a shift in risk management approach.",
      "llm_answer": "\nEMR’s foreign‑currency liabilities slipped from **$22 million (2023) to $20 million (2024)** – a **$2 million decrease** (Chunk 3).  In contrast, LMT’s foreign‑currency hedge program is measured in **billions of dollars**, expanding from **$6.5 billion (2023) to $7.5 billion (2024)** in total notional exposure and reaching **$8.3 billion–$9.9 billion** in net cash‑flow hedges (Chunks 1 & 2).  This disparity shows that EMR’s FX risk is essentially immaterial and is likely managed through natural offsets or minimal hedging, whereas LMT maintains a **large, actively‑scaled hedge program** using forwards, options and cross‑currency swaps to protect billions of dollars of forecasted exposures.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the scale of EMR's foreign currency liabilities, reporting $22 million and $20 million instead of the correct $22 billion and $20 billion. This misrepresents the magnitude of EMR's liabilities by a factor of 1,000, rendering the quantitative comparison with LMT's $7.5 billion hedge exposure completely inaccurate. While LMT's hedge exposure figures are correctly reported ($7.5 billion in 2024, up from $6.5 billion), the EMR numbers are fundamentally wrong. (2) The calculation of a $2 million decrease in EMR's liabilities is incorrect due to the wrong base numbers; the actual reduction is $2 billion, not $2 million. The LMT figures and their trend are accurate, including the expansion of notional exposure and the range of net cash-flow hedges. (3) The multi-hop reasoning is partially sound—comparing EMR's liability reduction to LMT's active hedging program is valid, and the interpretation of LMT's use of derivatives (forwards, options, swaps) aligns with the ground truth. However, the erroneous scale of EMR's liabilities undermines the conclusion that EMR's FX risk is 'immaterial'—in reality, $20 billion is highly material, though reduced. The reasoning about LMT's proactive hedging strategy is accurate and well-supported. (4) The contextual relevance is high because the answer addresses both companies, the time frame, and attempts to infer risk management strategies. However, due to the severe quantitative inaccuracy in EMR's liability figures, the overall correctness score is low. The qualitative accuracy is moderate because the conceptual framework and entity identification (EMR, LMT, hedging instruments) are correct, but the faulty numbers distort the analysis. Quantitative accuracy is very low due to the billion-vs-million error, which is a critical failure in financial analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Enters_Into]-> FIN_INST -[Impacts]-> FIN_INST <-[Decreases]- ORG",
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 508,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 192,
      "question": "How does the $3.6 billion in dividends paid by AENB to AXP in 2023 relate to the leverage ratio requirements that both AENB and WFC are subject to under federal banking regulations?",
      "original_answer": "The $3.6 billion in dividends paid by AENB to AXP in 2023 is directly tied to AENB's compliance with leverage ratio requirements, as AENB must consider the impact of such distributions on its regulatory capital ratios. AENB, as a subsidiary bank of AXP, is subject to federal banking regulations that restrict dividend payments if they would cause the bank to fall short of required leverage ratios. Similarly, WFC, as a large bank holding company, is also subject to leverage and supplementary leverage ratio requirements under Basel III and FRB rules, which constrain its ability to make capital distributions like dividends. Therefore, both AENB and WFC must ensure that any dividend payments comply with these leverage constraints, making the $3.6 billion distribution by AENB a function of its ability to maintain required capital levels under the same type of regulatory framework that governs WFC.",
      "llm_answer": "\nThe $3.6 billion dividend that AENB distributed to its parent AXP in 2023 is constrained by the very same leverage‑ratio rules that govern both AENB and WFC under federal banking law.  As noted in the regulatory notice (Chunk 1) and in AENB’s own disclosures (Chunk 2), dividend payments may be limited if an institution’s risk‑based capital or leverage ratios fall below the minimum requirements or required buffers, and regulators can prohibit payouts that would render those ratios unsafe.  Consequently, the size of the dividend reflects the maximum distribution that AENB can make while still satisfying the leverage‑ratio standards that also apply to WFC, whose capital‑distribution restrictions (Chunk 3) likewise require compliance with those same leverage thresholds.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $3.6 billion dividend amount and the year 2023 are correctly stated, with no calculation errors. (2) The entities—AENB, AXP, and WFC—are accurately identified, and the regulatory context (federal banking regulations, leverage ratios, capital distribution constraints) is correctly described. (3) The multi-hop reasoning is sound: the answer correctly links AENB’s dividend payment to its regulatory leverage ratio requirements, and extends the logic to WFC by noting that both institutions are subject to similar Basel III and FRB capital rules, even though WFC is not directly involved in the dividend. This reflects proper synthesis across entities and regulatory frameworks. (4) The only minor shortcoming is a slight lack of specificity regarding AENB’s status as a subsidiary of AXP and the exact nature of the leverage ratio (e.g., supplementary leverage ratio for WFC), which is mentioned in the original answer but implied rather than explicitly stated. However, the core regulatory logic and constraints are accurately conveyed. Wording differs but semantic meaning matches. Overall, the answer is factually correct, contextually appropriate, and demonstrates strong reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP -[Subject_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 357,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does the geographic distribution of Microsoft's pre-tax income ($62.9B U.S. and $44.9B foreign in fiscal 2024) influence its exposure to the OECD's Pillar Two Model Rules, and how does this compare to Qualcomm's expected impact under the same Global Minimum Tax framework given their similar fiscal year 2025 implementation timeline?",
      "original_answer": "Microsoft's geographic distribution of pre-tax income shows significantly higher earnings in the U.S. ($62.9B) compared to foreign jurisdictions ($44.9B), which may reduce its exposure to the Pillar Two Model Rules since these rules target multinational enterprises with operations in low-tax jurisdictions. Microsoft notes it does not expect a material impact from Pillar Two. Similarly, Qualcomm acknowledges the global minimum tax framework will apply to them starting in fiscal 2025 and also states they do not expect a material impact on their financial statements, suggesting both companies anticipate minimal disruption from the same regulatory framework.",
      "llm_answer": "\nMicrosoft’s $44.9 billion of foreign pre‑tax income—concentrated in lower‑tax jurisdictions such as Ireland—places a material portion of its earnings under the OECD Pillar Two “global minimum tax” regime that will begin to apply to the company in fiscal 2025; although Microsoft presently does not expect a material effect on its consolidated financial statements, the geographic mix of its income means the new 15 % minimum rate could raise its effective tax rate if the rules are adopted in those jurisdictions (Chunk 1).  \n\nQualcomm, which is similarly subject to the same Pillar Two regulatory requirement and will face the rule in its fiscal 2025, operates mainly in jurisdictions whose tax rates are already at or above the 15 % threshold, so it likewise does not anticipate a material increase in global tax costs and is monitoring only for potential legislative changes (Chunk 2 & 3).  \n\nThus, while both Microsoft and Qualcomm are linked through the KG relationship ORG → Pillar Two → Global Minimum Tax ← ORG, Microsoft’s larger foreign‑income share gives it slightly higher exposure to the OECD rules, whereas Qualcomm’s comparable fiscal‑year 2025 implementation timeline and limited low‑tax operations mean its expected impact is expected to be similarly limited.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Microsoft's U.S. and foreign pre-tax income amounts ($62.9B and $44.9B) and both companies' fiscal 2025 implementation timeline for Pillar Two. It also accurately reflects that both Microsoft and Qualcomm do not expect a material impact. However, the LLM introduces specific details not present in the ground truth—namely, that Microsoft's foreign income is 'concentrated in lower-tax jurisdictions such as Ireland' and that its 'larger foreign-income share' implies higher exposure. These inferences go beyond the original data, which makes no mention of Ireland or comparative exposure levels. (2) Quantitatively, all numbers are accurate: $62.9B, $44.9B, 15%, fiscal 2025—all match or are consistent with the ground truth. No calculations are required, so no errors there. (3) The multi-hop reasoning is partially sound—linking both companies to Pillar Two and noting their similar timelines and expected minimal impacts is correct. However, the comparative claim that Microsoft has 'slightly higher exposure' due to geographic mix is speculative and not supported in the original answer, which treats both companies as similarly unaffected without ranking exposure. (4) The answer is contextually relevant and well-structured, but the added inference reduces qualitative accuracy. The core facts are correct, warranting a 7 for correctness—minor overreach but no major factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Negatively_Impacts]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 398,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does WMT's $37.2 billion in unrecorded purchase obligations expose the company to financial risks that aren't captured by the VAR models used by peers like MDLZ?",
      "original_answer": "WMT has $37.2 billion in unrecorded purchase obligations as of January 31, 2025, which includes firm commitments for inventory, utility purchases, and capital expenditures. These obligations are legally binding but are not reflected on the balance sheet. However, according to DIS's 10-K filing, VAR models — like the one used by MDLZ — exclude forecasted transactions and firm commitments when estimating financial risk exposure. MDLZ's VAR model specifically uses a parametric delta-gamma approximation technique based on interest rate, currency, and commodity price movements to estimate potential one-day losses, but does not include firm commitments in its calculations. This means that while WMT has significant off-balance sheet obligations, companies using VAR models like MDLZ do not incorporate these types of commitments into their risk assessments, leaving WMT potentially more exposed to market volatility that isn't captured through standard VAR modeling practices.",
      "llm_answer": "\nWMT discloses $37.2 bn of unrecorded purchase obligations—binding inventory, capital‑expenditure and service contracts, $15.9 bn of which are due within a year—that are excluded from its risk metrics because the VAR framework (linked via WMT → Firm Commitments → VAR Model → MDLZ) only measures market‑price risk under normal conditions and omits firm commitments, forecasted cash flows and contractual timing. Consequently, while MDLZ’s VAR model (which uses a 95 % confidence, one‑day parametric delta‑gamma approach and explicitly excludes firm commitments and foreign‑currency transactions) captures potential one‑day losses in interest‑rate, FX, commodity and equity positions, it does not reflect the liquidity and cash‑flow pressure created by WMT’s large, long‑dated purchase obligations, leaving a material off‑balance‑sheet financial risk unmeasured.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with strong multi-hop reasoning. (1) Quantitatively, the $37.2 billion unrecorded purchase obligations are correctly stated. The additional detail of $15.9 billion due within a year is not present in the original answer but does not contradict it and may reflect supplementary data; since it's plausible and not incorrect, it doesn't reduce accuracy. The 95% confidence level and one-day horizon for MDLZ's VAR model are accurate per typical disclosures and align with the ground truth's description, even if not explicitly stated in the original answer — this represents reasonable inference. (2) The entities — WMT, MDLZ, and implied use of VAR models — are correctly identified. The reference to DIS in the original answer (as the source stating VAR models exclude firm commitments) is missing in the LLM response, but the factual claim about MDLZ’s model excluding firm commitments is preserved and correctly attributed. (3) The reasoning is sound: the LLM correctly synthesizes that WMT has significant off-balance-sheet obligations, that VAR models like MDLZ’s exclude such firm commitments, and therefore standard risk models fail to capture liquidity and cash-flow risks from these obligations. This addresses the multi-hop logic: WMT's obligations → nature of VAR models (via MDLZ) → exclusion of firm commitments → resulting unmeasured risk. (4) The answer is semantically equivalent and slightly more detailed, particularly in specifying the components of the obligations and the technical aspects of the VAR model. The only minor gap is the omission of DIS as the source for the general limitation of VAR models, but the key causal chain and risk implication are preserved accurately. Hence, all scores are high, with correctness at 9 due to the slight expansion beyond the original without explicit source attribution for the $15.9B or DIS reference.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Does_Not_Relate_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 525,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does UNH's use of interest rate swaps to manage exposure to floating-rate liabilities compare with AMGN's use of similar instruments in relation to their respective $1.4 billion repayments of the 3.625% 2024 Notes?",
      "original_answer": "UNH uses interest rate swaps as part of its broader strategy to manage exposure to market interest rate fluctuations on both assets and liabilities, including $27 billion of floating-rate financial liabilities as of December 31, 2024. AMGN, on the other hand, specifically entered into interest rate swap contracts to convert fixed-rate coupons to floating-rate SOFR-based coupons, with $1.4 billion of such swaps maturing in 2024 in connection with the repayment of the 3.625% 2024 Notes. While both companies use interest rate swaps, UNH's application is broader in scope across its balance sheet, whereas AMGN's use is directly tied to specific debt instruments like the 3.625% 2024 Notes that were fully repaid in 2024.",
      "llm_answer": "\nUNH manages floating‑rate exposure by broadly diversifying its interest‑rate swaps across its $27 billion of floating‑rate liabilities and $49 billion of fixed‑rate debt, using swaps to match floating‑rate assets with floating‑rate obligations and thereby dampen interest‑rate volatility.  \nAMGN, by contrast, employs swaps as fair‑value hedges that specifically convert the fixed‑rate coupons on $1.4 billion of its 3.625% 2024 Notes into floating‑rate SOFR‑plus‑1.8% obligations, with the swaps maturing in direct connection with the repayment of those notes; thus both companies used swaps to address the $1.4 billion repayment, but UNH’s approach is a portfolio‑wide hedge while AMGN’s is a targeted hedge tied to that particular debt issuance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers are correct: $27 billion in floating-rate liabilities for UNH (implied in context), $1.4 billion tied to AMGN’s 3.625% 2024 Notes, and the use of SOFR-based swaps maturing in 2024 are all factually consistent. The mention of $49 billion in fixed-rate debt for UNH is additional context not in the original answer but does not contradict it and may reflect broader filing data; it does not detract from accuracy. (2) The core comparison—that UNH uses swaps broadly across its balance sheet while AMGN uses them as targeted fair-value hedges tied directly to the 3.625% 2024 Notes—is correctly synthesized and matches the original answer’s intent. (3) The reasoning is sound: the LLM correctly identifies multi-hop elements (both companies’ use of swaps, their differing scope, and connection to the $1.4 billion repayment), and the conclusion that AMGN’s swaps matured in connection with the note repayment is consistent with the ground truth. (4) Minor deduction in qualitative accuracy because the original answer emphasizes that AMGN’s swaps were used in connection with the repayment (which is confirmed), while the LLM implies both companies used swaps to address the $1.4 billion repayment—this could be misinterpreted as UNH also hedging that specific obligation, which is not stated in the ground truth. However, the phrasing 'both companies used swaps to address the $1.4 billion repayment' is likely a misstatement, since UNH’s $27 billion exposure is system-wide and not linked specifically to AMGN’s debt. This is a subtle but important distinction. Despite this, the overall semantic meaning and factual core are preserved, warranting a high score. Contextual relevance is perfect—the response directly addresses the comparative use of swaps in relation to the debt repayment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Impacts]-> FIN_INST <-[Decreases]- ORG",
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 510,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 194,
      "question": "How does the potential acceleration of AMD's 3.924% Senior Notes Due 2032 in the event of an 'Event of Default' compare with Oracle's exposure to similar default-triggered obligations under their Revolving Credit Agreement, particularly in terms of debt repayment structure and maturity conditions?",
      "original_answer": "AMD's 3.924% Senior Notes Due 2032 could be accelerated upon an Event of Default, which would require AMD to repay $1.0 billion in aggregate principal issued in 2022, plus accrued interest. Oracle, under its Revolving Credit Agreement, also faces potential acceleration if an Event of Default occurs, with the full $6.0 billion facility becoming due unless terminated earlier. Unlike AMD's notes, which are unsecured senior obligations, Oracle's Revolving Facility allows borrowing, prepayment, and reborrowing until March 8, 2027, with interest rates tied to credit ratings. Both companies face significant financial obligations upon default, but Oracle's structure allows more flexibility in managing short-term liquidity.",
      "llm_answer": "\nAMD’s 3.924% Senior Notes due 2032 are unsecured senior obligations whose indenture (dated June 9 2022) specifies that an Event of Default automatically accelerates the notes’ maturity, requiring immediate repayment of principal plus accrued interest and permitting optional early redemption or a 101 % change‑of‑control repurchase; this acceleration is tied in the knowledge‑graph to the same Event‑of‑Default risk factor that also applies to Oracle.  \nOracle’s $6 billion Revolving Credit Agreement likewise provides that upon an Event of Default the entire $6 billion facility—originally maturing on March 8 2027—becomes immediately due and payable, obligating the borrower to repay all outstanding loans with accrued interest, thereby mirroring the acceleration principle but extending it to the whole revolving commitment rather than a single note issue.  \nThus, while both companies embed default‑triggered acceleration, AMD’s applies to a specific senior‑note issue with defined repayment and early‑redemption terms tied to a 2032 maturity, whereas Oracle’s accelerates the entire revolving credit facility, converting its 2027 maturity into an instant repayment obligation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: AMD's $1.0 billion 3.924% Senior Notes Due 2032 issued in 2022 can be accelerated upon Event of Default, requiring immediate repayment of principal and interest; Oracle's $6.0 billion Revolving Credit Agreement, maturing March 8, 2027, also accelerates in full upon default. These numbers, dates, and amounts are all factually correct and match the original answer. (2) Quantitative accuracy is perfect: dollar amounts ($1.0B and $6.0B), interest rate (3.924%), maturity dates (2032 for AMD, 2027 for Oracle), and the absence of calculation errors confirm full precision. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies, two debt instruments, and compares their acceleration mechanics, repayment structures, and maturity conditions. It correctly identifies that AMD’s obligation is tied to a fixed-note issuance with a distant maturity, while Oracle’s involves a revolving facility with earlier maturity and greater liquidity flexibility. (4) The only minor shortcoming is that the LLM does not explicitly mention Oracle’s interest rates being tied to credit ratings or the ability to reborrow—details present in the ground truth that add nuance to the flexibility point. However, the core contrast in debt structure (fixed note vs. revolving facility) is clearly articulated. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy due to near-perfect factual and reasoning alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Issues_Financial_Instrument]-> FIN_INST -[Accelerated_Maturity]-> RISK_FACTOR <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1514,
        "completion_tokens": 438,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 195,
      "question": "How does the $31.0 billion of trust assets under reinsurance agreements at GE, which are subject to strict investment guidelines, compare to General Dynamics' $191 million in marketable securities held in trust as of December 31, 2021, in terms of investment policy and risk exposure?",
      "original_answer": "GE holds $31.0 billion in trust assets associated with reinsurance contracts and is subject to strict investment guidelines that include limitations on asset class concentration, issuer exposure, and duration variances, with a focus on diversification and credit quality while considering risk-based capital requirements. These trust assets are managed to support insurance liabilities and are reviewed periodically for asset allocation changes, including the potential inclusion of non-traditional asset classes. In contrast, General Dynamics held $191 million in marketable securities in trust as of December 31, 2021, governed by an investment policy that restricts purchases to investment-grade fixed-income securities with a maximum maturity of five years, indicating a more conservative and short-duration approach. This highlights a significant difference in scale and investment strategy between the two companies' trust asset management, with GE facing broader credit, interest rate, and reinvestment risks due to the larger and more diverse asset base.",
      "llm_answer": "\nGE’s $31.0 billion of trust assets placed in reinsurance‑security trusts are subject to extensive, contract‑specific investment guidelines that limit asset‑class concentration, single‑issuer exposure and duration, and may even allow the ceding insurer to withdraw or control the assets—exposing GE to credit, interest‑rate, equity and liquidity risks; by contrast, General Dynamics holds only $191 million of marketable securities in trust, governed by a far more limited policy that permits only investment‑grade fixed‑income securities with maturities of up to five years and carries no equity risk, reflecting a much narrower investment policy and a comparatively lower risk exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth in both quantitative and qualitative aspects. (1) Quantitatively, all numbers are correct: $31.0 billion for GE and $191 million for General Dynamics as of December 31, 2021, with no calculation errors. The dollar amounts and time reference (implied by the original context) are accurate. (2) The LLM correctly identifies the entities: GE's trust assets under reinsurance agreements and General Dynamics' marketable securities in trust. (3) The reasoning is sound and reflects multi-hop synthesis: it contrasts GE’s broader, more complex investment guidelines (covering asset concentration, issuer exposure, duration) with General Dynamics’ narrow, conservative policy limited to investment-grade fixed-income securities with maturities up to five years. The LLM accurately infers that GE faces greater risk exposure (credit, interest rate, equity, liquidity) due to scale and asset diversity, while General Dynamics avoids equity risk and maintains a lower-risk profile. (4) The only minor shortcoming is that the LLM adds a detail not present in the ground truth—'the ceding insurer may withdraw or control the assets'—which, while plausible in reinsurance contexts, is not stated in the original answer and slightly exceeds the provided information. However, this does not introduce factual inaccuracy but adds an assumption. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong reasoning across entities and policies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Subject_To]-> FIN_INST <-[Has]- ORG",
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 419,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 195,
      "question": "How do the observable market data inputs used in Lockheed Martin's fixed income pricing models compare to the inputs used in PayPal's derivative valuations, given both institutions rely on Level 2 pricing methodologies?",
      "original_answer": "Lockheed Martin's fixed income investments categorized as Level 2 are valued using pricing models that incorporate verifiable observable market data such as interest rates, yield curves at commonly quoted intervals, and credit spreads. Similarly, PayPal values a majority of its derivative instruments using pricing models that consider observable inputs like currency rates, interest rate yield curves, option volatility, and equity prices. Both institutions rely on Level 2 methodologies, indicating a shared dependence on observable market factors to determine fair value, although applied to different asset classes—fixed income for Lockheed Martin and derivatives for PayPal.",
      "llm_answer": "\nLockheed Martin values its fixed‑income securities under Level 2 using observable inputs such as quoted interest‑rate curves, credit spreads and broker‑provided bids for comparable securities (chunks 1 & 2), while PayPal prices its derivative instruments with Level 2 models that rely on market‑observable data including interest‑rate curves, currency‑exchange rates, option volatility and equity‑price quotes (chunk 3). Both companies apply the same accounting‑policy‑linked pricing framework—Fixed Income Investments → Pricing Models ← Depends On PYPL—so the Level 2 methodology is shared, but the specific observable inputs differ: Lockheed focuses on rate‑ and credit‑related data for bonds, whereas PayPal adds foreign‑exchange and volatility inputs for derivatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Lockheed Martin uses observable inputs like interest rate curves, credit spreads, and broker bids for fixed income securities under Level 2; PayPal uses observable inputs such as interest rate curves, currency exchange rates, option volatility, and equity prices for derivatives—both consistent with the original answer. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense, but all descriptive financial inputs are correctly reported. (3) The multi-hop reasoning is sound: the model correctly identifies that both firms use Level 2 methodologies but apply them to different asset classes (fixed income vs. derivatives), and it accurately contrasts the specific inputs each company uses. (4) The only minor shortcoming is the mention of 'broker-provided bids for comparable securities' and a vague reference to an 'accounting-policy-linked pricing framework' and 'Depends On PYPL'—phrasing not present in the original and potentially over-interpreting the linkage. However, broker bids are a reasonable proxy for observable market data in Level 2, so this does not constitute a factual error. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Valued_By]-> ACCOUNTING_POLICY <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 395,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 196,
      "question": "How does the sensitivity of AVGO's fixed rate senior notes to interest rate changes compare to the impact of CSCO's interest rate swap on their fixed-rate debt, given both companies' exposure to market interest rate fluctuations?",
      "original_answer": "AVGO's $56.3 billion in fixed rate senior notes as of November 3, 2024, would see a $1.7 billion change in fair value with a 50 basis point interest rate shift, while CSCO has an interest rate swap with a notional amount of $0.5 billion that converts a portion of its fixed-rate debt to floating, offsetting changes in fair value due to interest rate movements. CSCO’s swap specifically hedges a senior note due in fiscal 2025, whereas AVGO uses treasury rate lock contracts to hedge anticipated future debt issuances, indicating differing hedging strategies despite both managing interest rate risk on fixed-rate debt.",
      "llm_answer": "\nAVGO’s fixed‑rate senior notes ( $56.3 bn outstanding ) are estimated to swing in fair value by roughly **$1.7 bn for a 50‑basis‑point move in market rates** (about **$3.4 bn per 100 bp**), a direct sensitivity that would affect reported fair‑value but not current interest expense.  \nCSCO, however, mitigates its interest‑rate exposure by entering into a **$0.5 bn interest‑rate swap** that converts the fixed rate of a portion of its senior notes to a SOFR‑based floating rate; the swap’s gain or loss offsets the fair‑value change of the hedged debt, effectively **neutralizing the interest‑rate impact on cash‑flow** for that tranche.  \nThus, while AVGO’s debt shows a multi‑billion‑dollar fair‑value sensitivity per 50 bp, CSCO’s swap largely eliminates the interest‑rate sensitivity of the covered fixed‑rate portion.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AVGO has $56.3 billion in fixed-rate senior notes with a $1.7 billion fair value sensitivity to a 50 basis point interest rate change; CSCO has a $0.5 billion interest rate swap that converts fixed-rate debt to floating, hedging a portion of its senior notes. These numbers match the original answer exactly, and the implied $3.4 billion per 100 bps calculation is mathematically sound. (2) The answer correctly identifies that AVGO's exposure affects fair value but not interest expense, and that CSCO’s swap offsets fair value changes through hedge accounting, effectively neutralizing the impact—this reflects proper understanding of accounting treatment under ASC 815. (3) Multi-hop reasoning is strong: the model synthesizes AVGO’s direct sensitivity with CSCO’s offsetting swap mechanism, correctly contrasting their hedging strategies. (4) The only minor omission is that the original answer specifies CSCO’s swap hedges a note due in fiscal 2025 and that AVGO uses treasury rate locks for *future* debt issuances—contextual details that add precision but do not alter the core conclusion. The LLM captures the essential comparison in risk management approach. Wording differs but semantic meaning and factual content are equivalent. No irrelevant or incorrect information is introduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Impacts]-> FIN_INST <-[Holds]- ORG",
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 386,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 196,
      "question": "How does BMY's joint research and commercialization obligations with Pfizer under the Eliquis alliance compare to Pfizer's financial commitments in its collaboration with Beam for in vivo base editing programs, particularly in terms of upfront payments and potential milestone obligations?",
      "original_answer": "BMY and Pfizer share joint research and commercialization responsibilities under the Eliquis alliance, with Pfizer receiving co-exclusive license rights in exchange for an upfront payment and potential milestone payments, which are being amortized over BMY’s co-promotion obligation period. Separately, Pfizer paid Beam $300 million upfront upon entering their collaboration for in vivo base editing programs and may pay up to an additional $1.05 billion in development, regulatory, and commercial milestone payments across three targets, for a total potential deal value of $1.35 billion. This shows that Pfizer’s financial commitment to Beam could significantly exceed its initial payments under the Eliquis alliance, depending on development progress and milestone achievements.",
      "llm_answer": "\nUnder the Eliquis alliance, Pfizer’s upfront payment and any contingent milestone proceeds are recorded as deferred income and amortized over the term of BMS’s co‑promotion and market‑exclusivity obligations, reflecting the parties’ joint executive committee, shared research, development, manufacturing and commercialization responsibilities (Chunk 1).  \nIn contrast, Pfizer’s 2021 collaboration with Beam included a $300 million upfront payment that was expensed as acquired‑in‑process R&D and provides for up to $1.05 billion of development, regulatory and commercial milestone payments, with Beam eligible for royalties and a 65%/35% profit‑share on any licensed program (Chunks 2‑3).  \nThus, BMY’s financial exposure is spread out and linked to ongoing joint commercialization, whereas Pfizer’s exposure to Beam consists of an immediate expense plus contingent milestone and royalty obligations tied to opt‑in licensing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Pfizer made a $300 million upfront payment to Beam (Chunk 2), with up to $1.05 billion in potential milestone payments, totaling $1.35 billion—this matches the original answer. The characterization of Eliquis alliance terms—upfront and milestone payments amortized over BMY’s co-promotion period—is factually sound. (2) Quantitative accuracy is perfect: all dollar amounts ($300M upfront, $1.05B milestones) are correctly reported, and the implied total of $1.35B is accurate even if not explicitly stated. (3) Multi-hop reasoning is strong: the model correctly contrasts BMY-Pfizer joint obligations (shared responsibilities, amortized payments) with Pfizer-Beam’s one-way financial commitment (upfront R&D expense + contingent milestones). (4) Minor deduction in qualitative accuracy because the LLM refers to 'BMS’s co-promotion' instead of 'BMY’s' (though BMS = Bristol Myers Squibb = BMY, this could cause confusion if not recognized), and it introduces a detail about a 65%/35% profit-share and royalties not present in the original answer, which may be correct but goes beyond the ground truth. However, this does not contradict the original and adds context. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> ACCOUNTING_POLICY -[Introduces]-> COMP <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 376,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How do Texas Instruments' accounting practices for lease extension and termination options compare with Cisco's treatment of similar provisions in their customer financing arrangements, particularly regarding the impact on long-term liabilities and revenue recognition?",
      "original_answer": "Texas Instruments accounts for lease extension and termination options by recognizing lease assets and liabilities based on the present value of lease payments when it is reasonably certain they will be exercised, using their incremental borrowing rate. This affects long-term liabilities on their balance sheet. Cisco, on the other hand, includes similar extension and termination provisions in its customer financing arrangements, which are primarily collateralized and affect the timing of revenue recognition. Cisco also defers revenue on arrangements involving guarantees until the risk is removed. Both companies incorporate these options into their financial reporting, but with different implications: TXN affects liability valuation, while CSCO affects revenue timing and credit exposure.",
      "llm_answer": "\nTexas Instruments records a lease liability and right‑of‑use asset for any extension or early‑termination option that is “reasonably certain” to be exercised, measuring the liability at the present value of the remaining lease payments; Cisco, however, embeds similar extension/termination provisions in its customer‑financing arrangements but does not record a lease‑liability for the option itself—instead it carries the arrangement as a financing receivable, often deferring the related revenue and recognizing it ratably over the service period.  In Cisco’s financing portfolio the options can affect the size of financing receivables (e.g., a 15 % decline in receivables) and, when third‑party guarantees are provided, a liability is recognized only for the guaranteed amount, with any deferred revenue being recognized when the guarantee is removed.  Consequently, while TI’s practice increases long‑term liabilities through the present‑value lease liability, Cisco’s comparable provisions primarily influence revenue timing and contingent liabilities rather than creating a comparable long‑term lease liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Texas Instruments recognizes lease liabilities and right-of-use assets when extension/termination options are reasonably certain to be exercised, using present value of lease payments, which impacts long-term liabilities. Cisco treats similar provisions in customer financing arrangements as financing receivables, defers revenue, and recognizes it over time—particularly when guarantees are involved. The distinction in financial impact—TI on liabilities, CSCO on revenue timing and credit exposure—is correctly captured. (2) Quantitative accuracy is perfect: the mention of a '15% decline in receivables' is not in the original answer but does not contradict it and may reflect additional context from Cisco's filings; no incorrect numbers or calculations are present. Since the original answer does not include specific figures, the LLM’s inclusion of a percentage is acceptable as contextual detail, not an error. (3) Multi-hop reasoning is sound: the model correctly synthesizes across two companies, two accounting standards (leases vs. customer financing), and two financial statement impacts (liabilities vs. revenue). (4) Semantic equivalence is strong—wording differs but meaning matches. The only minor gap is that the original emphasizes Cisco’s collateralized arrangements and risk removal more explicitly, which the LLM touches on via 'guarantee is removed' but could have emphasized more. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Contains]-> FIN_INST <-[Provides]- ORG",
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 435,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does Disney's 73% stake in National Geographic influence the content differentiation strategy on Disney+, and what implications does this have for subscriber acquisition costs relative to YouTube's content licensing model?",
      "original_answer": "Disney's 73% stake in National Geographic allows it to integrate National Geographic-branded programming directly into Disney+ as a top-level tile within the interface, providing exclusive access to content that is not subject to third-party licensing fees (chunk 1 and chunk 2). This vertical integration reduces dependency on external content providers and lowers long-term content acquisition costs. In contrast, YouTube, as a digital video service competitor, relies more heavily on licensed and third-party content, which may involve ongoing licensing expenditures (chunk 3). This structural advantage could give Disney+ a cost edge in subscriber acquisition by leveraging proprietary content like National Geographic to attract and retain users at a lower marginal cost than YouTube.",
      "llm_answer": "\nDisney’s 73 % equity stake in National Geographic gives it exclusive control of the brand’s library, which it markets as a flagship “National Geographic” tile within Disney+ (Chunk 2), allowing the platform to differentiate its offering with premium, non‑fiction programming that cannot be replicated by rivals (Chunk 1). Because the content is owned internally, Disney can acquire and retain subscribers at a lower marginal cost than YouTube, whose video‑streaming service must license third‑party titles and contend with the same competitive set of digital‑video platforms highlighted by Google (Chunk 3); thus, Disney’s vertically integrated stake reduces licensing outlays and lowers subscriber‑acquisition expenses relative to YouTube’s more costly, market‑driven licensing model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Disney's 73% stake in National Geographic, the use of National Geographic as a top-level tile on Disney+, the advantage of owning proprietary content, and the contrast with YouTube's reliance on licensed third-party content are all correctly represented. (2) Quantitative accuracy is perfect: the 73% stake is correctly cited, and no other numerical values require verification. Format variations (e.g., '73 %' with space) do not affect correctness. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across ownership (chunk 1), content integration (chunk 2), and competitive comparison with YouTube's licensing model (chunk 3). It logically connects vertical integration to lower subscriber acquisition costs. (4) The only minor shortcoming is slight overstatement in claiming 'exclusive control'—while Disney has a 73% stake, it does not own 100%, so full control may be debatable; however, in practice, a majority stake typically confers operational control. This nuance does not significantly detract from the overall correctness. The answer is semantically equivalent to the original and highly relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> COMP -[Includes]-> PRODUCT <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 352,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does the impact of regulatory exclusivity expiration timelines on BMY's biologic products compare to MRK's experience with Januvia family market exclusivity delays, considering the role of regulatory exclusivity in extending market protection beyond patent terms?",
      "original_answer": "BMY's biologic products, such as Opdivo and Yervoy, benefit from 12 years of regulatory exclusivity in the U.S., which prevents the FDA from approving biosimilars until 12 years after initial approval. This regulatory exclusivity can extend beyond patent terms and provide additional market protection. In contrast, MRK's Januvia family of products saw their key U.S. patent expire in January 2023, but due to favorable court rulings and settlement agreements on a later-expiring salt-form patent, MRK expects to maintain market exclusivity until May 2026 for Januvia and Janumet and July 2026 for Janumet XR. This shows that while BMY relies on the standard 12-year biologic exclusivity framework, MRK was able to extend market exclusivity for its chemical products through litigation and secondary patents, highlighting different strategies and outcomes tied to regulatory exclusivity mechanisms.",
      "llm_answer": "\nBMY’s biologic products are covered by a statutory 12‑year regulatory exclusivity period that automatically extends market protection well beyond the underlying patent term, so biosimilars cannot launch until after that window—an exclusivity regime that, like the 5‑year (plus up‑to‑6‑month pediatric) exclusivity granted to chemical products, can only be shortened by successful patent challenges or by the limited “8+2+1” EU rules that still leave a long protected interval (Chunk 1).  In contrast, MRK’s Januvia family lost its core patent in 2023 but did not lose market exclusivity in the United States until May 2026 (and in Europe earlier), because a later‑expiring salt‑form patent, pediatric‑exclusivity extensions and the interplay of regulatory‑exclusivity provisions postponed generic entry despite the patent expiry (Chunk 3); this delayed exclusivity, coupled with the EU “8+2+1” regime that allowed a generic filing only after 10–11 years, produced a sharp sales decline once the extended protection finally lapsed (Chunk 3).  Thus, while BMY’s 12‑year biologic exclusivity provides a relatively fixed, long‑term shield, MRK’s experience shows that regulatory exclusivity can be strategically used to push protection beyond patent life—but also creates a pronounced, delayed revenue hit when that extended protection finally ends.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with strong semantic equivalence. (1) Correctly identifies BMY's 12-year U.S. biologic regulatory exclusivity (e.g., for Opdivo/Yervoy) and contrasts it with MRK's Januvia family, whose core patent expired in 2023 but exclusivity extended to May/July 2026 via secondary patents and settlements. The LLM correctly notes that MRK’s extension was due to a later-expiring salt-form patent and pediatric exclusivity, aligning with the original answer. (2) Quantitatively, the LLM accurately references the 2023 patent expiry and 2026 exclusivity end dates, though it generalizes the end to 'May 2026' without specifying July 2026 for Janumet XR—this is a minor omission, not an error. It also correctly frames the 12-year exclusivity for biologics. The mention of EU '8+2+1' rules and pediatric extensions adds context not in the original but is factually sound and relevant. (3) Multi-hop reasoning is strong: the model synthesizes regulatory exclusivity mechanisms across biologics (BMY) and small molecules (MRK), compares statutory vs. litigation-driven extensions, and draws a valid conclusion about differing strategies and outcomes. (4) The answer is fully contextually relevant, directly addressing the comparison of regulatory exclusivity impacts and the role in extending protection beyond patents. The only reason for not scoring 10 is the slight imprecision in not distinguishing the July 2026 date for Janumet XR, though the core timeline and strategic insight remain correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Provides]-> REGULATORY_REQUIREMENT <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1591,
        "completion_tokens": 430,
        "total_tokens": 2021
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does MetLife's issuance of 40,000 shares of Series F preferred stock, with redemption terms tied to a 'rating agency event,' intersect with AIG's exposure to financial risks from potential rating downgrades, particularly given AIG's acknowledgment that a downgrade could limit its ability to write new business and impair customer retention?",
      "original_answer": "MetLife has issued 40,000 shares of Series F preferred stock, which includes a redemption clause triggered by a 'rating agency event'—defined as a change in rating criteria that lowers equity credit assigned to such securities. This creates a financial contingency for MetLife should credit agencies revise their treatment of these instruments. Similarly, AIG acknowledges in its 10-K that a downgrade in its Insurer Financial Strength ratings could materially impair its ability to write new business and retain customers. Therefore, both companies face strategic and operational risks tied to rating agency actions, with MetLife facing potential redemption obligations and AIG facing direct business constraints due to a potential loss of creditworthiness.",
      "llm_answer": "\nMetLife’s 40,000‑share Series F preferred stock is redeemable at any time within 90 days of a “rating agency event,” with a redemption price of $25,500 per share (or $25,000 after March 15 2025) plus accrued dividends – a trigger that is explicitly defined to include any rating downgrade that lowers the equity credit assigned to the security (Chunk 2). Because a downgrade is a rating‑agency event, it creates a direct negative‑impact linkage from the Series F instrument to the risk factor “Rating Downgrade,” which in turn negatively affects AIG (Chunk 1 → KG triplet Series F → Rating Downgrade → AIG). AIG’s own disclosure notes that such a downgrade could limit its ability to write new business and impair customer retention, underscoring the financial risk that MetLife’s redemption feature amplifies for AIG (Chunk 3).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific quantitative details not present in the ground truth, such as a redemption price of $25,500 per share (or $25,000 after March 15, 2025) and a 90-day redemption window. These figures are not found in the original answer or implied by it, and there is no indication in the ground truth that such specific pricing or timing terms exist. This constitutes a significant issue in quantitative accuracy, as these numbers appear fabricated or hallucinated. (2) While the core factual elements—MetLife issuing 40,000 shares of Series F preferred stock with a 'rating agency event' tied to reduced equity credit and AIG’s exposure to business risks from rating downgrades—are correctly identified and aligned with the ground truth, the addition of unsupported specifics undermines factual reliability. (3) The multi-hop reasoning is logically sound: the model correctly links MetLife’s Series F stock redemption trigger to rating agency actions, connects that to the broader risk of rating downgrades, and maps it to AIG’s vulnerability in terms of business writing and customer retention. This synthesis across entities and risks demonstrates strong qualitative reasoning. (4) Contextually, the answer is highly relevant, directly addressing the intersection of MetLife’s financial instrument and AIG’s risk exposure. However, the hallucinated redemption terms reduce correctness. The answer would score higher if not for the unsupported numbers. Overall, the core logic and structure are correct, but the inclusion of unverified quantitative details limits the score to 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Negatively_Impacts]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 442,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does the use of matrix pricing for U.S. Government Securities differ between LMT's portfolio as of December 31, 2021, and UPS's valuation methodology for similar assets, based on their respective Level 2 classifications?",
      "original_answer": "LMT reported $121 million in U.S. Government Securities as of December 31, 2021, which were classified under Level 2 inputs, indicating they were valued using matrix pricing or similar methods when broker quotes were unavailable. UPS also utilized matrix pricing for Level 2 marketable securities, including U.S. government debt, though the specific amount was not disclosed. Both companies rely on matrix pricing as a fallback when direct market data is not available, aligning with the broader accounting policy described by MO, which lists matrix pricing as a standard valuation technique for government securities when broker quotes are absent.",
      "llm_answer": "\nLMT reports $121 million of U.S. Government securities classified as Level 2 on its balance sheet as of December 31 2021, and the filing explicitly states that these securities are valued using **matrix pricing** (Chunk 1).  Both LMT and UPS apply matrix‑pricing‑type techniques for Level 2 assets, but while LMT’s portfolio disclosures show the actual Level 2 amount of government securities, UPS’s disclosure only describes the methodology—stating that its Level 2 marketable securities (e.g., corporate bonds, municipal bonds) are valued with “market corroborated pricing, matrix pricing or other models that utilize observable inputs such as yield curves” (Chunk 3).  The underlying principle of using matrix pricing for observable market data is therefore common to both companies, even though the level of quantitative detail disclosed differs (Chunk 2 describes the generic matrix‑pricing approach used for government securities).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $121 million figure for LMT's U.S. Government Securities as of December 31, 2021, is correct, and no specific amount is attributed to UPS, which matches the original answer. (2) The qualitative analysis correctly identifies that both LMT and UPS use matrix pricing for Level 2 assets, particularly when direct broker quotes are unavailable, and notes that UPS’s disclosures focus on methodology rather than specific amounts. (3) The multi-hop reasoning is sound: it synthesizes LMT’s quantitative disclosure with UPS’s methodological description and connects both to the broader use of matrix pricing for government securities under Level 2 inputs. (4) The only minor shortcoming is a slight omission of the reference to MO’s accounting policy, which provides additional context about matrix pricing as a standard fallback technique—this contextual nuance is missing but does not detract significantly from the core accuracy. Wording differences are semantically equivalent, and all key facts, entities, dates, and reasoning are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 320,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does PM's use of market inputs for derivative valuations compare to MDLZ's approach for its real estate fund investments, given the differing levels of observability in their respective valuation models?",
      "original_answer": "PM values its derivative contracts using standard valuation models based on readily observable market inputs such as foreign exchange spot rates, interest rate differentials, and maturity dates. In contrast, MDLZ values its real estate fund investments using the present value of future cash flows, relying on unobservable inputs like projected operating performance and local market conditions. While PM's approach falls under Level 1 or 2 fair value measurements due to the use of observable data, MDLZ's real estate fund valuations are categorized as Level 3 due to the reliance on unobservable inputs that cannot be corroborated by market data.",
      "llm_answer": "\nPM values its derivative contracts with standard models that use readily observable market inputs—such as prevailing foreign‑exchange spot rates and interest‑rate differentials—giving the valuations a Level 1, high‑observability character (Chunk 1). MDLZ, however, measures its real‑estate fund investments through NAV‑based and appraisal‑driven valuation models that rely on periodic appraisals, unobservable assumptions and discounted‑cash‑flow projections, placing those assets in Level 2/3 of its fair‑value hierarchy where inputs are far less observable (Chunks 2 & 3). Thus, while PM’s derivative valuations are anchored in transparent market data, MDLZ’s real‑estate fund valuations depend on model‑derived, less‑observable inputs, even though both firms’ accounting policies link “Valuation Models” to “Real Estate Funds” in the knowledge‑graph (PM → Valuation Models → Real Estate Funds ← Discloses MDLZ).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its factual content and conveys the key distinction between PM's and MDLZ's valuation approaches. (1) It correctly states that PM uses observable market inputs (foreign exchange spot rates, interest rate differentials) in standard models, leading to Level 1 or 2 classification—though it slightly overstates this by saying 'Level 1, high-observability character', whereas the ground truth specifies Level 1 or 2, not exclusively Level 1. (2) For MDLZ, the LLM accurately notes the use of unobservable inputs like discounted cash flows and appraisals, placing valuations in Level 2/3. However, the ground truth explicitly categorizes MDLZ’s real estate fund valuations as Level 3 due to reliance on unobservable inputs, while the LLM says Level 2/3, which is less precise. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across PM and MDLZ, contrasting their valuation models and linking them to the fair value hierarchy. (4) The mention of NAV-based models and appraisal-driven approaches adds detail not in the original but does not contradict it; however, the parenthetical reference to a 'knowledge-graph' link (PM → Valuation Models → Real Estate Funds ← Discloses MDLZ) appears fabricated or irrelevant, as there is no such disclosed relationship in the context—this is a minor distraction but doesn't undermine the core accuracy. Overall, the answer captures the essential contrast with high fidelity, meriting a strong score, but loses points for slight imprecision in fair value level classification and inclusion of potentially spurious connections.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> ACCOUNTING_POLICY -[Valued_By]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 443,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does MetLife's repayment strategy for its junior subordinated debentures compare to AIG's obligations under the AIGLH-issued junior subordinated debentures, particularly in terms of liquidity constraints and deferral provisions?",
      "original_answer": "MetLife has provisions allowing it to defer interest payments on its junior subordinated debentures under certain conditions, which in turn triggers dividend stopper provisions. Additionally, MetLife is subject to replacement capital covenants that require it to raise specified replacement securities before repaying, redeeming, or purchasing the debentures. In contrast, AIG's obligations under the AIGLH-issued junior subordinated debentures include specific maturities such as $54 million of 8.5% debentures due in 2030, $142 million of 8.125% debentures due in 2046, and $31 million of 7.57% debentures due in 2045, all of which are guaranteed by AIG Parent. However, AIG does not guarantee any of the borrowings of AIGLH post-distribution of debentures, indicating a different liquidity risk profile compared to MetLife's structured repayment and deferral constraints.",
      "llm_answer": "\nMetLife’s junior subordinated debentures can be repaid only after it satisfies trigger‑event and capital‑support covenants that require cash from replacement securities, a restriction that underlies its recent regulatory‑approved repurchases of $79 million and $148 million of surplus notes (Chunk 1).  \nIn contrast, the AIGLH junior subordinated debentures—$54 million, $142 million and $31 million of 8.5 %, 8.125 % and 7.57 % issues maturing 2030‑2046 and guaranteed by the AIG Parent—are subject only to that parent guarantee and fixed‑rate maturities, with AIG noting it does not guarantee the borrowings and providing no comparable deferral trigger, so repayment hinges on AIG’s own liquidity rather than on trigger‑event constraints (Chunks 2‑3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All quantitative values are correct: $54 million of 8.5% debentures due 2030, $142 million of 8.125% due 2046, and $31 million of 7.57% due 2045 — all match the original answer exactly. Dollar amounts, percentages, and maturities are correctly reported with acceptable formatting (e.g., $142 million). (2) The answer addresses all parts of the question: it contrasts MetLife’s deferral provisions and replacement capital covenants with AIGLH’s fixed maturities and parent guarantee, while noting AIG’s lack of ongoing guarantees post-distribution. (3) Entity accuracy is strong: MetLife, AIG, AIGLH, and the correct security types (junior subordinated debentures) are properly identified. The mention of MetLife’s regulatory-approved repurchases of surplus notes (though not in the original answer) adds context without introducing error. (4) Multi-hop reasoning is sound: the model correctly synthesizes that MetLife’s repayment is constrained by trigger events and replacement capital requirements, whereas AIGLH’s obligations depend on fixed maturities and parent guarantees, with repayment liquidity resting with AIG. The only minor shortcoming is that the LLM does not explicitly mention MetLife’s dividend stopper provision triggered by interest deferral — a detail present in the original answer — which slightly reduces completeness in qualitative terms. However, the core comparison on liquidity constraints and deferral provisions remains substantively accurate. Overall, the answer is factually correct, well-structured, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Repay]-> FIN_INST -[Issues]-> COMP <-[Involved_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 445,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "How does NVIDIA's competitive positioning against Samsung in the SoC and GPU markets influence Intel's strategic challenges in scaling its IFS Foundry Services, particularly given Intel's historical manufacturing delays and competitive pressures?",
      "original_answer": "NVIDIA competes with Samsung in the SoC and GPU markets, which are critical to automotive, gaming, and accelerated computing applications. Samsung is also a key competitor to Intel's IFS Foundry Services, which Intel established as part of its IDM 2.0 strategy to become a major foundry provider. Intel highlights that IFS must compete with established players like Samsung on multiple fronts including time-to-market, process performance, and ecosystem support. However, Intel's history of manufacturing delays, such as the setbacks with its 10nm and Intel 4 (formerly 7nm) process technologies, creates a disadvantage compared to Samsung's mature foundry capabilities. These delays have already impacted Intel's product competitiveness and gross margins, and could hinder IFS's ability to attract customers in a market where timely access to advanced processes is critical. Therefore, NVIDIA's competitive pressure on Samsung indirectly affects Intel's ability to scale IFS, as Samsung remains a dual threat both in end-product markets and in the underlying manufacturing ecosystem.",
      "llm_answer": "\nNVIDIA’s competitive positioning against Samsung—evident in the SoC and GPU markets where Samsung is listed as a direct rival—underscores that Samsung is a principal foundry competitor that Intel’s IFS must confront, especially as Intel seeks to scale its IDM 2.0 foundry business; this rivalry is compounded by Intel’s historical manufacturing delays (e.g., the 10 nm and Intel 4 setbacks) that make it harder to match Samsung’s (and TSMC’s) advanced‑process performance, capacity and price advantages.  The broader industry consolidation highlighted by NVIDIA’s ARM acquisition and AMD’s Xilinx deal intensifies competitive pressure on Intel’s IFS, forcing the company to accelerate process‑technology development, secure sufficient manufacturing capacity and deliver compelling ecosystem support to succeed in the foundry arena.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: NVIDIA competes with Samsung in SoC and GPU markets; Samsung is a key competitor to Intel's IFS Foundry Services; Intel's manufacturing delays (10nm and Intel 4) are accurately cited as historical setbacks impacting competitiveness. There are no numeric values requiring calculation, but the named process nodes (10nm, Intel 4) match the original answer exactly. (2) Quantitative accuracy is perfect—no incorrect or misstated figures, and the technical terms (Intel 4, 10nm) are used correctly. (3) The multi-hop reasoning is sound: the answer correctly links NVIDIA vs. Samsung competition to Samsung’s dual role as a product and foundry competitor, which in turn affects Intel’s ability to scale IFS amid its own delays. It also adds context about industry consolidation (NVIDIA-ARM, AMD-Xilinx), which, while not in the original answer, is factually accurate and enhances the strategic landscape without distorting the core logic. (4) The only minor gap is that the original answer emphasizes how NVIDIA’s pressure on Samsung *indirectly* affects Intel’s IFS scaling by keeping Samsung strong in both end markets and manufacturing—this causal chain is slightly less explicit in the LLM version, though implied. Otherwise, the answer is semantically equivalent, contextually rich, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Competes_With]-> COMP -[Competes_With]-> PRODUCT <-[Competes_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1504,
        "completion_tokens": 393,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "Given that Alphabet repurchased $62.0 billion in Class A and Class C shares in 2024, how does the difference in voting rights between Class A and Class B shares at both Alphabet and Comcast impact their respective share repurchase strategies, particularly in light of Comcast's concentrated ownership of Class B shares by a single individual?",
      "original_answer": "Alphabet's share repurchase strategy in 2024 focused on Class A and Class C shares, with $62.0 billion repurchased, while maintaining the balance between voting classes since Class B shares automatically convert to Class A upon sale. This preserves the concentrated voting power of Class B holders. Similarly, Comcast's Class B shares, which carry 15 votes per share and represent 33⅓% of the combined voting power, are entirely owned by Brian L. Roberts. This concentrated ownership influences Comcast's repurchase strategy, as repurchases of Class A shares increase the relative voting power of the Class B shares. Both companies manage their share structures to maintain governance control while returning capital to shareholders.",
      "llm_answer": "\nAlphabet’s 2024 repurchase of **$62 billion** was directed exclusively at its non‑voting **Class C** and the lower‑voting **Class A** shares, thereby preserving the disproportionate **10‑vote‑per‑share** weight of the **Class B** securities that remain unconverted and un‑repurchased (Chunk 1).  In contrast, Comcast’s capital structure gives **Class B** shares **15 votes each** and, as disclosed in its 2024 10‑K, are **beneficially owned in their entirety by Brian L. Roberts**, making that block responsible for roughly **33 ⅓ % of the total voting power** while **Class A holders collectively control only 66 ⅔ % of voting power** (Chunk 2).  Because the Class B stake is concentrated in a single individual and is non‑dilutable, Comcast’s share‑repurchase program (summarized in the same filing) can safely target Class A shares without jeopardizing the controlling owner’s voting dominance, whereas Alphabet must avoid buying Class B shares to maintain its existing voting balance (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Alphabet repurchased $62 billion in Class A and C shares in 2024; Class B shares have 10 votes (implied by 'disproportionate 10-vote-per-share weight'); Comcast's Class B shares have 15 votes and are fully owned by Brian L. Roberts, representing 33⅓% of voting power. These numbers match the original answer exactly. (2) Quantitative accuracy is perfect: $62 billion, 15 votes, 33⅓%, and 66⅔% are all correctly reported. The dollar amount and percentages are consistent with the ground truth. (3) The multi-hop reasoning is sound: the model correctly infers that Alphabet avoids repurchasing Class B to preserve voting balance due to their conversion feature, while Comcast can repurchase Class A shares safely because doing so increases the relative voting power of the already concentrated Class B block. The explanation of governance implications is logically coherent and synthesizes information across both companies. (4) Minor deduction in qualitative accuracy because the original answer mentions that Alphabet's Class B shares 'automatically convert to Class A upon sale'—a key structural detail that explains why repurchasing Class A/C doesn't disrupt control—but this is only implicitly covered in the LLM answer ('remain unconverted and un-repurchased'). Otherwise, the LLM provides richer detail (e.g., Class A collective voting share) and maintains full contextual relevance by directly addressing the impact of voting rights on repurchase strategies at both firms.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 432,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "How does Amgen's focus on NSCLC therapies compare with Bristol Myers Squibb's recent FDA approval of Opdivo Qvantig in terms of administration method and potential market expansion for adult solid tumor indications?",
      "original_answer": "Amgen's 2024 disclosures highlight its strategic focus on NSCLC therapies, indicating a strong commitment to oncology innovation. Meanwhile, Bristol Myers Squibb's FDA approval in December 2024 for Opdivo Qvantig enables subcutaneous administration for most previously approved adult solid tumor indications of Opdivo, either as monotherapy, maintenance therapy, or in combination with chemotherapy or cabozantinib. This administration route offers a more convenient alternative to traditional intravenous delivery, potentially expanding market access and improving patient adherence. The combination of Amgen’s ongoing NSCLC development and BMS’s subcutaneous innovation in Opdivo Qvantig reflects divergent strategies in addressing the same therapeutic area, with BMS leveraging delivery mechanism improvements to enhance market positioning in solid tumor oncology.",
      "llm_answer": "\nAmgen’s strategic emphasis on non‑small cell lung cancer is reflected in its KG link (AMGN → NSCLC), whereas BMS’s newly FDA‑approved Opdivo Qvantig introduces a subcutaneously administered nivolumab‑hyaluronidase formulation that expands the existing Opdivo label to “most previously approved adult, solid‑tumor Opdivo indications” as monotherapy, maintenance or in combination. This novel delivery route and the broadened adult solid‑tumor indication create a distinct market‑expansion opportunity that complements Amgen’s NSCLC focus.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Amgen's focus on NSCLC and BMS's FDA approval of Opdivo Qvantig with accurate details on administration method (subcutaneous) and the scope of approved indications. It accurately reflects that Opdivo Qvantig expands to 'most previously approved adult solid tumor indications' and can be used in monotherapy, maintenance, or combination settings. The only minor omission is the specific approval date (December 2024), which is present in the ground truth but not mentioned in the LLM response—however, this does not impact the core factual accuracy. (2) There are no numeric values, percentages, or financial figures requiring verification; all qualitative descriptors (e.g., 'subcutaneously administered', 'broadened adult solid-tumor indication') align with the original. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Amgen and BMS), compares their strategic approaches (Amgen’s disease-area focus vs. BMS’s delivery innovation), and draws a valid contrast in market expansion strategies. (4) The answer is semantically equivalent to the ground truth, with slightly more technical phrasing (e.g., 'nivolumab-hyaluronidase formulation') but retains full factual fidelity. Contextual relevance is perfect, addressing both administration method and market expansion implications as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT -[Impacts]-> PRODUCT <-[Announces]- ORG",
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 388,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "Given CMCSA's non-dilutable 33 1/3% voting power protection for Class B shares and the conversion mechanism to Class A shares, how does this structure limit GOOGL's influence despite its stake in Class A common stock?",
      "original_answer": "CMCSA's capital structure protects 33 1/3% of the voting power through Class B shares, which cannot be diluted by additional issuances of common stock. Each Class B share converts on a 1:1 basis into Class A shares, but this conversion is subject to restrictions. Meanwhile, GOOGL holds a stake in Class A common stock, which carries voting rights that could otherwise influence corporate decisions. However, due to CMCSA's structural protections, even if all Class B shares were converted to Class A, the non-dilutable voting safeguard would still preserve the 33 1/3% voting control, limiting GOOGL’s ability to shift governance outcomes through its Class A stake alone.",
      "llm_answer": "\nCMCSA’s charter fixes a **33 ⅓ % non‑dilutable voting block for Class B shares** (9.44 million shares outstanding) and allocates the remaining **≈66 ⅔ % of the vote to Class A shares**.  Class B stock can only be converted into Class A on a **share‑for‑share basis**, so any additional Class A shares acquired by GOOGL do not increase its voting power and cannot dilute the protected Class B block.  As a result, even though GOOGL holds a large stake in the issued Class A common stock, its effective voting influence is capped by the immutable 33 ⅓ % Class B voting shield and the limited conversion rights, curbing its ability to control CMCSA’s decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies CMCSA's 33 1/3% non-dilutable voting power for Class B shares and explains that this block cannot be diluted by additional Class A issuances, which matches the original answer. The ≈66 2/3% allocation to Class A is a reasonable inference and semantically consistent. (2) The numeric values—33 1/3%, 66 2/3%, 1:1 conversion—are all correct; the mention of '9.44 million shares outstanding' is additional detail not in the ground truth but does not contradict it and may be factually accurate based on external data, so it does not penalize the score. No calculations are required, and all percentages are correctly represented. (3) The reasoning correctly synthesizes the structural protection of voting power and how GOOGL’s Class A stake is limited in influence due to the fixed voting split and conversion restrictions. The logic that GOOGL cannot increase its voting power through additional Class A acquisitions is sound and directly addresses the multi-hop nature of the question (structure → voting control → impact on GOOGL). (4) The answer is contextually fully relevant, directly addressing how CMCSA's share structure limits GOOGL's influence. The only minor shortcoming is that it does not explicitly state that even full conversion of Class B to Class A would preserve the 33 1/3% control—a point emphasized in the original—but this is implied in the explanation of non-dilutability and conversion limits. Thus, the answer is slightly less complete but still factually and semantically aligned. Hence, a high score of 9 is justified.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Converts_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 447,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "How does the 13.2% increase in South Africa's total tobacco market volume, partly offset by higher illicit trade prevalence, affect both PEP's merger-related socioeconomic obligations and MO's illicit trade risk exposure in their respective international operations?",
      "original_answer": "The 13.2% increase in South Africa's total tobacco market volume, which was partly offset by higher illicit trade prevalence, directly impacts both companies through different mechanisms. For PEP, this market dynamic influences the scope and cost of their socioeconomic program obligations in South Africa, which are explicitly included in their merger and integration charges. For MO, the increased prevalence of illicit trade associated with this market growth contributes to the illicit trade risks outlined in their filings, which they state can lead to lost sales, brand dilution, and potential legal or regulatory actions against their distribution channels.",
      "llm_answer": "\nThe 13.2 % surge in South Africa’s total tobacco‑market volume—partly muted by a higher estimated prevalence of illicit trade—reinforces PEP’s merger‑related socioeconomic commitments in the country, since the acquisition‑integration charges explicitly earmark liabilities for socioeconomic programmes in South Africa (Chunk 1) and the market expansion makes those obligations more salient (Chunk 2). At the same time, the same rise in illicit‑trade activity that accompanies the volume growth heightens MO’s international risk exposure, because illicit trade is a negative risk factor that directly impacts MO’s operations and can trigger regulatory, tax and reputational consequences for its Africa‑Middle‑East business (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 13.2% increase in South Africa's tobacco market volume is correctly cited, and no other numerical values require verification. (2) The answer correctly identifies that PEP's merger-related socioeconomic obligations are explicitly included in their integration charges, and the growing market makes these obligations more salient—consistent with the original answer's emphasis on scope and cost. (3) For MO, the LLM correctly links increased illicit trade prevalence to heightened risk exposure, citing regulatory, tax, and reputational consequences, which maps to the original answer’s mention of lost sales, brand dilution, and legal/regulatory actions. The only minor shortcoming is that the LLM does not explicitly mention 'lost sales' or 'brand dilution'—key impacts noted in the ground truth—though 'reputational consequences' partially captures brand risk. (4) The multi-hop reasoning is sound: it connects market volume growth → illicit trade rise → differential impact on PEP (socioeconomic obligations) and MO (risk exposure), synthesizing across entities and causal chains. Wording differs but meaning is semantically equivalent. All entities (PEP, MO, South Africa, merger charges, illicit trade) are correctly identified and contextualized. Minor deduction in qualitative accuracy for slightly less comprehensive risk description for MO.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Negatively_Impacts]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 398,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 203,
      "question": "How do the legal risks associated with securities litigation in Slack's IPO compare to Meta's exposure from its privacy-related lawsuits, particularly in terms of procedural outcomes and potential financial liabilities?",
      "original_answer": "Slack faced securities litigation related to its IPO, where a motion to dismiss was partially granted and partially denied in 2020, followed by a Ninth Circuit reversal in 2025 that led to the dismissal of the complaint with prejudice, significantly reducing its legal exposure. In contrast, Meta faced a $725 million settlement in a consumer privacy class action, which was approved in 2023, and continues to face ongoing litigation and regulatory scrutiny, including a $5.0 billion FTC penalty paid in 2020 and pending appeals in several state attorney general cases. Unlike Slack's litigation, which was ultimately dismissed, Meta's legal challenges have resulted in substantial financial liabilities and ongoing regulatory constraints.",
      "llm_answer": "\nSlack’s securities litigation—stemming from its IPO and dominated by a motion to dismiss that was partially granted, appealed through the Ninth Circuit, vacated by the U.S. Supreme Court and then reversed with prejudice—leaves the size of any monetary award uncertain, whereas Meta’s privacy‑related actions have already produced a $725 million class‑action settlement and a $5 billion FTC penalty, with additional liability still pending in ongoing appeals. Both cases involve undisclosed potential damages, but Slack’s exposure remains contingent on future rulings, while Meta has incurred multi‑billion‑dollar financial obligations and continues to face regulatory scrutiny. The competitive relationship between Google (GOOGL) and Slack further contextualizes the heightened legal risks each company confronts.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key legal outcomes and financial liabilities for both Slack and Meta. It accurately states Meta's $725 million class-action settlement and $5 billion FTC penalty, both of which match the ground truth in amount and context. The procedural history of Slack’s litigation is mostly correct: the motion to dismiss was partially granted and later reversed, ultimately leading to dismissal with prejudice. However, the LLM adds that the case was 'vacated by the U.S. Supreme Court,' which is not mentioned in the ground truth and appears to be an unsupported detail—this is a minor factual overreach. (2) Quantitatively, all dollar amounts ($725 million, $5 billion) are correct and properly attributed. The timeline is generally accurate: the FTC penalty was paid in 2020, and the $725 million settlement was approved in 2023. The ground truth notes the Ninth Circuit reversal occurred in 2025, which the LLM does not specify but does not contradict. The missing year for the reversal slightly reduces precision. (3) The multi-hop reasoning is sound: the model correctly contrasts Slack’s ultimately dismissed litigation (with uncertain financial exposure) against Meta’s realized and ongoing liabilities. It captures the core distinction—dismissal vs. substantial paid settlements and ongoing scrutiny. The mention of Google (GOOGL) as a competitor to Slack, while factually plausible, is irrelevant to the question about legal risks in securities vs. privacy litigation and slightly detracts from focus. (4) The answer is semantically close to the ground truth, with only minor embellishments and one unsupported procedural claim (Supreme Court vacatur). Scores reflect high accuracy in numbers and reasoning, with a small deduction in qualitative accuracy due to the unverified Supreme Court detail and slight overreach in context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Competes_With]-> COMP -[Files]-> LITIGATION <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 509,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 203,
      "question": "How does the difference in vesting timelines for RSU awards between PM and WMT affect the recognition period of compensation costs, given PM's $160 million in unrecognized RSU costs and WMT's shift from 25% annual vesting to 8% quarterly vesting?",
      "original_answer": "PM has $160 million in unrecognized compensation costs from non-vested RSU awards, which are expected to be recognized over a weighted-average period of seventeen months, typically over three years or upon specific events like death, disability, or reaching age 58. This vesting schedule aligns with PM's policy where RSU awards generally vest on the third anniversary of the grant date. In contrast, WMT shifted its vesting schedule for RSU awards in fiscal 2023 to an 8% quarterly vesting rate over three years, down from a previous 25% annual vesting rate over four years. This change in WMT's vesting schedule accelerates the recognition of compensation costs earlier in the vesting period compared to PM’s structure. As a result, WMT’s updated vesting approach leads to a more evenly distributed cost recognition over the three-year period, whereas PM's cost recognition is more back-loaded due to its cliff-vesting structure tied to specific events or the three-year anniversary.",
      "llm_answer": "\nThe difference in vesting timelines changes how quickly each company recognizes RSU compensation expense: PM’s RSU awards vest on the third anniversary of the grant and its $160 million of unrecognized compensation is amortized over a weighted‑average of about 17 months (or upon death/disability), so the cost is spread over roughly 1½ years; in contrast, WMT shifted from a 25 %‑per‑year schedule over four years to an 8 %‑per‑quarter schedule over a three‑year period, meaning its RSU expense will now be recognized ratably across the full three‑year vesting horizon with quarterly installments, shortening the overall recognition period relative to the prior four‑year annual vesting. This contrast is reflected in the disclosed accounting policies for both firms (PM → RSU → Vesting Schedule ← WMT).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies PM's $160 million in unrecognized compensation costs and the 17-month weighted-average recognition period, aligning with the ground truth. It accurately notes PM's cliff-vesting on the third anniversary and recognition upon specific events like death or disability. For WMT, it correctly states the shift from 25% annual vesting over four years to 8% quarterly over three years. However, it slightly mischaracterizes the prior WMT vesting as 'over four years' without clarifying that the original plan was 25% per year for four years (totaling 100%), which is correct but less precise in framing. (2) All numbers are accurate: $160 million, 17 months (~1.5 years), 25%, 8%, three-year and four-year periods. The statement that PM's cost is amortized over 'roughly 1½ years' is a reasonable interpretation of a weighted average of 17 months. The quarterly rate of 8% over 12 quarters (3 years) correctly sums to 96%, with the remaining 4% likely vesting at the end, which the model implies by referencing a full three-year ratable recognition. (3) The multi-hop reasoning is sound: the model correctly contrasts PM’s back-loaded, event-driven cliff vesting with WMT’s shift toward earlier and more evenly distributed recognition due to quarterly vesting. It draws the correct conclusion that WMT’s change accelerates cost recognition compared to its prior structure and relative to PM’s. However, it does not explicitly state that PM’s structure leads to more back-loaded expense recognition, which is a key comparative insight in the ground truth. (4) The answer is contextually excellent—directly addresses the question about how vesting differences affect compensation cost recognition. The synthesis across PM and WMT is logical and relevant. Minor deduction in correctness due to incomplete articulation of the back-loading versus even distribution contrast, though the implication is present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Vest]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 526,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How does the $620 million unrecognized tax benefit risk at Boeing compare to Lockheed Martin's assessment of Pillar 2's impact, given the OECD's global minimum tax framework and differing implementation timelines across jurisdictions?",
      "original_answer": "Boeing identifies a $620 million risk in unrecognized tax benefits related to federal tax matters under audit, with Pillar 2's global minimum tax of 15% potentially applying to its worldwide operations, though it expects minimal impact due to lack of material operations in low-tax jurisdictions. Meanwhile, Lockheed Martin also anticipates no material impact from Pillar 2 on its effective tax rate or consolidated results, despite the framework's phased implementation starting in 2024 and 2025. This assessment is complicated by the OECD's Pillar 2 model rules, which, while providing a framework, allow for varied national adoption timelines and potential modifications to domestic tax incentives, as noted by General Electric's evidence.",
      "llm_answer": "\nBoeing estimates that as much as **$620 million** of unrecognized tax benefits may be resolved in the next 12 months, a risk that stems from the OECD’s **Pillar 2** global‑minimum‑tax framework whose model rules are slated for implementation on **January 1, 2024** (with some aspects extending to 2025) and whose final form remains uncertain in the United States—yet Boeing has no material operations in low‑tax jurisdictions, so the regime is not expected to raise its global tax costs materially.  In contrast, **Lockheed Martin** says it is **monitoring** the same Pillar 2 rollout but, given the phased adoption (effective 2024‑2025) and the limited presence of its operations in jurisdictions with rates below the 15 % minimum, it **does not expect any material impact** on its effective tax rate, consolidated results, financial position, or cash flows.  Both companies are therefore subject to the same regulatory requirement, but Boeing quantifies a specific $620 million exposure while Lockheed projects the Pillar 2 effect to be essentially immaterial.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: Boeing's $620 million unrecognized tax benefit risk is accurately stated, and the connection to OECD Pillar 2 with a 15% global minimum tax is properly contextualized. The implementation timeline (2024–2025) is correctly cited. Lockheed Martin’s assessment of no material impact is also accurately reported. (2) Quantitative elements—$620 million, 15%, 2024–2025 rollout—are all factually correct and match the original answer. No calculation errors. (3) Multi-hop reasoning is sound: the model correctly synthesizes Boeing’s specific tax exposure with the broader Pillar 2 framework and contrasts it with Lockheed Martin’s similar conclusion of immaterial impact, despite different phrasing. The mention of Boeing quantifying a specific exposure while Lockheed is monitoring but not expecting material effects captures the nuance. (4) The only minor shortcoming is that the LLM omits the reference to General Electric’s evidence about national adoption variability, which adds context to implementation complexity. However, this is a supporting detail and does not undermine the core comparison. Wording differs but semantic meaning is equivalent. Overall, the answer is factually robust, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Impacts]-> REGULATORY_REQUIREMENT -[Related_To]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 368,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How will the implementation of ASU No. 2023-07 impact the way PepsiCo reports its newly reorganized segments starting in Q1 2025, and how does this align with Altria's adoption timeline and disclosure requirements under the same standard?",
      "original_answer": "PepsiCo will recast its historical segment reporting beginning in Q1 2025 to reflect its new organizational structure, which includes combining FLNA and QFNA into PepsiCo Foods North America and reorganizing international food businesses into Latin America Foods, EMEA, and Other International Foods. This aligns with ASU No. 2023-07, which requires incremental disclosures of disaggregated expense information by reportable segment. Altria adopted the standard in 2024 and included expanded disclosures in Note 17, with interim requirements to be implemented starting Q1 2025. Thus, both companies are aligning with the new standard's timeline for retrospective application and enhanced reporting beginning in 2025.",
      "llm_answer": "\nThe implementation of ASU No. 2023‑07 will force PepsiCo to recast its newly‑structured segments—PepsiCo Foods North America, Latin America Foods, EMEA, and Other International Foods—starting in the first quarter of 2025 and to disclose disaggregated expense information for each reportable segment in the footnotes, as described in Chunk 1 and reinforced by the KG link “Segment Reporting → ASU No. 2023‑07.”  Altria has already adopted the same ASU for its 2024 fiscal year (Chunk 2) and, per its 10‑K (Chunk 3), will begin including the required interim segment‑expense disclosures in its first‑quarter 2025 filings, aligning its adoption timeline and disclosure requirements with PepsiCo’s recasting and expanded reporting under the new standard.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PepsiCo will recast its segments starting Q1 2025, the new segments are accurately named (PepsiCo Foods North America, Latin America Foods, EMEA, Other International Foods), and the requirement under ASU No. 2023-07 to disclose disaggregated expense information by segment is correctly stated. Altria’s adoption in 2024 and interim disclosure starting Q1 2025 is factually correct. (2) Quantitative elements—dates (Q1 2025, 2024 adoption)—are accurate and match the original answer; no numerical calculations are required. (3) Multi-hop reasoning is sound: the model correctly synthesizes PepsiCo’s reorganization with ASU implementation timing and aligns it with Altria’s timeline, showing cross-company and cross-temporal understanding. (4) The only minor shortcoming is the phrase 'force PepsiCo to recast' which slightly overstates the standard’s role—the standard requires enhanced disclosures and allows retrospective recasting, but the reorganization itself is management-driven. However, this does not undermine the factual core. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong qualitative and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Introduces]-> ACCOUNTING_POLICY -[Impacts]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 355,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How does the expiration timeline of Merck's MK-7962 (sotatercept) patent protection in the U.S. compare to Pfizer's broader patent strategy for biologics, especially considering potential extensions in both portfolios?",
      "original_answer": "Merck's MK-7962 (sotatercept) has a base U.S. patent expiration of 2027, with potential additional protection extending to 2037 if patent term extensions (PTEs) are granted. This reflects a strategy of relying on both initial and extended patent coverage for biologics. Pfizer also leverages PTEs and supplementary protection certificates (SPCs), particularly in Europe, to extend exclusivity beyond basic patent expirations. Both companies utilize regulatory exclusivity and patent filings to maximize product lifecycle management, though Pfizer explicitly notes variability in extension outcomes due to external factors.",
      "llm_answer": "\nMerck’s MK‑7962 (sotatercept) is slated to lose its basic U.S. patent protection in 2027 (Chunk 1), but the method‑of‑use patents and the 12‑year data‑exclusivity granted upon approval push the effective market exclusivity to 2037, with the possibility of additional extensions such as a PTE (Chunk 2).  \nPfizer’s broader biologic patent strategy, by contrast, is built around extending protection through multiple regulatory levers—including PTEs, supplemental protection certificates, pediatric exclusivity and pending patent applications—so that its products often retain market exclusivity well beyond the 2037 horizon and can even outlast the 2028 generic launch of Eliquis referenced in its disclosures (Chunk 3); this layered approach is reflected in the KG link that ties “Patent Protection” directly to Pfizer (PFE) (KG).",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM correctly identifies Merck's base patent expiration for MK-7962 (sotatercept) in 2027 and the potential extension to 2037 with PTEs, aligning with the ground truth. However, it introduces 'method-of-use patents' and '12-year data exclusivity' as reasons for the 2037 date, which are not mentioned in the original answer and may conflate different exclusivity mechanisms. The original answer only cites potential PTEs as the basis for extension to 2037, making the LLM's justification partially speculative. 2) Quantitatively, the years 2027 and 2037 are correct. But the LLM implies that data exclusivity alone extends protection to 2037, which is inaccurate—12-year biologic data exclusivity would only reach 2039 if approved in 2027, and the original answer does not specify approval year or tie exclusivity to that mechanism. The mention of '2028 generic launch of Eliquis' is extraneous and not relevant to the question about patent strategies for biologics. 3) The multi-hop reasoning is sound in comparing Merck’s and Pfizer’s strategies around patent term extensions and lifecycle management. The LLM correctly notes that Pfizer uses multiple levers (PTEs, SPCs, pediatric exclusivity), which matches the original’s emphasis on regulatory and patent extensions. However, the original answer does not claim Pfizer’s protections 'often retain market exclusivity well beyond 2037' or 'outlast the 2028 generic launch of Eliquis'—this extrapolation lacks support in the ground truth. 4) Despite overreaching on specifics, the LLM captures the core idea that both companies use PTEs and regulatory tools to extend exclusivity. The comparison is conceptually valid, and key entities (Merck, MK-7962/sotatercept, Pfizer, PTEs, SPCs) are accurate. The answer is highly relevant and well-structured, but minor factual overstatements and unsupported numerical inferences reduce quantitative and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> PRODUCT -[Subject_To]-> REGULATORY_REQUIREMENT <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 516,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How do cost overruns under fixed-price contracts impact both Lockheed Martin's financial performance and GE's operational execution, given the sensitivity of these contracts to inflationary pressures and project complexity?",
      "original_answer": "Lockheed Martin reported cumulative reach-forward losses of $270 million and $280 million on two fixed-price contracts as of December 31, 2023, with potential for additional losses if cost overruns continue. These contracts are especially vulnerable to inflation, as noted in RTX's 10-K, which stated that rising material and labor costs can lead to losses on fixed-price contracts when overruns occur. Similarly, GE's operational execution is negatively impacted by cost overruns, particularly in large-scale projects such as those in its Power and Renewable Energy segments, where delays or technical issues can lead to contractual penalties and joint liability in consortiums. This highlights how both companies face significant financial and operational risks stemming from fixed-price contract structures under current economic and project execution conditions.",
      "llm_answer": "\nLockheed Martin’s fixed‑price development contracts create a direct link to cost‑overrun risk that is recorded as “reach‑forward” losses; as disclosed in Chunk 1, cumulative losses of roughly $270 million (Aeronautics) and $280 million (RMS) have already been booked, and the 2023 profit‑booking adjustments that added $1.6 billion to sales were reversed when estimated completion costs exceeded contract price, thereby cutting net sales and segment operating profit. Because these contracts are highly sensitive to inflation‑driven cost growth and technical complexity, any overrun forces an earnings charge that depresses LMT’s financial performance. For GE, the same inflationary pressures and project complexity translate into operational strain—Chunk 2 explains that rising material, component and labor prices cannot be passed through on fixed‑price aerospace contracts, leading to losses, while Chunk 3 details how supply‑chain disruptions, large‑scale project execution risks, and contractual penalties for schedule or quality failures can erode GE’s cash flow and profitability, a risk amplified by the Fixed‑Price → Cost Overrun → GE negative‑impact chain in the knowledge graph.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $270 million and $280 million cumulative reach-forward losses for Lockheed Martin as of December 31, 2023, matching the ground truth in both amount and context. It accurately links these losses to fixed-price contracts and inflationary sensitivity, citing rising material and labor costs. For GE, it correctly describes operational execution risks due to cost overruns, supply-chain disruptions, and contractual penalties, particularly in large-scale projects. (2) All numeric values are accurate: $270 million (Aeronautics) and $280 million (RMS) align with the original answer. The mention of a $1.6 billion reversal in profit-booking adjustments is additional detail not in the ground truth but does not contradict it and is plausible within the context of cost overruns affecting financials; however, since this specific figure isn't in the original answer, it introduces a minor unverified claim. Still, no calculation errors are present. (3) Multi-hop reasoning is strong: the LLM synthesizes information across Lockheed Martin’s financial reporting, inflation impacts (referencing RTX’s 10-K indirectly via 'Chunk 2'), and GE’s project execution risks (via 'Chunk 3'), correctly tracing the chain from fixed-price contracts → cost overruns → financial/operational impacts. It appropriately connects inflation and complexity to both companies’ vulnerabilities. (4) The answer is semantically equivalent to the ground truth, with slightly more granular financial mechanics explained (e.g., impact on net sales and segment profit). The only minor gap is the lack of explicit mention of 'joint liability in consortiums' for GE, which is a small omission but doesn't undermine the overall accuracy. Thus, the answer earns a 9/10 for correctness—excellent but not perfect due to one unverified figure and slight omission in GE’s risk description.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> FIN_INST -[Negatively_Impacts]-> RISK_FACTOR <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 514,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 207,
      "question": "How does MDLZ's use of commodity futures for raw material price risk compare with COST's disclosure of Level 1 financial liabilities in terms of fair value measurement and derivative instrument exposure?",
      "original_answer": "MDLZ actively uses commodity futures to hedge against price risk for raw materials like cocoa, sugar, and wheat, with these instruments classified as Level 1 financial liabilities measured at fair value based on quoted market prices. In contrast, COST disclosed that it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis as of August 28, 2022, indicating no direct exposure to exchange-traded commodity futures like those used by MDLZ. This highlights a strategic difference in derivative usage and fair value exposure between the two companies.",
      "llm_answer": "\nMDLZ treats commodity futures—exchange‑traded Level 1 financial instruments—as the core hedge for raw‑material price risk, recording them at fair value derived from quoted market prices and reporting both the asset and liability sides of the derivative in its balance sheet (chunks 1 & 2); these futures are explicitly linked in the KG as Commodity Futures → Level 1 Financial Liabilities and are disclosed as part of MDLZ’s derivative‑risk exposure. By contrast, COST’s 2022 filing states that it held **no** Level 1 financial assets or liabilities measured at fair value on a recurring basis, so its disclosure of Level 1 derivative instruments is essentially absent and any fair‑value measurements for its derivatives occur at Level 2 or Level 3 (chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: MDLZ uses commodity futures (e.g., cocoa, sugar, wheat) as Level 1 financial liabilities measured at fair value using quoted market prices, and these are actively used for hedging raw material price risk. COST disclosed zero Level 1 financial assets or liabilities measured at fair value on a recurring basis as of August 28, 2022 (implied in the LLM answer by referencing the 2022 filing), indicating no exposure to exchange-traded derivatives like commodity futures. (2) There are no numeric values requiring calculation, but the qualitative references to disclosures are correctly attributed to the right companies and timeframes. The absence of Level 1 instruments at COST is correctly stated. (3) The multi-hop reasoning is sound—comparing MDLZ’s active use and classification of derivatives with COST’s lack of Level 1 exposure demonstrates proper synthesis across two companies and their respective risk management strategies. (4) The LLM slightly omits mentioning that COST holds no Level 3 instruments either (mentioned in original answer), but this does not detract significantly from the core comparison. Wording differences (e.g., 'essentially absent') preserve semantic equivalence. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> FIN_INST -[Includes]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 391,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 208,
      "question": "What is the total number of UPS Class A shares that are convertible into Class B shares, and how does this compare to the assets held in Lockheed Martin's nonqualified pension trust as of December 31, 2024?",
      "original_answer": "As of December 31, 2024, there were 4.6 billion UPS Class A shares that are fully convertible into Class B shares. Lockheed Martin reported $658 million in assets held in a separate trust for its nonqualified defined benefit pension plans as of the same date.",
      "llm_answer": "\nThe UPS 10‑K (Chunks 2 & 3) states that **4.6 billion Class A shares were authorized as of 31 December 2024** and that these shares are “fully convertible into Class B shares at any time.”  By contrast, Lockheed Martin’s non‑qualified pension trust held **$658 million of assets on 31 December 2024** (Chunk 1).  In other words, the convertible Class A share count (4.6 billion) is a quantity measured in shares, whereas Lockheed Martin’s trust assets amount to roughly **$0.658 billion**, making the share count vastly larger in numeric terms.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, it accurately reports 4.6 billion UPS Class A shares as convertible into Class B shares as of December 31, 2024, and correctly states that Lockheed Martin's nonqualified pension trust held $658 million in assets on the same date. Number formats are consistent and acceptable (4.6 billion, $658 million). (2) The answer is complete, addressing both parts of the multi-part question: the number of convertible shares and the comparison with Lockheed Martin’s trust assets. (3) Entity accuracy is perfect: UPS and Lockheed Martin are correctly identified, with accurate reference to Class A/B shares and nonqualified pension trust assets. The date (December 31, 2024) is consistently used. (4) The reasoning is sound and appropriately highlights that the two figures are measured in different units (shares vs. dollars), while still providing a valid numeric comparison by converting $658 million to 0.658 billion. This demonstrates correct multi-hop synthesis across two companies and filings. The semantic meaning fully aligns with the original answer, with added clarity in framing the comparison. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Holds]-> FIN_INST -[Held_By]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 349,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How does the sensitivity of AVGO's fixed rate senior notes to interest rate changes compare to CSCO's use of interest rate swaps in managing similar debt exposure, given the specific fair value impacts and hedging strategies outlined?",
      "original_answer": "AVGO's fixed rate senior notes are highly sensitive to interest rate changes, with a 50 basis point increase in rates causing a $1.7 billion decline in fair value as of November 3, 2024. In contrast, CSCO actively manages this risk using an interest rate swap with a $0.5 billion notional amount, which converts fixed interest payments on a portion of its senior notes to floating rates based on SOFR, thereby offsetting changes in the fair value of the hedged debt. This indicates that while AVGO faces significant exposure due to the size of its unhedged fixed-rate debt ($56.3 billion), CSCO employs targeted hedging strategies to mitigate similar risks on its smaller fixed-rate debt base.",
      "llm_answer": "\nAVGO’s $56.3 bn (and $40.8 bn) fixed‑rate senior notes are directly exposed to market rates – a 50‑bp move would alter their fair value by roughly $1.7 bn (≈$3.4 bn per 100‑bp), as shown in its 10‑K (Chunk 1).  CSCO counters a comparable exposure by entering a $0.5 bn fair‑value interest‑rate swap that converts the fixed‑rate senior notes to a SOFR‑based floating rate, so the swap’s gains and losses offset the fair‑value change and the net impact on earnings is essentially neutralized (Chunks 2 & 3).  In other words, AVGO’s notes bear the full $1.7 bn‑per‑50‑bp sensitivity, whereas CSCO’s hedging swap offsets that sensitivity, illustrating a hedged versus an un‑hedged approach to the same debt‑exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key numbers are correct: AVGO's $56.3 billion fixed-rate debt, $1.7 billion fair value decline from a 50 bp rate increase, and CSCO's $0.5 billion notional interest rate swap are all accurately reported. The implied duration sensitivity (~$3.4 billion per 100 bp) is a reasonable extrapolation and not contradicted by the original. (2) The qualitative reasoning correctly contrasts AVGO's unhedged exposure with CSCO's active hedging via fair value swaps that convert fixed to floating rates (SOFR-based), thereby offsetting fair value changes. The conclusion that this represents a hedged vs. unhedged strategy is logically sound and matches the original. (3) Multi-hop synthesis is strong: the model correctly pulls data from both AVGO and CSCO filings, compares their risk management approaches, and interprets the financial implications. (4) Minor deduction in qualitative accuracy due to the mention of '$40.8 bn' in parentheses without context—this figure does not appear in the ground truth and could confuse, though it doesn't invalidate the main argument. Otherwise, the answer is semantically equivalent, contextually precise, and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Hedges_Fixed_Rate_Senior_Notes]-> FIN_INST <-[Designates]- ORG",
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 351,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How do PM and MDLZ differ in their application of the parametric delta-gamma approximation technique within their VAR models to estimate one-day loss under normal market conditions?",
      "original_answer": "PM applies the parametric delta-gamma approximation technique by observing interest rate and forward currency rate movements primarily over the preceding quarter for determining VAR at year-end, and over each of the four preceding quarters for average, high, and low VAR amounts during the year. MDLZ also uses the parametric delta-gamma method but extends its parameter estimation to include commodity price movements, in addition to interest rates and currencies. Furthermore, MDLZ observes movements over the prior quarter for year-end VAR calculations and across each of the four prior quarters for average VAR amounts, similar to PM, but explicitly accounts for the non-linear behavior of currency and commodity options in its computation.",
      "llm_answer": "\nBoth PM and MDLZ apply a parametric delta‑gamma approximation within their VAR models to estimate a one‑day loss under normal market conditions using a 95 % confidence level. PM limits the technique to interest‑rate‑sensitive and foreign‑currency derivatives, deriving its parameter relationships from observed quarterly movements and excluding hedged transactions, whereas MDLZ expands the approximation to interest rates, currencies, commodities (and market‑sensitive equity), treats options as non‑linear and values them accordingly, and incorporates debt and commodity exposures; unlike the variance‑covariance method described for DIS, only PM and MDLZ explicitly use the parametric delta‑gamma approach. Thus, PM’s VAR focuses on FX and interest‑rate derivative risk, while MDLZ’s VAR captures a broader set of fixed‑income, currency, commodity and equity risks and reflects the impact on pre‑tax earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core differences between PM and MDLZ in their use of the parametric delta-gamma approximation technique within VAR models. (1) It correctly identifies that both companies use the parametric delta-gamma method for estimating one-day VaR under normal market conditions at a 95% confidence level, which aligns with the ground truth. (2) Quantitatively, no specific numbers (e.g., dollar amounts, exact percentages beyond confidence level) are required, and the 95% confidence level mentioned is consistent with typical VaR disclosures and does not contradict the ground truth. (3) The qualitative differences are well-articulated: PM focuses on interest rate and foreign currency derivatives, using recent quarterly data, while MDLZ extends the model to include commodities and equity exposures, and explicitly treats options as non-linear—this matches the ground truth’s emphasis on MDLZ accounting for non-linear behavior of currency and commodity options. (4) The LLM correctly notes that both use prior quarter data for year-end VAR and multiple quarters for average VAR, though it doesn’t explicitly mention 'high and low VAR amounts over four quarters' as in the original answer—this is a minor omission but does not undermine the overall correctness. (5) The synthesis across entities (PM vs. MDLZ) is sound, and the comparison highlights the broader risk coverage in MDLZ’s model. The only slight gap is that the original answer specifies MDLZ uses the four prior quarters for average, high, and low VAR, while the LLM only references average VAR—this nuance is missing but not critical to the main contrast. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with high completeness and reasoning quality.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> MACRO_CONDITION -[Relates_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 492,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How does Medtronic's emphasis on increasing global patient access to its therapies compare with Amgen's challenges in maintaining patient affordability under pressure from payers like Express Scripts, particularly in light of Express Scripts' role in negotiating deeper discounts that limit access to Amgen's products such as Repatha?",
      "original_answer": "Medtronic aims to expand global patient access to its therapies by leveraging its product pipeline and local presence, as stated in its 2024 10-K. In contrast, Amgen faces significant challenges in ensuring patient affordability for products like Repatha due to increasing payer pressure, particularly from large PBMs such as Express Scripts. Express Scripts, as part of the top six integrated health plans and PBMs controlling 94% of U.S. pharmacy prescriptions, utilizes Rebate Management Organizations to negotiate deeper discounts, which in turn leads to formulary restrictions and higher out-of-pocket costs for patients. This dynamic negatively affects Amgen's product sales and patient access, especially for Medicare patients who abandon prescriptions due to high co-pays, despite Amgen's efforts to lower the list price of Repatha. Therefore, while Medtronic's strategy positively impacts patient access, Amgen's ability to maintain access is constrained by the market power of entities like Express Scripts.",
      "llm_answer": "\nMedtronic’s 10‑K explicitly states that its mission is to “increase the adoption of our products and services in markets around the globe” and to use its scale to expand patient access to life‑saving therapies (Chunk 1).  In stark contrast, Amgen reports that payer pressure—particularly from large PBMs such as Express Scripts, which negotiate deeper rebates, impose step‑therapy and formulary restrictions on Repatha, and shift more cost to patients—has limited the drug’s affordability and sales, a risk amplified by payer consolidation (the top six plans control ~94 % of prescriptions) and state 340B legislation that forces deeper discounts (Chunk 2‑3).  The knowledge‑graph pattern captures this dynamic: Medtronic → Patient Access → Express Scripts → Amgen, showing how Medtronic’s positive drive for global access is counter‑balanced by the negative impact that payer‑driven discount pressures have on Amgen’s product reach (KG triplet relationship).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Medtronic's mission to expand global patient access is accurately cited from its 2024 10-K (implied in 'mission to increase adoption...globally'), and Amgen's challenges with payer pressure, particularly from Express Scripts, are correctly described. The 94% market share of the top six PBMs and health plans is accurately reported. (2) Quantitative accuracy is perfect: the 94% figure matches the original, and no other numbers (e.g., prices, rebates) are misstated. Format and context are consistent. (3) Multi-hop reasoning is sound: the answer correctly links Medtronic’s global access strategy with Amgen’s constrained access due to PBM-driven rebates and formulary restrictions, and references the structural role of Express Scripts within a consolidated payer system. The mention of 340B legislation and step-therapy adds contextual depth supported by the knowledge graph. (4) The only minor shortcoming is the reference to a 'knowledge-graph pattern' and 'KG triplet relationship', which introduces a meta-level explanation not present in the original and slightly distracts from the core comparison. However, this does not introduce factual error. The core contrast—Medtronic expanding access vs. Amgen facing access barriers due to payer power—is clearly and correctly articulated. Semantic equivalence is strong, with appropriate flexibility in wording. All entities (Medtronic, Amgen, Express Scripts, Repatha), strategies, and market dynamics are accurately represented.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Positively_Impacts]-> RISK_FACTOR -[Negatively_Impacts]-> COMP <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 434,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 210,
      "question": "How does Alphabet's share repurchase strategy prioritize certain stock classes relative to their conversion rights, and what might this imply about potential voting control considerations given that Class A shares are also publicly traded by another major corporation?",
      "original_answer": "Alphabet repurchased $62.2 billion of Class A and Class C shares in 2023, with $36.3 billion remaining available under the repurchase authorization as of December 31, 2023. Notably, Class B common stock—which carries 10 votes per share—can be converted to Class A shares at the stockholder's option or automatically upon sale or transfer. The company has focused repurchases on Class A and Class C shares rather than Class B, preserving the weighted voting power associated with Class B shares. Meanwhile, Class A common stock is also publicly traded by Comcast Corporation (CMCSA), suggesting Class A shares may represent a broader market standard for voting equity that could be strategically maintained for governance purposes.",
      "llm_answer": "\nAlphabet’s repurchase program focuses on buying back and retiring **Class A and Class C** shares—leaving the super‑voting **Class B** shares untouched—so that the pool of low‑ or non‑voting equity is systematically reduced while the 10‑vote‑per‑share **Class B** stakes (which can convert into Class A at any time) remain intact, preserving insider voting dominance; the $70 bn Board‑approved capacity (with $36.3 bn still available as of Dec 2023) and the automatic conversion of Class B upon sale/transfer underscore this priority. Because **Class A shares are also publicly held by another major corporation (Comcast)**, the ongoing retirement of Class A stock can further curb external voting influence and reinforce Alphabet’s control over the voting structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies Alphabet's share repurchase strategy focusing on Class A and Class C shares while preserving Class B super-voting shares, and notes the conversion rights and automatic conversion upon sale/transfer. It also correctly references Comcast (CMCSA) as another corporation publicly trading Class A shares, linking this to voting control implications. However, the repurchase amount stated as $70 billion is incorrect—the ground truth states $62.2 billion was repurchased in 2023, with $36.3 billion remaining authorized. The $70 billion figure appears to be a misstatement or conflation with total authorization rather than actual repurchases. The remaining $36.3 billion available is correctly cited. 2) Quantitative accuracy is partially compromised: while $36.3 billion remaining is accurate, the $70 billion figure lacks support in the original data and contradicts the $62.2 billion repurchased. No calculation is provided to justify $70 billion, making this a material discrepancy. 3) Qualitatively, the reasoning is strong: the model correctly infers that avoiding repurchases of Class B shares preserves insider voting control, understands conversion mechanics, and makes a valid multi-hop connection between Alphabet’s repurchase behavior and Comcast’s public trading of Class A shares as a potential governance signal. 4) Contextual relevance is excellent—the answer directly addresses all parts of the question: repurchase priorities, conversion rights, voting control, and the significance of another major firm trading Class A shares. Despite the numerical error, the core logic and synthesis are sound, warranting a high correctness score with a deduction for the inaccurate repurchase amount.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Convertible_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 471,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 210,
      "question": "How might UnitedHealth Group's formulary restrictions on high-cost biologics, as demonstrated by Repatha's access challenges, impact Eli Lilly's ability to maintain revenue growth for its biologic therapies given their dependence on patient access?",
      "original_answer": "UnitedHealth Group, as one of the top six integrated health plans and PBMs controlling 94% of U.S. pharmacy prescriptions, has significant leverage to impose formulary restrictions and require prior authorization for high-cost biologics. This is exemplified by the access limitations placed on Repatha, which resulted in reduced patient affordability and use despite price reductions. Eli Lilly acknowledges that its revenue prospects for biologics are directly affected by patient access issues, including payer restrictions such as prior authorization and formulary exclusions. Given the concentration of payer power and the precedent set by Repatha’s access challenges, Eli Lilly’s ability to maintain revenue growth for its biologic therapies may be significantly constrained if similar restrictions are applied to its products.",
      "llm_answer": "\nUnitedHealth’s formulary limits on high‑cost biologics—exemplified by the step‑therapy and prior‑authorization hurdles that have cut into Repatha’s patient access—show how payer‑driven restrictions can sharply curb usage of expensive therapies (Chunk 1).  As Chunk 2 details, such payer actions, amplified by industry consolidation and 340B‑related pressures, not only lower sales of the affected product but also force manufacturers to offer deeper rebates and discounts, further eroding revenue (Chunk 2).  Because Eli Lilly’s biologic revenues depend critically on broad patient access, continued or expanding formulary constraints by large payers like UnitedHealth risk dampening demand, pressuring prices, and ultimately threatening Lilly’s ability to sustain its biologic‑driven growth (Chunk 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: UnitedHealth's formulary restrictions on high-cost biologics, exemplified by Repatha's access challenges (step-therapy, prior authorization), are accurately described. The impact on patient access and usage is correctly conveyed. (2) There are no numeric values in the original or LLM answer requiring verification—thus, quantitative accuracy is 10. (3) The multi-hop reasoning is sound: the LLM correctly links UnitedHealth’s payer power to restrictions on biologics (via Repatha example), connects this to broader industry trends (consolidation, 340B pressures), and synthesizes how such dynamics affect Eli Lilly’s revenue through reduced demand, pricing pressure, and rebates. The only minor gap is that the original emphasizes UnitedHealth’s market share (top 6 plan controlling 94% of prescriptions), which the LLM omits—this contextual detail strengthens the argument but does not undermine the core reasoning. (4) The LLM answer fully addresses the question about how formulary restrictions could impact Eli Lilly’s revenue growth, with accurate entity identification (UnitedHealth, Repatha, Eli Lilly), correct causal logic, and appropriate emphasis on patient access dependence. Wording differs but meaning is preserved. Contextual relevance is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Competes_With]-> COMP -[Negatively_Impacts]-> RISK_FACTOR <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 381,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 211,
      "question": "How does Oracle's use of its $3.0 billion commercial paper program compare with Cisco's treatment of its $9.0 billion in senior fixed-rate notes, particularly in light of their shared exposure to short-term debt financing mechanisms?",
      "original_answer": "Oracle maintains a $3.0 billion commercial paper program, which allows it to issue unsecured short-term promissory notes under a private placement exemption. As of May 31, 2022, Oracle had no outstanding commercial paper notes. Cisco, on the other hand, had $9.0 billion in principal amount of senior fixed-rate notes outstanding as of July 30, 2022, which rank at par with any commercial paper notes it may issue in the future under its short-term debt financing program. Cisco also uses interest rate swaps to convert fixed interest rates on $1.5 billion of these notes to floating rates based on LIBOR. This indicates that while Oracle actively manages short-term liquidity through a flexible commercial paper facility, Cisco has a larger, more structured long-term debt profile with embedded risk management through interest rate hedging.",
      "llm_answer": "\nOracle’s $3 billion commercial‑paper program (Chunk 1) is an unsecured short‑term note facility that, as of May 2022, had no outstanding issuances, whereas Cisco holds $9 billion of senior fixed‑rate notes (Chunks 2 & 3) that are explicitly ranked at par with commercial‑paper notes under its own short‑term financing program. The KG link Commercial Paper Notes → Senior Fixed‑Rate Notes → CSCO shows that both companies’ debt categories are interrelated, and Cisco further hedges $1.5 billion of those notes with interest‑rate swaps (Chunk 2), underscoring a shared reliance on short‑term debt mechanisms despite Oracle’s currently unused program.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) All key facts are correct: Oracle's $3.0 billion commercial paper program with no outstanding notes as of May 2022 (date slightly generalized to 'May 2022' vs 'May 31, 2022', which is acceptable); Cisco's $9.0 billion in senior fixed-rate notes outstanding as of July 30, 2022; the par ranking of Cisco’s commercial paper with its senior notes; and the use of interest rate swaps on $1.5 billion of those notes to convert fixed to floating rates based on LIBOR. (2) Quantitative accuracy is perfect: all dollar amounts ($3B, $9B, $1.5B) and time references are correct or acceptably approximated. (3) Multi-hop reasoning is sound—LLM correctly links Oracle’s short-term program with Cisco’s longer-term notes and recognizes their shared exposure to short-term debt mechanisms, noting the structural relationship (par ranking) and risk management via swaps. (4) The only minor shortcoming is a slight lack of emphasis on the contrast in debt strategy—Oracle’s flexible, unused short-term facility vs. Cisco’s active long-term debt with hedging—though this is implied. The mention of 'KG link' and 'Chunks' appears to reflect internal referencing and does not detract from factual content. Overall, the answer is semantically equivalent to the ground truth with excellent reasoning and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Issues]-> FIN_INST -[Related_To]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 387,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 211,
      "question": "How does the extension of ASU 2022-06's optional hedging relief until 2024 impact FedEx's and Caterpillar's management of LIBOR-related interest rate risk in their respective derivative instruments?",
      "original_answer": "ASU 2022-06 extends the optional expedients and exceptions for accounting related to reference rate reform, including LIBOR, until December 31, 2024. FedEx, which references this ASU, continues to monitor its contracts and hedging relationships affected by LIBOR, though it has not yet experienced a material impact. Caterpillar, which actively uses interest rate contracts as part of its risk management strategy, benefits from the extended relief by maintaining flexibility in accounting for LIBOR-based hedging relationships without disruption. The extension allows both companies to continue transitioning away from LIBOR without immediate accounting complications, supporting consistent treatment of derivative instruments tied to legacy rates.",
      "llm_answer": "\nThe FASB’s ASU 2022‑06—providing optional expedients for accounting for contracts, hedging relationships and other transactions affected by reference‑rate reform—has been extended to remain applicable through December 31 2024, allowing both FedEx and Caterpillar to keep using the relief for their LIBOR‑indexed derivatives; FedEx disclosed in its 2023 10‑K that the standard is effective until 2024 and that it continues to monitor its LIBOR‑linked contracts with no material impact, while Caterpillar’s 10‑K shows that it formally documents hedge relationships and designates fixed‑to‑floating interest‑rate contracts (and certain forward rate agreements) as fair‑value or cash‑flow hedges, which under the extended ASU can retain hedge‑accounting treatment without redesignation or remeasurement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: ASU 2022-06 extends relief until December 31, 2024—this date is correctly stated. FedEx’s disclosure of monitoring LIBOR-linked contracts with no material impact is accurately represented and tied to its 2023 10-K. Caterpillar’s use of interest rate contracts, including fair-value and cash-flow hedges, is correctly described with proper context on hedge accounting under the extension. (2) Quantitative accuracy is perfect: the end date of the extension (December 31, 2024) is correct, and no numerical calculations are required beyond that. Format and precision are consistent with the original. (3) Multi-hop reasoning is sound: the answer synthesizes information across both companies and correctly links the accounting standard to each firm’s hedging practices. It explains how the extension supports continued hedge accounting without redesignation, which reflects the intended benefit of the relief. (4) The only minor shortcoming is that the LLM does not explicitly state that both companies are using the extension to support their transition away from LIBOR—a point emphasized in the original answer. However, this is implied in the discussion of continued hedge accounting. Wording differs but semantic meaning is equivalent. No factual errors or entity misidentifications are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Introduces]- ORG",
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 387,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does Boeing's use of Citibank, N.A. as administrative agent in its Five-Year Credit Agreement compare with Caterpillar's engagement of Citibank in its multi-facility credit agreements in terms of syndication structure and amendment activity in 2022 and 2023?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, and amended on August 25, 2022, involved Citibank, N.A. as administrative agent alongside JPMorgan Chase Bank, N.A. as syndication agent, with both also serving as joint lead arrangers and joint book managers. Caterpillar, on the other hand, had Citibank, N.A. acting as agent in both its 3-Year and 5-Year Facilities dated September 1, 2022, with additional roles for Citibank Europe plc and MUFG Bank, Ltd. in local currency management. Both companies saw Citibank play a central role in structuring and managing credit facilities, but Caterpillar’s agreements included more complex international components, while Boeing’s amendment in 2022 was a singular update to its existing agreement.",
      "llm_answer": "\nBoeing’s Five‑Year Credit Agreement (dated Oct 30 2019) names Citibank, N.A. as administrative agent, with JPMorgan Chase listed as syndication agent and both banks as joint lead arrangers, and it was amended once in August 2022 (see Chunk 1/2). Caterpillar, by contrast, uses a multi‑facility structure— a 3‑year and a 5‑year credit agreement (both dated Sept 1 2022) that designate Citibank, N.A. as the facility agent (and as local‑currency agent in the addenda) and involve multiple local‑currency banks, and it executed an amendment to its 5‑year facility in August 2023 (see Chunk 3). Thus, while both companies rely on Citibank as a key agent, Boeing’s syndication includes a separate syndication agent and joint lead arrangers with a single amendment in 2022, whereas Caterpillar’s facilities feature multiple agent roles and an amendment activity concentrated in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Boeing's Five-Year Credit Agreement was dated October 30, 2019, and amended on August 25, 2022; Citibank, N.A. served as administrative agent with JPMorgan Chase Bank, N.A. as syndication agent and joint lead arranger—this matches the original. Caterpillar’s 3-Year and 5-Year Facilities were both dated September 1, 2022, with Citibank, N.A. as agent and additional roles for local currency banks including Citibank Europe plc and MUFG Bank, Ltd., and an amendment occurred in August 2023 to the 5-year facility. (2) Quantitative accuracy is perfect: all dates (Oct 30, 2019; Aug 25, 2022; Sept 1, 2022; Aug 2023) are correct and match the ground truth. (3) The multi-hop reasoning is sound—correctly comparing syndication structures (Boeing’s joint lead arrangers vs. Caterpillar’s multi-agent, multi-facility international setup) and amendment timing (2022 for Boeing, 2023 for Caterpillar). (4) The only minor shortcoming is that the LLM does not explicitly mention the 'joint book managers' role shared by Citibank and JPMorgan in Boeing’s agreement, which is included in the ground truth. It also omits explicit mention of Citibank Europe plc’s role, though it references 'multiple local-currency banks.' These are small omissions but do not detract significantly from the overall correctness. Semantic equivalence is maintained, and the conclusion about Citibank’s central role and structural complexity differences is valid. Hence, a score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Regulates]-> COMP <-[Partners_With]- ORG",
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 429,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does the dual-class stock structure at META, which gives Class B shareholders disproportionate voting control, compare to CMCSA's dual-class framework in terms of potential impact on investor confidence, especially given CMCSA's Class B to Class A conversion mechanism?",
      "original_answer": "META's dual-class stock structure gives Class B shareholders, such as Mark Zuckerberg, disproportionate voting control, which could make its Class A common stock less attractive to some investors. This is due to reduced corporate governance protections and potential conflicts of interest. Similarly, CMCSA has a dual-class framework where Class B common stockholders hold 33⅓% of the voting power, and each share of Class B stock is convertible, share for share, into Class A stock. The conversion mechanism in CMCSA could allow for shifts in voting control, much like META's structure, though CMCSA's Class B shares currently represent a much smaller total quantity (9,444,375 issued and outstanding). This structural similarity may affect investor confidence in both companies, especially if control remains concentrated in a minority of shareholders.",
      "llm_answer": "\nBoth META and CMCSA employ dual‑class share structures that concentrate voting power in a minority of shares, but META’s Class B shares carry 15 votes each and, through its controlled‑company status and Delaware anti‑takeover provisions (Chunk 3), can limit minority‑shareholder influence and depress the stock price, whereas CMCSA’s Class B shares, which control only 33 ⅓ % of the vote yet are non‑dilutable and convertible share‑for‑share into Class A (Chunks 1‑2), provide a conversion mechanism that can mitigate some governance concerns but also signals that voting power may shift; this KG relationship—where CMCSA’s Class A Common Stock is linked to META and can negatively impact it—highlights that the conversion feature introduces a distinct confidence‑related risk by potentially altering voting dynamics over time.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core idea that both META and CMCSA have dual-class structures that concentrate voting power, and it correctly identifies CMCSA's Class B to Class A conversion mechanism. However, there are significant factual inaccuracies affecting correctness. First, the claim that META's Class B shares carry '15 votes each' is incorrect—the ground truth does not specify vote multiples, and public filings indicate Class B shares have 10 votes per share, not 15. This is a critical quantitative error. Second, the LLM introduces a 'KG relationship—where CMCSA’s Class A Common Stock is linked to META and can negatively impact it'—which is factually baseless and not supported by the original answer or known financial linkages; the two companies are unrelated in ownership structure. This undermines qualitative accuracy. While the answer correctly notes CMCSA’s Class B shares hold 33⅓% of voting power and are convertible share-for-share (matching the ground truth), it fails to mention the specific number of Class B shares outstanding (9,444,375), a key quantitative detail in the original answer. The reasoning around investor confidence is partially sound, but the erroneous vote count and fabricated inter-company link distort the analysis. The contextual relevance remains high because the response addresses the comparative governance impact and conversion mechanism as asked. Overall, the answer is partially correct with major factual flaws in numbers and entity relationships, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Depends_On]-> FIN_INST <-[Negatively_Impacts]- ORG",
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 419,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "What was The Coca-Cola Company's net sales to equity method investees in 2021, and which regions does Coca-Cola FEMSA specifically cover in its bottling and distribution operations?",
      "original_answer": "The Coca-Cola Company's net sales to equity method investees in 2021 were $14,471 million. Coca-Cola FEMSA operates in several countries including Mexico (central, southeast, and northeast), Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil (parts of São Paulo, Minas Gerais, Mato Grosso do Sul, Paraná, Santa Catarina, parts of Rio Grande do Sul, Goiás, and Rio de Janeiro), Argentina (Buenos Aires and surrounding areas), and Uruguay.",
      "llm_answer": "\nIn 2021 The Coca‑Cola Company reported **net sales to equity‑method investees of $14,471 million** (Chunk 3).  \nCoca‑Cola FEMSA, the Company’s largest bottling partner, operates in a broad territory that includes **Mexico (central, southeast and northeast regions and Mexico City), Guatemala, Nicaragua, Costa Rica (nationwide), Panama, Colombia, Venezuela, Brazil (major parts of São Paulo, Minas Gerais, Mato Grosso do Sul, Paraná, Santa Catarina, Rio Grande do Sul, Goiás and Rio de Janeiro), Argentina (the federal capital of Buenos Aires and surrounding areas) and Uruguay (nationwide)** (Chunk 2).  \nThis geographic reach is reflected in the knowledge‑graph link **Costa Rica (GPE) → Coca‑Cola FEMSA (COMP)**, which ties the GPE mentioned in Chunk 1 to FEMSA’s operations and ultimately to KO, illustrating how FEMSA’s bottling footprint is mapped across those regions (Chunk 1).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and matches the ground truth in all key aspects. (1) Quantitatively, the net sales figure of $14,471 million in 2021 is correct and matches the original answer exactly. (2) The regions covered by Coca-Cola FEMSA are accurately listed, with only minor additional detail (e.g., 'Mexico City', 'nationwide' in Costa Rica and Uruguay) not present in the ground truth but factually consistent and not contradictory. The core regions—Mexico, Central America, South America, and specific Brazilian and Argentine areas—are correctly identified. (3) The multi-hop reasoning is sound: the answer links Coca-Cola's financial data to its equity investee Coca-Cola FEMSA and correctly maps the geographic operations, even referencing a knowledge-graph link to justify the connection, demonstrating proper synthesis across entities. (4) Semantic equivalence is maintained: while the LLM adds slight elaboration (e.g., 'federal capital', 'nationwide'), all information is factually aligned with the ground truth. The only reason for not scoring a 10 is that the original answer does not specify 'nationwide' for Costa Rica and Uruguay or explicitly mention Mexico City, so the LLM slightly exceeds the provided ground truth without error. Overall, the answer is factually correct, complete, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Operates_In]-> COMP <-[Depends_On]- ORG",
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 368,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does the decline in Remicade sales due to biosimilar competition impact Merck's overall immunology segment revenue, and how does this compare to AbbVie's exposure to biosimilar pressures on biologics like Humira?",
      "original_answer": "Merck's Remicade sales declined by 9% in 2021 and 20% in 2020 due to biosimilar competition in Europe, where it lost market exclusivity in 2015. This decline directly affected its immunology segment, which includes Remicade and Simponi, both impacted by biosimilar pressures. In 2021, Remicade generated $299 million in international sales, contributing to the overall decline in the segment. AbbVie, on the other hand, faces similar biosimilar threats, particularly with Humira, which is now facing direct biosimilar competition in Europe and other countries. Unlike Merck, AbbVie continues to invest heavily in biologics infrastructure and emphasizes patent protection and regulatory exclusivity to delay biosimilar entry, particularly in the U.S. market.",
      "llm_answer": "\nMerck’s immunology revenue is being hit directly by biosimilar pressure on Remicade – the product still generated about $299 million in international sales in 2021 but fell 9 % that year, pulling down the segment that also includes Simponi (see Chunk 2 and the immunology row in Chunk 3).  This mirrors AbbVie’s exposure, where biosimilar competition is likewise eroding sales of its flagship biologic Humira, a risk factor that the company explicitly flags for its biologics portfolio (Chunk 1).  In both cases the KG relationship ORG ‑ [Faces] → RISK_FACTOR ‑ [Negatively_Impacts] → PRODUCT ← [Produces] ORG captures how each firm’s biologic (Remicade for Merck, Humira for AbbVie) is negatively impacted by biosimilar competition, with the resulting revenue declines shaping their respective immunology‑segment outlooks.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $299 million in international Remicade sales in 2021, the 9% decline in 2021, and the mention of biosimilar pressure are all consistent with the original answer. The 20% decline in 2020 is not mentioned, which is a minor omission, but the core quantitative data for 2021 is accurate. (2) The LLM correctly identifies Merck’s immunology segment being impacted by Remicade and Simponi, and AbbVie’s exposure via Humira. It accurately captures the parallel risks both companies face from biosimilars. (3) The reasoning is sound: it synthesizes the impact on Merck’s segment revenue and compares it to AbbVie’s situation, noting the shared risk factor. The reference to a knowledge graph relationship adds analytical depth, though slightly meta, it doesn’t detract from correctness. (4) The only minor shortcoming is the lack of mention of Merck’s earlier 20% decline in 2020 and the detail about AbbVie’s strategy of patent protection and delaying U.S. biosimilar entry, which is present in the original. However, the core comparison and factual content are semantically equivalent and contextually appropriate. Thus, the answer is excellent but not perfect, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Faces]-> RISK_FACTOR -[Negatively_Impacts]-> PRODUCT <-[Produces]- ORG",
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 370,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How did Honeywell's investment in Garrett's Series B Preferred Stock, originally tied to indemnification agreements, impact its long-term receivables after the partial redemptions in late 2021, and what was the remaining present value of the unredeemed shares as of December 31, 2021?",
      "original_answer": "Honeywell received $375 million and 834.8 million shares of Garrett's Series B Preferred Stock as part of the resolution of indemnification and tax matters agreements following Garrett's emergence from bankruptcy. The Series B Preferred Stock was subject to mandatory redemptions, with the First Partial Redemption of $211 million completed on December 28, 2021, and a planned Second Partial Redemption of $200 million in early 2022. As of December 31, 2021, the present value of the remaining mandatory redemptions of the Series B Preferred Stock was $423 million, which was included in Honeywell’s long-term receivables and investments.",
      "llm_answer": "\nHoneywell’s long‑term receivable that arose from the Garrett indemnification and tax‑matters agreements was measured at the present value of the mandatory redemption schedule (discounted at 7.25 %); after the $211 million first‑partial redemption executed on December 28 2021, the unredeemed Series B Preferred shares retained a present‑value of roughly **$207 million** as of December 31 2021—exactly the amount disclosed in the company’s long‑term receivables together with the $34 million short‑term investment in Garrett securities.  This accounting treatment mirrors the present‑value approach used by GE for its own preferred‑stock (carrying value $5.935 billion), underscoring how redeemable securities are valued and reduced when partial redemptions occur.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors, particularly in the key quantitative result. The ground truth states that the present value of the remaining mandatory redemptions of Garrett's Series B Preferred Stock was $423 million as of December 31, 2021. However, the LLM incorrectly reports this value as $207 million, which is less than half the correct amount. Additionally, the LLM mentions a 'short-term investment in Garrett securities' of $34 million, which is not present in the original answer and introduces unverified information. The $211 million first partial redemption on December 28, 2021, is correctly stated, but the subsequent calculation or reasoning leading to $207 million is flawed and unsupported by the ground truth. (2) The discount rate of 7.25% and the comparison to GE’s accounting treatment are not mentioned in the original answer and appear to be hallucinated or incorrectly inferred. These details, while potentially plausible in a broader accounting context, are not part of the verified facts and distract from the core answer. (3) The multi-hop reasoning is partially sound in that the model recognizes the connection between partial redemptions and the present value impact on long-term receivables. However, it fails to correctly synthesize the actual redemption schedule: after a $211 million redemption against an initial $375 million cash and stock package, the remaining redemption obligations were $200 million (planned for 2022), but the present value was $423 million—indicating the $375 million was not the total face value, but rather part of a larger structured payout. The LLM misunderstands this structure, leading to a severe miscalculation. (4) The contextual relevance is high because the answer addresses the right topic, company, instrument, and timeframe, and attempts to explain the accounting treatment. However, due to the critical error in the present value figure—$207M vs. $423M—the correctness and quantitative accuracy scores are very low. The qualitative accuracy is slightly higher because the model grasps the general concept of present-value accounting for redeemable securities, but it applies it incorrectly to the specific case.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Redeems]-> COMP <-[Invests_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 592,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How does the voting power distribution in CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, relate to the repurchase activity and voting structure of GOOGL's Class A and Class B common stock, given the interplay between their respective share classes and repurchase programs?",
      "original_answer": "In CMCSA, Class B common stock has 15 votes per share and represents 33 1/3% of the combined voting power, which is entirely owned by Brian L. Roberts. This structure ensures concentrated voting control despite broader share repurchases of Class A stock. Similarly, GOOGL’s Class A shares carry one vote each, while Class B shares have 10 votes per share, and the company repurchased $62.2 billion of Class A and Class C shares in 2023, with $36.3 billion remaining under the repurchase authorization. These repurchases primarily affect the float of lower-vote shares, preserving the relative control of insiders who hold Class B stock. Thus, both companies maintain dual-class structures that insulate control while using share repurchases to manage capital allocation.",
      "llm_answer": "\nCMCSA’s Class B common stock carries 15 votes per share and, with only 9.4 million shares outstanding, supplies about one‑third of the company’s total voting power, a stake that is fully owned by Brian L. Roberts and is non‑dilutable (Chunk 2 & Chunk 3).  By contrast, Alphabet’s Class B shares carry 10 votes per share but are convertible and represent a smaller share of total votes; Alphabet’s repurchase program only targets Class A and Class C shares, leaving the voting power of its Class B shares untouched (Chunk 1).  Thus, while any CMCSA repurchase of Class A shares would increase the relative weight of the already‑controlled Class B votes, Alphabet’s share‑repurchase activity does not affect its Class B voting structure, preserving the distinct control dynamics between the two firms.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the core dual-class structures of both CMCSA and GOOGL, noting that CMCSA's Class B stock has 15 votes per share and is fully owned by Brian L. Roberts, contributing significantly to voting power. It also correctly states that GOOGL’s repurchases target only Class A and Class C shares, preserving Class B control. However, there are key quantitative inaccuracies: the LLM claims CMCSA Class B represents 'about one-third' of voting power (which aligns with the ground truth's 33 1/3%), but incorrectly introduces '9.4 million shares outstanding'—a figure not present in the original answer or typically highlighted in standard disclosures as directly tied to voting power distribution. More critically, the LLM omits specific repurchase figures for GOOGL: $62.2 billion repurchased in 2023 and $36.3 billion remaining authorization—key data points in the ground truth. (2) These missing dollar amounts represent a failure in quantitative completeness. While the qualitative point about repurchases not affecting Class B voting power is correct, the absence of exact figures reduces precision. The claim that CMCSA has 'non-dilutable' shares is not in the original and may be an overinterpretation. (3) The multi-hop reasoning is sound: the model correctly synthesizes that repurchasing low-vote shares (Class A in both cases) increases the relative control of insiders holding high-vote classes. It draws a valid comparison between the two companies’ strategies of maintaining control via dual-class structures while using repurchases to manage capital. (4) Despite missing key numbers, the core logic and entity identification (CMCSA, GOOGL, Brian L. Roberts, share classes) are accurate, and the answer remains contextually relevant and well-reasoned. Hence, correctness is reduced primarily due to missing financial figures, warranting a 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 512,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How does the Value-at-Risk (VAR) calculation methodology under normal market conditions used by MDLZ compare to PM's approach, particularly in terms of the time horizon for observing interest rate and currency movements and the confidence interval applied?",
      "original_answer": "Both MDLZ and PM use a VAR model that assumes normal market conditions and applies a 95% confidence interval with a one-day holding period. However, MDLZ observes interest rate, currency exchange, and commodity price movements over the prior quarter for point-in-time VAR calculations and over each of the four prior quarters for average VAR amounts. Similarly, PM observes interest rate and forward currency rate movements primarily over the preceding quarter for point-in-time VAR and over each of the four preceding quarters for average, high, and low VAR amounts. This indicates a largely consistent methodology between the two companies, with both relying on quarterly historical data for risk estimation under normal market conditions.",
      "llm_answer": "\nBoth MDLZ and PM calculate VAR under **normal market conditions** using a **95 % confidence interval** and a **one‑day holding period** with a parametric δ‑γ approximation.  \n- MDLZ determines the underlying interest‑rate, currency and commodity movements by observing those rates over the **prior quarter** (and over four prior quarters for average VAR), as described in Chunk 1/2.  \n- PM follows the same practice, basing its inter‑relationships on observations of interest‑rate and forward‑currency movements over the **preceding quarter** (and the four preceding quarters for average, high and low VAR), as set out in Chunk 3.  \n\nThus, the two companies employ an identical time horizon (one‑day) and confidence level (95 %) for their VAR methodology, differing only in the specific wording of the observed variables (e.g., “forward currency rate” versus “currency exchange”).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the 95% confidence interval, one-day holding period, and use of prior quarter (and four prior quarters) for both point-in-time and average VAR calculations are accurately reported for both MDLZ and PM. (2) The answer is complete, addressing both elements of the question: time horizon for observing interest rate and currency movements, and the confidence interval applied. (3) Entity accuracy is perfect—MDLZ and PM are correctly identified, and their respective VAR methodologies are accurately attributed. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly identifies that both companies use nearly identical methodologies, differing only in terminology (e.g., 'forward currency rate' vs. 'currency exchange'), which does not affect the substantive equivalence. (5) The semantic meaning is equivalent to the original answer, with slightly more technical detail (e.g., mention of parametric δ-γ approximation and 'Chunk' references), but no factual deviation. All key facts are preserved and correctly synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Depends_On]-> MACRO_CONDITION <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 325,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does Apple's reliance on China Mainland for manufacturing, as a component of its Greater China segment, compare with Microsoft's operational footprint in Greater China, particularly in terms of regional support infrastructure and localized product offerings?",
      "original_answer": "Apple relies heavily on China Mainland for manufacturing, which is a key part of its Greater China segment that also includes Hong Kong and Taiwan. This reliance exposes Apple to risks such as trade tensions, tariffs, and supply chain disruptions. Microsoft operates in Greater China through its regional operations center in Singapore, which supports Japan, India, Greater China, and Asia-Pacific. Microsoft also localizes many of its products to reflect local languages and conventions, modifying user interfaces and translating text to better serve the region. Both companies are significantly engaged in Greater China, but Apple's exposure is more supply-chain intensive while Microsoft's is more focused on localized customer engagement and regional support infrastructure.",
      "llm_answer": "\nApple’s Greater China segment is essentially built around manufacturing that is concentrated in China Mainland – the bulk of its hardware is assembled by outsourcing partners on the mainland, a dependence that makes the segment especially exposed to trade‑policy shocks and supply‑chain interruptions (see Chunk 1, which notes that “substantially all of the Company's manufacturing is performed…in China mainland” and that “political events…can materially adversely affect the Company”).  By contrast, Microsoft’s footprint in Greater China is anchored by a dedicated regional operations hub (e.g., the Singapore center that “supports the Japan, India, Greater China, and Asia‑Pacific region”) and a strategy of product localization—modifying user interfaces, translating text, and tailoring offerings to local conventions (Chunk 3).  Consequently, while Apple’s Greater China exposure is primarily manufacturing‑centric and vulnerable to geopolitical and tariff risks, Microsoft’s presence relies on a broader regional support infrastructure and extensive localized product adaptations, giving it a more diversified operational footprint in the same geographic segment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: Apple's manufacturing reliance on China Mainland is accurately described, including the associated risks (trade policy, supply chain disruptions), and Microsoft's regional operations center in Singapore supporting Greater China is correctly identified. The contrast between Apple's supply-chain-intensive exposure and Microsoft's customer-engagement and infrastructure-focused presence is clearly and correctly articulated. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) Multi-hop reasoning is sound: the LLM synthesizes information about Apple’s manufacturing footprint and associated risks with Microsoft’s regional support structure and localization efforts, correctly contrasting their operational models in Greater China. (4) The LLM uses slightly different phrasing (e.g., 'manufacturing-centric', 'diversified operational footprint') but preserves the full meaning of the original answer. All entities—Apple, Microsoft, Greater China, Singapore operations hub, product localization—are accurately referenced. No omissions or inaccuracies. Thus, all scores are 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> GPE -[Includes]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 369,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does UPS's use of pricing models for foreign currency derivatives (classified as Level 2) contrast with GE's use of Level 3 valuation techniques in its insurance and pension liabilities, particularly regarding the role of unobservable inputs?",
      "original_answer": "UPS primarily uses pricing models with observable inputs like yield curves and exchange rates for its foreign currency derivatives, which are classified as Level 2 due to reliance on market-observable data. In contrast, GE employs Level 3 valuation techniques—such as discounted cash flow (DCF) methodologies—for certain insurance and pension liabilities, where significant unobservable assumptions are required. This distinction highlights that while UPS’s derivatives are grounded in active market data, GE’s long-duration insurance contracts and postretirement benefit obligations require internal modeling with assumptions not corroborated by market data, resulting in a higher degree of estimation uncertainty.",
      "llm_answer": "\nUPS classifies its foreign‑currency derivatives as Level 2 because they are priced with models that rely on observable market inputs such as yield curves and exchange rates (Chunk 1).  \nIn contrast, GE measures its run‑off insurance and pension liabilities with Level 3 techniques that depend on significant unobservable assumptions—e.g., cash‑flow forecasts, mortality and morbidity assumptions, and discount‑rate selections—where changes are recorded in AOCI rather than earnings (Chunk 3).  \nThis contrast is captured by the accounting‑policy hierarchy: UPS’s pricing models are Level 2 (observable), whereas GE’s valuation methods are Level 3 (unobservable) and are explicitly disclosed as using “techniques that use significant assumptions not observable in the market” (Chunk 2), a relationship reflected in the KG link Pricing Models → Level 3 Valuation → GE.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: UPS uses Level 2 pricing models for foreign currency derivatives based on observable inputs like yield curves and exchange rates; GE uses Level 3 valuation techniques involving unobservable inputs such as cash-flow forecasts, mortality, and discount rate assumptions for insurance and pension liabilities. The distinction between Level 2 (observable) and Level 3 (unobservable) is correctly articulated. (2) There are no numeric values in the question or answer requiring calculation, so quantitative accuracy is not applicable in terms of sums or percentages—however, the absence of numerical errors and correct referencing of accounting levels (Level 2 vs Level 3) supports a perfect score here. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across entities (UPS vs GE), valuation levels, and financial instruments (derivatives vs insurance/pension liabilities), drawing a valid contrast in use of observable vs unobservable inputs. (4) The only minor shortcoming is the mention of AOCI (Accumulated Other Comprehensive Income) treatment, which, while plausible, is not present in the original answer and slightly extends beyond the provided ground truth—this does not introduce inaccuracy but adds a detail not confirmed by the source, slightly reducing qualitative accuracy. Otherwise, the answer is semantically equivalent, contextually precise, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Uses]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 419,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does Coca-Cola's reliance on Swire Beverages for distribution in Hong Kong compare to Colgate-Palmolive's operational performance in the same market, given both companies' reported activities in the region?",
      "original_answer": "Coca-Cola relies on Swire Beverages for distribution in Hong Kong, where Swire is one of Coca-Cola's top bottling partners, contributing to a significant portion of Coca-Cola’s non-U.S. unit case volume, which totaled 83% of worldwide volume in 2021. In the same region, Colgate-Palmolive reported $2,867 million in Asia Pacific net sales in 2021, with growth led by the Greater China region, particularly in Oral Care categories such as toothpaste and manual toothbrushes. While Coca-Cola’s distribution strategy in Hong Kong is managed through its bottler partner, Colgate-Palmolive directly manages its operations and achieved 3.0% organic sales growth in Asia Pacific, driven by volume increases and cost savings. This comparison highlights differing market strategies—Coca-Cola through a key bottling partner versus Colgate-Palmolive through direct brand growth—within the same geographic region.",
      "llm_answer": "\nCoca‑Cola’s distribution in Hong Kong is executed through Swire Beverages – one of its five largest independent bottlers that operates in Hong Kong (and elsewhere) and, together with the other four bottlers, accounted for 41 % of Coca‑Cola’s worldwide unit‑case volume; the relationship is a contractual bottler agreement in which Swire acts as an independent contractor while Coca‑Cola retains pricing and territorial rights.  In contrast, Colgate‑Palmolive’s Asia‑Pacific operations, which include Hong Kong, delivered a 6 % rise in net sales and a 9 % increase in operating profit in 2021, driven by 3 % volume growth and cost‑saving initiatives, underscoring a strong operational performance in the same market.  (KG: Swire Beverages → Operates_In → Hong Kong ← Operates_In → Colgate‑Palmolive).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly impact correctness, particularly in quantitative accuracy. (1) The claim that Swire Beverages and the other four largest independent bottlers accounted for 41% of Coca-Cola’s worldwide unit-case volume is not supported by the ground truth, which states that non-U.S. unit case volume (not bottler-specific) was 83% of worldwide volume in 2021. The 41% figure does not appear in the original answer and appears to be fabricated or misattributed. (2) The LLM states Colgate-Palmolive achieved a 6% rise in net sales and 9% increase in operating profit in 2021 in Asia-Pacific, but the original answer only mentions $2,867 million in net sales and 3.0% organic sales growth (driven by volume and cost savings); it does not specify operating profit growth or a 6% net sales increase. These numbers are inconsistent with the ground truth. (3) While both companies operate in Hong Kong—Coca-Cola via Swire Beverages and Colgate-Palmolive directly—the LLM correctly identifies the contractual nature of Coca-Cola’s distribution and Colgate’s operational growth focus, showing sound qualitative reasoning about differing strategies. (4) The answer is contextually relevant and addresses the comparison between Coca-Cola’s distribution reliance and Colgate’s operational performance, but the incorrect figures undermine the validity of the comparison. Semantic equivalence fails on key metrics. The qualitative synthesis of multi-hop information (linking bottler operations to regional performance) is partially correct but weakened by inaccurate data sourcing. Minor formatting like 'Hong Kong' with non-breaking spaces is acceptable. Overall, the answer gets the general strategic contrast right but fails on core numerical accuracy, leading to a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> COMP -[Operates_In]-> GPE <-[Operates_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 493,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does BAC's investment in CDOs, which contain embedded derivatives, compare to JPM's valuation methodology for similar structured notes with embedded derivatives, particularly in terms of risk exposure and modeling techniques?",
      "original_answer": "BAC invests in CDOs that are part of its broader involvement with VIEs, and while the Corporation does not consolidate these vehicles, it recognizes maximum loss exposure tied to the value of its investment balances. These CDOs are linked to embedded derivatives, as noted in the context of hybrid instruments where credit protection has been sold to the issuer, exposing the investor to credit events. JPM, on the other hand, explicitly discloses that structured notes with embedded derivatives are valued using discounted cash flow analyses and models such as Black-Scholes or simulation models, depending on the derivative features. JPM also adjusts valuations for its own credit risk (DVA), indicating a more detailed and model-driven approach to managing the risk of these instruments. This comparison highlights differing approaches to both risk exposure and valuation transparency in handling similar financial products.",
      "llm_answer": "\nBAC’s exposure to CDOs that contain embedded derivatives is treated as a VIE investment whose maximum loss is limited to the outstanding investment balance and to any off‑balance‑sheet commitments (e.g., unfunded liquidity), so the risk is framed by the possibility that the underlying assets could become worthless (Chunk 1).  \nIn contrast, JPM’s valuation of similar structured notes with embedded derivatives is disclosed as a discounted‑cash‑flow analysis that explicitly models the derivative’s option features (e.g., Black‑Scholes or simulation), adjusts for the firm’s own credit‑risk (DVA), and classifies the fair value as Level 2/3 in the hierarchy (Chunk 3).  \nBoth institutions hold hybrid CDO/CLN instruments that embed derivatives, but while BAC’s risk is measured by VIE loss‑exposure and investment‑balance limits, JPM’s risk is captured through detailed derivative‑pricing models and fair‑value hierarchy disclosures (Chunk 2).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All factual elements are correct: BAC's risk exposure to CDOs with embedded derivatives is properly framed through its VIE investment structure, with maximum loss exposure tied to the carrying value of its investments and off-balance-sheet commitments. The mention of unfunded liquidity as a potential extension of risk is consistent with the type of disclosures found in BAC's filings. (2) For JPM, the valuation methodology is accurately described: the use of discounted cash flow models, specific modeling techniques like Black-Scholes or simulation models, DVA adjustments, and classification within Level 2/3 of the fair value hierarchy are all factually correct and reflect JPM’s disclosed practices. There are no numeric values in the question or answer that require verification, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—correctly contrasting BAC’s balance-sheet and exposure-based risk framing with JPM’s model-driven, valuation-transparent approach. The synthesis across entities (BAC vs. JPM) and concepts (risk exposure vs. modeling techniques) is logical and complete. (4) The only minor shortcoming is that the original answer emphasizes JPM’s 'more detailed and model-driven approach' as a comparative conclusion, which the LLM implies but does not explicitly state as a comparative assessment of transparency or sophistication. This slight softening of the comparative insight prevents a perfect 10, but the core qualitative and contextual accuracy remains very high. All entities (BAC, JPM, CDOs, VIEs, DVA, Black-Scholes) are correctly identified and used in context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Invests_In]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1488,
        "completion_tokens": 462,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 215,
      "question": "How does the voting structure of CMCSA's Class B Common Stock compare to NFLX's common stock voting rights, given the specific limitations outlined in CMCSA's disclosure?",
      "original_answer": "CMCSA's Class B Common Stock has limited voting rights, only allowing votes on specific matters such as exiting the core payments business, certain consolidation or merger transactions, or amendments to the certificate of incorporation, and votes are calculated by multiplying shares held by the applicable conversion rate. In contrast, NFLX grants one vote per share on all matters to be voted upon by stockholders, providing more generalized voting power. CMCSA's disclosure also indicates that Class B Common Stock was issued and outstanding as of 2023, reinforcing the structured governance framework in place.",
      "llm_answer": "\nCMCSA’s Class B Common Stock (shown in Chunk 1 as 9.4 million shares issued and outstanding) has essentially no general voting rights; it may vote only on a narrowly defined set of matters—such as any decision to exit the core payments business, certain consolidation/merger transactions, or charter amendments—and when it does, the Class B (and C) votes are cast together with the Class A votes, with each share’s vote multiplied by the applicable conversion rate (details in Chunk 2). By contrast, NFLX’s common stock (Chunk 3) confers one vote per share on **all** matters to be voted upon, with no special limitations or aggregation requirements. Therefore, the voting structure of CMCSA’s Class B shares is far more restricted and must be coordinated with Class A holders, whereas NFLX’s common stock enjoys unrestricted, equal‑weight voting rights.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: CMCSA's Class B Common Stock has limited voting rights on specific matters (exit from core payments business, mergers, charter amendments), votes are calculated using a conversion rate, and Class B shares are cast together with Class A. NFLX common stock provides one vote per share on all matters, with no restrictions—this contrast is correctly highlighted. (2) Quantitative accuracy is perfect: the 9.4 million shares figure for CMCSA Class B is correctly cited from the source (Chunk 1), and no other numerical claims are made that contradict the ground truth. Format and referencing are precise. (3) Multi-hop reasoning is sound—information is synthesized across CMCSA and NFLX disclosures, correctly comparing governance structures. The only minor omission is that the original answer notes Class B was 'issued and outstanding as of 2023' to emphasize the ongoing governance framework, which the LLM mentions implicitly via the share count but does not explicitly tie to 2023. (4) Semantic equivalence is strong; wording differs but meaning matches. The addition of 'cast together with Class A' and 'aggregation requirements' adds clarity not in the original but is factually supported. No irrelevant or incorrect information is included. Thus, the answer is excellent but not perfect due to the slight lack of emphasis on the 2023 context for the governance structure's current applicability.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Subject_To]-> ACCOUNTING_POLICY <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 414,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 215,
      "question": "How does the treatment of embedded derivatives within CDOs by Morgan Stanley compare to JPMorgan Chase's valuation methodology for similar instruments, given their respective involvement in structured note products?",
      "original_answer": "Morgan Stanley treats CDOs as hybrid instruments containing embedded derivatives, where credit protection has been sold to the issuer of the note, and if there is a credit event of a reference entity, the principal balance of the note may not be repaid in full. JPMorgan Chase, on the other hand, values structured notes using discounted cash flow analyses that consider the embedded derivative features through models like Black-Scholes or simulation models, with adjustments for the Firm's own credit risk (DVA). Both firms recognize the complexity and risk associated with these instruments, but differ in how they disclose and value the embedded derivatives within their portfolios.",
      "llm_answer": "\nBoth Morgan Stanley and JPMorgan Chase issue CDOs that contain embedded derivatives, but they treat the valuation and risk of those derivatives differently. Morgan Stanley discusses CDOs in the context of VIE consolidation—treating them as hybrid instruments whose principal may not be fully repaid on a credit event and whose fate is tied to the Firm’s servicer or collateral‑manager rights—whereas JPMorgan Chase applies a explicit valuation model (discounted‑cash‑flow and option‑pricing such as Black‑Scholes) to the embedded derivative, adjusts it for its own credit‑risk (DVA), and classifies the resulting fair value as Level 2/3. Thus, Morgan Stanley’s focus is on VIE control and repayment risk, while JPMorgan Chase’s methodology relies on observable market inputs and model‑based pricing of the embedded derivative.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Both firms are correctly identified, and their respective methodologies for handling embedded derivatives in CDOs and structured notes are accurately described: Morgan Stanley treats CDOs as hybrid instruments with credit protection sold to the issuer and potential non-repayment of principal upon a credit event, while JPMorgan Chase uses discounted cash flow and option-pricing models (e.g., Black-Scholes) with DVA adjustments. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes differences in disclosure and valuation approaches between the two firms, noting Morgan Stanley’s focus on VIE consolidation and servicer rights versus JPMorgan’s model-driven, market-input-based valuation classified in Level 2/3. This adds contextual depth beyond the original answer without introducing inaccuracies. (4) Semantic equivalence is maintained—wording differs but meaning matches. The only minor gap is that the LLM emphasizes VIE consolidation more than the original, which focuses on the hybrid nature and credit event risk, but this is a valid interpretive expansion based on Morgan Stanley’s disclosures and does not detract from factual correctness. Thus, the answer is fully contextually relevant and qualitatively strong, warranting a 9/10 for correctness (near-perfect, with slight emphasis divergence).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> FIN_INST -[Related_To]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 418,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 216,
      "question": "How does Abbott's exposure to intellectual property risks, particularly regarding patent enforcement, intersect with AbbVie's legal actions through its subsidiary Forest Laboratories Holdings Limited to protect the exclusivity of Vraylar, and what implications does this have for both companies' pharmaceutical revenue streams?",
      "original_answer": "Abbott faces significant risks related to the expiration or loss of intellectual property protection, which could reduce future revenues and operating income. In parallel, AbbVie's subsidiary Forest Laboratories Holdings Limited is actively involved in patent enforcement litigation concerning Vraylar (cariprazine), seeking to prevent generic competition from companies like Sun Pharmaceutical and Aurobindo Pharma. This litigation, initiated in the U.S. District Court for the District of Delaware in December 2019, aims to preserve market exclusivity for Vraylar, a key pharmaceutical product. If successful, the enforcement of these patents would protect AbbVie’s revenue from Vraylar. However, if generic versions are allowed to enter the market, both companies could face competitive pressure—Abbott due to its reliance on strong IP protections and AbbVie through reduced exclusivity for Vraylar—highlighting the interplay between IP enforcement and pharmaceutical revenue sustainability.",
      "llm_answer": "\nAbbott’s 10‑K (Chunk 1) warns that the expiration, invalidation or circumvention of its patent and trademark rights could materially reduce its future revenues and operating income, and that any material litigation over its patents is a key risk factor. At the same time, AbbVie’s wholly‑owned subsidiary Forest Laboratories Holdings Limited is litigating in the U.S. District Court for the District of Delaware (Chunks 2 & 3) to enforce cariprazine (Vraylar) patents and seek declaratory and injunctive relief against generic manufacturers, with Gedeon Richter acting as co‑plaintiff; this enforcement is precisely the “Patent Enforcement” nexus that links Abbott (ABT) → Patent Enforcement → Forest Laboratories → AbbVie (ABBV) in the knowledge‑graph. By defending Vraylar’s exclusivity, AbbVie protects a major revenue driver for its pharmaceutical business, while any adverse outcome in that litigation—or a weakening of Abbott’s own IP position—could erode the patent‑based revenue streams of both companies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Abbott's exposure to IP risks due to patent expiration or litigation is accurately described, and AbbVie's subsidiary Forest Laboratories Holdings Limited is correctly identified as engaged in patent enforcement for Vraylar (cariprazine) in the U.S. District Court for the District of Delaware. The involvement of Gedeon Richter as co-plaintiff is an additional detail not in the original answer but is factually correct and adds precision. (2) There are no numeric values, dates, or calculations in the question or answers that conflict; the December 2019 filing date mentioned in the original is omitted in the LLM answer, which is a minor omission but does not detract significantly from accuracy. (3) The multi-hop reasoning is sound: the LLM correctly links Abbott’s general IP risk → patent enforcement mechanisms → Forest Labs → AbbVie → Vraylar exclusivity → revenue implications for both firms. The explicit mention of the knowledge-graph path (ABT → Patent Enforcement → Forest Laboratories → ABBV) demonstrates strong synthesis. (4) The semantic meaning fully matches the original: both emphasize the interplay between IP protection, litigation outcomes, and pharmaceutical revenue sustainability. The LLM answer enhances the original with slightly more structural clarity and correct entity mapping. Only a 9 is given because the absence of the December 2019 date, while not critical, represents a minor completeness gap in a multi-hop legal timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Depends_On]-> REGULATORY_REQUIREMENT -[Involved_In]-> COMP <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1547,
        "completion_tokens": 430,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 216,
      "question": "How does Citigroup's use of foreign currency forwards and cross-currency swaps in its net investment hedging strategy compare to Morgan Stanley's reliance on VaR models for managing market risk exposure in trading portfolios?",
      "original_answer": "Citigroup utilizes foreign currency forwards, cross-currency swaps, and options to hedge foreign exchange risk on equity investments in non-U.S.-dollar subsidiaries, recording changes in fair value in CTA within AOCI under ASC 815. In contrast, Morgan Stanley employs Value-at-Risk (VaR) models as a key risk management tool to estimate aggregate market risk exposure across trading portfolios, incorporating diversification and hedging effects, while acknowledging VaR's limitations in capturing extreme market events or liquidity constraints. Southern Company Gas, which connects the two entities, also uses weather derivative instruments and other risk management tools to mitigate weather-related revenue volatility in its gas marketing services segment, demonstrating a broader industry application of risk management frameworks.",
      "llm_answer": "\nCitigroup manages the foreign‑exchange risk of its net‑investment positions by using foreign‑currency forwards and cross‑currency swaps and, per ASC 815, records the resulting fair‑value changes in the foreign‑currency translation adjustment (CTA) within AOCI (Chunk 1); in contrast, Morgan Stanley does not employ such accounting‑based hedges for market risk but instead relies on Value‑at‑Risk (VaR) models that aggregate a range of market factors to estimate a portfolio’s market‑risk exposure, acknowledging the model’s limitations and the fact that VaR estimates are not directly comparable across firms (Chunk 3). Both banks are linked through the broader “Risk Management Tools” accounting policy (Chunk 1), and, like other regulated entities that use hedging mechanisms to stabilize earnings (e.g., Southern Company Gas’s weather‑derivative programs) (Chunk 2), Citigroup’s hedge is implemented via specific derivative instruments and hedge‑accounting treatment, whereas Morgan Stanley’s risk management is model‑centric and focused on VaR‑based market‑risk monitoring.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: Citigroup uses foreign currency forwards and cross-currency swaps (and options, though not emphasized in the LLM answer) to hedge net investments, with fair value changes recorded in CTA within AOCI under ASC 815. Morgan Stanley relies on VaR models to estimate market risk exposure across trading portfolios, acknowledging limitations regarding extreme events and lack of cross-firm comparability. (2) There are no numeric values, dates, or calculations in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense—however, the absence of any incorrect figures earns a perfect score by default. (3) The multi-hop reasoning is sound: the LLM correctly contrasts Citigroup’s accounting-based hedging strategy with Morgan Stanley’s model-driven risk monitoring, and appropriately references Southern Company Gas as an example of broader risk management practices (e.g., weather derivatives), linking entities through shared risk management frameworks. (4) The only minor shortcoming is that the LLM answer does not explicitly mention Citigroup’s use of 'options' as part of its hedging instruments, which is included in the original answer. This omission is minor given the focus on forwards and swaps in the question. Wording differs but semantic meaning and technical accuracy are preserved. Contextual relevance is excellent, directly addressing the comparative risk management approaches and connecting them to broader industry practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Evaluates]-> ACCOUNTING_POLICY -[Includes]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 436,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 217,
      "question": "How does Colgate-Palmolive's use of option contracts to hedge foreign exchange risk compare to Walmart's exposure through firm commitments, given the impact of these financial instruments on their respective cash flow stability?",
      "original_answer": "Colgate-Palmolive utilizes option contracts as part of its foreign exchange risk management strategy, hedging portions of its foreign currency purchases and firm commitments with contracts valued using observable market rates, aiming to minimize earnings volatility from currency fluctuations. These contracts, with a typical duration of no more than 12 months, are aligned with the company's policy of matching derivative terms to underlying exposures. In contrast, Walmart reports $37.2 billion in unrecorded purchase obligations as of January 31, 2025, including $15.9 billion due within one year, which includes firm commitments for inventory, utilities, and capital expenditures. These obligations are legally binding and expose Walmart to cash flow risks if market conditions change. The impact of Colgate's use of option contracts is to stabilize the U.S. dollar equivalent value of foreign currency transactions, while Walmart lacks such financial instrument protections on its firm commitments, leaving it more exposed to market volatility affecting its cash flow stability.",
      "llm_answer": "\nColgate‑Palmolive mitigates foreign‑exchange volatility by using cash‑flow‑designated option contracts—gains and losses are deferred in AOCI and recognized only when the hedged transaction settles, which smooths earnings and preserves cash‑flow stability; Walmart, however, is exposed through large firm‑commitment purchase obligations (≈ $15.9 bn due within a year of $37.2 bn total unrecorded commitments) that are not offset by option contracts, so foreign‑currency movements flow directly into its cash‑flow profile.  The KG link shows CL’s option contracts feed into firm‑commitment hedges, whereas those same firm‑commitments represent the primary FX exposure for WMT, creating a clear contrast in cash‑flow resilience.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Colgate-Palmolive's use of option contracts for foreign exchange risk management and Walmart's exposure through firm commitments. All key financial figures are accurate: $37.2 billion in total unrecorded purchase obligations and $15.9 billion due within one year as of January 31, 2025, matching the ground truth. These numbers are reported with acceptable formatting (≈ $15.9 bn, $37.2 bn). (2) Quantitatively, all values are correct and properly contextualized. There are no calculation errors. (3) The multi-hop reasoning is sound: the model correctly contrasts Colgate’s proactive hedging (using options to stabilize cash flows, with gains/losses deferred in AOCI) with Walmart’s lack of such protections on its firm commitments, leading to greater cash flow exposure. It accurately reflects that Colgate uses options to hedge firm commitments, while Walmart’s firm commitments themselves represent the exposure. The mention of AOCI (accumulated other comprehensive income) adds technical depth consistent with accounting standards for cash flow hedges. (4) The only minor shortcoming is the reference to 'KG link'—a meta-level note not present in the original answer—which slightly detracts from clarity but does not introduce factual error. Otherwise, the answer is semantically equivalent, contextually precise, and demonstrates strong synthesis across entities and financial concepts. Thus, correctness is high, with full quantitative accuracy and excellent qualitative and contextual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Utilizes]-> FIN_INST -[Impacts]-> FIN_INST <-[Has_Stake_In]- ORG",
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 427,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 217,
      "question": "How does the adoption timeline of ASU No. 2023-07 for segment reporting differ between TMO and CVS, and what specific disclosures were required by each company as a result of this new standard?",
      "original_answer": "TMO adopted ASU No. 2023-07 for its 2024 annual report and applied it retrospectively, resulting in increased disclosures in Note 11. CVS adopted the standard on January 1, 2024, for fiscal year reporting and is required to provide additional disclosures related to its reportable segments, including the CODM's title, how the CODM uses segment operating results, and alignment of interim reporting with annual requirements, as detailed in Note 19. Both companies applied the standard retrospectively to prior periods, but TMO implemented it specifically for the 2024 annual report while CVS also aligned it with interim reporting requirements starting after December 15, 2024.",
      "llm_answer": "\nThe adoption timeline differs: CVS adopted ASU 2023‑07 on January 1 2024 for its 2024 fiscal year, with the new segment‑reporting disclosures effective for interim periods beginning after December 15 2024, whereas ThermoFisher (TMO) will apply the ASU to its 2024 annual report (and the ensuing interim periods) using a retrospective approach—meaning the first full adoption will appear in the 2024 annual filing (expected early 2025). Both companies must disclose disaggregated segment expenses, the CODM’s title and how the segment metric is used to evaluate performance and allocate resources, and they must align interim and annual segment disclosures—CVS’s required disclosures are detailed in Note 19 of its 10‑K and TMO’s in Note 11—and, as shown in the 3M (MMM) filing, the standard is being implemented retrospectively across the sector (see Note 22).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates and adoption timelines are correct: CVS adopted ASU No. 2023-07 on January 1, 2024, with interim disclosures required after December 15, 2024; TMO applied it to its 2024 annual report with retrospective application—consistent with the original answer. The mention of Note 11 for TMO and Note 19 for CVS matches the ground truth. (2) The required disclosures—CODM's title, how segment results are used, alignment of interim and annual reporting—are correctly identified for both companies. (3) The reasoning is sound: the LLM correctly synthesizes that both companies applied the standard retrospectively, while distinguishing the timing and scope (annual vs. interim). (4) The only minor issue is the reference to '3M (MMM)' and Note 22, which was not part of the original question or ground truth and introduces extraneous information, slightly diluting focus. However, this does not detract from the core correctness. Wording differs but maintains semantic equivalence. All parts of the question are addressed: adoption timelines and specific disclosures for both TMO and CVS. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> ACCOUNTING_POLICY -[Impacts]-> ACCOUNTING_POLICY <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 367,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "What was the impact of the Philippines' corporate income tax rate reduction on ACN's 2021 effective tax rate, and how does this compare to AMD's disclosure of tax reform effects in the same period?",
      "original_answer": "ACN benefited from the Philippines' corporate income tax rate reduction enacted in Q1 2021, which favorably impacted its 2021 effective tax rate of 21.8%, partially offsetting other unfavorable tax factors like GILTI-related foreign tax credit limitations. In contrast, AMD reported no impact from the Tax Reform Act in 2021, as shown by the $0 value in their tax provision table for that line item, indicating different exposure or geographic applicability of the reform.",
      "llm_answer": "\nAccenture (ACN), which operates in the Philippines, saw its 2021 effective tax rate rise 0.1 percentage point to **21.8 %**; the newly enacted Philippines corporate‑income‑tax‑rate reduction partially offset other unfavorable items (such as repatriation costs and GILTI credit limits), thereby limiting the increase.  By contrast, AMD’s 2021 filing discloses **no material impact** from that same tax reform—the “Tax Reform Act” line item shows a dash for 2021 and 2020, indicating that AMD did not experience any offsetting benefit from the Philippine rate cut.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies ACN's 2021 effective tax rate as 21.8%, which matches the ground truth. It accurately notes that the Philippines' tax rate reduction partially offset unfavorable tax items, including GILTI-related limitations. However, it incorrectly states that the effective tax rate 'rose 0.1 percentage point to 21.8%', a detail not present in the original answer and unsupported by the provided ground truth—no such change magnitude is mentioned. This introduces a potentially misleading quantitative claim. (2) The AMD disclosure is accurately represented: the LLM correctly states there was 'no material impact' and references a dash in the tax provision table, equivalent to the ground truth's '$0 value'. While 'dash' is a formatting interpretation, it semantically aligns with zero impact. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across ACN and AMD, comparing their respective exposures to the Philippine tax reform. It draws a valid contrast in geographic applicability or exposure. (4) The answer is contextually complete and relevant, addressing both parts of the question. The only deviation is the unsupported claim about the 0.1 percentage point increase, which slightly undermines quantitative accuracy but does not invalidate the core facts. Hence, correctness is high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Operates_In]-> GPE -[Regulates]-> REGULATORY_REQUIREMENT <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 381,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Honeywell's use of pricing models for valuing fixed income investments in its pension plans compare to 3M's valuation methodology, particularly in terms of reliance on observable versus unobservable inputs?",
      "original_answer": "Honeywell values its fixed income investments using pricing models, broker bids, or discounted cash flows, incorporating adjustments for credit and liquidity risks when necessary. 3M similarly uses pricing models that rely on observable inputs like interest rates and yield curves for Level 2 fixed income investments, while Level 3 investments depend on unobservable inputs such as projected annuity payments and discount rates. Both companies apply discounted cash flow techniques in certain cases and disclose the use of NAV practical expedients for certain fund types, though 3M explicitly categorizes its fixed income investments by valuation hierarchy levels, whereas Honeywell focuses on the nature of the valuation adjustments made.",
      "llm_answer": "\nHoneywell values its fixed‑income pension assets with pricing models that start from observable market quotes (prices, yields, broker bids) but must adjust those quotes for unobservable risks such as credit and liquidity, a practice reflected in its 10‑K disclosure. 3M’s valuation framework, as shown in its filing, explicitly separates assets into Level 1 (directly observable), Level 2 (observable inputs with modest estimation) and Level 3 (primarily unobservable), where Level 3 includes discounted‑cash‑flow or NAV‑based measurements that rely on inputs like projected cash‑flow amounts and discount rates that cannot be corroborated—so while both companies blend observable and unobservable inputs, 3M’s methodology depends more heavily on Level 3, unobservable‑input measurements than Honeywell’s more limited adjustments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that both Honeywell and 3M use pricing models for fixed income investments, with Honeywell relying on observable inputs (e.g., broker bids, yields) but making adjustments for unobservable risks like credit and liquidity. 3M is accurately described as using a formal three-level hierarchy (Level 1 to Level 3), with Level 2 based on observable inputs and Level 3 on unobservable ones such as projected cash flows and discount rates. The mention of discounted cash flow and NAV-based measurements for Level 3 matches the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across both companies’ methodologies, compares their use of observable vs. unobservable inputs, and highlights that 3M explicitly categorizes by valuation level while Honeywell focuses on adjustment rationale. The conclusion that 3M relies more heavily on Level 3 inputs is a reasonable inference supported by the ground truth’s note that 3M explicitly categorizes by level, including Level 3 unobservable inputs. (4) The only minor shortcoming is that the LLM slightly overemphasizes 3M’s 'heavier' reliance on Level 3 inputs—while 3M does disclose Level 3 usage, the ground truth does not assert that its reliance is greater than Honeywell’s, only that 3M categorizes explicitly. This is a subtle interpretive stretch but does not invalidate the overall correctness. Wording differences are semantically equivalent and acceptable. All entities (Honeywell, 3M, pricing models, broker bids, discounted cash flows, NAV, Level 2/Level 3) are accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Uses]-> ACCOUNTING_POLICY -[Valued_By]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 501,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does the voting power distribution tied to Class B common stock conversion mechanisms at CMCSA compare with the share repurchase strategy for Class A and Class C shares at GOOGL, given the differing impacts on equity structure and shareholder control?",
      "original_answer": "At CMCSA, Class B common stockholders control 33 1/3% of the voting power, which is non-dilutable and convertible share-for-share into Class A common stock, while the voting power of Class A shares depends on the total number of Class A and Class B shares outstanding. This structure ensures continued influence by Class B holders. In contrast, GOOGL has repurchased $62.2 billion of Class A and Class C shares in 2023, with an additional $36.3 billion remaining under the repurchase authorization. These repurchases reduce the number of outstanding shares, increasing the proportional ownership of remaining shareholders, including those holding Class B shares, which carry 10 votes per share. Since Class B shares automatically convert to Class A upon sale or transfer, these repurchases indirectly influence the balance of voting control by reducing the total pool of shares subject to Class A voting calculations. Thus, while CMCSA’s structure protects Class B voting power through fixed percentages and conversion rules, GOOGL’s equity control dynamics are shaped by aggressive repurchases that affect the relative ownership and voting influence of remaining shareholders.",
      "llm_answer": "\nCMCSA’s Class B common stock carries a fixed 33 ⅓ % of the voting power that is non‑dilutable and can be converted share‑for‑share into Class A shares, preserving a concentrated, stable control block; by contrast, GOOGL’s share‑repurchase program targets its Class A and Class C shares—$50.3 bn, $59.3 bn and $62.2 bn repurchased in 2021‑23 with a further $70 bn authorized—so that retiring those shares shrinks the equity base and thereby raises the relative voting weight of the remaining Class B shares (which carry 10 votes per share and may convert to Class A), altering the equity structure and shareholder‑control dynamics in a way that differs from CMCSA’s fixed Class B voting percentage.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core structural differences between CMCSA's fixed voting power for Class B shares and GOOGL's use of share repurchases to influence control, which demonstrates sound qualitative understanding and contextual relevance. However, there are significant quantitative inaccuracies that undermine factual correctness. The ground truth states GOOGL repurchased $62.2 billion in 2023 with $36.3 billion remaining in authorization, but the LLM incorrectly reports repurchases of $50.3B, $59.3B, and $62.2B over 2021–2023 and claims $70B authorized, which contradicts the original data. These figures are not supported by the ground truth and appear fabricated or misattributed. While the explanation of CMCSA’s 33⅓% non-dilutable voting power and share-for-share convertibility is accurate, the GOOGL repurchase figures are critical errors because they misrepresent the scale, timing, and authorization details—key financial facts in the comparison. The reasoning about how repurchases increase the relative voting weight of Class B shares is logically sound and correctly identifies the indirect effect on control, showing good multi-hop synthesis between repurchase activity and voting structure. The mention that Class B shares convert to Class A upon transfer is omitted but implied in the conversion context. Overall, the answer gets the conceptual framework right but fails on key numerical precision, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Has_Stake_In]-> FIN_INST -[Depends_On]-> FIN_INST <-[Discloses]- ORG",
      "token_usage": {
        "prompt_tokens": 1496,
        "completion_tokens": 402,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Altria's exposure to FCTC-driven advertising restrictions, as outlined in its 2022 10-K, compare to Philip Morris International's experience with implemented advertising bans in markets like Australia and Russia, and what implications does this have for their respective international marketing strategies?",
      "original_answer": "Altria acknowledges in its 2022 10-K that while the U.S. is a signatory to the FCTC, it is not a party to the agreement, and therefore FCTC-driven advertising restrictions have limited direct regulatory impact in the U.S. However, the document notes that the FCTC has called for and influenced advertising bans globally. In contrast, Philip Morris International (PMI) reports that in markets like Australia and Russia, governments have already banned the display of tobacco products at the point of sale, which severely restricts visibility and marketing potential. These bans align with FCTC guidelines recommending the prohibition of all forms of communication with adult smokers. Given that Altria's primary market remains the U.S., where such bans are not yet widespread, its international marketing strategy is less constrained compared to PMI, which operates more heavily in FCTC-compliant markets where advertising and product visibility restrictions are already enforced. This divergence suggests that PMI must adapt more aggressively to restrictive advertising environments, while Altria faces more potential future risk if the U.S. adopts similar FCTC-aligned policies.",
      "llm_answer": "\nAltria’s 2022 10‑K discloses that, while the United States has not ratified the FCTC, the treaty’s signatories are advancing proposals that could impose sweeping advertising and packaging curbs on its overseas business (Chunk 1). In contrast, Philip Morris International has already faced those curbs in practice – Australia and Russia have enacted point‑of‑sale display bans and comprehensive advertising restrictions that limit branding and force plain‑packaging (Chunks 2 & 3). Thus, PMI’s international marketing strategy is now constrained to minimal‑branding, compliance‑driven packaging and limited promotional channels, whereas Altria must anticipate and prepare for comparable future restrictions across its global markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and reasoning. (1) It accurately states that the U.S. has not ratified the FCTC, which limits direct regulatory impact on Altria—consistent with the original answer. It also correctly contrasts Altria’s forward-looking exposure with Philip Morris International’s (PMI) actual experience in Australia and Russia, where advertising and point-of-sale display bans are in effect. The mention of plain packaging, while not explicitly detailed in the ground truth, is a reasonable inference given the context of FCTC-aligned policies in those countries and is factually accurate. (2) There are no numerical values, dates, or financial metrics in the question or answers, so quantitative accuracy is not applicable in a traditional sense; however, all referenced facts (e.g., treaty status, country-level policies) are correctly represented, warranting a 10. (3) The multi-hop reasoning—linking Altria’s U.S.-centric exposure to FCTC influence versus PMI’s operational reality in regulated markets—is sound and logically synthesized. However, the LLM slightly overemphasizes Altria’s 'overseas business' exposure, which is minimal compared to PMI; Altria’s primary operations are domestic, and its international footprint is limited, so the implication that it faces significant future risk abroad is less supported. The original answer correctly frames the risk as potential future adoption of FCTC policies *in the U.S.*, not overseas. This minor misdirection reduces qualitative accuracy slightly. (4) The answer remains highly contextually relevant, addressing all components of the question: FCTC exposure, comparison with PMI’s experience, and implications for marketing strategies. Wording differs but meaning is semantically equivalent in most parts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Calls_For]-> REGULATORY_REQUIREMENT <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 499,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Goldman Sachs' competitive disadvantage to JPMorgan in cryptocurrency offerings, influenced by Dodd-Frank compliance burdens, compare with Morgan Stanley's exposure to regulatory risks in emerging markets that could impact its cross-border cryptocurrency-related financial activities?",
      "original_answer": "Goldman Sachs faces a competitive disadvantage compared to JPMorgan due to Dodd-Frank compliance burdens that restrict its ability to offer cryptocurrencies and digital assets, as stated in its 2024 10-K filing. JPMorgan, as a competitor, offers these products, giving it a strategic edge in evolving financial markets. Meanwhile, Morgan Stanley's 2024 10-K highlights exposure to regulatory risks in emerging markets, where uncertain and rapidly changing laws could hinder its ability to structure and enforce cryptocurrency-related transactions across borders. Both firms face regulatory constraints, but Goldman Sachs' limitations are self-imposed due to U.S. regulatory frameworks, while Morgan Stanley's risks stem from external geopolitical and legal environments in foreign jurisdictions.",
      "llm_answer": "\nGoldman Sachs’ cryptocurrency offering is at a competitive disadvantage to JPMorgan because U.S. Dodd‑Frank rules—such as the ban on proprietary trading and tighter capital‑requirement limits—apply more heavily to U.S. banks, giving non‑U.S. rivals like JPMorgan greater flexibility to launch digital‑asset products; this regulatory drag is explicitly cited in GS’s 10‑K as a factor that can “differentiate between U.S.-based and non‑U.S.-based banking organizations” and affect its competitive position. In contrast, Morgan Stanley’s cross‑border crypto‑related activities are exposed to a different set of regulatory hazards: its 2024 10‑K warns that emerging‑market jurisdictions face “uncertain, evolving and subject‑to‑sudden‑change” securities laws, sanctions, AML and anti‑corruption rules, and political instability, any of which could impair its ability to operate or enforce crypto‑related transactions abroad. Thus, while GS loses ground to JPMorgan inside the United States due to domestic compliance burdens, MS faces external regulatory volatility in emerging markets that could constrain its global crypto‑finance initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Goldman Sachs faces a competitive disadvantage to JPMorgan due to Dodd-Frank compliance burdens, as stated in its 2024 10-K; JPMorgan offers cryptocurrency products, giving it a strategic edge; Morgan Stanley’s 2024 10-K highlights regulatory risks in emerging markets affecting cross-border crypto activities. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable—scored as 10 by default since no errors exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across Goldman Sachs, JPMorgan, and Morgan Stanley, distinguishing between domestic U.S. regulatory constraints (Dodd-Frank) and external emerging-market regulatory volatility. One minor inaccuracy: the LLM incorrectly refers to JPMorgan as a 'non-U.S. rival', which is false—JPMorgan is a U.S.-based bank. This mischaracterization slightly affects qualitative accuracy but does not undermine the core reasoning. (4) The answer is contextually excellent, addressing all parts of the complex, multi-firm, multi-regulatory question with precise sourcing from the 2024 10-Ks. Semantic equivalence is maintained despite rephrasing. The error in labeling JPMorgan as non-U.S. is notable but does not distort the overall regulatory contrast being made.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Competes_With]-> COMP -[Offers]-> PRODUCT <-[Impacted_By]- ORG",
      "token_usage": {
        "prompt_tokens": 1521,
        "completion_tokens": 398,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does the adoption of ASU 2022-04 impact the disclosure requirements for supplier finance obligations at both 3M and GE, particularly in terms of the roll-forward information introduced in 2024?",
      "original_answer": "The adoption of ASU 2022-04 requires companies like 3M and GE to disclose key terms, balance sheet presentation, and the confirmed amount outstanding under supplier finance programs. For 3M, this includes a $0.3 billion balance in confirmed invoices as of December 31, 2024, with $1.5 billion of invoices confirmed and paid during the year. GE adopted the standard on January 1, 2023, and in line with the ASU's phased requirements, began providing the annual roll-forward information in 2024. This roll-forward requirement, applicable prospectively from January 1, 2024, aligns both companies' disclosures to include changes in confirmed invoice balances over the reporting period, enhancing transparency in their accounts payable disclosures.",
      "llm_answer": "\nThe adoption of ASU 2022‑04 requires both 3M and GE to disclose the key terms of their supplier‑finance programs, the balance‑sheet presentation of confirmed‑invoice obligations, and a prospective roll‑forward of those balances—starting with the 2024 filings. 3M’s Note 16 reveals a $0.3 billion confirmed‑invoice balance and $1.5 billion of invoices confirmed and paid in 2024, illustrating the roll‑forward data now required, while GE’s 10‑K notes that it adopted the standard on Jan 1 2023 and that the roll‑forward disclosure applies prospectively from Jan 1 2024, confirming that both companies must include the new roll‑forward information in their 2024 reporting.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The dollar amounts ($0.3 billion confirmed balance, $1.5 billion confirmed and paid) and dates (adoption on January 1, 2023 for GE, roll-forward starting January 1, 2024) are accurately reported. Format variations (e.g., $0.3 billion vs $300 million) are acceptable and semantically equivalent. (2) Completeness: The answer addresses all parts of the multi-hop question—impact on both 3M and GE, disclosure requirements under ASU 2022-04, and specifically the introduction of roll-forward information in 2024. (3) Entity accuracy: Both companies (3M and GE), the accounting standard (ASU 2022-04), relevant time periods, and financial disclosures (confirmed invoice balances) are correctly identified. (4) Reasoning: The LLM correctly synthesizes that GE adopted the standard in 2023 but began roll-forward disclosures in 2024 per the prospective requirement, and that 3M’s 2024 data illustrates the new disclosure. This reflects sound multi-hop reasoning across time, entities, and accounting rules. (5) Semantic equivalence: While phrased differently (e.g., referencing 'Note 16' for 3M), the LLM conveys the same factual content as the original answer. No factual errors, omissions, or misinterpretations are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Agrees]-> ACCOUNTING_POLICY -[Applies_To]-> ACCOUNTING_POLICY <-[Adopts]- ORG",
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 368,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does MDT's geographic revenue concentration in 'Other Countries' expose it to similar regulatory and reimbursement challenges as those impacting AMGN's drug pricing strategies in international markets?",
      "original_answer": "MDT reports $32.251 billion in net sales from 'Total other countries, excluding Ireland' in fiscal 2024, which represents the majority of its revenue outside the U.S. This significant international exposure subjects MDT to regulatory environments where governments increasingly control healthcare costs through reimbursement and coverage limitations. As outlined in the DHR filing, these limitations include direct price controls, reference pricing, and mandatory licensing, which tie reimbursement to outcomes and constrain revenue potential. Similarly, AMGN notes that many countries outside the U.S. apply price controls, therapeutic-reference pricing, and volume caps, which limit both pricing and market access for its biologics. Both companies face parallel pressures from global payers seeking cost predictability and imposing narrower coverage criteria, despite operating in different healthcare sectors.",
      "llm_answer": "\nMedtronic (MDT) derives a sizeable portion of its revenue from markets outside the United States—$15.7 bn from “Rest of world” and $32.3 bn from “Total other countries, excluding Ireland” (Chunk 1)—so its financial results are tightly tied to the regulatory environment of those jurisdictions. Those foreign markets are subject to coverage limitations that restrict reimbursement and compel price adjustments, a relationship captured by the KG triple — Other Countries → Coverage Limitations → AMGN (Chunk 3) — and driven by the same governmental pricing, reimbursement and austerity pressures described in Chunk 2 (e.g., PAMA, Inflation‑Reduction Act, managed‑care purchasing, compulsory licensing). Consequently, just as Amgen faces PDAB‑mandated price caps, EU‑wide legislative pricing reforms and other international reimbursement constraints that shape its drug‑pricing strategy, Medtronic’s overseas sales are exposed to comparable regulatory and reimbursement challenges that can erode margins and force strategic pricing responses.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies MDT's significant international revenue exposure and draws a valid comparison to AMGN's challenges with international drug pricing, reimbursement constraints, and regulatory pressures. The core reasoning about parallel regulatory environments—such as price controls, reference pricing, and coverage limitations—is semantically aligned with the ground truth and supported by appropriate conceptual links (e.g., governmental cost containment, payer pressures). However, there is a critical error in quantitative accuracy: the LLM states MDT has $15.7 billion from 'Rest of world' and $32.3 billion from 'Total other countries, excluding Ireland', implying these are separate figures. In reality, the ground truth reports only one figure—$32.251 billion from 'Total other countries, excluding Ireland'—and does not mention a $15.7 billion 'Rest of world' component. This suggests the LLM either misrepresents or double-counts revenue segments, introducing a significant factual inaccuracy. 2) The number $32.3 billion is acceptably close to the correct $32.251 billion (rounding difference), but the inclusion of an unsupported $15.7 billion figure undermines quantitative precision. No calculation is required in the question, but the presentation of multiple geographic revenue buckets where only one is provided in the source constitutes a factual error. 3) The multi-hop reasoning is strong: the model connects MDT’s geographic revenue concentration to international regulatory risks, then links those to AMGN’s experience via shared mechanisms like price controls and reimbursement limitations, using knowledge graph logic (KG triple reference). This synthesis across companies and regulatory themes is logically sound and contextually appropriate. 4) Despite the numerical error, the qualitative analysis and contextual relevance are high—the answer addresses the central question about parallel regulatory exposures and correctly identifies mechanisms like compulsory licensing, reference pricing, and payer-driven cost containment affecting both firms. The conclusion that both face strategic pricing pressures due to global cost-containment trends is valid. Thus, while the core insight is correct, the quantitative inaccuracy prevents a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Discloses]-> GPE -[Control]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 610,
        "total_tokens": 2112
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does the combined capital buffer requirement above the minimum risk-based capital ratios for SCHW and JPM compare, considering their respective application of countercyclical and capital conservation buffers?",
      "original_answer": "SCHW is subject to a stress capital buffer of 2.5% and a capital conservation buffer of 2.5%, with the countercyclical capital buffer at 0%, resulting in a total buffer requirement of 5.0% above the minimum risk-based capital ratios. JPM, on the other hand, applies a fixed capital conservation buffer of 2.5% and a stress capital buffer (SCB) of 2.9%, with the countercyclical buffer also at 0%, leading to a total buffer requirement of 5.4% above the minimum. Therefore, JPM has a slightly higher combined buffer requirement than SCHW due to its higher SCB. This comparison reflects how both firms are subject to similar regulatory buffer frameworks, but with firm-specific SCB and CCyB determinations.",
      "llm_answer": "\nThe combined “extra” buffer that SCHW must hold above its minimum risk‑based capital ratio is **5 percent** – a 2.5 percent stress‑capital buffer (CSC) plus a 2.5 percent capital‑conservation buffer (CSB), while its counter‑cyclical buffer is 0 percent.  \nIn contrast, JPM’s combined buffer above its minimum is only **2.5 percent**, consisting of its fixed 2.5 percent capital‑conservation buffer and a 0 percent counter‑cyclical buffer (and it is not subject to a GSIB surcharge).  \n\nThus, SCHW’s total buffer requirement is roughly **double** that of JPM (5 % vs. 2.5 %).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors. (1) It incorrectly states that JPM's combined buffer is only 2.5%, when the ground truth specifies a stress capital buffer (SCB) of 2.9% and a capital conservation buffer (CCoB) of 2.5%, totaling 5.4%. The LLM omits the SCB for JPM entirely, claiming it is 'not subject to a GSIB surcharge'—this is irrelevant and incorrect reasoning, as the SCB is distinct from the GSIB surcharge. (2) The LLM mislabels the stress capital buffer for SCHW as 'CSC' and 'CSB', which are not standard acronyms and suggest confusion in terminology. (3) The calculation for SCHW is correct (2.5% + 2.5% = 5.0%), but for JPM, it fails to include the 2.9% SCB, leading to a grossly inaccurate comparison. (4) The conclusion that SCHW’s buffer is 'double' JPM’s is false—JPM actually has a higher requirement (5.4% vs 5.0%). (5) The reasoning is flawed: the model fails to correctly synthesize multi-hop information about both firms' buffer components, especially missing JPM’s SCB. While the entities (SCHW, JPM) and general buffer types are mentioned, the incorrect data and logic severely undermine accuracy. Contextual relevance is moderate as it addresses the right topic and structure, but factual correctness is low.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": "ORG -[Subject_To]-> REGULATORY_REQUIREMENT -[Consists_Of]-> REGULATORY_REQUIREMENT <-[Subject_To]- ORG",
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 353,
        "total_tokens": 1689
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 600,
    "successful_evaluations": 600,
    "failed_evaluations": 0,
    "average_correctness_score": 8.12,
    "average_quantitative_accuracy": 8.84,
    "average_qualitative_accuracy": 8.25,
    "average_contextual_relevance": 9.57,
    "score_distribution": {
      "excellent": 411,
      "good": 90,
      "fair": 81,
      "poor": 18
    }
  },
  "original_experiment_metadata": {
    "model": "nemotron-nano-30b-reasoning",
    "experiment": "e1_kg_minimal",
    "pattern": "qualitative_3hop_cross_company_type1",
    "total_questions": 600,
    "successful": 600,
    "failed": 0,
    "elapsed_seconds": 12556.55,
    "timestamp": "2026-02-02T19:09:42.300530"
  }
}